FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Michelsen, K
   Schmid, V
   Metz, J
   Heusser, K
   Liebel, U
   Schwede, T
   Spang, A
   Schwappach, B
AF Michelsen, Kai
   Schmid, Volker
   Metz, Jutta
   Heusser, Katja
   Liebel, Urban
   Schwede, Torsten
   Spang, Anne
   Schwappach, Blanche
TI Novel cargo-binding site in the beta and delta subunits of coatomer
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MEMBRANE-PROTEINS;
   ALPHA-COP; SORTING SIGNALS; YEAST; TRANSPORT; LOCALIZATION; TRAFFICKING;
   RECEPTOR
AB Arginine (R)-based ER localization signals are sorting motifs that confer transient ER localization to unassembled subunits of multimeric membrane proteins. The COPI vesicle coat binds R-based signals but the molecular details remain unknown. Here, we use reporter membrane proteins based on the proteolipid Pmp2 fused to GFP and allele swapping of COPI subunits to map the recognition site for R-based signals. We show that two highly conserved stretches - in the beta- and delta-COPI subunits-are required to maintain Pmp2GFP reporters exposing R-based signals in the ER. Combining a deletion of 21 residues in delta-COP together with the mutation of three residues in beta-COP gave rise to a COPI coat that had lost its ability to recognize R-based signals, whilst the recognition of C-terminal di-lysine signals remained unimpaired. A homology model of the COPI trunk domain illustrates the recognition of R-based signals by COPI.
C1 Heidelberg Univ, Zentrum Mol Biol, D-69120 Heidelberg, Germany.
   European Mol Biol Lab, Cell Biol Cell Biophys Unit, D-69117 Heidelberg, Germany.
   Univ Basel, Swiss Trop Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Schwappach, B (corresponding author), Heidelberg Univ, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.
EM b.schwappach@zmbh.uni-heidelberg.de
RI Spang, Anne/A-7029-2008; Schwede, Torsten/A-4650-2008; Spang,
   Anne/M-7223-2019; Liebel, Urban/D-8519-2011
OI Spang, Anne/0000-0002-2387-6203; Schwede, Torsten/0000-0003-2715-335X;
   Spang, Anne/0000-0002-2387-6203; Schwappach, Blanche/0000-0003-0225-6432
FU Wellcome TrustWellcome Trust [081671] Funding Source: Medline
CR Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   AUSUBEL FM, 1997, CURRENT PROTOCOLS  M
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400
   DUDEN R, 1994, J BIOL CHEM, V269, P24486
   Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985
   Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724
   Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905
   Faulstich D, 1996, J CELL BIOL, V135, P53, DOI 10.1083/jcb.135.1.53
   Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101
   Heusser K, 2006, J CELL SCI, V119, P4353, DOI 10.1242/jcs.03196
   Langer JD, 2007, FEBS LETT, V581, P2083, DOI 10.1016/j.febslet.2007.03.020
   Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480
   Michelsen K, 2006, TRAFFIC, V7, P903, DOI 10.1111/j.1600-0854.2006.00430.x
   Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013
   Mrowiec T, 2006, BIOL CHEM, V387, P1227, DOI 10.1515/BC.2006.152
   Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054
   O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1
   O'Sullivan O, 2004, J MOL BIOL, V340, P385, DOI 10.1016/j.jmb.2004.04.058
   Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915
   OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928
   Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543
   Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783
   ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027
   Sato K, 2001, J CELL BIOL, V152, P935, DOI 10.1083/jcb.152.5.935
   Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521
   SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895
   Schultz MC, 1999, METHODS, V17, P161, DOI 10.1006/meth.1998.0727
   Shikano S, 2003, P NATL ACAD SCI USA, V100, P5783, DOI 10.1073/pnas.1031748100
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Yuan HB, 2003, CURR BIOL, V13, P638, DOI 10.1016/S0960-9822(03)00208-2
   Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4
   Zerangue N, 2001, P NATL ACAD SCI USA, V98, P2431, DOI 10.1073/pnas.051630198
NR 39
TC 46
Z9 49
U1 0
U2 6
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD OCT 22
PY 2007
VL 179
IS 2
BP 209
EP 217
DI 10.1083/jcb.200704142
PG 9
WC Cell Biology
SC Cell Biology
GA 223AA
UT WOS:000250340400007
PM 17954604
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Paul, R
   Abel, S
   Wassmann, P
   Beck, A
   Heerklotz, H
   Jenal, U
AF Paul, Ralf
   Abel, Soren
   Wassmann, Paul
   Beck, Andreas
   Heerklotz, Heiko
   Jenal, Urs
TI Activation of the diguanylate cyclase PleD by phosphorylation-mediated
   dimerization
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BACTERIAL RESPONSE REGULATORS; CAULOBACTER-CRESCENTUS;
   SIGNAL-TRANSDUCTION; CELL-CYCLE; MIMICS PHOSPHORYLATION; DYNAMIC
   LOCALIZATION; ALLOSTERIC CONTROL; RECEIVER DOMAIN; DI-GMP; PROTEINS
AB Diguanylate cyclases (DGCs) are key enzymes of second messenger signaling in bacteria. Their activity is responsible for the condensation of two GTP molecules into the signaling compound cyclic di-GMP. Despite their importance and abundance in bacteria, catalytic and regulatory mechanisms of this class of enzymes are poorly understood. In particular, it is not clear if oligomerization is required for catalysis and if it represents a level for activity control. To address this question we perform in vitro and in vivo analysis of the Caulobacter crescentus diguanylate cyclase PleD. PleD is a member of the response regulator family with two N-terminal receiver domains and a C-terminal diguanylate cyclase output domain. PleD is activated by phosphorylation but the structural changes inflicted upon activation of PleD are unknown. We show that PleD can be specifically activated by beryllium fluoride in vitro, resulting in dimerization and c-di-GMP synthesis. Cross-linking and fractionation experiments demonstrated that the DGC activity of PleD is contained entirely within the dimer fraction, confirming that the dimer represents the enzymatically active state of PleD. In contrast to the catalytic activity, allosteric feedback regulation of PleD is not affected by the activation status of the protein, indicating that activation by dimerization and product inhibition represent independent layers of DGC control. Finally, we present evidence that dimerization also serves to sequester activated PleD to the differentiating Caulobacter cell pole, implicating protein oligomerization in spatial control and providing a molecular explanation for the coupling of PleD activation and subcellular localization.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Kingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022; Abel, Soren/0000-0002-4041-6989;
   Wassmann, Paul/0000-0001-7391-1065
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Aravind L, 1999, FEMS MICROBIOL LETT, V176, P111, DOI 10.1111/j.1574-6968.1999.tb13650.x
   Aravind L, 1997, TRENDS BIOCHEM SCI, V22, P458, DOI 10.1016/S0968-0004(97)01148-1
   Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Gomelsky M, 2002, TRENDS BIOCHEM SCI, V27, P497, DOI 10.1016/S0968-0004(02)02181-3
   Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Heinzel FP, 1997, J IMMUNOL, V158, P4381
   Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019
   HURLEY JH, 2003, SCI STKE, pPE1
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040
   Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05
   Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Ponting CP, 1997, CURR BIOL, V7, pR674, DOI 10.1016/S0960-9822(06)00352-6
   Renatus M, 2001, P NATL ACAD SCI USA, V98, P14250, DOI 10.1073/pnas.231465798
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603
   Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805
   Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Wemmer DE, 2005, J BACTERIOL, V187, P8229, DOI 10.1128/JB.187.24.8229-8230.2005
   Yan D, 1999, P NATL ACAD SCI USA, V96, P14789, DOI 10.1073/pnas.96.26.14789
   Zhang XF, 2006, MOL MICROBIOL, V60, P658, DOI 10.1111/j.1365-2958.2006.05138.x
   Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714
NR 34
TC 122
Z9 126
U1 1
U2 17
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 5
PY 2007
VL 282
IS 40
BP 29170
EP 29177
DI 10.1074/jbc.M704702200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 215DH
UT WOS:000249788000012
PM 17640875
OA Bronze
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Andonie, JL
   Kohler, G
AF Knechtle, Beat
   Knechtle, Patrizia
   Andonie, Jorge Luis
   Kohler, Goetz
TI Influence of anthropometry on race performance in extreme endurance
   triathletes: World Challenge Deca Iron Triathlon 2006
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID DISTANCE RUNNING PERFORMANCE; SKINFOLD THICKNESSES; EXERCISE CAPACITY;
   AFRICAN RUNNERS; LEVEL; MARATHON; MORPHOLOGY; SUCCESS; ECONOMY; BOYS
AB Objective: To investigate the influence of anthropometric variables on race performance in ultra-endurance triathletes in an ultra-triathlon.
   Design: Descriptive field study.
   Setting: The "World Challenge Deca Iron Triathlon 2006'' in Monterrey, Mexico, in which everyday for 10 consecutive days athletes had to perform the distance of one Ironman triathlon of 3.8 km swimming, 180 km cycling and 42.195 km running.
   Subjects: Eight male ultra-endurance athletes (mean (SD) age 40.6 (10.7) years, weight 76.4 (8.4) kg, height 175 (4) cm and body mass index (BMI) 24.7 (2.2) kg/m(2)).
   Interventions: None.
   Main outcome measures: Direct measurement of body mass, height, leg length, skinfold thicknesses, limb circumference and calculation of BMI, skeletal muscle mass (SM), percentage SM (% SM) and percentage body fat (% BF) in order to correlate measured and calculated anthropometric variables with race performance.
   Results: Race time was not significantly (p > 0.05) influenced by the directly measured variables, height, leg length, body mass, average skinfold thicknesses, or circumference of thigh, calf or upper arm. Furthermore, no significant (p. 0.05) correlation was observed between race time and the calculated variables, BMI, % SM and % BF.
   Conclusions: In a multistage ultra-triathlon over 10 Ironman triathlon distances in 10 consecutive days, there was no effect of body mass, height, leg length, skinfold thicknesses, limb circumference, BMI, % SM or % BF on race performance in the only eight finishers.
C1 Gesundheitszentrum, St Gallen, Switzerland.
   Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
   Multisport Andonie, Monterrey, Nuevo Leon, Mexico.
RP Knechtle, B (corresponding author), Gesundheitszentrum, St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P512
   Arrese AL, 2006, J SPORT SCI, V24, P69, DOI 10.1080/02640410500127751
   Bale P, 1986, Br J Sports Med, V20, P170
   Bale P, 1985, J SPORT SCI, V3, P115, DOI 10.1080/02640418508729741
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Berg K, 2003, SPORTS MED, V33, P59, DOI 10.2165/00007256-200333010-00005
   BOSCH AN, 1990, EUR J APPL PHYSIOL O, V61, P68, DOI 10.1007/BF00236696
   Christensen C L, 1983, Br J Sports Med, V17, P166
   CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010
   Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86
   Hagan R D, 1987, Br J Sports Med, V21, P3
   Kenney W L, 1985, Br J Sports Med, V19, P207
   Landers GJ, 2000, ANN HUM BIOL, V27, P387, DOI 10.1080/03014460050044865
   Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416
   Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7
   LAURENSON NM, 1993, INT J SPORTS MED, V14, P455, DOI 10.1055/s-2007-1021210
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEEDY HE, 1965, RES QUART, V36, P158, DOI 10.1080/10671188.1965.10614674
   Legaz A, 2005, BRIT J SPORT MED, V39, P851, DOI 10.1136/bjsm.2005.018960
   Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083
   Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003
   Rahmani A, 2004, EUR J APPL PHYSIOL, V91, P399, DOI 10.1007/s00421-003-0989-x
   RIEDENAU RP, 1968, RES QUART, V29, P200
   Saltin B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P209
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   SJODIN B, 1985, SPORTS MED, V2, P83
   Sleivert GG, 1996, SPORTS MED, V22, P8, DOI 10.2165/00007256-199622010-00002
   TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001
   Weston AR, 1999, J APPL PHYSIOL, V86, P915
   Weston AR, 2000, MED SCI SPORT EXER, V32, P1130, DOI 10.1097/00005768-200006000-00015
   Yeung SS, 2001, J SPORT MED PHYS FIT, V41, P170
NR 31
TC 27
Z9 28
U1 2
U2 14
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD OCT
PY 2007
VL 41
IS 10
BP 644
EP 648
DI 10.1136/bjsm.2006.035014
PG 5
WC Sport Sciences
SC Sport Sciences
GA 212UA
UT WOS:000249621100007
PM 17556527
OA Green Published
DA 2021-01-25
ER

PT J
AU Hippenmeyer, S
   Huber, RM
   Ladle, DR
   Murphy, K
   Arber, S
AF Hippenmeyer, Simon
   Huber, Roland M.
   Ladle, David R.
   Murphy, Kenneth
   Arber, Silvia
TI ETS transcription factor erm controls subsynaptic gene expression in
   skeletal muscles
SO NEURON
LA English
DT Article
ID NICOTINIC ACETYLCHOLINE-RECEPTOR; CONGENITAL MYASTHENIC SYNDROME;
   EPSILON-SUBUNIT GENE; GA-BINDING PROTEIN; NEUROMUSCULAR-JUNCTION;
   POSTSYNAPTIC DIFFERENTIATION; SYNAPTIC EXPRESSION; MOTOR-NEURONS;
   IN-VIVO; VERTEBRATE LIMB
AB Accumulation of specific proteins at synaptic structures is essential for synapse assembly and function, but mechanisms regulating local protein enrichment remain poorly understood. At the neuromuscular junction (NMJ), subsynaptic nuclei underlie motor axon terminals within extrafusal muscle fibers and are transcriptionally distinct from neighboring nuclei. In this study, we show that expression of the ETS transcription factor Erm is highly concentrated at subsynaptic nuclei, and its mutation in mice leads to severe downregulation of many genes with normally enriched subsynaptic expression. Erm mutant mice display an expansion of the muscle central domain in which acetylcholine receptor (AChR) clusters accumulate, show gradual fragmentation of AChR clusters, and exhibit symptoms of muscle weakness mimicking congenital myasthenic syndrome (CMS). Together, our findings define Erm as an upstream regulator of a transcriptional program selective to subsynaptic nuclei at the NMJ and underscore the importance of transcriptional control of local synaptic protein accumulation.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Hippenmeyer, Simon/0000-0003-2279-1061; Arber,
   Silvia/0000-0002-6261-250X
CR Arber S, 2002, CURR OPIN NEUROBIOL, V12, P100, DOI 10.1016/S0959-4388(02)00296-9
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502
   Burden SJ, 2002, J NEUROBIOL, V53, P501, DOI 10.1002/neu.10137
   CALDWELL JH, 1986, J GEN PHYSIOL, V87, P907, DOI 10.1085/jgp.87.6.907
   Chakkalakal JV, 2003, BIOESSAYS, V25, P25, DOI 10.1002/bies.10205
   Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894
   d'Exaerde AD, 2002, EMBO REP, V3, P1075, DOI 10.1093/embo-reports/kvf220
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   DELAPEYRIERE O, 1993, DEVELOPMENT, V118, P601
   Duclert A, 1996, J BIOL CHEM, V271, P17433, DOI 10.1074/jbc.271.29.17433
   Engel AG, 2003, J NEUROCYTOL, V32, P1017, DOI 10.1023/B:NEUR.0000020639.22895.28
   Fromm L, 1998, GENE DEV, V12, P3074, DOI 10.1101/gad.12.19.3074
   Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   Jaworski A, 2007, MOL CELL BIOL, V27, P5040, DOI 10.1128/MCB.02228-06
   Jevsek M, 2006, P NATL ACAD SCI USA, V103, P6374, DOI 10.1073/pnas.0601468103
   Kardon G, 2002, DEV CELL, V3, P533, DOI 10.1016/S1534-5807(02)00291-5
   Kardon G, 2003, DEV CELL, V5, P937, DOI 10.1016/S1534-5807(03)00360-5
   Kishi M, 2005, J CELL BIOL, V169, P355, DOI 10.1083/jcb.200411012
   Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924
   KOIKE S, 1995, P NATL ACAD SCI USA, V92, P10624, DOI 10.1073/pnas.92.23.10624
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830
   Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6
   MOSS SJ, 1987, EMBO J, V6, P3917, DOI 10.1002/j.1460-2075.1987.tb02732.x
   Nazarian J, 2005, PHYSIOL GENOMICS, V21, P70, DOI 10.1152/physiolgenomics.00227.2004
   Nichols P, 1999, ANN NEUROL, V45, P439, DOI 10.1002/1531-8249(199904)45:4<439::AID-ANA4>3.0.CO;2-W
   O'Leary DA, 2007, MOL CELL BIOL, V27, P3470, DOI 10.1128/MCB.00659-06
   Ohno K, 1999, NEUROMUSCULAR DISORD, V9, P131, DOI 10.1016/S0960-8966(99)00007-3
   Pang YW, 2006, J COMP NEUROL, V498, P129, DOI 10.1002/cne.21047
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005
   Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   SIMON AM, 1993, MOL CELL BIOL, V13, P5133, DOI 10.1128/MCB.13.9.5133
   Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014
   VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
NR 50
TC 31
Z9 31
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD SEP 6
PY 2007
VL 55
IS 5
BP 726
EP 740
DI 10.1016/j.neuron.2007.07.028
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 216DB
UT WOS:000249857000009
PM 17785180
DA 2021-01-25
ER

PT J
AU Dames, SA
   Schonichen, A
   Schulte, A
   Barboric, M
   Peterlin, BM
   Grzesiek, S
   Geyer, M
AF Dames, Sonja A.
   Schoenichen, Andre
   Schulte, Antje
   Barboric, Matjaz
   Peterlin, B. Matija
   Grzesiek, Stephan
   Geyer, Matthias
TI Structure of the Cyclin T binding domain of Hexim 1 and molecular basis
   for its recognition of P-TEFb
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Cyclin T1; NMR spectroscopy; transcription elongation
ID POLYMERASE-II TRANSCRIPTION; BROMODOMAIN PROTEIN BRD4;
   SMOOTH-MUSCLE-CELLS; 7SK SNRNA; DIPOLAR COUPLINGS; NMR STRUCTURE;
   COILED-COIL; HIV-1 NEF; ELONGATION; COMPLEXES
AB Hexim1 is a cellular protein that associates with the positive transcription elongation factor b (P-TEFb) to regulate RNA polymerase 11 elongation of nascent mRNA transcripts. It directly binds to Cyclin T1 of P-TEFb and inhibits the kinase activity of Cdk9, leading to an arrest of transcription elongation. Here, we report the solution structure of the Cyclin T binding domain (TBD) of Hexim1 that forms a parallel coiled-coil homodimer composed of two segments and a preceding alpha helix that folds back onto the first coiled-coil unit. NMR titration, fluorescence, and immunoprecipitation experiments revealed the binding interface to Cyclin T1, which covers a large surface on the first coiled-coil segment. Electrostatic interactions between an acidic patch on Hexim1 and positively charged residues of Cyclin T1 drive the complex formation that is confirmed by mutagenesis data on Hexim1 mediated transcription regulation in cells. Thus, our studies provide structural insights how Hexim1 recognizes the Cyclin T1 subunit of P-TEFb, which is a key step toward the regulation of transcription elongation.
C1 Univ Basel, Dept Biol Struct, Biozentrum Basel, CH-4003 Basel, Switzerland.
   Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany.
   Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr, San Francisco, CA 94143 USA.
RP Dames, SA (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum Basel, CH-4003 Basel, Switzerland.
EM sonja.dames@unibas.ch; matthias.geyer@mpi-dortmund.mpg.de
RI Barboric, Matjaz/C-9918-2009
OI Barboric, Matjaz/0000-0002-9715-2291; Geyer,
   Matthias/0000-0002-7718-5002; Grzesiek, Stephan/0000-0003-1998-4225;
   Dames, Sonja/0000-0001-7495-6943
FU NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI049104, R01AI049104, R01AI049104, R01AI049104, R01AI049104,
   R01AI049104, R01AI049104, R01AI049104, R01AI049104, R01AI049104,
   R01AI049104, R01AI049104, R01AI049104, R01AI049104, R01AI049104] Funding
   Source: NIH RePORTER; NIAID NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [R01 AI049104, R01
   AI49104] Funding Source: Medline
CR Barboric M, 2005, EMBO J, V24, P4291, DOI 10.1038/sj.emboj.7600883
   Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8
   Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c
   Cheng KY, 2006, J BIOL CHEM, V281, P23167, DOI 10.1074/jbc.M600480200
   Dames SA, 1998, NAT STRUCT BIOL, V5, P687, DOI 10.1038/1382
   Dames SA, 2006, J BIOMOL NMR, V36, P39, DOI 10.1007/s10858-006-9010-4
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dulac C, 2005, J BIOL CHEM, V280, P30619, DOI 10.1074/jbc.M502471200
   Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006
   Goodrich JA, 2006, NAT REV MOL CELL BIO, V7, P612, DOI 10.1038/nrm1946
   GOODY RS, 2003, KINETIC ANAL MACROMO, P153
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kusuhara M, 1999, BIOMED RES-TOKYO, V20, P273, DOI 10.2220/biomedres.20.273
   LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3
   Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200
   Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275
   Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003
   Nabuurs SB, 2004, PROTEINS, V55, P483, DOI 10.1002/prot.20118
   Nguyen VT, 2001, NATURE, V414, P322, DOI 10.1038/35104581
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Ouchida R, 2003, GENES CELLS, V8, P95, DOI 10.1046/j.1365-2443.2003.00618.x
   Pavletich NP, 1999, J MOL BIOL, V287, P821, DOI 10.1006/jmbi.1999.2640
   Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981
   Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904
   Taube R, 2002, MOL CELL BIOL, V22, P321, DOI 10.1128/MCB.22.1.321-331.2002
   Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2
   Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029
   Yang ZY, 2001, NATURE, V414, P317, DOI 10.1038/35104575
   Yik JHN, 2004, MOL CELL BIOL, V24, P5094, DOI 10.1128/MCB.24.12.5094-5105.2004
   Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5
NR 39
TC 47
Z9 49
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 4
PY 2007
VL 104
IS 36
BP 14312
EP 14317
DI 10.1073/pnas.0701848104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 208QF
UT WOS:000249333600026
PM 17724342
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lee, EH
   Hsin, J
   Mayans, O
   Schulten, K
AF Lee, Eric H.
   Hsin, Jen
   Mayans, Olga
   Schulten, Klaus
TI Secondary and tertiary structure elasticity of titin Z1Z2 and a titin
   chain model
SO BIOPHYSICAL JOURNAL
LA English
DT Review
ID MOLECULAR-DYNAMICS SIMULATIONS; MUSCLE PROTEIN TITIN; ATOMIC-FORCE
   MICROSCOPY; IMMUNOGLOBULIN-LIKE MODULES; FREE-ENERGY CALCULATION; IG
   DOMAIN; MECHANICAL STABILITY; SINGLE MOLECULES; ACTIN-BINDING; KINASE
   DOMAIN
AB The giant protein titin, which is responsible for passive elasticity in muscle fibers, is built from similar to 300 regular immunoglobulin-like (Ig) domains and FN-III repeats. While the soft elasticity derived from its entropic regions, as well as the stiff mechanical resistance derived from the unfolding of the secondary structure elements of Ig- and FN-III domains have been studied extensively, less is known about the mechanical elasticity stemming from the orientation of neighboring domains relative to each other. Here we address the dynamics and energetics of interdomain arrangement of two adjacent Ig-domains of titin, Z1, and Z2, using molecular dynamics ( MD) simulations. The simulations reveal conformational flexibility, due to the domain-domain geometry, that lends an intermediate force elasticity to titin. We employ adaptive biasing force MD simulations to calculate the energy required to bend the Z1Z2 tandem open to identify energetically feasible interdomain arrangements of the Z1 and Z2 domains. The finding is cast into a stochastic model for Z1Z2 interdomain elasticity that is generalized to a multiple domain chain replicating many Z1Z2-like units and representing a long titin segment. The elastic properties of this chain suggest that titin derives so-called tertiary structure elasticity from bending and twisting of its domains. Finally, we employ steered molecular dynamics simulations to stretch individual Z1 and Z2 domains and characterize the so-called secondary structure elasticity of the two domains. Our study suggests that titin's overall elastic response at weak force stems from a soft entropic spring behavior ( not described here), from tertiary structure elasticity with an elastic spring constant of similar to 0.001-1 pN/angstrom and, at strong forces, from secondary structure elasticity.
C1 Univ Illinois, Beckman Inst, Dept Phys, Urbana, IL 61801 USA.
   Univ Illinois, Beckman Inst, Ctr Biophys & Computat Biol, Coll Med, Urbana, IL 61801 USA.
   Univ Basel, Div Marine Biol Biozentrum, Basel, Switzerland.
RP Schulten, K (corresponding author), Univ Illinois, Beckman Inst, Dept Phys, Urbana, IL 61801 USA.
EM kschulte@ks.uiuc.edu
RI Mayans, Olga/A-3954-2008; Schulten, Klaus/D-5561-2009
OI Mayans, Olga/0000-0001-6876-8532
FU NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969, P41RR005969, P41RR005969, P41RR005969, P41RR005969,
   P41RR005969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM073655, R01GM073655,
   R01GM073655, R01GM073655] Funding Source: NIH RePORTER; NCRR NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P41 RR05969, P41 RR005969] Funding Source: Medline;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM073655] Funding Source: Medline
CR Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981
   Best RB, 2003, J MOL BIOL, V330, P867, DOI 10.1016/S0022-2836(03)00618-1
   Bird RB, 1987, DYNAMICS POLYM LIQUI
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Chandrasekhar S, 1943, REV MOD PHYS, V15, P0001, DOI 10.1103/RevModPhys.15.1
   Cieplak M, 2004, PROTEINS, V56, P285, DOI 10.1002/prot.20081
   Craig D, 2004, STRUCTURE, V12, P21, DOI 10.1016/j.str.2003.11.024
   Darve E, 2002, MOL SIMULAT, V28, P113, DOI 10.1080/08927020211975
   Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978
   Duan YL, 2006, ARCH BIOCHEM BIOPHYS, V454, P16, DOI 10.1016/j.abb.2006.07.017
   Duff N, 2006, BIOPHYS J, V91, P3446, DOI 10.1529/biophysj.105.074278
   Erickson HP, 1997, SCIENCE, V276, P1090, DOI 10.1126/science.276.5315.1090
   FLORY PJ, 2003, STAT MECH POLYM CHAI
   Fowler SB, 2002, J MOL BIOL, V322, P841, DOI 10.1016/S0022-2836(02)00805-7
   FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563
   Gao M, 2003, P NATL ACAD SCI USA, V100, P14784, DOI 10.1073/pnas.2334390100
   Gao M, 2002, J MUSCLE RES CELL M, V23, P513, DOI 10.1023/A:1023466608163
   Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5
   Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2
   Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X
   Gao M, 2006, PHYS CHEM CHEM PHYS, V8, P3692, DOI 10.1039/b606019f
   Gautel M, 1996, J CELL SCI, V109, P2747
   Geierhaas CD, 2006, BIOPHYS J, V91, P263, DOI 10.1529/biophysj.105.077057
   Granzier HL, 2006, EXERC SPORT SCI REV, V34, P50, DOI 10.1249/00003677-200604000-00002
   Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8
   Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423
   Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013
   Grubmuller H, 1991, MOL SIMULAT, V6, P121, DOI 10.1080/08927029108022142
   Gullingsrud JR, 1999, J COMPUT PHYS, V151, P190, DOI 10.1006/jcph.1999.6218
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132
   Henin J, 2006, J PHYS CHEM B, V110, P16718, DOI 10.1021/jp0601116
   Higgins MJ, 2006, BIOPHYS J, V90, P640, DOI 10.1529/biophysj.105.066571
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028
   Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6
   Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9
   Izrailev S., 1998, COMPUTATIONAL MOL DY, V4
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kac M., 1947, AM MATHEM MONTHLY, V54, P369, DOI DOI 10.2307/2304386
   KAWAKAMI M, 2006, BIOPHYS J, V11, P1710
   Kellermayer MSZ, 1996, BIOCHEM BIOPH RES CO, V221, P491, DOI 10.1006/bbrc.1996.0624
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kellermayer MSZ, 2001, BIOPHYS J, V80, P852, DOI 10.1016/S0006-3495(01)76064-X
   Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463
   Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571
   Lee EH, 2006, STRUCTURE, V14, P497, DOI 10.1016/j.str.2005.12.005
   Lee G, 2006, NATURE, V440, P246, DOI 10.1038/nature04437
   Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938
   Li MS, 2006, P NATL ACAD SCI USA, V103, P93, DOI 10.1073/pnas.0503758103
   Li PC, 2003, J CHEM PHYS, V119, P9260, DOI 10.1063/1.1615233
   Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468
   Linke WA, 1998, J CELL SCI, V111, P1567
   Linke WA, 2000, HISTOL HISTOPATHOL, V15, P799, DOI 10.14670/HH-15.799
   Lu H, 2000, BIOPHYS J, V79, P51, DOI 10.1016/S0006-3495(00)76273-4
   Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3
   Lu H, 1999, PROTEINS, V35, P453, DOI 10.1002/(SICI)1097-0134(19990601)35:4<453::AID-PROT9>3.0.CO;2-M
   LU H, 2000, ELASTIC FILAMENTS CE
   Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Marszalek PE, 1999, NATURE, V402, P100
   Maruyama K, 1997, FASEB J, V11, P341
   Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603
   Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3
   Michels KB, 2002, ANN EPIDEMIOL, V12, P21, DOI 10.1016/S1047-2797(01)00238-1
   Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4
   Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604
   MROSEK M, 2007, FASEB J
   Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8
   Nagy A, 2005, BIOPHYS J, V89, P329, DOI 10.1529/biophysj.104.057737
   Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6
   Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211
   Pabon G, 2006, BIOPHYS J, V91, P467, DOI 10.1529/biophysj.106.082594
   Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597
   Park S, 2004, J CHEM PHYS, V120, P5946, DOI 10.1063/1.1651473
   Park S, 2003, J CHEM PHYS, V119, P3559, DOI 10.1063/1.1590311
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050
   Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0
   Risken H. Z., 1989, FOKKER PLANCK EQUATI
   Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607
   Sarkar A, 2005, J BIOL CHEM, V280, P6261, DOI 10.1074/jbc.C400573200
   Sarkar A, 2007, BIOPHYS J, V92, pL36, DOI 10.1529/biophysj.106.097741
   Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182
   SCHULTEN K, 1980, PHYSICA A, V100, P599, DOI 10.1016/0378-4371(80)90170-3
   SCHULTEN K, 1982, FESTKORPERPROBLEME, V22
   Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260
   Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001
   Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853
   Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   Van der Ven PFM, 1999, J MUSCLE RES CELL M, V20, P569, DOI 10.1023/A:1005569225773
   Vazina AA, 2006, J STRUCT BIOL, V155, P251, DOI 10.1016/j.jsb.2006.03.025
   Wang K, 1996, ADV BIOPHYS, V33, P123
   Wang Y, 2005, STRUCTURE, V13, P1107, DOI 10.1016/j.str.2005.05.005
   WHITING A, 1992, J MOL BIOL, V205, P262
   Williams PM, 2003, NATURE, V422, P446, DOI 10.1038/nature01517
   YIN Y, 2006, IN PRESS BIOPHYS J
   Zhang B, 2001, BIOPHYS J, V80, P597, DOI 10.1016/S0006-3495(01)76040-7
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 106
TC 36
Z9 36
U1 0
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD SEP
PY 2007
VL 93
IS 5
BP 1719
EP 1735
DI 10.1529/biophysj.107.105528
PG 17
WC Biophysics
SC Biophysics
GA 199VB
UT WOS:000248722200028
PM 17496052
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Seelig, A
AF Seelig, Anna
TI The role of the lipid membrane for the function of the ABC transporter
   P-glycoprotein
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Meeting Abstract
CT 48th International Conference on the Bioscience of Lipids
CY SEP 04-08, 2007
CL Turku, FINLAND
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
NR 4
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PD SEP
PY 2007
VL 149
SU S
BP S71
EP S71
DI 10.1016/j.chemphyslip.2007.06.159
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 207HA
UT WOS:000249241000152
DA 2021-01-25
ER

PT J
AU Seelig, J
AF Seelig, Joachim
TI Protein meets lipid - The role of lipid in protein folding
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Meeting Abstract
CT 48th International Conference on the Bioscience of Lipids
CY SEP 04-08, 2007
CL Turku, FINLAND
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PD SEP
PY 2007
VL 149
SU S
BP S1
EP S1
DI 10.1016/j.chemphyslip.2007.06.002
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 207HA
UT WOS:000249241000002
DA 2021-01-25
ER

PT J
AU Affolter, M
   Barde, Y
AF Affolter, Markus
   Barde, Yves
TI Self-renewal in the fly kidney
SO DEVELOPMENTAL CELL
LA English
DT Editorial Material
ID STEM-CELLS; MIDGUT
AB Tissue stem cells are typically rare and located in niches that prescribe low rates of cell division and survival. In the latest issue of CellStem Cell, Singh et al. (2007) demonstrate that, in the adult fly, epithelial cells exist that are neither in niches nor in small numbers, divide at high rates, and are multipotent.
C1 Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Biozentrum Univ Basel, Kingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X; Affolter, Markus/0000-0002-5171-0016
CR Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014
   Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012
   Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160
   Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700
NR 10
TC 6
Z9 7
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1534-5807
J9 DEV CELL
JI Dev. Cell
PD SEP
PY 2007
VL 13
IS 3
BP 321
EP 322
DI 10.1016/j.devcel.2007.08.002
PG 2
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 208FC
UT WOS:000249304200004
PM 17765675
DA 2021-01-25
ER

PT J
AU Kohalmy, K
   Tamasi, V
   Kobori, L
   Sarvary, E
   Pascussi, JM
   Porrogi, P
   Rozman, D
   Prough, RA
   Meyer, UA
   Monostory, K
AF Kohalmy, Krisztina
   Tamasi, Viola
   Kobori, Laszlo
   Sarvary, Eniko
   Pascussi, Jean-Marc
   Porrogi, Palma
   Rozman, Damjana
   Prough, Russell A.
   Meyer, Urs A.
   Monostory, Katalin
TI Dehydroepiandrosterone induces human CYP2B6 through the constitutive
   androstane receptor
SO DRUG METABOLISM AND DISPOSITION
LA English
DT Article
ID CYTOCHROME P-450 REDUCTASE; PEROXISOMAL ENZYMES; CYP3A EXPRESSION; GENE
   INDUCTION; NUCLEAR; DHEA; RAT; CAR; IDENTIFICATION; METABOLITES
AB Dehydroepiandrosterone ( DHEA), the major precursor of androgens and estrogens, has several beneficial effects on the immune system, on memory function, and in modulating the effects of diabetes, obesity, and chemical carcinogenesis. Treatment of rats with DHEA influences expression of cytochrome P450 ( P450) genes, including peroxisome proliferator-activated receptor alpha ( PPAR alpha)- and pregnane X receptor (PXR)-mediated induction of CYP4As and CYP3A23, and suppression of CYP2C11. DHEA treatment elevated the expression and activities of CYP3A4, CYP2C9, CYP2C19, and CYP2B6 in primary cultures of human hepatocytes. Induction of CYP3A4 in human hepatocytes was consistent with studies in rats, but induction of CYP2Cs was unexpected. The role of PXR in this response was studied in transient transfection assays. DHEA activated hPXR in a concentration-dependent manner. Because CYP2B6 induction by DHEA in human hepatocytes might involve either PXR or constitutive androstane receptor ( CAR) activation, we performed experiments in primary hepatocytes from CAR knockout mice and observed that CAR was required for maximal induction of Cyp2b10 by DHEA. Furthermore, CAR-mediated Cyp2b10 induction by DHEA was inhibited by the inverse agonist of CAR, androstanol (5 alpha-androstan-3 alpha-ol). Further evidence for CAR activation was provided by cytoplasmic/nuclear transfer of CAR upon DHEA treatment. Elucidation of CAR activation and subsequent induction of CYP2B6 by DHEA presented an additional mechanism by which the sterol can modify the expression of P450s. The effect of DHEA on the activation of the xenosensors PPAR alpha, PXR, and CAR, and the consequent potential for adverse drug/toxicant interactions should be considered in humans treated with this nutriceutical agent.
C1 Hungarian Acad Sci, Chem Res Ctr, Budapest, Hungary.
   Semmelweis Univ, Transplantat & Surg Clin, Budapest, Hungary.
   Univ Montpellier I, Inst Natl Sante Rech Med, INSERM, U632,EA 3768, Montpellier, France.
   Univ Ljubljana, Ljubljana, Slovenia.
   Univ Louisville, Louisville, KY 40292 USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Monostory, K (corresponding author), POB 17, H-1525 Budapest, Hungary.
EM monostor@chemres.hu
RI Russell A, Prough/AAH-5907-2020; pascussi, jean marc/F-9311-2013;
   Monostory, Katalin/N-1064-2016
OI pascussi, jean marc/0000-0002-5168-5383; Rozman,
   Damjana/0000-0002-6501-2163; Prough, Russell/0000-0001-8901-8490
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK54774, R01 DK054774, R01
   DK054774-08, R01 DK054774-06, R01 DK054774-07, R01 DK054774-05] Funding
   Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R01DK054774, R01DK054774,
   R01DK054774, R01DK054774, R01DK054774, R01DK054774, R01DK054774,
   R01DK054774] Funding Source: NIH RePORTER
CR Baulieu EE, 2000, P NATL ACAD SCI USA, V97, P4279, DOI 10.1073/pnas.97.8.4279
   Bayliss M K, 1996, Methods Mol Med, V2, P369, DOI 10.1385/0-89603-335-X:369
   Chalbot S, 2005, DRUG METAB DISPOS, V33, P563, DOI 10.1124/dmd.104.003004
   Ferrini J B, 1998, Methods Mol Biol, V107, P341
   Fitzpatrick JL, 2001, ARCH BIOCHEM BIOPHYS, V389, P278, DOI 10.1006/abbi.2001.2341
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Gu S, 2003, MOL PHARMACOL, V63, P722, DOI 10.1124/mol.63.3.722
   GUENGERICH FP, 1986, J BIOL CHEM, V261, P5051
   HENDERSON E, 1992, AIDS RES HUM RETROV, V8, P625, DOI 10.1089/aid.1992.8.625
   Heyn H, 1996, DRUG METAB DISPOS, V24, P948
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Kawano H, 2003, J CLIN ENDOCR METAB, V88, P3190, DOI 10.1210/jc.2002-021603
   KRONBACH T, 1989, MOL PHARMACOL, V36, P89
   Labrie F, 2005, J ENDOCRINOL, V187, P169, DOI 10.1677/joe.1.06264
   Labrie F, 1997, J CLIN ENDOCR METAB, V82, P2396, DOI 10.1210/jc.82.8.2396
   Ledirac N, 2000, DRUG METAB DISPOS, V28, P1391
   Legrain S, 2000, J CLIN ENDOCR METAB, V85, P3208, DOI 10.1210/jc.85.9.3208
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Lubet RA, 1998, CANCER RES, V58, P921
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Miller KKM, 2004, DRUG METAB DISPOS, V32, P305, DOI 10.1124/dmd.32.3.305
   Miller WL, 2002, MOL CELL ENDOCRINOL, V198, P7, DOI 10.1016/S0303-7207(02)00363-5
   Miners JO, 1996, METHOD ENZYMOL, V272, P139, DOI 10.1016/S0076-6879(96)72017-7
   Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244
   Pascussi JM, 2001, EUR J BIOCHEM, V268, P6346, DOI 10.1046/j.0014-2956.2001.02540.x
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Peters JM, 1996, MOL PHARMACOL, V50, P67
   PROUGH RA, 1994, CANCER RES, V54, P2878
   RAO MS, 1992, CANCER RES, V52, P2977
   Ripp SL, 2003, MOL PHARMACOL, V64, P113, DOI 10.1124/mol.64.1.113
   Ripp SL, 2002, DRUG METAB DISPOS, V30, P570, DOI 10.1124/dmd.30.5.570
   Singleton DW, 1999, DRUG METAB DISPOS, V27, P193
   SRIVASTAVA PK, 1991, MOL PHARMACOL, V40, P69
   VANDERHO.TA, 1974, J BIOL CHEM, V249, P6302
   Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Webb SJ, 2006, DRUG METAB REV, V38, P89, DOI 10.1080/03602530600569877
   Webb SJ, 1996, MOL PHARMACOL, V49, P276
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   WU HQ, 1989, CANCER RES, V49, P2337
NR 40
TC 38
Z9 40
U1 1
U2 8
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0090-9556
EI 1521-009X
J9 DRUG METAB DISPOS
JI Drug Metab. Dispos.
PD SEP
PY 2007
VL 35
IS 9
BP 1495
EP 1501
DI 10.1124/dmd.107.016303
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 202RM
UT WOS:000248920800010
PM 17591676
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Broz, P
   Mueller, CA
   Muller, SA
   Philippsen, A
   Sorg, I
   Engel, A
   Cornelis, GR
AF Broz, Petr
   Mueller, Catherine A.
   Mueller, Shirley A.
   Philippsen, Ansgar
   Sorg, Isabel
   Engel, Andreas
   Cornelis, Guy R.
TI Function and molecular architecture of the Yersinia injectisome tip
   complex
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID III SECRETION SYSTEM; ENTEROPATHOGENIC ESCHERICHIA-COLI; OUTER-MEMBRANE
   PROTEINS; YOP TRANSLOCATION PORE; TARGET-CELL CONTACT;
   SHIGELLA-FLEXNERI; V-ANTIGEN; HOST MEMBRANES; PLASMA-MEMBRANE;
   ENTEROCOLITICA
AB By quantitative immunoblot analyses and scanning transmission electron microscopy (STEM), we determined that the needle of the Yersinia enterocolitica E40 injectisome consists of 139 +/- 19 YscF subunits and that the tip complex is formed by three to five LcrV monomers. A pentamer represented the best fit for an atomic model of this complex. The N-terminal globular domain of LcrV forms the base of the tip complex, while the central globular domain forms the head. Hybrids between LcrV and its orthologues PcrV (Pseudomonas aeruginosa) or AcrV (Aeromonas salmonicida) were engineered and recombinant Y. enterocolitica expressing the different hybrids were tested for their capacity to form the translocation pore by a haemolysis assay. There was a good correlation between haemolysis, insertion of YopB into erythrocyte membranes and interaction between YopB and the N-terminal globular domain of the tip complex subunit. Hence, the base of the tip complex appears to be critical for the functional insertion of YopB into the host cell membrane.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   ME Muller Inst Struct Biol, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790
CR Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   BURROWS TW, 1956, BRIT J EXP PATHOL, V37, P481
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010
   Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200
   Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069
   Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   Fu YX, 1998, MOL MICROBIOL, V27, P359, DOI 10.1046/j.1365-2958.1998.00684.x
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nikolaus T, 2001, J BACTERIOL, V183, P6036, DOI 10.1128/JB.183.20.6036-6045.2001
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   SAXTON WO, 1979, ULTRAMICROSCOPY, V4, P343, DOI 10.1016/S0304-3991(79)80044-3
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999
   Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879
NR 44
TC 107
Z9 111
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD SEP
PY 2007
VL 65
IS 5
BP 1311
EP 1320
DI 10.1111/j.1365-2958.2007.05871.x
PG 10
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 207HN
UT WOS:000249242300013
PM 17697254
OA Bronze
DA 2021-01-25
ER

PT J
AU de Quervain, DJF
   Kolassa, IT
   Ertl, V
   Onyut, PL
   Neuner, F
   Elbert, T
   Papassotiropoulos, A
AF de Quervain, Dominique J-F
   Kolassa, Iris-Tatjana
   Ertl, Verena
   Onyut, P. Lamaro
   Neuner, Frank
   Elbert, Thomas
   Papassotiropoulos, Andreas
TI A deletion variant of the alpha 2b-adrenoceptor is related to emotional
   memory in Europeans and Africans
SO NATURE NEUROSCIENCE
LA English
DT Review
ID POSTTRAUMATIC-STRESS-DISORDER; DECLARATIVE MEMORY
AB Emotionally arousing events are recalled better than neutral events. This phenomenon, which helps us to remember important and potentially vital information, depends on the activation of noradrenergic transmission in the brain. Here we show that a deletion variant of ADRA2B, the gene encoding the alpha 2b-adrenergic receptor, is related to enhanced emotional memory in healthy Swiss subjects and in survivors of the Rwandan civil war who experienced highly aversive emotional situations.
C1 Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland.
   Univ Konstanz, Dept Psychol, D-78457 Constance, Germany.
   Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
   Mbarara Univ Sci & Technol, Fac Sci & Educ, Mbarara, Uganda.
   Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland.
   Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
RP de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8032 Zurich, Switzerland.
EM quervain@bli.unizh.ch; andreas.papas@unibas.ch
RI Elbert, Thomas/C-8556-2009; Kolassa, Iris Tatjana/Y-3032-2018
OI Elbert, Thomas/0000-0003-1332-4939; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; de Quervain, Dominique/0000-0001-7131-2464
CR Brickenkamp R., 1998, D2 TEST ATTENTION
   CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0
   Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9
   Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445
   LANG PJ, 1999, A4 CTR RES PSYCH U F
   Maheu FS, 2004, BEHAV NEUROSCI, V118, P420, DOI 10.1037/0735-7044.118.2.420
   McGaugh J.L., 2003, MEMORY EMOTION MAKIN
   McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9
   O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703
   Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3
   Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200
   Stein MB, 2002, AM J PSYCHIAT, V159, P1675, DOI 10.1176/appi.ajp.159.10.1675
   Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101
   Wechsler D., 1981, WECHSLER ADULT INTEL
NR 14
TC 139
Z9 139
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD SEP
PY 2007
VL 10
IS 9
BP 1137
EP 1139
DI 10.1038/nn1945
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 205VZ
UT WOS:000249144000015
PM 17660814
DA 2021-01-25
ER

PT J
AU Affolter, M
   Basler, K
AF Affolter, Markus
   Basler, Konrad
TI The Decapentaplegic morphogen gradient: from pattern formation to growth
   regulation
SO NATURE REVIEWS GENETICS
LA English
DT Review
ID CELL-CYCLE PROGRESSION; WING IMAGINAL DISC; DPP MORPHOGEN; POSITIONAL
   INFORMATION; SIGNALING PATHWAY; OPTOMOTOR-BLIND; GENE-COMPLEX; THICK
   VEINS; I RECEPTORS; DROSOPHILA
AB Morphogens have been linked to numerous developmental processes, including organ patterning and the control of organ size. Here we review how different experimental approaches have led to an unprecedented level of molecular knowledge about the patterning role of the Drosophila melanogaster morphogen Decapentaplegic (DPP, the homologue of vertebrate bone morphogenetic protein, or BMP), the first validated secreted morphogen. In addition, we discuss how little is known about the role of the DPP morphogen in the control of organ growth and organ size. Continued efforts to elucidate the role of DPP in D. melanogaster is likely to shed light on this fundamental question in the near future.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; konrad.basler@molbio.uzh.ch
OI Affolter, Markus/0000-0002-5171-0016; Basler, Konrad/0000-0003-3534-1529
CR Adachi-Yamada T, 2002, DEV BIOL, V251, P74, DOI 10.1006/dbio.2002.0821
   Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112
   Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005
   ARORA K, 1995, CELL, V81, P781, DOI 10.1016/0092-8674(95)90539-1
   Ashe HL, 2006, DEVELOPMENT, V133, P385, DOI 10.1242/dev.02238
   Bangi E, 2006, DEVELOPMENT, V133, P3295, DOI 10.1242/dev.02513
   Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101
   BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0
   Belenkaya TY, 2004, CELL, V119, P231, DOI 10.1016/j.cell.2004.09.031
   BOHN H, 1974, J EMBRYOL EXP MORPH, V32, P81
   BOHN H, 1967, Zoologischer Anzeiger, V(30, P499
   BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X
   BRYANT PJ, 1985, DEV BIOL, V107, P355, DOI 10.1016/0012-1606(85)90317-3
   BRYANT SV, 1981, SCIENCE, V212, P993, DOI 10.1126/science.212.4498.993
   Burke R, 1996, DEVELOPMENT, V122, P2261
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x
   Chen Y, 2001, NATURE, V411, P607, DOI 10.1038/35079121
   Cook O, 2004, DEVELOPMENT, V131, P2113, DOI 10.1242/dev.01100
   Cordier F, 2006, J MOL BIOL, V361, P659, DOI 10.1016/j.jmb.2006.06.045
   Day SJ, 2000, DEVELOPMENT, V127, P2977
   de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0
   Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646
   Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x
   Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762
   Fujise M, 2003, DEVELOPMENT, V130, P1515, DOI 10.1242/dev.00379
   Funakoshi Y, 2001, DEVELOPMENT, V128, P67
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   GARCIABELLIDO A, 1971, DEV BIOL, V24, P61, DOI 10.1016/0012-1606(71)90047-9
   Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751
   GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025
   GONZALEZGAITAN M, 1994, MECH DEVELOP, V46, P183, DOI 10.1016/0925-4773(94)90070-1
   GRIEDER NC, 1995, CELL, V81, P791, DOI 10.1016/0092-8674(95)90540-5
   Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500
   Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725
   Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573
   JURSNICH VA, 1990, DEV BIOL, V140, P413, DOI 10.1016/0012-1606(90)90090-6
   Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200
   Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081
   Kruse K, 2004, DEVELOPMENT, V131, P4843, DOI 10.1242/dev.01335
   Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X
   Lawrence PA, 1996, CELL, V85, P951, DOI 10.1016/S0092-8674(00)81297-0
   LAWRENCE PA, 1972, J CELL SCI, V11, P815
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   LETSOU A, 1995, CELL, V80, P899, DOI 10.1016/0092-8674(95)90293-7
   Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522
   Lunde K, 2003, DEVELOPMENT, V130, P235, DOI 10.1242/dev.00207
   Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705
   Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552
   Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a
   Moser M, 2005, DEV BIOL, V286, P647, DOI 10.1016/j.ydbio.2005.08.036
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   MULLER B, 2002, THESIS U ZURICH
   Nakato H, 2002, J CELL SCI, V115, P123
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   NELLEN D, 1994, CELL, V78, P225, DOI 10.1016/0092-8674(94)90293-3
   PENTON A, 1994, CELL, V78, P239, DOI 10.1016/0092-8674(94)90294-1
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   RAFTERY LA, 1995, GENETICS, V139, P241
   Rodriguez DD, 2004, DEV BIOL, V268, P481, DOI 10.1016/j.ydbio.2004.01.005
   Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030
   RUBERTE E, 1995, CELL, V80, P889, DOI 10.1016/0092-8674(95)90292-9
   Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401
   SEKELSKY JJ, 1995, GENETICS, V139, P1347
   Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242
   Serrano N, 1997, CURR BIOL, V7, pR186, DOI 10.1016/S0960-9822(97)70085-X
   Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784
   Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   SPENCER FA, 1982, CELL, V28, P451, DOI 10.1016/0092-8674(82)90199-4
   STAEHLINGHAMPTON K, 1995, DEVELOPMENT, V121, P3393
   STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X
   Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9
   Torres-Vazquez J, 2000, DEV BIOL, V227, P388, DOI 10.1006/dbio.2000.9900
   Weigmann K, 1997, DEVELOPMENT, V124, P3555
   Winter SE, 2004, DEVELOPMENT, V131, P6071, DOI 10.1242/dev.01538
   WOLPERT L, 1989, DEVELOPMENT, V107, P3
   XU T, 1993, DEVELOPMENT, V117, P1223
   ZECCA M, 1995, DEVELOPMENT, V121, P2265
   Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201
NR 90
TC 283
Z9 287
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0056
EI 1471-0064
J9 NAT REV GENET
JI Nat. Rev. Genet.
PD SEP
PY 2007
VL 8
IS 9
BP 663
EP 674
DI 10.1038/nrg2166
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 202DO
UT WOS:000248882400013
PM 17703237
DA 2021-01-25
ER

PT J
AU Lee, SJ
   Bohm, A
   Krug, M
   Boos, W
AF Lee, Sung-Jae
   Boehm, Alex
   Krug, Michael
   Boos, Winfried
TI The ABC of binding-protein-dependent transport in archaea
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID LATERAL GENE-TRANSFER; ESCHERICHIA-COLI; ATP-BINDING;
   THERMOCOCCUS-LITORALIS; CRYSTAL-STRUCTURE; MALTOSE TRANSPORT;
   TRANSCRIPTIONAL REGULATOR; PYROCOCCUS-FURIOSUS; SULFOLOBUS-SOLFATARICUS;
   CASSETTE TRANSPORTER
AB The recent solution of the crystal structure of an entire binding-protein-dependent ABC transporter complex from the archaeon Archaeoglobus fulgidus by I-ocher and his colleagues marks a milestone in the understanding of the ABC transport mechanism. The structure elegantly demonstrates how the motor ATPase alternately opens and closes the inside and outside pores of the transporter and how the substrate-binding protein delivers its substrate. Binding-protein-dependent sugar ABC transporters in the archaea and in bacteria have an additional feature that could connect ABC transporters to gene regulation and to the control of transport activity by cellular processes.
C1 Kyung Hee Univ, Res Inst Basic Sci, Dept Biol, Seoul 130701, South Korea.
   Univ Basel, Biozentrum, Mol Microbiol Div, CH-4056 Basel, Switzerland.
   Univ Konstanz, Dept Biol, D-78457 Constance, Germany.
RP Boos, W (corresponding author), Kyung Hee Univ, Res Inst Basic Sci, Dept Biol, Seoul 130701, South Korea.
EM winfried.boos@uni-konstanz.de
CR Albers SV, 2004, J BIOENERG BIOMEMBR, V36, P5, DOI 10.1023/B:JOBB.0000019593.84933.e6
   Albers SV, 1999, J BACTERIOL, V181, P4285, DOI 10.1128/JB.181.14.4285-4291.1999
   Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003
   Albers SV, 1999, MOL MICROBIOL, V31, P1595, DOI 10.1046/j.1365-2958.1999.01286.x
   AMES GF, 1990, FEMS MICROBIOL LETT, V75, P429, DOI 10.1016/S0168-6445(05)80008-7
   AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397
   Austermuhle MI, 2004, J BIOL CHEM, V279, P28243, DOI 10.1074/jbc.M403508200
   BISHOP L, 1989, P NATL ACAD SCI USA, V86, P6953, DOI 10.1073/pnas.86.18.6953
   Bohm A, 2004, CURR OPIN MICROBIOL, V7, P151, DOI 10.1016/j.mib.2004.02.009
   Bohm A, 2002, J BIOL CHEM, V277, P3708, DOI 10.1074/jbc.M107905200
   Boos W, 2000, TRENDS GENET, V16, P404, DOI 10.1016/S0168-9525(00)02086-2
   BOOS W, 1974, ANNU REV BIOCHEM, V43, P123, DOI 10.1146/annurev.bi.43.070174.001011
   Boos W., 1996, ESCHERICHIA COLI SAL, P1175
   Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004
   Chen J, 2001, P NATL ACAD SCI USA, V98, P1525, DOI 10.1073/pnas.041542498
   Daus ML, 2006, J BIOL CHEM, V281, P3856, DOI 10.1074/jbc.M511953200
   DEAN DA, 1989, P NATL ACAD SCI USA, V86, P9134, DOI 10.1073/pnas.86.23.9134
   Diederichs K, 2000, EMBO J, V19, P5951, DOI 10.1093/emboj/19.22.5951
   Diez J, 2001, J MOL BIOL, V305, P905, DOI 10.1006/jmbi.2000.4203
   DiRuggiero J, 2000, MOL MICROBIOL, V38, P684, DOI 10.1046/j.1365-2958.2000.02161.x
   Elferink MGL, 2001, MOL MICROBIOL, V39, P1494, DOI 10.1046/j.1365-2958.2001.02336.x
   Evdokimov AG, 2001, J MOL BIOL, V305, P891, DOI 10.1006/jmbi.2000.4202
   Geiduschek EP, 2005, MOL MICROBIOL, V56, P1397, DOI 10.1111/j.1365-2958.2005.04627.x
   Greller G, 1999, J BIOL CHEM, V274, P20259, DOI 10.1074/jbc.274.29.20259
   Hall DR, 1999, EMBO J, V18, P1435, DOI 10.1093/emboj/18.6.1435
   Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956
   Herman P, 2006, PROTEINS, V63, P754, DOI 10.1002/prot.20952
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0
   Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993
   Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626
   Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9
   Horlacher R, 1998, J BACTERIOL, V180, P680, DOI 10.1128/JB.180.3.680-689.1998
   Joly N, 2004, J BIOL CHEM, V279, P33123, DOI 10.1074/jbc.M403615200
   Karpowich N, 2001, STRUCTURE, V9, P571, DOI 10.1016/S0969-2126(01)00617-7
   Krug M, 2006, J BIOL CHEM, V281, P10976, DOI 10.1074/jbc.M512809200
   Lee SJ, 2000, EMBO J, V19, P5353, DOI 10.1093/emboj/19.20.5353
   Lee SJ, 2005, MOL MICROBIOL, V57, P1797, DOI 10.1111/j.1365-2958.2005.04804.x
   Lee SJ, 2003, J BIOL CHEM, V278, P983, DOI 10.1074/jbc.M210236200
   Lee SJ, 2007, MOL MICROBIOL, V65, P305, DOI 10.1111/j.1365-2958.2007.05780.x
   Lee SJ, 2007, MOL MICROBIOL, V64, P1499, DOI 10.1111/j.1365-2958.2007.05737.x
   Linton KJ, 1998, MOL MICROBIOL, V28, P5, DOI 10.1046/j.1365-2958.1998.00764.x
   Mourez M, 1997, MOL MICROBIOL, V26, P821, DOI 10.1046/j.1365-2958.1997.6271992.x
   Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066
   Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219
   Nelson KE, 1999, NATURE, V399, P323
   NICHOLS JC, 1993, J BIOL CHEM, V268, P17602
   Panagiotidis CH, 1998, MOL MICROBIOL, V30, P535, DOI 10.1046/j.1365-2958.1998.01084.x
   Quiocho FA, 1996, MOL MICROBIOL, V20, P17, DOI 10.1111/j.1365-2958.1996.tb02484.x
   Schmitt L, 2003, J MOL BIOL, V330, P333, DOI 10.1016/S0022-2836(03)00592-8
   Sharma S, 2000, J BACTERIOL, V182, P6570, DOI 10.1128/JB.182.23.6570-6576.2000
   Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2
   SPURLINO JC, 1991, J BIOL CHEM, V266, P5202
   Szabo Z, 2007, J BACTERIOL, V189, P772, DOI 10.1128/JB.01547-06
   THOMM M, 2006, IN PRESS ARCHAEA EVO
   Verdon G, 2003, J MOL BIOL, V330, P343, DOI 10.1016/S0022-2836(03)00575-8
   Xavier KB, 1996, J BACTERIOL, V178, P4773, DOI 10.1128/jb.178.16.4773-4777.1996
   Yuan YR, 2001, J BIOL CHEM, V276, P32313, DOI 10.1074/jbc.M100758200
NR 58
TC 26
Z9 27
U1 0
U2 7
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0966-842X
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD SEP
PY 2007
VL 15
IS 9
BP 389
EP 397
DI 10.1016/j.tim.2007.08.002
PG 9
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 219YW
UT WOS:000250125100002
PM 17764951
DA 2021-01-25
ER

PT J
AU Meier, S
   Grzesiek, S
   Blackledge, M
AF Meier, Sebastian
   Grzesiek, Stephan
   Blackledge, Martin
TI Mapping the conformational landscape of urea-denatured ubiquitin using
   residual dipolar couplings
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID ANGULAR-DEPENDENCE; UNFOLDED PROTEINS; LONG-RANGE; NMR; CONSTANTS;
   STATE; BACKBONE; DYNAMICS; ALIGNMENT; BIOMOLECULES
AB Characterization of the unfolded state is a fundamental prerequisite for understanding protein stability and folding. We have investigated local conformational sampling in urea-denatured ubiquitin at pH 2.5 by measuring an extensive set of residual dipolar couplings (RDCs) under conditions of partial molecular alignment. Seven experimental RDCs per peptide unit, including complementary fixed-geometry and interproton (H-1(N)-H-1(N) and H-1(N)-H-1(alpha)) couplings, were used to investigate the structural properties of the peptide chain. Amino-acid-specific potentials that simultaneously reproduce all RDCs in the molecule are found to sample more extended conformations than the standard statistical coil description. Analysis of (3)J(HNH alpha) scalar couplings measured under the same conditions suggests that neither polyproline II nor extended beta-regions dominate this additional sampling of extended conformations. Using this approach we propose a model of the conformational landscape throughout the peptide chain of urea-denatured ubiquitin, providing an essential description for understanding the unfolded state.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   UJF, CNRS, UMR 5075, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
   Univ Copenhagen, Inst Mol Biol & Physiol, DK-2100 Copenhagen, Denmark.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch; martin.blackledge@ibs.fr
RI Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225
CR ALEXANDRESCU AT, 1993, BIOCHEMISTRY-US, V32, P1707, DOI 10.1021/bi00058a003
   Almond A, 2002, J AM CHEM SOC, V124, P9986, DOI 10.1021/ja026876i
   Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   Choy WY, 2002, J MOL BIOL, V316, P101, DOI 10.1006/jmbi.2001.5328
   Daggett V, 2003, NAT REV MOL CELL BIO, V4, P497, DOI 10.1038/nrm1126
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DILL KA, 1991, ANNU REV BIOCHEM, V60, P795, DOI 10.1146/annurev.biochem.60.1.795
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   DYSON HJ, 2005, NAT REV, V9, P197
   FADEL AR, 1995, J BIOMOL NMR, V6, P221, DOI 10.1007/BF00211787
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Flory P.J., 1969, STAT MECH CHAIN MOL
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Jacob J, 2004, J MOL BIOL, V338, P369, DOI 10.1016/j.jmb.2004.02.065
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Makowska J, 2006, P NATL ACAD SCI USA, V103, P1744, DOI 10.1073/pnas.0510549103
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Merchant KA, 2007, P NATL ACAD SCI USA, V104, P1528, DOI 10.1073/pnas.0607097104
   Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Ottiger M, 1998, J AM CHEM SOC, V120, P12334, DOI 10.1021/ja9826791
   PARDI A, 1984, J MOL BIOL, V180, P741, DOI 10.1016/0022-2836(84)90035-4
   Peti W, 2000, J AM CHEM SOC, V122, P12017, DOI 10.1021/ja001390s
   Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656
   Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   SCHELLMAN JA, 1964, PROTEINS, V2, P1
   Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   TIFFANY ML, 1968, BIOPOLYMERS, V6, P1767, DOI 10.1002/bip.1968.360061212
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100
   VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024
   WHITNEY PL, 1962, J BIOL CHEM, V237, P1735
   Wirmer J, 2002, J BIOMOL NMR, V23, P47, DOI 10.1023/A:1015384805098
   Wirmer J, 2006, J BIOMOL NMR, V35, P175, DOI 10.1007/s10858-006-9026-9
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 54
TC 69
Z9 69
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD AUG 8
PY 2007
VL 129
IS 31
BP 9799
EP 9807
DI 10.1021/ja0724339
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 196LW
UT WOS:000248484400062
PM 17636913
DA 2021-01-25
ER

PT J
AU Zumbuehl, A
   Ferreira, L
   Kuhn, D
   Astashkina, A
   Long, L
   Yeo, Y
   Iaconis, T
   Ghannoum, M
   Fink, GR
   Langer, R
   Kohane, DS
AF Zumbuehl, Andreas
   Ferreira, Lino
   Kuhn, Duncan
   Astashkina, Anna
   Long, Lisa
   Yeo, Yoon
   Iaconis, Tiffany
   Ghannoum, Mahmoud
   Fink, Gerald R.
   Langer, Robert
   Kohane, Daniel S.
TI Antifungal hydrogels
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE antibiotic; Candida albicans; matrix
ID CANDIDA-ALBICANS; AMPHOTERICIN-B; ENZYMATIC-SYNTHESIS; BIOFILM
   FORMATION; SURFACE; BACTERIA
AB Fungi are increasingly identified as major pathogens in bloodstream infections, often involving indwelling devices. Materials with antifungal properties may provide an important deterrent to these infections. Here we describe amphogel, a dextran-based hydrogel into which amphotericin B is adsorbed. Amphogel kills fungi within 2 h of contact and can be reused for at least 53 days without losing its effectiveness against Candida albicans. The antifungal material is biocompatible in vivo and does not cause hemolysis in human blood. Amphogel inoculated with C albicans and implanted in mice prevents fungal infection. Amphogel also mitigates fungal biofilm formation. An antifungal matrix with these properties could be used to coat a variety of medical devices such as catheters as well as industrial surfaces.
C1 Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.
   MIT, Cambridge, MA 02139 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.
   Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.
   Case Western Reserve Univ, Univ Hosp Cleveland, Ctr Med Mycol, Cleveland, OH 44106 USA.
   Harvard Univ, Sch Med, Childrens Hosp, Dept Anesthesiol,Div Crit Care Med, Boston, MA 02115 USA.
RP Fink, GR (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
EM gfink@wi.mit.edu; rlanger@mit.edu; daniel.kohane@childrens.harvard.edu
OI ferreira, lino/0000-0001-8985-9302
FU NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R44DE017846, R43DE017846, R44DE017846] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM073626,
   R01GM073626, R37GM035010, R37GM035010, R01GM073626, R37GM035010,
   R01GM073626, R37GM035010, R01GM035010, R01GM073626, R01GM035010,
   R01GM073626, R01GM035010, R01GM035010, R01GM035010, R37GM035010,
   R01GM035010, R01GM035010, R01GM073626, R01GM035010, R01GM073626,
   R37GM035010, R01GM073626, R01GM035010, R01GM035010, R01GM035010,
   R01GM035010, R01GM035010, R01GM035010, R01GM073626, R01GM035010,
   R01GM035010, R01GM073626, R01GM073626, R01GM035010, R01GM035010,
   R01GM035010, R01GM073626, R37GM035010, R01GM073626, R01GM035010,
   R01GM035010, R01GM035010, R01GM035010, R01GM073626, R01GM073626,
   R37GM035010, R37GM035010, R37GM035010] Funding Source: NIH RePORTER;
   NIDCR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [DE017846, R43 DE017846, R44 DE017846]
   Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01 GM073626, GM073626,
   GM035010, R01 GM035010] Funding Source: Medline
CR Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Cereghetti DM, 2006, SYNTHESIS-STUTTGART, P914, DOI 10.1055/s-2006-926368
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chandra J, 2005, APPL ENVIRON MICROB, V71, P8795, DOI 10.1128/AEM.71.12.8795-8801.2005
   Chang JY, 2002, J CONTROL RELEASE, V82, P39, DOI 10.1016/S0168-3659(02)00086-X
   DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Ferreira L, 2004, J BIOMED MATER RES A, V68A, P584, DOI 10.1002/jbm.a.20102
   Ferreira L, 2002, BIOMATERIALS, V23, P3957, DOI 10.1016/S0142-9612(02)00132-1
   Ferreira L, 2002, BIOMACROMOLECULES, V3, P333, DOI 10.1021/bm010150h
   Frazier RA, 2000, BIOMATERIALS, V21, P957, DOI 10.1016/S0142-9612(99)00270-7
   Hartsel S, 1996, TRENDS PHARMACOL SCI, V17, P445, DOI 10.1016/S0165-6147(96)01012-7
   Hirota K, 2005, FEMS MICROBIOL LETT, V248, P37, DOI 10.1016/j.femsle.2005.05.019
   Imbert C, 2003, J ANTIMICROB CHEMOTH, V51, P281, DOI 10.1093/jac/dkg088
   Kuhn DM, 2002, ANTIMICROB AGENTS CH, V46, P1773, DOI 10.1128/AAC.46.6.1773-1780.2002
   Kuhn Duncan M, 2004, Curr Opin Investig Drugs, V5, P186
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Lin J, 2003, BIOTECHNOL BIOENG, V83, P168, DOI 10.1002/bit.10651
   Mehvar R, 2000, J CONTROL RELEASE, V69, P1, DOI 10.1016/S0168-3659(00)00302-3
   NGUYEN MH, 1995, ARCH INTERN MED, V155, P2429, DOI 10.1001/archinte.155.22.2429
   O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49
   Roosjen A, 2003, MICROBIOL-SGM, V149, P3239, DOI 10.1099/mic.0.26519-0
   Shishu, 2006, INT J PHARM, V326, P20, DOI 10.1016/j.ijpharm.2006.07.001
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Verstrepen KJ, 2004, NAT REV MICROBIOL, V2, P533, DOI 10.1038/nrmicro927
   Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946
   Zumbuehl A, 2004, ANGEW CHEM INT EDIT, V43, P5181, DOI 10.1002/anie.200460489
NR 28
TC 70
Z9 70
U1 1
U2 34
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 7
PY 2007
VL 104
IS 32
BP 12994
EP 12998
DI 10.1073/pnas.0705250104
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 198TL
UT WOS:000248650300009
PM 17664427
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Zhou, H
   Jungbluth, H
   Sewry, CA
   Feng, L
   Bertini, E
   Bushby, K
   Straub, V
   Roper, H
   Rose, MR
   Brockington, M
   Kinali, M
   Manzur, A
   Robb, S
   Appleton, R
   Messina, S
   D'Amico, A
   Quinlivan, R
   Swash, M
   Muller, CR
   Brown, S
   Treves, S
   Muntoni, F
AF Zhou, Haiyan
   Jungbluth, Heinz
   Sewry, Caroline A.
   Feng, Lucy
   Bertini, Enrico
   Bushby, Kate
   Straub, Volker
   Roper, Helen
   Rose, Michael R.
   Brockington, Martin
   Kinali, Maria
   Manzur, Adnan
   Robb, Stephanie
   Appleton, Richard
   Messina, Sonia
   D'Amico, Adele
   Quinlivan, Ros
   Swash, Michael
   Mueller, Clemens R.
   Brown, Susan
   Treves, Susan
   Muntoni, Francesco
TI Molecular mechanisms and phenotypic variation in RYRI=related congenital
   myopathies
SO BRAIN
LA English
DT Article
DE skeletal muscle ryanodine receptor gene (RYRI); central core disease
   (CCD); multi-minicore disease (MmD); genotype-phenotype correlations
ID CENTRAL CORE DISEASE; MUSCLE RYANODINE RECEPTOR; MULTI-MINICORE DISEASE;
   MALIGNANT HYPERTHERMIA SUSCEPTIBILITY; RECESSIVE RYR1 MUTATIONS; CA2+
   RELEASE CHANNEL; MULTIMINICORE DISEASE; GENE; OPHTHALMOPLEGIA;
   IDENTIFICATION
AB Dominant mutations in the skeletal muscle ryanodine receptor (RYRI) gene are well-recognized causes of both malignant hyperthermia susceptibility (MHS) and central core disease (CCD). More recently, recessive RYRI mutations have been described in few congenital myopathy patients with variable pathology, including multi-minicores. Although a clinical overlap between patients with dominant and recessive RYRI mutations exists, in most cases with recessive mutations the pattern of muscle weakness is remarkably different from that observed in dominant CCD.
   In order to characterize the spectrum of congenital myopathies associated with RYRI mutations, we have investigated a cohort of 44 patients from 28 families with clinical and/or histopathological features suggestive of RYRI involvement. We have identified 25 RYRI mutations, 9 of them novel, including 12 dominant and 13 recessive mutations. With only one exception, dominant mutations were associated with a CCD phenotype, prominent cores and predominantly occurred in the RYRI C-terminal exons 101 and 102. In contrast, the 13 recessive RYRI mutations were distributed evenly along the entire RYRI gene and were associated with a wide range of clinicopathological phenotypes.
   Protein expression studies in nine cases suggested a correlation between specific mutations, RyRI protein levels and resulting phenotype: in particular, whilst patients with dominant or recessive mutations associated with typical CCD phenotypes appeared to have normal RyRI expression, individuals with more generalized weakness, multi-minicores and external ophthalmoplegia had a pronounced depletion of the RyRI protein.
   The phenomenon of protein depletion was observed in some patients compound heterozygous for recessive mutations at the genomic level and silenced another allele in skeletal muscle, providing additional information on the mechanism of disease in these patients.
   Our data represent the most extensive study of RYRI-related myopathies and indicate complex genotype-phenotype correlations associated with mutations differentially affecting assembly and function of the RyRI calcium release channel.
C1 Hammersmith Hosp, Imperial Coll, Dubowitz Neuromuscular Ctr, London W12 0NN, England.
   St Thomas Hosp, Evelina Childrens Hosp, Dept Paediat Neurol, London SE1 7EH, England.
   Robert Jones & Agnes Hunt Orthopaed Hosp, Ctr Inherited Neuromuscular Disorders, Oswestry SY10 7AG, Shrops, England.
   Osped Bambino, Mol Med Unit, Rome, Italy.
   Univ Newcastle Upon Tyne, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
   Kings Coll Hosp, Dept Neurol, London, England.
   Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England.
   Univ Messina, Dept Neurosci Psychiat & Anaesthesiol, Messina, Italy.
   Royal London Hosp, Dept Neurol, London E1 1BB, England.
   Univ Wurzburg, Inst Human Genet, Biozentrum Hubland, D-97070 Wurzburg, Germany.
   Univ Basel, Dept Anaesthesia & Res, CH-4031 Basel, Switzerland.
RP Muntoni, F (corresponding author), Hammersmith Hosp, Imperial Coll, Dubowitz Neuromuscular Ctr, London W12 0NN, England.
EM f.muntoni@imperial.ac.uk
RI Jungbluth, Heinz/B-8893-2012; Bertini, Enrico/ABG-1278-2020; Bertini,
   Enrico/A-2284-2014
OI Bertini, Enrico/0000-0001-9276-4590; Messina, Sonia/0000-0001-7994-3391;
   Treves, Susan/0000-0002-0007-9631; Straub, Volker/0000-0001-9046-3540;
   Swash, Michael/0000-0002-8717-8914; Jungbluth, Heinz/0000-0002-7159-3427
CR Barone V, 1999, J MED GENET, V36, P115
   Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3
   DEUFEL T, 1992, NEUROMUSCULAR DISORD, V2, P389, DOI 10.1016/S0960-8966(06)80010-6
   Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999
   Du GG, 2004, J BIOL CHEM, V279, P37566, DOI 10.1074/jbc.M406637200
   Dubowitz V., 2007, MUSCLE BIOPSY PRACTI
   Ducreux S, 2006, BIOCHEM J, V395, P259, DOI 10.1042/BJ20051282
   Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231
   Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719
   Galli L, 2002, CELL CALCIUM, V32, P143, DOI 10.1016/S0143-4160(02)00138-0
   Galli L, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9442
   Jungbluth H, 2005, NEUROLOGY, V65, P1930, DOI 10.1212/01.wnl.0000188870.37076.f2
   Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P785, DOI 10.1016/j.nmd.2004.08.006
   Jungbluth H, 2003, EUR J PAEDIATR NEURO, V7, P23, DOI 10.1016/S1090-3798(02)00136-8
   Jungbluth H, 2002, NEUROLOGY, V59, P284, DOI 10.1212/WNL.59.2.284
   Jungbluth H, 2007, NEUROMUSCULAR DISORD, V17, P338, DOI 10.1016/j.nmd.2007.01.016
   Lynch PJ, 1997, ANESTHESIOLOGY, V86, P620, DOI 10.1097/00000542-199703000-00014
   Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581
   Monnier N, 2005, HUM MUTAT, V26, P413, DOI 10.1002/humu.20231
   Monnier N, 2003, HUM MOL GENET, V12, P1171, DOI 10.1093/hmg/ddg121
   Monnier N, 2000, HUM MOL GENET, V9, P2599, DOI 10.1093/hmg/9.18.2599
   QUANE KA, 1993, NAT GENET, V5, P51, DOI 10.1038/ng0993-51
   Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   SHUAIB A, 1987, MEDICINE, V66, P389, DOI 10.1097/00005792-198709000-00004
   Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008
   Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077
   Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092
   ZHANG YL, 1993, NAT GENET, V5, P46, DOI 10.1038/ng0993-46
   Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500
   Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221
   Zorzato F, 2003, HUM MOL GENET, V12, P379, DOI 10.1093/hmg/ddg032
   Zorzato F, 2007, IUBMB LIFE, V59, P14, DOI 10.1080/15216540601187803
NR 33
TC 106
Z9 112
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0006-8950
J9 BRAIN
JI Brain
PD AUG
PY 2007
VL 130
BP 2024
EP 2036
DI 10.1093/brain/awm096
PN 8
PG 13
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 205EV
UT WOS:000249097700008
PM 17483490
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Wendeler, MW
   Nufer, O
   Hauri, HP
AF Wendeler, Markus W.
   Nufer, Oliver
   Hauri, Hans-Peter
TI Improved maturation of CFTR by an ER export signal
SO FASEB JOURNAL
LA English
DT Article
DE cystic fibrosis; membrane traffic; transport signal
ID TRANSMEMBRANE CONDUCTANCE REGULATOR; EARLY SECRETORY PATHWAY;
   COPII-DEPENDENT EXPORT; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM;
   DELTA-F508 CFTR; PDZ DOMAINS; CHLORIDE CHANNEL; MOLECULAR-BASIS;
   GENE-THERAPY
AB The cystic fibrosis transmembrane conductance regulator ( CFTR) is a cAMP-regulated chloride channel in the plasma membrane of several epithelial cells. Maturation of CFTR is inefficient in most cells, with only a fraction of nascent chains being properly folded and transported to the cell surface. The most common mutation in CFTR, CFTR- Delta F508, leads to the genetic disease cystic fibrosis. CFTR- Delta F508 has a temperature-sensitive folding defect and is almost quantitatively degraded in the endoplasmic reticulum ( ER). Here we tested whether a strong ER export signal appended to CFTR improves its transport and surface expression. We show that a single valine ER export signal at the C terminus of the cytoplasmic tail of CFTR improves maturation of wild-type CFTR by 2-fold. This conservative mutation interfered with neither plasma membrane localization nor stability of mature CFTR. In contrast, the valine signal was unable to rescue CFTR- Delta F508 from ER-associated degradation. Our finding of improved maturation of CFTR mediated by a valine signal may be of potential use in gene therapy of cystic fibrosis. Moreover, failure of the valine signal to rescue CFTR- Delta F508 from ER degradation indicates that the inability of CFTR-Delta F508 to leave the ER is unlikely to be due to a malfunctioning ER export signal.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
CR Bannykh SI, 2000, TRAFFIC, V1, P852, DOI 10.1034/j.1600-0854.2000.011105.x
   Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5
   Bezprozvanny I, 2001, P NATL ACAD SCI USA, V98, P787, DOI 10.1073/pnas.98.3.787
   Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041
   Bradbury NA, 1999, PHYSL REV S, V79, P175, DOI DOI 10.1152/physrev.1999.79.1.S175
   Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3
   CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8
   Cyr DM, 2005, NAT STRUCT MOL BIOL, V12, P2, DOI 10.1038/nsmb0105-2
   Davidson MH, 2006, ATHEROSCLEROSIS SUPP, V7, P1, DOI 10.1016/S1567-5688(06)80003-6
   Davies JC, 2001, J GENE MED, V3, P409, DOI 10.1002/jgm.200
   Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509
   Gelman MS, 2002, J BIOL CHEM, V277, P11709, DOI 10.1074/jbc.M111958200
   Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101
   Griesenbach U, 2002, GENE THER, V9, P1344, DOI 10.1038/sj.gt.3301791
   JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4
   Jilling T, 1997, INT REV CYTOL, V172, P193, DOI 10.1016/S0074-7696(08)62361-X
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Kleizen B, 2000, EUR J CELL BIOL, V79, P544, DOI 10.1078/0171-9335-00078
   KOPITO RR, 1999, PHYSIOL REV, V79, P167
   Liu SS, 2005, J PHARMACOL EXP THER, V314, P846, DOI 10.1124/jpet.105.083519
   Liu XH, 2006, J BIOL CHEM, V281, P8275, DOI 10.1074/jbc.M512458200
   Liu XM, 2002, NAT BIOTECHNOL, V20, P47, DOI 10.1038/nbt0102-47
   Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879
   LUKACS GL, 1994, EMBO J, V13, P6076, DOI 10.1002/j.1460-2075.1994.tb06954.x
   Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316
   Mickle JE, 1998, HUM MOL GENET, V7, P729, DOI 10.1093/hmg/7.4.729
   Miller E, 2002, EMBO J, V21, P6105, DOI 10.1093/emboj/cdf605
   Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1
   Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759
   Nufer O, 2002, J CELL SCI, V115, P619
   Ostrowski LE, 2003, MOL THER, V8, P637, DOI 10.1016/S1525-0016(03)00221-1
   PIND S, 1994, J BIOL CHEM, V269, P12784
   Reddy MM, 1999, NATURE, V402, P301, DOI 10.1038/46297
   Riordan JR, 2005, ANNU REV PHYSIOL, V67, P701, DOI 10.1146/annurev.physiol.67.032003.154107
   Riordan JR, 1999, AM J HUM GENET, V64, P1499, DOI 10.1086/302429
   RIORDAN JR, 1989, SCIENCE, V245, P1066
   Riordan JR, 1999, PEDIATR PULM, P83
   Short DB, 1998, J BIOL CHEM, V273, P19797, DOI 10.1074/jbc.273.31.19797
   Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73
   Sun F, 2006, J BIOL CHEM, V281, P36856, DOI 10.1074/jbc.M607085200
   Sun WM, 2006, GENET MED, V8, P339, DOI 10.1097/01.gim.0000223549.57443.16
   Swiatecka-Urban A, 2002, J BIOL CHEM, V277, P40099, DOI 10.1074/jbc.M206964200
   Varga K, 2004, J BIOL CHEM, V279, P22578, DOI 10.1074/jbc.M401522200
   Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5
   Wang SS, 2000, CELL, V103, P169, DOI 10.1016/S0092-8674(00)00096-9
   Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035
   Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043
   WARD CL, 1994, J BIOL CHEM, V269, P25710
   WARD CL, 1995, CELL, V83, P121, DOI 10.1016/0092-8674(95)90240-6
   YANG YP, 1993, HUM MOL GENET, V2, P1253, DOI 10.1093/hmg/2.8.1253
   Yoo JS, 2002, J BIOL CHEM, V277, P11401, DOI 10.1074/jbc.M110263200
   Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041
   ZHAO W, 2006, J BIOL CHEM
NR 55
TC 4
Z9 4
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD AUG
PY 2007
VL 21
IS 10
BP 2352
EP 2358
DI 10.1096/fj.07-8128com
PG 7
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 196AS
UT WOS:000248454400010
PM 17392477
DA 2021-01-25
ER

PT J
AU Chanut-Delalande, H
   Jung, AC
   Lin, L
   Baer, MM
   Bilstein, A
   Cabernard, C
   Leptin, M
   Affolter, M
AF Chanut-Delalande, Helene
   Jung, Alain C.
   Lin, Li
   Baer, Magdalena M.
   Bilstein, Andreas
   Cabernard, Clemens
   Leptin, Maria
   Affolter, Markus
TI A genetic mosaic analysis with a repressible cell marker screen to
   identify genes involved in tracheal cell migration during drosophila air
   sac morphogenesis
SO GENETICS
LA English
DT Article
ID TRANSDUCING ADAPTER MOLECULE; FGF RECEPTOR HOMOLOG; BRANCHING
   MORPHOGENESIS; GROWTH-FACTOR; HEPARAN-SULFATE; DOWN-REGULATION; HRS;
   BINDING; PROTEIN; SYSTEM
AB Branching morphogenesis of the Drosophila tracheal system relies on the fibroblast growth factor receptor (FGFR) signaling pathway. The Drosophila FGF ligand Branchless (Bnl) and the FGFR Breathless (Bt1/FGFR) are required for cell migration during the establishment of the interconnected network of tracheal tubes. However, due to an important maternal contribution of members of the FGFR pathway in the oocyte, a thorough genetic dissection of the role of components of the FGFR signaling cascade in tracheal cell migration is impossible in the embryo. To bypass this shortcoming, we studied tracheal cell migration in the dorsal air sac primordium, a structure that forms during late larval development. Using a mosaic analysis with a repressible cell marker (MARCM) clone approach in mosaic animals, combined with an ethyl methanesulfonate (EMS)-mutagenesis screen of the left arm of the second chromosome, we identified novel genes implicated in cell migration. We screened 1123 mutagenized lines and identified 47 lines displaying tracheal cell migration defects in the air sac primordium. Using complementation analyses based on lethality, mutations in 20 of these lines were genetically mapped to specific genomic areas. Three of the mutants were mapped to either the Mhc or the stam complementation groups. Further experiments confirmed that these genes are required for cell migration in the tracheal air sac primordium.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Univ Cologne, Inst Genet, D-50674 Cologne, Germany.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Jung, Alain/AAC-6598-2019; Cabernard, Clemens/A-9033-2010; Jung,
   Alain/X-5384-2019
OI Jung, Alain/0000-0002-4049-4151; CHANUT-DELALANDE,
   Helene/0000-0002-1720-2069; Affolter, Markus/0000-0002-5171-0016;
   Cabernard, Clemens/0000-0003-3706-6401; Baer,
   Magdalena/0000-0003-3315-0921
CR Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785
   Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200
   Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088
   Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004
   BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Cabernard C, 2004, J APPL PHYSIOL, V97, P2347, DOI 10.1152/japplphysiol.00435.2004
   Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002
   Endo K, 2000, FEBS LETT, V477, P55, DOI 10.1016/S0014-5793(00)01760-9
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Guha A, 2005, DEV BIOL, V287, P192, DOI 10.1016/j.ydbio.2005.09.005
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Imam F, 1999, GENETICS, V152, P307
   Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019
   Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lin XH, 1999, DEVELOPMENT, V126, P3715
   Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Manning G., 1993, DEV DROSOPHILA MELAN, V1, P609
   Michelson AM, 1998, DEVELOPMENT, V125, P4379
   MOGAMI K, 1986, P NATL ACAD SCI USA, V83, P1393, DOI 10.1073/pnas.83.5.1393
   ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0
   Pandey A, 2000, J BIOL CHEM, V275, P38633, DOI 10.1074/jbc.M007849200
   Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312
   Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Takata H, 2000, GENES CELLS, V5, P57, DOI 10.1046/j.1365-2443.2000.00303.x
   Takeshita T, 1996, BIOCHEM BIOPH RES CO, V225, P1035, DOI 10.1006/bbrc.1996.1290
   Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Wang XJ, 2006, DEV CELL, V10, P483, DOI 10.1016/j.devcel.2006.02.003
   Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1
   WHITTEN J, 1980, GENET BIOL DROSOPHIL, P499
   Yamashita RA, 2000, J MUSCLE RES CELL M, V21, P491, DOI 10.1023/A:1026589626422
NR 42
TC 15
Z9 15
U1 0
U2 2
PU GENETICS
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202 USA
SN 0016-6731
J9 GENETICS
JI Genetics
PD AUG
PY 2007
VL 176
IS 4
BP 2177
EP 2187
DI 10.1534/genetics.107.073890
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 211NH
UT WOS:000249530000021
PM 17603108
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Majlessi, L
   Combaluzier, B
   Albrecht, I
   Garcia, JE
   Nouze, C
   Pieters, J
   Leclerc, C
AF Majlessi, Laleh
   Combaluzier, Benoit
   Albrecht, Imke
   Garcia, Jessica E.
   Nouze, Clemence
   Pieters, Jean
   Leclerc, Claude
TI Inhibition of phagosome maturation by mycobacteria does not interfere
   with presentation of mycobacterial antigens by MHC molecules
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID CLASS-II MOLECULES; PROTEIN-KINASE-G; CATHEPSIN-S; T-CELLS; TUBERCULOSIS
   PHAGOSOME; EXOGENOUS ANTIGENS; INVARIANT CHAIN; COMPLEX; TRAFFICKING;
   EXPRESSION
AB Pathogenic mycobacteria escape host innate immune responses by surviving within phagosomes of host macrophages and blocking their delivery to lysosomes. Avoiding lysosomal delivery may also be involved in the capacity of living mycobacteria to modulate MHC class I- or II-dependent T cell responses, which may contribute to their pathogenicity in vivo. In this study, we show that the presentation of mycobacterial Ags is independent of the site of intracellular residence inside professional APCs. Infection of mouse macrophages or dendritic cells in vitro with mycobacterial mutants that are unable to escape lysosomal transfer resulted in an identical efficiency of Ag presentation compared with wild-type mycobacteria. Moreover, in vivo, such mutants induced CD4(+) Th1 or CD8(+) CTL responses in mice against various mycobacterial Ags that were comparable to those induced by their wild-type counterparts. These results suggest that the limiting factor for the generation of an adaptive immune response against mycobacteria is not the degree of lysosomal delivery. These findings are important in the rational design of improved vaccines to combat mycobacterial diseases.
C1 Inst Pasteur, INSERM, Unite 883, F-75724 Paris 15, France.
   Unite Regulat Immunitaire & Vaccinnol, Inst Pasteur, Paris, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Majlessi, L (corresponding author), Inst Pasteur, INSERM, Unite 883, 25 Rue Docteur Roux, F-75724 Paris 15, France.
EM lmajless@pasteur.fr
OI Pieters, Jean/0000-0002-5284-9757
CR Albrecht I, 2006, INT IMMUNOL, V18, P755, DOI 10.1093/intimm/dxl013
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Barker LP, 1997, INFECT IMMUN, V65, P1497, DOI 10.1128/IAI.65.4.1497-1504.1997
   Blander JM, 2006, NATURE, V440, P808, DOI 10.1038/nature04596
   Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007
   Bryant PW, 2002, ADV IMMUNOL, V80, P71, DOI 10.1016/S0065-2776(02)80013-X
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257
   Clemens DL, 2000, INFECT IMMUN, V68, P5154, DOI 10.1128/IAI.68.9.5154-5166.2000
   Clemens DL, 1996, J EXP MED, V184, P1349, DOI 10.1084/jem.184.4.1349
   DAVIDSON HW, 1989, J CELL BIOL, V109, P85, DOI 10.1083/jcb.109.1.85
   Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003
   Denis O, 1998, INFECT IMMUN, V66, P1527, DOI 10.1128/IAI.66.4.1527-1533.1998
   Driessen C, 1999, J CELL BIOL, V147, P775, DOI 10.1083/jcb.147.4.775
   Engering AJ, 1997, EUR J IMMUNOL, V27, P2417, DOI 10.1002/eji.1830270941
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3
   Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911
   Hackam DJ, 1997, J BIOL CHEM, V272, P29810, DOI 10.1074/jbc.272.47.29810
   Hervas-Stubbs S, 2006, INFECT IMMUN, V74, P3396, DOI 10.1128/IAI.02086-05
   Hmama Z, 1998, J IMMUNOL, V161, P4882
   Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912
   HUYGEN K, 1994, INFECT IMMUN, V62, P363, DOI 10.1128/IAI.62.2.363-370.1994
   Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003
   KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629
   Lewinsohn DM, 2006, J IMMUNOL, V177, P437, DOI 10.4049/jimmunol.177.1.437
   Lo-Man R, 2000, INFECT IMMUN, V68, P3079, DOI 10.1128/IAI.68.6.3079-3089.2000
   Majlessi L, 2006, INFECT IMMUN, V74, P2128, DOI 10.1128/IAI.74.4.2128-2137.2006
   Majlessi L, 2003, INFECT IMMUN, V71, P7173, DOI 10.1128/IAI.71.12.7173-7177.2003
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Noss EH, 2001, J IMMUNOL, V167, P910, DOI 10.4049/jimmunol.167.2.910
   OJCIUS DM, 1993, BIOCHEM BIOPH RES CO, V197, P1216, DOI 10.1006/bbrc.1993.2606
   Okkels LM, 2004, J BACTERIOL, V186, P2487, DOI 10.1128/JB.186.8.2487-2491.2004
   PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550
   PETERS PJ, 1991, NATURE, V349, P669, DOI 10.1038/349669a0
   Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1
   Pieters J, 1997, BIOL CHEM, V378, P751
   Pluger EBE, 2002, EUR J IMMUNOL, V32, P467, DOI 10.1002/1521-4141(200202)32:2<467::AID-IMMU467>3.0.CO;2-Y
   Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859
   Ramachandra L, 1999, IMMUNOL REV, V168, P217, DOI 10.1111/j.1600-065X.1999.tb01295.x
   Ramachandra L, 2001, J EXP MED, V194, P1421, DOI 10.1084/jem.194.10.1421
   Roy CR, 2006, NAT REV IMMUNOL, V6, P136, DOI 10.1038/nri1775
   Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906
   SHI GP, 1992, J BIOL CHEM, V267, P7258
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   Tekaia F., 1999, Tubercle and Lung Disease, V79, P329, DOI 10.1054/tuld.1999.0220
   Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538
   TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Villadangos JA, 1997, J EXP MED, V186, P549, DOI 10.1084/jem.186.4.549
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   WATTS C, 1988, EMBO J, V7, P1937, DOI 10.1002/j.1460-2075.1988.tb03031.x
   WIKER HG, 1992, MICROBIOL REV, V56, P648, DOI 10.1128/MMBR.56.4.648-661.1992
   Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001
   XU SM, 1994, J IMMUNOL, V153, P2568
NR 57
TC 26
Z9 26
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD AUG 1
PY 2007
VL 179
IS 3
BP 1825
EP 1833
DI 10.4049/jimmunol.179.3.1825
PG 9
WC Immunology
SC Immunology
GA 194BU
UT WOS:000248319700046
PM 17641049
OA Bronze
DA 2021-01-25
ER

PT J
AU Engel, A
   Winkler, FK
AF Engel, Andreas
   Winkler, Fritz K.
TI 3rd International conference on structure, dynamics and function of
   proteins in biological membranes
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Maurice E Mueller Inst, Biozentrum, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Maurice E Mueller Inst, Biozentrum, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM Andreas.Engel@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2007
VL 159
IS 2
BP 165
EP 165
DI 10.1016/j.jsb.2007.07.003
PG 1
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 198MG
UT WOS:000248631600001
PM 17660061
DA 2021-01-25
ER

PT J
AU Eifler, N
   Duckely, M
   Sumanovski, LT
   Egan, TM
   Oksche, A
   Konopka, JB
   Luthi, A
   Engel, A
   Werten, PJL
AF Eifler, Nora
   Duckely, Myriam
   Sumanovski, Lazar T.
   Egan, Terrance M.
   Oksche, Alexander
   Konopka, James B.
   Luethi, Anita
   Engel, Andreas
   Werten, Paul J. L.
TI Functional expression of mammalian receptors and membrane channels in
   different cells
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Structure, Dynamics and Function of
   Proteins in Biological Membranes
CY MAY 14-19, 2006
CL Mt Verita, SWITZERLAND
DE eukaryotic expression systems; membrane protein expression; protein
   activity; protein localization; protein solubility
ID PROTEIN-COUPLED RECEPTORS; MU-OPIOID-RECEPTOR; ALPHA-FACTOR PHEROMONE;
   LARGE-SCALE PRODUCTION; SACCHAROMYCES-CEREVISIAE; PACEMAKER CHANNELS;
   LACTOCOCCUS-LACTIS; LIPID RAFTS; PURIFICATION; BACULOVIRUS
AB In native tissues, the majority of medically important membrane proteins is only present at low concentrations, making their overexpression in recombinant systems a prerequisite for structural studies. Here, we explore the commonly used eukaryotic expression systems-yeast, baculovirus/insect cells (Sf9) and Semliki Forest Virus (SFV)/mammalian cells-for the expression of seven different eukaryotic membrane proteins from a variety of protein families. The expression levels, quality, biological activity, localization and solubility of all expressed proteins are compared in order to identify the advantages of one system over the other. SFV-transfected mammalian cell lines provide the closest to native environment for the expression of mammalian membrane proteins, and they exhibited the best overall performance. But depending on the protein, baculovirus-infected Sf9 cells performed almost as well as mammalian cells. The lowest expression levels for the proteins tested here were obtained in yeast. (C) 2007 Published by Elsevier Inc.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA.
   Forsch Inst Mol Pharmakol, D-13125 Berlin, Germany.
   SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Oksche, Alexander/M-6678-2019; Horstmann, Britta/C-2154-2008
OI Oksche, Alexander/0000-0003-4592-1770; Egan,
   Terrance/0000-0002-7249-3161; Konopka, James/0000-0001-5989-4086
CR Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818
   Akermoun M, 2005, PROTEIN EXPRES PURIF, V44, P65, DOI 10.1016/j.pep.2005.04.016
   Andre N, 2006, PROTEIN SCI, V15, P1115, DOI 10.1110/ps.062098206
   Barbuti A, 2004, CIRC RES, V94, P1325, DOI 10.1161/01.RES.0000127621.54132.AE
   Borgnia M, 1999, ANNU REV BIOCHEM, V68, P425, DOI 10.1146/annurev.biochem.68.1.425
   Davis I., 1997, CHILD WELFARE RES RE, V2, P272
   deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996
   DIFRANCESCO D, 1986, NATURE, V324, P470, DOI 10.1038/324470a0
   Ding SH, 1999, J GEN PHYSIOL, V113, P695, DOI 10.1085/jgp.113.5.695
   Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703
   Dolby V, 2004, PROTEIN EXPRES PURIF, V37, P455, DOI 10.1016/j.pep.2004.06.018
   Drew D, 2005, PROTEIN SCI, V14, P2011, DOI 10.1110/ps.051466205
   Duvernay MT, 2005, CELL SIGNAL, V17, P1457, DOI 10.1016/j.cellsig.2005.05.020
   Egan TM, 2004, J NEUROSCI, V24, P3413, DOI 10.1523/JNEUROSCI.5429-03.2004
   Eroglu C, 2002, EMBO REP, V3, P491, DOI 10.1093/embo-reports/kvf088
   Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768
   Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006
   Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279
   GINIGER E, 1985, CELL, V40, P767, DOI 10.1016/0092-8674(85)90336-8
   Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6
   Hasslacher M, 1997, PROTEIN EXPRES PURIF, V11, P61, DOI 10.1006/prep.1997.0765
   He QF, 1999, EUR J BIOCHEM, V263, P561, DOI 10.1046/j.1432-1327.1999.00526.x
   Heymann JB, 1999, NEWS PHYSIOL SCI, V14, P187
   Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631
   Hu YC, 2005, ACTA PHARMACOL SIN, V26, P405, DOI 10.1111/j.1745-7254.2005.00078.x
   Innamorati G, 1997, J BIOL CHEM, V272, P2486
   JENNESS DD, 1986, MOL CELL BIOL, V6, P318, DOI 10.1128/MCB.6.1.318
   Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   Kempf J, 2002, J BIOTECHNOL, V95, P181, DOI 10.1016/S0168-1656(02)00008-1
   Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886
   Klaassen CHW, 1999, BIOCHEM J, V342, P293, DOI 10.1042/0264-6021:3420293
   Konopka JB, 1996, P NATL ACAD SCI USA, V93, P6764, DOI 10.1073/pnas.93.13.6764
   Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   Kunji ERS, 2003, BBA-BIOMEMBRANES, V1610, P97, DOI 10.1016/S0005-2736(02)00712-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lagane B, 2000, J BIOL CHEM, V275, P33197, DOI 10.1074/jbc.C000576200
   Lee BK, 2001, J BIOL CHEM, V276, P37950
   Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8
   LILJESTROM P, 1991, BIO-TECHNOL, V9, P1356, DOI 10.1038/nbt1291-1356
   Liu K, 2005, P NATL ACAD SCI USA, V102, P2192, DOI 10.1073/pnas.0409232102
   Lu M, 2003, TRAFFIC, V4, P416, DOI 10.1034/j.1600-0854.2003.00097.x
   Luckow Verne A., 1993, Current Opinion in Biotechnology, V4, P564, DOI 10.1016/0958-1669(93)90078-B
   Lundstrom Kenneth, 2006, Journal of Structural and Functional Genomics, V7, P77, DOI 10.1007/s10969-006-9011-2
   Lundstrom Kenneth, 2003, Methods Mol Med, V76, P525
   Makuc J, 2004, FEMS YEAST RES, V4, P795, DOI 10.1016/j.femsyr.2004.06.003
   MARQUARDT T, 1992, J CELL BIOL, V117, P505, DOI 10.1083/jcb.117.3.505
   Menzel R, 1997, YEAST, V13, P1211, DOI 10.1002/(SICI)1097-0061(199710)13:13<1211::AID-YEA168>3.0.CO;2-8
   Monne M, 2005, PROTEIN SCI, V14, P3048, DOI 10.1110/ps.051689905
   Oksche A, 2002, MOL ENDOCRINOL, V16, P799, DOI 10.1210/me.16.4.799
   OREILLY DR, 1988, BACULOVIRUS EXPRESSI
   Oshima A, 2003, J BIOL CHEM, V278, P1807, DOI 10.1074/jbc.M207713200
   Pausch MH, 1997, TRENDS BIOTECHNOL, V15, P487, DOI 10.1016/S0167-7799(97)01119-0
   Puri N, 2006, TRAFFIC, V7, P1482, DOI 10.1111/j.1600-0854.2006.00490.x
   Ratnala VRP, 2004, EUR J BIOCHEM, V271, P2636, DOI 10.1111/j.1432-1033.2004.04192.x
   Robben JH, 2004, MOL BIOL CELL, V15, P5693, DOI 10.1091/mbc.E04-04-0337
   Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734
   Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806
   Sarramegna V, 2005, PROTEIN EXPRES PURIF, V43, P85, DOI 10.1016/j.pep.2005.05.007
   Shukla AK, 2006, BIOCHEM BIOPH RES CO, V349, P6, DOI 10.1016/j.bbrc.2006.07.210
   Shusta EV, 1998, NAT BIOTECHNOL, V16, P773, DOI 10.1038/nbt0898-773
   STAUFFER KA, 1991, J CELL BIOL, V115, P141, DOI 10.1083/jcb.115.1.141
   Surade S, 2006, PROTEIN SCI, V15, P2178, DOI 10.1110/ps.062312706
   SWILLENS S, 1992, TRENDS PHARMACOL SCI, V13, P430, DOI 10.1016/0165-6147(92)90139-W
   Tate CG, 2003, BBA-BIOMEMBRANES, V1610, P141, DOI 10.1016/S0005-2736(02)00719-8
   Tate CG, 1998, METHOD ENZYMOL, V296, P443
   Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316
   Uozumi N, 2001, AM J PHYSIOL-CELL PH, V281, pC733
   Valkonen M, 2003, APPL ENVIRON MICROB, V69, P2065, DOI 10.1128/AEM.69.4.2065-2072.2003
   Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X
   Yasui M, 1999, NATURE, V402, P184
   Yin DZ, 2005, BIOCHEM BIOPH RES CO, V329, P281, DOI 10.1016/j.bbrc.2005.01.130
   Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec
NR 74
TC 31
Z9 31
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2007
VL 159
IS 2
BP 179
EP 193
DI 10.1016/j.jsb.2007.01.014
PG 15
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 198MG
UT WOS:000248631600003
PM 17368047
DA 2021-01-25
ER

PT J
AU Javelle, A
   Lupo, D
   Li, XD
   Merrick, M
   Chami, M
   Ripoche, P
   Winkler, FK
AF Javelle, Arnaud
   Lupo, Domenico
   Li, Xiao-Dan
   Merrick, Mike
   Chami, Mohamed
   Ripoche, Pierre
   Winkler, Fritz K.
TI Structural and mechanistic aspects of Amt/Rh proteins (vol 158, pg 472,
   2007)
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Correction
DE ammonia channels; ammonium transporters; Rhesus proteins; AmtB;
   liposomes
ID ESCHERICHIA-COLI; AMMONIUM TRANSPORTERS; MOLECULAR CHARACTERIZATION;
   MEMBRANE FLUIDITY; CRYSTAL-STRUCTURE; ION-TRANSPORT; RHESUS-B; AMTB;
   NH4+; NH3
AB Amt/Rh proteins, which mediate movement of ammonium across cell membranes, are spread throughout the three kingdoms of life. Most functional studies on various members of the family have been performed using cellular assays in heterologous expression systems, which are, however, not very well suited for detailed mechanistic studies. Although now generally considered to be ammonia conducting channels, based on a number of experimental studies and structural insights, the possibility remains that some plant Amts facilitate net ammonium ion transport. The Escherichia coli channel ArntB has become the model system of choice for analysis of the mechanism of ammonia conductance, increasingly also through molecular dynamics simulations. Further progress in a more detailed mechanistic understanding of these proteins requires a reliable in vitro assay using purified protein, allowing quantitative kinetic measurements under a variety of experimental conditions for different Amt/Rh proteins, including mutants. Here, we critically review the existing functional data in the context of the most interesting and unresolved mechanistic questions and we present our results, obtained using an in vitro assay set up with the purified E. coli channel AmtB. (C) 2007 Elsevier Inc. All rights reserved.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   John Innes Ctr Plant Sci Res, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Inst Natl Transfus Sanguine, INSERM, U665, F-75015 Paris, France.
RP Winkler, FK (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM fritz.winkler@psi.ch
OI li, xiaodan/0000-0001-8647-7317
CR AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH
   ALBALDAWI NF, 1992, BIOPHYS J, V61, P1470, DOI 10.1016/S0006-3495(92)81953-7
   Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102
   Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200
   Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y
   Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z
   Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001
   Conroy MJ, 2005, BRIT J HAEMATOL, V131, P543, DOI 10.1111/j.1365-2141.2005.05786.x
   Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536
   Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002
   Hemker MB, 2003, BRIT J HAEMATOL, V122, P333, DOI 10.1046/j.1365-2141.2003.04425.x
   Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X
   Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102
   Javelle A, 2003, MOL MICROBIOL, V47, P411, DOI 10.1046/j.1365-2958.2003.03303.x
   Javelle A, 2001, FEBS LETT, V505, P393, DOI 10.1016/S0014-5793(01)02802-2
   Javelle A, 1999, FEMS MICROBIOL ECOL, V30, P355, DOI 10.1111/j.1574-6941.1999.tb00663.x
   Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094
   Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200
   Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004
   Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200
   JAYAKUMAR A, 1986, J BACTERIOL, V166, P281, DOI 10.1128/jb.166.1.281-284.1986
   Kaback H R, 1974, Methods Enzymol, V31, P698
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67
   Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c
   Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012
   Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728
   Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200
   Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005
   Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8
   Marini AM, 2000, NAT GENET, V26, P341
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5
   Mayer M, 2006, PLANT BIOLOGY, V8, P522, DOI 10.1055/s-2006-923877
   Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369
   Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051
   Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135
   Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003
   Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Rigaud JL, 2003, METHOD ENZYMOL, V372, P65
   Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101
   SEVERI E, MOL MEMB BIOL
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799
   Soupene E, 2001, MOL CELL BIOL, V21, P5733, DOI 10.1128/MCB.21.17.5733-5741.2001
   Swietach P, 2003, PROG BIOPHYS MOL BIO, V83, P69, DOI 10.1016/S0079-6107(03)00027-0
   VANBLITTERSWIJK WJ, 1987, BIOCHEMISTRY-US, V26, P1746, DOI 10.1021/bi00380a038
   von Wiren N, 2004, TOP CURR GENET, V9, P95
   Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200
   WESTHOFF CM, 2004, J BIOL CHEM, DOI UNSP M311853200
   Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6
   Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026
   Yang HY, 2007, BIOPHYS J, V92, P877, DOI 10.1529/biophysj.106.090191
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657
NR 61
TC 1
Z9 1
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2007
VL 159
IS 2
BP 243
EP 252
DI 10.1016/S1047-8477(07)00165-7
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 198MG
UT WOS:000248631600009
PM 17660063
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Koser, J
   Huang, NP
   Schwarz-Herion, K
   Aebi, U
AF Lim, Roderick Y. H.
   Koeser, Joachim
   Huang, Ning-ping
   Schwarz-Herion, Kyrill
   Aebi, Ueli
TI Nanomechanical interactions of phenylalanine-glycine nucleoporins
   studied by single molecule force-volume spectroscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Conference on Structure, Dynamics and Function of
   Proteins in Biological Membranes
CY MAY 14-19, 2006
CL Mt Verita, SWITZERLAND
DE atomic force microscopy; binding promiscuity; nanomechanics; nuclear
   pore complex; natively unfolded proteins; nucleoporins
ID NUCLEAR-PORE COMPLEX; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT;
   ENTROPIC ELASTICITY; BINDING-DYNAMICS; STRUCTURAL BASIS; REPEAT REGIONS;
   PROTEIN IMPORT; MICROSCOPY; DNA
AB Phenylalanine-glycine (FG)-repeat nucleoporins (Nups) form the major components of the selective gating mechanism in the nuclear pore complex (NPC). Hence, a primary requirement is to understand how they vacillate between preventing the access of passively diffusing molecules and promoting the translocation of receptor-bound cargo into the NPC. To shed light on such behavior, we have studied the nanomechanical properties of a cysteine-modified FG-rich C-terminal domain of hNup153 (i.e., cNup153) and its interactions with importin-beta. This is carried out using single molecule force spectroscopy (SMFS) with the atomic force microscope (AFM). In the absence of importin-beta, cNup153 is highly flexible and can be reversibly stretched and relaxed without any change to its intrinsic entropic elasticity, indicating a lack of intra-FG interactions, i.e., natively unfolded. Importin-beta-modified AFM tips reveal complex binding topologies with cNup153, and provide evidence for binding promiscuity in FG-receptor interactions. These differences suggest that cooperativity between FG-domains arises from FG-receptor interactions instead of FG-FG interactions. On a technical note, this work highlights an improved SMFS technique which involves pre-passivating the underlying substrate surface with polyethylene glycol to reduce undesirable AFM tip-surface effects. A high yield of acceptable data is subsequently obtained from the low surface coverage of target molecules by implementing SMFS measurements in force-volume (FV) mode. (C) 2007 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Best RB, 2003, ANAL CHIM ACTA, V479, P87, DOI 10.1016/S0003-2670(02)01572-6
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Conti E, 2006, CURR OPIN STRUC BIOL, V16, P237, DOI 10.1016/j.sbi.2006.03.010
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Diamant H, 2000, PHYS REV E, V61, P6740, DOI 10.1103/PhysRevE.61.6740
   Diamant H, 2000, MACROMOLECULES, V33, P8050, DOI 10.1021/ma991021k
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344
   Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x
   Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213
   Kienberger F., 2000, Single Molecules, V1, P123, DOI 10.1002/1438-5171(200006)1:2<123::AID-SIMO123>3.3.CO;2-V
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lim R, 2002, LANGMUIR, V18, P6116, DOI 10.1021/la011789+
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Nevo R, 2003, NAT STRUCT BIOL, V10, P553, DOI 10.1038/nsb940
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Ortiz C, 1999, MACROMOLECULES, V32, P780, DOI 10.1021/ma981245n
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rief M, 1999, NAT STRUCT BIOL, V6, P346
   Rotsch C, 1997, LANGMUIR, V13, P2825, DOI 10.1021/la960874s
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 49
TC 34
Z9 34
U1 1
U2 8
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2007
VL 159
IS 2
BP 277
EP 289
DI 10.1016/j.jsb.2007.01.018
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 198MG
UT WOS:000248631600013
PM 17446086
DA 2021-01-25
ER

PT J
AU Kohler, G
   Rost, F
   Seelig, J
AF Kohler, Gotz
   Rost, Florian
   Seelig, Joachim
TI Simultaneous separation of intracellular and extracellular lactate NMR
   signals of human erythrocytes
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE hemoglobin; susceptibility; MRS; RBC; pyruvate
ID RED-BLOOD-CELLS; MAGNETIC-SUSCEPTIBILITY; METABOLIC FLUXES;
   CHEMICAL-SHIFT; MAS-NMR; P-31; SPECTRA; GLUCOSE; PLASMA; C-13
AB Intracellular/extracellular lactate (Lac) distribution has been determined before in human and animal erythrocytes (red blood cells [RBCs]) with various methods. However, all previous methods determine intra- and extracellular Lac separately or indirectly. Now, C-13-NMR spectroscopy has been used to monitor intra- and extracellular Lac simultaneously in intact RBCs. Isolated human RBCs were incubated with [3-C-13]-Lac, [3-C-13]-pyruvate (Pyr), and [1-C-13]-glucose (Gluc). A distortionless enhancement by polarization transfer (DEPT) sequence was used (TR = 3.3 s, N = 128) to monitor the C-13-NMR resonances in both compartments. The intra- and extracellular methyl group resonances of Lac and Pyr were clearly separated by 9.6 Hz and 7.0 Hz, respectively, under normoxic conditions due to the RBC chemical-shift effect. The results show that the chemical-shift effect of RBCs is convenient to monitor intra- and extracellular Lac simultaneously in intact RBCs under normoxic conditions.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kohler, G (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM goetz.kohler@unibas.ch
CR Aime S, 2002, MAGN RESON MED, V47, P10, DOI 10.1002/mrm.10048
   Bifone A, 1996, P NATL ACAD SCI USA, V93, P12932, DOI 10.1073/pnas.93.23.12932
   BUONO MJ, 1986, EUR J APPL PHYSIOL O, V55, P326, DOI 10.1007/BF02343807
   Connes P, 2004, J APPL PHYSIOL, V97, P326, DOI 10.1152/japplphysiol.00715.2003
   DANIEL SS, 1964, J APPL PHYSIOL, V19, P1100
   Decker DG, 1942, AM J PHYSIOL, V138, P0007
   FOXDAL P, 1990, EUR J APPL PHYSIOL O, V61, P218, DOI 10.1007/BF00357603
   Hildebrand A, 2000, INT J SPORTS MED, V21, P463, DOI 10.1055/s-2000-7412
   Humpfer E, 1997, MAGNET RESON MED, V38, P334, DOI 10.1002/mrm.1910380224
   KIRK K, 1988, BIOCHEMISTRY-US, V27, P8795, DOI 10.1021/bi00424a016
   KIRK K, 1985, J MAGN RESON, V62, P568, DOI 10.1016/0022-2364(85)90230-6
   Kuchel PW, 2004, MAGNET RESON MED, V52, P663, DOI 10.1002/mrm.20139
   LABOTKA RJ, 1984, BIOCHEMISTRY-US, V23, P5549, DOI 10.1021/bi00318a026
   Messana I, 1999, J BIOCHEM BIOPH METH, V39, P63, DOI 10.1016/S0165-022X(99)00005-6
   Narayan K S, 1990, NMR Biomed, V3, P23
   NICHOLS G, 1953, J CLIN INVEST, V32, P113, DOI 10.1172/JCI102718
   OGINO T, 1985, P NATL ACAD SCI USA, V82, P1099, DOI 10.1073/pnas.82.4.1099
   Philp DJ, 2004, MAGN RESON MED, V51, P441, DOI 10.1002/mrm.20019
   POTTS JR, 1990, BIOCHEM J, V266, P925
   ROUGHTON FJ, 1973, J APPL PHYSIOL, V35, P861
   SCHRADER MC, 1993, BIOCHIM BIOPHYS ACTA, V1182, P162, DOI 10.1016/0925-4439(93)90138-Q
   SKELTON MS, 1995, AM J PHYSIOL-REG I, V268, pR1121
   Spees WM, 2001, MAGN RESON MED, V45, P533, DOI 10.1002/mrm.1072
   Vaihkonen L K, 1999, Equine Vet J Suppl, P443
   Vaihkonen LK, 2001, AM J PHYSIOL-REG I, V281, pR19, DOI 10.1152/ajpregu.2001.281.1.R19
   VANZIJL PCM, 1991, P NATL ACAD SCI USA, V88, P3228, DOI 10.1073/pnas.88.8.3228
   Vivi A, 1997, BREAST CANCER RES TR, V43, P15, DOI 10.1023/A:1005781320906
   WELLARD RM, 1994, J MAGN RESON SER B, V104, P276, DOI 10.1006/jmrb.1994.1085
NR 28
TC 2
Z9 2
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0740-3194
EI 1522-2594
J9 MAGN RESON MED
JI Magn. Reson. Med.
PD AUG
PY 2007
VL 58
IS 2
BP 213
EP 217
DI 10.1002/mrm.21309
PG 5
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 196NC
UT WOS:000248488300001
PM 17654594
OA Bronze
DA 2021-01-25
ER

PT J
AU Schindler, C
   Spang, A
AF Schindler, Christina
   Spang, Anne
TI Interaction of SNARES with ArfGAPs precedes recruitment of Sec18p/NSF
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GTPASE-ACTIVATING PROTEIN; SENSITIVE FUSION PROTEIN; MEMBRANE-FUSION;
   YEAST VACUOLES; COPI VESICLES; V-SNARES; GOLGI; NSF; COMPLEXES;
   SUBPOPULATIONS
AB Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins are key components of the fusion machinery in vesicular transport and in homotypic membrane fusion. We previously found that ADP-ribosylation factor GTPase activating proteins (ArfGAPs) promoted a conformational change on SNAREs that allowed recruitment of the small GTPase Arf1p in stoichiometric amounts. Here, we show that the ArfGAP Gcs1p accelerates vesicle M-target membrane W-SNARE complex formation in vitro, indicating that ArfGAPs may act as folding chaperones. These SNARE complexes were resolved in the presence of ATP by the yeast homologues of a-soluble N-ethylmaleimide-sensitive factor attachment protein and N-ethylmaleimide-sensitive factor, Sec17p and Sec18p, respectively. In addition, Sec18p and Sec17p also recognized the "activated" SNAREs even when they were not engaged in v-t-SNARE complexes. Here again, the induction of a conformational change by ArfGAPs was essential. Surprisingly, recruitment of Sec18p to SNAREs did not require Sec17p or ATP hydrolysis. Moreover, Sec18p displaced prebound Arf1p from SNAREs, indicating that Sec18p may have more than one function: first, to ensure that all vesicle coat proteins are removed from the SNAREs before the engagement in a trans-SNARE complex; and second, to resolve cis-SNARE complexes after fusion has occurred.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Aoe T, 1999, J BIOL CHEM, V274, P20545, DOI 10.1074/jbc.274.29.20545
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Donaldson JG, 2000, CURR OPIN CELL BIOL, V12, P475, DOI 10.1016/S0955-0674(00)00119-8
   FAIRBANKS G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030
   Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7
   Hohl TM, 1998, MOL CELL, V2, P539, DOI 10.1016/S1097-2765(00)80153-7
   Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138
   Huber I, 2001, METHOD ENZYMOL, V329, P307
   Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117
   Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017
   Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061
   Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3
   Morgan A, 2004, CURR BIOL, V14, pR968, DOI 10.1016/j.cub.2004.10.045
   MORGAN A, 1994, J BIOL CHEM, V269, P29347
   Nichols BJ, 1997, NATURE, V387, P199, DOI 10.1038/387199a0
   Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075
   Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   ROBINSON M, 2006, MOL BIOL CELL, V1, P1
   Rossi G, 1997, J BIOL CHEM, V272, P16610, DOI 10.1074/jbc.272.26.16610
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   SHARROCKS AD, 1994, GENE, V138, P105, DOI 10.1016/0378-1119(94)90789-7
   SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0
   Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015
   Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   Steel GJ, 1999, BIOCHEMISTRY-US, V38, P7764, DOI 10.1021/bi990315v
   Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61
   Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X
   WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945
   Wickner W, 2002, EMBO J, V21, P1241, DOI 10.1093/emboj/21.6.1241
   Xu ZY, 1998, CELL, V93, P1125, DOI 10.1016/S0092-8674(00)81457-9
NR 35
TC 19
Z9 20
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD AUG
PY 2007
VL 18
IS 8
BP 2852
EP 2863
DI 10.1091/mbc.E06-08-0756
PG 12
WC Cell Biology
SC Cell Biology
GA 197UG
UT WOS:000248581400007
PM 17522384
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Belting, HG
   Affolter, M
AF Belting, Heinz-Georg
   Affolter, Markus
TI It takes guts to make a single lumen
SO NATURE CELL BIOLOGY
LA English
DT Editorial Material
ID DROSOPHILA; MORPHOGENESIS; CLAUDINS; MATRIX
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Belting,
   Heinz-Georg/0000-0002-1538-4364
CR Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621
   Furuse M, 2006, TRENDS CELL BIOL, V16, P181, DOI 10.1016/j.tcb.2006.02.006
   Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4
   Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012
   Kroschewski R, 2004, NEWS PHYSIOL SCI, V19, P61, DOI 10.1152/nips.01501.2003
   Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Montesano R, 2002, J CELL SCI, V115, P4419, DOI 10.1242/jcs.00164
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722
   Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012
   Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404
NR 12
TC 3
Z9 3
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD AUG
PY 2007
VL 9
IS 8
BP 880
EP 881
DI 10.1038/ncb0807-880
PG 2
WC Cell Biology
SC Cell Biology
GA 196MM
UT WOS:000248486700009
PM 17671457
DA 2021-01-25
ER

PT J
AU Lim, RYH
AF Lim, Roderick Y. H.
TI Gate-crashing the nuclear pore complex
SO STRUCTURE
LA English
DT Editorial Material
ID FG-REPEAT DOMAINS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN IMPORT;
   NUCLEOPORINS; MECHANISM; EXPORT; CYCLE
AB As a third in a series of MID simulations investigating the binding dynamics between nuclear transport receptors and FG-repeats, Isgro and Schulten (2007b) unveil that close, physical intimacy between partners is likely to ensure a hassle-free passage through the nuclear pore complex.
C1 Univ Basel, ME Muller Inst Struct Biol, NCCR Nanoscale Sci, Biozentrum, CH-4056 Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, ME Muller Inst Struct Biol, NCCR Nanoscale Sci, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087
CR Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200
   Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x
   Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011
   Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048
   Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027
   Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5
NR 19
TC 2
Z9 2
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0969-2126
J9 STRUCTURE
JI Structure
PD AUG
PY 2007
VL 15
IS 8
BP 889
EP 891
DI 10.1016/j.str.2007.07.005
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 201HN
UT WOS:000248822200003
PM 17697993
DA 2021-01-25
ER

PT J
AU Wassmann, P
   Chan, C
   Paul, R
   Beck, A
   Heerklotz, H
   Jenal, U
   Schirmer, T
AF Wassmann, Paul
   Chan, Carmen
   Paul, Ralf
   Beck, Andreas
   Heerklotz, Heiko
   Jenal, Urs
   Schirmer, Tilman
TI Structure of BeF3--modified response regulator PleD: Implications for
   diguanylate cyclase activation, catalysis, and feedback inhibition
SO STRUCTURE
LA English
DT Article
ID CYCLIC DIGUANYLATE; ALLOSTERIC CONTROL; CRYSTAL-STRUCTURE; DIMERIZATION;
   DOMAIN; PHOSPHORYLATION; INTERFACE; MOLECULE
AB Cyclic di-guanosine monophosphate (c-di-GMP) is a ubiquitous bacterial second messenger involved in the regulation of cell surface-associated traits and persistence. We have determined the crystal structure of PleD from Caulobacter crescentus, a response regulator with a diguanylate cyclase (DGC) domain, in its activated form. The BeF3- modification of its receiver domain causes rearrangement with respect to an adaptor domain, which, in turn, promotes dimer formation, allowing for the efficient encounter of two symmetric catalytic domains. The substrate analog GTP alpha S and two putative cations are bound to the active sites in a manner similar to adenylate cyclases, suggesting an analogous two-metal catalytic mechanism. An allosteric c-di-GMP-binding mode that crosslinks DGC and an adaptor domain had been identified before. Here, a second mode is observed that crosslinks the DGC domains within a PleD dimer. Both modes cause noncompetitive product inhibition by domain immobilization.
C1 Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Focal Area Growth & Dev, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
OI Wassmann, Paul/0000-0001-7391-1065; Heerklotz, Heiko/0000-0003-4615-7022
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   AMIOT N, 2006, SYSNTHESIS, V24, P4290
   Bachhawat P, 2005, STRUCTURE, V13, P1353, DOI 10.1016/j.str.2005.06.006
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381
   Doublie S, 1998, NATURE, V391, P251
   EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200
   LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0
   Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   McPhail D, 1997, J CHEM SOC FARADAY T, V93, P2283, DOI 10.1039/a701327b
   Nowak E, 2006, J BIOL CHEM, V281, P9659, DOI 10.1074/jbc.M512004200
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915
   Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603
   Steegborn C, 2005, NAT STRUCT MOL BIOL, V12, P32, DOI 10.1038/nsmb880
   Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805
   Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059
   Velazquez-Campoy Adrian, 2004, Methods Mol Biol, V261, P35
NR 33
TC 152
Z9 157
U1 2
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD AUG
PY 2007
VL 15
IS 8
BP 915
EP 927
DI 10.1016/j.str.2007.06.016
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 201HN
UT WOS:000248822200007
PM 17697997
DA 2021-01-25
ER

PT J
AU Randall, G
   Panis, M
   Cooper, JD
   Tellinghuisen, TL
   Sukhodolets, KE
   Pfeffer, S
   Landthaler, M
   Landgraf, P
   Kan, S
   Lindenbach, BD
   Chien, M
   Weir, DB
   Russo, JJ
   Ju, J
   Brownstein, MJ
   Sheridan, R
   Sander, C
   Zavolan, M
   Tuschl, T
   Rice, CM
AF Randall, Glenn
   Panis, Maryline
   Cooper, Jacob D.
   Tellinghuisen, Timothy L.
   Sukhodolets, Karen E.
   Pfeffer, Sebastien
   Landthaler, Markus
   Landgraf, Pablo
   Kan, Sherry
   Lindenbach, Brett D.
   Chien, Minchen
   Weir, David B.
   Russo, James J.
   Ju, Jingyue
   Brownstein, Michael J.
   Sheridan, Robert
   Sander, Chris
   Zavolan, Mihaela
   Tuschl, Thomas
   Rice, Charles M.
TI Cellular cofactors affecting hepatitis C virus infection and replication
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE antivirals; miR-122; RNAi; HCVcc-siRNA
ID TRACT-BINDING PROTEIN; RNA REPLICATION; CORE PROTEIN; IN-VIVO; EFFICIENT
   REPLICATION; GENOTYPE 2A; IDENTIFICATION; NS5A; TRANSLATION; MICRORNAS
AB Recently identified hepatitis C virus (HCV) isolates that are infectious in cell culture provide a genetic system to evaluate the significance of virus-host interactions for HCV replication. We have completed a systematic RNAi screen wherein siRNAs were designed that target 62 host genes encoding proteins that physically interact with HCV RNA or proteins or belong to cellular pathways thought to modulate HCV infection. This includes 10 host proteins that we identify in this study to bind HCV NS5A. siRNAs that target 26 of these host genes alter infectious HCV production >3-fold. included in this set of 26 were siRNAs that target Dicer, a principal component of the RNAi silencing pathway. Contrary to the hypothesis that RNAi is an antiviral pathway in mammals, as has been reported for sub-genomic HCV replicons, siRNAs that target Dicer inhibited HCV replication. Furthermore, siRNAs that target several other components of the RNAi pathway also inhibit HCV replication. MicroRNA profiling of human liver, human hepatoma Huh-7.5 cells, and Huh-7.5 cells that harbor replicating HCV demonstrated that miR-122 is the predominant microRNA in each environment. miR-122 has been previously implicated in positively regulating the replication of HCV genotype 1 replicons. We find that 2'-O-methyl antisense oligonucleotide depletion of miR-122 also inhibits HCV genotype 2a replication and infectious virus production. Our data define 26 host genes that modulate HCV infection and indicate that the requirement for functional RNAi for HCV replication is dominant over any antiviral activity this pathway may exert against HCV.
C1 Rockefeller Univ, Ctr Study Hepatitis C, Lab Viral & Infect Dis, New York, NY 10021 USA.
   Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA.
   Columbia Genome Ctr, New York, NY 10032 USA.
   Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   Craig Venter Inst, Rockville, MD 20850 USA.
   Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
RP Rice, CM (corresponding author), Rockefeller Univ, Ctr Study Hepatitis C, Lab Viral & Infect Dis, 1230 York Ave, New York, NY 10021 USA.
EM ricec@rockefeller.edu
RI Pfeffer, Sebastien/H-3212-2019; Zavolan, Mihaela/S-3888-2016; Pal, Deb
   K/F-3318-2011; Landthaler, Markus/A-1427-2010; Pfeffer,
   Sebastien/A-6512-2010; Sander, Chris/H-1452-2011
OI Pfeffer, Sebastien/0000-0002-8458-348X; Landthaler,
   Markus/0000-0002-1075-8734; Pfeffer, Sebastien/0000-0002-8458-348X;
   Sander, Chris/0000-0001-6059-6270; Randall, Glenn/0000-0001-7417-3615;
   Zavolan, Mihaela/0000-0002-8832-2041
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA057973, R01CA057973, R01CA057973, R01CA085883,
   R01CA057973, R01CA057973, R01CA057973, R01CA057973, R01CA057973,
   R01CA057973, R01CA057973, K01CA107092, R01CA057973, K01CA107092,
   R01CA057973, K01CA107092, K01CA107092, R01CA057973, R01CA057973,
   R01CA057973, R01CA057973, R01CA057973, R01CA085883, R01CA057973,
   R01CA057973, K01CA107092, R01CA085883, R01CA057973, R01CA085883,
   K01CA107092, R01CA085883, R01CA057973] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [F32AI051820, F32AI051820, F32AI051820] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086,
   P30DK042086, P30DK042086, P30DK042086, P30DK042086, P30DK042086] Funding
   Source: NIH RePORTER; Intramural NIH HHSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA Funding
   Source: Medline; NCI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01 CA085883, R01 CA057973, K01 CA107092, CA 57973, CA
   85883, CA 107092] Funding Source: Medline; NIAID NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [AI
   40034, 5F32 AI 51820-03, F32 AI051820, N01AI40034] Funding Source:
   Medline; NIDDK NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30 DK042086, P30 DK
   42086] Funding Source: Medline
CR ALI N, 1995, J VIROL, V69, P6367, DOI 10.1128/JVI.69.10.6367-6375.1995
   Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200
   Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756
   Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Blight KJ, 2003, J VIROL, V77, P3181, DOI 10.1128/JVI.77.5.3181-3190.2003
   Blight KJ, 2000, SCIENCE, V290, P1972, DOI 10.1126/science.290.5498.1972
   Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071
   Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102
   Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066
   Coito C, 2004, J VIROL, V78, P3502, DOI 10.1128/JVI.78.7.3502-3513.2004
   Cormier EG, 2004, P NATL ACAD SCI USA, V101, P7270, DOI 10.1073/pnas.0402253101
   Cullen BR, 2006, NAT IMMUNOL, V7, P563, DOI 10.1038/ni1352
   Edgar AJ, 2000, BIOCHEM BIOPH RES CO, V277, P622, DOI 10.1006/bbrc.2000.3727
   Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005
   Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101
   Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004
   Gitlin L, 2003, J VIROL, V77, P7159, DOI 10.1128/JVI.77.13.7159-7165.2003
   Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836
   Haft CR, 2000, MOL BIOL CELL, V11, P4105, DOI 10.1091/mbc.11.12.4105
   Hamamoto I, 2005, J VIROL, V79, P13473, DOI 10.1128/JVI.79.21.13473-13482.2005
   Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100
   Hussy P, 1996, VIROLOGY, V224, P93, DOI 10.1006/viro.1996.0510
   Ito T, 1999, VIROLOGY, V254, P288, DOI 10.1006/viro.1998.9541
   Ito T, 1997, J VIROL, V71, P8698, DOI 10.1128/JVI.71.11.8698-8706.1997
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102
   Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023
   Korf M, 2005, J HEPATOL, V43, P225, DOI 10.1016/j.jhep.2005.02.046
   Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Mendelsohn Andrew R., 1994, Current Opinion in Biotechnology, V5, P482, DOI 10.1016/0958-1669(94)90061-2
   Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897
   Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659
   PEFFER S, 2003, CLONING SMALL RNA MO
   Petrik J, 1999, J GEN VIROL, V80, P3109, DOI 10.1099/0022-1317-80-12-3109
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Randall G, 2005, HEPATOLOGY, V41, P1220, DOI 10.1002/hep.20731
   Randall G, 2004, VIRUS RES, V102, P19, DOI 10.1016/j.virusres.2004.01.011
   Randall G, 2003, P NATL ACAD SCI USA, V100, P235, DOI 10.1073/pnas.0235524100
   Randall G, 2006, GASTROENTEROLOGY, V131, P1584, DOI 10.1053/j.gastro.2006.08.043
   Reed KE, 1997, J VIROL, V71, P7187, DOI 10.1128/JVI.71.10.7187-7197.1997
   Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005
   Spangberg K, 2000, VIROLOGY, V274, P378, DOI 10.1006/viro.2000.0461
   Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199
   Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7
   Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028
   Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247
   Yanagi M, 1999, VIROLOGY, V262, P250, DOI 10.1006/viro.1999.9889
   Zhang J, 2004, VIROLOGY, V320, P135, DOI 10.1016/j.virol.2003.11.023
   Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004
   Zhang PZ, 2000, GENOMICS, V70, P253, DOI 10.1006/geno.2000.6380
   Zheng Y, 2005, J MICROBIOL, V43, P529
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   Zhu Q, 2003, J VIROL, V77, P9204, DOI 10.1128/JVI.77.17.9204-9210.2003
   1997, WKLY EPIDEMIOL REC, V72, P341
NR 64
TC 436
Z9 452
U1 0
U2 36
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 31
PY 2007
VL 104
IS 31
BP 12884
EP 12889
DI 10.1073/pnas.0704894104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 198CF
UT WOS:000248603900053
PM 17616579
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Ackermann, M
   Schauerte, A
   Stearns, SC
   Jenal, U
AF Ackermann, Martin
   Schauerte, Alexandra
   Stearns, Stephen C.
   Jenal, Urs
TI Experimental evolution of aging in a bacterium
SO BMC EVOLUTIONARY BIOLOGY
LA English
DT Article
ID MORTALITY; SENESCENCE
AB Background: Aging refers to a decline in reproduction and survival with increasing age. According to evolutionary theory, aging evolves because selection late in life is weak and mutations exist whose deleterious effects manifest only late in life. Whether the assumptions behind this theory are fulfilled in all organisms, and whether all organisms age, has not been clear. We tested the generality of this theory by experimental evolution with Caulobacter crescentus, a bacterium whose asymmetric division allows mother and daughter to be distinguished. Results: We evolved three populations for 2000 generations in the laboratory under conditions where selection was strong early in life, but very weak later in life. All populations evolved faster growth rates, mostly by decreasing the age at first division. Evolutionary changes in aging were inconsistent. The predominant response was the unexpected evolution of slower aging, revealing the limits of theoretical predictions if mutations have unanticipated phenotypic effects. However, we also observed the spread of a mutation causing earlier aging of mothers whose negative effect was reset in the daughters. Conclusion: Our results confirm that late-acting deleterious mutations do occur in bacteria and that they can invade populations when selection late in life is weak. They suggest that very few organisms - perhaps none- can avoid the accumulation of such mutations over evolutionary time, and thus that aging is probably a fundamental property of all cellular organisms.
C1 [Ackermann, Martin] ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland.
   [Ackermann, Martin; Schauerte, Alexandra; Jenal, Urs] Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   [Stearns, Stephen C.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.
RP Ackermann, M (corresponding author), ETH, Inst Integrat Biol, CH-8092 Zurich, Switzerland.
EM Martin.Ackermann@env.ethz.ch; Alexandra@Schauerte.ch;
   Stephen.Stearns@yale.edu; Urs.Jenal@unibas.ch
RI Stearns, Stephen/F-4099-2012; Ackermann, Martin/V-4554-2017
OI Ackermann, Martin/0000-0003-0087-4819; Stearns,
   Stephen/0000-0002-6621-4373
CR ABRAMS PA, 1993, EVOLUTION, V47, P877, DOI [10.2307/2410191, 10.1111/j.1558-5646.1993.tb01241.x]
   Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532
   Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x
   Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.0.CO;2-Y
   Charlesworth B, 2000, GENETICS, V156, P927
   Charlesworth B., 1994, EVOLUTION AGE STRUCT
   DEPAEPE M, 2006, PLOS BIOL, V5
   Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Gavrilov L. A., 2000, SEX LONGEVITY SEXUAL
   Gray DA, 2000, CAN J ZOOL, V78, P140, DOI 10.1139/cjz-78-1-140
   JAZWINSKI SM, 1993, GENETICA, V91, P35, DOI 10.1007/BF01435986
   JURGENS K, 1994, MAR ECOL PROG SER, V112, P169, DOI 10.3354/meps112169
   Kern S, 2001, EVOLUTION, V55, P1822, DOI 10.1111/j.0014-3820.2001.tb00831.x
   MEDAWAR PB, 1952, USOLVED PROBLEM BIOL
   MORTIMER RK, 1959, NATURE, V183, P1751, DOI 10.1038/1831751a0
   Partridge L, 1996, P ROY SOC B-BIOL SCI, V263, P1365, DOI 10.1098/rspb.1996.0200
   PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0
   Pletcher SD, 1998, GENETICS, V148, P287
   Poindexter JS, 2000, APPL ENVIRON MICROB, V66, P4105, DOI 10.1128/AEM.66.9.4105-4111.2000
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   Reznick D, 2006, PLOS BIOL, V4, P136, DOI 10.1371/journal.pbio.0040007
   Reznick DN, 2004, NATURE, V431, P1095, DOI 10.1038/nature02936
   Rose M., 1991, EVOLUTIONARY BIOL AG
   SERVICE PM, 1985, EVOLUTION, V39, P943, DOI 10.1111/j.1558-5646.1985.tb00436.x
   Sokal R. R., 1995, BIOMETRY
   *SPSS INC, 2005, SPSS 11 0 4
   Stearns SC, 2000, P NATL ACAD SCI USA, V97, P3309, DOI 10.1073/pnas.060289597
   Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045
   WEISMANN A, 1882, DAUER LEBENS
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x
   Williams PD, 2003, EVOLUTION, V57, P1478
NR 33
TC 34
Z9 36
U1 1
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2148
J9 BMC EVOL BIOL
JI BMC Evol. Biol.
PD JUL 28
PY 2007
VL 7
AR 126
DI 10.1186/1471-2148-7-126
PG 10
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 252KB
UT WOS:000252444300001
PM 17662151
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mueller, P
   Quintana, A
   Griesemer, D
   Hoth, M
   Pieters, J
AF Mueller, Philipp
   Quintana, Ariel
   Griesemer, Desiree
   Hoth, Markus
   Pieters, Jean
TI Disruption of the cortical actin cytoskeleton does not affect store
   operated Ca2+ channels in human T-cells
SO FEBS LETTERS
LA English
DT Article
DE CRAC; T-cells; actin; cytoskeleton
ID WISKOTT-ALDRICH-SYNDROME; MEDIATED CALCIUM-ENTRY; PLASMA-MEMBRANE;
   ACTIVATION MECHANISM; HUMAN PLATELETS; INFLUX FACTOR; CRAC;
   POLYMERIZATION; INHIBITION; DEPLETION
AB Lymphocyte signaling and activation leads to the influx of extracellular Ca (2+) via the activation of Ca (2+) release activated Ca 21 (CRAC) channels in the plasma membrane. Activation of CRAC channels occurs following emptying of the endoplasmic reticulmn intracellular Ca (2+) stores. One model to explain the coupling of store-emptying to CRAC activation is the secretion-like conformational coupling model. This model proposes that store depletion increases junctions between the endoplasmic reticulurn and the plasma membrane in a manner that could be regulated by the cortical actin cytoskeleton. Here, we show that stabilization or depolymerization of the actin cytoskeleton failed to affect CRAC activation. NVe therefore conclude that rearrangement of the actin cytoskeleton is dispensable for store-operated Ca (2+) entry in T-cells. (c) 2007 Published by Elsevier B.V. on behalf of the Federation of European Biochemical Societies.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Saarland, Dept Physiol, Homburg, Germany.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Griesemer, Desiree/A-9152-2018
OI Griesemer, Desiree/0000-0002-0551-038X; Pieters,
   Jean/0000-0002-5284-9757; Hoth, Markus/0000-0001-7080-4643
CR Anton IM, 2002, IMMUNITY, V16, P193, DOI 10.1016/S1074-7613(02)00268-6
   Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x
   Bautista DM, 2002, J PHYSIOL-LONDON, V541, P877, DOI 10.1113/jphysiol.2001.016154
   Bearer EL, 2002, INT REV CYTOL, V217, P137
   Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155
   Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150
   Bolotina VM, 2005, TRENDS BIOCHEM SCI, V30, P378, DOI 10.1016/j.tibs.2005.05.009
   BUBB MR, 1994, J BIOL CHEM, V269, P14869
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   COUE M, 1987, FEBS LETT, V213, P316, DOI 10.1016/0014-5793(87)81513-2
   Csutora P, 2006, J BIOL CHEM, V281, P34926, DOI 10.1074/jbc.M606504200
   DONNADIEU E, 1993, PFLUG ARCH EUR J PHY, V424, P448, DOI 10.1007/BF00374907
   Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702
   FLANAGAN MD, 1980, J BIOL CHEM, V255, P835
   Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Hardie RC, 2003, ANNU REV PHYSIOL, V65, P735, DOI 10.1146/annurev.physiol.65.092101.142505
   Hermosura MC, 2000, NATURE, V408, P735, DOI 10.1038/35047115
   Holda JR, 1997, FEBS LETT, V403, P191, DOI 10.1016/S0014-5793(97)00051-3
   HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0
   Huang W, 2005, J IMMUNOL, V174, P2602, DOI 10.4049/jimmunol.174.5.2602
   Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497
   Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055
   Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015
   MOLINA IJ, 1993, J IMMUNOL, V151, P4383
   Montell C, 2004, NAT CELL BIOL, V6, P690, DOI 10.1038/ncb0804-690
   Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036
   Parekh AB, 1997, PHYSIOL REV, V77, P901
   Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003
   Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y
   Patterson RL, 1999, CELL, V98, P487, DOI 10.1016/S0092-8674(00)81977-7
   Prakriya M, 2001, J PHYSIOL-LONDON, V536, P3, DOI 10.1111/j.1469-7793.2001.t01-1-00003.x
   PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6
   Quintana A, 2005, PFLUG ARCH EUR J PHY, V450, P1, DOI 10.1007/s00424-004-1364-4
   RANDRIAMAMPITA C, 1993, NATURE, V364, P809, DOI 10.1038/364809a0
   Redondo PC, 2003, BIOCHEM J, V370, P255, DOI 10.1042/BJ20021505
   Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019
   Rosado JA, 2000, BIOCHEM J, V351, P429, DOI 10.1042/0264-6021:3510429
   Rosado JA, 2000, J BIOL CHEM, V275, P7527, DOI 10.1074/jbc.275.11.7527
   Rosado JA, 2005, J CELL PHYSIOL, V205, P262, DOI 10.1002/jcp.20399
   ROSSIER MF, 1991, BIOCHEM J, V274, P643, DOI 10.1042/bj2740643
   Sabala P, 2002, BIOCHEM BIOPH RES CO, V296, P484, DOI 10.1016/S0006-291X(02)00893-8
   Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089
   Snapper SB, 1998, IMMUNITY, V9, P81, DOI 10.1016/S1074-7613(00)80590-7
   SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302
   Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200
   Stromer MH, 1998, HISTOL HISTOPATHOL, V13, P283, DOI 10.14670/HH-13.283
   THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466
   Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003
   Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
   Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014
   Xie Q, 2002, J BIOL CHEM, V277, P16559, DOI 10.1074/jbc.M109518200
   Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5
   Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108
   Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004
   Zipfel PA, 2006, CURR BIOL, V16, P35, DOI 10.1016/j.cub.2005.12.024
NR 57
TC 15
Z9 15
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-5793
EI 1873-3468
J9 FEBS LETT
JI FEBS Lett.
PD JUL 24
PY 2007
VL 581
IS 18
BP 3557
EP 3562
DI 10.1016/j.febslet.2007.06.068
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 196HV
UT WOS:000248473200040
PM 17624329
DA 2021-01-25
ER

PT J
AU Schwarz-Herion, K
   Maco, B
   Sauder, U
   Fahrenkrog, B
AF Schwarz-Herion, Kyrill
   Maco, Bohumil
   Sauder, Ursula
   Fahrenkrog, Birthe
TI Domain topology of the p62 complex within the 3-D architecture of the
   nuclear pore complex
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE nuclear pore complex; p62 complex; nucleoporins; FG-repeats;
   immuno-electron microscopy
ID NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL BASIS; NUCLEOPORIN P62; PROTEIN;
   GLYCOPROTEINS; BASKET; GLYCOSYLATION; LOCALIZATION; ANTIBODIES;
   COMPONENTS
AB The nuclear pore complex (NPC) is the only known gateway for exchange of macromolecules between the cytoplasm and nucleus of eukaryotic cells. One key compound of the NPC is the p62 subcomplex, which consists of the nucleoporins; p62, p54, and p58/p45 and is supposed to be involved in nuclear protein import and export. Here we show the localization of distinct domains of the p62 complex by immuno-electron microscopy using isolated nuclei from Xenopus oocytes. To determine the exact position of the p62 complex, we examined the localization of the C and N-terminal domains of p62 by immunogold-labeling using domain-specific antibodies against p62. In addition we expressed epitope-tagged versions of p62, p54, and p58 in Xenopus oocytes and localized the domains with antibodies against the tags. This first systematic analysis of the domain topology of the p62 complex within the NPC revealed that the p62 complex is anchored to the cytoplasmic face of the NPC most likely by the coiled-coil domains of the three nucleoporins. Furthermore, we found the phenylalanine-glycine (FG)-repeat domain of p62, but not of p58 and p54, to be of mobile and flexible nature.(c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, ME Muller Inst Struct Biol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Maco,
   Bohumil/0000-0001-8444-313X
CR Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x
   BUSS F, 1995, J CELL BIOL, V128, P251, DOI 10.1083/jcb.128.3.251
   CARMOFONSECA M, 1991, EUR J CELL BIOL, V55, P17
   CORDES VC, 1993, EUR J CELL BIOL, V60, P185
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   DABAUVALLE MC, 1988, CHROMOSOMA, V97, P193, DOI 10.1007/BF00292960
   DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552
   DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Fahrenkrog B, 2000, J STRUCT BIOL, V129, P295, DOI 10.1006/jsbi.2000.4223
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Fahrenkrog Birthe, 2002, Results Probl Cell Differ, V35, P25
   FINLAY DR, 1991, J CELL BIOL, V114, P169, DOI 10.1083/jcb.114.1.169
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   GUAN TL, 1995, MOL BIOL CELL, V6, P1591
   Hu TH, 1998, GENE, V221, P245, DOI 10.1016/S0378-1119(98)00467-3
   Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538
   Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Paulillo SM, 2006, J MOL BIOL, V363, P39, DOI 10.1016/j.jmb.2006.08.021
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027
NR 37
TC 32
Z9 32
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 20
PY 2007
VL 370
IS 4
BP 796
EP 806
DI 10.1016/j.jmb.2007.05.030
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 188FI
UT WOS:000247904400015
PM 17544442
DA 2021-01-25
ER

PT J
AU Chattopadhyay, A
   Meier, M
   Ivaninskii, S
   Burkhard, P
   Speroni, F
   Campanini, B
   Bettati, S
   Mozzarelli, A
   Rabeh, WM
   Li, L
   Cook, PF
AF Chattopadhyay, Arundhati
   Meier, Markus
   Ivaninskii, Sergei
   Burkhard, Peter
   Speroni, Francesca
   Campanini, Barbara
   Bettati, Stefano
   Mozzarelli, Andrea
   Rabeh, Wael M.
   Li, Lei
   Cook, Paul F.
TI Structure, mechanism, and conformational dynamics of O-acetylserine
   sulfhydrylase from Salmonella typhimurium: Comparison of a and b
   isozymes
SO BIOCHEMISTRY
LA English
DT Article
ID TIME-RESOLVED FLUORESCENCE; ANION-BINDING SITE; ESCHERICHIA-COLI;
   TRYPTOPHAN SYNTHETASE; ACTIVE-SITE; PROTEIN; IDENTIFICATION;
   SPECTROSCOPY; LOCATION; CYSTEINE
AB O-Acetylserine sulfhydrylase is a pyridoxal 5'-phosphate-dependent enzyme that catalyzes the final step in the cysteine biosynthetic pathway in enteric bacteria and plants, the replacement of the beta-acetoxy group of O-acetyl-L-serine by a thiol to give L-cysteine. Two isozymes are found in Salmonella typhimurium, with the A-isozyme expressed under aerobic and the B-isozyme expressed under anaerobic conditions. The structure of O-acetylserine sulfhydrylase B has been solved to 2.3 A and exhibits overall a fold very similar to that of the A-isozyme. The main difference between the two isozymes is the more hydrophilic active site of the B-isozyme with two ionizable residues, C280 and D281, replacing the neutral residues S300 and P299, respectively, in the A-isozyme. D281 is above the re face of the cofactor and is within hydrogen-bonding distance to Y286, while C280 is located about 3.4 A from the pyridine nitrogen (N1) of the internal Schiff base. The B-isozyme has a turnover number (V/E-t) 12.5-fold higher than the A-isozyme and an similar to 10-fold lower K-m for O-acetyl-L-serine. Studies of the first half-reaction by rapid-scanning stopped-flow indicate a first-order conversion of the internal Schiff base to the alpha-aminoacrylate intermediate at any concentration of O-acetyl-L-serine. The K-d values for formation of the external Schiff base with cysteine and serine, obtained by spectral titration, are pH dependent and exhibit a pK(a) of 7.0-7.5 (for a group that must be unprotonated for optimum binding) with values, above pH 8.0, of about 3.0 and 30.0 mM, respectively. In both cases the neutral enolimine is favored at high pH. Failure to observe the pK(a) for the alpha-amines of cysteine and serine in the pK(ESB) vs pH profile suggests a compensatory effect resulting from titration of a group on the enzyme with a pK(a) in the vicinity of the alpha-amine's pK(a). The pH dependence of the first-order rate constant for decay of the alpha-aminoacrylate intermediate to give pyruvate and ammonia gives a pK(a) of about 9 for the active site lysine (K41), a pH unit higher than that of the A-isozyme. The difference in pH dependence of the pK(ESB) for cysteine and serine, the higher pK(a) for K41, and the preference for the neutral species at high pH compared to the A-isozyme can be explained by titration of C280 to give the thiolate. Subtle conformational differences between O-acetylserine sulfhydrylase A and O-acetylserine sulfhydrylase B are detected by comparing the absorption and emission spectra of the internal aldimine in the absence and presence of the product acetate and of the external aldimine with L-serine. The two isozymes show a different equilibrium distribution of the enolimine and ketoenamine tautomers, likely as a result of a more polar active site for O-acetylserine sulfhydrylase B. The distribution of cofactor tautomers is dramatically affected by the ligation state of the enzyme. In the presence of acetate, which occupies the alpha-carboxylate subsite, the equilibrium between tautomers is shifted toward the ketoenamine tautomer, as a result of a conformational change affecting the structure of the active site. This finding, in agreement with structural data, suggests for the O-acetylserine sulfhydrylase B-isozyme a higher degree of conformational flexibility linked to catalysis.
C1 Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Burkhard, P (corresponding author), Univ Connecticut, Inst Mat Sci, 97 N Eagleville Rd, Storrs, CT 06269 USA.
EM Peter.Burkhard@uconn.edu; barbara.campanini@unipr.it; pcook@ou.edu
RI Rabeh, Wael/AAO-4647-2020; Campanini, Barbara/L-9723-2017; Meier,
   Markus/F-2798-2011; Mozzarelli, Andrea/C-3615-2014; Bettati,
   Stefano/V-9975-2018
OI Rabeh, Wael/0000-0001-6071-8581; Campanini, Barbara/0000-0003-0359-0627;
   Meier, Markus/0000-0003-1068-746X; Mozzarelli,
   Andrea/0000-0003-3762-0062; Bettati, Stefano/0000-0001-6787-0594
CR BECKER MA, 1969, J BIOL CHEM, V244, P2418
   Benci S, 1999, BBA-PROTEIN STRUCT M, V1429, P317, DOI 10.1016/S0167-4838(98)00229-5
   Benci S, 1997, BIOCHEMISTRY-US, V36, P15419, DOI 10.1021/bi970464i
   Benci S, 1999, J PHOTOCH PHOTOBIO B, V48, P17, DOI 10.1016/S1011-1344(99)00003-2
   Bergethon PR, 1998, PHYS BASIS BIOCH FDN
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2000, J MOL BIOL, V303, P279, DOI 10.1006/jmbi.2000.4109
   Burkhard P, 1999, J MOL BIOL, V291, P941, DOI 10.1006/jmbi.1999.3002
   Burkhard P, 1998, J MOL BIOL, V283, P121, DOI 10.1006/jmbi.1998.2037
   BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x
   Campanini B, 2005, PROTEIN SCI, V14, P2115, DOI 10.1110/ps.051492805
   Claus MT, 2005, BIOCHEMISTRY-US, V44, P8620, DOI 10.1021/bi050485+
   COOK PF, 1992, BIOCHEMISTRY-US, V31, P2298, DOI 10.1021/bi00123a013
   COOK PF, 1976, J BIOL CHEM, V251, P2023
   Cook PF, 1996, J BIOL CHEM, V271, P25842, DOI 10.1074/jbc.271.42.25842
   Daum S, 2003, BIOCHEMISTRY-US, V42, P106, DOI 10.1021/bi0268044
   FAEDER EJ, 1970, BIOCHEMISTRY-US, V9, P4043, DOI 10.1021/bi00823a003
   Flint DH, 1996, J BIOL CHEM, V271, P16053, DOI 10.1074/jbc.271.27.16053
   GOLDBERG ME, 1968, BIOCHEMISTRY-US, V7, P3662, DOI 10.1021/bi00850a045
   Hwang CC, 1996, BIOCHEMISTRY-US, V35, P6358, DOI 10.1021/bi9602472
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503
   KREDICH NM, 1966, J BIOL CHEM, V241, P4955
   Lakowicz J.R., 1983, PRINCIPLES FLUORESCE
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   MCCLURE GD, 1994, BIOCHEMISTRY-US, V33, P1674, DOI 10.1021/bi00173a009
   MCLACHLAN AD, 1982, ACTA CRYSTALLOGR A, V38, P871, DOI 10.1107/S0567739482001806
   MONROE RS, 1988, J BACTERIOL, V170, P42, DOI 10.1128/jb.170.1.42-47.1988
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045
   Rabeh WM, 2004, J BIOL CHEM, V279, P26803, DOI 10.1074/jbc.R400001200
   SCHNACKERZ KD, 1995, BIOCHEMISTRY-US, V34, P12152, DOI 10.1021/bi00038a008
   Strambini GB, 1996, BIOCHEMISTRY-US, V35, P8392, DOI 10.1021/bi952919e
   TAI CH, 1995, BIOCHEMISTRY-US, V34, P12311, DOI 10.1021/bi00038a027
   TAI CH, 1993, BIOCHEMISTRY-US, V32, P6433, DOI 10.1021/bi00076a017
   Tai CH, 2001, BIOCHEMISTRY-US, V40, P7446, DOI 10.1021/bi015511s
   1994, ACTA CRYSTALLOGR, V50, P760
NR 38
TC 49
Z9 50
U1 1
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 17
PY 2007
VL 46
IS 28
BP 8315
EP 8330
DI 10.1021/bi602603c
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 188BI
UT WOS:000247893000011
PM 17583914
DA 2021-01-25
ER

PT J
AU Pachkov, M
   Dandekar, T
   Korbel, J
   Bork, P
   Schuster, S
AF Pachkov, Mikhail
   Dandekar, Thomas
   Korbel, Jan
   Bork, Peer
   Schuster, Stefan
TI Use of pathway analysis and genome context methods for functional
   genomics of Mycoplasma pneumoniae nucleotide metabolism
SO GENE
LA English
DT Article
DE elementary modes; functional genomics; genome context methods;
   Mycoplasma pneumoniae; nucleotide metabolism; STRING
ID BIOCHEMICAL NETWORKS; SEQUENCE; ENZYMES; GENES; MODES; DEFINITION;
   PHYLOGENY; PATHOGEN; SYSTEMS; EXAMPLE
AB Elementary modes analysis allows one to reveal whether a set of known enzymes is sufficient to sustain functionality of the cell. Moreover, it is helpful in detecting missing reactions and predicting which enzymes could fill these gaps. Here, we perform a comprehensive elementary modes analysis and a genomic context analysis of Mycoplasma pneumoniae nucleotide metabolism, and search for new enzyme activities. The purine and pyrimidine networks are reconstructed by assembling enzymes annotated in the genome or found experimentally. We show that these reaction sets are sufficient for enabling synthesis of DNA and RNA in M. pneumoniae. Special focus is on the key modes for growth. Moreover, we make an educated guess on the nutritional requirements of this micro-organism. For the case that M. pneumoniae does not require adenine as a substrate, we suggest adenylosuccinate synthetase (EC 6.3.4.4), adenylosuccinate lyase (EC 4.3.2.2) and GMP reductase (EC 1.7.1.7) to be operative. GMP reductase activity is putatively assigned to the NRDI_MYCPN gene on the basis of the genomic context analysis. For the pyrimidine network, we suggest CTP synthase (EC 6.3.4.2) to be active. Further experiments on the nutritional requirements are needed to make a decision. Pyrimidine metabolism appears to be more appropriate as a drug target than purine metabolism since it shows lower plasticity. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Basel, Div Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Jena, Fac Biol & Pharmaceut, Dept Bioinformat, D-07743 Jena, Germany.
   Univ Wurzburg, Dept Bioinformat, Biozentrum, D-97074 Wurzburg, Germany.
   European Mol Biol Lab, D-69117 Heidelberg, Germany.
   Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.
   Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.
RP Pachkov, M (corresponding author), Univ Basel, Div Bioinformat, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mikhail.pachkov@unibas.ch
RI Dandekar, Thomas/A-4431-2017; Korbel, Jan O/G-6470-2012; Bork,
   Peer/F-1813-2013
OI Dandekar, Thomas/0000-0003-1886-7625; Korbel, Jan O/0000-0002-2798-3794;
   Bork, Peer/0000-0002-2627-833X
CR BenMenachem G, 1997, MICROBIOL-UK, V143, P1933, DOI 10.1099/00221287-143-6-1933
   Carlson R, 2004, BIOTECHNOL BIOENG, V86, P149, DOI 10.1002/bit.20044
   CASSELL GH, 1997, HARRISONS PRINCIPLES
   Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145
   CLYDE WA, 1993, CLIN INFECT DIS, V17, pS32
   COHEN RM, 1971, J BIOL CHEM, V246, P7566
   Dandekar T, 2000, NUCLEIC ACIDS RES, V28, P3278, DOI 10.1093/nar/28.17.3278
   Dandekar T, 1999, BIOCHEM J, V343, P115, DOI 10.1042/0264-6021:3430115
   Dandekar T, 2003, BIOSYSTEMS, V70, P255, DOI 10.1016/S0303-2647(03)00067-4
   FINCH LR, 1992, MYCOPLASMAS MOL BIOL, pCH13
   Forster J, 2002, BIOTECHNOL BIOENG, V79, P703, DOI 10.1002/bit.10378
   Forster MR, 1999, BRIT J PHILOS SCI, V50, P83, DOI 10.1093/bjps/50.1.83
   Green ML, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-76
   Heinrich R., 1996, REGULATION CELLULAR
   HIMMELREICH R, 1996, NUCLEIC ACIDS RES, V24, P4430
   Hutchison CA, 1999, SCIENCE, V286, P2165, DOI 10.1126/science.286.5447.2165
   Huynen M, 2000, GENOME RES, V10, P1204, DOI 10.1101/gr.10.8.1204
   Huynen MA, 2003, CURR OPIN CELL BIOL, V15, P191, DOI 10.1016/S0955-0674(03)00009-7
   Jacobs E, 1997, WIEN KLIN WOCHENSCHR, V109, P574
   Keam SJ, 2004, DRUGS, V64, P2091, DOI 10.2165/00003495-200464180-00011
   Klamt S, 2003, TRENDS BIOTECHNOL, V21, P64, DOI 10.1016/S0167-7799(02)00034-3
   Koonin EV, 1996, TRENDS GENET, V12, P334, DOI 10.1016/0168-9525(96)20010-1
   Ma HW, 2003, BIOINFORMATICS, V19, P270, DOI 10.1093/bioinformatics/19.2.270
   MAVROVOUNIOTIS ML, 1990, BIOTECHNOL BIOENG, V36, P1119, DOI 10.1002/bit.260361107
   Mombach JCM, 2006, COMPUT BIOL MED, V36, P542, DOI 10.1016/j.compbiomed.2005.03.004
   MOROWITZ HJ, 1962, SCI AM, V206, P117, DOI 10.1038/scientificamerican0362-117
   NEALE GAM, 1983, J BACTERIOL, V156, P1001, DOI 10.1128/JB.156.3.1001-1005.1983
   Osterman A, 2003, CURR OPIN CHEM BIOL, V7, P238, DOI 10.1016/S1367-5931(03)00027-9
   Pettersson B, 1996, J BACTERIOL, V178, P4131, DOI 10.1128/jb.178.14.4131-4142.1996
   Pfeiffer T, 1999, BIOINFORMATICS, V15, P251, DOI 10.1093/bioinformatics/15.3.251
   PFEIFFER T, 2000, BIOTHERMOKINETICS 20, P229
   Pollack J. Dennis, 2002, OMICS A Journal of Integrative Biology, V6, P247, DOI 10.1089/15362310260256909
   Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140
   Pollack JD, 2002, FRONT BIOSCI-LANDMRK, V7, pD1762, DOI 10.2741/pollack
   Pollack JD, 1997, TRENDS MICROBIOL, V5, P413
   Poolman MG, 2003, EUR J BIOCHEM, V270, P430, DOI 10.1046/j.1432-1033.2003.03390.x
   Price ND, 2002, GENOME RES, V12, P760, DOI 10.1101/gr.218002
   Rawadi G, 1998, INT J SYST BACTERIOL, V48, P305, DOI 10.1099/00207713-48-1-305
   Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998
   RODWELL AW, 1983, METHODS MYCOPLASMOLO, V1, P413
   Romero P, 2005, GENOME BIOL, V6
   Sasaki Y, 2002, NUCLEIC ACIDS RES, V30, P5293, DOI 10.1093/nar/gkf667
   Schilling CH, 1999, BIOTECHNOL PROGR, V15, P296, DOI 10.1021/bp990048k
   Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073
   Schilling CH, 2000, J THEOR BIOL, V203, P249, DOI 10.1006/jtbi.2000.1088
   Schuster S, 2000, NAT BIOTECHNOL, V18, P326, DOI 10.1038/73786
   Schuster S, 2005, FEBS J, V272, P5278, DOI 10.1111/j.1742-4658.2005.04924.x
   Schuster S, 1999, TRENDS BIOTECHNOL, V17, P53, DOI 10.1016/S0167-7799(98)01290-6
   Schuster S, 2002, BIOINFORMATICS, V18, P351, DOI 10.1093/bioinformatics/18.2.351
   Schuster S, 2002, J MATH BIOL, V45, P153, DOI 10.1007/s002850200143
   SCHUSTER S, 1994, J BIOL SYST, V2, P165, DOI DOI 10.1142/S0218339094000131
   Schwartz JM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-186
   Schwender J, 2004, NATURE, V432, P779, DOI 10.1038/nature03145
   Umejiego NN, 2004, J BIOL CHEM, V279, P40320, DOI 10.1074/jbc.M407121200
   van Noort V, 2003, TRENDS GENET, V19, P238, DOI 10.1016/S0168-9525(03)00056-8
   von Kamp A, 2006, BIOINFORMATICS, V22, P1930, DOI 10.1093/bioinformatics/btl267
   von Mering C, 2003, P NATL ACAD SCI USA, V100, P15428, DOI 10.1073/pnas.2136809100
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005
   Westberg J, 2004, GENOME RES, V14, P221, DOI 10.1101/gr.1673304
   WILLIAMS MV, 1988, DNA REPLICATION MUTA, P440
NR 61
TC 14
Z9 14
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0378-1119
EI 1879-0038
J9 GENE
JI Gene
PD JUL 15
PY 2007
VL 396
IS 2
BP 215
EP 225
DI 10.1016/j.gene.2007.02.033
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA 190UV
UT WOS:000248087000001
PM 17467928
DA 2021-01-25
ER

PT J
AU Gaidatzis, D
   Nimwegen, E
   Hausser, J
   Zavolan, M
AF Gaidatzis, Dimos
   van Nimwegen, Erik
   Hausser, Jean
   Zavolan, Mihaela
TI Inference of miRNA targets using evolutionary conservation and pathway
   analysis (vol 8, pg 248, 2007)
SO BMC BIOINFORMATICS
LA English
DT Correction
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM d.gaidatzis@unibas.ch; erik.vannimwegen@unibas.ch;
   jean.hausser@unibas.ch; mihaela.zavolan@unibas.ch
CR Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-248
NR 2
TC 3
Z9 3
U1 0
U2 0
PU BIOMED CENTRAL LTD
PI LONDON
PA MIDDLESEX HOUSE, 34-42 CLEVELAND ST, LONDON W1T 4LB, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD JUL 12
PY 2007
VL 8
AR 248
DI 10.1186/1471-2105-8-248
PG 1
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 200BN
UT WOS:000248739000001
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Seelig, J
AF Ziegler, Andre
   Seelig, Joachim
TI High affinity of the cell-penetrating peptide HIV-1 Tat-PTD for DNA
SO BIOCHEMISTRY
LA English
DT Article
ID HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN TRANSDUCTION; BINDING MECHANISM;
   MAMMALIAN-CELLS; TUMOR CELLS; IN-VIVO; RNA; INTERNALIZATION;
   FLUORESCENCE; COMPLEXES
AB During cellular uptake of fluorescently labeled cell-penetrating peptides (CPPs), intense fluorescent signals are commonly observed in the nucleus of the cell, suggesting intracellular CPP relocation and potential binding to the genome of the host. We therefore investigated the interaction of the CPP HIV-1 Tat(47-57) with double-stranded DNA, and we also tested whether the fluorescence intensity of the labeled CPP allows for linear predictions of its intracellular concentration. Using isothermal titration calorimetry, we observe that the CPP has a high affinity for salmon sperm DNA as characterized by a microscopic dissociation constant of 126 nM. The binding is exothermic, with a reaction enthalpy of -4.63 kcal/mol CPP (28 degrees C). The dissociation constant and reaction enthalpy decrease further at higher temperatures. The affinity of the CPP for DNA is thus 1-2 magnitudes higher than for extracellular heparan sulfate, the likely mediator of the CPP uptake. Accordingly, the high affinity for DNA confers stability to extracellular transport complexes of CPP and DNA but potentially affects the regulation and molecular organization of the host's genome after nuclear uptake. Moreover, the CPP leads to the condensation of DNA as evidenced by the pronounced increase in light-scattering intensity. The fluorescence quantum yield of the FITC-labeled CPP decreases considerably at concentrations > 5 mu mol/L, at pH < 7, and upon binding to DNA and glycosaminoglycans. This change in fluorescence quantum yield impedes the microscopic identification of uptake routes and the comparison of uptake efficiency of different CPPs, especially if the accumulation in subcellular compartments (self-quenching and pH difference) and transitory binding partners (quenching and condensation) is unknown.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Ziegler, A (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Kingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andre.ziegler@unibas.ch
CR BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201
   Choi YH, 1999, HUM GENE THER, V10, P2657, DOI 10.1089/10430349950016690
   Choosakoonkriang S, 2003, J PHARM SCI-US, V92, P1710, DOI 10.1002/jps.10437
   Clamme JP, 2003, BIOPHYS J, V84, P1960, DOI 10.1016/S0006-3495(03)75004-8
   Dizhe EB, 2006, BIOCHEMISTRY-MOSCOW+, V71, P1350, DOI 10.1134/S0006297906120108
   Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200
   FERGUSON LR, 1981, MUTAT RES, V82, P31, DOI 10.1016/0027-5107(81)90135-4
   Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200
   Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808
   Hunter AC, 2006, ADV DRUG DELIVER REV, V58, P1523, DOI 10.1016/j.addr.2006.09.008
   Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279
   KAMINE J, 1991, VIROLOGY, V182, P570, DOI 10.1016/0042-6822(91)90598-6
   Kankia BI, 2001, NUCLEIC ACIDS RES, V29, P2795, DOI 10.1093/nar/29.13.2795
   KARN J, 1991, BIOCHIMIE, V73, P9, DOI 10.1016/0300-9084(91)90068-C
   KATCHALSKY A, 1959, BIOCHIM BIOPHYS ACTA, V33, P120
   KAWSKI A, 1983, PHOTOCHEM PHOTOBIOL, V38, P487, DOI 10.1111/j.1751-1097.1983.tb03372.x
   KORNGUTH SE, 1961, EXP CELL RES, V24, P484, DOI 10.1016/0014-4827(61)90448-7
   Kwoh DY, 1999, BBA-GENE STRUCT EXPR, V1444, P171, DOI 10.1016/S0167-4781(98)00274-7
   Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4
   Lundback T, 1996, P NATL ACAD SCI USA, V93, P4754, DOI 10.1073/pnas.93.10.4754
   MANDELGUTFREUND Y, 1995, J MOL BIOL, V253, P370, DOI 10.1006/jmbi.1995.0559
   MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x
   Mano M, 2005, BIOCHEM J, V390, P603, DOI 10.1042/BJ20050577
   Mascotti DP, 1997, BIOCHEMISTRY-US, V36, P7272, DOI 10.1021/bi970272n
   MATSUYA Y, 1985, J CELL SCI, V78, P273
   Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470
   Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y
   MELLMAN I, 1986, ANNU REV BIOCHEM, V55, P663, DOI 10.1146/annurev.bi.55.070186.003311
   Metzger AU, 1997, BIOCHEM BIOPH RES CO, V241, P31, DOI 10.1006/bbrc.1997.7770
   OLMSTED J, 1977, BIOCHEMISTRY-US, V16, P3647, DOI 10.1021/bi00635a022
   Pedreno E, 2005, J INORG BIOCHEM, V99, P2074, DOI 10.1016/j.jinorgbio.2005.07.005
   Rana TM, 1999, ARCH BIOCHEM BIOPHYS, V365, P175, DOI 10.1006/abbi.1999.1206
   RICHARDSON T, 1959, P SOC EXP BIOL MED, V101, P382
   ROSS PD, 1974, BIOPOLYMERS, V13, P415, DOI 10.1002/bip.1974.360130218
   RYSER HJP, 1965, SCIENCE, V150, P501, DOI 10.1126/science.150.3695.501
   Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033
   SCHAUENSTEIN K, 1978, J HISTOCHEM CYTOCHEM, V26, P277, DOI 10.1177/26.4.77868
   Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2
   Seksek O, 1996, J CELL SCI, V109, P257
   Sjoback R, 1998, BIOPOLYMERS, V46, P445
   SLICE LW, 1992, BIOCHEMISTRY-US, V31, P12062, DOI 10.1021/bi00163a014
   Szeto HH, 2004, FASEB J, V18, P118, DOI 10.1096/fj.04-1982fje
   Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5
   Trehin R, 2004, PHARM RES-DORDR, V21, P33, DOI 10.1023/B:PHAM.0000012149.83119.bf
   Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P605
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Vives E, 2003, CURR PROTEIN PEPT SC, V4, P125, DOI 10.2174/1389203033487306
   WEEKS KM, 1990, SCIENCE, V249, P1281, DOI 10.1126/science.2205002
   WIDOM J, 1983, BIOPOLYMERS, V22, P1595, DOI 10.1002/bip.360220612
   Willbold D, 1998, J MOL BIOL, V277, P749, DOI 10.1006/jmbi.1998.1636
   Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253
   Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
NR 58
TC 58
Z9 62
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUL 10
PY 2007
VL 46
IS 27
BP 8138
EP 8145
DI 10.1021/bi700416h
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 184YE
UT WOS:000247677700021
PM 17555330
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Suda, K
   Engel, A
   Fotiadis, D
AF Hoogenboom, Bart W.
   Suda, Kitaru
   Engel, Andreas
   Fotiadis, Dimitrios
TI The supramolecular assemblies of voltage-dependent anion channels in the
   native membrane
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE atomic force microscopy; outer mitochondrial membrane; supramolecular
   structure; transmission electron microscopy; voltage-dependent anion
   channel
ID MITOCHONDRIAL OUTER-MEMBRANE; PERMEABILITY TRANSITION PORE;
   HEXOKINASE-BINDING PROTEIN; SELECTIVE CHANNEL; NEUROSPORA-CRASSA;
   PLANT-MITOCHONDRIA; VDAC; PURIFICATION; FORCE; MODEL
AB Voltage-dependent anion channels (VDACs) are major constituents of the outer mitochondrial membrane (OMM). These primary transporters of nucleotides, ions and metabolites mediate a substantial portion of the OMM molecular traffic. To study the native supramolecular organization of the VDAC, we have isolated, characterized and imaged OMMs from potato tubers. SDS-PAGE and mass spectrometry of OMMs revealed the presence of the VDAC isoforms POM34 and POM36, as well as the translocase of the OMM complex. Tubular two-dimensional crystals of the VDAC spontaneously formed after incubation of OMMs for two to three months at 4 degrees C. Transmission electron microscopy revealed an oblique lattice and unit cells housing six circular depressions arranged in a hexagon. Atomic force microscopy of freshly isolated OMMs demonstrated (i) the existence of monomers to tetramers, hexamers and higher oligorners of the VDAC and (ii) its spatial arrangement within the oligomers in the native membrane. We discuss the importance of the observed oligomerization for modulation of the VDAC function, for the binding of hexokinase and creatine kinase to the OMM and for n-dtochondria-mediated apoptosis. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch; dimitrios.fotiadis@unibas.ch
OI Hoogenboom, Bart/0000-0002-8882-4324
CR Abrecht H, 2000, J BIOL CHEM, V275, P40992, DOI 10.1074/jbc.M006437200
   Azoulay-Zohar H, 2004, BIOCHEM J, V377, P347, DOI 10.1042/BJ20031465
   BENZ R, 1994, BBA-REV BIOMEMBRANES, V1197, P167, DOI 10.1016/0304-4157(94)90004-3
   BENZ R, 1985, CRC CR REV BIOCH MOL, V19, P145, DOI 10.3109/10409238509082542
   Bernardi P, 1999, PHYSIOL REV, V79, P1127
   BONNER WD, 1967, METHOD ENZYMOL, V10, P126
   BRDICZKA D, 1990, BIOCHIM BIOPHYS ACTA, V1018, P234, DOI 10.1016/0005-2728(90)90256-4
   Brdiczka D, 1998, BIOFACTORS, V8, P235, DOI 10.1002/biof.5520080311
   Casadio R, 2002, FEBS LETT, V520, P1, DOI 10.1016/S0014-5793(02)02758-8
   Cesura AM, 2003, J BIOL CHEM, V278, P49812, DOI 10.1074/jbc.M304748200
   Colombini M, 1996, Ion Channels, V4, P169
   Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d
   COLOMBINI M, 1979, NATURE, V279, P643, DOI 10.1038/279643a0
   Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233
   Dolder M, 1999, J STRUCT BIOL, V127, P64, DOI 10.1006/jsbi.1999.4141
   FELGNER PL, 1979, J BIOL CHEM, V254, P4946
   FORTE M, 1987, J BIOENERG BIOMEMBR, V19, P341, DOI 10.1007/BF00768537
   Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013
   GUO XW, 1995, J STRUCT BIOL, V114, P41, DOI 10.1006/jsbi.1995.1004
   Halestrap AP, 2000, BIOCHEM SOC T, V28, P170, DOI 10.1042/bst0280170
   Heins L, 1996, PLANT J, V9, P829, DOI 10.1046/j.1365-313X.1996.9060829.x
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Hoogenboom BW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866229
   Jansch L, 1998, J BIOL CHEM, V273, P17251, DOI 10.1074/jbc.273.27.17251
   Jiao Y, 2004, LANGMUIR, V20, P10038, DOI 10.1021/la048650u
   KRAUSE J, 1986, BIOCHIM BIOPHYS ACTA, V860, P690, DOI 10.1016/0005-2736(86)90568-7
   Lemasters JJ, 1999, J BIOENERG BIOMEMBR, V31, P305, DOI 10.1023/A:1005419617371
   LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3
   LINDEN M, 1982, FEBS LETT, V141, P189, DOI 10.1016/0014-5793(82)80044-6
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   MANNELLA CA, 1986, METHOD ENZYMOL, V125, P595
   Mannella CA, 1996, J BIOENERG BIOMEMBR, V28, P163, DOI 10.1007/BF02110647
   Mannella CA, 1998, J STRUCT BIOL, V121, P207, DOI 10.1006/jsbi.1997.3954
   MANNELLA CA, 1982, J CELL BIOL, V94, P680, DOI 10.1083/jcb.94.3.680
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010
   NEUBURGER M, 1982, ARCH BIOCHEM BIOPHYS, V217, P312, DOI 10.1016/0003-9861(82)90507-0
   NEUPERT W, 1971, EUR J BIOCHEM, V19, P523, DOI 10.1111/j.1432-1033.1971.tb01344.x
   PARSONS DF, 1965, CAN J BOTANY, V43, P647, DOI 10.1139/b65-072
   PFALLER R, 1985, J BIOL CHEM, V260, P8188
   RAUCH G, 1994, BIOCHEM BIOPH RES CO, V200, P908, DOI 10.1006/bbrc.1994.1536
   Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0
   Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279
   SZABO I, 1993, FEBS LETT, V330, P206, DOI 10.1016/0014-5793(93)80274-X
   THOMAS L, 1991, J STRUCT BIOL, V106, P161, DOI 10.1016/1047-8477(91)90085-B
   Wilson JE, 1985, REGULATION CARBOHYDR, P45
   XIE GC, 1990, ARCH BIOCHEM BIOPHYS, V276, P285, DOI 10.1016/0003-9861(90)90040-6
   Xu X, 1999, J MEMBRANE BIOL, V170, P89, DOI 10.1007/s002329900540
   Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356
   ZALMAN LS, 1980, J BIOL CHEM, V255, P1771
   Zamzami N, 2003, CURR BIOL, V13, pR71, DOI 10.1016/S0960-9822(02)01433-1
   ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A
NR 54
TC 128
Z9 130
U1 1
U2 25
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 6
PY 2007
VL 370
IS 2
BP 246
EP 255
DI 10.1016/j.jmb.2007.04.073
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 180ZW
UT WOS:000247407500005
PM 17524423
DA 2021-01-25
ER

PT J
AU Camilleri, AA
   Willmann, R
   Sadasivam, G
   Lin, S
   Ruegg, MA
   Gesemann, M
   Fuhrer, C
AF Camilleri, Alain A.
   Willmann, Raffaella
   Sadasivam, Gayathri
   Lin, Shuo
   Rueegg, Markus A.
   Gesemann, Matthias
   Fuhrer, Christian
TI Tyrosine phosphatases such as SHP-2 act in a balance with Src-family
   kinases in stabilization of postsynaptic clusters of acetylcholine
   receptors
SO BMC NEUROSCIENCE
LA English
DT Article
ID NEUROMUSCULAR-JUNCTION; SYNAPSE FORMATION; MAMMALIAN MUSCLE;
   ALPHA-V-BETA-3 INTEGRIN; REQUIRES RAPSYN; C2 MYOTUBES; IN-VIVO; AGRIN;
   PHOSPHORYLATION; MAINTENANCE
AB Background: Development of neural networks requires that synapses are formed, eliminated and stabilized. At the neuromuscular junction (NMJ), agrin/MuSK signaling, by triggering downstream pathways, causes clustering and phosphorylation of postsynaptic acetylcholine receptors (AChRs). Postnatally, AChR aggregates are stabilized by molecular pathways that are poorly characterized. Gain or loss of function of Src-family kinases (SFKs) disassembles AChR clusters at adult NMJs in vivo, whereas AChR aggregates disperse rapidly upon withdrawal of agrin from cultured src(-/-); fyn(-/)-myotubes. This suggests that a balance between protein tyrosine phosphatases (PTPs) and protein tyrosine kinases (PTKs) such as those of the Src-family may be essential in stabilizing clusters of AChRs.
   Results: We have analyzed the role of PTPs in maintenance of AChR aggregates, by adding and then withdrawing agrin from cultured myotubes in the presence of PTP or PTK inhibitors and quantitating remaining AChR clusters. In wild-type myotubes, blocking PTPs with pervanadate caused enhanced disassembly of AChR clusters after agrin withdrawal. When added at the time of agrin withdrawal, SFK inhibitors destabilized AChR aggregates but concomitant addition of pervanadate rescued cluster stability. Likewise in src-/-; fyn-/-myotubes, in which agrin-induced AChR clusters form normally but rapidly disintegrate after agrin withdrawal, pervanadate addition stabilized AChR clusters. The PTP SHP-2, known to be enriched at the NMJ, associated and colocalized with MuSK, and agrin increased this interaction. Specific SHP-2 knockdown by RNA interference reduced the stability of AChR clusters in wild-type myotubes. Similarly, knockdown of SHP-2 in adult mouse soleus muscle by electroporation of RNA interference constructs caused disassembly of pretzel-shaped AChR-rich areas in vivo. Finally, we found that src-/-; fyn-/-myotubes contained elevated levels of SHP-2 protein.
   Conclusion: Our data are the first to show that the fine balance between PTPs and SFKs is a key aspect in stabilization of postsynaptic AChR clusters. One phosphatase that acts in this equilibrium is SHP-2. Thus, PTPs such as SHP-2 stabilize AChR clusters under normal circumstances, but when these PTPs are not balanced by SFKs, they render clusters unstable.
C1 Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Fuhrer, C (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.
EM camilleri@hifo.uzh.ch; raffaella.willmann@gmail.com;
   gayathri_sadasivam@yahoo.com; shuo.lin@unibas.ch;
   markus-a.ruegg@unibas.ch; gesemann@hifo.uzh.ch; chfuhrer@hifo.unizh.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Fuhrer, Christian/0000-0001-8216-8883
CR Ackley BD, 2005, J NEUROSCI, V25, P7517, DOI 10.1523/JNEUROSCI.2010-05.2005
   CASE RD, 1994, J BIOL CHEM, V269, P10467
   CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355
   Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005
   Chen B, 2002, DEV BIOL, V252, P170, DOI 10.1006/dbio.2002.0847
   Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321
   Dong XP, 2006, NEUROSIGNALS, V15, P53, DOI 10.1159/000094484
   Dunah AW, 2005, NAT NEUROSCI, V8, P458, DOI 10.1038/nn1416
   Feng GS, 1999, EXP CELL RES, V253, P47, DOI 10.1006/excr.1999.4668
   Ferns M, 1996, J CELL BIOL, V132, P937, DOI 10.1083/jcb.132.5.937
   FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I
   Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951
   Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6
   Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695
   Higuchi M, 2004, CANCER SCI, V95, P442, DOI 10.1111/j.1349-7006.2004.tb03229.x
   Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1
   Huk KH, 2002, MOL NEUROBIOL, V25, P79
   Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kaksonen M, 2000, J CELL SCI, V113, P4421
   Kaufmann N, 2002, NEURON, V34, P27, DOI 10.1016/S0896-6273(02)00643-8
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004
   KUMMER TT, 2005, CURR OPIN NEUROBIOL
   Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4
   Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200
   Ling Y, 2003, MOL ENDOCRINOL, V17, P1824, DOI 10.1210/me.2003-0143
   Madhavan R, 2005, MOL CELL NEUROSCI, V28, P403, DOI 10.1016/j.mcn.2004.10.005
   Marangi PA, 2001, EMBO J, V20, P7060, DOI 10.1093/emboj/20.24.7060
   Marangi PA, 2002, J CELL BIOL, V157, P883, DOI 10.1083/jcb.200202110
   Megeath LJ, 2003, NEUROSCIENCE, V122, P659, DOI 10.1016/S0306-4522(03)00602-X
   MEI L, 1995, LIFE SCI, V57, P1459, DOI 10.1016/0024-3205(95)02118-3
   MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441
   Mittaud P, 2004, MOL CELL BIOL, V24, P7841, DOI 10.1128/MCB.24.18.7841-7854.2004
   Mittaud P, 2001, J BIOL CHEM, V276, P14505, DOI 10.1074/jbc.M007024200
   Moransard M, 2003, J BIOL CHEM, V278, P7350, DOI 10.1074/jbc.M210865200
   Moult PR, 2006, J NEUROSCI, V26, P2544, DOI 10.1523/JNEUROSCI.4322-05.2006
   NGO ST, 2006, INT J BIOCH CELL BIO
   PENG ZY, 1995, ONCOGENE, V11, P1955
   PUMIGLIA KM, 1992, BIOCHEM J, V286, P441, DOI 10.1042/bj2860441
   Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001
   Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305
   SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6
   SWOPE SL, 1993, J BIOL CHEM, V268, P25152
   Tanowitz M, 1999, J NEUROSCI, V19, P9426
   WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121
   Walter AO, 1999, ONCOGENE, V18, P1911, DOI 10.1038/sj.onc.1202513
   Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205
   Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200
   Wiesner A, 2006, CELL MOL LIFE SCI, V63, P2818, DOI 10.1007/s00018-006-6081-z
   Willmann R, 2002, CELL MOL LIFE SCI, V59, P1296, DOI 10.1007/s00018-002-8509-4
   Willmann R, 2006, EMBO J, V25, P4050, DOI 10.1038/sj.emboj.7601288
   Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x
   Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4
NR 58
TC 9
Z9 9
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2202
J9 BMC NEUROSCI
JI BMC Neurosci.
PD JUL 2
PY 2007
VL 8
AR 46
DI 10.1186/1471-2202-8-46
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA 190XC
UT WOS:000248093000001
PM 17605785
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Krijt, J
   Niederkofler, V
   Salie, R
   Sefc, L
   Pelichovska, T
   Vokurka, M
   Necas, E
AF Krijt, Jan
   Niederkofler, Vera
   Salie, Rishard
   Sefc, Ludek
   Pelichovska, Tereza
   Vokurka, Martin
   Necas, Emanuel
TI Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice
SO BLOOD CELLS MOLECULES AND DISEASES
LA English
DT Article
DE hemojuvelin; Hamp1; Hamp2; sex difference; phlebotomy
ID JUVENILE HEMOCHROMATOSIS; PEPTIDE HEPCIDIN; IRON OVERLOAD; MOUSE; LIVER;
   HFE; ANEMIA; GENES
AB Hemojuvelin (Hjv) is an essential component of the pathway regulating hepcidin (Hamp1) gene expression. Mice with targeted disruption of the Hjv gene (Hjv(-/-) mice) fail to upregulate hepatic Hamp1 expression following iron overload. The main aim of the study was to determine whether the Hjv protein is also necessary for Hamp1 downregulation. In addition, sex differences in Hamp1 expression in Hjv(-/-) mice were also examined.
   Male and female Hjv(-/-) mice (129 SvJ background) were used for the experiments, tissue Hamp1 and Hamp2 mRNA content was determined by real-time PCR.
   Hepatic Hamp1 mRNA content in male Hjv(-/-) mice was low (0.6% of Hjv(+/+) males), however, female Hjv(-/-) mice displayed only moderately reduced (to 17%) Hamp1 mRNA levels. Hepatic non-heme iron concentration was similar in Hjv(-/-) mice of both sexes. Disruption of the Hjv gene did not affect Hamp1 mRNA content in the myocardium or Hamp2 mRNA content in the pancreas.
   Single phlebotomy resulted in significant reduction of Hamp1 mRNA in both male and female Hjv(+/+) mice (to 17% and 27% of controls respectively), measured 20 h after treatment. In Hjv(-/-) mice, phlebotomy decreased Hamp1 mRNA content to 46% in males and to 11% in females. Bleeding also significantly decreased (to 16%) hepatic Hamp2 mRNA levels in Hjv(-/-) females.
   The obtained results indicate that the pathway mediating hepcidin downregulation by phlebotomy does not require functional hemojuvelin protein. In addition, they confirm a significant effect of sex on hepcidin gene expression. (c) 2007 Elsevier Inc. All rights reserved.
C1 Charles Univ Prague, Inst Pathophysiol, Prague 12853 2, Czech Republic.
   Charles Univ Prague, Fac Med 1, Ctr Expt Hematol, Prague 12853 2, Czech Republic.
   Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
RP Krijt, J (corresponding author), Charles Univ Prague, Inst Pathophysiol, Prague 12853 2, Czech Republic.
EM JKRI@LF1.CUNI.CZ
RI Krijt, Jan/B-2359-2009; Sefc, Ludek/J-1848-2014; Necas,
   Emanuel/G-4455-2013; Vokurka, Martin/F-7533-2017
OI Sefc, Ludek/0000-0003-2846-220X; Necas, Emanuel/0000-0002-6101-4639;
   Vokurka, Martin/0000-0001-5943-5939
CR Ahmad KA, 2002, BLOOD CELL MOL DIS, V29, P361, DOI 10.1006/bcmd.2002.0575
   Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777
   Bekri S, 2006, GASTROENTEROLOGY, V131, P788, DOI 10.1053/j.gastro.2006.07.007
   Bondi A, 2005, HAEMATOLOGICA, V90, P1161
   Constante M, 2006, AM J PHYSIOL-GASTR L, V291, pG229, DOI 10.1152/ajpgi.00092.2006
   Courselaud B, 2004, BLOOD CELL MOL DIS, V32, P283, DOI 10.1016/j.bcmd.2003.11.003
   Daraio F, 2005, BLOOD CELL MOL DIS, V35, P174, DOI 10.1016/j.bcmd.2005.02.001
   Flanagan JM, 2006, ACTA HAEMATOL-BASEL, V116, P249, DOI 10.1159/000095875
   Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014
   Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5
   Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049
   Ilyin G, 2003, FEBS LETT, V542, P22, DOI 10.1016/S0014-5793(03)00329-6
   Krijt J, 2004, J HEPATOL, V40, P891, DOI 10.1016/j.jhep.2004.02.029
   Kulaksiz H, 2005, J ENDOCRINOL, V184, P361, DOI 10.1677/joe.1.05729
   Lee P, 2006, ACTA HAEMATOL-BASEL, V115, P123, DOI 10.1159/000089479
   Lee P, 2004, P NATL ACAD SCI USA, V101, P9263, DOI 10.1073/pnas.0403108101
   Lou DQ, 2004, BLOOD, V103, P2816, DOI 10.1182/blood-2003-07-2524
   Muckenthaler MU, 2004, BLOOD CELL MOL DIS, V33, P125, DOI 10.1016/j.bcmd.2004.05.003
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Nicolas G, 2002, J CLIN INVEST, V110, P1037, DOI 10.1172/JCI200215686
   Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683
   Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787
   Papanikolaou G, 2004, NAT GENET, V36, P77, DOI 10.1038/ng1274
   Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573
   Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200
   Torrance JDB., 1980, METHODS HEMATOLOGY, V1, P90
   Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103
   Vokurka M, 2006, PHYSIOL RES, V55, P667
   Wallace DF, 2005, GUT, V54, P980, DOI 10.1136/gut.2004.062018
   Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010
   Weizer-Stern O, 2006, BRIT J HAEMATOL, V135, P129, DOI 10.1111/j.1365-2141.2006.06258.x
   Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631
NR 32
TC 15
Z9 19
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1079-9796
EI 1096-0961
J9 BLOOD CELL MOL DIS
JI Blood Cells Mol. Dis.
PD JUL-AUG
PY 2007
VL 39
IS 1
BP 92
EP 95
DI 10.1016/j.bcmd.2007.02.004
PG 4
WC Hematology
SC Hematology
GA 179OQ
UT WOS:000247299900012
PM 17395503
DA 2021-01-25
ER

PT J
AU Vanacova, S
   Stefl, R
AF Vanacova, Stepanka
   Stefl, Richard
TI The exosome and RNA quality control in the nucleus
SO EMBO REPORTS
LA English
DT Review
DE RNA decay; exoribonuclease; exosome; structure; nuclear polyadenylation;
   TRAMP
ID HEXAMERIC RING STRUCTURE; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA;
   POLYMERASE-II; RIBOSOMAL-RNA; POLY(A) POLYMERASE; ARCHAEAL EXOSOME;
   STRUCTURAL BASIS; TRANSCRIPTS; DEGRADATION
AB To control the quality of RNA biogenesis in the nucleus, cells use sophisticated molecular machines. These machines recognize and degrade not only RNA trimmings-the leftovers of RNA processing-but also incorrectly processed RNAs that contain defects. By using this mechanism, cells ensure that only high-quality RNAs are engaged in protein synthesis and other cellular processes. The exosome-a complex of several exoribonucleolytic and RNA-binding proteins-is the central 3'-end RNA degradation and processing factor in this surveillance apparatus. The exosome operates with auxiliary factors that stimulate its activity and recruit its RNA substrates in the crowded cellular environment. In this review, we discuss recent structural and functional data related to the nuclear quality-control apparatus, including the long-awaited structure of the human exosome and its activity.
C1 Masaryk Univ, Natl Ctr Biomol Res, CZ-62500 Brno, Czech Republic.
   Univ Basel, Biozentrum, CH-4057 Basel, Switzerland.
RP Stefl, R (corresponding author), Masaryk Univ, Natl Ctr Biomol Res, Kamenice 5-A4, CZ-62500 Brno, Czech Republic.
EM stefl@chemi.muni.cz
RI Stefl, Richard/D-7010-2012; Vanacova, Stepanka/D-6858-2012
OI Vanacova, Stepanka/0000-0001-8807-0684
CR Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399
   Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606
   Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181
   Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9
   Buttner K, 2005, MOL CELL, V20, P461, DOI 10.1016/j.molcel.2005.10.018
   Carneiro T, 2007, MOL CELL BIOL, V27, P4157, DOI 10.1128/MCB.00120-07
   Carroll KL, 2004, MOL CELL BIOL, V24, P6241, DOI 10.1128/MCB.24.14.6241-6252.2004
   Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5
   Choi JM, 2004, J BIOL CHEM, V279, P755, DOI 10.1074/jbc.M309628200
   Conrad NK, 2000, GENETICS, V154, P557
   Das B, 2003, MOL CELL BIOL, V23, P5502, DOI 10.1128/MCB.23.16.5502-5515.2003
   Das B, 2006, P NATL ACAD SCI USA, V103, P10871, DOI 10.1073/pnas.0604562103
   David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103
   Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103
   de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128
   Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035
   Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184
   Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206
   Fasken MB, 2005, NAT STRUCT MOL BIOL, V12, P482, DOI 10.1038/nsmb945
   Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104
   Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702
   Hieronymus H, 2004, GENE DEV, V18, P2652, DOI 10.1101/gad.1241204
   Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110
   Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612
   Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964
   Jensen TH, 2003, MOL CELL, V11, P1129, DOI 10.1016/S1097-2765(03)00191-6
   Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406
   Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804
   Kuai L, 2004, P NATL ACAD SCI USA, V101, P8581, DOI 10.1073/pnas.0402888101
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Libri D, 2002, MOL CELL BIOL, V22, P8254, DOI 10.1128/MCB.22.23.8254-8266.2002
   Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037
   Lorentzen E, 2005, NAT STRUCT MOL BIOL, V12, P575, DOI 10.1038/nsmb952
   Lorentzen E, 2005, MOL CELL, V20, P473, DOI 10.1016/j.molcel.2005.10.020
   Lorentzen E, 2007, EMBO REP, V8, P470, DOI 10.1038/sj.embor.7400945
   Midtgaard SF, 2006, P NATL ACAD SCI USA, V103, P11898, DOI 10.1073/pnas.0604731103
   Mitchell P, 2003, MOL CELL BIOL, V23, P6982, DOI 10.1128/MCB.23.19.6982-6992.2003
   Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8
   Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856
   Olesen Jens Raabjerg, 2005, RNA Biol, V2, P45, DOI 10.4161/rna.2.2.1633
   Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699
   Steinmetz EJ, 1996, MOL CELL BIOL, V16, P6993, DOI 10.1128/mcb.16.12.6993
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   Symmons MF, 2000, STRUCTURE, V8, P1215, DOI 10.1016/S0969-2126(00)00521-9
   Thomsen R, 2003, RNA, V9, P1049, DOI 10.1261/rna.5170303
   Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0
   Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000
   van Hoof A, 1999, CELL, V99, P347, DOI 10.1016/S0092-8674(00)81520-2
   Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189
   Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028
   Walter P, 2006, MOL MICROBIOL, V62, P1076, DOI 10.1111/j.1365-2958.2006.05393.x
   Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030
NR 52
TC 102
Z9 102
U1 0
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD JUL
PY 2007
VL 8
IS 7
BP 651
EP 657
DI 10.1038/sj.embor.7401005
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 184OO
UT WOS:000247651500012
PM 17603538
OA Green Published
DA 2021-01-25
ER

PT J
AU Cornelis, GR
AF Cornelis, G. R.
TI Assembly and operation of the Yersinia injectisome
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
CY JUL 07-12, 2007
CL Vienna, AUSTRIA
SP Federat European Biochem Soc
C1 [Cornelis, G. R.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2007
VL 274
SU 1
BP 20
EP 20
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JO
UT WOS:000253283800030
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, M. N.
TI TOR signalling and control of cell growth in yeast and mammals
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
CY JUL 07-12, 2007
CL Vienna, AUSTRIA
SP Federat European Biochem Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2007
VL 274
SU 1
BP 64
EP 64
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JO
UT WOS:000253283800104
DA 2021-01-25
ER

PT J
AU Lussi, Y
   Fahrenkrog, B
AF Lussi, Y.
   Fahrenkrog, B.
TI Elucidating the effects of nucleoporin Nup88 overexpression
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
CY JUL 07-12, 2007
CL Vienna, AUSTRIA
SP Federat European Biochem Soc
C1 [Lussi, Y.; Fahrenkrog, B.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2007
VL 274
SU 1
BP 81
EP 81
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JO
UT WOS:000253283800152
DA 2021-01-25
ER

PT J
AU Mueller, A
   Broz, P
   Muller, SA
   Philippsen, A
   Engel, A
   Cornelis, GR
AF Mueller, A.
   Broz, P.
   Mueller, S. A.
   Philippsen, A.
   Engel, A.
   Cornelis, G. R.
TI Structural and functional characterisation of the LcrV tip complex of
   the Yersinia injectisome needle
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
CY JUL 07-12, 2007
CL Vienna, AUSTRIA
SP Federat European Biochem Soc
C1 [Mueller, A.; Cornelis, G. R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Broz, P.; Mueller, S. A.; Philippsen, A.; Engel, A.] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790
CR Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
NR 1
TC 1
Z9 1
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2007
VL 274
SU 1
BP 190
EP 190
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JO
UT WOS:000253283800584
DA 2021-01-25
ER

PT J
AU Sorg, I
   Wagner, S
   Amstutz, M
   Muller, SA
   Cornelis, GR
AF Sorg, I.
   Wagner, S.
   Amstutz, M.
   Mueller, S. A.
   Cornelis, G. R.
TI The Yersinia basal body protein YscU plays a role in recognition of Type
   III export substrates
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 32nd Congress of the Federation-of-European-Biochemical-Societies (FEBS)
CY JUL 07-12, 2007
CL Vienna, AUSTRIA
SP Federat European Biochem Soc
C1 [Sorg, I.; Wagner, S.; Amstutz, M.; Mueller, S. A.; Cornelis, G. R.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Wagner, Stefanie/A-5756-2011
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2007
VL 274
SU 1
BP 190
EP 190
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JO
UT WOS:000253283800585
DA 2021-01-25
ER

PT J
AU Nikonov, AV
   Hauri, HP
   Lauring, B
   Kreibich, G
AF Nikonov, Andrei V.
   Hauri, Hans-Peter
   Lauring, Brett
   Kreibich, Gert
TI Climp-63-mediated binding of microtubules to the ER affects the lateral
   mobility of translocon complexes
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE endoplasmic reticulum; translocon complexes; microtubules; FRAP;
   CLIMP-63
ID ROUGH ENDOPLASMIC-RETICULUM; FLUID MOSAIC MODEL; MEMBRANE-PROTEINS;
   MICROSOMAL-MEMBRANES; NASCENT CHAINS; DYNAMICS; ORGANIZATION; LINKING;
   TAXOL; P63
AB Microtubules are frequently seen in close proximity to membranes of the endoplasmic reticulum (ER), and the membrane protein CLIMP-63 is thought to mediate specific interaction between these two structures. It was, therefore, of interest to investigate whether these microtubules are in fact responsible for the highly restricted lateral mobility of the translocon complexes in M3/18 cells as described before. As determined by fluorescence recovery after photobleaching, the breakdown of microtubules caused by drug treatment or by overexpression of the microtubule-severing protein spastin, resulted in an increased lateral mobility of the translocons that are assembled into polysomes. Also, the expression of a CLIMP-63 mutant lacking the microtubule-binding domain resulted in a significant increase of the lateral mobility of the translocon complexes. The most striking increase in the diffusion rate of the translocon complexes was observed in M3/18 cells transfected with a siRNA that effectively knocked down the expression of the endogenous CLIMP-63. It appears, therefore, that interaction of microtubules with the ER results in the immobilization of translocon complexes that are part of membrane-bound polysomes, and may play a role in the mechanism that segregates the rough and smooth domains of the ER.
C1 NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Columbia Univ Coll Phys & Surg, Dept Pathol, New York, NY 10032 USA.
RP Kreibich, G (corresponding author), NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA.
EM kreibg01@popmail.med.nyu.edu
CR ADELMAN MR, 1973, J CELL BIOL, V56, P206, DOI 10.1083/jcb.56.1.206
   Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200
   Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500
   BIERER BE, 1987, J CELL BIOL, V105, P1147, DOI 10.1083/jcb.105.3.1147
   Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008
   Christensen AK, 1999, ANAT REC, V255, P116, DOI 10.1002/(SICI)1097-0185(19990601)255:2<116::AID-AR2>3.0.CO;2-O
   CHRISTENSEN AK, 1987, AM J ANAT, V178, P1, DOI 10.1002/aja.1001780102
   Clemons WM, 2004, CURR OPIN STRUC BIOL, V14, P390, DOI 10.1016/j.sbi.2004.07.006
   DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6
   Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883
   Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193
   Evans KJ, 2005, J CELL BIOL, V168, P599, DOI 10.1083/jcb.200409058
   Farah CA, 2005, J BIOL CHEM, V280, P9439, DOI 10.1074/jbc.M412304200
   FAWEETT DW, 1966, ATLAS FINE STRUCTURE
   GILMORE R, 1993, CELL, V75, P589, DOI 10.1016/0092-8674(93)90476-7
   JACOBSON K, 1995, SCIENCE, V268, P1441, DOI 10.1126/science.7770769
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   JORDAN MA, 1993, P NATL ACAD SCI USA, V90, P9552, DOI 10.1073/pnas.90.20.9552
   Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   KREIBICH G, 1978, J CELL BIOL, V77, P464, DOI 10.1083/jcb.77.2.464
   Lippincott-Schwartz J, 1999, METHOD CELL BIOL, V58, P261
   Lippincott-Schwartz J, 2001, NAT REV MOL CELL BIO, V2, P444, DOI 10.1038/35073068
   MARCANTONIO EE, 1982, EUR J BIOCHEM, V124, P217, DOI 10.1111/j.1432-1033.1982.tb05928.x
   Margetic D, 1999, INTERNET J CHEM, V2
   Marsh BJ, 2001, P NATL ACAD SCI USA, V98, P2399, DOI 10.1073/pnas.051631998
   McCallum CD, 2000, J CELL BIOL, V149, P591, DOI 10.1083/jcb.149.3.591
   Menetret JF, 2000, MOL CELL, V6, P1219, DOI 10.1016/S1097-2765(00)00118-0
   NIKONOV AV, 1992, TSITOLOGIYA+, V34, P31
   Nikonov AV, 2002, J CELL BIOL, V158, P497, DOI 10.1083/jcb.200201116
   Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043
   Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x
   Potter MD, 2000, J BIOL CHEM, V275, P33828, DOI 10.1074/jbc.M005294200
   Potter MD, 2000, J BIOL CHEM, V275, P2037, DOI 10.1074/jbc.275.3.2037
   RAJASEKARAN AK, 1993, J CELL SCI, V105, P333
   Rapoport TA, 2004, TRENDS CELL BIOL, V14, P568, DOI 10.1016/j.tcb.2004.09.002
   Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271
   RENNISON ME, 1992, J CELL SCI, V102, P239
   SABATINI DD, 1976, ENZYMES BIOLOGICAL M, V2, P531
   SABATINI DD, 1995, METABOLIC BASIS INHE, P459
   SABORIO JL, 1974, J MOL BIOL, V85, P195, DOI 10.1016/0022-2836(74)90360-X
   SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0
   SCHIFF PB, 1980, P NATL ACAD SCI-BIOL, V77, P1561, DOI 10.1073/pnas.77.3.1561
   SCHWEIZER A, 1995, J CELL SCI, V108, P2477
   SCHWEIZER A, 1993, EUR J CELL BIOL, V60, P366
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1993, J CELL SCI, V104, P685
   Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200
   Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   SPECTOR I, 1989, CELL MOTIL CYTOSKEL, V13, P127, DOI 10.1002/cm.970130302
   Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505
   TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557
   VAZ WLC, 1982, BIOCHEMISTRY-US, V21, P5608, DOI 10.1021/bi00265a034
   VAZQUEZ D, 1974, FEBS LETT, V43, pS63
   Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554
   Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202
   Wakatsuki T, 2001, J CELL SCI, V114, P1025
   WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511
   WENGLER G, 1972, EUR J BIOCHEM, V27, P162, DOI 10.1111/j.1432-1033.1972.tb01822.x
   WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0
   Yvon AMC, 1999, MOL BIOL CELL, V10, P947, DOI 10.1091/mbc.10.4.947
   ZHANG F, 1991, J CELL BIOL, V115, P75, DOI 10.1083/jcb.115.1.75
NR 63
TC 40
Z9 41
U1 0
U2 4
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 1
PY 2007
VL 120
IS 13
BP 2248
EP 2258
DI 10.1242/jcs.008979
PG 11
WC Cell Biology
SC Cell Biology
GA 185TA
UT WOS:000247732100013
PM 17567679
OA Bronze
DA 2021-01-25
ER

PT J
AU Magnaghi, V
   Ballabio, M
   Bettler, B
   Procacci, P
   Motta, M
AF Magnaghi, V
   Ballabio, M.
   Bettler, B.
   Procacci, P.
   Motta, M.
TI GABA receptors are functionally active in the peripheral nervous system:
   New insights from the GABA-B(1)-/- knockout mice
SO JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
LA English
DT Meeting Abstract
CT Annual Meeting of the Peripheral-Nerve-Society
CY JUL 14-18, 2007
CL Snowbird, UT
SP Peripheral Nerve Soc
C1 Univ Milan, Dept Endocrinol, I-20122 Milan, Italy.
   Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20122 Milan, Italy.
   Univ Milan, Inst Histol Embryol Neurocytol, I-20122 Milan, Italy.
   Univ Basel, Biozentrum, Pharmazentrum, CH-4003 Basel, Switzerland.
RI bettler, bernhard/AAO-8018-2020; Procacci, Patrizia/L-2155-2016
OI Procacci, Patrizia/0000-0003-4726-2115
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1085-9489
J9 J PERIPHER NERV SYST
JI J. Peripher. Nerv. Syst.
PD JUL
PY 2007
VL 12
SU 1
BP 54
EP 55
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 207IA
UT WOS:000249243600149
DA 2021-01-25
ER

PT J
AU Yao, YX
   Zhao, YG
   Xu, HT
   Smith, LP
   Lawrie, CH
   Sewer, A
   Zavolan, M
   Nair, V
AF Yao, Yongxiu
   Zhao, Yuguang
   Xu, Hongtao
   Smith, Lorraine P.
   Lawrie, Charles H.
   Sewer, Alain
   Zavolan, Mihaela
   Nair, Venugopal
TI Marek's disease virus type 2 (MDV-2)-encoded microRNAs show no sequence
   conservation with those encoded by MDV-1
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID LATENCY-ASSOCIATED TRANSCRIPT; AVIAN-LEUKOSIS VIRUS; GENE-EXPRESSION;
   CELL-LINES; HERPESVIRUS; ANTIBODIES; CHICKENS; STRAIN; IDENTIFICATION;
   LYMPHOMAS
AB MicroRNAs (miRNAs) are increasingly being recognized as major regulators of gene expression in many organisms, including viruses. Among viruses, members of the family Herpesviridae account for the majority of the currently known virus-encoded miRNAs. The highly oncogenic Marek's disease virus type 1 (MDV-1), an avian herpesvirus, has recently been shown to encode eight miRNAs clustered in the MEQ and LAT regions of the viral genome. The genus Mardivirus, to which MDV-1 belongs, also includes the nononcogenic but antigenically related MDV-2. As MDV-1 and MDV-2 are evolutionarily very close, we sought to determine if MDV-2 also encodes miRNAs. For this, we cloned, sequenced, and analyzed a library of small RNAs from the lymphoblastoid cell line MSB-1, previously shown to be coinfected with both MDV-1 and MDV-2. Among the 5,099 small RNA sequences determined from the library, we identified 17 novel MDV-2-specific miRNAs. Out of these, 16 were clustered in a 4.2-kb long repeat region that encodes R-LORF2 to R-LORF5. The single miRNA outside the cluster was located in the short repeat region, within the C-terminal region of the ICP4 homolog. The expression of these miRNAs in MSB-1 cells and infected chicken embryo fibroblasts was further confirmed by Northern blotting analysis. The identification of miRNA clusters within the repeat regions of MDV-2 demonstrates conservation of the relative genomic positions of miRNA clusters in MDV-1 and MDV-2, despite the lack of sequence homology among the miRNAs of the two viruses. The identification of these novel miRNAs adds to the growing list of virus-encoded miRNAs.
C1 Inst Anim Hlth, Avian Oncogen Virus Grp, Compton RG20 7NN, Berks, England.
   Univ Oxford, Nuffield Dept Clin LabSci, LRF Mol Haematol Unit, Oxford OX3 9DU, England.
   Univ Basel, Div Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Nair, V (corresponding author), Inst Anim Hlth, Avian Oncogen Virus Grp, Compton RG20 7NN, Berks, England.
EM venu.gopal@bbsrc.ac.uk
RI Nair, Venugopal/D-4447-2016; Zavolan, Mihaela/S-3888-2016
OI Nair, Venugopal/0000-0002-8255-516X; Zavolan,
   Mihaela/0000-0002-8832-2041; Lawrie, Charles/0000-0002-8882-1131
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/C518265/1] Funding
   Source: Medline
CR AKIYAMA Y, 1974, BIKEN J, V17, P105
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Aly MM, 1996, AVIAN PATHOL, V25, P81, DOI 10.1080/03079459608419122
   Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803
   BACON LD, 1989, J VIROL, V63, P504, DOI 10.1128/JVI.63.2.504-512.1989
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Biggs P. M., 1972, Oncogenesis and herpesviruses. Proceedings of a symposium held at Christ's College, Cambridge, England 20 to 25 June 1971., P88
   Buchen-Osmond C, 2006, ICTVDB UNIVERSAL VIR
   Burnside J, 2006, J VIROL, V80, P8778, DOI 10.1128/JVI.00831-06
   Cai X, 2006, PLOS PATHOG, V2, pe23, DOI DOI 10.1371/JOURNAL.PPAT.0020023
   Cantello JL, 1997, J VIROL, V71, P1353, DOI 10.1128/JVI.71.2.1353-1361.1997
   FYNAN E, 1992, J VIROL, V66, P5860, DOI 10.1128/JVI.66.10.5860-5866.1992
   FYNAN EF, 1993, J GEN VIROL, V74, P2163, DOI 10.1099/0022-1317-74-10-2163
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Gupta A, 2006, NATURE, V442, P82, DOI 10.1038/nature04836
   HIRAI K, 1990, ARCH VIROL, V114, P153, DOI 10.1007/BF01310745
   Izumiya Y, 2001, CURR TOP MICROBIOL, V255, P191
   Lee LF, 2000, P NATL ACAD SCI USA, V97, P6091, DOI 10.1073/pnas.97.11.6091
   LEE LF, 1983, J IMMUNOL, V130, P1003
   LI DS, 1994, J VIROL METHODS, V50, P185, DOI 10.1016/0166-0934(94)90175-9
   Matzura O, 1996, COMPUT APPL BIOSCI, V12, P247
   McGeoch DJ, 2006, VIRUS RES, V117, P90, DOI 10.1016/j.virusres.2006.01.002
   Nair V, 2006, TRENDS MICROBIOL, V14, P169, DOI 10.1016/j.tim.2006.02.007
   NAIR V, 2004, MAREKS DIS EVOLVING, P32
   Osterrieder N, 2006, NAT REV MICROBIOL, V4, P283, DOI 10.1038/nrmicro1382
   Osterrieder N., 2004, MAREKS DIS EVOLVING, P17
   Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Sarnow P, 2006, NAT REV MICROBIOL, V4, P651, DOI 10.1038/nrmicro1473
   SCHAT KA, 1989, INT J CANCER, V44, P101, DOI 10.1002/ijc.2910440119
   SCHAT KA, 1978, JNCI-J NATL CANCER I, V60, P1075, DOI 10.1093/jnci/60.5.1075
   SCHAT KA, 1978, INFECT IMMUN, V22, P225, DOI 10.1128/IAI.22.1.225-232.1978
   SUGAYA K, 1990, J VIROL, V64, P5773, DOI 10.1128/JVI.64.12.5773-5782.1990
   Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576
   Tulman ER, 2000, J VIROL, V74, P7980, DOI 10.1128/JVI.74.17.7980-7988.2000
   WITTER RL, 1984, AVIAN PATHOL, V13, P75, DOI 10.1080/03079458408418510
   WITTER RL, 1990, AVIAN DIS, V34, P944, DOI 10.2307/1591388
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 39
TC 77
Z9 104
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2007
VL 81
IS 13
BP 7164
EP 7170
DI 10.1128/JVI.00112-07
PG 7
WC Virology
SC Virology
GA 180YW
UT WOS:000247404900039
PM 17459919
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Stelter, P
   Kunze, R
   Flemming, D
   Hopfner, D
   Diepholz, M
   Philippsen, P
   Bottcher, B
   Hurt, E
AF Stelter, Philipp
   Kunze, Ruth
   Flemming, Dirk
   Hoepfner, Dominic
   Diepholz, Meikel
   Philippsen, Peter
   Boettcher, Bettina
   Hurt, Ed
TI Molecular basis for the functional interaction of dynein light chain
   with the nuclear-pore complex
SO NATURE CELL BIOLOGY
LA English
DT Article
ID MESSENGER-RNA EXPORT; SACCHAROMYCES-CEREVISIAE; NUCLEOPORIN COMPLEX;
   TERMINAL DOMAIN; PROTEIN IMPORT; TRANSPORT; YEAST; MECHANISM; NSP1P;
   RAT7P/NUP159P
AB Nucleocytoplasmic transport occurs through nuclear pore complexes (NPCs) embedded in the nuclear envelope(1). Here, we discovered an unexpected role for yeast dynein light chain (Dyn2) 2 in the NPC. Dyn2 is a previously undescribed nucleoporin that functions as molecular glue to dimerize and stabilize the Nup82-Nsp1-Nup159 complex, a module of the cytoplasmic pore filaments(3). Biochemical analyses showed that Dyn2 binds to a linear motif ( termed DIDNup159) inserted between the Phe-Gly repeat and coiled-coil domain of Nup159. Electron microscopy revealed that the reconstituted Dyn2 DIDNup159 complex forms a rigid rod-like structure, in which five Dyn2 homodimers align like 'pearls on a string' between two extented DIDNup159 strands. These findings imply that the rigid 20 nm long Dyn2-DIDNup159 filament projects the Nup159 Phe-Gly repeats from the Nup82 module. Thus, it is possible that dynein light chain plays a role in organizing natively unfolded Phe-Gly repeats within the NPC scaffold to facilitate nucleocytoplasmic transport.
C1 Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   EMBL, D-69117 Heidelberg, Germany.
RP Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.
EM ed.hurt@bzh.uni-heidelberg.de
RI Bottcher, Bettina/E-9397-2010; Ed Hurt, Dr./AAE-8874-2019
OI Bottcher, Bettina/0000-0002-7962-4849; Ed Hurt, Dr./0000-0002-4535-8255
CR BABLER J, 2001, MOL CELL, V8, P517
   Bailer SM, 2000, J BIOL CHEM, V275, P23540, DOI 10.1074/jbc.M001963200
   Bailer SM, 2001, MOL CELL BIOL, V21, P7944, DOI 10.1128/MCB.21.23.7944-7955.2001
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Belgareh N, 1998, MOL BIOL CELL, V9, P3475, DOI 10.1091/mbc.9.12.3475
   Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004
   Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006
   Del Priore V, 1997, J CELL SCI, V110, P2987
   Delphin C, 1997, MOL BIOL CELL, V8, P2379, DOI 10.1091/mbc.8.12.2379
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dick T, 1996, MOL GEN GENET, V251, P38
   DOYE V, 1994, EMBO J, V13, P6062, DOI 10.1002/j.1460-2075.1994.tb06953.x
   DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x
   Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374
   Fan JS, 1998, J BIOL CHEM, V273, P33472, DOI 10.1074/jbc.273.50.33472
   GORSCH LC, 1995, J CELL BIOL, V129, P939, DOI 10.1083/jcb.129.4.939
   GRANDI P, 1995, J CELL BIOL, V130, P1263, DOI 10.1083/jcb.130.6.1263
   GRANDI P, 1995, EMBO J, V14, P76, DOI 10.1002/j.1460-2075.1995.tb06977.x
   Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152
   Hodge CA, 1999, EMBO J, V18, P5778, DOI 10.1093/emboj/18.20.5778
   Hurwitz ME, 1998, P NATL ACAD SCI USA, V95, P11241, DOI 10.1073/pnas.95.19.11241
   Komori M, 1997, EMBO J, V16, P44, DOI 10.1093/emboj/16.1.44
   Liang J, 1999, NAT STRUCT BIOL, V6, P735
   Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200
   Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387
   Miki F, 2002, MOL BIOL CELL, V13, P930, DOI 10.1091/mbc.01-11-0543
   Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528
   Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Puig O, 1998, YEAST, V14, P1139
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Sheeman B, 2003, CURR BIOL, V13, P364, DOI 10.1016/S0960-9822(03)00013-7
   Siniossoglou S, 1998, EMBO J, V17, P6449, DOI 10.1093/emboj/17.22.6449
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314
   vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032
NR 40
TC 71
Z9 71
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD JUL
PY 2007
VL 9
IS 7
BP 788
EP U108
DI 10.1038/ncb1604
PG 18
WC Cell Biology
SC Cell Biology
GA 186EA
UT WOS:000247760700014
PM 17546040
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Bar, H
   Kreplak, L
   Strelkov, SV
   Aebi, U
AF Herrmann, Harald
   Baer, Harald
   Kreplak, Laurent
   Strelkov, Sergei V.
   Aebi, Ueli
TI Intermediate filaments: from cell architecture to nanomechanics
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID MICE LACKING VIMENTIN; ATOMIC-FORCE MICROSCOPY; NUCLEAR LAMINA; FOCAL
   ADHESIONS; DESMIN CYTOSKELETON; DISEASE; MUSCLE; MUTATIONS; PROTEIN;
   MECHANOTRANSDUCTION
AB Intermediate filaments (IFs) constitute a major structural element of animal cells. They build two distinct systems, one in the nucleus and one in the cytoplasm. In both cases, their major function is assumed to be that of a mechanical stress absorber and an integrating device for the entire cytoskeleton. In line with this, recent disease mutations in human IF proteins indicate that the nanomechanical properties of cell-type-specific IFs are central to the pathogenesis of diseases as diverse as muscular dystrophy and premature ageing. However, the analysis of these various diseases suggests that IFs also have an important role in cell-type-specific physiological functions.
C1 German Canc Res Ctr, B065 Funct Architecture Cell, D-69120 Heidelberg, Germany.
   Heidelberg Univ, Dept Cardiol, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Catholic Univ Louvain, Dept Pharmaceut Sci, B-3000 Louvain, Belgium.
RP Herrmann, H (corresponding author), German Canc Res Ctr, B065 Funct Architecture Cell, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de; aebi@unibas.ch
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652; kreplak,
   laurent/0000-0001-9370-9809
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Bar H, 2007, J STRUCT BIOL, V158, P107, DOI 10.1016/j.jsb.2006.10.029
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459
   Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011
   Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060
   Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906
   Capetanaki Y, 2002, TRENDS CARDIOVAS MED, V12, P339, DOI 10.1016/S1050-1738(02)00184-6
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen QH, 2005, CIRC RES, V97, P1018, DOI 10.1161/01.RES.0000189262.92896.0b
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024
   Davies PF, 2005, ANN BIOMED ENG, V33, P1714, DOI 10.1007/s10439-005-8774-0
   DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007
   Esue O, 2006, J BIOL CHEM, V281, P30393, DOI 10.1074/jbc.M605452200
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   Franke WW, 2006, EUR J CELL BIOL, V85, P69, DOI 10.1016/j.ejcb.2005.11.003
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Gerull B, 2004, NAT GENET, V36, P1162, DOI 10.1038/ng1461
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725
   GOLDMAN RD, 1979, ANNU REV PHYSIOL, V41, P703, DOI 10.1146/annurev.ph.41.030179.003415
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8
   Green KJ, 2005, ADV PROTEIN CHEM, V70, P143, DOI 10.1016/S0065-3233(04)70006-6
   Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   Haubold KW, 2003, J APPL PHYSIOL, V95, P1617, DOI 10.1152/japplphysiol.00408.2003
   Helfand BT, 2003, ANNU REV CELL DEV BI, V19, P445, DOI 10.1146/annurev.cellbio.19.111401.092306
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y
   Hohenadl M, 1999, BIOPHYS J, V77, P2199, DOI 10.1016/S0006-3495(99)77060-8
   Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   Izawa I, 2006, CANCER SCI, V97, P167, DOI 10.1111/j.1349-7006.2006.00161.x
   Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425
   KARTENBECK J, 1984, J CELL BIOL, V98, P1072, DOI 10.1083/jcb.98.3.1072
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   KIRMSE R, 2007, J BIOL CHEM
   Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101
   Kiss B, 2006, J STRUCT BIOL, V155, P327, DOI 10.1016/j.jsb.2006.03.020
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514
   Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643
   Langbein L, 2005, J INVEST DERMATOL, V125, P428, DOI 10.1111/j.0022-202X.2005.23860.x
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   Li R, 2002, INT J DEV NEUROSCI, V20, P259, DOI 10.1016/S0736-5748(02)00019-9
   Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122
   Lieber RL, 1996, J APPL PHYSIOL, V80, P278
   Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje
   MALCYAN A, 2005, CIRCULATION, V112, P3451
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255
   Milner DJ, 2000, J CELL BIOL, V150, P1283, DOI 10.1083/jcb.150.6.1283
   Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179
   Mounkes LC, 2004, CURR OPIN CELL BIOL, V16, P322, DOI 10.1016/j.ceb.2004.03.009
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   MULLER DJ, 1995, BIOPHYS J, V68, P1681
   Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355
   Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200
   Parbhu AN, 1999, BIOCHEMISTRY-US, V38, P11755, DOI 10.1021/bi990746d
   PARK AC, 1972, J SOC COSMET CHEM, V23, P3
   Parry DAD, 2006, J STRUCT BIOL, V155, P370, DOI 10.1016/j.jsb.2006.03.017
   Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023
   Perng MD, 2006, AM J HUM GENET, V79, P197, DOI 10.1086/504411
   Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157
   Runembert I, 2004, AM J PHYSIOL-RENAL, V287, pF960, DOI 10.1152/ajprenal.00064.2004
   SADOSHIMA J, 1993, EMBO J, V12, P1681, DOI 10.1002/j.1460-2075.1993.tb05813.x
   Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005
   Sanbe A, 2005, P NATL ACAD SCI USA, V102, P13592, DOI 10.1073/pnas.0503324102
   Schiffers PMH, 2000, ARTERIOSCL THROM VAS, V20, P611, DOI 10.1161/01.ATV.20.3.611
   Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0
   Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Terzi F, 1997, J CLIN INVEST, V100, P1520, DOI 10.1172/JCI119675
   Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446
   Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937
   Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003
   Uyama N, 2006, GUT, V55, P1276, DOI 10.1136/gut.2005.078865
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101
   Wilhelmsen K, 2005, J CELL BIOL, V171, P799, DOI 10.1083/jcb.200506083
   Windoffer R, 2006, J CELL BIOL, V173, P341, DOI 10.1083/jcb.200511124
   Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4
NR 105
TC 402
Z9 408
U1 3
U2 97
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD JUL
PY 2007
VL 8
IS 7
BP 562
EP 573
DI 10.1038/nrm2197
PG 12
WC Cell Biology
SC Cell Biology
GA 181VF
UT WOS:000247463500016
PM 17551517
DA 2021-01-25
ER

PT J
AU Kopp, C
   Longordo, F
   Luthi, A
AF Kopp, Caroline
   Longordo, Fabio
   Luethi, Anita
TI Experience-dependent changes in NMDA receptor composition at mature
   central synapses
SO NEUROPHARMACOLOGY
LA English
DT Review
DE learning; mature synapses; NMDA receptor trafficking; sensory
   experience; sleep; synaptic plasticity
ID LONG-TERM-POTENTIATION; OCULAR DOMINANCE PLASTICITY; BIDIRECTIONAL
   SYNAPTIC PLASTICITY; ADULT VISUAL-CORTEX; NR2A SUBUNIT EXPRESSION;
   CORTICAL PLASTICITY; DIFFERENTIAL ROLES; CRITICAL PERIOD; AMPA
   RECEPTORS; CA1 REGION
AB N-methyl-D-aspartate receptor (NMDAR) activation is obligatory for the induction of diverse forms of synaptic plasticity. The molecular composition and the function of NMDARs are themselves modified by synaptic activity, which, in turn, alters the ability of synapses to undergo subsequent plastic modification. This homeostatic control of synaptic plasticity is well-known for the experience-dependent development of sensory cortices. However, it is now becoming clear that NMDAR properties may not only be altered at juvenile, but also at mature synapses. Diverse types of behavioral manipulation, such as sensory experience, learning and sleep deprivation alter the NR2A/NR2B ratio of hippocampal or cortical NNIDARs. As an additional facet to the dynamics of NMDAR function, NMDAR trafficking is regulated by G-protein-coupled neurotransmitter receptors implicated in learning and arousal, such as orexin and dopamine. These findings suggest that mature glutamatergic synapses may be modified by recent activity via alterations in synaptic NMDAR function. Rapid forms of NMDAR trafficking, perhaps controlled by the neurochemical environment featuring specific states of arousal and learning, may regulate plasticity and modulate cognitive abilities in adulthood. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Luthi, A (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anita.luthi@unibas.ch
OI Luthi, Anita/0000-0002-4954-4143
CR Aou S, 2003, NEUROSCIENCE, V119, P1221, DOI 10.1016/S0306-4522(02)00745-5
   Artola A, 2006, EUR J NEUROSCI, V23, P261, DOI 10.1111/j.1460-9568.2005.04552.x
   Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6
   Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034
   Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070
   Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013
   BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1
   Bear MF, 2003, PHILOS T ROY SOC B, V358, P649, DOI 10.1098/rstb.2002.1255
   Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005
   Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016
   Borgland SL, 2006, NEURON, V49, P589, DOI 10.1016/j.neuron.2006.01.016
   Bredt DS, 2003, NEURON, V40, P361, DOI 10.1016/S0896-6273(03)00640-8
   Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149
   Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073
   Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008
   CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803
   Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021
   Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003
   Clayton DA, 2002, J NEUROSCI, V22, P3628
   Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3
   Duffy SN, 2001, LEARN MEMORY, V8, P26, DOI 10.1101/lm.36301
   Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X
   Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100
   Flint AC, 1997, J NEUROSCI, V17, P2469
   Foster TC, 2001, J NEUROPHYSIOL, V85, P1377
   Franks KM, 2005, NEURON, V47, P101, DOI 10.1016/j.neuron.2005.05.024
   Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803
   Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270
   Grosshans DR, 2002, NAT NEUROSCI, V5, P27, DOI 10.1038/nn779
   Gu Q, 2002, NEUROSCIENCE, V111, P815, DOI 10.1016/S0306-4522(02)00026-X
   Guan ZW, 2004, BRAIN RES, V1018, P38, DOI 10.1016/j.brainres.2004.05.032
   Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1
   Harris GC, 2006, TRENDS NEUROSCI, V29, P571, DOI 10.1016/j.tins.2006.08.002
   He HY, 2006, J NEUROSCI, V26, P2951, DOI 10.1523/JNEUROSCI.5554-05.2006
   HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0
   Heuss C, 2000, TRENDS NEUROSCI, V23, P469, DOI 10.1016/S0166-2236(00)01643-X
   Heynen AJ, 2003, NAT NEUROSCI, V6, P854, DOI 10.1038/nn1100
   Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8
   KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1
   Kew JNC, 1998, J NEUROSCI, V18, P1935
   Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714
   Kim HH, 2006, J NEUROSCI, V26, P9548, DOI 10.1523/JNEUROSCI.1727-06.2006
   Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031
   Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0
   Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6
   Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006
   Lambe EK, 2005, J NEUROSCI, V25, P5225, DOI 10.1523/JNEUROSCI.0719-05.2005
   Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028
   Lebel D, 2006, LEARN MEMORY, V13, P566, DOI 10.1101/lm.276606
   Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049
   Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814
   Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615
   Lu HC, 2001, NEURON, V32, P619, DOI 10.1016/S0896-6273(01)00501-3
   Lu J, 2006, J NEUROSCI, V26, P193, DOI 10.1523/JNEUROSCI.2244-05.2006
   Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8
   Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2
   Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012
   Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758
   Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649
   Massey PV, 2004, J NEUROSCI, V24, P7821, DOI 10.1523/JNEUROSCI.1697-04.2004
   McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781
   McDermott CM, 2003, J NEUROSCI, V23, P9687
   Migaud M, 1998, NATURE, V396, P433
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005
   MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701
   Nakazawa T, 2006, EMBO J, V25, P2867, DOI 10.1038/sj.emboj.7601156
   Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x
   Nikonenko I, 2002, HIPPOCAMPUS, V12, P585, DOI 10.1002/hipo.10095
   Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004
   Perez-Otano I, 2004, NEUROSIGNALS, V13, P175, DOI 10.1159/000077524
   Pham TA, 2004, LEARN MEMORY, V11, P738, DOI 10.1101/lm.75304
   Philpot BD, 2003, J NEUROSCI, V23, P5583
   Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8
   Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027
   Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2
   Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876
   Quinlan EM, 1999, NAT NEUROSCI, V2, P352
   Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9
   Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533
   Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587
   Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498
   Rodrigues SM, 2001, J NEUROSCI, V21, P6889
   SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0
   Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368
   Sawtell NB, 2003, NEURON, V38, P977, DOI 10.1016/S0896-6273(03)00323-4
   Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087
   Schilstrom B, 2006, J NEUROSCI, V26, P8549, DOI 10.1523/JNEUROSCI.5179-05.2006
   Selbach O, 2004, NEUROSCIENCE, V127, P519, DOI 10.1016/j.neuroscience.2004.05.012
   SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0
   Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005
   Tang YP, 1999, NATURE, V401, P63
   Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8
   Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327
   Vanhoutte P, 2003, CURR OPIN NEUROBIOL, V13, P366, DOI 10.1016/S0959-4388(03)00073-4
   Vicini S, 1998, J NEUROPHYSIOL, V79, P555
   Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404
   Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803
   White TL, 2004, BRAIN RES, V1021, P1, DOI 10.1016/j.brainres.2004.05.114
   Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134
   Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005
   Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2
   Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014
NR 103
TC 43
Z9 45
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUL
PY 2007
VL 53
IS 1
BP 1
EP 9
DI 10.1016/j.neuropharm.2007.03.014
PG 9
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 205WP
UT WOS:000249145600001
PM 17499817
DA 2021-01-25
ER

PT J
AU Pittaluga, A
   Raiteri, L
   Longordo, F
   Luccini, E
   Barbiero, VS
   Racagni, G
   Popoli, M
   Raiteri, M
AF Pittaluga, Anna
   Raiteri, Luca
   Longordo, Fabio
   Luccini, Elisa
   Barbiero, Valentina Sara
   Racagni, Giorgio
   Popoli, Maurizio
   Raiteri, Maurizio
TI Antidepressant treatments and function of glutamate ionotropic receptors
   mediating amine release in hippocampus
SO NEUROPHARMACOLOGY
LA English
DT Article
DE reboxetine; fluoxetine; AMPA receptors; NMDA receptors; noradrenaline
   release; serotonin release; superfused synaptosomes
ID METHYL-D-ASPARTATE; RAT CEREBRAL-CORTEX; NON-NMDA RECEPTORS;
   PROTEIN-KINASE-C; DOPAMINE RELEASE; 5-HYDROXYTRYPTAMINE RELEASE;
   NORADRENALINE RELEASE; LAMINAR DISTRIBUTION; NERVE-TERMINALS; ANTERIOR
   HALF
AB Previous evidences showed that, besides noradrenaline (NA) and 5-hydroxytryptarnine (5-HT), glutamate transmission is involved in the mechanism of action of antidepressants (ADs), although the relations between aminergic and glutarnatergic systems are poorly understood. The aims of this investigation were to evaluate changes in the function of glutamate AMPA and NMDA receptors produced by acute and chronic administration of the two ADs reboxetine and fluoxetine, selective inhibitors of NA and 5-HT uptake, respectively. Rats were treated acutely (intraperitoneal injection) or chronically (osmotic minipump infusion) with reboxetine or fluoxetine. Isolated hippocampal nerve endings (synaptosomes) prepared following acute/chronic treatments were labelled with [3 H]NA or [3 H]5-HT and [H-3]amine release was monitored during exposure in superfusion to NMDA/glycine, AMPA or K+-depolarization. Acute and chronic reboxetine reduced the release of [3H]NA evoked by NMDA/glycine or by AMPA. The NMDA/glycine-evoked release of [3H]NA was also down-regulated by chronic fluoxetine. Only acute, but not chronic, fluoxetine inhibited the AMPA-evoked release of [3H]5-HT. The release of [3H]NA and [3H]5-HT elicited by K+-depolarization was almost abolished by acute reboxetine or fluoxetine, respectively, but recovered during chronic ADs administration. ADs reduced NMDA receptor-mediated releasing effects in noradrenergic terminals after acute and chronic administration, although by different mechanisms. Chronic treatments markedly reduced the expression level of NR1 subunit in synaptic membranes. The noradrenergic and serotonergic release systems seem to be partly functionally interconnected and interact with glutarnatergic transmission to down-regulate its function. The results obtained support the view that glutamate plays a major role in AD activity. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Genoa, Dept Expt Med, Pharmacol & Toxicol Sect, I-16148 Genoa, Italy.
   Univ Genoa, Ctr Excellence Biomed Res, I-16148 Genoa, Italy.
   Univ Basel, Div Pharmacol Neurobiol Biozentrum, CH-4056 Basel, Switzerland.
   Univ Milan, Dept Pharmacol Sci, Ctr Neuropharmacol, I-20133 Milan, Italy.
   Univ Milan, Ctr Excellence Neurodegenerat Dis, I-20133 Milan, Italy.
RP Pittaluga, A (corresponding author), Univ Genoa, Dept Expt Med, Pharmacol & Toxicol Sect, Viale Cembrano 4, I-16148 Genoa, Italy.
EM pittalug@pharmatox.unige.it
RI Racagni, Giorgio A./B-5826-2011; luccini, elisa/C-4297-2008; Pittaluga,
   Anna/C-5960-2008
CR Adell A, 2005, DRUG DISCOV TODAY, V10, P578, DOI 10.1016/S1359-6446(05)03398-2
   Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217
   AUDET MA, 1988, J COMP NEUROL, V274, P307, DOI 10.1002/cne.902740302
   AUDET MA, 1989, J CHEM NEUROANAT, V2, P29
   Barbon A, 2006, BIOL PSYCHIAT, V59, P713, DOI 10.1016/j.biopsych.2005.10.018
   BARTANUSZ V, 1995, NEUROSCIENCE, V66, P247, DOI 10.1016/0306-4522(95)00084-V
   Bonanno G, 2005, J NEUROSCI, V25, P3270, DOI 10.1523/JNEUROSCI.5033-04.2005
   Boyer PA, 1998, J MOL NEUROSCI, V10, P219, DOI 10.1007/BF02761776
   CERRITO F, 1979, EUR J PHARMACOL, V57, P427, DOI 10.1016/0014-2999(79)90506-5
   Choudary PV, 2005, P NATL ACAD SCI USA, V102, P15653, DOI 10.1073/pnas.0507901102
   DESCE JM, 1991, J PHARMACOL EXP THER, V259, P692
   FINK K, 1990, EUR J PHARMACOL, V185, P115, DOI 10.1016/0014-2999(90)90219-V
   FOX K, 1999, NAT NEUROSCI, V185, P115
   GOTHERT M, 1979, N-S ARCH PHARMACOL, V310, P93, DOI 10.1007/BF00499879
   GOTHERT M, 1980, N-S ARCH PHARMACOL, V313, P21, DOI 10.1007/BF00505800
   Invernizzi RW, 2004, PROG NEURO-PSYCHOPH, V28, P819, DOI 10.1016/j.pnpbp.2004.05.026
   KAMISAKI Y, 1992, EUR J PHARMACOL, V217, P57, DOI 10.1016/0014-2999(92)90511-2
   KREBS MO, 1991, J NEUROCHEM, V56, P81, DOI 10.1111/j.1471-4159.1991.tb02565.x
   LANGER SZ, 1980, PHARMACOL REV, V32, P337
   Martinez-Turrillas R, 2005, NEUROPHARMACOLOGY, V49, P1178, DOI 10.1016/j.neuropharm.2005.07.006
   Millan MJ, 2004, EUR J PHARMACOL, V500, P371, DOI 10.1016/j.ejphar.2004.07.038
   Mongeau R, 1997, BRAIN RES REV, V23, P145, DOI 10.1016/S0165-0173(96)00017-3
   NOWAK G, 1993, J PHARMACOL EXP THER, V265, P1380
   Owen JCE, 2006, BRAIN RES BULL, V70, P62, DOI 10.1016/j.brainresbull.2006.03.020
   Pallotta M, 2001, NEUROPHARMACOLOGY, V41, P294, DOI 10.1016/S0028-3908(01)00078-8
   Paul IA, 2003, ANN NY ACAD SCI, V1003, P250, DOI 10.1196/annals.1300.016
   PAUL IA, 1994, J PHARMACOL EXP THER, V269, P95
   PITTALUGA A, 1990, EUR J PHARMACOL, V191, P231, DOI 10.1016/0014-2999(90)94153-O
   Pittaluga A, 1997, N-S ARCH PHARMACOL, V356, P29, DOI 10.1007/PL00005025
   Pittaluga A, 2001, J NEUROCHEM, V76, P139, DOI 10.1046/j.1471-4159.2001.00057.x
   Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795
   RAITERI M, 1992, J PHARMACOL EXP THER, V260, P238
   RAITERI M, 1983, EUR J PHARMACOL, V91, P141, DOI 10.1016/0014-2999(83)90377-1
   Skeberdis VA, 2001, NEUROPHARMACOLOGY, V40, P856, DOI 10.1016/S0028-3908(01)00005-3
   Skolnick P, 1999, EUR J PHARMACOL, V375, P31, DOI 10.1016/S0014-2999(99)00330-1
   Skolnick P, 2002, AMINO ACIDS, V23, P153, DOI 10.1007/s00726-001-0121-7
   STARKE K, 1981, ANNU REV PHARMACOL, V21, P7, DOI 10.1146/annurev.pa.21.040181.000255
   Tiraboschi E, 2004, NEUROREPORT, V15, P2393, DOI 10.1097/00001756-200410250-00018
   Vizi ES, 2004, NEUROCHEM INT, V45, P443, DOI 10.1016/j.neuint.2003.11.016
   WANG JKT, 1992, J NEUROCHEM, V58, P204, DOI 10.1111/j.1471-4159.1992.tb09297.x
   Zarate CA, 2003, ANN NY ACAD SCI, V1003, P273, DOI 10.1196/annals.1300.017
NR 41
TC 57
Z9 57
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUL
PY 2007
VL 53
IS 1
BP 27
EP 36
DI 10.1016/j.neuropharm.2007.04.006
PG 10
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA 205WP
UT WOS:000249145600004
PM 17543354
DA 2021-01-25
ER

PT J
AU Orolin, J
   Vecera, R
   Jung, D
   Meyer, UA
   Skottova, N
   Anzenbacher, P
AF Orolin, J.
   Vecera, R.
   Jung, D.
   Meyer, U. A.
   Skottova, N.
   Anzenbacher, P.
TI Hypolipidemic effects of silymarin are not mediated by the peroxisome
   proliferator-activated receptor alpha
SO XENOBIOTICA
LA English
DT Article
DE Silymarin; PPAR alpha; cholesterol; cytochrome P4504A
ID POLYPHENOLIC FRACTION; PPAR-ALPHA; FATTY-ACID; GENE; LIPOPROTEINS;
   EXPRESSION; INDUCTION; TARGET
AB Silymarin is widely used in supportive therapy of liver diseases. It has been shown lately that silymarin has beneficial effects on some risk factors of atherosclerosis owing to its hypolipidemic properties. PPAR alpha plays a key role in lipid metabolism and homeostasis as its target genes are involved in catabolism of fatty acids by beta-oxidation (e.g. acyl-CoA oxidase) and by omega-oxidation (e.g. cytochrome P4504A). Here we studied the possibility that hypolipidemic effects of silymarin may be mediated by PPAR alpha. Rats fed with a high-cholesterol diet with either silymarin or fenofibrate (as a positive control both for PPAR alpha expression as well as for lipid determination) were used. The effects of silymarin on expression of PPAR alpha both at the mRNA (including selected target genes) as well as the protein level were determined. In parallel, the levels of cholesterol and triacylglycerols were determined. Our results confirmed the hypolipidemic effects of silymarin and demonstrated that these effects are probably not mediated by PPAR alpha because of unchanged mRNA levels of PPAR alpha target genes. Furthermore, this work shows for the first time that cholesterol itself inhibits expression of CYP4A mRNA.
C1 Palacky Univ, Inst Pharmacol, Fac Med, Olomouc 77515, Czech Republic.
   Univ Basel, Dept Pharmacol Neurobiol, Biozentrum, CH-4003 Basel, Switzerland.
RP Vecera, R (corresponding author), Palacky Univ, Inst Pharmacol, Fac Med, Hnevotinska 3, Olomouc 77515, Czech Republic.
EM vecera@seznam.cz
CR Basaga H, 1997, CELL BIOCHEM FUNCT, V15, P27
   Bordji K, 2000, J BIOL CHEM, V275, P12243, DOI 10.1074/jbc.275.16.12243
   Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Frederiksen KS, 2003, J MOL ENDOCRINOL, V30, P317, DOI 10.1677/jme.0.0300317
   Gustafsson JA, 1998, NUTR REV, V56, pS20
   Haubenwallner S, 1995, J LIPID RES, V36, P2541
   HAUG A, 1987, J NUTR, V117, P1011
   HAVEL RJ, 1955, J CLIN INVEST, V34, P1345, DOI 10.1172/JCI103182
   Hunt MC, 2000, J BIOL CHEM, V275, P28947, DOI 10.1074/jbc.M002782200
   Johnson EF, 1996, FASEB J, V10, P1241
   Krecman V, 1998, PLANTA MED, V64, P138, DOI 10.1055/s-2006-957391
   Latruffe N, 2000, BIOCHEM PHARMACOL, V60, P1027, DOI 10.1016/S0006-2952(00)00416-0
   Lemberger T, 1996, J BIOL CHEM, V271, P1764, DOI 10.1074/jbc.271.3.1764
   Lichtenstein AH, 1998, NUTR REV, V56, pS3
   LIU CH, 1995, LIPIDS, V30, P527, DOI 10.1007/BF02537027
   Mandard S, 2004, CELL MOL LIFE SCI, V61, P393, DOI 10.1007/s00018-003-3216-3
   Morazzoni Paolo, 1995, Fitoterapia, V66, P3
   MUERHOFF AS, 1992, J BIOL CHEM, V267, P19051
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Simanek V., 2001, Czech Journal of Food Sciences, V19, P106
   Skottova N, 2003, PHARMACOL RES, V47, P17, DOI 10.1016/S1043-6618(02)00252-9
   Skottova Nina, 1998, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V141, P39
   Skottova Nina, 2000, Acta Universitatis Palackianae Olomucensis Facultatis Medicae, V144, P55
   Sobolova L, 2006, PHARMACOL RES, V53, P104, DOI 10.1016/j.phrs.2005.09.004
   SORENSEN HN, 1993, BIOCHIM BIOPHYS ACTA, V1171, P263, DOI 10.1016/0167-4781(93)90064-K
   Sterchele PF, 1996, ARCH BIOCHEM BIOPHYS, V326, P281, DOI 10.1006/abbi.1996.0077
   Sumanasekera WK, 2003, J BIOL CHEM, V278, P4467, DOI 10.1074/jbc.M211261200
   Tirona RG, 2005, J PHARM SCI-US, V94, P1169, DOI 10.1002/jps.20324
   Valenzuela Alfonso, 1994, Biological Research, V27, P105
   van Raalte DH, 2004, PHARM RES-DORDR, V21, P1531, DOI 10.1023/B:PHAM.0000041444.06122.8d
   Watts GF, 1999, CURR OPIN LIPIDOL, V10, P561, DOI 10.1097/00041433-199912000-00011
   Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198
NR 33
TC 7
Z9 7
U1 0
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0049-8254
EI 1366-5928
J9 XENOBIOTICA
JI Xenobiotica
PD JUL
PY 2007
VL 37
IS 7
BP 725
EP 735
DI 10.1080/00498250701463333
PG 11
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 194XQ
UT WOS:000248377500004
PM 17620219
DA 2021-01-25
ER

PT J
AU Landgraf, P
   Rusu, M
   Sheridan, R
   Sewer, A
   Iovino, N
   Aravin, A
   Pfeffer, S
   Rice, A
   Kamphorst, AO
   Landthaler, M
   Lin, C
   Socci, ND
   Hermida, L
   Fulci, V
   Chiaretti, S
   Foa, R
   Schliwka, J
   Fuchs, U
   Novosel, A
   Muller, RU
   Schermer, B
   Bissels, U
   Inman, J
   Phan, Q
   Chien, MC
   Weir, DB
   Choksi, R
   De Vita, G
   Frezzetti, D
   Trompeter, HI
   Hornung, V
   Teng, G
   Hartmann, G
   Palkovits, M
   Di Lauro, R
   Wernet, P
   Macino, G
   Rogler, CE
   Nagle, JW
   Ju, JY
   Papavasiliou, FN
   Benzing, T
   Lichter, P
   Tam, W
   Brownstein, MJ
   Bosio, A
   Borkhardt, A
   Russo, JJ
   Sander, C
   Zavolan, M
   Tuschl, T
AF Landgraf, Pablo
   Rusu, Mirabela
   Sheridan, Robert
   Sewer, Alain
   Iovino, Nicola
   Aravin, Alexei
   Pfeffer, Sebastien
   Rice, Amanda
   Kamphorst, Alice O.
   Landthaler, Markus
   Lin, Carolina
   Socci, Nicholas D.
   Hermida, Leandro
   Fulci, Valerio
   Chiaretti, Sabina
   Foa, Robin
   Schliwka, Julia
   Fuchs, Uta
   Novosel, Astrid
   Mueller, Roman-Ulrich
   Schermer, Bernhard
   Bissels, Ute
   Inman, Jason
   Phan, Quang
   Chien, Minchen
   Weir, David B.
   Choksi, Ruchi
   De Vita, Gabriella
   Frezzetti, Daniela
   Trompeter, Hans-Ingo
   Hornung, Veit
   Teng, Grace
   Hartmann, Gunther
   Palkovits, Miklos
   Di Lauro, Robert
   Wernet, Peter
   Macino, Giuseppe
   Rogler, Charles E.
   Nagle, James W.
   Ju, Jingyue
   Papavasiliou, F. Nina
   Benzing, Thomas
   Lichter, Peter
   Tam, Wayne
   Brownstein, Michael J.
   Bosio, Andreas
   Borkhardt, Arndt
   Russo, James J.
   Sander, Chris
   Zavolan, Mihaela
   Tuschl, Thomas
TI A mammalian microRNA expression atlas based on small RNA library
   sequencing
SO CELL
LA English
DT Article
ID MENTAL-RETARDATION PROTEIN; POSTTRANSCRIPTIONAL REGULATION;
   GENE-EXPRESSION; C-ELEGANS; IDENTIFICATION; CLONING; MODULATION;
   ZEBRAFISH; VIRUSES; TARGETS
AB MicroRNAs (miRNAs) are small noncoding regulatory RNAs that reduce stability and/or translation of fully or partially sequence-complementary target mRNAs. In order to identify miRNAs and to assess their expression patterns, we sequenced over 250 small RNA libraries from 26 different organ systems and cell types of human and rodents that were enriched in neuronal as well as normal and malignant hematopoietic cells and tissues. We present expression profiles derived from clone count data and provide computational tools for their analysis. Unexpectedly, a relatively small set of miRNAs, many of which are ubiquitously expressed, account for most of the differences in miRNA profiles between cell lineages and tissues. This broad survey also provides detailed and accurate information about mature sequences, precursors, genome locations, maturation processes, inferred transcriptional units, and conservation patterns. We also propose a subclassification scheme for miRNAs for assisting future experimental and computational functional analyses.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, New York, NY 10021 USA.
   Deutsch Krebsforschungszentrum, Div Mol Genet, D-69120 Heidelberg, Germany.
   Univ Munich, Dr Von Haunerschen Kinderspital, Dept Hematol & Oncol, D-80337 Munich, Germany.
   Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany.
   Miltenyi Biotec GmbH, D-50829 Cologne, Germany.
   Inst Genom Res, Rockville, MD 20850 USA.
   J Craig Venter Inst, Funct Genom, Rockville, MD 20850 USA.
   Columbia Genome Ctr, Russ Berrie Pavilion, New York, NY 10032 USA.
   Univ Dusseldorf, Med Ctr, Inst Transplantat Diagnost & Cell Therapeut, D-40225 Dusseldorf, Germany.
   Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA.
   Hungarian Acad Sci Semmelweis Univ, Lab Neuromorphol, Budapest, Hungary.
   Albert Einstein Coll Med, Bronx, NY 10461 USA.
   Cornell Univ, Joan & Sanford I Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA.
   Univ Bonn, Univ Hosp, Div Clin Pharmacol, D-53105 Bonn, Germany.
   Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
   IRGS, Biogem Scarl, I-83031 Ariano Irpino, Italy.
   Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   NIH, NINDS, DNA Sequencing Facil, Bethesda, MD 20892 USA.
   Univ Munich, Dept Internal Med, Div Clin Pharmacol, D-80366 Munich, Germany.
   Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.
   IBM Corp, CNRS, F-678084 Strasbourg, France.
   Cold Spring Harbor Lab, Howard Hughes Med Inst, Sch Biol Sci, Cold Spring Harbor, NY 11724 USA.
   Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA.
   Univ Dusseldorf, Med Ctr, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany.
   Univ Lausanne, Dept Med Genet, Computat Biol Grp, CH-1005 Lausanne, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu
RI Hornung, Veit/C-3565-2012; Hartmann, Gunther/P-7492-2017; Pal, Deb
   K/F-3318-2011; Palkovits, Miklos/F-2707-2013; fulci,
   valerio/J-1963-2015; Zavolan, Mihaela/S-3888-2016; Pfeffer,
   Sebastien/H-3212-2019; Di Lauro, Roberto/A-2746-2012; De Vita,
   Gabriella/H-4422-2011; Frezzetti, Daniela/AAI-2410-2019; Sander,
   Chris/H-1452-2011; Pfeffer, Sebastien/A-6512-2010; Benzing,
   Thomas/X-5476-2019; Landthaler, Markus/A-1427-2010; Schermer,
   Bernhard/E-9972-2014
OI Hornung, Veit/0000-0002-4150-194X; Hartmann,
   Gunther/0000-0003-1021-2018; Palkovits, Miklos/0000-0003-0578-0387;
   fulci, valerio/0000-0002-1173-585X; Pfeffer,
   Sebastien/0000-0002-8458-348X; Di Lauro, Roberto/0000-0001-9493-3036; De
   Vita, Gabriella/0000-0002-7302-1174; Frezzetti,
   Daniela/0000-0002-7500-5506; Sander, Chris/0000-0001-6059-6270; Pfeffer,
   Sebastien/0000-0002-8458-348X; Landthaler, Markus/0000-0002-1075-8734;
   Schermer, Bernhard/0000-0002-5194-9000; Hermida,
   Leandro/0000-0003-3887-518X; Zavolan, Mihaela/0000-0002-8832-2041
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047] Funding
   Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [P01 GM073047-03, P01
   GM073047, P01 GM073047-01] Funding Source: Medline
CR Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803
   Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031
   Berezikov E, 2005, HUM MOL GENET, V14, pR183, DOI 10.1093/hmg/ddi271
   Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914
   Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906
   Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27
   Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839
   Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202
   Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137
   Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793
   Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103
   De Vita G, 2005, MOL ENDOCRINOL, V19, P76, DOI 10.1210/me.2004-0172
   Diederichs S, 2006, CANCER RES, V66, P6097, DOI 10.1158/0008-5472.CAN-06-0537
   Eisenberg E, 2005, TRENDS GENET, V21, P77, DOI 10.1016/j.tig.2004.12.005
   Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158
   Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051
   Jin P, 2004, NAT NEUROSCI, V7, P113, DOI 10.1038/nn1174
   Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050
   Kim DDY, 2004, GENOME RES, V14, P1719, DOI 10.1101/gr.2855504
   Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278
   Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843
   Kluiver J, 2006, LEUKEMIA, V20, P1931, DOI 10.1038/sj.leu.2404387
   Kogler G, 2004, J EXP MED, V200, P123, DOI 10.1084/jem.20040440
   Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304
   Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791
   Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6
   Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387
   Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002
   Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506
   Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   PFEFFER S, 2003, CURRENT PROTOCOLS MO
   Plante I, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/64347
   Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Rigoutsos I, 2006, P NATL ACAD SCI USA, V103, P6605, DOI 10.1073/pnas.0601688103
   Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015
   Smalheiser NR, 2005, TRENDS GENET, V21, P322, DOI 10.1016/j.tig.2005.04.008
   Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227
   Takada S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl653
   Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406
   van Boxel-Dezaire AHH, 2006, IMMUNITY, V25, P361, DOI 10.1016/j.immuni.2006.08.014
   Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070
   Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041
NR 69
TC 2648
Z9 3830
U1 12
U2 308
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUN 29
PY 2007
VL 129
IS 7
BP 1401
EP 1414
DI 10.1016/j.cell.2007.04.040
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 188HQ
UT WOS:000247911400024
PM 17604727
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Sorg, I
   Wagner, S
   Amstutz, M
   Muller, SA
   Broz, P
   Lussi, Y
   Engel, A
   Cornelis, GR
AF Sorg, Isabel
   Wagner, Stefanie
   Amstutz, Marlise
   Mueller, Shirley A.
   Broz, Petr
   Lussi, Yvonne
   Engel, Andreas
   Cornelis, Guy R.
TI YscU recognizes translocators as export substrates of the Yersinia
   injectisome
SO EMBO JOURNAL
LA English
DT Article
DE effectors; targeting; translocation; type III secretion; Yops
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; PROTEIN SECRETION SYSTEM;
   MESSENGER-RNA SIGNAL; III SECRETION; SALMONELLA-TYPHIMURIUM; NEEDLE
   COMPLEX; SHIGELLA-FLEXNERI; EUKARYOTIC CELLS; BACTERIAL INJECTISOMES;
   SPECIFICITY SWITCH
AB YscU is an essential component of the export apparatus of the Yersinia injectisome. It consists of an N-terminal transmembrane domain and a long cytoplasmic C-terminal domain, which undergoes auto-cleavage at a NPTH site. Substitutions N263A and P264A prevented cleavage of YscU and abolished export of LcrV, YopB and YopD but not of Yop effectors. As a consequence, yscU(N263A) mutant bacteria made needles without the LcrV tip complex and they could not form translocation pores. The graft of the export signal of the effector YopE, at the N-terminus of LcrV, restored LcrV export and assembly of the tip complex. Thus, YscU cleavage is required to acquire the conformation allowing recognition of translocators, which represent an individual category of substrates in the hierarchy of export. In addition, yscUN(263A) mutant bacteria exported reduced amounts of the YscP ruler and made longer needles. Increasing YscP export resulted in needles with normal size, depending on the length of the ruler. Hence, the effect of the yscUN(263A) mutation on needle length was the consequence of a reduced YscP export.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   ME Muller Inst Struct Biol, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Lussi, Yvonne/A-4415-2009; Wagner, Stefanie/A-5756-2011; Broz,
   Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790; Wagner, Stefanie/0000-0002-3873-7011;
   Lussi, Yvonne/0000-0002-5753-0235
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   ALLAOUI A, 1995, J BACTERIOL, V177, P4230, DOI 10.1128/jb.177.15.4230-4237.1995
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x
   Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, J BACTERIOL, V187, P2881, DOI 10.1128/JB.187.8.2881-2889.2005
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deng WY, 2005, INFECT IMMUN, V73, P2135, DOI 10.1128/IAI.73.4.2135-2146.2005
   Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006
   Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002
   Lavander M, 2003, ADV EXP MED BIOL, V529, P109
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Mori T, 2006, NUCL MED BIOL, V33, P281, DOI 10.1016/j.nucmedbio.2005.11.002
   Moriya N, 2006, J MOL BIOL, V359, P466, DOI 10.1016/j.jmb.2006.03.025
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x
   Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
   Zhu K, 2002, BIOCHEMISTRY-US, V41, P9516, DOI 10.1021/bi0203280
NR 53
TC 83
Z9 84
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUN 20
PY 2007
VL 26
IS 12
BP 3015
EP 3024
DI 10.1038/sj.emboj.7601731
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 190DM
UT WOS:000248038200018
PM 17510628
OA Green Published
DA 2021-01-25
ER

PT J
AU Rakhmatullina, E
   Braun, T
   Kaufmann, T
   Spillmann, H
   Malinova, V
   Meier, W
AF Rakhmatullina, Ekaterina
   Braun, Thomas
   Kaufmann, Thomas
   Spillmann, Hannes
   Malinova, Violeta
   Meier, Wolfgang
TI Functionalization of gold and silicon surfaces by copolymer brushes
   using surface-initiated ATRP(a)
SO MACROMOLECULAR CHEMISTRY AND PHYSICS
LA English
DT Article
DE ATRP initiator; films; polymer brushes; self-assembly; surface-initiated
   ATRP
ID TRANSFER RADICAL POLYMERIZATION; AMPHIPHILIC BLOCK-COPOLYMERS;
   ATOM-TRANSFER POLYMERIZATION; POLYMERS; VESICLES; METHACRYLATE;
   HOMOPOLYMERS; MONOLAYER; MEMBRANES; STYRENE
AB Surface-initiated ATRP was used for step-by-step growth of poly(butyl methacrylate)co-poly(2,2-dimethylaminoethyl methacrylate) (PBMA-co-PDMAEMA) brushes from gold and silicon substrates. A one-step procedure was found to have high efficiency for initiator anchoring. The polymer brushes were characterized in situ by contact angle measurements ellipsometry, and X-ray photoelectron spectroscopy (XPS). Detachment of the polymer brushes from both substrates allowed an exact determination of molecular weight and polydispersity indexes given by GPC. H-1 NMR confirmed the chemical structure of the detached brushes. Comparison of theoretical predictions and experimental data showed that the first PBMA block had a folded conformation while copolymerization of the second DAAAEMA induced stretching of the brushes.
C1 Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Maurice E Muller Inst High Resolut Electron M, CH-4056 Basel, Switzerland.
RP Meier, W (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM wolfgang.meier@unibas.ch
CR Advincula R, 2002, LANGMUIR, V18, P8672, DOI 10.1021/la025962t
   Antonietti M, 2003, ADV MATER, V15, P1323, DOI 10.1002/adma.200300010
   Antonietti M, 1996, MACROMOLECULES, V29, P3800, DOI 10.1021/ma951446g
   Bermudez H, 2003, EUROPHYS LETT, V64, P550, DOI 10.1209/epl/i2003-00264-2
   Bontempo D, 2002, ADV MATER, V14, P1239, DOI 10.1002/1521-4095(20020903)14:17<1239::AID-ADMA1239>3.0.CO;2-P
   Coessens V, 2001, PROG POLYM SCI, V26, P337, DOI 10.1016/S0079-6700(01)00003-X
   Cringus-Fundeanu I, 2007, LANGMUIR, V23, P5120, DOI 10.1021/la063531v
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Ejaz M, 2000, MACROMOLECULES, V33, P2870, DOI 10.1021/ma991927q
   Haddleton DM, 1999, MACROMOLECULES, V32, P2110, DOI 10.1021/ma981670g
   Haddleton DM, 2000, MACROMOL SYMP, V157, P201, DOI 10.1002/1521-3900(200007)157:1<201::AID-MASY201>3.0.CO;2-P
   Hu DJ, 2005, POLYMER, V46, P7563, DOI 10.1016/j.polymer.2005.06.030
   Huang WX, 2003, NANOTECHNOLOGY, V14, P1075, DOI 10.1088/0957-4484/14/10/304
   Huang WX, 2002, MACROMOLECULES, V35, P1175, DOI 10.1021/ma011159e
   Husseman M, 1999, MACROMOLECULES, V32, P1424, DOI 10.1021/ma981290v
   Hyun J, 2001, MACROMOLECULES, V34, P5644, DOI 10.1021/ma002125u
   Ivanova R, 2001, ADV COLLOID INTERFAC, V89, P351, DOI 10.1016/S0001-8686(00)00049-X
   Iwata R, 2004, BIOMACROMOLECULES, V5, P2308, DOI 10.1021/bm049613k
   Jeyaprakash JD, 2002, MACROMOL RAPID COMM, V23, P277, DOI 10.1002/1521-3927(20020301)23:4<277::AID-MARC277>3.0.CO;2-U
   Jordan R, 1998, J AM CHEM SOC, V120, P243, DOI 10.1021/ja973392r
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   KELLER RN, 1946, INORG SYN, V2, P1, DOI 10.1002/9780470132333.ch1
   Kim DJ, 2005, MACROMOL CHEM PHYS, V206, P1941, DOI 10.1002/macp.200500268
   Kim JB, 2000, J AM CHEM SOC, V122, P7616, DOI 10.1021/ja001652q
   Kim JB, 2003, J POLYM SCI POL CHEM, V41, P386, DOI 10.1002/pola.10568
   Kita-Tokarczyk K, 2005, POLYMER, V46, P3540, DOI 10.1016/j.polymer.2005.02.083
   Kobayashi M, 2005, CHEM LETT, V34, P1582, DOI 10.1246/cl.2005.1582
   Kong XX, 2001, MACROMOLECULES, V34, P1837, DOI 10.1021/ma001152h
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Maoz R., 1995, SUPRAMOL SCI, V2, P9, DOI DOI 10.1016/0968-5677(96)85635-5
   MAOZ R, 1995, THIN FILMS, P20
   Matrab T, 2006, DIAM RELAT MATER, V15, P639, DOI 10.1016/j.diamond.2005.11.024
   Matyjaszewski K, 1999, MACROMOLECULES, V32, P8716, DOI 10.1021/ma991146p
   Mecke A, 2006, SOFT MATTER, V2, P751, DOI 10.1039/b605165k
   MORI S, 1990, J LIQ CHROMATOGR, V13, P1719, DOI 10.1080/01483919008048988
   Nardin C, 2000, CHEM COMMUN, P1433, DOI 10.1039/b004280n
   Opsteen JA, 2004, PURE APPL CHEM, V76, P1309, DOI 10.1351/pac200476071309
   Osborne VL, 2002, CHEM COMMUN, P1838, DOI 10.1039/b204737c
   Prokhorova SA, 2003, NANOTECHNOLOGY, V14, P1098, DOI 10.1088/0957-4484/14/10/306
   Queffelec J, 2000, MACROMOLECULES, V33, P8629, DOI 10.1021/ma000871t
   Shah RR, 2000, MACROMOLECULES, V33, P597, DOI 10.1021/ma991264c
   Stoenescu R, 2002, CHEM COMMUN, P3016, DOI 10.1039/b209352a
   Tsubokawa N, 1997, J APPL POLYM SCI, V65, P2165, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2165::AID-APP13>3.0.CO;2-2
   Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357
   Vriezema DM, 2003, ANGEW CHEM INT EDIT, V42, P772, DOI 10.1002/anie.200390204
   WANG JS, 1995, MACROMOLECULES, V28, P7901, DOI 10.1021/ma00127a042
   Wang LY, 2004, CHEM COMMUN, P2840, DOI 10.1039/b411163j
   Weaver JVM, 2004, MACROMOLECULES, V37, P2395, DOI 10.1021/ma0356358
   XU C, 2006, POLYM MAT SCI ENG, V94, P308
   Yamamoto Y, 2002, J CONTROL RELEASE, V82, P359, DOI 10.1016/S0168-3659(02)00147-5
   Zhang K, 2006, POLYM BULL, V57, P253, DOI 10.1007/s00289-006-0554-y
   Zhang X, 1999, MACROMOLECULES, V32, P1763, DOI 10.1021/ma981332f
   Zhao B, 1999, J AM CHEM SOC, V121, P3557, DOI 10.1021/ja984428y
   Zhou F, 2005, CHEM COMMUN, P5999, DOI 10.1039/b512106j
   Zhou QY, 2002, LANGMUIR, V18, P3324, DOI 10.1021/la015670c
NR 55
TC 29
Z9 30
U1 0
U2 40
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1022-1352
EI 1521-3935
J9 MACROMOL CHEM PHYS
JI Macromol. Chem. Phys.
PD JUN 19
PY 2007
VL 208
IS 12
BP 1283
EP 1293
DI 10.1002/macp.200700119
PG 11
WC Polymer Science
SC Polymer Science
GA 186OP
UT WOS:000247788300005
DA 2021-01-25
ER

PT J
AU Huentelman, MJ
   Papassotiropoulos, A
   Craig, DW
   Hoerndli, FJ
   Pearson, JV
   Huynh, KD
   Corneveaux, J
   Hanggi, J
   Mondadori, CRA
   Buchmann, A
   Reiman, EM
   Henke, K
   de Quervain, DJF
   Stephan, DA
AF Huentelman, Matthew J.
   Papassotiropoulos, Andreas
   Craig, David W.
   Hoerndli, Frederic J.
   Pearson, John V.
   Huynh, Kim-Dung
   Corneveaux, Jason
   Haenggi, Juergen
   Mondadori, Christian R. A.
   Buchmann, Andreas
   Reiman, Eric M.
   Henke, Katharina
   de Quervain, Dominique J. -F.
   Stephan, Dietrich A.
TI Calmodulin-binding transcription activator 1 (CAMTA1) alleles predispose
   human episodic memory performance
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID MILD MENTAL IMPAIRMENT; COMPLEX HUMAN-DISEASES; MEDIAL TEMPORAL-LOBE;
   ALZHEIMERS-DISEASE; POOLED DNA; DELETED REGION; IDENTIFICATION;
   NEUROBLASTOMA; HIPPOCAMPUS; ASSOCIATION
AB Little is known about the genes and proteins involved in the process of human memory. To identify genetic factors related to human episodic memory performance, we conducted an ultra-high-density genome-wide screen at > 500 000 single nucleotide polymorphisms (SNPs) in a sample of normal young adults stratified for performance on an episodic recall memory test. Analysis of this data identified SNPs within the calmodulin-binding transcription activator 1 (CAMTA1) gene that were significantly associated with memory performance. A follow up study, focused on the CAMTA1 locus in an independent cohort consisting of cognitively normal young adults, singled out SNP rs4908449 with a P-value of 0.0002 as the most significant associated SNP in the region. These validated genetic findings were further supported by the identification of CAMTA1 transcript enrichment in memory-related human brain regions and through a functional magnetic resonance imaging experiment on individuals matched for memory performance that identified CAMTA1 allele-specific upregulation of medial temporal lobe brain activity in those individuals harboring the 'at-risk' allele for poorer memory performance. The CAMTA1 locus encodes a purported transcription factor that interfaces with the calcium-calmodulin system of the cell to alter gene expression patterns. Our validated genomic and functional biological findings described herein suggest a role for CAMTA1 in human episodic memory.
C1 Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
   Univ Zurich, Dept Psychiat, CH-8032 Zurich, Switzerland.
   Banner Alzheimers Inst, Phoenix, AZ 85006 USA.
   Univ Arizona, Dept Psychiat, Tucson, AZ 85724 USA.
   Univ Zurich, Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, Div Mol Psychol, CH-4055 Basel, Switzerland.
RP Stephan, DA (corresponding author), Translat Genom Res Inst, Neurogenom Div, 445 N Fifth St, Phoenix, AZ 85004 USA.
EM dstephan@tgen.org
RI Craig, David Wesley/K-6961-2019; Pearson, John V/F-2249-2011; Pearson,
   John/AAT-4211-2020
OI Craig, David Wesley/0000-0003-2040-1955; Pearson, John
   V/0000-0003-0904-4598; de Quervain, Dominique/0000-0001-7131-2464;
   Hoerndli, Frederic/0000-0001-6838-0386; Hanggi,
   Jurgen/0000-0001-8124-6018; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
FU NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [P30 AG19610] Funding Source: Medline; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [R01 MH057899-06]
   Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [R01MH057899, R01MH057899, R01MH057899, R01MH057899, R01MH057899,
   R01MH057899, R01MH057899, R01MH057899, R01MH057899] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) [P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610] Funding Source: NIH RePORTER
CR Alkia M, 2006, EPILEPSY BEHAV, V8, P750, DOI 10.1016/j.yebeh.2006.03.007
   Barbashina V, 2005, CLIN CANCER RES, V11, P1119
   Blitzer RD, 2005, BIOL PSYCHIAT, V57, P113, DOI 10.1016/j.biopsych.2004.02.031
   Bouche N, 2002, J BIOL CHEM, V277, P21851, DOI 10.1074/jbc.M200268200
   Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337
   Bublak P, 2002, NEUROPSYCHOLOGY, V16, P577, DOI 10.1037//0894-4105.16.4.577
   Butcher LM, 2005, MOL PSYCHIATR, V10, P384, DOI 10.1038/sj.mp.4001589
   Butcher LM, 2005, HUM MOL GENET, V14, P1315, DOI 10.1093/hmg/ddi142
   Calkins ME, 2005, AM J PSYCHIAT, V162, P1963, DOI 10.1176/appi.ajp.162.10.1963
   Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623
   Choi MS, 2005, J BIOL CHEM, V280, P40820, DOI 10.1074/jbc.M504616200
   Craig DW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-138
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Degonda N, 2005, NEURON, V46, P505, DOI 10.1016/j.neuron.2005.02.030
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8
   EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.1989.03430180093036
   Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019
   Groth RD, 2003, BIOCHEM BIOPH RES CO, V311, P1159, DOI 10.1016/j.bbrc.2003.09.002
   Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884
   Henrich KO, 2006, CLIN CANCER RES, V12, P131, DOI 10.1158/1078-0432.CCR-05-1431
   Ikura M, 2006, P NATL ACAD SCI USA, V103, P1159, DOI 10.1073/pnas.0508640103
   Insausti R, 1998, AM J NEURORADIOL, V19, P659
   Katoh M, 2003, INT J ONCOL, V23, P1219
   Konig IR, 2004, GENET EPIDEMIOL, V26, P31, DOI 10.1002/gepi.10290
   Kortvely E, 2003, J HISTOCHEM CYTOCHEM, V51, P541, DOI 10.1177/002215540305100416
   Krasuski JS, 2002, AM J PSYCHIAT, V159, P74, DOI 10.1176/appi.ajp.159.1.74
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   Meaburn E, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-52
   Merrill MA, 2005, TRENDS PHARMACOL SCI, V26, P645, DOI 10.1016/j.tips.2005.10.003
   Mizuno K, 2005, J PHARMACOL SCI, V98, P191, DOI 10.1254/jphs.CRJ05005X
   Nakatani K, 2004, INT J ONCOL, V24, P1407
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449
   Risch N, 1998, GENOME RES, V8, P1273, DOI 10.1101/gr.8.12.1273
   Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516
   Rogaeva E, 2007, NAT GENET, V39, P168, DOI 10.1038/ng1943
   Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002
   Tully T, 2003, NAT REV DRUG DISCOV, V2, P267, DOI 10.1038/nrd1061
   Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114
   von Gunten A, 2005, EUR NEUROL, V54, P154, DOI 10.1159/000090104
NR 44
TC 46
Z9 46
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD JUN 15
PY 2007
VL 16
IS 12
BP 1469
EP 1477
DI 10.1093/hmg/ddm097
PG 9
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 190UA
UT WOS:000248084900008
PM 17470457
OA Green Accepted, Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Urban, J
   Soulard, A
   Huber, A
   Lippman, S
   Mukhopadhyay, D
   Deloche, O
   Wanke, V
   Anrather, D
   Ammerer, G
   Riezman, H
   Broach, JR
   De Virgilio, C
   Hall, MN
   Loewith, R
AF Urban, Jorg
   Soulard, Alexandre
   Huber, Alexandre
   Lippman, Soyeon
   Mukhopadhyay, Debdyuti
   Deloche, Olivier
   Wanke, Valeria
   Anrather, Dorothea
   Ammerer, Gustav
   Riezman, Howard
   Broach, James R.
   De Virgilio, Claudio
   Hall, Michael N.
   Loewith, Robbie
TI Sch9 is a major target of TORC1 in Saccharomyces cerevisiae
SO MOLECULAR CELL
LA English
DT Article
ID CELL-GROWTH CONTROL; P70 S6 KINASE; SIGNAL-TRANSDUCTION; LIFE-SPAN;
   TRANSLATION INITIATION; TRANSCRIPTION FACTORS; BUDDING YEAST;
   RAPTOR-MTOR; PROTEIN; PATHWAY
AB The Target of Rapamycin (TOR) protein is a Ser/ Thr kinase that functions in two distinct multiprotein complexes: TORC1 and TORC2. These conserved complexes regulate many different aspects of cell growth in response to intracellular and extracellular cues. Here we report that the AGC kinase Sch9 is a substrate of yeast TORC1. Six amino acids in the C terminus of Sch9 are directly phosphorylated by TORC1. Phosphorylation of these residues is lost upon rapamycin treatment as well as carbon or nitrogen starvation and transiently reduced following application of osmotic, oxidative, or thermal stress. TORC1-dependent phosphorylation is required for Sch9 activity, and replacement of residues phosphorylated by TORC1 with Asp/Glu renders Sch9 activity TORC1 independent. Sch9 is required for TORC1 to properly regulate ribosome biogenesis, translation initiation, and entry into G(0) phase, but not expression of Gln3-dependent genes. Our results suggest that Sch9 functions analogously to the mammalian TORC1 substrate S6K1 rather than the mTORC2 substrate PKB/Akt.
C1 Univ Geneva, Dept Mol Biol, Ctr Med Univ, CH-1211 Geneva, Switzerland.
   Univ Geneva, Dept Biochem, Ctr Med Univ, CH-1211 Geneva, Switzerland.
   Univ Geneva, Dept Microbiol & Mol Med, Ctr Med Univ, CH-1211 Geneva, Switzerland.
   Univ Basel, Dept Biochem, Biozentrum, CH-4056 Basel, Switzerland.
   Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.
   Univ Vienna, Dept Biochem, Max F Perutz Labs, Dept Biochem, A-1030 Vienna, Austria.
RP Loewith, R (corresponding author), Univ Geneva, Dept Mol Biol, Ctr Med Univ, CH-1211 Geneva, Switzerland.
EM robbie.loewith@moibio.unige.ch
RI Loewith, Robbie/S-6289-2016; De Virgilio, Claudio/B-4707-2012
OI Loewith, Robbie/0000-0002-2482-603X; De Virgilio,
   Claudio/0000-0001-8826-4323; Broach, James/0000-0003-1197-0312; Riezman,
   Howard/0000-0003-4680-9422; Soulard, Alexandre/0000-0003-3556-1994
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086, P01CA041086, P01CA041086,
   P01CA041086, P01CA041086, P01CA041086] Funding Source: NIH RePORTER; NCI
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [CA41086] Funding Source: Medline
CR Ali SM, 2005, J BIOL CHEM, V280, P19445, DOI 10.1074/jbc.C500125200
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264
   Burgess RR, 2000, METHOD ENZYMOL, V328, P141, DOI 10.1016/S0076-6879(00)28396-1
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003
   Colomina N, 2003, MOL CELL BIOL, V23, P7415, DOI 10.1128/MCB.23.20.7415-7424.2003
   Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200
   CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Duvel K, 2003, MOL CELL, V11, P1467, DOI 10.1016/S1097-2765(03)00228-4
   Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042
   Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006
   Inagaki M, 1999, MOL CELL BIOL, V19, P8344
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   KRUSE C, 1985, P NATL ACAD SCI USA, V82, P7515, DOI 10.1073/pnas.82.22.7515
   Liu K, 2005, BIOCHEM SOC T, V33, P1170, DOI 10.1042/BST0331170
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298
   Montagne Jacques, 2004, VVolume 42, P265
   Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022
   Morano KA, 1999, EMBO J, V18, P5953, DOI 10.1093/emboj/18.21.5953
   Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Scherens B, 2006, FEMS YEAST RES, V6, P777, DOI 10.1111/j.1567-1364.2006.00060.x
   Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002
   SOBKO A, 2006, SCI STKE, pRE9
   Wang YX, 1998, J CELL BIOL, V140, P1063, DOI 10.1083/jcb.140.5.1063
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 43
TC 524
Z9 543
U1 1
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1097-2765
J9 MOL CELL
JI Mol. Cell
PD JUN 8
PY 2007
VL 26
IS 5
BP 663
EP 674
DI 10.1016/j.molcel.2007.04.020
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 180PM
UT WOS:000247378000006
PM 17560372
DA 2021-01-25
ER

PT J
AU Reiman, EM
   Webster, JA
   Myers, AJ
   Hardy, J
   Dunckley, T
   Zismann, VL
   Joshipura, KD
   Pearson, JV
   Hu-Lince, D
   Huentelman, MJ
   Craig, DW
   Coon, KD
   Liang, WS
   Herbert, RH
   Beach, T
   Rohrer, KC
   Zhao, AS
   Leung, D
   Bryden, L
   Marlowe, L
   Kaleem, M
   Mastroeni, D
   Grover, A
   Heward, CB
   Ravid, R
   Rogers, J
   Hutton, ML
   Melquist, S
   Petersen, RC
   Alexander, GE
   Caselli, RJ
   Kukull, W
   Papassotiropoulos, A
   Stephan, DA
AF Reiman, Eric M.
   Webster, Jennifer A.
   Myers, Amanda J.
   Hardy, John
   Dunckley, Travis
   Zismann, Victoria L.
   Joshipura, Keta D.
   Pearson, John V.
   Hu-Lince, Diane
   Huentelman, Matthew J.
   Craig, David W.
   Coon, Keith D.
   Liang, Winnie S.
   Herbert, RiLee H.
   Beach, Thomas
   Rohrer, Kristen C.
   Zhao, Alice S.
   Leung, Doris
   Bryden, Leslie
   Marlowe, Lauren
   Kaleem, Mona
   Mastroeni, Diego
   Grover, Andrew
   Heward, Christopher B.
   Ravid, Rivka
   Rogers, Joseph
   Hutton, Michael L.
   Melquist, Stacey
   Petersen, Ron C.
   Alexander, Gene E.
   Caselli, Richard J.
   Kukull, Walter
   Papassotiropoulos, Andreas
   Stephan, Dietrich A.
TI GAB2 alleles modify Alzheimer's risk in APOE epsilon 4 carriers
SO NEURON
LA English
DT Article
ID MILD COGNITIVE IMPAIRMENT; APOLIPOPROTEIN-E; HIPPOCAMPAL VOLUME;
   DISEASE; GENOME; GENE; ASSOCIATION; POPULATION; GENOTYPE; BRAIN
AB The apolipoprotein E (APOE) epsilon 4 allele is the best established genetic risk factor for late-onset Alzheimer's disease (LOAD). We conducted genome-wide surveys of 502,627 single-nucleotide polymorphisms (SNPs) to characterize and confirm other LOAD susceptibility genes. In epsilon 4 carriers from neuropathologically verified discovery, neuropathologically verified replication, and clinically characterized replication cohorts of 1411 cases and controls, LOAD was associated with six SNPs from the GRB-associated binding protein 2 (GAB2) gene and a common haplotype encompassing the entire GAB2 gene. SNP rs2373115 (p = 9 x 10(-11)) was associated with an odds ratio of 4.06 (confidence interval 2.81-14.69), which interacts with APOE epsilon 4 to further modify risk. GAB2 was overexpressed in pathologically vulnerable neurons; the Gab2 protein was detected in neurons, tangle-bearing neurons, and dystrophic neuritis; and interference with GAB2 gene expression increased tau phosphorylation. Our findings suggest that GAB2 modifies LOAD risk in APOE epsilon 4 carriers and influences Alzheimer's neuropathology.
C1 Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
   Banner Alzheimers Inst, Phoenix, AZ 85006 USA.
   Univ Arizona, Dept Psychiat, Tucson, AZ 85724 USA.
   Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA.
   NIA, Neurogenet Lab, Bethesda, MD 20892 USA.
   Inst Neurol, Reta Lila Weston Labs, Dept Mol Neurosci, London WC1N 3BG, England.
   St Josephs Hosp, Div Thorac Oncol Res, Phoenix, AZ 85013 USA.
   Sun Hlth Res Inst, Sun City, AZ 85351 USA.
   Kronos Sci Lab, Phoenix, AZ 85016 USA.
   Dutch Royal Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands.
   Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.
   Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA.
   Arizona State Univ, Dept Psychol, Tempe, AZ 85281 USA.
   Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA.
   Univ Basel, Biozentrum, Div Mol Psychol & Life Sci Training Facil, Basel, Switzerland.
   Univ Washington, Natl Alzheimers Coordinating Ctr, Dept Epidemiol, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA.
   Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA.
RP Reiman, EM (corresponding author), Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
EM eric.reiman@bannerhealth.com; dstephan@tgen.org
RI Pearson, John/AAT-4211-2020; Leung, Doris/O-4074-2019; Hardy,
   John/C-2451-2009; Myers, Amanda J/B-1796-2010; Craig, David
   Wesley/K-6961-2019; Leung, Doris G/R-5447-2016; Pearson, John
   V/F-2249-2011
OI Leung, Doris/0000-0002-2558-7798; Hardy, John/0000-0002-3122-0423;
   Myers, Amanda J/0000-0002-3100-9396; Craig, David
   Wesley/0000-0003-2040-1955; Leung, Doris G/0000-0002-2558-7798; Pearson,
   John V/0000-0003-0904-4598; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; Kukull, Walter/0000-0001-8761-9014
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA Funding Source:
   Medline; Medical Research CouncilMedical Research Council UK (MRC)
   [G0701075] Funding Source: Medline; NHLBI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL084744]
   Funding Source: Medline; NIA NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) [P50 AG08702, P50 AG005136, P50 AG005128, P50
   AG016570, P50 AG05134, P50 AG016574, P30 AG10161, P50 AG005146, P30
   AG019610, K01 AG024079-01A2, P30 AG013846, P50 AG005681, P30 AG01542,
   R21 AG029576, R01 AG023193, P50 AG05128, P50 AG025711, P50 AG005142, P50
   AG16570, P50 AG05136, P50 AG008671, P50 AG 05681, P30 AG012300, P50
   AG08671, P50 AG17824, P50 AG16574, P50 AG05146, U01 AG016976, P50
   AG05142, R21 AG029576-01, P30 AG017824, P30-AG12300, K01 AG024079, P50
   AG008702, P30 AG13846, K01 AG024079-02, P30 AG010161, P50 AG05144,
   AG025688, P50 AG005134, P50 AG025688, P50 AG005144, K01AG024079, P50
   AG25711, P30 AG19610, R01 AG23193] Funding Source: Medline; NIMH NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01 MH60451, P50 MH060451] Funding Source: Medline; NINDS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [U24NS051872, P50 NS039764, R01 NS39764, U24
   NS051872] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451, P50MH060451, P50MH060451, P50MH060451, P50MH060451,
   P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [U24NS051872,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, U24NS051872,
   P50NS039764, P50NS039764, P50NS039764, U24NS051872, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, U24NS051872, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, U24NS051872, P50NS039764,
   P50NS039764, P50NS039764, U24NS051872, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764,
   P50NS039764, P50NS039764, P50NS039764, P50NS039764, P50NS039764] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [P50AG005681, P50AG016574,
   P50AG005681, P30AG013846, P50AG005136, P50AG005136, P50AG005134,
   P50AG005134, P50AG005134, P50AG008671, P50AG025688, P50AG008702,
   P30AG019610, P50AG005128, P30AG019610, P50AG005134, P50AG005146,
   P50AG005144, P50AG016574, P50AG005134, P50AG016570, P50AG005136,
   P50AG008702, P50AG005136, P30AG010161, P30AG013846, P50AG025688,
   P50AG016574, P50AG016570, P50AG005146, P50AG005681, P50AG005146,
   P50AG005134, P50AG005134, P50AG005136, P50AG005146, P50AG005146,
   P30AG010161, P50AG025688, P50AG016570, P50AG005144, P30AG010161,
   P50AG008671, P50AG016574, P50AG005146, P50AG005134, U01AG016976,
   P30AG019610, P50AG005144, P50AG005128, P50AG016570, P50AG005128,
   P30AG010161, P50AG005144, P50AG008671, P50AG005146, P50AG008671,
   P50AG005136, P50AG005134, P50AG005134, P50AG005128, P50AG005142,
   P30AG012300, P50AG025688, P50AG008671, P50AG005681, P50AG005136,
   P30AG010161, U01AG016976, P30AG019610, P50AG005144, P50AG005142,
   P50AG025711, P50AG005681, P50AG005134, P50AG005136, P50AG005146,
   P50AG016570, P50AG005136, P50AG005136, P50AG005681, P50AG005134,
   P50AG005144, P50AG005134, P50AG025711, P50AG005681, P50AG016574,
   P30AG012300, P50AG016574, P50AG008671, P50AG016574, P50AG005681,
   P50AG005134, P50AG005128, P30AG010161, P50AG005136, P50AG008702,
   P50AG016570, P50AG016570, P30AG019610, P30AG019610, P50AG005681,
   P50AG005142, P50AG008671, P50AG005146, P50AG016570, P50AG005681,
   P30AG010161, P30AG013846, P50AG005128, P50AG005136, P30AG012300,
   P30AG019610, P50AG005142, P50AG016574, P50AG005144, P50AG005146,
   P50AG005146, P50AG008671, P50AG025711, P50AG005134, P50AG005681,
   P50AG005146, P50AG005134, P50AG005136, P50AG016570, P50AG005146,
   P50AG005128, P50AG008702, P30AG010161, P50AG005136, P30AG010161,
   P30AG019610, P50AG005146, P50AG005134, P50AG016574, P50AG005134,
   P50AG005134, P50AG016570, P50AG005136, P50AG005681, P50AG016570,
   P50AG005142, P50AG008702, P50AG005146, P50AG016574, P50AG008671,
   P50AG005146, P50AG008671, P30AG013846, P50AG005681, P50AG025688,
   P50AG016570, P30AG010161, P50AG005142, P50AG016574, P30AG017824,
   P30AG017824, P50AG005144, P50AG005142, P50AG005134, P30AG012300,
   P50AG016574, P30AG010161, P50AG005136, P50AG016574, P50AG005134,
   P50AG005681, P50AG005134, P50AG016570, P30AG013846, P50AG016570,
   P50AG005136, P50AG016570, P50AG008702, P50AG008702, P50AG008671,
   P50AG005136, P30AG010161, P50AG005134, P30AG013846, P50AG005142,
   P50AG025688, P50AG005146, P50AG005146, P50AG005134, P30AG017824,
   P50AG005142, P50AG005134, P50AG005142, P50AG005128, P50AG008702,
   P50AG005136, P50AG008702, P50AG005142, P50AG005136, P50AG005136,
   P50AG016570, P50AG005146, P50AG008671, P50AG005134, P50AG005136,
   P50AG005134, P50AG005134, P50AG016570, P50AG005146, P30AG010161,
   P50AG005146, P50AG005144, P50AG008702, P50AG005134, P50AG005136,
   P50AG005146, P50AG016570, P50AG025688, P50AG005128, P50AG005136,
   P50AG005146, P50AG005134, P50AG008702, P50AG005142, P50AG025688,
   P50AG008702, P30AG012300, P30AG012300, P50AG005681, P50AG005128,
   P50AG005681, P50AG005134, P50AG005681, P50AG016574, P50AG005136,
   P50AG008702, P50AG005128, P50AG005142, P30AG010161, P50AG005136,
   P50AG005136, P50AG005146, P50AG005146, P50AG005128, P50AG005146,
   P50AG005134, P50AG008671, P50AG008671, P50AG008702, P30AG012300,
   P30AG013846, P50AG005681, P50AG016570, P50AG005134, P50AG005146,
   P50AG005142, P30AG010161, P50AG005136, P50AG005142, P50AG005136,
   P30AG019610, P50AG005136, P50AG008702, P50AG005128, P50AG005142,
   P50AG005134, P50AG016574, P50AG005128, P50AG005142, P30AG019610,
   P50AG025688, P30AG019610, P50AG005146, P30AG019610, P50AG005128,
   P30AG010161, P50AG016574, P50AG005128, P50AG005142, P50AG005134,
   P30AG012300, P30AG019610, P50AG005144, U01AG016976, P50AG005128,
   P50AG005681, P50AG005128, P50AG005136, P50AG005144, P50AG005681,
   P50AG005136, P30AG017824, P50AG016570, P30AG019610, P50AG005128,
   P50AG008671, P50AG005136, P30AG013846, P50AG005142, P50AG016570,
   P50AG005142, P50AG008702, P30AG019610, P50AG005681, P30AG019610,
   U01AG016976, P50AG005681, P50AG025688, P50AG025688, P50AG008671,
   P50AG025688, P30AG012300, P50AG016570, P50AG005136, P50AG005146,
   P50AG005128, P30AG012300, P50AG008702, P50AG005128, P50AG005146,
   P50AG005128, P50AG016574, P50AG005146, P50AG016570, P50AG008702,
   P50AG025711, U01AG016976, P50AG005146, P50AG008671, P50AG005136,
   P30AG013846, P50AG005146, P30AG012300, P50AG025688, P30AG010161,
   P30AG010161, P50AG008702, P30AG013846, P50AG005142, P50AG005146,
   P50AG005146, P50AG016570, P30AG019610, P50AG016570, P30AG010161,
   P50AG005681, P50AG005146, P50AG005146, P30AG012300, P50AG005142,
   P50AG005142, P50AG005144, P50AG005134, P50AG005134, P50AG008702,
   P50AG005142, P50AG005142, P50AG005681, P50AG005146, P30AG012300,
   P50AG005142, P50AG005144, P50AG005136, P50AG005146, P50AG025688,
   P50AG005142, P50AG025688, P50AG025688, P30AG010161, P50AG005134,
   P50AG005136, P50AG005681, P50AG005681, P50AG005134, P50AG016574,
   P50AG005134, P50AG005681, P50AG025688, P50AG005681, P30AG012300,
   P50AG005146, P30AG010161, P50AG005128, P30AG017824, P30AG019610,
   P50AG005136, P50AG005128, P50AG005146, P50AG025688, P50AG005146,
   P30AG013846, P50AG008702, P50AG005681, P50AG008702, P50AG005681,
   P50AG025688, P50AG008671, P30AG010161, P50AG005128, P50AG025688,
   P30AG010161, P30AG019610, P50AG005128, P50AG008702, P30AG012300,
   P50AG025688, P50AG008702, P50AG005134, P50AG005136, P50AG005128,
   P30AG010161, P50AG005128, P50AG025688, P50AG005142, P30AG013846,
   P50AG005142, P50AG008702, P50AG025688, P50AG005134, P50AG005128,
   P50AG005142, P30AG013846, P50AG005128, P50AG008702, P50AG025688,
   P50AG005136, P50AG008702, P50AG005146, P50AG005136, P50AG005142,
   P50AG005136, P50AG005128, P50AG005142, U01AG016976, P50AG005136,
   P50AG005142, P30AG013846, P50AG005144, P50AG005136, P50AG005142,
   P50AG005136, P50AG005146, P50AG005144, P30AG019610, P50AG005134,
   P30AG013846, P50AG005136, P30AG010161, P50AG008702, P50AG005142,
   P50AG005681, P50AG016574, P30AG012300, P50AG005128, P50AG005142,
   P50AG005136, P50AG005128, P50AG016570, P50AG005144, P50AG016574,
   P50AG005136, P30AG013846, P50AG005681, P30AG012300, P50AG005128,
   P50AG005136, P50AG005134, P30AG013846, P50AG016574, P50AG005134,
   P50AG005146, P50AG005146, P50AG005128, P50AG005136, P30AG019610,
   P50AG005681, P50AG005134, P50AG005146, P50AG005142, P50AG005134,
   P30AG013846, P50AG008702, P30AG012300, P50AG016574, P50AG005142,
   P50AG005142, P50AG005144, P30AG013846, P50AG025688, P50AG005146,
   P50AG005146, P50AG005134, P50AG016574, P50AG025688, P50AG005134,
   P50AG005142, P50AG016574, P50AG005128, P50AG005134, P30AG012300,
   P50AG008702, P30AG010161, P30AG010161, P50AG005681, P50AG005134,
   P50AG005681, P30AG012300, P50AG008671, P50AG005136, P50AG005128,
   P50AG005134, P30AG010161, P50AG005134, P50AG005681, P50AG008702,
   P50AG005136, P50AG016574, P50AG008671, P50AG005142, P50AG005146,
   P50AG005142, P50AG005681, P30AG013846, P50AG005136, P50AG005146,
   P50AG025688, P30AG012300, P50AG005142, P50AG016570, P30AG012300,
   P50AG025688, P50AG005142, P50AG016574, P50AG005681, P50AG005136,
   P50AG005128, P50AG025688, P50AG005136, P50AG005681, P50AG005142,
   P50AG005136, P30AG013846, P30AG010161, P50AG025711, P50AG008671,
   P50AG008702, P30AG019610, P50AG005142, P50AG005146, P50AG005128,
   Z01AG000950, Z01AG000950, P50AG008702, P50AG005681, P50AG005128,
   P50AG016574, P30AG010161, P30AG010161, P50AG005146, P30AG010161,
   P30AG012300, P50AG005136, P50AG005681, P50AG005136, P30AG013846,
   P50AG008671, P50AG005134, P50AG005134, P50AG005681, P50AG008671,
   P50AG005134, P50AG005136, P50AG005134, P50AG005128, P50AG005681,
   P30AG019610, P50AG016570, P50AG005134, P30AG013846, P50AG005681,
   P50AG005136, P50AG005134, P50AG005144, P30AG010161, P50AG016570,
   P50AG008671, P30AG013846, P50AG005146, P50AG005134, P50AG005146,
   P50AG005128, P30AG012300, P50AG016574, P50AG005681, P50AG005142,
   U01AG016976, P50AG016570, P50AG005146, P50AG005146, P50AG008671,
   P50AG005146, P30AG010161, P50AG025688, P50AG005146, P30AG010161,
   P50AG005142, P50AG005136, P50AG008671, P30AG012300, P50AG008671,
   P50AG016570, P50AG005136, P50AG016574, P50AG016574, P50AG005681,
   P30AG019610, P30AG012300, P50AG005134, P50AG005134, P50AG005146,
   P50AG005142, P50AG008702, P50AG005128, P30AG010161, P50AG016570,
   P50AG016574, P50AG016570, P50AG005142, P50AG005146, P50AG005128,
   P30AG010161, R01AG023193, P50AG005681, P50AG005681, P50AG005681,
   P50AG005146, P50AG005146, P50AG008671, P50AG005128, P50AG005681,
   P50AG008671, P50AG005681, P50AG005134, P30AG010161, P50AG005128,
   P50AG005146, P50AG025688, P50AG005681, P50AG005142, P50AG008702,
   P50AG005142, P30AG012300, P50AG005146, P50AG005136, P50AG005144,
   P50AG005128, P50AG016570, P50AG005128, P30AG010161, P50AG005146,
   P50AG005142, P50AG016574, P50AG005134, P50AG005136, P50AG005142,
   P30AG013846, P50AG008671, P50AG005142, P50AG005134, P50AG016570,
   P50AG005134, P50AG005681, P50AG008702, P50AG005128, P50AG005142,
   P50AG008702, P50AG005134, P50AG005146, P50AG016570, P50AG005128,
   P50AG005128, P50AG005144, P30AG013846, P50AG005681, P30AG010161,
   P50AG005144, P30AG012300, P30AG012300, P50AG005681, P50AG005681,
   P50AG005146, P30AG017824, P50AG008671, P50AG025711, P50AG005146,
   P30AG013846, P30AG012300, P50AG005142, P30AG010161, P50AG005146,
   P50AG005128, P50AG008671, P30AG010161, P50AG005681, P50AG016574,
   P50AG005136, P50AG005681, P30AG013846, P50AG008702, U01AG016976,
   P30AG012300, P30AG010161, P50AG005142, P50AG025688, P50AG005146,
   P50AG008671, P50AG008702, P50AG005681, P30AG013846, P50AG008702,
   P50AG005146, P50AG005128, P50AG008702, P50AG005144, P50AG005136,
   P50AG016570, P50AG016570, P50AG005681, P50AG005142, P50AG005134,
   P50AG008702, P50AG005136, P50AG005681, P50AG016574, P50AG016574,
   P50AG005136, P50AG008671, P50AG005136, P50AG005146, P50AG005134,
   P50AG005134, P50AG005146, P50AG005142, P50AG016574, P50AG016574,
   P50AG008702, P30AG013846, P50AG008702, P50AG005681, P50AG005134,
   P50AG008671, P50AG008671, P50AG005136, P50AG005136, P50AG005136,
   P30AG010161, P50AG005142, P50AG016570, P30AG013846, P30AG010161,
   P50AG005134, P50AG025688, P50AG005134, P50AG005146, P50AG005134,
   P50AG005128, P30AG010161, P50AG025688, P50AG005144, P50AG008671,
   P50AG008702, Z01AG000950, P50AG008702, P50AG005146, P50AG016574,
   P30AG010161, P50AG008702, P50AG005146, P50AG005136, P50AG008702,
   P30AG013846, P50AG005136, U01AG016976, P50AG005134, P50AG005134,
   P50AG005681, P50AG005144, P50AG005146, P50AG008671, P50AG008702,
   P50AG005134, P50AG005144, P50AG016574, P50AG005136, P50AG005134,
   P50AG008702, P50AG005146, P50AG005681, P50AG005136, P30AG012300,
   P50AG005146, P30AG012300, U01AG016976, P50AG005128, P50AG005146,
   P50AG016574, P30AG012300, P30AG010161, P50AG005136, P50AG005146,
   P50AG005134, P50AG025688, P50AG016574, P50AG016570, P50AG005681,
   P50AG016574, P50AG005146, P50AG005146, P50AG005134, P50AG008702,
   P30AG012300, P50AG005128, P50AG005681, P30AG012300, P50AG005146,
   P50AG005681, P50AG005134, P50AG005144, P50AG016574, P50AG005142,
   P30AG019610, P30AG013846, P50AG005681, P50AG005134, P50AG016574,
   P50AG005128, P50AG005146, P50AG005136, P50AG005136, P50AG005681,
   P30AG012300, P30AG013846, P50AG008702, P50AG005681, P50AG005136,
   P50AG005681, P30AG017824, P50AG008702, P50AG005136, P50AG005134,
   P50AG005142, P50AG005142, P50AG005134, P50AG005146, P30AG013846,
   P50AG005681, P50AG005681, P50AG005146, P50AG005134, P50AG005136,
   P30AG013846, P50AG005681, P30AG019610, P50AG005134, P50AG005681,
   P50AG008671, P50AG008671, P50AG005142, P50AG005146, P50AG008702,
   P50AG005146, P50AG005681, P30AG012300, P50AG005134, P50AG008671,
   P50AG016570, P50AG008702, P50AG005136, P50AG005128, P50AG016574,
   P50AG005142, P50AG005134, P50AG016570, P50AG016570, P50AG005142,
   R01AG023193, P30AG012300, P50AG025688, P50AG005128, P50AG008702,
   P50AG005681, P50AG005681, P50AG005146, P50AG008671, P50AG005136,
   P50AG005128, P50AG005128, P50AG008702, P30AG010161, P50AG025688,
   P50AG005134, P50AG016574, P50AG008702, P50AG008702, P50AG005681,
   P50AG008702, P30AG012300, P50AG005134, P50AG005128, P30AG017824,
   U01AG016976, P50AG005146, P50AG005142, P50AG005142, P50AG016574,
   P50AG005136, P50AG008671, P50AG016574, P50AG005146, P50AG005146,
   P50AG016574, P50AG016574, P50AG005134, P50AG016570, P50AG005142,
   P50AG016574, P50AG016574, P50AG005144, P50AG005142, P50AG008671,
   P50AG025688, P50AG005146, P50AG005134, P50AG005146, P30AG019610,
   P50AG005142, P50AG005128, P50AG008702, P30AG012300, P50AG005142,
   P50AG005134, P50AG008702, P50AG016574, P50AG005136, P50AG005146,
   P50AG016574, P50AG005136, P50AG005128, P50AG005136, P30AG010161,
   P50AG005142, P50AG005146, P50AG005134, P50AG005142, P50AG005136,
   P50AG005142, P30AG012300, P50AG008702, P50AG005128, P50AG016570,
   P50AG008671, P30AG013846, P30AG019610, P50AG025688, P50AG025711,
   P30AG013846, P50AG005136, P30AG010161, P30AG010161, P30AG019610,
   P50AG005146, P50AG005128, P50AG005134, P50AG005128, P50AG005146,
   P50AG005681, P30AG010161, P50AG005128, P50AG005144, P50AG008702,
   P30AG017824, P50AG005136, P50AG025688, P30AG013846, P50AG005134,
   P50AG005146, P50AG005134, P50AG005146, P50AG005142, P50AG005136,
   P30AG010161, P50AG005146, P30AG012300, P50AG005128, P50AG008671,
   P50AG016570, P50AG005134, P50AG008671, P30AG012300, P50AG005681,
   P50AG016574, P50AG005136, P50AG005144, P50AG025688, P50AG005134,
   P50AG025688, P30AG012300, P50AG005146, P50AG025688, P50AG005134,
   P30AG010161, P50AG005142, P30AG019610, P50AG005134, P50AG005146,
   P50AG005146, P50AG005142, P50AG008702, P50AG008702, P50AG008671,
   P30AG010161, P50AG005681, P50AG005142, P50AG016574, P50AG005128,
   P50AG005681, P30AG010161, P50AG005144, P50AG025711, P50AG005134,
   P50AG008671, P50AG025711, P50AG005134, P50AG005144, P50AG005128,
   P50AG005681, P50AG005681, P30AG010161, P50AG005146, P50AG005146,
   P50AG005144, P50AG008671, P50AG005146, P50AG005134, P50AG005146,
   P50AG008671, P50AG016574, P50AG008702, P50AG008702, P50AG005134,
   P50AG005144, P50AG005136, P50AG008702, P50AG005146, P50AG005144,
   P50AG005136, P50AG008702, P50AG005128, P50AG025688, P50AG008702,
   P50AG005136, P30AG013846, P50AG005136, P30AG010161, P50AG005146,
   P50AG005681, P50AG005134, P50AG016570, P50AG016574, P50AG005681,
   P50AG005136, P50AG008702, Z01AG000950, P50AG008702, P50AG005128,
   P50AG005142, P50AG005146, P50AG005136, P50AG005142, P50AG005136,
   P50AG008702, P50AG005681, P50AG008702, P30AG019610, P30AG012300,
   P50AG005142, P50AG005146, P50AG005681, P50AG005146, P50AG005681,
   U01AG016976, P50AG025688, P50AG008702, P50AG016574, P30AG010161,
   P50AG005142, U01AG016976, P30AG013846, P30AG012300, P50AG008702,
   P50AG008702, P30AG017824, P50AG008702, P50AG016574, P50AG005681,
   P50AG005146, P50AG005128, P30AG012300, P50AG005144, P50AG005134,
   P50AG005146, P50AG005134, P50AG005128, P50AG016570, P30AG010161,
   P50AG005146, P50AG005134, P50AG005146, P30AG012300, P50AG005136,
   P50AG005128, P50AG005128, P50AG016574, K01AG024079, P50AG005142,
   P50AG005142, P50AG025688, P50AG005146, P50AG005128, P50AG005681,
   P50AG005142, P50AG005134, P30AG012300, P50AG005128, P50AG016570,
   P50AG005134, P50AG016574, P50AG005134, P50AG008671, P50AG005146,
   P50AG016574, P50AG005142, P50AG008671, P50AG025711, P50AG025711,
   P50AG016570, P30AG013846, P50AG005128, P50AG005128, P50AG016574,
   P50AG016570, P50AG005134, P50AG005144, P30AG013846, P50AG005134,
   P50AG005142, P50AG005134, P50AG005136, P50AG016574, P50AG016570,
   P50AG005681, P30AG012300, P50AG016574, P30AG012300, P50AG005128,
   P50AG005128, P50AG005681, P50AG005136, P30AG012300, U01AG016976,
   P50AG025688, P30AG013846, P50AG005144, P50AG005142, P50AG025711,
   P50AG016574, P50AG005142, P50AG005681, P50AG008702, P50AG005136,
   P50AG005142, P50AG008702, P50AG005142, P50AG005128, P50AG005681,
   P50AG005136, P30AG010161, P50AG005681, P30AG010161, P50AG005134,
   P50AG005128, P50AG005146, P50AG016574, P30AG019610, P50AG008671,
   P50AG016570, P50AG008702, P50AG025688, K01AG024079, P50AG008702,
   P50AG005681, P50AG005136, P50AG016574, P50AG005134, P50AG005136,
   P50AG005128, P50AG008702, P50AG025688, P50AG005142, P50AG025688,
   P30AG012300, P30AG012300, P50AG005146, P50AG005134, P50AG016574,
   P50AG008671, P50AG005146, P50AG016574, P30AG012300, P50AG008671,
   P30AG013846, P50AG005136, P50AG005142, P50AG005142, P50AG008671,
   P30AG013846, P50AG016574, P50AG005136, P30AG010161, P30AG013846,
   P50AG005136, P50AG005128, P50AG016570, P30AG012300, P50AG016574,
   P50AG005128, P50AG005134, P30AG012300, P50AG005136, P30AG012300,
   P50AG016570, P50AG025688, P50AG016570, P50AG005134, P30AG010161,
   P30AG010161, P50AG016570, P30AG010161, P50AG025688, P50AG005136,
   P50AG008702, P50AG005146, P50AG008671, P50AG005136, P50AG005146,
   P50AG008671, P50AG005142, P30AG019610, P50AG005134, P50AG005136,
   P50AG008702, P50AG005681, P50AG005136, P50AG008702, P50AG005681,
   P30AG013846, P50AG005142, P50AG008702, P50AG005136, P30AG013846,
   P30AG013846, P50AG008671, P50AG005134, P50AG005142, P50AG005134,
   P50AG005681, P50AG005144, P50AG008671, P30AG012300, P30AG013846,
   P50AG005142, P50AG016574, P30AG013846, P50AG008702, P50AG016570,
   P50AG005136, P30AG010161, P30AG010161, P50AG005681, P30AG013846,
   P50AG008671, P50AG005681, P30AG019610, P50AG016574, P50AG005681,
   P50AG025711, P50AG005128, R01AG023193, P50AG008702, P30AG012300,
   P50AG005681, P30AG010161, P50AG016570, P50AG005134, P50AG005146,
   P50AG005142, P50AG005136, P50AG005142, P50AG025688, P50AG005136,
   P50AG005681, P50AG005128, P50AG005128, P30AG013846, P50AG008702,
   P50AG005136, P50AG005136, P50AG005136, P50AG025688, P50AG008702,
   P50AG005134, P50AG005136, P50AG005146, P50AG016574, P50AG005146,
   P30AG012300, P50AG005681, P50AG008671, P50AG005134, P50AG008671,
   P50AG016574, P50AG005681, P50AG016570, P50AG005146, P50AG005142,
   P50AG005136, P50AG005681, P50AG005128, P50AG005146, P50AG005142,
   P50AG005134, P50AG005681, P50AG005134, P50AG005136, P50AG008671,
   P50AG005136, P50AG005128, P30AG010161, P50AG005146, P30AG012300,
   P30AG012300, P50AG005128, P30AG019610, P50AG005142, P50AG005146,
   P30AG010161, P50AG005146, P50AG005144, P30AG012300, P50AG005128,
   P50AG005128, P50AG005128, P50AG005128, P50AG005128, P50AG016574,
   P50AG008702, P50AG005136, P50AG005142, P30AG013846, P50AG005128,
   P50AG025688, P30AG010161, P50AG025688, P50AG005144, P50AG005142,
   P50AG005134, P50AG005681, P50AG008702, P50AG005146, P50AG005146,
   P50AG005136, P30AG010161, P50AG005136, P30AG012300, P50AG005136,
   P50AG008671, P50AG005681, P50AG005128, P50AG005142, P50AG005136,
   P50AG005136, P30AG012300, P50AG016570, P50AG005146, P50AG016570,
   P30AG010161, P50AG005134, P50AG016574, P50AG025688, P30AG019610,
   P30AG019610, P50AG008702, P50AG005146, P50AG016574, P50AG005136,
   P50AG008671, P30AG012300, P50AG005144, P30AG012300, P30AG019610,
   P50AG005136, P50AG008671, P50AG016574, P50AG005134, P50AG005142,
   P50AG005146, P50AG005136, P50AG005136, P50AG005681, P50AG005142,
   P50AG008702, P50AG005144, P50AG025688, P50AG005142, P50AG005134,
   P50AG008671, P50AG005142, P50AG005144, P50AG005146, P50AG016574,
   P50AG005136, P50AG005134, P50AG005142, P50AG005134, P50AG016574,
   P30AG019610, P50AG025688, P50AG005681, P50AG005134, P30AG019610,
   P50AG005144, P50AG008702, P50AG016570, P30AG012300, P50AG016574,
   P30AG013846, P50AG005134, P50AG005142, P50AG008702, P50AG016570,
   P50AG005134, P50AG008702, P50AG005142, P50AG025711, P50AG005681,
   P50AG016574, P50AG005136, P50AG005146, P50AG005146, P50AG005146,
   P50AG008671, P30AG010161, P50AG008702, P50AG005146, P50AG005146,
   P30AG019610, P50AG005134, P50AG008702, P50AG005144, P50AG005136,
   P50AG005136, P50AG005136, P50AG005142, P50AG008702, P50AG005681,
   P30AG013846, P50AG008702, P50AG005136, U01AG016976, P50AG005136,
   P50AG008671, P50AG005128, P50AG005142, P50AG005144, P30AG019610,
   P50AG005146, P50AG025688, P50AG025688, P50AG005128, P50AG005144,
   P50AG008702, P30AG012300, P50AG016570, P50AG008702, P30AG012300,
   P50AG008702, P50AG016570, P50AG016570, P30AG013846, P50AG005142,
   P50AG005134, P50AG005146, P30AG012300, P50AG005681, P50AG005134,
   P50AG016570, P50AG016574, P50AG008671, P50AG005136, P50AG008671,
   P50AG005146, P50AG016574, P50AG016574, P50AG005146, P30AG019610,
   P50AG008702, P50AG005142, P30AG010161, P50AG005146, P50AG008702,
   P50AG005681, P50AG008671, P30AG012300, P50AG005128, P50AG016570,
   P50AG005136, P50AG016574, P50AG005681, P50AG005136, P50AG016570,
   P30AG012300, P50AG005681, P50AG005136, P50AG025711, P50AG005128,
   P50AG005681, P50AG005136, P50AG005134, P50AG005681, P30AG019610,
   P50AG005134, P50AG005128, P50AG016574, P50AG005134, P50AG005146,
   P30AG010161, P50AG005128, P50AG005681, P50AG008702, P50AG005146,
   P30AG013846, P30AG013846, P50AG005136, P50AG005142, P50AG005142,
   P50AG005128, P50AG005142, P50AG005146, P50AG005681, P50AG005681,
   P50AG005681, P50AG008671, P50AG005128, P50AG025711, P50AG005144,
   P50AG008671, P30AG010161, P30AG012300, P50AG005142, P50AG005146,
   P50AG005144, P50AG005136, P30AG013846, P50AG005136, P50AG016570,
   P50AG005146, P30AG010161, P50AG005681, P50AG025711, P30AG013846,
   P50AG025688, P30AG013846, P50AG005146, P50AG005142, P50AG005681,
   P50AG005146, P50AG016570, P30AG012300, P50AG005136, P50AG008702,
   P50AG005134, P50AG005136, P50AG008671, P50AG008702, P50AG005136,
   P30AG010161, P50AG005136, P50AG005146, P50AG005681, P50AG005136,
   P50AG005136, P50AG005681, P50AG005134, P50AG025688, P50AG005681,
   P50AG005136, P50AG008671, P50AG008702, P50AG008671, P50AG005136,
   P50AG005134, P50AG016574, P50AG008671, P50AG005136, P50AG005134,
   P50AG016570, P50AG005146, P50AG025688, P30AG013846, P50AG025688,
   P50AG008671, P50AG008671, P50AG005136, P50AG005134, P50AG008702,
   P50AG005128, P50AG005142, P50AG005128, P50AG005134, P50AG005144,
   P50AG005142, P50AG005136, P50AG005134, P50AG005134, P50AG016574,
   P50AG005144, P50AG005134, P30AG013846, P50AG005134, P50AG005136,
   P50AG005146, P50AG005134, P50AG005134, P50AG016574, P50AG005142,
   P50AG005128, P50AG005681, P30AG013846, P30AG010161, P50AG005128,
   P50AG005128, P30AG010161, P50AG005136, P50AG025688, P50AG005142,
   P50AG005681, P50AG016574, P50AG005128, P50AG016574, P50AG005142,
   P50AG005128, P50AG005134, P50AG005144, P50AG005134, P30AG017824,
   P30AG013846, P50AG005142, P50AG016570, P50AG008702, P50AG005142,
   P50AG005146, P50AG005128, P50AG005144, P50AG005136, P50AG025688,
   P50AG008671, P50AG005128, P50AG016570, P50AG016574, P30AG019610,
   P50AG008702, P50AG005142, P50AG016570, P50AG025688, P50AG005681,
   P50AG008702, P50AG008702, P50AG005134, P50AG016570, P50AG005146,
   P50AG005134, P30AG012300, P50AG005134, P50AG016570, P50AG016574,
   P50AG005128, P50AG005134, P50AG005136, P50AG005146, P50AG005681,
   P50AG005142, P50AG005134, P30AG019610, P50AG005681, P50AG005128,
   P50AG005144, P50AG025711, P50AG025688, P50AG005681, P50AG005128,
   P30AG012300, P50AG005146, P50AG025711, P50AG008671, P50AG005134,
   P50AG005146, P30AG013846, P50AG016570, P50AG005134, P50AG016570,
   P50AG025711, P30AG017824, P30AG010161, P50AG005134, P30AG012300,
   P50AG005128, P50AG005128, P50AG025711, P50AG008702, P50AG005136,
   P50AG008671, P50AG005136, P50AG005146, P50AG005134, P50AG008702,
   P30AG010161, P50AG016574, P50AG005128, P50AG025711, P50AG005136,
   P30AG010161, P30AG010161, P50AG016570, P50AG005142, P50AG005681,
   P50AG005146, P50AG005146, P50AG005146, P50AG005136, P50AG005146,
   P50AG005146, P30AG019610, P50AG005128, P50AG016574, P50AG008702,
   P50AG005146, P50AG005146, P50AG025688, P50AG005134, P50AG005146,
   P50AG016570, P50AG005134, P30AG013846, P50AG005681, P50AG005136,
   P50AG008702, P50AG005134, P50AG005146, P50AG005134, P50AG025688,
   P50AG005136, P50AG005134, P50AG005681, P50AG005681, P50AG005146,
   P50AG008702, P50AG005128, P50AG005146, P50AG025688, P50AG025688,
   P50AG008671, P50AG005144, P50AG005146, P50AG016574, P50AG005681,
   P50AG005681, P50AG005136, P50AG016574, P50AG005136, P30AG012300,
   P50AG016574, P50AG016570, P30AG013846, P50AG005142, P50AG005128,
   U01AG016976, P50AG008671, P50AG005681, P50AG005681, P50AG005134,
   P30AG010161, P50AG008702, P50AG005142, P30AG019610, P50AG005146,
   U01AG016976, P50AG005134, P50AG005142, P50AG005681, P50AG005146,
   P50AG005142, P50AG005136, P50AG016574, P30AG012300, P50AG005136,
   P50AG005146, P50AG025688, P30AG010161, P50AG005136, P50AG005136,
   P50AG005681, P50AG025711, P50AG005144, P50AG005146, P50AG008671,
   P30AG010161, P50AG016570, P50AG005146, P50AG005128, P30AG010161,
   P50AG005136, P50AG005134, P50AG005142, P50AG005681, P50AG005681,
   P50AG005681, P50AG005136, P50AG005134, P50AG005136, P50AG005134,
   P50AG005128, P50AG016570, P50AG005142, P30AG010161, P50AG016574,
   P50AG016574, P30AG010161, P50AG016570, P50AG016570, P50AG005128,
   P30AG019610, P50AG005128, P50AG005142, P50AG005136, P50AG008671,
   P50AG005146, P50AG005146, P50AG005136, P50AG005136, P50AG005146,
   P30AG012300, P30AG019610, P50AG005681, P50AG016574, P50AG005146,
   P50AG005128, P50AG025711, P50AG005128, P50AG005146, P50AG008702,
   P50AG008671, P50AG005134, P50AG008702, P50AG016570, P50AG005142,
   P30AG017824, P50AG005136, P50AG008702, P50AG005681, P50AG005134,
   P30AG013846, P50AG008671, P50AG005128, P50AG005144, P50AG025688,
   P50AG016570, P50AG005134, P50AG005134, P50AG005134, P50AG005128,
   P50AG005134, P50AG005146, P50AG008671, P30AG012300, P50AG005128,
   P50AG005146, P30AG013846, P50AG005136, P50AG005128, P50AG005681,
   P50AG005142, P50AG005134, P30AG012300, P50AG005134, P50AG025711,
   P50AG005136, P50AG005681, P50AG005128, P50AG005681, P50AG008702,
   P50AG005681, P50AG008671, P50AG016570, P50AG005134, P50AG016574,
   P30AG012300, P50AG005142, P50AG016574, P50AG005134, P50AG005681,
   P50AG008671, P50AG016574, P50AG005136, P50AG008702, P30AG019610,
   P50AG005142, P50AG005136, P50AG005144, P50AG005134, P50AG008702,
   P50AG005681, P50AG025711, P50AG005146, P50AG005146, P50AG016574,
   P50AG005144, P50AG005681, P50AG005142, P50AG005146, P30AG010161,
   P50AG005128, P50AG008702, P50AG005134, P50AG005146, P50AG016570,
   P50AG008671, P50AG005142, P50AG005136, P50AG005136, P50AG008702,
   P30AG019610, P50AG005146, P50AG008671, P30AG010161, P30AG019610,
   P30AG010161, P30AG010161, P50AG005681, P50AG016574, P50AG016570,
   P50AG016570, P50AG008671, P50AG016570, P50AG005144, P50AG005681,
   P50AG008702, P50AG025688, P50AG005144, P30AG013846, P30AG013846,
   P50AG016574, P50AG005142, P50AG005136, P50AG025688, P50AG005146,
   P50AG025688, P30AG012300, P50AG025688, P50AG005134, P50AG016574,
   P30AG010161, P50AG005134, P50AG005144, P50AG005136, P50AG005134,
   P50AG016570, P50AG005136, P50AG005681, P50AG025688, P50AG005681,
   P50AG008702, P50AG016570, P50AG005136, P50AG005681, P50AG005681,
   P50AG005128, P50AG005144, P50AG008702, P50AG005128, P50AG005146,
   P50AG008702, P50AG005142, P50AG005681, P50AG016570, P50AG005681,
   P50AG005144, P30AG019610, P50AG016574, P50AG005681, P50AG005146,
   P30AG013846, P30AG012300, P50AG005681, P50AG005134, P50AG005136,
   P30AG010161, P50AG008702, P30AG013846, P50AG008702, P50AG005146,
   P30AG013846, P50AG005681, P30AG019610, P50AG005142, P50AG008702,
   P50AG005144, P50AG016574, P50AG008702, P30AG012300, P50AG005134,
   P50AG005142, P30AG012300, P30AG017824, P50AG016574, P30AG010161,
   P50AG005134, P50AG005142, P50AG005142, P30AG012300, P50AG005134,
   P50AG005134, P50AG005681, P30AG010161, P50AG005128, P50AG016574,
   P50AG005128, P50AG005134, P50AG005146, P50AG005681, P50AG016574,
   P50AG005144, P30AG013846, P50AG005146, P50AG025711, P50AG005146,
   P30AG013846, P50AG016574, P50AG005146, P50AG005681, P50AG005681,
   P50AG005134, P50AG005681, P30AG010161, P50AG005134, P50AG005136,
   P50AG005134, P30AG019610, P50AG005146, P50AG016570, P30AG010161,
   P50AG005142, P50AG005144, P50AG005146, P30AG013846, P50AG008671,
   P50AG005128, P30AG010161, P30AG019610, P50AG005134, P50AG005681,
   P50AG008702, P50AG005144, P50AG005146, P50AG005144, P50AG005142,
   P50AG025711, P50AG016570, P30AG019610, P50AG005681, P50AG005128,
   P50AG005136, U01AG016976, P50AG016570, P50AG005146, P50AG016570,
   P50AG016574, P50AG016570, P30AG012300, P50AG005146, P50AG005134,
   P50AG005146, P50AG005128, P50AG005681, P50AG005142, P50AG005146,
   P50AG005146, P50AG005146, P30AG010161, P50AG005681, P50AG008671,
   P50AG005136, P50AG008702, P50AG008702, P50AG008702, P50AG005144,
   P50AG016574, P50AG005144, P30AG012300, P30AG010161, P50AG016570,
   P50AG005142, P50AG025688, P50AG005144, P50AG005128, P30AG013846,
   P50AG016570, P30AG010161, P50AG005134, P50AG005142, P50AG005136,
   P30AG010161, P50AG008671, P50AG005134, P50AG005134, P50AG016574,
   P50AG008702, P30AG012300, P50AG005681, P50AG008702, P50AG005146,
   P30AG019610, P50AG008702, P30AG019610, P50AG005144, P50AG016574,
   P50AG005134, P50AG008671, P30AG010161, P50AG005134, P50AG008702,
   P50AG008702, P50AG005136, P50AG008671, P30AG019610, P30AG010161,
   P50AG008702, P50AG005134, P30AG010161, P50AG005134, P50AG016574,
   P50AG005128, P30AG012300, P50AG005146, P50AG005146, P50AG005681,
   P30AG017824, P50AG008671, P30AG012300, P50AG005134, P50AG005134,
   P50AG005128, P30AG012300, P50AG005142, P50AG005146, P50AG005144,
   P50AG005142, P50AG025688, P50AG005134, P50AG005142, P50AG005142,
   P50AG005136, P50AG016570, P50AG005134, P50AG008671, P30AG019610,
   P30AG010161, P50AG008671, P50AG005681, P50AG005134, P50AG008702,
   P30AG017824, P50AG005136, P50AG005134, P50AG016574, P50AG005146,
   P50AG005142, P50AG005136, P50AG005142, P50AG005128, P50AG008702,
   P30AG010161, P50AG005134, P50AG005681, P50AG005146, P50AG005146,
   P50AG005681, P30AG019610, K01AG024079, P50AG005146, P50AG016574,
   P50AG005134, P30AG012300, P50AG016570, P50AG005681, P50AG005144,
   P50AG005142, P50AG016570, P50AG005142, P50AG005142, P50AG005134,
   P50AG005681, P30AG010161, P50AG005134, P50AG016574, P30AG019610,
   P50AG005681, P50AG005134, P50AG005146, P50AG005142, P30AG019610,
   P50AG005128, P30AG012300, P50AG005136, P50AG005142, P30AG019610,
   P50AG005134, P50AG005681, P50AG005142, P30AG010161, P50AG005681,
   P50AG005136, P50AG005144, P50AG008702, P50AG005146, P50AG005134,
   P30AG012300, P50AG005134, P50AG005128, P50AG005681, P50AG005136,
   U01AG016976, P50AG005681, P30AG017824, P50AG008702, P50AG016570,
   P50AG008671, P30AG012300, P50AG005142, P50AG005146, P50AG016574,
   P50AG008702, P50AG008671, P50AG005136, P50AG016574, P50AG005146,
   P30AG010161, P50AG005128, P50AG005681, P50AG016574, P50AG005134,
   P50AG016574, P50AG005146, P50AG005136, P50AG005681, P50AG005134,
   P50AG016570, P50AG005134, P50AG005142, P50AG005146, P50AG005142,
   P50AG005146, P50AG005136, P50AG025688, P30AG010161, P50AG008671,
   P30AG013846, P50AG008671, P30AG012300, P50AG005128, P50AG005134,
   P50AG005146, P50AG005128, P30AG010161, P50AG005681, P50AG005128,
   P50AG005681, P50AG005136, R01AG023193, P50AG005128, P50AG005681,
   P50AG005146, P50AG005128, P30AG012300, P50AG005142, P50AG005142,
   P50AG005146, P50AG005136, P50AG005134, P50AG008702, P50AG005134,
   P50AG005128, P50AG005144, P50AG025711, P50AG016574, P30AG010161,
   P50AG025711, P50AG008702, P30AG010161, P30AG019610, P50AG008702,
   P50AG016574, P50AG005134, P50AG005128, P50AG005136, P50AG005681,
   P50AG025711, P50AG005681, P50AG005136, P30AG019610, P30AG010161,
   P50AG005142, P50AG008702, P50AG005681, P50AG005146, P30AG013846,
   P50AG008702, P50AG005142, R01AG023193, P50AG005142, P30AG010161,
   P50AG016570, P50AG008702, P50AG016570, P30AG012300, P50AG005146,
   P50AG016570, P30AG019610, P30AG013846, P50AG005146, P50AG005136,
   P50AG005136, P30AG019610, P50AG005136, P50AG005681, P50AG005142,
   P50AG008702, P30AG010161, P30AG013846, P50AG005142, P50AG025688,
   P50AG005146, P30AG019610, P50AG005146, P50AG005128, P50AG005134,
   P50AG005128, P50AG005681, P50AG005136, P50AG005146, P50AG005136,
   P50AG005134, R21AG029576, P50AG016574, P50AG005142, P50AG005128,
   P50AG016570, P30AG019610, P50AG005134, P50AG005681, P30AG013846,
   P50AG016570, P30AG019610, P30AG010161, P50AG008702, P30AG012300,
   P50AG016570, P30AG010161, P50AG005128, P50AG016574, P30AG017824,
   P50AG005681, P50AG016574, P50AG016574, P50AG005128, P50AG008671,
   P30AG010161, P50AG008702, P50AG005136, P30AG013846, P50AG005146,
   P50AG005128, P50AG005681, P30AG019610, P50AG008671, U01AG016976,
   P50AG016574, P50AG005681, P50AG005142, P50AG005134, P50AG016574,
   P30AG019610, P50AG008702, P30AG019610, P50AG016570, P30AG013846,
   P50AG005142, P30AG017824, P50AG005681, P50AG016574, P50AG005146,
   P50AG025688, P50AG005146, Z01AG000950, P50AG016574, P50AG008702,
   P50AG005681, P50AG005146, P50AG005681, P50AG005144, P50AG005146,
   P30AG013846, P50AG005146, P50AG005146, P50AG005136, P50AG005134,
   P50AG016570, P50AG005134, P30AG019610, P50AG008702, P50AG008702,
   P50AG005128, P50AG005146, P50AG005146, P50AG005144, P50AG005146,
   P50AG005142, P30AG013846, P30AG010161, P50AG005146, P30AG010161,
   P50AG005681, P30AG012300, P30AG013846, P30AG012300, P50AG005142,
   P50AG005146, P50AG005142, P50AG005681, P50AG008702, P50AG005142,
   P50AG005681, P30AG019610, R21AG029576, P30AG013846, P30AG010161,
   P50AG005134, P50AG005134, P50AG005134, P50AG005681, P50AG005146,
   P30AG013846, P50AG005128, P30AG013846, P50AG016574, P50AG016570,
   P30AG013846, P50AG016570, P50AG005136, P50AG005136, P50AG008702,
   P50AG005142, P30AG010161, P50AG016574, P50AG005134, P50AG008671,
   P50AG005136, P50AG016574, P50AG005142, P50AG005134, P30AG012300,
   P50AG016570, P30AG010161, P50AG005134, P50AG008702, P30AG010161,
   P50AG005146, P50AG005146, P50AG005134, P50AG005146, P50AG005136,
   P50AG008671, P50AG008702, P50AG025688, P50AG025711, P50AG008671,
   P50AG005142, P50AG005146, P50AG016570, P50AG016574, P50AG025688,
   P50AG016570, P50AG005134, P30AG010161, P50AG005146, P50AG005136,
   P50AG005136, P50AG016570, P50AG005146, P50AG016574, P50AG005128,
   P50AG005142, P50AG005142, P50AG016574, P50AG005681, P50AG005136,
   P30AG010161, P50AG005146, P50AG005134, P50AG008702, P50AG005134,
   P50AG005681, P50AG005134, P30AG010161, P30AG013846, P50AG005134,
   P50AG016570, P50AG016570, P50AG005136, P50AG005128, P50AG005134,
   P30AG013846, P50AG005142, P50AG005681, P50AG005134, P30AG012300,
   P50AG016574, P50AG005134, P50AG016570, P30AG012300, P50AG008702,
   P50AG005134, P50AG005142, P30AG012300, P30AG010161, P30AG013846,
   P50AG016574, P50AG016570, P50AG025688, P50AG005144, P30AG019610,
   P50AG005146, P50AG005128, P50AG025688, P50AG005681, P30AG010161,
   P50AG016574, P30AG013846, P30AG010161, P50AG005144, P50AG005146,
   P50AG005144, P50AG016570, P50AG005128, P50AG005136, P50AG005146,
   P50AG008702, P50AG016574, P50AG008671, Z01AG000950, P30AG019610,
   P50AG005128, P50AG005136, P50AG005134, P50AG005142, P50AG005134,
   P50AG005134, P50AG008702, P50AG005681, P50AG005681, P30AG017824,
   P30AG017824, P50AG025688, P50AG005128, P50AG005136, P50AG005128,
   P50AG005142, P50AG005146, P50AG005146, P50AG005146, P50AG005128,
   P50AG016574, P50AG016570, P30AG010161, P50AG005136, P50AG005134,
   P50AG005146, P30AG012300, P50AG005146, P50AG005681, P50AG005136,
   P50AG005142, P50AG005146, P50AG005128, P50AG005146, P50AG005681,
   P50AG008671, P50AG005142, P30AG010161, P50AG005128, P30AG012300,
   P50AG005136, P50AG005681, P50AG005142, P50AG005136, P50AG025711,
   P50AG005142, P50AG005136, P50AG025711, P50AG005146, P50AG008702,
   P50AG005134, P50AG005146, P50AG005134, P50AG005681, P50AG008702,
   P50AG016574, P50AG005681, P50AG005128, P30AG012300, P50AG005142,
   P50AG025688, P30AG013846, P50AG005128, P50AG005681, P50AG016574,
   P50AG005144, P50AG005134, P50AG005681, P50AG008702, P50AG005134,
   P50AG005142, P50AG025688, U01AG016976, U01AG016976, P30AG012300,
   P50AG005681, P50AG025688, P50AG005681, P50AG016570, P30AG012300,
   P50AG005681, P50AG016574, P50AG005142, P50AG005142, P50AG005134,
   P50AG005681, P50AG005146, P50AG005134, P50AG005128, P30AG012300,
   P50AG005144, P50AG005146, P50AG005681, P50AG005128, P50AG005681,
   P50AG025688, P50AG025688, P50AG016574, P50AG005681, P50AG005136,
   P50AG005144, P50AG005136, P50AG005134, P50AG008702, P50AG005681,
   P50AG005681, P50AG025711, P50AG005134, P50AG005681, P50AG005134,
   P50AG025711, P30AG019610, P50AG005681, P50AG005134, P50AG005146,
   P50AG016574, P50AG005681, P50AG005136, P50AG005681, P50AG005146,
   P50AG008702, P50AG005136, P50AG008702, P50AG005142, P50AG005146,
   P30AG010161, P50AG016570, P50AG008702, P50AG005142, P30AG012300,
   P30AG010161, P50AG005134, P50AG005134, P50AG005144, P50AG008671,
   P50AG005681, P50AG005681, P50AG005136, P30AG013846, P50AG016574,
   P50AG005681, P50AG008671, P50AG005136, P50AG005134, P50AG005136,
   P50AG005142, P50AG005681, P50AG005134, P50AG005128, P50AG005681,
   P30AG010161, P50AG016570, P50AG005681, P50AG005681, P50AG005681,
   P50AG005128, P50AG008702, U01AG016976, P50AG005134, P50AG005136,
   P50AG005134, P50AG005681, P50AG005142, P30AG012300, P50AG008702,
   P50AG005134, P30AG012300, P50AG005136, P50AG016570, P50AG016570,
   P50AG025688, P50AG005681, P50AG005134, P50AG005136, P50AG008702,
   P50AG016574, P50AG005681, P50AG005681, P50AG008671, P50AG008671,
   P50AG016574, P50AG005142, P50AG008671, P50AG005681, P50AG005128,
   P50AG008702, P50AG005144, P50AG025688, P50AG005134, P50AG005128,
   P50AG016574, P30AG012300, P50AG005144, P50AG005128, P30AG017824,
   P50AG005144, P30AG010161, P50AG005142, P50AG005146, P30AG010161,
   P50AG005136, P50AG016574, P50AG005144, P50AG005134, P50AG025688,
   P50AG005136, P50AG005136, P50AG005136, P30AG012300, P50AG005136,
   P50AG005142, P30AG013846, P50AG005681, P50AG005681, P50AG005146,
   P50AG008702, P30AG013846, P30AG012300, P50AG005128, P50AG016574,
   P50AG005134, P50AG025688, P50AG005144, P30AG019610, P30AG019610,
   P50AG005681, P30AG013846, P50AG008702, P30AG019610, P50AG008702,
   P50AG008671, P50AG008702, P50AG005681, P30AG012300, P50AG005134,
   P50AG005681, P50AG005128, P50AG025688, P50AG005146, P50AG005136,
   P50AG008702, P50AG005681, P50AG005681, P50AG005142, P50AG025688,
   P50AG005142, P50AG005146, P50AG005681, P30AG010161, P50AG005134,
   P50AG005146, P50AG005142, P30AG013846, P30AG017824, P30AG012300,
   P50AG005142, P50AG005681, P30AG010161, P50AG005134, P50AG008702,
   P50AG005681, P30AG010161, P50AG005134, P50AG005136, P30AG010161,
   P50AG008671, P50AG005134, P50AG008671, P50AG005146, P30AG010161,
   P30AG010161, P50AG005142, P50AG008702, P50AG025688, P50AG005134,
   P50AG008671, P50AG005128, P50AG016574, P30AG010161, P50AG005146,
   P50AG005142, P50AG005146, U01AG016976, P50AG005136, P50AG008702,
   P50AG008671, P50AG008671, P50AG008702, P50AG016574, P50AG005142,
   P50AG008702, P50AG005681, P50AG016574, P50AG005146, P50AG005136,
   P50AG005136, P30AG019610, P50AG005134, U01AG016976, P50AG016570,
   P50AG008671, P50AG005146, P30AG017824, P50AG008702, P50AG016570,
   P50AG005136, P50AG005136, P50AG025688, P30AG012300, P50AG005142,
   P30AG012300, P50AG005142, P50AG005136, P50AG005146, P30AG012300,
   P50AG005146, P50AG005128, P50AG005128, P50AG005681, P30AG010161,
   P50AG005146, U01AG016976, P50AG005681, P50AG016570, P50AG008702,
   P50AG008702, U01AG016976, P50AG016574, P50AG016570, P50AG008702,
   P50AG005142, P50AG025688, P50AG005136, P50AG005146, P50AG025711,
   P50AG016570, P50AG008671, U01AG016976, P50AG016574, P30AG013846,
   P50AG005681, P50AG005146, P50AG005144, P50AG005136, P50AG005136,
   P50AG008702, P50AG016574, P50AG005146, P50AG005146, P30AG012300,
   P50AG005144, P30AG010161, P50AG005142, P50AG016570, P50AG008671,
   P50AG005146, P30AG019610, P50AG005136, P50AG005681, P30AG012300,
   P50AG005146, P50AG025688, P30AG012300, P50AG008671, P50AG005146,
   P30AG012300, P50AG005134, P50AG016570, P50AG005681, P50AG005128,
   P30AG019610, P50AG008702, P50AG008702, P50AG005681, P50AG005681,
   P50AG008671, P50AG005146, P30AG012300, P50AG005136, P50AG005136,
   P50AG005142, P30AG012300, P50AG005681, P30AG012300, P50AG005142,
   P50AG008702, P50AG005136, P50AG005134, P50AG005142, P50AG005142,
   P50AG005681, P50AG005134, P50AG016570, P50AG005134, P50AG005146,
   P50AG016574, P50AG005142, P50AG005134, P50AG005128, P30AG010161,
   P50AG005128, P50AG008702, P50AG005128, P50AG005142, P50AG025711,
   P50AG005136, P30AG012300, P30AG012300, P50AG005681, P50AG005146,
   P30AG019610, P30AG012300, P50AG008702, P50AG005146, P50AG005128,
   P50AG025688, P50AG005128, P30AG012300, P50AG005134, P50AG008702,
   P50AG005134, P50AG016574, P50AG016570, P50AG005681, P50AG005142,
   P50AG005142, P50AG016574, P50AG005146, P50AG016574, P50AG005128,
   P30AG012300, P50AG005128, P50AG008671, P50AG016570, P50AG005146,
   P50AG005146, P50AG008702, P50AG016570, P50AG025688, P50AG005146,
   P50AG016570, P30AG013846, P50AG025688, P50AG005681, P50AG005146,
   P50AG005134, P50AG005681, P50AG005134, P30AG010161, P50AG005136,
   P50AG008671, P50AG016574, P50AG005128, P50AG005146, P50AG005134,
   P50AG025688, P30AG010161, P30AG012300, P50AG005128, P50AG008671,
   P50AG016574, P50AG005136, P50AG005146, P50AG005134, P50AG005134,
   P30AG010161, P50AG005134, P50AG005128, P50AG005142, P50AG005681,
   P30AG012300, P50AG005136, P50AG008671, P30AG012300, P50AG016570,
   P50AG005134, P30AG010161, P50AG005146, P50AG005146, P50AG016574,
   P50AG005146, P50AG005142, P50AG025688, P50AG005142, P50AG005681,
   P50AG005146, P50AG005134, P50AG005134, P50AG016574, P50AG005146,
   P50AG005136, P50AG005681, P30AG010161, P30AG010161, P30AG012300,
   P50AG025688, P50AG016570, P50AG005128, P50AG005136, P50AG005128,
   P50AG005681, P30AG019610, P50AG005142, P50AG025711, P30AG019610,
   P30AG010161, P50AG008702, P50AG005128, P50AG025688, P50AG005142,
   P30AG010161, P50AG005681, P50AG008671, P30AG013846, P50AG025711,
   P50AG005142, P30AG013846, P50AG005146, P30AG012300, P50AG008671,
   P50AG005681, P50AG005128, P50AG008702, P50AG005144, P30AG010161,
   P50AG005136, P50AG005128, P30AG010161, P50AG008702, P50AG005144,
   P50AG025688, P30AG012300, P30AG012300, P30AG013846, P50AG005146,
   P50AG005136, P50AG008671, P50AG005681, U01AG016976, P50AG005128,
   P50AG016574, P50AG025688, P50AG005134, P50AG005681, P50AG005146,
   P50AG005136, P50AG005142, P50AG008671, P50AG005681, P50AG005144,
   P50AG005146, P50AG005142, P30AG012300, P50AG016570, P50AG016570,
   P50AG008702, P50AG008671, P50AG005681, P50AG016570, P50AG005134,
   U01AG016976, P50AG005146, P30AG012300, P50AG008702, P50AG005134,
   P30AG012300, P50AG005128, P50AG016574, P50AG005681, P50AG016570,
   P50AG008671, P50AG005134, P50AG005146, P30AG010161, P50AG005128,
   P50AG005142, P50AG005144, P50AG008702, P50AG025688, P50AG016570,
   P50AG005128, P50AG005136, P30AG019610, P50AG005128, P50AG005136,
   P50AG016574, P50AG005134, P50AG025688, P50AG005136, P30AG010161,
   P50AG008671, P50AG005146, P30AG010161, P50AG005144, P50AG005146,
   P50AG005134, P30AG012300, P30AG012300, P50AG008702, P50AG005134,
   P50AG005146, P50AG016570, P30AG010161, P50AG005128, P50AG005134,
   P30AG019610, P50AG005136, P50AG005681, P50AG005128, P30AG013846,
   P50AG005146, P30AG010161, P50AG025688, P50AG025688, P50AG005136,
   P50AG016574, P50AG008702, P50AG005134, P50AG005681, P50AG005146,
   P50AG005136, P50AG016574, P50AG005144, P50AG005681, P50AG005142,
   P50AG005146, P50AG005146, P50AG005134, P30AG012300, P50AG008671,
   P50AG008702, P50AG025688, P50AG005681, P50AG005134, P30AG010161,
   P50AG005146, P50AG005144, P50AG008671, P50AG005144, P50AG016574,
   P50AG005128, U01AG016976, P50AG005681, P50AG008702, P50AG005681,
   P50AG005142, P50AG008702, P30AG010161, P30AG010161, P50AG005136,
   P30AG012300, P50AG005681, P50AG008702, P50AG005128, P50AG005128,
   P50AG005681, P30AG013846, P30AG012300, P50AG005134, P50AG016574,
   P50AG016570, P50AG008702, P50AG005681, P50AG005128, P30AG012300,
   P30AG012300, P50AG008702, P50AG005142, P50AG005136, P50AG008702,
   P50AG005142, P30AG019610, P50AG005146, P50AG008702, P50AG005146,
   P50AG016570, P50AG005128, P50AG005146, P50AG025711, P50AG005134,
   P50AG025688, P50AG005136, P50AG025688, P50AG005681, P50AG005128,
   P50AG016570, P50AG008702, P50AG005144, P30AG019610, P50AG005146,
   P50AG016574, P50AG005142, P50AG008671, P50AG005142, P50AG008702,
   P50AG005144, P30AG019610, P50AG016570, P50AG005134, P50AG008702,
   P30AG010161, P30AG012300, P50AG016570, P50AG008671, P50AG005142,
   P30AG013846, P50AG016570, P50AG005146, P50AG005142, P50AG005142,
   P30AG013846, P50AG008671, P50AG005146, P50AG025688, P30AG010161,
   P50AG005136, P50AG005134, P50AG025688, P30AG010161, P50AG005144,
   P50AG005146, P50AG005146, P50AG016570, P30AG013846, P30AG019610,
   P50AG008702, P50AG005128, P50AG005142, P50AG005681, P50AG016570,
   P50AG005136, P50AG005136, P50AG005146, P50AG005146, P50AG005681,
   P50AG005128, P50AG016574, P30AG012300, P50AG005144, P50AG008702,
   P50AG005134, P50AG005136, P50AG005144, P50AG025688, P50AG016570,
   P50AG005681, P50AG016574, P50AG005142, P50AG008702, P50AG016570,
   P50AG005136, P30AG010161, P50AG016574, P30AG010161, P50AG005144,
   P30AG019610, P50AG008671, P50AG005134, P50AG005146, P50AG016574,
   P50AG005681, P50AG005146, P50AG005128, P50AG005136, P50AG005146,
   P50AG005142, P50AG005146, P50AG005142, P50AG005146, P50AG008702,
   Z01AG000950, P50AG005681, P50AG008702, P50AG005681, P50AG005144,
   P50AG025688, P50AG005128, P30AG012300, P50AG005134, P50AG005136,
   P50AG005681, P50AG005681, P30AG013846, P50AG005134, P50AG005144,
   P50AG005146, P30AG012300, P50AG005142, P30AG019610, P30AG012300,
   P30AG012300, P50AG016570, P50AG005136, P50AG016574, P50AG005136,
   P50AG005134, P50AG005144, U01AG016976, P50AG005134, P50AG005142,
   P50AG005142, P50AG005681, P30AG013846, P50AG025688, P50AG005134,
   P30AG012300, P50AG005146, P50AG025688, P50AG005128, P30AG010161,
   P50AG005146, P50AG005136, K01AG024079, P30AG010161, P30AG010161,
   P50AG025688, P50AG005136, P50AG005134, P50AG005681, P50AG016570,
   P50AG008702, P50AG005681, P50AG005134, P50AG008702, P50AG005681,
   P50AG016570, P30AG012300, P50AG005146, P50AG005134, P50AG005134,
   P50AG005681, P50AG005136, P30AG012300, P50AG005128, P30AG019610,
   P50AG005128, P50AG005136, P50AG025711, P50AG005146, P50AG016574,
   P50AG008702, P30AG013846, P50AG005128, P30AG013846, P50AG005146,
   P30AG013846, P50AG008671, P50AG005681, P50AG005142, P50AG005142,
   P50AG016574, P50AG005681, P50AG005142, P50AG005134, P50AG005134,
   P50AG005681, P50AG005681, U01AG016976, P50AG008702, P50AG008671,
   P50AG005142, P50AG008702, P50AG016574, P50AG005136, P50AG005146,
   P50AG005142, P50AG005134, P50AG016574, P50AG005136, P50AG025711,
   P50AG005146, P50AG025688, P50AG005134, P50AG005134, P50AG016574,
   P50AG005136, P30AG010161, P50AG005136, P50AG005136, P50AG005134,
   P50AG016574, P50AG005134, P50AG005136, P50AG005681, P50AG005128,
   P50AG005134, P50AG025688, P50AG005136, P50AG005146, P50AG005146,
   P50AG005144, P50AG005681, P50AG005681, P50AG005142, P50AG005146,
   P30AG010161, P50AG005146, P50AG005142, P50AG005136, P50AG016570,
   P50AG025688, P50AG005136, P50AG008702, P50AG016574, P50AG016570,
   P50AG008671, P50AG005136, P50AG005136, P30AG010161, P30AG013846,
   P50AG005136, P50AG016570, P50AG005134, P50AG008702, P50AG005136,
   P50AG008671, P50AG005136, P30AG010161, P50AG025688, P30AG010161,
   P50AG005134, P50AG005142, P50AG005128, P50AG005142, P50AG005681,
   P30AG010161, P50AG005128, P30AG012300, P30AG012300, P50AG005144,
   P50AG005128, P50AG008671, P50AG005142, P50AG005134, P50AG005142,
   U01AG016976, P50AG005134, P50AG005681, P50AG005134, P30AG010161,
   P50AG005128, P50AG005134, P50AG005146, P50AG005146, P50AG005144,
   P50AG005128, P30AG013846, P50AG005134, P50AG005142, P50AG025688,
   P50AG016574, P50AG005146, P50AG005136, P50AG005142, P50AG016570,
   P50AG005144, P50AG025711, P50AG008702, P50AG025688, P50AG025688,
   P50AG005142, P50AG005134, P50AG005681, P50AG025711, P50AG025688,
   P50AG016570, P50AG005142, P50AG005142, P50AG008702, P50AG008702,
   P50AG016570, P50AG005134, P50AG005136, P50AG008702, P50AG005128,
   P50AG005136, P50AG005136, P30AG013846, P30AG010161, P50AG005146,
   P50AG005134, P50AG016570, P50AG005128, P50AG005146, P50AG016570,
   P50AG005134, P50AG016574, P30AG010161, P50AG005146, P50AG016574,
   P50AG016570, P50AG005142, P50AG008671, P50AG005136, P50AG008702,
   P30AG010161, P50AG025688, P50AG005142, P50AG005681, P50AG005136,
   P50AG005134, P50AG016574, P50AG005128, P50AG005681, P50AG005142,
   P50AG005136, P50AG005136, P50AG005681, P50AG008702, P50AG005142,
   P50AG005134, P50AG005136, P50AG008702, P50AG005134, P50AG005136,
   P50AG008702, P50AG005128, P50AG005136, P50AG005128, P30AG013846,
   P50AG016574, P50AG016570, P50AG008702, P50AG008702, P50AG008671,
   P50AG005128, P50AG005134, P50AG025688, P50AG005134, P30AG012300,
   P50AG008702, P50AG005146, P50AG008671, P50AG008671, P50AG005142,
   P50AG005681, P50AG005136, P50AG005144, U01AG016976, P50AG005136,
   P30AG019610, P50AG005128, P50AG005681, P50AG005128, P50AG016574,
   P50AG005142, P50AG005146, P50AG005146, P50AG005146, P50AG005134,
   P50AG005144, P50AG005142, P50AG005136, P30AG010161, P50AG016574,
   P50AG005136, P50AG005128, P50AG005681, P50AG008702, P50AG005146,
   P50AG016574, P50AG005134, P50AG005681, P30AG013846, P50AG005144,
   P50AG005144, P50AG025688, P50AG005146, P50AG005144, U01AG016976,
   P50AG008671, P50AG005134, P50AG005681, P30AG013846, P50AG016570,
   P50AG008671, P50AG005134, P30AG012300, P50AG005134, P30AG010161,
   P50AG025711, P50AG005136, P50AG005134, P50AG005128, P30AG019610,
   P30AG012300, P50AG005136, P30AG010161, P50AG005134, P50AG005681,
   P30AG010161, P50AG005134, P50AG005134, P50AG016570, P50AG025688,
   P30AG013846, P50AG005134, P50AG005146, P50AG005142, P50AG005128,
   P50AG016570, P50AG025688, P50AG005146, P50AG008671, P50AG005134,
   P50AG005146, P50AG008671, P50AG005134, P50AG005144, P50AG008702,
   P50AG005681, P50AG005128, P50AG016574, P50AG016574, P50AG005146,
   P50AG005128, P50AG008702, P30AG010161, P50AG008671, P50AG005146,
   P30AG019610, P30AG013846, P50AG005136, P50AG005136, P50AG005136,
   P30AG012300, P50AG016574, P50AG005681, P50AG005681, P30AG019610,
   P50AG016570, P50AG005134, P50AG005136, P50AG016570, P50AG005142,
   P50AG005681, P50AG016574, P50AG005142, P50AG005134, P50AG005681,
   P50AG005144, P50AG016574, P50AG008702, P50AG008702, P50AG005142,
   P50AG016574, P50AG005146, P50AG016574, P50AG005144, P50AG025711,
   P50AG005128, P50AG008702, P50AG005681, P50AG005134, P50AG005146,
   P30AG010161, P50AG005134, P50AG005146, P30AG012300, P30AG012300,
   P50AG005134, P50AG005142, P50AG005128, P50AG016574, P30AG010161,
   P50AG005142, P30AG012300, P50AG005142, P50AG008702, P50AG016574,
   P50AG005142, K01AG024079, P50AG005146, P50AG005134, P50AG005128,
   P50AG016574, P50AG005681, P50AG005681, P30AG010161, P30AG010161,
   P50AG005681, P50AG005142, P50AG005134, P50AG008702, P50AG005681,
   P50AG005128, P50AG005142, P50AG005136, P50AG005142, P50AG005134,
   P50AG005681, P50AG005134, P50AG008671, P50AG016574, P30AG010161,
   P50AG005136, P50AG005681, P50AG005142, P50AG005136, P50AG005146,
   P50AG008702, P30AG017824, P50AG005681, P50AG005134, P50AG025711,
   P30AG019610, P50AG005144, P50AG005142, P30AG012300, P50AG005128,
   P50AG005134, P50AG005146, P50AG016570, P50AG005134, P50AG005142,
   P50AG016574, P30AG010161, P50AG005146, P30AG010161, P30AG010161,
   P50AG008702, P50AG005144, P50AG008671, P50AG005142, P30AG010161,
   P50AG005128, P50AG008671, P50AG005128, P50AG025688, P50AG008702,
   P50AG008702, P50AG005681, U01AG016976, P50AG005681, P50AG005146,
   P30AG010161, P50AG005681, P30AG012300, P50AG005681, P50AG008671,
   P30AG013846, P50AG005134, P50AG005142, P30AG013846, P50AG008671,
   P50AG005142, P50AG008702, P50AG016574, P50AG005144, P50AG005134,
   P50AG005144, P30AG010161, P50AG005128, P50AG005146, P50AG005128,
   P50AG005134, P50AG005134, P30AG010161, P50AG005136, P30AG010161] Funding
   Source: NIH RePORTER
CR Ahmadian A, 2000, ANAL BIOCHEM, V280, P103, DOI 10.1006/abio.2000.4493
   Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226
   Baki L, 2004, EMBO J, V23, P2586, DOI 10.1038/sj.emboj.7600251
   Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934
   Bobinski M, 2000, NEUROSCIENCE, V95, P721
   BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809
   Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005
   Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419
   CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.1989.03430180093036
   Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349
   Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168
   Gu HH, 2001, NATURE, V412, P186, DOI 10.1038/35084076
   Hua JP, 2007, BIOINFORMATICS, V23, P57, DOI 10.1093/bioinformatics/btl536
   Jack CR, 1999, NEUROLOGY, V52, P1397, DOI 10.1212/WNL.52.7.1397
   Johnson SC, 2006, NEUROBIOL AGING, V27, P1604, DOI 10.1016/j.neurobiolaging.2005.09.017
   Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200
   Koncz G, 2002, IMMUNOL LETT, V82, P41, DOI 10.1016/S0165-2478(02)00017-2
   Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642
   Lai E, 1998, GENOMICS, V54, P31, DOI 10.1006/geno.1998.5581
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Li KC, 2004, P NATL ACAD SCI USA, V101, P15561, DOI 10.1073/pnas.0402962101
   Li RN, 2004, NEUROBIOL AGING, V25, P991, DOI 10.1016/j.neurobiolaging.2003.10.016
   Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006
   Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4
   Papassotiropoulos A, 2006, J CLIN PSYCHIAT, V67, P652, DOI 10.4088/JCP.v67n0418
   Pratt JC, 2000, J IMMUNOL, V165, P4158, DOI 10.4049/jimmunol.165.8.4158
   Pritchard JK, 2000, GENETICS, V155, P945
   Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   Zompi S, 2004, J LEUKOCYTE BIOL, V76, P896, DOI 10.1189/jlb.0304179
NR 32
TC 363
Z9 374
U1 0
U2 18
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD JUN 7
PY 2007
VL 54
IS 5
BP 713
EP 720
DI 10.1016/j.neuron.2007.05.022
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 179ZQ
UT WOS:000247329900006
PM 17553421
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Danckwardt, S
   Kaufmann, I
   Gentzel, M
   Foerstner, KU
   Gantzert, AS
   Gehring, NH
   Neu-Yilik, G
   Bork, P
   Keller, W
   Wilm, M
   Hentze, MW
   Kulozik, AE
AF Danckwardt, Sven
   Kaufmann, Isabelle
   Gentzel, Marc
   Foerstner, Konrad U.
   Gantzert, Anne-Susan
   Gehring, Niels H.
   Neu-Yilik, Gabriele
   Bork, Peer
   Keller, Walter
   Wilm, Matthias
   Hentze, Matthias W.
   Kulozik, Andreas E.
TI Splicing factors stimulate polyadenylation via USEs at non-canonical 3 '
   end formation signals
SO EMBO JOURNAL
LA English
DT Article
DE F2; mRNA processing; polyadenylation; splicing factor; upstream sequence
   element (USE)
ID MESSENGER-RNA POLYADENYLATION; UPSTREAM SEQUENCE ELEMENT; POLY(A) SITE
   RECOGNITION; GAIN-OF-FUNCTION; ALTERNATIVE POLYADENYLATION; FACTOR
   CPSF-73; U1 SNRNP; IN-VIVO; SPECIFICITY FACTOR; GENE-EXPRESSION
AB The prothrombin (F2) 3' end formation signal is highly susceptible to thrombophilia-associated gain-of-function mutations. In its unusual architecture, the F2 3' UTR contains an upstream sequence element (USE) that compensates for weak activities of the non-canonical cleavage site and the downstream U-rich element. Here, we address the mechanism of USE function. We show that the F2 USE contains a highly conserved nonameric core sequence, which promotes 30 end formation in a position-and sequence-dependent manner. We identify proteins that specifically interact with the USE, and demonstrate their function as trans-acting factors that promote 30 end formation. Interestingly, these include the splicing factors U2AF35, U2AF65 and hnRNPI. We show that these splicing factors not only modulate 30 end formation via the USEs contained in the F2 and the complement C2 mRNAs, but also in the biocomputationally identified BCL2L2, IVNS and ACTR mRNAs, suggesting a broader functional role. These data uncover a novel mechanism that functionally links the splicing and 30 end formation machineries of multiple cellular mRNAs in an USE-dependent manner.
C1 Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany.
   EMBL, Mol Med Partnership Unit, Heidelberg, Germany.
   Univ Basel, Biozentrum, Basel, Switzerland.
   European Mol Biol Lab, Heidelberg, Germany.
RP Hentze, MW (corresponding author), Univ Heidelberg, Dept Pediat Oncol Hematol & Immunol, Neuenheimer Feld 156, D-69120 Heidelberg, Germany.
EM Matthias.Hentze@embl.de; andreas.kulozik@med.uni-heidelberg.de
RI Forstner, Konrad U./B-1531-2010; Hentze, Matthias/V-3980-2017; Kulozik,
   Andreas/AAO-2432-2020; Bork, Peer/F-1813-2013
OI Forstner, Konrad U./0000-0002-1481-2996; Hentze,
   Matthias/0000-0002-4023-7876; Bork, Peer/0000-0002-2627-833X; Wilm,
   Matthias/0000-0002-5461-6834; Gentzel, Marc/0000-0002-4482-6010
CR Awasthi S, 2003, RNA, V9, P1400, DOI 10.1261/rna.5104603
   Barabino SML, 1999, CELL, V99, P9, DOI 10.1016/S0092-8674(00)80057-4
   Brackenridge S, 2000, MOL CELL BIOL, V20, P2660, DOI 10.1128/MCB.20.8.2660-2669.2000
   Chuvpilo S, 1999, IMMUNITY, V10, P261, DOI 10.1016/S1074-7613(00)80026-6
   Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755
   Danckwardt S, 2006, J THROMB HAEMOST, V4, P1078, DOI 10.1111/j.1538-7836.2006.01885.x
   Danckwardt S, 2006, ACTA HAEMATOL-BASEL, V115, P192, DOI 10.1159/000090934
   Danckwardt S, 2004, BLOOD, V104, P428, DOI 10.1182/blood-2003-08-2894
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002
   EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547
   Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037
   Gehring NH, 2001, NAT GENET, V28, P389, DOI 10.1038/ng578
   Gilmartin GM, 2005, GENE DEV, V19, P2517, DOI 10.1101/gad.1378105
   GILMARTIN GM, 1995, GENE DEV, V9, P72, DOI 10.1101/gad.9.1.72
   Graveley BR, 1996, MOL CELL BIOL, V16, P4942
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544
   Hirose Y, 2000, GENE DEV, V14, P1415
   Hu J, 2005, RNA, V11, P1485, DOI 10.1261/rna.2107305
   Kameoka S, 2004, EMBO J, V23, P1782, DOI 10.1038/sj.emboj.7600187
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Keller W, 1997, CURR OPIN CELL BIOL, V9, P329, DOI 10.1016/S0955-0674(97)80004-X
   Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037
   Legendre M, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-7
   Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226
   Liang SC, 2006, RNA, V12, P111, DOI 10.1261/rna.2213506
   Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325
   Lutz CS, 1998, RNA, V4, P1493, DOI 10.1017/S1355838298981183
   Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363
   Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a
   McCracken S, 2003, J BIOL CHEM, V278, P44153, DOI 10.1074/jbc.M306856200
   McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002
   Millevoi S, 2002, EMBO REP, V3, P869, DOI 10.1093/embo-reports/kvf173
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Moreira A, 1998, GENE DEV, V12, P2522, DOI 10.1101/gad.12.16.2522
   Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200
   Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X
   NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Rosonina E, 2005, MOL CELL BIOL, V25, P6734, DOI 10.1128/MCB.25.15.6734-6746.2005
   Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404
   SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834
   TAAGAKI Y, 1996, CELL, V87, P941
   Vagner S, 2000, GENE DEV, V14, P403
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779
   WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605
   Zhao H, 1999, ADV ENG SOFTW, V30, P445, DOI 10.1016/S0965-9978(99)00008-3
   Zhao WQ, 1996, MOL CELL BIOL, V16, P2378
NR 52
TC 54
Z9 54
U1 4
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD JUN 6
PY 2007
VL 26
IS 11
BP 2658
EP 2669
DI 10.1038/sj.emboj.7601699
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 176KO
UT WOS:000247084100005
PM 17464285
OA Green Published
DA 2021-01-25
ER

PT J
AU Peter, JC
   Nicholson, JR
   Heydet, D
   Lecourt, AC
   Hoebeke, J
   Hofbauer, KG
AF Peter, Jean-Christophe
   Nicholson, Janet R.
   Heydet, Deborah
   Lecourt, Anne-Catherine
   Hoebeke, Johan
   Hofbauer, Karl G.
TI Antibodies against the melanocortin-4 receptor act as inverse agonists
   in vitro and in vivo
SO AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE
   PHYSIOLOGY
LA English
DT Article
DE food intake; G protein-coupled receptor; body weight; agouti-related;
   protein; immunization
ID AGOUTI-RELATED PROTEIN; MONOCLONAL-ANTIBODY; ACETYLCHOLINE-RECEPTOR;
   ENERGY HOMEOSTASIS; SYSTEM; EXPRESSION
AB Functionally active antibodies (Abs) against central G-protein-coupled receptors have not yet been reported. We selected the hypothalamic melanocortin-4 receptor (MC4-R) as a target because of its crucial role in the regulation of energy homeostasis. A 15 amino acid sequence of the N-terminal (NT) domain was used as an antigen. This peptide showed functional activity in surface plasmon resonance experiments and in studies on HEK-293 cells overexpressing the human MC4-R (hMC4-R). Rats immunized against the NT peptide produced specific antibodies, which were purified and characterized in vitro. In HEK-293 cells, rat anti-NT Abs showed specific immunofluorescence labeling of hMC4-R. They reduced the production of cAMP under basal conditions and after stimulation with a synthetic MC4-R agonist. Rats immunized against the NT peptide developed a phenotype consistent with MC4-R blockade, that is, increased food intake and body weight, increased liver and fat pad weight, and elevated plasma triglycerides. In a separate experiment in rats, an increase in food intake could be produced after injection of purified Abs into the third ventricle. Similar results were obtained in rats injected with anti-NT Abs raised in rabbits. Our data show for the first time that active immunization of rats against the NT sequence of the MC4-R results in specific Abs, which appear to stimulate food intake by acting as inverse agonists in the hypothalamus.
C1 Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   CNRS, Lab Immunol & Therapeut Chem, Inst Biol Mol & Cellulaire, UPR 9021, Strasbourg, France.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9
   Bohen SP, 2003, P NATL ACAD SCI USA, V100, P1926, DOI 10.1073/pnas.0437875100
   Bronner G, 2006, J CLIN ENDOCR METAB, V91, P535, DOI 10.1210/jc.2005-0919
   Chen M, 2006, REGUL PEPTIDES, V136, P40, DOI 10.1016/j.regpep.2006.04.010
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087
   Elies R, 1998, EUR J BIOCHEM, V251, P659, DOI 10.1046/j.1432-1327.1998.2510659.x
   Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395
   Fan T, 2000, ENDOCRINOLOGY, V141, P3072
   GANTZ I, 1993, J BIOL CHEM, V268, P15174
   Kamel R, 2005, BIOCHEM PHARMACOL, V70, P1009, DOI 10.1016/j.bcp.2005.07.005
   Kornbluth A, 1998, Inflamm Bowel Dis, V4, P328, DOI 10.1002/ibd.3780040415
   Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   Mobini R, 2000, HYBRIDOMA, V19, P135, DOI 10.1089/02724570050031176
   NEIMARK J, 1993, PEPTIDE RES, V6, P219
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135
   Peter JC, 2005, FASEB J, V19, P943, DOI 10.1096/fj.04-3042com
   Peter JC, 2004, J BIOL CHEM, V279, P55697, DOI 10.1074/jbc.M407213200
   Schuna AA, 2000, AM J HEALTH-SYST PH, V57, P225, DOI 10.1093/ajhp/57.3.225
   Sebhat IK, 2002, J MED CHEM, V45, P4589, DOI 10.1021/jm025539h
   Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248
   Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927
   Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200
   Tota MR, 1999, BIOCHEMISTRY-US, V38, P897, DOI 10.1021/bi9815602
   Yang YK, 1999, J BIOL CHEM, V274, P14100, DOI 10.1074/jbc.274.20.14100
NR 28
TC 14
Z9 14
U1 0
U2 2
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0363-6119
EI 1522-1490
J9 AM J PHYSIOL-REG I
JI Am. J. Physiol.-Regul. Integr. Comp. Physiol.
PD JUN
PY 2007
VL 292
IS 6
BP R2151
EP R2158
DI 10.1152/ajpregu.00878.2006
PG 8
WC Physiology
SC Physiology
GA 185QK
UT WOS:000247725300007
PM 17322114
DA 2021-01-25
ER

PT J
AU Fulci, V
   Chiaretti, S
   Goldoni, M
   Azzalin, G
   Carucci, N
   Tavolaro, S
   Castellano, L
   Magrelli, A
   Citarella, F
   Messina, M
   Maggio, R
   Peragine, N
   Santangelo, S
   Mauro, FR
   Landgraf, P
   Tuschl, T
   Weir, DB
   Chien, MC
   Russo, JJ
   Ju, JY
   Sheridan, R
   Sander, C
   Zavolan, M
   Guarini, A
   Foa, R
   Macino, G
AF Fulci, Valerio
   Chiaretti, Sabina
   Goldoni, Marina
   Azzalin, Gianluca
   Carucci, Nicoletta
   Tavolaro, Simona
   Castellano, Leandro
   Magrelli, Armando
   Citarella, Franca
   Messina, Monica
   Maggio, Roberta
   Peragine, Nadia
   Santangelo, Simona
   Mauro, Francesca Romana
   Landgraf, Pablo
   Tuschl, Thomas
   Weir, David B.
   Chien, Minchen
   Russo, James J.
   Ju, Jingyue
   Sheridan, Robert
   Sander, Chris
   Zavolan, Mihaela
   Guarini, Anna
   Foa, Robin
   Macino, Giuseppe
TI Quantitative technologies establish a novel microRNA profile of chronic
   lymphocytic leukemia
SO BLOOD
LA English
DT Article
ID ZAP-70 EXPRESSION; CELL-GROWTH; B-CELLS; RNA; APOPTOSIS; MIRNAS; GENES;
   DEREGULATION; PROGRESSION; SIGNATURES
AB MicroRNAs (miRNAs) are a novel class of small noncoding RNAs that modulate the expression of genes at the post-transcriptional level. These small molecules have been shown to be involved in cancer, apoptosis, and cell metabolism. In the present study we provide an informative profile of the expression of miRNAs in primary chronic lymphocytic leukemia (CLL) cells using 2 independent and quantitative methods: miRNA cloning and quantitative real-time-polymerase chain reaction (qRT-PCR) of mature miRNAs. Both approaches show that miR-21 and miR-155 are dramatically overexpressed in patients with CLL, although the corresponding genomic loci are not amplified. miR-150 and miR-92 are also significantly deregulated in patients with CLL. In addition, we detected a marked miR-15a and miR-16 decrease in about 11% of cases. Finally, we identified a set of miRNAs whose expression correlates with biologic parameters of prognostic relevance, particularly with the mutational status of the IgV(H) genes. In summary, the results of this study offer for the first time a comprehensive and quantitative profile of miRNA expression in CLL and their healthy counterpart, suggesting that miRNAs could play a primary role in the disease itself.
C1 Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Rome, Italy.
   Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Sez Ematol, Rome, Italy.
   Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   Columbia Univ, Genome Ctr, New York, NY 10027 USA.
   Columbia Univ, Dept Chem Engn, New York, NY 10027 USA.
   Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Macino, G (corresponding author), Policlin Umberto 1, Clin Med 5, Viale Regina Elena, I-00161 Rome, Italy.
EM macino@bce.uniroma1.it
RI Zavolan, Mihaela/S-3888-2016; fulci, valerio/J-1963-2015; Goldoni,
   Marina/AAA-1668-2021; Goldoni, Marina/AAC-2178-2020; Magrelli,
   Armando/A-5478-2010; Pal, Deb K/F-3318-2011; Sander, Chris/H-1452-2011;
   Magrelli, Armando/K-4330-2019
OI fulci, valerio/0000-0002-1173-585X; Goldoni, Marina/0000-0002-5196-9618;
   Magrelli, Armando/0000-0002-5036-3710; Sander,
   Chris/0000-0001-6059-6270; Magrelli, Armando/0000-0002-5036-3710; Mauro,
   Francesca Romana/0000-0003-2425-9474; Messina,
   Monica/0000-0003-3531-4766; Castellano, Leandro/0000-0002-3059-4829;
   MAGGIO, ROBERTA/0000-0001-8319-4418; Zavolan,
   Mihaela/0000-0002-8832-2041
CR Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
   Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995
   Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101
   Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406
   Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200
   Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102
   Costinean S, 2006, P NATL ACAD SCI USA, V103, P7024, DOI 10.1073/pnas.0602266103
   Crespo M, 2003, NEW ENGL J MED, V348, P1764, DOI 10.1056/NEJMoa023143
   Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703
   Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602
   Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102
   Fais F, 1998, J CLIN INVEST, V102, P1515, DOI 10.1172/JCI3009
   Gentile M, 2005, CURR OPIN ONCOL, V17, P597, DOI 10.1097/01.cco.0000181403.75460.c7
   Gu J, 1998, NUCLEIC ACIDS RES, V26, P160, DOI 10.1093/nar/26.1.160
   Guarini A, 2003, BLOOD, V102, P1035, DOI 10.1182/blood-2002-12-3639
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   KUPPERS R, 1993, AM J PATHOL, V143, P230
   KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Liu CN, 2005, NUCLEIC ACIDS RES, V33, pD112, DOI 10.1093/nar/gki041
   Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005
   Masdehors P, 2000, BLOOD, V96, P269, DOI 10.1182/blood.V96.1.269.013k10_269_274
   Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24
   Meinhardt G, 1999, J MOL MED-JMM, V77, P282, DOI 10.1007/s001090050351
   Messmer BT, 2005, J CLIN INVEST, V115, P755, DOI 10.1172/JCI23409
   Metzler M, 2004, GENE CHROMOSOME CANC, V39, P167, DOI 10.1002/gcc.10316
   Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Rassenti LZ, 2004, NEW ENGL J MED, V351, P893, DOI 10.1056/NEJMoa040857
   Raymond CK, 2005, RNA, V11, P1737, DOI 10.1261/rna.2148705
   Ringshausen I, 2002, BLOOD, V100, P3741, DOI 10.1182/blood-2002-02-0539
   Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639
   Seitz H, 2006, CELL, V125, P827, DOI 10.1016/j.cell.2006.05.018
   Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103
   Tam W, 2006, GENE CHROMOSOME CANC, V45, P211, DOI 10.1002/gcc.20282
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037
   Wiestner A, 2003, BLOOD, V101, P4944, DOI 10.1182/blood-2002-10-3306
   Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025
NR 44
TC 358
Z9 394
U1 0
U2 40
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD JUN 1
PY 2007
VL 109
IS 11
BP 4944
EP 4951
DI 10.1182/blood-2006-12-062398
PG 8
WC Hematology
SC Hematology
GA 174MJ
UT WOS:000246946100055
PM 17327404
DA 2021-01-25
ER

PT J
AU Goldie, KN
   Wedig, T
   Mitra, AK
   Aebi, U
   Herrmann, H
   Hoenger, A
AF Goldie, Kenneth N.
   Wedig, Tatjana
   Mitra, Alok K.
   Aebi, Ueli
   Herrmann, Harald
   Hoenger, Andreas
TI Dissecting the 3-D structure of vimentin intermediate filaments by
   cryo-electron tomography
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE vimentin; intermediate filament; protofibrils; cryo-electron tomography
ID MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; KERATIN FILAMENTS;
   ATOMIC-STRUCTURE; PROTEINS; DYNAMICS; POLYMORPHISM; MICROTUBULE;
   DIVERSITY; SPECIMENS
AB Vimentin polymerizes via complex lateral interactions of coiled-coil dimers into long, flexible filaments referred to as intermediate filaments (IFs). Intermediate in diameter between microtubules and microfilaments, IFs constitute the third cytoskeletal filament system of metazoan cells. Here we investigated the molecular basis of the 3-D architecture of vimentin IFs by cryo-electron microscopy (cryo-EM) as well as cryo-electron tomography (Cryo-ET) 3-D reconstruction. We demonstrate that vimentin filaments in cross-section exhibit predominantly a four-stranded protofibrilar organization with a right-handed supertwist with a helical pitch of about 96 nm. Compact filaments imaged by cryo-EM appear surprisingly straight and hence appear very stiff. In addition, IFs exhibited an increased flexibility at sites of partial unraveling. This is in strong contrast to chemically fixed, negatively stained preparations of vimentin filaments that generally exhibit smooth bending without untwisting. At some point along the filament unraveling may be triggered and propagates in a cooperative manner so that long stretches of filaments appear to have unraveled rapidly in a coordinated fashion. (c) 2006 Elsevier Inc. All rights reserved.
C1 European Mol Biol Lab, Struct & Comp Biol Unit, D-69117 Heidelberg, Germany.
   Univ Auckland, Sch Biol Sci, Auckland 1020, New Zealand.
   DKFZ, German Canc Res Ctr, D-69115 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Hoenger, A (corresponding author), European Mol Biol Lab, Struct & Comp Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM andreas.hoenger@colorado.edu
RI Mitra, Alok/P-7800-2016
OI Mitra, Alok/0000-0003-0891-5697; Hoenger, Andreas/0000-0001-9176-6658
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   DePianto D, 2004, EXP CELL RES, V301, P68, DOI 10.1016/j.yexcr.2004.08.007
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1
   FRANKE WW, 1978, P NATL ACAD SCI USA, V75, P5034, DOI 10.1073/pnas.75.10.5034
   FUCHS E, 1983, CELL, V34, P332, DOI 10.1016/0092-8674(83)90367-7
   Fuchs E, 2001, GENE DEV, V15, P1, DOI 10.1101/gad.861501
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   Magin TM, 2004, EXP CELL RES, V301, P91, DOI 10.1016/j.yexcr.2004.08.018
   MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977
   McGough A, 1998, CURR OPIN STRUC BIOL, V8, P166, DOI 10.1016/S0959-440X(98)80034-1
   McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Nicastro D, 2006, SCIENCE, V313, P944, DOI 10.1126/science.1128618
   Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7
   Norlen L, 2004, J INVEST DERMATOL, V123, P715, DOI 10.1111/j.0022-202X.2004.23213.x
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4
   Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694
   Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2004, METHOD CELL BIOL, V78, P25
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8
   Watts NR, 2002, J STRUCT BIOL, V137, P109, DOI 10.1006/jsbi.2002.4469
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
   Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005
NR 41
TC 49
Z9 52
U1 1
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2007
VL 158
IS 3
BP 378
EP 385
DI 10.1016/j.jsb.2006.12.007
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 174FQ
UT WOS:000246927800012
PM 17289402
DA 2021-01-25
ER

PT J
AU Gregorini, M
   Wang, J
   Xie, XS
   Milligan, RA
   Engel, A
AF Gregorini, Marco
   Wang, Jin
   Xie, Xiao-Song
   Milligan, Ronald A.
   Engel, Andreas
TI Three-dimensional reconstruction of bovine brain V-ATPase by
   cryo-electron microscopy and single particle analysis
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE bovine brain V-ATPase; cryo-electron microscopy; single particle
   analysis; 3D reconstruction
ID VESICLE PROTON PUMP; VACUOLAR H+-ATPASE; ELECTRON-MICROSCOPY;
   CROSS-LINKING; SUBUNIT; IMAGES; YEAST; (H+)-ATPASE; SYNTHASE; COMPLEX
AB Bovine V-ATPase from brain clathrin-coated vesicles was investigated by cryo-electron microscopy and single particle analysis. Our studies revealed great flexibility of the central linker region connecting V-1 and V-0. As a consequence, the two sub-complexes were processed separately and the resulting volumes were merged computationally. We present the first three-dimensional (3D) map of a V-ATPase obtained from cryo-electron micrographs. The overall resolution was estimated 34 angstrom by Fourier shell correlation (0.5 cutoff). Our 3D reconstruction shows a large peripheral stalk and a smaller, isolated peripheral density, suggesting a second, less well-resolved peripheral connection. The 3D map reveals new features of the large peripheral stator and of the collar-like density attached to the membrane domain. Our analyses of the membrane domain indicate the presence of six proteolipid subunits. In addition, we could localize the V-0 subunit a flanking the large peripheral stalk. (c) 2007 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Texas, Southwestern Med Ctr, Dallas, TX 75390 USA.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   ADACHI I, 1990, J BIOL CHEM, V265, P967
   ARAI H, 1988, J BIOL CHEM, V263, P8796
   Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200
   Bernal RA, 2004, STRUCTURE, V12, P1789, DOI 10.1016/j.str.2004.07.017
   BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207
   BROWN D, 1992, AM J PHYSIOL, V263, pC913
   Brown D, 1996, J EXP BIOL, V199, P2345
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Chaban Y, 2002, EMBO REP, V3, P982, DOI 10.1093/embo-reports/kvf196
   Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200
   Domgall I, 2002, J BIOL CHEM, V277, P13115, DOI 10.1074/jbc.M112011200
   Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   FENG Y, 1992, J BIOL CHEM, V267, P5817
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   FRANK J, 1982, J MOL BIOL, V161, P134, DOI 10.1016/0022-2836(82)90282-0
   Gruber G, 2000, BIOCHEMISTRY-US, V39, P8609, DOI 10.1021/bi000103u
   Hirata R, 1997, J BIOL CHEM, V272, P4795, DOI 10.1074/jbc.272.8.4795
   Inoue T, 2003, J BIOENERG BIOMEMBR, V35, P291, DOI 10.1023/A:1025720713747
   Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617
   Leng XH, 1996, J BIOL CHEM, V271, P22487, DOI 10.1074/jbc.271.37.22487
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Meier T, 2005, SCIENCE, V308, P659, DOI 10.1126/science.1111199
   Muller V, 2003, CELL MOL LIFE SCI, V60, P474, DOI 10.1007/s000180300040
   Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200
   PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A
   Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517
   PUOPOLO K, 1992, J BIOL CHEM, V267, P5171
   Radermacher M, 2001, J STRUCT BIOL, V135, P26, DOI 10.1006/jsbi.2001.4395
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   SCHISKE P, 1973, IMAGE PROCESSING COM, P82
   Seelert H, 2000, NATURE, V405, P418
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   STEINMETZ PR, 1986, AM J PHYSIOL, V251, pF173
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   VAANANEN HK, 1990, J CELL BIOL, V111, P1305, DOI 10.1083/jcb.111.3.1305
   VANHEEL M, 1981, ULTRAMICROSCOPY, V6, P187, DOI 10.1016/S0304-3991(81)80197-0
   Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033
   Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.0.CO;2-W
   Wilkens S, 2005, MICRON, V36, P109, DOI 10.1016/j.micron.2004.10.002
   Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804
   Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200
   Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200
   XIE XS, 1986, J BIOL CHEM, V261, P2492
   Xie XS, 1996, J BIOL CHEM, V271, P30980
   Xu T, 1999, J BIOL CHEM, V274, P28909, DOI 10.1074/jbc.274.41.28909
NR 47
TC 18
Z9 20
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2007
VL 158
IS 3
BP 445
EP 454
DI 10.1016/j.jsb.2007.01.002
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 174FQ
UT WOS:000246927800018
PM 17349803
DA 2021-01-25
ER

PT J
AU Javelle, A
   Lupo, D
   Li, XD
   Merrick, M
   Chami, M
   Ripoche, P
   Winkler, FK
AF Javelle, Arnaud
   Lupo, Domenico
   Li, Xiao-Dan
   Merrick, Mike
   Chami, Mohamed
   Ripoche, Pierre
   Winkler, Fritz K.
TI Structural and mechanistic aspects of Amt/Rh proteins
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE ammonia channels; ammonium transporters; rhesus proteins; AmtB;
   liposomes
ID ESCHERICHIA-COLI; AMMONIUM TRANSPORTERS; MOLECULAR CHARACTERIZATION;
   CRYSTAL-STRUCTURE; ION-TRANSPORT; RHESUS-B; NH4+; AMTB; NH3;
   GLYCOPROTEIN
AB Amt/Rh proteins, which mediate movement of ammonium across cell membranes, are spread throughout the three kingdoms of life. Most functional studies on various members of the family have been performed using cellular assays in heterologous expression systems, which are, however, not very well suited for detailed mechanistic studies. Although now generally considered to be ammonia conducting channels, based on a number of experimental studies and structural insights, the possibility remains that some plant Arms facilitate net ammonium ion transport. The Escherichia coli channel AmtB has become the model system of choice for analysis of the mechanism of ammonia conductance, increasingly also through molecular dynamics simulations. Further progress in a more detailed mechanistic understanding of these proteins requires a reliable in vitro assay using purified protein, allowing quantitative kinetic measurements under a variety of experimental conditions for different Amt/Rh proteins, including mutants. Here, we critically review the existing functional data in the context of the most interesting and unresolved mechanistic questions and we present our results, obtained using an in vitro assay set up with the purified E. coli channel AmtB. (c) 2007 Elsevier Inc. All rights reserved.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   INSERM, U665, INTS, F-75015 Paris, France.
RP Winkler, FK (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM fritz.winkler@psi.ch
OI li, xiaodan/0000-0001-8647-7317
CR AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH
   ALBALDAWI NF, 1992, BIOPHYS J, V61, P1470, DOI 10.1016/S0006-3495(92)81953-7
   Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102
   Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200
   Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y
   Boldt M, 2003, PFLUG ARCH EUR J PHY, V446, P652, DOI 10.1007/s00424-003-1122-z
   Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001
   Conroy MJ, 2005, BRIT J HAEMATOL, V131, P543, DOI 10.1111/j.1365-2141.2005.05786.x
   Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536
   Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002
   Hemker MB, 2003, BRIT J HAEMATOL, V122, P333, DOI 10.1046/j.1365-2141.2003.04425.x
   Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X
   Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102
   Javelle A, 2003, MOL MICROBIOL, V47, P411, DOI 10.1046/j.1365-2958.2003.03303.x
   Javelle A, 2001, FEBS LETT, V505, P393, DOI 10.1016/S0014-5793(01)02802-2
   Javelle A, 1999, FEMS MICROBIOL ECOL, V30, P355, DOI 10.1111/j.1574-6941.1999.tb00663.x
   Javelle A, 2005, BIOCHEM J, V390, P215, DOI 10.1042/BJ20042094
   Javelle A, 2004, J BIOL CHEM, V279, P8530, DOI 10.1074/jbc.M312399200
   Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200
   JAYAKUMAR A, 1986, J BACTERIOL, V166, P281, DOI 10.1128/jb.166.1.281-284.1986
   Kaback H R, 1974, Methods Enzymol, V31, P698
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   LANDE MB, 1995, J GEN PHYSIOL, V106, P67, DOI 10.1085/jgp.106.1.67
   Le Van Kim C, 2006, BLOOD REV, V20, P93, DOI 10.1016/j.blre.2005.04.002
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Liu YM, 2006, J PHYS CHEM A, V110, P1375, DOI 10.1021/jp054261c
   Ludewig U, 2006, TRANSFUS CLIN BIOL, V13, P111, DOI 10.1016/j.tracli.2006.02.012
   Ludewig U, 2004, J PHYSIOL-LONDON, V559, P751, DOI 10.1113/jphysiol.2004.067728
   Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200
   Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005
   Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8
   Marini AM, 2000, NAT GENET, V26, P341
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Marini AM, 2006, CURR GENET, V49, P364, DOI 10.1007/s00294-006-0062-5
   Mayer M, 2006, PLANT BIOLOGY, V8, P522, DOI 10.1055/s-2006-923877
   Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369
   Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051
   Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135
   Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003
   Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Rigaud JL, 2003, METHOD ENZYMOL, V372, P65
   Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101
   SEVERI E, IN PRESS MOL MEMB BI
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799
   Soupene E, 2001, MOL CELL BIOL, V21, P5733, DOI 10.1128/MCB.21.17.5733-5741.2001
   Swietach P, 2003, PROG BIOPHYS MOL BIO, V83, P69, DOI 10.1016/S0079-6107(03)00027-0
   VANBLITTERSWIJK WJ, 1987, BIOCHEMISTRY-US, V26, P1746, DOI 10.1021/bi00380a038
   von Wiren N, 2004, TOP CURR GENET, V9, P95
   Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200
   WESTHOFF CM, 2004, J BIOL CHEM, DOI UNSP M311853200
   Winkler F, 2006, PFLUG ARCH EUR J PHY, V451, P701, DOI 10.1007/s00424-005-1511-6
   Wood CC, 2006, FEBS LETT, V580, P3931, DOI 10.1016/j.febslet.2006.06.026
   YANG H, 2007, MOL DYNAMICS SIMULAT, V92, P877
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657
NR 60
TC 51
Z9 53
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2007
VL 158
IS 3
BP 472
EP 481
DI 10.1016/j.jsb.2007.01.004
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 174FQ
UT WOS:000246927800021
PM 17368911
DA 2021-01-25
ER

PT J
AU Boerries, M
   Most, P
   Gledhill, JR
   Walker, JE
   Katus, HA
   Koch, WJ
   Aebi, U
   Schoenenberger, CA
AF Boerries, Melanie
   Most, Patrick
   Gledhill, Jonathan R.
   Walker, John E.
   Katus, Hugo A.
   Koch, Walter J.
   Aebi, Ueli
   Schoenenberger, Cora-Ann
TI Ca2+-dependent interaction of S100A1 with F-1-ATPase leads to an
   increased ATP content in cardiomyocytes
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID MITOCHONDRIAL OXIDATIVE-PHOSPHORYLATION; CA2+-BINDING PROTEIN S100A1;
   ALPHA-ALPHA PROTEIN; ENERGY-METABOLISM; HEART-FAILURE; ACTIVATION;
   IDENTIFICATION; SUPPORT; TARGET; CA2+
AB S100A1, a Ca2+-sensing protein of the EF-hand family that is expressed predominantly in cardiac muscle, plays a pivotal role in cardiac contractility in vitro and in vivo. It has recently been demonstrated that by restoring Ca2+ homeostasis, S100A1 was able to rescue contractile dysfunction in failing rat hearts. Myocardial contractility is regulated not only by Ca2+ homeostasis but also by energy metabolism, in particular the production of ATP. Here, we report a novel interaction of S100A1 with mitochondrial F-1-ATPase, which affects F-1-ATPase activity and cellular ATP production. In particular, cardiomyocytes that overexpress S100A1 exhibited a higher ATP content than control cells, whereas knockdown of S100A1 expression decreased ATP levels. In pull-down experiments, we identified the alpha- and beta-chain of F-1-ATPase to interact with S100A1 in a Ca2+-dependent manner. The interaction was confirmed by colocalization studies of S100A1 and F-1-ATPase and the analysis of the S100A1-F-1-ATPase complex by gel filtration chromatography. The functional impact of this association is highlighted by an S100A1-mediated increase of F-1-ATPase activity. Consistently, ATP synthase activity is reduced in cardiomyocytes from S100A1 knockout mice. Our data indicate that S100A1 might play a key role in cardiac energy metabolism.
C1 Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Freiburg, Inst Pharmacol & Toxicol, D-79104 Freiburg, Germany.
   Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA.
   Heidelberg Univ, Div Cardiol, Dept Internal Med 3, D-69115 Heidelberg, Germany.
   MRC, Dunn Human Nutr Unit, Cambridge CB2 2XY, England.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM cora-ann.schoenenberger@unibas.ch
OI Walker, John/0000-0001-7929-2162
FU Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U105663150] Funding Source: Medline
CR Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082
   Bosetti F, 2000, MOL CELL BIOCHEM, V215, P31, DOI 10.1023/A:1026558922596
   Cadenas S, 2000, BIOCHEM J, V348, P209, DOI 10.1042/0264-6021:3480209
   Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296
   Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002
   Duchen MR, 2004, DIABETES, V53, pS96, DOI 10.2337/diabetes.53.2007.S96
   Florholmen G, 2004, J MOL CELL CARDIOL, V37, P1183, DOI 10.1016/j.yjmcc.2004.09.008
   HAIMOTO H, 1987, J NEUROCHEM, V48, P917, DOI 10.1111/j.1471-4159.1987.tb05604.x
   Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Ingwall JS, 2004, CIRC RES, V95, P135, DOI 10.1161/01.RES.0000137170.41939.d9
   KATO K, 1985, BIOCHIM BIOPHYS ACTA, V842, P146, DOI 10.1016/0304-4165(85)90196-5
   LEHNINGER AL, 1967, FED PROC, V26, P1333
   Maco B, 2001, PHYSIOL RES, V50, P567
   Most P, 2005, J CELL SCI, V118, P421, DOI 10.1242/jcs.01614
   Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454
   Most P, 2003, J BIOL CHEM, V278, P48404, DOI 10.1074/jbc.M308587200
   Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200
   Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598
   Most P, 2007, FUTUR CARDIOL, V3, P5, DOI 10.2217/14796678.3.1.5
   Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415
   Orriss GL, 1998, STRUCT FOLD DES, V6, P831, DOI 10.1016/S0969-2126(98)00085-9
   REMPPIS A, 2002, BASIC RES CARDIOL, V97, P156
   Sambrano GR, 2002, NATURE, V420, P712, DOI 10.1038/nature01306
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   SIMONIAN A, 1989, NEUROCHEM RES, V14, P761, DOI 10.1007/BF00964955
   Territo PR, 2000, AM J PHYSIOL-CELL PH, V278, pC423
   Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200
   Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095
   ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2
   ZIMMER DB, 1993, CELL CALCIUM, V14, P323, DOI 10.1016/0143-4160(93)90053-9
   ZIMMER DB, 1986, J BIOL CHEM, V261, P1424
NR 32
TC 68
Z9 69
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUN
PY 2007
VL 27
IS 12
BP 4365
EP 4373
DI 10.1128/MCB.02045-06
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 177JS
UT WOS:000247150000016
PM 17438143
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Collin, S
   Guilvout, I
   Chami, M
   Pugsley, AP
AF Collin, Severine
   Guilvout, Ingrid
   Chami, Mohamed
   Pugsley, Anthony P.
TI YaeT-independent multimerization and outer membrane association of
   secretin PulD
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID CONSERVED BACTERIAL PROTEIN; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI;
   PSEUDOMONAS-AERUGINOSA; NEISSERIA-MENINGITIDIS; CYTOPLASMIC MEMBRANE;
   OMP85; COMPLEX; DOMAIN; IDENTIFICATION
AB Previous studies demonstrated that targeting of the dodecameric secretin PulD to the Escherichia coli outer membrane is strictly dependent on the chaperone-like pilotin PulS. Here, we report that PulD multimerization and membrane association in strains producing PulS were unaffected when the levels of the essential outer membrane assembly factor YaeT(Omp85) were reduced by controlled expression of a paraBAD-yaeT transcriptional fusion. This behaviour contrasted markedly to that of the trimeric porin LamB, which remained monomeric under these conditions. Furthermore, resistance to extraction by the detergent Sarkosyl and by urea, and susceptibility to trypsin digestion all suggested that PulD localized to the outer membrane in YaeT-depleted cells. We conclude that, unlike classical beta-barrel outer membrane proteins such as LamB, multimerization of PulD is largely YaeT-independent.
C1 Inst Pasteur, URA2172, Mol Genet Unit, F-75724 Paris 15, France.
   Inst Pasteur, URA2172, CNRS, F-75724 Paris 15, France.
   Univ Basel, Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, URA2172, Mol Genet Unit, 25 Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr
CR Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x
   BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980
   Bitter W, 2003, ARCH MICROBIOL, V179, P307, DOI 10.1007/s00203-003-0541-8
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   DENFERT C, 1989, J BIOL CHEM, V264, P17462
   DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x
   Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200
   Dong CJ, 2006, NATURE, V444, P226, DOI 10.1038/nature05267
   FILIP C, 1973, J BACTERIOL, V115, P717, DOI 10.1128/JB.115.3.717-722.1973
   Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   KORNACKER MG, 1989, MOL MICROBIOL, V4, P73
   Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Meng GY, 2006, EMBO J, V25, P2297, DOI 10.1038/sj.emboj.7601132
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200
   SCHIEPEK G, 1995, PSYCHOTHERAPIE FORUM, V3, P1
   SCHNAITMAN CA, 1971, J BACTERIOL, V108, P545, DOI 10.1128/JB.108.1.545-552.1971
   STRUYVE M, 1991, J MOL BIOL, V218, P141, DOI 10.1016/0022-2836(91)90880-F
   Ureta AR, 2007, J BACTERIOL, V189, P446, DOI 10.1128/JB.01103-06
   Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   WEISS MS, 1990, FEBS LETT, V267, P268, DOI 10.1016/0014-5793(90)80942-C
   Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
   Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103
NR 33
TC 42
Z9 42
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2007
VL 64
IS 5
BP 1350
EP 1357
DI 10.1111/j.1365-2958.2007.05743.x
PG 8
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 177TO
UT WOS:000247175600015
PM 17542925
DA 2021-01-25
ER

PT J
AU De Ferrari, GV
   Papassotiropoulos, A
   Biechele, T
   De-Vrieze, FW
   Avila, ME
   Major, MB
   Myers, A
   Saez, K
   Henriquez, JP
   Zhao, A
   Wollmer, MA
   Nitsch, RM
   Hock, C
   Morris, CM
   Hardy, J
   Moon, RT
AF De Ferrari, Giancarlo V.
   Papassotiropoulos, Andreas
   Biechele, Travis
   De-Vrieze, Fabienne Wavrant
   Avila, Miguel E.
   Major, Michael B.
   Myers, Amanda
   Saez, Katia
   Henriquez, Juan P.
   Zhao, Alice
   Wollmer, M. Axel
   Nitsch, Roger M.
   Hock, Christoph
   Morris, Chris M.
   Hardy, John
   Moon, Randall T.
TI Common genetic variation within the Low-Density Lipoprotein
   Receptor-Related Protein 6 and late-onset Alzheimer's disease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE neurodegenerative; LRP-6; single-nucleotide polymorphism; APOE; Wnt
ID GLYCOGEN-SYNTHASE KINASE-3-BETA; RECEPTOR-RELATED PROTEIN-5; AMYLOID
   PRECURSOR PROTEIN; WNT SIGNALING PATHWAY; FAMILY-BASED TESTS;
   ALPHA-T-CATENIN; APOLIPOPROTEIN-E; CHROMOSOME 12; HIPPOCAMPAL-NEURONS;
   SEQUENCE VARIANTS
AB Genome-wide linkage studies have defined a broad susceptibility region for late-onset Alzheimer's disease on chromosome 12, which contains the Low-Density Lipoprotein Receptor-Related Protein 6 (LRP6) gene, a coreceptor for Wnt signaling. Here, we report the association between common LRP6 variants and late-onset Alzheimer's disease in a multicenter case-control series as well as in a large family-based series ascertained by the National Institute of Mental Health-National Institute on Aging Genetics Initiative. As shown in the genome-wide linkage studies, our association depends mainly on apolipoprotein E-epsilon 4 (APOE-epsilon 4) carrier status. Haplotype tagging single-nucleotide polymorphisms (SNPs) with a set of seven allelic variants of LRP6 identified a putative risk haplotype, which includes a highly conserved coding sequence SNP: Ile-1062 -> Val. Functional analyses revealed that the associated allele Val-1062, an allele previously linked to low bone mass, has decreased beta-catenin signaling in HEK293T cells. Our study unveils a genetic relationship between LRP6 and APOE and supports the hypothesis that altered Wnt/beta-catenin signaling may be involved in this neuroclegenerative disease.
C1 Univ Washington, Howard Hughes Med Inst, Sch Med, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Sch Med, Seattle, WA 98195 USA.
   Univ Washington, Inst Stem Cell & Regenerat Med, Sch Med, Seattle, WA 98195 USA.
   Univ Concepcion, Dept Bioquim & Biol Mol, Concepcion 4089100, Chile.
   Univ Concepcion, Dept Estadist, Concepcion 4089100, Chile.
   Univ Concepcion, Dept Biol Celular, Concepcion 4089100, Chile.
   Univ Basel, Biozentrum, Div Mol Psychol, CH-4055 Basel, Switzerland.
   Univ Basel, Biozentrum, Life Sci Training Facil, CH-4055 Basel, Switzerland.
   Univ Zurich, Dept Psychiat Res, CH-8029 Zurich, Switzerland.
   NIA, Lab Neurogenet, NIH, Bethesda, MD 20892 USA.
   Newcastle Gen Hosp, Inst Aging & Hlth, Newcastle Upon Tyne N64 6BE, Tyne & Wear, England.
RP De Ferrari, GV (corresponding author), Univ Washington, Howard Hughes Med Inst, Sch Med, Seattle, WA 98195 USA.
EM gdeferrari@udec.cl; rtmoon@u.washington.edu
RI Moon, Randall/M-5605-2019; Wollmer, Marc A/B-5038-2009; Myers, Amanda
   J/B-1796-2010; Moon, Randall/B-1743-2014; Hardy, John/C-2451-2009
OI Myers, Amanda J/0000-0002-3100-9396; Moon, Randall/0000-0002-9352-1408;
   Hardy, John/0000-0002-3122-0423; Papassotiropoulos,
   Andreas/0000-0002-2210-9651; De Ferrari, Giancarlo/0000-0003-0932-125X;
   Morris, Christopher/0000-0002-3749-0993; Major,
   Michael/0000-0002-6753-8513
FU Medical Research CouncilMedical Research Council UK (MRC) [G0701075]
   Funding Source: Medline; NIA NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) [U24 AG021886] Funding Source: Medline; NIMH
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [U01 MH 46281, U01 MH046281, U01 MH046290, U01 MH 46372, U01 MH
   46290] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [U01MH046290, U01MH046290, U01MH046281, U01MH046281, U01MH046290,
   U01MH046281, U01MH046281, U01MH046290, U01MH046281, U01MH046290,
   U01MH046281, U01MH046290, U01MH046281, U01MH046290, U01MH046290,
   U01MH046281, U01MH046290, U01MH046290, U01MH046281, U01MH046281] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Aging (NIA) [U24AG021886, U24AG021886,
   U24AG021886, U24AG021886, U24AG021886, U24AG021886, U24AG021886,
   U24AG021886, U24AG021886, U24AG021886, U24AG021886, U24AG021886,
   U24AG021886, U24AG021886, U24AG021886, U24AG021886, U24AG021886,
   U24AG021886, U24AG021886, U24AG021886, U24AG021886, U24AG021886,
   U24AG021886, U24AG021886, U24AG021886, U24AG021886, U24AG021886,
   U24AG021886] Funding Source: NIH RePORTER
CR Abu-Khalil A, 2004, J COMP NEUROL, V474, P276, DOI 10.1002/cne.20112
   Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028
   Alvarez G, 2002, BIPOLAR DISORD, V4, P153, DOI 10.1034/j.1399-5618.2002.01150.x
   Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Blacker D, 2003, HUM MOL GENET, V12, P23, DOI 10.1093/hmg/ddg007
   Blomqvist MEL, 2004, NEUROSCI LETT, V358, P220, DOI 10.1016/j.neulet.2004.01.032
   Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061
   Busby V, 2004, NEUROMOL MED, V5, P133, DOI 10.1385/NMM:5:2:133
   Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004
   Caricasole A, 2003, TRENDS PHARMACOL SCI, V24, P233, DOI 10.1016/S0165-6147(03)00100-7
   Caruso A, 2006, J NEUROCHEM, V98, P364, DOI 10.1111/j.1471-4159.2006.03867.x
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   Daw EW, 2000, AM J HUM GENET, V66, P196, DOI 10.1086/302710
   De Ferrari GV, 2006, ONCOGENE, V25, P7545, DOI 10.1038/sj.onc.1210064
   De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208
   De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7
   Ertekin-Taner N, 2003, HUM MOL GENET, V12, P3133, DOI 10.1093/hmg/ddg343
   Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258
   Haines JL, 2006, INVEST OPHTH VIS SCI, V47, P329, DOI 10.1167/iovs.05-0116
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117
   Herz J, 2001, NEURON, V29, P571, DOI 10.1016/S0896-6273(01)00234-3
   Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295
   Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556
   Kang DE, 2002, CELL, V110, P751, DOI 10.1016/S0092-8674(02)00970-4
   Kang DE, 2000, J CLIN INVEST, V106, P1159, DOI 10.1172/JCI11013
   Katsu T, 2003, NEUROSCI LETT, V353, P53, DOI 10.1016/j.neulet.2003.09.017
   Kehoe P, 1999, HUM MOL GENET, V8, P237, DOI 10.1093/hmg/8.2.237
   Kim DH, 1998, J BIOCHEM-TOKYO, V124, P1072, DOI 10.1093/oxfordjournals.jbchem.a022223
   Kozlovsky N, 2002, EUR NEUROPSYCHOPHARM, V12, P13, DOI 10.1016/S0924-977X(01)00131-6
   Lake SL, 2000, AM J HUM GENET, V67, P1515, DOI 10.1086/316895
   Lako M, 1998, HUM MOL GENET, V7, P813, DOI 10.1093/hmg/7.5.813
   Li YH, 2001, MOL NEUROBIOL, V23, P53
   Magoori K, 2003, J BIOL CHEM, V278, P11331, DOI 10.1074/jbc.M211987200
   Malek G, 2005, P NATL ACAD SCI USA, V102, P11900, DOI 10.1073/pnas.0503015102
   Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370
   Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100
   Mayeux R, 2002, AM J HUM GENET, V70, P237, DOI 10.1086/324773
   Miyaoka T, 1999, SCHIZOPHR RES, V38, P1, DOI 10.1016/S0920-9964(98)00179-0
   Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427
   Mudher A, 2002, TRENDS NEUROSCI, V25, P22, DOI 10.1016/S0166-2236(00)02031-2
   Mudher A, 2001, J NEUROSCI, V21, P4987, DOI 10.1523/JNEUROSCI.21-14-04987.2001
   Myers A, 2002, AM J MED GENET, V114, P235, DOI 10.1002/ajmg.10183
   Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241
   Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260
   Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504
   Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720
   Pei JJ, 1999, J NEUROPATH EXP NEUR, V58, P1010, DOI 10.1097/00005072-199909000-00011
   PericakVance MA, 1997, JAMA-J AM MED ASSOC, V278, P1237, DOI 10.1001/jama.278.15.1237
   Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640
   Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124
   Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918
   Robitaille J, 2002, NAT GENET, V32, P326, DOI 10.1038/ng957
   Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614
   Russ C, 2002, MOL PSYCHIATR, V7, P104, DOI 10.1038/sj/mp/4000941
   Russ C, 2001, MOL PSYCHIATR, V6, P320, DOI 10.1038/sj.mp.4000852
   Saunders AJ, 2003, HUM MOL GENET, V12, P2765, DOI 10.1093/hmg/ddg310
   Scott WK, 2000, AM J HUM GENET, V66, P922, DOI 10.1086/302828
   Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje
   STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977
   Sun X, 2002, NEUROSCI LETT, V321, P61, DOI 10.1016/S0304-3940(01)02583-6
   Takashima A, 1998, NEUROSCI RES, V31, P317, DOI 10.1016/S0168-0102(98)00061-3
   Takashima A, 1998, P NATL ACAD SCI USA, V95, P9637, DOI 10.1073/pnas.95.16.9637
   Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117
   van Meurs JBJ, 2006, J BONE MINER RES, V21, P141, DOI 10.1359/JBMR.050904
   Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110
   Wu WS, 1998, JAMA-J AM MED ASSOC, V280, P619, DOI 10.1001/jama.280.7.619
   Zhang ZH, 1998, NATURE, V395, P698, DOI 10.1038/27208
   Zhou JH, 1997, NEUROREPORT, V8, P2085, DOI 10.1097/00001756-199705260-00054
NR 69
TC 200
Z9 201
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 29
PY 2007
VL 104
IS 22
BP 9434
EP 9439
DI 10.1073/pnas.0603523104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 174IN
UT WOS:000246935700063
PM 17517621
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Meier, M
   Seelig, J
AF Meier, Matthias
   Seelig, Joachim
TI Thermodynamics of the coil reversible arrow beta-sheet transition in a
   membrane environment
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE random coil-beta-sheet transition; peptide-membrane interaction;
   peptide-aggregation; (KIGAKI)(3) peptide
ID NUCLEAR-MAGNETIC-RESONANCE; AMINO-ACID REPLACEMENT; SHORT LINEAR
   PEPTIDE; LIPID-MEMBRANES; AMYLOID PEPTIDE(1-40); AMPHIPATHIC PEPTIDES;
   HAIRPIN STRUCTURE; HELIX FORMATION; MODEL SYSTEMS; HEAD GROUP
AB Biologically important peptides such as the Alzheimer peptide A beta(1-40) display a reversible random coil reversible arrow beta-structure transition at anionic membrane surfaces. In contrast to the well-studied random coil reversible arrow alpha-helix transition of amphipathic peptides, there is a dearth on information on the thermodynamic and kinetic parameters of the random coil reversible arrow beta-structure transition. Here, we present a new method to quantitatively analyze the thermodynamic parameters of the membrane-induced beta-structure formation. We have used the model peptide (KIGAKI)(3) and eight analogues in which two adjacent amino acids were substituted by their D-enantiomers. The positions of the d,d pairs were shifted systematically along the three identical segments of the peptide chain. The beta-structure content of the peptides was measured in solution and when bound to anionic lipid membranes with circular dichroism spectroscopy. The thermodynamic binding parameters were determined with isothermal titration calorimetry and the binding isotherms were analysed by combining a surface partition equilibrium with the Gouy-Chapman theory. The thermodynamic parameters were found to be linearly correlated with the extent of beta-structure formation. beta-Structure formation at the membrane surface is characterized by an enthalpy change of Delta H(beta)=-0.23 kcal/mol per residue, an entropy change of Delta S beta=-0.24, cal/mol K residue and a free energy change of Delta G beta= -0.15 kcal/mol residue. An increase in temperature induces an unfolding of beta-structure. The residual free energy of membrane-induced beta-structure formation is close to that of membrane-induced alpha-helix formation. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
RI Meier, Matthias/C-6917-2013
CR AUER HE, 1978, BIOCHEMISTRY-US, V17, P2798, DOI 10.1021/bi00607a015
   Aveyard Robert, 1973, INTRO PRINCIPLES SUR
   Bishop CR, 2001, J MOL BIOL, V309, P975, DOI 10.1006/jmbi.2001.4715
   BLANCO FJ, 1994, NAT STRUCT BIOL, V1, P584, DOI 10.1038/nsb0994-584
   Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200
   Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070
   Ciani B, 2003, J AM CHEM SOC, V125, P9038, DOI 10.1021/ja030074l
   CONSTANTINE KL, 1995, J AM CHEM SOC, V117, P10841, DOI 10.1021/ja00149a007
   Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611
   GALLY HU, 1975, BIOCHEMISTRY-US, V14, P3647, DOI 10.1021/bi00687a021
   Gellman SH, 1998, CURR OPIN CHEM BIOL, V2, P717, DOI 10.1016/S1367-5931(98)80109-9
   Honda S, 2000, J MOL BIOL, V295, P269, DOI 10.1006/jmbi.1999.3346
   Hutchinson EG, 1998, PROTEIN SCI, V7, P2287, DOI 10.1002/pro.5560071106
   Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e
   KIM CWA, 1993, NATURE, V362, P267, DOI 10.1038/362267a0
   KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014
   Kuznetsov SV, 2003, BIOCHEMISTRY-US, V42, P4321, DOI 10.1021/bi026893k
   Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346
   Li YL, 2003, BIOCHEMISTRY-US, V42, P7245, DOI 10.1021/bi0341760
   Lu JX, 2005, BIOCHEMISTRY-US, V44, P10208, DOI 10.1021/bi050730p
   MATSUZAKI K, 1995, PEPTIDE CH, P129
   Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626
   Munoz V, 2006, BIOCHEMISTRY-US, V45, P7023, DOI 10.1021/bi052556a
   NAKAISHI A, 1988, J PHYS CHEM-US, V92, P6161, DOI 10.1021/j100332a062
   PEDERSON D, 1971, BIOPOLYMERS, V10, P2133, DOI 10.1002/bip.360101109
   RamirezAlvarado M, 1996, NAT STRUCT BIOL, V3, P604, DOI 10.1038/nsb0796-604
   ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005
   SCHERER PG, 1987, EMBO J, V6, P2915, DOI 10.1002/j.1460-2075.1987.tb02595.x
   SEARLE MS, 1995, NAT STRUCT BIOL, V2, P999, DOI 10.1038/nsb1195-999
   Searle MS, 1996, PROTEIN ENG, V9, P559, DOI 10.1093/protein/9.7.559
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020
   Streicher WW, 2006, J AM CHEM SOC, V128, P30, DOI 10.1021/ja056392x
   Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e
   TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525
   TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051
   Wang M, 2006, P NATL ACAD SCI USA, V103, P2600, DOI 10.1073/pnas.0508121103
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wieprecht T, 2002, BIOPHYS CHEM, V96, P191, DOI 10.1016/S0301-4622(02)00025-X
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   Wieprecht T, 1996, BIOCHEMISTRY-US, V35, P10844, DOI 10.1021/bi960362c
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v
   Wimley WC, 2004, J MOL BIOL, V342, P703, DOI 10.1016/j.jmb.2004.06.093
   Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640
NR 49
TC 31
Z9 31
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 25
PY 2007
VL 369
IS 1
BP 277
EP 289
DI 10.1016/j.jmb.2007.02.082
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 170KA
UT WOS:000246661100022
PM 17412361
DA 2021-01-25
ER

PT J
AU Wanaverbecq, N
   Semyanov, A
   Pavlov, I
   Walker, MC
   Kullmann, DM
AF Wanaverbecq, Nicolas
   Semyanov, Alexey
   Pavlov, Ivan
   Walker, Matthew C.
   Kullmann, Dimitri M.
TI Cholinergic axons modulate GABAergic signaling among hippocampal
   interneurons via postsynaptic alpha 7 nicotinic receptors
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE nicotinic; GABA(A) receptor; interneurons; cholinergic; hippocampus;
   inhibition
ID PROTEIN-KINASE-C; LONG-TERM POTENTIATION; ACETYLCHOLINE-RECEPTORS;
   SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; ALZHEIMERS-DISEASE; CA1 NEURONS;
   FUNCTIONAL MODULATION; INHIBITORY SYNAPSES; GABA(A) RECEPTORS
AB Homopentameric alpha 7 nicotinic receptors have a high affinity for acetylcholine ( ACh), are permeable to Ca2+ ions, and are abundant in hippocampal interneurons. Although nicotinic agonists evoke inward currents and Ca2+ transients in stratum radiatum interneurons, the role of endogenous ACh in modulating synaptic integration by interneurons is incompletely understood. Many cholinergic axonal varicosities do not have postsynaptic specializations, but alpha 7 receptors frequently occur close to synaptic GABA(A) receptors. These observations raise the possibility that alpha 7 nicotinic receptors activated by ACh released from cholinergic axons modulate GABAergic transmission in interneurons. We show that agonists of alpha 7 receptors profoundly depress GABAergic IPSCs recorded in stratum radiatum interneurons in the CA1 region of the hippocampus. This depression is accompanied by a small increase in GABA release. alpha 7 nicotinic receptor agonists also depress GABA- or muscimol-evoked currents in interneurons, indicating that the major effect is a postsynaptic modulation of GABA(A) receptors. The depression of GABA- evoked currents is abolished by chelating Ca2+ in the recorded interneuron and attenuated by inhibitors of PKC. We also show that stimuli designed to release endogenous ACh from cholinergic axons evoke an alpha 7 receptor-dependent heterosynaptic depression of GABAergic IPSCs in interneurons. This heterosynaptic modulation is amplified by blocking cholinesterases. These results reveal a novel mechanism by which cholinergic neurons modulate information processing in the hippocampus.
C1 UCL, Inst Neurol, London WC1N 3BG, England.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.
EM d.kullmann@ion.ucl.ac.uk
RI Walker, Matthew C/C-1577-2008; Pavlov, Ivan/B-5939-2008; Kullmann,
   Dimitri M/A-3162-2009; Semyanov, Alexey/A-7654-2010
OI Walker, Matthew C/0000-0002-0812-0352; Pavlov, Ivan/0000-0002-9559-4600;
   Kullmann, Dimitri M/0000-0001-6696-3545; Semyanov,
   Alexey/0000-0002-6800-0942; Pavlov, Ivan/0000-0003-1266-6988;
   Wanaverbecq, Nicolas/0000-0001-5486-2771
FU Medical Research CouncilMedical Research Council UK (MRC) [G0400136,
   G116/147, G0501424(76812), G0501424] Funding Source: Medline
CR Akopian A, 1998, J NEUROPHYSIOL, V80, P1105
   Alkondon M, 2000, EUR J PHARMACOL, V393, P59, DOI 10.1016/S0014-2999(00)00006-6
   Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x
   Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396
   Alkondon M, 1998, BRAIN RES, V810, P257, DOI 10.1016/S0006-8993(98)00880-4
   BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971
   Brandon NJ, 2002, J NEUROSCI, V22, P6353
   Brandon NJ, 2000, J BIOL CHEM, V275, P38856, DOI 10.1074/jbc.M004910200
   BROWNING MD, 1990, P NATL ACAD SCI USA, V87, P1315, DOI 10.1073/pnas.87.4.1315
   Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x
   Buhler AV, 2002, J NEUROPHYSIOL, V87, P548, DOI 10.1152/jn.00316.2001
   Chapell R, 1998, J BIOL CHEM, V273, P32595, DOI 10.1074/jbc.273.49.32595
   COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0
   Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5
   COUTURIER S, 1990, NEURON, V5, P847, DOI 10.1016/0896-6273(90)90344-F
   Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223
   DAVIES P, 1976, LANCET, V2, P1403
   DESAULLES E, 1991, EUR J PHARMACOL, V203, P137, DOI 10.1016/0014-2999(91)90803-X
   Descarries L, 2004, PROG BRAIN RES, V145, P45, DOI 10.1016/S0079-6123(03)45002-4
   Fabian-Fine R, 2001, J NEUROSCI, V21, P7993
   Feng J, 2001, J NEUROSCI, V21, P6502
   Fisher JL, 2000, NEUROPHARMACOLOGY, V39, P2756, DOI 10.1016/S0028-3908(00)00102-7
   Frazier CJ, 1998, J NEUROSCI, V18, P8228
   Frazier CJ, 1998, J NEUROSCI, V18, P1187
   FREEDMAN R, 1993, J NEUROSCI, V13, P1965
   Freedman R, 1997, P NATL ACAD SCI USA, V94, P587, DOI 10.1073/pnas.94.2.587
   FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X
   Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917
   FROTSCHER M, 1986, CELL TISSUE RES, V246, P293, DOI 10.1007/BF00215891
   Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006
   Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0
   Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x
   Henneberger C, 2002, J NEUROPHYSIOL, V88, P595, DOI 10.1152/jn.2002.88.2.595
   Herber DL, 2004, J HISTOCHEM CYTOCHEM, V52, P1367, DOI 10.1369/jhc.4A6319.2004
   Hogan DB, 2004, LANCET NEUROL, V3, P622, DOI 10.1016/S1474-4422(04)00883-X
   Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1
   HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145
   Ji DY, 2000, J NEUROPHYSIOL, V83, P2682
   Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x
   Jovanovic JN, 2004, J NEUROSCI, V24, P522, DOI 10.1523/JNEUROSCI.3606-03.2004
   Kawai H, 2002, J NEUROSCI, V22, P7903
   Khiroug L, 2003, J NEUROSCI, V23, P9024
   Kittler JT, 2003, CURR OPIN NEUROBIOL, V13, P341, DOI 10.1016/S0959-4388(03)00064-3
   Kullmann PHM, 2004, J NEUROPHYSIOL, V91, P542, DOI 10.1152/jn.00559.2003
   LEE MG, 1994, NEUROSCIENCE, V62, P1033, DOI 10.1016/0306-4522(94)90341-7
   Lu YM, 2000, NEURON, V26, P197, DOI 10.1016/S0896-6273(00)81150-2
   Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003
   MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443
   Maggi L, 2004, J PHYSIOL-LONDON, V559, P863, DOI 10.1113/jphysiol.2004.067041
   Maggi L, 2003, P NATL ACAD SCI USA, V100, P2059, DOI 10.1073/pnas.0437947100
   MANABE T, 1993, J NEUROPHYSIOL, V70, P1451
   MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895
   McQuiston AR, 1999, J NEUROSCI, V19, P2887
   Mesulam M, 2004, LEARN MEMORY, V11, P43, DOI 10.1101/lm.69204
   Mesulam MM, 2004, PROG BRAIN RES, V145, P67, DOI 10.1016/S0079-6123(03)45004-8
   Mogg AJ, 2002, J PHARMACOL EXP THER, V302, P197, DOI 10.1124/jpet.302.1.197
   MULLE C, 1992, NEURON, V8, P135, DOI 10.1016/0896-6273(92)90115-T
   Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001
   Papke RL, 2000, EUR J PHARMACOL, V393, P179, DOI 10.1016/S0014-2999(00)00009-1
   Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833
   Ripoll N, 2004, CURR MED RES OPIN, V20, P1057, DOI 10.1185/030079904125004060
   Rossi DJ, 2003, J PHYSIOL-LONDON, V548, P97, DOI 10.1113/jphysiol.2002.036459
   SEGUELA P, 1993, J NEUROSCI, V13, P596
   Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5
   Semyanov A, 2003, CNS NEUROL DISORD-DR, V2, P240, DOI 10.2174/1568007033482832
   Semyanov A, 2001, NAT NEUROSCI, V4, P718, DOI 10.1038/89506
   SIGEL E, 1988, P NATL ACAD SCI USA, V85, P6192, DOI 10.1073/pnas.85.16.6192
   SMITH MK, 1990, J BIOL CHEM, V265, P1837
   STELZER A, 1994, NEUROSCIENCE, V62, P813, DOI 10.1016/0306-4522(94)90479-0
   Tanaka T, 1997, J NEUROSCI, V17, P2959
   Umbriaco D, 1995, HIPPOCAMPUS, V5, P605, DOI 10.1002/hipo.450050611
   Vizi ES, 2004, EUR J PHARMACOL, V500, P499, DOI 10.1016/j.ejphar.2004.07.018
   Wang J, 2003, J NEUROSCI, V23, P826
   Wang JH, 1996, J NEUROPHYSIOL, V75, P1687
   WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0
   Zago WM, 2006, MOL CELL NEUROSCI, V31, P549, DOI 10.1016/j.mcn.2005.11.009
   Zhang JM, 2007, J PHYSIOL-LONDON, V579, P753, DOI 10.1113/jphysiol.2006.124578
NR 77
TC 56
Z9 57
U1 0
U2 8
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD MAY 23
PY 2007
VL 27
IS 21
BP 5683
EP 5693
DI 10.1523/JNEUROSCI.1732-07.2007
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 171FM
UT WOS:000246720700016
PM 17522313
OA Green Accepted, Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Reig, N
   del Rio, C
   Casagrande, F
   Ratera, M
   Gelpi, JL
   Torrents, D
   Henderson, PJF
   Xie, H
   Baldwin, SA
   Zorzano, A
   Fotiadis, D
   Palacin, M
AF Reig, Nuria
   del Rio, Cesar
   Casagrande, Fabio
   Ratera, Merce
   Gelpi, Josep Lluis
   Torrents, David
   Henderson, Peter J. F.
   Xie, Hao
   Baldwin, Stephen A.
   Zorzano, Antonio
   Fotiadis, Dimitrios
   Palacin, Manuel
TI Functional and structural characterization of the first prokaryotic
   member of the L-amino acid transporter (LAT) family - A model for APC
   transporters
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LYSINURIC PROTEIN INTOLERANCE; MULTIPLE SEQUENCE ALIGNMENT;
   ESCHERICHIA-COLI; LIGHT SUBUNIT; THIOL MODIFICATION; LACTOSE PERMEASE;
   GENOME SEQUENCE; SYSTEM X(C)(-); IDENTIFICATION; CYSTINE
AB We have identified YkbA from Bacillus subtilis as a novel member of the L-amino acid transporter (LAT) family of amino acid transporters. The protein is similar to 30% identical in amino acid sequence to the light subunits of human heteromeric amino acid transporters. Purified His-tagged YkbA from Escherichia coli membranes reconstituted in proteoliposomes exhibited sodium-independent, obligatory exchange activity for L-serine and L-threonine and also for aromatic amino acids, albeit with less activity. Thus, we propose that YkbA be renamed SteT(Ser/Thr exchanger transporter). Kinetic analysis supports a sequential mechanism of exchange for SteT. Freeze-fracture analysis of purified, functionally active SteT in proteoliposomes, together with blue native polyacrylamide gel electrophoresis and transmission electron microscopy of detergent-solubilized purified SteT, suggest that the transporter exists in a monomeric form. Freeze-fracture analysis showed spherical particles with a diameter of 7.4 nm. Transmission electron microscopy revealed elliptical particles (diameters 6 x 7 nm) with a distinct central depression. To our knowledge, this is the first functional characterization of a prokaryotic member of the LAT family and the first structural data on an APC (amino acids, polyamines, and choline for organocations) transporter. SteT represents an excellent model to study the molecular architecture of the light subunits of heteromeric amino acid transporters and other APC transporters.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Univ Barcelona, Fac Biol, Inst Res Biomed, E-08028 Barcelona, Spain.
   Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, E-08028 Barcelona, Spain.
   Inst Res Biomed, E-08028 Barcelona, Spain.
   Inst Catalana Recerca & Estudis Avancats, Barcelona Supercomp Ctr, Life Sci Program, E-08034 Barcelona, Spain.
   Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England.
   CIBERER, E-08028 Barcelona, Spain.
RP Fotiadis, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
EM dimitrios.fotiadis@unibas.ch; mpalacin@pcb.ub.es
RI Henderson, Peter JF/Q-1907-2018; Gelpi, Josep Ll./M-6401-2013; Zorzano,
   Antonio/R-5479-2018; Torrents, David/G-5785-2015
OI Gelpi, Josep Ll./0000-0002-0566-7723; Torrents,
   David/0000-0002-6086-9037
FU ICREAICREA Funding Source: Custom
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Baker DA, 2003, NAT NEUROSCI, V6, P743, DOI 10.1038/nn1069
   Bassi MT, 2001, PFLUG ARCH EUR J PHY, V442, P286, DOI 10.1007/s004240100537
   Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815
   CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420
   Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chang AB, 2004, MOL MEMBR BIOL, V21, P171, DOI 10.1080/09687680410001720830
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Chillaron J, 2001, AM J PHYSIOL-RENAL, V281, pF995
   Chillaron J, 1996, J BIOL CHEM, V271, P17761, DOI 10.1074/jbc.271.30.17761
   COSTELLO MJ, 1987, J BIOL CHEM, V262, P17072
   DEKKER JP, 1988, BIOCHIM BIOPHYS ACTA, V936, P307, DOI 10.1016/0005-2728(88)90006-0
   DIERKS T, 1988, BIOCHIM BIOPHYS ACTA, V943, P231, DOI 10.1016/0005-2736(88)90555-X
   Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705
   ELENO N, 1994, J PHYSIOL-LONDON, V479, P291, DOI 10.1113/jphysiol.1994.sp020296
   Feliubadalo L, 1999, NAT GENET, V23, P52
   Fernandez E, 2002, AM J PHYSIOL-RENAL, V283, pF540, DOI 10.1152/ajprenal.00071.2002
   Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200
   Habermeier A, 2003, J BIOL CHEM, V278, P19492, DOI 10.1074/jbc.M210254200
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   Hu LYA, 1999, BIOCHEM J, V339, P649, DOI 10.1042/0264-6021:3390649
   Ivanova N, 2003, NATURE, V423, P87, DOI 10.1038/nature01582
   Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797
   Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200
   Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878
   Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200
   KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   Lopez O, 1998, FEBS LETT, V426, P314, DOI 10.1016/S0014-5793(98)00363-9
   Meier C, 2002, EMBO J, V21, P580, DOI 10.1093/emboj/21.4.580
   Palacin M, 2005, PHYSIOLOGY, V20, P112, DOI 10.1152/physiol.00051.2004
   Palacin M, 2004, PFLUG ARCH EUR J PHY, V447, P490, DOI 10.1007/s00424-003-1062-7
   Reig N, 2002, EMBO J, V21, P4906, DOI 10.1093/emboj/cdf500
   Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405
   Sato H, 2005, J BIOL CHEM, V280, P37423, DOI 10.1074/jbc.M506439200
   Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455
   SCHAGGER H, 1988, ANAL BIOCHEM, V173, P201, DOI 10.1016/0003-2697(88)90179-0
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Torras-Llort M, 2001, J MEMBRANE BIOL, V180, P213, DOI 10.1007/s002320010072
   Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437
   Torrents D, 1999, NAT GENET, V21, P293
   Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200
   Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z
   Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
NR 46
TC 33
Z9 34
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 4
PY 2007
VL 282
IS 18
BP 13270
EP 13281
DI 10.1074/jbc.M610695200
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 162BC
UT WOS:000246060300015
PM 17344220
OA Bronze
DA 2021-01-25
ER

PT J
AU Meier, S
   Jensen, PR
   Adamczyk, P
   Bachinger, HP
   Holstein, TW
   Engel, J
   Ozbek, S
   Grzesiek, S
AF Meier, Sebastian
   Jensen, Pernille Rose
   Adamczyk, Patrizia
   Bachinger, Hans Peter
   Holstein, Thomas W.
   Engel, Juergen
   Oezbek, Suat
   Grzesiek, Stephan
TI Sequence-structure and structure-function analysis in cysteine-rich
   domains forming the ultrastable nematocyst wall
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE molecular evolution; conformational diversity; NMR structure;
   cysteine-rich; dihedral angle preference
ID HYDRA NEMATOCYSTS; CIS/TRANS ISOMERIZATION; DISULFIDE LINKAGE; PROLINE
   RESIDUES; REFLEX RESPONSE; NMR STRUCTURE; PROTEIN; MINICOLLAGEN;
   ALIGNMENT; PEPTIDES
AB The nematocyst wall of cnidarians is a unique biomaterial that withstands extreme osmotic pressures, allowing an ultrafast discharge of the nematocyst capsules. Assembly of the highly robust nernatocyst wall is achieved by covalent linkage of cysteine-rich domains (CRDs) from two main protein components, minicollagens and nematocyst outer wall antigen (NOWA). The bipolar minicollagens have different disulfide patterns and topologies in their N and C-terminal CRDs. The functional significance of this polarity has been elusive. Here, we show by NMR structural analysis that all representative cysteine-rich domains of NOWA are structurally related to N-terminal minicollagen domains. Natural sequence insertions in NOWA CRDs have very little effect on the tightly knit domain structures, nor do they preclude the efficient folding to a single native conformation. The different folds in NOWA CRDs and the atypical C-terminal minicollagen domain on the other hand can be directly related to different conformational preferences in the reduced states. Ultrastructural analysis in conjunction with aggregation studies argues for an association between the similar NOWA and N-terminal minicollagen domains in early stages of the nernatocyst wall assembly, which is followed by the controlled association between the unusual structures of C-terminal minicollagen domains. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Heidelberg, Inst Zool, Dept Mol Evolut & Genom, D-69120 Heidelberg, Germany.
   Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97201 USA.
   Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Meier, S (corresponding author), Univ Copenhagen, Inst Mol Biol & Physiol, August Krogh Bldg,Universitetsparken 13, DK-2100 Copenhagen, Denmark.
EM smeier@aki.ku.dk; stephan.grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015; Jensen, Pernille Rose/AAX-5696-2020;
   Jensen, Pernille Rose/J-8648-2016; Ozbek, Suat/D-3701-2014
OI Meier, Sebastian/0000-0003-3761-3217; Jensen, Pernille
   Rose/0000-0003-4359-848X; Jensen, Pernille Rose/0000-0003-4359-848X;
   Grzesiek, Stephan/0000-0003-1998-4225; Ozbek, Suat/0000-0003-2569-3942
CR BLANQUET R, 1966, SCIENCE, V154, P152, DOI 10.1126/science.154.3745.152
   Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689
   Boulegue C, 2006, J MOL BIOL, V358, P846, DOI 10.1016/j.jmb.2006.02.031
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   Fasman G. D., 1975, CRC HDB BIOCH MOL BI
   Ferraro DM, 2006, J MOL BIOL, V359, P390, DOI 10.1016/j.jmb.2006.03.047
   Ferraro DM, 2005, J MOL BIOL, V352, P575, DOI 10.1016/j.jmb.2005.07.012
   FISCHER S, 1994, J AM CHEM SOC, V116, P11931, DOI 10.1021/ja00105a036
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Grishin NV, 2001, J STRUCT BIOL, V134, P167, DOI 10.1006/jsbi.2001.4335
   HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341
   HOLSTEIN T, 1984, SCIENCE, V223, P830, DOI 10.1126/science.6695186
   HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206
   Huth JR, 1997, PROTEIN SCI, V6, P2359
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Meier S, 2004, FEBS LETT, V569, P112, DOI 10.1016/j.febslet.2004.05.034
   Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   Pokidysheva E, 2004, J BIOL CHEM, V279, P30395, DOI 10.1074/jbc.M403734200
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Shi T, 2006, ANGEW CHEM INT EDIT, V45, P1780, DOI 10.1002/anie.200503470
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   ZHANG RM, 1989, J BIOL CHEM, V264, P18472
NR 39
TC 18
Z9 19
U1 0
U2 5
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 4
PY 2007
VL 368
IS 3
BP 718
EP 728
DI 10.1016/j.jmb.2007.02.026
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 162BB
UT WOS:000246060200009
PM 17362991
DA 2021-01-25
ER

PT J
AU Padavattan, S
   Schirmer, T
   Schmidt, M
   Akdis, C
   Valenta, R
   Mittermann, I
   Soldatova, L
   Slater, J
   Mueller, U
   Markovic-Housley, Z
AF Padavattan, Sivaraman
   Schirmer, Tilman
   Schmidt, Margit
   Akdis, Cezmi
   Valenta, Rudolf
   Mittermann, Irene
   Soldatova, Lyudmila
   Slater, Jay
   Mueller, Ulrich
   Markovic-Housley, Zora
TI Identification of a B-cell epitope of hyaluronidase, a major bee venom
   allergen, from its crystal structure in complex with a specific fab
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE hyaluronidase; bee venom allergen; B-cell epitope; hyaluronidase/Fab
   complex; X-ray structure
ID SITE-DIRECTED MUTAGENESIS; YELLOW JACKET VENOM; WATER-MOLECULES;
   ANTIBODY; ANTIGEN; SEQUENCE; IMMUNOTHERAPY; FEATURES; CLASSIFICATION;
   MECHANISMS
AB The major allergens of honeybee venom, hyaluronidase (Hyal) and phospholipase A2, can induce life-threatening IgE-mediated allergic reactions in humans. Although conventional immunotherapy is effective, up to 40% of patients develop allergic side effects including anaphylaxis and thus, there is a need for an improved immunotherapy. A murine monoclonal anti-Hyal IgG1 antibody (mAb 21E11), that competed for Hyal binding with lgEs from sera of bee venom allergic patients, was raised. The fragment of these IgG antibodies which bind to antigen (Fab) was produced and complexed (1:1) with Hyal. The crystal structure determination of Hyal/Fab 21E11 complex (2.6 angstrom) enabled the identification of the Hyal-IgG interface which provides indirect information on the Hyal-IgE interaction (B-cell epitope). The epitope is composed of a linear array of nine residues (Arg138, His141-Arg148) located at the tip of a helix-turn-helix motive which protrudes away, from the globular core and fits tightly into the deep surface pocket formed by the residues from the six complementarity determining regions (CDRs) of the Fab. The epitope is continuous and yet its conformation appears to be essential for Ab recognition, since the synthetic 15-mer peptide comprising the entire epitope (Arg138-Glu152) is neither recognized by mAb 21E11 nor by human IgEs. The structure of the complex provides the basis for the rational design of Hyal derivatives with reduced allergenic activity, which could be used in the development of safer allergen-specific immunotherapy. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.
   Swiss Inst Allergy & Asthma Res, Dept Cellular Allergol Immunol, CH-7270 Davos, Switzerland.
   Med Univ Vienna, Dept Pathophysiol, Div Immunopathol, Christian Doppler Lab Allergy Res, A-1090 Vienna, Austria.
   US FDA, OPS ONDQA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.
   US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA.
   SpitalBern, CH-3001 Bern, Switzerland.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
RI Akdis, Cezmi/AAV-4844-2020; Mueller, Uwe/B-6293-2013
OI Mittermann, Irene/0000-0002-6240-6730; Padavattan,
   Sivaraman/0000-0002-1732-5421
CR Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089
   BRADEN BC, 1995, FASEB J, V9, P9
   Breithaupt C, 2003, P NATL ACAD SCI USA, V100, P9446, DOI 10.1073/pnas.1133443100
   Cohen GH, 2005, ACTA CRYSTALLOGR D, V61, P628, DOI 10.1107/S0907444905007870
   Collis AVJ, 2003, J MOL BIOL, V325, P337, DOI 10.1016/S0022-2836(02)01222-6
   CONNOLLY ML, 1993, J MOL GRAPHICS, V11, P139, DOI 10.1016/0263-7855(93)87010-3
   DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439
   Davies DR, 1996, P NATL ACAD SCI USA, V93, P7, DOI 10.1073/pnas.93.1.7
   Denepoux S, 2000, FEBS LETT, V465, P39, DOI 10.1016/S0014-5793(99)01703-2
   Ferreira F, 1998, FASEB J, V12, P231
   Furmonaviciene R, 2005, BIOINFORMATICS, V21, P4201, DOI 10.1093/bioinformatics/bti700
   Gendel SM, 2002, ANN NY ACAD SCI, V964, P87
   HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314
   HARDINGHAM TE, 1972, BIOCHIM BIOPHYS ACTA, V279, P401, DOI 10.1016/0304-4165(72)90160-2
   Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695
   HENRISSAT B, 1991, BIOCHEM J, V280, P309, DOI 10.1042/bj2800309
   Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109
   Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Jutel M, 2006, ALLERGY, V61, P796, DOI 10.1111/j.1398-9995.2006.01175.x
   Kabat E. A., 1991, SEQUENCES PROTEINS I
   King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440
   Knudson W, 2002, MATRIX BIOL, V21, P15, DOI 10.1016/S0945-053X(01)00186-X
   Kolarich D, 2005, FEBS J, V272, P5182, DOI 10.1111/j.1742-4658.2005.04841.x
   Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460
   Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAURENT TC, 1992, FASEB J, V6, P2397
   LAURENT TC, 1989, CIBA FDN S, V143
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   LESLIE AGW, 1992, JOINT CCP4 ESF EACBM, V26
   Li KB, 2004, BIOINFORMATICS, V20, P2572, DOI 10.1093/bioinformatics/bth286
   Linhart B, 2005, CURR OPIN IMMUNOL, V17, P646, DOI 10.1016/j.coi.2005.09.010
   MacCallum RM, 1996, J MOL BIOL, V262, P732, DOI 10.1006/jmbi.1996.0548
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   MARKOVICHOUSLEY Z, 2002, STRUCTURAL EVIDENCE, P19
   Martin ACR, 1996, PROTEINS, V25, P130, DOI 10.1002/(SICI)1097-0134(199605)25:1<130::AID-PROT11>3.3.CO;2-Y
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   MULLER U, 1992, J ALLERGY CLIN IMMUN, V89, P529, DOI 10.1016/0091-6749(92)90319-W
   Muller UR, 2002, ALLERGY, V57, P570, DOI 10.1034/j.1398-9995.2002.02157.x
   Muller UR, 1999, ALLERGOLOGIE, V22, pS51
   PADLAN EA, 1989, P NATL ACAD SCI USA, V86, P5938, DOI 10.1073/pnas.86.15.5938
   PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203
   POLJAK RJ, 1991, MOL IMMUNOL, V28, P1341, DOI 10.1016/0161-5890(91)90036-J
   READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622
   Roers A, 2005, EXPERT OPIN BIOL TH, V5, P1349, DOI 10.1517/14712598.5.10.1349
   SCHULZEGAHMEN U, 1993, J MOL BIOL, V234, P1098, DOI 10.1006/jmbi.1993.1663
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   SHERIFF S, 1987, P NATL ACAD SCI USA, V84, P8075, DOI 10.1073/pnas.84.22.8075
   SHERMAN L, 1994, CURR OPIN CELL BIOL, V6, P726, DOI 10.1016/0955-0674(94)90100-7
   Skov LK, 2006, ACTA CRYSTALLOGR D, V62, P595, DOI 10.1107/S0907444906010687
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   SOLDATOVA LN, 2006, IN PRESS ASTHMA ALLE
   Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Valenta R, 2004, ADV IMMUNOL, V82, P105, DOI 10.1016/S0065-2776(04)82003-0
   YSERN X, 1994, J MOL BIOL, V238, P496
NR 60
TC 62
Z9 67
U1 0
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 4
PY 2007
VL 368
IS 3
BP 742
EP 752
DI 10.1016/j.jmb.2007.02.036
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 162BB
UT WOS:000246060200011
PM 17374540
DA 2021-01-25
ER

PT J
AU Lamoureux, G
   Klein, ML
   Berneche, S
AF Lamoureux, Guillaume
   Klein, Michael L.
   Berneche, Simon
TI A stable water chain in the hydrophobic pore of the AmtB ammonium
   transporter
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; PROTON-TRANSFER; MECHANISM
AB The accessibility of water molecules to the pore of the AmtB ammonium transporter is studied using molecular dynamics simulations. Free energy calculations show that the so-called hydrophobic pore can stabilize a chain of water molecules in a well of a few kcal/mol, using a favorable electrostatic binding pocket as an anchoring point. Moreover, the structure of the water chain matches precisely the electronic density maxima observed in x-ray diffraction experiments. This result questions the general assumption that the AmtB pore only contains ammonia (NH3) molecules diffusing in a single. le fashion. The probable presence of water molecules in the pore would influence the relative stability of NH3 and NH4+, and thus calls for a reassessment of the overall permeation mechanism in ammonium transporters.
C1 Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Lamoureux, G (corresponding author), Univ Penn, Dept Chem, Ctr Mol Modeling, Philadelphia, PA 19104 USA.
EM lamourgu@cmm.upenn.edu; simon.berneche@unibas.ch
RI Lamoureux, Guillaume/K-4038-2013; Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM040712,
   R01GM040712, R01GM040712, R01GM040712, R01GM040712, R01GM040712,
   R01GM040712, R01GM040712, R01GM040712, R01GM040712, R01GM040712,
   R01GM040712, R01GM040712, R01GM040712, R01GM040712, R01GM040712,
   R01GM040712, R01GM040712, R01GM040712, R01GM040712, R01GM040712,
   R01GM040712] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [R01
   GM040712, GM 40712] Funding Source: Medline
CR Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102
   Berneche S, 1998, BIOPHYS J, V75, P1603, DOI 10.1016/S0006-3495(98)77604-0
   Bostick DL, 2007, PLOS COMPUT BIOL, V3, P231, DOI 10.1371/journal.pcbi.0030022
   Darve E, 2001, J CHEM PHYS, V115, P9169, DOI 10.1063/1.1410978
   Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002
   Henin J, 2004, J CHEM PHYS, V121, P2904, DOI 10.1063/1.1773132
   Javelle A, 2006, J BIOL CHEM, V281, P39492, DOI 10.1074/jbc.M608325200
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   KLEINER D, 1985, FEMS MICROBIOL LETT, V32, P87, DOI 10.1111/j.1574-6968.1985.tb01185.x
   Lin YC, 2006, J AM CHEM SOC, V128, P10876, DOI 10.1021/ja0631549
   Luzhkov VB, 2006, BIOCHEMISTRY-US, V45, P10807, DOI 10.1021/bi0610799
   Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369
   Nygaard TP, 2006, BIOPHYS J, V91, P4401, DOI 10.1529/biophysj.106.089714
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zoete V, 2004, J CHEM PHYS, V120, P7085, DOI 10.1063/1.1643721
NR 16
TC 32
Z9 32
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAY 1
PY 2007
VL 92
IS 9
BP L82
EP L84
DI 10.1529/biophysj.106.102756
PG 3
WC Biophysics
SC Biophysics
GA 154YI
UT WOS:000245544100004
PM 17351012
OA Green Published
DA 2021-01-25
ER

PT J
AU Vuilleumier, R
   Boeuf, G
   Fuentes, M
   Gehring, WJ
   Falcon, J
AF Vuilleumier, Robin
   Boeuf, Gilles
   Fuentes, Michael
   Gehring, Walter J.
   Falcon, Jack
TI Cloning and early expression pattern of two melatonin biosynthesis
   enzymes in the turbot (Scophthalmus maximus)
SO EUROPEAN JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE arylalkylamine N-acetyltransferase; flatfish;
   hydroxyindole-O-methyltransferase; orthodenticle homeobox 5; pineal
   organ; retina
ID HYDROXYINDOLE-O-METHYLTRANSFERASE; ARYLALKYLAMINE N-ACETYLTRANSFERASE;
   CHICKEN PINEAL-GLAND; CIRCADIAN CLOCK; TRANSCRIPTIONAL REGULATION;
   PROTEASOMAL PROTEOLYSIS; NUCLEOTIDE-SEQUENCE; GENOME DUPLICATION;
   MOLECULAR-CLONING; MESSENGER-RNA
AB Melatonin biosynthesis from serotonin involves the sequential activation of the arylalkylamine N-acetyltransferase (AANAT) and hydroxyindole-O-methyltransferase (HIOMT). Photoperiod synchronizes a daily rhythm in pineal and retinal melatonin secretion through controlling AANAT activity. Teleost fish possess two Aanat, one expressed in the retina (AANAT1) and the other expressed in the pineal gland (AANAT2). We report here the full-length cloning of Aanat1, Aanat2, SmHiomt and Otx5 (orthodenticle homeobox homolog 5) in the turbot (Scophthalmus maximus, Sm), a flatfish belonging to an evolutionary recent group of Teleost. The temporal expression pattern of the genes investigated is consistent with the idea that OTX5 is needed for photoreceptor specification, and that the pineal gland differentiates before the retina. SmAanat2 expression remained pineal specific during the period of time investigated, whereas SmOtx5 and SmHiomt expressions were seen in both the retina and pineal gland. Our results do not support the existence of a second SmHiomt, as is the case for SmAanat. Neither SmAanat2 nor SmHiomt mRNAs displayed cyclic accumulation in the pineal organ of embryos and larvae maintained under a light-dark cycle from fertilization onward. This is in marked contrast with the situation observed with zebrafish Aanat2, indicating that the molecular mechanisms controlling the development of the pineal melatonin system have been modified during the evolution of Teleost.
C1 UPMC, CNRS, Observ Oceanol Banyuls Mer, Lab Arago,UMR 7628, F-66651 Banyuls sur Mer, France.
   GDR 2821, F-66651 Banyuls sur Mer, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Falcon, J (corresponding author), UPMC, CNRS, Observ Oceanol Banyuls Mer, Lab Arago,UMR 7628, F-66651 Banyuls sur Mer, France.
EM falcon@obs-banyuls.fr
RI FALCON, Jack/I-5302-2013
OI FALCON, Jack/0000-0002-7572-6581
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Appelbaum L, 2005, J BIOL CHEM, V280, P11544, DOI 10.1074/jbc.M412935200
   Bairoch A, 1997, NUCLEIC ACIDS RES, V25, P217, DOI 10.1093/nar/25.1.217
   BERNARD M, 1993, BIOCHEM J, V290, P661, DOI 10.1042/bj2900661
   Bernard M, 2001, J NEUROCHEM, V79, P248, DOI 10.1046/j.1471-4159.2001.00555.x
   Besseau L, 2006, EXP EYE RES, V82, P620, DOI 10.1016/j.exer.2005.08.025
   Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3
   Coon SL, 1999, J BIOL CHEM, V274, P9076, DOI 10.1074/jbc.274.13.9076
   Coon SL, 2006, MOL CELL ENDOCRINOL, V252, P2, DOI 10.1016/j.mce.2006.03.039
   Decressac S, 2002, J PINEAL RES, V33, P225, DOI 10.1034/j.1600-079X.2002.02922.x
   Delaunay F, 2000, SCIENCE, V289, P297, DOI 10.1126/science.289.5477.297
   DONOHUE SJ, 1993, DNA CELL BIOL, V12, P715, DOI 10.1089/dna.1993.12.715
   EVANS BI, 1993, VISUAL NEUROSCI, V10, P1055, DOI 10.1017/S0952523800010166
   Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1
   Falcon J, 2001, ENDOCRINOLOGY, V142, P1804, DOI 10.1210/en.142.5.1804
   Falcon J, 2007, FISH PHYSIOL, V25, P243, DOI 10.1016/S1546-5098(06)25006-4
   Falcon J, 2007, TRENDS ENDOCRIN MET, V18, P81, DOI 10.1016/j.tem.2007.01.002
   Forsell J, 1997, INT J DEV BIOL, V41, P591
   Forsell J, 2002, DEV BRAIN RES, V136, P51, DOI 10.1016/S0165-3806(02)00351-6
   Forsell J, 2001, J EXP BIOL, V204, P2517
   Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0
   Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591
   Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543
   Gamse JT, 2002, NAT GENET, V30, P117, DOI 10.1038/ng793
   Ganguly S, 2002, CELL TISSUE RES, V309, P127, DOI 10.1007/s00441-002-0579-y
   Ganguly S, 2005, P NATL ACAD SCI USA, V102, P1222, DOI 10.1073/pnas.0406871102
   Ganguly S, 2001, P NATL ACAD SCI USA, V98, P8083, DOI 10.1073/pnas.141118798
   Gastel JA, 1998, SCIENCE, V279, P1358, DOI 10.1126/science.279.5355.1358
   Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895
   GRAF W, 1990, J NEUROBIOL, V21, P1136, DOI 10.1002/neu.480210716
   Greve P, 1996, BIOCHEM J, V319, P761, DOI 10.1042/bj3190761
   GUERLOTTE J, 1992, CELL MOL NEUROBIOL, V12, P177, DOI 10.1007/BF00713371
   Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z
   ISHIDA I, 1987, J BIOL CHEM, V262, P2895
   ISHIDA I, 1987, MOL BRAIN RES, V2, P185, DOI 10.1016/0169-328X(87)90025-8
   Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025
   Kim JS, 2007, ENDOCRINOLOGY, V148, P1475, DOI 10.1210/en.2006-1420
   Klein DC, 2007, J BIOL CHEM, V282, P4233, DOI 10.1074/jbc.R600036200
   Klein DC, 1997, RECENT PROG HORM RES, V52, P307
   LAUDER GV, 1983, SCIENCE, V219, P1235, DOI 10.1126/science.6828853
   Mano H, 1999, MOL BRAIN RES, V73, P110, DOI 10.1016/S0169-328X(99)00242-9
   NELSON JS, 1997, COPEIA, V3, P647
   Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518
   Plouhinec JL, 2003, MOL BIOL EVOL, V20, P513, DOI 10.1093/molbev/msg085
   Ribelayga C, 1999, ENDOCRINOLOGY, V140, P1375, DOI 10.1210/en.140.3.1375
   Sambrook J, 2001, MOL CLONING
   Schomerus C, 2005, ANN NY ACAD SCI, V1057, P372, DOI 10.1196/annals.1356.028
   Schreiber AM, 2001, COMP BIOCHEM PHYS B, V129, P587, DOI 10.1016/S1096-4959(01)00346-3
   VOISIN P, 1992, BIOCHEM J, V282, P571, DOI 10.1042/bj2820571
   Vuilleumier R, 2006, ENDOCRINOLOGY, V147, P2273, DOI 10.1210/en.2005-1565
   Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704
   Zhdanova IV, 2001, BRAIN RES, V903, P263, DOI 10.1016/S0006-8993(01)02444-1
NR 52
TC 23
Z9 25
U1 0
U2 15
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0953-816X
EI 1460-9568
J9 EUR J NEUROSCI
JI Eur. J. Neurosci.
PD MAY
PY 2007
VL 25
IS 10
BP 3047
EP 3057
DI 10.1111/j.1460-9568.2007.05578.x
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 176WJ
UT WOS:000247115300012
PM 17561818
DA 2021-01-25
ER

PT J
AU Mrosek, M
   Labeit, D
   Witt, S
   Heerklotz, H
   von Castelmur, E
   Labeit, S
   Mayans, O
AF Mrosek, Michael
   Labeit, Dietmar
   Witt, Stephanie
   Heerklotz, Heiko
   von Castelmur, Eleonore
   Labeit, Siegfried
   Mayans, Olga
TI Molecular determinants for the recruitment of the ubiquitin-ligase
   MuRF-1 onto M-line titin
SO FASEB JOURNAL
LA English
DT Article
DE elastic filament titin; muscle atrophy; X-ray crystallography; binding
   studies
ID KINASE DOMAIN; PROTEIN TITIN; IG TANDEMS; MUSCLE; IDENTIFICATION;
   ACTIVATION; INTERACTS; DYNAMICS; SYSTEM; MODEL
AB Titin forms an intrasarcomeric filament system in vertebrate striated muscle, which has elastic and signaling properties and is thereby central to mechanotransduction. Near its C-terminus and directly preceding a kinase domain, titin contains a conserved pattern of Ig and FnIII modules ( Ig(A168)- Ig(A169)-FnIII(A170), hereby A168-A170) that recruits the E3 ubiquitinligase MuRF-1 to the filament. This interaction is thought to regulate myofibril turnover and the trophic state of muscle. We have elucidated the crystal structure of A168-A170, characterized MuRF-1 variants by circular dichroism ( CD) and SEC-MALS, and studied the interaction of both components by isothermal calorimetry, SPOTS blots, and pull- down assays. This has led to the identification of the molecular determinants of the binding. A168-A170 shows an extended, rigid architecture, which is characterized by a shallow surface groove that spans its full length and a distinct loop protrusion in its middle point. In MuRF-1, a C- terminal helical domain is sufficient to bind A168-A170 with high affinity. This helical region predictably docks into the surface groove of A168-A170. Furthermore, pull- down assays demonstrate that the loop protrusion in A168-A170 is a key mediator of MuRF-1 recognition. Our findings indicate that this region of titin could serve as a target to attempt therapeutic inhibition of MuRF-1-mediated muscle turnover, where binding of small molecules to its distinctive structural features could block MuRF-1 access.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intesivmed, Mannheim, Germany.
RP Mayans, O (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM olga.mayans@unibas.ch
RI Mayans, Olga/A-3954-2008
OI von Castelmur, Eleonore/0000-0001-7061-4890; Heerklotz,
   Heiko/0000-0003-4615-7022; Mayans, Olga/0000-0001-6876-8532
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   BROWN RE, 1989, ANAL BIOCHEM, V180, P136, DOI 10.1016/0003-2697(89)90101-2
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448
   Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892
   Dai KS, 2001, J BIOL CHEM, V276, P23992, DOI 10.1074/jbc.M011208200
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x
   Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8
   Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LEAHY DJ, 1992, SCIENCE, V258, P987, DOI 10.1126/science.1279805
   LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Marino M, 2006, STRUCTURE, V14, P1437, DOI 10.1016/j.str.2006.07.009
   Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603
   McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089
   Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993
   Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
NR 33
TC 69
Z9 69
U1 0
U2 11
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD MAY
PY 2007
VL 21
IS 7
BP 1383
EP 1392
DI 10.1096/fj.06-7644com
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 162VG
UT WOS:000246117000014
PM 17215480
DA 2021-01-25
ER

PT J
AU Winn, PJ
   Zahran, M
   Battey, JND
   Zhou, YX
   Wade, RC
   Banerjee, A
AF Winn, Peter J.
   Zahran, Mai
   Battey, James N. D.
   Zhou, Yanxiang
   Wade, Rebecca C.
   Banerjee, Amit
TI Structural and electrostatic properties of ubiquitination and related
   pathways
SO FRONTIERS IN BIOSCIENCE-LANDMARK
LA English
DT Article
DE electrostatic potential; ubiquitin; ubiquitin like protein; ubiquitin
   conjugating enzyme; high throughput modelling; structure-based design;
   review
ID CONJUGATING ENZYME; BINDING INTERFACE; CRYSTAL-STRUCTURE; PROTEIN;
   INSIGHTS; YEAST; SITE; SUMO; IDENTIFICATION; UBC9
AB Post-translational modification by ubiquitin and ubiquitin-like (UBL) proteins is a key mechanism for cellular control. The specificity of the enzymes of ubiquitination and their close paralogs is dependent on their molecular electrostatic potentials. For example, analysis of molecular electrostatic potentials and electrostatically key residues can account for the selectivity of different E1s (activating enzymes) and of different SUMO proteases. The molecular interactions of the ubiquitin conjugating enzymes, the ubiquitin family proteins (UFP) and UBL domains are discussed in detail. An interesting observation is that the Non Canonical Ubiquitin Conjugating Enzymes (NCUBEs) have electrostatic potentials that are more similar to the UBC9 orthologs, the SUMO conjugating enzymes, than they are to other ubiquitin conjugating enzymes. It had previously been suggested that UBC9 may select for SUMO based on its difference in electrostatic potential as compared to other E2s but the NCUBE exception suggests that this may not be the case. The web site http://www.ubiquitin-resource.org/allows users to find the E2s most electrostatically similar to a query E2. Where possible, models have been made for all E2 domains in the SMART database (http://smart.embl-heidelberg.de/). A brief overview of molecular electrostatic potentials and their application to understanding protein function is also given.
C1 EML Res gGmbH, D-69118 Heidelberg, Germany.
   Univ Paris 07, Dept Mol & Genom Bioinformat, Paris, France.
   Heidelberg Univ, IWR, D-69120 Heidelberg, Germany.
   Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Munich, Dept Chem & Biochem, D-81377 Munich, Germany.
   Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Detroit, MI 48201 USA.
   Univ Bonn, Fac Med, Dept Int Med Educ & Dev, D-53105 Bonn, Germany.
RP Winn, PJ (corresponding author), EML Res gGmbH, Villa Bosch,Schloss Wolfsbrunneneweg 33, D-69118 Heidelberg, Germany.
EM Peter.Winn@eml-r.villa-bosch.de
RI Wade, Rebecca/L-1489-2019
OI Wade, Rebecca/0000-0001-5951-8670; Winn, Peter/0000-0003-4706-723X
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM59467] Funding Source: Medline; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM059467, R01GM059467,
   R01GM059467, R01GM059467, R01GM059467] Funding Source: NIH RePORTER
CR Bencsath KP, 2002, J BIOL CHEM, V277, P47938, DOI 10.1074/jbc.M207442200
   Blomberg N, 1999, PROTEINS, V37, P379, DOI 10.1002/(SICI)1097-0134(19991115)37:3<379::AID-PROT6>3.0.CO;2-K
   Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415
   Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008
   De Rienzo F, 2001, BIOPHYS J, V81, P3090, DOI 10.1016/S0006-3495(01)75947-4
   De Rienzo F, 2000, PROTEIN SCI, V9, P1439, DOI 10.1110/ps.9.8.1439
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1
   Downes BP, 2006, J BIOL CHEM, V281, P27145, DOI 10.1074/jbc.M602283200
   Fogolari F, 2002, J MOL RECOGNIT, V15, P377, DOI 10.1002/jmr.577
   Gabdoulline RR, 2006, NUCLEIC ACIDS RES, V34, pW79, DOI 10.1093/nar/gkl216
   Gabdoulline RR, 2002, CURR OPIN STRUC BIOL, V12, P204, DOI 10.1016/S0959-440X(02)00311-1
   Gabdoulline RR, 1999, TRENDS BIOCHEM SCI, V24, P285, DOI 10.1016/S0968-0004(99)01412-7
   Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6
   Gerlt JA, 2000, GENOME BIOL, V1
   GETZOFF ED, 1992, NATURE, V358, P347, DOI 10.1038/358347a0
   Giraud MF, 1998, ACTA CRYSTALLOGR D, V54, P891, DOI 10.1107/S0907444998002480
   GOEBL MG, 1988, SCIENCE, V241, P1331, DOI 10.1126/science.2842867
   Goettsch S, 2002, FRONT BIOSCI-LANDMRK, V7, pA148, DOI 10.2741/goet
   Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020
   JENTSCH S, 1987, NATURE, V329, P131, DOI 10.1038/329131a0
   Johnson G, 2003, NEUROSCI LETT, V337, P37, DOI 10.1016/S0304-3940(02)01298-3
   KAISER P, 1994, J BIOL CHEM, V269, P8797
   Kaiser P, 1995, FEBS LETT, V377, P193, DOI 10.1016/0014-5793(95)01323-7
   King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652
   Kinoshita K, 2004, BIOINFORMATICS, V20, P1329, DOI 10.1093/bioinformatics/bth073
   KNIGHT E, 1988, J BIOL CHEM, V263, P4520
   Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7
   Larsen CN, 1996, BIOCHEMISTRY-US, V35, P6735, DOI 10.1021/bi960099f
   Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079
   Liu Q, 1999, J BIOL CHEM, V274, P16979, DOI 10.1074/jbc.274.24.16979
   Livesay DR, 2003, BIOCHEMISTRY-US, V42, P3464, DOI 10.1021/bi026918f
   LOEB KR, 1992, J BIOL CHEM, V267, P7806
   Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552
   Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777
   MADURA JD, 1995, COMPUT PHYS COMMUN, V91, P57, DOI 10.1016/0010-4655(95)00043-F
   McCoy AJ, 1997, J MOL BIOL, V268, P570, DOI 10.1006/jmbi.1997.0987
   Merkley N, 2004, J BIOL CHEM, V279, P47139, DOI 10.1074/jbc.M409576200
   Mika S, 2006, PLOS COMPUT BIOL, V2, P698, DOI 10.1371/journal.pcbi.0020079
   Miura T, 1999, J MOL BIOL, V290, P213, DOI 10.1006/jmbi.1999.2859
   Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085
   Osaka F, 1997, MOL CELL BIOL, V17, P3388, DOI 10.1128/MCB.17.6.3388
   QIN S, 1991, J BIOL CHEM, V266, P15549
   REBOUDRAVAUX M, 2002, PROTEIN DEGRADATION
   Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086
   SHEN L, 2006, BIOCH J
   STEIN M, 2006, INTEGRATING STRUCTUR
   STEIN M, 2007, PERSONAL COMMUNICATI
   SUNG P, 1988, GENE DEV, V2, P1476, DOI 10.1101/gad.2.11.1476
   Tatham MH, 2003, BIOCHEMISTRY-US, V42, P9959, DOI 10.1021/bi0345283
   Tokumoto M, 1999, FEBS LETT, V458, P375, DOI 10.1016/S0014-5793(99)01189-8
   Tong H, 1997, J BIOL CHEM, V272, P21381, DOI 10.1074/jbc.272.34.21381
   Townsley FM, 1998, YEAST, V14, P747, DOI 10.1002/(SICI)1097-0061(19980615)14:8<747::AID-YEA271>3.3.CO;2-K
   Townsley FM, 1997, P NATL ACAD SCI USA, V94, P2362, DOI 10.1073/pnas.94.6.2362
   Ullmann GM, 1997, BIOCHEMISTRY-US, V36, P16187, DOI 10.1021/bi971241v
   Ullmann GM, 2000, PROTEINS, V38, P301
   Wade RC, 2001, INT J QUANTUM CHEM, V83, P122, DOI 10.1002/qua.1204
   Wade RC, 1998, P NATL ACAD SCI USA, V95, P5942, DOI 10.1073/pnas.95.11.5942
   Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456
   Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700
   Whitby FG, 1998, J BIOL CHEM, V273, P34983, DOI 10.1074/jbc.273.52.34983
   Winn PJ, 2005, PROTEINS, V58, P367, DOI 10.1002/prot.20318
   Winn PJ, 2004, STRUCTURE, V12, P1563, DOI 10.1016/j.str.2004.06.017
   Xu Z, 2005, BIOCHEM J, V386, P325, DOI 10.1042/BJ20041210
   Yu HT, 1996, CURR BIOL, V6, P455, DOI 10.1016/S0960-9822(02)00513-4
   Yuan WM, 2001, EMBO J, V20, P362, DOI 10.1093/emboj/20.3.362
   Zhang XY, 2006, MULTISCALE MODEL SIM, V5, P1196, DOI 10.1137/050647670
   Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101
   Zhu JH, 2005, PROTEINS, V58, P618, DOI 10.1002/prot.20331
NR 73
TC 9
Z9 9
U1 1
U2 3
PU FRONTIERS IN BIOSCIENCE INC
PI IRVINE
PA 16471 SCIENTIFIC WAY, IRVINE, CA 92618 USA
SN 1093-9946
EI 1093-4715
J9 FRONT BIOSCI-LANDMRK
JI Front. Biosci.
PD MAY 1
PY 2007
VL 12
BP 3419
EP 3430
DI 10.2741/2323
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 163KG
UT WOS:000246157900053
PM 17485310
DA 2021-01-25
ER

PT J
AU Nicholson, JR
   Peter, JC
   Lecourt, AC
   Matsumoto, T
   Barde, YA
   Hofbauer, KG
AF Nicholson, Janet R.
   Peter, Jean-Christophe
   Lecourt, Anne-Catherine
   Matsumoto, T.
   Barde, Yves-Alain
   Hofbauer, Karl G.
TI Activation of melanocortin-4 receptors stimulates hypothalamic BDNF
   release to decrease food intake.
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Meeting Abstract
CT 15th European Congress on Obesity
CY APR 22-25, 2007
CL Budapest, HUNGARY
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
J9 INT J OBESITY
JI Int. J. Obes.
PD MAY
PY 2007
VL 31
SU 1
BP S21
EP S21
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 158YW
UT WOS:000245832700117
DA 2021-01-25
ER

PT J
AU Wildemann, D
   Schiene-Fischer, C
   Aumuller, T
   Bachmann, A
   Kiefhaber, T
   Lucke, C
   Fischer, G
AF Wildemann, Dirk
   Schiene-Fischer, Cordelia
   Aumuller, Tobias
   Bachmann, Annett
   Kiefhaber, Thomas
   Lucke, Christian
   Fischer, Gunter
TI A nearly isosteric photosensitive amide-backbone substitution allows
   enzyme activity switching in ribonuclease S
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID TERMINAL EICOSAPEPTIDE SEQUENCE; BOVINE PANCREATIC RIBONUCLEASE; PEPTIDE
   ANALOGS; AMINO-ACID; CIS/TRANS ISOMERIZATION; HORSERADISH-PEROXIDASE;
   THIOAMIDE GROUP; ALPHA-HELICES; TRH ANALOG; PROTEIN
AB psi[CS-NH](4)-RNase S, a site specific modified version of RNase S obtained by thioxylation (O/S exchange) at the Ala(4)-Ala(5)- peptide bond, was used to evaluate the impact of protein backbone photoswitching on bioactivity. psi[CS-NH](4)-RNase S was yielded by recombination of the S-protein and the respective chemically synthesized thioxylated S-peptide derivative. Comparison with RNase S revealed similar thermodynamic stability of the complex and an unperturbed enzymatic activity toward cytidine 2',3'-cyclic monophosphate (cCMP). Reversible photoisomerization with a highly increased cis/trans isomer ratio of the thioxopeptide bond of psi[CS-NH](4)-RNase S in the photostationary state occurred under UV irradiation conditions (254 nm). The slow thermal reisomerization (t(1/2) = 180 s) permitted us to determine the enzymatic activity of cis psi[CS-NH](4)-RNase S by measurement of inital rates of cCMP hydrolysis. Despite thermodynamic stability of cis psi[CS-NH](4)-RNase S, its enzymatic activity is completely abolished but recovers after reisomerization. We conclude that the thioxopeptide bond modified polypeptide backbone represents a versatile probe for site-directed photoswitching of proteins.
C1 Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Fischer, G (corresponding author), Max Planck Res Unit Enzymol Prot Folding, Weinbergweg 22, D-06120 Halle, Germany.
EM fischer@enzyme-halle.mpg.de
RI Kiefhaber, Thomas/A-3028-2010
CR Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s
   AIZAWA M, 1977, ARCH BIOCHEM BIOPHYS, V182, P305, DOI 10.1016/0003-9861(77)90311-3
   ALEXANDROVA M, 1987, ENDOCRINOL EXP, V21, P43
   ANGYAL R, 1985, ENDOCRINOL EXP, V19, P213
   Banghart M, 2004, NAT NEUROSCI, V7, P1381, DOI 10.1038/nn1356
   Borisenko V, 2005, J PHOTOCH PHOTOBIO A, V173, P21, DOI 10.1016/j.jphotochem.2004.12.026
   Bose M, 2006, J AM CHEM SOC, V128, P388, DOI 10.1021/ja055467u
   Chambers JJ, 2006, J NEUROPHYSIOL, V96, P2792, DOI 10.1152/jn.00318.2006
   Frank R, 2000, ANGEW CHEM INT EDIT, V39, P1120, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1120::AID-ANIE1120>3.0.CO;2-H
   Goldberg JM, 1999, P NATL ACAD SCI USA, V96, P2019, DOI 10.1073/pnas.96.5.2019
   Hamachi I, 1998, CHEM LETT, P537, DOI 10.1246/cl.1998.537
   Helbing J, 2004, J AM CHEM SOC, V126, P8823, DOI 10.1021/ja049227a
   James DA, 2001, PROTEIN ENG, V14, P983, DOI 10.1093/protein/14.12.983
   Jensen JH, 2005, J PHYS CHEM A, V109, P6634, DOI 10.1021/jp051922x
   Joshi HV, 1996, J AM CHEM SOC, V118, P12038, DOI 10.1021/ja960592e
   KARTHA G, 1967, NATURE, V213, P862, DOI 10.1038/213862a0
   KRUSZYNSKI M, 1985, EXPERIENTIA, V41, P1576
   Kumita JR, 2002, PROTEIN ENG, V15, P561, DOI 10.1093/protein/15.7.561
   Lednev IK, 1996, J PHYS CHEM-US, V100, P13338, DOI 10.1021/jp9610067
   Liu D, 1997, BIOORG MED CHEM LETT, V7, P2677, DOI 10.1016/S0960-894X(97)10044-0
   LODI PJ, 1993, BIOCHEMISTRY-US, V32, P4338, DOI 10.1021/bi00067a024
   MARCHIORI F, 1968, J AM CHEM SOC, V90, P5889, DOI 10.1021/ja01023a040
   MARCHIORI F, 1972, BIOCHIM BIOPHYS ACTA, V257, P210, DOI 10.1016/0005-2795(72)90272-3
   MARKLEY JL, 1975, BIOCHEMISTRY-US, V14, P3546, DOI 10.1021/bi00687a006
   MORODER L, 1969, J AM CHEM SOC, V91, P3921, DOI 10.1021/ja01042a040
   Moroder L, 2005, J PEPT SCI, V11, P258, DOI 10.1002/psc.661
   Muranaka N, 2002, FEBS LETT, V510, P10, DOI 10.1016/S0014-5793(01)03211-2
   Nakayama K, 2005, BIOCONJUGATE CHEM, V16, P1360, DOI 10.1021/bc049724g
   Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624
   Pieroni O, 2001, ACCOUNTS CHEM RES, V34, P9, DOI 10.1021/ar990141+
   Raines RT, 1998, CHEM REV, V98, P1045, DOI 10.1021/cr960427h
   Reimer U, 2002, BIOPHYS CHEM, V96, P203, DOI 10.1016/S0301-4622(02)00013-3
   Renner C, 2006, CHEMBIOCHEM, V7, P869, DOI 10.1002/cbic.200500531
   RICHARDS FM, 1959, J BIOL CHEM, V234, P1459
   ROCCHI R, 1972, BIOCHEMISTRY-US, V11, P50, DOI 10.1021/bi00751a010
   ROCCHI R, 1969, J AM CHEM SOC, V91, P492, DOI 10.1021/ja01030a048
   Rod TH, 2003, P NATL ACAD SCI USA, V100, P6980, DOI 10.1073/pnas.1230801100
   SANCHO J, 1992, BIOCHEMISTRY-US, V31, P2253, DOI 10.1021/bi00123a006
   Satzger H, 2005, J PHYS CHEM B, V109, P4770, DOI 10.1021/jp045151t
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   Schiene-Fischer C, 2001, J AM CHEM SOC, V123, P6227, DOI 10.1021/ja0042480
   SCHREIER AA, 1976, J MOL BIOL, V105, P409, DOI 10.1016/0022-2836(76)90101-7
   SCHUTKOWSKI M, 1994, EUR J BIOCHEM, V221, P455, DOI 10.1111/j.1432-1033.1994.tb18758.x
   THOMSON J, 1994, BIOCHEMISTRY-US, V33, P8587, DOI 10.1021/bi00194a025
   TSUKAHARA T, 1991, INT J BIOCHEM, V23, P79
   Volgraf M, 2006, NAT CHEM BIOL, V2, P47, DOI 10.1038/nchembio756
   Wachtveitl J, 2004, BIOPHYS J, V86, P2350, DOI 10.1016/S0006-3495(04)74292-7
   Wang MH, 1996, BIOCHEM J, V320, P187, DOI 10.1042/bj3200187
   WANG Y, 1989, J AM CHEM SOC, V111, P8274, DOI 10.1021/ja00203a037
   Watney JB, 2003, J AM CHEM SOC, V125, P3745, DOI 10.1021/ja028487u
   Weston DG, 1999, BBA-GEN SUBJECTS, V1428, P463, DOI 10.1016/S0304-4165(99)00099-9
   Wildemann D, 1999, CHEM COMMUN, P1809, DOI 10.1039/a905678e
   Woolley GA, 2005, ACCOUNTS CHEM RES, V38, P486, DOI 10.1021/ar040091v
   WYCKOFF HW, 1967, J BIOL CHEM, V242, P3749
   WYCKOFF HW, 1970, J BIOL CHEM, V245, P305
   ZEGERS I, 1994, PROTEIN SCI, V3, P2322, DOI 10.1002/pro.5560031217
   Zhao JZ, 2004, CHEM-EUR J, V10, P6093, DOI 10.1002/chem.200400400
   Zhao JZ, 2003, CHEM COMMUN, P2810, DOI 10.1039/b309927j
NR 58
TC 57
Z9 57
U1 0
U2 19
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD APR 25
PY 2007
VL 129
IS 16
BP 4910
EP 4918
DI 10.1021/ja069048o
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 158HQ
UT WOS:000245782800027
PM 17397159
DA 2021-01-25
ER

PT J
AU Soulard, A
   Hall, MN
AF Soulard, Alexandre
   Hall, Michael N.
TI SnapShot: mTOR signaling
SO CELL
LA English
DT Editorial Material
ID TRANSDUCTION PATHWAYS; KINASE-ACTIVITY; GROWTH; INSULIN; RICTOR;
   PHOSPHORYLATION; PROLIFERATION; REVEALS; GTPASE; PRAS40
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Soulard, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
OI Soulard, Alexandre/0000-0003-3556-1994
CR Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882
   Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206
   Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
NR 15
TC 37
Z9 42
U1 0
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD APR 20
PY 2007
VL 129
IS 2
BP 434
EP U14
AR E1
DI 10.1016/j.cell.2007.04.010
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 167TI
UT WOS:000246474600028
PM 17449000
DA 2021-01-25
ER

PT J
AU Gottler, T
   Klostermeier, D
AF Goettler, Thomas
   Klostermeier, Dagmar
TI Dissection of the nucleotide cycle of B-subtilis DNA gyrase and its
   modulation by DNA
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE DNA gyrase; DNA supercoiling; DNA relaxation; adenine nucleotide
   binding; DNA binding
ID N-TERMINAL FRAGMENT; TOPOISOMERASE-II; ATPASE ACTIVITY;
   DEOXYRIBONUCLEIC-ACID; CRYSTAL-STRUCTURE; BASE-PAIRS; PURIFICATION;
   MECHANISM; HYDROLYSIS; SUBUNITS
AB DNA topoisomerases catalyze the inter-conversion of different topological forms of DNA. While all type II DNA topoisomerases relax supercoiled DNA, DNA gyrase is the only enyzme that introduces negative supercoils into DNA at the expense of ATP hydrolysis.
   We present here a biophysical characterization of the nucleotide cycle of DNA gyrase from Bacillus subtilis, both in the absence and presence of DNA. B. subtilis DNA gyrase is highly homologous to its well-studied Escherichia coli counterpart, but exhibits unique mechanistic features. The active heterotetramer of B. subtilis DNA gyrase is formed by mixing the GyrA and GyrB subunits. GyrB undergoes nucleotide-induced dimerization and is an ATP-operated clamp. The intrinsic ATPase activity of gyrase is stimulated tenfold in the presence of plasmid DNA. However, in contrast to the E. coli homolog, the rate-limiting step in the nucleotide cycle of B. subtilis GyrB is ATP hydrolysis, not product dissociation or an associated conformational change. Furthermore, there is no cooperativity between the two DNA and ATP binding sites in B. subtilis DNA gyrase. Nevertheless, the enzyme is as efficient in negative supercoiling as the E. coli DNA gyrase.
   Our results provide evidence that the evolutionary goal of efficient DNA supercoiling can be realized by similar architecture, but differences in the underlying mechanism. The basic mechanistic features are conserved among DNA gyrases, but the kinetics of individual steps can vary significantly even between closely related enzymes. This suggests that each topoisomerase represents a different solution to the complex reaction sequence in DNA supercoiling. (c) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
CR Adam H., 1962, METHODEN ENZYMATISCH, P573
   ALI JA, 1993, BIOCHEMISTRY-US, V32, P2717, DOI 10.1021/bi00061a033
   ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018
   Baird CL, 2001, J BIOL CHEM, V276, P27893, DOI 10.1074/jbc.M102544200
   Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5
   Barnes MH, 2003, PROTEIN EXPRES PURIF, V29, P259, DOI 10.1016/S1046-5928(03)00068-8
   BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101
   Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0
   Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369
   Corbett KD, 2004, P NATL ACAD SCI USA, V101, P7293, DOI 10.1073/pnas.0401595101
   Costenaro L, 2005, STRUCTURE, V13, P287, DOI 10.1016/j.str.2004.12.011
   Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0
   Fass D, 1999, NAT STRUCT BIOL, V6, P322
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108
   HIGGINS NP, 1978, P NATL ACAD SCI USA, V75, P1773, DOI 10.1073/pnas.75.4.1773
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Kampranis SC, 1998, J BIOL CHEM, V273, P26305, DOI 10.1074/jbc.273.41.26305
   KLEVAN L, 1980, BIOCHEMISTRY-US, V19, P5229, DOI 10.1021/bi00564a012
   Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786
   Li Z, 2006, MOL MICROBIOL, V60, P140, DOI 10.1111/j.1365-2958.2006.05070.x
   Lindsley JE, 1999, METH MOL B, V94, P187
   LINDSLEY JE, 1993, J BIOL CHEM, V268, P8096
   LIU LF, 1978, P NATL ACAD SCI USA, V75, P2098, DOI 10.1073/pnas.75.5.2098
   Manjunatha UH, 2002, NUCLEIC ACIDS RES, V30, P2144, DOI 10.1093/nar/30.10.2144
   MAXWELL A, 1984, J BIOL CHEM, V259, P4472
   McLaughlin SH, 2004, J MOL BIOL, V344, P813, DOI 10.1016/j.jmb.2004.09.055
   MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960
   MORIYA S, 1985, NUCLEIC ACIDS RES, V13, P2251, DOI 10.1093/nar/13.7.2251
   Mueller-Planitz F, 2006, J BIOL CHEM, V281, P23395, DOI 10.1074/jbc.M604119200
   ORR E, 1982, J BACTERIOL, V151, P524, DOI 10.1128/JB.151.1.524-527.1982
   OSHEROFF N, 1983, J BIOL CHEM, V258, P9536
   Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057
   Ruthenburg AJ, 2005, J BIOL CHEM, V280, P26177, DOI 10.1074/jbc.M502838200
   Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465
   Segel I.H., 1993, ENZYME KINETICS BEHA
   STAUDENBAUER WL, 1981, NUCLEIC ACIDS RES, V9, P3589, DOI 10.1093/nar/9.15.3589
   SUGINO A, 1980, NUCLEIC ACIDS RES, V8, P3865, DOI 10.1093/nar/8.17.3865
   SUGINO A, 1980, J BIOL CHEM, V255, P6299
   SUGINO A, 1977, P NATL ACAD SCI USA, V74, P4767, DOI 10.1073/pnas.74.11.4767
   SUGINO A, 1980, J BACTERIOL, V141, P1331, DOI 10.1128/JB.141.3.1331-1339.1980
   SUGINO A, 1978, P NATL ACAD SCI USA, V75, P4342
   TAMURA JK, 1992, J BIOL CHEM, V267, P9214
   Weikl T, 2000, J MOL BIOL, V303, P583, DOI 10.1006/jmbi.2000.4157
   WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0
   Wu LCC, 1995, ARCH BIOCHEM BIOPHYS, V324, P123, DOI 10.1006/abbi.1995.9919
NR 48
TC 22
Z9 22
U1 0
U2 2
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 13
PY 2007
VL 367
IS 5
BP 1392
EP 1404
DI 10.1016/j.jmb.2007.01.055
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 154LH
UT WOS:000245508200014
PM 17320901
DA 2021-01-25
ER

PT J
AU Lino, MM
   Atanasoski, S
   Kvajo, M
   Fayard, B
   Moreno, E
   Brenner, HR
   Suter, U
   Monard, D
AF Lino, Maria Maddalena
   Atanasoski, Suzana
   Kvajo, Mirna
   Fayard, Berengere
   Moreno, Eliza
   Brenner, Hans Rudolf
   Suter, Ueli
   Monard, Denis
TI Mice lacking protease nexin-1 show delayed structural and functional
   recovery after sciatic nerve crush
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE protease nexin-1; Schwann cell; BDNF; fibrin; nerve crush; serine
   proteases
ID GLIA-DERIVED NEXIN; SCHWANN-CELL PROLIFERATION; PERIPHERAL-NERVE;
   PLASMINOGEN-ACTIVATOR; NEURITE OUTGROWTH; NEUROTROPHIC FACTOR;
   ALZHEIMERS-DISEASE; SYSTEM DEVELOPMENT; AMYLOID PROTEIN; P75 RECEPTOR
AB Multiple molecular mechanisms influence nerve regeneration. Because serine proteases were shown to affect peripheral nerve regeneration, we performed nerve crush experiments to study synapse reinnervation in adult mice lacking the serpin protease nexin-1 (PN-1). PN-1 is a potent endogenous inhibitor of thrombin, trypsin, tissue plasminogen activators (tPAs), and urokinase plasminogen activators. Compared with the wild type, a significant delay in synapse reinnervation was detected in PN-1 knock-out ( KO) animals, which was associated with both reduced proliferation and increased apoptosis of Schwann cells. Various factors known to affect Schwann cells were also altered. Fibrin deposits, tPA activity, mature BDNF, and the low-affinity p75 neurotrophin receptor were increased in injured sciatic nerves of mutant mice. To test whether the absence of PN-1 in Schwann cells or in the axon caused delay in reinnervation, PN-1 was overexpressed exclusively in the nerves of PN-1K0 mice. Neuronal PN-1 expression did not rescue the delayed reinnervation. The results suggest that Schwann cell-derived PN-1 is crucial for proper reinnervation through its contribution to the autocrine control of proliferation and survival. Thus, the precise balance between distinct proteases and serpins such as PN-1 can modulate the overall impact on the kinetics of recovery.
C1 Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   Swiss Fed Inst Technol, Inst Cell Biol, CH-8093 Zurich, Switzerland.
   Univ Basel, Inst Physiol, Dept Clin Biol Sci, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Physiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Monard, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM denis.monard@fmi.ch
RI Suter, Ueli/A-1624-2010; Atanasoski, Suzana/A-3275-2011
OI Atanasoski, Suzana/0000-0001-7340-0775
CR Akassoglou K, 2000, J CELL BIOL, V149, P1157, DOI 10.1083/jcb.149.5.1157
   Akassoglou K, 2003, NEUROSCI LETT, V338, P185, DOI 10.1016/S0304-3940(02)01387-3
   Akassoglou K, 2002, NEURON, V33, P861, DOI 10.1016/S0896-6273(02)00617-7
   Atanasoski S, 2006, J NEUROSCI, V26, P2124, DOI 10.1523/JNEUROSCI.4594-05.2006
   Atanasoski S, 2006, GLIA, V53, P147, DOI 10.1002/glia.20263
   Atanasoski S, 2004, NEURON, V43, P499, DOI 10.1016/j.neuron.2004.08.001
   Atanasoski S, 2001, MOL CELL NEUROSCI, V18, P581, DOI 10.1006/mcne.2001.1055
   BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9
   Boyd JG, 2001, J NEUROBIOL, V49, P314, DOI 10.1002/neu.10013
   Boyd JG, 2002, EUR J NEUROSCI, V15, P613, DOI 10.1046/j.1460-9568.2002.01891.x
   BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305
   Chao M, 1998, BRAIN RES REV, V26, P295, DOI 10.1016/S0165-0173(97)00036-2
   Chou SM, 1998, J NEUROL SCI, V160, pS73, DOI 10.1016/S0022-510X(98)00202-0
   Cosgaya JM, 2002, SCIENCE, V298, P1245, DOI 10.1126/science.1076595
   DEVOR M, 1979, EXP NEUROL, V64, P260, DOI 10.1016/0014-4886(79)90267-X
   Donovan FM, 1997, J NEUROSCI, V17, P5316
   FAWCETT JW, 1990, ANNU REV NEUROSCI, V13, P43, DOI 10.1146/annurev.neuro.13.1.43
   Fayard B, 2005, J NEUROSCI RES, V80, P18, DOI 10.1002/jnr.20432
   Ferri CC, 1999, NEUROSCI LETT, V272, P191, DOI 10.1016/S0304-3940(99)00618-7
   Festoff BW, 1996, SEMIN THROMB HEMOST, V22, P267, DOI 10.1055/s-2007-999018
   Frey D, 2000, J NEUROSCI, V20, P2534
   Friedmann I, 1999, FASEB J, V13, P533
   GARCIAROCHA M, 1994, NEUROSCI LETT, V180, P123, DOI 10.1016/0304-3940(94)90502-9
   GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847
   Higashimori H, 2006, PLAST RECONSTR SURG, V117, P152, DOI 10.1097/01.prs.0000186537.62939.07
   Hirakawa H, 2004, NEUROREPORT, V15, P405, DOI 10.1097/00001756-200403010-00004
   Hirakawa H, 2003, EXP CELL RES, V284, P196, DOI 10.1016/S0014-4827(02)00035-6
   HOUENOU LJ, 1995, P NATL ACAD SCI USA, V92, P895, DOI 10.1073/pnas.92.3.895
   Kioussi C, 1996, TRENDS GENET, V12, P84, DOI 10.1016/0168-9525(96)81411-9
   Knauer DJ, 2000, J BIOL CHEM, V275, P37340, DOI 10.1074/jbc.M003909200
   Knauer MF, 1997, J BIOL CHEM, V272, P12261, DOI 10.1074/jbc.272.19.12261
   KRYSTOSEK A, 1984, J CELL BIOL, V98, P773, DOI 10.1083/jcb.98.2.773
   KRYSTOSEK A, 1981, SCIENCE, V213, P1532, DOI 10.1126/science.7197054
   Kvajo M, 2004, J NEUROSCI, V24, P9734, DOI 10.1523/JNEUROSCI.3306-04.2004
   LANTZ MS, 1994, METHOD ENZYMOL, V235, P563
   Luthi A, 1997, J NEUROSCI, V17, P4688
   MANSUY IM, 1993, DEVELOPMENT, V119, P1119
   Marcinkiewicz M, 1998, MOL BRAIN RES, V59, P229, DOI 10.1016/S0169-328X(98)00141-7
   MEIER R, 1989, NATURE, V342, P548, DOI 10.1038/342548a0
   Meins M, 2001, J NEUROSCI, V21, P8830, DOI 10.1523/JNEUROSCI.21-22-08830.2001
   MONARD D, 1992, ANN NY ACAD SCI, V674, P237, DOI 10.1111/j.1749-6632.1992.tb27492.x
   MONARD D, 1988, TRENDS NEUROSCI, V11, P541, DOI 10.1016/0166-2236(88)90182-8
   Monard D, 1993, Perspect Dev Neurobiol, V1, P165
   Niclou SP, 1998, EUR J NEUROSCI, V10, P1590, DOI 10.1046/j.1460-9568.1998.00183.x
   Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135
   REICHARDT LF, 1991, ANNU REV NEUROSCI, V14, P531, DOI 10.1146/annurev.ne.14.030191.002531
   Richard B, 2004, J CELL PHYSIOL, V201, P138, DOI 10.1002/jcp.20103
   SCOTTI AL, 1994, CELL TISSUE RES, V278, P409, DOI 10.1007/BF00414183
   SENDTNER M, 1992, NATURE, V360, P757, DOI 10.1038/360757a0
   Siconolfi LB, 2001, J NEUROSCI, V21, P4348, DOI 10.1523/JNEUROSCI.21-12-04348.2001
   Siconolfi LB, 2001, J NEUROSCI, V21, P4336, DOI 10.1523/JNEUROSCI.21-12-04336.2001
   SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865
   Smirnova IV, 1998, J NEUROBIOL, V36, P64, DOI 10.1002/(SICI)1097-4695(199807)36:1<64::AID-NEU6>3.3.CO;2-4
   Smirnova IV, 1996, J NEUROCHEM, V67, P2188
   SMITHSWINTOSKY VL, 1995, J NEUROSCI, V15, P5840
   SOMMER J, 1987, BIOCHEMISTRY-US, V26, P6407, DOI 10.1021/bi00394a016
   SON YJ, 1995, NEURON, V14, P125, DOI 10.1016/0896-6273(95)90246-5
   SON YJ, 1995, NEURON, V14, P133, DOI 10.1016/0896-6273(95)90247-3
   Son YJ, 1996, TRENDS NEUROSCI, V19, P280, DOI 10.1016/S0166-2236(96)10032-1
   Stoffel W, 1997, CURR OPIN NEUROBIOL, V7, P654, DOI 10.1016/S0959-4388(97)80085-2
   Syroid DE, 2000, J NEUROSCI, V20, P5741
   Tolwani RJ, 2004, J NEUROSCI RES, V77, P662, DOI 10.1002/jnr.20181
   Turgeon VL, 1998, J NEUROSCI, V18, P6882
   VAUGHAN PJ, 1995, J NEUROSCI, V15, P5389
   VAUGHAN PJ, 1994, BRAIN RES, V668, P160, DOI 10.1016/0006-8993(94)90521-5
   WAGNER SL, 1989, P NATL ACAD SCI USA, V86, P8284, DOI 10.1073/pnas.86.21.8284
   Walsh PN, 2002, ESSAYS BIOCHEM, V38, P95, DOI 10.1042/bse0380095
   Yeiser EC, 2004, J NEUROSCI, V24, P10521, DOI 10.1523/JNEUROSCI.1390-04.2004
   Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1111/j.1460-9568.2000.01312.x
   ZURN AD, 1988, DEV NEUROSCI-BASEL, V10, P17, DOI 10.1159/000111951
NR 70
TC 22
Z9 23
U1 0
U2 1
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD APR 4
PY 2007
VL 27
IS 14
BP 3677
EP 3685
DI 10.1523/JNEUROSCI.0277-07.2007
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA 153WU
UT WOS:000245468300008
PM 17409231
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Lichtneckert, R
   Bello, B
   Reichert, H
AF Lichtneckert, Robert
   Bello, Bruno
   Reichert, Heinrich
TI Cell lineage-specific expression and function of the empty spiracles
   gene in adult brain development of Drosophila melanogaster
SO DEVELOPMENT
LA English
DT Article
DE empty spiracles; ems; brain development; neuroblast lineage; MARCM;
   Drosophila; neurogenesis
ID DEVELOPING CEREBRAL-CORTEX; CENTRAL-NERVOUS-SYSTEM; LATE LARVAL STAGE;
   MUSHROOM BODY; HOMEOBOX GENES; MOUSE-BRAIN; POSTEMBRYONIC NEUROBLASTS;
   NEURAL PROLIFERATION; HEAD DEVELOPMENT; MOSAIC ANALYSIS
AB The empty spiracles (ems) gene, encoding a homeodomain transcription factor, is a member of the cephalic gap gene family that acts in early specification of the anterior neuroectoderm in the embryonic brain of Drosophila. Here we show that ems is also expressed in the mature adult brain in the lineage-restricted clonal progeny of a single neuroblast in each brain hemisphere. These ems-expressing neuronal cells are located ventral to the antennal lobes and project a fascicle to the superior medial protocerebrum. All adult-specific secondary neurons in this lineage persistently express ems during postembryonic larval development and continue to do so throughout metamorphosis and into the adult. Mosaic-based MARCM mutant analysis and genetic rescue experiments demonstrate that ems function is autonomously required for the correct number of cells in the persistently expressing adult-specific lineage. Moreover, they indicate that ems is also required cell autonomously for the formation of the correct projections in this specific lineage. This analysis of ems expression and function reveals novel and unexpected roles of a cephalic gap gene in translating lineage information into cell number control and projection specificity in an individual clonal unit of the adult brain.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Lichtneckert, R (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Robert.Lichtneckert@stud.unibas.ch
CR Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8
   Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N
   Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8
   Cecchi C, 2002, GENE, V291, P1, DOI 10.1016/S0378-1119(02)00623-6
   Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   DELAESCALERA S, 1990, EMBO J, V9, P3593, DOI 10.1002/j.1460-2075.1990.tb07570.x
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   Gangemi RMR, 2001, MECH DEVELOP, V109, P323, DOI 10.1016/S0925-4773(01)00546-9
   Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x
   Hassan BA, 2000, NEURON, V25, P549, DOI 10.1016/S0896-6273(00)81059-4
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Hitier R, 2001, MECH DEVELOP, V103, P3, DOI 10.1016/S0925-4773(01)00312-4
   JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157
   Kambadur R, 1998, GENE DEV, V12, P246, DOI 10.1101/gad.12.2.246
   Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8
   Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8
   Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5
   Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000
   Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614
   Martini SR, 2000, DEVELOPMENT, V127, P2663
   Martini SR, 2005, J NEUROBIOL, V64, P133, DOI 10.1002/neu.20130
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002
   Shinozaki K, 2002, DEVELOPMENT, V129, P3479
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
   Zapala MA, 2005, P NATL ACAD SCI USA, V102, P10357, DOI 10.1073/pnas.0503357102
   Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962
NR 50
TC 13
Z9 13
U1 0
U2 1
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR 1
PY 2007
VL 134
IS 7
BP 1291
EP 1300
DI 10.1242/dev.02814
PG 10
WC Developmental Biology
SC Developmental Biology
GA 144YM
UT WOS:000244832500006
PM 17314131
OA Bronze
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Seelig, J
AF Heerklotz, Heiko
   Seelig, Joachim
TI Leakage and lysis of lipid membranes induced by the lipopeptide
   surfactin
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE antibiotic peptide; membrane lysis; membrane permeabilization;
   asymmetric partitioning; calcein leakage
ID ISOTHERMAL TITRATION CALORIMETRY; BACILLUS-SUBTILIS; OCTYL GLUCOSIDE;
   PHOSPHATIDYLCHOLINE VESICLES; ANTIBACTERIAL PEPTIDES;
   MOLECULAR-MECHANISM; TRITON X-100; SOLUBILIZATION; DETERGENTS;
   PERMEABILIZATION
AB Surfactin is a lipopeptide produced by Bacillus subtilis which possesses antimicrobial activity. We have studied the leakage and lysis of POPC vesicles induced by surfactin using calcein fluorescence de-quenching, isothermal titration calorimetry and P-31 solid state NMR. Membrane leakage starts at a surfactin-to-lipid ratio in the membrane, R-b approximate to 0.05, and an aqueous surfactin concentration of C-S(W) approximate to 2 mu M. The transient, graded nature of leakage and the apparent coupling with surfactin translocation to the inner leaflet of the vesicles, suggests that this low-concentration effect is due to a bilayer-couple mechanism. Different permeabilization behaviour is found at R-b approximate to 0.15 and attributed to surfactin-rich clusters, which can induce leaks and stabilize them by covering their hydrophobic edges. Membrane lysis or solubilization to micellar structures starts at R-b(sat) = 0.22 and C-S(W) = 9 mu M and is completed at R-m(sol) = 0.43 and C-S(W) = 11 mu M. The membrane - water partition coefficient of surfactin is obtained as K = 2 x 10(4) M-1. These data resolve inconsistencies in the literature and shed light on the variety of effects often referred to as detergent-like effects of antibiotic peptides on membranes. The results are compared with published parameters characterizing the hemolytic and antibacterial activity.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr,70, CH-4056 Basel, Switzerland.
EM heerklotz@gmx.net
OI Heerklotz, Heiko/0000-0003-4615-7022
CR ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2
   Beven L, 1997, RES MICROBIOL, V148, P163, DOI 10.1016/S0923-2508(97)87647-4
   Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8
   Cameotra SS, 2004, CURR OPIN MICROBIOL, V7, P262, DOI 10.1016/j.mib.2004.04.006
   Carrillo C, 2003, BBA-BIOMEMBRANES, V1611, P91, DOI 10.1016/S0005-2736(03)00029-4
   Chellani Mohan, 1999, American Biotechnology Laboratory, V17, P18
   DELAMAZA A, 1994, BIOCHEM J, V303, P907, DOI 10.1042/bj3030907
   Dufour S, 2005, BBA-GEN SUBJECTS, V1726, P87, DOI 10.1016/j.bbagen.2005.06.015
   EDWARDS K, 1991, J COLLOID INTERF SCI, V147, P1, DOI 10.1016/0021-9797(91)90129-V
   ENCINAS MV, 1982, CHEM PHYS LETT, V91, P55, DOI 10.1016/0009-2614(82)87031-0
   HEERKLOTZ H, 1994, BBA-BIOMEMBRANES, V1196, P114, DOI 10.1016/0005-2736(94)00222-3
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2004, J PHYS CHEM B, V108, P4909, DOI 10.1021/jp0371938
   Heerklotz H, 2001, BIOPHYS J, V81, P1547, DOI 10.1016/S0006-3495(01)75808-0
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Hildebrand A, 2002, LANGMUIR, V18, P2836, DOI 10.1021/la011421c
   KAMEDA Y, 1974, CHEM PHARM BULL, V22, P938
   Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9
   Kinsinger RF, 2003, J BACTERIOL, V185, P5627, DOI 10.1128/JB.185.18.5627-5631.2003
   Kracht M, 1999, J ANTIBIOT, V52, P613, DOI 10.7164/antibiotics.52.613
   Ladokhin AS, 1995, BIOPHYS J, V69, P1964, DOI 10.1016/S0006-3495(95)80066-4
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   LANGE Y, 1981, J BIOL CHEM, V256, P5321
   Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004
   LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7
   LOHNER K, 1997, ADV BIOPH C, V6, P53
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   Pantaler E, 2000, BBA-BIOMEMBRANES, V1509, P397, DOI 10.1016/S0005-2736(00)00322-9
   PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006
   Prenner EJ, 2001, BBA-BIOMEMBRANES, V1510, P83, DOI 10.1016/S0005-2736(00)00337-0
   Rauch C, 2000, BIOPHYS J, V78, P3036, DOI 10.1016/S0006-3495(00)76842-1
   SHEETZ MP, 1974, P NATL ACAD SCI USA, V71, P4457, DOI 10.1073/pnas.71.11.4457
   VINSON PK, 1989, BIOPHYS J, V56, P669, DOI 10.1016/S0006-3495(89)82714-6
   Vollenbroich D, 1997, BIOLOGICALS, V25, P289, DOI 10.1006/biol.1997.0099
   Vollenbroich D, 1997, APPL ENVIRON MICROB, V63, P44, DOI 10.1128/AEM.63.1.44-49.1997
   Wenk MR, 1997, J PHYS CHEM B, V101, P5224, DOI 10.1021/jp9707955
   Wieprecht T, 1999, BIOCHEMISTRY-US, V38, P10377, DOI 10.1021/bi990913+
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P442, DOI 10.1021/bi992146k
   Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n
NR 43
TC 119
Z9 130
U1 0
U2 48
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0175-7571
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD APR
PY 2007
VL 36
IS 4-5
BP 305
EP 314
DI 10.1007/s00249-006-0091-5
PG 10
WC Biophysics
SC Biophysics
GA 158WO
UT WOS:000245826200006
PM 17051366
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, Michael N.
TI TOR signaling and control of cell growth
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology 2007 Annual Meeting
CY APR 28-MAY 02, 2007
CL Washington, DC
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
CR Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 1
TC 0
Z9 0
U1 0
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2007
VL 21
IS 5
BP A206
EP A206
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 157HD
UT WOS:000245708501419
DA 2021-01-25
ER

PT J
AU Sprecher, SG
   Reichert, H
   Hartenstein, V
AF Sprecher, Simon G.
   Reichert, Heinrich
   Hartenstein, Volker
TI Gene expression patterns in primary neuronal clusters of the Drosophila
   embryonic brain
SO GENE EXPRESSION PATTERNS
LA English
DT Article
DE Drosophila; embryonic brain; brain development; hox genes; pair rule
   genes; segment polarity genes; head gap genes; retinal patterning genes;
   columnar patterning genes
ID CENTRAL-NERVOUS-SYSTEM; MSH HOMEOBOX GENE; MUSHROOM BODIES; EYE
   DEVELOPMENT; EMPTY-SPIRACLES; NEUROBLAST FORMATION; OLFACTORY CIRCUIT;
   GOOSEBERRY-DISTAL; SEGMENT POLARITY; COLUMN IDENTITY
AB The brain of Drosophila is formed by approximately 100 lineages, each lineage being derived from a stem cell-like neuroblast that segregates from the procephalic neurectoderm of the early embryo. A neuroblast map has been established in great detail for the early embryo, and a suite of molecular markers has been defined for all neuroblasts included in this map [Urbach, R., Technau, G.M. (2003a) Molecular markers for identified neuroblasts in the developing brain of Drosophila. Development 130, 3621-3637]. However, the expression of these markers was not followed into later embryonic or larval stages, mainly due to the fact that anatomical landmarks to which expression patterns could be related had not been defined. Such markers, in the form of stereotyped clusters of neurons whose axons project along cohesive bundles ("primary axon bundles" or "PABs") are now available [Younossi-Hartenstein, A., Nguyen, B., Shy, D., Hartenstein, V. 2006. Embryonic origin of the Drosophila brain neuropile. J. Comp. Neurol. 497, 981-998]. In the present study we have mapped the expression of molecular markers in relationship to primary neuronal clusters and their PABs. The markers we analyzed include many of the genes involved in patterning of the brain along the anteroposterior axis (cephalic gap genes, segment polarity genes) and dorso-ventral axis (columnar patterning genes), as well as genes expressed in the dorsal protocerebrum and visual system (early eye genes). Our analysis represents an important step along the way to identify neuronal lineages of the mature brain with genes expressed in the early embryo in discrete neuroblasts. Furthermore, the analysis helped us to reconstruct the morphogenetic movements that transform the two-dimensional neuroblast layer of the early embryo into the three-dimensional larval brain and provides the basis for deeper understanding of how the embryonic brain develops. (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90024 USA.
RP Sprecher, SG (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM ss3924@nyu.edu
RI Sprecher, Simon/B-5188-2012; Sprecher, Simon/K-4249-2015
OI Sprecher, Simon/0000-0001-9060-3750
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [NS 29367, R01 NS029367, R01 NS054814, R56
   NS029367] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL
   DISORDERS AND STROKEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R01NS054814, R01NS054814,
   R01NS029367, R01NS029367, R01NS029367, R01NS029367, R01NS029367,
   R01NS029367, R01NS029367, R01NS029367, R01NS054814, R01NS029367,
   R01NS054814, R56NS029367, R01NS054814, R01NS054814, R01NS054814,
   R01NS029367, R01NS029367, R01NS054814, R01NS054814, R01NS054814,
   R01NS029367, R01NS029367, R01NS029367, R01NS054814, R01NS029367,
   R01NS054814, R01NS054814] Funding Source: NIH RePORTER
CR Ashburner M., 1989, DROSOPHILA LAB MANUA, P214
   Aspland SE, 1997, DEVELOPMENT, V124, P741
   Bhat KM, 1996, DEVELOPMENT, V122, P2921
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   BROADUS J, 1995, MECH DEVELOP, V53, P393, DOI 10.1016/0925-4773(95)00454-8
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Chizhikov VV, 2005, DEV BIOL, V277, P287, DOI 10.1016/j.ydbio.2004.10.011
   Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496
   Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   Hirth F, 1998, EUR J NEUROSCI, V10, P384
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Isshiki T, 1997, DEVELOPMENT, V124, P3099
   JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700
   Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3
   JURGENS G, 1988, ARCH DEV BIOL, V197, P345
   Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8
   KAPHINGST K, 1994, CELL, V78, P437, DOI 10.1016/0092-8674(94)90422-7
   Kosman D, 1998, DEV GENES EVOL, V208, P290, DOI 10.1007/s004270050184
   Kurusu M, 2002, DEVELOPMENT, V129, P409
   Laissue PP, 1999, J COMP NEUROL, V405, P543
   Lee T, 1999, DEVELOPMENT, V126, P4065
   Lehmann M, 1996, EMBO J, V15, P4825, DOI 10.1002/j.1460-2075.1996.tb00863.x
   LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1
   Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Marin EC, 2005, DEVELOPMENT, V132, P725, DOI 10.1242/dev.01614
   Marti E, 2002, TRENDS NEUROSCI, V25, P89, DOI 10.1016/S0166-2236(02)02062-3
   McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603
   MEINERTZHAGEN IA, 1993, PROG RETIN RES, V12, P13, DOI 10.1016/0278-4327(93)90003-C
   MOHLER J, 1995, MECH DEVELOP, V50, P151, DOI 10.1016/0925-4773(94)00332-H
   Morante J, 2004, SEMIN CELL DEV BIOL, V15, P137, DOI 10.1016/j.semcdb.2003.09.007
   Nagao T, 2000, DEV GENES EVOL, V210, P289, DOI 10.1007/s004270050316
   Nassif C, 1998, J COMP NEUROL, V402, P10
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4
   Pabst O, 1998, MECH DEVELOP, V73, P85, DOI 10.1016/S0925-4773(98)00035-5
   Page DT, 2002, DEVELOPMENT, V129, P2121
   Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435
   Panganiban G, 2002, DEVELOPMENT, V129, P4371
   PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1
   Pera EM, 1998, DEV GENES EVOL, V208, P168, DOI 10.1007/s004270050170
   Pereanu W, 2004, CURR OPIN GENET DEV, V14, P382, DOI 10.1016/j.gde.2004.06.010
   Pignoni F, 1997, DEVELOPMENT, V124, P271
   Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5
   Ramaekers A, 2005, CURR BIOL, V15, P982, DOI 10.1016/j.cub.2005.04.032
   Renn SCP, 1999, J NEUROBIOL, V41, P189
   Richter S, 1998, DEV GENES EVOL, V208, P37, DOI 10.1007/s004270050151
   Rudolph KM, 1997, DEVELOPMENT, V124, P4297
   Shen WP, 1997, DEVELOPMENT, V124, P45
   Shimamura K, 1995, DEVELOPMENT, V121, P3923
   SKEATH JB, 1995, NATURE, V376, P427, DOI 10.1038/376427a0
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372
   Strausfeld NJ, 1998, LEARN MEMORY, V5, P11
   STRAUSS R, 1993, J NEUROSCI, V13, P1852, DOI 10.1523/jneurosci.13-05-01852.1993
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wang WD, 1996, MECH DEVELOP, V58, P203, DOI 10.1016/S0925-4773(96)00562-X
   Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591
   Younossi-Hartenstein A, 1997, MICROSC RES TECHNIQ, V39, P479, DOI 10.1002/(SICI)1097-0029(19971215)39:6<479::AID-JEMT3>3.0.CO;2-9
   Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   ZHANG Y, 1994, DEVELOPMENT, V120, P1151
NR 74
TC 24
Z9 24
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-133X
EI 1872-7298
J9 GENE EXPR PATTERNS
JI Gene Expr. Patterns
PD APR
PY 2007
VL 7
IS 5
BP 584
EP 595
DI 10.1016/j.modgep.2007.01.004
PG 12
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 161MJ
UT WOS:000246019000006
PM 17300994
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Grieder, NC
   Charlafti, I
   Kloter, U
   Jackle, H
   Schafer, U
   Gehring, WJ
AF Grieder, Nicole C.
   Charlafti, Ilias
   Kloter, Urs
   Jaeckle, Herbert
   Schaefer, Ulrich
   Gehring, Walter J.
TI Misexpression screen in Drosophila melanogaster aiming to reveal novel
   factors involved in formation of body parts
SO GENETICS
LA English
DT Article
ID HOMEOTIC GENE ANTENNAPEDIA; ZINC-FINGER PROTEIN; IMAGINAL DISCS; EYE
   DEVELOPMENT; GENOME PROJECT; WING FORMATION; EXPRESSION;
   TRANSDETERMINATION; NOTCH; SIGNALS
AB To identify novel factors that lead a fly imaginal disc to adopt its developmental fate, we carried out a modular dominant misexpression screen in imaginal discs. We have identified two factors that appear to change the fate of the respective body structure and appear to lead to the transformation of a body part. In one mutant line, notum tissue, normally derived from wing imaginal tissue, formed close to the site of the sternopleural bristles, which are leg disc derivatives. In the other line, the arista is transformed into a tubular structure, resembling an abnormal leg. We found that ectopic expression of abrupt was responsible for this potential transformation of the arista.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany.
RP Grieder, NC (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM nicole.griedcr@unibas.ch
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Beinert N, 2004, CHROMOSOMA, V113, P271, DOI 10.1007/s00412-004-0313-5
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   CELNIKER SE, 2002, GENOME BIOL, V0003
   Cohen Stephen M., 1993, P747
   CRISP J, 1997, DROS INF SERV, V80, P90
   CZERNY T, 1995, MOL CELL, V3, P2997
   de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157
   DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215
   Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421
   Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323
   Emerald BS, 2001, CURR BIOL, V11, pR1025, DOI 10.1016/S0960-9822(01)00616-9
   GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x
   Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946
   GEHRING W, 1966, JUL KLAUS ARCH, V41, P44
   GEHRING WJ, 1993, GENE, V135, P215, DOI 10.1016/0378-1119(93)90068-E
   Gerlitz O, 2002, INT J DEV BIOL, V46, P173
   Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751
   Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   HADORN E, 1963, DEV BIOL, V7, P617, DOI 10.1016/0012-1606(63)90146-5
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   HU S, 1995, GENE DEV, V9, P2936, DOI 10.1101/gad.9.23.2936
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Katsuyama T, 2005, P NATL ACAD SCI USA, V102, P15918, DOI 10.1073/pnas.0507945102
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Maves L, 1998, DEVELOPMENT, V125, P115
   Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006
   Neumann CJ, 1996, DEVELOPMENT, V122, P3477
   Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435
   PARKS AL, 1993, DEV BIOL, V157, P484, DOI 10.1006/dbio.1993.1151
   Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9
   Rorth P, 1998, DEVELOPMENT, V125, P1049
   SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x
   SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0
   SCHUBIGER G, 1971, DEV BIOL, V26, P277, DOI 10.1016/0012-1606(71)90127-8
   SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824
   Spradling AC, 1999, GENETICS, V153, P135
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   STEINER E, 1976, ROUX ARCH DEV BIOL, V180, P9, DOI 10.1007/BF00848882
   Sugimura K, 2004, NEURON, V43, P809, DOI 10.1016/j.neuron.2004.08.016
   Sustar A, 2005, CELL, V120, P383, DOI 10.1016/j.cell.2004.12.008
   Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314
   Toba G, 1999, GENETICS, V151, P725
   WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467
NR 57
TC 11
Z9 11
U1 0
U2 4
PU GENETICS
PI BALTIMORE
PA 428 EAST PRESTON ST, BALTIMORE, MD 21202 USA
SN 0016-6731
J9 GENETICS
JI Genetics
PD APR
PY 2007
VL 175
IS 4
BP 1707
EP 1718
DI 10.1534/genetics.106.064212
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 167JU
UT WOS:000246448800015
PM 17179072
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hausser, HJ
   Ruegg, MA
   Brenner, RE
   Ksiazek, I
AF Hausser, Heinz-Juergen
   Ruegg, Markus A.
   Brenner, Rolf E.
   Ksiazek, Iwona
TI Agrin is highly expressed by chondrocytes and is required for normal
   growth
SO HISTOCHEMISTRY AND CELL BIOLOGY
LA English
DT Article
DE agrin; chondrocyte; growth plate; skeletal growth
ID MUSCLE-DERIVED AGRIN; INDIAN-HEDGEHOG; FACTOR RECEPTOR-3; BASAL LAMINA;
   CARTILAGE; COLLAGEN; DIFFERENTIATION; ISOFORMS; BONE; MICE
AB Agrin is a heparan sulfate proteoglycan that is best known for its crucial involvement in the organization and maintenance of postsynaptic structures at the neuromuscular junction. Consistent with this role, mice deficient of agrin die at birth due to respiratory failure. Here we examined the early postnatal development of agrin-deficient mice in which perinatal death was prevented by transgenic expression of neural agrin in motor neurons. Such transgenic, agrin-deficient mice were born at Mendelian ratio but exhibited severe postnatal growth retardation. Growth plate morpholgy was markedly altered in these mice, with changes being most prominent in the hypertrophic zone. Compression of this zone was not caused by reduced viability of hypertrophic chondrocytes, as no differences in the apoptosis rates could be observed. Furthermore, deposition of the major cartilage matrix components collagen type II and aggrecan was slightly reduced in these mice. Consistent with a role for agrin in skeletal development, we show for the first time that agrin is highly expressed by chondrocytes and localizes to the growth plate in wild-type mice. Our data show that agrin is expressed in cartilage and that it plays a critical role in normal skeletal growth.
C1 Univ Ulm, RKU, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, D-89081 Ulm, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hausser, HJ (corresponding author), Univ Ulm, RKU, Dept Orthoped, Div Biochem Joint & Connect Tissue Dis, Oberer Eselsberg 45, D-89081 Ulm, Germany.
EM heinz-juergen.hausser@uni-ulm.de
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Aszodi A, 1998, J CELL BIOL, V143, P1399, DOI 10.1083/jcb.143.5.1399
   BELLUS GA, 1995, NAT GENET, V10, P357, DOI 10.1038/ng0795-357
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Church V, 2002, J CELL SCI, V115, P4809, DOI 10.1242/jcs.00152
   CSTELL M, 1999, J CELL BIOL, V147, P1109
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1
   FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Girkontaite I, 1996, MATRIX BIOL, V15, P231, DOI 10.1016/S0945-053X(96)90114-6
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237
   Gress CJ, 2000, J CELL BIOL, V149, P983, DOI 10.1083/jcb.149.4.983
   Groffen AJ, 1998, J HISTOCHEM CYTOCHEM, V46, P19, DOI 10.1177/002215549804600104
   Gustafsson E, 2003, ANN NY ACAD SCI, V995, P140, DOI 10.1111/j.1749-6632.2003.tb03217.x
   Inoue T, 2004, CELL, V118, P795, DOI 10.1016/j.cell.2004.09.001
   Iwasaki M, 1997, MECH DEVELOP, V69, P197, DOI 10.1016/S0925-4773(97)00145-7
   JACENKO O, 1993, NATURE, V365, P56, DOI 10.1038/365056a0
   Karaplis A., 2002, PRINCIPLES BONE BIOL, P33
   Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594
   Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657
   Kwan KM, 1997, J CELL BIOL, V136, P459, DOI 10.1083/jcb.136.2.459
   LIETH E, 1992, DEV BIOL, V149, P41, DOI 10.1016/0012-1606(92)90262-F
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3
   Masiakowski P, 1998, CURR BIOL, V8, pR407, DOI 10.1016/S0960-9822(98)70263-5
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Naski MC, 1998, DEVELOPMENT, V125, P4977
   NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471
   OCONNOR LT, 1994, J NEUROSCI, V14, P1141
   ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   RUPP F, 1992, J NEUROSCI, V12, P3535
   Saldanha J, 1998, PROTEIN SCI, V7, P1632, DOI 10.1002/pro.5560070718
   Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112
   Somerville JN, 2004, CALCIFIED TISSUE INT, V74, P469, DOI 10.1007/s00223-003-0101-x
   St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072
   TAVORMINA PL, 1995, NAT GENET, V9, P321, DOI 10.1038/ng0395-321
   Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1
   van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033
   Vanky P, 1998, BONE, V22, P331, DOI 10.1016/S8756-3282(97)00286-X
   Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613
   Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324
NR 45
TC 18
Z9 18
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0948-6143
EI 1432-119X
J9 HISTOCHEM CELL BIOL
JI Histochem. Cell Biol.
PD APR
PY 2007
VL 127
IS 4
BP 363
EP 374
DI 10.1007/s00418-006-0258-2
PG 12
WC Cell Biology; Microscopy
SC Cell Biology; Microscopy
GA 144FU
UT WOS:000244782400002
PM 17186266
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Bar, H
   Mucke, N
   Katus, HA
   Aebi, U
   Herrmann, H
AF Baer, Harald
   Muecke, Norbert
   Katus, Hugo A.
   Aebi, Ueli
   Herrmann, Harald
TI Assembly defects of desmin disease mutants carrying deletions in the
   alpha-helical rod domain are rescued by wild type protein
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE myofibrillar myopathy; desmin; deletion mutation; assembly; intermediate
   filament disease
ID INTERMEDIATE-FILAMENT PROTEINS; SKELETAL MYOPATHY; IN-VITRO; MISSENSE
   MUTATIONS; MUSCLE DISEASE; HUMAN VIMENTIN; GENETIC-BASIS; CELLS; HEAD;
   CARDIOMYOPATHY
AB Most mutations of desmin that cause severe autosomal dominant forms of myofibrillar myopathy are point mutations and locate in the central a-helical coiled-coil rod domain. Recently, two in-frame deletions of one and three amino acids, respectively, in the a-helix have been described and discussed to drastically interfere with the architecture of the desmin dimer and possibly also the formation of tetramers and higher order complexes [Kaminska, A., Strelkov, S.V., Goudeau, B., Olive, M., Dagvadorj, A., Fidzianska, A., Simon-Casteras, M., Shatunov, A., Dalakas, M.C., Ferrer, I., Kwiecinski, H., Vicart, P., Goldfarb, L.G., 2004. Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum. Genet. 114, 306-313.]. Therefore, it was proposed that they may poison intermediate filament (IF) assembly. We have now recombinantly synthesized both mutant proteins and subjected them to comprehensive in vitro assembly experiments. While exhibiting assembly defects when analyzed on their own, both one-to-one mixtures of the respective mutant protein with wild type desmin facilitated proper filament formation. Transient transfection studies complemented this fundamental finding by demonstrating that wild type desmin is also rescuing these assembly defects in vivo. In summary, our findings strongly question the previous hypothesis that it is assembly incompetence due to molecular rearrangements caused by the mutations, which triggers the development of disease. As an alternative, we propose that these mutations cause subtle age-dependent structural alterations of desmin IFs that eventually lead to disease. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   DKFZ, German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
RP Bar, H (corresponding author), Univ Heidelberg, Dept Cardiol, Bergheimer Str 58, D-69120 Heidelberg, Germany.
EM h.baer@dkfz.de
CR Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132
   Arbustini E, 2006, EUR J HEART FAIL, V8, P477, DOI 10.1016/j.ejheart.2005.11.003
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Fidzianska A, 2005, NEUROMUSCULAR DISORD, V15, P525, DOI 10.1016/j.nmd.2005.05.006
   FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8
   HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   HOFMANN I, 1991, EUR J CELL BIOL, V56, P328
   Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje
   Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007
   Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Muntoni F, 2006, BRAIN, V129, P1260, DOI 10.1093/brain/awl062
   NIEHRS C, 1992, J BIOL CHEM, V267, P15938
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Park KY, 2000, J MED GENET, V37, P851, DOI 10.1136/jmg.37.11.851
   Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4
   Patterson C, 2006, J MOL CELL CARDIOL, V40, P438, DOI 10.1016/j.yjmcc.2006.01.003
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   PINSET C, 1988, DIFFERENTIATION, V38, P28, DOI 10.1111/j.1432-0436.1988.tb00588.x
   PRUSZCZYK P, 2006, INT J CARDIOL
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4
NR 43
TC 14
Z9 15
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD APR
PY 2007
VL 158
IS 1
BP 107
EP 115
DI 10.1016/j.jsb.2006.10.029
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 154UO
UT WOS:000245533500010
PM 17188893
DA 2021-01-25
ER

PT J
AU Malone, JG
   Williams, R
   Christen, M
   Jenal, U
   Spiers, AJ
   Rainey, PB
AF Malone, J. G.
   Williams, R.
   Christen, M.
   Jenal, U.
   Spiers, A. J.
   Rainey, P. B.
TI The structure-function relationship of WspR, a Pseudomonas fluorescens
   response regulator with a GGDEF output domain
SO MICROBIOLOGY-SGM
LA English
DT Article
ID CYCLIC DI-GMP; PENTAPEPTIDE SCANNING MUTAGENESIS; BIOFILM FORMATION;
   ALLOSTERIC CONTROL; EXPERIMENTAL POPULATIONS; ADAPTIVE DIVERGENCE;
   DIGUANYLATE CYCLASE; TWITCHING MOTILITY; SWISS-MODEL; PHOSPHODIESTERASE
AB The GGDEF response regulator WspR couples the chemosensory Wsp pathway to the overproduction of acetylated cellulose and cell attachment in the Pseudomonas fluorescens SBW25 wrinkly spreader (WS) genotype. Here, it is shown that WspR is a diguanylate cyclase (DGC), and that DGC activity is elevated in the WS genotype compared to that in the ancestral smooth (SM) genotype. A structure-function analysis of 120 wspR mutant alleles was employed to gain insight into the regulation and activity of WspR. Firstly, 44 random and defined pentapeptide insertions were produced in WspR, and the effects determined using assays based on colony morphology, attachment to surfaces and cellulose production. The effects of mutations within WspR were interpreted using a homology model, based on the crystal structure of Caulobacter crescentus PleD. Mutational analyses indicated that WspR activation occurs as a result of disruption of the interdomain interface, leading to the release of effector-domain repression by the N-terminal receiver domain. Quantification of attachment and cellulose production raised significant questions concerning the mechanisms of WspR function. The conserved RYGGEEF motif of WspR was also subjected to mutational analysis, and 76 single amino acid residue substitutions were tested for their effects on WspR function. The RYGGEEF motif of WspR is functionally conserved, with almost every mutation abolishing function.
C1 Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Ctr Ecol & Hydrol, Oxford OX1 3SR, England.
   Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
RP Rainey, PB (corresponding author), Univ Oxford, Dept Plant Sci, S Parks Rd, Oxford OX1 3RB, England.
EM p.rainey@auckland.ac.nz
RI Rainey, Paul/A-3207-2008; Spiers, Andrew/I-3535-2012; Malone,
   Jacob/G-8319-2011
OI Rainey, Paul/0000-0003-0879-5795; Spiers, Andrew/0000-0003-0463-8629;
   Christen, Matthias/0000-0001-7724-4562; Malone,
   Jacob/0000-0003-1959-6820
FU Natural Environment Research CouncilNERC Natural Environment Research
   Council [CEH010021, ceh010021] Funding Source: researchfish
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andrade MO, 2006, MOL MICROBIOL, V62, P537, DOI 10.1111/j.1365-2958.2006.05386.x
   Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o
   BANTINAKI E, 2007, IN PRESS GENETICS
   Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036
   Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002
   Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buckler DR, 2002, STRUCTURE, V10, P153, DOI 10.1016/S0969-2126(01)00706-7
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381
   Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x
   Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x
   Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hallet B, 1997, NUCLEIC ACIDS RES, V25, P1866, DOI 10.1093/nar/25.9.1866
   Hayes F, 2000, TRENDS MICROBIOL, V8, P571, DOI 10.1016/S0966-842X(00)01857-6
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Johnson MR, 2005, MOL MICROBIOL, V55, P664, DOI 10.1111/j.1365-2958.2004.04419.x
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   KING EO, 1954, J LAB CLIN MED, V44, P301
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Mattison K, 2002, J BIOL CHEM, V277, P32714, DOI 10.1074/jbc.M204122200
   Miller J., 1972, EXPT MOL GENETICS, P352
   Muchova K, 2004, MOL MICROBIOL, V53, P829, DOI 10.1111/j.1365-2958.2004.04171.x
   Park SU, 2002, KOREAN J RADIOL, V3, P16, DOI 10.3348/kjr.2002.3.1.16
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900
   Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x
   Rashid MH, 2003, FEMS MICROBIOL LETT, V227, P113, DOI 10.1016/S0378-1097(03)00657-8
   Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x
   Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Spiers AJ, 2002, GENETICS, V161, P33
   Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x
   SUMMERS DK, 1988, EMBO J, V7, P851, DOI 10.1002/j.1460-2075.1988.tb02884.x
   Ude S, 2006, ENVIRON MICROBIOL, V8, P1997, DOI 10.1111/j.1462-2920.2006.01080.x
   Walthers D, 2003, J BACTERIOL, V185, P317, DOI 10.1128/JB.185.1.317-324.2003
   WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469
   Zhang GY, 1997, NATURE, V386, P247, DOI 10.1038/386247a0
NR 63
TC 82
Z9 87
U1 1
U2 16
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD APR
PY 2007
VL 153
BP 980
EP 994
DI 10.1099/mic.0.2006/002824-0
PN 4
PG 15
WC Microbiology
SC Microbiology
GA 160RE
UT WOS:000245959200007
PM 17379708
OA Bronze
DA 2021-01-25
ER

PT J
AU Perrot, M
   Guieysse-Peugeot, AL
   Massoni, A
   Espagne, C
   Claverol, S
   Silva, RM
   Jeno, P
   Santos, M
   Bonneu, M
   Boucherie, H
AF Perrot, Michel
   Guieysse-Peugeot, Anne-Laure
   Massoni, Aurelie
   Espagne, Christelle
   Claverol, Stephane
   Monteiro Silva, Raquel
   Jeno, Paul
   Santos, Manuel
   Bonneu, Marc
   Boucherie, Helian
TI Yeast proteome map (update 2006)
SO PROTEOMICS
LA English
DT Article
DE proteome; Saccharomyces cerevisiae; yeast
ID SACCHAROMYCES-CEREVISIAE; PROTEINS; IDENTIFICATION; DATABASE
AB To improve the potential of two-dimensional gel electrophoresis for proteomic investigations in yeast we have undertaken the systematic identification of Saccharomyces cerevisiae proteins separated on 2-D gels. We report here the identification of 187 novel protein spots. They were identified by two methods, mass spectrometry and gene inactivation. These identifications extend the number of protein spots identified on our yeast 2-D proteome map to 602, i.e. nearly half the detectable spots of the proteome map. These spots correspond to 417 different proteins. The reference map and the list of identified proteins can be accessed on the Yeast Protein Map server (www.ibgc.u-bordeaux2.fr/YPM).
C1 CNRS, IBGC, UMR 5095, F-33077 Bordeaux, France.
   Univ Bordeaux 2, F-33076 Bordeaux, France.
   Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal.
   Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
RP Boucherie, H (corresponding author), CNRS, IBGC, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.
EM H.Boucherie@ibgc.u-bordeaux2.fr
RI Silva, Raquel M/B-8337-2008; Santos, Manuel/E-6704-2010
OI Silva, Raquel M/0000-0001-5926-8042; Santos, Manuel/0000-0002-0437-1146
CR Blanc JF, 2005, PROTEOMICS, V5, P3778, DOI 10.1002/pmic.200401194
   Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   Kobi D, 2004, FEMS YEAST RES, V5, P213, DOI 10.1016/j.femsyr.2004.07.004
   Kolkman A, 2005, TRENDS BIOTECHNOL, V23, P598, DOI 10.1016/j.tibtech.2005.09.004
   LUDWIG JR, 1982, MOL CELL BIOL, V2, P117, DOI 10.1128/MCB.2.2.117
   Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263
   MONRIBOT C, 2000, PROTEOME RES 2 DIMEN, P31
   Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200
   Perrot M, 1999, ELECTROPHORESIS, V20, P2280, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2280::AID-ELPS2280>3.3.CO;2-H
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Wildgruber R, 2002, PROTEOMICS, V2, P727, DOI 10.1002/1615-9861(200206)2:6<727::AID-PROT727>3.0.CO;2-2
   Yin ZK, 2004, PROTEOMICS, V4, P2425, DOI 10.1002/pmic.200300760
NR 13
TC 15
Z9 15
U1 0
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD APR
PY 2007
VL 7
IS 7
BP 1117
EP 1120
DI 10.1002/pmic.200600952
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 157RT
UT WOS:000245739100010
PM 17351888
DA 2021-01-25
ER

PT J
AU Facciotti, F
   Cavallari, M
   Schuemann, J
   Nebenius-Oosthuizen, D
   Angenieux, C
   Signorino-Gello, F
   de la Salle, H
   Mori, L
   De Libero, G
AF Facciotti, F.
   Cavallari, M.
   Schuemann, J.
   Nebenius-Oosthuizen, D.
   Angenieux, C.
   Signorino-Gello, F.
   de la Salle, H.
   Mori, L.
   De Libero, G.
TI CD1e participates in generation of iNKT cell ligands
SO SWISS MEDICAL WEEKLY
LA English
DT Meeting Abstract
C1 Univ Basel Hosp, Res Dept, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Strasbourg, INSERM, U725, Etablissement Francais Sang, Strasbourg, France.
RI Facciotti, Federica/AAA-3518-2019; Schuemann, Jan/A-4346-2011; De La
   Salle, Henri/H-9353-2016
OI Facciotti, Federica/0000-0002-2541-9428; Schuemann,
   Jan/0000-0002-7554-8818; De La Salle, Henri/0000-0001-5136-0776
NR 0
TC 0
Z9 0
U1 0
U2 0
PU E M H SWISS MEDICAL PUBLISHERS LTD
PI MUTTENZ
PA FARNSBURGERSTR 8, CH-4132 MUTTENZ, SWITZERLAND
SN 1424-7860
J9 SWISS MED WKLY
JI Swiss Med. Wkly.
PD MAR 30
PY 2007
VL 137
SU 157
BP 20S
EP 20S
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA 152IN
UT WOS:000245355800062
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Aanismaa, P
   Seelig, A
AF Aeaenismaa, Paeivi
   Seelig, Anna
TI P-glycoprotein kinetics measured in plasma membrane vesicles and living
   cells
SO BIOCHEMISTRY
LA English
DT Article
ID ATP HYDROLYSIS; CATALYTIC CYCLE; DRUG TRANSPORT; BINDING; STATE;
   GLYCOLYSIS; ACTIVATION; DEPENDENCE; MECHANISM; SITES
AB P-glycoprotein (MDR1, ABCB1) is an ATP-dependent efflux transporter of a large variety of compounds. To understand P-glycoprotein in more detail, it is important to elucidate its activity in the cellular ensemble as well as in plasma membrane vesicles (under conditions where other ATP dependent proteins are blocked). We measured P-glycoprotein activity in inside-out vesicles formed from plasma membranes of MDR1-transfected mouse embryo fibroblasts (NIH-MDR1-G185) for comparison with previous measurements of P-glycoprotein activity in living NIH-MDR1-G185 cells. In plasma membrane vesicles activity was measured by monitoring phosphate release upon ATP hydrolysis and in living cells by monitoring the extracellular acidification rate upon ATP synthesis via glycolysis. P-glycoprotein was stimulated as a function of the concentration with 19 structurally different drugs, including local anesthetics, cyclic peptides, and cytotoxic drugs. The concentrations of half-maximum P-glycoprotein activation, K-1, were identical in inside-out plasma membrane vesicles and in living cells and covered a broad range of concentrations (K-1 similar to (10(-8)-10(-3)) M). The influence of the pH, drug association, and vesicle aggregation on the concentration of half-maximum P-glycoprotein activation was investigated. The turnover numbers in plasma membrane vesicles and in living cells were also approximately identical if the latter were measured in the presence of pyruvate. However, in the absence of pyruvate they were higher in living cells. The rate of ATP hydrolysis/ATP synthesis decreased exponentially with decreasing free energy of drug binding from water to the transporter, Delta G(tw(1))(0) (or increasing binding affinity). This suggests that drug release from the transmembrane domains has to occur before ATP is hydrolyzed for resetting the transporter.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504
   ARRUDA JAL, 1980, J LAB CLIN MED, V96, P450
   BROXTERMAN HJ, 1991, J CELL PHARM, V2, P239
   Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Garrigues A, 2002, ANAL BIOCHEM, V305, P106, DOI 10.1006/abio.2002.5650
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188
   Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836
   KAMINSKAS E, 1978, BIOCHEM J, V174, P453, DOI 10.1042/bj1740453
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Rosenberg MF, 2005, J BIOL CHEM, V280, P2857, DOI 10.1074/jbc.M410296200
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 2006, BIOPHYS J, V90, P3825, DOI 10.1529/biophysj.106.082008
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8
   Sharom FJ, 2005, J BIOENERG BIOMEMBR, V37, P481, DOI 10.1007/s10863-005-9496-6
   SHAROM FJ, 1993, J BIOL CHEM, V268, P24197
   Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200
   URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956
   WILHELM G, 1971, FEBS LETT, V17, P158, DOI 10.1016/0014-5793(71)80587-2
   YAHYA A M, 1988, Drug Metabolism and Drug Interactions, V6, P1
NR 38
TC 45
Z9 45
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAR 20
PY 2007
VL 46
IS 11
BP 3394
EP 3404
DI 10.1021/bi0619526
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 145HB
UT WOS:000244854800048
PM 17302433
DA 2021-01-25
ER

PT J
AU Bello, B
   Holbro, N
   Reichert, H
AF Bello, Bruno
   Holbro, Niklaus
   Reichert, Heinrich
TI Polycomb group genes are required for neural stem cell survival in
   postembryonic neurogenesis of Drosophila
SO DEVELOPMENT
LA English
DT Article
DE polycomb group; Drosophila; neurogenesis; Hox genes; neuroblasts
ID TRITHORAX GROUP PROTEINS; NEUROBLAST SELF-RENEWAL;
   CENTRAL-NERVOUS-SYSTEM; CHROMOSOMAL-PROTEIN; WILD-TYPE; PROLIFERATION;
   DIVISION; MELANOGASTER; EXPRESSION; MUTANT
AB Genes of the Polycomb group (PcG) are part of a cellular memory system that maintains appropriate inactive states of Hox gene expression in Drosophila. Here, we investigate the role of PcG genes in postembryonic development of the Drosophila CNS. We use mosaic-based MARCM techniques to analyze the role of these genes in the persistent larval neuroblasts and progeny of the central brain and thoracic ganglia. We find that proliferation in postembryonic neuroblast clones is dramatically reduced in the absence of Polycomb, Sex combs extra, Sex combs on midleg, Enhancer of zeste or Suppressor of zeste 12. The proliferation defects in these PcG mutants are due to the loss of neuroblasts by apoptosis in the mutant clones. Mutation of PcG genes in postembryonic lineages results in the ectopic expression of posterior Hox genes, and experimentally induced misexpression of posterior Hox genes, which in the wild type causes neuroblast death, mimics the PcG loss-of-function phenotype. Significantly, full restoration of wild-type-like properties in the PcG mutant lineages is achieved by blocking apoptosis in the neuroblast clones. These findings indicate that loss of PcG genes leads to aberrant derepression of posterior Hox gene expression in postembryonic neuroblasts, which causes neuroblast death and termination of proliferation in the mutant clones. Our findings demonstrate that PcG genes are essential for normal neuroblast survival in the postembryonic CNS of Drosophila. Moreover, together with data on mammalian PcG genes, they imply that repression of aberrant reactivation of Hox genes may be a general and evolutionarily conserved role for PcG genes in CNS development.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bello, B (corresponding author), Univ Basel, Biozentrum, Klingelberg Str 50, CH-4056 Basel, Switzerland.
EM Bruno.Bello@unibas.ch
CR Awad TA, 1997, DEV BIOL, V187, P283, DOI 10.1006/dbio.1997.8587
   Barna M, 2002, DEV CELL, V3, P499, DOI 10.1016/S1534-5807(02)00289-7
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017
   Beuchle D, 2001, DEVELOPMENT, V128, P993
   Bornemann D, 1998, GENETICS, V150, P675
   Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Carrington EA, 1996, DEVELOPMENT, V122, P4073
   Chia W, 2002, CURR OPIN GENET DEV, V12, P459, DOI 10.1016/S0959-437X(02)00326-X
   DECAMILLIS M, 1994, ROUX ARCH DEV BIOL, V203, P429, DOI 10.1007/BF00188692
   Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5
   IkeshimaKataoka H, 1997, NATURE, V390, P625
   Jan YN, 2001, NAT REV NEUROSCI, V2, P772, DOI 10.1038/35097516
   Kennison JA, 1995, ANNU REV GENET, V29, P289, DOI 10.1146/annurev.ge.29.120195.001445
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299
   Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572
   Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385
   MARTIN EC, 1993, DEVELOPMENT, V117, P641
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004
   Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060
   Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5
   Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0
   Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587
   Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142
   Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910
   Pirrotta V, 1998, CELL, V93, P333, DOI 10.1016/S0092-8674(00)81162-9
   PROKOP A, 1994, DEVELOPMENT, V120, P2567
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907
   Schumacher A, 1997, TRENDS GENET, V13, P167, DOI 10.1016/S0168-9525(97)01133-5
   Shakhova O, 2005, J MOL MED, V83, P596, DOI 10.1007/s00109-005-0682-0
   SIMON J, 1995, CURR OPIN CELL BIOL, V7, P376, DOI 10.1016/0955-0674(95)80093-X
   Simon JA, 2002, CURR OPIN GENET DEV, V12, P210, DOI 10.1016/S0959-437X(02)00288-5
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   SMOUSE D, 1990, DEV BIOL, V139, P169, DOI 10.1016/0012-1606(90)90286-R
   SOTO MC, 1995, GENETICS, V140, P231
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   TRUMAN JW, 1993, DEV DROSOPHILA MELAN, V2, P1245
   Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005
   Wang J, 2006, DEVELOPMENT, V133, P1231, DOI 10.1242/dev.02299
   Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016
NR 46
TC 47
Z9 48
U1 0
U2 1
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD MAR 15
PY 2007
VL 134
IS 6
BP 1091
EP 1099
DI 10.1242/dev.02793
PG 9
WC Developmental Biology
SC Developmental Biology
GA 144YJ
UT WOS:000244832200008
PM 17287254
OA Bronze
DA 2021-01-25
ER

PT J
AU Snyers, L
   Vlcek, S
   Dechat, T
   Skegro, D
   Korbei, B
   Gajewski, A
   Mayans, O
   Schofer, C
   Foisner, R
AF Snyers, Luc
   Vlcek, Sylvia
   Dechat, Thomas
   Skegro, Darko
   Korbei, Barbara
   Gajewski, Andreas
   Mayans, Olga
   Schoefer, Christian
   Foisner, Roland
TI Lamina-associated polypeptide 2-alpha forms homo-trimers via its C
   terminus, and oligomerization is unaffected by a disease-causing
   mutation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID NUCLEAR-STRUCTURE DYNAMICS; A-TYPE LAMINS; CHROMOSOME ASSOCIATION;
   LAP2-ALPHA; PROTEIN; BAF; CHROMATIN; ENVELOPE; REGION; DOMAIN
AB The nucleoplasmic protein, Lamina-associated polypeptide (LAP) 2 alpha, is one of six alternatively spliced products of the LAP2gene, which share a common N-terminal region. In contrast to the other isoforms, which also share most of their C termini, LAP2 alpha has a large unique C-terminal region that contains binding sites for chromatin, A-type lamins, and retinoblastorna protein. By immunoprecipitation analyses of LAP2a complexes from cells expressing differently tagged LAP2 alpha proteins and fragments, we demonstrate that LAP21y forms higher order structures containing multiple LAP2 alpha molecules in vivo and that complex formation is mediated by the C terminus. Solid phase binding assays using recombinant and in vitro translated LAP2 alpha fragments showed direct interactions of LAP2 alpha C termini. Cross-linking of LAP2 alpha complexes and multiangle light-scattering of purified LAP2 alpha revealed the existence of stable homo-trimers in vivo and in vitro. Finally, we show that, in contrast to the LAP2 alpha-lamin A interaction, its self-association is not affected by a disease-linked single point mutation in the LAP2 alpha C terminus.
C1 Med Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria.
   Med Univ Vienna, Ctr Anat & Cell Biol, A-1090 Vienna, Austria.
   Univ Basel, Biozentrum, Div Marine Biol, CH-4056 Basel, Switzerland.
RP Foisner, R (corresponding author), Med Univ Vienna, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria.
EM roland.foisner@meduniwien.ac.at
RI Foisner, Roland/AAD-1833-2019; Mayans, Olga/A-3954-2008
OI Mayans, Olga/0000-0001-6876-8532; Schofer,
   Christian/0000-0001-9570-5692; Korbei, Barbara/0000-0002-0439-0435
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P 17871] Funding
   Source: Medline
CR Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879
   Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Dechat T, 2000, J CELL SCI, V113, P3473
   Dechat T, 2000, J STRUCT BIOL, V129, P335, DOI 10.1006/jsbi.2000.4212
   Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529
   Dechat T, 1998, EMBO J, V17, P4887, DOI 10.1093/emboj/17.16.4887
   Dorner D, 2006, J CELL BIOL, V173, P83, DOI 10.1083/jcb.200511149
   Foisner R, 2001, J CELL SCI, V114, P3791
   Gajewski A, 2004, J BIOL CHEM, V279, P35813, DOI 10.1074/jbc.M402546200
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Hutchison CJ, 2004, NAT CELL BIOL, V6, P1062, DOI 10.1038/ncb1104-1062
   Markiewicz E, 2002, MOL BIOL CELL, V13, P4401, DOI 10.1091/mbc.E02-07-0450
   Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532
   Segura-Totten M, 2004, TRENDS CELL BIOL, V14, P261, DOI 10.1016/j.tcb.2004.03.004
   Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221
   Suzuki Y, 2004, EMBO J, V23, P4670, DOI 10.1038/sj.emboj.7600452
   Taylor MRG, 2005, HUM MUTAT, V26, P566, DOI 10.1002/humu.20250
   Vlcek S, 1999, EMBO J, V18, P6370, DOI 10.1093/emboj/18.22.6370
   Vlcek S, 2002, J BIOL CHEM, V277, P18898, DOI 10.1074/jbc.M200048200
NR 22
TC 12
Z9 12
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 2
PY 2007
VL 282
IS 9
BP 6308
EP 6315
DI 10.1074/jbc.M605782200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 145LS
UT WOS:000244867200037
PM 17213199
OA Other Gold
DA 2021-01-25
ER

PT J
AU Soldatova, LN
   Tsai, C
   Dobrovolskaia, E
   Markovic-Housley, Z
   Slater, JE
AF Soldatova, Lyudmila N.
   Tsai, Chaoming
   Dobrovolskaia, Ekaterina
   Markovic-Housley, Zora
   Slater, Jay E.
TI Characterization of the N-glycans of recombinant bee venom hyaluronidase
   (Api m 2) expressed in insect cells
SO ALLERGY AND ASTHMA PROCEEDINGS
LA English
DT Article
DE allergen; bee venom allergy; honeybee; hymenoptera; hyaluronidase;
   recombinant
ID HIGH-LEVEL EXPRESSION; DUST MITE ALLERGEN; GLYCOSYLATION; CARBOHYDRATE;
   PURIFICATION; IGE
AB Honeybee venom hyaluronidase (Api m 2) is a major glycoprotein allergen. Previous studies have indicated that recombinant Api m 2 expressed in insect cells has enzyme activity and IgE binding comparable with that Of native Api m 2. In contrast, Api m 2 expressed in Escherichia coli does not. In this study, we characterized the carbohydrate side chains of Api m 2 expressed in insect cells, and compared our data with the established carbohydrate structure of native Api m 2. We assessed both the monosaccharide and the oligosaccharide content of recombinant Api m 2 using fluorophore-assisted carbohydrate electrophoresis and HPLC. To identify the amino acid residues at which glycosylation occurs, we digested recombinant Api m 2 with endoproteinase Glu-C and identified the fragments that contained carbohydrate by specific staining. Recombinant Api m 2 expressed in insect cells contains N-acetylglucosamine, mannose, and fucose, as well as trace amounts of glucose and galactose, and the oligosaccharide analysis is consistent with heterogeneous oligosaccharide chains consisting of two to seven monosaccharides. No sialic acid or N-acetylgalactosamine were detected. These results are similar to published data for native Api m 2, although some monosaccharide components appear to be absent in the recombinant protein. Analysis of proteolytic digests indicates that of the four candidate N-glycosylation sites, carbohydrate chains are attached at asparagines 115 and 263. Recombinant Api m 2 expressed in insect cells has enzymic activity and IgE binding comparable with the native protein, and its carbohydrate composition is very similar.
C1 US FDA, Ctr Biol Evaluat & Res, Bethesda, MD 20014 USA.
   Univ Basel, Dept Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
RP Slater, JE (corresponding author), US FDA, Lab Immunobiochem, Ctr Biol Evaluat & Res, 1401 Rockville Pike,HFM 422, Rockville, MD 20852 USA.
EM jay.slater@fda.hhs.gov
CR Best EA, 2000, PROTEIN EXPRES PURIF, V20, P462, DOI 10.1006/prep.2000.1327
   DUDLER T, 1992, BIOCHIM BIOPHYS ACTA, V1165, P201, DOI 10.1016/0005-2760(92)90188-2
   Hakkaart GAJ, 1998, CLIN EXP ALLERGY, V28, P45, DOI 10.1046/j.1365-2222.1998.00164.x
   HARDY MR, 1988, ANAL BIOCHEM, V170, P54, DOI 10.1016/0003-2697(88)90089-9
   HEWICK RM, 1981, J BIOL CHEM, V256, P7990
   Huecas S, 1999, EUR J BIOCHEM, V261, P539, DOI 10.1046/j.1432-1327.1999.00307.x
   JACKSON P, 1994, METHOD ENZYMOL, V230, P250
   Jarvis DL, 1998, CURR OPIN BIOTECH, V9, P528, DOI 10.1016/S0958-1669(98)80041-4
   Kao G, 2004, VACCINE, V22, P335, DOI 10.1016/j.vaccine.2003.08.008
   KEMENY DM, 1984, EUR J BIOCHEM, V139, P217, DOI 10.1111/j.1432-1033.1984.tb07997.x
   King TP, 2000, INT ARCH ALLERGY IMM, V123, P99, DOI 10.1159/000024440
   Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737
   KUBELKA V, 1995, GLYCOCONJUGATE J, V12, P77, DOI 10.1007/BF00731872
   MANNEBERG M, 1994, PROTEIN SCI, V3, P30
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Morrow KS, 2001, CLIN REV ALLERG IMMU, V21, P141, DOI 10.1385/CRIAI:21:2-3:141
   Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   Takahashi K, 2000, INT ARCH ALLERGY IMM, V122, P108, DOI 10.1159/000024366
   TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534
   Vailes LD, 1998, J ALLERGY CLIN IMMUN, V101, P274, DOI 10.1016/S0091-6749(98)70393-8
   van Ree R, 2000, J BIOL CHEM, V275, P11451, DOI 10.1074/jbc.275.15.11451
   VOSS T, 1993, EUR J BIOCHEM, V217, P913, DOI 10.1111/j.1432-1033.1993.tb18321.x
   YEH JC, 1993, BIOCHEMISTRY-US, V32, P11087, DOI 10.1021/bi00092a019
NR 24
TC 15
Z9 16
U1 0
U2 3
PU OCEAN SIDE PUBLICATIONS INC
PI PROVIDENCE
PA 95 PITMAN ST, PROVIDENCE, RI 02906 USA
SN 1088-5412
EI 1539-6304
J9 ALLERGY ASTHMA PROC
JI Allergy Asthma Proc.
PD MAR-APR
PY 2007
VL 28
IS 2
BP 210
EP 215
DI 10.2500/aap.2007.28.2947
PG 6
WC Allergy
SC Allergy
GA 160IO
UT WOS:000245934300016
PM 17479607
DA 2021-01-25
ER

PT J
AU Gaidatzis, D
   van Nimwegen, E
   Hausser, J
   Zavolan, M
AF Gaidatzis, Dimos
   van Nimwegen, Erik
   Hausser, Jean
   Zavolan, Mihaela
TI Inference of miRNA targets using evolutionary conservation and pathway
   analysis
SO BMC BIOINFORMATICS
LA English
DT Article
ID COMPUTATIONAL IDENTIFICATION; MICRORNA; GENES; EXPRESSION; PREDICTION;
   ZEBRAFISH; RNAS; ENCODES; CLONING; MOTIFS
AB Background: MicroRNAs have emerged as important regulatory genes in a variety of cellular processes and, in recent years, hundreds of such genes have been discovered in animals. In contrast, functional annotations are available only for a very small fraction of these miRNAs, and even in these cases only partially.
   Results: We developed a general Bayesian method for the inference of miRNA target sites, in which, for each miRNA, we explicitly model the evolution of orthologous target sites in a set of related species. Using this method we predict target sites for all known miRNAs in flies, worms, fish, and mammals. By comparing our predictions in fly with a reference set of experimentally tested miRNA-mRNA interactions we show that our general method performs at least as well as the most accurate methods available to date, including ones specifically tailored for target prediction in fly. An important novel feature of our model is that it explicitly infers the phylogenetic distribution of functional target sites, independently for each miRNA. This allows us to infer species-specific and clade-specific miRNA targeting. We also show that, in long human 3' UTRs, miRNA target sites occur preferentially near the start and near the end of the 3' UTR.
   To characterize miRNA function beyond the predicted lists of targets we further present a method to infer significant associations between the sets of targets predicted for individual miRNAs and specific biochemical pathways, in particular those of the KEGG pathway database. We show that this approach retrieves several known functional miRNA-mRNA associations, and predicts novel functions for known miRNAs in cell growth and in development.
   Conclusion: We have presented a Bayesian target prediction algorithm without any tunable parameters, that can be applied to sequences from any clade of species. The algorithm automatically infers the phylogenetic distribution of functional sites for each miRNA, and assigns a posterior probability to each putative target site. The results presented here indicate that our general method achieves very good performance in predicting miRNA target sites, providing at the same time insights into the evolution of target sites for individual miRNAs. Moreover, by combining our predictions with pathway analysis, we propose functions of specific miRNAs in nervous system development, inter-cellular communication and cell growth. The complete target site predictions as well as the miRNA/pathway associations are accessible on the ElMMo web server.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM d.gaidatzis@unibas.ch; erik.vannimwegen@unibas.ch;
   jean.hausser@unibas.ch; mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Hausser, Jean/0000-0002-3321-7199; van Nimwegen,
   Erik/0000-0001-6338-1312; Zavolan, Mihaela/0000-0002-8832-2041
CR Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031
   Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914
   Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906
   Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Bui JD, 2000, CELL, V100, P457, DOI 10.1016/S0092-8674(00)80681-9
   Burgler C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-88
   Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605
   Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102
   Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503
   Enright AJ, 2004, GENOME BIOL, V5
   Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020
   Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013
   Hipfner DR, 2002, GENETICS, V161, P1527
   Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014
   Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372
   Michael MZ, 2003, MOL CANCER RES, V1, P882
   Naguibneva I, 2006, NAT CELL BIOL, V8, P278, DOI 10.1038/ncb1373
   Nelson JM, 2006, J CORP FINANC, V12, P187, DOI 10.1016/j.jcorpfin.2005.07.002
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607
   Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102
   Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105
   Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060
   Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019
   van Nimwegen E, 2006, PLOS GENET, V2, P587, DOI 10.1371/journal.pgen.0020024
   Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010
   Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519
   Wittbrodt J, 2002, NAT REV GENET, V3, P53, DOI 10.1038/nrg704
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044
   Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x
   Zanesi N, 2006, CANCER RES, V66, P915, DOI 10.1158/0008-5472.CAN-05-3426
NR 64
TC 229
Z9 235
U1 0
U2 26
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAR 1
PY 2007
VL 8
AR 69
DI 10.1186/1471-2105-8-69
PG 22
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 150AN
UT WOS:000245188100001
PM 17331257
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Zieseniss, A
   Schroeder, U
   Buchmeier, S
   Schoenenberger, CA
   van den Heuvel, J
   Jockusch, BM
   Illenberger, S
AF Zieseniss, Anke
   Schroeder, Ulrich
   Buchmeier, Sabine
   Schoenenberger, Cora-Ann
   van den Heuvel, Joop
   Jockusch, Brigitte M.
   Illenberger, Susanne
TI Raver1 is an integral component of muscle contractile elements
SO CELL AND TISSUE RESEARCH
LA English
DT Article
DE hnRNP; striated muscle; smooth muscle; sarcomere; myofibril; mouse
ID SKELETAL-MUSCLE; GENE-EXPRESSION; STRIATED-MUSCLE; CARDIAC-MUSCLE;
   MESSENGER-RNAS; PROTEIN; CELLS; LOCALIZATION; SARCOMERE; TURNOVER
AB Raver1, a ubiquitously expressed protein, was originally identified as a ligand for metavinculin, the muscle-specific isoform of the microfilament-associated protein vinculin. The protein resides primarily in the nucleus, where it colocalises and may interact with polypyrimidine-tract-binding protein, which is involved in alternative splicing processes. During skeletal muscle differentiation, raver1 translocates to the cytoplasm and eventually targets the Z-line of sarcomeres. Here, it colocalises with metavinculin, vinculin and alpha-actinin, all of which have biochemically been identified as raver1 ligands. To obtain more information about the potential role of raver1 in muscle structure and function, we have investigated its distribution and fine localisation in mouse striated and smooth muscle, by using three monoclonal antibodies that recognise epitopes in different regions of the raver1 protein. Our immunofluorescence and immunoelectron-microscopic results indicate that the cytoplasmic accumulation of raver1 is not confined to skeletal muscle but also occurs in heart and smooth muscle. Unlike vinculin and metavinculin, cytoplasmic raver1 is not restricted to costameres but additionally represents an integral part of the sarcomere. In isolated myofibrils and in ultrathin sections of skeletal muscle, raver1 has been found concentrated at the I-Z-I band. A minor fraction of raver1 is present in the nuclei of all three types of muscle. These data indicate that, during muscle differentiation, raver1 might link gene expression with structural functions of the contractile machinery of muscle.
C1 Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Bioctr, D-38092 Braunschweig, Germany.
   Univ Basel, Biozentrum, Maurice E Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany.
   Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA.
RP Illenberger, S (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, Bioctr, Spielmann Str 7, D-38092 Braunschweig, Germany.
EM S.Illenberger@tu-bs.de
CR Bang ML, 2001, J CELL BIOL, V153, P413, DOI 10.1083/jcb.153.2.413
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   Frank R, 1996, Methods Mol Biol, V66, P149
   GHETTI A, 1992, NUCLEIC ACIDS RES, V20, P3671, DOI 10.1093/nar/20.14.3671
   Gromak N, 2003, EMBO J, V22, P6356, DOI 10.1093/emboj/cdg609
   Huttelmaier S, 2001, J CELL BIOL, V155, P775, DOI 10.1083/jcb.200105044
   Janmey PA, 1998, PHYSIOL REV, V78, P763
   Jeyaseelan R, 1997, J BIOL CHEM, V272, P22800, DOI 10.1074/jbc.272.36.22800
   Jockusch BM, 2003, NEWS PHYSIOL SCI, V18, P7, DOI 10.1152/nips.01413.2002
   Jockusch H, 2003, J CELL SCI, V116, P1611, DOI 10.1242/jcs.00364
   Kleinhenz B, 2005, FEBS LETT, V579, P4254, DOI 10.1016/j.febslet.2005.07.001
   KOTELIANSKY VE, 1983, FEBS LETT, V159, P158, DOI 10.1016/0014-5793(83)80437-2
   Lange S, 2006, TRENDS CELL BIOL, V16, P11, DOI 10.1016/j.tcb.2005.11.007
   Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463
   Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181
   Littlefield R, 2001, NAT CELL BIOL, V3, P544, DOI 10.1038/35078517
   MARTIN AF, 1981, J BIOL CHEM, V256, P964
   Mayboroda O, 1997, CELL MOTIL CYTOSKEL, V37, P166, DOI 10.1002/(SICI)1097-0169(1997)37:2<166::AID-CM9>3.0.CO;2-6
   MCKENNA NM, 1986, J CELL BIOL, V103, P2163, DOI 10.1083/jcb.103.6.2163
   Michele DE, 1999, J CELL BIOL, V145, P1483, DOI 10.1083/jcb.145.7.1483
   Miller MK, 2003, J MOL BIOL, V333, P951, DOI 10.1016/j.jmb.2003.09.012
   MORRIS EJ, 1994, J CELL SCI, V107, P377
   PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008
   Russell B, 2000, J APPL PHYSIOL, V88, P1127
   Sanchez-Carbayo M, 2003, ONCOGENE, V22, P5298, DOI 10.1038/sj.onc.1206616
   SLOT JW, 1985, EUR J CELL BIOL, V38, P87
   Spellman R, 2005, BIOCHEM SOC T, V33, P457, DOI 10.1042/BST0330457
   TOKUYASU KT, 1981, P NATL ACAD SCI-BIOL, V78, P7619, DOI 10.1073/pnas.78.12.7619
   VALCARCEL J, 1997, CURR BIOL, V7, P705
   Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063
   Weins A, 2001, J CELL BIOL, V155, P393, DOI 10.1083/jcb.200012039
   Witt S, 2004, J BIOL CHEM, V279, P31533, DOI 10.1074/jbc.M314245200
   Young P, 2001, J CELL BIOL, V154, P123, DOI 10.1083/jcb.200102110
   ZAK R, 1977, J BIOL CHEM, V252, P3430
NR 34
TC 12
Z9 12
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0302-766X
J9 CELL TISSUE RES
JI Cell Tissue Res.
PD MAR
PY 2007
VL 327
IS 3
BP 583
EP 594
DI 10.1007/s00441-006-0322-1
PG 12
WC Cell Biology
SC Cell Biology
GA 134NW
UT WOS:000244091100015
PM 17096167
DA 2021-01-25
ER

PT J
AU Wendeler, MW
   Paccaud, JP
   Hauri, HP
AF Wendeler, Markus W.
   Paccaud, Jean-Pierre
   Hauri, Hans-Peter
TI Role of Sec24 isoforms in selective export of membrane proteins from the
   endoplasmic reticulum
SO EMBO REPORTS
LA English
DT Article
DE COPII; ERGIC-53; endoplasmic reticulum export signal; protein transport;
   Sec24
ID SACCHAROMYCES-CEREVISIAE; LECTIN ERGIC-53; ER EXPORT; COPII; TRANSPORT;
   COAT; VESICLES; CARGO; GOLGI; COMPLEX
AB Sec24 of the COPII (coat protein complex II) vesicle coat mediates the selective export of membrane proteins from the endoplasmic reticulum (ER) in yeast. Human cells express four Sec24 isoforms, but their role is unknown. Here, we report the differential effects of Sec24 isoform-specific silencing on the transport of the membrane reporter protein ERGIC-53 (ER-Golgi intermediate compartment-53) carrying the cytosolic ER export signals di-phenylalanine, di-tyrosine, di-leucine, di-isoleucine, di-valine or terminal valine. Knockdown of single Sec24 isoforms showed dependence of di-leucine-mediated transport on Sec24A, but transport mediated by the other signals was not affected. By contrast, double knockdown of Sec24A with one of the other three Sec24 isoforms impaired all aromatic/hydrophobic signal-dependent transport. Double knockdown of Sec24B/C or Sec24B/D preferentially affected di-leucine-mediated transport, whereas knockdown of Sec24C/D affected di-isoleucine- and valine-mediated transport. The isoform-selective transport correlated with binding preferences of the signals for the corresponding isoforms in vitro. Thus, human Sec24 isoforms expand the repertoire of cargo for signal-mediated ER export, but are in part functionally redundant.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   OM Pharma, CH-1217 Geneva, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Barlowe C, 2003, CELL, V114, P395, DOI 10.1016/S0092-8674(03)00650-0
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Kim J, 2005, J BIOL CHEM, V280, P7758, DOI 10.1074/jbc.M411091200
   Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3
   Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759
   Nufer O, 2002, J CELL SCI, V115, P619
   Pagano A, 1999, J BIOL CHEM, V274, P7833, DOI 10.1074/jbc.274.12.7833
   Peng RW, 2000, J BIOL CHEM, V275, P11521, DOI 10.1074/jbc.275.15.11521
   Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973
   Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
NR 19
TC 120
Z9 123
U1 1
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD MAR
PY 2007
VL 8
IS 3
BP 258
EP 264
DI 10.1038/sj.embor.7400893
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 152JZ
UT WOS:000245359600014
PM 17255961
OA Green Published
DA 2021-01-25
ER

PT J
AU Hungerbuehler, AK
   Philippsen, P
   Gladfelter, AS
AF Hungerbuehler, A. Katrin
   Philippsen, Peter
   Gladfelter, Amy S.
TI Limited functional redundancy and oscillation of cyclins in
   multinucleated Ashbya gossypii fungal cells
SO EUKARYOTIC CELL
LA English
DT Article
ID B-TYPE CYCLINS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; S-PHASE;
   SUBCELLULAR-LOCALIZATION; USTILAGO-MAYDIS; GENE DELETION; G(1) CYCLINS;
   MORPHOGENESIS; SPECIFICITY
AB Cyclin protein behavior has not been systematically investigated in multinucleated cells with asynchronous mitoses. Cyclins are canonical oscillating cell cycle proteins, but it is unclear how fluctuating protein gradients can be established in multinucleated cells where nuclei in different stages of the division cycle share the cytoplasm. Previous work in A. gossypii, a filamentous fungus in which nuclei divide asynchronously in a common cytoplasm, demonstrated that one G1 and one B-type cyclin do not fluctuate in abundance across the division cycle. We have undertaken a comprehensive analysis of all G1 and B-type cyclins in A. gossypii to determine whether any of the cyclins show periodic abundance across the cell cycle and to examine whether cyclins exhibit functional redundancy in such a cellular environment. We localized all G1 and B-type cyclins and notably found that only AgClb5/6p varies in subcellular localization during the division cycle. AgClb5/6p is lost from nuclei at the meta-anaphase transition in a D-box-dependent manner. These data demonstrate that efficient nuclear autonomous protein degradation can occur within multinucleated cells residing in a common cytoplasm. We have shown that three of the five cyclins in A. gossypii are essential genes, indicating that there is minimal functional redundancy in this multinucleated system. In addition, we have identified a cyclin, AgClb3/4p, that is essential only for sporulation. We propose that the cohabitation of different cyclins in nuclei has led to enhanced substrate specificity and limited functional redundancy within classes of cyclins in multinucleated cells.
C1 Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA.
   Biozentrum Univ Basel, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Gladfelter, AS (corresponding author), Dartmouth Coll, Dept Biol, Gilman Hall, Hanover, NH 03755 USA.
EM amy.gladfelter@dartmouth.edu
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Archambault V, 2005, CELL CYCLE, V4, P125, DOI 10.4161/cc.4.1.1402
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bachewich C, 2005, EUKARYOT CELL, V4, P95, DOI 10.1128/EC.4.1.95-102.2005
   BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329
   Bensen ES, 2005, MOL BIOL CELL, V16, P3387, DOI 10.1091/mbc.E04-12-1081
   Boisnard-Lorig C, 2001, PLANT CELL, V13, P495, DOI 10.1105/tpc.13.3.495
   Bose I, 2001, J BIOL CHEM, V276, P7176, DOI 10.1074/jbc.M010546200
   Castillo-Lluva S, 2005, PLANT CELL, V17, P3544, DOI 10.1105/tpc.105.036319
   Cross FR, 2000, MOL CELL BIOL, V20, P4782, DOI 10.1128/MCB.20.13.4782-4790.2000
   Cross FR, 1999, MOL CELL, V4, P11, DOI 10.1016/S1097-2765(00)80183-5
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Donaldson AD, 1998, MOL CELL, V2, P173, DOI 10.1016/S1097-2765(00)80127-6
   Donaldson AD, 2000, EMBO REP, V1, P507
   Edgington NP, 2001, J CELL SCI, V114, P4599
   Fisher DL, 1996, EMBO J, V15, P850, DOI 10.1002/j.1460-2075.1996.tb00420.x
   Garcia-Muse T, 2004, J CELL SCI, V117, P487, DOI 10.1242/jcs.00877
   Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6
   Gladfelter AS, 2007, EUKARYOT CELL, V6, P182, DOI 10.1128/EC.00364-06
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0
   Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43927
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Hood JK, 2001, J CELL SCI, V114, P589
   Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184
   Jacobson MD, 2000, MOL CELL BIOL, V20, P4483, DOI 10.1128/MCB.20.13.4483-4493.2000
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Lazo BCY, 2005, EUKARYOT CELL, V4, P90, DOI 10.1128/EC.4.1.90-94.2005
   LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305
   Loeb JDJ, 1999, MOL CELL BIOL, V19, P4019
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329
   Miller ME, 2000, MOL CELL BIOL, V20, P542, DOI 10.1128/MCB.20.2.542-555.2000
   Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001
   Miller ME, 2001, J CELL SCI, V114, P1811
   Moore JD, 2003, SCIENCE, V300, P987, DOI 10.1126/science.1081418
   Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8
   Roberts JM, 1999, CELL, V98, P129, DOI 10.1016/S0092-8674(00)81007-7
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495
   Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C
   Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
NR 45
TC 16
Z9 17
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD MAR
PY 2007
VL 6
IS 3
BP 473
EP 486
DI 10.1128/EC.00273-06
PG 14
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 153ZC
UT WOS:000245475600012
PM 17122387
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Stephens, C
   Christen, B
   Fuchs, T
   Sundaram, V
   Watanabe, K
   Jenal, U
AF Stephens, Craig
   Christen, Beat
   Fuchs, Thomas
   Sundaram, Vidyodhaya
   Watanabe, Kelly
   Jenal, Urs
TI Genetic analysis of a novel pathway for D-xylose metabolism in
   Caulobacter crescentus
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID L-ARABINOSE METABOLISM; ESCHERICHIA-COLI K-12; ALTERNATIVE PATHWAY;
   REGULATORY ELEMENTS; PSEUDOMONAS-FRAGI; MOLECULAR-CLONING; ENCODED
   REGULON; GENOME SEQUENCE; DEHYDROGENASE; TRANSCRIPTION
AB Genetic data suggest that the oligotrophic freshwater bacterium Caulobacter crescentus metabolizes D-xylose through a pathway yielding alpha-ketoglutarate, comparable to the recently described L-arabinose degradation pathway of Azospirillum brasilense. Enzymes of the C. crescentus pathway, including an NAD(+)-dependent xylose dehydrogenase, are encoded in the xylose-inducible xylXABCD operon (CC0823-CC0819).
C1 Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.
   Univ Basel, Biozentrum, CH-4054 Basel, Switzerland.
RP Stephens, C (corresponding author), Santa Clara Univ, Dept Biol, 500 El Camino Real, Santa Clara, CA 95053 USA.
EM cstephens@scu.edu
RI Christen, Beat/AAC-2974-2021
OI Christen, Beat/0000-0002-9528-3685
CR AHLEM C, 1982, J BIOL CHEM, V257, P2926
   Bochner BR, 2003, NAT REV GENET, V4, P309, DOI 10.1038/nrg1046
   BUCHERT J, 1986, BIOTECHNOL LETT, V8, P541, DOI 10.1007/BF01028079
   CARTER AT, 1993, GENE, V130, P155, DOI 10.1016/0378-1119(93)90362-7
   DAGLEY S, 1965, BIOCHEM J, V95, P48, DOI 10.1042/bj0950048
   DAHMS AS, 1974, BIOCHEM BIOPH RES CO, V60, P1433
   DAHMS AS, 1982, METHOD ENZYMOL, V89, P226
   DAVIS EO, 1987, J BIOL CHEM, V262, P13928
   DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Harhangi HR, 2003, ARCH MICROBIOL, V180, P134, DOI 10.1007/s00203-003-0565-0
   Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004
   Jeffries T W, 1983, Adv Biochem Eng Biotechnol, V27, P1
   Johnsen U, 2004, J BACTERIOL, V186, P6198, DOI 10.1128/JB.186.18.6198-6207.2004
   LAWLIS VB, 1984, APPL ENVIRON MICROB, V47, P15, DOI 10.1128/AEM.47.1.15-21.1984
   LOKMAN BC, 1991, MOL GEN GENET, V230, P161, DOI 10.1007/BF00290664
   Mannisto MK, 1999, ARCH MICROBIOL, V171, P189, DOI 10.1007/s002030050698
   Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   Osteras M, 1997, MICROBIOL-SGM, V143, P1639, DOI 10.1099/00221287-143-5-1639
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   RILEY RG, 1976, MICROBIOS, V16, P219
   Romano AH, 1996, RES MICROBIOL, V147, P448, DOI 10.1016/0923-2508(96)83998-2
   RYGUS T, 1991, ARCH MICROBIOL, V155, P535, DOI 10.1007/BF00245346
   SCHELER A, 1991, ARCH MICROBIOL, V155, P526, DOI 10.1007/BF00245345
   Watanabe S, 2006, J BIOL CHEM, V281, P2612, DOI 10.1074/jbc.M506477200
   Watanabe S, 2006, J BIOL CHEM, V281, P28876, DOI 10.1074/jbc.M602585200
   WEIMBERG R, 1961, J BIOL CHEM, V236, P629
   West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002
   YAMANAKA K, 1977, AGR BIOL CHEM TOKYO, V41, P1493, DOI 10.1080/00021369.1977.10862702
NR 30
TC 114
Z9 123
U1 0
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD MAR
PY 2007
VL 189
IS 5
BP 2181
EP 2185
DI 10.1128/JB.01438-06
PG 5
WC Microbiology
SC Microbiology
GA 139WH
UT WOS:000244462800082
PM 17172333
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Meinen, S
   Barzaghi, P
   Lin, S
   Lochmuller, H
   Ruegg, MA
AF Meinen, Sarina
   Barzaghi, Patrizia
   Lin, Shuo
   Lochmueller, Hanns
   Ruegg, Markus A.
TI Linker molecules between laminins and dystroglycan ameliorate
   laminin-alpha 2-deficient muscular dystrophy at all disease stages
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; ALPHA-DYSTROGLYCAN; ENZYME REPLACEMENT;
   GENE-EXPRESSION; AGRIN RECEPTOR; BINDING-SITE; MUTANT MICE; MOUSE MODEL;
   MINI-AGRIN; MUSCLE
AB Mutations in laminin-alpha 2 cause a severe congenital muscular dystrophy, called MDC1A. The two main receptors that interact with laminin-alpha 2 are dystroglycan and alpha 7 beta 1 integrin. We have previously shown in mouse models for MDC1A that muscle-specific overexpression of a miniaturized form of agrin (mini-agrin), which binds to dystroglycan but not to alpha 7 beta 1 integrin, substantially ameliorates the disease (Moll, J., P. Barzaghi, S. Lin, G. Bezakova, H. Lochmuller, E. Engvall, U. Muller, and M. A. Ruegg. 2001. Nature. 413: 302-307; Bentzinger, C. F., P. Barzaghi, S. Lin, and M. A. Ruegg. 2005. Matrix Biol. 24: 326-332.). Now we show that late-onset expression of mini-agrin still prolongs life span and improves overall health, although not to the same extent as early expression. Furthermore, a chimeric protein containing the dystroglycan-binding domain of perlecan has the same activities as mini-agrin in ameliorating the disease. Finally, expression of full-length agrin also slows down the disease. These experiments are conceptual proof that linking the basement membrane to dystroglycan by specifically designed molecules or by endogenous ligands, could be a means to counteract MDC1A at a progressed stage of the disease, and thus opens new possibilities for the development of treatment options for this muscular dystrophy.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Munich, Dept Neurol, Friedrich Baur Inst, D-80336 Munich, Germany.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Lochmuller, Hanns/0000-0003-2324-8001
CR Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441
   Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x
   Burgess RW, 2002, J NEUROCHEM, V83, P271, DOI 10.1046/j.1471-4159.2002.01102.x
   COHEN SA, 1986, NATURE, V320, P769, DOI 10.1038/320769a0
   Davies KE, 2006, NAT REV MOL CELL BIO, V7, P762, DOI 10.1038/nrm2024
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6
   Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610
   Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190
   GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Ghersa P, 1998, GENE THER, V5, P1213, DOI 10.1038/sj.gt.3300713
   Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004
   Hayashi YK, 1998, NAT GENET, V19, P94, DOI 10.1038/ng0598-94
   Herrmann R, 2000, HUM MOL GENET, V9, P2335, DOI 10.1093/oxfordjournals.hmg.a018926
   Ido H, 2004, J BIOL CHEM, V279, P10946, DOI 10.1074/jbc.M313626200
   Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853
   Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuang W, 1999, LAB INVEST, V79, P1601
   Luna L.G., 1968, MANUAL HISTOLOGIC ST
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318
   Meinen S, 2006, GENE THER, V13, P869
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Miura P, 2006, TRENDS MOL MED, V12, P122, DOI 10.1016/j.molmed.2006.01.002
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Mostacciuolo ML, 1996, HUM GENET, V97, P277, DOI 10.1007/BF02185752
   Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Raben N, 2003, MOL GENET METAB, V80, P159, DOI 10.1016/j.ymgme.2003.08.022
   Raben N, 2001, HUM MOL GENET, V10, P2039, DOI 10.1093/hmg/10.19.2039
   RINGER SA, 2001, PERSPECTIVES NEONATO, V2, P4
   RUEGG MA, 2005, MOL MECH MUSC DYSTRO
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   SOROKIN LM, 1992, EXP CELL RES, V201, P137, DOI 10.1016/0014-4827(92)90357-E
   Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200
   Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863
   Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2
   Vachon PH, 1997, J CLIN INVEST, V100, P1870, DOI 10.1172/JCI119716
   Vachon PH, 1996, J CELL BIOL, V134, P1483, DOI 10.1083/jcb.134.6.1483
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 58
TC 57
Z9 57
U1 0
U2 1
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA
SN 0021-9525
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR
PY 2007
VL 176
IS 7
BP 979
EP 993
DI 10.1083/jcb.200611152
PG 15
WC Cell Biology
SC Cell Biology
GA 150JB
UT WOS:000245211200009
PM 17389231
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Fierz, B
   Satzger, H
   Root, C
   Gilch, P
   Zinth, W
   Kiefhaber, T
AF Fierz, Beat
   Satzger, Helmut
   Root, Christopher
   Gilch, Peter
   Zinth, Wolfgang
   Kiefhaber, Thomas
TI Loop formation in unfolded polypeptide chains on the picoseconds to
   microseconds time scale
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE conformational substates; femtoseconds spectroscopy; peptide dynamics;
   protein folding; triplet-triplet energy transfer
ID DENATURED STATE; RESIDUAL STRUCTURE; INTRACHAIN DIFFUSION; SPEED LIMIT;
   PROTEIN; DYNAMICS; ENERGY; NMR; SOLVENT; UREA
AB Intrachain loop formation allows unfolded polypeptide chains to search for favorable interactions during protein folding. We applied triplet-triplet energy transfer between a xanthone moiety and naphthylalanine to directly measure loop formation in various unfolded polypepticle chains with loop regions consisting of polyserine, poly(glycine-serine) or polyproline. By combination of femtosecond and nanosecond laserflash experiments loop formation could be studied over many orders of magnitude in time from picoseconds to microseconds. The results reveal processes on different time scales indicating motions on different hierarchical levels of the free energy surface. A minor (< 15%) very fast reaction with a time constant of approximate to 3 ps indicates equilibrium conformations with donor and acceptor in contact at the time of the laserflash. Complex kinetics of loop formation were observed on the 50- to 500-ps time scale, which indicate motions within a local well on the energy landscape. Conformations within this well can form loops by undergoing local motions without having to cross major barriers. Exponential kinetics observed on the 10- to 100-ns time scale are caused by diffusional processes involving large-scale motions that allow the polypepticle chain to explore the complete conformational space. These results indicate that the free energy landscape for unfolded polypepticle chains and native proteins have similar properties. The presence of local energy minima reduces the conformational space and accelerates the conformational search for energetically favorable local intrachain contacts.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Munich, Dept Phys, Lehrstuhl Biomol Opt, D-80538 Munich, Germany.
RP Kiefhaber, T (corresponding author), Natl Res Council Canada, Steacie Inst Mol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010; Fierz, Beat/H-3143-2012
OI Fierz, Beat/0000-0002-2991-3044
CR ANSARI A, 1985, P NATL ACAD SCI USA, V82, P5000, DOI 10.1073/pnas.82.15.5000
   AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021
   BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   Bredenbeck J, 2003, P NATL ACAD SCI USA, V100, P6452, DOI 10.1073/pnas.1036583100
   Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   Fenimore PW, 2004, P NATL ACAD SCI USA, V101, P14408, DOI 10.1073/pnas.0405573101
   Fenimore PW, 2002, P NATL ACAD SCI USA, V99, P16047, DOI 10.1073/pnas.212637899
   Fierz B, 2005, PROTEIN FOLDING HANDBOOK, P809, DOI 10.1002/9783527619498.ch22
   Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101
   Fleming PJ, 2005, PROTEIN FOLDING HANDBOOK, P710, DOI 10.1002/9783527619498.ch20
   FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933
   FRAUENFELDER H, 1979, NATURE, V280, P558, DOI 10.1038/280558a0
   Frauenfelder H, 2001, P NATL ACAD SCI USA, V98, P2370, DOI 10.1073/pnas.041614298
   Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701
   HAZES B, 1992, PROTEINS, V12, P278, DOI 10.1002/prot.340120306
   Heinz B, 2006, PHYS CHEM CHEM PHYS, V8, P3432, DOI 10.1039/b603560d
   Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i
   Krieger F, 2004, CHEM PHYS, V307, P209, DOI 10.1016/j.chemphys.2004.05.036
   Lee JC, 2005, J AM CHEM SOC, V127, P16388, DOI 10.1021/ja0561901
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   MILLER WG, 1967, J MOL BIOL, V23, P67, DOI 10.1016/S0022-2836(67)80067-6
   Moglich A, 2005, J MOL BIOL, V345, P153, DOI 10.1016/j.jmb.2004.10.036
   Moglich A, 2006, P NATL ACAD SCI USA, V103, P12394, DOI 10.1073/pnas.0604748103
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P213, DOI 10.1016/0010-4655(82)90173-4
   Riedle E, 2000, APPL PHYS B-LASERS O, V71, P457, DOI 10.1007/s003400000351
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sari N, 2000, BIOCHEMISTRY-US, V39, P965, DOI 10.1021/bi9920230
   Satzger H, 2004, J PHYS CHEM A, V108, P10072, DOI 10.1021/jp047583+
   Satzger H, 2003, CHEM PHYS LETT, V372, P216, DOI 10.1016/S0009-2614(03)00364-6
   SCHIMMEL PR, 1967, P NATL ACAD SCI USA, V58, P52, DOI 10.1073/pnas.58.1.52
   Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799
   SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715
   Wagner C, 1999, P NATL ACAD SCI USA, V96, P6716, DOI 10.1073/pnas.96.12.6716
   Wilhelm T, 1997, OPT LETT, V22, P1494, DOI 10.1364/OL.22.001494
   Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523
   Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
NR 45
TC 58
Z9 58
U1 0
U2 23
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 13
PY 2007
VL 104
IS 7
BP 2163
EP 2168
DI 10.1073/pnas.0611087104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 139NJ
UT WOS:000244438500025
PM 17284588
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Brockhaus, M
   Ganz, P
   Huber, W
   Bohrmann, B
   Loetscher, HR
   Seelig, J
AF Brockhaus, Manfred
   Ganz, Peter
   Huber, Walter
   Bohrmann, Bernd
   Loetscher, Hans-Ruedi
   Seelig, Joachim
TI Thermodynamic studies on the interaction of antibodies with beta-amyloid
   peptide
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ISOTHERMAL TITRATION CALORIMETRY; ALZHEIMERS-DISEASE; LIPID-MEMBRANES;
   BINDING; IMMUNIZATION; OLIGOMERS; MODEL; NEUROPATHOLOGY; A-BETA(1-40);
   ASSOCIATION
AB Antibodies against beta-amyloid peptides (A beta s) are considered an important therapeutic opportunity in Alzheimer's disease. Despite the vast interest in A beta no thermodynamic data on the interaction of antibodies with A beta are available as yet. In the present study we use isothermal titration calorimetry (ITC) and surface plasmon resonance to provide a quantitative thermodynamic analysis of the interaction between soluble monomeric A beta(1-40) and mouse monoclonal antibodies (mAb). Using four different antibodies directed against the N-terminal, middle, and C-terminal A beta epitopes, we measured the thermodynamic parameters for the binding to A beta. Each antibody species was found to have two independent and equal binding sites for A beta with binding constants in the range of 10(7) to 10(8) M-1. The binding reaction was essentially enthalpy driven with a reaction enthalpy of Delta H-A beta(0) approximate to -19 to -8 kcal/mol, indicating the formation of tight complexes. The loss in conformational freedom was supported by negative values for the reaction entropy Delta S-A beta(0). We also measured the heat capacity change of the 1mAb:2A beta reaction. Delta C-p,A beta(0) 0 was large and negative but could not be explained exclusively by the hydrophobic effect. The free energy of binding was found to be linearly correlated with the size of the epitope.
C1 F Hoffmann La Roche & Co Ltd, Dept PRBD, CH-4070 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), F Hoffmann La Roche & Co Ltd, Dept PRBD, CH-4070 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR Ababou A, 2006, J MOL RECOGNIT, V19, P79, DOI 10.1002/jmr.750
   Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100
   Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046
   Cliff MJ, 2005, J MOL BIOL, V346, P717, DOI 10.1016/j.jmb.2004.12.017
   DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398
   Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842
   Fanghanel J, 2003, BIOPHYS CHEM, V100, P351, DOI 10.1016/S0301-4622(02)00292-2
   Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2
   HAMMES GG, 2000, THERMODYNAMICS KINET, P124
   Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385
   Hernaiz MJ, 2002, EUR J BIOCHEM, V269, P2860, DOI 10.1046/j.1432-1033.2002.02964.x
   Hortschansky P, 2005, PROTEIN SCI, V14, P2915, DOI 10.1110/ps.051585905
   Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605
   Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559
   Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e
   Katragadda M, 2004, J BIOL CHEM, V279, P54987, DOI 10.1074/jbc.M409963200
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   McLaurin J, 2002, NAT MED, V8, P1263, DOI 10.1038/nm790
   MURPHY KP, 1992, ADV PROTEIN CHEM, V43, P313, DOI 10.1016/S0065-3233(08)60556-2
   Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   Stites WE, 1997, CHEM REV, V97, P1233, DOI 10.1021/cr960387h
   Sundberg EJ, 2000, BIOCHEMISTRY-US, V39, P15375, DOI 10.1021/bi000704l
   Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e
   TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P604
   Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a
   Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
NR 33
TC 18
Z9 19
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD FEB 8
PY 2007
VL 111
IS 5
BP 1238
EP 1243
DI 10.1021/jp0664059
PG 6
WC Chemistry, Physical
SC Chemistry
GA 131SI
UT WOS:000243889800038
PM 17266280
DA 2021-01-25
ER

PT J
AU Weitz, D
   Harder, D
   Casagrande, F
   Fotiadis, D
   Obrdlik, P
   Kelety, B
   Daniel, H
AF Weitz, Dietmar
   Harder, Daniel
   Casagrande, Fabio
   Fotiadis, Dimitrios
   Obrdlik, Petr
   Kelety, Bela
   Daniel, Hannelore
TI Functional and structural characterization of a prokaryotic peptide
   transporter with features similar to mammalian PEPT1
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BLUE NATIVE ELECTROPHORESIS; DIPEPTIDE TRANSPORTER; H+/PEPTIDE
   COTRANSPORTER; CHARGE TRANSLOCATION; IDENTIFICATION; SUBSTRATE;
   PURIFICATION; RECOGNITION; PHYSIOLOGY; HISTIDINE
AB The ydgR gene of Escherichia coli encodes a protein of the proton-dependent oligopeptide transporter (POT) family. We cloned YdgR and overexpressed the His-tagged fusion protein in E. coli BL21 cells. Bacterial growth inhibition in the presence of the toxic phosphonopeptide alafosfalin established YgdR functionality. Transport was abolished in the presence of the proton ionophore carbonyl cyanide p-chlorophenylhydrazone, suggesting a proton-coupled transport mechanism. YdgR transports selectively only di- and tripeptides and structurally related peptidomimetics (such as aminocephalosporins) with a substrate recognition pattern almost identical to the mammalian peptide transporter PEPT1. The YdgR protein was purified to homogeneity from E. coli membranes. Blue native-polyacrylamide gel electrophoresis and transmission electron microscopy of detergent-solubilized YdgR suggest that it exists in monomeric form. Transmission electron microscopy revealed a crown-like structure with a diameter of similar to 8 nm and a central density. These are the first structural data obtained from a proton-dependent peptide transporter, and the YgdR protein seems an excellent model for studies on substrate and inhibitor interactions as well as on the molecular architecture of cell membrane peptide transporters.
C1 Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, D-85350 Freising Weihenstephan, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Iongate Biosci GmbH, D-65926 Frankfurt, Germany.
RP Daniel, H (corresponding author), Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, Forum 5, D-85350 Freising Weihenstephan, Germany.
EM daniel@wzw.tum.de
RI Daniel, Hannelore/B-8982-2009
OI Harder, Daniel/0000-0003-4226-9748
CR Bolger MB, 1998, J PHARM SCI-US, V87, P1286, DOI 10.1021/js980090u
   Brandsch M, 2004, EUR J PHARM SCI, V21, P53, DOI 10.1016/S0928-0987(03)00142-8
   Chen XZ, 2000, BIOCHEM BIOPH RES CO, V272, P726, DOI 10.1006/bbrc.2000.2851
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500
   Covitz KMY, 1998, BIOCHEMISTRY-US, V37, P15214, DOI 10.1021/bi981128k
   Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4
   Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149
   DEKKER JP, 1988, BIOCHIM BIOPHYS ACTA, V936, P307, DOI 10.1016/0005-2728(88)90006-0
   Dieck ST, 1999, GLIA, V25, P10, DOI 10.1002/(SICI)1098-1136(19990101)25:1<10::AID-GLIA2>3.0.CO;2-Y
   Doring F, 1996, J PHYSIOL-LONDON, V497, P773
   Doring F, 1998, J BIOL CHEM, V273, P23211, DOI 10.1074/jbc.273.36.23211
   Fei YJ, 1997, BIOCHEMISTRY-US, V36, P452, DOI 10.1021/bi962058p
   Fei YJ, 1998, BIOCHEM BIOPH RES CO, V246, P39, DOI 10.1006/bbrc.1998.8566
   Ganapathy ME, 1998, BIOCHEM BIOPH RES CO, V246, P470, DOI 10.1006/bbrc.1998.8628
   Geibel S, 2006, J BIOMOL SCREEN, V11, P262, DOI 10.1177/1087057105285110
   GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984
   Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   HIGGINS CF, 1986, METHOD ENZYMOL, V125, P365
   Meyer-Lipp K, 2004, BIOCHEMISTRY-US, V43, P12606, DOI 10.1021/bi0489053
   Otto C, 1996, AM J PHYSIOL, V271, P210
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x
   Tamai I, 1998, J PHARM SCI-US, V87, P1542, DOI 10.1021/js980186o
   Terada T, 1996, FEBS LETT, V394, P196, DOI 10.1016/0014-5793(96)00952-0
   Terada T, 2004, CURR DRUG METAB, V5, P85, DOI 10.2174/1389200043489153
   Theis S, 2002, MOL PHARMACOL, V61, P214, DOI 10.1124/mol.61.1.214
   Theis S, 2001, PROTEIN EXPRES PURIF, V22, P436, DOI 10.1006/prep.2001.1455
   Yeung AK, 1998, BIOCHEM BIOPH RES CO, V250, P103, DOI 10.1006/bbrc.1998.9283
   Zhuang JP, 1999, J STRUCT BIOL, V125, P63, DOI 10.1006/jsbi.1998.4059
   Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009
NR 32
TC 55
Z9 60
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 2
PY 2007
VL 282
IS 5
BP 2832
EP 2839
DI 10.1074/jbc.M604866200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 130IS
UT WOS:000243793900009
PM 17158458
OA Bronze
DA 2021-01-25
ER

PT J
AU Pulliainen, AT
   Enninga, J
   Fernandez-Arenas, E
   Griffiths, G
AF Pulliainen, Arto Tapio
   Enninga, Jost
   Fernandez-Arenas, Elena
   Griffiths, Gareth
TI A course with a difference - Fighting infectious diseases with
   technology and knowledge-transfer
SO EMBO REPORTS
LA English
DT Editorial Material
ID MYCOBACTERIUM-TUBERCULOSIS
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Turku, Dept Med Biochem & Mol Biol, SF-20500 Turku, Finland.
   Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.
   Univ Complutense Madrid, Dept Microbiol 2, Madrid, Spain.
   EMBL, Heidelberg, Germany.
RP Pulliainen, AT (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM arto.pulliainen@unibas.ch; jostenn@pasteur.fr; arenas@farm.ucm.es;
   griffiths@embl.de
OI Pulliainen, Arto Tapio/0000-0002-9361-8963
CR Aziz MA, 2006, LANCET, V368, P2142, DOI 10.1016/S0140-6736(06)69863-2
   Harris E, 2004, EMBO REP, V5, P7, DOI 10.1038/sj.embor.7400058
   Reynaud EG, 2005, EMBO REP, V6, P103, DOI 10.1038/sj.embor.7400338
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015
NR 5
TC 0
Z9 0
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD FEB
PY 2007
VL 8
IS 2
BP 117
EP 120
DI 10.1038/sj.embor.7400907
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 145LL
UT WOS:000244866500003
PM 17268500
OA Green Published
DA 2021-01-25
ER

PT J
AU Numakawa, Y
   Matsumoto, T
   Yokomaku, D
   Taguchi, T
   Niki, E
   Hatanaka, H
   Kunugi, H
   Numakawa, T
AF Numakawa, Yumiko
   Matsumoto, Tomoya
   Yokomaku, Daisaku
   Taguchi, Takahisa
   Niki, Etsuo
   Hatanaka, Hiroshi
   Kunugi, Hiroshi
   Numakawa, Tadahiro
TI 17 beta-estradiol protects cortical neurons against oxidative
   stress-induced cell death through reduction in the activity of
   mitogen-activated protein kinase and in the accumulation of
   intracellular calcium
SO ENDOCRINOLOGY
LA English
DT Article
ID FACTOR-INDUCED POTENTIATION; CEREBELLAR GRANULE NEURONS; RAPID GLUTAMATE
   RELEASE; RAT HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR;
   PHOSPHATIDYLINOSITOL 3-KINASE; ALZHEIMERS-DISEASE; ESTROGEN PROTECTS;
   MAPK PATHWAY; ESTRADIOL
AB Although many studies have suggested that estrogen acts as a neuroprotective agent in oxidative stress, the underlying mechanism has not been fully elucidated. In the present study, we examined the effect of 17 beta-estradiol (17 beta-E2) on H2O2-induced death signaling in cultured cortical neurons. Exposure of the cortical neurons to H2O2 triggered a series of events, including overactivation of p44/42 MAPK and intracellular Ca2+ accumulation via voltage-gated Ca2+ channels and ionotropic glutamate receptors, resulting in apoptotic-like cell death. The MAPK pathway might work as death signaling in our system, because the MAPK pathway inhibitor, U0126, blocked H2O2-induced MAPK activation, Ca2+ overload, and cell death. Interestingly, a similar inhibitory effect on H2O2-triggeredMAPKactivation, Ca2+ accumulation, and cell death was observed in cultures incubated with 17 beta-E2 for 24h before exposure to H2O2, suggesting that the protective effect of 17 beta-E2 is induced via attenuating overactivation of the MAPK pathway. Furthermore, we found that ionotropic glutamate receptor subunits, including NR2A and GluR2/3, but not NR2B and GluR1, were down-regulated in the 17 beta-E2-treated cultures. The down-regulation of these glutamate receptor subunits was also observed after chronic treatment with U0126. Therefore, it is possible that 17 beta-E2 down-regulates the expression of the ionotropic glutamate receptors by reducing activity of the MAPK pathway, which might be important for the protective effect of 17 beta-E2 against oxidative stress-induced toxicity.
C1 Natl Inst Adv Ind Sci & Technol, Human Stress Signal Res Ctr, Ikeda, Osaka, Japan.
   Natl Inst Adv Ind Sci & Technol, Neuron Res Grp, Special Div Human Life Technol, Ikeda, Osaka, Japan.
   Osaka Univ, Inst Prot Res, Div Prot Biosynth, Suita, Osaka 5650871, Japan.
   Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Tokyo 1878502, Japan.
RP Matsumoto, T (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Tomoya.Matsumoto@unibas.ch
OI Kunugi, Hiroshi/0000-0002-7209-3790
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [18700374] Funding Source: KAKEN
CR Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662
   Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434
   ARIMATSU Y, 1986, DEV BRAIN RES, V26, P151, DOI 10.1016/0165-3806(86)90017-9
   Bai XT, 2003, J NEUROCYTOL, V32, P71, DOI 10.1023/A:1027380315902
   BEHL C, 1994, CELL, V77, P817, DOI 10.1016/0092-8674(94)90131-7
   Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846
   Behl C, 1997, MOL PHARMACOL, V51, P535
   BEHL C, 1995, BIOCHEM BIOPH RES CO, V216, P473, DOI 10.1006/bbrc.1995.2647
   Bossy-Wetzel E, 2004, NAT MED, V10, pS2, DOI 10.1038/nm1067
   Brinton RD, 1997, NEUROCHEM RES, V22, P1339, DOI 10.1023/A:1022015005508
   CHOWEN JA, 1992, NEUROENDOCRINOLOGY, V56, P895, DOI 10.1159/000126321
   Crosby M, 2003, ECON LETT, V80, P35, DOI 10.1016/S0165-1765(03)00042-9
   Dluzen D E, 2000, J Gend Specif Med, V3, P36
   Foy MR, 2001, NEUROBIOL LEARN MEM, V76, P239, DOI 10.1006/nlme.2001.4018
   HARTLEY DM, 1993, J NEUROSCI, V13, P1993
   Henderson VW, 2006, NEUROSCIENCE, V138, P1031, DOI 10.1016/j.neuroscience.2005.06.017
   Hilton GD, 2006, ENDOCRINOLOGY, V147, P1246, DOI 10.1210/en.2005-1258
   Honda K, 2000, J NEUROSCI RES, V60, P321, DOI 10.1002/(SICI)1097-4547(20000501)60:3<321::AID-JNR6>3.3.CO;2-K
   Huang Y, 2004, BRAIN RES, V1026, P254, DOI 10.1016/j.brainres.2004.08.038
   Hurn PD, 2000, J CEREBR BLOOD F MET, V20, P631, DOI 10.1097/00004647-200004000-00001
   Jovanovic JN, 2000, NAT NEUROSCI, V3, P323
   Kawai K, 2001, NEUROPATHOLOGY, V21, P13, DOI 10.1046/j.1440-1789.2001.00362.x
   Mailly F, 1999, J NEUROCHEM, V73, P1181, DOI 10.1046/j.1471-4159.1999.0731181.x
   Matsumoto T, 2006, MOL CELL NEUROSCI, V31, P70, DOI 10.1016/j.mcn.2005.09.002
   Matsumoto Y, 2004, STROKE, V35, P185, DOI 10.1161/01.STR.0000106910.42815.C2
   Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009
   MATTSON MP, 1995, J NEUROCHEM, V65, P1740
   Numakawa T, 2004, J BIOL CHEM, V279, P43245, DOI 10.1074/jbc.M406733200
   Numakawa T, 2002, J BIOL CHEM, V277, P6520, DOI 10.1074/jbc.M109139200
   Numakawa T, 2002, J BIOL CHEM, V277, P28861, DOI 10.1074/jbc.M202927200
   Numakawa T, 2001, J NEUROSCI RES, V66, P96, DOI 10.1002/jnr.1201
   Numakawa Y, 2006, J NEUROCHEM, V97, P1191, DOI 10.1111/j.1471-4159.2006.03827.x
   Parducz A, 2006, NEUROSCIENCE, V138, P977, DOI 10.1016/j.neuroscience.2005.07.008
   Pike CJ, 1999, J NEUROCHEM, V72, P1552, DOI 10.1046/j.1471-4159.1999.721552.x
   Satoh T, 1998, J NEUROCHEM, V70, P316
   Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745
   Simpkins J, 1997, AM J MED, V103, p19S, DOI 10.1016/s0002-9343(97)00260-x
   Singer CA, 1999, J NEUROSCI, V19, P2455
   Singer CA, 1998, NEUROREPORT, V9, P2565, DOI 10.1097/00001756-199808030-00025
   Singer CA, 1996, NEUROSCI LETT, V212, P13, DOI 10.1016/0304-3940(96)12760-9
   SOHRABJI F, 1995, P NATL ACAD SCI USA, V92, P11110, DOI 10.1073/pnas.92.24.11110
   Stanciu M, 2000, J BIOL CHEM, V275, P12200, DOI 10.1074/jbc.275.16.12200
   Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336
   Weaver CE, 1997, BRAIN RES, V761, P338, DOI 10.1016/S0006-8993(97)00449-6
   WEISS JH, 1990, SCIENCE, V247, P1474, DOI 10.1126/science.2157282
   Yamagishi S, 2005, BRAIN RES, V1038, P223, DOI 10.1016/j.brainres.2005.01.041
   Yokomaku D, 2003, MOL ENDOCRINOL, V17, P831, DOI 10.1210/me.2002-0314
   Zhang CY, 1999, J NEUROCYTOL, V28, P525, DOI 10.1023/A:1007053204929
   Zhang L, 2001, NEUROREPORT, V12, P1919, DOI 10.1097/00001756-200107030-00030
NR 49
TC 44
Z9 48
U1 0
U2 0
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD FEB
PY 2007
VL 148
IS 2
BP 627
EP 637
DI 10.1210/en.2006-1210
PG 11
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 126NV
UT WOS:000243520500018
PM 17082253
OA Bronze
DA 2021-01-25
ER

PT J
AU Gladfelter, AS
   Sustreanu, N
   Hungerbuehler, AK
   Voegeli, S
   Galati, V
   Philippsen, P
AF Gladfelter, Amy S.
   Sustreanu, Nicoleta
   Hungerbuehler, A. Katrin
   Voegeli, Sylvia
   Galati, Virginie
   Philippsen, Peter
TI The anaphase-promoting complex/cyclosome is required for anaphase
   progression in multinucleated Ashbya gossypii cells
SO EUKARYOTIC CELL
LA English
DT Article
ID MITOTIC CYCLIN CLB2; BUDDING YEAST; INHIBITOR PDS1; KEN BOX; APC;
   COMPLEX; PROTEOLYSIS; MITOSIS; KINASE; CDC20
AB Regulated protein degradation is essential for eukaryotic cell cycle progression. The anaphase-promoting complex/cyclosome (APC/C is responsible for the protein destruction required for the initiation of anaphase and the exit from mitosis, including the degradation of securin and B-type cyclins. We initiated a study of the APC/C in the multinucleated, filamentous ascomycete Ashbya gossypii to understand the mechanisms underlying the asynchronous mitosis observed in these cells. These experiments were motivated by previous work which demonstrated that the mitotic cyclin AgClb1/2p persists through anaphase, suggesting that the APC/C may not be required for the division cycle in A. gossypii. We have now found that the predicted APC/C components AgCdc23p and AgDoc1p and the targeting factors AgCdc20p and AgCdh1p are essential for growth and nuclear division. Mutants lacking any of these factors arrest as germlings with nuclei blocked in mitosis. A likely substrate of the APC/C is the securin homologue AgPds1p, which is present in all nuclei in hyphae except those in anaphase. The destruction box sequence of AgPds1p is required for this timed disappearance. To investigate how the APC/C may function to degrade AgPds1p in only the subset of anaphase nuclei, we localized components and targeting subunits of the APC/C. Remarkably, AgCdc23p, AgDoc1p, and AgCdc16p were found in all nuclei in all cell cycle stages, as were the APC/C targeting factors AgCdc20p and AgCdh1p. These data suggest that the AgAPC/C may be constitutively active across the cell cycle and that proteolysis in these multinucleated cells may be regulated at the level of substrates rather than by the APC/C itself.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gladfelter, AS (corresponding author), Dartmouth Coll, Dept Biol, Gilman Hall, Hanover, NH 03755 USA.
EM Amy.Gladfelter@dartmouth.edu
CR Agarwal R, 2002, GENE DEV, V16, P1371, DOI 10.1101/gad.971402
   Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022
   Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901
   Carroll CW, 2005, CURR BIOL, V15, P11, DOI 10.1016/j.cub.2004.12.066
   Carroll CW, 2002, NAT CELL BIOL, V4, P880, DOI 10.1038/ncb871
   Castillo-Lluva S, 2004, J CELL SCI, V117, P4143, DOI 10.1242/jcs.01304
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Cohen-Fix O, 1999, GENE DEV, V13, P1950, DOI 10.1101/gad.13.15.1950
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546
   Grossberger R, 1999, J BIOL CHEM, V274, P14500, DOI 10.1074/jbc.274.20.14500
   Hall MC, 2004, CELL CYCLE, V3, P1278, DOI 10.4161/cc.3.10.1153
   Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102
   Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Huang JN, 2001, J CELL BIOL, V154, P85, DOI 10.1083/jcb.200102007
   Huang JY, 1999, EMBO J, V18, P2184, DOI 10.1093/emboj/18.8.2184
   JAMES SW, 1995, J CELL SCI, V108, P3485
   Jaspersen SL, 1999, CURR BIOL, V9, P227, DOI 10.1016/S0960-9822(99)80111-0
   Jensen S, 2001, J CELL BIOL, V152, P27, DOI 10.1083/jcb.152.1.27
   Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   King RW, 1996, SCIENCE, V274, P1652, DOI 10.1126/science.274.5293.1652
   Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023
   LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4
   Lim HH, 1998, CURR BIOL, V8, P231, DOI 10.1016/S0960-9822(98)70088-0
   MOHR C, 1997, THESIS U BASEL SWITZ
   MORRIS NR, 1976, EXP CELL RES, V98, P204, DOI 10.1016/0014-4827(76)90480-8
   Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8
   Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006
   ODONNELL KL, 1991, J CELL SCI, V99, P711
   Passmore LA, 2004, BIOCHEM SOC T, V32, P724, DOI 10.1042/BST0320724
   Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084
   Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3
   Pfleger CM, 2000, GENE DEV, V14, P655
   Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201
   PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565
   Schott EJ, 1998, GENETICS, V148, P599
   Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165
   Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2
   Shirayama M, 1998, EMBO J, V17, P1336, DOI 10.1093/emboj/17.5.1336
   Shirayama M, 1999, NATURE, V402, P203
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066
   Thornton BR, 2004, CELL CYCLE, V3, P629
   Tinker-Kulberg RL, 1999, GENE DEV, V13, P1936, DOI 10.1101/gad.13.15.1936
   Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460
   Wasch R, 2002, NATURE, V418, P556, DOI 10.1038/nature00856
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Yamamoto A, 1996, J CELL BIOL, V133, P85, DOI 10.1083/jcb.133.1.85
   Ye XS, 1998, MOL BIOL CELL, V9, P3019, DOI 10.1091/mbc.9.11.3019
   Yeong FM, 2000, MOL CELL, V5, P501, DOI 10.1016/S1097-2765(00)80444-X
   Zachariae W, 1998, SCIENCE, V282, P1721, DOI 10.1126/science.282.5394.1721
NR 58
TC 5
Z9 5
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
EI 1535-9786
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD FEB
PY 2007
VL 6
IS 2
BP 182
EP 197
DI 10.1128/EC.00364-06
PG 16
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 146MF
UT WOS:000244937800006
PM 17158735
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Shin, H
   Mally, M
   Kuhn, M
   Paroz, C
   Cornelis, GR
AF Shin, Hwain
   Mally, Manuela
   Kuhn, Marina
   Paroz, Cecile
   Cornelis, Guy R.
TI Escape from immune surveillance by Capnocytophaga canimorsus
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID TOLL-LIKE RECEPTORS; NF-KAPPA-B; DOG-BITE; EFFECTOR PROTEIN;
   PORPHYROMONAS-GINGIVALIS; YERSINIA-ENTEROCOLITICA; FATAL SEPTICEMIA;
   INTERFERON-GAMMA; III SECRETION; P38 MAPK
AB Capnocytophaga canimorsus, a commensal bacterium from dogs' mouths, can cause septicemia or meningitis in humans through bites or scratches. Here, we describe and characterize the inflammatory response of human and mouse macrophages on C. canimorsus infection. Macrophages infected with 10 different strains failed to release tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 alpha. Macrophages infected with live and heat-killed (HK) C. canimorsus 5 (Cc5), a strain isolated from a patient with fatal septicemia, did not release IL-6, IL-8, interferon-gamma, macrophage inflammatory protein-1 beta, and nitric oxide (NO). This absence of a proinflammatory response was characterized by the inability of Toll-like receptor (TLR) 4 to respond to Cc5. Moreover, live but not HK Cc5 blocked the release of TNF-alpha and NO induced by HK Yersinia enterocolitica. In addition, live Cc5 down-regulated the expression of TLR4 and dephosphorylated p38 mitogen-activated protein kinase. These results highlight passive and active mechanisms of immune evasion by C. canimorsus, which may explain its capacity to escape from the host immune system.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Alugupalli KR, 1996, FEMS MICROBIOL LETT, V145, P209
   Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Chen BC, 1999, IMMUNOLOGY, V97, P124, DOI 10.1046/j.1365-2567.1999.00747.x
   Ciantar M, 2005, J CLIN MICROBIOL, V43, P1894, DOI 10.1128/JCM.43.4.1894-1901.2005
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Deshmukh PM, 2004, AM J MED SCI, V327, P369, DOI 10.1097/00000441-200406000-00015
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   FISCHER LJ, 1995, INFECT IMMUN, V63, P3484, DOI 10.1128/IAI.63.9.3484-3490.1995
   Frandsen EVG, 1997, CLIN DIAGN LAB IMMUN, V4, P458, DOI 10.1128/CDLI.4.4.458-464.1997
   Frieling JTM, 1997, ANTIMICROB AGENTS CH, V41, P1439, DOI 10.1128/AAC.41.7.1439
   Galdiero M, 2002, INFECT IMMUN, V70, P558, DOI 10.1128/IAI.70.2.558-568.2002
   GRIEGO RD, 1995, J AM ACAD DERMATOL, V33, P1019, DOI 10.1016/0190-9622(95)90296-1
   HANTSON P, 1991, ANN EMERG MED, V20, P93, DOI 10.1016/S0196-0644(05)81130-8
   Hayashi F, 2001, MICROBIOL IMMUNOL, V45, P17, DOI 10.1111/j.1348-0421.2001.tb01269.x
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   JANSEN HJ, 1994, ORAL MICROBIOL IMMUN, V9, P345, DOI 10.1111/j.1399-302X.1994.tb00284.x
   Jung YD, 2002, CYTOKINE, V18, P206, DOI 10.1006/cyto.2002.1034
   Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018
   Kuramitsu HK, 2005, J PERIODONTOL, V76, P2047, DOI 10.1902/jop.2005.76.11-S.2047
   Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477
   Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202
   Lin D., 2001, AM GENOMIC PROTEOMIC, V1, P38
   Lin M, 2004, CELL MICROBIOL, V6, P175, DOI 10.1046/j.1462-5822.2003.00355.x
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   MURRAY HW, 1985, J IMMUNOL, V134, P1619
   NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Notredame C, 2002, PHARMACOGENOMICS, V3, P131, DOI 10.1517/14622416.3.1.131
   Ochiai K, 1998, J MED MICROBIOL, V47, P1087, DOI 10.1099/00222615-47-12-1087
   PEEL MM, 1993, PATHOLOGY, V25, P379, DOI 10.3109/00313029309090863
   Prive C, 2000, EUR J IMMUNOL, V30, P2235, DOI 10.1002/1521-4141(2000)30:8&lt;2235::AID-IMMU2235&gt;3.0.CO;2-9
   RIETSCHEL ET, 1994, FASEB J, V8, P217
   Saab M, 1998, INT J CLIN PRACT, V52, P205
   Schmeck B, 2005, J IMMUNOL, V175, P2843, DOI 10.4049/jimmunol.175.5.2843
   Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200
   Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011
   Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186
   Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x
   Vandamme P, 1996, INT J SYST BACTERIOL, V46, P782, DOI 10.1099/00207713-46-3-782
   VANHONSEBROUCK AY, 1991, ACTA CLIN BELG, V46, P364, DOI 10.1080/17843286.1991.11718192
   Yoshimura A, 2002, INFECT IMMUN, V70, P218, DOI 10.1128/IAI.70.1.218-225.2002
NR 45
TC 41
Z9 41
U1 0
U2 1
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD FEB 1
PY 2007
VL 195
IS 3
BP 375
EP 386
DI 10.1086/510243
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 122PA
UT WOS:000243237700011
PM 17205476
OA Bronze
DA 2021-01-25
ER

PT J
AU Signorell, GA
   Kaufmann, TC
   Kukulski, W
   Engel, A
   Remigy, HW
AF Signorell, Gian A.
   Kaufmann, Thomas C.
   Kukulski, Wanda
   Engel, Andreas
   Remigy, Herve-W.
TI Controlled 2D crystallization of membrane proteins using
   methyl-beta-cyclodextrin
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE 2D crystallization; membrane protein; cyclodextrin; electron microscopy
ID 2-DIMENSIONAL CRYSTALLIZATION; ESCHERICHIA-COLI; CRYSTALS; PORIN;
   RECONSTITUTION; INHIBITION; TRANSITION; RESOLUTION; REDUCTASE; CHANNELS
AB High-resolution structural data of membrane proteins can be obtained by studying 2D crystals by electron crystallography. Finding the right conditions to produce these crystals is one of the major bottlenecks encountered in 2D crystallography. Many reviews address 2D crystallization techniques in attempts to provide guidelines for crystallographers. Several techniques including new approaches to remove detergent like the biobeads technique and the development of dedicated devices have been described (dialysis and dilution machines). In addition, 2D crystallization at interfaces has been studied, the most prominent method being the 2D crystallization at the lipid monolayer. A new approach based on detergent complexation by cyclodextrins is presented in this paper. To prove the ability of cyclodextrins to remove detergent from ternary mixtures (lipid, detergent and protein) in order to get 2D crystals, this method has been tested with OmpF, a typical P-barrel protein, and with SoPIP2;1, a typical alpha-helical protein. Experiments over different time ranges were performed to analyze the kinetic effects of detergent removal with cyclodextrins on the formation of 2D crystals. The quality of the produced crystals was assessed with negative stain electron microscopy, cryo-electron microscopy and diffraction. Both proteins yielded crystals comparable in quality to previous crystallization reports. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Basel, ME Muller Inst Microscopy, Biozentrum, Basel, Switzerland.
RP Remigy, HW (corresponding author), Univ Basel, ME Muller Inst Microscopy, Biozentrum, Basel, Switzerland.
EM herve.remigy@unibas.ch
RI Kukulski, Wanda/H-1766-2013
CR Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014
   Chami M, 2001, J STRUCT BIOL, V133, P64, DOI 10.1006/jsbi.2001.4344
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   DeGrip WJ, 1998, BIOCHEM J, V330, P667
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DORSET DL, 1983, J MOL BIOL, V165, P701, DOI 10.1016/S0022-2836(83)80275-7
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Hasler L, 1998, J STRUCT BIOL, V121, P162, DOI 10.1006/jsbi.1998.3960
   HOLZENBURG A, 1989, BIOCHEMISTRY-US, V28, P4187, DOI 10.1021/bi00436a010
   HOVMOLLER S, 1983, J MOL BIOL, V165, P401, DOI 10.1016/S0022-2836(83)80264-2
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Kohl A, 2005, STRUCTURE, V13, P1131, DOI 10.1016/j.str.2005.04.020
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311
   NAKAYAMA H, 1980, BIOCHIM BIOPHYS ACTA, V601, P1, DOI 10.1016/0005-2736(80)90508-8
   REGENASS M, 1985, EXPERIENTIA, V41, P808
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Rosenbusch JP, 2001, MICRON, V32, P75, DOI 10.1016/S0968-4328(00)00021-4
   Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938
   Schmidt-Krey I, 1998, J STRUCT BIOL, V123, P87, DOI 10.1006/jsbi.1998.4018
   Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200
   Sundaresan V, 2005, J MOL BIOL, V346, P617, DOI 10.1016/j.jmb.2004.11.070
   Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316
   Turk E, 2000, J BIOL CHEM, V275, P25711, DOI 10.1074/jbc.M003127200
   WINGFIELD P, 1979, NATURE, V280, P696, DOI 10.1038/280696a0
   Zampighi GA, 2003, J MOL BIOL, V325, P201, DOI 10.1016/S0022-2836(02)01200-7
NR 31
TC 64
Z9 66
U1 3
U2 24
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD FEB
PY 2007
VL 157
IS 2
BP 321
EP 328
DI 10.1016/j.jsb.2006.07.011
PG 8
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 132OJ
UT WOS:000243951800003
PM 16979348
DA 2021-01-25
ER

PT J
AU Jung, D
   Elferink, MGL
   Stellaard, F
   Groothuis, GMM
AF Jung, Diana
   Elferink, Marieke G. L.
   Stellaard, Frans
   Groothuis, Geny M. M.
TI Analysis of bile acid-induced regulation of FXR target genes in human
   liver slices
SO LIVER INTERNATIONAL
LA English
DT Article
DE cholestasis; expression; human in vivo system; NTCP; nuclear receptors;
   species differences
ID FARNESOID-X-RECEPTOR; HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; RAT-LIVER; SALT
   TRANSPORTERS; TRANSCRIPTION FACTORS; HORMONE RECEPTORS; DRUG-METABOLISM;
   MOUSE-LIVER; NTCP GENE; EXPRESSION
AB Information about the role of nuclear receptors has rapidly increased over the last decade. However, details about their role in human are lacking. Owing to species differences, a powerful human in vitro system is needed. This study uses for the first time precision-cut human liver slices in the nuclear receptor field. The farnesoid X receptor (FXR) was chosen as a model. We were able to demonstrate that human liver slices efficiently take up bile acids and show a stable expression of a wide variety of genes relevant for bile acid metabolism, including bile acid transporters, cytochrome P450 enzymes and transcription factors. Treatment with chenodeoxycholate induced small heterodimer partner, bile salt export pump and p-glycoprotein, ABCB4 and repressed cholesterol 7 alpha hydroxylase, hepatocyte nuclear factor (HNF)1, HNF4 and organic anion transporting peptide (OATP)1B1. OATP1B3, FXR, HNF3 beta and cytochrome P450 enzyme remained relatively constant. In contrast to what has been observed in mice and rat studies, SHP induction did not result in repression of sodium-dependent bile acid cotransporter expression. Further, regulation of genes seemed to be dependent on concentration and time. Taken together, the study shows that the use of liver slices is a powerful technique that enables to study nuclear receptors in the human liver.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   Univ Groningen, Ctr Pharm, Dept Pharmacokinet & Drug Delivery, Groningen, Netherlands.
   Univ Groningen, Univ Med Ctr Groningen, Pediat Lab, Ctr Liver Digest & Metab Dis, Groningen, Netherlands.
RP Jung, D (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Diana.Jung@unibas.ch
CR Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200
   Aranda A, 2001, PHYSIOL REV, V81, P1269
   Arrese M, 2003, J HEPATOL, V38, P148, DOI 10.1016/S0168-8278(02)00379-3
   Borlak J, 2004, XENOBIOTICA, V34, P935, DOI 10.1080/00498250400008363
   BRUUSGAARD A, 1979, CLIN CHIM ACTA, V93, P1, DOI 10.1016/0009-8981(79)90237-7
   Claudel T, 2003, GASTROENTEROLOGY, V125, P544, DOI 10.1016/S0016-5085(03)00896-5
   Cross DM, 2000, DRUG METAB REV, V32, P219, DOI 10.1081/DMR-100100574
   Davis RA, 2002, J LIPID RES, V43, P533
   de Graaf IAM, 2000, DRUG METAB DISPOS, V28, P1100
   Denson LA, 2001, GASTROENTEROLOGY, V121, P140, DOI 10.1053/gast.2001.25503
   Elferink MGL, 2004, AM J PHYSIOL-GASTR L, V287, pG1008, DOI 10.1152/ajpgi.00071.2004
   FAUSA O, 1975, SCAND J GASTROENTERO, V10, P747
   Fickert P, 2001, GASTROENTEROLOGY, V121, P170, DOI 10.1053/gast.2001.25542
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684
   Geier A, 2003, HEPATOLOGY, V38, P345, DOI 10.1053/jhep.2003.50317
   Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001
   Green RM, 1996, GASTROENTEROLOGY, V111, P193, DOI 10.1053/gast.1996.v111.pm8698199
   Greuet J, 1997, HEPATOLOGY, V25, P1166, DOI 10.1002/hep.510250520
   Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P566, DOI 10.1007/s00424-003-1130-z
   Hagenbuch B, 2004, PFLUG ARCH EUR J PHY, V447, P653, DOI 10.1007/s00424-003-1168-y
   Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647
   Huang L, 2003, J BIOL CHEM, V278, P51085, DOI 10.1074/jbc.M308321200
   Jacobs MN, 2002, P NUTR SOC, V61, P105, DOI 10.1079/PNS2001140
   Jung D, 2004, AM J PHYSIOL-GASTR L, V286, pG752, DOI 10.1152/ajpgi.00456.2003
   Jung D, 2002, GASTROENTEROLOGY, V122, P1954, DOI 10.1053/gast.2002.33583
   Jung D, 2001, J BIOL CHEM, V276, P37206, DOI 10.1074/jbc.M103988200
   Jung D, 2003, HEPATOLOGY, V37, P622, DOI 10.1053/jhep.2003.50100
   Keitel V, 2005, HEPATOLOGY, V41, P1160, DOI 10.1002/hep.20682
   Liu YP, 2003, J CLIN INVEST, V112, P1678, DOI 10.1172/JCI18945
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   Meier PJ, 2002, ANNU REV PHYSIOL, V64, P635, DOI 10.1146/annurev.physiol.64.082201.100300
   Nagoshi E, 2005, METHOD ENZYMOL, V393, P543, DOI 10.1016/S0076-6879(05)93028-0
   Olinga P, 2001, J HEPATOL, V35, P187, DOI 10.1016/S0168-8278(01)00103-9
   Olinga P, 2001, DRUG TARGETING ORGAN, P309
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Repa JJ, 1999, CURR OPIN BIOTECH, V10, P557, DOI 10.1016/S0958-1669(99)00031-2
   Rippin SJ, 2001, HEPATOLOGY, V33, P776, DOI 10.1053/jhep.2001.23433
   Setchell KDR, 1997, GASTROENTEROLOGY, V112, P226, DOI 10.1016/S0016-5085(97)70239-7
   Shih DQ, 2001, NAT GENET, V27, P375, DOI 10.1038/86871
   St-Pierre MV, 2001, J EXP BIOL, V204, P1673
   Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120
   Trauner M, 1998, J CLIN INVEST, V101, P2092, DOI 10.1172/JCI1680
   van de Bovenkamp M, 2005, TOXICOL SCI, V85, P632, DOI 10.1093/toxsci/kfi127
   Wolters H, 2002, J HEPATOL, V37, P556, DOI 10.1016/S0168-8278(02)00247-7
   Zollner G, 2003, J HEPATOL, V39, P480, DOI 10.1016/S0168-8278(03)00228-9
NR 47
TC 44
Z9 44
U1 1
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1478-3223
EI 1478-3231
J9 LIVER INT
JI Liver Int.
PD FEB
PY 2007
VL 27
IS 1
BP 137
EP 144
DI 10.1111/j.1478-3231.2006.01393.x
PG 8
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 126SE
UT WOS:000243534600019
PM 17241392
DA 2021-01-25
ER

PT J
AU Scarsi, M
   Podvinec, M
   Roth, A
   Hug, H
   Kersten, S
   Albrecht, H
   Schwede, T
   Meyer, UA
   Rucker, C
AF Scarsi, Marco
   Podvinec, Michael
   Roth, Adrian
   Hug, Hubert
   Kersten, Sander
   Albrecht, Hugo
   Schwede, Torsten
   Meyer, Urs A.
   Ruecker, Christoph
TI Sulfonylureas and glinides exhibit peroxisome proliferator-activated
   receptor gamma activity: A combined virtual screening and biological
   assay approach
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID TYPE-2 DIABETES-MELLITUS; PPAR-GAMMA; LIGAND-BINDING; CLINICAL
   PHARMACOKINETICS; ALPHA/GAMMA AGONIST; INSULIN-RESISTANCE; NUCLEAR
   RECEPTORS; AGENTS; ACID; NATEGLINIDE
AB Most drugs currently employed in the treatment of type 2 diabetes either target the sulfonylurea receptor stimulating insulin release (sulfonylureas, glinides), or target the peroxisome proliferator-activated receptor (PPAR gamma) improving insulin resistance (thiazolidinediones). Our work shows that sulfonylureas and glinides additionally bind to PPAR gamma and exhibit PPAR gamma agonistic activity. This activity was predicted in silico by virtual screening and confirmed in vitro in a binding assay, a transactivation assay, and by measuring the expression of PPAR gamma target genes. Among the measured compounds, gliquidone and glipizide (two sulfonylureas), as well as nateglinide (a glinide), exhibit PPAR gamma agonistic activity at concentrations comparable with those reached under pharmacological treatment. The most active of these compounds, gliquidone, is shown to be as potent as pioglitazone at inducing PPAR gamma target gene expression. This dual mode of action of sulfonylureas and glinides may open new perspectives for the molecular pharmacology of antidiabetic drugs, because it provides evidence that drugs can be designed that target both the sulfonylurea receptor and PPAR gamma. Targeting both receptors could increase pancreatic insulin secretion and improve insulin resistance. Glinides, sulfonylureas, and other acidified sulfonamides may be promising leads in the development of new PPAR gamma agonists. In addition, we provide a unified concept of the PPAR gamma binding ability of seemingly disparate compound classes.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Hoffmann La Roche Ag, CH-4002 Basel, Switzerland.
   TheraSTrat AG, Allschwil, Switzerland.
   DSM Nutr Prod Human Nutr & Hlth, Kaiseraugst, Switzerland.
   Univ Wageningen & Res Ctr, Nutr Metab & Genom Grp, Wageningen, Netherlands.
   BioFocus DPI, Allschwil, Switzerland.
RP Scarsi, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM marco.scarsi@unibas.ch
RI Kersten, Sander/A-1116-2011; Albrecht, Hugo/F-9569-2011; Rucker,
   Christoph/C-5519-2009; Schwede, Torsten/A-4650-2008
OI Kersten, Sander/0000-0003-4488-7734; Albrecht, Hugo/0000-0002-3951-1866;
   Schwede, Torsten/0000-0003-2715-335X
CR CANTELLO BCC, 1994, J MED CHEM, V37, P3977, DOI 10.1021/jm00049a017
   Cox SL, 2005, DRUG TODAY, V41, P579, DOI 10.1358/dot.2005.41.9.925347
   Cronet P, 2001, STRUCTURE, V9, P699, DOI 10.1016/S0969-2126(01)00634-7
   Culy CR, 2001, DRUGS, V61, P1625, DOI 10.2165/00003495-200161110-00008
   Durgam GG, 2005, J MED CHEM, V48, P4919, DOI 10.1021/jm049609r
   Ebdrup S, 2003, J MED CHEM, V46, P1306, DOI 10.1021/jm021027r
   Ericsson H, 2004, DRUG METAB DISPOS, V32, P923
   Farret A, 2005, FUND CLIN PHARMACOL, V19, P647, DOI 10.1111/j.1472-8206.2005.00375.x
   Ferry G, 2001, EUR J PHARMACOL, V417, P77, DOI 10.1016/S0014-2999(01)00907-4
   Fukuen S, 2005, J BIOL CHEM, V280, P23653, DOI 10.1074/jbc.M412113200
   Gampe RT, 2000, MOL CELL, V5, P545, DOI 10.1016/S1097-2765(00)80448-7
   Gut Joseph, 2005, Expert Opin Drug Metab Toxicol, V1, P537, DOI 10.1517/17425255.1.3.537
   Hatorp V, 2002, CLIN PHARMACOKINET, V41, P471, DOI 10.2165/00003088-200241070-00002
   Hazama Y, 2006, DIABETES RES CLIN PR, V71, P251, DOI 10.1016/j.diabres.2005.08.004
   Hermanson O, 2002, TRENDS ENDOCRIN MET, V13, P55, DOI 10.1016/S1043-2760(01)00527-6
   Hug H, 2004, DRUG DISCOV TODAY, V9, P948, DOI 10.1016/S1359-6446(04)03252-0
   Hug H, 2003, PHARMACOGENETICS, V13, P767, DOI 10.1097/00008571-200312000-00007
   IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149
   Inukai K, 2005, BIOCHEM BIOPH RES CO, V328, P484, DOI 10.1016/j.bbrc.2004.12.190
   Jaber LA, 1996, PHARMACOTHERAPY, V16, P760
   Jonsson A, 2000, EUR J CLIN PHARMACOL, V56, P711, DOI 10.1007/s002280000214
   Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036
   Langtry HD, 1998, DRUGS, V55, P563, DOI 10.2165/00003495-199855040-00007
   LAUDET V, 2002, NUCL RECEPTOR FACTBO
   Luzio SD, 2001, J CLIN ENDOCR METAB, V86, P4874, DOI 10.1210/jc.86.10.4874
   Martin JA, 2005, BIOORG MED CHEM LETT, V15, P51, DOI 10.1016/j.bmcl.2004.10.042
   McLeod JF, 2004, CLIN PHARMACOKINET, V43, P97, DOI 10.2165/00003088-200443020-00003
   Minoura H, 2004, EUR J PHARMACOL, V494, P273, DOI 10.1016/j.ejphar.2004.04.038
   Momose Y, 2002, CHEM PHARM BULL, V50, P100, DOI 10.1248/cpb.50.100
   Momose Y, 2002, J MED CHEM, V45, P1518, DOI 10.1021/jm010490l
   Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B
   Nolte RT, 1998, NATURE, V395, P137
   Owens DR, 2000, DIABETES CARE, V23, P518, DOI 10.2337/diacare.23.4.518
   Parker JC, 2002, ADV DRUG DELIVER REV, V54, P1173, DOI 10.1016/S0169-409X(02)00093-5
   Perfetti Riccardo, 2005, Curr Diab Rep, V5, P340, DOI 10.1007/s11892-005-0091-3
   Picard F, 2002, ANNU REV NUTR, V22, P167, DOI 10.1146/annurev.nutr.22.010402.102808
   Rangwala SM, 2004, TRENDS PHARMACOL SCI, V25, P331, DOI 10.1016/j.tips.2004.03.012
   Renaud JP, 2000, CELL MOL LIFE SCI, V57, P1748, DOI 10.1007/PL00000656
   Rucker C, 2006, BIOORGAN MED CHEM, V14, P5178, DOI 10.1016/j.bmc.2006.04.005
   Sauerberg P, 2002, J MED CHEM, V45, P789, DOI 10.1021/jm010964g
   SCARSI M, 2005, 3 INT S PPARS EFF SA, P39
   Schopfer FJ, 2005, P NATL ACAD SCI USA, V102, P2340, DOI 10.1073/pnas.0408384102
   Shi GQ, 2005, J MED CHEM, V48, P4457, DOI 10.1021/jm0502135
   Staels B, 2005, DIABETES, V54, P2460, DOI 10.2337/diabetes.54.8.2460
   vonNicolai H, 1997, ARZNEIMITTEL-FORSCH, V47, P247
   Wang MH, 2003, J CELL BIOCHEM, V89, P38, DOI 10.1002/jcb.10492
   Weaver ML, 2001, DRUG METAB DISPOS, V29, P415
   *WHO, 2002, COST DIAB WHO FACT S
   Willson TM, 2001, ANNU REV BIOCHEM, V70, P341, DOI 10.1146/annurev.biochem.70.1.341
   Willson TM, 2000, J MED CHEM, V43, P527, DOI 10.1021/jm990554g
   Xu HE, 1999, MOL CELL, V3, P397, DOI 10.1016/S1097-2765(00)80467-0
   Xu HE, 2001, P NATL ACAD SCI USA, V98, P13919, DOI 10.1073/pnas.241410198
   Yamamoto K, 2005, BIOORG MED CHEM LETT, V15, P517, DOI 10.1016/j.bmcl.2004.11.053
   2006, GLURENORM SUMMARY PR
   2004, DRUGS R D, V5, P98
NR 55
TC 38
Z9 44
U1 0
U2 9
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD FEB
PY 2007
VL 71
IS 2
BP 398
EP 406
DI 10.1124/mol.106.024596
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 127RV
UT WOS:000243604900002
PM 17082235
DA 2021-01-25
ER

PT J
AU Meier, S
   Strohmeier, M
   Blackledge, M
   Grzesiek, S
AF Meier, Sebastian
   Strohmeier, Mark
   Blackledge, Martin
   Grzesiek, Stephan
TI Direct observation of dipolar couplings and hydrogen bonds across a
   beta-hairpin in 8 M urea
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SCALAR COUPLINGS; DENATURED PROTEIN; A-STATE; NMR; MODEL; UBIQUITIN;
   NETWORK; ANGLES; DOMAIN
AB A detailed, quantitative description of the unfolded states of proteins at atomic resolution has been elusive due to enormous experimental and theoretical problems resulting from the huge number of degrees of freedom of an unfolded structural ensemble. In particular, direct long-range information has been extremely sparse. Here we show that such long-range information can be obtained by NMR with high sensitivity and precision from H-N-H-N residual dipolar couplings (RDCs) and hydrogen bond (Hbonds) scalar couplings for an unfolded, perdeuterated (amide protonated) protein (urea-denatured ubiquitin at pH 2.5). Besides numerous sequential contacts, the RDCs reveal the persistence of nativelike structure in ubiquitin's first beta-hairpin. This native-like structure is confirmed by the direct detection of H-bonds via (h3)J(NC') H-bond scalar couplings as well as by chemical shifts, (3)J(HNHA) couplings, and relaxation rates. A quantitative analysis suggests that despite 25% native backbone torsion angles indicated by the chemical shifts, the H-bonds of the hairpin are formed to a much lesser degree in urea.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   UJF, CEA, CNRS, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   COLLEY CS, 2000, CHEM COMMUN, P253
   Cordier F, 2004, BIOCHEMISTRY-US, V43, P11295, DOI 10.1021/bi049314f
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   FRANK MK, 1995, PROTEIN SCI, V4, P2605, DOI 10.1002/pro.5560041218
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Wirmer J, 2006, J BIOMOL NMR, V35, P175, DOI 10.1007/s10858-006-9026-9
   Wu ZR, 2002, J AM CHEM SOC, V124, P9672, DOI 10.1021/ja026845n
   ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20
NR 22
TC 48
Z9 49
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 31
PY 2007
VL 129
IS 4
BP 754
EP 755
DI 10.1021/ja067522k
PG 2
WC Chemistry, Multidisciplinary
SC Chemistry
GA 128UH
UT WOS:000243683800015
PM 17243799
DA 2021-01-25
ER

PT J
AU Duma, L
   Haussinger, D
   Rogowski, M
   Lusso, P
   Grzesiek, S
AF Duma, Luminita
   Haeussinger, Daniel
   Rogowski, Marco
   Lusso, Paolo
   Grzesiek, Stephan
TI Recognition of RANTES by extracellular parts of the CCR5 receptor
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE chemokine; HIV-1; sulfation; heteronuclear NMR; chemical shift mapping
ID CELL-DERIVED FACTOR-1-ALPHA; HIGH-AFFINITY BINDING; HIV-1 ENTRY;
   CRYSTAL-STRUCTURE; TERMINAL REGION; AMINO-TERMINUS; AOP-RANTES;
   N-TERMINUS; CHEMOKINE; IDENTIFICATION
AB The chemokine RANTES (regulated upon activation, normal T-cell expressed and secreted) is a natural ligand of CCR5, one of the major HIV-1 coreceptors. It is secreted as part of the immune response to human immunodeficiency virus 1 (HIV-1) and inhibits infection by CCR5-dependent (R5) HIV-1 isolates. We have investigated the interaction of RANTES with several peptides derived from the extracellular domains of CCR5 by heteronuclear NMR spectroscopy in aqueous solution. We show that a peptide comprising the first 25 amino acid residues of the CCR5 N-terminal domain and sulfated at the Y10 and Y14 side-chains binds with micromolar affinity exclusively to the monomeric form of RANTES. In contrast to the tight binding of the sulfated peptide, the affinity of the same peptide in non-sulfated form was reduced by more than two orders of magnitude. Peptides derived from the CCR5 extracellular loops ECL1, ECL2 and ECL3 showed only very moderate and mostly non-specific binding. Chemical shift mapping of the interaction of the sulfated Nterminal peptide reveals a contiguous binding surface on RANTES, which comprises amino acid residues of the first beta-strand, the N-loop, the fourth strand and the turns around residues 30 and 40. This binding surface largely overlaps with the dimer interface and is strongly positively charged, providing a rationale for the exclusive binding of the monomer to the peptide and the requirement of the negative sulfate groups at the Y10 and Y14 side-chains. The binding surface also largely overlaps with the segments that were identified previously as crucial for HIV blockade by peptide scanning and mutagenesis studies. These data offer new insights into the structure-function relation of the RANTES-CCR5 interaction and may be helpful for the design of novel HIV-1 inhibitors. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland.
   DIBIT, Unit Human Virol, Milan, Italy.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Haussinger, Daniel/C-6617-2016
OI Haussinger, Daniel/0000-0002-4798-0072; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505
   BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
   Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x
   Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661
   Blanpain C, 1999, J BIOL CHEM, V274, P34719, DOI 10.1074/jbc.274.49.34719
   CHUNG CW, 1995, BIOCHEMISTRY-US, V34, P9307, DOI 10.1021/bi00029a005
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077
   Dagani R, 1996, CHEM ENG NEWS, V74, P8
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0
   Farzan M, 2000, J BIOL CHEM, V275, P33516, DOI 10.1074/jbc.M007228200
   Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2
   Farzan M, 2002, J BIOL CHEM, V277, P29484, DOI 10.1074/jbc.M203361200
   Farzan M, 2002, J BIOL CHEM, V277, P40397, DOI 10.1074/jbc.M206784200
   Farzan M, 1998, J VIROL, V72, P1160, DOI 10.1128/JVI.72.2.1160-1164.1998
   Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gong JH, 1996, J BIOL CHEM, V271, P10521, DOI 10.1074/jbc.271.18.10521
   Gozansky EK, 2005, J MOL BIOL, V345, P651, DOI 10.1016/j.jmb.2004.11.003
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027
   Hoover DM, 2000, PROTEIN PEPTIDE LETT, V7, P73
   Kish-Catalone TM, 2006, ANTIMICROB AGENTS CH, V50, P1497, DOI 10.1128/AAC.50.4.1497-1509.2006
   Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   Laurence JS, 2000, BIOCHEMISTRY-US, V39, P3401, DOI 10.1021/bi9923196
   Lederman MM, 2004, SCIENCE, V306, P485, DOI 10.1126/science.1099288
   Lemay J, 2005, NAT IMMUNOL, V6, P535, DOI 10.1038/ni0605-535a
   Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653
   Pakianathan DR, 1997, BIOCHEMISTRY-US, V36, P9642, DOI 10.1021/bi970593z
   Pastore C, 2003, ANTIMICROB AGENTS CH, V47, P509, DOI 10.1128/AAC.47.2.509-517.2003
   Paterlini MG, 2002, BIOPHYS J, V83, P3012, DOI 10.1016/S0006-3495(02)75307-1
   Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E
   Proudfoot AEI, 2003, P NATL ACAD SCI USA, V100, P1885, DOI 10.1073/pnas.0334864100
   Rajarathnam K, 2006, BIOCHEMISTRY-US, V45, P7882, DOI 10.1021/bi0605944
   Samson M, 1997, J BIOL CHEM, V272, P24934, DOI 10.1074/jbc.272.40.24934
   Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259
   SCHALL TJ, 1994, CURR OPIN IMMUNOL, V6, P865, DOI 10.1016/0952-7915(94)90006-X
   Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014
   Simmons G, 1997, SCIENCE, V276, P276, DOI 10.1126/science.276.5310.276
   SKELTON NJ, 1995, BIOCHEMISTRY-US, V34, P5329, DOI 10.1021/bi00016a004
   Veldkamp CT, 2006, J MOL BIOL, V359, P1400, DOI 10.1016/j.jmb.2006.04.052
   Wilken J, 1999, CHEM BIOL, V6, P43, DOI 10.1016/S1074-5521(99)80019-2
   Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0
   Zhou NM, 2000, EUR J IMMUNOL, V30, P164, DOI 10.1002/1521-4141(200001)30:1<164::AID-IMMU164>3.0.CO;2-X
NR 46
TC 71
Z9 74
U1 0
U2 9
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 26
PY 2007
VL 365
IS 4
BP 1063
EP 1075
DI 10.1016/j.jmb.2006.10.040
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 127BZ
UT WOS:000243561600014
PM 17101151
DA 2021-01-25
ER

PT J
AU Poteryaev, D
   Fares, H
   Bowerman, B
   Spang, A
AF Poteryaev, Dmitry
   Fares, Hanna
   Bowerman, Bruce
   Spang, Anne
TI Caenorhabditis elegans SAND-1 is essential for RAB-7 function in
   endosomal traffic
SO EMBO JOURNAL
LA English
DT Article
DE C. elegans; early to late endosome transport; endosomes; RAB7; RAB
   GTPases
ID DOMAIN PROTEIN; GENETIC-ANALYSIS; ENDOCYTOSIS; TRANSPORT; GTPASES;
   RECEPTOR; GOLGI; RECRUITMENT; COMPONENTS; COMPLEX
AB The small rab-GTPase RAB-7 acts in endosome and endosome to lysosome traffic. We identified SAND-1 as a protein required for RAB-7 function based on similarities between SAND-1 and RAB-7 RNAi phenotypes. Although the initial uptake of yolk protein in oocytes, or of soluble secreted (ss) GFP in coelomocytes, appeared normal, further transport along the endocytic traffic route was delayed in the absence of SAND- 1 function, and yolk proteins failed to reach yolk granules efficiently. Moreover, in coelomocytes, ssGFP and BSA-Texas-Red were endocytosed but not transported to lysosomes. We show that SAND-1 is essential for RAB-7 function at the transition from early to late endosomes, but not for RAB-7 function at lysosomes.
C1 Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.
   Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Klingelberg Str 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Poteryaev, Dmitry/0000-0003-2695-8869
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM65235, R01 GM065235] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM065235, R01GM065235, R01GM065235, R01GM065235, R01GM065235]
   Funding Source: NIH RePORTER
CR Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683
   CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P
   DiracSvejstrup AB, 1997, EMBO J, V16, P465, DOI 10.1093/emboj/16.3.465
   Fares H, 2001, GENETICS, V159, P133
   Fares H, 2001, NAT GENET, V28, P64, DOI 10.1038/88281
   FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435
   Gerst JE, 1999, CELL MOL LIFE SCI, V55, P707, DOI 10.1007/s000180050328
   Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311
   Grant B, 2001, NAT CELL BIOL, V3, P573, DOI 10.1038/35078549
   HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x
   Hermann GJ, 2005, MOL BIOL CELL, V16, P3273, DOI 10.1091/mbc.E05-01-0060
   Hersh BM, 2002, P NATL ACAD SCI USA, V99, P4355, DOI 10.1073/pnas.062065399
   Ihrke G, 2004, TRAFFIC, V5, P946, DOI 10.1111/j.1600-0854.2004.00236.x
   Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0
   Lazar T, 1997, TRENDS BIOCHEM SCI, V22, P468, DOI 10.1016/S0968-0004(97)01150-X
   MERESSE S, 1995, J CELL SCI, V108, P3349
   Mizuno K, 2003, MOL BIOL CELL, V14, P3741, DOI 10.1091/mbc.E02-08-0495
   Morse J.M., 2002, INT J QUAL METH, V1, DOI [https://doi.org/10.1177/160940690200100202, DOI 10.1177/160940690200100202]
   Munro E, 2004, DEV CELL, V7, P413, DOI 10.1016/j.devcel.2004.08.001
   Nicot AS, 2006, MOL BIOL CELL, V17, P3062
   PAINI E, 1997, EMBO J, V16, P15
   Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500
   Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967
   Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X
   Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606
   Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Sacher M, 1998, EMBO J, V17, P2494, DOI 10.1093/emboj/17.9.2494
   Sciorra VA, 2005, MOL BIOL CELL, V16, P776, DOI 10.1091/mbc.E04-08-0700
   Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   SOLDATI T, 1994, NATURE, V369, P76, DOI 10.1038/369076a0
   Stockinger W, 2002, EMBO J, V21, P4259, DOI 10.1093/emboj/cdf435
   STROME S, 1986, J EMBRYOL EXP MORPH, V97, P15
   Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200
   Wang John Q., 2003, Current Neuropharmacology, V1, P1, DOI 10.2174/1570159033360548
   Yang XP, 1998, EMBO J, V17, P4954, DOI 10.1093/emboj/17.17.4954
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
   Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011
NR 42
TC 74
Z9 88
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JAN 24
PY 2007
VL 26
IS 2
BP 301
EP 312
DI 10.1038/sj.emboj.7601498
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 129LJ
UT WOS:000243730700003
PM 17203072
OA Green Published
DA 2021-01-25
ER

PT J
AU Fierz, B
   Kiefhaber, T
AF Fierz, Beat
   Kiefhaber, Thomas
TI End-to-end vs interior loop formation kinetics in unfolded polypeptide
   chains
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID INTRAMOLECULAR CONTACT FORMATION; INTRACHAIN DIFFUSION; FLEXIBLE
   POLYMERS; REACTION-RATES; SPEED LIMIT; PROTEIN; DYNAMICS; UREA;
   STABILITY; XANTHONE
AB The conformational search for favorable intramolecular interactions during protein folding is limited by intrachain diffusion processes. Recent studies on the dynamics of loop formation in unfolded polypeptide chains have focused on loops involving residues near the chain ends. During protein folding, however, most contacts are formed between residues in the interior of the chain. We compared the kinetics of end-to-end loop formation (type I loops) to the formation of end-to-interior (type II loops) and interior-to-interior loops (type III loops) using triplet-triplet energy transfer from xanthone to naphthylalanine. The results show that formation of type II and type III loops is slower compared to type I loops of the same size and amino acid sequence. The rate constant for type II loop formation decreases with increasing overall chain dimensions up to a limiting value, at which loop formation is about 2.5-fold slower for type II loops compared to type I loops. Comparing type II loops of different loop size and amino acid sequence shows that the ratio of loop dimension over total chain dimension determines the rate constant for loop formation. Formation of type III loops is 1.7-fold slower than formation of type II loops, indicating that local chain motions are strongly coupled to motions of other chain segments which leads to faster dynamics toward the chain ends. Our results show that differences in the kinetics of formation of type I, type II, and type III loops are mainly caused by differences in internal flexibility at the different positions in the polypeptide chain. Interactions of the polypeptide chain with the solvent contribute to the kinetics of loop formation, which are strongly viscosity-dependent. However, the observed differences in the kinetics of formation of type I, type II, and type III loops are not due to the increased number of peptide-solvent interactions in type II and type III loops compared to type I loops as indicated by identical viscosity dependencies for the kinetics of formation of the different types of loops.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Fierz, Beat/H-3143-2012; Kiefhaber, Thomas/A-3028-2010
OI Fierz, Beat/0000-0002-2991-3044; 
CR ALLERHAN.A, 1972, J CHEM PHYS, V56, P3718, DOI 10.1063/1.1677754
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   Bieri O, 1999, BIOL CHEM, V380, P923, DOI 10.1515/BC.1999.114
   Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100
   Fierz B, 2005, PROTEIN FOLDING HANDBOOK, P809, DOI 10.1002/9783527619498.ch22
   Flory P.J., 1969, STAT MECH CHAIN MOL
   FRANK MK, 1995, PROTEIN SCI, V4, P2605, DOI 10.1002/pro.5560041218
   FRIEDMAN B, 1993, MACROMOLECULES, V26, P4888, DOI 10.1021/ma00070a025
   GRAHAM R, 1978, J CHEM SOC PERK T 1, P876, DOI 10.1039/p19780000876
   Green N M, 1975, Adv Protein Chem, V29, P85, DOI 10.1016/S0065-3233(08)60411-8
   Heinz B, 2006, PHYS CHEM CHEM PHYS, V8, P3432, DOI 10.1039/b603560d
   Hudgins RR, 2002, J AM CHEM SOC, V124, P556, DOI 10.1021/ja010493n
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i
   Krieger F, 2004, CHEM PHYS, V307, P209, DOI 10.1016/j.chemphys.2004.05.036
   Ladurner AG, 1997, J MOL BIOL, V273, P330, DOI 10.1006/jmbi.1997.1304
   Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220
   Lee S, 1997, MACROMOLECULES, V30, P2633, DOI 10.1021/ma961351u
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Moglich A, 2005, J MOL BIOL, V345, P153, DOI 10.1016/j.jmb.2004.10.036
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2
   Ortiz-Repiso M, 1998, MACROMOLECULES, V31, P8356, DOI 10.1021/ma980254t
   Ortiz-Repiso M, 1998, MACROMOLECULES, V31, P8363, DOI 10.1021/ma980255l
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   PERICO A, 1990, MACROMOLECULES, V23, P797, DOI 10.1021/ma00205a017
   PERICO A, 1989, BIOPOLYMERS, V28, P1527, DOI 10.1002/bip.360280905
   Satzger H, 2004, J PHYS CHEM A, V108, P10072, DOI 10.1021/jp047583+
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715
   Viguera AR, 1997, NAT STRUCT BIOL, V4, P939, DOI 10.1038/nsb1197-939
   Wang LP, 2005, J MOL BIOL, V353, P719, DOI 10.1016/j.jmb.2005.08.038
NR 36
TC 60
Z9 60
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 24
PY 2007
VL 129
IS 3
BP 672
EP 679
DI 10.1021/ja0666396
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 126HO
UT WOS:000243503700048
PM 17227031
DA 2021-01-25
ER

PT J
AU Meier, S
   Jensen, PR
   David, CN
   Chapman, J
   Holstein, TW
   Grzesiek, S
   Ozbek, S
AF Meier, Sebastian
   Jensen, Pernille R.
   David, Charles N.
   Chapman, Jarrod
   Holstein, Thomas W.
   Grzesiek, Stephan
   Ozbek, Suat
TI Continuous molecular evolution of protein-domain structures by single
   amino acid changes
SO CURRENT BIOLOGY
LA English
DT Article
ID CONFORMATIONAL DIVERSITY; HYDRA NEMATOCYSTS; SEQUENCE SPACE;
   MINICOLLAGEN; FOLD; NOWA
AB Protein structures cluster into families of folds that can result from extremely different amino acid sequences [11]. Because the enormous amount of genetic information generates a limited number of protein folds [2], a particular domain structure often assumes numerous functions. How new protein structures and new functions evolve under these limitations remains elusive. Molecular evolution may be driven by the ability of biomacromolecules to adopt multiple conformations as a bridge between different folds [3-6]. This could allow proteins to explore new structures and new tasks while part of the structural ensemble retains the initial conformation and function as a safeguard [7]. Here we show that a global structural switch can arise from single amino acid changes in cysteine-rich domains (CRD) of cnidarian nematocyst proteins. The ability of these CRDs to form two structures with different disulfide patterns from an identical cysteine pattern is distinctive [8]. By applying a structure-based mutagenesis approach, we demonstrate that a cysteine-rich domain can interconvert between two natively occurring domain structures via a bridge state containing both structures. Comparing cnidarian CRD sequences leads us to believe that the mutations we introduced to stabilize each structure reflect the birth of new protein folds in evolution.
C1 Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany.
   Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.
   Univ Heidelberg, Dept Mol Evolut & Genom, D-69130 Heidelberg, Germany.
RP Meier, S (corresponding author), Univ Copenhagen, Inst Mol Biol & Physiol, August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen, Denmark.
EM smeier@aki.ku.dk; soezbek@zoo.uni-heidelberg.de
RI Jensen, Pernille Rose/J-8648-2016; Ozbek, Suat/D-3701-2014; Jensen,
   Pernille Rose/AAX-5696-2020; Meier, Sebastian/A-4279-2015
OI Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille
   Rose/0000-0003-4359-848X; Meier, Sebastian/0000-0003-3761-3217; Ozbek,
   Suat/0000-0003-2569-3942; Grzesiek, Stephan/0000-0003-1998-4225
CR Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482
   Babajide A, 2001, J THEOR BIOL, V212, P35, DOI 10.1006/jtbi.2001.2343
   BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202
   BornbergBauer E, 1997, BIOPHYS J, V73, P2393, DOI 10.1016/S0006-3495(97)78268-7
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   Cordes MHJ, 2000, NAT STRUCT BIOL, V7, P1129
   Deechongkit S, 2004, NATURE, V430, P101, DOI 10.1038/nature02611
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206
   James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731
   James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X
   JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   Meier S, 2004, FEBS LETT, V569, P112, DOI 10.1016/j.febslet.2004.05.034
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Nuchter T, 2006, CURR BIOL, V16, pR316, DOI 10.1016/j.cub.2006.03.089
   Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018
   Schultes EA, 2000, SCIENCE, V289, P448, DOI 10.1126/science.289.5478.448
   SCRUTTON CT, 1979, ORIGIN MAJOR INVERTE, P161
   Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616
   Socolich M, 2005, NATURE, V437, P512, DOI 10.1038/nature03991
   Van Dorn LO, 2006, BIOCHEMISTRY-US, V45, P10542, DOI 10.1021/bi060853p
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
NR 26
TC 46
Z9 46
U1 1
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD JAN 23
PY 2007
VL 17
IS 2
BP 173
EP 178
DI 10.1016/j.cub.2006.10.063
PG 6
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 130PJ
UT WOS:000243811200027
PM 17240343
DA 2021-01-25
ER

PT J
AU Blattler, SM
   Rencurel, F
   Kaufmann, MR
   Meyer, UA
AF Blaettler, Sharon M.
   Rencurel, Franck
   Kaufmann, Michel R.
   Meyer, Urs A.
TI In the regulation of cytochrome P450 genes, phenobarbital targets LKB1
   for necessary activation of AMP-activated protein kinase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE drug metabolism; induction; mitochondria; reactive oxygen species
ID NUCLEAR RECEPTOR CAR; CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X
   RECEPTOR; HEPATOMA-CELL LINE; METABOLIZING-ENZYMES; SKELETAL-MUSCLE;
   EXPRESSION; INDUCTION; PHOSPHORYLATION; SYNTHASE
AB Transcriptional activation of cytochrome P450 (CYP) genes and various drug metabolizing enzymes by the prototypical inducer phenobarbital (PB) and many other drugs and chemicals is an adaptive response of the organism to exposure to xenobiotics. The response to PS is mediated by the nuclear receptor constitutive androstane receptor (CAR), whereas the chicken xenobiotic receptor (CXR) has been characterized as the PB mediator in chicken hepatocytes. Our previous results suggested an involvement of AMP-activated protein kinase (AMPK) in the molecular mechanism of PB induction. Here, we show that the mechanism of AMPK activation is related to an effect of PB-type inducers on mitochondrial function with consequent formation of reactive oxygen species (ROS) and phosphorylation of AMPK by the upstream kinase LKB1. Gain- and loss-of-function experiments demonstrate that LKB1-activated AMPK is necessary in the mechanism of drug induction and that this is an evolutionary conserved pathway for detoxification of exogenous and endogenous chemicals. The activation of LKB1 adds a proximal target to the so far elusive sequence of events by which PB and other drugs induce the transcription of multiple genes.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
CR Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571
   Chen ZP, 2000, AM J PHYSIOL-ENDOC M, V279, pE1202
   Chomyn A, 2003, BIOCHEM BIOPH RES CO, V304, P519, DOI 10.1016/S0006-291X(03)00625-9
   Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8
   Kim EK, 2004, J BIOL CHEM, V279, P19970, DOI 10.1074/jbc.M402165200
   KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477
   Konrad D, 2005, DIABETOLOGIA, V48, P954, DOI 10.1007/s00125-005-1713-7
   LAHTELA JT, 1985, DIABETES, V34, P911, DOI 10.2337/diabetes.34.9.911
   Leff T, 2003, BIOCHEM SOC T, V31, P224
   Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110
   Lochhead PA, 2000, DIABETES, V49, P896, DOI 10.2337/diabetes.49.6.896
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Nishikawa T, 2000, NATURE, V404, P787
   Oeda T, 1997, ANDROLOGIA, V29, P125
   Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101
   Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
   Sakuma T, 2001, XENOBIOTICA, V31, P223, DOI 10.1080/00498250110046451
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   WOODHOUSE K, 1992, DRUG AGING, V2, P243, DOI 10.2165/00002512-199202030-00007
   Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200
   Yoshida Y, 1996, BIOCHEM BIOPH RES CO, V229, P182, DOI 10.1006/bbrc.1996.1777
   Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599
   Zou MH, 2004, J BIOL CHEM, V279, P43940, DOI 10.1074/jbc.M404421200
NR 37
TC 60
Z9 62
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 16
PY 2007
VL 104
IS 3
BP 1045
EP 1050
DI 10.1073/pnas.0610216104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 129WP
UT WOS:000243761100065
PM 17213310
OA Bronze, Green Published
DA 2021-01-25
ER

PT S
AU Frederix, PLTM
   Bosshart, PD
   Engel, A
   Akiyama, T
   De Rooij, NF
   Staufer, U
AF Frederix, Patrick L. T. M.
   Bosshart, Patrick D.
   Engel, Andreas
   Akiyama, Terunobu
   De Rooij, Nico F.
   Staufer, Urs
GP IEEE
TI Comparison of two redox couples for AFM-SECM
SO 2007 IEEE SENSORS, VOLS 1-3
SE IEEE Sensors
LA English
DT Proceedings Paper
CT 6th IEEE Sensors Conference
CY OCT 28-31, 2007
CL Atlanta, GA
SP IEEE Sensors Council
ID ATOMIC-FORCE MICROSCOPY; PROBES; CANTILEVER; BIOLOGY
AB Batch-fabricated conductive cantilevers that are merely insulated except for a small part at the tip, enable combination of atomic force microscopy and scanning electrochemical microscopy. This allows correlation of topographical features with a lateral, resolution of about 1nm and functional features at a resolution <10nm. Our interest is in proteins embedded in biological membranes. To study these several parameters must be optimized. E.g. the influence of the support on topographical and electrochemical data should be minimal. The choice of redox couple plays an additional role, since they have different sizes, charges, formal potentials and kinetic properties. In this paper two different redox molecules are compared in electrochemical experiments with our conductive cantilevers.
C1 [Frederix, Patrick L. T. M.; Bosshart, Patrick D.; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Biomech, Basel, Switzerland.
   [Akiyama, Terunobu; De Rooij, Nico F.; Staufer, Urs] Univ Neuchatel, Inst Microbiol, Neuchatel, Switzerland.
RP Frederix, PLTM (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Biomech, Basel, Switzerland.
EM patrick.frederix@unibas.ch
RI Staufer, Urs/J-6866-2016
OI Staufer, Urs/0000-0002-3519-6467
FU Swiss university; Swiss national centers of competence in nanoscale
   science and structural biology; states of Basel-Stadt and Neuchatel; EU
   Nanomot project [29084]; JPK-instruments; M.E. Muller foundation
FX Financial support was received from the Swiss university conference, the
   Swiss national centers of competence in nanoscale science and structural
   biology, the states of Basel-Stadt and Neuchatel, the EU Nanomot project
   (grant 29084), JPK-instruments and the M.E. Muller foundation.
CR Akiyama T, 2004, JPN J APPL PHYS 1, V43, P3865, DOI 10.1143/JJAP.43.3865
   AKIYAMA T, 2003, 12 INT C SCANN TUNN
   Bard AJ, 2001, ELECTROCHEMICAL METH
   BOSSHART PD, 2007, UNPUB AFM SECM
   Davoodi A, 2005, ELECTROCHEM SOLID ST, V8, pB21, DOI 10.1149/1.1911900
   Dobson PS, 2005, ANAL CHEM, V77, P424, DOI 10.1021/ac048930e
   Fasching RJ, 2005, SENSOR ACTUAT B-CHEM, V108, P964, DOI 10.1016/j.snb.2004.10.058
   Frederix PLTM, 2005, NANOTECHNOLOGY, V16, P997, DOI 10.1088/0957-4484/16/8/001
   Gardner CE, 2002, ANAL CHEM, V74, p576A, DOI 10.1021/ac0221482
   Gullo MR, 2006, ANAL CHEM, V78, P5436, DOI 10.1021/ac0521495
   Kranz C, 2001, ANAL CHEM, V73, P2491, DOI 10.1021/ac001099v
   Macpherson JV, 2000, ANAL CHEM, V72, P276, DOI 10.1021/ac990921w
   NIKAIDO H, 2003, MICROBIOLOGY MOL BIO, V67
   Zoski CG, 2002, ELECTROANAL, V14, P1041, DOI 10.1002/1521-4109(200208)14:15/16<1041::AID-ELAN1041>3.0.CO;2-8
NR 14
TC 0
Z9 0
U1 1
U2 4
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1930-0395
BN 978-1-4244-1261-7
J9 IEEE SENSOR
PY 2007
BP 703
EP 706
DI 10.1109/ICSENS.2007.4388496
PG 4
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic; Remote Sensing; Optics
SC Computer Science; Engineering; Remote Sensing; Optics
GA BHN71
UT WOS:000254563600178
DA 2021-01-25
ER

PT J
AU Schirmer, T
   Wassmann, P
   Samoray, D
AF Schirmer, Tilman
   Wassmann, Paul
   Samoray, Dietrich
TI Structure of the full-length response regulator PleD in its activated
   state
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE allosteric enzymes; signal transduction; response regulator
C1 [Schirmer, Tilman; Wassmann, Paul; Samoray, Dietrich] Univ Basel, Biozentrum, Basel, Switzerland.
EM tilman.schirmer@unibas.ch
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200
NR 4
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2007
VL 63
SU S
MA MS03 P17
BP S124
EP S125
DI 10.1107/S0108767307097280
PG 2
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UW
UT WOS:000478082400269
OA Bronze
DA 2021-01-25
ER

PT J
AU Hofbauer, KG
   Nicholson, JR
   Boss, O
AF Hofbauer, Karl G.
   Nicholson, Janet R.
   Boss, Olivier
TI The obesity epidemic: Current and future pharmacological treatments
SO ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
SE Annual Review of Pharmacology and Toxicology
LA English
DT Review; Book Chapter
DE appetite; satiety; energy balance; adipose tissue; drugs
ID CANNABINOID-1 RECEPTOR BLOCKER; CILIARY NEUROTROPHIC FACTOR; LIFE-STYLE
   MODIFICATION; WEIGHT-LOSS; CALORIE RESTRICTION; METABOLIC-SYNDROME;
   FOOD-INTAKE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; RISK-FACTORS
AB The unabated rise in the prevalence of obesity is a challenge for global health care systems. Efforts to reverse this trend by dietary or behavioral counseling have not been successful, which has stimulated efforts to find a role for pharmacotherapy. Currently only a small number of antiobesity drugs are approved for long-term use and only a few compounds are in clinical development. Despite recent progress in the understanding of the regulation of energy balance, drug discovery has been less productive than expected. In the present review, the clinically available antiobesity agents are discussed. Examples of drug candidates that are currently in development are given and the possible future range of antiobesity agents is illustrated by the targets being addressed in drug discovery. Finally, the efficacy of antiobesity agents and their value in the treatment of obesity are assessed in comparison with other therapeutic approaches, such as surgery and changes in lifestyle.
C1 Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   Sirtris Pharmaceut Inc, Cambridge, MA 02139 USA.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014
   Arner P, 2005, DIABETOLOGIA, V48, P2203, DOI 10.1007/s00125-005-1956-3
   Arterburn DE, 2004, ARCH INTERN MED, V164, P994, DOI 10.1001/archinte.164.9.994
   Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4
   Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951
   Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035
   Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2
   Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204
   Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151
   Bensimhon DR, 2006, AM HEART J, V151, P598, DOI 10.1016/j.ahj.2005.03.005
   Birkenfeld AL, 2005, CLIN AUTON RES, V15, P200, DOI 10.1007/s10286-005-0270-y
   Blanc S, 2003, J CLIN ENDOCR METAB, V88, P16, DOI 10.1210/jc.2002-020405
   Boggiano MM, 2005, OBES REV, V6, P307, DOI 10.1111/j.1467-789X.2005.00218.x
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Boss O, 2006, EXPERT OPIN THER TAR, V10, P119, DOI 10.1517/14728222.10.1.119
   Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143
   Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003
   Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136
   Chen HC, 2005, ARTERIOSCL THROM VAS, V25, P482, DOI 10.1161/01.ATV.0000151874.81059.ad
   Chiesi M, 2001, TRENDS PHARMACOL SCI, V22, P247, DOI 10.1016/S0165-6147(00)01664-3
   Cohen P, 2004, J NUTR, V134, p2455S
   Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Crampin EJ, 2004, EXP PHYSIOL, V89, P1, DOI 10.1113/expphysiol.2003.026740
   Crookes PE, 2006, ANNU REV MED, V57, P243, DOI 10.1146/annurev.med.56.062904.144928
   Cruz ML, 2005, ANNU REV NUTR, V25, P435, DOI 10.1146/annurev.nutr.25.050304.092625
   Cummings DE, 2005, CURR DRUG TARGETS, V6, P153, DOI 10.2174/1389450053174569
   Cummings DE, 2004, J CLIN ENDOCR METAB, V89, P2608, DOI 10.1210/jc.2004-0433
   Curran MP, 2004, DRUGS, V64, P2845, DOI 10.2165/00003495-200464240-00010
   Dalle Grave R, 2004, OBES RES, V12, P2005, DOI 10.1038/oby.2004.251
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537
   DeWald T, 2006, AM HEART J, V151, P604, DOI 10.1016/j.ahj.2005.03.007
   Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457
   Diamond LE, 2004, INT J IMPOT RES, V16, P51, DOI 10.1038/sj.ijir.3901139
   Dulloo AG, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P405, DOI 10.1201/9780203508756.ch20
   Dulloo AG, 2005, ACTA PHYSIOL SCAND, V184, P295, DOI 10.1111/j.1365-201X.2005.01466.x
   Ettinger MP, 2003, JAMA-J AM MED ASSOC, V289, P1826, DOI 10.1001/jama.289.14.1826
   Farooqi IS, 2005, ANNU REV MED, V56, P443, DOI 10.1146/annurev.med.56.062904.144924
   Fishman AP, 1999, CIRCULATION, V99, P156, DOI 10.1161/01.CIR.99.1.156
   Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050
   Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X
   Flodmark CE, 2006, INT J OBESITY, V30, P579, DOI 10.1038/sj.ijo.0803290
   Friedman JM, 2004, NAT MED, V10, P563, DOI 10.1038/nm0604-563
   GREENWAY FL, 2004, HDB OBESITY, P329
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Gura T, 2003, SCIENCE, V299, P849, DOI 10.1126/science.299.5608.849
   GUYTON AC, 1988, AM J MED SCI, V295, P320, DOI 10.1097/00000441-198804000-00018
   Halford JCG, 2004, CURR DRUG TARGETS, V5, P637, DOI 10.2174/1389450043345191
   Hansen BC, 1999, TOXICOL SCI, V52, P56, DOI 10.1093/toxsci/52.suppl_1.56
   Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x
   Harper ME, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P363
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hauner H, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P219, DOI 10.1201/9780203508756.pt4
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Heffernan M, 2001, ENDOCRINOLOGY, V142, P5182, DOI 10.1210/en.142.12.5182
   Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539
   Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089
   Hesselink MKC, 2003, OBES RES, V11, P1429, DOI 10.1038/oby.2003.192
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005
   HOFABUER KG, 2006, IN PRESS J EXP CLIN
   Hofbauer KG, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P467
   Hofbauer KG, 2002, TRENDS ECOL EVOL, V17, P328, DOI 10.1016/S0169-5347(02)02515-6
   Hoist B, 2006, J CLIN INVEST, V116, P637, DOI 10.1172/JCI27999
   Holst JJ, 2006, DIABETOLOGIA, V49, P253, DOI 10.1007/s00125-005-0107-1
   Horvath TL, 2005, NAT NEUROSCI, V8, P561, DOI 10.1038/nn1453
   Ingram DK, 2004, ANN NY ACAD SCI, V1019, P412, DOI 10.1196/annals.1297.074
   Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Katz DL, 2005, ANNU REV PUBL HEALTH, V26, P61, DOI 10.1146/annurev.publhealth.26.021304.144415
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kokoeva MV, 2005, SCIENCE, V310, P679, DOI 10.1126/science.1115360
   Kolanowski J, 1999, DRUG SAFETY, V20, P119, DOI 10.2165/00002018-199920020-00003
   Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048
   Korner J, 2004, J CLIN ENDOCR METAB, V89, P2616, DOI 10.1210/jc.2004-0341
   Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A
   Lafontan M, 2005, ANNU REV PHARMACOL, V45, P119, DOI 10.1146/annurev.pharmtox.45.120403.095843
   Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298
   Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342
   LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804
   Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013
   Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102
   Mashiko S, 2005, ENDOCRINOLOGY, V146, P3080, DOI 10.1210/en.2004-1150
   Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071
   Moyers SB, 2005, J AM DIET ASSOC, V105, P948, DOI 10.1016/j.jada.2005.03.010
   Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5
   Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE
   Nisoli E, 2004, PHARMACOL RES, V50, P453, DOI 10.1016/j.phrs.2004.02.004
   Noble D, 2002, SCIENCE, V295, P1678, DOI 10.1126/science.1069881
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   O'Rahilly S, 2004, NAT MED, V10, P351, DOI 10.1038/nm0404-351
   Park A, 2004, REGUL PEPTIDES, V119, P1, DOI 10.1016/j.regpep.2004.02.006
   Patel MR, 2006, AM HEART J, V151, P633, DOI 10.1016/j.ahj.2005.03.006
   Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406
   Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Puhl R M, 2003, Obes Rev, V4, P213, DOI 10.1046/j.1467-789X.2003.00122.x
   Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580
   Reaven GM, 2005, ANNU REV NUTR, V25, P391, DOI 10.1146/annurev.nutr.24.012003.132155
   Ryan DH, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P245, DOI 10.1201/9780203508756.ch12
   SCHMITTER PC, 2000, ECSA REV, V13, P2
   Schwartz MW, 2004, J CLIN ENDOCR METAB, V89, P5889, DOI 10.1210/jc.2004-0906
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   SIMONSMORTON DG, 2006, JAMA-J AM MED ASSOC, V295, P761
   Sinclair DA, 2006, SCI AM, V294, P48, DOI 10.1038/scientificamerican0306-48
   Summerbell CD, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001871.pub2
   Takahashi N, 2003, ENDOCRINOLOGY, V144, P2184, DOI 10.1210/en.2002-221045
   Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012
   Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007
   Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X
   Wadden TA, 2004, OBES RES, V12, p151S, DOI 10.1038/oby.2004.282
   Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156
   Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0
   Wessells H, 2005, PEPTIDES, V26, P1972, DOI 10.1016/j.peptides.2004.11.035
   Wolfe BM, 2005, JAMA-J AM MED ASSOC, V294, P1960, DOI 10.1001/jama.294.15.1960
   Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789
   Wynne K, 2005, J ENDOCRINOL, V184, P291, DOI 10.1677/joe.1.05866
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   Yanagisawa T, 2000, TOHOKU J EXP MED, V192, P181, DOI 10.1620/tjem.192.181
   Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586
   Young Andrew, 2005, Adv Pharmacol, V52, P99
   ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0
   ZHI J, 1994, CLIN PHARMACOL THER, V56, P82, DOI 10.1038/clpt.1994.104
NR 131
TC 66
Z9 67
U1 0
U2 9
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0362-1642
EI 1545-4304
J9 ANNU REV PHARMACOL
JI Annu. Rev. Pharmacol. Toxicol.
PY 2007
VL 47
BP 565
EP 592
DI 10.1146/annurev.pharmtox.47.120505.105256
PG 28
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 139VW
UT WOS:000244461700018
PM 17002599
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Fudge, D
AF Kreplak, Laurent
   Fudge, Douglas
TI Biomechanical properties of intermediate filaments: from tissues to
   single filaments and back
SO BIOESSAYS
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; HAGFISH SLIME GLAND; LIVING ENDOTHELIAL-CELLS;
   ALPHA-KERATIN FIBERS; IN-VITRO; MECHANICAL-PROPERTIES; THREAD CELLS;
   VISCOELASTIC PROPERTIES; ACTIN-FILAMENTS; EPTATRETUS-STOUTI
AB The animal cell cytoskeleton consists of three interconnected filament systems: actin-containing microfilaments (MFs), microtubules (MTs), and the lesser known intermediate filaments (IFs). All IF proteins share a common tripartite domain structure and the ability to assemble into 8-12 nm wide filaments. Electron microscopy data suggest that lFs are built according to a completely different plan from that of MFs and MTs. lFs are known to impart mechanical stability to cells and tissues but, until recently, the biomechanical properties of single IFs were unknown. However, with the discovery of naturally occurring micrometer-wide IF bundles and the development of new methodologies to mechanically probe single filaments, it is now possible to propose a more unified view of IF biomechanics. Unlike IVIFs and MTs, single IFs can now be described as flexible, extensible and tough, which has important implications for our understanding of cell and tissue mechanics. Furthermore, the molecular mechanisms at play when lFs are deformed point toward a pivotal role for them in mechanotransduction. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada.
RP Kreplak, L (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Laurent.kreplak@unibas.ch
OI kreplak, laurent/0000-0001-9370-9809
CR Abu-Lail NI, 2003, J MICROSC-OXFORD, V212, P217, DOI 10.1111/j.1365-2818.2003.01261.x
   Akkermans RLC, 2004, PHILOS T ROY SOC A, V362, P1783, DOI 10.1098/rsta.2004.1395
   Aranda-Espinoza H, 2002, FEBS LETT, V531, P397, DOI 10.1016/S0014-5793(02)03515-9
   ASTBURY WT, 1931, GEN PHILOS T R SOC A, V230, P75
   ASTBURY WT, 1933, PHILOS T R SOC A, V232, P33
   Baden HP, 1974, 1ST HUM HAIR S, P388
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191
   Beil M, 2003, NAT CELL BIOL, V5, P803, DOI 10.1038/ncb1037
   Bendit E. G., 1960, TEXT RES J, V30, P547
   Bloom S, 1996, J MOL CELL CARDIOL, V28, P2123, DOI 10.1006/jmcc.1996.0204
   Bousquet O, 2001, J CELL BIOL, V155, P747, DOI 10.1083/jcb.200104063
   Brown HG, 1998, J MICROSC-OXFORD, V191, P229
   Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640
   CRICK FHC, 1952, NATURE, V170, P882, DOI 10.1038/170882b0
   Davies PF, 2005, ANN BIOMED ENG, V33, P1714, DOI 10.1007/s10439-005-8774-0
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   DOBB MG, 1967, S FIBROUS PROTEINS, V1, P267
   DOWNING SW, 1984, J CELL BIOL, V98, P653, DOI 10.1083/jcb.98.2.653
   DOWNING SW, 1981, SCIENCE, V214, P1143, DOI 10.1126/science.7302586
   DOWNING SW, 1981, SCIENCE, V212, P326, DOI 10.1126/science.212.4492.326
   Felgner H, 1996, J CELL SCI, V109, P509
   FERNHOLM B, 1981, ACTA ZOOL-STOCKHOLM, V62, P137, DOI 10.1111/j.1463-6395.1981.tb00623.x
   Feughelman M., 1959, TEXT RES J, V29, P223, DOI DOI 10.1177/004051755902900305
   Fraser R. D. B., 1972, KERATINS THEIR COMPO
   FUCHS E, 1992, P NATL ACAD SCI USA, V89, P6906, DOI 10.1073/pnas.89.15.6906
   Fudge DS, 2005, J EXP BIOL, V208, P4613, DOI 10.1242/jeb.01963
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102
   GILLESPIE JM, 1974, AUST J BIOL SCI, V27, P617
   GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923
   Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   Hansma HG, 2004, CURR OPIN STRUC BIOL, V14, P380, DOI 10.1016/j.sbi.2004.05.005
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   Helmke BP, 2003, BIOPHYS J, V84, P2691, DOI 10.1016/S0006-3495(03)75074-7
   Helmke BP, 2001, BIOPHYS J, V80, P184, DOI 10.1016/S0006-3495(01)76006-7
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060
   HOFMANN I, 1991, EUR J CELL BIOL, V56, P328
   Hohenadl M, 1999, BIOPHYS J, V77, P2199, DOI 10.1016/S0006-3495(99)77060-8
   Howard J., 2001, MECH MOTOR PROTEINS
   Huang S, 2005, CANCER CELL, V8, P175, DOI 10.1016/j.ccr.2005.08.009
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Kippenberger S, 2005, J BIOL CHEM, V280, P3060, DOI 10.1074/jbc.M409590200
   Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101
   Kiss B, 2006, J STRUCT BIOL, V155, P327, DOI 10.1016/j.jsb.2006.03.020
   KOCH EA, 1991, CELL TISSUE RES, V264, P79, DOI 10.1007/BF00305724
   KOCH EA, 1994, J CELL SCI, V107, P3133
   KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0
   KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303
   KURACHI M, 1995, CELL MOTIL CYTOSKEL, V30, P221, DOI 10.1002/cm.970300306
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   Liu XM, 2002, BIOPHYS J, V83, P2705, DOI 10.1016/S0006-3495(02)75280-6
   Loranger A, 1997, AM J PATHOL, V151, P1673
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Morton W. E., 1993, PHYS PROPERTIES TEXT
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Norlen L, 2003, J INVEST DERMATOL, V120, P555, DOI 10.1046/j.1523-1747.2003.12102.x
   Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102
   Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006
   Paramio JM, 2002, BIOESSAYS, V24, P836, DOI 10.1002/bies.10140
   PARK AC, 1972, J SOC COSMET CHEM, V23, P3
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P261, DOI 10.1073/pnas.37.5.261
   Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200
   Rief M, 2000, ADV EXP MED BIOL, V481, P129
   Rowat AC, 2005, J R SOC INTERFACE, V2, P63, DOI 10.1098/rsif.2004.0022
   Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407
   Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944
   Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0
   SHIRINSKY VP, 1989, J CELL BIOL, V109, P331, DOI 10.1083/jcb.109.1.331
   SPITZER RH, 1988, CELL MOTIL CYTOSKEL, V11, P31, DOI 10.1002/cm.970110105
   STEINERT PM, 1978, P NATL ACAD SCI USA, V75, P6098, DOI 10.1073/pnas.75.12.6098
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Takei T, 1997, J CELL PHYSIOL, V173, P64, DOI 10.1002/(SICI)1097-4652(199710)173:1<64::AID-JCP8>3.0.CO;2-H
   Tarbell JM, 2005, ANN BIOMED ENG, V33, P1719, DOI 10.1007/s10439-005-8775-z
   Trickey WR, 2004, J ORTHOPAED RES, V22, P131, DOI 10.1016/S0736-0266(03)00150-5
   Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937
   VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F
   Wang JX, 2006, EXP CELL RES, V312, P205, DOI 10.1016/j.yexcr.2005.11.004
   Wang N, 2000, AM J PHYSIOL-CELL PH, V279, pC188
   Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101
   Yamada S, 2003, J STRUCT BIOL, V143, P45, DOI 10.1016/S1047-8477(03)00101-1
   Zlatanova J, 2000, PROG BIOPHYS MOL BIO, V74, P37, DOI 10.1016/S0079-6107(00)00014-6
NR 97
TC 77
Z9 78
U1 2
U2 29
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD JAN
PY 2007
VL 29
IS 1
BP 26
EP 35
DI 10.1002/bies.20514
PG 10
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 123ZP
UT WOS:000243336700005
PM 17187357
DA 2021-01-25
ER

PT J
AU Beck, A
   Jurcevic, P
   Heerklotz, H
AF Beck, Andreas
   Jurcevic, Petar
   Heerklotz, Heiko
TI Membrane solubilisation on the way from arts to routine technology: The
   effect of mixing detergents
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 51st Annual Meeting of the Biophysical-Society
CY MAR 03-07, 2007
CL Baltimore, MD
SP Biophys Soc
C1 Biozentrum Univ Basel, Basel, Switzerland.
RI Jurcevic, Petar/O-4268-2014
OI Jurcevic, Petar/0000-0003-1234-6386
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2007
SU S
BP 16A
EP 16A
PG 1
WC Biophysics
SC Biophysics
GA 132WA
UT WOS:000243972400070
DA 2021-01-25
ER

PT J
AU Tsamaloukas, AD
   Szadkowska-, H
   Heerklotz, H
AF Tsamaloukas, Alekos D.
   Szadkowska-, Halina
   Heerklotz, Heiko
TI Nonideal mixing in multicomponent lipid/detergent systems
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 51st Annual Meeting of the Biophysical-Society
CY MAR 03-07, 2007
CL Baltimore, MD
SP Biophys Soc
C1 Univ Toronto, Toronto, ON, Canada.
   Biozentrum Univ Basel, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2007
SU S
BP 59A
EP 59A
PG 1
WC Biophysics
SC Biophysics
GA 132WA
UT WOS:000243972400275
DA 2021-01-25
ER

PT J
AU van Nimwegen, E
AF van Nimwegen, Erik
TI Finding regulatory elements and regulatory motifs: a general
   probabilistic framework
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT Otto Warburg International Summer School and Workshop on Networks and
   Regulation
CY 2005
CL Berlin, GERMANY
ID FACTOR-BINDING-SITES; MULTIPLE SEQUENCE ALIGNMENT;
   SACCHAROMYCES-CEREVISIAE; DNA; DROSOPHILA; GENOME; ALGORITHM; MODULES;
   MODELS; IDENTIFICATION
AB Over the last two decades a large number of algorithms has been developed for regulatory motif finding. Here we show how many of these algorithms, especially those that model binding specificities of regulatory factors with position specific weight matrices (WMs), naturally arise within a general Bayesian probabilistic framework. We discuss how WMs are constructed from sets of regulatory sites, how sites for a given WM can be discovered by scanning of large sequences, how to cluster WMs, and more generally how to cluster large sets of sites from different WMs into clusters. We discuss how 'regulatory modules', clusters of sites for subsets of WMs, can be found in large intergenic sequences, and we discuss different methods for ab initio motif finding, including expectation maximization ( EM) algorithms, and motif sampling algorithms. Finally, we extensively discuss how module finding methods and ab initio motif finding methods can be extended to take phylogenetic relations between the input sequences into account, i.e. we show how motif finding and phylogenetic footprinting can be integrated in a rigorous probabilistic framework. The article is intended for readers with a solid background in applied mathematics, and preferably with some knowledge of general Bayesian probabilistic methods. The main purpose of the article is to elucidate that all these methods are not a disconnected set of individual algorithmic recipes, but that they are just different facets of a single integrated probabilistic theory.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, Basel, Switzerland.
EM erik.vannimwegan@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
CR Abramowitz M., 1974, HDB MATH FUNCTIONS F
   BARASH Y, 2003, P 7 ANN INT C RES CO, P28
   Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578
   BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8
   Berman BP, 2002, P NATL ACAD SCI USA, V99, P757, DOI 10.1073/pnas.231608898
   Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007
   Blanchette M, 2002, J COMPUT BIOL, V9, P211, DOI 10.1089/10665270252935421
   Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902
   Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   DAVIDSNO EH, 2001, GENOMIC REGULATORY S
   Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, P345
   Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603
   Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705
   Durbin R., 1998, BIOL SEQUENCE ANAL
   EISEN M, 2005, GENOME BIOL, V6, pP7
   ERB I, 2006, IEE P SYST BIOL ICCS
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Frenkel D, 1996, UNDERSTANDING MOL SI
   Frith MC, 2001, BIOINFORMATICS, V17, P878, DOI 10.1093/bioinformatics/17.10.878
   Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519
   Jaynes E. T., 2003, PROBABILITY THEORY L
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671
   LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Liu J. S., 2001, MONTE CARLO STRATEGI
   Liu JS, 1999, J AM STAT ASSOC, V94, P1, DOI 10.2307/2669673
   Liu X, 2001, Pac Symp Biocomput, P127
   Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717
   Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102
   McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602
   McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774
   Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098
   Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98
   Muller T, 2002, MOL BIOL EVOL, V19, P8, DOI 10.1093/oxfordjournals.molbev.a003985
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002
   RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5
   Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939
   Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-129
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   Thijs G, 2001, BIOINFORMATICS, V17, P1113, DOI 10.1093/bioinformatics/17.12.1113
   Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608
   Timothy B, 1994, P 2 INT C INT SYST M, V2, P28
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
   Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329
   ZAVOLAN M, 2003, P IEEE C COMP S BIOI
NR 56
TC 31
Z9 31
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PY 2007
VL 8
SU 6
AR S4
DI 10.1186/1471-2105-8-S6-S4
PG 26
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 216PG
UT WOS:000249890200004
PM 17903285
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Blattler, SM
   Rencurel, F
   Harach, T
   Kaufmann, MR
   Tamasi, V
   Beer, M
   Meyer, UA
AF Blaettler, Sharon M.
   Rencurel, Franck
   Harach, Taoufiq
   Kaufmann, Michel R.
   Tamasi, Viola
   Beer, Markus
   Meyer, Urs A.
TI THE "PHENOBARBITAL RECEPTOR": PHENOBARBITAL AFFECTS MITOCHONDRIAL
   FUNCTION AND ACTIVATES PROTEINKINASES PKCZETA, LKB1 AND AMPK
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 8th Annual Meeting of the International-Society-for-Study-of-Xenobiotics
CY OCT 09-12, 2007
CL Sendai, JAPAN
SP Int Soc Study Xenobiot
ID KINASE
C1 [Blaettler, Sharon M.; Rencurel, Franck; Harach, Taoufiq; Kaufmann, Michel R.; Tamasi, Viola; Beer, Markus; Meyer, Urs A.] Univ Basel, Biozentrum, Basel, Switzerland.
CR Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
NR 2
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2532
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2007
VL 39
SU 1
MA 326
BP 232
EP 232
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 670RD
UT WOS:000283444100323
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, Urs A.
TI Endo-xenobiotic crosstalk and the regulation of cytochromes P450
SO DRUG METABOLISM REVIEWS
LA English
DT Review
DE cytochrome P450; constitutive androstane receptor; pregnane X receptor;
   heme; AMP-activated protein kinase
ID ACTIVATED PROTEIN-KINASE; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE
   RECEPTOR; DRUG-METABOLIZING-ENZYMES; NUCLEAR RECEPTOR; TRANSCRIPTIONAL
   ACTIVATION; GENE; PORPHYRIA; DEFICIENT; SYNTHASE
AB Evolution has provided organisms with an elaborate defense system against foreign compounds and against the accumulation of potentially toxic endogenous molecules, e.g. bile acids. Cytochromes P450 represent an important group of enzymes in this system. This article describes experiments started in the 1970's in Dallas on the coordination of heme and cytochrome P450 synthesis and how these studies evolved over the years into a concept of molecular links between xenobiotic metabolism and endogenous pathways of sterol, lipid, bile acid and energy homeostasis.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
CR Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104
   CONNEY AH, 1960, J PHARMACOL EXP THER, V130, P1
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200
   Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200
   Gnerre C, 2004, PHARMACOGENETICS, V14, P635, DOI 10.1097/00008571-200410000-00001
   GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   HANDSCHIN C, 2003, NOVA ACTA LEPOLDINA, V329, P205
   Hankinson O, 2005, ARCH BIOCHEM BIOPHYS, V433, P379, DOI 10.1016/j.abb.2004.09.031
   Jung D, 2006, J BIOL CHEM, V281, P19081, DOI 10.1074/jbc.M600116200
   Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195
   Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986
   Meyer UA, 2000, LANCET, V356, P1667, DOI 10.1016/S0140-6736(00)03167-6
   Meyer UA, 2004, NAT REV GENET, V5, P669, DOI 10.1038/nrg1428
   MEYER UA, 1971, SCIENCE, V171, P64, DOI 10.1126/science.171.3966.64
   Meyer UA, 1998, SEMIN LIVER DIS, V18, P43, DOI 10.1055/s-2007-1007139
   Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013
   Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   REMMER H, 1959, NATURWISSENSCHAFTEN, V46, P580, DOI 10.1007/BF01750924
   Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
   SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
NR 27
TC 13
Z9 14
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2532
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2007
VL 39
IS 2-3
BP 639
EP 646
DI 10.1080/03602530701498737
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 207HK
UT WOS:000249242000031
PM 17786644
DA 2021-01-25
ER

PT J
AU Karow, AR
   Theissen, B
   Klostermeier, D
AF Karow, Anne R.
   Theissen, Bettina
   Klostermeier, Dagmar
TI Authentic interdomain communication in an RNA helicase reconstituted by
   expressed protein ligation of two helicase domains
SO FEBS JOURNAL
LA English
DT Article
DE expressed protein ligation; helicase; interdomain communication;
   RNA-dependent ATPase
ID DEAD-BOX PROTEIN; 23S RIBOSOMAL-RNA; CRYSTAL-STRUCTURE;
   ADENOSINE-TRIPHOSPHATASE; CHEMICAL LIGATION; KINETIC-ANALYSIS; BINDING;
   DBPA; YXIN; NMR
AB RNA helicases mediate structural rearrangements of RNA or RNA-protein complexes at the expense of ATP hydrolysis. Members of the DEAD box helicase family consist of two flexibly connected helicase domains. They share nine conserved sequence motifs that are involved in nucleotide binding and hydrolysis, RNA binding, and helicase activity. Most of these motifs line the cleft between the two helicase domains, and extensive communication between them is required for RNA unwinding. The two helicase domains of the Bacillus subtilis RNA helicase YxiN were produced separately as intein fusions, and a functional RNA helicase was generated by expressed protein ligation. The ligated helicase binds adenine nucleotides with very similar affinities to the wild-type protein. Importantly, its intrinsically low ATPase activity is stimulated by RNA, and the Michaelis-Menten parameters are similar to those of the wild-type. Finally, ligated YxiN unwinds a minimal RNA substrate to an extent comparable to that of the wild-type helicase, confirming authentic interdomain communication.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Kingelberg Str 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
CR ADAM H, 1962, ADENOSIN 5 DIPHOSPHA, P573
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Bates PA, 2001, PROTEINS, P39
   Camarero JA, 2002, P NATL ACAD SCI USA, V99, P8536, DOI 10.1073/pnas.132033899
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   David R, 2004, EUR J BIOCHEM, V271, P663, DOI 10.1111/j.1432-1033.2004.03978.x
   DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629
   Evans TC, 1999, BIOPOLYMERS, V51, P333, DOI 10.1002/(SICI)1097-0282(1999)51:5<333::AID-BIP3>3.0.CO;2-#
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   HIRATA R, 1990, J BIOL CHEM, V265, P6726
   Hofmann RM, 2002, CURR OPIN BIOTECH, V13, P297, DOI 10.1016/S0958-1669(02)00326-9
   KANE PM, 1989, J CELL SCI, P161
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Mathys S, 1999, GENE, V231, P1, DOI 10.1016/S0378-1119(99)00103-1
   Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447
   Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Talavera MA, 2005, BIOCHEMISTRY-US, V44, P959, DOI 10.1021/bi048253i
   Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y
   WITTUNG P, 1995, EUR J BIOCHEM, V228, P149, DOI 10.1111/j.1432-1033.1995.0149o.x
   Xu R, 1999, P NATL ACAD SCI USA, V96, P388, DOI 10.1073/pnas.96.2.388
   Yagi H, 2004, J AM CHEM SOC, V126, P16632, DOI 10.1021/ja045279o
   Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463
   Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006
NR 31
TC 18
Z9 18
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD JAN
PY 2007
VL 274
IS 2
BP 463
EP 473
DI 10.1111/j.1742-4658.2006.05593.x
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 122NU
UT WOS:000243234500017
PM 17229151
DA 2021-01-25
ER

PT J
AU Batista, R
   Martins, I
   Jenoe, P
   Ricardo, CP
   Oliveira, MM
AF Batista, Rita
   Martins, Isabel
   Jenoe, Paul
   Ricardo, Candido Pinto
   Oliveira, Maria Margarida
TI A proteomic study to identify soya allergens - The human response to
   transgenic versus non-transgenic soya samples
SO INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
LA English
DT Article
DE allergenicity; food safety; immune response; proteomics; transgenic food
ID SOYBEAN TRYPSIN-INHIBITOR; IGE-BINDING PROTEINS; GLYCINE-MAX; MOLECULAR
   CHARACTERIZATION; POTENTIAL ALLERGENICITY; IDENTIFICATION;
   SOLUBILIZATION; PURIFICATION; EXPRESSION; CYSTATINS
AB Background: In spite of being among the main foods responsible for allergic reactions worldwide, soybean (Glycine max)-derived products continue to be increasingly widespread in a variety of food products due to their well-documented health benefits. Soybean also continues to be one of the elected target crops for genetic modification. The aim of this study was to characterize the soya proteome and, specifically, IgE-reactive proteins as well as to compare the IgE response in soya-allergic individuals to genetically modified Roundup Ready soya((R)) versus its non-transgenic control. Methods: We performed two-dimensional gel electrophoresis of protein extracts from a 5% genetically modified Roundup Ready flour sample and its non-transgenic control followed by Western blotting with plasma from 5 soya-sensitive individuals. We used peptide tandem mass spectrometry to identify soya proteins ( 55 protein matches), specifically IgE-binding ones, and to evaluate differences between transgenic and non-transgenic samples. Results: We identified 2 new potential soybean allergens - one is maturation associated and seems to be part of the late embryogenesis abundant proteins group and the other is a cysteine proteinase inhibitor. None of the individuals tested reacted differentially to the transgenic versus non-transgenic samples under study. Conclusion: Soybean endogenous allergen expression does not seem to be altered after genetic modification. Proteomics should be considered a powerful tool for functional characterization of plants and for food safety assessment. Copyright (c) 2007 S. Karger AG, Basel.
C1 Inst Nacl Saude Dr Ricardo Jorge, P-1649016 Lisbon, Portugal.
   Univ Tecn Lisboa, Inst Super Agron, P-1100 Lisbon, Portugal.
   Univ Lisbon, Fac Ciencias, Dept Biol Vegetal, P-1699 Lisbon, Portugal.
   Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Biol Expt & Technol, P-2780 Oeiras, Portugal.
   Univ Basel, Biozentrum, Div Biochem, Basel, Switzerland.
RP Batista, R (corresponding author), Inst Nacl Saude Dr Ricardo Jorge, Av Padre Cruz, P-1649016 Lisbon, Portugal.
EM rita.batista@insa.min-saude.pt
RI Ricardo, Candido P P/B-7891-2008; Martins, Isabel/I-7255-2012; Oliveira,
   M. Margarida/H-9318-2012
OI Ricardo, Candido P P/0000-0003-4905-1274; Martins,
   Isabel/0000-0002-0136-1671; Oliveira, M. Margarida/0000-0002-0095-1952;
   Batista, Rita/0000-0002-2081-682X
CR Ali-Benali MA, 2005, BBA-GENE STRUCT EXPR, V1730, P56, DOI 10.1016/j.bbaexp.2005.05.011
   Arai S, 2002, J AGR FOOD CHEM, V50, P6612, DOI 10.1021/jf0201935
   AXEN RE, 1988, NEW ENG REG ALLERGY, V9, P503
   BARNETT D, 1987, J ALLERGY CLIN IMMUN, V80, P558, DOI 10.1016/0091-6749(87)90007-8
   Batista R, 2005, J ALLERGY CLIN IMMUN, V116, P403, DOI 10.1016/j.jaci.2005.04.014
   Baur X, 1996, ALLERGY, V51, P326, DOI 10.1111/j.1398-9995.1996.tb00093.x
   BLUM H, 1987, ELECTROPHORESIS, V8, P93, DOI 10.1002/elps.1150080203
   BURKS AW, 1994, INT ARCH ALLERGY IMM, V105, P143
   Codina R, 1997, CLIN EXP ALLERGY, V27, P424, DOI 10.1046/j.1365-2222.1997.d01-514.x
   Corpillo D, 2004, PROTEOMICS, V4, P193, DOI 10.1002/pmic.200300540
   CROWELL DN, 1992, PLANT MOL BIOL, V18, P459, DOI 10.1007/BF00040662
   DJURTOFT R, 1991, ADV EXP MED BIOL, V289, P281
   *FAO UN, 1995, REP FAO TECHN CONS F
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   GONZALEZ R, 1991, INT ARCH ALLER A IMM, V95, P53, DOI 10.1159/000235454
   GONZALEZ R, 1992, CLIN EXP ALLERGY, V22, P748, DOI 10.1111/j.1365-2222.1992.tb02814.x
   GONZALEZ R, 1995, LANCET, V346, P48, DOI 10.1016/S0140-6736(95)92676-3
   Gu XL, 2001, INT ARCH ALLERGY IMM, V126, P218, DOI 10.1159/000049517
   Hajduch M, 2005, PLANT PHYSIOL, V137, P1397, DOI 10.1104/pp.104.056614
   Helm RM, 2000, CURR OPIN IMMUNOL, V12, P647, DOI 10.1016/S0952-7915(00)00157-6
   Helm RM, 1998, INT ARCH ALLERGY IMM, V117, P29, DOI 10.1159/000023987
   Herbert B, 1999, ELECTROPHORESIS, V20, P660, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<660::AID-ELPS660>3.0.CO;2-Q
   Herman EM, 2003, PLANT PHYSIOL, V132, P36, DOI 10.1104/pp.103.021865
   Hoffmann-Sommergruber K, 2002, BIOCHEM SOC T, V30, P930, DOI 10.1042/BST0300930
   Kleine-Tebbe J, 2002, J ALLERGY CLIN IMMUN, V110, P797, DOI 10.1067/mai.2002.128946
   Koiwa H, 2000, FEBS LETT, V471, P67, DOI 10.1016/S0014-5793(00)01368-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lehesranta SJ, 2005, PLANT PHYSIOL, V138, P1690, DOI 10.1104/pp.105.060152
   Lin J, 2006, INT ARCH ALLERGY IMM, V141, P91, DOI 10.1159/000094535
   Magni C, 2005, J AGR FOOD CHEM, V53, P2275, DOI 10.1021/jf0491512
   Massonneau A, 2005, BBA-GENE STRUCT EXPR, V1729, P186, DOI 10.1016/j.bbaexp.2005.05.004
   Mendieta NLR, 1997, J SCI FOOD AGR, V75, P405, DOI 10.1002/(SICI)1097-0010(199712)75:4&lt;405::AID-JSFA904&gt;3.0.CO;2-V
   Metcalfe DD, 2005, NAT IMMUNOL, V6, P857, DOI 10.1038/ni0905-857
   Midoro-Horiuti T, 2001, ANN ALLERG ASTHMA IM, V87, P261, DOI 10.1016/S1081-1206(10)62238-7
   Mittag D, 2004, J ALLERGY CLIN IMMUN, V113, P148, DOI 10.1016/j.jaci.2003.09.030
   Mooney BP, 2004, PHYTOCHEMISTRY, V65, P1733, DOI 10.1016/j.phytochem.2004.04.011
   MOROZ LA, 1980, NEW ENGL J MED, V302, P1126, DOI 10.1056/NEJM198005153022005
   Natarajan S, 2005, ANAL BIOCHEM, V342, P214, DOI 10.1016/j.ab.2005.04.046
   NEUHOFF V, 1985, ELECTROPHORESIS, V6, P427, DOI 10.1002/elps.1150060905
   OGAWA T, 1991, J NUTR SCI VITAMINOL, V37, P555, DOI 10.3177/jnsv.37.555
   OGAWA T, 1993, BIOSCI BIOTECH BIOCH, V57, P1030, DOI 10.1271/bbb.57.1030
   Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709
   PANDEY A, 2000, SCI STKE, V37, pPL1
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ramagli LS, 1999, METH MOL B, V112, P99
   Rihs HP, 1999, J ALLERGY CLIN IMMUN, V104, P1293, DOI 10.1016/S0091-6749(99)70027-8
   Taylor S. L., 1997, Nutrition Abstracts and Reviews. Series A, Human and Experimental, V67, P1163
   Taylor SL, 1996, CRIT REV FOOD SCI, V36, pS91, DOI 10.1080/10408399609527761
   Tsuji H, 2001, BBA-GENE STRUCT EXPR, V1518, P178, DOI 10.1016/S0167-4781(00)00310-9
   Yaklich RW, 1999, CROP SCI, V39, P1444, DOI 10.2135/cropsci1999.3951444x
NR 50
TC 50
Z9 58
U1 0
U2 51
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-2438
EI 1423-0097
J9 INT ARCH ALLERGY IMM
JI Int. Arch. Allergy Immunol.
PY 2007
VL 144
IS 1
BP 29
EP 38
DI 10.1159/000102611
PG 10
WC Allergy; Immunology
SC Allergy; Immunology
GA 201BY
UT WOS:000248807700004
PM 17496424
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Engel, J
AF Engel, Juergen
TI Visions for novel biophysical elucidations of extracellular matrix
   networks
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE extracellular matrix; network; molecular machine; integrin; structure;
   dynamics
ID INTEGRIN ALPHA-V-BETA-3; PROTEIN MOLECULES; CRYSTAL-STRUCTURE;
   STRUCTURAL BASIS; 20S PROTEASOME; RNA-POLYMERASE; MACHINE; TOMOGRAPHY;
   LAMININ; CELLS
AB The extracellular matrix consists of multifunctional molecules, which are composed of a large numbers of different domains. Clearly these domains and even the entire molecules do not function independently as isolated species, but interact with each other in large networks. In many cases specific regions of the networks may be considered as molecular machines in which the different molecules are arranged in highly defined spatial structures and act in a dynamic, concerted fashion. At present most structural information is limited to single molecules, and dynamics have been measured mainly for pairs of interacting partners in solution. Work needs to be extended to large integrated systems and the functions of molecular machines need to be explored. Electron tomography, fluorescence resonance energy transfer, and other biophysical techniques are very promising. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Engel, J (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM juergen.engel@unibas.ch
CR Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783
   Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542
   Canty EG, 2004, J CELL BIOL, V165, P553, DOI 10.1083/jcb.200312071
   Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000
   Coban O, 2006, BIOPHYS J, V90, P4605, DOI 10.1529/biophysj.105.078840
   Deisenhofer J, 2004, BIOSCIENCE REP, V24, P323, DOI 10.1007/s10540-005-2737-4
   Eichman BF, 2004, CELL, V119, P3, DOI 10.1016/j.cell.2004.09.023
   Engel J, 2004, INT J BIOCHEM CELL B, V36, P997, DOI 10.1016/j.biocel.2003.12.009
   Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799
   Friedl P, 2004, HISTOCHEM CELL BIOL, V122, P183, DOI 10.1007/s00418-004-0682-0
   Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010
   Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0
   Groll M, 2003, INT J BIOCHEM CELL B, V35, P606, DOI 10.1016/S1357-2725(02)00390-4
   Hansen U, 2003, J BIOL CHEM, V278, P37352, DOI 10.1074/jbc.M304325200
   He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957
   HUBER R, 1989, BIOSCIENCE REP, V9, P635, DOI 10.1007/BF01114805
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Kellermayer MSZ, 2005, PHYSIOL MEAS, V26, pR119, DOI 10.1088/0967-3334/26/4/R02
   Klostermeier D, 2001, BIOPOLYMERS, V61, P159
   Le Gros MA, 2005, CURR OPIN STRUC BIOL, V15, P593, DOI 10.1016/j.sbi.2005.08.008
   Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048
   Mould AP, 2004, NATURE, V432, P27, DOI 10.1038/432027a
   Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Oster G, 2003, TRENDS CELL BIOL, V13, P114, DOI 10.1016/S0962-8924(03)00004-7
   Pickart CM, 2004, NAT REV MOL CELL BIO, V5, P177, DOI 10.1038/nrm1336
   Rossmann MG, 2004, CURR OPIN STRUC BIOL, V14, P171, DOI 10.1016/j.sbi.2004.02.001
   Sasaki T, 1996, J CELL SCI, V109, P2895
   Sasaki T, 2004, J CELL BIOL, V164, P959, DOI 10.1083/jcb.200401058
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Springer TA, 2004, ADV PROTEIN CHEM, V68, P29
   Spronk HMH, 2003, BIOESSAYS, V25, P1220, DOI 10.1002/bies.10360
   Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5
   Vale RD, 2003, J CELL BIOL, V163, P445, DOI 10.1083/jcb.200308093
   Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002
   Wiberg C, 2003, J BIOL CHEM, V278, P37698, DOI 10.1074/jbc.M304638200
   Woodside DG, 2001, THROMB HAEMOSTASIS, V86, P316
   Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535
   Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334
   Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040
   YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0
   Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006
NR 46
TC 3
Z9 3
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PY 2007
VL 39
IS 2
BP 311
EP 318
DI 10.1016/j.biocel.2006.08.003
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 130BJ
UT WOS:000243773800006
PM 16973404
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Kohler, G
AF Knechtle, Beat
   Kohler, Goetz
TI Influence of anthropometry on race performance in ultra-endurance
   triathletes in the longest triathlon in North America
SO INTERNATIONAL SPORTMED JOURNAL
LA English
DT Review
DE body mass index; BMI; skeletal muscle mass; fat mass; ultra-endurance
   event; extreme sports; triathlon
ID DISTANCE RUNNING PERFORMANCE; BODY-COMPOSITION; SKINFOLD THICKNESSES;
   SWIMMING PERFORMANCE; EXERCISE CAPACITY; AFRICAN RUNNERS; MARATHON;
   LEVEL; SWIMMERS; SOMATOTYPE
AB Background: Little is known about the effects of anthropometry on race performance in ultra-endurance athletes. Research question: The investigation of the influence of anthropometric parameters on race performance in ultra-endurance triathletes in the longest triathlon in North America. Type of study: Descriptive field study. Methods: Body mass, body height, length of lower limbs, skinfold thicknesses, circumferences of extremities ( as well as calculation of BMI), percent skeletal muscle mass (% SM) and percent body fat (% BF) were determined in the 8 male starters of the Virginia Triple Iron Triathlon 2006 in the USA. This race is the longest triathlon in North America, where athletes have to perform a 11.4 km swim, 540 km cycle ride and 126.6 km run within 68 hours. The measured and calculated anthropometric parameters were correlated with race performance in order to find factors that influence race performance in ultra-endurance triathletes. Results: In the 5 successful finishers of the race, race time was not significantly influenced by the directly measured anthropometric properties of body height, length of limbs, body mass, average skinfold thickness, and the limb perimeters of thigh, calf and upper arm ( p > 0.05). Furthermore, no significant influence was observed between race time and the calculated parameters BMI, % BF and % SM ( p > 0.05). Conclusions: In the Virginia Triple Iron Triathlon 2006, no influence was observed from body mass, body height, length of limbs, skinfold thickness, perimeters of extremities, BMI, % SM and % BF on race performance in the only 5 successful finishers.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4003 Basel, Switzerland.
EM beat.knechtle@hispeed.ch; goetz.kohler@unibas.ch
CR Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P512
   Arrese AL, 2006, J SPORT SCI, V24, P69, DOI 10.1080/02640410500127751
   Bale P, 1986, Br J Sports Med, V20, P170
   Bale P, 1985, J SPORT SCI, V3, P115, DOI 10.1080/02640418508729741
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   BOSCH AN, 1990, EUR J APPL PHYSIOL O, V61, P68, DOI 10.1007/BF00236696
   Christensen C L, 1983, Br J Sports Med, V17, P166
   CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010
   Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86
   Foley J P, 1989, Br J Sports Med, V23, P30
   Geladas ND, 2005, INT J SPORTS MED, V26, P139, DOI 10.1055/s-2004-817862
   Hagan R D, 1987, Br J Sports Med, V21, P3
   Jagomagi Gennadi, 2005, Anthropologischer Anzeiger, V63, P213
   Kenney W L, 1985, Br J Sports Med, V19, P207
   Landers GJ, 2000, ANN HUM BIOL, V27, P387, DOI 10.1080/03014460050044865
   Larsen HB, 2004, ANN HUM BIOL, V31, P159, DOI 10.1080/03014460410001663416
   Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7
   LAURENSON NM, 1993, INT J SPORTS MED, V14, P455, DOI 10.1055/s-2007-1021210
   Leake CN, 1991, J SPORT SCI, V9, P125, DOI 10.1080/02640419108729874
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEEDY HE, 1965, RES QUART, V36, P158, DOI 10.1080/10671188.1965.10614674
   Legaz A, 2005, BRIT J SPORT MED, V39, P851, DOI 10.1136/bjsm.2005.018960
   Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083
   Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003
   McLean BD, 1989, J SPORT SCI, V7, P247, DOI 10.1080/02640418908729845
   *R DEV COR TEAM, 2005, LANG ENV STAT COMP
   Rahmani A, 2004, EUR J APPL PHYSIOL, V91, P399, DOI 10.1007/s00421-003-0989-x
   RIEDENAU RP, 1958, RES QUART, V29, P200
   Saltin B, 1995, Scand J Med Sci Sports, V5, P315
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   SIDERS WA, 1993, J SPORT MED PHYS FIT, V33, P166
   SJODIN B, 1985, SPORTS MED, V2, P83
   Sleivert GG, 1996, SPORTS MED, V22, P8, DOI 10.2165/00007256-199622010-00002
   TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001
   Tuuri G, 2002, MED SCI SPORT EXER, V34, P2110, DOI 10.1097/00005768-200212000-00037
   Weston AR, 1999, J APPL PHYSIOL, V86, P915
   Weston AR, 2000, MED SCI SPORT EXER, V32, P1130, DOI 10.1097/00005768-200006000-00015
   Yeung SS, 2001, J SPORT MED PHYS FIT, V41, P170
NR 38
TC 2
Z9 2
U1 0
U2 7
PU INT FEDERATION SPORTS MEDICINE
PI NEWLANDS
PA UCT/MRC RES UNIT EXERC SCI SPORTS MED, U CAPETOWN, BOUNDARY ROAD,
   NEWLANDS, 7700, SOUTH AFRICA
SN 1528-3356
J9 INT SPORTMED J
JI Int. Sportmed. J.
PY 2007
VL 8
IS 2
BP 87
EP 96
PG 10
WC Sport Sciences
SC Sport Sciences
GA 203FZ
UT WOS:000248961800006
DA 2021-01-25
ER

PT J
AU Seelig, A
AF Seelig, Anna
TI The role of size and charge for blood-brain barrier permeation of drugs
   and fatty acids
SO JOURNAL OF MOLECULAR NEUROSCIENCE
LA English
DT Article; Proceedings Paper
CT International Workshop on Brain Uptake and Utilization of Fatty Acids,
   Lipids and Lipoproteins
CY OCT 07-09, 2004
CL Bethesda, MD
DE P-glycoprotein; passive influx; stokes; active efflux; membrane packing
   density
ID P-GLYCOPROTEIN; ATPASE ACTIVITY; SUBSTRATE RECOGNITION; PASSIVE
   DIFFUSION; ABC TRANSPORTERS; LIPID-BILAYER; LIVING CELLS; MEMBRANES;
   BINDING; RESISTANCE
AB The lipid bilayer is the diffusion barrier of biological membranes. Highly protective membranes such as the blood-brain barrier (BBB) are reinforced by ABC transporters such as P-glycoprotein (MDR1, ABCB1) and multidrug resistance associated proteins (MRPs, ABCCs). The transporters bind their substrates in the cytosolic lipid bilayer leaflet before they reach the cytosol and flip them to the outer leaflet. The large majority of drugs targeted to the central nervous system (CNS) are intrinsic substrates of these transporters. Whether an intrinsic substrate can cross the BBB depends on whether passive influx is higher than active efflux. In this paper, we show that passive influx can be estimated quantitatively on the basis of Stokesian diffusion, taking into account the ionization constant and the cross-sectional area of the molecule in its membrane bond conformation, as well as the lateral packing density of the membrane. Active efflux by ABC transporters was measured. The calculated net flux is in excellent agreement with experimental results. The approach is exemplified with several drugs and fatty acid analogs. It shows that compounds with small cross-sectional areas (A(D)< 70 angstrom(2)) and/ or intermediate or low charge exhibit higher passive influx than efflux and, therefore, cross the BBB despite being intrinsic substrates. Large (A(D)< 70 angstrom(2)) or highly charged compounds show higher efflux than influx. They cannot cross the BBB and are, thus, apparent substrates for ABC transporters. The strict size and charge limitation for BBB permeation results from the synergistic interaction between passive influx and active efflux.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   ALTENBACH C, 1985, BIOCHIM BIOPHYS ACTA, V818, P410, DOI 10.1016/0005-2736(85)90016-1
   Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504
   BASSOLINOKLIMAS D, 1993, BIOCHEMISTRY-US, V32, P12624, DOI 10.1021/bi00210a010
   Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   Burton PS, 2002, J PHARMACOL EXP THER, V303, P889, DOI 10.1124/jpet.102.035006
   CISTOLA DP, 1986, BIOCHEMISTRY-US, V25, P2804, DOI 10.1021/bi00358a011
   Didziapetris R, 2003, J DRUG TARGET, V11, P391, DOI 10.1080/10611860310001648248
   FINKELSTEIN A, 1987, THEORY REALITY
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200
   Hamilton JA, 1998, J LIPID RES, V39, P467
   Hamilton JA, 1999, DIABETES, V48, P2255, DOI 10.2337/diabetes.48.12.2255
   Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836
   KAMP F, 1992, P NATL ACAD SCI USA, V89, P11367, DOI 10.1073/pnas.89.23.11367
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P147, DOI 10.1016/S0925-4439(97)00025-2
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Mealey KL, 2001, PHARMACOGENETICS, V11, P727, DOI 10.1097/00008571-200111000-00012
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Ogawa K, 2006, EPILEPSY RES, V71, P76, DOI 10.1016/j.eplepsyres.2006.05.016
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   PANI L, 1990, EUR J PHARMACOL, V190, P217, DOI 10.1016/0014-2999(90)94128-K
   Pauletti GM, 1997, PHARMACEUT RES, V14, P164, DOI 10.1023/A:1012040425146
   Saparov SM, 2006, BIOPHYS J, V90, pL86, DOI 10.1529/biophysj.106.084343
   SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 2006, BIOPHYS J, V90, P3825, DOI 10.1529/biophysj.106.082008
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1994, P NATL ACAD SCI USA, V91, P68, DOI 10.1073/pnas.91.1.68
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   SEELIG A, 2002, MEMBRANE STRUCTURE E, P355
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305
   Thuerauf N, 2006, EUR ARCH PSY CLIN N, V256, P281, DOI 10.1007/s00406-006-0662-6
   Varma MVS, 2005, MOL PHARMACEUT, V2, P12, DOI 10.1021/mp0499196
   WATTS A, 1986, BIOCHIM BIOPHYS ACTA, V861, P368, DOI 10.1016/0005-2736(86)90440-2
   Zhao YL, 2002, EUR J PHARMACOL, V445, P115, DOI 10.1016/S0014-2999(02)01661-8
NR 48
TC 74
Z9 74
U1 0
U2 14
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0895-8696
J9 J MOL NEUROSCI
JI J. Mol. Neurosci.
PY 2007
VL 33
IS 1
BP 32
EP 41
DI 10.1007/s12031-007-0055-y
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 213MD
UT WOS:000249670800006
PM 17901543
OA Green Accepted
DA 2021-01-25
ER

PT S
AU Melchers, F
   Yamagami, T
   Rolink, A
   Andersson, J
AF Melchers, Fritz
   Yamagami, Tamotsu
   Rolink, Antonius
   Andersson, Jan
BE Gupta, S
   Alt, F
   Cooper, M
   Melchers, F
   Rajewsky, K
TI Rules for the Rearrangement Events at the L Chain Gene Loci of the Mouse
SO MECHANISMS OF LYMPHOCYTE ACTIVATION AND IMMUNE REGULATION XI: B CELL
   BIOLOGY
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID MATURE B-CELLS; IMMUNOGLOBULIN; REPERTOIRE; SELECTION
C1 [Melchers, Fritz] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   [Melchers, Fritz] Max Planck Inst Infect Biol, Berlin, Germany.
   [Yamagami, Tamotsu; Rolink, Antonius; Andersson, Jan] Univ Basel, Ctr Biomed, DKBW, Dept Dev & Mol Immunol, Basel, Switzerland.
RP Melchers, F (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
CR Burnet F M, 1976, CA Cancer J Clin, V26, P119, DOI 10.3322/canjclin.26.2.119
   FEDDERSEN RM, 1985, P NATL ACAD SCI USA, V82, P4793, DOI 10.1073/pnas.82.14.4793
   JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849
   Kirschbaum T, 1996, EUR J IMMUNOL, V26, P1613, DOI 10.1002/eji.1830260731
   Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649
   Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571
   Melchers F., 1999, FUNDAMENTAL IMMUNOLO, p183 ~224
   Mostoslavsky R, 1998, GENE DEV, V12, P1801, DOI 10.1101/gad.12.12.1801
   PRAK EL, 1995, J EXP MED, V182, P541, DOI 10.1084/jem.182.2.541
   SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3
   Yamagami T, 1999, IMMUNITY, V11, P309, DOI 10.1016/S1074-7613(00)80106-5
   Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7
NR 14
TC 4
Z9 4
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 0065-2598
BN 978-0-387-46530-2
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2007
VL 596
BP 63
EP 70
D2 10.1007/0-387-46530-8
PG 8
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BLQ19
UT WOS:000270764700007
PM 17338176
DA 2021-01-25
ER

PT J
AU Tsamaloukas, AD
   Keller, S
   Heerklotz, H
AF Tsamaloukas, Alekos D.
   Keller, Sandro
   Heerklotz, Heiko
TI Uptake and release protocol for assessing membrane binding and
   permeation by way of isothermal titration calorimetry
SO NATURE PROTOCOLS
LA English
DT Article
ID LIPID-MEMBRANES; THERMODYNAMIC CHARACTERIZATION; UNILAMELLAR VESICLES;
   BASIC PEPTIDES; ACIDIC LIPIDS; SOLUBILIZATION; TRANSLOCATION;
   CHOLESTEROL; SENSITIVITY; BILAYERS
AB The activity of many biomolecules and drugs crucially depends on whether they bind to biological membranes and whether they translocate to the opposite lipid leaflet and trans aqueous compartment. A general strategy to measure membrane binding and permeation is the uptake and release assay, which compares two apparent equilibrium situations established either by the addition or by the extraction of the solute of interest. Only solutes that permeate the membrane sufficiently fast do not show any dependence on the history of sample preparation. This strategy can be pursued for virtually all membrane-binding solutes, using any method suitable for detecting binding. Here, we present in detail one example that is particularly well developed, namely the nonspecific membrane partitioning and flip-flop of small, nonionic solutes as characterized by isothermal titration calorimetry. A complete set of experiments, including all sample preparation procedures, can typically be accomplished within 2 days. Analogous protocols for studying charged solutes, virtually water-insoluble, hydrophobic compounds or specific ligands are also considered.
C1 [Heerklotz, Heiko] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Tsamaloukas, Alekos D.] Univ Toronto, Dept Chem & Phys, Toronto, ON M5S 3H6, Canada.
   [Keller, Sandro] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@utoronto.ca
RI Keller, Sandro/G-7202-2016; Keller, Sandro/T-3487-2019; Horstmann,
   Britta/C-2154-2008
OI Keller, Sandro/0000-0001-5469-8772; Heerklotz, Heiko/0000-0003-4615-7022
CR Barany-Wallje E, 2005, BIOPHYS J, V89, P2513, DOI 10.1529/biophysj.105.067694
   Cambridge SB, 2006, ANGEW CHEM INT EDIT, V45, P2229, DOI 10.1002/anie.200503339
   Chellani Mohan, 1999, American Biotechnology Laboratory, V17, P18
   Gilbert D, 2007, CHEMBIOCHEM, V8, P89, DOI 10.1002/cbic.200600437
   Hagen V, 2005, ANGEW CHEM INT EDIT, V44, P7887, DOI 10.1002/anie.200502411
   Heerklotz H, 2004, J PHYS-CONDENS MAT, V16, pR441, DOI 10.1088/0953-8984/16/15/R01
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Heerklotz HH, 1999, BIOPHYS J, V76, P2606, DOI 10.1016/S0006-3495(99)77413-8
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9
   Keller S, 2006, J AM CHEM SOC, V128, P1279, DOI 10.1021/ja056389d
   KELLER S, CHEMBIOCHEM
   KRESHECK GC, 1974, J COLLOID INTERF SCI, V48, P481, DOI 10.1016/0021-9797(74)90193-3
   Ladbury JE, 2004, BIOTECHNIQUES, V37, P885, DOI 10.2144/04376TE01
   LADBURY JE, 2004, BIOCALORIMETRY, V2
   LIN LN, 1994, BIOCHEMISTRY-US, V33, P6564, DOI 10.1021/bi00187a025
   MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J
   MASCOTTI DP, 1990, P NATL ACAD SCI USA, V87, P3142, DOI 10.1073/pnas.87.8.3142
   MONTICH G, 1993, BIOCHIM BIOPHYS ACTA, V1146, P17, DOI 10.1016/0005-2736(93)90333-U
   Murphy KP, 1999, MED RES REV, V19, P333, DOI 10.1002/(SICI)1098-1128(199907)19:4<333::AID-MED6>3.0.CO;2-5
   Murray D, 1999, BIOPHYS J, V77, P3176, DOI 10.1016/S0006-3495(99)77148-1
   Patel DR, 2001, BIOCHEMISTRY-US, V40, P7054, DOI 10.1021/bi010345+
   RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   SPOLAR RS, 1989, P NATL ACAD SCI USA, V86, P8382, DOI 10.1073/pnas.86.21.8382
   Tsamaloukas A, 2005, BIOPHYS J, V89, P1109, DOI 10.1529/biophysj.105.061846
   TSAMALOUKAS A, 2006, J PHYS CONDENS MATTE, V18
   Tsamaloukas A, 2006, BIOPHYS J, V90, P4479, DOI 10.1529/biophysj.105.080127
   Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
NR 35
TC 40
Z9 40
U1 1
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
J9 NAT PROTOC
JI Nat. Protoc.
PY 2007
VL 2
IS 3
BP 695
EP 704
DI 10.1038/nprot.2007.98
PG 10
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 262GY
UT WOS:000253138200026
PM 17406632
DA 2021-01-25
ER

PT J
AU Muller, DJ
   Engel, A
AF Mueller, Daniel J.
   Engel, Andreas
TI Atomic force microscopy and spectroscopy of native membrane proteins
SO NATURE PROTOCOLS
LA English
DT Article
ID SCANNING PROBE MICROSCOPY; CONFORMATIONAL-CHANGES; CANTILEVERS;
   MOLECULES; SURFACES; IMAGES
AB Membrane proteins comprise 30% of the proteome of higher organisms. They mediate energy conversion, signal transduction, solute transport and secretion. Their native environment is a bilayer in a physiological buffer solution, hence their structure and function are preferably assessed in this environment. The surface structure of single membrane proteins can be determined in buffer solutions by atomic force microscopy (AFM) at a lateral resolution of less than 1 nm and a vertical resolution of 0.1-0.2 nm. Moreover, single proteins can be directly addressed, stuck to the AFM stylus and subsequently unfolded, revealing the molecular interactions of the protein studied. The examples discussed here illustrate the power of AFM in the structural analysis of membrane proteins in a native environment.
C1 [Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Mueller, Daniel J.] Tech Univ Dresden, Ctr Biotechnol, D-8027 Dresden, Germany.
RP Engel, A (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
CR Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898
   BUTT HJ, 1993, J MICROSC-OXFORD, V169, P75, DOI 10.1111/j.1365-2818.1993.tb03280.x
   Chon JWM, 2000, J APPL PHYS, V87, P3978, DOI 10.1063/1.372455
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   Garcia R, 2002, SURF SCI REP, V47, P197, DOI 10.1016/S0167-5729(02)00077-8
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   HOOGENBOOM BW, 2006, APPL PHYS LETT, V88
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Moller C, 1999, BIOPHYS J, V77, P1150, DOI 10.1016/S0006-3495(99)76966-3
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   SCHWARZ UD, 1994, J MICROSC-OXFORD, V173, P183, DOI 10.1111/j.1365-2818.1994.tb03441.x
   Seelert H, 2000, NATURE, V405, P418
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   Stark M, 2001, BIOPHYS J, V80, P3009, DOI 10.1016/S0006-3495(01)76266-2
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786
   Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326
   Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200
NR 29
TC 151
Z9 161
U1 2
U2 69
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
J9 NAT PROTOC
JI Nat. Protoc.
PY 2007
VL 2
IS 9
BP 2191
EP 2197
DI 10.1038/nprot.2007.309
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 262HM
UT WOS:000253139600016
PM 17853875
DA 2021-01-25
ER

PT J
AU Gattiker, A
   Niederhauser-Wiederkehr, C
   Moore, J
   Hermida, L
   Primig, M
AF Gattiker, Alexandre
   Niederhauser-Wiederkehr, Christa
   Moore, James
   Hermida, Leandro
   Primig, Michael
TI The GermOnline cross-species systems browser provides comprehensive
   information on genes and gene products relevant for sexual reproduction
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID GERM-CELL DIFFERENTIATION; SACCHAROMYCES-CEREVISIAE; EXPRESSION;
   SPORULATION; MEIOSIS; GENOME; KNOWLEDGEBASE; TRANSCRIPTOME; INTERNET;
   DATABASE
AB We report a novel release of the GermOnline knowledgebase covering genes relevant for the cell cycle, gametogenesis and fertility. GermOnline was extended into a cross-species systems browser including information on DNA sequence annotation, gene expression and the function of gene products. The database covers eight model organisms and Homo sapiens, for which complete genome annotation data are available. The database is now built around a sophisticated genome browser (Ensembl), our own microarray information management and annotation system (MIMAS) used to extensively describe experimental data obtained with high-density oligonucleotide microarrays (GeneChips) and a comprehensive system for online editing of database entries (MediaWiki). The RNA data include results from classical microarrays as well as tiling arrays that yield information on RNA expression levels, transcript start sites and lengths as well as exon composition. Members of the research community are solicited to help GermOnline curators keep database entries on genes and gene products complete and accurate. The database is accessible at http://www.germonline.org/.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM michael.primig@unibas.ch
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Hermida,
   Leandro/0000-0003-3887-518X
CR Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133
   Briza P, 2002, YEAST, V19, P403, DOI 10.1002/yea.843
   Caddick S, 2006, NATURE, V442, P744, DOI 10.1038/442744c
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103
   DESSIMOZ C, 2005, LECT NOTES COMPUTER, V3678
   Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399
   Enyenihi AH, 2003, GENETICS, V163, P47
   Gil Manuel, 2005, Journal of Bioinformatics and Computational Biology, V3, P1429, DOI 10.1142/S0219720005001636
   Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a
   Hermida L, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-190
   Hochwagen A, 2005, MOL CELL BIOL, V25, P4767, DOI 10.1128/MCB.25.11.4767-4781.2005
   Huber W, 2006, BIOINFORMATICS, V22, P1963, DOI 10.1093/bioinformatics/btl289
   Iguchi N, 2006, P NATL ACAD SCI USA, V103, P7712, DOI 10.1073/pnas.0510999103
   Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104
   McLean DJ, 2002, MOL ENDOCRINOL, V16, P2780, DOI 10.1210/me.2002-0059
   Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Primig M, 2003, NAT GENET, V35, P291, DOI 10.1038/ng1203-291
   Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3
   Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880
   Wiederkehr C, 2004, BIOINFORMATICS, V20, P808, DOI 10.1093/bioinformatics/bth030
   Wiederkehr C, 2004, NUCLEIC ACIDS RES, V32, pD560, DOI 10.1093/nar/gkh055
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Yager K, 2006, NATURE, V440, P278, DOI 10.1038/440278a
NR 25
TC 17
Z9 17
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2007
VL 35
SI SI
BP D457
EP D462
DI 10.1093/nar/gkl957
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 126EI
UT WOS:000243494600093
PM 17145711
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Pachkov, M
   Erb, I
   Molina, N
   van Nimwegen, E
AF Pachkov, Mikhail
   Erb, Ionas
   Molina, Nacho
   van Nimwegen, Erik
TI SwissRegulon: a database of genome-wide annotations of regulatory sites
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BINDING-SITES; TRANSCRIPTIONAL REGULATION; OPERON ORGANIZATION;
   SEQUENCES; ELEMENTS; GENES
AB SwissRegulon (http://www.swissregulon.unibas.ch) is a database containing genome-wide annotations of regulatory sites in the intergenic regions of genomes. The regulatory site annotations are produced using a number of recently developed algorithms that operate on multiple alignments of orthologous intergenic regions from related genomes in combination with, whenever available, known sites from the literature, and ChIP-on-chip binding data. Currently SwissRegulon contains annotations for yeast and 17 prokaryotic genomes. The database provides information about the sequence, location, orientation, posterior probability and, whenever available, binding factor of each annotated site. To enable easy viewing of the regulatory site annotations in the context of other features annotated on the genomes, the sites are displayed using the GBrowse genome browser interface and can be queried based on any annotated genomic feature. The database can also be queried for regulons, i.e. sites bound by a common factor.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Molina, Nacho/F-2244-2010
OI Molina, Nacho/0000-0003-0233-3055; van Nimwegen,
   Erik/0000-0001-6338-1312; Erb, Ionas/0000-0002-2331-9714
CR Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157
   Bergman CM, 2005, BIOINFORMATICS, V21, P1747, DOI 10.1093/bioinformatics/bti173
   Blanco E, 2006, NUCLEIC ACIDS RES, V34, pD63, DOI 10.1093/nar/gkj116
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Davuluri RV, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-25
   Dieterich C, 2003, NUCLEIC ACIDS RES, V31, P55, DOI 10.1093/nar/gkg007
   ERB I, 2006, IEEE P 1 INT C COMP, P111
   Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458
   Ghosh D, 2000, NUCLEIC ACIDS RES, V28, P308, DOI 10.1093/nar/28.1.308
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   HONG EL, 2006, SACCHAROMYCES GENOME
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113
   Makita Y, 2004, NUCLEIC ACIDS RES, V32, pD75, DOI 10.1093/nar/gkh074
   McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774
   Moses AM, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P324
   Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002
   Salgado H, 2000, NUCLEIC ACIDS RES, V28, P65, DOI 10.1093/nar/28.1.65
   Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183
   Timothy B, 1994, P 2 INT C INT SYST M, V2, P28
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
   Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115
   Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329
   Wingender E, 1996, NUCLEIC ACIDS RES, V24, P238, DOI 10.1093/nar/24.1.238
   Zhao LL, 2005, J SOL-GEL SCI TECHN, V33, P103, DOI 10.1007/s10971-005-6708-9
   Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607
NR 35
TC 96
Z9 96
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2007
VL 35
SI SI
BP D127
EP D131
DI 10.1093/nar/gkl857
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 126EI
UT WOS:000243494600026
PM 17130146
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Clarke, ND
   Ezkurdia, I
   Kopp, J
   Read, RJ
   Schwede, T
   Tress, M
AF Clarke, Neil D.
   Ezkurdia, Iakes
   Kopp, Jurgen
   Read, Randy J.
   Schwede, Torsten
   Tress, Michael
TI Domain definition and target classification for CASP7
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 7th Meeting on Critical Assessment of Techniques for Protein Structure
   Prediction
CY NOV 26-30, 2006
CL Pacific Grove, CA
DE CASP7; protein structure; domain definition; target classification;
   structure prediction
ID DATABASE
AB Experimentally determined protein structures formed the basis of the CASP7 prediction assessments. These target structures were assigned to one or more tertiary structure prediction categories and where necessary were divided into structural domains. Boundaries for these domains were based on visual inspection of the targets and superpositions of the target with template structures. Target domains were classified into three different categories for assessment. "high accuracy modeling," "template-based modeling " and "free modeling." Assessment categories were determined by structural similarity between the target domain and the nearest structural templates in the PDB and by the accuracy of the models submitted by the predictors or by whether or not template information was used to generate the predictions. In CASP7 108 of the 123 target domains were evaluated in the template-based modeling category and the remaining 15 target domains were classified as free modeling. A total of 28 target domains from the template-based modeling category were also assessed in the high accuracy category and four overlapped with the free modeling category.
C1 Spanish Natl Canc Res Ctr, Struct & Computat Biol Programme, Madrid, Spain.
   Genome Inst Singapore, Singapore 138627, Singapore.
   Univ Basel, Biozentrum, Swiss Inst Bioinformat, Basel, Switzerland.
   Wellcome Trust Bldg, CIMR, Cambridge CB2 0XY, England.
RP Tress, M (corresponding author), Spanish Natl Canc Res Ctr, Struct & Computat Biol Programme, Madrid, Spain.
EM mtress@cnio.es
RI Schwede, Torsten/A-4650-2008; Clarke, Neil/D-9613-2014; Read, Randy
   J/L-1418-2013; Ezkurdia, Iakes/H-9334-2015
OI Schwede, Torsten/0000-0003-2715-335X; Read, Randy J/0000-0001-8273-0047;
   Kopp, Juergen/0000-0001-5633-7399; Ezkurdia, Iakes/0000-0001-9074-5302;
   Tress, Michael/0000-0001-9046-6370
CR Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671
   Jauch R, 2007, PROTEINS, V69, P57, DOI 10.1002/prot.21771
   Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753
   Lopez G, 2007, PROTEINS, V69, P165, DOI 10.1002/prot.21651
   MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159
   Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902
   Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024
   Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662
   Tress M, 2005, PROTEINS, V61, P8, DOI 10.1002/prot.20717
   Tress M, 2007, PROTEINS, V69, P137, DOI 10.1002/prot.21675
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
NR 12
TC 18
Z9 18
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PY 2007
VL 69
SU 8
BP 10
EP 18
DI 10.1002/prot.21686
PG 9
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 239EU
UT WOS:000251502400003
PM 17654725
OA Bronze
DA 2021-01-25
ER

PT J
AU Kopp, J
   Bordoli, L
   Battey, JND
   Kiefer, F
   Schwede, T
AF Kopp, Jurgen
   Bordoli, Lorenza
   Battey, James N. D.
   Kiefer, Florian
   Schwede, Torsten
TI Assessment of CASP7 predictions for template-based modeling targets
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 7th Meeting on Critical Assessment of Techniques for Protein Structure
   Prediction
CY NOV 26-30, 2006
CL Pacific Grove, CA
DE CASP; template based protein modeling; comparative modeling; model
   quality assessment
ID PROGRESS
AB This manuscript presents the assessment of the template-based modeling category of the seventh Critical Assessment of Techniques for Protein Structure Prediction (CASP7). The accuracy of predicted protein models for 108 target domains was assessed based on a detailed comparison between the experimental and predicted structures. The assessment was performed using numerical measures for backbone and structural alignment accuracy, and by scoring correctly modeled hydrogen bond interactions in the predictions. Based on these criteria, our statistical analysis identified a number of groups whose predictions were on average significantly more accurate. Furthermore, the predictions for six target proteins were evaluated for the accuracy of their modeled cofactor binding sites. We also assessed the ability of predictors to improve over the best available single template structure, which showed that the best groups produced models closer to the target structure than the best single template for a significant number of targets. In addition, we assessed the accuracy of the error estimates (local confidence values) assigned to predictions on a per residue basis. Finally, we discuss some general conclusions about the state of the art of template-based modeling methods and their usefulness for practical applications.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Torsten.Schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Kopp, Juergen/0000-0001-5633-7399
CR BENT HA, 1984, J CHEM EDUC, V61, P774, DOI 10.1021/ed061p774
   Clarke ND, 2007, PROTEINS, V69, P10, DOI 10.1002/prot.21686
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Jauch R, 2007, PROTEINS, V69, P57, DOI 10.1002/prot.21771
   Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   Ortiz AR, 2002, PROTEIN SCI, V11, P2606, DOI 10.1110/ps.0215902
   Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   Tress M, 2005, PROTEINS, V61, P8, DOI 10.1002/prot.20717
   Tress M, 2005, PROTEINS, V61, P27, DOI 10.1002/prot.20720
   Venclovas C, 2003, PROTEINS, V53, P585, DOI 10.1002/prot.10530
   Virnau P, 2006, PLOS COMPUT BIOL, V2, P1074, DOI 10.1371/journal.pcbi.0020122
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Wang G, 2005, PROTEINS, V61, P46, DOI 10.1002/prot.20721
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   1994, ACTA CRYSTALOGR D BI, V50, P760
NR 18
TC 86
Z9 86
U1 1
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PY 2007
VL 69
SU 8
BP 38
EP 56
DI 10.1002/prot.21753
PG 19
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 239EU
UT WOS:000251502400006
PM 17894352
DA 2021-01-25
ER

PT J
AU Battey, JND
   Kopp, J
   Bordoli, L
   Read, RJ
   Clarke, ND
   Schwede, T
AF Battey, James N. D.
   Kopp, Jurgen
   Bordoli, Lorenza
   Read, Randy J.
   Clarke, Neil D.
   Schwede, Torsten
TI Automated server predictions in CASP7
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 7th Meeting on Critical Assessment of Techniques for Protein Structure
   Prediction
CY NOV 26-30, 2006
CL Pacific Grove, CA
DE CASP7; automated modeling server; model quality assessment
ID PROTEIN-STRUCTURE PREDICTION; REMOTE HOMOLOGY DETECTION;
   FOLD-RECOGNITION; STRUCTURAL GENOMICS; SEQUENCE PROFILES; SWISS-MODEL;
   META-SERVER; DATABASE; ALIGNMENT; INFORMATION
AB With each round of CASP (Critical Assessment of Techniques for Protein Structure Prediction), automated prediction servers have played an increasingly important role. Today, most protein structure prediction approaches in some way depend on automated methods for fold recognition or model building. The accuracy of server predictions has significantly increased over the last years, and, in CASP7, we observed a continuation of this trend. In the template-based modeling category, the best prediction server was ranked third overall, i.e. it outperformed all but two of the human participating groups. This server also ranked among the very best predictors in the free modeling category as well, being clearly beaten by only one human group. In the high accuracy (HA) subset of TBM, two of the top five groups were servers. This article summarizes the contribution of automated structure prediction servers in the CASP7 experiment, with emphasis on 3D structure prediction, as well as information on their prediction scope and public availability.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Univ Cambridge, Inst Med Res, Dept Haematol, Cambridge, England.
   Genome Inst Singapore, Singapore, Singapore.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Clarke, Neil/D-9613-2014; Read, Randy J/L-1418-2013; Schwede,
   Torsten/A-4650-2008
OI Read, Randy J/0000-0001-8273-0047; Schwede, Torsten/0000-0003-2715-335X;
   Kopp, Juergen/0000-0001-5633-7399
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bates PA, 2001, PROTEINS, P39
   Bau D, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-402
   Bordoli L, 2007, PROTEINS, V69, P129, DOI 10.1002/prot.21671
   Bryson K, 2007, CURR PROTEIN PEPT SC, V8, P181, DOI 10.2174/138920307780363415
   BU D, 2007, MACHINE LEARNING BIO
   Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105
   Cheng HL, 2005, COUNS PSYCHOL, V33, P72, DOI 10.1177/0011000004270343
   Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113
   Cheng JL, 2006, BIOINFORMATICS, V22, P1456, DOI 10.1093/bioinformatics/btl102
   Cheng JL, 2005, BIOINFORMATICS, V21, pI75, DOI 10.1093/bioinformatics/bti1004
   Cheng JL, 2005, DATA MIN KNOWL DISC, V11, P213, DOI 10.1007/s10618-005-0001-y
   Chivian D, 2003, PROTEINS, V53, P524, DOI 10.1002/prot.10529
   Clarke ND, 2007, PROTEINS, V69, P10, DOI 10.1002/prot.21686
   Contreras-Moreira B, 2003, PROTEINS, V53, P424, DOI 10.1002/prot.10549
   Debe DA, 2006, PROTEINS, V64, P960, DOI 10.1002/prot.21049
   Fischer D, 1999, PROTEINS, P209
   Fischer D, 2003, PROTEINS, V53, P503, DOI 10.1002/prot.10538
   Fox JA, 2006, NUCLEIC ACIDS RES, V34, pW3, DOI 10.1093/nar/gkl379
   Friedberg I, 2004, CURR OPIN STRUC BIOL, V14, P307, DOI 10.1016/j.sbi.2004.04.005
   Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959
   Hamilton N, 2004, PROTEINS, V56, P679, DOI 10.1002/prot.20160
   Hawkins T, 2006, PROTEIN SCI, V15, P1550, DOI 10.1110/ps.062153506
   Hung LH, 2005, NUCLEIC ACIDS RES, V33, pW77, DOI 10.1093/nar/gki403
   Ishida Takashi, 2003, Genome Inform, V14, P228
   Izarzugaza JMG, 2007, PROTEINS, V69, P152, DOI 10.1002/prot.21637
   Jauch R, 2007, PROTEINS, V69, P57, DOI 10.1002/prot.21771
   Jones DT, 2005, PROTEINS, V61, P143, DOI 10.1002/prot.20731
   Kalisman N, 2005, BIOINFORMATICS, V21, P3931, DOI 10.1093/bioinformatics/bti630
   Karplus K, 2005, PROTEINS, V61, P135, DOI 10.1002/prot.20730
   Karplus K, 1999, PROTEINS, P121
   Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540
   Kim DE, 2005, PROTEINS, V61, P193, DOI 10.1002/prot.20737
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056
   Kopp J, 2007, PROTEINS, V69, P38, DOI 10.1002/prot.21753
   Kosinski J, 2005, PROTEINS, V61, P106, DOI 10.1002/prot.20726
   Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740
   Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557
   Liu S, 2007, PROTEINS, V68, P636, DOI 10.1002/prot.21459
   Lopez G, 2007, PROTEINS, V69, P165, DOI 10.1002/prot.21651
   LUND O, 2002, CPHMODELS 2 0 X3M CO
   MacCallum RM, 2004, BIOINFORMATICS, V20, P224, DOI 10.1093/bioinformatics/bth913
   Marsden RL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-86
   Martin ACR, 1997, PROTEINS, P14
   Meller J, 2001, PROTEINS, V45, P241, DOI 10.1002/prot.1145
   Moult J, 2005, PROTEINS, V61, P3, DOI 10.1002/prot.20716
   Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011
   Offman MN, 2006, BIOINFORMATICS, V22, P1838, DOI 10.1093/bioinformatics/btl192
   Ogata K, 2000, J MOL GRAPH MODEL, V18, P258, DOI 10.1016/S1093-3263(00)00037-1
   Pandit SB, 2006, BIOPHYS J, V91, P4180, DOI 10.1529/biophysj.106.084293
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095
   Poleksic A, 2005, BIOINFORMATICS, V21, P2827, DOI 10.1093/bioinformatics/bti433
   Punta M, 2005, BIOINFORMATICS, V21, P2960, DOI 10.1093/bioinformatics/bti454
   RAGHAVA GPS, 2006, P 7 M CRIT ASS TECHN
   Rangwala H, 2005, BIOINFORMATICS, V21, P4239, DOI 10.1093/bioinformatics/bti687
   Rangwala H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-455
   Read RJ, 2007, PROTEINS, V69, P27, DOI 10.1002/prot.21662
   Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805
   Saini HK, 2005, BIOINFORMATICS, V21, P2917, DOI 10.1093/bioinformatics/bti445
   Schlessinger A, 2006, BIOINFORMATICS, V22, P891, DOI 10.1093/bioinformatics/btl032
   Schlessinger A, 2005, PROTEINS, V61, P115, DOI 10.1002/prot.20587
   Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Su CT, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-319
   Teodorescu O, 2004, PROTEINS, V54, P41, DOI 10.1002/prot.10474
   Tobi D, 2000, PROTEINS, V41, P40, DOI 10.1002/1097-0134(20001001)41:1<40::AID-PROT70>3.0.CO;2-U
   Tomii K, 2005, PROTEINS, V61, P114, DOI 10.1002/prot.20727
   Tomii K, 2004, BIOINFORMATICS, V20, P594, DOI 10.1093/bioinformatics/btg474
   Torda AE, 2004, NUCLEIC ACIDS RES, V32, pW532, DOI 10.1093/nar/gkh357
   Tress M, 2007, PROTEINS, V69, P137, DOI 10.1002/prot.21675
   Wallner B, 2007, NUCLEIC ACIDS RES, V35, pW369, DOI 10.1093/nar/gkm319
   Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195
   Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031
   Xu Jinbo, 2003, J Bioinform Comput Biol, V1, P95, DOI 10.1142/S0219720003000186
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101
   Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702
   Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649
   Zhou HY, 2005, PROTEINS, V58, P321, DOI 10.1002/prot.20308
NR 81
TC 83
Z9 87
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PY 2007
VL 69
SU 8
BP 68
EP 82
DI 10.1002/prot.21761
PG 15
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 239EU
UT WOS:000251502400008
PM 17894354
OA Bronze
DA 2021-01-25
ER

PT J
AU Bordoli, L
   Kiefer, F
   Schwede, T
AF Bordoli, Lorenza
   Kiefer, Florian
   Schwede, Torsten
TI Assessment of disorder predictions in CASP7
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 7th Meeting on Critical Assessment of Techniques for Protein Structure
   Prediction
CY NOV 26-30, 2006
CL Pacific Grove, CA
DE CASP7; assessment of disorder prediction; intrinsic protein disorder;
   natively unstructured proteins; ROC
ID OPERATING CHARACTERISTIC CURVES; PROTEIN DISORDER; STRUCTURAL
   PROTEOMICS; INTRINSIC DISORDER; AREAS
AB Intrinsically unstructured regions in proteins have been associated with numerous important biological cellular functions. As measuring native disorder experimentally is technically challenging, computational methods for prediction of disordered regions in a protein have gained much interest in recent years. As part of the seventh Critical Assessment of Techniques for Protein Structure Prediction (CASP7), we have assessed 19 methods for disorder prediction based on their results for 96 target proteins. Prediction accuracy was assessed using detailed numerical comparison between the predicted disorder and the experimental structures. On average, methods participating in CASP7 have improved accuracy in comparison to the previous assessment in CASP6. Overall, however, no improvement over the best methods in CASP6 was observed in CASP7. Significant differences between different prediction methods were identified with regard to their sensitivity and specificity in correctly predicting ordered and disordered residues based on a protein target sequence, which is of relevance for practical applications of these computational tools.
C1 Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595
   Dyson HJ, 2001, METHOD ENZYMOL, V339, P258
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708
   HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747
   Jin YM, 2005, PROTEINS, V61, P167, DOI 10.1002/prot.20734
   Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002
   Melamud E, 2003, PROTEINS, V53, P561, DOI 10.1002/prot.10533
   Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x
   Oldfield CJ, 2005, PROTEINS, V59, P444, DOI 10.1002/prot.20446
   Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208
   Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045
   Receveur-Brechot V, 2006, PROTEINS, V62, P24, DOI 10.1002/prot.20750
   ROMERO P, 1997, IEEE INT C NEUR NETW, V1, P90
   SHIMIZU K, 2006, POODLE PREDICTING PR
   Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623
   Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev
   Vucetic S, 2003, PROTEINS, V52, P573, DOI 10.1002/prot.10437
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
NR 22
TC 73
Z9 76
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-3585
J9 PROTEINS
JI Proteins
PY 2007
VL 69
SU 8
BP 129
EP 136
DI 10.1002/prot.21671
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 239EU
UT WOS:000251502400014
PM 17680688
DA 2021-01-25
ER

PT J
AU Vrieseling, E
   Arber, S
AF Vrieseling, Eline
   Arber, Silvia
TI Target-induced transcriptional control of dendritic patterning and
   connectivity in motor neurons by the ETS gene Pea3
SO CELL
LA English
DT Article
ID LUMBOSACRAL SPINAL-CORD; SENSORY NEURONS; MOTONEURONS; POOLS;
   SPECIFICATION; INNERVATION; AFFERENTS; ARBORIZATION; EXPRESSION;
   BULLFROG
AB The apposition of axon terminals and dendrites, is critical for the control of neuronal activation, but how distinct neuronal subpopulations establish selective dendrite patterns and acquire specific presynaptic inputs remains unclear. Spinal motor neuron (MN) pools project to specific target muscles and are activated by selective synaptic inputs from group la proprioceptive afferents (IaPAs). Here, we show that MN pools with radially projecting dendrites respond to sensory stimulation with monosynaptic latency and are strikingly different from MN pools with dendrites that avoid the central gray matter, which are only activated through indirect connections. We provide genetic evidence that the induction of the ETS transcription factor Pea3 by GDNF is essential in two cervical MN pools to control dendrite patterning and selectivity of IaPA connectivity. These findings suggest that target-induced transcriptional programs control MN dendrite orientation and play a crucial role in the establishment of sensory-motor connections in the spinal cord.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
RI Pecho-Vrieseling, Eline/AAP-7239-2020
OI Arber, Silvia/0000-0002-6261-250X
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   BALDISSERA F, 1981, HDB PHYSL INTEGRATIO
   BAULAC M, 1981, ACTA ANAT, V109, P209
   BLASER PF, 1990, DEV BRAIN RES, V57, P139, DOI 10.1016/0165-3806(90)90193-3
   BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137
   BROWN AG, 1981, ORG SPINAL CORD
   Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V
   FRANK E, 1988, STRATEGIES SELECTIVE
   Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012
   Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   KALB RG, 1994, DEVELOPMENT, V120, P3063
   Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545
   LICHTMAN JW, 1984, J NEUROSCI, V4, P1754
   LICHTMAN JW, 1984, J NEUROSCI, V4, P1745
   Liebl DJ, 1997, J NEUROSCI, V17, P9113
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Mears SC, 1997, J NEUROSCI, V17, P3128
   MEL BW, 1994, NEURAL COMPUT, V6, P1031, DOI 10.1162/neco.1994.6.6.1031
   Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0
   OKADO N, 1990, ANAT EMBRYOL, V182, P113
   Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249
   Polleux F, 2000, NATURE, V404, P567
   RALL W, 1962, ANN NY ACAD SCI, V96, P1071, DOI 10.1111/j.1749-6632.1962.tb54120.x
   RALL W, 1967, J NEUROPHYSIOL, V30, P1169
   ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209
   Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90
   Salie R, 2005, NEURON, V45, P189, DOI 10.1016/j.neuron.2005.01.002
   Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916
   SZEKELY G, 1980, ACTA BIOL ACAD SCI H, V31, P305
   Wenner P, 1995, J NEUROSCI, V15, P8191
   Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748
NR 43
TC 127
Z9 129
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0092-8674
J9 CELL
JI Cell
PD DEC 29
PY 2006
VL 127
IS 7
BP 1439
EP 1452
DI 10.1016/j.cell.2006.10.042
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 128WI
UT WOS:000243690000022
PM 17190606
DA 2021-01-25
ER

PT J
AU van Nimwegen, E
AF van Nimwegen, Erik
TI Influenza escapes immunity along neutral networks
SO SCIENCE
LA English
DT Editorial Material
ID MUTATIONAL ROBUSTNESS; PROTEIN EVOLUTION; DYNAMICS; PATHOGENS;
   SELECTION; SEARCH; SPACE; RNA
C1 Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
CR Bastolla U, 2003, J MOL EVOL, V56, P243, DOI 10.1007/s00239-002-2350-0
   Bornberg-Bauer E, 1999, P NATL ACAD SCI USA, V96, P10689, DOI 10.1073/pnas.96.19.10689
   Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921
   Elena SF, 1996, SCIENCE, V272, P1802, DOI 10.1126/science.272.5269.1802
   Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712
   Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451
   Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Huynen MA, 1996, P NATL ACAD SCI USA, V93, P397, DOI 10.1073/pnas.93.1.397
   KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0
   Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745
   LAU KF, 1990, P NATL ACAD SCI USA, V87, P638, DOI 10.1073/pnas.87.2.638
   Newman MEJ, 1998, P ROY SOC B-BIOL SCI, V265, P1333, DOI 10.1098/rspb.1998.0438
   SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   van Nimwegen E, 1999, THEOR COMPUT SCI, V229, P41, DOI 10.1016/S0304-3975(99)00119-X
   van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716
   vanNimwegen E, 1997, PHYS LETT A, V229, P144, DOI 10.1016/S0375-9601(97)00192-8
   Voigt CA, 2001, P NATL ACAD SCI USA, V98, P3778, DOI 10.1073/pnas.051614498
   Wagner A, 1999, J EXP ZOOL, V285, P119
NR 20
TC 39
Z9 39
U1 0
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD DEC 22
PY 2006
VL 314
IS 5807
BP 1884
EP 1886
DI 10.1126/science.1137300
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 119EY
UT WOS:000242996800033
PM 17185589
DA 2021-01-25
ER

PT J
AU Farhadi, J
   Fulco, I
   Miot, S
   Wirz, D
   Haug, M
   Dickinson, SC
   Hollander, AP
   Daniels, AU
   Pierer, G
   Heberer, M
   Martin, I
AF Farhadi, Jian
   Fulco, Ilario
   Miot, Sylvie
   Wirz, Dieter
   Haug, Martin
   Dickinson, Sally C.
   Hollander, Anthony P.
   Daniels, A. U.
   Pierer, Gerhard
   Heberer, Michael
   Martin, Ivan
TI Precultivation of engineered human nasal cartilage enhances the
   mechanical properties relevant for use in facial reconstructive surgery
SO ANNALS OF SURGERY
LA English
DT Article
ID TISSUE; CHONDROCYTES; REDIFFERENTIATION; PROLIFERATION; CAPACITY; YIELD
AB Objective: To investigate if precultivation of human engineered nasal cartilage grafts of clinically relevant size would increase the suture retention strength at implantation and the tensile and bending stiffness 2 weeks after implantation.
   Summary Background Information: To be used for reconstruction of nasal cartilage defects, engineered grafts need to be reliably sutured at implantation and resist to bending/tension forces about 2 weeks after surgery, when fixation is typically removed.
   Methods: Nasal septum chondrocytes from 4 donors were expanded for 2 passages and statically loaded on 15 X 5 X 2-mm size nonwoven meshes of esterified hyaluronan (Hyaff-11). Constructs were implanted for 2 weeks in nude mice between muscle fascia and subcutaneous tissue either directly after cell seeding or after 2 or 4 weeks of preculture in chondrogenic medium. Engineered tissues and native nasal cartilage were assessed histologically, biochemically, and biomechanically.
   Results: Engineered constructs reproducibly developed with culture time into cartilaginous tissues with increasing content of glycosaminoglycans and collagen type II. Suture retention strength was significantly higher (3.6 +/- 2.2-fold) in 2-week precultured constructs than in freshly seeded meshes. Following in vivo implantation, tissues further developed and maintained the original scaffold size and shape. The bending stiffness was significantly higher (1.8 +/- 0.8-fold) if constructs were precultured for 2 weeks than if they were directly implanted, whereas tensile stiffness was close to native cartilage in all groups.
   Conclusion: In our experimental setup, preculture for 2 weeks was necessary to engineer nasal cartilage grafts with enhanced mechanical properties relevant for clinical use in facial reconstructive surgery.
C1 Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Res Dept, CH-4031 Basel, Switzerland.
   Univ Basel, Orthopaed Biomech Lab, Biozentrum Pharmazentrum, Basel, Switzerland.
   Southmead Gen Hosp, Univ Bristol Acad Rheumatol, Avon Orthopaed Ctr, Bristol, Avon, England.
RP Farhadi, J (corresponding author), Univ Basel Hosp, Dept Surg, Spitalstr 21, CH-4031 Basel, Switzerland.
EM jfarhadi@uhbs.ch
RI Fulco, Ilario/Y-3177-2019; Martin, Ivan/K-9286-2016
OI Martin, Ivan/0000-0001-6493-0432
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   Ball ST, 2004, CLIN ORTHOP RELAT R, P276, DOI 10.1097/01.blo.0000126227.80845.a0
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Brun P, 1999, J MATER SCI-MATER M, V10, P683, DOI 10.1023/A:1008960413362
   FAMDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173
   Gurley JM, 2001, PLAST RECONSTR SURG, V108, P1895, DOI 10.1097/00006534-200112000-00007
   HAISCH A, 2005, EUR ARCH OTORHINOLAR
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9
   Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Moretti M, 2005, TISSUE ENG, V11, P1421, DOI 10.1089/ten.2005.11.1421
   Murrell GL, 2004, LARYNGOSCOPE, V114, P2092, DOI 10.1097/01.mlg.0000149440.20608.7c
   Ohara K, 1997, PLAST RECONSTR SURG, V99, P1030, DOI 10.1097/00006534-199704000-00017
   Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5
   Solchaga LA, 1999, J ORTHOP RES, V17, P205, DOI 10.1002/jor.1100170209
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   Vunjak-Novakovic G, 1999, J ORTHOP RES, V17, P130, DOI 10.1002/jor.1100170119
NR 19
TC 34
Z9 34
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0003-4932
J9 ANN SURG
JI Ann. Surg.
PD DEC
PY 2006
VL 244
IS 6
BP 978
EP 985
DI 10.1097/01.sla.0000247057.16710.be
PG 8
WC Surgery
SC Surgery
GA 111SL
UT WOS:000242474700017
PM 17122623
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Marsano, A
   Wendt, D
   Raiteri, R
   Gottardi, R
   Stolz, M
   Wirz, D
   Daniels, AU
   Salter, D
   Jakob, M
   Quinn, TM
   Martin, I
AF Marsano, Anna
   Wendt, David
   Raiteri, Roberto
   Gottardi, Riccardo
   Stolz, Martin
   Wirz, Dieter
   Daniels, Alma U.
   Salter, Donald
   Jakob, Marcel
   Quinn, Thomas M.
   Martin, Ivan
TI Use of hydrodynamic forces to engineer cartilaginous tissues resembling
   the non-uniform structure and function of meniscus
SO BIOMATERIALS
LA English
DT Article
DE bioreactor; shear; cartilage tissue engineering; chondrocyte
ID ARTICULAR-CARTILAGE; ELASTIC-MODULUS; INDENTATION; BIOREACTOR;
   ORGANIZATION; CANTILEVERS; DESIGN
AB The aim of this study was to demonstrate that differences in the local composition of bi-zonal fibrocartilaginous tissues result in different local biomechanical properties in compression and tension. Bovine articular chondrocytes were loaded into hyaluronan-based meshes (HYAFF((R))-11) and cultured for 4 weeks in mixed flask, a rotary Cell Culture System (RCCS), or statically. Resulting tissues were assessed histologically, immunohistochemically, by scanning electron microscopy and mechanically in different regions. Local mechanical analyses in compression and tension were performed by indentation-type scanning force microscopy and by tensile tests on punched out concentric rings, respectively. Tissues cultured in mixed flask or RCCS displayed an outer region positively stained for versican and type I collagen. and an inner region positively stained for glycosaminoglycans and types I and II collagen. The outer fibrocartilaginous capsule included bundles (up to 2 mu m diameter) of collagen fibers and was stiffer in tension (up to 3.6-fold higher elastic modulus), whereas the inner region was stiffer in compression (up to 3.8-fold higher elastic modulus). Instead, molecule distribution and mechanical properties were similar in the outer and inner regions of statically grown tissues. In conclusion, exposure of articular chondrocyte-based constructs to hydrodynamic flow generated tissues with locally different composition and mechanical properties, resembling some aspects of the complex structure and function of the outer and inner zones of native meniscus. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel Hosp, Dept Surg, Inst Surg Res & Hosp Management, ZLF, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Res, Inst Surg Res & Hosp Management, ZLF, CH-4031 Basel, Switzerland.
   Univ Genoa, Dept Biophys & Elect Engn, Genoa, Italy.
   Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, Basel, Switzerland.
   Univ Basel, Orthopaed Biomech Lab, Basel, Switzerland.
   Univ Edinburgh, Dept Pathol, Edinburgh EH8 9YL, Midlothian, Scotland.
   Ecole Polytech Fed Lausanne, Cartilage Biomech Grp, CH-1015 Lausanne, Switzerland.
RP Martin, I (corresponding author), Univ Basel Hosp, Dept Surg, Inst Surg Res & Hosp Management, ZLF, Hebelstr 20,Room 405, CH-4031 Basel, Switzerland.
EM imartin@uhbs.ch
RI Martin, Ivan/K-9286-2016; Gottardi, Riccardo/AAA-5047-2019
OI Gottardi, Riccardo/0000-0001-8040-5531; Marsano,
   Anna/0000-0002-3084-0823; Martin, Ivan/0000-0001-6493-0432
CR Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Arnoczky SP, 1999, CLIN ORTHOP RELAT R, pS244
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   AufderHeide AC, 2004, ANN BIOMED ENG, V32, P1161
   Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950
   Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Cappella B, 1997, NANOTECHNOLOGY, V8, P82, DOI 10.1088/0957-4484/8/2/006
   CHEUNG HS, 1987, CONNECT TISSUE RES, V16, P343, DOI 10.3109/03008208709005619
   COX SJ, 1975, CLIN ORTHOP RELAT R, P175
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   FITHIAN DC, 1990, CLIN ORTHOP RELAT R, P19
   Goertzen DJ, 1997, MED ENG PHYS, V19, P412, DOI 10.1016/S1350-4533(97)00011-8
   Kambic HE, 2005, J ORTHOP RES, V23, P142, DOI 10.1016/j.orthres.2004.06.016
   Kellner K, 2001, J DRUG TARGET, V9, P439, DOI 10.3109/10611860108998778
   Lappa M, 2003, BIOTECHNOL BIOENG, V84, P518, DOI 10.1002/bit.10821
   Lechner K, 2000, J ORTHOPAED RES, V18, P945, DOI 10.1002/jor.1100180614
   Marsano A, 2006, BIORHEOLOGY, V43, P553
   MARSANO A, 2006, OSTEOARTHRITIS  0804
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Martin I, 1999, EXP CELL RES, V253, P681, DOI 10.1006/excr.1999.4708
   Mikic B, 2000, J REHABIL RES DEV, V37, P127
   Naumann A, 2002, J HISTOCHEM CYTOCHEM, V50, P1049, DOI 10.1177/002215540205000807
   Neto C, 2001, LANGMUIR, V17, P2097, DOI 10.1021/la001506y
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Peretti GM, 2001, J ORTHOPAED RES, V19, P278, DOI 10.1016/S0736-0266(00)90010-X
   Petersen W, 1998, ANAT EMBRYOL, V197, P317, DOI 10.1007/s004290050141
   Portner R, 2005, J BIOSCI BIOENG, V100, P235, DOI 10.1263/jbb.100.235
   PROCTOR CS, 1989, J ORTHOP RES, V7, P771, DOI 10.1002/jor.1100070602
   RADMACHER M, 1994, BIOPHYS J, V66, P2159, DOI 10.1016/S0006-3495(94)81011-2
   Raiteri R, 1998, COLLOID SURFACE A, V136, P191, DOI 10.1016/S0927-7757(97)00339-7
   Roos H, 1998, ARTHRITIS RHEUM, V41, P687, DOI 10.1002/1529-0131(199804)41:4<687::AID-ART16>3.0.CO;2-2
   SAAMANEN AM, 1988, INT J SPORTS MED, V9, P127, DOI 10.1055/s-2007-1024993
   SEGAWA K, 1992, ANAT RECORD, V234, P493, DOI 10.1002/ar.1092340405
   Setton LA, 1999, CLIN ORTHOP RELAT R, pS254, DOI 10.1097/00003086-199910001-00025
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Torii A, 1996, MEAS SCI TECHNOL, V7, P179, DOI 10.1088/0957-0233/7/2/010
   Tortonese M, 1997, IEEE ENG MED BIOL, V16, P28, DOI 10.1109/51.582173
   Vanlandingham MR, 1997, J ADHESION, V64, P31, DOI 10.1080/00218469708010531
   Vunjak-Novakovic G, 1999, J ORTHOP RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 2002, BIORHEOLOGY, V39, P259
   WEINAND C, 2005, P ORTH RES SOC M
   Wong M, 2000, J BIOMECH, V33, P1049, DOI 10.1016/S0021-9290(00)00084-1
   ZELLNER J, 2005, P ORTH RES SOC M
NR 43
TC 38
Z9 41
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2006
VL 27
IS 35
BP 5927
EP 5934
DI 10.1016/j.biomaterials.2006.08.020
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 099YK
UT WOS:000241633500007
PM 16949667
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Miedema, H
   Vrouenraets, M
   Wierenga, J
   Eisenberg, B
   Schirmer, T
   Basle, A
   Meijberg, W
AF Miedema, Henk
   Vrouenraets, Maarten
   Wierenga, Jenny
   Eisenberg, Bob
   Schirmer, Tilman
   Basle, Arnaud
   Meijberg, Wim
TI Conductance and selectivity fluctuations in D127 mutants of the
   bacterial porin OmpF
SO EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
LA English
DT Article
DE current fluctuations; OmpF D127 mutant; ion selectivity; OmpF Loop L3
ID SPONTANEOUS GATING ACTIVITY; OUTER-MEMBRANE PORINS; ESCHERICHIA-COLI;
   MOLECULAR-DYNAMICS; BROWNIAN DYNAMICS; CHANNEL; MUTATIONS; RESIDUES; PH;
   IONIZATION
AB A recent molecular dynamics study questioned the protonation state and physiological role of aspartate 127 (D127) of E. coli porin OmpF. To address that question we isolated two OmpF mutants with D127 either neutralized (D127N) or replaced by a positively charged lysine (D127K). The charge state of the residue at position 127 has clear effects on both conductance and selectivity. The D127K but not the D127N mutant expresses resilient conductance and selectivity fluctuations. These fluctuations reflect, we think, either changes in the ionization state of K127 and/or transitions between unstable subconformations as induced by the electrostatic repulsion between two positively charged residues, K127 and the nearby R167. Our results slightly favor the view that in WT OmpF residue D127 is deprotonated. As for the role of D127 in OmpF functionality, the gating of both mutants shows very similar sensitivity toward voltage as WT OmpF. Moreover, the current fluctuations of the D127K mutant were observed also in the absence of an applied electric field. We therefore dismiss D127 as a key residue in the control mechanism of the voltage-dependent gating of OmpF.
C1 Biomade Technol Fdn, NL-9747 AG Groningen, Netherlands.
   Rush Univ, Med Ctr, Dept Mol Biophys & Physiol, Chicago, IL 60612 USA.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Miedema, H (corresponding author), Biomade Technol Fdn, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.
EM miedema@biomade.nl
RI Eisenberg, Robert S/G-8716-2018; Eisenberg, Robert/P-6070-2019
OI Eisenberg, Robert S/0000-0002-4860-5434; 
CR Alcaraz A, 2004, BIOPHYS J, V87, P943, DOI 10.1529/biophysj.104/043414
   Bainbridge G, 1998, FEBS LETT, V431, P305, DOI 10.1016/S0014-5793(98)00761-3
   Basle A, 2004, PROTEIN ENG DES SEL, V17, P665, DOI 10.1093/protein/gzh078
   Bredin J, 2002, BIOCHEM J, V363, P521, DOI 10.1042/0264-6021:3630521
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Cymes GD, 2005, NATURE, V438, P975, DOI 10.1038/nature04293
   Danelon C, 2003, BIOPHYS CHEM, V104, P591, DOI 10.1016/S0301-4622(03)00062-0
   Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132
   Eisenberg RS, 1996, J MEMBRANE BIOL, V150, P1, DOI 10.1007/s002329900026
   EISENBERG RS, 1996, NEW DEV THEORETICAL, P269
   Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7
   Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7
   KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451
   Klebba PE, 1998, CURR OPIN MICROBIOL, V1, P238, DOI 10.1016/S1369-5274(98)80017-9
   Liu NZ, 2000, PROTEIN ENG, V13, P491, DOI 10.1093/protein/13.7.491
   Liu NZ, 1998, PROTEIN ENG, V11, P797, DOI 10.1093/protein/11.9.797
   Miedema H, 2004, BIOPHYS J, V87, P3137, DOI 10.1529/biophysj.104.041384
   Nestorovich EM, 2003, BIOPHYS J, V85, P3718, DOI 10.1016/S0006-3495(03)74788-2
   Phale PS, 1997, P NATL ACAD SCI USA, V94, P6741, DOI 10.1073/pnas.94.13.6741
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   Philippsen A, 2002, BIOPHYS J, V82, P1667, DOI 10.1016/S0006-3495(02)75517-3
   Robertson KM, 2002, BIOCHEM CELL BIOL, V80, P517, DOI 10.1139/O02-145
   Saint N, 1996, J BIOL CHEM, V271, P20676, DOI 10.1074/jbc.271.34.20676
   Saxena K, 1999, BIOCHEMISTRY-US, V38, P2206, DOI 10.1021/bi982296f
   SCHINDLER H, 1978, P NATL ACAD SCI USA, V75, P3751, DOI 10.1073/pnas.75.8.3751
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Tieleman DP, 1998, BIOPHYS J, V74, P2786, DOI 10.1016/S0006-3495(98)77986-X
   TODT JC, 1992, BIOCHEMISTRY-US, V31, P10471, DOI 10.1021/bi00158a009
   TODT JC, 1992, BIOCHEMISTRY-US, V31, P10479, DOI 10.1021/bi00158a010
   VanGelder P, 1997, J MOL BIOL, V269, P468, DOI 10.1006/jmbi.1997.1063
   Varma S, 2006, BIOPHYS J, V90, P112, DOI 10.1529/biophysj.105.059329
   Varma S, 2004, BIOPHYS J, V86, P690, DOI 10.1016/S0006-3495(04)74148-X
   Vrouenraets M, 2006, BIOPHYS J, V90, P1202, DOI 10.1529/biophysj.105.072298
NR 35
TC 16
Z9 16
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0175-7571
EI 1432-1017
J9 EUR BIOPHYS J BIOPHY
JI Eur. Biophys. J. Biophys. Lett.
PD DEC
PY 2006
VL 36
IS 1
BP 13
EP 22
DI 10.1007/s00249-006-0084-4
PG 10
WC Biophysics
SC Biophysics
GA 103OY
UT WOS:000241897800002
PM 16858566
DA 2021-01-25
ER

PT J
AU Melchers, F
AF Melchers, Fritz
TI Anergic B cells caught in the act
SO IMMUNITY
LA English
DT Editorial Material
ID IMMATURE; LYMPHOCYTES; SELECTION; ANTIBODY; ANTIGEN
C1 Max Planck Inst Infect Biol, Senior Res Grp Lymphocyte Dev, D-10117 Berlin, Germany.
   Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland.
RP Melchers, F (corresponding author), Max Planck Inst Infect Biol, Senior Res Grp Lymphocyte Dev, D-10117 Berlin, Germany.
CR Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834
   Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256
   GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017
   Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813
   NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0
   NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
NR 10
TC 14
Z9 14
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD DEC
PY 2006
VL 25
IS 6
BP 864
EP 867
DI 10.1016/j.immuni.2006.11.003
PG 4
WC Immunology
SC Immunology
GA 120LY
UT WOS:000243087500005
PM 17174929
DA 2021-01-25
ER

PT J
AU Scotton, P
   Bleckmann, D
   Stebler, M
   Sciandra, F
   Brancaccio, A
   Meier, T
   Stetefeld, J
   Ruegg, MA
AF Scotton, Patrick
   Bleckmann, Dorothee
   Stebler, Michael
   Sciandra, Francesca
   Brancaccio, Andrea
   Meier, Thomas
   Stetefeld, Jorg
   Ruegg, Markus A.
TI Activation of muscle-specific receptor tyrosine kinase and binding to
   dystroglycan are regulated by alternative mRNA splicing of agrin
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DYSTROPHIN-ASSOCIATED GLYCOPROTEINS; FIBERS IN-VIVO; ALPHA-DYSTROGLYCAN;
   NEUROMUSCULAR-JUNCTION; CRYSTAL-STRUCTURE; POSTSYNAPTIC DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; MUSCULAR-DYSTROPHY; INNERVATED MUSCLE;
   LAMININ-BINDING
AB Agrin induces the aggregation of postsynaptic proteins at the neuromuscular junction (NMJ). This activity requires the receptor-tyrosine kinase MuSK. Agrin isoforms differ in short amino acid stretches at two sites, called A and B, that are localized in the two most C-terminal laminin G (LG) domains. Importantly, agrin isoforms greatly differ in their activities of inducing MuSK phosphorylation and of binding to alpha-dystroglycan. By using site- directed mutagenesis, we characterized the amino acids important for these activities of agrin. We find that the conserved tripeptide asparagine-glutamate-isoleucine in the eight-amino acid long insert at the B-site is necessary and sufficient for full MuSK phosphorylation activity. However, even if all eight amino acids were replaced by alanines, this agrin mutant still has significantly higher MuSK phosphorylation activity than the splice version lacking any insert. We also show that binding to alpha-dystroglycan requires at least two LG domains and that amino acid inserts at the A and the B splice sites negatively affect binding.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Santhera Pharmaceut Switzerland Ltd, CH-4410 Liestal, Switzerland.
   Univ Cattolica Sacro Cuore, Ist Biochim & Biochim Clin, CNR, Ist Chim Riconoscimento Mol, I-00168 Rome, Italy.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch; markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019; Brancaccio, Andrea/C-5876-2009; Stetefeld,
   Joerg/H-7630-2017; Sciandra, Francesca/AAY-4650-2020
OI Ruegg, Markus/0000-0002-4974-9384; Brancaccio,
   Andrea/0000-0003-4690-8826; Stetefeld, Joerg/0000-0003-1478-3248;
   Sciandra, Francesca/0000-0002-2123-1516
FU TelethonFondazione Telethon [GGP06225] Funding Source: Medline
CR Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441
   BOWE MA, 1994, NEURON, V12, P1173, DOI 10.1016/0896-6273(94)90324-7
   BRANCACCIO A, 1995, FEBS LETT, V368, P139, DOI 10.1016/0014-5793(95)00628-M
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Campanelli JT, 1996, DEVELOPMENT, V122, P1663
   CAMPANELLI JT, 1994, CELL, V77, P663, DOI 10.1016/0092-8674(94)90051-5
   COHEN B, 1990, P NATL ACAD SCI USA, V87, P4458, DOI 10.1073/pnas.87.12.4458
   Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623
   Cornish T, 1999, J CELL SCI, V112, P1213
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504
   Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052
   HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H
   Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3
   Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013
   Hopf C, 1996, J BIOL CHEM, V271, P5231
   IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Khan AA, 2001, SCIENCE, V292, P1681, DOI 10.1126/science.1056594
   Khurana TS, 2003, NAT REV DRUG DISCOV, V2, P379, DOI 10.1038/nrd1085
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Meier T, 1997, J NEUROSCI, V17, P6534
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200
   Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001
   Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001
   STONE DM, 1995, J NEUROSCI, V15, P6767
   Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003
   SUGIYAMA J, 1994, NEURON, V13, P103, DOI 10.1016/0896-6273(94)90462-6
   Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   TRAUNECKER A, 1991, TRENDS BIOTECHNOL, V9, P109, DOI 10.1016/0167-7799(91)90038-J
   Tseng CN, 2003, J BIOL CHEM, V278, P17236, DOI 10.1074/jbc.M300282200
   WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267
   YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1
NR 60
TC 32
Z9 33
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 1
PY 2006
VL 281
IS 48
BP 36835
EP 36845
DI 10.1074/jbc.M607887200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 108DP
UT WOS:000242220800042
PM 17012237
OA Other Gold
DA 2021-01-25
ER

PT J
AU Rencurel, F
   Foretz, M
   Kaufmann, MR
   Stroka, D
   Looser, R
   Leclerc, I
   Xavier, GDS
   Rutter, GA
   Viollet, B
   Meyer, UA
AF Rencurel, Franck
   Foretz, Marc
   Kaufmann, Michel R.
   Stroka, Deborah
   Looser, Renate
   Leclerc, Isabelle
   Xavier, Gabriela da Silva
   Rutter, Guy A.
   Viollet, Benoit
   Meyer, Urs A.
TI Stimulation of AMP-activated protein kinase is essential for the
   induction of drug metabolizing enzymes by phenobarbital in human and
   mouse liver
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID NUCLEAR RECEPTOR CAR; CATALYTIC SUBUNIT; GENE-EXPRESSION; GLUCOSE;
   COMPLEX; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; HEPATOCYTES;
   CASCADE
AB Our previous studies have suggested a role for AMP-activated protein kinase (AMPK) in the induction of CYP2B6 by phenobarbital (PB) in hepatoma-derived cells (Rencurel et al., 2005). In this study, we showed in primary human hepatocytes that: 1) 5'-phosphoribosyl-5-aminoimidazol-4-carboxamide 1-beta-D-ribofuranoside and the biguanide metformin, known activators of AMPK, dose-dependently increase the expression of CYP2B6 and CYP3A4 to an extent similar to that of PB. 2) PB, but not the human nuclear receptor constitutive active/androstane receptor (CAR) ligand 6-(4-chlorophenyl)imidazol[2,1-6][1,3]thiazole-5-carbaldehyde, dose-dependently increase AMPK activity. 3) Pharmacological inhibition of AMPK activity with compound C or dominant-negative forms of AMPK blunt the inductive response to phenobarbital. Furthermore, in transgenic mice with a liver-specific deletion of both the alpha 1 and alpha 2 AMPK catalytic subunits, basal levels of Cyp2b10 and Cyp3a11 mRNA were increased but not in primary culture of mouse hepatocytes. However, phenobarbital or 1,4 bis[2-(3,5-dichloropyridyloxy)]benzene, a mouse CAR ligand, failed to induce the expression of these genes in the liver or cultured hepatocytes from mice lacking hepatic expression of the alpha 1 and alpha 2 subunits of AMPK. The distribution of CAR between the nucleus and cytosol was not altered in hepatocytes from mice lacking both AMPK catalytic subunits. These data highlight the essential role of AMPK in the CAR-mediated signal transduction pathway.
C1 Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Bern, Dept Visceral Surg, Bern, Switzerland.
   Univ Bern, Dept Clin Res, Bern, Switzerland.
   Inst Cochin, Dept Endocrinol Metab & Canc, Paris, France.
   Inst Natl Sante & Rech Med, U567, Paris, France.
   Ctr Natl Rech Sci, Unite Mixte Rech 8104, Paris, France.
   Univ Paris 05, Fac Med Rene Descartes, Paris, France.
   Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England.
   Univ London Imperial Coll Sci Technol & Med, Dept Cell Biol, Div Med, London, England.
RP Rencurel, F (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM franck.rencurel@unibas.ch
RI Viollet, Benoit/O-6927-2017; Stroka, Deborah M/F-1806-2013; FORETZ,
   Marc/O-7334-2017
OI Viollet, Benoit/0000-0002-0121-0224; FORETZ, Marc/0000-0001-7017-9032;
   Rutter, Guy/0000-0001-6360-0343; Leclerc, Isabelle/0000-0003-0044-7921;
   da Silva Xavier, Gabriela/0000-0002-0678-012X; Stroka,
   Deborah/0000-0002-3517-3871
FU Diabetes UKDiabetes UK [13/0004672] Funding Source: Medline; Wellcome
   TrustWellcome Trust Funding Source: Medline
CR BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506
   BONTEMPS F, 1978, BIOCHEM J, V174, P603, DOI 10.1042/bj1740603
   Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005
   Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347
   Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005
   Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Hosseinpour F, 2006, MOL PHARMACOL, V69, P1095, DOI 10.1124/mol.105.019505
   Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Kobayashi K, 2003, MOL PHARMACOL, V64, P1069, DOI 10.1124/mol.64.5.1069
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607
   Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200
   SABINA RL, 1985, J BIOL CHEM, V260, P6107
   Sakuma T, 2001, XENOBIOTICA, V31, P223, DOI 10.1080/00498250110046451
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   SOTANIEMI EA, 1989, DIABETES RES CLIN EX, V11, P131
   Stein SC, 2000, BIOCHEM J, V345, P437, DOI 10.1042/0264-6021:3450437
   STRAIN AJ, 1994, GUT, V35, P433, DOI 10.1136/gut.35.4.433
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Viollet B, 2003, J CLIN INVEST, V111, P91, DOI 10.1172/JCI200316567
   Woods A, 2000, MOL CELL BIOL, V20, P6704, DOI 10.1128/MCB.20.18.6704-6711.2000
   Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031
   Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282
   Yoshinari K, 2003, FEBS LETT, V548, P17, DOI 10.1016/S0014-5793(03)00720-8
   Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 34
TC 73
Z9 77
U1 0
U2 5
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
EI 1521-0111
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD DEC
PY 2006
VL 70
IS 6
BP 1925
EP 1934
DI 10.1124/mol.106.029421
PG 10
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 106XQ
UT WOS:000242135700011
PM 16988011
DA 2021-01-25
ER

PT J
AU Gerebtzoff, G
   Seelig, A
AF Gerebtzoff, Gregori
   Seelig, Anna
TI In silico prediction of blood - Brain barrier permeation using the
   calculated molecular cross-sectional area as main parameter
SO JOURNAL OF CHEMICAL INFORMATION AND MODELING
LA English
DT Article
ID WATER PARTITION-COEFFICIENTS; CAPILLARY-ELECTROPHORESIS; H-1-RECEPTOR
   ANTAGONIST; DRUG TRANSPORT; VITRO MODEL; MEMBRANE; PH; PERMEABILITY;
   ABSORPTION; PRESSURE
AB The cross-sectional area, A(D), of a compound oriented in an amphiphilic gradient such as the air-water or lipid-water interface has previously been shown to be crucial for membrane partitioning and permeation, respectively. Here, we developed an algorithm that determines the molecular axis of amphiphilicity and the cross-sectional area, A(Dcalc), perpendicular to this axis. Starting from the conformational ensemble of each molecule, the three-dimensional conformation selected as the membrane-binding conformation was the one with the smallest cross-sectional area, A(DcalcM), and the strongest amphiphilicity. The calculated, A(DcalcM), and the measured, AD, cross-sectional areas correlated linearly (n = 55, slope, m = 1.04, determination coefficient, r(2) = 0.95). The calculated cross-sectional areas, A(DcalcM), were then used together with the calculated octanol-water distribution coefficients, log D-7.4, of the 55 compounds (with a known ability to permeate the blood-brain barrier) to establish a calibration diagram for the prediction of blood-brain barrier permeation. It yielded a limiting cross-sectional area (A(DcalcM) = 70 angstrom(2)) and an optimal range of octanol-water distribution coefficients (-1.4 <= log D-7.4 < 7.0). The calibration diagram was validated with an independent set of 43 compounds with the known ability to permeate the blood-brain barrier, yielding a prediction accuracy of 86%. The incorrectly predicted compounds exhibited log D-7.4 values comprised between -0.6 and -1.4, suggesting that the limitation for log D-7.4 is less rigorous than the limitation for AD. An accuracy of 83% has been obtained for a second validation set of 42 compounds which were previously shown to be difficult to predict. The calculated parameters, A(DcalcM) and log D-7.4, thus allow for a fast and accurate prediction of blood-brain barrier permeation. Analogous calibration diagrams can be established for other membrane barriers.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR BALDUCCI R, 1994, J CHEM INF COMP SCI, V34, P822, DOI 10.1021/ci00020a016
   Balon K, 1999, PHARMACEUT RES, V16, P882, DOI 10.1023/A:1018882221008
   BARLOW RB, 1982, BRIT J PHARMACOL, V77, P559, DOI 10.1111/j.1476-5381.1982.tb09331.x
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001
   Budavari S., 1996, MERCK INDEX ENCY CHE
   Cecchelli R, 1999, ADV DRUG DELIVER REV, V36, P165, DOI 10.1016/S0169-409X(98)00083-0
   Clark DE, 2003, DRUG DISCOV TODAY, V8, P927, DOI 10.1016/S1359-6446(03)02827-7
   Crivori P, 2000, J MED CHEM, V43, P2204, DOI 10.1021/jm990968+
   Crowe A, 2004, DRUG DEV IND PHARM, V30, P449, DOI 10.1081/DDC-120037471
   Cruciani C, 2000, J MOL STRUC-THEOCHEM, V503, P17, DOI 10.1016/S0166-1280(99)00360-7
   de Boer T, 1999, J PHARMACEUT BIOMED, V19, P529, DOI 10.1016/S0731-7085(98)00249-0
   Deconinck E, 2006, J CHEM INF MODEL, V46, P1410, DOI 10.1021/ci050518s
   DeLano W.L., PYMOL MOL GRAPHICS S
   Ecker GF, 2004, CURR MED CHEM, V11, P1617, DOI 10.2174/0929867043365071
   Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e
   FINKELSTEIN A, 1987, WATER MOVEMENT LIPID, V4, pCH6
   Fischer H, 2000, CHIMIA, V54, P640
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FISCHER H, 1997, 4 INT C DRUG ABS ED
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   GIARDINA G, 1994, J MED CHEM, V37, P3482, DOI 10.1021/jm00047a006
   GOBAS FAPC, 1988, J PHARM SCI, V77, P265, DOI 10.1002/jps.2600770317
   Hansch C, 1990, COMPREHENSIVE MED CH
   HOWARD PH, 1996, HDB PHYS PROPERTIES
   Huckel E, 1931, Z PHYS, V72, P310, DOI 10.1007/BF01341953
   Huckel E, 1931, Z PHYS, V70, P204, DOI 10.1007/BF01339530
   Kansy M, 1998, J MED CHEM, V41, P1007, DOI 10.1021/jm970530e
   KONTTURI K, 1992, J PHARM SCI, V81, P970, DOI 10.1002/jps.2600811003
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   MEYLAN WM, 1995, J PHARM SCI-US, V84, P83, DOI 10.1002/jps.2600840120
   Narayanan R, 2005, BIOORGAN MED CHEM, V13, P3017, DOI 10.1016/j.bmc.2005.01.061
   NIELSEN PE, 1997, AAPS ANN M BOST MA
   Norinder U, 2002, ADV DRUG DELIVER REV, V54, P291, DOI 10.1016/S0169-409X(02)00005-4
   O'Neill M.J., 2001, MERCK INDEX ENCY CHE
   Pagliara A, 1998, J MED CHEM, V41, P853, DOI 10.1021/jm9704311
   PALEMO PJ, 1998, Patent No. 6228863
   PETERS MD, 1990, CLIN PHARMACY, V9, P165
   RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055
   ROHRBAUGH RH, 1987, ANAL CHEM, V59, P1048, DOI 10.1021/ac00134a025
   Ruell JA, 2003, EUR J PHARM SCI, V20, P393, DOI 10.1016/j.ejps.2003.08.006
   SANGSTER J, 1994, J PHYS CHEM REF DATA, V23, P295, DOI 10.1063/1.555959
   SAYLE R, PHYSL IONIZATION PKA
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   SEELIG A, 1994, P NATL ACAD SCI USA, V91, P68, DOI 10.1073/pnas.91.1.68
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG A, 2006, IN PRESS EXPERT OPIN
   Seelig A., 2002, ENCY PHYS SCI TECHNO, P355
   SEELIG J, 1980, Q REV BIOPHYS, V13, P19, DOI 10.1017/S0033583500000305
   Suomalainen P, 2004, J MED CHEM, V47, P1783, DOI 10.1021/jm0309001
   Tam KY, 2001, ANAL CHIM ACTA, V434, P157, DOI 10.1016/S0003-2670(01)00810-8
   TOLLENAERE JP, 1977, EUR J MED CHEM, V12, P199
   VANDEWATERBEEMD H, 2003, DRUG BIOAVAILABILITY
   Wan H, 2003, RAPID COMMUN MASS SP, V17, P2639, DOI 10.1002/rcm.1229
   Wang RX, 2000, PERSPECT DRUG DISCOV, V19, P47, DOI 10.1023/A:1008763405023
   Wohnsland F, 2001, J MED CHEM, V44, P923, DOI 10.1021/jm001020e
   YAMAGUCHI T, 1994, ARZNEIMITTEL-FORSCH, V44-1, P59
   Zhang QY, 2004, CHINESE J CHEM, V22, P605
NR 59
TC 60
Z9 60
U1 0
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9596
J9 J CHEM INF MODEL
JI J. Chem Inf. Model.
PD NOV 27
PY 2006
VL 46
IS 6
BP 2638
EP 2650
DI 10.1021/ci0600814
PG 13
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Computer Science,
   Information Systems; Computer Science, Interdisciplinary Applications
SC Pharmacology & Pharmacy; Chemistry; Computer Science
GA 109HF
UT WOS:000242298100042
PM 17125204
DA 2021-01-25
ER

PT J
AU Devasahayam, G
   Ritz, D
   Helliwell, SB
   Burke, DJ
   Sturgill, TW
AF Devasahayam, Gina
   Ritz, Danilo
   Helliwell, Stephen B.
   Burke, Daniel J.
   Sturgill, Thomas W.
TI Pmr1, a golgi Ca2+/Mn2+-ATPase, is a regulator of the target of
   rapamycin (TOR) signaling pathway in yeast
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Npr1 kinase
ID RSP5-BUL1/2 UBIQUITIN LIGASE; AMINO-ACID PERMEASE;
   SACCHAROMYCES-CEREVISIAE; NPR1 KINASE; SECRETORY PATHWAY;
   ENDOPLASMIC-RETICULUM; TRYPTOPHAN PERMEASE; PROTEIN-TRANSPORT;
   PLASMA-MEMBRANE; LOCALIZATION
AB The rapamycin-FKBP12 complex inhibits target of rapamycin (TOR) kinase in TORC1. We screened the yeast nonessential gene deletion collection to identify mutants that conferred rapamycin resistance, and we identified PMR1, encoding the Golgi Ca2+/Mn2+-ATPase. Deleting PMR1 in two genetic backgrounds confers rapamycin resistance. Epistasis analyses show that Pmr1 functions upstream from Npr1 and Gln-3 in opposition to Lst8, a regulator of TOR. Npr1 kinase is largely cytoplasmic, and a portion localizes to the Golgi where amino acid permeases are modified and sorted. Nuclear translocation of Gln-3 and Gln-3 reporter activity in pmr1 cells are impaired, but expression of functional Gap1 in the plasma membrane of a pmr1 strain in response to nitrogen limitation is enhanced. These two phenotypes suggest up-regulation of Npr1 function in the absence of Pmr1. Together, our results establish that Pmr1-dependent Ca2+ and/or Mn2+ ion homeostasis is necessary for TOR signaling.
C1 Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Charlottesville, VA 22908 USA.
   Univ Virginia, Hlth Sci Ctr, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA.
   Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Sturgill, TW (corresponding author), Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, 1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.
EM tws7w@virginia.edu
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM062890,
   R01GM062890, R29GM040334, R01GM040334, R01GM040334, R01GM040334,
   R29GM040334, R01GM040334, R01GM040334, R01GM040334, R01GM062890,
   R29GM040334, R01GM040334, R01GM040334, R01GM040334, R01GM040334,
   R29GM040334, R29GM040334, R01GM062890, R01GM062890, R01GM040334,
   R29GM040334, R01GM040334] Funding Source: NIH RePORTER; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM062890, GM62890, GM40334, R01 GM040334]
   Funding Source: Medline
CR AMBERG D, 2005, METHODS YEAST GENETI, P103
   Baron CL, 2002, SCIENCE, V295, P325, DOI 10.1126/science.1066759
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141
   Crespo JL, 2004, J BIOL CHEM, V279, P37512, DOI 10.1074/jbc.M407372200
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200
   Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149
   Feller A, 2006, J BIOL CHEM, V281, P28546, DOI 10.1074/jbc.M605551200
   FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   GUTHRIE C, 1991, GUIDE YEAST GENETICS, P21
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649
   Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107
   Johnston SD, 2001, MOL CELL BIOL, V21, P1784, DOI 10.1128/MCB.21.5.1784-1794.2001
   Kaeberlein M, 2002, GENETICS, V160, P83
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Lorenz MC, 1998, EMBO J, V17, P1236, DOI 10.1093/emboj/17.5.1236
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Omura F, 2004, FEMS MICROBIOL LETT, V230, P227, DOI 10.1016/S0378-1097(03)00918-2
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Roberg KJ, 1997, GENETICS, V147, P1569
   RUDOLPH HK, 1989, CELL, V58, P133, DOI 10.1016/0092-8674(89)90410-8
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SUTTON A, 1991, MOL CELL BIOL, V11, P2133, DOI 10.1128/MCB.11.4.2133
   TAKATALOMS, 2006, PROTEOMICS, V6, P302
   Tate JJ, 2006, J BIOL CHEM, V281, P28460, DOI 10.1074/jbc.M604171200
   VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 38
TC 29
Z9 29
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 21
PY 2006
VL 103
IS 47
BP 17840
EP 17845
DI 10.1073/pnas.0604303103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 111PG
UT WOS:000242464900048
PM 17095607
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Guilvout, I
   Chami, M
   Engel, A
   Pugsley, AP
   Bayan, N
AF Guilvout, Ingrid
   Chami, Mohamed
   Engel, Andreas
   Pugsley, Anthony P.
   Bayan, Nicolas
TI Bacterial outer membrane secretin PulD assembles and inserts into the
   inner membrane in the absence of its pilotin
SO EMBO JOURNAL
LA English
DT Article
DE chaperone; outer membrane; pilotin; secretin; type II secretion
ID PHAGE-SHOCK-PROTEIN; GRAM-NEGATIVE BACTERIA; CHAPERONE-LIKE PROTEIN;
   C-TERMINAL DOMAIN; ESCHERICHIA-COLI; PULLULANASE SECRETION;
   NEISSERIA-MENINGITIDIS; KLEBSIELLA-PNEUMONIAE; CYTOPLASMIC MEMBRANE;
   OLIGOMERIC RINGS
AB Dodecamerization and insertion of the outer membrane secretin PulD is entirely determined by the C-terminal half of the polypeptide (PulD-CS). In the absence of its cognate chaperone PulS, PulD-CS and PulD mislocalize to the inner membrane, from which they are extractable with detergents but not urea. Electron microscopy of PulD-CS purified from the inner membrane revealed apparently normal dodecameric complexes. Electron microscopy of PulD-CS and PulD in inner membrane vesicles revealed inserted secretin complexes. Mislocalization of PulD or PulD-CS to this membrane induces the phage shock response, probably as a result of a decreased membrane electrochemical potential. Production of PulD in the absence of the phage shock response protein PspA and PulS caused a substantial drop in membrane potential and was lethal. Thus, PulD-CS and PulD assemble in the inner membrane if they do not associate with PulS. We propose that PulS prevents premature multimerization of PulD and accompanies it through the periplasm to the outer membrane. PulD is the first bacterial outer membrane protein with demonstrated ability to insert efficiently into the inner membrane.
C1 Inst Pasteur, Mol Genet Unit, F-75724 Paris 15, France.
   Inst Pasteur, CNRS, URA2172, F-75724 Paris 15, France.
   Univ Paris 11, CNRS, UMR 8619, F-91405 Orsay, France.
   Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, 25 Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr
RI Bayan, Nicolas/AAI-5034-2020
OI Bayan, Nicolas/0000-0001-7760-0811
CR Ast VM, 2002, MOL MICROBIOL, V44, P217, DOI 10.1046/j.1365-2958.2002.02870.x
   Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x
   Beis K, 2004, J BIOL CHEM, V279, P28227, DOI 10.1074/jbc.M402913200
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   BRISSETTE JL, 1990, P NATL ACAD SCI USA, V87, P862, DOI 10.1073/pnas.87.3.862
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   Buettner R, 2000, P NATL ACAD SCI USA, V97, P3201, DOI 10.1073/pnas.060242297
   Bulieris PV, 2003, J BIOL CHEM, V278, P9092, DOI 10.1074/jbc.M211177200
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   CHEN R, 1996, MOL MICROBIOL, V19, P1284
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Condemine G, 2000, MICROBIOL-UK, V146, P639, DOI 10.1099/00221287-146-3-639
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   Darwin AJ, 2005, MOL MICROBIOL, V57, P621, DOI 10.1111/j.1365-2958.2005.04694.x
   DECOCK H, 1990, J BIOL CHEM, V265, P4646
   deCock H, 1996, J BIOL CHEM, V271, P12885, DOI 10.1074/jbc.271.22.12885
   Demchick P, 1996, J BACTERIOL, V178, P768, DOI 10.1128/jb.178.3.768-773.1996
   DENFERT C, 1989, J BIOL CHEM, V264, P17462
   DENFERT C, 1987, MOL MICROBIOL, V1, P107, DOI 10.1111/j.1365-2958.1987.tb00534.x
   DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989
   Doerrler WT, 2005, J BIOL CHEM, V280, P27679, DOI 10.1074/jbc.M504796200
   DONG C, 2006, IN PRESS NATURE
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   Hankamer BD, 2004, J BIOL CHEM, V279, P8862, DOI 10.1074/jbc.M307889200
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Harms N, 2001, J BIOL CHEM, V276, P18804, DOI 10.1074/jbc.M011194200
   KLEEREBEZEM M, 1993, MOL MICROBIOL, V7, P947, DOI 10.1111/j.1365-2958.1993.tb01186.x
   Kleerebezem M, 1996, EMBO J, V15, P162, DOI 10.1002/j.1460-2075.1996.tb00344.x
   Kleinschmidt JH, 1999, BIOCHEMISTRY-US, V38, P5006, DOI 10.1021/bi982465w
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Koronakis V, 1997, MOL MICROBIOL, V23, P617, DOI 10.1046/j.1365-2958.1997.d01-1880.x
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   MEERMAN HJ, 1994, BIO-TECHNOL, V12, P1107, DOI 10.1038/nbt1194-1107
   Miller J.H., 1992, SHORT COURSE BACTERI
   Model P, 1997, MOL MICROBIOL, V24, P255, DOI 10.1046/j.1365-2958.1997.3481712.x
   Mogensen JE, 2005, PROTEIN SCI, V14, P2814, DOI 10.1110/ps.051628705
   Montoya M, 2003, BBA-BIOMEMBRANES, V1609, P19, DOI 10.1016/S0005-2736(02)00663-6
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Possot OM, 1997, MOL MICROBIOL, V24, P457, DOI 10.1046/j.1365-2958.1997.3451726.x
   Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000
   Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200
   Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014
   Schafer U, 1999, J BIOL CHEM, V274, P24567, DOI 10.1074/jbc.274.35.24567
   Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Werner J, 2005, MOL MICROBIOL, V57, P1450, DOI 10.1111/j.1365-2958.2005.04775.x
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
NR 54
TC 102
Z9 103
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD NOV 15
PY 2006
VL 25
IS 22
BP 5241
EP 5249
DI 10.1038/sj.emboj.7601402
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 108BM
UT WOS:000242215000001
PM 17082772
OA Green Published
DA 2021-01-25
ER

PT J
AU Mulet, JM
   Martin, DE
   Loewith, R
   Hall, MN
AF Mulet, Jose M.
   Martin, Dietmar E.
   Loewith, Robbie
   Hall, Michael N.
TI Mutual antagonism of target of rapamycin and calcineurin signaling
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; TRANSCRIPTION FACTORS;
   GENE-EXPRESSION; CELL-GROWTH; NUCLEAR-LOCALIZATION; YEAST; PATHWAY;
   TOR2; ORGANIZATION
AB Growth and stress are generally incompatible states. Stressed cells adapt to an insult by restraining growth, and conversely, growing cells keep stress responses at bay. This is evident in many physiological settings, including for example, the effect of stress on the immune or nervous system, but the underlying signaling mechanisms mediating such mutual antagonism are poorly understood. In eukaryotes, a central activator of cell growth is the protein kinase target of rapamycin (TOR) and its namesake signaling network. Calcineurin is a conserved, Ca2+/calmodulin-dependent protein phosphatase and target of the immunosuppressant FK506 (tacrolimus) that is activated in yeast during stress to promote cell survival. Here we show yeast mutants defective for TOR complex 2 (TORC2) or the essential homologous TORC2 effectors, SLM1 and SLM2, exhibited constitutive activation of calcineurin-dependent transcription and actin depolarization. Conversely, cells defective in calcineurin exhibited SLM1 hyperphosphorylation and enhanced interaction between TORC2 and SLM1. Furthermore, a mutant SLM1 protein (SLM1(Delta C14)) lacking a sequence related to the consensus calcineurin docking site (PxIxIT) was insensitive to calcineurin, and SLM1(Delta C14) slm2 mutant cells were hypersensitive to oxidative stress. Thus, TORC2-SLM signaling negatively regulates calcineurin, and calcineurin negatively regulates TORC2-SLM. These findings provide a molecular basis for the mutual antagonism of growth and stress.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Loewith, Robbie/S-6289-2016; Mulet, Jose Miguel/B-9063-2016
OI Loewith, Robbie/0000-0002-2482-603X; Mulet, Jose
   Miguel/0000-0002-9087-3838; Hall, Michael N/0000-0002-2998-0757
CR Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Cyert MS, 2001, ANNU REV GENET, V35, P647, DOI 10.1146/annurev.genet.35.102401.091302
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Halpain S, 1998, J NEUROSCI, V18, P9835
   Heath VL, 2004, EUKARYOT CELL, V3, P695, DOI 10.1128/EC.3.3.695-704.2004
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Kingsbury TJ, 2000, GENE DEV, V14, P1595
   Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Martin DE, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-148
   Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445
   Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X
   Mizunuma M, 1998, NATURE, V392, P303
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Shitamukai A, 2004, J BIOL CHEM, V279, P3651, DOI 10.1074/jbc.M306098200
   Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432
   Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yokoyama H, 2006, EMBO REP, V7, P519, DOI 10.1038/sj.embor.7400647
   Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200
NR 34
TC 54
Z9 56
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 3
PY 2006
VL 281
IS 44
BP 33000
EP 33007
DI 10.1074/jbc.M604244200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 099UJ
UT WOS:000241621400008
PM 16959779
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Oscarson, M
   Zanger, UM
   Rifki, OF
   Klein, K
   Eichelbaum, M
   Meyer, UA
AF Oscarson, Mikael
   Zanger, Ulrich M.
   Rifki, Oktay F.
   Klein, Kathrin
   Eichelbaum, Michel
   Meyer, Urs A.
TI Transcriptional profiling of genes induced in the livers of patients
   treated with carbamazepine
SO CLINICAL PHARMACOLOGY & THERAPEUTICS
LA English
DT Article
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; CULTURED HUMAN
   HEPATOCYTES; DISTAL ENHANCER MODULE; NUCLEAR RECEPTOR; DRUG-METABOLISM;
   CYTOCHROME-P450 EXPRESSION; CYP3A4 EXPRESSION; CYP2B6 GENE; INDUCTION
AB Background. The antiepileptic drug carbamazepine (CBZ) is a potent inducer of human drug metabolism, resulting in serious interactions with many commonly prescribed drugs. The molecular mechanisms underlying this response are not well understood, however, and the spectrum of CBZ-inducible genes in human liver has not been thoroughly investigated.
   Methods. The availability of liver ribonucleic acid from 2 epileptic patients treated with CBZ and from 7 control subjects enabled us to study the global induction response of drug-metabolizing enzymes, drug transporters, and nuclear receptors in vivo.
   Results: Using-expression profiling, we identified 64 significantly up-regulated transcripts but only I significantly down-regulated transcript (SLC22A5). We confirmed the induction of several genes that previously have been shown to be inducible by drugs in vitro, including multiple cytochrome P450 (CYP) genes in the CYP1A, CYP2A, CYP2B, CYP2C, and CYP3A subfamilies, as well as glutathione S-transferase A1, uridine diphosphate-glucuronosyltransferase 1As, the drug transporter ABCC2, and the nuclear receptors CAR (constitutive androstane receptor) and PXR (pregnane X receptor). Moreover, we identified a number of additional genes not previously known to be induced by CBZ, including CYP39A1, sulfotransferase 1A1, glutathione S-transferase Z1, and the drug transporters SLCO1A2, ABCG2, and ABCB7, as well as the glucocorticoid and aldosterone receptors. In transactivation studies in CV-1 cells, we demonstrated that both CBZ and its major metabolite, CBZ-10,11-epoxide, activate the nuclear receptor PXR in a concentration-dependent fashion and at therapeutic concentrations with 50% inhibitory concentration values of approximately 50 mu mol/L.
   Conclusions: CBZ is a potent inducer of a broad spectrum of drug-metabolizing enzymes and drug transporters in the human liver, and these effects are mediated at least in part by activation of PXR.
C1 Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany.
RP Meyer, UA (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelberg Str 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
RI Zanger, Ulrich M./A-9364-2012
OI Zanger, Ulrich M./0000-0002-5276-2002
CR Apeland T, 2001, ACTA NEUROL SCAND, V103, P294, DOI 10.1034/j.1600-0404.2001.103005294.x
   Benedetti MS, 2001, FUND CLIN PHARMACOL, V15, P75, DOI 10.1046/j.1472-8206.2001.00011.x
   Bertilsson L, 1997, BRIT J CLIN PHARMACO, V44, P186, DOI 10.1046/j.1365-2125.1997.00630.x
   BERTILSSON L, 1986, CLIN PHARMACOKINET, V11, P177, DOI 10.2165/00003088-198611030-00001
   Chan LMS, 2004, EUR J PHARM SCI, V21, P25, DOI 10.1016/j.ejps.2003.07.003
   Chen YP, 2003, MOL PHARMACOL, V64, P316, DOI 10.1124/mol.64.2.316
   Chen ZS, 2003, CANCER RES, V63, P4048
   Chung JY, 2005, CLIN PHARMACOL THER, V77, P486, DOI 10.1016/j.clpt.2005.02.006
   Denison MS, 2003, ANNU REV PHARMACOL, V43, P309, DOI 10.1146/annurev.pharmtox.43.100901.135828
   Duanmu ZB, 2002, DRUG METAB DISPOS, V30, P997, DOI 10.1124/dmd.30.9.997
   Dussault I, 2003, P NATL ACAD SCI USA, V100, P833, DOI 10.1073/pnas.0336235100
   Faber KN, 2003, ADV DRUG DELIVER REV, V55, P107, DOI 10.1016/S0169-409X(02)00173-4
   Falkner KC, 2001, MOL PHARMACOL, V60, P611
   Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200
   Fretland AJ, 2000, CHEM-BIOL INTERACT, V129, P41, DOI 10.1016/S0009-2797(00)00197-6
   Fromm MF, 2000, AM J PATHOL, V157, P1575, DOI 10.1016/S0002-9440(10)64794-3
   Fujita A, 2002, FEBS LETT, V532, P373, DOI 10.1016/S0014-5793(02)03712-2
   Ganapathy ME, 2000, J BIOL CHEM, V275, P1699, DOI 10.1074/jbc.275.3.1699
   Gerbal-Chaloin S, 2001, DRUG METAB DISPOS, V29, P242
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663
   Grube M, 2006, CIRCULATION, V113, P1114, DOI 10.1161/CIRCULATIONAHA.105.586107
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Jones SA, 2002, METHOD ENZYMOL, V357, P161
   Kaminski WE, 2001, BIOCHEM BIOPH RES CO, V285, P1295, DOI 10.1006/bbrc.2001.5326
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   KERR BM, 1994, BIOCHEM PHARMACOL, V47, P1969, DOI 10.1016/0006-2952(94)90071-X
   Kitteringham NR, 1996, J PHARMACOL EXP THER, V278, P1018
   KLIPSTEIN FA, 1964, BLOOD, V23, P68, DOI 10.1182/blood.V23.1.68.68
   Kruse R, 1968, Monatsschr Kinderheilkd, V116, P378
   Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005
   Lakehal F, 2002, EPILEPSY RES, V52, P79, DOI 10.1016/S0920-1211(02)00188-2
   LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X
   Levesque E, 2001, BIOCHEMISTRY-US, V40, P3869, DOI 10.1021/bi002607y
   Li-Hawkins J, 2000, J BIOL CHEM, V275, P16543, DOI 10.1074/jbc.M001810200
   Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   Madan A, 2003, DRUG METAB DISPOS, V31, P421, DOI 10.1124/dmd.31.4.421
   Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   MOREL F, 1993, CANCER RES, V53, P231
   Panesar SK, 1996, DRUG METAB DISPOS, V24, P619
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Payen L, 2002, CELL BIOL TOXICOL, V18, P221, DOI 10.1023/A:1016020626941
   Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
   Rattya J, 2001, NEUROLOGY, V57, P440, DOI 10.1212/WNL.57.3.440
   Rausch-Derra LC, 2001, HEPATOLOGY, V33, P1469, DOI 10.1053/jhep.2001.25088
   Ripp SL, 2002, DRUG METAB DISPOS, V30, P570, DOI 10.1124/dmd.30.5.570
   ROSENBERRY KR, 1983, J PEDIATR-US, V102, P472, DOI 10.1016/S0022-3476(83)80681-7
   Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421
   Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   SOTANIEMI EA, 1995, BRIT J CLIN PHARMACO, V39, P71, DOI 10.1111/j.1365-2125.1995.tb04412.x
   Spina E, 1996, CLIN PHARMACOKINET, V31, P198, DOI 10.2165/00003088-199631030-00004
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523
   Stevens JC, 2003, J PHARMACOL EXP THER, V307, P573, DOI 10.1124/jpet.103.054841
   Sueyoshi T, 1999, J BIOL CHEM, V274, P6043, DOI 10.1074/jbc.274.10.6043
   Suzuki M, 2003, J BIOL CHEM, V278, P22644, DOI 10.1074/jbc.M212399200
   Taketani S, 2003, BLOOD, V101, P3274, DOI 10.1182/blood-2002-04-1212
   Tateishi T, 1999, CHEM-BIOL INTERACT, V117, P257, DOI 10.1016/S0009-2797(98)00110-0
   Teng S, 2003, DRUG METAB DISPOS, V31, P1296, DOI 10.1124/dmd.31.11.1296
   Tong Z, 1998, CHEM RES TOXICOL, V11, P1332, DOI 10.1021/tx980144f
   Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581
   Tunca A, 2005, ACTA NEUROL BELG, V105, P46
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Wang HB, 2003, J BIOL CHEM, V278, P14146, DOI 10.1074/jbc.M212482200
   Wilkinson GR, 2005, NEW ENGL J MED, V352, P2211, DOI 10.1056/NEJMra032424
   Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
NR 73
TC 84
Z9 91
U1 0
U2 8
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0009-9236
J9 CLIN PHARMACOL THER
JI Clin. Pharmacol. Ther.
PD NOV
PY 2006
VL 80
IS 5
BP 440
EP 456
DI 10.1016/j.clpt.2006.08.013
PG 17
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 107OZ
UT WOS:000242182200002
PM 17112801
DA 2021-01-25
ER

PT J
AU Sprecher, SG
   Urbach, R
   Technau, GM
   Rijli, FM
   Reichert, H
   Hirth, F
AF Sprecher, Simon G.
   Urbach, Rolf
   Technau, Gerhard M.
   Rijli, Filippo M.
   Reichert, Heinrich
   Hirth, Frank
TI The columnar gene vnd is required for tritocerebral neuromere formation
   during embryonic brain development of Drosophila
SO DEVELOPMENT
LA English
DT Article
DE Drosophila; brain development; neuromere; DV patterning; ventral nervous
   system defective; Hox gene; labial; neuroblast; programmed cell death
ID CENTRAL-NERVOUS-SYSTEM; HOMEOBOX GENE; NEUROBLAST FORMATION; CELL-DEATH;
   SEGMENT POLARITY; EXPRESSION; SPECIFICATION; NEUROGENESIS; IDENTITY;
   NEUROECTODERM
AB In Drosophila, evolutionarily conserved transcription factors are required for the specification of neural lineages along the anteroposterior and dorsoventral axes, such as Hox genes for anteroposterior and columnar genes for dorsoventral patterning. In this report, we analyse the role of the columnar patterning gene ventral nervous system defective (vnd) in embryonic brain development. Expression of vnd is observed in specific subsets of cells in all brain neuromeres. Loss-of-function analysis focussed on the tritocerebrum shows that inactivation of vnd results in regionalized axonal patterning defects, which are comparable with the brain phenotype caused by mutation of the Hox gene labial ( lab). However, in contrast to lab activity in specifying tritocerebral neuronal identity, vnd is required for the formation and specification of tritocerebral neural lineages. Thus, in early vnd mutant embryos, the Tv1-Tv5 neuroblasts, which normally express lab, do not form. Later in embryogenesis, vnd mutants show an extensive loss of lab-expressing cells because of increased apoptotic activity, resulting in a gap-like brain phenotype that is characterized by an almost complete absence of the tritocerebral neuromere. Correspondingly, genetic block of apoptosis in vnd mutant embryos partially restores tritocerebral cells as well as axon tracts. Taken together, our results indicate that vnd is required for the genesis and proper identity specification of tritocerebral neural lineages during embryonic brain development of Drosophila.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   ULP, Inst Genet & Biol Mol & Cellulaire, UMR 7104, CNRS,INSRM, F-67404 Illkirch Graffenstaden, France.
   CU Strasbourg, Strasbourg, France.
   Univ Mainz, Inst Genet, D-55099 Mainz, Germany.
RP Hirth, F (corresponding author), Kings Coll London, MRC, Ctr Neurodegenerat Res, De Crespigny Pk, London SE5 8AF, England.
EM frank.hirth@unibas.ch
RI Hirth, Frank/B-8384-2015; RIJLI, Filippo/AAP-2516-2020; Sprecher,
   Simon/B-5188-2012; Sprecher, Simon/K-4249-2015
OI RIJLI, Filippo/0000-0003-0515-0182; Sprecher, Simon/0000-0001-9060-3750;
   Hirth, Frank/0000-0001-8581-9450
FU Medical Research CouncilMedical Research Council UK (MRC) [G0701498]
   Funding Source: Medline
CR ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W
   BIER E, 1992, GENE DEV, V6, P2137, DOI 10.1101/gad.6.11.2137
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   DAlessio M, 1996, MECH DEVELOP, V58, P217, DOI 10.1016/S0925-4773(96)00583-7
   Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212
   Hirth F, 2001, DEVELOPMENT, V128, P4781
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Isshiki T, 1997, DEVELOPMENT, V124, P3099
   JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700
   JIMENEZ F, 1990, NEURON, V5, P81, DOI 10.1016/0896-6273(90)90036-F
   JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x
   Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60
   KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9
   LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1
   McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603
   MELLERICK DM, 1995, DEV BIOL, V171, P306, DOI 10.1006/dbio.1995.1283
   Mellerick DM, 2002, J NEUROBIOL, V50, P118, DOI 10.1002/neu.10022
   Mergliano J, 2003, DEVELOPMENT, V130, P5779, DOI 10.1242/dev.00824
   Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875
   Page DT, 2000, DEV GENES EVOL, V210, P559, DOI 10.1007/s004270000097
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1
   Pattyn A, 2003, DEVELOPMENT, V130, P4149, DOI 10.1242/dev.00641
   Pattyn A, 2003, GENE DEV, V17, P729, DOI 10.1101/gad.255803
   Pereanu W, 2004, CURR OPIN GENET DEV, V14, P382, DOI 10.1016/j.gde.2004.06.010
   Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989
   Richter S, 1998, DEV GENES EVOL, V208, P37, DOI 10.1007/s004270050151
   Samad OA, 2004, DEVELOPMENT, V131, P4071, DOI 10.1242/dev.01282
   SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111
   Skeath JB, 1999, BIOESSAYS, V21, P922, DOI 10.1002/(SICI)1521-1878(199911)21:11<922::AID-BIES4>3.0.CO;2-T
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   SPANA EP, 1995, DEVELOPMENT, V121, P3187
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   Sussel L, 1999, DEVELOPMENT, V126, P3359
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   TREMML G, 1992, DEVELOPMENT, V116, P447
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   Urbach R, 2006, DEVELOPMENT, V133, P4315, DOI 10.1242/dev.02605
   Von Ohlen T, 2000, DEV BIOL, V224, P362, DOI 10.1006/dbio.2000.9789
   Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591
NR 49
TC 16
Z9 16
U1 0
U2 1
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD NOV 1
PY 2006
VL 133
IS 21
BP 4331
EP 4339
DI 10.1242/dev.02606
PG 9
WC Developmental Biology
SC Developmental Biology
GA 094CR
UT WOS:000241217400019
PM 17038518
OA Bronze
DA 2021-01-25
ER

PT J
AU Sprecher, SG
   Hirth, F
AF Sprecher, Simon G.
   Hirth, Frank
TI Expression and function of the columnar patterning gene msh in late
   embryonic brain development of Drosophila
SO DEVELOPMENTAL DYNAMICS
LA English
DT Article
DE Drosophila; brain development; neuromere; glia; axon tract; columnar
   gene; muscle specific homeobox; msh; Drop
ID CENTRAL-NERVOUS-SYSTEM; HOMEOBOX GENE; EMPTY-SPIRACLES; SEGMENT
   POLARITY; CELL-DEATH; SPECIFICATION; NEUROBLAST; HEAD; TRITOCEREBRUM;
   NEUROGENESIS
AB In Drosophila, specification of neural identity requires a network of conserved transcription factors, such as the columnar genes for dorsoventral patterning. Here, we analyze the expression and function of the columnar patterning gene muscle specific homeobox (msh) in late embryonic brain development. Expression of msh is observed in all brain neuromeres, including neurons and neuropile glia. Functional analysis demonstrates that msh is essential for proper development of the tritocerebral neuromere and brain neuropile glia. Thus, msh mutants display a severe loss of neural and glial tissue together with axonal patterning defects. This gap-like phenotype initially correlates with defects in neural and glial cell formation and during later embryonic development is associated with increased apoptotic activity. Taken together, our results provide evidence that the columnar patterning gene msh is required for correct tritocerebral neuromere development, as well as for neuropile glia formation and axogenesis in embryonic brain development of Drosophila.
C1 Univ Basel, Biozentrum, Div Mol Zool, CH-4056 Basel, Switzerland.
RP Hirth, F (corresponding author), Univ Basel, Biozentrum, Div Mol Zool, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM frank.hirth@unibas.ch
RI Hirth, Frank/B-8384-2015; Sprecher, Simon/B-5188-2012; Sprecher,
   Simon/K-4249-2015
OI Sprecher, Simon/0000-0001-9060-3750; Hirth, Frank/0000-0001-8581-9450
FU Medical Research CouncilMedical Research Council UK (MRC) [G0701498]
   Funding Source: Medline; Alzheimers Research UKAlzheimer's Research UK
   (ARUK) [ARUK-PhD2012-18] Funding Source: Researchfish
CR ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Bach A, 2003, DEVELOPMENT, V130, P4025, DOI 10.1242/dev.00609
   Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W
   Buescher M, 1997, DEVELOPMENT, V124, P673
   CAMPBELL G, 1994, DEVELOPMENT, V120, P2957
   CAMPOSORTEGA JA, 1997, EMBRYONI CDEV DROSOP
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   DAlessio M, 1996, MECH DEVELOP, V58, P217, DOI 10.1016/S0925-4773(96)00583-7
   Fernandez-Llebrez P, 2004, J NEUROPATH EXP NEUR, V63, P574, DOI 10.1093/jnen/63.6.574
   Fraser AG, 1997, EMBO J, V16, P2805, DOI 10.1093/emboj/16.10.2805
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   Hartenstein V, 1998, J COMP NEUROL, V402, P32
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   Hirth F, 2001, DEVELOPMENT, V128, P4781
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Isshiki T, 1997, DEVELOPMENT, V124, P3099
   JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700
   JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x
   LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1
   McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603
   Meier S, 2006, MECH DEVELOP, V123, P76, DOI 10.1016/j.mod.2005.09.004
   MELLERICK DM, 1995, DEV BIOL, V171, P306, DOI 10.1006/dbio.1995.1283
   Nassif C, 1998, J COMP NEUROL, V402, P10
   Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875
   Page DT, 2000, DEV GENES EVOL, V210, P559, DOI 10.1007/s004270000097
   Parker RJ, 2006, SEMIN CELL DEV BIOL, V17, P66, DOI 10.1016/j.semcdb.2005.11.012
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1
   Pereanu W, 2004, CURR OPIN GENET DEV, V14, P382, DOI 10.1016/j.gde.2004.06.010
   Ramos C, 2004, DEV DYNAM, V230, P446, DOI 10.1002/dvdy.20070
   Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001
   SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111
   Skeath JB, 1999, BIOESSAYS, V21, P922, DOI 10.1002/(SICI)1521-1878(199911)21:11<922::AID-BIES4>3.0.CO;2-T
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591
   XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981
   Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793
NR 44
TC 3
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
PD NOV
PY 2006
VL 235
IS 11
BP 2920
EP 2929
DI 10.1002/dvdy.20936
PG 10
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 103VW
UT WOS:000241916000002
PM 16929521
DA 2021-01-25
ER

PT J
AU Jokic, N
   de Aguilar, JLG
   Dimou, L
   Lin, S
   Fergani, A
   Ruegg, MA
   Schwab, ME
   Dupuis, L
   Loeffler, JP
AF Jokic, Natasa
   de Aguilar, Jose-Luis Gonzalez
   Dimou, Leda
   Lin, Shuo
   Fergani, Anissa
   Ruegg, Markus A.
   Schwab, Martin E.
   Dupuis, Luc
   Loeffler, Jean-Philippe
TI The neurite outgrowth inhibitor Nogo-A promotes denervation in an
   amyotrophic lateral sclerosis model
SO EMBO REPORTS
LA English
DT Article
DE amyotrophic lateral sclerosis; G86R mouse; neuromuscular junction;
   Nogo-A; skeletal muscle
ID NEUROMUSCULAR-JUNCTION; MOTONEURON DISEASE; MOTOR-NEURONS; MOUSE MODEL;
   ALS MICE; IN-VIVO; MUSCLE; EXPRESSION; SYNAPSE; INJURY
AB Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss and muscle wasting. In muscles of ALS patients, Nogo-A-a protein known to inhibit axon regeneration-is ectopically expressed at levels that correlate with the severity of the clinical symptoms. We now show that the genetic ablation of Nogo-A extends survival and reduces muscle denervation in a mouse model of ALS. In turn, overexpression of Nogo-A in wild-type muscle fibres leads to shrinkage of the postsynapse and retraction of the presynaptic motor ending. This suggests that the expression of Nogo-A occurring early in ALS skeletal muscle could cause repulsion and destabilization of the motor nerve terminals, and subsequent dying back of the axons and motor neurons.
C1 INSERM, U692, Lab Signalisat Mol & Neurodegenerescence, F-67085 Strasbourg, France.
   Univ Strasbourg 1, Fac Med, UMRS692, F-67085 Strasbourg, France.
   Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland.
   Swiss Fed Inst Technol, Dept Biol, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Loeffler, JP (corresponding author), INSERM, U692, Lab Signalisat Mol & Neurodegenerescence, 11 Rue Humann, F-67085 Strasbourg, France.
EM loeffler@neurochem.u-strasbg.fr
RI LOEFFLER, Jean-Philippe/AAS-4401-2020; Dupuis, Luc/A-6981-2012; Schwab,
   Martin/B-6818-2016; Dimou, Leda/E-7968-2012; Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244
   CARONI P, 1988, NEURON, V1, P85, DOI 10.1016/0896-6273(88)90212-7
   Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021
   DUCLERT A, 1995, PHYSIOL REV, V75, P339
   Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101
   Dupuis L, 2002, NEUROBIOL DIS, V10, P358, DOI 10.1006/nbdi.2002.0522
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9
   Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004
   Frey D, 2000, J NEUROSCI, V20, P2534
   GrandPre T, 2002, NATURE, V417, P547, DOI 10.1038/417547a
   Jokic N, 2005, ANN NEUROL, V57, P553, DOI 10.1002/ana.20420
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kieran D, 2005, J CELL BIOL, V169, P561, DOI 10.1083/jcb.200501085
   Kong XC, 2004, EMBO REP, V5, P183, DOI 10.1038/sj.embor.7400065
   Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004
   Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Lino MM, 2002, J NEUROSCI, V22, P4825, DOI 10.1523/JNEUROSCI.22-12-04825.2002
   Miller TM, 2005, ANN NEUROL, V57, P773, DOI 10.1002/ana.20453
   Nakanishi ST, 2005, J NEUROSCI, V25, P2226, DOI 10.1523/JNEUROSCI.5065-04.2005
   Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082
   Oertle T, 2003, J NEUROSCI, V23, P5393
   Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287
   Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653
   RIPPS ME, 1995, P NATL ACAD SCI USA, V92, P689, DOI 10.1073/pnas.92.3.689
   Simonen M, 2003, NEURON, V38, P201, DOI 10.1016/S0896-6273(03)00226-5
   VALENZUELA DM, 1995, NEURON, V15, P573, DOI 10.1016/0896-6273(95)90146-9
   Wang J, 2005, NEUROBIOL DIS, V20, P943, DOI 10.1016/j.nbd.2005.06.005
NR 33
TC 108
Z9 112
U1 0
U2 13
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1469-221X
J9 EMBO REP
JI EMBO Rep.
PD NOV
PY 2006
VL 7
IS 11
BP 1162
EP 1167
DI 10.1038/sj.embor.7400826
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 109AE
UT WOS:000242279500020
PM 17039253
OA Green Published
DA 2021-01-25
ER

PT J
AU Cornelis, GR
AF Cornelis, Guy R.
TI The type III secretion injectisome
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID YERSINIA YOP VIRULON; FLAGELLAR EXPORT APPARATUS; TARGET-CELL CONTACT;
   SHIGELLA-FLEXNERI; PROTEIN-SECRETION; NEEDLE COMPLEX; V-ANTIGEN;
   SUBSTRATE-SPECIFICITY; STRUCTURAL INSIGHTS; TRANSLOCATORS YOPB
AB The type III secretion injectisome is a complex nanomachine that allows bacteria to deliver protein effectors across eukaryotic cellular membranes. In recent years, significant progress has been made in our understanding of its structure, assembly and mode of operation. The principal structural components of the injectisome, from the base located in the bacterial cytosol to the tip of the needle protruding from the cell surface, have been investigated in detail. The structures of several constituent proteins were solved at the atomic level and important insights into the assembly process have been gained. However, despite the ongoing concerted efforts of molecular and structural biologists, the role of many of the constituent components of this nanomachine remain unknown.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992
   Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Andersson K, 1996, MOL MICROBIOL, V20, P1057, DOI 10.1111/j.1365-2958.1996.tb02546.x
   Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597
   Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0
   Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blaylock B, 2006, J BACTERIOL, V188, P3525, DOI 10.1128/JB.188.10.3525-3534.2006
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Burghout P, 2004, J BACTERIOL, V186, P5366, DOI 10.1128/JB.186.16.5366-5375.2004
   Burr SE, 2003, DIS AQUAT ORGAN, V57, P167, DOI 10.3354/dao057167
   Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605
   Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 2006, CURR OPIN MICROBIOL, V9, P201, DOI 10.1016/j.mib.2006.01.002
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Crago AM, 1998, MOL MICROBIOL, V30, P47, DOI 10.1046/j.1365-2958.1998.01036.x
   Creighton T., 1992, PROTEINS STRUCTURES
   Crepin VF, 2005, J BACTERIOL, V187, P2881, DOI 10.1128/JB.187.8.2881-2889.2005
   Crepin VF, 2005, MOL MICROBIOL, V55, P1658, DOI 10.1111/j.1365-2958.2005.04508.x
   Daefler S, 1998, MOL MICROBIOL, V28, P1367, DOI 10.1046/j.1365-2958.1998.00908.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x
   DEANE JE, 2006, P NATL ACAD SCI US
   Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   Ehrbar K, 2004, J BACTERIOL, V186, P1215, DOI 10.1128/JB.186.4.1215-1219.2004
   Enninga J, 2005, NAT METHODS, V2, P959, DOI 10.1038/NMETH804
   Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06
   Evdokimov AG, 2003, NAT STRUCT BIOL, V10, P789, DOI 10.1038/nsb982
   Evdokimov AG, 2002, ACTA CRYSTALLOGR D, V58, P398, DOI 10.1107/S090744490200015X
   Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101
   Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x
   FIELDS KA, 1994, J BACTERIOL, V176, P569, DOI 10.1128/jb.176.3.569-579.1994
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004
   Gonzalez-Pedrajo B, 2002, MOL MICROBIOL, V45, P967, DOI 10.1046/j.1365-2958.2002.03047.x
   Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   GRANT SR, 2006, ANN REV MICROBI 0605
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684
   Harrington A, 2006, BIOCHEMISTRY-US, V45, P626, DOI 10.1021/bi0512593
   Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x
   IKEDA T, 1985, J MOL BIOL, V184, P735, DOI 10.1016/0022-2836(85)90317-1
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Jackson MW, 2000, FEMS MICROBIOL LETT, V186, P85, DOI 10.1111/j.1574-6968.2000.tb09086.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Kauppi AM, 2003, CHEM BIOL, V10, P241, DOI 10.1016/S1074-5521(03)00046-2
   Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200
   Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   MARIOVITS T, 2006, NATURE, V441, P637, DOI DOI 10.1038/NATURE04822
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Minamino T, 2000, MOL MICROBIOL, V35, P1052, DOI 10.1046/j.1365-2958.2000.01771.x
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Moriya N, 2006, J MOL BIOL, V359, P466, DOI 10.1016/j.jmb.2006.03.025
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, MOL MICROBIOL, V61, P119, DOI 10.1111/j.1365-2958.2006.05219.x
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997
   Ogino T, 2006, J BACTERIOL, V188, P2801, DOI 10.1128/JB.188.8.2801-2811.2006
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x
   Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001
   Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x
   Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   Quinaud M, 2005, J BIOL CHEM, V280, P36293, DOI 10.1074/jbc.M508089200
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737
   RUSSEL M, 1994, SCIENCE, V265, P612, DOI 10.1126/science.8036510
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102
   Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499
   Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Trame CB, 2003, ACTA CRYSTALLOGR D, V59, P389, DOI 10.1107/S0907444902020826
   Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005
   van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200
   van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999
   Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x
   Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005
   Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554
   Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879
   Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456
   Young HS, 2003, BIOPHYS J, V84, P571, DOI 10.1016/s0006-3495(03)74877-2
   Zhou DG, 2001, MICROBES INFECT, V3, P1293, DOI 10.1016/S1286-4579(01)01489-7
NR 149
TC 734
Z9 750
U1 3
U2 109
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
EI 1740-1534
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD NOV
PY 2006
VL 4
IS 11
BP 811
EP 825
DI 10.1038/nrmicro1526
PG 15
WC Microbiology
SC Microbiology
GA 096FQ
UT WOS:000241363400010
PM 17041629
DA 2021-01-25
ER

PT J
AU Schmid, MC
   Scheidegger, F
   Dehio, M
   Balmelle-Devaux, N
   Schulein, R
   Guye, P
   Chennakesava, CS
   Biedermann, B
   Dehio, C
AF Schmid, Michael C.
   Scheidegger, Florine
   Dehio, Michaela
   Balmelle-Devaux, Nadege
   Schulein, Ralf
   Guye, Patrick
   Chennakesava, Cuddapah S.
   Biedermann, Barbara
   Dehio, Christoph
TI A translocated bacterial protein protects vascular endothelial cells
   from apoptosis
SO PLOS PATHOGENS
LA English
DT Article
ID NF-KAPPA-B; ELEMENT-BINDING PROTEIN; OUTER-MEMBRANE PROTEINS; IV
   SECRETION SYSTEMS; BARTONELLA-HENSELAE; CYCLIC-AMP; ADENYLATE-CYCLASE;
   PORIN PORB; NEUTROPHIL APOPTOSIS; UP-REGULATION
AB The modulation of host cell apoptosis by bacterial pathogens is of critical importance for the outcome of the infection process. The capacity of Bartonella henselae and B. quintana to cause vascular tumor formation in immunocompromised patients is linked to the inhibition of vascular endothelial cell (EC) apoptosis. Here, we show that translocation of BepA, a type IV secretion (T4S) substrate, is necessary and sufficient to inhibit EC apoptosis. Ectopic expression in ECs allowed mapping of the anti-apoptotic activity of BepA to the Bep intracellular delivery domain, which, as part of the signal for T4S, is conserved in other T4S substrates. The anti-apoptotic activity appeared to be limited to BepA orthologs of B. henselae and B. quintana and correlated with (i) protein localization to the host cell plasma membrane, (ii) elevated levels of intracellular cyclic adenosine monophosphate (cAMP), and (iii) increased expression of cAMP-responsive genes. The pharmacological elevation of cAMP levels protected ECs from apoptosis, indicating that BepA mediates anti-apoptosis by heightening cAMP levels by a plasma membrane-associated mechanism. Finally, we demonstrate that BepA mediates protection of ECs against apoptosis triggered by cytotoxic T lymphocytes, suggesting a physiological context in which the anti-apoptotic activity of BepA contributes to tumor formation in the chronically infected vascular endothelium.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
   Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Schmid, Michael/0000-0002-3445-0013
CR Abramovitch R, 2004, CANCER RES, V64, P1338, DOI 10.1158/0008-5472.CAN-03-2089
   Adrain C, 2005, J BIOL CHEM, V280, P4663, DOI 10.1074/jbc.M410915200
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10
   Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819
   Bernot D, 2005, J CELL PHYSIOL, V202, P434, DOI 10.1002/jcp.20134
   Biedermann BC, 1999, J IMMUNOL, V162, P7022
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Clifton DR, 1998, P NATL ACAD SCI USA, V95, P4646, DOI 10.1073/pnas.95.8.4646
   Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio M, 2005, THROMB HAEMOSTASIS, V94, P347, DOI 10.1160/TH05-02-0106
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Fischer SE, 2004, J EXP MED, V200, P905, DOI 10.1084/jem.20040402
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396
   Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895
   Hippenstiel S, 2002, AM J PHYSIOL-LUNG C, V283, pL830, DOI 10.1152/ajplung.00467.2001
   Hueffer K, 2004, CELL MICROBIOL, V6, P1019, DOI 10.1111/j.1462-5822.2004.00451.x
   Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221
   KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988
   Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001
   Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Kummer M, 2005, J IMMUNOL, V174, P1947, DOI 10.4049/jimmunol.174.4.1947
   Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200
   Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200
   Martin MC, 2001, J BIOL CHEM, V276, P45041, DOI 10.1074/jbc.M105197200
   Massari P, 2000, P NATL ACAD SCI USA, V97, P9070, DOI 10.1073/pnas.97.16.9070
   Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533
   Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068
   MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U
   Muller A, 1999, EMBO J, V18, P339, DOI 10.1093/emboj/18.2.339
   Muller A, 2002, EMBO J, V21, P1916, DOI 10.1093/emboj/21.8.1916
   Nagai H, 2005, P NATL ACAD SCI USA, V102, P826, DOI 10.1073/pnas.0406239101
   Nishihara H, 2003, P NATL ACAD SCI USA, V100, P8921, DOI 10.1073/pnas.1533221100
   Nishihara H, 2004, J BIOL CHEM, V279, P26176, DOI 10.1074/jbc.M313346200
   Orlov SN, 1999, CELL DEATH DIFFER, V6, P661, DOI 10.1038/sj.cdd.4400539
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Rossi AG, 1995, BIOCHEM BIOPH RES CO, V217, P892, DOI 10.1006/bbrc.1995.2855
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sassone-Corsi P, 1998, INT J BIOCHEM CELL B, V30, P27, DOI 10.1016/S1357-2725(97)00093-9
   Schildberg FA, 2005, CELL TISSUE RES, V320, P91, DOI 10.1007/s00441-004-1066-4
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005
   Weinrauch Y, 1999, ANNU REV MICROBIOL, V53, P155, DOI 10.1146/annurev.micro.53.1.155
   Yusta B, 2000, J BIOL CHEM, V275, P35345, DOI 10.1074/jbc.M005510200
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
   Zhou B, 2005, INT J BIOCHEM CELL B, V37, P1483, DOI 10.1016/j.biocel.2005.02.012
   Ziganghirova N. A., 2004, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P106
   Zychlinsky A, 1997, TRENDS MICROBIOL, V5, P201, DOI 10.1016/S0966-842X(97)01044-5
NR 58
TC 90
Z9 93
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD NOV
PY 2006
VL 2
IS 11
BP 1083
EP 1097
AR e115
DI 10.1371/journal.ppat.0020115
PG 15
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 116FE
UT WOS:000242787100008
PM 17121462
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Thorsteinsdottir, HB
   Schwede, T
   Zoete, V
   Meuwly, M
AF Thorsteinsdottir, Holmfridur B.
   Schwede, Torsten
   Zoete, Vincent
   Meuwly, Markus
TI How inaccuracies in protein structure models affect estimates of
   protein-ligand interactions: Computational analysis of HIV-1 protease
   inhibitor binding
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE molecular dynamics; homology modeling; HIV; ligand binding
ID ORALLY BIOAVAILABLE INHIBITOR; FREE-ENERGY CALCULATIONS;
   MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; SWISS-MODEL; CRYSTALLOGRAPHIC
   ANALYSIS; RETROVIRAL PROTEASES; SEQUENCE ALIGNMENTS; DRUG DESIGN;
   COMPLEXES
AB The influence of possible inaccuracies that can arise during homology modeling of protein structures used for ligand binding studies were investigated with the molecular mechanics generalized Born surface area (MM-GBSA) method. For this, a family of well-characterized HIV-I protease-inhibitor complexes was used. Validation of MM-GBSA led to a correlation coefficient ranging from 0.72 to 0.93 between calculated and experimental binding free energies Delta G. All calculated Delta G values were based on molecular dynamics simulations with explicit solvent. Errors introduced into the protein structure through misplacement of side-chains during rotamer modeling led to a correlation coefficient between Delta G(calc) and Delta G(exp) of 0.75 compared with 0.90 for the correctly placed side chains. This is in contrast to homology models for members of the retroviral protease family with template structures ranging in sequence identity between 32% and 51%. For these protein models, the correlation coefficients vary between 0.84 and 0.87, which is considerably closer to the original protein (0.90). It is concluded that HIV-I low sequence identity with the template structure still allows creating sufficiently reliable homology models to be used for ligand-binding studies, although placement of the rotamers is a critical step during the modeling.
C1 Univ Basel, Dept Chem, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
   UNIL, BEP, Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Meuwly, M (corresponding author), Univ Basel, Dept Chem, Biozentrum, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM m.meuwly@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
CR ABDELMEGUID SS, 1993, BIOCHEMISTRY-US, V32, P7972, DOI 10.1021/bi00082a019
   Ajay, 1995, J MED CHEM, V38, P4953
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Backbro K, 1997, J MED CHEM, V40, P898, DOI 10.1021/jm960588d
   BALDWIN ET, 1995, STRUCTURE, V3, P581, DOI 10.1016/S0969-2126(01)00192-7
   Bardi JS, 1997, BIOCHEMISTRY-US, V36, P6588, DOI 10.1021/bi9701742
   Bartels C, 2005, J COMPUT CHEM, V26, P1294, DOI 10.1002/jcc.20270
   BERMAN HM, 2000, PROTEIN DATA BANK NU, V28, P235
   BLUNDELL TL, 1987, NATURE, V326, P347, DOI 10.1038/326347a0
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   BROOKS CL, 1985, BIOPOLYMERS, V24, P843, DOI 10.1002/bip.360240509
   BROOKS CL, 1989, J MOL BIOL, V208, P159, DOI 10.1016/0022-2836(89)90093-4
   Bursulaya BD, 2003, J COMPUT AID MOL DES, V17, P755, DOI 10.1023/B:JCAM.0000017496.76572.6f
   Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503
   CHEN ZG, 1994, J BIOL CHEM, V269, P26344
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Cozzetto D, 2005, PROTEINS, V58, P151, DOI 10.1002/prot.20284
   Fornabaio M, 2004, J MED CHEM, V47, P4507, DOI 10.1021/jm030596b
   Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Gustchina A, 1996, PROTEIN SCI, V5, P1453, DOI 10.1002/pro.5560050802
   HARTE WE, 1993, J AM CHEM SOC, V115, P1231, DOI 10.1021/ja00057a003
   Hasel W, 1988, TETRAHEDRON COMPUT M, V1, P103, DOI DOI 10.1016/0898-5529(88)90015-2
   HERMANN RB, 1972, J PHYS CHEM-US, V76, P2754, DOI 10.1021/j100663a023
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   HOOG SS, 1995, J MED CHEM, V38, P3246, DOI 10.1021/jm00017a008
   HOSUR MV, 1994, J AM CHEM SOC, V116, P847, DOI 10.1021/ja00082a004
   JHOTI H, 1994, BIOCHEMISTRY-US, V33, P8417, DOI 10.1021/bi00194a005
   JOHNSON MS, 1994, CRIT REV BIOCHEM MOL, V29, P1, DOI 10.3109/10409239409086797
   KAGEYAMA S, 1993, ANTIMICROB AGENTS CH, V37, P810, DOI 10.1128/AAC.37.4.810
   Kaldor SW, 1997, J MED CHEM, V40, P3979, DOI 10.1021/jm9704098
   KIM EE, 1995, J AM CHEM SOC, V117, P1181, DOI 10.1021/ja00108a056
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405
   Laco GS, 1997, BIOCHEMISTRY-US, V36, P10696, DOI 10.1021/bi9707436
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee CY, 1998, PROTEIN ENG, V11, P429, DOI 10.1093/protein/11.6.429
   Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272
   Lee MS, 2002, J CHEM PHYS, V116, P10606, DOI 10.1063/1.1480013
   Lepsik M, 2004, PROTEINS, V57, P279, DOI 10.1002/prot.20192
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   McQuarrie D. A., 1976, STAT MECH
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Miller M, 1997, PROTEINS, V27, P184, DOI 10.1002/(SICI)1097-0134(199702)27:2&lt;184::AID-PROT4&gt;3.0.CO;2-G
   Munshi S, 1998, ACTA CRYSTALLOGR D, V54, P1053, DOI 10.1107/S0907444998003588
   PEARL LH, 1987, NATURE, V329, P351, DOI 10.1038/329351a0
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Silva AM, 1996, J MOL BIOL, V255, P321, DOI 10.1006/jmbi.1996.0026
   Srinivasan J, 1998, J AM CHEM SOC, V120, P9401, DOI 10.1021/ja981844+
   STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038
   Tame JRH, 1999, J COMPUT AID MOL DES, V13, P99, DOI 10.1023/A:1008068903544
   Tawa GJ, 1998, J AM CHEM SOC, V120, P8856, DOI 10.1021/ja9733090
   THOMPSON SK, 1994, J MED CHEM, V37, P3100, DOI 10.1021/jm00045a015
   TIDOR B, 1994, J MOL BIOL, V238, P405, DOI 10.1006/jmbi.1994.1300
   TONG L, 1995, STRUCTURE, V3, P33, DOI 10.1016/S0969-2126(01)00133-2
   VERKHIVKER G, 1995, PROTEIN ENG, V8, P677, DOI 10.1093/protein/8.7.677
   Wang YX, 1996, BIOCHEMISTRY-US, V35, P9945, DOI 10.1021/bi961268z
   WILDERSPIN AF, 1994, J MOL BIOL, V239, P97, DOI 10.1006/jmbi.1994.1353
   Wlodawer A, 1998, ANNU REV BIOPH BIOM, V27, P249, DOI 10.1146/annurev.biophys.27.1.249
   Wu J, 1998, BIOCHEMISTRY-US, V37, P4518, DOI 10.1021/bi972183g
   Zoete V, 2005, PROTEINS, V61, P79, DOI 10.1002/prot.20528
   Zoete V, 2003, J COMPUT AID MOL DES, V17, P861, DOI 10.1023/B:JCAM.0000021882.99270.4c
   Zoete V, 2002, J MOL BIOL, V315, P21, DOI 10.1006/jmbi.2001.5173
NR 66
TC 18
Z9 18
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PD NOV 1
PY 2006
VL 65
IS 2
BP 407
EP 423
DI 10.1002/prot.21096
PG 17
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 087NI
UT WOS:000240748700014
PM 16941468
DA 2021-01-25
ER

PT J
AU Sokolova, AV
   Kreplak, L
   Wedig, T
   Mucke, N
   Svergun, DI
   Herrmann, H
   Aebi, U
   Strelkov, SV
AF Sokolova, Anna V.
   Kreplak, Laurent
   Wedig, Tatjana
   Muecke, Norbert
   Svergun, Dmitri I.
   Herrmann, Harald
   Aebi, Ueli
   Strelkov, Sergei V.
TI Monitoring intermediate filament assembly by small-angle x-ray
   scattering reveals the molecular architecture of assembly intermediates
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE 3D structure; vimentin
ID BIOLOGICAL MACROMOLECULES; KERATIN FILAMENTS; HUMAN VIMENTIN; PROTEIN;
   DISEASE; CELLS; DIMER; POLYMORPHISM; MECHANISMS; DYNAMICS
AB intermediate filaments (IF's), along with microtubules, microfilaments, and associated cross-bridging proteins, constitute the cytoskeleton of metazoan cells. While crystallographic data on the dimer representing the elementary IF "building block" have recently become available, little structural detail is known about both the mature IF architecture and its assembly pathway. Here, we have applied solution small-angle x-ray scattering to investigate the in vitro assembly of a 53-kDa human IF protein vimentin at pH 8.4 by systematically varying the ionic strength conditions, and complemented these experiments by electron microscopy and analytical ultracentrifugation. While a vimentin solution in 5 mM Tris(.)HCl (pH 8.4) contains predominantly tetramers, addition of 20 mM NaCl induces further lateral assembly evidenced by the shift of the sedimentation coeficient and yields a distinct octameric intermediate. Four octamers eventually associate into unit-length filaments (ULFs) that anneal longitudinally. Based on the small-angle x-ray scattering experiments supplemented by crystallographic data and additional structural constraints, 3D molecular models of the vimentin tetramer, octamer, and ULF were constructed. Within each of the three oligomers, the adjacent dimers are aligned exclusively in an approximately half-staggered antiparallel A(11) mode with a distance of 3.2-3.4 nm between their axes. The ULF appears to be a dynamic and a relatively loosely packed structure with a roughly even mass distribution over its cross-section.
C1 Russian Acad Sci, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 119991, Russia.
   Russian Acad Sci, Inst Crystallog, Moscow 119991, Russia.
   Univ Basel, Biozentrum, Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany.
RP Strelkov, SV (corresponding author), Catholic Univ Louvain, Dept Pharmaceut Sci, Herestr 49 Bus 822, B-3000 Louvain, Belgium.
EM sergei.strelkov@pharm.kuleuven.be
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652; Svergun,
   Dmitri/0000-0003-0830-5696; Sokolova, Anna/0000-0002-2772-7395; kreplak,
   laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Goldman RD, 1996, J CELL BIOL, V134, P971, DOI 10.1083/jcb.134.4.971
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Hess JF, 2004, J BIOL CHEM, V279, P44841, DOI 10.1074/jbc.M406257200
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7
   Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871
   Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   SAYERS Z, 1990, J STRUCT BIOL, V103, P212, DOI 10.1016/1047-8477(90)90039-F
   SOELLNER P, 1985, P NATL ACAD SCI USA, V82, P7929, DOI 10.1073/pnas.82.23.7929
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2004, METHOD CELL BIOL, V78, P25
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 2002, CURR OPIN STRUC BIOL, V12, P654, DOI 10.1016/S0959-440X(02)00363-9
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
NR 39
TC 74
Z9 74
U1 0
U2 7
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 31
PY 2006
VL 103
IS 44
BP 16206
EP 16211
DI 10.1073/pnas.0603629103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 103IS
UT WOS:000241879500028
PM 17050693
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Christen, B
   Christen, M
   Paul, R
   Schmid, F
   Folcher, M
   Jenoe, P
   Meuwly, M
   Jenal, U
AF Christen, Beat
   Christen, Matthias
   Paul, Ralf
   Schmid, Franziska
   Folcher, Marc
   Jenoe, Paul
   Meuwly, Markus
   Jenal, Urs
TI Allosteric control of cyclic di-GMP signaling
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID EAL DOMAIN PROTEIN; DIGUANYLATE CYCLASE; RESPONSE REGULATOR; BIOFILM
   FORMATION; ESCHERICHIA-COLI; ADENYLYL-CYCLASE; GGDEF-DOMAIN;
   CAULOBACTER-CRESCENTUS; CELLULOSE BIOSYNTHESIS; ACETOBACTER-XYLINUM
AB Cyclic di-guanosine monophosphate is a bacterial second messenger that has been implicated in biofilm formation, antibiotic resistance, and persistence of pathogenic bacteria in their animal host. Although the enzymes responsible for the regulation of cellular levels of c-di-GMP, diguanylate cyclases (DGC) and phosphodiesterases, have been identified recently, little information is available on the molecular mechanisms involved in controlling the activity of these key enzymes or on the specific interactions of c-di-GMP with effector proteins. By using a combination of genetic, biochemical, and modeling techniques we demonstrate that an allosteric binding site for c-di-GMP (I-site) is responsible for non-competitive product inhibition of DGCs. The I-site was mapped in both multi- and single domain DGC proteins and is fully contained within the GGDEF domain itself. In vivo selection experiments and kinetic analysis of the evolved I-site mutants led to the definition of an RXXD motif as the core c-di-GMP binding site. Based on these results and based on the observation that the I-site is conserved in a majority of known and potential DGC proteins, we propose that product inhibition of DGCs is of fundamental importance for c-di-GMP signaling and cellular homeostasis. The definition of the I-site binding pocket provides an entry point into unraveling the molecular mechanisms of ligand-protein interactions involved in c-di-GMP signaling and makes DGCs a valuable target for drug design to develop new strategies against biofilmrelated diseases.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Christen, Beat/AAC-2974-2021
OI Christen, Beat/0000-0002-9528-3685; Christen,
   Matthias/0000-0001-7724-4562
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x
   Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x
   Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Galperin MY, 2001, FEMS MICROBIOL LETT, V204, P213, DOI 10.1016/S0378-1097(01)00434-7
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x
   Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   McAdams HH, 1997, P NATL ACAD SCI USA, V94, P814, DOI 10.1073/pnas.94.3.814
   Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200
   OCHI Y, 1981, ACTA ENDOCRINOL-COP, V98, P62, DOI 10.1530/acta.0.0980062
   OTOOLE GA, 1999, METHOD ENZYMOL, V34, P586
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   Rosenfeld N, 2002, J MOL BIOL, V323, P785, DOI 10.1016/S0022-2836(02)00994-4
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Simm R, 2005, J BACTERIOL, V187, P6816, DOI 10.1128/JB.187.19.6816-6823.2005
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Sunahara RK, 1998, J BIOL CHEM, V273, P16332, DOI 10.1074/jbc.273.26.16332
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756
   Tischler AD, 2002, J BACTERIOL, V184, P4104, DOI 10.1128/JB.184.15.4104-4113.2002
   Tucker CL, 1998, P NATL ACAD SCI USA, V95, P5993, DOI 10.1073/pnas.95.11.5993
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006
   Zhang GY, 1997, NATURE, V388, P204, DOI 10.1038/40675
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x
NR 44
TC 198
Z9 210
U1 2
U2 36
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 20
PY 2006
VL 281
IS 42
BP 32015
EP 32024
DI 10.1074/jbc.M603589200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 094JI
UT WOS:000241235300087
PM 16923812
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Floto, RA
   MacAry, PA
   Boname, JM
   Mien, TS
   Kampmann, B
   Hair, JR
   Huey, OS
   Houben, ENG
   Pieters, J
   Day, C
   Oehlmann, W
   Singh, M
   Smith, KGC
   Lehner, PJ
AF Floto, R. Andres
   MacAry, Paul A.
   Boname, Jessica M.
   Mien, Tan Suet
   Kampmann, Beate
   Hair, James R.
   Huey, Oh Seen
   Houben, Edith N. G.
   Pieters, Jean
   Day, Cheryl
   Oehlmann, Wulf
   Singh, Mahavir
   Smith, Kenneth G. C.
   Lehner, Paul J.
TI Dendritic cell stimulation by mycobacterial Hsp70 is mediated through
   CCR5
SO SCIENCE
LA English
DT Article
ID T-CELLS; CHEMOKINES; CCR5-DELTA-32; TUBERCULOSIS; IMMUNITY
AB An effective host immune response to mycobacterial infection must control pathogen dissemination without inducing immunopathology. Constitutive overexpression of mycobacterial heat shock protein (myHsp70) is associated with impaired bacterial persistence, but the immune-mediated mechanisms are unknown. We found that myHsp70, in addition to enhancing antigen delivery to human dendritic cells, signaled through the CCR5 chemokine receptor, promoting dendritic cell aggregation, immune synapse formation between dendritic cells and T cells, and the generation of effector immune responses. Thus, CCR5 acts as a pattern-recognition receptor for myHsp70, which may have implications for both the pathophysiology of tuberculosis and the use of myHsps in tumor-directed immunotherapy.
C1 Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Cambridge CB2 XY, England.
   Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Program Immunol, Singapore 117597, Singapore.
   Nanyang Technol Univ, Sch Biol Sci, Div Cell & Mol Biol, Singapore, Singapore.
   Univ London Imperial Coll Sci Technol & Med, Dept Paediat, London SW7 2AZ, England.
   Univ London Imperial Coll Sci Technol & Med, Wellcome Ctr Clin Trop Med, London SW7 2AZ, England.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Nuffield Dept Med, Oxford OX1 3SY, England.
   Lionex Diagnost & Therapeut GmbH, D-38124 Braunschweig, Germany.
RP Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med, Hills Rd, Cambridge CB2 XY, England.
EM pjl30@cam.ac.uk
RI Tan, Suet/A-2224-2011; Day, Cheryl L/J-9844-2012; Houben, Edith
   N.G./B-2110-2015
OI Day, Cheryl L/0000-0002-6497-4846; Houben, Edith
   N.G./0000-0002-8805-2002; Tan, Suet-Mien/0000-0003-2371-8739; Lehner,
   Paul Joseph/0000-0001-9383-1054; MacAry, Paul/0000-0002-1139-8996;
   Smith, Kenneth/0000-0003-3829-4326; Pieters, Jean/0000-0002-5284-9757;
   Boname, Jessica/0000-0002-5149-5934
FU Medical Research CouncilMedical Research Council UK (MRC) [G0600823,
   G108/485, G9800943] Funding Source: Medline; Wellcome TrustWellcome
   Trust [077273] Funding Source: Medline
CR Alberti J, 2003, NAT IMMUNOL, V4, P485, DOI 10.1038/ni915
   Baba M, 1999, P NATL ACAD SCI USA, V96, P5698, DOI 10.1073/pnas.96.10.5698
   Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603
   Bodnar KA, 2001, INFECT IMMUN, V69, P800, DOI 10.1128/IAI.69.2.800-809.2001
   Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651
   Cyster JG, 2005, ANNU REV IMMUNOL, V23, P127, DOI 10.1146/annurev.immunol.23.021704.115628
   de Silva E, 2004, FEMS MICROBIOL LETT, V241, P1, DOI 10.1016/j.femsle.2004.09.040
   Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0
   Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057
   Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305
   Kampmann B, 2000, J INFECT DIS, V182, P895, DOI 10.1086/315766
   Luther SA, 2001, NAT IMMUNOL, V2, P102, DOI 10.1038/84205
   MacAry PA, 2004, IMMUNITY, V20, P95, DOI 10.1016/S1074-7613(03)00357-1
   Nieto M, 1997, J EXP MED, V186, P153, DOI 10.1084/jem.186.1.153
   Revy P, 2001, NAT IMMUNOL, V2, P925, DOI 10.1038/ni713
   Srivastava P, 2002, ANNU REV IMMUNOL, V20, P395, DOI 10.1146/annurev.immunol.20.100301.064801
   Wang YF, 2002, J IMMUNOL, V169, P2422, DOI 10.4049/jimmunol.169.5.2422
NR 20
TC 121
Z9 130
U1 0
U2 9
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 20
PY 2006
VL 314
IS 5798
BP 454
EP 458
DI 10.1126/science.1133515
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 096MW
UT WOS:000241382500039
PM 17053144
DA 2021-01-25
ER

PT J
AU Millevoi, S
   Loulergue, C
   Dettwiler, S
   Karaa, SZ
   Keller, W
   Antoniou, M
   Vagner, S
AF Millevoi, Stefania
   Loulergue, Clarisse
   Dettwiler, Sabine
   Karaa, Sarah Zeineb
   Keller, Walter
   Antoniou, Michael
   Vagner, Stephan
TI An interaction between U2AF 65 and CFIm links the splicing and 3 ' end
   processing machineries
SO EMBO JOURNAL
LA English
DT Article
DE cleavage factor I; mRNA 3 ' processing; polyadenylation; splicing; U2AF
ID PRE-MESSENGER-RNA; FACTOR-I-M; VERTEBRATE POLY(A) POLYMERASE;
   LAST-INTRON REMOVAL; PROTEIN INTERACTIONS; PROTEOMIC ANALYSIS;
   CARBOXYL-TERMINUS; 3-END FORMATION; U1 SNRNP; POLYADENYLATION
AB The protein factor U2 snRNP Auxiliary Factor (U2AF) 65 is an essential component required for splicing and involved in the coupling of splicing and 30 end processing of vertebrate pre-mRNAs. Here we have addressed the mechanisms by which U2AF 65 stimulates pre-mRNA 30 end processing. We identify an arginine/serine-rich region of U2AF 65 that mediates an interaction with an RS-like alternating charge domain of the 59 kDa subunit of the human cleavage factor I (CF I-m), an essential 30 processing factor that functions at an early step in the recognition of the 30 end processing signal. Tethered functional analysis shows that the U2AF 65/CF I-m 59 interaction stimulates in vitro 30 end cleavage and polyadenylation. These results therefore uncover a direct role of the U2AF 65/CF I-m 59 interaction in the functional coordination of splicing and 30 end processing.
C1 Inst Claudius Regaud, INSERM, U563, F-31052 Toulouse, France.
   Univ Toulouse 3, F-31062 Toulouse, France.
   Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet,Nucl Biol Grp, London, England.
   Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Vagner, S (corresponding author), Inst Claudius Regaud, INSERM, U563, 20-24 Rue Pont St Pierre, F-31052 Toulouse, France.
EM Vagner@toulouse.inserm.fr
RI Millevoi, Stefania/M-7244-2014; Vagner, Stephan/G-3664-2013
OI Millevoi, Stefania/0000-0003-1659-3552; vagner,
   stephan/0000-0003-1452-7164
CR Antoniou M, 1998, NUCLEIC ACIDS RES, V26, P721, DOI 10.1093/nar/26.3.721
   Bauren G, 1998, GENE DEV, V12, P2759, DOI 10.1101/gad.12.17.2759
   Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501
   BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411
   Blanchette M, 2004, MOL CELL, V14, P775, DOI 10.1016/j.molcel.2004.06.012
   BOELENS WC, 1993, CELL, V72, P881, DOI 10.1016/0092-8674(93)90577-D
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755
   Cooke C, 1999, MOL CELL BIOL, V19, P4971
   Cooke C, 1996, MOL CELL BIOL, V16, P2579
   Cooke C, 2002, MOL CELL BIOL, V22, P4579, DOI 10.1128/MCB.22.13.4579-4586.2002
   Custodio N, 1999, EMBO J, V18, P2855, DOI 10.1093/emboj/18.10.2855
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475
   GamaCarvalho M, 1997, J CELL BIOL, V137, P975, DOI 10.1083/jcb.137.5.975
   Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960
   Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761
   Hertel KJ, 1997, CURR OPIN CELL BIOL, V9, P350, DOI 10.1016/S0955-0674(97)80007-5
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Kielkopf CL, 2001, CELL, V106, P595, DOI 10.1016/S0092-8674(01)00480-9
   Kim H, 2001, BIOCHEM BIOPH RES CO, V289, P513, DOI 10.1006/bbrc.2001.5992
   Ko B, 2002, J MOL BIOL, V318, P1189, DOI 10.1016/S0022-2836(02)00240-1
   Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a
   Millevoi S, 2002, EMBO REP, V3, P869, DOI 10.1093/embo-reports/kvf173
   Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0
   NESIC D, 1995, MOL CELL BIOL, V15, P488, DOI 10.1128/MCB.15.1.488
   NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363
   NESIC D, 1993, MOL CELL BIOL, V13, P3359, DOI 10.1128/MCB.13.6.3359
   NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552
   NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086
   Philipps D, 2003, NUCLEIC ACIDS RES, V31, P6502, DOI 10.1093/nar/gkg845
   Rappsilber J, 2002, GENOME RES, V12, P1231, DOI 10.1101/gr.473902
   Reed R, 2000, CURR OPIN CELL BIOL, V12, P340, DOI 10.1016/S0955-0674(00)00097-1
   Rudner DZ, 1998, MOL CELL BIOL, V18, P1765, DOI 10.1128/MCB.18.4.1765
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8
   Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2
   Takagaki Y, 2000, MOL CELL BIOL, V20, P1515, DOI 10.1128/MCB.20.5.1515-1525.2000
   Vagner S, 2000, GENE DEV, V14, P403
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647
   ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243
   Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031
NR 44
TC 120
Z9 126
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD OCT 18
PY 2006
VL 25
IS 20
BP 4854
EP 4864
DI 10.1038/sj.emboj.7601331
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 104VY
UT WOS:000241989900015
PM 17024186
OA Green Published
DA 2021-01-25
ER

PT J
AU Dames, SA
   Aregger, R
   Vajpai, N
   Bernado, P
   Blackledge, M
   Grzesiek, S
AF Dames, Sonja Alexandra
   Aregger, Regula
   Vajpai, Navratna
   Bernado, Pau
   Blackledge, Martin
   Grzesiek, Stephan
TI Residual dipolar couplings in short peptides reveal systematic
   conformational preferences of individual amino acids
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID 8 M UREA; LONG-RANGE; POLYACRYLAMIDE GELS; C-ALPHA; NMR; ALIGNMENT;
   PROTEINS; STATE; MODEL
AB Residual dipolar couplings (RDCs) observed by NMR in solution under weak alignment conditions can monitor average net orientations and order parameters of individual bonds. By their simple geometrical dependence, RDCs bear particular promise for the quantitative characterization of conformations in partially folded or unfolded proteins. We have systematically investigated the influence of amino acid substitutions X on the conformation of unfolded model peptides EGAAXAASS as monitored by their H-1(N)-N-15 and H-1(alpha)-C-13(alpha) RDCs detected at natural abundance of N-15 and C-13 in strained polyacrylamide gels. In total, 14 single amino acid substitutions were investigated. The RDCs show a specific dependence on the substitution X that correlates to steric or hydrophobic interactions with adjacent amino acids. In particular, the RDCs for the glycine and proline substitutions indicate less or more order, respectively, than the other amino acids. The RDCs for aromatic substitutions tryptophane and tyrosine give evidence of a kink in the peptide backbone. This effect is also observable for orientation by Pf1 phages and corroborated by variations in C-13(alpha) secondary shifts and (3)J(HNH alpha) scalar couplings in isotropic samples. RDCs for a substitution with the beta-turn sequence KNGE differ from single amino acid substitutions. Terminal effects and next neighbor effects could be demonstrated by further specific substitutions. The results were compared to statistical models of unfolded peptide conformations derived from PDB coil subsets, which reproduce overall trends for H-1(N)-N-15 RDCs for most substitutions, but deviate more strongly for H-1(alpha)-C-13(alpha) RDCs. The outlined approach opens the possibility to obtain a systematic experimental characterization of the influence of individual amino acid/amino acid interactions on orientational preferences in polypeptides.
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Inst Biol Struct Jean Pierre Ebel, Grenoble, France.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Bernado, Pau/F-9643-2013
OI Dames, Sonja/0000-0001-7495-6943; Grzesiek, Stephan/0000-0003-1998-4225;
   Bernado, Pau/0000-0001-7395-5922
CR Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   Doruker P, 1999, J PHYS CHEM B, V103, P178, DOI 10.1021/jp983308+
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Fredriksson K, 2004, J AM CHEM SOC, V126, P12646, DOI 10.1021/ja048287d
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Jensen P, 2004, J BIOMOL NMR, V30, P443, DOI 10.1007/s10858-004-5318-0
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   LEVITT M, 1976, J MOL BIOL, V104, P59, DOI 10.1016/0022-2836(76)90004-8
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Louhivuori M, 2004, J BIOMOL NMR, V29, P517, DOI 10.1023/B:JNMR.0000034347.01925.ad
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Ohnishi S, 2003, PROTEINS, V50, P546, DOI 10.1002/prot.10327
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 27
TC 46
Z9 46
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 18
PY 2006
VL 128
IS 41
BP 13508
EP 13514
DI 10.1021/ja063606h
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 093GZ
UT WOS:000241157600046
PM 17031964
DA 2021-01-25
ER

PT J
AU Paulillo, SM
   Powers, MA
   Ullman, KS
   Fahrenkrog, B
AF Paulillo, Sara M.
   Powers, Maureen A.
   Ullman, Katharine S.
   Fahrenkrog, Birthe
TI Changes in nucleoporin domain topology in response to chemical effectors
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE nuclear pore complex; nuclear transport; calcium; Nup153; Nup214
ID NUCLEAR-PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; CRYOELECTRON
   TOMOGRAPHY; CONFORMATIONAL-CHANGES; CA2+ STORES; CALCIUM; ARCHITECTURE;
   IMPORT; DEPLETION; MICROSCOPY
AB Nucleoporins represent the molecular building blocks of nuclear pore complexes (NPCs), which mediate facilitated macromolecular trafficking between the cytoplasm and nucleus of eukaryotic cells. Phenylalanineglycine (FG) repeat motifs are found in about one-third of the nucleoporins, and they provide major binding or docking sites for soluble transport receptors. We have shown recently that localization of the FG-repeat domains of vertebrate nucleoporins Nup153 and Nup214 within the NPC is influenced by its transport state. To test whether chemical effectors, such as calcium and ATP, influence the localization of the FG-repeat domains of Nup153 and Nup214 within the NPC, we performed immuno-electron microscopy of Xenopus oocyte nuclei using domain-specific antibodies against Nup153 and Nup214, respectively. Ca2+ and ATP are known to induce conformational changes in the NPC architecture, especially at the cytoplasmic face, but also at the nuclear basket of the NPC. We have found concentrations of calcium in the micromolar range or I MM ATP in the surrounding buffer leaves the spatial distribution of the FG-repeat of Nup153 and Nup214 largely unchanged. In contrast, ATP depletion, calcium store depletion by EGTA or thapsigargin, and high concentrations of divalent cation (i.e. 2 mM Ca2+ and 2 mM Mg2+) constrain the distribution of the FG-repeats of Nup153 and Nup214. Our data suggest that the location of the FG-repeat domains of Nup153 and Nup214 is sensitive to chemical changes within the near-field enviromnent of the NPC. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.
   Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Ullman,
   Katharine/0000-0003-3693-2830
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM061275,
   R01GM061275, R01GM061275, R01GM059975, R01GM059975, R01GM059975,
   R01GM061275, R01GM059975, R01GM059975, R01GM061275, R01GM059975,
   R01GM061275, R01GM061275, R01GM061275, R01GM059975, R01GM061275,
   R01GM059975, R01GM061275, R01GM059975, R01GM061275, R01GM061275,
   R01GM061275, R01GM059975, R01GM061275] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM59975, GM61275, R01 GM059975, R01
   GM061275-07, R01 GM061275] Funding Source: Medline
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   Assandri R, 1997, J MEMBRANE BIOL, V157, P301, DOI 10.1007/s002329900237
   BANHEGYI G, 1993, BIOCHEM J, V292, P99, DOI 10.1042/bj2920099
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Erickson ES, 2004, BIOPHYS CHEM, V112, P1, DOI 10.1016/j.bpc.2004.06.010
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Feja B, 1999, J MICROSC-OXFORD, V193, P15, DOI 10.1046/j.1365-2818.1999.00436.x
   FRANK J, 1988, TRENDS BIOCHEM SCI, V13, P123, DOI 10.1016/0968-0004(88)90063-1
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Gerasimenko O, 2004, J CELL SCI, V117, P3087, DOI 10.1242/jcs.01295
   Goldberg MW, 2000, J MOL BIOL, V300, P519, DOI 10.1006/jmbi.2000.3891
   GREBER UF, 1995, J CELL BIOL, V128, P5, DOI 10.1083/jcb.128.1.5
   Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Jaggi RD, 2003, BIOPHYS J, V84, P665
   Kao YS, 2004, J BIOMED SCI, V11, P206, DOI 10.1159/000076033
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   MALIS T, 1988, J ELECTRON MICR TECH, V8, P193, DOI 10.1002/jemt.1060080206
   Moore-Nichols D, 2002, BIOPHYS J, V83, P1421, DOI 10.1016/S0006-3495(02)73913-1
   Mooren OL, 2004, PHYS BIOL, V1, P125, DOI 10.1088/1478-3967/1/2/008
   NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091
   NEWMEYER DD, 1988, CELL, V52, P641, DOI 10.1016/0092-8674(88)90402-3
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x
   PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875
   Petersen OH, 1998, CELL CALCIUM, V23, P87, DOI 10.1016/S0143-4160(98)90106-3
   Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184
   Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   STEHNOBITTEL L, 1995, SCIENCE, V270, P1835, DOI 10.1126/science.270.5243.1835
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strubing C, 1999, J GEN PHYSIOL, V113, P239, DOI 10.1085/jgp.113.2.239
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   Waldron RT, 1997, J BIOL CHEM, V272, P6440, DOI 10.1074/jbc.272.10.6440
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
NR 48
TC 26
Z9 27
U1 0
U2 2
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 13
PY 2006
VL 363
IS 1
BP 39
EP 50
DI 10.1016/j.jmb.2006.08.021
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 094PB
UT WOS:000241250300005
PM 16962132
DA 2021-01-25
ER

PT J
AU Basle, A
   Rummel, G
   Storici, P
   Rosenbusch, JP
   Schirmer, T
AF Basle, Arnaud
   Rummel, Gabriele
   Storici, Paola
   Rosenbusch, Juerg P.
   Schirmer, Tilman
TI Crystal structure of osmoporin OmpC from E-coli at 2.0 angstrom
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE porin; osmoporin; OmpC; outer membrane; crystal structure
ID OUTER-MEMBRANE PERMEABILITY; ELECTRON-DENSITY MAPS; PORIN CHANNELS;
   DYNAMICS SIMULATION; MOLECULAR-DYNAMICS; BROWNIAN DYNAMICS; EXPRESSION;
   MUTANTS; GENES; MECHANISM
AB Porins form transmembrane pores in the outer membrane of Gram-negative bacteria with matrix porin OmpF and osmoporin OmpC from Escherichia coli being differentially expressed depending on environmental conditions. The three-dimensional structure of OmpC has been determined to 2.0 angstrom resolution by X-ray crystallography. As expected from the high sequence similarity, OmpC adopts the OmpF-like 16-stranded hollow beta-barrel fold with three beta-barrels associated to form a tight trimer. Unlike in OmpF, the extracellular loops form a continuous wall at the perimeter of the vestibule common to the three pores, due to a 14-residues insertion in loop L4. The pore constriction and the periplasmic outlet are very similar to OmpF with 74% of the pore lining residues being conserved. Overall, only few ionizable residues are exchanged at the pore lining. The OmpC structure suggests that not pore size, but electrostatic pore potential and particular atomic details of the pore linings are the critical parameters that physiologically distinguish OmpC from OmpF. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
OI storici, paola/0000-0002-2590-3332
CR Baalaji NS, 2005, ACTA CRYSTALLOGR F, V61, P773, DOI 10.1107/S1744309105022086
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Batchelor E, 2005, J BACTERIOL, V187, P5723, DOI 10.1128/JB.187.16.5723-5731.2005
   Begic S, 2006, MICROBIOL-SGM, V152, P485, DOI 10.1099/mic.0.28428-0
   BENSON SA, 1988, J MOL BIOL, V203, P961, DOI 10.1016/0022-2836(88)90121-0
   BUEHLER LK, 1991, J BIOL CHEM, V266, P24446
   Castillo-Keller M, 2006, J BACTERIOL, V188, P576, DOI 10.1128/JB.188.2.576-586.2006
   Chen S, 2004, J BACTERIOL, V186, P6689, DOI 10.1128/JB.186.20.6689-6697.2004
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   DELANO WL, PHYMOL MOL GRAPHIC S
   Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132
   Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   GARAVITO RM, 1986, METHOD ENZYMOL, V125, P309
   GEHRING KB, 1989, J BIOL CHEM, V264, P2810
   HARDER KJ, 1981, ANTIMICROB AGENTS CH, V20, P549, DOI 10.1128/AAC.20.4.549
   Hernandez-Alles S, 1999, MICROBIOL-UK, V145, P673, DOI 10.1099/13500872-145-3-673
   HEYDE M, 1987, MOL GEN GENET, V208, P511, DOI 10.1007/BF00328148
   Im W, 2002, J MOL BIOL, V322, P851, DOI 10.1016/S0022-2836(02)00778-7
   Im W, 2002, J MOL BIOL, V319, P1177, DOI 10.1016/S0022-2836(02)00380-7
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KARSHIKOFF A, 1994, J MOL BIOL, V240, P372, DOI 10.1006/jmbi.1994.1451
   Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983
   LAKEY JH, 1991, FEBS LETT, V278, P31, DOI 10.1016/0014-5793(91)80076-F
   Liu XQ, 2001, MICROBIOL-SGM, V147, P2981, DOI 10.1099/00221287-147-11-2981
   Liu XQ, 1998, J BACTERIOL, V180, P3917, DOI 10.1128/JB.180.15.3917-3922.1998
   Low AS, 2001, MOL MICROBIOL, V42, P619, DOI 10.1046/j.1365-2958.2001.02647.x
   MATSUYAMA S, 1984, J BACTERIOL, V158, P1041, DOI 10.1128/JB.158.3.1041-1047.1984
   MISRA R, 1988, J BACTERIOL, V170, P528, DOI 10.1128/jb.170.2.528-533.1988
   MIZUNO T, 1984, P NATL ACAD SCI-BIOL, V81, P1966, DOI 10.1073/pnas.81.7.1966
   NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   NOGAMI T, 1985, J BACTERIOL, V164, P797, DOI 10.1128/JB.164.2.797-801.1985
   OVERBEEKE N, 1980, FEBS LETT, V112, P229, DOI 10.1016/0014-5793(80)80186-4
   PAGES JM, 2004, BACTERIAL EUKARYOTIC, P41
   Phale PS, 1998, BIOCHEMISTRY-US, V37, P15663, DOI 10.1021/bi981215c
   Phale PS, 2001, BIOCHEMISTRY-US, V40, P6319, DOI 10.1021/bi010046k
   Philippsen A., 2002, DINO VISUALIZING STR
   Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x
   Prilipov A, 1998, J BACTERIOL, V180, P3388, DOI 10.1128/JB.180.13.3388-3392.1998
   SCHIEPEK G, 1995, PSYCHOTHERAPIE FORUM, V3, P1
   Schirmer T, 1998, J STRUCT BIOL, V121, P101, DOI 10.1006/jsbi.1997.3946
   Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Varma S, 2004, BIOPHYS J, V86, P690, DOI 10.1016/S0006-3495(04)74148-X
   Walthers D, 2004, BACTERIAL EUKARYOTIC, P1
   YOSHIMURA F, 1985, ANTIMICROB AGENTS CH, V27, P84, DOI 10.1128/AAC.27.1.84
NR 47
TC 142
Z9 144
U1 2
U2 19
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 6
PY 2006
VL 362
IS 5
BP 933
EP 942
DI 10.1016/j.jmb.2006.08.002
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 095RF
UT WOS:000241324800006
PM 16949612
DA 2021-01-25
ER

PT J
AU Meier, M
   Blatter, XL
   Seelig, A
   Seelig, J
AF Meier, M.
   Blatter, X. Li
   Seelig, A.
   Seelig, J.
TI Interaction of verapamil with lipid membranes and P-glycoprotein:
   Connecting thermodynamics and membrane structure with functional
   activity
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID NUCLEAR MAGNETIC-RESONANCE; CYTOCHROME-C-OXIDASE; FATTY ACYL CHAINS;
   HEAD GROUP; PHOSPHOLIPID-MEMBRANES; MULTIDRUG TRANSPORTER; ATPASE
   ACTIVITY; DRUG TRANSPORT; DEUTERIUM; BILAYERS
AB Verapamil and amlodipine are calcium ion influx inhibitors of wide clinical use. They are partially charged at neutral pH and exhibit amphiphilic properties. The noncharged species can easily cross the lipid membrane. We have measured with solid-state NMR the structural changes induced by verapamil upon incorporation into phospholipid bilayers and have compared them with earlier data on amlodipine and nimodipine. Verapamil and amlodipine produce a rotation of the phosphocholine headgroup away from the membrane surface and a disordering of the fatty acid chains. We have determined the thermodynamics of verapamil partitioning into neutral and negatively charged membranes with isothermal titration calorimetry. Verapamil undergoes a pK-shift of Delta pK(a) = 1.2 units in neutral lipid membranes and the percentage of the noncharged species increases from 5% to 45%. Verapamil partitioning is increased for negatively charged membranes and the binding isotherms are strongly affected by the salt concentration. The electrostatic screening can be explained with the Gouy-Chapman theory. Using a functional phosphate assay we have measured the affinity of verapamil, amlodipine, and nimodipine for P-glycoprotein, and have calculated the free energy of drug binding from the aqueous phase to the active center of P-glycoprotein in the lipid phase. By combining the latter results with the lipid partitioning data it was possible, for the first time, to determine the true affinity of the three drugs for the P-glycoprotein active center if the reaction takes place exclusively in the lipid matrix.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
EM seelig@unibas.ch
RI Meier, Matthias/C-6917-2013
CR Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504
   AVEYARD R, 1973, CAMBRIDGE CHEM TESTS
   BAUERLE HD, 1991, BIOCHEMISTRY-US, V30, P7203, DOI 10.1021/bi00243a023
   BIENVENUE A, 1982, J BIOL CHEM, V257, P3032
   Biltonen R L, 1979, Methods Enzymol, V61, P287
   BLUME A, 1982, BIOCHEMISTRY-US, V21, P6230, DOI 10.1021/bi00267a031
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0
   Eytan GD, 1996, J BIOL CHEM, V271, P12897, DOI 10.1074/jbc.271.22.12897
   Ferte J, 2000, EUR J BIOCHEM, V267, P277, DOI 10.1046/j.1432-1327.2000.01046.x
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FLOGEL M, 1975, BIOCHEMISTRY-US, V14, P2610, DOI 10.1021/bi00683a008
   GALLY HU, 1975, BIOCHEMISTRY-US, V14, P3647, DOI 10.1021/bi00687a021
   GALLY HU, 1976, H-S Z PHYSIOL CHEM, V357, P1447
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   GEREBTZOFF G, 2006, IN PRESS J CHEM INF
   Goldberg RN, 2002, J PHYS CHEM REF DATA, V31, P231, DOI 10.1063/1.1416902
   HABERKORN RA, 1977, J AM CHEM SOC, V99, P7353, DOI 10.1021/ja00464a043
   HASEGAWA J, 1984, J PHARM SCI, V73, P442, DOI 10.1002/jps.2600730405
   Heerklotz H, 2004, J PHYS CHEM B, V108, P4909, DOI 10.1021/jp0371938
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   KASS RS, 1989, AM J CARDIOL, V64, P35
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1327.2001.02041.x
   Macho V, 2001, APPL MAGN RESON, V20, P405, DOI 10.1007/BF03162288
   MARTIN BR, 1964, INTRO BIOPHYS CHEM
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   MORIN PE, 1991, BIOCHEMISTRY-US, V30, P8494, DOI 10.1021/bi00098a030
   OLDFIELD E, 1978, BIOCHEMISTRY-US, V17, P2727, DOI 10.1021/bi00607a006
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   Pohl EE, 1998, BBA-BIOMEMBRANES, V1373, P170, DOI 10.1016/S0005-2736(98)00098-4
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Sauna ZE, 2004, BIOCHEMISTRY-US, V43, P2262, DOI 10.1021/bi035965k
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG A, 2002, ENCY PHYS SCI TECHNO
   SEELIG J, 1981, BIOCHEMISTRY-US, V20, P3922, DOI 10.1021/bi00516a040
   SEELIG J, 1978, BIOCHEMISTRY-US, V17, P3310, DOI 10.1021/bi00609a021
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   SHEPHERD JCW, 1978, BIOCHIM BIOPHYS ACTA, V514, P83, DOI 10.1016/0005-2736(78)90078-0
   TAMM LK, 1983, BIOCHEMISTRY-US, V22, P1474, DOI 10.1021/bi00275a023
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
NR 49
TC 42
Z9 42
U1 0
U2 10
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD OCT
PY 2006
VL 91
IS 8
BP 2943
EP 2955
DI 10.1529/biophysj.106.089581
PG 13
WC Biophysics
SC Biophysics
GA 086VI
UT WOS:000240700700023
PM 16877510
OA Green Published
DA 2021-01-25
ER

PT J
AU Lill, Y
   Lill, MA
   Fahrenkrog, B
   Schwarz-Herion, K
   Paulillo, S
   Aebi, U
   Hecht, B
AF Lill, Yoriko
   Lill, Markus A.
   Fahrenkrog, Birthe
   Schwarz-Herion, Kyrill
   Paulillo, Sara
   Aebi, Ueli
   Hecht, Bert
TI Single hepatitis-B virus core capsid binding to individual nuclear pore
   complexes in HeLa cells
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PARTICLE TRACKING; DIFFUSION; ARCHITECTURE; TRANSPORT; DOMAINS; SURFACE;
   IMPORT
AB We investigate the interaction of hepatitis B virus capsids lacking a nuclear localization signal with nuclear pore complexes (NPCs) in permeabilized HeLa cells. Confocal and wide-field optical images of the nuclear envelope show well-spaced individual NPCs. Specific interactions of capsids with single NPCs are characterized by extended residence times of capsids in the focal volume which are characterized by fluorescence correlation spectroscopy. In addition, single-capsid-tracking experiments using fast wide-field fluorescence microscopy at 50 frames/s allow us to directly observe specific binding via a dual-color colocalization of capsids and NPCs. We find that binding occurs with high probability on the nuclear-pore ring moiety, at 44 +/- 9 nm radial distance from the central axis.
C1 Univ Basel, Inst Phys, Nanoopt Grp, Natl Competence Ctr Res Nanoscale Sci, CH-4056 Basel, Switzerland.
   Univ Basel, Biograph Lab 3R, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Mol Pharm, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
RP Hecht, B (corresponding author), Univ Basel, Inst Phys, Nanoopt Grp, Natl Competence Ctr Res Nanoscale Sci, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM bert.hecht@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011; Lill, Markus A/E-5118-2017; Hecht,
   Bert/B-4996-2010
OI Lill, Markus A/0000-0003-3023-5188; Hecht, Bert/0000-0002-4883-8676;
   Fahrenkrog, Birthe/0000-0003-4080-9413
CR ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807
   ARNHEITER H, 1985, CELL, V41, P259, DOI 10.1016/0092-8674(85)90079-0
   Babcock HP, 2004, BIOPHYS J, V87, P2749, DOI 10.1529/biophysj.104.042234
   BASCHE T, 1999, SINGLE MOL OPTICAL D
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2
   Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45
   Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915
   Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005
   KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0
   Lommerse PHM, 2004, BIOPHYS J, V86, P609, DOI 10.1016/S0006-3495(04)74139-9
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100
   Rigler R., 2001, SINGLE MOL SPECTROSC
   Sako Y, 2000, NAT CELL BIOL, V2, P168
   Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193
   Saxton MJ, 1996, BIOPHYS J, V70, P1250, DOI 10.1016/S0006-3495(96)79682-0
   Schmidt T, 1996, P NATL ACAD SCI USA, V93, P2926, DOI 10.1073/pnas.93.7.2926
   Schutz G. J., 2000, Single Molecules, V1, P153, DOI 10.1002/1438-5171(200006)1:2<153::AID-SIMO153>3.3.CO;2-J
   Schutz GJ, 2000, EMBO J, V19, P892, DOI 10.1093/emboj/19.5.892
   Seisenberger G, 2001, SCIENCE, V294, P1929, DOI 10.1126/science.1064103
   Steven AC, 2005, ADV VIRUS RES, V64, P125, DOI 10.1016/S0065-3527(05)64005-5
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Uppenbrink J, 1999, SCIENCE, V283, P1667, DOI 10.1126/science.283.5408.1667
   Vrljic M, 2002, BIOPHYS J, V83, P2681, DOI 10.1016/S0006-3495(02)75277-6
   Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101
NR 29
TC 12
Z9 12
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD OCT
PY 2006
VL 91
IS 8
BP 3123
EP 3130
DI 10.1529/biophysj.106.087650
PG 8
WC Biophysics
SC Biophysics
GA 086VI
UT WOS:000240700700039
PM 16877503
OA Green Published
DA 2021-01-25
ER

PT J
AU Martin, DE
   Powers, T
   Hall, MN
AF Martin, Dietmar E.
   Powers, Ted
   Hall, Michael N.
TI Regulation of ribosome biogenesis: where is TOR?
SO CELL METABOLISM
LA English
DT Editorial Material
ID SACCHAROMYCES-CEREVISIAE; GROWTH; LOCALIZATION; RAPAMYCIN; NETWORK;
   KINASES; SIGNAL; TARGET; RNA
AB Li et al. (2006) have shown that TOR complex 1 in yeast binds directly to the rDNA promoter and thereby activates Pol 1-dependent synthesis of 35S RNA. This is an important advance in the understanding of how ribosome biogenesis is regulated in response to environmental conditions.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Calif Davis, Coll Biol Sci, Davis, CA 95616 USA.
RP Martin, DE (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Hall, Michael N/0000-0002-2998-0757
CR Bachmann RA, 2006, J BIOL CHEM, V281, P7357, DOI 10.1074/jbc.M512218200
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Laferte A, 2006, GENE DEV, V20, P2030, DOI 10.1101/gad.386106
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008
   Moss T, 2004, CURR OPIN GENET DEV, V14, P210, DOI 10.1016/j.gde.2004.02.005
   Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 12
TC 36
Z9 37
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD OCT
PY 2006
VL 4
IS 4
BP 259
EP 260
DI 10.1016/j.cmet.2006.09.002
PG 2
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 093QG
UT WOS:000241182900002
PM 17011497
DA 2021-01-25
ER

PT J
AU Polak, P
   Hall, MN
AF Polak, Pazit
   Hall, Michael N.
TI mTORC2 caught in a SINful Akt
SO DEVELOPMENTAL CELL
LA English
DT Editorial Material
ID PHOSPHORYLATION; CYTOSKELETON; AKT/PKB; GROWTH; RICTOR
AB The target of rapamycin (TOR), a central controller of cell growth, is found in two distinct, highly conserved multiprotein complexes. Three recent papers in Cell (Jacinto et al., 2006), Developmental Cell (Shiota et al., 2006; this issue), and Current Biology (Frias et al., 2006) shed light on mTOR complex 2 (mTORC2) composition and in vivo function. An important new finding is that mTORC2 determines Akt/PKB substrate specificity rather than absolute activity.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Polak, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI Hall, Michael N/0000-0002-2998-0757
CR Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   JACINTO E, 2006, IN PRESS CELL, V127
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 10
TC 40
Z9 40
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 1534-5807
J9 DEV CELL
JI Dev. Cell
PD OCT
PY 2006
VL 11
IS 4
BP 433
EP 434
DI 10.1016/j.devcel.2006.09.005
PG 2
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 092UR
UT WOS:000241123300002
PM 17011481
DA 2021-01-25
ER

PT J
AU Knechtle, P
   Wendland, J
   Philippsen, P
AF Knechtle, Philipp
   Wendland, Juergen
   Philippsen, Peter
TI The SH3/PH domain protein AgBoi1/2 collaborates with the Rho-type GTPase
   AgRho3 to prevent nonpolar growth at hyphal tips of Ashbya gossypii
SO EUKARYOTIC CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE GENOME; CELL POLARITY; BUDDING YEAST; ACTIN
   CYTOSKELETON; FILAMENTOUS FUNGI; FISSION YEAST; HOST STRAINS;
   MORPHOGENESIS; MECHANISM; ESTABLISHMENT
AB Unlike most other cells, hyphae of filamentous fungi permanently elongate and lack nonpolar growth phases. We identified AgBoil/2p in the filamentous ascomycete Ashbya gossypii as a component required to prevent nonpolar growth at hyphal tips. Strains lacking AgBoil/2p frequently show spherical enlargement at hyphall tips with concomitant depolarization of actin patches and loss of tip-located actin cables. These enlarged tips can repolarize and resume hyphall tip extension in the previous polarity axis. AgBoil/2p permanently localizes to hyphal tips and transiently to sites of septation. Only the tip localization is important for sustained elongation of hyphae. In a yeast two-hybrid experiment, we identified the Rho-type GTPase AgRho3p as an interactor of AgBoil/2p. AgRho3p is also required to prevent nonpolar growth at hyphal tips, and strains deleted for both AgBOI1/2 and AgRHO3 phenocopied the respective single-deletion strains, demonstrating that AgBoi1/2p and AgRho3p function in a common pathway. Monitoring the polarisome of growing hyphae using AgSpa2p fused to the green fluorescent protein as a marker, we found that polarisome disassembly precedes the onset of nonpolar growth in strains lacking AgBoil/2p or AgRho3p. AgRho3p locked in its GTP-bound form interacts with the Rho-binding domain of the polarisome-associated formin AgBni1p, implying that AgRho3p has the capacity to directly activate formin-driven actin cable nucleation. We conclude that AgBoil/2p and AgRho3p support polarisome-mediated actin cable formation at hyphal tips, thereby ensuring permanent polar tip growth.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Knechtle, Philipp/0000-0003-0377-9446; Wendland,
   Juergen/0000-0001-8350-253X
CR Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121
   Adams A., 1998, METHODS YEAST GENETI
   Akada R, 1997, MOL GEN GENET, V254, P267, DOI 10.1007/s004380050415
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399
   Bauer Y, 2004, MOL BIOL CELL, V15, P4622, DOI 10.1091/mbc.E04-02-0104
   BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295
   Bender L, 1996, J CELL BIOL, V133, P879, DOI 10.1083/jcb.133.4.879
   Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948
   BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0
   Boyce KJ, 2005, MOL MICROBIOL, V55, P1487, DOI 10.1111/j.1365-2958.2005.04485.x
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   CHANG EC, 1994, CELL, V79, P131, DOI 10.1016/0092-8674(94)90406-5
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040
   Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7
   Esser K., 1994, MYCOTA COMPREHENSIVE
   Evangelista Marie, 2002, Nature Cell Biology, V4, P260
   Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221
   FUKUI Y, 1988, MOL GEN GENET, V215, P26, DOI 10.1007/BF00331298
   Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   Hallett MA, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-16
   Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007
   Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005
   Hermida L, 2005, NUCLEIC ACIDS RES, V33, pD348, DOI 10.1093/nar/gki009
   James P, 1996, GENETICS, V144, P1425
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310
   Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101
   Matsui Y, 1996, J CELL BIOL, V133, P865, DOI 10.1083/jcb.133.4.865
   Mayer BJ, 2001, J CELL SCI, V114, P1253
   Momany M, 1999, GENETICS, V151, P557
   Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5
   Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150
   Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045
   Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021
   Pruyne D, 2000, J CELL SCI, V113, P571
   Rebecchi MJ, 1998, ANNU REV BIOPH BIOM, V27, P503, DOI 10.1146/annurev.biophys.27.1.503
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Roumanie O, 2005, J CELL BIOL, V170, P583, DOI 10.1083/jcb.200504108
   Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433
   Shaw BD, 2002, FUNGAL GENET BIOL, V37, P263, DOI 10.1016/S1087-1845(02)00531-5
   Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Stapleton D, 1999, NAT STRUCT BIOL, V6, P44
   STEINER S, 1995, GENETICS, V140, P973
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Toya M, 1999, MOL BIOL CELL, V10, P2745, DOI 10.1091/mbc.10.8.2745
   Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06
   Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377
   Weiner OD, 2002, CURR OPIN CELL BIOL, V14, P196, DOI 10.1016/S0955-0674(02)00310-1
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wendland J, 2002, FUNGAL GENET BIOL, V37, P81, DOI 10.1016/S1087-1845(02)00034-8
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 65
TC 21
Z9 21
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD OCT
PY 2006
VL 5
IS 10
BP 1635
EP 1647
DI 10.1128/EC.00210-06
PG 13
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 095YN
UT WOS:000241344300007
PM 16950929
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hofbauer, KG
   Nicholson, JR
AF Hofbauer, K. G.
   Nicholson, J. R.
TI Pharmacotherapy of obesity
SO EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
LA English
DT Review
DE appetite; energy balance; metabolism; adipose tissue; drugs
ID WEIGHT-LOSS; METABOLIC-SYNDROME; FOOD-INTAKE; ENERGY-BALANCE;
   CARDIOVASCULAR-DISEASE; MELANOCORTIN RECEPTORS; SCIENTIFIC STATEMENT;
   OVERWEIGHT PATIENTS; NEUROPEPTIDE-Y; PEPTIDE YY3-36
AB Obesity has become a significant health problem in industrialised and developing countries, and despite all nutritional and behavioural approaches, its prevalence is still increasing. In recent years, the identification and characterisation of central and peripheral mechanisms involved in the regulation of energy balance has made remarkable progress and provided numerous targets for novel antiobesity agents. However, only few antiobesity drugs are on the market and not many compounds have entered clinical development. In the present review, the clinically available agents are discussed and their pharmacological profiles are compared. Some of the drugs that are currently in clinical development are mentioned as examples of the possible future range of antiobesity agents. Selected topics in drug discovery are presented to illustrate novel targets and concepts for the pharmacotherapy of obesity.
C1 Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Ahima RS, 2004, PHYSIOL BEHAV, V81, P223, DOI 10.1016/j.physbeh.2004.02.014
   Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001
   Arterburn DE, 2004, ARCH INTERN MED, V164, P994, DOI 10.1001/archinte.164.9.994
   Aucott L, 2005, HYPERTENSION, V45, P1035, DOI 10.1161/01.HYP.0000165680.59733.d4
   Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951
   Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035
   Batkai S, 2004, CIRCULATION, V110, P1996, DOI 10.1161/01.CIR.0000143230.23252.D2
   Batterham RL, 2003, NEW ENGL J MED, V349, P941, DOI 10.1056/NEJMoa030204
   Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151
   Birkenfeld AL, 2005, CLIN AUTON RES, V15, P200, DOI 10.1007/s10286-005-0270-y
   Boggiano MM, 2005, OBES REV, V6, P307, DOI 10.1111/j.1467-789X.2005.00218.x
   Boss O, 2006, EXPERT OPIN THER TAR, V10, P119, DOI 10.1517/14728222.10.1.119
   Bouskila M, 2005, INT J OBESITY, V29, pS17, DOI 10.1038/sj.ijo.0802908
   Bray GA, 1999, ENDOCR REV, V20, P805, DOI 10.1210/er.20.6.805
   Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
   Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136
   Chiesi M, 2001, TRENDS PHARMACOL SCI, V22, P247, DOI 10.1016/S0165-6147(00)01664-3
   Collins S, 2004, MOL ENDOCRINOL, V18, P2123, DOI 10.1210/me.2004-0193
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Cummings DE, 2005, CURR DRUG TARGETS, V6, P153, DOI 10.2174/1389450053174569
   Curran MP, 2004, DRUGS, V64, P2845, DOI 10.2165/00003495-200464240-00010
   Davidson MH, 1999, JAMA-J AM MED ASSOC, V281, P235, DOI 10.1001/jama.281.3.235
   Degen L, 2005, GASTROENTEROLOGY, V129, P1430, DOI 10.1053/j.gastro.2005.09.001
   Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537
   Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457
   Diamond LE, 2004, INT J IMPOT RES, V16, P51, DOI 10.1038/sj.ijir.3901139
   Dulloo AG, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P405, DOI 10.1201/9780203508756.ch20
   Fishman AP, 1999, CIRCULATION, V99, P156, DOI 10.1161/01.CIR.99.1.156
   Flegal KM, 2005, PHYSIOL BEHAV, V86, P599, DOI 10.1016/j.physbeh.2005.08.050
   Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X
   GREENWAY FL, 2004, HDB OBESITY, P329
   Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404
   Gura T, 2003, SCIENCE, V299, P849, DOI 10.1126/science.299.5608.849
   Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003
   Halford JCG, 2004, CURR DRUG TARGETS, V5, P637, DOI 10.2174/1389450043345191
   Harper J A, 2001, Obes Rev, V2, P255, DOI 10.1046/j.1467-789X.2001.00043.x
   Harper ME, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P363
   Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1
   Hauner H, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P219, DOI 10.1201/9780203508756.pt4
   Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847
   Heffernan M, 2001, ENDOCRINOLOGY, V142, P5182, DOI 10.1210/en.142.12.5182
   Herzog H, 2003, EUR J PHARMACOL, V480, P21, DOI 10.1016/j.ejphar.2003.08.089
   Hesselink MKC, 2003, OBES RES, V11, P1429, DOI 10.1038/oby.2003.192
   Heymsfield SB, 1999, JAMA-J AM MED ASSOC, V282, P1568, DOI 10.1001/jama.282.16.1568
   Juurlink DN, 2004, NEW ENGL J MED, V351, P543, DOI 10.1056/NEJMoa040135
   Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289
   Katz DL, 2005, ANNU REV PUBL HEALTH, V26, P61, DOI 10.1146/annurev.publhealth.26.021304.144415
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kolanowski J, 1999, DRUG SAFETY, V20, P119, DOI 10.2165/00002018-199920020-00003
   Korner J, 2004, J CLIN ENDOCR METAB, V89, P2616, DOI 10.1210/jc.2004-0341
   Kuo JJ, 2003, HYPERTENSION, V41, P768, DOI 10.1161/01.HYP.0000048194.97428.1A
   Lafontan M, 2005, ANNU REV PHARMACOL, V45, P119, DOI 10.1146/annurev.pharmtox.45.120403.095843
   Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342
   LEIBEL RL, 1995, NEW ENGL J MED, V332, P621, DOI 10.1056/NEJM199503093321001
   Levine JA, 2005, SCIENCE, V307, P584, DOI 10.1126/science.1106561
   Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012
   Maggard MA, 2005, ANN INTERN MED, V142, P547, DOI 10.7326/0003-4819-142-7-200504050-00013
   Marie LS, 2005, P NATL ACAD SCI USA, V102, P18632, DOI 10.1073/pnas.0509240102
   Mashiko S, 2005, ENDOCRINOLOGY, V146, P3080, DOI 10.1210/en.2004-1150
   Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380
   Moller DE, 2005, ANNU REV MED, V56, P45, DOI 10.1146/annurev.med.56.082103.104751
   Mori H, 2004, NAT MED, V10, P739, DOI 10.1038/nm1071
   Moyers SB, 2005, J AM DIET ASSOC, V105, P948, DOI 10.1016/j.jada.2005.03.010
   Nawrocki AR, 2005, DRUG DISCOV TODAY, V10, P1219, DOI 10.1016/S1359-6446(05)03569-5
   Nisoli E, 2004, PHARMACOL RES, V50, P453, DOI 10.1016/j.phrs.2004.02.004
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   O'Rahilly S, 2004, NAT MED, V10, P351, DOI 10.1038/nm0404-351
   Park A, 2004, REGUL PEPTIDES, V119, P1, DOI 10.1016/j.regpep.2004.02.006
   Pertwee RG, 2006, BRIT J PHARMACOL, V147, pS163, DOI 10.1038/sj.bjp.0706406
   Poirier P, 2006, CIRCULATION, V113, P898, DOI 10.1161/CIRCULATIONAHA.106.171016
   Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272
   Ryan DH, 2004, PHARMACOTHERAPY OF OBESITY: OPTIONS AND ALTERNATIVES, P245, DOI 10.1201/9780203508756.ch12
   Schmitz O, 2004, DIABETES, V53, pS233, DOI 10.2337/diabetes.53.suppl_3.S233
   Schwartz MW, 2005, SCIENCE, V307, P375, DOI 10.1126/science.1104344
   Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012
   Ueno H, 2005, REGUL PEPTIDES, V126, P11, DOI 10.1016/j.regpep.2004.08.007
   Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X
   Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156
   Wagner JA, 2001, J AM COLL CARDIOL, V38, P2048, DOI 10.1016/S0735-1097(01)01671-0
   Wessells H, 2005, PEPTIDES, V26, P1972, DOI 10.1016/j.peptides.2004.11.035
   Wolfe BM, 2005, JAMA-J AM MED ASSOC, V294, P1960, DOI 10.1001/jama.294.15.1960
   Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62
   Yanagisawa T, 2000, TOHOKU J EXP MED, V192, P181, DOI 10.1620/tjem.192.181
   Yanovski SZ, 2002, NEW ENGL J MED, V346, P591, DOI 10.1056/NEJMra012586
NR 84
TC 15
Z9 15
U1 0
U2 3
PU JOHANN AMBROSIUS BARTH VERLAG MEDIZINVERLAGE HEIDELBERG GMBH
PI STUTTGART
PA RUEDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0947-7349
J9 EXP CLIN ENDOCR DIAB
JI Exp. Clin. Endocrinol. Diabet.
PD OCT
PY 2006
VL 114
IS 9
BP 475
EP 484
DI 10.1055/s-2006-924241
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 108IF
UT WOS:000242232800001
PM 17115344
DA 2021-01-25
ER

PT J
AU Seelig, A
   Gerebtzoff, G
AF Seelig, Anna
   Gerebtzoff, Gregori
TI Enhancement of drug absorption by noncharged detergents through membrane
   and P-glycoprotein binding
SO EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
LA English
DT Review
DE active efflux; detergents; membrane packing density; modulators; passive
   influx; P-glycoprotein; solubilisers; substrates
ID BLOOD-BRAIN-BARRIER; PLURONIC BLOCK-COPOLYMERS; CACO-2 CELL MONOLAYERS;
   MALE WISTAR RATS; MULTIDRUG-RESISTANCE; IN-VITRO; ATPASE ACTIVITY;
   CREMOPHOR-EL; LIPID MONOLAYERS; SOLUTOL HS-15
AB Noncharged detergents are used as excipients in drug formulations. Until recently, they were considered as inert compounds, enhancing drug absorption essentially by improving drug solubility. However, many detergents insert into lipid membranes, although to different extents, and change the lateral packing density of membranes at high concentrations. Moreover, they bind to the efflux transporter P-glycoprotein (P-gp) and most likely to related transporters and metabolising enzymes with overlapping substrate specificities. If their affinity to P-gp is higher than that of the coadministered drug they act as modulators or inhibitors of P-gp and enhance drug absorption. Inhibition of P-gp and related proteins can, however, cause severe side effects. This paper first reviews the membrane binding propensity of different noncharged detergents (including poloxamers) and discusses their ability to bind to P-gp. Second, literature data on drug uptake enhancement by noncharged detergents, obtained in vivo and in vitro, are analysed at the molecular level. The present analysis provides the tools for an approximate and simple prior estimate of the membrane and P-gp binding ability of noncharged detergents based on a modular binding approach.
C1 Univ Basel, Biozentrum, CH-4057 Basel, Switzerland.
   F Hofmann La Roche Ltd, CH-4070 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4057 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Attwood D., 1983, SURFACTANT SYSTEMS T
   Banerjee SK, 2000, LIFE SCI, V67, P2011, DOI 10.1016/S0024-3205(00)00786-4
   Batrakova EV, 1999, PHARM RES-DORDR, V16, P1366, DOI 10.1023/A:1018990706838
   Batrakova EV, 2001, J PHARMACOL EXP THER, V296, P551
   Begley GS, 2005, MOL IMMUNOL, V42, P137, DOI 10.1016/j.molimm.2004.07.005
   Bittner B, 2002, ARZNEIMITTELFORSCH, V52, P684
   Bittner B, 2005, LETT DRUG DES DISCOV, V2, P193, DOI 10.2174/1570180053765165
   Bittner B, 2003, BIOPHARM DRUG DISPOS, V24, P173, DOI 10.1002/bdd.353
   BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7
   Bogman K, 2005, CLIN PHARMACOL THER, V77, P24, DOI 10.1016/j.clpt.2004.09.001
   Bogman K, 2003, J PHARM SCI, V92, P1250, DOI 10.1002/jps.10395
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   Borrel MN, 1995, BIOCHEM PHARMACOL, V50, P2069, DOI 10.1016/0006-2952(95)02112-4
   Chang LC, 2005, J COLLOID INTERF SCI, V285, P640, DOI 10.1016/j.jcis.2004.11.011
   Chiba P, 2002, ARCH PHARM, V335, P223, DOI 10.1002/1521-4184(200205)335:5<223::AID-ARDP223>3.0.CO;2-D
   COGGER VC, 2006, IN PRESS ATHEROSCLER
   COON JS, 1991, CANCER RES, V51, P897
   Coors EA, 2005, ANN ALLERG ASTHMA IM, V95, P593, DOI 10.1016/S1081-1206(10)61024-1
   CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695
   Dean M, 2001, J LIPID RES, V42, P1007
   DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0
   Demina T, 2005, BIOCHEMISTRY-US, V44, P4042, DOI 10.1021/bi048373q
   Dintaman JM, 1999, PHARMACEUT RES, V16, P1550, DOI 10.1023/A:1015000503629
   DRORI S, 1995, EUR J BIOCHEM, V228, P1020, DOI 10.1111/j.1432-1033.1995.1020m.x
   DUDEJA PK, 1995, ARCH BIOCHEM BIOPHYS, V319, P309, DOI 10.1006/abbi.1995.1298
   Ecker G, 1999, MOL PHARMACOL, V56, P791
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FISCHER H, 1997, 4 INT C DRUG ABS ED
   FRICHE E, 1990, CANCER COMMUN, V2, P297
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Gaucher G, 2005, J CONTROL RELEASE, V109, P169, DOI 10.1016/j.jconrel.2005.09.034
   Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   GOBAS FAPC, 1988, J PHARM SCI, V77, P265, DOI 10.1002/jps.2600770317
   Gonzalez RCB, 2004, INT J PHARMACEUT, V279, P27, DOI 10.1016/j.ijpharm.2004.04.010
   Gonzalez RCB, 2004, BIOPHARM DRUG DISPOS, V25, P37, DOI 10.1002/bdd.383
   Gonzalez RCB, 2002, INT J PHARMACEUT, V245, P143, DOI 10.1016/S0378-5173(02)00339-3
   HAVEL M, 1987, CLIN THER, V9, P373
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Hirsch-Ernst KI, 2001, TOXICOLOGY, V167, P47, DOI 10.1016/S0300-483X(01)00457-7
   Hugger ED, 2002, J PHARM SCI-US, V91, P1991, DOI 10.1002/jps.10176
   Jagannath C, 1999, LIFE SCI, V64, P1733, DOI 10.1016/S0024-3205(99)00111-3
   Johnson BM, 2002, AAPS PHARMSCI, V4
   Kabanov AV, 2003, ADV DRUG DELIVER REV, V55, P151, DOI 10.1016/S0169-409X(02)00176-X
   Krylova OO, 2004, BIOCHEMISTRY-US, V43, P3696, DOI 10.1021/bi035768l
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Lennernas H, 2003, DRUG BIOAVAILABILITY
   Liang XM, 2005, J COLLOID INTERF SCI, V285, P360, DOI 10.1016/j.jcis.2004.11.042
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912
   Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960
   Litman T., 1995, Cellular Pharmacology, V2, P9
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lo YI, 2003, J CONTROL RELEASE, V90, P37, DOI 10.1016/S0168-3659(03)00163-9
   LOE DW, 1993, BRIT J CANCER, V68, P342, DOI 10.1038/bjc.1993.338
   Maskarinec SA, 2002, BIOPHYS J, V82, P1453, DOI 10.1016/S0006-3495(02)75499-4
   MEIER M, IN PRESS BIOPHYSICAL
   Miller DW, 1999, PHARM RES-DORDR, V16, P396, DOI 10.1023/A:1018873702411
   Nerurkar MM, 1997, J PHARM SCI-US, V86, P813, DOI 10.1021/js960483y
   NERVI P, 2004, THESIS U BASEL SWITZ
   NERVI P, UNPUB SURFACTANTS P
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   Orlowski S, 1998, Cancer Biochem Biophys, V16, P85
   Otten D, 2000, J PHYS CHEM B, V104, P12119, DOI 10.1021/jp001505e
   Pendse S, 2003, CURR DRUG TARGETS, V4, P469, DOI 10.2174/1389450033490894
   Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x
   Rebbeor JF, 1998, BBA-BIOMEMBRANES, V1369, P85, DOI 10.1016/S0005-2736(97)00185-5
   Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6
   Regev R, 1999, EUR J BIOCHEM, V259, P18, DOI 10.1046/j.1432-1327.1999.00037.x
   RIEHM H, 1972, CANCER RES, V32, P1195
   Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   Seeballuck F, 2003, PHARMACEUT RES, V20, P1085, DOI 10.1023/A:1024422625596
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 2006, BIOPHYS J, V90, P3825, DOI 10.1529/biophysj.106.082008
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Seelig A., 2002, ENCY PHYS SCI TECHNO, P355
   SEELIG J, 1980, Q REV BIOPHYS, V13, P1
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P189, DOI 10.1046/j.1432-1327.1998.2540189.x
   SPOELSTRA EC, 1991, BIOCHEM PHARMACOL, V41, P349, DOI 10.1016/0006-2952(91)90531-9
   Stouch TR, 2002, ADV DRUG DELIVER REV, V54, P315, DOI 10.1016/S0169-409X(02)00006-6
   Tanigawara Y, 2000, THER DRUG MONIT, V22, P137, DOI 10.1097/00007691-200002000-00029
   THEIS JGW, 1995, J CLIN ONCOL, V13, P2508, DOI 10.1200/JCO.1995.13.10.2508
   THEWALT JL, 1986, CHEM PHYS LIPIDS, V39, P93, DOI 10.1016/0009-3084(86)90103-9
   THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735
   URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008
   WAKITA M, 1992, CHEM PHARM BULL, V40, P1361
   Wang SW, 2004, J PHARM SCI-US, V93, P2755, DOI 10.1002/jps.20183
   WASSALL SR, 1986, BIOCHEMISTRY-US, V25, P319, DOI 10.1021/bi00350a006
   Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0
   WOODCOCK DM, 1992, BRIT J CANCER, V66, P62, DOI 10.1038/bjc.1992.217
   Wu GH, 2005, BIOPHYS J, V89, P3159, DOI 10.1529/biophysj.104.052290
   Wu GH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.028101
   Zamek-Gliszczynski MJ, 2006, EUR J PHARM SCI, V27, P447, DOI 10.1016/j.ejps.2005.12.007
   Zhang YC, 2001, CLIN PHARMACOKINET, V40, P159, DOI 10.2165/00003088-200140030-00002
   ZORDANNUDO T, 1993, CANCER RES, V53, P5994
NR 102
TC 57
Z9 58
U1 0
U2 14
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1742-5255
J9 EXPERT OPIN DRUG MET
JI Expert Opin. Drug Metab. Toxicol.
PD OCT
PY 2006
VL 2
IS 5
BP 733
EP 752
DI 10.1517/17425255.2.5.733
PG 20
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 167VG
UT WOS:000246480000006
PM 17014392
DA 2021-01-25
ER

PT J
AU Cottet, S
   Michaut, L
   Boisset, G
   Schlecht, U
   Gehring, W
   Schorderet, DF
AF Cottet, Sandra
   Michaut, Lydia
   Boisset, Gaeelle
   Schlecht, Ulrich
   Gehring, Walter
   Schorderet, Daniel F.
TI Biological characterization of gene response in Rpe65(-/-) mouse model
   of Leber's congenital amaurosis during progression of the disease
SO FASEB JOURNAL
LA English
DT Article
DE microarray; LCA; apoptosis
ID ALPHA-B-CRYSTALLIN; RETINAL-PIGMENT EPITHELIUM; HEAT-SHOCK-PROTEIN;
   A-CRYSTALLIN; PROTECTIVE ACTIVITY; BINDING-PROTEIN; DOWN-REGULATION;
   VISUAL-PIGMENT; MESSENGER-RNA; VITAMIN-A
AB RPE65 is the retinal isomerase essential for conversion of all-trans-retinyl ester to 11-cis-retinol in the visual cycle. Leber's congenital amaurosis (LCA), an autosomal recessive form of RP resulting in blindness, is commonly caused by mutations in the Rpe65 gene. Whereas the molecular mechanisms by which these mutations contribute to retinal disease remain largely unresolved, affected patients show marked RPE damage and photoreceptor degeneration. We evaluated gene expression in Rpe65(-/-) mouse model of LCA before and at the onset of photoreceptor cell death in 2, 4, and 6 month old animals. Microarray analysis demonstrates altered expression of genes involved in phototransduction, apoptosis regulation, cytoskeleton organization, and extracellular matrix (ECM) constituents. Cone-specific phototransduction genes are strongly decreased, reflecting early loss of cones. In addition, remaining rods show modified expression of genes encoding components of the cytoskeleton and ECM. This may affect rod physiology and interaction with the adjacent RPE and lead to loss of survival signals, as reflected by the alteration of apoptosis-related genes Together, these results suggest that RPE65 defect triggers an overall remodeling of the neurosensitive retina that may, in turn, disrupt photoreceptor homeostasis and induce apoptosis signaling cascade toward retinal cell death.
C1 Inst Res Ophthalmol, Sion, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Lausanne, Lausanne, Switzerland.
   Ecole Polytech Fed Lausanne, Lausanne, Switzerland.
RP Cottet, S (corresponding author), Av Grand Champsec 64, CH-1950 Sion 4, Switzerland.
EM sandra.cottet@iro.vsnet.ch
CR Ablonczy Z, 2002, J BIOL CHEM, V277, P40491, DOI 10.1074/jbc.M205507200
   Acharya S, 1998, J BIOL CHEM, V273, P31599, DOI 10.1074/jbc.273.47.31599
   Aguirre G D, 1998, Mol Vis, V4, P23
   ANDERSON DH, 1986, INVEST OPHTH VIS SCI, V27, P168
   Andley UP, 2000, J BIOL CHEM, V275, P36823, DOI 10.1074/jbc.M004233200
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247
   Breitschopf K, 2000, MOL CELL BIOL, V20, P1886, DOI 10.1128/MCB.20.5.1886-1896.2000
   Cavusoglu N, 2003, MOL CELL PROTEOMICS, V2, P494, DOI 10.1074/mcp.M300029-MCP200
   Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3
   D'Alessio G, 2002, EUR J BIOCHEM, V269, P3122, DOI 10.1046/j.1432-1033.2002.03004.x
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   DERETIC D, 1994, J BIOL CHEM, V269, P16853
   Dirks RPH, 1998, EXP EYE RES, V66, P267, DOI 10.1006/exer.1997.0439
   DOW KE, 1994, EXP NEUROL, V128, P233, DOI 10.1006/exnr.1994.1132
   Dufour EM, 2003, NEUROBIOL DIS, V14, P166, DOI 10.1016/S0969-9961(03)00102-5
   Eckmiller MS, 2004, PROG RETIN EYE RES, V23, P495, DOI 10.1016/j.preteyeres.2004.04.005
   Eckmiller MS, 1998, ACTA ANAT, V162, P133
   El Matri L, 2006, GRAEF ARCH CLIN EXP, V244, P1104, DOI 10.1007/s00417-005-0096-2
   Felbor U, 1998, CYTOGENET CELL GENET, V81, P12, DOI 10.1159/000015001
   FITZGERALD PG, 1991, CURR EYE RES, V10, P417, DOI 10.3109/02713689109001750
   FUKUCHI T, 1994, EXP EYE RES, V58, P231, DOI 10.1006/exer.1994.1012
   Galvin JA, 2005, OPHTHALMOLOGY, V112, P349, DOI 10.1016/j.ophtha.2004.08.023
   Gollapalli DR, 2003, BIOCHEMISTRY-US, V42, P11824, DOI 10.1021/bi035227w
   Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194
   Hanein S, 2004, HUM MUTAT, V23, P306, DOI 10.1002/humu.20010
   Hasson T, 1999, CURR BIOL, V9, pR838, DOI 10.1016/S0960-9822(00)80040-8
   HEAD MW, 1995, EXP EYE RES, V61, P423, DOI 10.1016/S0014-4835(05)80137-X
   Hodge C, 1998, J BIOL CHEM, V273, P31327, DOI 10.1074/jbc.273.47.31327
   Hollyfield JG, 1999, INVEST OPHTH VIS SCI, V40, P2767
   HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Inatani M, 2002, PROG RETIN EYE RES, V21, P429, DOI 10.1016/S1350-9462(02)00009-5
   Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237
   Jin MH, 2005, CELL, V122, P449, DOI 10.1016/j.cell.2005.06.042
   Johnson EC, 1996, EXP EYE RES, V62, P663, DOI 10.1006/exer.1996.0077
   Jones SE, 1999, INVEST OPHTH VIS SCI, V40, P3017
   Kamradt MC, 2005, J BIOL CHEM, V280, P11059, DOI 10.1074/jbc.M413382200
   Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200
   KANTOROW M, 1994, P NATL ACAD SCI USA, V91, P3112, DOI 10.1073/pnas.91.8.3112
   Kapphahn RJ, 2003, BIOCHEMISTRY-US, V42, P15310, DOI 10.1021/bi034774e
   Kelsell RE, 1998, AM J HUM GENET, V63, P274, DOI 10.1086/301905
   KLEMENZ R, 1991, P NATL ACAD SCI USA, V88, P3652, DOI 10.1073/pnas.88.9.3652
   Kusaka S, 1998, JPN J OPHTHALMOL, V42, P218, DOI 10.1016/S0021-5155(97)00136-6
   Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7
   LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945
   Lorenz B, 2000, INVEST OPHTH VIS SCI, V41, P2735
   Magabo KS, 2000, INVEST OPHTH VIS SCI, V41, P3056
   Manes G, 1998, FEBS LETT, V423, P133, DOI 10.1016/S0014-5793(98)00081-7
   Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384
   Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200
   Marlhens F, 1997, NAT GENET, V17, P139, DOI 10.1038/ng1097-139
   Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4
   Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008
   Mata NL, 2004, J BIOL CHEM, V279, P635, DOI 10.1074/jbc.M310042200
   Mata NL, 2002, NEURON, V36, P69, DOI 10.1016/S0896-6273(02)00912-1
   Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238
   Mehlen P, 1996, J BIOL CHEM, V271, P16510, DOI 10.1074/jbc.271.28.16510
   Mehlen P, 1996, EMBO J, V15, P2695, DOI 10.1002/j.1460-2075.1996.tb00630.x
   Mielke K, 2000, PROG NEUROBIOL, V61, P45, DOI 10.1016/S0301-0082(99)00042-8
   Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088
   Narfstrom K., 1999, Veterinary Ophthalmology, V2, P75
   Park J, 1997, J BIOL CHEM, V272, P16725, DOI 10.1074/jbc.272.27.16725
   PIATIGORSKY J, 1988, P NATL ACAD SCI USA, V85, P3479, DOI 10.1073/pnas.85.10.3479
   Porto FBO, 2002, J GENE MED, V4, P390, DOI 10.1002/jgm.278
   Puthalakath H, 2001, SCIENCE, V293, P1829, DOI 10.1126/science.1062257
   Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813
   Sakaguchi H, 2003, EXP EYE RES, V76, P131, DOI 10.1016/S0014-4835(02)00249-X
   Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6
   Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712
   Selles-Navarro I, 2001, EXP NEUROL, V167, P282, DOI 10.1006/exnr.2000.7573
   Sinha D, 1998, Mol Vis, V4, P8
   Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X
   Van Hooser JP, 2000, P NATL ACAD SCI USA, V97, P8623, DOI 10.1073/pnas.150236297
   Veske A, 1999, GENOMICS, V57, P57, DOI 10.1006/geno.1999.5754
   WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0
   Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0
   Woodruff ML, 2003, NAT GENET, V35, P158, DOI 10.1038/ng1246
   WRIGSTAD A, 1992, EXP EYE RES, V55, P805, DOI 10.1016/0014-4835(92)90007-F
   Xi JH, 2003, MOL VIS, V9, P410
   Xue LL, 2004, CELL, V117, P761, DOI 10.1016/j.cell.2004.05.016
   Yoshimura N, 2003, INVEST OPHTH VIS SCI, V44, P2211, DOI 10.1167/iovs.02-0704
   Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653
   Znoiko SL, 2002, INVEST OPHTH VIS SCI, V43, P1604
NR 84
TC 36
Z9 36
U1 0
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD OCT
PY 2006
VL 20
IS 12
BP 2036
EP 2049
DI 10.1096/fj.06-6211com
PG 14
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 093GS
UT WOS:000241156900012
PM 17012256
DA 2021-01-25
ER

PT J
AU Helfer, H
   Gladfelter, AS
AF Helfer, Hanspeter
   Gladfelter, Amy S.
TI AgSwe1p regulates mitosis in response to morphogenesis and nutrients in
   multinucleated Ashbya gossypii cells
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; FILAMENTOUS GROWTH; BUDDING
   YEAST; TYROSINE PHOSPHORYLATION; ASPERGILLUS-NIDULANS; SWE1P
   DEGRADATION; NUCLEAR DIVISION; FISSION YEAST; CYCLE CONTROL
AB Nuclei in the filamentous, multinucleated fungus Ashbya gossypii divide asynchronously. We have investigated what internal and external signals spatially direct mitosis within these hyphal cells. Mitoses are most common near cortical septin rings found at growing tips and branchpoints. In septin mutants, mitoses are no longer concentrated at branchpoints, suggesting that the septin rings function to locally promote mitosis near new branches. Similarly, cells lacking AgSwe1p kinase (a Wee1 homologue), AgHsl1p (a Nim1-related kinase), and AgMih1p phosphatase (the Cdc25 homologue that likely counteracts AgSwe1p activity) also have mitoses distributed randomly in the hyphae as opposed to at branchpoints. Surprisingly, however, no phosphorylation of the CDK tyrosine 18 residue, the conserved substrate of Swe1p kinases, was detected in normally growing cells. In contrast, abundant CDK tyrosine phosphorylation was apparent in starving cells, resulting in diminished nuclear density. This starvation-induced CDK phosphorylation is AgSwe1p dependent, and overexpressed AgSwe1p is sufficient to delay nuclei even in rich nutrient conditions. In starving cells lacking septins or AgSwe1p negative regulators, the nuclear density is further diminished compared with wild type. We have generated a model in which AgSwe1p may regulate mitosis in response to cell intrinsic morphogenesis cues and external nutrient availability in multinucleated cells.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA.
RP Gladfelter, AS (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Amy.Gladfelter@Dartmouth.edu
CR Ahn SH, 1999, MOL BIOL CELL, V10, P3301, DOI 10.1091/mbc.10.10.3301
   Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Barral Y, 1999, GENE DEV, V13, P176, DOI 10.1101/gad.13.2.176
   BATRA L R, 1973, U S Department of Agriculture Technical Bulletin, V1469, P1
   BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329
   Belenguer P, 1997, BIOCHEM BIOPH RES CO, V232, P204, DOI 10.1006/bbrc.1997.6253
   Cid VJ, 2001, MOL BIOL CELL, V12, P1645, DOI 10.1091/mbc.12.6.1645
   CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Douglas LM, 2005, EUKARYOT CELL, V4, P1503, DOI 10.1128/EC.4.9.1503-1512.2005
   Edgington NP, 1999, MOL CELL BIOL, V19, P1369
   Entian KD, 1998, METHOD MICROBIOL, V26, P431
   Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008
   Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gladfelter AS, 2006, NAT REV MICROBIOL, V4, P223, DOI 10.1038/nrmicro1345
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Harris SD, 2004, FUNGAL GENET BIOL, V41, P391, DOI 10.1016/j.fgb.2003.11.007
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Kellogg DR, 2003, J CELL SCI, V116, P4883, DOI 10.1242/jcs.00908
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   La Valle R, 2001, GENETICS, V158, P549
   Lew DJ, 2003, CURR OPIN CELL BIOL, V15, P648, DOI 10.1016/j.ceb.2003.09.001
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000
   Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X
   Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008
   MCELVER J, 1992, YEAST, V8, P627
   McMillan JN, 1999, MOL CELL BIOL, V19, P5981
   McMillan JN, 1999, MOL CELL BIOL, V19, P6929
   McMillan JN, 1998, J CELL BIOL, V142, P1487, DOI 10.1083/jcb.142.6.1487
   Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160
   NYGAARD OF, 1960, BIOCHIM BIOPHYS ACTA, V38, P298, DOI 10.1016/0006-3002(60)91245-2
   RITZ K, 1995, FEMS MICROBIOL ECOL, V16, P269, DOI 10.1016/0168-6496(94)00090-J
   Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   SHIOZAKI K, 1995, NATURE, V378, P739, DOI 10.1038/378739a0
   Shulewitz MJ, 1999, MOL CELL BIOL, V19, P7123
   Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678
   Sia RAL, 1996, MOL BIOL CELL, V7, P1657
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312
NR 50
TC 40
Z9 40
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT
PY 2006
VL 17
IS 10
BP 4494
EP 4512
DI 10.1091/mbc.E06-03-0215
PG 19
WC Cell Biology
SC Cell Biology
GA 092HJ
UT WOS:000241087300030
PM 16899511
OA Green Published
DA 2021-01-25
ER

PT J
AU Schmitter, D
   Filkowski, J
   Sewer, A
   Pillai, RS
   Oakeley, EJ
   Zavolan, M
   Svoboda, P
   Filipowicz, W
AF Schmitter, Daniela
   Filkowski, Jody
   Sewer, Alain
   Pillai, Ramesh S.
   Oakeley, Edward J.
   Zavolan, Mihaela
   Svoboda, Petr
   Filipowicz, Witold
TI Effects of Dicer and Argonaute down-regulation on mRNA levels in human
   HEK293 cells
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID DOUBLE-STRANDED-RNA; DROSOPHILA-MELANOGASTER; ANIMAL DEVELOPMENT;
   MICRORNA FUNCTION; PASSENGER-STRAND; EXPRESSION; SIRNAS; MIRNAS;
   CLEAVAGE; TURNOVER
AB RNA interference and the microRNA (miRNA) pathway can induce sequence-specific mRNA degradation and/or translational repression. The human genome encodes hundreds of miRNAs that can post-transcriptionally repress thousands of genes. Using reporter constructs, we observed that degradation of mRNAs bearing sites imperfectly complementary to the endogenous let-7 miRNA is considerably stronger in human HEK293 than HeLa cells. The degradation did not result from the Ago2-mediated endonucleolytic cleavage but it was Dicer- and Ago2-dependent. We used this feature of HEK293 to address the size of a pool of transcripts regulated by RNA silencing in a single cell type. We generated HEK293 cell lines depleted of Dicer or individual Ago proteins. The cell lines were used for microarray analyses to obtain a comprehensive picture of RNA silencing. The 3'-untranslated region sequences of a few hundred transcripts that were commonly up-regulated upon Ago2 and Dicer knock-downs showed a significant enrichment of putative miRNA-binding sites. The up-regulation upon Ago2 and Dicer knock-downs was moderate and we found no evidence, at the mRNA level, for activation of silenced genes. Taken together, our data suggest that, independent of the effect on translation, miRNAs affect levels of a few hundred mRNAs in HEK293 cells.
C1 Friedrich Miescher Inst Biomed Res, CH-4002 Basel, Switzerland.
   Univ Basel, Div Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Filipowicz, W (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4002 Basel, Switzerland.
EM svoboda@fmi.ch; filipowi@fmi.ch
RI Svoboda, Petr/AAC-1501-2020; Svoboda, Petr/G-3890-2012; Zavolan,
   Mihaela/S-3888-2016
OI Svoboda, Petr/0000-0002-4370-3705; Zavolan, Mihaela/0000-0002-8832-2041
CR Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Billy E, 2001, P NATL ACAD SCI USA, V98, P14428, DOI 10.1073/pnas.261562698
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703
   Elbashir SM, 2001, EMBO J, V20, P6877, DOI 10.1093/emboj/20.23.6877
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Hall TMT, 2005, STRUCTURE, V13, P1403, DOI 10.1016/j.str.2005.08.005
   Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704
   Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274
   Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096
   Newbury SF, 2006, EMBO REP, V7, P143, DOI 10.1038/sj.embor.7400628
   Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724
   Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079
   Pillai RS, 2004, RNA, V10, P1518, DOI 10.1261/rna.7131604
   Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605
   Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020
   Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006
   Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514
   Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030
   Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865
   Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004
   Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070
   Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
   Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5
NR 49
TC 149
Z9 156
U1 0
U2 10
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT
PY 2006
VL 34
IS 17
BP 4801
EP 4815
DI 10.1093/nar/gkl646
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 097DR
UT WOS:000241427300020
PM 16971455
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Kobayashi, M
   Michaut, L
   Ino, A
   Honjo, K
   Nakajima, T
   Maruyama, Y
   Mochizuki, H
   Ando, M
   Ghangrekar, I
   Takahashi, K
   Saigo, K
   Ueda, R
   Gehring, WJ
   Furukubo-Tokunaga, K
AF Kobayashi, Masatomo
   Michaut, Lydia
   Ino, Ayako
   Honjo, Ken
   Nakajima, Taiki
   Maruyama, Yasushi
   Mochizuki, Hiroaki
   Ando, Mai
   Ghangrekar, Indrayani
   Takahashi, Kuniaki
   Saigo, Kaoru
   Ueda, Ryu
   Gehring, Walter J.
   Furukubo-Tokunaga, Katsuo
TI Differential microarray analysis of Drosophila mushroom body transcripts
   using chemical ablation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE hydroxyurea; RNAi; brain development; learning and memory
ID TERM-MEMORY; BRAIN; BODIES; GENE; EXPRESSION; RECEPTOR; REVEALS;
   EYELESS; PATHWAY; LOCALIZATION
AB Mushroom bodies (MBs) are the centers for olfactory associative learning and elementary cognitive functions in the Drosophila brain. As a way to systematically elucidate genes preferentially expressed in MBs, we have analyzed genome-wide alterations in transcript profiles associated with MB ablation by hydroxyurea. We selected 100 genes based on microarray data and examined their expression patterns in the brain by in situ hybridization. Seventy genes were found to be expressed in the posterodorsal cortex, which harbors the MB cell bodies. These genes encode proteins of diverse functions, including transcription, signaling, cell adhesion, channels, and transporters. Moreover, we have examined developmental functions of 40 of the microarray-identified genes by transgenic RNA interference; 8 genes were found to cause mild-to-strong MB defects when suppressed with a MB-Gal4 driver. These results provide important information not only on the repertoire of genes that control MB development but also on the repertoire of neural factors that may have important physiological functions in MB plasticity.
C1 Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
   Univ Tsukuba, Tsukuba Adv Alliance, Tsukuba, Ibaraki 3058572, Japan.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Natl Inst Genet, Genet Strains Res Ctr, Mishima, Shizuoka 4118540, Japan.
   Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan.
RP Gehring, WJ (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.
EM walter.gehring@unibas.ch; tokunaga@sakura.cc.tsukuba.ac.jp
RI Honjo, Ken/O-1603-2018
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [17570001] Funding Source: KAKEN
CR Adachi Y, 2003, MECH DEVELOP, V120, P1113, DOI 10.1016/j.mod.2003.08.007
   Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N
   Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104
   Crittenden JR, 1998, LEARN MEMORY, V5, P38
   Davis RL, 2004, NEURON, V44, P31, DOI 10.1016/j.neuron.2004.09.008
   Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651
   deBelle JS, 1996, P NATL ACAD SCI USA, V93, P9875, DOI 10.1073/pnas.93.18.9875
   DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280
   Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046
   Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2
   Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4
   Han PL, 1996, J NEUROBIOL, V31, P88, DOI 10.1002/(SICI)1097-4695(199609)31:1<88::AID-NEU8>3.3.CO;2-Q
   HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143
   Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074
   Henry GL, 2003, CURR OPIN NEUROBIOL, V13, P570, DOI 10.1016/S0959-4388(03)00107-7
   Isabel G, 2004, SCIENCE, V304, P1024, DOI 10.1126/science.1094932
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Kamikouchi A, 1998, BIOCHEM BIOPH RES CO, V242, P181, DOI 10.1006/bbrc.1997.7870
   KASTEL PL, 2005, INT REV NEUROBIOL, V63, P41
   Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247
   Kurusu M, 2000, P NATL ACAD SCI USA, V97, P2140, DOI 10.1073/pnas.040564497
   Kurusu M, 2002, DEVELOPMENT, V129, P409
   Lam G, 1999, DEV BIOL, V212, P204, DOI 10.1006/dbio.1999.9343
   Lee T, 1999, DEVELOPMENT, V126, P4065
   Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0
   Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024
   Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100
   Mischel PS, 2004, NAT REV NEUROSCI, V5, P782, DOI 10.1038/nrn1518
   Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6
   Nicolai M, 2003, J NEUROBIOL, V57, P291, DOI 10.1002/neu.10277
   Noveen A, 2000, DEVELOPMENT, V127, P3475
   ODELL KMC, 1995, NEURON, V15, P55, DOI 10.1016/0896-6273(95)90064-0
   Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200
   Pascual A, 2005, DEV BIOL, V280, P177, DOI 10.1016/j.ydbio.2005.01.017
   Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200
   PROKOP A, 1994, DEV BIOL, V161, P321, DOI 10.1006/dbio.1994.1034
   Reuter JE, 2003, DEVELOPMENT, V130, P1203, DOI 10.1242/dev.00319
   Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5
   Strausfeld NJ, 2003, MICROSC RES TECHNIQ, V62, P151, DOI 10.1002/jemt.10368
   Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7
   Takeuchi H, 2002, FEBS LETT, V513, P230, DOI 10.1016/S0014-5793(02)02319-0
   Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112
   Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672
   Zhao XY, 2001, J COMP NEUROL, V441, P187, DOI 10.1002/cne.1406
   Zirlinger M, 2001, P NATL ACAD SCI USA, V98, P5270, DOI 10.1073/pnas.091094698
NR 50
TC 23
Z9 23
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 26
PY 2006
VL 103
IS 39
BP 14417
EP 14422
DI 10.1073/pnas.0606571103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 090RG
UT WOS:000240968100031
PM 16971484
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU DeBeer-Schmitt, L
   Dewhurst, CD
   Hoogenboom, BW
   Petrovic, C
   Eskildsen, MR
AF DeBeer-Schmitt, L.
   Dewhurst, C. D.
   Hoogenboom, B. W.
   Petrovic, C.
   Eskildsen, M. R.
TI Field dependent coherence length in the superclean, high-kappa
   superconductor CeCoIn5
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID ANGLE NEUTRON-SCATTERING; FLUX-LINE-LATTICE; MIXED-STATE; VORTEX
   LATTICE; PHASE; CORE
AB Using small-angle neutron scattering, we have studied the flux-line lattice (FLL) in the superclean, high-kappa superconductor CeCoIn5. The FLL undergoes a first-order symmetry and reorientation transition at similar to 0.55 T at 50 mK. In addition, the FLL form factor in this material is found to be independent of the applied magnetic field, in striking contrast to the exponential decrease usually observed in superconductors. This result is consistent with a strongly field-dependent coherence length, proportional to the vortex separation.
C1 Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.
   Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
   Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA.
RP DeBeer-Schmitt, L (corresponding author), Univ Notre Dame, Dept Phys, Notre Dame, IN 46556 USA.
EM eskildsen@nd.edu
RI Eskildsen, Morten Ring/E-7779-2011; DeBeer-Schmitt, Lisa/I-3313-2015;
   Petrovic, Cedomir/A-8789-2009
OI Eskildsen, Morten Ring/0000-0001-5211-1771; DeBeer-Schmitt,
   Lisa/0000-0001-9679-3444; Petrovic, Cedomir/0000-0001-6063-1881;
   Hoogenboom, Bart/0000-0002-8882-4324
CR Aoki H, 2004, J PHYS-CONDENS MAT, V16, pL13, DOI 10.1088/0953-8984/16/3/L02
   Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001
   Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.187004
   Brown SP, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.067004
   CHRISTEN DK, 1977, PHYS REV B, V15, P4506, DOI 10.1103/PhysRevB.15.4506
   CLEM JR, 1975, J LOW TEMP PHYS, V18, P427, DOI 10.1007/BF00116134
   Eskildsen MR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.187001
   Eskildsen MR, 1997, PHYS REV LETT, V78, P1968, DOI 10.1103/PhysRevLett.78.1968
   Huxley A, 2000, NATURE, V406, P160, DOI 10.1038/35018020
   Ichioka M, 1999, PHYS REV B, V59, P8902, DOI 10.1103/PhysRevB.59.8902
   Izawa K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.057002
   Kabanov VV, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.132511
   Kakuyanagi K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.047602
   Kasahara Y, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.214515
   Kealey PG, 2000, PHYS REV LETT, V84, P6094, DOI 10.1103/PhysRevLett.84.6094
   Kim JS, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.134524
   Klein T, 2001, NATURE, V413, P404, DOI 10.1038/35096534
   Kogan VG, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134505
   Kogan VG, 1997, PHYS REV B, V55, pR8693, DOI 10.1103/PhysRevB.55.R8693
   MACHIDA K, COMMUNICATION
   Martin C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.020503
   Movshovich R, 2001, PHYS REV LETT, V86, P5152, DOI 10.1103/PhysRevLett.86.5152
   Murphy TP, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.100514
   Ormeno RJ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.047005
   Ozcan S, 2003, EUROPHYS LETT, V62, P412, DOI 10.1209/epl/i2003-00411-9
   Paglione J, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.246405
   Park WK, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.052509
   Petrovic C, 2001, J PHYS-CONDENS MAT, V13, pL337, DOI 10.1088/0953-8984/13/17/103
   Radovan HA, 2003, NATURE, V425, P51, DOI 10.1038/nature01842
   Ronning F, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.104528
   Rourke PMC, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.107005
   Sidorov VA, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.157004
   Sonier JE, 2004, J PHYS-CONDENS MAT, V16, pS4499, DOI 10.1088/0953-8984/16/40/006
   TACHIKI M, 1979, PHYS REV B, V20, P1915, DOI 10.1103/PhysRevB.20.1915
   Tanatar MA, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.067002
   Tayama T, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.180504
   Vorontsov A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.237001
   Won H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.180504
   Yaron U, 1997, PHYS REV LETT, V78, P3185, DOI 10.1103/PhysRevLett.78.3185
NR 39
TC 34
Z9 34
U1 1
U2 3
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
EI 1079-7114
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD SEP 22
PY 2006
VL 97
IS 12
AR 127001
DI 10.1103/PhysRevLett.97.127001
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 086NN
UT WOS:000240680400052
PM 17025991
DA 2021-01-25
ER

PT J
AU Jackson-Fisher, AJ
   Bellinger, G
   Shum, E
   Duong, JK
   Perkins, AS
   Gassmann, M
   Muller, W
   Lloyd, KCK
   Stern, DF
AF Jackson-Fisher, A. J.
   Bellinger, G.
   Shum, E.
   Duong, J. K.
   Perkins, A. S.
   Gassmann, M.
   Muller, W.
   Lloyd, K. C. Kent
   Stern, D. F.
TI Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of
   ErbB4
SO ONCOGENE
LA English
DT Article
DE ErbB; HER-4; breast cancer; MMTV-Neu; carcinoma
ID GROWTH-FACTOR RECEPTOR; BREAST-CANCER CELLS; CONSTITUTIVELY ACTIVE
   ERBB4; TRANSGENIC MICE; NEU PROTOONCOGENE; TYROSINE KINASES;
   PROGNOSTIC-SIGNIFICANCE; ACTIVATING MUTATIONS; NEUREGULIN RECEPTOR;
   MESSENGER-RNA
AB The four members of the ErbB family of receptor tyrosine kinases are involved in development and tumorigenesis of the mammary gland. Whereas the epidermal growth factor receptor, ErbB2 and ErbB3 are positively associated with various cancers, clinical studies of ErbB4 in breast cancer are contradictory. Results from tissue culture analyses and some clinical studies suggested that ErbB4 is either a tumor suppressor or is a negative regulator of ErbB2-driven tumors. Neu-Cre-ErbB4(flox/null) mice in which ErbB4 was inactivated by Cre-lox-mediated recombination in the mammary gland developed MMTV-Neu-driven mammary tumors with a similar latency period to mice with one or two wild-type ErbB4 alleles. Moreover, there was no difference in the histologies of tumors that developed, nor in the propensity to form lung metastases. Taken together these results suggest that ErbB4 is not a potent, highly penetrant tumor suppressor, nor is it a factor in Neu-mediated tumorigenesis in this model.
C1 Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA.
   Columbia Univ, Sch Publ Hlth, New York, NY USA.
   Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, Basel, Switzerland.
   McGill Univ, Royal Univ Hosp, Mol Oncol Grp, Montreal, PQ, Canada.
   Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA.
RP Stern, DF (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St,Room BML 342,POB 208023, New Haven, CT 06520 USA.
EM df.stern@yale.edu
OI Lloyd, David/0000-0002-5656-0571; Gassmann, Martin/0000-0001-6201-3032
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065, R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065, R01CA080065, R01CA080065, R01CA080065, R01CA080065,
   R01CA080065] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [R01CA80065] Funding Source:
   Medline
CR Abd El-Rehim DM, 2004, BRIT J CANCER, V91, P1532, DOI 10.1038/sj.bjc.6602184
   Andrechek ER, 2000, P NATL ACAD SCI USA, V97, P3444, DOI 10.1073/pnas.050408497
   Bacus SS, 1996, AM J PATHOL, V148, P549
   Barnes NLP, 2005, CLIN CANCER RES, V11, P2163, DOI 10.1158/1078-0432.CCR-04-1633
   Bieche I, 2003, INT J CANCER, V106, P758, DOI 10.1002/ijc.11273
   Chen XM, 1996, J BIOL CHEM, V271, P7620, DOI 10.1074/jbc.271.13.7620
   Cohen BM, 1996, J BIOL CHEM, V271, P4813
   DiGiovanna MP, 2005, J CLIN ONCOL, V23, P1152, DOI 10.1200/JCO.2005.09.055
   Elenius K, 1997, J BIOL CHEM, V272, P26761, DOI 10.1074/jbc.272.42.26761
   Elenius K, 1999, ONCOGENE, V18, P2607, DOI 10.1038/sj.onc.1202612
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Gilbertson RJ, 1997, CANCER RES, V57, P3272
   Gullick WJ, 2003, J PATHOL, V200, P279, DOI 10.1002/path.1335
   GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578
   Haugen DRF, 1996, CANCER RES, V56, P1184
   Jones FE, 1999, J CELL BIOL, V147, P77, DOI 10.1083/jcb.147.1.77
   Junttila TT, 2005, CANCER RES, V65, P1384, DOI 10.1158/0008-5472.CAN-04-3150
   Junttila TT, 2003, CLIN CANCER RES, V9, P5346
   Kew TY, 2000, BRIT J CANCER, V82, P1163, DOI 10.1054/bjoc.1999.1057
   Knowlden JM, 1998, ONCOGENE, V17, P1949, DOI 10.1038/sj.onc.1202107
   Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200
   Li BL, 1997, MOL CELL BIOL, V17, P3155, DOI 10.1128/MCB.17.6.3155
   Lodge AJ, 2003, J CLIN PATHOL, V56, P300, DOI 10.1136/jcp.56.4.300
   Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   Maatta JA, 2006, MOL BIOL CELL, V17, P67, DOI 10.1091/mbc.E05-05-0402
   Muller WJ, 1996, MOL CELL BIOL, V16, P5726
   MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5
   Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159
   Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314
   Pawlowski V, 2000, CLIN CANCER RES, V6, P4217
   Penington DJ, 2002, CELL GROWTH DIFFER, V13, P247
   Rio C, 2000, J BIOL CHEM, V275, P10379, DOI 10.1074/jbc.275.14.10379
   Sartor CI, 2001, MOL CELL BIOL, V21, P4265, DOI 10.1128/MCB.21.13.4265-4275.2001
   Schroeder JA, 1998, CELL GROWTH DIFFER, V9, P451
   Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149
   SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068
   Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507
   Srinivasan R, 2000, CANCER RES, V60, P1483
   Srinivasan R, 1998, J PATHOL, V185, P236, DOI 10.1002/(SICI)1096-9896(199807)185:3<236::AID-PATH118>3.0.CO;2-7
   Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b
   Stern DF, 2000, BREAST CANCER RES, V2, P176, DOI 10.1186/bcr51
   Suo Z, 2002, J PATHOL, V196, P17, DOI 10.1002/path.1003
   Suo ZH, 2001, VIRCHOWS ARCH, V439, P62, DOI 10.1007/s004280000392
   Tang CK, 1999, CANCER RES, V59, P5315
   Tang CK, 1998, CANCER RES, V58, P3415
   Thor AD, 2002, HUM PATHOL, V33, P628, DOI 10.1053/hupa.2002.124034
   Thuret S, 2004, J NEUROCHEM, V91, P1302, DOI 10.1111/j.1471-4159.2004.02809.x
   Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100
   Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.2002.20.3.719
   von Mehren M, 2005, J CLIN ONCOL, V23, P8, DOI 10.1200/JCO.2005.09.961
   Williams CC, 2004, J CELL BIOL, V167, P469, DOI 10.1083/jcb.200403155
   Williams EE, 2003, CANCER LETT, V192, P67, DOI 10.1016/S0304-3835(02)00690-0
   Witton CJ, 2003, J PATHOL, V200, P290, DOI 10.1002/path.1370
   YANG YM, 1995, J CELL BIOL, V131, P215, DOI 10.1083/jcb.131.1.215
NR 55
TC 17
Z9 18
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0950-9232
J9 ONCOGENE
JI Oncogene
PD SEP 14
PY 2006
VL 25
IS 41
BP 5664
EP 5672
DI 10.1038/sj.onc.1209574
PG 9
WC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics &
   Heredity
GA 085IZ
UT WOS:000240599100008
PM 16652155
OA Bronze
DA 2021-01-25
ER

PT J
AU Stetefeld, J
   Jenny, M
   Burkhard, P
AF Stetefeld, J.
   Jenny, M.
   Burkhard, P.
TI Intersubunit signaling in glutamate-1-semialdehyde-aminomutase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE negative cooperativity; x-ray crystallography; integrated approach;
   subunit communication; protein dynamics
ID GLUTAMATE 1-SEMIALDEHYDE AMINOTRANSFERASE; SEMIALDEHYDE
   AMINOTRANSFERASE; DEPENDENT ENZYMES; PROTEIN DYNAMICS; BINDING;
   MECHANISM; LOOP; CATALYSIS; ACID; AMINOLEVULINATE
AB Enzymes are highly dynamic and tightly controlled systems. However, allosteric communication linked to catalytic turnover is poorly understood. We have performed an integrated approach to trap several catalytic intermediates in the alpha 2-dimeric key enzyme of chlorophyll biosynthesis, glutamate-1-semialdehyde aminomutase. Our data reveal an active-site "gating loop," which undergoes a dramatic conformational change during catalysis, that is simultaneously open in one subunit and closed in the other. This loop movement requires a beta-sheet-to-alpha-helix transition to assume the closed conformation, thus facilitating transport of substrate toward, and concomitantly forming, an integral part of the active site. The accompanying intersubunit cross-talk, which controls negative cooperativity between the allosteric pair, was explored at the atomic level. The central elements of the communication triad are the cofactor bound to different catalytic intermediates, the interface helix, and the gating loop. Together, they form a molecular switch in which the cofactor acts as a central signal transmitter linking the subunit interface with the gating loop.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch
RI Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248
CR ALEXANDER FW, 1994, EUR J BIOCHEM, V219, P953, DOI 10.1111/j.1432-1033.1994.tb18577.x
   [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760
   Berendsen HJC, 2000, CURR OPIN STRUC BIOL, V10, P165, DOI 10.1016/S0959-440X(00)00061-0
   Bishop K, 1999, FEBS LETT, V450, P57, DOI 10.1016/S0014-5793(99)00465-2
   Bruice TC, 2002, ACCOUNTS CHEM RES, V35, P139, DOI 10.1021/ar0001665
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2001, NAT STRUCT BIOL, V8, P963, DOI 10.1038/nsb1101-963
   Contestabile R, 2000, J BIOL CHEM, V275, P3879, DOI 10.1074/jbc.275.6.3879
   Denessiouk KA, 1999, PROTEINS, V35, P250, DOI 10.1002/(SICI)1097-0134(19990501)35:2<250::AID-PROT10>3.0.CO;2-X
   Denesyuk AI, 2003, BBA-PROTEINS PROTEOM, V1647, P234, DOI 10.1016/S1570-9639(03)00057-8
   Eisenmesser EZ, 2002, SCIENCE, V295, P1520, DOI 10.1126/science.1066176
   FETROW JS, 1995, FASEB J, V9, P708
   FIRST EA, 1993, BIOCHEMISTRY-US, V32, P13658, DOI 10.1021/bi00212a034
   FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x
   FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451
   GRIMM B, 1991, J BIOL CHEM, V266, P12495
   Hennig M, 1997, P NATL ACAD SCI USA, V94, P4866, DOI 10.1073/pnas.94.10.4866
   HOFRICHTER J, 1976, ANNU REV BIOPHYS BIO, V5, P511, DOI 10.1146/annurev.bb.05.060176.002455
   HOL WGJ, 1985, PROG BIOPHYS MOL BIO, V45, P149, DOI 10.1016/0079-6107(85)90001-X
   Jardetzky O, 1996, PROG BIOPHYS MOL BIO, V65, P171, DOI 10.1016/S0079-6107(96)00010-7
   JORDAN PM, 1973, J BIOL CHEM, V248, P1019
   JOSEPH D, 1990, SCIENCE, V249, P1425, DOI 10.1126/science.2402636
   KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0
   KOSHLAND DE, 1963, SCIENCE, V142, P1533, DOI 10.1126/science.142.3599.1533
   KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047
   KRAUT J, 1988, SCIENCE, V242, P533, DOI 10.1126/science.3051385
   Li J, 2004, J BIOL CHEM, V279, P32968, DOI 10.1074/jbc.M403611200
   Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295
   MAUZERALL D, 1956, J BIOL CHEM, V219, P435
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Moser J, 2001, EMBO J, V20, P6583, DOI 10.1093/emboj/20.23.6583
   PAULING L, 1948, NATURE, V161, P707, DOI 10.1038/161707a0
   PUGH CE, 1992, J BIOL CHEM, V267, P1584
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   SMITH MA, 1992, BIOCHEMISTRY-US, V31, P11249, DOI 10.1021/bi00160a041
   Stevens SY, 2001, NAT STRUCT BIOL, V8, P947, DOI 10.1038/nsb1101-947
   Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881
   TURK D, 1992, THESIS TU MUNCHEN MU
   TYACKE RJ, 1993, BIOCHEM J, V293, P697, DOI 10.1042/bj2930697
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
NR 40
TC 27
Z9 27
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 12
PY 2006
VL 103
IS 37
BP 13688
EP 13693
DI 10.1073/pnas.0600306103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 086BO
UT WOS:000240648300026
PM 16954186
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Farhadi, J
   Fulco, I
   Miot, S
   Wirz, D
   Haug, M
   Dickinson, SC
   Hollander, AP
   Daniels, A
   Pierer, G
   Heberer, M
   Martin, I
AF Farhadi, J.
   Fulco, I.
   Miot, S.
   Wirz, D.
   Haug, M.
   Dickinson, S. C.
   Hollander, A. P.
   Daniels, A.
   Pierer, G.
   Heberer, M.
   Martin, I.
TI Pre-cultivation of engineered human nasal cartilage enhances the
   mechanical properties relevant for use in facial reconstructive surgery
SO BRITISH JOURNAL OF SURGERY
LA English
DT Meeting Abstract
CT 93rd Annual Congress of the Swiss-Society-of-Surgery
CY JUN 21-23, 2006
CL Lugano, SWITZERLAND
SP Swiss Soc Surg
C1 Univ Basel Hosp, Dept Surg, Basel, Switzerland.
   Univ Basel Hosp, Res Dept, Basel, Switzerland.
   Univ Basel, LOB, Biozentrum, Pharmazentrum, Basel, Switzerland.
   Univ Bristol, Southmead Hosp, Avon Orthopaed Ctr, Bristol, Avon, England.
   ICFS, Dept Chirurg, Basel, Switzerland.
RI Martin, Ivan/K-9286-2016
NR 0
TC 0
Z9 0
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0007-1323
J9 BRIT J SURG
JI Br. J. Surg.
PD SEP
PY 2006
VL 93
IS 9
BP 1155
EP 1155
PG 1
WC Surgery
SC Surgery
GA 082NS
UT WOS:000240394200031
DA 2021-01-25
ER

PT J
AU Vallee, B
   Funato, K
   Meier, K
   Friant, S
   Riezman, H
AF Vallee, B.
   Funato, K.
   Meier, K.
   Friant, S.
   Riezman, H.
TI Synthesis, transport, and function of ceramides in yeast
SO CHEMISTRY AND PHYSICS OF LIPIDS
LA English
DT Meeting Abstract
CT 47th International Conference on Bioscience of Lipids
CY SEP 05-10, 2006
CL Pecs, HUNGARY
SP Hungarian Biochem Soc, Hungarian Acad Sci, Biol Res Ctr, Straub Heritage Fdn, European Lipidom Initiat, Int Lecithin & Phospholipid Soc
C1 IBPC, UMR 5086, Lyon, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0009-3084
J9 CHEM PHYS LIPIDS
JI Chem. Phys. Lipids
PD SEP
PY 2006
VL 143
IS 1-2
BP 51
EP 52
PG 2
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 075JL
UT WOS:000239880900036
DA 2021-01-25
ER

PT J
AU Kopp, C
   Nicholson, JR
   Luthi, A
AF Kopp, C.
   Nicholson, J. R.
   Luthi, A.
TI Sleep deprivation alters synaptic plasticity and NMDA receptor function
   in the mouse hippocampus
SO JOURNAL OF SLEEP RESEARCH
LA English
DT Meeting Abstract
CT 18th Congress of the European-Sleep-Research-Society
CY SEP 12-16, 2006
CL Innsbruck, AUSTRIA
SP European Sleep Res Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0962-1105
J9 J SLEEP RES
JI J. Sleep Res.
PD SEP
PY 2006
VL 15
SU 1
BP 252
EP 252
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 076NW
UT WOS:000239966000702
DA 2021-01-25
ER

PT J
AU Junne, T
   Schwede, T
   Goder, V
   Spiess, M
AF Junne, Tina
   Schwede, Torsten
   Goder, Veit
   Spiess, Martin
TI The plug domain of yeast Sec61p is important for efficient protein
   translocation, but is not essential for cell viability
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SIGNAL SEQUENCE ORIENTATION; ENDOPLASMIC-RETICULUM; ER MEMBRANE; ANCHOR
   PROTEINS; SWISS-MODEL; SECY; PORE; BIP; INSERTION; RESIDUES
AB The Sec61/SecY translocon mediates translocation of proteins across the membrane and integration of membrane proteins into the lipid bilayer. The structure of the translocon revealed a plug domain blocking the pore on the lumenal side. It was proposed to be important for gating the protein conducting channel and for maintaining the permeability barrier in its unoccupied state. Here, we analyzed in yeast the effect of introducing destabilizing point mutations in the plug domain or of its partial or complete deletion. Unexpectedly, even when the entire plug domain was deleted, cells were viable without growth phenotype. They showed an effect on signal sequence orientation of diagnostic signal-anchor proteins, a minor defect in cotranslational and a significant deficiency in posttranslational translocation. Steady-state levels of the mutant protein were reduced, and when coexpressed with wild-type Sec61p, the mutant lacking the plug competed poorly for complex partners. The results suggest that the plug is unlikely to be important for sealing the translocation pore in yeast but that it plays a role in stabilizing Sec61p during translocon formation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
RI Schwede, Torsten/A-4650-2008; Goder, Veit/F-8092-2016
OI Schwede, Torsten/0000-0003-2715-335X; Goder, Veit/0000-0003-0854-4873;
   Spiess, Martin/0000-0001-7139-0550
CR Alder NN, 2005, J CELL BIOL, V168, P389, DOI 10.1083/jcb.200409174
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Cannon KS, 2005, J CELL BIOL, V169, P219, DOI 10.1083/jcb.200412019
   Cheng ZL, 2005, J CELL BIOL, V168, P67, DOI 10.1083/jcb.200408188
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   Eusebio A, 1998, EXP CELL RES, V241, P181, DOI 10.1006/excr.1998.4042
   FLOWER AM, 1995, EMBO J, V14, P884, DOI 10.1002/j.1460-2075.1995.tb07070.x
   Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Haigh NG, 2002, J CELL BIOL, V156, P261, DOI 10.1083/jcb.200110074
   Hamman BD, 1998, CELL, V92, P747, DOI 10.1016/S0092-8674(00)81403-8
   Harley CA, 1998, J BIOL CHEM, V273, P24963, DOI 10.1074/jbc.273.38.24963
   Harris CR, 1999, J BACTERIOL, V181, P3438, DOI 10.1128/JB.181.11.3438-3444.1999
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P936
   Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540
   Plath K, 1998, CELL, V94, P795, DOI 10.1016/S0092-8674(00)81738-9
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   STIRLING CJ, 1992, MOL BIOL CELL, V3, P129
   TAM PC, 2005, EMBO J
   Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   Wilkinson BM, 2000, J BIOL CHEM, V275, P521, DOI 10.1074/jbc.275.1.521
NR 35
TC 57
Z9 59
U1 0
U2 6
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD SEP
PY 2006
VL 17
IS 9
BP 4063
EP 4068
DI 10.1091/mbc.E06-03-0200
PG 6
WC Cell Biology
SC Cell Biology
GA 078SZ
UT WOS:000240125000029
PM 16822836
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Marino, M
   Zou, PJ
   Svergun, D
   Garcia, P
   Edlich, C
   Simon, B
   Wilmanns, M
   Muhle-Gol, C
   Mayans, O
AF Marino, Marco
   Zou, Peijian
   Svergun, Dmitri
   Garcia, Pilar
   Edlich, Christian
   Simon, Bernd
   Wilmanns, Matthias
   Muhle-Gol, Claudia
   Mayans, Olga
TI The Ig doublet Z1Z2: A model system for the hybrid analysis of
   conformational dynamics in Ig tandems from titin
SO STRUCTURE
LA English
DT Article
ID RESIDUAL DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; SOLUTION SCATTERING;
   PROTEIN-STRUCTURE; ZIPPER MECHANISM; Z-DISC; DOMAINS; MACROMOLECULES;
   ASSIGNMENT; SUGGESTS
AB Titin is a gigantic elastic filament that determines sarcomere ultrastructure and stretch response in vertebrate muscle. It folds into numerous Ig and FnIII domains connected in tandem. Data on interdomain arrangements and dynamics are essential for understanding the function of this filament. Here, we report a mechanistic analysis of the conformational dynamics of two Ig domains from the N terminus of titin, Z1Z2, by using X-ray crystallography, SAXS, NMR relaxation data, and residual dipolar couplings in combination. Z1Z2 preferentially adopts semiextended conformations in solution, with close-hinge arrangements representing low-probability states. Although interdomain contacts are not observed, the linker appears to acquire moderate rigidity via small, local hydrophobic interactions. Thus, Z1Z2 constitutes an adaptable modular system with restricted dynamics. We speculate that its preexistent conformation contributes to the selective recruitment of the binding partner telethonin onto the repetitive surface of the filament. The structural interconversion of four Z1Z2 conformers is analyzed.
C1 European Mol Biol Lab, D-69117 Heidelberg, Germany.
   Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia.
   DESY, EMBL Outstn, D-22603 Hamburg, Germany.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Max Planck Inst Med Res, D-69120 Heidelberg, Germany.
RP Mayans, O (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM muhle@embl-heidelberg.de; olga.mayans@unibas.ch
RI Mayans, Olga/A-3954-2008
OI Mayans, Olga/0000-0001-6876-8532; Wilmanns,
   Matthias/0000-0002-4643-5435; Simon, Bernd/0000-0003-0164-5516; Svergun,
   Dmitri/0000-0003-0830-5696
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bax A, 2001, METHOD ENZYMOL, V339, P127, DOI 10.1016/S0076-6879(01)39313-8
   Bertini I, 2004, P NATL ACAD SCI USA, V101, P6841, DOI 10.1073/pnas.0308641101
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cierpicki T, 2004, J AM CHEM SOC, V126, P16259, DOI 10.1021/ja046054g
   Clore GM, 1998, J MAGN RESON, V131, P159, DOI 10.1006/jmre.1997.1345
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Edlich C, 2003, J BIOMOL NMR, V27, P283, DOI 10.1023/A:1025493410292
   Evans P. R., 1993, P CCP4 STUD WEEK DAT, P114
   Feigin L.A., 1987, STRUCTURE ANAL SMALL
   Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1
   Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8
   Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013
   HARPAZ Y, 1994, J MOL BIOL, V238, P528, DOI 10.1006/jmbi.1994.1312
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7
   Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   LESLIE AGW, 1992, JOINT CCP4 ESF EAMCB
   Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2
   Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754
   Lu GG, 2000, J APPL CRYSTALLOGR, V33, P176, DOI 10.1107/S0021889899012339
   LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161
   Marino M, 2005, J MUSCLE RES CELL M, V26, P355, DOI 10.1007/s10974-005-9017-6
   Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8
   Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422
   Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007
   Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050
   Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260
   Soroka V, 2003, STRUCTURE, V11, P1291, DOI 10.1016/j.str.2003.09.006
   Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736
   Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1
   Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732
   Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684
   Zou PJ, 2006, NATURE, V439, P229, DOI 10.1038/nature04343
   Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200
   Zweckstetter M, 2002, J BIOMOL NMR, V23, P127, DOI 10.1023/A:1016316415261
NR 43
TC 39
Z9 39
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD SEP
PY 2006
VL 14
IS 9
BP 1437
EP 1447
DI 10.1016/j.str.2006.07.009
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 085PQ
UT WOS:000240616400011
PM 16962974
OA Green Published
DA 2021-01-25
ER

PT J
AU Cordier, F
   Hartmann, B
   Rogowski, M
   Affolter, M
   Grzesiek, S
AF Cordier, Florence
   Hartmann, Britta
   Rogowski, Marco
   Affolter, Markus
   Grzesiek, Stephan
TI DNA recognition by the Brinker repressor - An extreme case of coupling
   between binding and folding
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein-DNA interaction; transcription factor; heteronuclear NMR;
   protein dynamics; protein folding
ID TRANSCRIPTIONAL REPRESSOR; UNSTRUCTURED PROTEINS; MORPHOGEN GRADIENT;
   CRYSTAL-STRUCTURE; DROSOPHILA; DPP; COMPLEX; NMR; HOMEODOMAIN; ALIGNMENT
AB The Brinker (Brk) nuclear repressor is a major element of the Drosophila Decapentaplegic morphogen signaling pathway. Its N-terminal part has weak homology to the Antennapedia homeodomain and binds to GC-rich DNA sequences. We have investigated the conformation and dynamics of the N-terminal 101 amino acid residues of Brk in the absence and in the presence of cognate DNA by solution NMR spectroscopy. In the absence of DNA, Brk is unfolded and highly flexible throughout the entire backbone. Addition of cognate DNA induces the formation of a well-folded structure for residues R46 to R95. This structure consists of four helices forming a helix-turn-helix motif that differs from homeodomains, but has similarities to the Tc3 transposase, the Pax-6 Paired domain, and the human centromere-binding protein. The GC-rich DNA recognition can be explained by specific major groove hydrogen bonds from the N-terminal end of helix alpha 3. The transition from a highly flexible, completely unfolded conformation in the absence of DNA to a well-formed structure in the complex presents a very extreme case of the "coupling of binding and folding" phenomenon. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Cell Biol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Div Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225; Affolter,
   Markus/0000-0002-5171-0016; Cordier, Florence/0000-0002-5963-7773
CR Affolter M, 2001, EMBO J, V20, P3298, DOI 10.1093/emboj/20.13.3298
   ARROWSMITH C, 1991, EUR J BIOCHEM, V202, P53, DOI 10.1111/j.1432-1033.1991.tb16344.x
   Bagby S, 1998, BIOCHEM CELL BIOL, V76, P368, DOI 10.1139/bcb-76-2-3-368
   Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101
   BILLETER M, 1993, J MOL BIOL, V234, P1084, DOI 10.1006/jmbi.1993.1661
   BRUNGER AT, 1992, X PLOR VERIONS 3 1 S
   Cordier F, 1999, J BIOMOL NMR, V13, P175, DOI 10.1023/A:1008301415843
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Fraenkel E, 1998, NAT STRUCT BIOL, V5, P692, DOI 10.1038/1382
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   GRONENBORN AM, 1985, PROG NUCL MAG RES SP, V17, P1, DOI 10.1016/0079-6565(85)80004-2
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HARD T, 1990, SCIENCE, V249, P157, DOI 10.1126/science.2115209
   Hard T, 1999, Q REV BIOPHYS, V32, P57, DOI 10.1017/S0033583599003509
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Iwahara J, 1998, EMBO J, V17, P827, DOI 10.1093/emboj/17.3.827
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Kalodimos CG, 2004, SCIENCE, V305, P386, DOI 10.1126/science.1097064
   Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lecuit T, 1996, NATURE, V381, P387, DOI 10.1038/381387a0
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Love JJ, 2004, BIOCHEMISTRY-US, V43, P8725, DOI 10.1021/bi049591m
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Marty T, 2001, DEVELOPMENT, V128, P2833
   Moser M, 2005, DEV BIOL, V286, P647, DOI 10.1016/j.ydbio.2005.08.036
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546
   Parker L, 2004, PROG MOLEC, V34, P73
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8
   Saller E, 2002, GENE DEV, V16, P1828, DOI 10.1101/gad.230002
   Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   TUNG CS, 1994, COMPUT APPL BIOSCI, V10, P427
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wintjens R, 1996, J MOL BIOL, V262, P294, DOI 10.1006/jmbi.1996.0514
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   WUTHERICH K, 1986, NMR PROTEINS NUCL AC
   Xiang BS, 1998, P NATL ACAD SCI USA, V95, P7412, DOI 10.1073/pnas.95.13.7412
   Xu HE, 1999, GENE DEV, V13, P1263, DOI 10.1101/gad.13.10.1263
   Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201
NR 57
TC 24
Z9 25
U1 0
U2 13
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 25
PY 2006
VL 361
IS 4
BP 659
EP 672
DI 10.1016/j.jmb.2006.06.045
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 080FQ
UT WOS:000240233700005
PM 16876822
DA 2021-01-25
ER

PT J
AU Rudolph, MG
   Heissmann, R
   Wittmann, JG
   Klostermeier, D
AF Rudolph, Markus G.
   Heissmann, Ramona
   Wittmann, Julia G.
   Klostermeier, Dagmar
TI Crystal structure and nucleotide binding of the Thermus thermophilus RNA
   helicase Hera N-terminal domain
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE DEAD box RNA helicase; nucleotide binding; X-ray crystallography
ID DEAD-BOX PROTEIN; INITIATION-FACTOR 4A; Q-MOTIF; ATP; RESOLUTION;
   STABILITY; MECHANISM; MODEL; EIF4A; STATE
AB DEAD box RNA helicases use the energy of ATP hydrolysis to unwind double-stranded RNA regions or to disrupt RNA/protein complexes. A minimal RNA helicase comprises nine conserved motifs distributed over two RecA-like domains. The N-terminal domain contains all motifs involved in nucleotide binding, namely the Q-motif, the DEAD box, and the P-loop, as well as the SAT motif, which has been implicated in the coordination of ATP hydrolysis and RNA unwinding. We present here the crystal structure of the N-terminal domain of the Thermus thermophilus RNA helicase Hera in complex with adenosine monophosphate (AMP). Upon binding of AMP the P-loop adopts a partially collapsed or half-open conformation that is still connected to the DEAD box motif, and the DEAD box in turn is linked to the SAT motif via hydrogen bonds. This network of interactions communicates changes in the P-loop conformation to distant parts of the helicase. The affinity of AMP is comparable to that of ADP and ATP, substantiating that the binding energy from additional phosphate moieties is directly converted into conformational changes of the entire helicase. Importantly, the N-terminal Hera domain forms a dimer in the crystal similar to that seen in another thermophilic prokaryote. It is possible that this mode of dimerization represents the prototypic architecture in RNA helicases of thermophilic origin. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Gottingen, Dept Mol Struct Biol, D-37077 Gottingen, Germany.
   Univ Bayreuth, Dept Expt Phys 4, D-95440 Bayreuth, Germany.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
OI Rudolph, Markus/0000-0003-0447-1101
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Carmel AB, 2004, RNA, V10, P66, DOI 10.1261/rna.5134304
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1
   Finnin MS, 1999, NATURE, V401, P188
   Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Henn A, 2002, J BIOL CHEM, V277, P46559, DOI 10.1074/jbc.M207438200
   Hible G, 2006, PROTEINS, V62, P489, DOI 10.1002/prot.20662
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9
   Jaenicke R, 1996, ADV PROTEIN CHEM, V48, P181
   JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025
   Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Koonin Eugene V., 1992, Protein Sequences and Data Analysis, V5, P43
   Kurimoto K, 2005, J STRUCT BIOL, V150, P58, DOI 10.1016/j.jsb.2005.01.006
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   MILLER S, 1987, NATURE, V328, P834, DOI 10.1038/328834a0
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651
   Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n
   Randak C, 1997, FEBS LETT, V410, P180, DOI 10.1016/S0014-5793(97)00574-7
   REINSTEIN J, 1988, BIOCHEMISTRY-US, V27, P4712, DOI 10.1021/bi00413a020
   REINSTEIN J, 1990, BIOCHEMISTRY-US, V29, P7440, DOI 10.1021/bi00484a013
   ROSE T, 1991, J BIOL CHEM, V266, P23654
   Rudolph MG, 2002, CURR OPIN IMMUNOL, V14, P52, DOI 10.1016/S0952-7915(01)00298-9
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0
   Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101
   Soultanas P, 2000, CURR OPIN STRUC BIOL, V10, P124, DOI 10.1016/S0959-440X(99)00059-7
   STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0
   Talavera MA, 2006, J MOL BIOL, V355, P697, DOI 10.1016/j.jmb.2005.10.058
   Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296
   Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6
   Velankar SS, 1999, CELL, V97, P75, DOI 10.1016/S0092-8674(00)80716-3
   WONG I, 1992, SCIENCE, V256, P350, DOI 10.1126/science.256.5055.350
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463
   YARRANTON GT, 1979, P NATL ACAD SCI USA, V76, P1658, DOI 10.1073/pnas.76.4.1658
   Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006
NR 59
TC 32
Z9 32
U1 0
U2 1
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 25
PY 2006
VL 361
IS 4
BP 731
EP 743
DI 10.1016/j.jmb.2006.06.065
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 080FQ
UT WOS:000240233700010
PM 16890241
DA 2021-01-25
ER

PT J
AU Honma, Y
   Kitamura, A
   Shioda, R
   Maruyama, H
   Ozaki, K
   Oda, Y
   Mini, T
   Jeno, P
   Maki, Y
   Yonezawa, K
   Hurt, E
   Ueno, M
   Uritani, M
   Hall, MN
   Ushimaru, T
AF Honma, Yoshimi
   Kitamura, Aiko
   Shioda, Ryo
   Maruyama, Hironori
   Ozaki, Kanako
   Oda, Yoko
   Mini, Thierry
   Jeno, Paul
   Maki, Yasushi
   Yonezawa, Kazuyoshi
   Hurt, Ed
   Ueno, Masaru
   Uritani, Masahiro
   Hall, Michael N.
   Ushimaru, Takashi
TI TOR regulates late steps of ribosome maturation in the nucleoplasm via
   Nog1 in response to nutrients
SO EMBO JOURNAL
LA English
DT Article
DE Nog1; nucleolus; rapamycin; ribosome maturation; TOR
ID GTP-BINDING PROTEIN; NUCLEOLAR PROTEIN; SACCHAROMYCES-CEREVISIAE;
   GENE-TRANSCRIPTION; SUBUNIT BIOGENESIS; YEAST PESCADILLO; PRE-RIBOSOMES;
   RAPAMYCIN; IDENTIFICATION; ACTIVATION
AB The protein kinase TOR (target of rapamycin) controls several steps of ribosome biogenesis, including gene expression of rRNA and ribosomal proteins, and processing of the 35S rRNA precursor, in the budding yeast Saccharomyces cerevisiae. Here we show that TOR also regulates late stages of ribosome maturation in the nucleoplasm via the nuclear GTP-binding protein Nog1. Nog1 formed a complex that included 60S ribosomal proteins and pre-ribosomal proteins Nop7 and Rlp24. The Nog1 complex shuttled between the nucleolus and the nucleoplasm for ribosome biogenesis, but it was tethered to the nucleolus by both nutrient depletion and TOR inactivation, causing cessation of the late stages of ribosome biogenesis. Furthermore, after this, Nog1 and Nop7 proteins were lost, leading to complete cessation of ribosome maturation. Thus, the Nog1 complex is a critical regulator of ribosome biogenesis mediated by TOR. This is the first description of a physiological regulation of nucleolus-to-nucleoplasm translocation of pre-ribosome complexes.
C1 Shizuoka Univ, Fac Sci, Dept Biol & Geosci, Shizuoka 4228529, Japan.
   Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
   Niigata Univ, Fac Sci, Dept Biol, Niigata 95021, Japan.
   Kobe Univ, Biosignal Res Ctr, Kobe, Hyogo 657, Japan.
   BZH, Heidelberg, Germany.
RP Ushimaru, T (corresponding author), Shizuoka Univ, Fac Sci, Dept Biol & Geosci, Ohya 836, Shizuoka 4228529, Japan.
EM sbtushi@ipc.shizuoka.ac.jp
RI Ueno, Masaru/G-3990-2019; Ed Hurt, Dr./AAE-8874-2019
OI Ed Hurt, Dr./0000-0002-4535-8255; Hall, Michael N/0000-0002-2998-0757
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [16570114] Funding Source: KAKEN
CR Adams CC, 2002, RNA, V8, P150, DOI 10.1017/S1355838202010026
   Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200
   Azzam R, 2004, SCIENCE, V305, P516, DOI 10.1126/science.1099402
   Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   D'Amours D, 2004, GENE DEV, V18, P2581, DOI 10.1101/gad.1247304
   DEBEUS E, 1994, J CELL BIOL, V127, P1799, DOI 10.1083/jcb.127.6.1799
   Du YCN, 2002, CELL, V109, P835, DOI 10.1016/S0092-8674(02)00773-0
   Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x
   Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6
   Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2
   Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Gelperin D, 2001, RNA, V7, P1268, DOI 10.1017/S1355838201013073
   Ghoshal K, 1996, BIOCHEM J, V317, P689, DOI 10.1042/bj3170689
   Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   HENRIQUEZ R, 1990, J BIOL CHEM, V265, P2209
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Jensen BC, 2003, J BIOL CHEM, V278, P32204, DOI 10.1074/jbc.M304198200
   Kallstrom G, 2003, MOL CELL BIOL, V23, P4344, DOI 10.1128/MCB.23.12.4344-4355.2003
   Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898
   Kressler D, 1999, MOL CELL BIOL, V19, P7897
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Lafontaine DLJ, 2001, NAT REV MOL CELL BIO, V2, P514, DOI 10.1038/35080045
   Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020
   Laping NJ, 2001, J AM SOC NEPHROL, V12, P883
   Lerch-Gaggl A, 2002, J BIOL CHEM, V277, P45347, DOI 10.1074/jbc.M208338200
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   Milkereit P, 2001, CELL, V105, P499, DOI 10.1016/S0092-8674(01)00358-0
   Nanduri J, 2001, MOL BIOL CELL, V12, P1835, DOI 10.1091/mbc.12.6.1835
   Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547
   Oeffinger M, 2002, RNA, V8, P626, DOI 10.1017/S1355838202020022
   Park JH, 2001, J CELL SCI, V114, P173
   Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183
   Rohde J, 2001, J BIOL CHEM, V276, P9583, DOI 10.1074/jbc.R000034200
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Sakumoto N, 2001, BIOCHEM BIOPH RES CO, V289, P608, DOI 10.1006/bbrc.2001.6021
   Saveanu C, 2003, MOL CELL BIOL, V23, P4449, DOI 10.1128/MCB.23.13.4449-4460.2003
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Stegmeier F, 2004, CURR BIOL, V14, P467, DOI 10.1016/j.cub.2004.03.009
   Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578
   Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   Van Nieuwenhoven FA, 2001, EUR J CELL BIOL, V80, P586, DOI 10.1078/0171-9335-00192
   Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261
   Visintin R, 2000, CURR OPIN CELL BIOL, V12, P752, DOI 10.1016/S0955-0674(00)00165-4
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
NR 60
TC 40
Z9 47
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD AUG 23
PY 2006
VL 25
IS 16
BP 3832
EP 3842
DI 10.1038/sj.emboj.7601262
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 087SW
UT WOS:000240763700011
PM 16888624
OA Green Published
DA 2021-01-25
ER

PT J
AU Kuisle, M
   Wanaverbecq, N
   Brewster, AL
   Freere, SGA
   Pinault, D
   Baram, TZ
   Luthi, A
AF Kuisle, Mira
   Wanaverbecq, Nicolas
   Brewster, Amy L.
   Frere, Samuel G. A.
   Pinault, Didier
   Baram, Tallie Z.
   Luthi, Anita
TI Functional stabilization of weakened thalamic pacemaker channel
   regulation in rat absence epilepsy
SO JOURNAL OF PHYSIOLOGY-LONDON
LA English
DT Article
ID CA2+-MEDIATED UP-REGULATION; VOLTAGE-ACTIVATED CURRENTS; I-H; FEBRILE
   SEIZURES; CALCIUM-CHANNEL; GENETIC MODEL; SUBUNIT EXPRESSION; PYRAMIDAL
   NEURONS; SPONTANEOUS SPIKE; WAVE DISCHARGES
AB Aberrant function of pacemaker currents (I-h), carried by hyperpolarization-activated cation non-selective (HCN) channels, affects neuronal excitability and accompanies epilepsy, but its distinct roles in epileptogenesis and chronic epilepsy are unclear. We probed I-h function and subunit composition during both pre- and chronically epileptic stages in thalamocortical (TC) neurones of the Genetic Absence Epilepsy Rat from Strasbourg (GAERS). Voltage gating of I-h was unaltered in mature somatosensory TC cells, both in vivo and in vitro. However, the enhancement of I-h by phasic, near-physiological, cAMP pulses was diminished by similar to 40% and the half-maximal cAMP concentration increased by similar to 5-fold. This decreased responsiveness of I-h to its major cellular modulator preceded epilepsy onset in GAERS, persisted throughout the chronic state, and was accompanied by an enhanced expression of the cAMP-insensitive HCN1 channel mRNA (> 50%), without changes in the mRNA levels of HCN2 and HCN4. To assess for alterations in TC cell excitability, we monitored the slow up-regulation of I-h that is induced by Ca2+-triggered cAMP synthesis and important for terminating in vitro synchronized oscillations. Remarkably, repetitive rebound Ca2+ spikes evoked normal slow I-h up-regulation in mature GAERS neurones; that sufficed to attenuate spontaneous rhythmic burst discharges. These adaptive mechanisms occurred upstream of cAMP turnover and involved enhanced intracellular Ca2+ accumulation upon repetitive low-threshold Ca2+ discharges. Therefore, HCN channels appear to play a dual role in epilepsy. Weakened cAMP binding to HCN channels precedes, and likely promotes, epileptogenesis in GAERS, whereas compensatory mechanisms stabilizing I-h function contribute to the termination of spike-and-wave discharges in chronic epilepsy.
C1 Univ Basel, Dept Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Calif Irvine, Dept Anat Neurobiol, Irvine, CA 92697 USA.
   Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA.
   Fac Med Strasbourg, INSERM U666, Physiopathol Clin & Expt Schizophrenie, F-67085 Strasbourg, France.
RP Luthi, A (corresponding author), Univ Basel, Dept Pharmacol & Neurobiol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anita.luthi@unibas.ch
RI Pinault, Didier/H-7816-2016; Baram, Tallie/J-6447-2014
OI Pinault, Didier/0000-0003-3807-4817; Luthi, Anita/0000-0002-4954-4143;
   Wanaverbecq, Nicolas/0000-0001-5486-2771
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS035439, R01NS035439, R37NS035439, R37NS035439, R01NS035439,
   R01NS035439, R01NS035439, R01NS035439, F31NS047993, R01NS035439,
   R37NS035439, R37NS035439, R01NS035439, R01NS035439, R01NS035439,
   R37NS035439, R01NS035439, R01NS035439, R37NS035439, F31NS047993,
   R37NS035439, R37NS035439, R01NS035439, R01NS035439, F31NS047993] Funding
   Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [NS47993, F31
   NS047993, R01 NS035439, NS35439, R37 NS035439] Funding Source: Medline
CR Altomare C, 2003, J PHYSIOL-LONDON, V549, P347, DOI 10.1113/jphysiol.2002.027698
   Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0
   Beck H, 1998, EPILEPSY RES, V32, P321, DOI 10.1016/S0920-1211(98)00062-X
   Bender RA, 2004, ADV EXP MED BIOL, V548, P213
   Bender RA, 2003, J NEUROSCI, V23, P6826, DOI 10.1523/jneurosci.23-17-06826.2003
   Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002
   Brewster AL, 2005, NEUROBIOL DIS, V19, P200, DOI 10.1016/j.nbd.2004.12.015
   BREWSTER AL, 2006, IN PRESS CEREB CORTE
   Budde T, 2005, J NEUROSCI, V25, P9871, DOI 10.1523/JNEUROSCI.2590-05.2005
   Budde T, 2000, NEURON, V26, P483, DOI 10.1016/S0896-6273(00)81180-0
   Chen C, 2001, J GEN PHYSIOL, V117, P491, DOI 10.1085/jgp.117.5.491
   Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480
   Cooper DMF, 2003, BIOCHEM SOC T, V31, P912
   Decher N, 2003, PFLUG ARCH EUR J PHY, V446, P633, DOI 10.1007/s00424-003-1127-7
   DiPasquale E, 1997, J NEUROPHYSIOL, V77, P621, DOI 10.1152/jn.1997.77.2.621
   Dutuit M, 2000, GLIA, V32, P15, DOI 10.1002/1098-1136(200010)32:1<15::AID-GLIA20>3.0.CO;2-#
   Dutuit M, 2002, J NEUROCHEM, V80, P1029, DOI 10.1046/j.0022-3042.2002.00768.x
   Frere SGA, 2004, MOL NEUROBIOL, V30, P279, DOI 10.1385/MN:30:3:279
   Gravante B, 2004, J BIOL CHEM, V279, P43847, DOI 10.1074/jbc.M401598200
   GUYON A, 1993, NEUROREPORT, V4, P1231, DOI 10.1097/00001756-199309000-00005
   Holter J, 2005, J MOL NEUROSCI, V25, P37, DOI 10.1385/JMN:25:1:037
   Ishige K, 2001, NEUROSCI LETT, V297, P207, DOI 10.1016/S0304-3940(00)01702-X
   Klein JP, 2004, BRAIN RES, V1000, P102, DOI 10.1016/j.brainres.2003.11.051
   Ludwig A, 2003, EMBO J, V22, P216, DOI 10.1093/emboj/cdg032
   Luthi A, 1999, ANN NY ACAD SCI, V868, P765, DOI 10.1111/j.1749-6632.1999.tb11354.x
   Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7
   Luthi A, 1998, J NEUROPHYSIOL, V79, P3284, DOI 10.1152/jn.1998.79.6.3284
   Luthi A, 1999, NAT NEUROSCI, V2, P634, DOI 10.1038/10189
   Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0
   Manning JPA, 2004, NEUROSCIENCE, V123, P5, DOI 10.1016/j.neuroscience.2003.09.026
   Meeren H, 2005, ARCH NEUROL-CHICAGO, V62, P371, DOI 10.1001/archneur.62.3.371
   Meuth SG, 2005, PFLUG ARCH EUR J PHY, V450, P111, DOI 10.1007/s00424-004-1377-z
   MONTPIED P, 1995, EPILEPSIA, V36, P911, DOI 10.1111/j.1528-1157.1995.tb01635.x
   NEHER E, 1992, METHOD ENZYMOL, V207, P123
   Nersesyan H, 2004, J CEREBR BLOOD F MET, V24, P589, DOI 10.1097/01.WCB.0000117688.98763.23
   Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4
   Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.physiol.58.1.299
   Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix
   Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x
   Pinault D, 2005, J NEUROSCI METH, V141, P231, DOI 10.1016/j.jneumeth.2004.06.015
   Pinault D, 2003, J PHYSIOL-LONDON, V552, P881, DOI 10.1113/jphysiol.2003.046573
   Poolos Nicholas P., 2004, Epilepsy Curr, V4, P3, DOI 10.1111/j.1535-7597.2004.04101.x
   Renier WO, 2000, NEUROSCI RES COMMUN, V26, P181, DOI 10.1002/1520-6769(200005/06)26:3<181::AID-NRC6>3.0.CO;2-F
   Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734
   Rudolf G, 2004, EPILEPSIA, V45, P301, DOI 10.1111/j.0013-9580.2004.50303.x
   Santoro B, 2004, J NEUROSCI, V24, P10750, DOI 10.1523/JNEUROSCI.3300-04.2004
   Santoro B, 2003, TRENDS NEUROSCI, V26, P550, DOI 10.1016/j.tins.2003.08.003
   Seidenbecher T, 1998, EUR J NEUROSCI, V10, P1103, DOI 10.1046/j.1460-9568.1998.00123.x
   Seifert R, 1999, P NATL ACAD SCI USA, V96, P9391, DOI 10.1073/pnas.96.16.9391
   Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011
   Slaght SNJ, 2002, J NEUROSCI, V22, P2323, DOI 10.1523/JNEUROSCI.22-06-02323.2002
   Song I, 2004, J NEUROSCI, V24, P5249, DOI 10.1523/JNEUROSCI.5546-03.2004
   Strauss U, 2004, EUR J NEUROSCI, V19, P3048, DOI 10.1111/j.0953-816X.2004.03392.x
   STUART GJ, 2000, SOC NEUR ABSTR, V30
   Su H, 2002, J NEUROSCI, V22, P3645
   Talley EM, 2000, MOL BRAIN RES, V75, P159, DOI 10.1016/S0169-328X(99)00307-1
   TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995
   van Welie I, 2004, P NATL ACAD SCI USA, V101, P5123, DOI 10.1073/pnas.0307711101
   Vasilyev DV, 2004, J PHYSIOL-LONDON, V560, P659, DOI 10.1113/jphysiol.2004.069104
   VERGNES M, 1990, BRAIN RES, V523, P87, DOI 10.1016/0006-8993(90)91638-W
   Vincent P, 2001, J NEUROSCI METH, V108, P189, DOI 10.1016/S0165-0270(01)00393-4
   Wang J, 2002, NEURON, V36, P451, DOI 10.1016/S0896-6273(02)00968-6
   Waxman SG, 2001, NAT REV NEUROSCI, V2, P652, DOI 10.1038/35090026
   Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511
   Zhang Y, 2004, J NEUROSCI, V24, P5239, DOI 10.1523/JNEUROSCI.0992-04.2004
   Zhang Y, 2002, J NEUROSCI, V22, P6362
NR 66
TC 55
Z9 58
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3751
EI 1469-7793
J9 J PHYSIOL-LONDON
JI J. Physiol.-London
PD AUG 15
PY 2006
VL 575
IS 1
BP 83
EP 100
DI 10.1113/jphysiol.2006.110486
PG 18
WC Neurosciences; Physiology
SC Neurosciences & Neurology; Physiology
GA 071SW
UT WOS:000239623400010
PM 16728450
OA Green Published
DA 2021-01-25
ER

PT J
AU Moglich, A
   Joder, K
   Kiefhaber, T
AF Moglich, Andreas
   Joder, Karin
   Kiefhaber, Thomas
TI End-to-end distance distributions and intrachain diffusion constants in
   unfolded polypeptide chains indicate intramolecular hydrogen bond
   formation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE chain collapse; chain dynamics; denaturant; FRET
ID MOLTEN GLOBULE STATE; RESIDUAL STRUCTURE; DENATURED STATE;
   ENERGY-TRANSFER; PROTEIN; DYNAMICS; BINDING; UREA; COOPERATIVITY;
   INTERMEDIATE
AB Characterization of the unfolded state is essential for the understanding of the protein folding reaction. We performed timeresolved FRET measurements to gain information on the dimensions and the internal dynamics of unfolded polypepticle chains. Using an approach based on global analysis of data obtained from two different donor-acceptor pairs allowed for the determination of distance distribution functions and diffusion constants between the chromophores. Results on a polypepticle chain consisting of 16 Gly-Ser repeats between the FRET chromophores reveal an increase in the average end-to-end distance from 18.9 to 39.2 angstrom between 0 and 8 M GdmCl. The increase in chain dimensions is accompanied by an increase in the end-to-end diffusion constant from (3.6 +/- 1.0) X 10(-7) cm(2) S-1 in water to (14.8 +/- 2.5) x 10(-7) cm(2) s(-1) in 8 M Gc1mCl. This finding suggests that intrachain interactions in water exist even in very flexible chains lacking hydrophobic groups, which indicates intramolecular hydrogen bond formation. The interactions are broken upon denaturant binding, which leads to increased chain flexibility and longer average end-to-end distances. This finding implies that rapid collapse of polypepticle chains during refolding of denaturant-unfolded proteins is an intrinsic property of polypepticle chains and can, at least in part, be ascribed to nonspecific intramolecular hydrogen bonding. Despite decreased intrachain diffusion constants, the conformational search is accelerated in the collapsed state because of shorter diffusion distances. The measured distance distribution functions and diffusion constants in combination with Szabo-SchultenSchulten theory were able to reproduce experimentally determined rate constants for end-to-end loop formation.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
OI Moglich, Andreas/0000-0002-7382-2772
CR Bachmann A, 2002, BIOPHYS CHEM, V96, P141, DOI 10.1016/S0301-4622(02)00020-0
   Baldwin RL, 2003, J BIOL CHEM, V278, P17581, DOI 10.1074/jbc.X200009200
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   Damaschun G, 1998, BIOCHEMISTRY-MOSCOW+, V63, P259
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Eaton WA, 1996, STRUCTURE, V4, P1133, DOI 10.1016/S0969-2126(96)00121-9
   FERSHT AR, 1987, TRENDS BIOCHEM SCI, V12, P301, DOI 10.1016/0968-0004(87)90146-0
   FIERZ B, 2005, PROTEIN FOLDING HDB, V2, P805
   Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101
   Flory P.J., 1969, STAT MECH CHAIN MOL
   FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105
   Gong HP, 2005, P NATL ACAD SCI USA, V102, P16227, DOI 10.1073/pnas.0508415102
   HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103
   HAAS E, 1975, P NATL ACAD SCI USA, V72, P1807, DOI 10.1073/pnas.72.5.1807
   Kay MS, 1996, NAT STRUCT BIOL, V3, P439, DOI 10.1038/nsb0596-439
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i
   Krieger F, 2004, CHEM PHYS, V307, P209, DOI 10.1016/j.chemphys.2004.05.036
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   LAKOWICZ JR, 1991, J PHYS CHEM-US, V95, P9654, DOI 10.1021/j100177a012
   LAKOWICZ JR, 1990, CHEM PHYS LETT, V173, P319, DOI 10.1016/0009-2614(90)85277-J
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Lopez MM, 2002, P NATL ACAD SCI USA, V99, P1298, DOI 10.1073/pnas.032665199
   MILLER WG, 1967, J MOL BIOL, V23, P67, DOI 10.1016/S0022-2836(67)80067-6
   Moglich A, 2005, J MOL BIOL, V345, P153, DOI 10.1016/j.jmb.2004.10.036
   Navon A, 2001, BIOCHEMISTRY-US, V40, P105, DOI 10.1021/bi001946o
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7
   Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054
   Richardson JM, 2005, P NATL ACAD SCI USA, V102, P1413, DOI 10.1073/pnas.0408004102
   Roder H, 2005, PROTEIN FOLDING HANDBOOK, P491, DOI 10.1002/9783527619498.ch15
   Sadqi M, 2003, P NATL ACAD SCI USA, V100, P12117, DOI 10.1073/pnas.2033863100
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   SCHELLMAN JA, 1987, BIOPOLYMERS, V26, P549, DOI 10.1002/bip.360260408
   Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1
   SCHIMMEL PR, 1967, P NATL ACAD SCI USA, V58, P52, DOI 10.1073/pnas.58.1.52
   Segel DJ, 1999, J MOL BIOL, V288, P489, DOI 10.1006/jmbi.1999.2703
   SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715
   TERAZIMA M, 1995, J CHEM PHYS, V102, P2506, DOI 10.1063/1.468679
   von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129
   Weast R.C., 1972, HDB CHEM PHYS
   Wirmer J, 2005, PROTEIN FOLDING HANDBOOK, P737, DOI 10.1002/9783527619498.ch21
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
NR 49
TC 194
Z9 194
U1 0
U2 51
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 15
PY 2006
VL 103
IS 33
BP 12394
EP 12399
DI 10.1073/pnas.0604748103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 075EW
UT WOS:000239867500036
PM 16894178
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Segawa, Y
   Suga, H
   Iwabe, N
   Oneyama, C
   Akagi, T
   Miyata, T
   Okada, M
AF Segawa, Yuko
   Suga, Hiroshi
   Iwabe, Naoyuki
   Oneyama, Chitose
   Akagi, Tsuyoshi
   Miyata, Takashi
   Okada, Masato
TI Functional development of Src tyrosine kinases during evolution from a
   unicellular ancestor to multicellular animals
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE choanoflagellate; Csk; sponge
ID COLON-CANCER CELLS; TRANSFORMING GENE; CRYSTAL-STRUCTURE; FAMILY
   KINASES; SARCOMA VIRUS; PROTEIN; ADHESION; CSK; CADHERIN; SPONGE
AB The Src family of tyrosine kinases play pivotal roles in regulating cellular functions characteristic of multicellular animals, including cell-cell interactions, cell-substrate adhesion, and cell migration. To investigate the functional alteration of Src kinases during evolution from a unicellular ancestor to multicellular animals, we characterized Src orthologs from the unicellular choanoflagellate Monosiga ovata and the primitive multicellular sponge Ephydatia fluviatilis. Here, we show that the src gene family and its C-terminal Src kinase (Csk)-mediated regulatory system already were established in the unicellular M. ovata and that unicellular Src has unique features relative to multicellular Src: It can be phosphorylated by Csk at the negative regulatory site but still exhibits substantial activity even in the phosphorylated form. Analyses of chimera molecules between M. ovata and E. fluviatilis Src orthologs reveal that structural alterations in the kinase domain are responsible for the unstable negative regulation of M. ovata Src. When expressed in vertebrate fibroblasts, M. ovata Src can induce cell transformation irrespective of the presence of Csk. These findings suggest that a structure of Src required for the stable Csk-mediated negative regulation still is immature in the unicellular M. ovata and that the development of stable negative regulation of Src may correlate with the evolution of multicellularity in animals.
C1 Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Osaka 5650871, Japan.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan.
   Osaka Biosci Inst, Mol Oncol Lab, Osaka 5670085, Japan.
   Waseda Univ, Tokyo 1698555, Japan.
RP Okada, M (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Oncogene Res, Osaka 5650871, Japan.
EM okadam@biken.osaka-u.ac.jp
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [16002014, 17570191, 17370048, 18790221] Funding Source: KAKEN
CR Akagi T, 2003, P NATL ACAD SCI USA, V100, P13567, DOI 10.1073/pnas.1834876100
   Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829
   BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251
   Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0
   Brunton VG, 2004, BBA-MOL CELL RES, V1692, P121, DOI 10.1016/j.bbamcr.2004.04.010
   COOPER JA, 1993, CELL, V73, P1051, DOI 10.1016/0092-8674(93)90634-3
   Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012
   DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   Frame MC, 2002, BBA-REV CANCER, V1602, P114, DOI 10.1016/S0304-419X(02)00040-9
   Fukuhara T, 2004, J CELL BIOL, V166, P393, DOI 10.1083/jcb.200401093
   HIBBERD DJ, 1975, J CELL SCI, V17, P191
   Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607
   HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311
   IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3
   King N, 2001, P NATL ACAD SCI USA, V98, P15032, DOI 10.1073/pnas.261477698
   King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853
   Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9
   LEADBEATER BSC, 1983, J MAR BIOL ASSOC UK, V63, P135, DOI 10.1017/S0025315400049857
   MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703
   Miller MA, 2000, ONCOGENE, V19, P3925, DOI 10.1038/sj.onc.1203714
   NADA S, 1994, ONCOGENE, V9, P3571
   NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4
   NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0
   NAGAFUCHI A, 1991, CELL, V65, P849, DOI 10.1016/0092-8674(91)90392-C
   OKADA M, 1991, J BIOL CHEM, V266, P24249
   OTTILIE S, 1992, ONCOGENE, V7, P1625
   Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160
   Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182
   Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041
   SHIBAMOTO S, 1995, J CELL BIOL, V128, P949, DOI 10.1083/jcb.128.5.949
   Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0
   Snell EA, 2001, CURR BIOL, V11, P967, DOI 10.1016/S0960-9822(01)00275-5
   SPECTOR DH, 1978, P NATL ACAD SCI USA, V75, P4102, DOI 10.1073/pnas.75.9.4102
   Suga H, 2001, GENE, V280, P195, DOI 10.1016/S0378-1119(01)00784-3
   Suga H, 1999, J MOL EVOL, V48, P646, DOI 10.1007/PL00006508
   TAKEICHI M, 1990, ANNU REV BIOCHEM, V59, P237, DOI 10.1146/annurev.biochem.59.1.237
   Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094
   WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121
   Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0
NR 40
TC 59
Z9 61
U1 0
U2 9
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 8
PY 2006
VL 103
IS 32
BP 12021
EP 12026
DI 10.1073/pnas.0600021103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 072VU
UT WOS:000239701900037
PM 16873552
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Heinz, B
   Schmidt, B
   Root, C
   Satzger, H
   Milota, F
   Fierz, B
   Kiefhaber, T
   Zinth, W
   Gilch, P
AF Heinz, B.
   Schmidt, B.
   Root, C.
   Satzger, H.
   Milota, F.
   Fierz, B.
   Kiefhaber, T.
   Zinth, W.
   Gilch, P.
TI On the unusual fluorescence properties of xanthone in water
SO PHYSICAL CHEMISTRY CHEMICAL PHYSICS
LA English
DT Article
ID INTERSYSTEM CROSSING KINETICS; SOLVENT DEPENDENCE; AROMATIC KETONES;
   ENERGY-TRANSFER; ABSORPTION; SPECTRA; TRIPLET; STATES; MOLECULES;
   DYNAMICS
AB Photo-excited xanthone is known to undergo ultrafast intersystem crossing (ISC) in the 1 ps time domain. Correspondingly, its fluorescence quantum yield in most solvents is very small (similar to 10(-4)). Surprisingly, the quantum yield in water is 100 times larger, while ISC is still rapid (similar to 1 ps), as seen by ultrafast pump probe absorption spectroscopy. Temperature dependent steady state and time resolved fluorescence experiments point to a delayed fluorescence mechanism, where the triplet (3)n pi* state primarily accessed by ISC is nearly isoenergetic with the photo-excited (1)pi pi* state. The delayed fluorescence of xanthone in water decays with a time constant of 700 ps, apparently by internal conversion between the (3)n pi* state and the lowest lying triplet state (3)pi pi*.
C1 Univ Munich, Dept Phys, D-80538 Munich, Germany.
   Natl Res Council Canada, Steacie Inst Mol Sci, Ottawa, ON K1A 0R6, Canada.
   Univ Vienna, Inst Phys Chem, A-1090 Vienna, Austria.
   Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Gilch, P (corresponding author), Univ Munich, Dept Phys, Oettingenstr 67, D-80538 Munich, Germany.
EM Peter.Gilch@physik.uni-muenchen.de
RI Milota, Franz/F-3817-2011; Kiefhaber, Thomas/A-3028-2010; Fierz,
   Beat/H-3143-2012
OI Fierz, Beat/0000-0002-2991-3044
CR ASTRUC D, 1982, TRIPLET STATE ODMR S
   Berlman IB, 1971, HDB FLUORESCENCE SPE
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   Cavaleri JJ, 1996, CHEM PHYS LETT, V259, P495, DOI 10.1016/0009-2614(96)00782-8
   CHAKRABARTI A, 1976, J PHYS CHEM-US, V80, P2966, DOI 10.1021/j100908a012
   CONNORS RE, 1987, J PHYS CHEM-US, V91, P819, DOI 10.1021/j100288a012
   CONNORS RE, 1982, J PHYS CHEM-US, V86, P1524, DOI 10.1021/j100206a012
   DAMSCHEN DE, 1978, J PHYS CHEM-US, V82, P2268, DOI 10.1021/j100510a002
   DeVault D., 1984, QUANTUM MECH TUNNELL
   ELSAYED MA, 1963, J CHEM PHYS, V38, P2834, DOI 10.1063/1.1733610
   Fukuzumi S, 2001, J AM CHEM SOC, V123, P7756, DOI 10.1021/ja010125j
   GREENE BI, 1979, J CHEM PHYS, V70, P1247, DOI 10.1063/1.437617
   HORNG ML, 1995, J PHYS CHEM-US, V99, P17311, DOI 10.1021/j100048a004
   IIJIMA K, 1989, J MOL STRUCT, V213, P263, DOI 10.1016/0022-2860(89)85126-9
   Kopecky J, 1992, PHOTOCHEMISTRY VISUA
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2004, CHEM PHYS, V307, P209, DOI 10.1016/j.chemphys.2004.05.036
   LAMI H, 1966, J PHYS-PARIS, V27, P398, DOI 10.1051/jphys:01966002707-8039800
   Ley C, 2000, J PHOTOCH PHOTOBIO A, V137, P87, DOI 10.1016/S1010-6030(00)00374-9
   Ley C, 2000, CHEM PHYS, V255, P335, DOI 10.1016/S0301-0104(00)00056-2
   MARCUS RA, 1989, J PHYS CHEM-US, V93, P3078, DOI 10.1021/j100345a040
   Mitsui M, 2000, J PHYS CHEM A, V104, P8660, DOI 10.1021/jp001049u
   Mohtat N, 1998, J PHYS CHEM B, V102, P7557, DOI 10.1021/jp981951q
   Morlet-Savary F, 1999, J PHOTOCH PHOTOBIO A, V126, P7, DOI 10.1016/S1010-6030(99)00117-3
   MURAI H, 1988, J PHYS CHEM-US, V92, P2120, DOI 10.1021/j100319a007
   Murov S. L., 1993, HDB PHOTOCHEMISTRY
   O'Connor D. V., 1984, TIME CORRELATED SING
   Ohshima Y, 2003, J PHYS CHEM A, V107, P8851, DOI 10.1021/jp030260d
   POWNALL HJ, 1971, J AM CHEM SOC, V93, P6429, DOI 10.1021/ja00753a016
   Satzger H, 2004, J PHYS CHEM A, V108, P10072, DOI 10.1021/jp047583+
   Satzger H, 2003, CHEM PHYS LETT, V372, P216, DOI 10.1016/S0009-2614(03)00364-6
   Seel M, 1997, MEAS SCI TECHNOL, V8, P449, DOI 10.1088/0957-0233/8/4/014
   STRICKLER SJ, 1962, J CHEM PHYS, V37, P814, DOI 10.1063/1.1733166
   Turro N. J., 1978, MODERN MOL PHOTOCHEM
NR 34
TC 32
Z9 32
U1 2
U2 34
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1463-9076
J9 PHYS CHEM CHEM PHYS
JI Phys. Chem. Chem. Phys.
PD AUG 7
PY 2006
VL 8
IS 29
BP 3432
EP 3439
DI 10.1039/b603560d
PG 8
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 073SD
UT WOS:000239762000011
PM 16855722
DA 2021-01-25
ER

PT J
AU Hartig, E
   Hartmann, A
   Schatzle, M
   Albertini, AM
   Jahn, D
AF Hartig, Elisabeth
   Hartmann, Anja
   Schatzle, Manuela
   Albertini, Alessandra M.
   Jahn, Dieter
TI The Bacillus subtilis nrdEF genes, encoding a class Ib ribonucleotide
   reductase, are essential for aerobic and anaerobic growth
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID TEMPERATURE-SENSITIVE MUTANTS; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA;
   OXYGEN LIMITATION; NITRITE REDUCTASE; PROTEIN; FNR; EXPRESSION;
   ENTEROBACTERIACEAE; TRANSCRIPTION
AB Ribonucleotide reductases (RNRs) are essential for the biosynthesis of the deoxyribonucleoside triphosphates of DNA. Recently, it was proposed that externally supplied deoxyribonucleosides or DNA is required for the growth of Bacillus subtilis under strict anaerobic conditions (M. J. Folmsbee, M. J. McInerney, and D. P. Nagle, Appl. Environ. Microbiol. 70:5252-5257, 2004). Cultivation of B. subtilis on minimal medium in the presence of oxygen indicators in combination with oxygen electrode measurements and viable cell counting demonstrated that growth occurred under strict anaerobic conditions in the absence of externally supplied deoxyribonucleosides. The nrdEF genes encode the only obvious RNR in B. subtilis. A temperature-sensitive nrdE mutant failed to grow under aerobic and anaerobic conditions, indicating that this oxygen-dependent class I RNR has an essential role under both growth conditions. Aerobic growth and anaerobic growth of the nrdE mutant were rescued by addition of deoxynucleotides. The nrd locus consists of an nrdI-nrdE-nrdF-ymaB operon. The 5' end of the corresponding mRNA revealed transcriptional start sites 45 and 48 bp upstream of the translational start of nrdl. Anaerobic transcription of the operon was found to be dependent on the presence of intact genes for the ResDE two-component redox regulatory system. Two potential ResD binding sites were identified approximately 62 bp (site A) and 50 bp (site B) upstream of the transcriptional start sites by a bioinformatic approach. Only mutation of site B eliminated nrd expression. Aerobic transcription was ResDE independent but required additional promoter elements localized between 88 and 275 bp upstream of the transcriptional start.
C1 Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany.
   Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
   Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy.
RP Hartig, E (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.
EM e.haertig@tu-bs.de
OI Jahn, Dieter/0000-0002-4064-9205
CR Ausubel F. M., 1995, CURRENT PROTOCOLS MO
   BAZILL GW, 1972, MOL GEN GENET, V117, P19, DOI 10.1007/BF00268833
   Boston T, 2003, J BACTERIOL, V185, P5310, DOI 10.1128/JB.185.17.5310-5313.2003
   ENGLERBLUM G, 1993, ANAL BIOCHEM, V210, P235, DOI 10.1006/abio.1993.1189
   Eschbach M, 2004, J BACTERIOL, V186, P4596, DOI 10.1128/JB.186.14.4596-4604.2004
   Folmsbee MJ, 2004, APPL ENVIRON MICROB, V70, P5252, DOI 10.1128/AEM.70.9.5252-5257.2004
   Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   Hartig E, 2004, J BACTERIOL, V186, P6477, DOI 10.1128/JB.186.19.6477-6484.2004
   Hoffmann T, 1998, J BACTERIOL, V180, P186, DOI 10.1128/JB.180.1.186-189.1998
   HOFFMANN T, 1995, FEMS MICROBIOL LETT, V131, P219, DOI 10.1111/j.1574-6968.1995.tb07780.x
   Jordan A, 1999, J BACTERIOL, V181, P3974, DOI 10.1128/JB.181.13.3974-3980.1999
   Jordan A, 1996, J BIOL CHEM, V271, P8779, DOI 10.1074/jbc.271.15.8779
   JORDAN A, 1994, P NATL ACAD SCI USA, V91, P12892, DOI 10.1073/pnas.91.26.12892
   Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71
   Jordan A, 1997, J BIOL CHEM, V272, P18044, DOI 10.1074/jbc.272.29.18044
   KARAMATA D, 1970, MOL GEN GENET, V108, P277, DOI 10.1007/BF00283358
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   LaCelle M, 1996, J BACTERIOL, V178, P3803, DOI 10.1128/jb.178.13.3803-3808.1996
   Lazarevic V, 1998, P NATL ACAD SCI USA, V95, P1692, DOI 10.1073/pnas.95.4.1692
   Marino M, 2000, MICROBIOL-SGM, V146, P97, DOI 10.1099/00221287-146-1-97
   Marino M, 2001, J BACTERIOL, V183, P6815, DOI 10.1128/JB.183.23.6815-6821.2001
   MARTIN G, 1992, J LAT AM STUD, V24, P226, DOI 10.1017/S0022216X00023270
   Masalha M, 2001, J BACTERIOL, V183, P7260, DOI 10.1128/JB.183.24.7260-7272.2001
   Munch R, 2003, NUCLEIC ACIDS RES, V31, P266, DOI 10.1093/nar/gkg037
   Nakano M., 2001, BACILLUS SUBTILIS IT, P393
   Nakano MM, 1997, J BACTERIOL, V179, P6749, DOI 10.1128/jb.179.21.6749-6755.1997
   Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998
   Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996
   Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165
   Poole AM, 2002, J MOL EVOL, V55, P180, DOI 10.1007/s00239-002-2315-3
   Ramos HC, 2000, J BACTERIOL, V182, P3072
   Reents H, 2006, J BACTERIOL, V188, P1103, DOI 10.1128/JB.188.3.1103-1112.2006
   Reichard P, 2002, ARCH BIOCHEM BIOPHYS, V397, P149, DOI 10.1006/abbi.2001.2637
   Rompf A, 1998, MOL MICROBIOL, V29, P985, DOI 10.1046/j.1365-2958.1998.00980.x
   Scharf C, 1998, J BACTERIOL, V180, P1869, DOI 10.1128/JB.180.7.1869-1877.1998
   Scotti C, 1996, MICROBIOL-SGM, V142, P2995, DOI 10.1099/13500872-142-11-2995
   Sun GF, 1996, J BACTERIOL, V178, P1374, DOI 10.1128/jb.178.5.1374-1385.1996
   Torrents E, 2003, MICROBIOL-SGM, V149, P1011, DOI 10.1099/mic.0.26133-0
   Vollack KU, 1999, MOL MICROBIOL, V31, P1681, DOI 10.1046/j.1365-2958.1999.01302.x
   Westers H, 2003, MOL BIOL EVOL, V20, P2076, DOI 10.1093/molbev/msg219
   Ye RW, 2000, J BACTERIOL, V182, P4458, DOI 10.1128/JB.182.16.4458-4465.2000
   ZAGOREC M, 1988, J BIOL CHEM, V263, P9718
NR 45
TC 25
Z9 25
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD AUG
PY 2006
VL 72
IS 8
BP 5260
EP 5265
DI 10.1128/AEM.00599-06
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 073ZC
UT WOS:000239780400017
PM 16885274
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Muller, DJ
   Sapra, KT
   Scheuring, S
   Kedrov, A
   Frederix, PL
   Fotiadis, D
   Engel, A
AF Mueller, Daniel J.
   Sapra, K. Tanuj
   Scheuring, Simon
   Kedrov, Alexej
   Frederix, Patrick L.
   Fotiadis, Dimitrios
   Engel, Andreas
TI Single-molecule studies of membrane proteins
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; PHOTOSYNTHETIC CORE COMPLEX; COUPLED RECEPTORS;
   NATIVE MEMBRANES; ATP SYNTHASE; RHODOPSIN; AFM; ACTIVATION; RESOLUTION;
   BACTERIORHODOPSIN
AB Characterizing membrane proteins with single-molecule techniques provides structural and functional insights that cannot be obtained with conventional approaches. Recent studies show that atomic force microscopy (AFM) in the I context of a 'lab on a tip' enables the measurement of multiple parameters of membrane proteins. This multifunctional tool can be applied to probe the oligomeric states and conformational changes of membrane protein assemblies in their native environment. The ability to determine diverse properties at high spatial resolution facilitates the mapping of structural flexibilities, electrostatic potentials and electric currents. By using the AFM tip as tweezer, it is possible to characterize unfolding and refolding pathways of single proteins and the location of their molecular interactions. These interactions dictate the stability of the protein and might be modulated by ligands that alter the protein's functional state.
C1 Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany.
   CNRS, Inst Curie, UMR168, F-75248 Paris, France.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Muller, DJ (corresponding author), Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany.
EM mueller@biotec.tu-dresden.de
RI Muller, Daniel J/A-5967-2010; Scheuring, Simon/L-9843-2018
OI Muller, Daniel J/0000-0003-3075-0665; Scheuring,
   Simon/0000-0003-3534-069X; Sapra, Tanuj/0000-0001-6945-0876; Kedrov,
   Alexej/0000-0001-9117-752X
CR Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823
   Ballesteros JA, 2001, MOL PHARMACOL, V60, P1
   Cisneros DA, 2005, STRUCTURE, V13, P235, DOI 10.1016/j.str.2004.12.005
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   Dimroth P, 2003, STRUCTURE, V11, P1469, DOI 10.1016/j.str.2003.11.011
   DRYJA TP, 1995, HUM MOL GENET, V4, P1739, DOI 10.1093/hmg/4.suppl_1.1739
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   Frederix PLTM, 2005, NANOTECHNOLOGY, V16, P997, DOI 10.1088/0957-4484/16/8/001
   Goncalves RP, 2005, J STRUCT BIOL, V149, P79, DOI 10.1016/j.jsb.2004.09.001
   Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102
   Hu XC, 1998, P NATL ACAD SCI USA, V95, P5935, DOI 10.1073/pnas.95.11.5935
   Junge W, 2005, SCIENCE, V308, P642, DOI 10.1126/science.1112617
   Kedrov A, 2006, N-S ARCH PHARMACOL, V372, P400, DOI 10.1007/s00210-005-0027-0
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026
   Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023
   Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   Muller DJ, 2002, PROG BIOPHYS MOL BIO, V79, P1, DOI 10.1016/S0079-6107(02)00009-3
   Muller DJ, 1998, FEBS LETT, V430, P105, DOI 10.1016/S0014-5793(98)00623-1
   Nevo R, 2005, EMBO REP, V6, P482, DOI 10.1038/sj.embor.7400403
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6
   Philippsen A, 2002, BIOPHYS J, V82, P1667, DOI 10.1016/S0006-3495(02)75517-3
   Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517
   Rader AJ, 2004, P NATL ACAD SCI USA, V101, P7246, DOI 10.1073/pnas.0401429101
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Sapra KT, 2006, J MOL BIOL, V358, P255, DOI 10.1016/j.jmb.2006.02.008
   Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085
   Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429
   Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200
   Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Seelert H, 2000, NATURE, V405, P418
   Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047
   Strunz T, 2000, BIOPHYS J, V79, P1206, DOI 10.1016/S0006-3495(00)76375-2
NR 43
TC 87
Z9 90
U1 1
U2 32
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD AUG
PY 2006
VL 16
IS 4
BP 489
EP 495
DI 10.1016/j.sbi.2006.06.001
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 079DZ
UT WOS:000240157000009
PM 16797964
DA 2021-01-25
ER

PT J
AU de Freitas, PS
   Wirz, D
   Stoiz, M
   Gopfert, B
   Friederich, NF
   Daniels, AU
AF de Freitas, P. Scandiucci
   Wirz, D.
   Stoiz, M.
   Goepfert, B.
   Friederich, N-F.
   Daniels, A. U.
TI Pulsatile dynamic stiffness of cartilage-like materials and use of
   agarose gels to validate mechanical methods and models
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE articular cartilage; hydrogel; mechanical properties; test method;
   agarose
ID ARTICULAR-CARTILAGE; UNCONFINED COMPRESSION; ELASTIC-MODULUS; INSIGHT;
   FORCE
AB Stiffness is a fundamental indicator of the functional state of articular cartilage. Reported test modes include compressive incremental strain to determine the equilibrium modulus, and sinusoidal strain to determine the dynamic modulus and stress/strain loss angle. Here, initial development is described for a method recognizing that gait is pulsatile. Agarose gels have been used by others for validation or comparison of mechanical test methods and models for cartilage and proteoglycan aggregate. Accordingly, gels ranging from 0.5 to 20% agarose were prepared. Pulsatile stiffness in both indentation and unconfined compression were closely reproducible. Stiffness as a function of agarose concentration rose exponentially, as found using other methods. Indentation stiffness was higher than for unconfined compression and ranged from similar to 2.0 kPa for 0.5% gel to similar to 3800 kPa for 20% gel. Pulsatile dynamic stiffness appears to be a useful method, although further development is needed. Agarose gel stiffness values obtained by other methods were reviewed for comparison. Unfortunately, reported values for a given agarose concentration ranged widely (e.g. fourfold) even when test methods were similar. Causes appear to include differences in molecular weight and gel preparation time-temperature regimens. Also, agarose is hygroscopic, leading to unintended variations in gel composition. Agarose gels are problematic materials for validation or comparison of cartilage mechanical test methods and models. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Basel, LOB, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   Univ Basel, ME Muller Inst Struct Biol, Basel, Switzerland.
   Bruderholz Hosp, Dept Orthoped Surg, Basel, Switzerland.
   Univ Basel, CH-4003 Basel, Switzerland.
RP Daniels, AU (corresponding author), Univ Basel, LOB, Biozentrum, Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM alma.daniels@unibas.ch
CR Adler A, 1998, J APPL PHYSIOL, V85, P231
   Appleyard RC, 2001, PHYS MED BIOL, V46, P541, DOI 10.1088/0031-9155/46/2/319
   Aymard P, 2001, BIOPOLYMERS, V59, P131, DOI 10.1002/1097-0282(200109)59:3<131::AID-BIP1013>3.0.CO;2-8
   BUECKLE IH, 1973, SCI HARDNESS TESTING
   CHEN Q, 2003, T SUMM BIOENG C KEY
   COSTA KD, 2003, T SUMM BIOENG C KEY
   Gu WY, 2003, J BIOMECH, V36, P593, DOI 10.1016/S0021-9290(02)00437-2
   GU WY, 1996, ADV BIOENG ASME BED, V33, P89
   HALIDAY D, 2001, FUNDAMENTALS PHYS
   HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3
   Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   LAKES RS, 1998, CRC MEC ENG SER, P1
   MANKIN HJ, 2000, ORTHOPAEDIC BASIC SC, pCH17
   Matzelle TR, 2002, J PHYS CHEM B, V106, P2861, DOI 10.1021/jp0128426
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Normand V, 2000, BIOMACROMOLECULES, V1, P730, DOI 10.1021/bm005583j
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
NR 20
TC 19
Z9 19
U1 0
U2 21
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2006
VL 78B
IS 2
BP 347
EP 357
DI 10.1002/jbm.b.30494
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067KF
UT WOS:000239300000019
PM 16470817
DA 2021-01-25
ER

PT J
AU Foeger, N
   Wiesel, N
   Lotsch, D
   Mucke, N
   Kreplak, L
   Aebi, U
   Gruenbaum, Y
   Herrmann, H
AF Foeger, Nicole
   Wiesel, Naama
   Lotsch, Dorothee
   Muecke, Norbert
   Kreplak, Laurent
   Aebi, Ueli
   Gruenbaum, Yosef
   Herrmann, Harald
TI Solubility properties and specific assembly pathways of the B-type lamin
   from Caenorhabditis elegans
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT 4th Workshop on Coiled Coils, Collagen and Co-Proteins
CY SEP 11-17, 2005
CL Alpbach, AUSTRIA
DE analytical ultracentrifugation; electron microscopy; intermediate
   filament; lamin assembly; nucleus; paracrystals
ID INTERMEDIATE-FILAMENTS; NUCLEAR LAMINA; BACULOVIRUS SYSTEM; TAIL;
   PROTEINS; HEAD; VIMENTIN; ENVELOPE; DOMAIN; DM(0)
AB Lamins are nucleus-specific intermediate filament (IF) proteins that together with a complex set of membrane proteins form a filamentous meshwork tightly adhering to the inner nuclear membrane and being associated with the nuclear pore complexes. This so-called nuclear lamina provides mechanical stability and, in addition, has been implicated in the spatial organization of the heterochromatin. While increasing knowledge on the biological function of lamins has been obtained in recent years, the assembly mechanism of lamin filaments at the molecular level has remained largely elusive. Therefore, we have now more systematically investigated lamin assembly in vitro. Using Caenorhabditis elegans lamin, which has been reported to assemble into 10-nm filaments under low ionic strength conditions, we investigated the assembly kinetics of this protein into filaments in more detail using both His-tagged and un-tagged recombinant proteins. In particular, we have characterized distinct intermediates in the filament assembly process by analytical ultracentrifugation, electron and atomic force microscopy. In contrast to the general view that lamins assemble only slowly into filaments, we show that in vitro association reactions are extremely fast, and depending on the ionic conditions employed, significant filamentous assemblies form within seconds. (c) 2006 Elsevier Inc. All rights reserved.
C1 German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany.
   Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Div Mol Genet, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
RI Foeger, Nicole/L-2620-2019
OI Foeger, Nicole/0000-0001-7775-7325; kreplak, laurent/0000-0001-9370-9809
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Bussiek M, 2005, J MOL BIOL, V345, P695, DOI 10.1016/j.jmb.2004.11.016
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   Foisner R, 2001, J CELL SCI, V114, P3791
   FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X
   GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2
   GIEFFERS C, 1991, EUR J CELL BIOL, V55, P191
   GOTZMANN J, 2005, HISTOCHEM CELL BIOL, P1
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Harborth J, 2001, J CELL SCI, V114, P4557
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   Klapper M, 1997, J CELL SCI, V110, P2519
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Krohne G, 1998, EUR J CELL BIOL, V77, P276, DOI 10.1016/S0171-9335(98)80086-1
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480
   Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4
NR 26
TC 46
Z9 47
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD AUG
PY 2006
VL 155
IS 2
BP 340
EP 350
DI 10.1016/j.jsb.2006.03.026
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 082OG
UT WOS:000240395600022
PM 16713298
DA 2021-01-25
ER

PT J
AU Raineteau, O
   Hugel, S
   Ozen, I
   Rietschin, L
   Sigrist, M
   Arber, S
   Gahwiler, BH
AF Raineteau, Olivier
   Hugel, Sylvain
   Ozen, Ilknur
   Rietschin, Lotty
   Sigrist, Markus
   Arber, Silvia
   Gaehwiler, Beat H.
TI Conditional labeling of newborn granule cells to visualize their
   integration into established circuits in hippocampal slice cultures
SO MOLECULAR AND CELLULAR NEUROSCIENCE
LA English
DT Article
ID NEWLY GENERATED NEURONS; ADULT HIPPOCAMPUS; RAT HIPPOCAMPUS; DENTATE
   GYRUS; SPINE MATURATION; NEUROGENESIS; BRAIN; FATE; DIFFERENTIATION;
   REORGANIZATION
AB The dentate gyros continues to produce new granule cells throughout life. Understanding the mechanisms underlying their integration into the pre-existing hippocampal circuitry is of crucial importance. In the present study, we developed an approach allowing visual tracking of newborn granule cells in hippocampal organotypic slices. By crossing neurogenin 2 (Ngn2-CreER (TM)) with Cre-reporter mice expressing YFP or GFP reporter genes, it was possible to observe living cells after treating slice cultures with 4-hydroxytamoxifen to induce Cre recombinase activation. Colocalization of GFP with the mitotic marker BrdU demonstrated that the GFP-expressing granule cells were born in vitro. They mature and integrate normally into the hippocampal circuitry, as shown using morphological and electrophysiological techniques. This ex vivo approach therefore offers a highly accessible model to study the effects of long-term treatments on maturation and integration of newborn granule cells. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Zurich, Brain Res Inst, Zurich, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
   Inst Neurosci Cellulaires & Integrat, Strasbourg, France.
   Univ Cambridge, Brain Repair Ctr, Cambridge CB2 1TN, England.
RP Raineteau, O (corresponding author), Cambridge Ctr Brain Repair, ED Adrian Bldg,Forvie Site,Robinson Way, Cambridge CB2 2PY, England.
EM olr21@cam.ac.uk
RI Raineteau, Olivier/I-1190-2014
OI Raineteau, Olivier/0000-0003-4294-2496; Sylvain,
   Hugel/0000-0003-2464-3601; Arber, Silvia/0000-0002-6261-250X
CR Acsady L, 1998, J NEUROSCI, V18, P3386
   ALTMAN J, 1990, J COMP NEUROL, V301, P365, DOI 10.1002/cne.903010304
   Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559
   Dailey ME, 1996, J NEUROSCI, V16, P2983
   De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046
   DESIMONI A, 2003, J PHYSL, V23, P23
   Drakew A, 1999, NEUROSCIENCE, V94, P767, DOI 10.1016/S0306-4522(99)00378-4
   Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005
   Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7
   Frotscher M, 2000, CEREB CORTEX, V10, P946, DOI 10.1093/cercor/10.10.946
   Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3
   GAHWILER BH, 1981, J NEUROSCI METH, V4, P329, DOI 10.1016/0165-0270(81)90003-0
   Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404
   Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Kamada M, 2004, EUR J NEUROSCI, V20, P2499, DOI 10.1111/j.1460-9568.2004.03721.x
   Markakis EA, 1999, J COMP NEUROL, V406, P449
   McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105
   Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022
   METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991
   Mori M, 2004, NATURE, V431, P453, DOI 10.1038/nature02854
   Namba T, 2005, EUR J NEUROSCI, V22, P1928, DOI 10.1111/j.1460-9568.2005.04396.x
   Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8
   OZEN I, UNPUB PROLIFERATING
   Parent JM, 1999, J NEUROSCI, V19, P4508
   Parent JM, 2002, PROG BRAIN RES, V135, P121
   Parent JM, 1997, J NEUROSCI, V17, P3727
   Raineteau O, 2004, MOL CELL NEUROSCI, V26, P241, DOI 10.1016/j.mcn.2004.01.003
   Rao MS, 2004, EUR J NEUROSCI, V19, P234, DOI 10.1111/j.0953-816X.2003.03123.x
   Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553
   SCHWARTZKROIN PA, 1994, HIPPOCAMPUS, V4, P239, DOI 10.1002/hipo.450040302
   Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0
   Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x
   van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427
   van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a
   Wang S, 2000, J NEUROBIOL, V42, P248, DOI 10.1002/(SICI)1097-4695(20000205)42:2<248::AID-NEU8>3.0.CO;2-J
   Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006
   Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199
NR 40
TC 16
Z9 17
U1 0
U2 5
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1044-7431
EI 1095-9327
J9 MOL CELL NEUROSCI
JI Mol. Cell. Neurosci.
PD AUG
PY 2006
VL 32
IS 4
BP 344
EP 355
DI 10.1016/j.mcn.2006.05.006
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 074YE
UT WOS:000239847700004
PM 16828306
DA 2021-01-25
ER

PT J
AU Berman, HM
   Burley, SK
   Chiu, W
   Sali, A
   Adzhubei, A
   Bourne, PE
   Bryant, SH
   Dunbrack, RL
   Fidelis, K
   Frank, J
   Godzik, A
   Henrick, K
   Joachimiak, A
   Heymann, B
   Jones, D
   Markley, JL
   Moult, J
   Montelione, GT
   Orengo, C
   Rossmann, MG
   Rost, B
   Saibil, H
   Schwede, T
   Standley, DM
   Westbrook, JD
AF Berman, Helen M.
   Burley, Stephen K.
   Chiu, Wah
   Sali, Andrej
   Adzhubei, Alexel
   Bourne, Philip E.
   Bryant, Stephen H.
   Dunbrack, Roland L., Jr.
   Fidelis, Krzysztof
   Frank, Joachim
   Godzik, Adam
   Henrick, Kim
   Joachimiak, Andrzej
   Heymann, Bernard
   Jones, David
   Markley, John L.
   Moult, John
   Montelione, Gaetano T.
   Orengo, Christine
   Rossmann, Michael G.
   Rost, Burkhard
   Saibil, Helen
   Schwede, Torsten
   Standley, Daron M.
   Westbrook, John D.
TI Outcome of a workshop on archiving structural models of biological
   macromolecules
SO STRUCTURE
LA English
DT Editorial Material
ID PROTEIN-STRUCTURE PREDICTION; DATA-BANK; CRYOELECTRON MICROSCOPY;
   ELECTRON CRYOMICROSCOPY; FOLD RECOGNITION; E-SCIENCE; MATURATION;
   DATABASE; VIRUS; REFINEMENT
C1 Rutgers State Univ, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08854 USA.
   SGX Pharmaceut Inc, San Diego, CA 92121 USA.
   Baylor Coll Med, Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA.
   Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA.
   Univ Oslo, Biotechnol Ctr Oslo, N-0317 Oslo, Norway.
   Univ Calif San Diego, Res Collaboratory Struct Bioinformat Prot Data Ba, San Diego Supercomp Ctr, La Jolla, CA 92093 USA.
   Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA.
   Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA.
   Univ Calif Davis, Genome & Biomed Sci Facil, Davis, CA 95616 USA.
   New York State Dept Hlth, Wadsworth Ctr, Dept Biomed Sci, Howard Hughes Med Inst, Albany, NY 12201 USA.
   Burnham Inst Med Res, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA.
   EMBL Outstn Hinxton, European Bioinformat Inst, Cambridge CB10 1SD, England.
   Argonne Natl Lab, Dept Struct Biol Ctr, Argonne, IL 60439 USA.
   NIAMSD, Struct Biol Res Lab, NIH, Bethesda, MD 20892 USA.
   UCL, Dept Comp Sci, Bioinformat Unit, London WC1E 6BT, England.
   Univ Wisconsin, Dept Biochem, BioMagResBank, Madison, WI 53706 USA.
   Univ Maryland, Inst Biotechnol, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA.
   Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Res Biotechnol, Piscataway, NJ 08854 USA.
   UCL, Dept Biochem & Mol Biol, Biomol Struct & Modeling Unit, London WC1E 6BT, England.
   Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
   Univ London Birkbeck Coll, Dept Crystallog, Bloomsbury Ctr Struct Biol, London WC1E 7HX, England.
   Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
   Osaka Univ, Inst Prot Res, Prot Data Bank Japan, Osaka 5650871, Japan.
RP Berman, HM (corresponding author), Rutgers State Univ, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08854 USA.
EM berman@rcsb.rutgers.edu
RI Godzik, Adam/AAW-1467-2020; Bourne, Philip E/C-2073-2008; Schwede,
   Torsten/A-4650-2008; Dunbrack, Roland/ABG-7141-2020; Standley,
   Daron/D-2343-2009; Godzik, Adam/A-7279-2009; Heymann,
   Bernard/H-8265-2019
OI Godzik, Adam/0000-0002-2425-852X; Schwede, Torsten/0000-0003-2715-335X;
   Godzik, Adam/0000-0002-2425-852X; Heymann, Bernard/0000-0002-8872-5326;
   Burley, Stephen/0000-0002-2487-9713; Moult, John/0000-0002-3012-2282;
   Westbrook, John/0000-0002-6686-5475; Berman, Helen/0000-0002-3337-0660;
   Dunbrack, Roland/0000-0001-7674-6667
CR Alber F, 2004, NUCL ACID M, V15, P73
   Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Baumeister W, 2004, BIOL CHEM, V385, P865, DOI 10.1515/BC.2004.113
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3
   Chiu W, 2005, STRUCTURE, V13, P363, DOI 10.1016/j.str.2004.12.016
   Coles SJ, 2006, J CHEM INF MODEL, V46, P1006, DOI 10.1021/ci050362w
   DRINKWATER G, 2004, P INT C PAR DISTR PR, V2, P815
   Frank J, 2002, ANNU REV BIOPH BIOM, V31, P303, DOI 10.1146/annurev.biophys.31.082901.134202
   Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Godzik Adam, 2003, Methods Biochem Anal, V44, P525
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Hey T, 2005, SCIENCE, V308, P817, DOI 10.1126/science.1110410
   Heymann JB, 2003, NAT STRUCT BIOL, V10, P334, DOI 10.1038/nsb922
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Jiang W, 2003, NAT STRUCT BIOL, V10, P131, DOI 10.1038/nsb891
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056
   Kryshtafovych A, 2005, PROTEINS, V61, P225, DOI 10.1002/prot.20740
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Madhusudhan M. S., 2005, PROTEOMICS PROTOCOLS, P831
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Marti-Renom MA, 2001, BIOINFORMATICS, V17, P746, DOI 10.1093/bioinformatics/17.8.746
   MATTHEWS B, 2002, CLRC SCI METADATA MO, V1
   Melo F, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P187
   Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133
   Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024
   Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005
   Pettitt CS, 2005, BIOINFORMATICS, V21, P3509, DOI 10.1093/bioinformatics/bti540
   Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059
   Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377
   Rost Burkhard, 2003, Methods Biochem Anal, V44, P559
   Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805
   Sanchez R, 2000, NUCLEIC ACIDS RES, V28, P250, DOI 10.1093/nar/28.1.250
   Schueler-Furman O, 2005, SCIENCE, V310, P638, DOI 10.1126/science.1112160
   Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   SIPPL MJ, 1995, CURR OPIN STRUC BIOL, V5, P229, DOI 10.1016/0959-440X(95)80081-6
   Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033
   Topf M, 2006, J MOL BIOL, V357, P1655, DOI 10.1016/j.jmb.2006.01.062
   Topf M, 2005, CURR OPIN STRUC BIOL, V15, P578, DOI 10.1016/j.sbi.2005.08.001
   Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Westbrook JD, 2005, INT TABLES CRYSTALLO, P195
   Zhou GD, 2003, J NEW MAT ELECTR SYS, V6, P61
   Zhou ZH, 2001, NAT STRUCT BIOL, V8, P868, DOI 10.1038/nsb1001-868
NR 53
TC 37
Z9 40
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD AUG
PY 2006
VL 14
IS 8
BP 1211
EP 1217
DI 10.1016/j.str.2006.06.005
PG 7
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 076HD
UT WOS:000239946700003
PM 16955948
DA 2021-01-25
ER

PT J
AU Marino, M
   Deuss, M
   Svergun, DI
   Konarev, PV
   Sterner, R
   Mayans, O
AF Marino, Marco
   Deuss, Miriam
   Svergun, Dmitri I.
   Konarev, Petr V.
   Sterner, Reinhard
   Mayans, Olga
TI Structural and mutational analysis of substrate complexation by
   anthranilate phosphoribosyltransferase from Sulfolobus solfataricus
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; QUINOLINIC ACID
   PHOSPHORIBOSYLTRANSFERASE; CRYSTAL-STRUCTURE; THYMIDINE PHOSPHORYLASE;
   MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; CATALYTIC
   MECHANISM; SCATTERING; PROTEINS; ENZYME
AB The metabolic synthesis and degradation of essential nucleotide compounds are primarily carried out by phosphoribosyltransferases (PRT) and nucleoside phosphorylases (NP), respectively. Despite the resemblance of their reactions, five classes of PRTs and NPs exist, where anthranilate PRT (AnPRT) constitutes the only evolutionary link between synthesis and degradation processes. We have characterized the active site of dimeric AnPRT from Sulfolobus solfataricus by elucidating crystal structures of the wild-type enzyme complexed to its two natural substrates anthranilate and 5-phosphoribosyl-1-pyrophosphate/Mg2+. These bind into two different domains within each protomer and are brought together during catalysis by rotational domain motions as shown by small angle x-ray scattering data. Steady-state kinetics of mutated AnPRT variants address the role of active site residues in binding and catalysis. Results allow the comparative analysis of PRT and pyrimidine NP families and expose related structural motifs involved in nucleotide/nucleoside recognition by these enzyme families.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany.
   Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany.
   Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia.
RP Mayans, O (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Olga.Mayans@unibas.ch
RI Konarev, Petr V/W-1380-2017; Sterner, Reinhard/ABI-6781-2020; Mayans,
   Olga/A-3954-2008
OI Mayans, Olga/0000-0001-6876-8532; Sterner, Reinhard/0000-0001-8177-8460;
   Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696
CR Brandl M, 2001, J MOL BIOL, V307, P357, DOI 10.1006/jmbi.2000.4473
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Degano M, 1996, BIOCHEMISTRY-US, V35, P5971, DOI 10.1021/bi952999m
   Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2
   Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I
   Heroux A, 2000, STRUCTURE, V8, P1309, DOI 10.1016/S0969-2126(00)00546-3
   HOMMEL U, 1989, EUR J BIOCHEM, V180, P33, DOI 10.1111/j.1432-1033.1989.tb14611.x
   Ivens A, 2001, EUR J BIOCHEM, V268, P2246, DOI 10.1046/j.1432-1327.2001.02102.x
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8
   KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kroemer M, 2004, ACTA CRYSTALLOGR D, V60, P1679, DOI 10.1107/S0907444904015215
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee CE, 2006, J MOL BIOL, V355, P784, DOI 10.1016/j.jmb.2005.11.016
   Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298
   Mendieta J, 2004, BIOCHEMISTRY-US, V43, P405, DOI 10.1021/bi034793o
   Meola M, 2003, J INORG BIOCHEM, V93, P235, DOI 10.1016/S0162-0134(02)00578-0
   MOGHADDAM A, 1995, P NATL ACAD SCI USA, V92, P998, DOI 10.1073/pnas.92.4.998
   MUSHEGIAN AR, 1994, PROTEIN SCI, V3, P1081, DOI 10.1002/pro.5560030711
   Norman RA, 2004, STRUCTURE, V12, P75, DOI 10.1016/j.str.2003.11.018
   Parish T, 2003, J BACTERIOL, V185, P6702, DOI 10.1128/JB.185.22.6702-6706.2003
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Prasad GS, 2001, CURR PROTEIN PEPT SC, V2, P301, DOI 10.2174/1389203013381017
   Pugmire MJ, 2002, BIOCHEM J, V361, P1, DOI 10.1042/0264-6021:3610001
   Pugmire MJ, 1998, STRUCTURE, V6, P1467, DOI 10.1016/S0969-2126(98)00145-2
   Rick SW, 1999, PROTEINS, V37, P242, DOI 10.1002/(SICI)1097-0134(19991101)37:2<242::AID-PROT9>3.0.CO;2-5
   SALERNO C, 1981, J BIOL CHEM, V256, P3671
   Sharma V, 1998, STRUCTURE, V6, P1587, DOI 10.1016/S0969-2126(98)00156-7
   Shin DH, 2005, J BIOL CHEM, V280, P18326, DOI 10.1074/jbc.M501622200
   Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3
   Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001
   Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   THOMPSON RE, 1978, BIOINORG CHEM, V9, P35, DOI 10.1016/S0006-3061(00)82004-9
   WALTER MR, 1990, J BIOL CHEM, V265, P14016
NR 39
TC 20
Z9 21
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 28
PY 2006
VL 281
IS 30
BP 21410
EP 21421
DI 10.1074/jbc.M601403200
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 065VF
UT WOS:000239187300077
PM 16714288
OA Bronze
DA 2021-01-25
ER

PT J
AU Bar, H
   Mucke, N
   Ringler, P
   Muller, SA
   Kreplak, L
   Katus, HA
   Aebi, U
   Herrmann, H
AF Baer, Harald
   Muecke, Norbert
   Ringler, Philippe
   Mueller, Shirley A.
   Kreplak, Laurent
   Katus, Hugo A.
   Aebi, Ueli
   Herrmann, Harald
TI Impact of disease mutations on the desmin filament assembly process
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE intermediate filament; analytical ultracentrifugation; inherited
   mutations; myofibrillar myopathy; desminopathy
ID KERATIN INTERMEDIATE-FILAMENTS; IN-VITRO; NETWORK FORMATION; HUMAN
   VIMENTIN; ROD DOMAIN; PROTEINS; DIMER; CYTOARCHITECTURE; MOLECULES;
   SEGMENTS
AB It has been documented that mutations in the human desmin gene lead to a severe type of myofibrillar myopathy, termed more specifically desminopathy, which affects cardiac and skeletal as well as smooth muscle. We showed recently that 14 recombinant versions of these disease-causing desmin variants, all involving single amino acid substitutions in the alpha-helical rod domain, interfere with in vitro filament formation at distinct stages of the assembly process. We now provide mechanistic details of how these mutations affect the filament assembly process by employing analytical ultracentrifugation, time-lapse electron microscopy of negatively stained and glycerol-sprayed/low-angle rotary metal-shadowed samples, quantitative scanning transmission electron microscopy, and viscometric studies. In particular, the soluble assembly intermediates of two of the mutated proteins exhibit unusually high s-values, compatible with octamers and other higher-order complexes. Moreover, several of the six filament-forming mutant variants deviated considerably from wild-type desmin with respect to their filament diameters and mass-per-length values. In the heteropolymeric situation with wild-type desmin, four of the mutant variants caused a pronounced "hyper-assembly", when assayed by viscometry. This indicates that the various mutations may cause abortion of filament formation by the mutant protein at distinct stages, and that some of them interfere severely with the assembly of wild-type desmin. Taken together, our findings provide novel insights into the basic intermediate filament assembly mechanisms and offer clues as to how amino acid changes within the desmin rod domain may interfere with the normal structural organization of the muscle cytoskeleton, eventually leading to desminopathy. (c) 2006 Elsevier Ltd. All rights reserved.
C1 German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
   Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz.de
OI kreplak, laurent/0000-0001-9370-9809
CR Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9
   FRANKE WW, 1978, CYTOBIOLOGIE, V17, P392
   Franz WM, 2001, LANCET, V358, P1627, DOI 10.1016/S0140-6736(01)06657-0
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Fuchs E, 1997, MOL BIOL CELL, V8, P189
   GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   HOFMANN I, 1991, EUR J CELL BIOL, V56, P328
   Hofmann I, 1997, EUR J CELL BIOL, V72, P122
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Liu JB, 2006, FASEB J, V20, P362, DOI 10.1096/fj.05-4869fje
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   PAULING L, 1951, NATURE, V168, P550, DOI 10.1038/168550a0
   Rogers KR, 1996, J STRUCT BIOL, V117, P55, DOI 10.1006/jsbi.1996.0069
   Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052
   Smith TA, 2004, PROTEINS, V55, P1043, DOI 10.1002/prot.20089
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
NR 37
TC 46
Z9 49
U1 0
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 28
PY 2006
VL 360
IS 5
BP 1031
EP 1042
DI 10.1016/j.jmb.2006.05.068
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 072JR
UT WOS:000239670200010
PM 16828798
DA 2021-01-25
ER

PT J
AU Marz, P
   Stetefeld, J
   Bendfeldt, K
   Nitsch, C
   Reinstein, J
   Shoeman, RL
   Dimitriades-Schmutz, B
   Schwager, M
   Leiser, D
   Ozcan, S
   Otten, U
   Ozbek, S
AF Maerz, Pia
   Stetefeld, Joerg
   Bendfeldt, Kerstin
   Nitsch, Cordula
   Reinstein, Jochen
   Shoeman, Robert L.
   Dimitriades-Schmutz, Beatrice
   Schwager, Martine
   Leiser, Dominic
   Ozcan, Sabire
   Otten, Uwe
   Ozbek, Suat
TI Ataxin-10 interacts with O-linked beta-N-acetylglucosamine transferase
   in the brain
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID GLCNAC-MODIFIED PROTEINS; TETRATRICOPEPTIDE REPEATS; NUCLEOCYTOPLASMIC
   GLYCOSYLATION; SUBSTRATE-SPECIFICITY; CEREBELLAR NEURONS;
   ALZHEIMERS-DISEASE; INSULIN-RESISTANCE; CELL LINE; NUCLEAR; EXPRESSION
AB Modification by O-GlcNAc involves a growing number of eucaryotic nuclear and cytosolic proteins. Glycosylation of intracellular proteins is a dynamic process that in several cases competes with and acts as a reciprocal modification system to phosphorylation. O-Linked beta-N-acetylglucosamine transferase (OGT) levels are highest in the brain, and neurodegenerative disorders such as Alzheimer disease have been shown to involve abnormally phosphorylated key proteins, probably as a result of hypoglycosylation. Here, we show that the neurodegenerative disease protein ataxin-10 (Atx-10) is associated with cytoplasmic OGT p110 in the brain. In PC12 cells and pancreas, this association is competed by the shorter OGT p78 splice form, which is down-regulated in brain. Overexpression of Atx-10 in PC12 cells resulted in the reconstitution of the Atx-10-OGT p110 complex and enhanced intracellular glycosylation activity. Moreover, in an in vitro enzyme assay using PC12 cell extracts, Atx-10 increased OGT activity 2-fold. These data indicate that Atx-10 might be essential for the maintenance of a critical intracellular glycosylation level and homeostasis in the brain.
C1 Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Anat, CH-4056 Basel, Switzerland.
   Max Planck Inst Med Res, Dept Biomol Mech, D-69120 Heidelberg, Germany.
   Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA.
   Heidelberg Univ, Inst Zool, D-69130 Heidelberg, Germany.
RP Ozbek, S (corresponding author), Univ Basel, Inst Physiol, Pestalozzistr 20, CH-4056 Basel, Switzerland.
EM soezbek@zoo.uni-heidelberg.de
RI bendfeldt, kerstin/AAZ-2197-2020; Stetefeld, Joerg/H-7630-2017; Ozbek,
   Suat/D-3701-2014
OI Stetefeld, Joerg/0000-0003-1478-3248; Ozbek, Suat/0000-0003-2569-3942
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R21DK065730] Funding Source:
   Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R21DK065730, R21DK065730] Funding
   Source: NIH RePORTER
CR Akimoto Y, 2003, BRAIN RES, V966, P194, DOI 10.1016/S0006-8993(02)04158-6
   Akimoto Y, 2003, INVEST OPHTH VIS SCI, V44, P3802, DOI 10.1167/iovs.03-0227
   Andrali SS, 2005, BIOCHEM BIOPH RES CO, V337, P149, DOI 10.1016/j.bbrc.2005.09.026
   Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094
   Gao Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P155, DOI 10.1016/S0003-9861(03)00234-0
   Griffith LS, 1999, EUR J BIOCHEM, V262, P824, DOI 10.1046/j.1432-1327.1999.00439.x
   HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005
   Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7
   Iyer SPN, 2003, J BIOL CHEM, V278, P24608, DOI 10.1074/jbc.M300036200
   Iyer SPN, 2003, BIOCHEMISTRY-US, V42, P2493, DOI 10.1021/bi020685a
   Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833
   Khidekel N, 2004, P NATL ACAD SCI USA, V101, P13132, DOI 10.1073/pnas.0403471101
   Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015
   Kreppel LK, 1997, J BIOL CHEM, V272, P9308
   Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078
   Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101
   Love DC, 2003, J CELL SCI, V116, P647, DOI 10.1242/jcs.00246
   Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983
   Lubas WA, 1997, J BIOL CHEM, V272, P9316
   Marshall S, 2003, ANAL BIOCHEM, V319, P304, DOI 10.1016/S0003-2697(03)00329-4
   Marz P, 2004, J BIOL CHEM, V279, P35542, DOI 10.1074/jbc.M405865200
   Matsuura T, 2000, NAT GENET, V26, P191, DOI 10.1038/79911
   MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126
   O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004
   Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200
   Robertson LA, 2004, J ALZHEIMERS DIS, V6, P489
   TORRES CR, 1984, J BIOL CHEM, V259, P3308
   Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399
   Vosseller K, 2001, BIOCHIMIE, V83, P575, DOI 10.1016/S0300-9084(01)01295-0
   Zachara Natasha Elizabeth, 2004, Methods Mol Biol, V284, P175
   Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016
   Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7
NR 32
TC 29
Z9 30
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 21
PY 2006
VL 281
IS 29
BP 20263
EP 20270
DI 10.1074/jbc.M601563200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 063RV
UT WOS:000239038200051
PM 16714295
OA Bronze
DA 2021-01-25
ER

PT J
AU Kyburz, A
   Friedlein, A
   Langen, H
   Keller, W
AF Kyburz, Andrea
   Friedlein, Arno
   Langen, Hanno
   Keller, Walter
TI Direct interactions between subunits of CPSF and the U2 snRNP contribute
   to the coupling of pre-mRNA 3 ' end processing and splicing
SO MOLECULAR CELL
LA English
DT Article
ID POLYADENYLATION SPECIFICITY FACTOR; CLEAVAGE FACTOR-I; BRANCH-SITE;
   PROTEIN; RECOGNITION; UPSTREAM; ASSOCIATION; SEQUENCES; MECHANISM;
   COMPLEX
AB Eukaryotic pre-mRNAs are capped at their 5' ends, polyadenylated at their 3' ends, and spliced before being exported from the nucleus to the cytoplasm. Although the three processing reactions can be studied separately in vitro, they are coupled in vivo. We identified subunits of the U2 snRNP in highly purified CPSF and showed that the two complexes physically interact. We therefore tested whether this interaction contributes to the coupling of 31 end processing and splicing. We found that CPSF is necessary for efficient splicing activity in coupled assays and that mutations in the pre-mRNA binding site of the U2 snRNP resulted in impaired splicing and in much reduced cleavage efficiency. Moreover, we showed that efficient cleavage required the presence of the U2 snRNA in coupled assays. We therefore propose that the interaction between CPSF and the U2 snRNP contributes to the coupling of splicing and 3' end formation.
C1 Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Roche Genet, CH-4070 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
CR Awasthi S, 2003, RNA, V9, P1400, DOI 10.1261/rna.5104603
   Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703
   BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411
   BIENROTH S, 1991, J BIOL CHEM, V266, P19768
   Bird G, 2005, MOL CELL, V20, P747, DOI 10.1016/j.molcel.2005.11.009
   BLACK DL, 1985, CELL, V42, P737, DOI 10.1016/0092-8674(85)90270-3
   Brackenridge S, 2000, MOL CELL BIOL, V20, P2660, DOI 10.1128/MCB.20.8.2660-2669.2000
   BROSI R, 1993, SCIENCE, V262, P102, DOI 10.1126/science.8211112
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   CHIOU HC, 1991, J VIROL, V65, P6677, DOI 10.1128/JVI.65.12.6677-6685.1991
   Cooke C, 1999, MOL CELL BIOL, V19, P4971
   Cooke C, 1996, MOL CELL BIOL, V16, P2579
   Cooke C, 2002, MOL CELL BIOL, V22, P4579, DOI 10.1128/MCB.22.13.4579-4586.2002
   Das BK, 1999, MOL CELL BIOL, V19, P6796
   Das R, 2000, MOL CELL, V5, P779, DOI 10.1016/S1097-2765(00)80318-4
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   Dichtl B, 2001, EMBO J, V20, P3197, DOI 10.1093/emboj/20.12.3197
   Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5
   GILMARTIN GM, 1995, GENE DEV, V9, P72, DOI 10.1101/gad.9.1.72
   Gornemann J, 2005, MOL CELL, V19, P53, DOI 10.1016/j.molcel.2005.05.007
   Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752
   Gozani O, 1996, GENE DEV, V10, P233, DOI 10.1101/gad.10.2.233
   Graveley BR, 1996, MOL CELL BIOL, V16, P4942
   Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   Hastings ML, 2001, CURR OPIN CELL BIOL, V13, P302, DOI 10.1016/S0955-0674(00)00212-X
   JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183
   JENNY A, 1995, NUCLEIC ACIDS RES, V23, P2629, DOI 10.1093/nar/23.14.2629
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   KELLER W, 1991, EMBO J, V10, P4241, DOI 10.1002/j.1460-2075.1991.tb05002.x
   Kramer A, 1999, J CELL BIOL, V145, P1355, DOI 10.1083/jcb.145.7.1355
   Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478
   Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226
   Lutz CS, 1996, GENE DEV, V10, P325, DOI 10.1101/gad.10.3.325
   MACDONALD CC, 1994, MOL CELL BIOL, V14, P6647, DOI 10.1128/MCB.14.10.6647
   McCracken S, 2003, J BIOL CHEM, V278, P44153, DOI 10.1074/jbc.M306856200
   McCracken S, 2002, MOL CELL BIOL, V22, P148, DOI 10.1128/MCB.22.1.148-160.2002
   Millevoi S, 2002, EMBO REP, V3, P869, DOI 10.1093/embo-reports/kvf173
   MINVIELLESEBASTIA L, 1994, SCIENCE, V266, P1702, DOI 10.1126/science.7992054
   MURTHY KGK, 1992, J BIOL CHEM, V267, P14804
   NESIC D, 1994, GENE DEV, V8, P363, DOI 10.1101/gad.8.3.363
   NESIC D, 1993, MOL CELL BIOL, V13, P3359, DOI 10.1128/MCB.13.6.3359
   NIWA M, 1990, GENE DEV, V4, P1552, DOI 10.1101/gad.4.9.1552
   NIWA M, 1991, GENE DEV, V5, P2086, DOI 10.1101/gad.5.11.2086
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Query CC, 1996, EMBO J, V15, P1392, DOI 10.1002/j.1460-2075.1996.tb00481.x
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Scott JM, 1996, VIROLOGY, V224, P498, DOI 10.1006/viro.1996.0556
   Tsai TF, 1998, DNA CELL BIOL, V17, P717, DOI 10.1089/dna.1998.17.717
   Vagner S, 2000, GENE DEV, V14, P403
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   WASSARMAN KM, 1993, GENE DEV, V7, P647, DOI 10.1101/gad.7.4.647
   Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8
   Will CL, 2002, EMBO J, V21, P4978, DOI 10.1093/emboj/cdf480
   Will CL, 2001, EMBO J, V20, P4536, DOI 10.1093/emboj/20.16.4536
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
   Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019
NR 58
TC 118
Z9 120
U1 1
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD JUL 21
PY 2006
VL 23
IS 2
BP 195
EP 205
DI 10.1016/j.molcel.2006.05.037
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 072BN
UT WOS:000239647700008
PM 16857586
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Tsamaloukas, A
AF Heerklotz, H
   Tsamaloukas, A
TI Gradual change or phase transition: Characterizing fluid
   lipid-cholesterol membranes on the basis of thermal volume changes
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID PHOSPHATIDYLETHANOLAMINE BILAYERS; CONDENSED COMPLEXES; LATERAL
   DIFFUSION; RAFTS; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; VESICLES;
   SPECTROSCOPY; CALORIMETRY; MIXTURES
AB Cholesterol has been reported to govern biomembrane permeability, elasticity, and the formation of lipid rafts. There has been a controversy whether binary lipid-cholesterol membranes should better be described in terms of a phase separation (liquid-ordered and liquid-disordered phases) or of gradual changes in largely homogeneous membranes. We present a new approach for detecting and characterizing phase equilibria in colloidal dispersions using pressure perturbation calorimetry (PPC). We apply this to the study of the thermal expansivity of mixtures of 1-palmitoyl-2-oleoyl sn-glycero-3-phosphatidylcholine (POPC) and cholesterol as a function of composition and temperature. We show that cholesterol can condense lipids not only laterally (with respect to interfacial area) but also in volume. A quantitative comparison with expansivity curves simulated assuming either phase separation or random mixing within one phase reveals that the real system shows an intermediate behavior due to submicroscopic demixing effects. However, both models yield consistent system parameters and are thus found to be useful for describing the systems to a similar approximation. Accordingly, one cholesterol may condense 3 +/- 1 1-palmitoyl-2-oleoyl- sn-glycero-3-phosphatidylcholine molecules by similar to -(1.4 +/- 0.5) vol% at 2 degrees C; both absolute values decrease with increasing temperature.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022
CR BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6
   BROWN MF, 1978, BIOCHEMISTRY-US, V17, P381, DOI 10.1021/bi00595a029
   Cevc G., 1985, PHOSPHOLIPID BILAYER
   Chalikian TV, 2003, ANNU REV BIOPH BIOM, V32, P207, DOI 10.1146/annurev.biophys.32.110601.141709
   de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5
   DEMEL R A, 1976, Biochimica et Biophysica Acta, V457, P109, DOI 10.1016/0304-4157(76)90008-3
   Edholm O, 2005, BIOPHYS J, V89, P1827, DOI 10.1529/biophysj.105.064329
   Filippov A, 2003, BIOPHYS J, V84, P3079, DOI 10.1016/S0006-3495(03)70033-2
   GREENWOOD AI, 2006, IN PRESS CHEM PHYS L
   Heerklotz H, 2004, J PHYS-CONDENS MAT, V16, pR441, DOI 10.1088/0953-8984/16/15/R01
   Henriksen J, 2006, BIOPHYS J, V90, P1639, DOI 10.1529/biophysj.105.067652
   Hsueh YW, 2005, BIOPHYS J, V88, P1799, DOI 10.1529/biophysj.104.051375
   Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0
   Ichimori H, 1999, CHEM PHYS LIPIDS, V100, P151, DOI 10.1016/S0009-3084(99)00050-X
   IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4
   Kahya N, 2004, J STRUCT BIOL, V147, P77, DOI 10.1016/j.jsb.2003.09.021
   Koenig BW, 2005, BBA-BIOMEMBRANES, V1715, P65, DOI 10.1016/j.bbamem.2005.07.006
   Kuzmin PI, 2005, BIOPHYS J, V88, P1120, DOI 10.1529/biophysj.104.048223
   LANDWEHR A, 1994, BER BUNSEN PHYS CHEM, V98, P214, DOI 10.1002/bbpc.19940980214
   Lin LN, 2002, ANAL BIOCHEM, V302, P144, DOI 10.1006/abio.2001.5524
   McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007
   MELCHIOR DL, 1980, BIOCHEMISTRY-US, V19, P4828, DOI 10.1021/bi00562a018
   Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2
   Petrache HI, 2004, MACROMOL SYMP, V219, P39, DOI 10.1002/masy.200550105
   Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097
   Radhakrishnan A, 2005, P NATL ACAD SCI USA, V102, P12662, DOI 10.1073/pnas.0506043102
   Rappolt M, 2003, EUR BIOPHYS J BIOPHY, V31, P575, DOI 10.1007/s00249-002-0253-z
   SANKARAM MB, 1991, P NATL ACAD SCI USA, V88, P8686, DOI 10.1073/pnas.88.19.8686
   Tauc P, 1998, BIOPHYS J, V74, P1864, DOI 10.1016/S0006-3495(98)77896-8
   THEWALT JL, 1992, BIOPHYS J, V63, P1176, DOI 10.1016/S0006-3495(92)81681-8
   Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8
   Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010
   VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021
   YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5
   Zuckermann MJ, 2004, METHOD ENZYMOL, V383, P198
NR 35
TC 50
Z9 50
U1 0
U2 13
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUL 15
PY 2006
VL 91
IS 2
BP 600
EP 607
DI 10.1529/biophysj.106.082669
PG 8
WC Biophysics
SC Biophysics
GA 057RA
UT WOS:000238611700022
PM 16632513
OA Green Published
DA 2021-01-25
ER

PT J
AU Bello, B
   Reichert, H
   Hirth, F
AF Bello, Bruno
   Reichert, Heinrich
   Hirth, Frank
TI The brain tumor gene negatively regulates neural progenitor cell
   proliferation in the larval central brain of Drosophila
SO DEVELOPMENT
LA English
DT Article
DE Drosophila; brain tumor; prospero; stem cell; progenitor cell;
   proliferation; tumour
ID CENTRAL-NERVOUS-SYSTEM; POSTEMBRYONIC NEUROBLASTS; SELF-RENEWAL;
   ASYMMETRIC DIVISION; MOSAIC ANALYSIS; STEM-CELLS; MELANOGASTER; PROTEIN;
   NEUROGENESIS; GRAINYHEAD
AB Brain development in Drosophila is characterized by two neurogenic periods, one during embryogenesis and a second during larval life. Although much is known about embryonic neurogenesis, little is known about the genetic control of postembryonic brain development. Here we use mosaic analysis with a repressible cell marker (MARCM) to study the role of the brain tumor (brat) gene in neural proliferation control and tumour suppression in postembryonic brain development of Drosophila. Our findings indicate that overproliferation in brat mutants is due to loss of proliferation control in the larval central brain and not in the optic lobe. Clonal analysis indicates that the brat mutation affects cell proliferation in a cell-autonomous manner and cell cycle marker expression shows that cells of brat mutant clones show uncontrolled proliferation, which persists into adulthood. Analysis of the expression of molecular markers, which characterize cell types in wild-type neural lineages, indicates that brat mutant clones comprise an excessive number of cells, which have molecular features of undifferentiated progenitor cells that lack nuclear Prospero (Pros). pros mutant clones phenocopy brat mutant clones in the larval central brain, and targeted expression of wild-type pros in brat mutant clones promotes cell cycle exit and differentiation of brat mutant cells, thereby abrogating brain tumour formation. Taken together, our results provide evidence that the tumour suppressor brat negatively regulates cell proliferation during larval central brain development of Drosophila, and suggest that Prospero acts as a key downstream effector of brat in cell fate specification and proliferation control.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hirth, F (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM frank.hirth@unibas.ch
RI Hirth, Frank/B-8384-2015
OI Hirth, Frank/0000-0001-8581-9450
FU Medical Research CouncilMedical Research Council UK (MRC) [G0701498]
   Funding Source: Medline
CR Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777
   Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947
   Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004
   Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   CamposOrtega JA, 1997, PERSPECT DEV NEUROBI, V4, P267
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Cenci C, 2005, DEVELOPMENT, V132, P3835, DOI 10.1242/dev.01932
   Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110
   Dyer MA, 2003, NAT GENET, V34, P53, DOI 10.1038/ng1144
   Edenfeld G, 2002, CURR OPIN GENET DEV, V12, P473, DOI 10.1016/S0959-437X(02)00328-3
   El-Husseini AE, 2001, GENOMICS, V71, P363, DOI 10.1006/geno.2000.6452
   Frank DJ, 2002, DEVELOPMENT, V129, P399
   FULTS D, 1992, GENOMICS, V14, P799, DOI 10.1016/S0888-7543(05)80191-0
   GATEFF E, 1993, MECH DEVELOP, V41, P15, DOI 10.1016/0925-4773(93)90052-Y
   Harris H, 2005, BIOESSAYS, V27, P833, DOI 10.1002/bies.20263
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   KURZIKDUMKE U, 1992, DIFFERENTIATION, V51, P91, DOI 10.1111/j.1432-0436.1992.tb00685.x
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lehman DA, 1999, DEVELOPMENT, V126, P1793
   Li L, 2000, GENE DEV, V14, P147
   Loop T, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-24
   Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531
   MATSUZAKI F, 1992, BIOCHEM BIOPH RES CO, V182, P1326, DOI 10.1016/0006-291X(92)91878-T
   Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011
   Peterson C, 2002, DEVELOPMENT, V129, P1467
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Prokopenko SN, 2005, SEMIN CELL DEV BIOL, V16, P423, DOI 10.1016/j.semcdb.2005.02.005
   Reddy GV, 1999, DEVELOPMENT, V126, P2083
   Schiebe M, 2001, J CANCER RES CLIN, V127, P325, DOI 10.1007/s004320000216
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sonoda J, 2001, GENE DEV, V15, P762, DOI 10.1101/gad.870801
   SONODA Y, 1995, CANCER RES, V55, P2166
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Uv AE, 1997, MOL CELL BIOL, V17, P6727, DOI 10.1128/MCB.17.11.6727
   WHITE K, 1978, DEV BIOL, V65, P296, DOI 10.1016/0012-1606(78)90029-5
   Woodhouse E, 1998, DEV GENES EVOL, V207, P542, DOI 10.1007/s004270050145
   Yan Q, 2005, MOL BIOL CELL, V16, P2470, DOI 10.1091/mbc.E04-11-1014
NR 44
TC 192
Z9 193
U1 0
U2 16
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JUL 15
PY 2006
VL 133
IS 14
BP 2639
EP 2648
DI 10.1242/dev.02429
PG 10
WC Developmental Biology
SC Developmental Biology
GA 055UH
UT WOS:000238475500005
PM 16774999
OA Bronze
DA 2021-01-25
ER

PT J
AU Jung, D
   Mangelsdorf, DJ
   Meyer, UA
AF Jung, Diana
   Mangelsdorf, David J.
   Meyer, Urs A.
TI Pregnane X receptor is a target of farnesoid X receptor
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SALT EXPORT PUMP; NEGATIVE FEEDBACK-REGULATION; BILE-ACID HOMEOSTASIS;
   NUCLEAR RECEPTOR; LITHOCHOLIC ACID; DRUG-METABOLISM; RESPONSE ELEMENTS;
   GENE-EXPRESSION; IDENTIFICATION; INDUCTION
AB The pregnaneXreceptor (PXR) is an essential component of the body's detoxification system. PXR is activated by a broad spectrum of xenobiotics and endobiotics, including bile acids and their precursors. Bile acids in high concentrations are toxic; therefore, their synthesis is tightly regulated by the farnesoid X receptor, and their catabolism involves several enzymes regulated by PXR. Here we demonstrate that the expression of PXR is regulated by farnesoid X receptor. Feeding mice with cholic acid or the synthetic farnesoid X receptor (FXR) agonist GW4064 resulted in a robust PXR induction. This effect was abolished in FXR knock-out mice. Long time bile acid treatment resulted in an increase of PXR target genes in wild type mice. A region containing four FXR binding sites (IR1) was identified in the mouse Pxr gene. This region was able to trigger an 8-fold induction after GW4064 treatment in transactivation studies. Deletion or mutation of single IR1 sites caused a weakened response. The importance of each individual IR1 element was assessed by cloning a triple or a single copy and was tested in transactivation studies. Two elements were able to trigger a strong response, one a moderate response, and one no response to GW4064 treatment. Mobility shift assays demonstrated that the two stronger responding elements were able to bind FXR protein. This result was confirmed by chromatin immunoprecipitation. These results strongly suggest that PXR is regulated by FXR. Bile acids activate FXR, which blocks synthesis of bile acids and also leads to the transcriptional activation of PXR, promoting breakdown of bile acids. The combination of the two mechanisms leads to an efficient protection of the liver against bile acid induced toxicity.
C1 Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dept Pharmacol, Dallas, TX 75390 USA.
RP Jung, D (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Kingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Diana.jung@unibas.ch
OI Mangelsdorf, David/0000-0002-4355-0796
CR Ananthanarayanan M, 2001, J BIOL CHEM, V276, P28857, DOI 10.1074/jbc.M011610200
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   Chen YH, 2005, TOXICOLOGY, V211, P242, DOI 10.1016/j.tox.2005.03.011
   CourjaultGautier F, 1997, EXP CELL RES, V234, P362, DOI 10.1006/excr.1997.3626
   Dunn RT, 1999, J PHARMACOL EXP THER, V290, P319
   Duran-Sandoval D, 2005, J BIOL CHEM, V280, P29971, DOI 10.1074/jbc.M501931200
   Falkner KC, 2001, MOL PHARMACOL, V60, P611
   FORMAN BM, 1995, CELL, V81, P687, DOI 10.1016/0092-8674(95)90530-8
   Fromm MF, 2000, AM J PATHOL, V157, P1575, DOI 10.1016/S0002-9440(10)64794-3
   Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200
   Goodwin B, 2001, MOL PHARMACOL, V60, P427
   Goodwin B, 2004, TRENDS PHARMACOL SCI, V25, P437, DOI 10.1016/j.tips.2004.06.007
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Grober J, 1999, J BIOL CHEM, V274, P29749, DOI 10.1074/jbc.274.42.29749
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   HOSOKAWA M, 1993, BIOCHEM PHARMACOL, V45, P2317, DOI 10.1016/0006-2952(93)90205-B
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Jung D, 2002, GASTROENTEROLOGY, V122, P1954, DOI 10.1053/gast.2002.33583
   Jung D, 2001, J BIOL CHEM, V276, P37206, DOI 10.1074/jbc.M103988200
   Jung D, 2003, HEPATOLOGY, V37, P622, DOI 10.1053/jhep.2003.50100
   Karpen SJ, 2005, HEPATOLOGY, V42, P266, DOI 10.1002/hep.20833
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kliewer SA, 2002, J LIPID RES, V43, P359
   KLIEWER SA, 2003, J NUTR S7, V133, P244
   Laffitte BA, 2000, J BIOL CHEM, V275, P10638, DOI 10.1074/jbc.275.14.10638
   LeCluyse EL, 2001, CHEM-BIOL INTERACT, V134, P283, DOI 10.1016/S0009-2797(01)00163-6
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Li T, 2005, AM J PHYSIOL-GASTR L, V288, P74, DOI DOI 10.1152/AJPGI.00258.2004
   Liu L, 1996, BIOCHEM PHARMACOL, V52, P1621, DOI 10.1016/S0006-2952(96)00569-2
   MADHU C, 1991, TOXICOL APPL PHARM, V109, P305, DOI 10.1016/0041-008X(91)90177-G
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   Marschall HU, 2005, GASTROENTEROLOGY, V129, P476, DOI 10.1053/j.gastro.2005.05.009
   Masahiko N, 2000, EUR J PHARM SCI, V11, P259, DOI 10.1016/S0928-0987(00)00112-3
   MIYAI K, 1975, LAB INVEST, V32, P527
   Owsley E, 2003, BIOCHEM BIOPH RES CO, V304, P191, DOI 10.1016/S0006-291X(03)00551-5
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Pascussi JM, 2000, MOL PHARMACOL, V58, P361
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Prince MI, 2002, GUT, V50, P436, DOI 10.1136/gut.50.3.436
   RADOMINSKA A, 1993, SEMIN LIVER DIS, V13, P219, DOI 10.1055/s-2007-1007351
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Synold TW, 2001, NAT MED, V7, P584, DOI 10.1038/87912
   Teng S, 2005, J PHARMACOL EXP THER, V312, P841, DOI 10.1124/jpet.104.076141
   Tirona RG, 2005, J PHARM SCI-US, V94, P1169, DOI 10.1002/jps.20324
   TUCHWEBER B, 1983, TOXICOL LETT, V19, P107, DOI 10.1016/0378-4274(83)90269-2
   Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784
   Wang HB, 2003, CLIN PHARMACOKINET, V42, P1331, DOI 10.2165/00003088-200342150-00003
   Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Wietholtz H, 1996, J HEPATOL, V24, P713, DOI 10.1016/S0168-8278(96)80268-6
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Xu DX, 2005, TOXICOL SCI, V87, P38, DOI 10.1093/toxsci/kfi239
   Yu JH, 2002, J BIOL CHEM, V277, P31441, DOI 10.1074/jbc.M200474200
   Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200
NR 64
TC 91
Z9 97
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 14
PY 2006
VL 281
IS 28
BP 19081
EP 19091
DI 10.1074/jbc.M600116200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 061BU
UT WOS:000238847000022
PM 16682417
OA Bronze
DA 2021-01-25
ER

PT J
AU Guzman, C
   Jeney, S
   Kreplak, L
   Kasas, S
   Kulik, AJ
   Aebi, U
   Forro, L
AF Guzman, C.
   Jeney, S.
   Kreplak, L.
   Kasas, S.
   Kulik, A. J.
   Aebi, U.
   Forro, L.
TI Exploring the mechanical properties of single vimentin intermediate
   filaments by atomic force microscopy
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE vimentin; intermediate filaments; atomic force microscopy; bending
   stiffness; axial sliding between dimmers; glutaraldehyde-stabilized
   filaments
ID HARD ALPHA-KERATIN; THERMAL FLUCTUATIONS; PROTEIN VIMENTIN; RIGIDITY;
   MICROTUBULES; ARCHITECTURE; MIGRATION; NETWORKS; REVEALS
AB Intermediate filaments (IFs), together with actin filaments and microtubules, compose the cytoskeleton. Among other functions, Ts impart mechanical stability to cells when exposed to mechanical stress and act as a support when the other cytoskeletal filaments cannot keep the structural integrity of the cells. Here we present a study on the bending properties of single vimentin Ts in which we used an atomic force microscopy (AFM) tip to elastically deform single filaments hanging over a porous membrane. We obtained a value for the bending modulus of non-stabilized IFs between 300 MPa. and 400 MPa. Our results together with previous ones suggest that lFs present axial sliding between their constitutive building blocks and therefore have a bending modulus that depends on the filament length. Measurements of glutaraldehyde-stabilized filaments were also performed to reduce the axial sliding between subunits and therefore provide a lower limit estimate of the Young's modulus of the filaments. The results show an increment of two to three times in the bending modulus for the stabilized Ts with respect to the non-stabilized ones, suggesting that the Young's modulus of vimentin IFs should be around 900 MPa or higher. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Ecole Polytech Fed Lausanne, Inst Phys Mat Complexe, CH-1015 Lausanne, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Ecole Polytech Fed Lausanne, Inst Neurosci, CH-1015 Lausanne, Switzerland.
   UNIL, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland.
RP Guzman, C (corresponding author), Ecole Polytech Fed Lausanne, Inst Phys Mat Complexe, CH-1015 Lausanne, Switzerland.
EM camilo.guzman@epfl.ch
RI Kulik, Andrzej J/A-1236-2010
OI kreplak, laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640
   Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   Colton R. J., 1998, PROCEDURES SCANNING
   DOBB MG, 1967, S FIBROUS PROTEINS, V1, P267
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   Gere J.M., 1997, MECH MAT
   GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Kis A, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.248101
   Kreis S, 2005, EXP CELL RES, V305, P110, DOI 10.1016/j.yexcr.2004.12.023
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355
   Onck PR, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178102
   PAMPALONI F, UNPUB P NATL ACAD SC
   Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694
   Salvetat JP, 1999, PHYS REV LETT, V82, P944, DOI 10.1103/PhysRevLett.82.944
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   VENIER P, 1994, J BIOL CHEM, V269, P13353
   Vinckier A, 1996, J VAC SCI TECHNOL B, V14, P1427, DOI 10.1116/1.589113
   Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071
   Watts NR, 2002, J STRUCT BIOL, V137, P109, DOI 10.1006/jsbi.2002.4469
   Wong P, 2003, J CELL BIOL, V163, P327, DOI 10.1083/jcb.200305032
   Yamada S, 2002, MOL BIOL CELL, V13, P382, DOI 10.1091/mbc.01-10-0522
NR 39
TC 84
Z9 84
U1 1
U2 19
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 14
PY 2006
VL 360
IS 3
BP 623
EP 630
DI 10.1016/j.jmb.2006.05.030
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 068HY
UT WOS:000239365400009
PM 16765985
OA Green Published
DA 2021-01-25
ER

PT J
AU Letzelter, M
   Sorg, I
   Mota, LJ
   Meyer, S
   Stalder, J
   Feldman, M
   Kuhn, M
   Callebaut, I
   Cornelis, GR
AF Letzelter, Michel
   Sorg, Isabel
   Mota, Luis Jaime
   Meyer, Salome
   Stalder, Jacqueline
   Feldman, Mario
   Kuhn, Marina
   Callebaut, Isabelle
   Cornelis, Guy R.
TI The discovery of SycO highlights a new function for type III secretion
   effector chaperones
SO EMBO JOURNAL
LA English
DT Article
DE effectors; targeting; translocation; type III secretion; Yops
ID YERSINIA TYROSINE PHOSPHATASE; PROTEIN-KINASE; TRANSLOCATORS YOPB;
   SHIGELLA-FLEXNERI; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; ENTEROCOLITICA;
   VIRULENCE; IDENTIFICATION; BINDING
AB Bacterial injectisomes deliver effector proteins straight into the cytosol of eukaryotic cells (type III secretion, T3S). Many effectors are associated with a specific chaperone that remains inside the bacterium when the effector is delivered. The structure of such chaperones and the way they interact with their substrate is well characterized but their main function remains elusive. Here, we describe and characterize SycO, a new chaperone for the Yersinia effector kinase YopO. The chaperone-binding domain (CBD) within YopO coincides with the membrane localization domain (MLD) targeting YopO to the host cell membrane. The CBD/MLD causes intrabacterial YopO insolubility and the binding of SycO prevents this insolubility but not folding and activity of the kinase. Similarly, SycE masks the MLD of YopE and SycT covers an aggregation-prone domain of YopT, presumably corresponding to its MLD. Thus, SycO, SycE and most likely SycT mask, inside the bacterium, a domain needed for proper localization of their cognate effector in the host cell. We propose that covering an MLD might be an essential function of T3S effector chaperones.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Paris 06, CNRS, Inst Mineral & Phys Milieux Xondenses, UMR 7590,Dept Biol Struct, F-75252 Paris 05, France.
   Univ Paris 07, CNRS, Inst Mineral & Phys Milieux Xondenses, UMR 7590,Dept Biol Struct, F-75221 Paris 05, France.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Feldman, Mario/A-2637-2014; Mota, Luis J/B-9497-2008
OI Feldman, Mario/0000-0003-4497-0976; Mota, Luis J/0000-0002-5592-8397
CR Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200
   Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Akeda Y, 2005, NATURE, V437, P911, DOI 10.1038/nature03992
   Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7
   Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006
   Birtalan S, 2001, NAT STRUCT BIOL, V8, P974, DOI 10.1038/nsb1101-974
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x
   Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Bronstein PA, 2000, J BACTERIOL, V182, P6638, DOI 10.1128/JB.182.23.6638-6644.2000
   Buttner CR, 2005, PROTEIN SCI, V14, P1993, DOI 10.1110/ps.051474605
   Cain RJ, 2004, MOL MICROBIOL, V54, P887, DOI 10.1111/j.1365-2958.2004.04336.x
   CORNELIS G, 1986, MICROB PATHOGENESIS, V1, P349, DOI 10.1016/0882-4010(86)90067-7
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   CORNELIS GR, 2006, EMBO J, V25, P3223, DOI DOI 10.1038/SJ.EMBOJ.7601202
   Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Ehrbar K, 2003, J BACTERIOL, V185, P6950, DOI 10.1128/JB.185.23.6950-6967.2003
   Elliott SJ, 1999, MOL MICROBIOL, V33, P1176, DOI 10.1046/j.1365-2958.1999.01559.x
   Evdokimov AG, 2002, ACTA CRYSTALLOGR D, V58, P398, DOI 10.1107/S090744490200015X
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Fu YX, 1998, J BACTERIOL, V180, P3393, DOI 10.1128/JB.180.13.3393-3399.1998
   Fu YX, 1999, NATURE, V401, P293
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   IRIARTE M, 1999, PATHOGENICITY ISLAND, P91
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7
   Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x
   Locher M, 2005, J BIOL CHEM, V280, P31149, DOI 10.1074/jbc.M500603200
   Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717
   Marcus SL, 2002, CELL MICROBIOL, V4, P435, DOI 10.1046/j.1462-5822.2002.00202.x
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Montagna LG, 2001, J BIOL CHEM, V276, P5005, DOI 10.1074/jbc.M009045200
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4
   Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Schlumberger MC, 2005, P NATL ACAD SCI USA, V102, P12548, DOI 10.1073/pnas.0503407102
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   Trame CB, 2003, ACTA CRYSTALLOGR D, V59, P389, DOI 10.1107/S0907444902020826
   Trulzsch K, 2003, INT J MED MICROBIOL, V293, P167, DOI 10.1078/1438-4221-00251
   van Eerde A, 2004, EMBO REP, V5, P477, DOI 10.1038/sj.embor.7400144
   VANNHIEU GT, 2000, CELL MICROBIOL, V2, P187, DOI DOI 10.1046/J.1462-5822.2000.00046.X
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
   Woestyn S, 1996, MOL MICROBIOL, V20, P1261, DOI 10.1111/j.1365-2958.1996.tb02645.x
   Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 70
TC 68
Z9 71
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JUL 12
PY 2006
VL 25
IS 13
BP 3223
EP 3233
DI 10.1038/sj.emboj.7601202
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 071TP
UT WOS:000239625800025
PM 16794578
OA Green Published
DA 2021-01-25
ER

PT J
AU Affolter, M
   Mann, R
AF Affolter, Markus
   Mann, Richard
TI Hyped-up for Hox in Hyderabad - Workshop on Upstream and Downstream of
   Hox Genes
SO EMBO REPORTS
LA English
DT Editorial Material
DE Hox genes; transcription; evolution
ID SEGMENTATION; POLYCOMB; TIME
C1 Univ Basel, Dept Biozentrum, CH-4056 Basel, Switzerland.
   Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
RP Affolter, M (corresponding author), Univ Basel, Dept Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM054510] Funding Source: Medline;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510] Funding
   Source: NIH RePORTER
CR Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6
   Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723
   Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753
   Maeda RK, 2006, DEVELOPMENT, V133, P1413, DOI 10.1242/dev.02323
   Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726
   Peel AD, 2005, NAT REV GENET, V6, P905, DOI 10.1038/nrg1724
   Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887
   Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907
   Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805
   Srinivasan S, 2005, DEVELOPMENT, V132, P1623, DOI 10.1242/dev.01713
   Zhang Y, 2004, COLD SPRING HARB SYM, V69, P309, DOI 10.1101/sqb.2004.69.309
NR 11
TC 1
Z9 1
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD JUL
PY 2006
VL 7
IS 7
BP 674
EP 678
DI 10.1038/sj.embor.7400734
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 058TP
UT WOS:000238687800007
PM 16799462
OA Green Published
DA 2021-01-25
ER

PT J
AU Hellstern, S
   Stetefeld, J
   Fauser, C
   Lustig, A
   Engel, J
   Holstein, TW
   Ozbek, S
AF Hellstern, Simon
   Stetefeld, Joerg
   Fauser, Charlotte
   Lustig, Ariel
   Engel, Juergen
   Holstein, Thomas W.
   Oezbek, Suat
TI Structure/function analysis of spinalin, a spine protein of Hydra
   nematocysts
SO FEBS JOURNAL
LA English
DT Article
ID SEA SNAKE; DISULFIDE LINKAGE; CRYSTAL-STRUCTURE; MINICOLLAGEN;
   NEUROTOXIN; RHODOCETIN; AGGLUTININ; RESOLUTION; CNIDARIA; HYDROZOA
AB The nematocyst capsules of the cnidarians are specialized explosive organelles that withstand high osmotic pressures of approximate to 15 MPa (150 bar). A tight disulfide network involving cysteine-rich capsule wall proteins, like minicollagens and nematocyst outer wall antigen, characterizes their molecular composition. Nematocyst discharge leads to the expulsion of a long inverted tubule that was coiled inside the capsule matrix before activation. Spinalin has been characterized as a glycine-rich, histidine-rich protein associated with spine structures on the surface of everted tubules. Here, we show that full-length Hydra spinalin can be expressed recombinantly in HEK293 cells and has the property to form disulfide-linked oligomers, reflecting its state in mature capsules. Furthermore, spinalin showed a high tendency to associate into dimers in vitro and in vivo. Our data, which show incomplete disulfide connectivity in recombinant spinalin, suggest a possible mechanism by which the spine structure may be linked to the overall capsule polymer.
C1 Inst Mol Evolut & Genom, D-69130 Heidelberg, Germany.
   Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
RP Ozbek, S (corresponding author), Inst Mol Evolut & Genom, Neuenheimer Feld 230, D-69130 Heidelberg, Germany.
EM soezbek@zoo.uni-heidelberg.de
RI Stetefeld, Joerg/H-7630-2017; Ozbek, Suat/D-3701-2014
OI Stetefeld, Joerg/0000-0003-1478-3248; Ozbek, Suat/0000-0003-2569-3942
CR DRENTH J, 1980, J BIOL CHEM, V255, P2652
   Eble JA, 2001, J BIOL CHEM, V276, P12274, DOI 10.1074/jbc.M009338200
   ENGEL J, 1994, METHOD ENZYMOL, V245, P469
   Engel U, 2002, J CELL SCI, V115, P3923, DOI 10.1242/jcs.00084
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   HOLSTEIN T, 1981, J ULTRA MOL STRUCT R, V75, P276, DOI 10.1016/S0022-5320(81)80085-8
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Koch AW, 1998, J CELL SCI, V111, P1545
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LOW BW, 1976, J BIOCHEM-TOKYO, V79, pP27
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   Paaventhan P, 2005, PROTEIN SCI, V14, P169, DOI 10.1110/ps.04945605
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Szczepanek S, 2002, J CELL SCI, V115, P745
   TAMIYA N, 1978, BIOCHIM BIOPHYS ACTA, V532, P199, DOI 10.1016/0005-2795(78)90464-6
   TARDENT P, 1982, CELL TISSUE RES, V224, P269, DOI 10.1007/BF00216873
   TSERNOGLOU D, 1976, FEBS LETT, V68, P1, DOI 10.1016/0014-5793(76)80390-0
   WEBER J, 1990, J BIOL CHEM, V265, P9664
   WRIGHT CS, 1977, J MOL BIOL, V111, P439, DOI 10.1016/S0022-2836(77)80063-6
NR 23
TC 9
Z9 9
U1 1
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2006
VL 273
IS 14
BP 3230
EP 3237
DI 10.1111/j.1742-4658.2006.05331.x
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 059QJ
UT WOS:000238747000010
PM 16774641
DA 2021-01-25
ER

PT J
AU Cheusova, T
   Khan, MA
   Schubert, SW
   Gavin, AC
   Buchou, T
   Jacob, G
   Sticht, H
   Allende, J
   Boldyreff, B
   Brenner, HR
   Hashemolhosseini, S
AF Cheusova, Tatiana
   Khan, Muhammad Amir
   Schubert, Steffen Wolfgang
   Gavin, Anne-Claude
   Buchou, Thierry
   Jacob, Germaine
   Sticht, Heinrich
   Allende, Jorge
   Boldyreff, Brigitte
   Brenner, Hans Rudolf
   Hashemolhosseini, Said
TI Casein kinase 2-dependent serine phosphory ation of MuSK regulates
   acetylcholine receptor aggregation at the neuromuscular junction
SO GENES & DEVELOPMENT
LA English
DT Article
DE MuSK; CK2; casein kinase; synapse; skeletal muscle; neuromuscular
   junction
ID MUSCLE-SPECIFIC KINASE; SYNAPSE FORMATION; SIGNAL-TRANSDUCTION;
   POSTSYNAPTIC SPECIALIZATIONS; TYROSINE KINASE; AGRIN ISOFORMS; MICE
   LACKING; IN-VIVO; CK2; CLUSTERS
AB The release of Agrin by motoneurons activates the muscle-specific receptor tyrosine kinase (MuSK) as the main organizer of subsynaptic specializations at the neuromuscular junction. MuSK downstream signaling is largely undefined. Here we show that protein kinase CK2 interacts and colocalizes with MuSK at post-synaptic specializations. We observed CK2-mediated phosphorylation of serine residues within the kinase insert (KI) of MuSK. Inhibition or knockdown of CK2, or exchange of phosphorylatable serines by alanines within the KI of MuSK, impaired acetylcholine receptor (AChR) clustering, whereas their substitution by residues that imitate constitutive phosphorylation led to aggregation of AChRs even in the presence of CK2 inhibitors. Impairment of AChR cluster formation after replacement of MuSK KI with KIs of other receptor tyrosine kinases correlates with potential CK2-dependent serine phosphorylation within KIs. MuSK activity was unchanged but AChR stability decreased in the presence of CK2 inhibitors. Muscle-specific CK2 beta knockout mice develop a myasthenic phenotype due to impaired muscle endplate structure and function. This is the first description of a regulatory cross-talk between MuSK and CK2 and of a role for the KI of the receptor tyrosine kinase MuSK for the development of subsynaptic specializations.
C1 Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany.
   Univ Basel, Biozentrum Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland.
   INSERM, EMI 0104, DRDC TS, F-38054 Grenoble 9, France.
   Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Biol Celular & Mol,Lab Biol Mol Transduc, Santiago, Chile.
   KinaseDetect, Res & Dev, DK-5230 Odense M, Denmark.
RP Hashemolhosseini, S (corresponding author), Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany.
EM sh@biochem.uni-erlangen.de
RI Hashemolhosseini, Said/N-2464-2013; BUCHOU, Thierry/F-3136-2019; BUCHOU,
   THIERRY/N-2553-2013
OI Hashemolhosseini, Said/0000-0002-6564-5649; BUCHOU,
   Thierry/0000-0002-9206-2377; Gavin, Anne-Claude/0000-0003-4917-2340;
   Sticht, Heinrich/0000-0001-5644-045X
CR Buchou T, 2003, MOL CELL BIOL, V23, P908, DOI 10.1128/MCB.23.3.908-915.2003
   Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004
   Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915
   Critchfield JW, 1997, P NATL ACAD SCI USA, V94, P6110, DOI 10.1073/pnas.94.12.6110
   Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321
   Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170
   Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449
   Escalier D, 2003, MOL REPROD DEV, V66, P190, DOI 10.1002/mrd.10346
   Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258
   Finn AJ, 2003, NAT NEUROSCI, V6, P717, DOI 10.1038/nn1071
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z
   Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029
   Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3
   Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911
   HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2
   Herbst R, 2002, DEVELOPMENT, V129, P5449, DOI 10.1242/dev.00112
   Herbst R, 2000, EMBO J, V19, P67, DOI 10.1093/emboj/19.1.67
   Huffine ME, 1996, J BIOL CHEM, V271, P28898, DOI 10.1074/jbc.271.46.28898
   Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435
   Korn I, 2001, MOL CELL BIOCHEM, V227, P37, DOI 10.1023/A:1013100604191
   Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651
   Lacazette E, 2003, J CELL BIOL, V161, P727, DOI 10.1083/jcb.200210156
   Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002
   Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3
   Luo ZG, 2003, J NEUROCYTOL, V32, P697, DOI 10.1023/B:NEUR.0000020618.65271.63
   LUPA MT, 1991, J CELL BIOL, V115, P765, DOI 10.1083/jcb.115.3.765
   McConville J, 2002, CURR OPIN PHARMACOL, V2, P296, DOI 10.1016/S1471-4892(02)00156-X
   Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev
   Meier T, 1997, J NEUROSCI, V17, P6534
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001
   Olsten MEK, 2004, BIOCHEM CELL BIOL, V82, P681, DOI 10.1139/O04-116
   Pagano MA, 2004, BIOCHEM BIOPH RES CO, V321, P1040, DOI 10.1016/j.bbrc.2004.07.067
   Sadasivam G, 2005, J NEUROSCI, V25, P10479, DOI 10.1523/JNEUROSCI.2103-05.2005
   Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Schubert SW, 2004, J BIOL CHEM, V279, P50358, DOI 10.1074/jbc.M404587200
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   SLATER CR, 1982, DEV BIOL, V94, P11, DOI 10.1016/0012-1606(82)90063-X
   Smith CL, 2001, J NEUROSCI, V21, P3151, DOI 10.1523/JNEUROSCI.21-09-03151.2001
   Song DH, 2003, J BIOL CHEM, V278, P24018, DOI 10.1074/jbc.M212260200
   Song DH, 2000, J BIOL CHEM, V275, P23790, DOI 10.1074/jbc.M909107199
   Strochlic L, 2004, P NATL ACAD SCI USA, V101, P18189, DOI 10.1073/pnas.0406905102
   Strochlic L, 2005, BIOESSAYS, V27, P1129, DOI 10.1002/bies.20305
   Swiatek W, 2006, J BIOL CHEM, V281, P12233, DOI 10.1074/jbc.M510580200
   Till JH, 2002, STRUCTURE, V10, P1187, DOI 10.1016/S0969-2126(02)00814-6
   Trachtenberg JT, 1996, NATURE, V379, P174, DOI 10.1038/379174a0
   ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K
   UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y
   Wang JM, 2003, NAT NEUROSCI, V6, P1017, DOI 10.1038/nn1128
   Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997
   Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205
   Weston C, 2003, J BIOL CHEM, V278, P6450, DOI 10.1074/jbc.M210249200
   Xu X, 1999, NAT GENET, V23, P118
   Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133
   Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015
NR 57
TC 43
Z9 48
U1 0
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD JUL 1
PY 2006
VL 20
IS 13
BP 1800
EP 1816
DI 10.1101/gad.375206
PG 17
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 059YO
UT WOS:000238768300014
PM 16818610
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Flames, N
   Long, JE
   Garratt, AN
   Fischer, TM
   Gassmann, M
   Birchmeier, C
   Lai, CH
   Rubenstein, JL
   Marin, O
AF Flames, N.
   Long, J. E.
   Garratt, A. N.
   Fischer, T. M.
   Gassmann, M.
   Birchmeier, C.
   Lai, C. H.
   Rubenstein, J. L.
   Marin, O.
TI Short- and long-range attraction of cortical gabaergic interneurons by
   neuregulin 1
SO INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
LA English
DT Meeting Abstract
CT 25th CINP Congress
CY JUL 09-13, 2006
CL Chicago, IL
SP CINP
C1 Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA.
   Univ Basel, Dept Physiol, Biozentrum Pharmazentrum, CH-4003 Basel, Switzerland.
RI Garratt, Alistair N/D-9893-2013
OI Garratt, Alistair N/0000-0001-9631-3041
NR 0
TC 0
Z9 0
U1 0
U2 4
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 1461-1457
J9 INT J NEUROPSYCHOPH
JI Int. J. Neuropsychopharmacol.
PD JUL
PY 2006
VL 9
SU 1
BP S22
EP S22
PG 1
WC Clinical Neurology; Neurosciences; Pharmacology & Pharmacy; Psychiatry
SC Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry
GA 070BO
UT WOS:000239495500083
DA 2021-01-25
ER

PT J
AU Levi, A
   Jenal, U
AF Levi, Assaf
   Jenal, Urs
TI Holdfast formation in motile swarmer cells optimizes surface attachment
   during Caulobacter crescentus development
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID C-DI-GMP; RESPONSE REGULATOR; FLAGELLAR MOTOR; ADHESIVE HOLDFAST; CYCLE
   CONTROL; IDENTIFICATION; PROTEINS; LOCALIZATION; REPLICATION;
   DEGRADATION
AB The adhesive holdfast is required for irreversible surface anchoring of Caulobacter crescentus cells. The holdfast is synthesized early during swarmer cell development and, together with pili and a functional flagellum, contributes to optimal attachment during cell differentiation. We present evidence that the timing of holdfast formation in swarmer cells is regulated posttranslationally and is dependent on the diguanylate cyclase PleD.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   ALLEY MRK, 1992, GENE DEV, V6, P825, DOI 10.1101/gad.6.5.825
   Bodenmiller D, 2004, J BACTERIOL, V186, P1438, DOI 10.1128/JB.186.5.1438-1447.2004
   CHIAVEROTTI TA, 1981, J BACTERIOL, V145, P1463, DOI 10.1128/JB.145.3.1463-1465.1981
   Cole JL, 2003, MOL MICROBIOL, V49, P1671, DOI 10.1046/j.1365-2958.2003.03664.x
   Entcheva-Dimitrov P, 2004, J BACTERIOL, V186, P8254, DOI 10.1128/JB.186.24.8254-8266.2004
   Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Janakiraman RS, 1999, J BACTERIOL, V181, P1118, DOI 10.1128/JB.181.4.1118-1125.1999
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   JOHNSON RC, 1977, GENETICS, V86, P25
   Kawagishi I, 1996, MOL MICROBIOL, V20, P693, DOI 10.1111/j.1365-2958.1996.tb02509.x
   Lauriano CM, 2004, J BACTERIOL, V186, P4864, DOI 10.1128/JB.186.15.4864-4874.2004
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   ONG CJ, 1990, J BACTERIOL, V172, P1448, DOI 10.1128/jb.172.3.1448-1456.1990
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   Skerker JM, 2000, EMBO J, V19, P3223, DOI 10.1093/emboj/19.13.3223
   Smith CS, 2003, J BACTERIOL, V185, P1432, DOI 10.1128/JB.185.4.1432-1442.2003
   SOMMER JM, 1988, J BACTERIOL, V170, P409, DOI 10.1128/jb.170.1.409-415.1988
   STEPHENS CM, 1993, MOL MICROBIOL, V9, P1169, DOI 10.1111/j.1365-2958.1993.tb01246.x
   Viollier PH, 2002, EMBO J, V21, P4420, DOI 10.1093/emboj/cdf454
   Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7
   Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x
NR 27
TC 57
Z9 57
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL
PY 2006
VL 188
IS 14
BP 5315
EP 5318
DI 10.1128/JB.01725-05
PG 4
WC Microbiology
SC Microbiology
GA 064HH
UT WOS:000239079300035
PM 16816207
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schubert, M
   Manolikas, T
   Rogowski, M
   Meier, BH
AF Schubert, Mario
   Manolikas, Theofanis
   Rogowski, Marco
   Meier, Beat H.
TI Solid-state NMR spectroscopy of 10% C-13 labeled ubiquitin: spectral
   simplification and stereospecific assignment of isopropyl groups
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE MAS; resonance assignment; solid state NMR; stereoselective isotope
   labeling; stereospecic assignment
ID NUCLEAR-MAGNETIC-RESONANCE; MICROCRYSTALLINE UBIQUITIN;
   PROTEIN-STRUCTURE; H-1-NMR ASSIGNMENTS; ESCHERICHIA-COLI; BACKBONE
AB We describe the simplification of C-13-C-13 correlation spectra obtained from a microcrystalline protein sample expressed on a growth medium of 10% fully C-13 labeled glucose diluted in 90% natural abundance glucose as compared to a fully labeled sample. Such a labeling scheme facilitates the backbone and side-chain resonance assignment of Phe, Tyr, His, Asp, Asn, Ile, Lys and Pro and yields an unambiguous stereospecific assignment of the valine C gamma 1, C gamma 2 C-13 resonances and of Leucine C delta 2.
C1 ETH, CH-8093 Zurich, Switzerland.
   Univ Basel, Dept Biol Struct, BioZentrum, CH-4056 Basel, Switzerland.
RP Meier, BH (corresponding author), ETH, CH-8093 Zurich, Switzerland.
EM beme@ethz.ch
RI Schubert, Mario/B-3972-2008; Meier, Beat H/K-4066-2016
OI Schubert, Mario/0000-0003-0278-4091; Meier, Beat H/0000-0002-9107-4464
CR Bockmann A, 2003, J BIOMOL NMR, V27, P323, DOI 10.1023/A:1025820611009
   Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070
   DRISCOLL PC, 1989, FEBS LETT, V243, P223, DOI 10.1016/0014-5793(89)80134-6
   Folmer RHA, 1997, J BIOMOL NMR, V9, P245, DOI 10.1023/A:1018670623695
   Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896
   Grimmer AR, 1997, MAGN RESON CHEM, V35, P86, DOI 10.1002/(SICI)1097-458X(199702)35:2<86::AID-OMR34>3.0.CO;2-2
   GUNTERT P, 1989, J AM CHEM SOC, V111, P3997
   HAVEL TF, 1991, PROG BIOPHYS MOL BIO, V56, P43, DOI 10.1016/0079-6107(91)90007-F
   HEDIGER S, 1995, CHEM PHYS LETT, V240, P449, DOI 10.1016/0009-2614(95)00505-X
   Heise H, 2005, J MAGN RESON, V173, P64, DOI 10.1016/j.jmr.2004.11.020
   Igumenova TI, 2004, J AM CHEM SOC, V126, P6720, DOI 10.1021/ja030547o
   Igumenova TI, 2004, J AM CHEM SOC, V126, P5323, DOI 10.1021/ja030546w
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108
   LeMaster DM, 1996, J AM CHEM SOC, V118, P9255, DOI 10.1021/ja960877r
   Pauli J, 2001, CHEMBIOCHEM, V2, P272, DOI 10.1002/1439-7633(20010401)2:4<272::AID-CBIC272>3.0.CO;2-2
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   SENN H, 1989, FEBS LETT, V249, P113, DOI 10.1016/0014-5793(89)80027-4
   Siemer AB, 2005, ANGEW CHEM INT EDIT, V44, P2441, DOI 10.1002/anie.200462952
   SZYPERSKI T, 1992, J BIOMOL NMR, V2, P323, DOI 10.1007/BF01874811
   van Gammeren AJ, 2005, J BIOMOL NMR, V31, P279, DOI 10.1007/s10858-005-1604-8
   Zech SG, 2005, J AM CHEM SOC, V127, P8618, DOI 10.1021/ja0503128
NR 22
TC 33
Z9 33
U1 1
U2 12
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD JUL
PY 2006
VL 35
IS 3
BP 167
EP 173
DI 10.1007/s10858-006-9025-x
PG 7
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 079EC
UT WOS:000240157300002
PM 16858625
OA Green Published
DA 2021-01-25
ER

PT J
AU Barde, YA
AF Barde, Yves-Alain
TI Neurotrophins and their roles in mammals
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD JUL-DEC
PY 2006
VL 20
IS 3-4
BP 76
EP 77
PG 2
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 123QD
UT WOS:000243309500014
DA 2021-01-25
ER

PT J
AU Bello, B
   Holbro, N
   Reichert, H
AF Bello, Bruno
   Holbro, Nicholas
   Reichert, Heinrich
TI Polycomb group genes are required for neural stem cell survival and
   proliferation in postembryonic neurogenesis of Drosophila
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD JUL-DEC
PY 2006
VL 20
IS 3-4
BP 82
EP 83
PG 2
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 123QD
UT WOS:000243309500022
DA 2021-01-25
ER

PT J
AU Clements, JS
   Gehring, WJ
   Callaerts, P
AF Clements, Jason S.
   Gehring, Walter J.
   Callaerts, Patrick
TI Target selection and synapse formation of ectopic photoreceptors in
   Drosophila melanogaster
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 Katholieke Univ Leuven VIB, Lab Dev Genet, Louvain, Belgium.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Callaerts, Patrick/I-8118-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD JUL-DEC
PY 2006
VL 20
IS 3-4
BP 104
EP 104
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 123QD
UT WOS:000243309500048
DA 2021-01-25
ER

PT J
AU Lichtneckert, R
   Bello, B
   Reichert, H
AF Lichtneckert, Robert
   Bello, Bruno
   Reichert, Heinrich
TI Cell lineage specific expression and function of the empty spiracles
   gene in adult brain development of Drosophila melanogaster
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, Div Mol Zool, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PD JUL-DEC
PY 2006
VL 20
IS 3-4
BP 162
EP 162
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 123QD
UT WOS:000243309500124
DA 2021-01-25
ER

PT J
AU Muller, SA
   Pozidis, C
   Stone, R
   Meesters, C
   Chami, M
   Engel, A
   Economou, A
   Stahlberg, H
AF Mueller, Shirley A.
   Pozidis, Charalambos
   Stone, Remington
   Meesters, Christian
   Chami, Mohamed
   Engel, Andreas
   Economou, Anastassios
   Stahlberg, Henning
TI Double hexameric ring assembly of the type III protein translocase
   ATPase HrcN
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID SALMONELLA-TYPHIMURIUM; ELECTRON-MICROSCOPY; NEEDLE COMPLEX; MEMBRANE
   ATPASE; SECRETION; EXPORT; FLII; OLIGOMERIZATION; APPARATUS; INTERACT
AB The specialized type III secretion (T3S) apparatus of pathogenic and symbiotic Gram-negative bacteria comprises a complex transmembrane organelle and an ATPase homologous to the F-1-ATPase beta subunit. The T3S ATPase HrcN of Pseudomonas syringae associates with the inner membrane, and its ATP hydrolytic activity is stimulated by dodecamerization. The structure of dodecameric HrcN (HrcN(12)) determined to 1.6 nm by cryo-electron microscopy is presented. HrcN(12) comprises two hexameric rings that are probably stacked face-to-face by the association of their C-terminal domains. It is 11.5 +/- 1.0 nm in diameter, 12.0 +/- 2.0 nm high and has a 2.0-3.8 nm wide inner channel. This structure is compared to a homology model based on the structure of the F-1-beta-ATPase. A model for its incorporation within the T3S apparatus is presented.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   FORTH, Inst Mol Biol & Biotechnol, GR-71110 Iraklion, Greece.
   Univ Crete, Dept Biol, GR-71110 Iraklion, Greece.
RP Stahlberg, H (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.
EM hstahlberg@ucdavis.edu
RI Economou, Anastassios/P-8292-2017; Stahlberg, Henning/H-1868-2011
OI Economou, Anastassios/0000-0002-1770-507X; Stahlberg,
   Henning/0000-0002-1185-4592; Meesters, Christian/0000-0003-2408-7588
CR ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0
   Akeda Y, 2004, J BACTERIOL, V186, P2402, DOI 10.1128/JB.186.8.2402-2412.2004
   Auvray F, 2002, J MOL BIOL, V318, P941, DOI 10.1016/S0022-2836(02)00172-9
   BIANCA R, 2002, MED SCI MONITOR, V8, P1
   Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0
   Claret L, 2003, MOL MICROBIOL, V48, P1349, DOI 10.1046/j.1365-2958.2003.03506.x
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Fan F, 1996, J BIOL CHEM, V271, P31981, DOI 10.1074/jbc.271.50.31981
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Macnab RM, 2004, BBA-MOL CELL RES, V1694, P207, DOI 10.1016/j.bbamcr.2004.04.005
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Minamino T, 2003, J BACTERIOL, V185, P3983, DOI 10.1128/JB.185.13.3983-3988.2003
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Plewniak F, 2003, NUCLEIC ACIDS RES, V31, P3829, DOI 10.1093/nar/gkg518
   Pozidis C, 2003, J BIOL CHEM, V278, P25816, DOI 10.1074/jbc.M301903200
   RUIZ T, 1993, ULTRAMICROSCOPY, V49, P417, DOI 10.1016/0304-3991(93)90247-U
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x
   Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101
   VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6
   Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509
NR 29
TC 42
Z9 47
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUL
PY 2006
VL 61
IS 1
BP 119
EP 125
DI 10.1111/j.1365-2958.2006.05219.x
PG 7
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 054CI
UT WOS:000238353300011
PM 16824099
OA Bronze
DA 2021-01-25
ER

PT J
AU Ruegg, MA
AF Rueegg, Markus A.
TI Novel ways to treat Congenital Muscular Dystrophies
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 11th International Congress on Neuromuscular Diseases
CY JUL 02-07, 2006
CL Istanbul, TURKEY
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD JUL
PY 2006
VL 16
SU 1
BP S95
EP S95
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 066KX
UT WOS:000239229400177
DA 2021-01-25
ER

PT J
AU Geiser, AH
   Sievert, MK
   Guo, LW
   Grant, JE
   Krebs, MP
   Fotiadis, D
   Engel, A
   Ruoho, AE
AF Geiser, Andrew H.
   Sievert, Michael K.
   Guo, Lian-Wang
   Grant, Jennifer E.
   Krebs, Mark P.
   Fotiadis, Dimitrios
   Engel, Andreas
   Ruoho, Arnold E.
TI Bacteriorhodopsin chimeras containing the third cytoplasmic loop of
   bovine rhodopsin activate transducin for GTP/GDP exchange
SO PROTEIN SCIENCE
LA English
DT Article
DE G-protein-coupled receptors; chimera; bacteriorhodopsin; rhodopsin;
   transducin; GTP exchange
ID PROTEIN-COUPLED RECEPTOR; GUANINE-NUCLEOTIDE EXCHANGE; BETA-ADRENERGIC
   RECEPTORS; SITE-DIRECTED MUTAGENESIS; COVALENT CROSS-LINKING;
   ALPHA-SUBUNIT; BETA-2-ADRENERGIC RECEPTORS; HALOBACTERIUM-SALINARUM;
   CONSTITUTIVE ACTIVATION; 3-DIMENSIONAL STRUCTURE
AB The mechanisms by which G-protein-coupled receptors (GPCRs) activate G-proteins are not well understood due to the lack of atomic structures of GPCRs in an active form or in GPCR/G-protein complexes. For study of GPCR/G-protein interactions, we have generated a series of chimeras by replacing the third cytoplasmic loop of a scaffold protein bacteriorhodopsin (bR) with various lengths of cytoplasmic loop 3 of bovine rhodopsin (Rh), and one such chimera containing loop 3 of the human beta(2)-adrenergic receptor. The chimeras expressed in the archaeon Halobacterium salinarum formed purple membrane lattices thus facilitating robust protein purification. Retinal was correctly incorporated into the chimeras, as determined by spectrophotometry. A 2D crystal ( lattice) was evidenced by circular dichroism analysis, and proper organization of homotrimers formed by the bR/Rh loop 3 chimera Rh3C was clearly illustrated by atomic force microscopy. Most interestingly, Rh3C (and Rh3G to a lesser extent) was functional in activation of GTP gamma S-35/GDP exchange of the transducin a subunit ( Gat) at a level 3.5-fold higher than the basal exchange. This activation was inhibited by GDP and by a high-affinity peptide analog of the Gat C terminus, indicating specificity in the exchange reaction. Furthermore, a specific physical interaction between the chimera Rh3C loop 3 and the Gat C terminus was demonstrated by cocentrifugation of transducin with Rh3C. This G alpha t-activating bR/Rh chimera is highly likely to be a useful tool for studying GPCR/G-protein interactions.
C1 Univ Wisconsin, Dept Pharmacol, Sch Med, Madison, WI 53706 USA.
   Univ Wisconsin, Dept Biomol Chem, Sch Med, Madison, WI 53706 USA.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Guo, LW (corresponding author), Univ Wisconsin, Dept Pharmacol, Sch Med, 1300 Univ Ave, Madison, WI 53706 USA.
EM lianwangguo@wisc.edu
OI Krebs, Mark/0000-0001-9017-6066
FU NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [S10RR013790] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM033138, R01GM033138, R01GM033138, R01GM033138, R01GM033138,
   R01GM033138, R01GM033138, R01GM033138, R01GM033138, R01GM033138,
   R01GM033138, R01GM033138, R01GM033138, R01GM033138, R01GM033138,
   R01GM033138, R01GM033138, R01GM033138, R01GM033138, R01GM033138,
   R01GM033138, R01GM033138, R01GM033138, R01GM033138, R01GM033138] Funding
   Source: NIH RePORTER; NCRR NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [S10 RR013790, S10 RR13790] Funding
   Source: Medline; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [GM33138, R01 GM033138] Funding
   Source: Medline
CR Abdulaev NG, 2002, STRUCTURE, V10, P515, DOI 10.1016/S0969-2126(02)00752-9
   AHL PL, 1990, BIOCHIM BIOPHYS ACTA, V1028, P141, DOI 10.1016/0005-2736(90)90148-H
   Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776
   Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l
   BRITHLINDNER M, 1977, FEBS LETT, V76, P41, DOI 10.1016/0014-5793(77)80116-6
   Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898
   Chen GQ, 1996, PROTEIN SCI, V5, P456
   Choi G, 2002, BIOCHEMISTRY-US, V41, P7318, DOI 10.1021/bi025507w
   COTECCHIA S, 1990, P NATL ACAD SCI USA, V87, P2896, DOI 10.1073/pnas.87.8.2896
   DIXON RAF, 1988, COLD SPRING HARB SYM, V53, P487, DOI 10.1101/SQB.1988.053.01.056
   Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768
   FRANKE RR, 1988, J BIOL CHEM, V263, P2119
   FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504
   FRASER CM, 1988, P NATL ACAD SCI USA, V85, P5478, DOI 10.1073/pnas.85.15.5478
   FRIELLE T, 1988, P NATL ACAD SCI USA, V85, P9494, DOI 10.1073/pnas.85.24.9494
   FUNG BKK, 1983, J BIOL CHEM, V258, P495
   Grant JE, 2006, J BIOL CHEM, V281, P6194, DOI 10.1074/jbc.M509511200
   Guo LW, 2005, BIOCONJUGATE CHEM, V16, P685, DOI 10.1021/bc050016k
   HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547
   Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798
   Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200
   Heymann JB, 2000, STRUCT FOLD DES, V8, P643, DOI 10.1016/S0969-2126(00)00151-9
   Itoh Y, 2001, P NATL ACAD SCI USA, V98, P4883, DOI 10.1073/pnas.051632998
   Jaakola VP, 2005, PROTEINS, V60, P412, DOI 10.1002/prot.20498
   Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200
   Kim JM, 2005, BIOCHEMISTRY-US, V44, P2284, DOI 10.1021/bi048328i
   Kim JM, 2004, P NATL ACAD SCI USA, V101, P12508, DOI 10.1073/pnas.0404519101
   Kisselev OG, 2004, J BIOL CHEM, V279, P51203, DOI 10.1074/jbc.M407341200
   Klein-Seetharaman J, 2004, P NATL ACAD SCI USA, V101, P3409, DOI 10.1073/pnas.0308713101
   KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950
   Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3
   Kudo M, 1996, J BIOL CHEM, V271, P22470, DOI 10.1074/jbc.271.37.22470
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049
   Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090
   Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   Lundstrom K, 2005, TRENDS BIOTECHNOL, V23, P103, DOI 10.1016/j.tibtech.2004.12.006
   LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880
   Marin EP, 2000, J BIOL CHEM, V275, P1930, DOI 10.1074/jbc.275.3.1930
   Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361
   Natochin M, 2003, J BIOL CHEM, V278, P37574, DOI 10.1074/jbc.M305136200
   ODOWD BF, 1988, J BIOL CHEM, V263, P15985
   Oesterhelt D, 1974, Methods Enzymol, V31, P667
   Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044
   Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Peck RF, 2000, MOL MICROBIOL, V35, P667, DOI 10.1046/j.1365-2958.2000.01739.x
   Pereira R, 2005, J BIOL CHEM, V280, P35696, DOI 10.1074/jbc.M504935200
   RASENICK MM, 1994, METHOD ENZYMOL, V237, P100
   Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   ROBB FT, 1995, ARCHAEA LAB MANUAL
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Terakita A, 2002, J BIOL CHEM, V277, P40, DOI 10.1074/jbc.M104960200
   Turner GJ, 1999, PROTEIN EXPRES PURIF, V17, P324, DOI 10.1006/prep.1999.1111
   WESSLINGRESNICK M, 1987, J BIOL CHEM, V262, P3697
   WONG SKF, 1990, J BIOL CHEM, V265, P6219
   Yeagle PL, 1997, BIOCHEMISTRY-US, V36, P9649, DOI 10.1021/bi970908a
NR 59
TC 7
Z9 7
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0961-8368
EI 1469-896X
J9 PROTEIN SCI
JI Protein Sci.
PD JUL
PY 2006
VL 15
IS 7
BP 1679
EP 1690
DI 10.1110/ps.062192306
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 059BB
UT WOS:000238707200010
PM 16815918
OA Green Published
DA 2021-01-25
ER

PT J
AU Ledermann, HP
   Schulte, AC
   Heidecker, HG
   Aschwanden, M
   Jager, KA
   Scheffler, K
   Steinbrich, W
   Bilecen, D
AF Ledermann, Hans-Peter
   Schulte, Anja-Carina
   Heidecker, Hanns-Georg
   Aschwanden, Markus
   Jaeger, Kurt A.
   Scheffler, Klaus
   Steinbrich, Wolfgang
   Bilecen, Deniz
TI Blood oxygenation level-dependent magnetic resonance imaging of the
   skeletal muscle in patients with peripheral arterial occlusive disease
SO CIRCULATION
LA English
DT Article
DE peripheral vascular disease; atherosclerosis; diagnosis; hemoglobin;
   muscles; magnetic resonance imaging; perfusion
ID INVESTIGATE PERFUSION RESERVE; DIGITAL SUBTRACTION; REACTIVE HYPEREMIA;
   MR-ANGIOGRAPHY; LOWER-LIMBS; BRAIN; BOLD; CONTRAST; SIGNAL;
   MICROCIRCULATION
AB Background-Blood oxygenation level-dependent ( BOLD) magnetic resonance imaging (MRI) has been used to measure T2* changes in skeletal muscle tissue of healthy volunteers. The BOLD effect is assumed to primarily reflect changes in blood oxygenation at the tissue level. We compared the calf muscle BOLD response of patients with peripheral arterial occlusive disease (PAOD) to that of an age-matched non-PAOD group during postischemic reactive hyperemia. Methods and Results-PAOD patients (n=17) with symptoms of intermittent calf claudication and an age-matched non-PAOD group (n=11) underwent T2*-weighted single-shot multiecho planar imaging on a whole-body magnetic resonance scanner at 1.5 T. Muscle BOLD MRI of the calf was performed during reactive hyperemia provoked by a cuff-compression paradigm. T2* maps were generated with an automated fitting procedure. Maximal T2* change (Delta T2*(max)) and time to peak to reach Delta T2*(max) for gastrocnemius, soleus, tibial anterior, and peroneal muscle were evaluated. Compared with the non-PAOD group, patients revealed significantly lower Delta T2*(max)-values, with a mean of 7.3 +/- 5.3% versus 13.1 +/- 5.6% (P < 0.001), and significantly delayed time-to-peak values, with a mean of 109.3 +/- 79.3 versus 32.2 +/- 13.3 seconds (P < 0.001). Conclusions-T2* time courses of the muscle BOLD MRI signal during postocclusive reactive hyperemia revealed statistically significant differences in the key parameters (Delta T2*(max); time to peak) in PAOD patients compared with age-matched non-PAOD controls.
C1 Univ Basel Hosp, Inst Diagnost Radiol, Dept Radiol, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Angiol, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Bilecen, D (corresponding author), Univ Basel Hosp, Inst Diagnost Radiol, Dept Radiol, Petersgraben 4, CH-4031 Basel, Switzerland.
EM dbilecen@uhbs.ch
OI Scheffler, Klaus/0000-0001-6316-8773
CR BERGLUND B, 1981, CLIN PHYSIOL, V1, P253, DOI 10.1111/j.1475-097X.1981.tb00893.x
   Bilecen D, 2002, J MAGN RESON IMAGING, V15, P621, DOI 10.1002/jmri.10117
   Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013
   CHEATLE TR, 1991, BRIT J SURG, V78, P405, DOI 10.1002/bjs.1800780408
   DAWSON JM, 1990, CARDIOVASC RES, V24, P390, DOI 10.1093/cvr/24.5.390
   Diehm C, 2004, ATHEROSCLEROSIS, V172, P95, DOI 10.1016/S0021-9150(03)00204-1
   Donahue KM, 1998, JMRI-J MAGN RESON IM, V8, P1106, DOI 10.1002/jmri.1880080516
   Fieno DS, 2004, CIRCULATION, V110, P1284, DOI 10.1161/01.CIR.0000140673.13057.34
   Gray S D, 1977, Bibl Anat, P535
   Haacke EM, 1997, HUM BRAIN MAPP, V5, P341, DOI 10.1002/(SICI)1097-0193(1997)5:5<341::AID-HBM2>3.0.CO;2-3
   Hamzei F, 2003, NEUROIMAGE, V20, P1393, DOI 10.1016/S1053-8119(03)00384-7
   Hennig J, 2000, P INT SOC MAGN RESON, V8, P122
   HICKEY NC, 1992, EUR J VASCULAR SURG, V6, P36, DOI 10.1016/S0950-821X(05)80092-1
   Hsu HB, 2004, RHEUMATOL INT, V24, P291, DOI 10.1007/s00296-003-0362-8
   HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8
   Jarm T, 2003, ADV EXP MED BIOL, V530, P661
   Jordan BF, 2004, MAGNET RESON MED, V52, P391, DOI 10.1002/mrm.20155
   KEY H, 1987, BRIT J RADIOL, V60, P1083, DOI 10.1259/0007-1285-60-719-1083
   Klocke FJ, 2003, J AM COLL CARDIOL, V41, P841, DOI 10.1016/S0735-1097(02)02930-3
   KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675
   Lebon V, 1998, MAGNET RESON MED, V40, P551, DOI 10.1002/mrm.1910400408
   Lebon V, 1998, MAGN RESON IMAGING, V16, P721, DOI 10.1016/S0730-725X(98)00088-5
   LEBON V, 1996, P 4 ANN M INT SOC MA, P424
   Lin CC, 2004, J DIABETES COMPLICAT, V18, P233, DOI 10.1016/S1056-8727(03)00029-1
   Mandeville JB, 2001, MAGNET RESON MED, V45, P443, DOI 10.1002/1522-2594(200103)45:3<443::AID-MRM1058>3.0.CO;2-3
   Noseworthy MD, 1999, JMRI-J MAGN RESON IM, V9, P814, DOI 10.1002/(SICI)1522-2586(199906)9:6<814::AID-JMRI8>3.0.CO;2-5
   Noseworthy Michael D, 2003, Semin Musculoskelet Radiol, V7, P307
   OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868
   PRIELMEIER F, 1993, J CEREBR BLOOD F MET, V13, P889, DOI 10.1038/jcbfm.1993.111
   PRIELMEIER F, 1994, MAGN RESON MED, V31, P678, DOI 10.1002/mrm.1910310615
   Prince MR, 1998, RADIOLOGY, V206, P592, DOI 10.1148/radiology.206.3.9494471
   Rofsky NM, 2000, RADIOLOGY, V214, P325, DOI 10.1148/radiology.214.2.r00fe42325
   Rossi M, 2004, BIOMED PHARMACOTHER, V58, P427, DOI 10.1016/j.biopha.2004.08.004
   Schulte AC, 2001, MAGNET RESON MED, V45, P811, DOI 10.1002/mrm.1109
   Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0
   Shiino A, 2003, J CEREBR BLOOD F MET, V23, P121, DOI 10.1097/01.WCB.0000037546.46809.CA
   SMITH TP, 1992, AM J ROENTGENOL, V158, P431, DOI 10.2214/ajr.158.2.1729803
   Speck O, 1998, MAGNET RESON MED, V40, P243, DOI 10.1002/mrm.1910400210
   Toussaint JF, 1996, MAGNET RESON MED, V35, P62, DOI 10.1002/mrm.1910350109
   Uludag K, 2004, MAGNET RESON MED, V51, P1088, DOI 10.1002/mrm.20067
   Uludag K, 2004, NEUROIMAGE, V23, P148, DOI 10.1016/j.neuroimage.2004.05.013
   Villringer A, 1997, ADV EXP MED BIOL, V413, P177
   Wacker CM, 2003, J AM COLL CARDIOL, V41, P834, DOI 10.1016/S0735-1097(02)02931-5
   YABLONSKIY DA, 1994, MAGNET RESON MED, V32, P749, DOI 10.1002/mrm.1910320610
NR 44
TC 103
Z9 112
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD JUN 27
PY 2006
VL 113
IS 25
BP 2929
EP 2935
DI 10.1161/CIRCULATIONAHA.105.605717
PG 7
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 057CG
UT WOS:000238572100012
PM 16785340
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Bauche, C
   Chenal, A
   Knapp, O
   Bodenreider, C
   Benz, R
   Chaffotte, A
   Ladant, D
AF Bauche, Cecile
   Chenal, Alexandre
   Knapp, Oliver
   Bodenreider, Christophe
   Benz, Roland
   Chaffotte, Alain
   Ladant, Daniel
TI Structural and functional characterization of an essential RTX subdomain
   of Bordetella pertussis adenylate cyclase toxin
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ESCHERICHIA-COLI HEMOLYSIN; T-CELL EPITOPES; ANTIGEN-PRESENTING CELLS;
   GRAM-NEGATIVE BACTERIA; ALPHA-HEMOLYSIN; TARGET-CELLS; BINDING; CALCIUM;
   PROTEIN; IDENTIFICATION
AB The adenylate cyclase toxin (CyaA) is one of the major virulence factors of Bordetella pertussis, the causative agent of whooping cough. CyaA is able to invade eukaryotic cells by a unique mechanism that consists in a calcium-dependent, direct translocation of the CyaA catalytic domain across the plasma membrane of the target cells. CyaA possesses a series of a glycine- and aspartate-rich nonapeptide repeats ( residues 1006-1613) of the prototype GGXG(N/D)DX(L/I/F)X ( where X represents any amino acid) that are characteristic of the RTX ( repeat in toxin) family of bacterial cytolysins. These repeats are arranged in a tandem fashion and may fold into a characteristic parallel beta-helix or beta-roll motif that constitutes a novel type of calcium binding structure, as revealed by the three-dimensional structure of the Pseudomonas aeruginosa alkaline protease. Here we have characterized the structure-function relationships of various fragments from the CyaA RTX subdomain. Our results indicate that the RTX functional unit includes both the tandem repeated nonapeptide motifs and the adjacent polypeptide segments, which are essential for the folding and calcium responsiveness of the RTX module. Upon calcium binding to the RTX repeats, a conformational rearrangement of the adjacent non-RTX sequences may act as a critical molecular switch to trigger the CyaA entry into target cells.
C1 Inst Pasteur, Unite Biochim Interact Macromol, CNRS, URA 2185, F-75724 Paris 15, France.
   Univ Wurzburg, Biozentrum, Theodor Boveri Inst, Biotechnol Lab, D-97074 Wurzburg, Germany.
   Univ Basel, Biozentrum, Abr Biophys Chem, CH-4056 Basel, Switzerland.
   Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris, France.
RP Ladant, D (corresponding author), Inst Pasteur, Unite Biochim Interact Macromol, CNRS, URA 2185, 28 Rue Dr Roux, F-75724 Paris 15, France.
EM ladant@pasteur.fr
RI Chenal, Alexandre/C-2240-2009
OI Chenal, Alexandre/0000-0002-4959-1003; Benz, Roland/0000-0002-9510-9265;
   LADANT, Daniel/0000-0003-1955-548X
CR BARRY EM, 1991, J BACTERIOL, V173, P720, DOI 10.1128/jb.173.2.720-726.1991
   BAUMANN U, 1993, EMBO J, V12, P3357, DOI 10.1002/j.1460-2075.1993.tb06009.x
   BAUMANN U, 1994, J MOL BIOL, V242, P244, DOI 10.1006/jmbi.1994.1576
   Bejerano M, 1999, MOL MICROBIOL, V31, P381, DOI 10.1046/j.1365-2958.1999.01183.x
   BELLALOU J, 1990, INFECT IMMUN, V58, P3242, DOI 10.1128/IAI.58.10.3242-3247.1990
   BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9
   BENZ R, 1994, J BIOL CHEM, V269, P27231
   BOEHM DF, 1990, INFECT IMMUN, V58, P1959, DOI 10.1128/IAI.58.6.1959-1964.1990
   Chervaux C, 1996, J BACTERIOL, V178, P1232, DOI 10.1128/jb.178.4.1232-1236.1996
   CONFER DL, 1982, SCIENCE, V217, P948, DOI 10.1126/science.6287574
   COOTE JG, 1992, FEMS MICROBIOL LETT, V88, P137, DOI 10.1111/j.1574-6968.1992.tb04961.x
   Cortajarena AL, 2003, J BIOL CHEM, V278, P19159, DOI 10.1074/jbc.M208552200
   El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200
   GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x
   GLASER P, 1988, MOL MICROBIOL, V2, P19, DOI 10.1111/j.1365-2958.1988.tb00003.x
   Gmira S, 2001, RES MICROBIOL, V152, P889, DOI 10.1016/S0923-2508(01)01272-4
   Guermonprez P, 2000, METHOD ENZYMOL, V326, P527
   Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035
   HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682
   HANSKI E, 1985, J BIOL CHEM, V260, P5526
   Hewlett EL, 2006, MOL MICROBIOL, V59, P447, DOI 10.1111/j.1365-2958.2005.04958.x
   HEWLETT EL, 1991, J BIOL CHEM, V266, P17503
   HEWLETT EL, 1989, J BIOL CHEM, V264, P19379
   IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x
   Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532
   KHELEF N, 1993, INFECT IMMUN, V61, P4064, DOI 10.1128/IAI.61.10.4064-4071.1993
   KHELEF N, 1995, FEMS MICROBIOL LETT, V134, P27, DOI 10.1016/0378-1097(95)00375-F
   Knapp O, 2003, BIOCHEMISTRY-US, V42, P8077, DOI 10.1021/bi034295f
   Ladant D, 1999, TRENDS MICROBIOL, V7, P172, DOI 10.1016/S0966-842X(99)01468-7
   LADANT D, 1995, J BIOL CHEM, V270, P3179
   LADANT D, 1989, J BIOL CHEM, V264, P4015
   Lally ET, 1999, TRENDS MICROBIOL, V7, P356, DOI 10.1016/S0966-842X(99)01530-9
   Lilie H, 2000, FEBS LETT, V470, P173, DOI 10.1016/S0014-5793(00)01308-9
   LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494
   Masin J, 2005, BIOCHEMISTRY-US, V44, P12759, DOI 10.1021/bi050459b
   Mattoo S, 2005, CLIN MICROBIOL REV, V18, P326, DOI 10.1128/CMR.18.2.326-382.2005
   Osicka R, 2000, INFECT IMMUN, V68, P247
   OSTOLAZA H, 1995, EUR J BIOCHEM, V228, P39, DOI 10.1111/j.1432-1033.1995.tb20225.x
   Rhodes CR, 2001, ARCH BIOCHEM BIOPHYS, V395, P169, DOI 10.1006/abbi.2001.2553
   ROGEL A, 1989, EMBO J, V8, P2755, DOI 10.1002/j.1460-2075.1989.tb08417.x
   ROGEL A, 1992, J BIOL CHEM, V267, P22599
   SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schindel C, 2001, EUR J BIOCHEM, V268, P800, DOI 10.1046/j.1432-1327.2001.01937.x
   SEBO P, 1993, MOL MICROBIOL, V9, P999, DOI 10.1111/j.1365-2958.1993.tb01229.x
   SEBO P, 1991, GENE, V104, P19, DOI 10.1016/0378-1119(91)90459-O
   SZABO G, 1994, J BIOL CHEM, V269, P22496
   WEISS AA, 1986, ANNU REV MICROBIOL, V40, P661, DOI 10.1146/annurev.mi.40.100186.003305
   Welch RA, 2001, CURR TOP MICROBIOL, V257, P85
   WELCH RA, 1991, MOL MICROBIOL, V5, P521, DOI 10.1111/j.1365-2958.1991.tb00723.x
NR 51
TC 73
Z9 76
U1 1
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 23
PY 2006
VL 281
IS 25
BP 16914
EP 16926
DI 10.1074/jbc.M601594200
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 053SV
UT WOS:000238326300012
PM 16627468
OA Other Gold
DA 2021-01-25
ER

PT J
AU Jung, AC
   Ribeiro, C
   Michaut, L
   Certa, U
   Affolter, M
AF Jung, Alain C.
   Ribeiro, Carlos
   Michaut, Lydia
   Certa, Ulrich
   Affolter, Markus
TI Polychaetoid/ZO-1 is required for cell specification and rearrangement
   during Drosophila tracheal morphogenesis
SO CURRENT BIOLOGY
LA English
DT Article
ID BRANCHING MORPHOGENESIS; GENE-EXPRESSION; TIGHT JUNCTIONS; PROTEIN ZO-1;
   IN-VIVO; MEMBRANE; ENCODES; LOCALIZATION; ADHESION; DISTINCT
AB The development of the complex network of epithelial tubes that ultimately forms the Drosophila tracheal system relies on cell migration, cell shape changes, cell rearrangements, cell differentiation, and branch fusion [1-3]. Most of these events are controlled by a combination of distinct transcription factors and cell-cell signaling molecules, but few proteins that do not fall within these two functional classes have been associated with tracheal development. We show that the MAGUK protein Polychaetoid (Pyd/ZO-1), the Drosophila homolog of the junctional protein ZO-1 [4], plays a dual role in the formation of tracheal tubes. pyd/ZO-1 mutant embryos display branch fusion defects due to the lack of reliable determination of the fusion cell fate. In addition, pyd/ZO-1 mutant embryos show impaired cell intercalation in thin tracheal branches. Pyd/ZO-1 localizes to the adherens junctions (AJs) in tracheal cells and might thus play a direct role in the regulation of the dynamic state of the AJ during epithelial remodeling. Our study suggests that MAGUK proteins might play important roles during AJ remodeling in epithelial morphogenesis.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Roche Ctr Med Genom, CH-4070 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Jung, Alain/X-5384-2019; Jung, Alain/AAC-6598-2019
OI Jung, Alain/0000-0002-4049-4151; Affolter, Markus/0000-0002-5171-0016;
   Ribeiro, Carlos/0000-0002-9542-7335
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Balda MS, 2000, EMBO J, V19, P2024, DOI 10.1093/emboj/19.9.2024
   Balda MS, 2003, TRENDS CELL BIOL, V13, P310, DOI 10.1016/S0962-8924(03)00105-3
   Bellen HJ, 2004, GENETICS, V167, P761, DOI 10.1534/genetics.104.026427
   Boube M, 2000, MECH DEVELOP, V91, P271, DOI 10.1016/S0925-4773(99)00315-9
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Chen CM, 1996, MECH DEVELOP, V57, P215, DOI 10.1016/0925-4773(96)00548-5
   Dimitratos SD, 1999, BIOESSAYS, V21, P912, DOI 10.1002/(SICI)1521-1878(199911)21:11<912::AID-BIES3>3.0.CO;2-Z
   EISENMANN DM, 1994, CURR OPIN GENET DEV, V4, P508, DOI 10.1016/0959-437X(94)90065-B
   Funke L, 2005, ANNU REV BIOCHEM, V74, P219, DOI 10.1146/annurev.biochem.74.082803.133339
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Gonzalez-Mariscal L, 2000, SEMIN CELL DEV BIOL, V11, P315, DOI 10.1006/scdb.2000.0178
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Horio Y, 1997, J BIOL CHEM, V272, P12885, DOI 10.1074/jbc.272.20.12885
   Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118
   Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103
   Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3
   KARPEN GH, 1992, GENETICS, V132, P737
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003
   Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055
   NEUMANN M, 2006, 7 EMBO, P36
   Oda H, 1999, DEV BIOL, V216, P406, DOI 10.1006/dbio.1999.9494
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73
   Takahisa M, 1996, GENE DEV, V10, P1783, DOI 10.1101/gad.10.14.1783
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Tejedor FJ, 1997, J NEUROSCI, V17, P152
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Wei XR, 2001, MECH DEVELOP, V100, P217, DOI 10.1016/S0925-4773(00)00550-5
   WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P
   Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93
   XU T, 1993, DEVELOPMENT, V117, P1223
   YOFFE KB, 1995, DEV BIOL, V170, P636, DOI 10.1006/dbio.1995.1243
NR 41
TC 39
Z9 39
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD JUN 20
PY 2006
VL 16
IS 12
BP 1224
EP 1231
DI 10.1016/j.cub.2006.04.048
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 057LP
UT WOS:000238597600027
PM 16782014
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Huang, NP
   Koser, J
   Deng, J
   Lau, KHA
   Schwarz-Herion, K
   Fahrenkrog, B
   Aebi, U
AF Lim, Roderick Y. H.
   Huang, Ning-Ping
   Koeser, Joachim
   Deng, Jie
   Lau, K. H. Aaron
   Schwarz-Herion, Kyrill
   Fahrenkrog, Birthe
   Aebi, Ueli
TI Flexible phenylalanine-glycine nucleoporins as entropic barriers to
   nucleocytoplasmic transport
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE force spectroscopy; nanomechanics; natively unfolded proteins; nuclear
   pore complex; selective gating
ID NUCLEAR-PORE COMPLEX; ATOMIC-FORCE MICROSCOPE; BINDING-DYNAMICS; REPEAT
   REGIONS; IMPORTIN-BETA; PERMEABILITY; POLYMERS; RESISTANCE; TOPOLOGY;
   SURFACES
AB Natively unfolded phenylalanine-glycine (FG)-repeat domains are alleged to form the physical constituents of the selective barrier-gate in nuclear pore complexes during nucleocytoplasmic transport. Presently, the biophysical mechanism behind the selective gate remains speculative because of a lack of information regarding the nanomechanical properties of the FG domains. In this work, we have applied the atomic force microscope to measure the mechanical response of individual and clusters of FG molecules. Single-molecule force spectroscopy reveals that FG molecules are unfolded and highly flexible. To provide insight into the selective gating mechanism, an experimental platform has been constructed to study the collective behavior of surface-tethered FG molecules at the nanoscale. Measurements indicate that the collective behavior of such FG molecules gives rise to an exponentially decaying long-range steric repulsive force. This finding indicates that the molecules are thermally mobile in an extended polymer brush-like conformation. This assertion is confirmed by observing that the brush-like conformation undergoes a reversible collapse transition in less polar solvent conditions. These findings reveal how FG-repeat domains may simultaneously function as an entropic barrier and a selective trap in the near-field interaction zone of nuclear pore complexes; i.e., selective gate.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011; Lau, Aaron/T-1397-2019; Lau, King Hang
   Aaron/D-2061-2010
OI Lau, Aaron/0000-0003-3676-9228; Lau, King Hang
   Aaron/0000-0003-3676-9228; Fahrenkrog, Birthe/0000-0003-4080-9413; Lim,
   Roderick/0000-0001-5015-6087
CR AUROY P, 1992, MACROMOLECULES, V25, P4134, DOI 10.1021/ma00042a014
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Brown HG, 1997, BIOCHEMISTRY-US, V36, P15035, DOI 10.1021/bi9721748
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fantner GE, 2006, BIOPHYS J, V90, P1411, DOI 10.1529/biophysj.105.069344
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Flory P.J., 1969, STAT MECH CHAIN MOL
   Gillies G, 2005, LANGMUIR, V21, P12342, DOI 10.1021/la0515120
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hoh JH, 1998, PROTEINS, V32, P223, DOI 10.1002/(SICI)1097-0134(19980801)32:2<223::AID-PROT8>3.0.CO;2-L
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Israelachvili J. N., 1995, INTERMOLECULAR SURFA
   Janshoff A, 2000, ANGEW CHEM INT EDIT, V39, P3213
   Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9
   Kinoshita M, 2003, J CHEM PHYS, V118, P8969, DOI 10.1063/1.1566935
   KUHL TL, 1994, BIOPHYS J, V66, P1479, DOI 10.1016/S0006-3495(94)80938-5
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Mukhopadhyay R, 2001, FEBS LETT, V505, P374, DOI 10.1016/S0014-5793(01)02844-7
   Ortiz C, 1999, MACROMOLECULES, V32, P780, DOI 10.1021/ma981245n
   OSHEA SJ, 1993, LANGMUIR, V9, P1826, DOI 10.1021/la00031a034
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Riener CK, 2003, ANAL CHIM ACTA, V479, P59, DOI 10.1016/S0003-2670(02)01373-9
   Rotsch C, 1997, LANGMUIR, V13, P2825, DOI 10.1021/la960874s
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156
   ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331
NR 41
TC 186
Z9 187
U1 1
U2 28
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 20
PY 2006
VL 103
IS 25
BP 9512
EP 9517
DI 10.1073/pnas.0603521103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 058JD
UT WOS:000238660400025
PM 16769882
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Honnappa, S
   Jahnke, W
   Seelig, J
   Steinmetz, MO
AF Honnappa, Srinivas
   Jahnke, Wolfgang
   Seelig, Joachim
   Steinmetz, Michel O.
TI Control of intrinsically disordered stathmin by multisite
   phosphorylation
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MICROTUBULE-DESTABILIZING ACTIVITY; IN-VITRO; TUBULIN; PROTEINS;
   BINDING; OP18/STATHMIN; DYNAMICS; SPINDLE; PREDICTION; INCREASES
AB Stathmin is an intrinsically disordered protein implicated in the regulation of microtubule dynamics and in the development of cancer. The microtubule destabilizing activity of stathmin is down-regulated by phosphorylation of four serine residues, Ser(16), Ser(25), Ser(38), and Ser(63). Here we have used calorimetric and spectroscopic methods, including nuclear magnetic resonance to analyze the properties of seven stathmin phosphoisoforms to bind tubulin and inhibit microtubule formation. We found that stathmin phosphorylation results in a substantial loss in hydration entropy upon tubulin-stathmin complex formation. Remarkably, a linear correlation between the free energy change of complex formation and the microtubule inhibition activities of stathmin phosphoisoforms was observed. This finding provides a biophysical basis for understanding the mechanism by which local stathmin activity gradients important for promoting localized microtubule growth are established. We further found that phosphorylation of Ser16 and Ser63 disrupts the formation of a tubulin-interacting beta-hairpin and a helical segment, respectively, explaining the dominant role of these residues in regulating cell cycle progression. The insight into the tubulin-stathmin interaction offers a molecular basis for understanding the nature and the factors that control intrinsically disordered protein systems in general.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   Novartis Pharma AG, NIBR, Discovery Technol, CH-4002 Basel, Switzerland.
   Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Steinmetz, MO (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM michel.steinmetz@psi.ch
OI Steinmetz, Michel/0000-0001-6157-3687
CR Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200
   Andersen SSL, 2000, TRENDS CELL BIOL, V10, P261, DOI 10.1016/S0962-8924(00)01786-4
   Andersen SSL, 1997, NATURE, V389, P640, DOI 10.1038/39382
   Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025
   Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5
   Budde PP, 2001, J CELL BIOL, V153, P149, DOI 10.1083/jcb.153.1.149
   Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7
   Clement MJ, 2005, BIOCHEMISTRY-US, V44, P14616, DOI 10.1021/bi0512492
   Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029
   Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345
   DI PG, 1997, FEBS LETT, V416, P149
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456
   Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566
   Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200
   Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129
   Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105
   Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253
   Iancu C, 2001, J CELL SCI, V114, P909
   Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b
   Kuntziger T, 2001, J BIOL CHEM, V276, P22979, DOI 10.1074/jbc.M101466200
   Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530
   Liu ZH, 2005, CANCER RES, V65, P1647, DOI 10.1158/0008-5472.CAN-04-1754
   Luque I, 1998, METHOD ENZYMOL, V295, P100
   Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200
   Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108
   Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393
   Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187
   Shumyatsky GP, 2005, CELL, V123, P697, DOI 10.1016/j.cell.2005.08.038
   SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294
   Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572
   Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105
   Tholey A, 1999, BIOPHYS J, V76, P76, DOI 10.1016/S0006-3495(99)77179-1
   Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008
   Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747
   Walczak CE, 2000, CURR OPIN CELL BIOL, V12, P52, DOI 10.1016/S0955-0674(99)00056-3
   Wallon G, 2000, EMBO J, V19, P213, DOI 10.1093/emboj/19.2.213
   Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002
   Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200
NR 40
TC 37
Z9 43
U1 0
U2 4
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 9
PY 2006
VL 281
IS 23
BP 16078
EP 16083
DI 10.1074/jbc.M513524200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 049DM
UT WOS:000237996000060
PM 16554300
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Zaia, J
AF Ziegler, A
   Zaia, J
TI Size-exclusion chromatography of heparin oligosaccharides at high and
   low pressure
SO JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL
   AND LIFE SCIENCES
LA English
DT Article
DE bio-gel; heparan sulfate proteoglycans; heparin-binding proteins;
   heparinase; heparin oligosaccharides; mass spectrometry; size-exclusion
   chromatography; superdex; van Deemter plot
ID MOLECULAR-WEIGHT; FLAVOBACTERIUM-HEPARINUM; ENZYMATIC DEGRADATION;
   MASS-SPECTROMETRY; SULFATE; PURIFICATION; LYASES; GLYCOSAMINOGLYCANS;
   STRATEGIES; SEPARATION
AB Recent findings on specific and non-specific interactions of glycosaminoglycans (GAGs) accentuate their pivotal role in biology and the call for improved sequencing tools. The present study evaluates size-exclusion chromatography (SEC) of heparin oligosaccharides at high and low pressure, requiring amounts as low as 0.2 microgram, using conventional UV detection after depolymerization with heparin lyases. Because of their high charge at physiological pH, SEC elution volumes of heparin oligosaccharides depend on both molecular size and charge repulsion from the matrix. As a consequence, SEC elution volumes of GAGs are smaller than those of globular proteins of similar molecular weight, and this might be exploited. Accordingly, larger heparin oligosaccharides are best separated according to their size at high ionic strength of the mobile phase (> 30 mM); in contrast, disaccharides are best separated according to their charge at low ionic strength, compatible with on-line coupling to mass spectrometry. Optimized SEC affords separation of characteristic heparin trisaccharides that contain uronic acid at the reducing end and suggest cellular storage of heparin as a free glycan. (c) 2006 Elsevier B.V. All rights reserved.
C1 Boston Univ, Proteoglycan & Glycosaminoglycan Struct Lab, Boston, MA 02118 USA.
RP Ziegler, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM andre.ziegler@unibas.ch
RI Zaia, Joseph/U-7850-2019
OI Zaia, Joseph/0000-0001-9497-8701
FU NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P41RR10888] Funding Source: Medline; NHLBI NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01HL74197] Funding Source: Medline; NATIONAL CENTER
   FOR RESEARCH RESOURCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Research Resources (NCRR) [P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888, P41RR010888, P41RR010888,
   P41RR010888, P41RR010888, P41RR010888] Funding Source: NIH RePORTER;
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL074197, R01HL074197,
   R01HL074197, R01HL074197] Funding Source: NIH RePORTER
CR CASU B, 1975, CARBOHYD RES, V39, P168, DOI 10.1016/S0008-6215(00)82654-3
   CONRAD HE, 1993, PURE APPL CHEM, V65, P787, DOI 10.1351/pac199365040787
   DIETRICH CP, 1973, J BIOL CHEM, V248, P6408
   ERNST S, 1995, CRIT REV BIOCHEM MOL, V30, P387, DOI 10.3109/10409239509083490
   FERRO DR, 1990, CARBOHYD RES, V195, P157, DOI 10.1016/0008-6215(90)84164-P
   Gabius HJ, 2002, BBA-GEN SUBJECTS, V1572, P165, DOI 10.1016/S0304-4165(02)00306-9
   GOLOVCHENKO NP, 1992, J CHROMATOGR, V591, P121, DOI 10.1016/0021-9673(92)80229-N
   Guo X, 2003, ANAL BIOCHEM, V312, P33, DOI 10.1016/S0003-2697(02)00428-1
   Henriksen J, 2004, J MASS SPECTROM, V39, P1305, DOI 10.1002/jms.723
   JANSSON L, 1975, BIOCHEM J, V145, P53, DOI 10.1042/bj1450053
   KOMATSU H, 1993, BIOL PHARM BULL, V16, P1189
   LAM LH, 1976, BIOCHEM BIOPH RES CO, V69, P570, DOI 10.1016/0006-291X(76)90558-1
   LeBrun L A, 2001, Methods Mol Biol, V171, P353
   Leteux C, 2001, J BIOL CHEM, V276, P12539, DOI 10.1074/jbc.M010291200
   Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979
   LINKER A, 1977, FED PROC, V36, P43
   LINKER A, 1965, J BIOL CHEM, V240, P3724
   LOHSE DL, 1992, J BIOL CHEM, V267, P24347
   MERCHANT ZM, 1985, BIOCHEM J, V229, P369, DOI 10.1042/bj2290369
   Mousa SA, 2002, CARDIOVASC DRUG REV, V20, P199
   Park YM, 1999, BIOCHEM J, V344, P723, DOI 10.1042/0264-6021:3440723
   Pavlov G, 2003, EUR BIOPHYS J BIOPHY, V32, P437, DOI 10.1007/s00249-003-0316-9
   RICE KG, 1989, CARBOHYD RES, V190, P219, DOI 10.1016/0008-6215(89)84127-8
   RICE KG, 1985, ANAL BIOCHEM, V150, P325, DOI 10.1016/0003-2697(85)90518-4
   Saad OM, 2003, ANAL CHEM, V75, P2985, DOI 10.1021/ac0340455
   Seog J, 2002, MACROMOLECULES, V35, P5601, DOI 10.1021/ma0121621
   SUGAHARA K, 1995, J BIOL CHEM, V270, P22914, DOI 10.1074/jbc.270.39.22914
   Thanawiroon C, 2004, J BIOL CHEM, V279, P2608, DOI 10.1074/jbc.M304772200
   Toida T, 1996, J BIOL CHEM, V271, P32040, DOI 10.1074/jbc.271.50.32040
   VANDEEMTER JJ, 1956, CHEM ENG SCI, V5, P271, DOI 10.1016/0009-2509(56)80003-1
   VETTER D, 1995, BIOCONJUGATE CHEM, V6, P316, DOI 10.1021/bc00033a013
   Vives RR, 1999, BIOCHEM J, V339, P767, DOI 10.1042/0264-6021:3390767
   Wittgren B, 2003, J CHROMATOGR A, V1002, P101, DOI 10.1016/S0021-9673(03)00729-5
   Yu GL, 2000, THROMB RES, V100, P549, DOI 10.1016/S0049-3848(00)00368-6
   Zaia J, 2003, J AM SOC MASS SPECTR, V14, P1270, DOI 10.1016/S1044-0305(03)00541-5
   Zaia J, 2004, MASS SPECTROM REV, V23, P161, DOI 10.1002/mas.10073
   Zhu YX, 2001, MACROMOL CHEM PHYSIC, V202, P61, DOI 10.1002/1521-3935(20010101)202:1<61::AID-MACP61>3.0.CO;2-H
   ZIEGLER A, 2004, J AM SOC MASS SPECTR, V15, pS62
NR 38
TC 39
Z9 41
U1 1
U2 17
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1570-0232
J9 J CHROMATOGR B
JI J. Chromatogr. B
PD JUN 6
PY 2006
VL 837
IS 1-2
BP 76
EP 86
DI 10.1016/j.jchromb.2006.04.013
PG 11
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 053NK
UT WOS:000238311600011
PM 16704936
DA 2021-01-25
ER

PT J
AU Seelig, A
AF Seelig, A
TI Unraveling membrane-mediated substrate-transporter interactions
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID P-GLYCOPROTEIN; RECEPTOR; BINDING
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4003 Basel, Switzerland.
EM anna.seelig@unibas.ch
CR Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   SCHWYZER R, 1987, EMBO J, V6, P2255, DOI 10.1002/j.1460-2075.1987.tb02498.x
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 1996, BIOCHEMISTRY-US, V35, P4365, DOI 10.1021/bi952434q
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Yu EW, 2003, SCIENCE, V300, P976, DOI 10.1126/science.1083137
NR 6
TC 7
Z9 7
U1 0
U2 2
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JUN
PY 2006
VL 90
IS 11
BP 3825
EP 3826
DI 10.1529/biophysj.106.082008
PG 2
WC Biophysics
SC Biophysics
GA 041UK
UT WOS:000237481500005
PM 16565039
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Zavolan, M
   van Nimwegen, E
AF Zavolan, Mihaela
   van Nimwegen, Erik
TI The types and prevalence of alternative splice forms
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID PROTEIN ISOFORMS; EXONS; IDENTIFICATION; DATABASE; GENE; INITIATION;
   DIVERSITY; SEQUENCES; PFAM
AB The finding that eukaryotic gene structures are extremely complex prompted the development of new experimental techniques for the accurate measurement of transcription start site usage and of the expression of alternative splice forms. On the computational side, analyses of large databases of splice variants revealed differences in the length, motif composition and selection pressure between constitutive and alternatively spliced exons. Such features are being incorporated into novel computational tools for gene structure prediction. The result of these investigations is a continuously improving catalogue of alternative splice forms. How the expression of these alternative splice forms is regulated remains one of the major open questions.
C1 Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Div Bioinformat, Klingelberstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI van Nimwegen, Erik/0000-0001-6338-1312; Zavolan,
   Mihaela/0000-0002-8832-2041
CR Bergeron A, 2002, BIOINFORMATICS, V18, pS54, DOI 10.1093/bioinformatics/18.suppl_2.S54
   BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411
   BREITBART RE, 1987, ANNU REV BIOCHEM, V56, P467, DOI 10.1146/annurev.biochem.56.1.467
   Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66
   CHERN TM, 2006, IN PRESS PLOS GENET
   Clark F, 2002, HUM MOL GENET, V11, P451, DOI 10.1093/hmg/11.4.451
   Dror G, 2005, BIOINFORMATICS, V21, P897, DOI 10.1093/bioinformatics/bti132
   Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44
   Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204
   Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149
   Florea L, 2005, GENOME RES, V15, P54, DOI 10.1101/gr.2889405
   Hiller M, 2005, NUCLEIC ACIDS RES, V33, P5611, DOI 10.1093/nar/gki870
   Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469
   Holste D, 2006, NUCLEIC ACIDS RES, V34, pD56, DOI 10.1093/nar/gkj048
   Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162
   Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100
   Kopelman NM, 2005, NAT GENET, V37, P588, DOI 10.1038/ng1575
   Kriventseva EV, 2003, TRENDS GENET, V19, P124, DOI 10.1016/S0168-9525(03)00023-4
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lee BTK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-189
   Magen A, 2005, NUCLEIC ACIDS RES, V33, P5574, DOI 10.1093/nar/gki858
   MARTIN A, 2006, NUCLEIC ACIDS RES, V34, P23
   Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850
   Nagasaki H, 2005, GENE, V364, P53, DOI 10.1016/j.gene.2005.07.027
   Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285
   Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004
   Philipps DL, 2004, RNA, V10, P1838, DOI 10.1261/rna.7136104
   Pospisil H, 2004, NUCLEIC ACIDS RES, V32, pD70, DOI 10.1093/nar/gkh136
   Ravasi T, 2003, GENOME RES, V13, P1430, DOI 10.1101/gr.949803
   Relogio A, 2005, J BIOL CHEM, V280, P4779, DOI 10.1074/jbc.M411976200
   Seneff Stephanie, 2004, Appl Bioinformatics, V3, P81, DOI 10.2165/00822942-200403020-00002
   Shuttleworth TL, 2002, J BIOL CHEM, V277, P23008, DOI 10.1074/jbc.M108991200
   Sorek R, 2004, TRENDS GENET, V20, P68, DOI 10.1016/j.tig.2003.12.004
   Sorek R, 2004, GENOME RES, V14, P1617, DOI 10.1101/gr.2572604
   Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803
   Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007
   Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031
   Sugnet C W, 2004, Pac Symp Biocomput, P66
   Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9
   Wang H, 2003, BIOINFORMATICS, V19, pi315, DOI 10.1093/bioinformatics/btg1044
   Wheelan SJ, 2000, BIOINFORMATICS, V16, P613, DOI 10.1093/bioinformatics/16.7.613
   Xing Y, 2005, BIOINFORMATICS, V21, P3701, DOI 10.1093/bioinformatics/bti613
   Xing Y, 2003, FEBS LETT, V555, P572, DOI 10.1016/S0014-5793(03)01354-1
   Xing Y, 2004, GENOME RES, V14, P426, DOI 10.1101/gr.1304504
   Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102
   Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303
   Zheng CL, 2005, RNA, V11, P1767, DOI 10.1261/rna.2650905
NR 49
TC 26
Z9 27
U1 0
U2 8
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
EI 1879-033X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD JUN
PY 2006
VL 16
IS 3
BP 362
EP 367
DI 10.1016/j.sbi.2006.05.002
PG 6
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 064IJ
UT WOS:000239082100013
PM 16713247
DA 2021-01-25
ER

PT J
AU Podvinec, M
   Meyer, UA
AF Podvinec, Michael
   Meyer, Urs A.
TI Prediction of cis-regulatory elements for drug-activated transcription
   factors in the regulation of drug-metabolising enzymes and drug
   transporters
SO EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
LA English
DT Review
DE drug induction; drug-metabolising enzymes; drug response elements; drug
   transporters; nuclear receptors; transcription factors; transcription
   factor binding
ID FACTOR-BINDING-SITES; RECEPTOR RESPONSE ELEMENTS; GENE-EXPRESSION;
   IN-SILICO; DNA-SEQUENCES; COMPUTATIONAL-DETECTION; FUNCTIONAL PROMOTER;
   NUCLEAR RECEPTORS; CYTOCHROMES P450; HUMAN GENOME
AB The expression of drug-metabolising enzymes is affected by many endogenous and exogenous factors, including sex, age, diet and exposure to xenobiotics and drugs. To understand fully how the organism metabolises a drug, these alterations in gene expression must be taken into account. The central process, the definition of likely regulatory elements in the genes coding for enzymes and transporters involved in drug disposition, can be vastly accelerated using existing and emerging bioinformatics methods to unravel the regulatory networks causing drug-mediated induction of genes. Here, various approaches to predict transcription factor interactions with regulatory DNA elements are reviewed.
C1 Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Podvinec, M (corresponding author), Univ Basel, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM michael.podvinec@unibas.ch; urs-a.meyer@unibas.ch
CR Aerts S, 2005, NUCLEIC ACIDS RES, V33, pW393, DOI 10.1093/nar/gki354
   Aerts S, 2003, BIOINFORMATICS, V19, pII5, DOI 10.1093/bioinformatics/btg1052
   Alkema WBL, 2004, NUCLEIC ACIDS RES, V32, pW195, DOI 10.1093/nar/gkh387
   Batzoglou S, 2000, GENOME RES, V10, P950, DOI 10.1101/gr.10.7.950
   Birney E, 2004, NUCLEIC ACIDS RES, V32, pD468, DOI 10.1093/nar/gkh038
   Bray N, 2003, GENOME RES, V13, P97, DOI 10.1101/gr.789803
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   Bucher P, 1996, COMPUT CHEM, V20, P3, DOI 10.1016/S0097-8485(96)80003-9
   Costas J, 2003, GENE, V310, P215, DOI 10.1016/S0378-1119(03)00556-0
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Dermitzakis ET, 2002, MOL BIOL EVOL, V19, P1114, DOI 10.1093/oxfordjournals.molbev.a004169
   Di Cara A, 2005, NUCLEIC ACIDS RES, V33, pW423, DOI 10.1093/nar/gki413
   Dickins M, 2004, CURR TOP MED CHEM, V4, P1745, DOI 10.2174/1568026043387115
   Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57
   Frech K, 1997, TRENDS BIOCHEM SCI, V22, P103
   Frech K, 1997, J MOL BIOL, V270, P674, DOI 10.1006/jmbi.1997.1140
   Frisch M, 2002, GENOME RES, V12, P349, DOI 10.1101/gr.206602. Article published online before print in January 2002
   Frith MC, 2003, NUCLEIC ACIDS RES, V31, P3666, DOI 10.1093/nar/gkg540
   Genolet R, 2005, J BIOL CHEM, V280, P24143, DOI 10.1074/jbc.M502649200
   Glass CK, 1996, J ENDOCRINOL, V150, P349, DOI 10.1677/joe.0.1500349
   Goetze S, 2005, MOL CELL BIOL, V25, P2260, DOI 10.1128/MCB.25.6.2260-2272.2005
   Gupta M, 2005, P NATL ACAD SCI USA, V102, P7079, DOI 10.1073/pnas.0408743102
   Gupta RK, 2005, J CLIN INVEST, V115, P1006, DOI 10.1172/JCI200522365
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563
   Hood L, 2004, SCIENCE, V306, P640, DOI 10.1126/science.1104635
   JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252
   Jung D, 2004, GUT, V53, P78, DOI 10.1136/gut.53.1.78
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Klaassen CD, 2005, CURR DRUG METAB, V6, P309, DOI 10.2174/1389200054633826
   Klingenhoff A, 1999, BIOINFORMATICS, V15, P180, DOI 10.1093/bioinformatics/15.3.180
   Kolchanov NA, 2002, NUCLEIC ACIDS RES, V30, P312, DOI 10.1093/nar/30.1.312
   Lavorgna G, 1998, TRENDS GENET, V14, P375, DOI 10.1016/S0168-9525(98)01551-0
   Lenhard Boris, 2003, J Biol, V2, P13, DOI 10.1186/1475-4924-2-13
   Li W, 2005, BIOINFORMATICS, V21, pI274, DOI 10.1093/bioinformatics/bti1046
   Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717
   Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769
   Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355
   Pascussi JM, 2004, XENOBIOTICA, V34, P633, DOI 10.1080/00498250412331285454
   Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   REYES H, 1992, SCIENCE, V256, P1193, DOI 10.1126/science.256.5060.1193
   Rigoutsos I, 1998, BIOINFORMATICS, V14, P55, DOI 10.1093/bioinformatics/14.1.55
   Rodriguez-Trelles F, 2003, INT J DEV BIOL, V47, P665
   Roulet E, 2002, NAT BIOTECHNOL, V20, P831, DOI 10.1038/nbt718
   Sandelin A, 2005, MOL ENDOCRINOL, V19, P595, DOI 10.1210/me.2004-0101
   Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012
   Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pW249, DOI 10.1093/nar/gkh372
   Schmid CD, 2004, NUCLEIC ACIDS RES, V32, pD82, DOI 10.1093/nar/gkh122
   SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Schneider Thomas D, 2002, Appl Bioinformatics, V1, P111
   SCHUG JO, 1997, CBILTR9971001V00 U P
   Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Sharan R, 2004, NUCLEIC ACIDS RES, V32, pW253, DOI 10.1093/nar/gkh385
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   Stormo GD, 2000, BIOINFORMATICS, V16, P16, DOI 10.1093/bioinformatics/16.1.16
   Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624
   Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608
   Timothy B, 1994, P 2 INT C INT SYST M, V2, P28
   Tirona RG, 2005, J PHARM SCI-US, V94, P1169, DOI 10.1002/jps.20324
   Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057
   Vavouri T, 2005, CURR OPIN GENET DEV, V15, P395, DOI 10.1016/j.gde.2005.05.002
   von Sternberg R, 2005, CYTOGENET GENOME RES, V110, P108, DOI 10.1159/000084942
   Vyhlidal CA, 2004, J BIOL CHEM, V279, P46779, DOI 10.1074/jbc.M408395200
   Werner T, 2000, Methods Mol Biol, V132, P337
   Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316
   Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140
   Yuh CH, 1998, SCIENCE, V279, P1896, DOI 10.1126/science.279.5358.1896
NR 77
TC 1
Z9 1
U1 0
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1742-5255
EI 1744-7607
J9 EXPERT OPIN DRUG MET
JI Expert Opin. Drug Metab. Toxicol.
PD JUN
PY 2006
VL 2
IS 3
BP 367
EP 379
DI 10.1517/17425255.2.3.367
PG 13
WC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Toxicology
GA 167VE
UT WOS:000246479800003
PM 16863440
DA 2021-01-25
ER

PT J
AU Garcia, P
   Ucurum, Z
   Bucher, R
   Svergun, DI
   Huber, T
   Lustig, A
   Konarev, PV
   Marino, M
   Mayans, O
AF Garcia, Pilar
   Ucurum, Zohre
   Bucher, Rainer
   Svergun, Dmitri I.
   Huber, Thomas
   Lustig, Ariel
   Konarev, Petr V.
   Marino, Marco
   Mayans, Olga
TI Molecular insights into the self-assembly mechanism of dystrophia
   myotonica kinase
SO FASEB JOURNAL
LA English
DT Article
DE kinase; coiled-coil; protein assembly; protein structure; X-ray
   crystallography; multiangle static light scattering; small angle X-ray
   scattering
ID RAY SOLUTION SCATTERING; HELICAL COILED COILS; GCN4 LEUCINE-ZIPPER;
   PROTEIN-KINASE; CYTOSKELETAL REORGANIZATION; BIOLOGICAL MACROMOLECULES;
   MYOSIN PHOSPHATASE; SALT BRIDGE; RHO-KINASE; PROGRAM
AB Self-assembly via coiled-coil domains (CC) is crucial for the regulation of the dystrophia myotonica kinase ( DMPK)-related family of kinases. These CC domains are thought to form dimeric arrangements and thus to mediate dimerization in these enzymes. Using size exclusion chromatography combined with multiangle static light scattering, we analyzed the oligomeric state of DMPK as well as that of a truncated variant lacking the CC fraction. Remarkably, both forms were found to assemble into robust dimers. In contrast, the CC domain in isolation yielded trimeric assemblies, indicating that the oligomerization properties of CC domains from this kinase family are more diversified than anticipated. The crystal structure of this CC has been elucidated to 1.6 angstrom resolution and its properties in solution established using sedimentation equilibrium and thermal denaturation. These data show that, contrary to expectations, the self-assembly of DMPK is not dictated by the association properties of its CC domain. Instead, it appears to be driven by sequence segments flanking both N and C termini of the catalytic kinase fraction, as suggested by models of head-to-head dimers based on small angle X-ray scattering data. Our findings support a shared pattern of assembly across DMPK, ROCKs, and MRCK members of this family.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   DESY, Hamburg Outstn, European Mol Biol Lab, D-2000 Hamburg, Germany.
   Russian Acad Sci, Inst Crystallog, Moscow, Russia.
   Univ Zurich, Inst Biochem, CH-8006 Zurich, Switzerland.
RP Mayans, O (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM olga.mayans@unibas.ch
RI Konarev, Petr V/W-1380-2017; Mayans, Olga/A-3954-2008
OI Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696;
   Mayans, Olga/0000-0001-6876-8532
CR Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418
   BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5
   Burkhard P, 2002, J MOL BIOL, V318, P901, DOI 10.1016/S0022-2836(02)00114-6
   Collaborative Computational Project Number 4, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388
   Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706
   Doran JD, 2004, BIOCHEM J, V384, P255, DOI 10.1042/BJ20040344
   Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200
   Fass D, 1996, NAT STRUCT BIOL, V3, P465, DOI 10.1038/nsb0596-465
   FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326
   Garcia P, 2004, ACTA CRYSTALLOGR D, V60, P2336, DOI 10.1107/S0907444904026873
   Gonzalez L, 1996, NAT STRUCT BIOL, V3, P1011, DOI 10.1038/nsb1296-1011
   Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Harper P.S, 1989, MYOTONIC DYSTROPHY
   Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373
   Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x
   JACOBS MD, 2005, J BIOL CHEM     1024
   Jiang H, 2004, HUM MOL GENET, V13, P3079, DOI 10.1093/hmg/ddh327
   Jin S, 2000, CELL MOTIL CYTOSKEL, V45, P133, DOI 10.1002/(SICI)1097-0169(200002)45:2<133::AID-CM5>3.0.CO;2-S
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kammerer RA, 2001, J BIOL CHEM, V276, P13685, DOI 10.1074/jbc.M010492200
   KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987
   LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee HC, 2003, PHYSIOL GENOMICS, V12, P147, DOI 10.1152/physiolgenomics.00095.2002
   Leung T, 1998, MOL CELL BIOL, V18, P130, DOI 10.1128/MCB.18.1.130
   LUMB KJ, 1995, BIOCHEMISTRY-US, V34, P8642, DOI 10.1021/bi00027a013
   Luo LQ, 1997, P NATL ACAD SCI USA, V94, P12963, DOI 10.1073/pnas.94.24.12963
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Madaule P, 1998, NATURE, V394, P491
   Meier M, 2002, J STRUCT BIOL, V137, P65, DOI 10.1006/jsbi.2002.4467
   Mounsey JP, 2000, HUM MOL GENET, V9, P2313, DOI 10.1093/oxfordjournals.hmg.a018923
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154
   Petoukhov MV, 2002, BIOPHYS J, V83, P3113, DOI 10.1016/S0006-3495(02)75315-0
   Piekny AJ, 2002, J CELL SCI, V115, P2271
   Porod G., 1982, SMALL ANGLE XRAY SCA
   Schulz PE, 2003, J NEUROPHYSIOL, V89, P1177, DOI 10.1152/jn.00504.2002
   Shimizu M, 2000, FEBS LETT, V475, P273, DOI 10.1016/S0014-5793(00)01692-6
   Shimizu T, 2003, J BIOL CHEM, V278, P46046, DOI 10.1074/jbc.M306458200
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   Wissmann A, 1997, GENE DEV, V11, P409, DOI 10.1101/gad.11.4.409
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Zhang RX, 2003, FEBS LETT, V546, P281, DOI 10.1016/S0014-5793(03)00601-X
NR 55
TC 18
Z9 19
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JUN
PY 2006
VL 20
IS 8
BP 1142
EP 1151
DI 10.1096/fj.05-5262com
PG 10
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 079XD
UT WOS:000240210300014
PM 16770013
DA 2021-01-25
ER

PT J
AU Meinen, S
   Ruegg, MA
AF Meinen, S.
   Ruegg, M. A.
TI Mini-agrin delivers in mice
SO GENE THERAPY
LA English
DT Editorial Material
ID CONGENITAL MUSCULAR-DYSTROPHY; GENE-TRANSFER; MUSCLE; DEFICIENT; MODEL
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Meinen, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095
   Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928
   Gregorevic P, 2004, NAT MED, V10, P828, DOI 10.1038/nm1085
   Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547
   Kuang W, 1999, LAB INVEST, V79, P1601
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016
   Wang Z, 2005, NAT BIOTECHNOL, V23, P321, DOI 10.1038/nbt1073
NR 11
TC 7
Z9 7
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0969-7128
EI 1476-5462
J9 GENE THER
JI Gene Ther.
PD JUN
PY 2006
VL 13
IS 11
BP 869
EP 870
PG 2
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Medicine, Research & Experimental
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity; Research & Experimental Medicine
GA 043NJ
UT WOS:000237607600001
PM 17262906
DA 2021-01-25
ER

PT J
AU Goymer, P
   Kahn, SG
   Malone, JG
   Gehrig, SM
   Spiers, AJ
   Rainey, PB
AF Goymer, Patrick
   Kahn, Sophie G.
   Malone, Jacob G.
   Gehrig, Stefanie M.
   Spiers, Andrew J.
   Rainey, Paul B.
TI Adaptive divergence in experimental populations of Pseudomonas
   fluorescens. II. Role of the GGDEF regulator WspR in evolution and
   development of the wrinkly spreader phenotype
SO GENETICS
LA English
DT Article
ID TERM EXPERIMENTAL EVOLUTION; RESPONSE REGULATOR; BIOFILM FORMATION;
   ESCHERICHIA-COLI; ACETOBACTER-XYLINUM; STRUCTURAL-ANALYSIS; CYCLIC
   DIGUANYLATE; DI-GMP; ADAPTATION; REQUIRES
AB Wrinkly spreader (WS) genotypes evolve repeatedly in model Pseudomonas populations undergoing adaptive radiation. Previous work identified genes contributing to the evolutionary success of WS. Here we scrutinize the GGDEF response regulator protein WspR and show that it is both necessary and sufficient for WS. Activation of WspR occurs by phosphorylation and different levels of activation generate phenotypic differences among WS genotypes. Five alleles of wspR each encoding a protein with a single amino acid substitution, were generated by mutagenesis. Two alleles are constitutively active and cause the ancestral genotype to develop a WS phenotype; the phenotypic effects are allele specific and independent of phosphorylation. Three alleles contain changes in the GGDEF domain and when overexpressed in WS cause reversion to the ancestral phenotype. Ability to mimic this effect by overexpression of a liberated N-terminal domain shows that in WS, regulatory components upstream of WspR are overactive. To connect changes at the nucleotide level with fitness, the effects of variant alleles were examined in both structured and unstructured environments: alleles had adaptive and deleterious effects With trade-offs evident across environments. Despite the proclivity of mutations within wspR to generate WS, sequence analysis of wspR front 53 independently obtained WS showed no evidence of sequence change in this gene.
C1 Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland, New Zealand.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England.
RP Rainey, PB (corresponding author), Univ Auckland, Sch Biol Sci, Private Bag 92019, Auckland, New Zealand.
EM p.rainey@auckland.ac.nz
RI Malone, Jacob/G-8319-2011; Rainey, Paul/A-3207-2008; Spiers,
   Andrew/I-3535-2012
OI Rainey, Paul/0000-0003-0879-5795; Spiers, Andrew/0000-0003-0463-8629;
   Malone, Jacob/0000-0003-1959-6820; Goymer, Patrick/0000-0002-2789-9373
CR Aguilar PS, 2001, EMBO J, V20, P1681, DOI 10.1093/emboj/20.7.1681
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Alfano JR, 1996, MOL MICROBIOL, V19, P715, DOI 10.1046/j.1365-2958.1996.415946.x
   BANTINAKI E, 2002, THESIS U OXFORD OXFO
   Bull JJ, 1997, GENETICS, V147, P1497
   Chamnongpol S, 2000, J MOL BIOL, V300, P291, DOI 10.1006/jmbi.2000.3848
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Cooper TF, 2003, P NATL ACAD SCI USA, V100, P1072, DOI 10.1073/pnas.0334340100
   Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001
   Crozat E, 2005, GENETICS, V169, P523, DOI 10.1534/genetics.104.035717
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   Da Re S, 2002, PROTEIN SCI, V11, P2644, DOI 10.1110/ps.0220402
   DARWIN C, ORIGIN SPECIES
   de Rosa R, 1999, NATURE, V399, P772, DOI 10.1038/21631
   Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034
   Dobzhansky T, 1951, GENETICS ORIGIN SPEC
   Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0
   FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x
   GEHRIG SM, 2005, THESIS U OXFORD OXFO
   Gerhart John, 1997, CELLS EMBRYOS EVOLUT
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Hoch J. A., 1995, 2 COMPONENT SIGNAL T
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4
   KING EO, 1954, J LAB CLIN MED, V44, P301
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Lack D., 1947, DARWINS FINCHES
   Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200
   LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289
   LOPER JE, 1994, APPL ENVIRON MICROB, V60, P1934, DOI 10.1128/AEM.60.6.1934-1941.1994
   Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845
   NAIKALOV I, 1996, BIOCHEMISTRY-US, V35, P11053
   Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   PEI JM, 1990, PROTEINS, V4, P2159
   POWELL BS, 1990, MOL MICROBIOL, V4, P2159, DOI 10.1111/j.1365-2958.1990.tb00577.x
   Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900
   Rainey PB, 1999, ENVIRON MICROBIOL, V1, P243, DOI 10.1046/j.1462-2920.1999.00040.x
   Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906
   Rainey PB, 1996, MOL MICROBIOL, V19, P521, DOI 10.1046/j.1365-2958.1996.391926.x
   Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Sambrook J, 1988, MOL CLONING LAB MANU
   Schlutter D, 2000, ECOLOGY ADAPTIVE RAD
   Siam R, 2003, NUCLEIC ACIDS RES, V31, P1775, DOI 10.1093/nar/gkg271
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   SIMPSON GG, 1953, MAJOR FEATURES EVOLT
   Smith JG, 2004, MOL MICROBIOL, V51, P887, DOI 10.1046/j.1365-2958.2003.03882.x
   Spiers AJ, 2002, GENETICS, V161, P33
   Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x
   Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Treves DS, 1998, MOL BIOL EVOL, V15, P789, DOI 10.1093/oxfordjournals.molbev.a025984
   West-Eberhard Mary Jane, 2003, pi
   Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422
NR 60
TC 66
Z9 68
U1 0
U2 31
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 0016-6731
EI 1943-2631
J9 GENETICS
JI Genetics
PD JUN
PY 2006
VL 173
IS 2
BP 515
EP 526
DI 10.1534/genetics.106.055863
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA 058FM
UT WOS:000238650900002
PM 16624907
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Appenzeller-Herzog, C
   Hauri, HP
AF Appenzeller-Herzog, Christian
   Hauri, Hans-Peter
TI The ER-Golgi intermediate compartment (ERGIC): in search of its identity
   and function
SO JOURNAL OF CELL SCIENCE
LA English
DT Review
DE ER-exit sites; ER-to-Golgi transport; ERGIC-53; protein sorting; COPI;
   COPII; tethering; fusion
ID TRANSITIONAL ENDOPLASMIC-RETICULUM; GUANINE-NUCLEOTIDE-EXCHANGE; SOLUBLE
   SECRETORY PROTEINS; HUMAN KDEL RECEPTOR; DYNAMICS IN-VIVO; VIRUS
   G-PROTEIN; QUALITY-CONTROL; COPII VESICLE; EXIT SITES; CIS-GOLGI
AB Protein traffic moving from the endoplasmic reticulum ( ER) to the Golgi complex in mammalian cells passes through the tubulovesicular membrane clusters of the ERGolgi intermediate compartment ( ERGIC), the marker of which is the lectin ERGIC-53. The dynamic nature and functional role of the ERGIC have been debated for quite some time. In the most popular current view, the ERGIC clusters are mobile transport complexes that deliver secretory cargo from ER-exit sites to the Golgi. Recent live-cell imaging data revealing the formation of anterograde carriers from stationary ERGIC-53- positive membranes, however, suggest a stable compartment model in which ER-derived cargo is first shuttled from ER-exit sites to stationary ERGIC clusters in a COPII-dependent step and subsequently to the Golgi in a second vesicular transport step. This model can better accommodate previous morphological and functional data on ER-to- Golgi traffic. Such a stationary ERGIC would be a major site of anterograde and retrograde sorting that is controlled by coat proteins, Rab and Arf GTPases, as well as tethering complexes, SNAREs and cytoskeletal networks. The ERGIC also contributes to the concentration, folding, and quality control of newly synthesized proteins.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI Appenzeller-Herzog, Christian/A-2894-2014
OI Appenzeller-Herzog, Christian/0000-0001-7430-294X
CR Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444
   Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200
   Alvarez C, 1999, J CELL BIOL, V147, P1205, DOI 10.1083/jcb.147.6.1205
   Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389
   ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19
   Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7
   Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5
   Barrowman J, 2000, EMBO J, V19, P862, DOI 10.1093/emboj/19.5.862
   Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095
   Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200
   BU GJ, 1995, EMBO J, V14, P2269, DOI 10.1002/j.1460-2075.1995.tb07221.x
   Cabrera M, 2003, MOL BIOL CELL, V14, P4114, DOI 10.1091/mbc.E03-04-0194
   Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200
   Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156
   Chao DS, 1999, J CELL BIOL, V144, P869, DOI 10.1083/jcb.144.5.869
   Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017
   Cheng GD, 2005, COLD REG SCI TECHNOL, V42, P169, DOI 10.1016/j.coldregions.2005.01.002
   DE M, 2000, J CELL SCI, V113, P2331
   Devarajan P, 1997, P NATL ACAD SCI USA, V94, P10711, DOI 10.1073/pnas.94.20.10711
   Echard A, 1998, SCIENCE, V279, P580, DOI 10.1126/science.279.5350.580
   Elkabetz Y, 2003, J BIOL CHEM, V278, P18922, DOI 10.1074/jbc.M208730200
   Fan JY, 2003, HISTOCHEM CELL BIOL, V120, P455, DOI 10.1007/s00418-003-0597-1
   Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076
   Fromme JC, 2005, CURR OPIN CELL BIOL, V17, P345, DOI 10.1016/j.ceb.2005.06.004
   Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762
   Gecz J, 2000, GENOMICS, V69, P242, DOI 10.1006/geno.2000.6326
   Gilbert A, 1998, EXP CELL RES, V242, P144, DOI 10.1006/excr.1998.4101
   Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0
   Godi A, 1998, P NATL ACAD SCI USA, V95, P8607, DOI 10.1073/pnas.95.15.8607
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Gurkan C, 2005, MOL BIOL CELL, V16, P3847, DOI 10.1091/mbc.E05-01-0062
   Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013
   HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41
   HAURI H-P, 1992, Current Opinion in Cell Biology, V4, P600, DOI 10.1016/0955-0674(92)90078-Q
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hay JC, 1998, J CELL BIOL, V141, P1489, DOI 10.1083/jcb.141.7.1489
   Haynes CM, 2002, J CELL BIOL, V158, P91, DOI 10.1083/jcb.200201053
   Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025
   Hermosilla R, 2004, TRAFFIC, V5, P993, DOI 10.1111/j.1600-0854.2004.00239.x
   Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711
   Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135
   Holleran EA, 2001, J BIOL CHEM, V276, P36598, DOI 10.1074/jbc.M104838200
   Holleran EA, 1996, J CELL BIOL, V135, P1815, DOI 10.1083/jcb.135.6.1815
   Horstmann H, 2002, J CELL SCI, V115, P4263, DOI 10.1242/jcs.00115
   HSU VW, 1991, NATURE, V352, P441, DOI 10.1038/352441a0
   Hui N, 1997, MOL BIOL CELL, V8, P1777
   Itin C, 1996, MOL BIOL CELL, V7, P483
   Ito M, 2002, BIOCHEM J, V361, P473, DOI 10.1042/0264-6021:3610473
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136
   Koster G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068101
   Koster G, 2003, P NATL ACAD SCI USA, V100, P15583, DOI 10.1073/pnas.2531786100
   Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285
   Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025
   LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6
   LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S
   LIPPINCOTTSCHWARTZ J, 1995, J CELL BIOL, V128, P293, DOI 10.1083/jcb.128.3.293
   Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013
   Machen TE, 2003, AM J PHYSIOL-CELL PH, V285, pC205, DOI 10.1152/ajpcell.00008.2003
   Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061
   Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101
   Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X
   Martinez-Menarguez JA, 2001, J CELL BIOL, V155, P1213, DOI 10.1083/jcb.200108029
   Matanis T, 2002, NAT CELL BIOL, V4, P986, DOI 10.1038/ncb891
   MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A
   Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x
   Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3
   Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6
   Moolenaar CEC, 1997, J CELL SCI, V110, P557
   Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1
   Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Munro S, 2004, NAT CELL BIOL, V6, P469, DOI 10.1038/ncb0604-469
   Nishimura N, 1997, SCIENCE, V277, P556, DOI 10.1126/science.277.5325.556
   OPRINS A, 1993, J CELL BIOL, V121, P49, DOI 10.1083/jcb.121.1.49
   Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195
   Palokangas H, 1998, MOL BIOL CELL, V9, P3561, DOI 10.1091/mbc.9.12.3561
   PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2
   Pezzati R, 1997, MOL BIOL CELL, V8, P1501
   Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   Presley JF, 2002, NATURE, V417, P187, DOI 10.1038/417187a
   Rabouille C, 2005, NAT REV MOL CELL BIO, V6, P812, DOI 10.1038/nrm1735
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Roghi C, 1999, J CELL SCI, V112, P4673
   Rossanese OW, 1999, J CELL BIOL, V145, P69, DOI 10.1083/jcb.145.1.69
   Sacher M, 2001, MOL CELL, V7, P433, DOI 10.1016/S1097-2765(01)00190-3
   Sapperstein SK, 1996, J CELL BIOL, V132, P755, DOI 10.1083/jcb.132.5.755
   SARASTE J, 1991, J CELL SCI, V100, P415
   Sato K, 2002, MOL BIOL CELL, V13, P2518, DOI 10.1091/mbc.E02-01-0027
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   Scheel AA, 1996, BIOCHEMISTRY-US, V35, P10203, DOI 10.1021/bi960807x
   SCHRODER S, 1995, J CELL BIOL, V131, P895, DOI 10.1083/jcb.131.4.895
   SCHWEIZER A, 1994, J BIOL CHEM, V269, P4035
   SCHWEIZER A, 1991, J CELL BIOL, V113, P45, DOI 10.1083/jcb.113.1.45
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8
   SESSO A, 1994, J CELL SCI, V107, P517
   Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13
   Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0
   Short B, 2002, CURR BIOL, V12, P1792, DOI 10.1016/S0960-9822(02)01221-6
   Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127
   SITIA R, 1992, MOL BIOL CELL, V3, P1067
   Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013
   Spiro MJ, 2001, GLYCOBIOLOGY, V11, P803, DOI 10.1093/glycob/11.10.803
   Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763
   Stephens DJ, 2000, J CELL SCI, V113, P2177
   Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736
   Stephens DJ, 2001, J CELL SCI, V114, P1053
   Tang BL, 1995, EUR J CELL BIOL, V68, P398
   Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399
   Tisdale EJ, 2003, J BIOL CHEM, V278, P52524, DOI 10.1074/jbc.M309343200
   Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180
   Vanslyke JK, 2000, MOL BIOL CELL, V11, P1933, DOI 10.1091/mbc.11.6.1933
   Varma D, 2006, J CELL BIOL, V172, P655, DOI 10.1083/jcb.200510120
   Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123
   Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042
   Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289
   Watson P, 2005, NAT CELL BIOL, V7, P48, DOI 10.1038/ncb1206
   Watson P, 2005, BBA-MOL CELL RES, V1744, P304, DOI 10.1016/j.bbamcr.2005.03.003
   Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004
   Whyte JRC, 2002, J CELL SCI, V115, P2627
   Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200
   Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135
   Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
   Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371
   Zhang T, 2001, J BIOL CHEM, V276, P27480, DOI 10.1074/jbc.M102786200
   Zuber C, 2004, FASEB J, V18, P917, DOI 10.1096/fj.03-1210fje
   Zuber C, 2001, P NATL ACAD SCI USA, V98, P10710, DOI 10.1073/pnas.191359198
NR 142
TC 272
Z9 282
U1 0
U2 34
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUN 1
PY 2006
VL 119
IS 11
BP 2173
EP 2183
DI 10.1242/jcs.03019
PG 11
WC Cell Biology
SC Cell Biology
GA 054YA
UT WOS:000238413300001
PM 16723730
OA Other Gold
DA 2021-01-25
ER

PT J
AU Schafer, T
   Maco, B
   Petfalski, E
   Tollervey, D
   Bottcher, B
   Aebi, U
   Hurt, E
AF Schafer, Thorsten
   Maco, Bohumil
   Petfalski, Elisabeth
   Tollervey, David
   Boettcher, Bettina
   Aebi, Ueli
   Hurt, Ed
TI Hrr25-dependent phosphorylation state regulates organization of the
   pre-40S subunit
SO NATURE
LA English
DT Article
ID PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROGRAPHS;
   NUCLEAR EXPORT; COMPLEX; YEAST; IDENTIFICATION; TRANSCRIPTION;
   BIOGENESIS; MATURATION
AB The formation of eukaryotic ribosomes is a multistep process that takes place successively in the nucleolar, nucleoplasmic and cytoplasmic compartments(1-4). Along this pathway, multiple preribosomal particles are generated, which transiently associate with numerous non-ribosomal factors before mature 60S and 40S subunits are formed(5-12). However, most mechanistic details of ribosome biogenesis are still unknown. Here we identify a maturation step of the yeast pre-40S subunit that is regulated by the protein kinase Hrr25 and involves ribosomal protein Rps3. A high salt concentration releases Rps3 from isolated pre-40S particles but not from mature 40S subunits. Electron microscopy indicates that pre-40S particles lack a structural landmark present in mature 40S subunits, the 'beak'. The beak is formed by the protrusion of 18S ribosomal RNA helix 33, which is in close vicinity to Rps3. Two protein kinases Hrr25 and Rio2 are associated with pre-40S particles. Hrr25 phosphorylates Rps3 and the 40S synthesis factor Enp1. Phosphorylated Rsp3 and Enp1 readily dissociate from the pre-ribosome, whereas subsequent dephosphorylation induces formation of the beak structure and salt-resistant integration of Rps3 into the 40S subunit. In vivo depletion of Hrr25 inhibits growth and leads to the accumulation of immature 40S subunits that contain unstably bound Rps3. We conclude that the kinase activity of Hrr25 regulates the maturation of 40S ribosomal subunits.
C1 Univ Heidelberg, Zentrum Biochem, D-69120 Heidelberg, Germany.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.
   European Mol Biol Lab, D-69117 Heidelberg, Germany.
RP Hurt, E (corresponding author), Univ Heidelberg, Zentrum Biochem, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.
EM cg5@ix.urz.uni-heidelberg.de
RI Bottcher, Bettina/E-9397-2010; Ed Hurt, Dr./AAE-8874-2019; Tollervey,
   David/AAR-6662-2020
OI Bottcher, Bettina/0000-0002-7962-4849; Ed Hurt, Dr./0000-0002-4535-8255;
   Tollervey, David/0000-0003-2894-2772; Schaefer,
   Thorsten/0000-0003-4867-8374; Maco, Bohumil/0000-0001-8444-313X
FU Natural Environment Research CouncilNERC Natural Environment Research
   Council [NE/C516928/1] Funding Source: researchfish; Wellcome
   TrustWellcome Trust Funding Source: Medline
CR Bassler J, 2001, MOL CELL, V8, P517, DOI 10.1016/S1097-2765(01)00342-2
   BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x
   Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769
   Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8
   Fatica A, 2002, MOL CELL, V9, P341, DOI 10.1016/S1097-2765(02)00458-6
   Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005
   FRANK J, 1982, J MOL BIOL, V161, P107, DOI 10.1016/0022-2836(82)90281-9
   FRANK J, 1981, SCIENCE, V214, P1353, DOI 10.1126/science.7313694
   Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001
   Geerlings TH, 2003, J BIOL CHEM, V278, P22537, DOI 10.1074/jbc.M300759200
   Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8
   Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001
   Harnpicharnchai P, 2001, MOL CELL, V8, P505, DOI 10.1016/S1097-2765(01)00344-6
   Ho Y, 1997, P NATL ACAD SCI USA, V94, P581, DOI 10.1073/pnas.94.2.581
   Leger-Silvestre I, 2004, EMBO J, V23, P2336, DOI 10.1038/sj.emboj.7600252
   Loar JW, 2004, GENETICS, V168, P1877, DOI 10.1534/genetics.104.032656
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Milkereit P, 2003, J BIOL CHEM, V278, P4072, DOI 10.1074/jbc.M208898200
   Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547
   Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732
   Saveanu C, 2001, EMBO J, V20, P6475, DOI 10.1093/emboj/20.22.6475
   Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121
   Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2
   Spahn CMT, 2001, CELL, V107, P373, DOI 10.1016/S0092-8674(01)00539-6
   Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0
   Warner JR, 2001, CELL, V107, P133, DOI 10.1016/S0092-8674(01)00531-1
   Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006
NR 27
TC 154
Z9 157
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 1
PY 2006
VL 441
IS 7093
BP 651
EP 655
DI 10.1038/nature04840
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 048AU
UT WOS:000237920800051
PM 16738661
DA 2021-01-25
ER

PT J
AU Walter, MA
   Seboek, D
   Demougin, P
   Bubendorf, L
   Oberholzer, M
   Muller-Brand, J
   Muller, B
AF Walter, Martin A.
   Seboek, Dalma
   Demougin, Philippe
   Bubendorf, Lukas
   Oberholzer, Martin
   Mueller-Brand, Jan
   Mueller, Beat
TI Extraction of high-integrity RNA suitable for microarray gene expression
   analysis from long-term stored human thyroid tissues
SO PATHOLOGY
LA English
DT Article
DE thyroid cancer; RNA extraction; fresh-frozen tissue; RNA integrity
   number; microarray
ID MESSENGER-RNA; PROGNOSTIC-FACTORS; PRESERVATION; TUMOR; DNA;
   QUANTIFICATION; IMPROVEMENT; QUALITY; STORAGE; CANCER
AB Introduction: Isolation of high-quality RNA from fresh-frozen thyroid tissues stored for more than a decade would open novel options for gene expression profiling. Herein, we describe successful extraction of high-integrity RNA from human thyroid tissues that were stored for more than a decade.
   Methods: Seventy-nine samples (15 goitres, 20 follicular adenomas, 30 papillary carcinomas, 14 follicular carcinomas) that were shock-frozen in isopentane and stored for a median of 11 years (range 1-16 years) were processed using standard precipitation and column filtration techniques. RNA integrity was assessed by electrophoresis using the RNA integrity number (RIN) algorithm and by gene expression profiling determining the 3'/5' ratio of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene and the percentage of transcripts detected on the Affymetrix U133 2.0 human genome GeneChip.
   Results: The median RNA yield was 1.9 mu g/mg tissue (papillary carcinoma 2.1 mu g/mg, range 0.2-7.2 mu g/mg; follicular carcinoma 2.4 mu g/mg, range 0.2-3.2 mu g/mg; goitre 1.4 mu g/mg, range 0.1-5.4 mu g/mg; follicular adenoma 1.6 mu g/mg, range 0.1-6.2 mu g/mg; p=0.46) with an 8.6 (7.3-9.8) median RIN. The median GAPDH gene 3'/5' ratio was 1.43 (1.34-1.52) and the median percentage of present calls was 48.1% (42.7-52.0%).
   Conclusions: Age and entity independent RNA suitable for expression profiling can be extracted from long-term stored fresh-frozen human thyroid tissues.
C1 Univ Basel Hosp, Inst Nucl Med, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Clin Endocrinol Diabetol & Clin Nutr, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
   Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland.
RP Walter, MA (corresponding author), Univ Basel Hosp, Inst Nucl Med, Petersgraben 4, CH-4031 Basel, Switzerland.
EM m.a.walter@gmx.net
RI Bubendorfl, Lukas/H-5880-2011; Walter, Martin A/B-5203-2017; Mueller,
   Beat/G-2662-2012
OI Walter, Martin A/0000-0001-6487-5349; 
CR ALBRECHT RM, 1973, CRYOBIOLOGY, V10, P233, DOI 10.1016/0011-2240(73)90036-9
   Brundage MD, 2002, CHEST, V122, P1037, DOI 10.1378/chest.122.3.1037
   Bundred NJ, 2001, CANCER TREAT REV, V27, P137, DOI 10.1053/ctrv.2000.0207
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999
   Chu TY, 2002, INT J GYNECOL CANCER, V12, P171, DOI 10.1046/j.1525-1438.2002.01085.x
   Eikmans M, 2000, J AM SOC NEPHROL, V11, P868
   Florell SR, 2001, MODERN PATHOL, V14, P116, DOI 10.1038/modpathol.3880267
   Gray JW, 2000, CARCINOGENESIS, V21, P443, DOI 10.1093/carcin/21.3.443
   Grotzer MA, 2000, MED PEDIATR ONCOL, V34, P438, DOI 10.1002/(SICI)1096-911X(200006)34:6<438::AID-MPO12>3.0.CO;2-Q
   GRUBER AD, 1994, J VET MED B, V41, P654, DOI 10.1111/j.1439-0450.1994.tb00276.x
   Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001
   Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054
   Jewell SD, 2002, AM J CLIN PATHOL, V118, P733
   Jukkola A, 2004, ENDOCR-RELAT CANCER, V11, P571, DOI 10.1677/erc.1.00826
   Karlsson H, 2003, CLIN CHEM, V49, P979, DOI 10.1373/49.6.979
   Kok T, 2000, J CLIN VIROL, V16, P59, DOI 10.1016/S1386-6532(99)00066-9
   Kyveris A, 2002, MOL VIS, V8, P51
   Macluskey M, 2006, BRIT J ORAL MAX SURG, V44, P116, DOI 10.1016/j.bjoms.2005.03.001
   Margalit O, 2005, BLOOD REV, V19, P223, DOI 10.1016/j.blre.2004.11.003
   Matsuo S, 1999, PATHOL INT, V49, P383, DOI 10.1046/j.1440-1827.1999.00887.x
   Mazzaferri E L, 2000, Endocr Pract, V6, P469
   MERYMAN HT, 1956, SCIENCE, V124, P515, DOI 10.1126/science.124.3221.515
   Mueller O, 2000, ELECTROPHORESIS, V21, P128, DOI 10.1002/(SICI)1522-2683(20000101)21:1<128::AID-ELPS128>3.0.CO;2-M
   Vincek V, 2003, LAB INVEST, V83, P1427, DOI 10.1097/01.LAB.0000090154.55436.D1
   Vincek V, 2003, LAB INVEST, V83, P137, DOI 10.1097/01.LAB.0000047490.26282.CF
   Voutilainen PE, 2003, ANTICANCER RES, V23, P4283
   Wong SCC, 2004, J CLIN PATHOL, V57, P766, DOI 10.1136/jcp.2003.007880
   Wulfkuhle J, 2004, EUR J CANCER, V40, P2623, DOI 10.1016/j.ejca.2004.05.020
NR 29
TC 9
Z9 9
U1 0
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0031-3025
EI 1465-3931
J9 PATHOLOGY
JI Pathology
PD JUN
PY 2006
VL 38
IS 3
BP 249
EP 253
DI 10.1080/00313020600696272
PG 5
WC Pathology
SC Pathology
GA 048IM
UT WOS:000237940800011
PM 16753748
DA 2021-01-25
ER

PT J
AU Vedrenne, C
   Hauri, HP
AF Vedrenne, C
   Hauri, HP
TI Morphogenesis of the endoplasmic reticulum: Beyond active membrane
   expansion
SO TRAFFIC
LA English
DT Review
DE CLIMP-63; endoplasmic reticulum; huntingtin; kinectin; membrane fusion;
   microtubules; p22; p97; VAP-B
ID CA2+-BINDING PROTEIN; HUNTINGTONS-DISEASE; QUALITY-CONTROL; MEDIATED
   INHIBITION; LIVING CELLS; ER NETWORK; IN-VITRO; MICROTUBULES; KINESIN;
   KINECTIN
AB The endoplasmic reticulum (ER) of higher eukaryotic cells is a dynamic network of interconnected membrane tubules that pervades almost the entire cytoplasm. On the basis of the morphological changes induced by the disruption of the cytoskeleton or molecular motor proteins, the commonly accepted model has emerged that microtubules and conventional kinesin (kinesin-1) are essential determinants in establishing and maintaining the structure of the ER by active membrane expansion. Surprisingly, very similar ER phenotypes have now been observed when the cytoskeleton-linking ER membrane protein of 63 kDa (CLIMP-63) is mutated, revealing stable attachment of ER membranes to the microtubular cytoskeleton as a novel requirement for ER maintenance. Additional recent findings suggest that ER maintenance also requires ongoing homotypic membrane fusion, possibly controlled by the p97/p47/VICP135 protein complex. Work on other proteins proposed to regulate ER structure, including huntingtin, the EF-hand Ca2+-binding protein p22, the vesicle-associated membrane protein-associated protein B and kinectin isoforms further contribute to the new emerging concept that ER shape is not only determined by motor driven processes but by a variety of different mechanisms.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
CR Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200
   Andrade J, 2004, BIOCHEM J, V384, P327, DOI 10.1042/BJ20040622
   Andrade J, 2004, MOL BIOL CELL, V15, P481, DOI 10.1091/mbc.E03-07-0500
   Barroso MR, 1996, J BIOL CHEM, V271, P10183, DOI 10.1074/jbc.271.17.10183
   Baumann O, 2001, INT REV CYTOL, V205, P149, DOI 10.1016/S0074-7696(01)05004-5
   Biehn SE, 2004, EXP CELL RES, V292, P78, DOI 10.1016/j.yexcr.2003.08.016
   Blocker A, 1997, J CELL BIOL, V137, P113, DOI 10.1083/jcb.137.1.113
   DABORA SL, 1988, CELL, V54, P27, DOI 10.1016/0092-8674(88)90176-6
   Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883
   Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021
   Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x
   Gunawardena S, 2005, ARCH NEUROL-CHICAGO, V62, P46, DOI 10.1001/archneur.62.1.46
   GUTEKUNST CA, 1995, P NATL ACAD SCI USA, V92, P8710, DOI 10.1073/pnas.92.19.8710
   Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086
   Hoffner G, 2002, J CELL SCI, V115, P941
   Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027
   Huyer G, 2004, MOL BIOL CELL, V15, P908, DOI 10.1091/mbc.E03-07-0546
   Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010
   Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x
   Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x
   Kegel KB, 2005, J BIOL CHEM, V280, P36464, DOI 10.1074/jbc.M503672200
   Klee M, 2005, J CELL BIOL, V168, P723, DOI 10.1083/jcb.200408169
   Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012
   Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   Kopito RR, 2000, EMBO REP, V1, P225, DOI 10.1093/embo-reports/kvd052
   Koster G, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.068101
   KUMAR J, 1995, SCIENCE, V267, P1834, DOI 10.1126/science.7892610
   Lane JD, 1999, MOL BIOL CELL, V10, P1909, DOI 10.1091/mbc.10.6.1909
   LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8
   Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033
   Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008
   Li SH, 1998, J NEUROSCI, V18, P1261, DOI 10.1523/jneurosci.18-04-01261.1998
   Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201
   McCullough S, 2005, J ANAT, V206, P415, DOI 10.1111/j.1469-7580.2005.00407.x
   Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333
   Omi K, 2005, BIOCHEM BIOPH RES CO, V338, P1229, DOI 10.1016/j.bbrc.2005.10.061
   Ong LL, 2000, J BIOL CHEM, V275, P32854, DOI 10.1074/jbc.M005650200
   Plitz T, 2001, MOL CELL BIOL, V21, P6044, DOI 10.1128/MCB.21.17.6044-6055.2001
   Santama N, 2004, J CELL SCI, V117, P4537, DOI 10.1242/jcs.01326
   SCHWEIZER A, 1995, J CELL SCI, V108, P2477
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   Singaraja RR, 2002, HUM MOL GENET, V11, P2815, DOI 10.1093/hmg/11.23.2815
   Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5
   Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020
   Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301
   Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2
   Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0
   TERASAKI M, 1992, J CELL SCI, V101, P315
   TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557
   TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510
   Timm S, 1999, MOL BIOL CELL, V10, P3473, DOI 10.1091/mbc.10.10.3473
   TOYOSHIMA I, 1992, J CELL BIOL, V118, P1121, DOI 10.1083/jcb.118.5.1121
   Toyoshima I, 1996, NEUROSCI LETT, V211, P171, DOI 10.1016/0304-3940(96)12752-X
   Turner MD, 2004, BBA-MOL CELL RES, V1693, P1, DOI 10.1016/j.bbamcr.2004.05.002
   Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112
   Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X
   Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554
   Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896
   Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202
   Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5
   Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437
NR 65
TC 122
Z9 124
U1 2
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD JUN
PY 2006
VL 7
IS 6
BP 639
EP 646
DI 10.1111/j.1600-0854.2006.00419.x
PG 8
WC Cell Biology
SC Cell Biology
GA 040BK
UT WOS:000237353800002
PM 16683914
OA Bronze
DA 2021-01-25
ER

PT J
AU von Bergen, M
   Barghorn, S
   Muller, SA
   Pickhardt, M
   Biernat, J
   Mandelkow, EM
   Davies, P
   Aebi, U
   Mandelkow, E
AF von Bergen, Martin
   Barghorn, Stefan
   Mueller, Shirley A.
   Pickhardt, Marcus
   Biernat, Jacek
   Mandelkow, Eva-Maria
   Davies, Peter
   Aebi, Ueli
   Mandelkow, Eckhard
TI The core of tau-paired helical filaments studied by scanning
   transmission electron microscopy and limited proteolysis
SO BIOCHEMISTRY
LA English
DT Article
ID DEPENDENT PROTEIN-KINASE; ALZHEIMERS-DISEASE; BETA-STRUCTURE; IN-VITRO;
   MONOCLONAL-ANTIBODY; RECOMBINANT-TAU; PHOSPHORYLATION; IDENTIFICATION;
   AGGREGATION; BRAIN
AB In Alzheimer's disease and frontotemporal dementias the microtubule-associated protein tau forms intracellular paired helical filaments (PHFs). The filaments formed in vivo consist mainly of full-length molecules of the six different isoforms present in adult brain. The substructure of the PHF core is still elusive. Here we applied scanning transmission electron microscopy (STEM) and limited proteolysis to probe the mass distribution of PHFs and their surface exposure. Tau filaments assembled from the three repeat domain have a mass per length (MPL) of similar to 60 kDa/nm and filaments from full-length tau (htau40 Delta K280 mutant) have similar to 160 kDa/nm, compared with similar to 130 kDa/nm for PHFs from Alzheimer's brain. Polyanionic cofactors such as heparin accelerate assembly but are not incorporated into PHFs. Limited proteolysis combined with N-terminal sequencing and mass spectrometry of fragments reveals a protease-sensitive N-terminal half and semiresistant PHF core starting in the first repeat and reaching to the C-terminus of tau. Continued proteolysis leads to a fragment starting at the end of the first repeat and ending in the fourth repeat. PHFs from tau isoforms with four repeats revealed an additional cleavage site within the middle of the second repeat. Probing the PHFs with antibodies detecting epitopes either over longer stretches in the C-terminal half of tau or in the fourth repeat revealed that they grow in a polar manner. These data describe the physical parameters of the PHFs and enabled us to build a model of the molecular arrangement within the filamentous structures.
C1 DESY, Max Planck Unit Struct Mol Biol, D-22607 Hamburg, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Albert Einstein Coll Med, Dept Pathol & Neurosci, Bronx, NY 10416 USA.
RP von Bergen, M (corresponding author), DESY, Max Planck Unit Struct Mol Biol, Notkestr 85, D-22607 Hamburg, Germany.
EM vbergen@mpasmb.desy.de; mand@mpasmb.desy.de
RI von Bergen, Martin/D-7960-2011
OI von Bergen, Martin/0000-0003-2732-2977
CR Abraha A, 2000, J CELL SCI, V113, P3737
   Ackmann M, 2000, J BIOL CHEM, V275, P30335, DOI 10.1074/jbc.M002590200
   Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078
   Barghorn S, 2000, BIOCHEMISTRY-US, V39, P11714, DOI 10.1021/bi000850r
   Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006
   Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100
   BIERNAT J, 1992, EMBO J, V11, P1593, DOI 10.1002/j.1460-2075.1992.tb05204.x
   Carmel G, 1996, J BIOL CHEM, V271, P32789, DOI 10.1074/jbc.271.51.32789
   Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b
   Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200
   CROWTHER RA, 1990, BIOCHIM BIOPHYS ACTA, V1096, P1, DOI 10.1016/0925-4439(90)90004-9
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712
   Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d
   GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051
   GOEDERT M, 1994, BIOCHEM J, V301, P871, DOI 10.1042/bj3010871
   GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V
   Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0
   Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200
   GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827
   GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017
   Hasegawa M, 1996, FEBS LETT, V384, P25, DOI 10.1016/0014-5793(96)00271-2
   JAKES R, 1991, EMBO J, V10, P2725, DOI 10.1002/j.1460-2075.1991.tb07820.x
   JEGANATHAN S, 2006, IN PRESS BIOCHEMISTR
   Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999
   Jicha GA, 1999, J NEUROCHEM, V72, P214, DOI 10.1046/j.1471-4159.1999.0720214.x
   Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E
   Jicha GA, 1999, J NEUROSCI RES, V55, P713, DOI 10.1002/(SICI)1097-4547(19990315)55:6<713::AID-JNR6>3.0.CO;2-G
   Kampers T, 1996, FEBS LETT, V399, P344, DOI 10.1016/S0014-5793(96)01386-5
   KHLISTUNOVA I, 2005, IN PRESS J BIOL CHEM
   King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839
   King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0
   Ksiezak-Reding H, 2005, MICROSC RES TECHNIQ, V67, P126, DOI 10.1002/jemt.20188
   Ksiezak-Reding H, 1998, BRAIN RES, V814, P86, DOI 10.1016/S0006-8993(98)01052-X
   KSIEZAKREDING H, 1994, NEUROBIOL AGING, V15, P11, DOI 10.1016/0197-4580(94)90140-6
   KSIEZAKREDING H, 1994, BRAIN RES, V649, P185, DOI 10.1016/0006-8993(94)91063-4
   Li L, 2002, J BIOL CHEM, V277, P41390, DOI 10.1074/jbc.M206334200
   LITERSKY JM, 1992, J BIOL CHEM, V267, P1563
   Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x
   Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101
   Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Scheler C, 1998, ELECTROPHORESIS, V19, P918, DOI 10.1002/elps.1150190607
   SCHWEERS O, 1994, J BIOL CHEM, V269, P24290
   Skrabana R, 2004, FEBS LETT, V568, P178, DOI 10.1016/j.febslet.2004.04.098
   SLOT JW, 1985, EUR J CELL BIOL, V38, P87
   STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   VINCENT IJ, 1992, P NATL ACAD SCI USA, V89, P2878, DOI 10.1073/pnas.89.7.2878
   von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129
   WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573
   WILSON DM, 1995, J BIOL CHEM, V270, P24306, DOI 10.1074/jbc.270.41.24306
   Wilson DM, 1997, AM J PATHOL, V150, P2181
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884
   WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4506, DOI 10.1073/pnas.85.12.4506
   YANG LS, 1995, EUR J BIOCHEM, V233, P9, DOI 10.1111/j.1432-1033.1995.009_1.x
NR 58
TC 101
Z9 101
U1 2
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAY 23
PY 2006
VL 45
IS 20
BP 6446
EP 6457
DI 10.1021/bi052530j
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 043TS
UT WOS:000237625200021
PM 16700555
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Hug, HJ
   Pellmont, Y
   Martin, S
   Frederix, PLTM
   Fotiadis, D
   Engel, A
AF Hoogenboom, BW
   Hug, HJ
   Pellmont, Y
   Martin, S
   Frederix, PLTM
   Fotiadis, D
   Engel, A
TI Quantitative dynamic-mode scanning force microscopy in liquid
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID ATOMIC-RESOLUTION; CANTILEVERS; SPECTROSCOPY
AB We describe a method to perform dynamic-mode scanning force microscopy in liquid with true atomic resolution. A frequency-modulation technique is used to maintain constant amplitude, phase, and frequency shift of the cantilever oscillation. As a consequence, the tip-sample interaction force is well defined and quantitative. The force sensitivity is demonstrated by imaging and deliberate bending of a peptide loop connecting transmembrane helices of the membrane protein bacteriorhodopsin. The experimental setup allows further enhancement of the force sensitivity by the use of small cantilevers. (c) 2006 American Institute of Physics.
C1 Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, ME Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Fed Labs Mat Testing & Rem, EMPA, CH-8600 Dubendorf, Switzerland.
RP Hoogenboom, BW (corresponding author), Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
EM Bart.Hoogenboom@unibas.ch
OI Hoogenboom, Bart/0000-0002-8882-4324
CR ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856
   Giessibl FJ, 1997, PHYS REV B, V56, P16010, DOI 10.1103/PhysRevB.56.16010
   Hoogenboom BW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866229
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   OHNESORGE F, 1993, SCIENCE, V260, P1451, DOI 10.1126/science.260.5113.1451
   Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267
   Schaffer TE, 1996, J APPL PHYS, V80, P3622, DOI 10.1063/1.363308
   Uchihashi T, 2004, APPL PHYS LETT, V85, P3575, DOI 10.1063/1.1803932
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Yang JL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895482
NR 12
TC 69
Z9 70
U1 0
U2 20
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAY 8
PY 2006
VL 88
IS 19
AR 193109
DI 10.1063/1.2202638
PG 3
WC Physics, Applied
SC Physics
GA 041SY
UT WOS:000237477400083
OA Green Published
DA 2021-01-25
ER

PT J
AU Albrecht, I
   Gatfield, J
   Mini, T
   Jeno, P
   Pieters, J
AF Albrecht, I
   Gatfield, J
   Mini, T
   Jeno, P
   Pieters, J
TI Essential role for cholesterol in the delivery of exogenous antigens to
   the MHC class I-presentation pathway
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE macropinocytosis; cholesterol; antigen presentation
ID DENDRITIC CELLS; ENDOPLASMIC-RETICULUM; CROSS-PRESENTATION; CONSTITUTIVE
   MACROPINOCYTOSIS; PHOSPHOINOSITIDE 3-KINASE; SOLUBLE-ANTIGEN; MEMBRANE;
   COMPARTMENT; PEPTIDES; PHAGOCYTOSIS
AB Cross-presentation, which is crucial for the generation of immunity against virus-infected and tumor cells, requires exogenous antigens to be internalized into antigen-presenting cells (APCs) followed by translocation to the cytosol by unknown mechanisms. One important entry route for such antigens is macropinocytosis. We here describe that cholesterol is essential for cross-presentation of antigens loaded via macropinocytosis into APCs. Modification of antigens by palmitoylation to target antigens to cholesterol-enriched plasma membrane domains resulted in a dramatically increased T cell activation. These results define cholesterol as an essential factor for cross-presentation and suggest that specific modification of antigens to increase their affinity for cholesterol may be utilized to enhance immunity.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147
   Ackerman AL, 2004, NAT IMMUNOL, V5, P678, DOI 10.1038/ni1082
   Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100
   Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183
   Amigorena S, 2003, NAT IMMUNOL, V4, P1047, DOI 10.1038/ni1103-1047
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   Amyere M, 2002, INT J MED MICROBIOL, V291, P487
   Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453
   Andrieu M, 2000, EUR J IMMUNOL, V30, P3256, DOI 10.1002/1521-4141(200011)30:11<3256::AID-IMMU3256>3.0.CO;2-H
   ANDROLEWICZ MJ, 1993, P NATL ACAD SCI USA, V90, P9130, DOI 10.1073/pnas.90.19.9130
   Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Benmohamed L, 2000, VACCINE, V18, P2843, DOI 10.1016/S0264-410X(00)00068-2
   BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283
   Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004
   BORNIG H, 1974, ACTA HISTOCHEM, V50, P110
   Brossart P, 1997, BLOOD, V90, P1594, DOI 10.1182/blood.V90.4.1594.1594_1594_1599
   Cardelli J, 2001, TRAFFIC, V2, P311, DOI 10.1034/j.1600-0854.2001.002005311.x
   Cella M, 1997, CURR OPIN IMMUNOL, V9, P10, DOI 10.1016/S0952-7915(97)80153-7
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Cresswell P, 1996, CELL, V84, P505, DOI 10.1016/S0092-8674(00)81025-9
   den Haan JMM, 2001, CURR OPIN IMMUNOL, V13, P437, DOI 10.1016/S0952-7915(00)00238-7
   Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341
   DRABIKOWSKI W, 1973, BIOCHIM BIOPHYS ACTA, V291, P61, DOI 10.1016/0005-2736(73)90060-6
   Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0
   Grimmer S, 2002, J CELL SCI, V115, P2953
   Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911
   Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512
   HEWLETT LJ, 1994, J CELL BIOL, V124, P689, DOI 10.1083/jcb.124.5.689
   HILTBOLD EM, 1993, INFECT AGENT DIS, V2, P314
   HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4
   Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912
   HUANG A, 1980, J BIOL CHEM, V255, P8015
   KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009
   Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X
   KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629
   Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910
   Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107
   Miki H, 1998, EMBO J, V17, P6932, DOI 10.1093/emboj/17.23.6932
   Moffett S, 2000, J BIOL CHEM, V275, P2191, DOI 10.1074/jbc.275.3.2191
   MONACO JJ, 1995, J LEUKOCYTE BIOL, V57, P543
   Muller-Taubenberger A, 2001, EMBO J, V20, P6772, DOI 10.1093/emboj/20.23.6772
   Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200
   Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5
   Norbury CC, 1997, EUR J IMMUNOL, V27, P280, DOI 10.1002/eji.1830270141
   Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039
   Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1
   RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011
   RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8
   ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683
   Rodriguez A, 1999, NAT CELL BIOL, V1, P362
   Rupper A, 2001, MOL BIOL CELL, V12, P2813, DOI 10.1091/mbc.12.9.2813
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   SOUSA CRE, 1995, J EXP MED, V182, P841, DOI 10.1084/jem.182.3.841
   SPIES T, 1990, NATURE, V348, P744, DOI 10.1038/348744a0
   STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283
   SWANSON JA, 1989, J CELL SCI, V94, P135
   Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018
   TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0
   TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.immunol.7.1.601
   Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Watts C, 1999, NAT CELL BIOL, V1, pE152, DOI 10.1038/14105
   Watts C, 2000, TRAFFIC, V1, P312, DOI 10.1034/j.1600-0854.2000.010404.x
   Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821
   WEST MA, 1989, J CELL BIOL, V109, P2731, DOI 10.1083/jcb.109.6.2731
   WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0
   West MA, 2000, CURR BIOL, V10, P839, DOI 10.1016/S0960-9822(00)00595-9
   Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539
NR 72
TC 11
Z9 11
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
EI 1460-2377
J9 INT IMMUNOL
JI Int. Immunol.
PD MAY
PY 2006
VL 18
IS 5
BP 755
EP 765
DI 10.1093/intimm/dxl013
PG 11
WC Immunology
SC Immunology
GA 039QG
UT WOS:000237320700014
PM 16608901
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Walter, D
   Wissing, S
   Madeo, F
   Fahrenkrog, B
AF Walter, David
   Wissing, Silke
   Madeo, Frank
   Fahrenkrog, Birthe
TI The inhibitor-of-apoptosis protein Bir1p protects against apoptosis in
   S-cerevisiae and is a substrate for the yeast homologue of Omi/HtrA2
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Bir1p; IAP; Nma111p; Omi/HtrA2; yeast apoptosis
ID PROGRAMMED CELL-DEATH; SERINE-PROTEASE; REGULATES APOPTOSIS; CASPASE
   ACTIVITY; HTRA FAMILY; SURVIVIN; IAP; MOTIF; XIAP; IDENTIFICATION
AB Inhibitor-of-apoptosis proteins (IAPs) play a crucial role in the regulation of metazoan apoptosis. IAPs are typically characterized by the presence of one to three baculovirus IAP repeat (BIR) domains that are essential for their anti-apoptotic activity. Bir1p is the sole BIR-protein in yeast and has been shown to participate in chromosome segregation events. Here, we show that Bir1p is a substrate for Nma111p, which is the homologue of the human pro-apoptotic serine protease Omi/HtrA2 and which is known to mediate apoptosis in yeast. Bir1p is a cytoplasmic and nuclear protein, and yeast cells lacking bir1 are more sensitive to apoptosis induced by oxidative stress. Consistently, overexpression of Bir1p reduces apoptosis-like cell death, whereas this protective effect can be antagonized in vivo by simultaneous overexpression of Nma111p. Moreover, chronologically aged cells that constitutively overexpress Bir1p show a delayed onset of cell death. Therefore, Bir1p, like its closest metazoan homologues deterin and survivin, has dual functions: it participates in chromosome segregation events and cytokinesis and exhibits anti-apoptotic activity.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Tubingen, Inst Physiol Chem, D-72076 Tubingen, Germany.
   Karl Franzens Univ Graz, IMB, A-8010 Graz, Austria.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011; Walter, David/A-8436-2008
OI Walter, David/0000-0003-4363-0339; Fahrenkrog,
   Birthe/0000-0003-4080-9413
CR Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8
   Ahn SH, 2005, CELL CYCLE, V4, P780, DOI 10.4161/cc.4.6.1745
   Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016
   Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018
   Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102
   Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5
   CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993
   Dohi T, 2004, J BIOL CHEM, V279, P34087, DOI 10.1074/jbc.C400236200
   Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7
   Garrido C, 2004, CURR OPIN CELL BIOL, V16, P639, DOI 10.1016/j.ceb.2004.09.008
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GORCZYCA W, 1993, CANCER RES, V53, P1945
   Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Jin SK, 2003, GENE DEV, V17, P359, DOI 10.1101/gad.1047003
   Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307
   Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707
   Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101
   Madeo F, 2004, CURR OPIN MICROBIOL, V7, P655, DOI 10.1016/j.mib.2004.10.012
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263
   Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x
   Ponting CP, 1997, PROTEIN SCI, V6, P464
   Qiu JZ, 2005, J BIOL CHEM, V280, P15370, DOI 10.1074/jbc.M413547200
   Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496
   Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6
   Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732
   Schulz JB, 1996, J NEUROSCI, V16, P4696
   Sekine K, 2005, BIOCHEM BIOPH RES CO, V330, P279, DOI 10.1016/j.bbrc.2005.02.165
   Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575
   Srinivasula SM, 2003, J BIOL CHEM, V278, P31469, DOI 10.1074/jbc.C300240200
   Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Tamm I, 1998, CANCER RES, V58, P5315
   Temme A, 2003, MOL BIOL CELL, V14, P78, DOI 10.1091/mbc.E02-04-0182
   Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170
   Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621
   Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200
   Verhagen AM, 2001, GENOME BIOL, V2
   Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Yang QH, 2003, GENE DEV, V17, P1487, DOI 10.1101/gad.1097903
   Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208
NR 55
TC 105
Z9 110
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 1
PY 2006
VL 119
IS 9
BP 1843
EP 1851
DI 10.1242/jcs.02902
PG 9
WC Cell Biology
SC Cell Biology
GA 042SF
UT WOS:000237549000017
PM 16608876
OA Other Gold
DA 2021-01-25
ER

PT J
AU Nicholson, JR
   Kohler, G
   Schaerer, F
   Senn, C
   Weyermann, P
   Hofbauer, KG
AF Nicholson, JR
   Kohler, G
   Schaerer, F
   Senn, C
   Weyermann, P
   Hofbauer, KG
TI Peripheral administration of a melanocortin 4-receptor inverse agonist
   prevents loss of lean body mass in tumor-bearing mice
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID RECEPTOR; OBESITY; RATS; ANTAGONIST; CACHEXIA; ANATOMY
AB Cachexia affects many different chronically ill patient populations, including those with cancer. It results in loss of body weight, particularly of lean body mass ( LBM), and is estimated to be responsible for over 20% of all cancer-related deaths. Currently, available drugs are ineffective, and new therapies are urgently needed. Melanocortin 4-receptor ( MC4-R) blockade has been shown recently to be effective in preventing cancer cachexia in rodent models. In the present study, we have tested a MC4-R blocker, ML00253764 [ 2-{2-[ 2-( 5-bromo-2-methoxyphenyl)ethyl]-3-fluorophenyl}-4,5-dihydro-1H-imidazoliumhydrochloride]( Vos et al., 2004), in vitro and in vivo. In membranes of human embryonic kidney 293 cells expressing human MC4-R, ML00253764 displaced [ Nle(4), D-Phe7]-alpha-melanocyte-stimulating hormone binding with an IC50 of 0.32 mu M. At concentrations above 1 mu M, ML00253764 decreased cAMP accumulation ( maximal reduction of -20%) indicative of inverse agonist activity. ML00253764 was administered twice daily ( 15 mg/kg s.c.) for 13 days to C57BL6 mice bearing s.c. Lewis lung carcinoma tumors. Food intake and body weight were measured, and body composition was assessed using magnetic resonance relaxometry. ML00253764 stimulated light-phase food intake relative to vehicle-treated controls ( p < 0.05), although no effect was observed on 24-h food intake. During the 21 days of the experiment, the LBM of tumor vehicle-treated mice decreased ( p < 0.05). In contrast, the tumor-bearing mice treated with ML00253764 maintained their LBM. These data support the view that MC4-R blockade may be a suitable approach for the treatment of cancer cachexia and that MC4-R inverse agonists may have potential as drug candidates.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Santhera Pharmaceut, Liestal, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Allen M, 2002, J BIOMOL SCREEN, V7, P35, DOI 10.1177/108705710200700106
   Argiles JM, 2005, INT J BIOCHEM CELL B, V37, P1609, DOI 10.1016/j.biocel.2005.03.007
   Bagnol D, 1999, J NEUROSCI, V19
   BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8
   Bruera E, 1998, SUPPORT CARE CANCER, V6, P109, DOI 10.1007/s005200050143
   Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518
   Cheung W, 2005, J CLIN INVEST, V115, P1659, DOI 10.1172/JCI22521
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   HOFBAUER KG, 2003, PHARMACOTHERAPY CACH
   Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864
   Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6
   Kask A, 2000, NEUROSCI LETT, V283, P1, DOI 10.1016/S0304-3940(00)00837-5
   Kunnecke B, 2004, OBES RES, V12, P1604, DOI 10.1038/oby.2004.200
   Lawrence CB, 2001, J NEUROENDOCRINOL, V13, P490, DOI 10.1046/j.1365-2826.2001.00660.x
   MARKEWICZ B, 1993, AM J PHYSIOL, V265, pE478
   Markison S, 2005, ENDOCRINOLOGY, V146, P2766, DOI 10.1210/en.2005-0142
   Marks DL, 2003, ANN NY ACAD SCI, V994, P258, DOI 10.1111/j.1749-6632.2003.tb03188.x
   Marks DL, 2003, ENDOCRINOLOGY, V144, P1513, DOI 10.1210/en.2002-221099
   Marks DL, 2001, CANCER RES, V61, P1432
   Nijenhuis WAJ, 2001, MOL ENDOCRINOL, V15, P164, DOI 10.1210/me.15.1.164
   Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135
   PROVENCHER SW, 1982, COMPUT PHYS COMMUN, V27, P229, DOI 10.1016/0010-4655(82)90174-6
   Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927
   Taicher GZ, 2003, ANAL BIOANAL CHEM, V377, P990, DOI 10.1007/s00216-003-2224-3
   Vos TJ, 2004, J MED CHEM, V47, P1602, DOI 10.1021/jm034244g
   Wisse BE, 2001, ENDOCRINOLOGY, V142, P3292, DOI 10.1210/en.142.8.3292
NR 27
TC 55
Z9 55
U1 0
U2 1
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD MAY
PY 2006
VL 317
IS 2
BP 771
EP 777
DI 10.1124/jpet.105.097725
PG 7
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 033WY
UT WOS:000236885000037
PM 16436498
DA 2021-01-25
ER

PT J
AU Engel, J
AF Engel, Juergen
TI Guest editorial letter: Molecular machines in the matrix?
SO MATRIX BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
EM juergen.engel@unibas.ch
CR Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8
   Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000
   COBAN O, IN PRESS BIOPHY 0331
   de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064
   Groll M, 2005, METHOD ENZYMOL, V398, P329, DOI 10.1016/S0076-6879(05)98027-0
   He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Wallrabe H, 2005, CURR OPIN BIOTECH, V16, P19, DOI 10.1016/j.copbio.2004.12.002
NR 9
TC 1
Z9 1
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD MAY
PY 2006
VL 25
IS 4
BP 200
EP 201
DI 10.1016/j.matbio.2006.04.001
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 055EV
UT WOS:000238433700001
PM 16682178
DA 2021-01-25
ER

PT J
AU Jastrzebska, B
   Fotiadis, D
   Jang, GF
   Stenkamp, RE
   Engel, A
   Palczewski, K
AF Jastrzebska, B
   Fotiadis, D
   Jang, GF
   Stenkamp, RE
   Engel, A
   Palczewski, K
TI Functional and structural characterization of rhodopsin oligomers
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; TANDEM MASS-SPECTROMETRY; DRIVEN
   FRAGMENTATION PROCESSES; ENERGY COLLISIONAL ACTIVATION; STAGE QUADRUPOLE
   INSTRUMENT; NATIVE DISC MEMBRANES; FATTY-ACIDS; TRANSDUCIN ACTIVATION;
   MECHANISTIC PROPOSAL; LITHIATED ADDUCTS
AB A major question in G protein-coupled receptor signaling concerns the quaternary structure required for signal transduction. Do these transmembrane receptors function as monomers, dimers, or larger oligomers? We have investigated the oligomeric state of the model G protein-coupled receptor rhodopsin (Rho), which absorbs light and initiates a phototransduction-signaling cascade that forms the basis of vision. In this study, different forms of Rho were isolated using gel filtration techniques in mild detergents, including n-dodecyl-beta-D-maltoside, n-tetradecyl-beta-D-maltoside, and n-hexadecyl-beta-D-maltoside. The quaternary structure of isolated Rho was determined by transmission electron microscopy, demonstrating that in micelles containing n-dodecyl-beta-D-maltoside, Rho exists as a mixture of monomers and dimers whereas in n-tetradecyl-beta-D-maltoside and n-hexadecyl-beta-D-maltoside Rho forms higher ordered structures. Especially in n-hexadecyl-beta-D-maltoside, most of the particles are present in tightly packed rows of dimers. The oligomerization of Rho seems to be important for interaction with its cognate G protein, transducin. Although the activated Rho (Meta II) monomer or dimers are capable of activating the G protein, transducin, the activation process is much faster when Rho exists as organized dimers. Our studies provide direct comparisons between signaling properties of Meta II in different quaternary complexes.
C1 Case Western Reserve Univ, Dept Pharmacol, Sch Med, Case Sch Med, Cleveland, OH 44106 USA.
   Univ Basel, ME Muller Inst Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.
   Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA.
RP Palczewski, K (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Sch Med, Case Sch Med, BRB Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM kxp65@case.edu
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30
   EY001730, R01 EY008061, EY01730, EY08061] Funding Source: Medline; NIGMS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM63020, R01 GM063020] Funding Source:
   Medline; NATIONAL EYE INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R01EY008061, R29EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R29EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, R29EY008061,
   R01EY008061, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   R29EY008061, P30EY001730, R29EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, R01EY008061, R29EY008061, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM063020, R01GM063020,
   R01GM063020, R01GM063020] Funding Source: NIH RePORTER
CR Aveldano MI, 1995, ARCH BIOCHEM BIOPHYS, V324, P331, DOI 10.1006/abbi.1995.0046
   AVELDANO MI, 1988, BIOCHEMISTRY-US, V27, P1229, DOI 10.1021/bi00404a024
   Baneres JL, 2003, J MOL BIOL, V329, P815, DOI 10.1016/S0022-2836(03)00439-X
   Calvert PD, 2001, NATURE, V411, P90, DOI 10.1038/35075083
   FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020
   FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023
   Fanelli F, 2005, CHEM REV, V105, P3297, DOI 10.1021/cr000095n
   FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073
   Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768
   Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046
   Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102
   Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200
   Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200
   Herrick-Davis K, 2005, J BIOL CHEM, V280, P40144, DOI 10.1074/jbc.M507396200
   Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P892, DOI 10.1016/S1044-0305(00)00159-8
   Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P797, DOI 10.1016/S1044-0305(00)00151-3
   Hsu FF, 1999, J AM SOC MASS SPECTR, V10, P600, DOI 10.1016/S1044-0305(99)00041-0
   Hsu FF, 2001, J AM SOC MASS SPECTR, V12, P61, DOI 10.1016/S1044-0305(00)00194-X
   Hsu FF, 2000, J AM SOC MASS SPECTR, V11, P986, DOI 10.1016/S1044-0305(00)00172-0
   Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200
   Mansoor SE, 2006, P NATL ACAD SCI USA, V103, P3060, DOI 10.1073/pnas.0511010103
   Mesnier D, 2004, J BIOL CHEM, V279, P49664, DOI 10.1074/jbc.M404941200
   Moritz OL, 2001, J BIOL CHEM, V276, P28242, DOI 10.1074/jbc.M101476200
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48
   Park PSH, 2004, BIOCHEMISTRY-US, V43, P15643, DOI 10.1021/bi047907k
   Park PSH, 2005, P NATL ACAD SCI USA, V102, P8793, DOI 10.1073/pnas.0504016102
   Pulfer M, 2003, MASS SPECTROM REV, V22, P332, DOI 10.1002/mas.10061
   Pulfer MK, 2004, J AM SOC MASS SPECTR, V15, P194, DOI 10.1016/j.jasms.2003.10.011
   Schadel SA, 2003, J BIOL CHEM, V278, P24896, DOI 10.1074/jbc.M302115200
   STUBBS GW, 1978, BIOCHEMISTRY-US, V17, P215, DOI 10.1021/bi00595a003
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   WHITE DC, 1995, SIGNATURE LIPID BIOM, P255
NR 41
TC 113
Z9 117
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 28
PY 2006
VL 281
IS 17
BP 11917
EP 11922
DI 10.1074/jbc.M600422200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 035GH
UT WOS:000236988100060
PM 16495215
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Ducreux, S
   Zorzato, F
   Ferreiro, A
   Jungbluth, H
   Muntoni, F
   Monnier, N
   Muller, CR
   Treves, S
AF Ducreux, S
   Zorzato, F
   Ferreiro, A
   Jungbluth, H
   Muntoni, F
   Monnier, N
   Muller, CR
   Treves, S
TI Functional properties of ryanodine receptors carrying three amino acid
   substitutions identified in patients affected by multi-minicore disease
   and central core disease, expressed in immortalized lymphocytes
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE calcium channel; central core disease; lymphoblastoid cell line;
   malignant hyperthermia; multi-minicore disease; ryanodine; receptor
ID CA2+ RELEASE CHANNEL; MALIGNANT HYPERTHERMIA SUSCEPTIBILITY;
   CALCIUM-RELEASE; RYR1 MUTATIONS; MUSCLE BIOPSY; DOMAIN; CHLOROCRESOL;
   PHENOTYPE; ACTIVATOR; MYOPATHY
AB More than 80 mutations in the skeletal muscle ryanodine receptor gene have been found to be associated with autosomal dominant forms of malignant hyperthermia and central core disease, and with recessive forms of multi-minicore disease. Studies on the functional effects of pathogenic dominant mutations have shown that they mostly affect intracellular Ca2+ homoeostasis, either by rendering the channel hypersensitive to activation (malignant hypenhermia) or by altering the amount of Ca2+ released subsequent to physiological or pharmacological activation (central core disease). In the present paper, we show, for the first time, data on the functional effect of two recently identified recessive ryanodine receptor I amino acid substitutions, P3527S and V4849I, as well as that of R999H, another substitution that was identified in two siblings that were affected by multi-minicore disease. We studied the intracellular Ca2+ homocostasis of EBV (Epstein-Barr virus)-transfonned lymphoblastoid cells from the affected patients, their healthy relatives and control individuals. Our results show that the P3527S substitution in the homozygous state affected the amount of Ca2+ released after pharmacological activation with 4-chloro-m-cresol and caffeine, but did not affect the size of the thapsigargin-sensitive Ca2+ stores. The other substitutions had no effect on either the size of the intracellular Ca2+ stores. or on the amount of Ca2+ released after ryanodine receptor activation; however, both the P3527S and V4849I substitutions had a small but significant effect on the resting Ca2+ concentration.
C1 Univ Basel Hosp, Dept Anaesthesia & Res, CH-4031 Basel, Switzerland.
   Univ Ferrara, Dipartimento Med Sperimentale & Diagnost, I-44100 Ferrara, Italy.
   UPMC, Grp Hosp Pitie Salpetriere, Inst Myol, INSERM,U582, Paris, France.
   Hammersmith Hosp, Imperial Coll, Dubowitz Neuromusc Ctr, London W12 0NN, England.
   CHU Grenoble, INSERM, U607, Lab Biochim & Genet Mol, Grenoble, France.
   Univ Wurzburg, Biozentrum, Inst Humangenet, D-97074 Wurzburg, Germany.
RP Treves, S (corresponding author), ZLF Lab 408, Dept Anesthesia & Res, Hebelstr 20, CH-4031 Basel, Switzerland.
EM susan.treves@unibas.ch
RI Jungbluth, Heinz/B-8893-2012; Ferreiro, Ana/F-5371-2011; DUCREUX,
   SYLVIE/D-6257-2013
OI Ferreiro, Ana/0000-0003-2806-5386; DUCREUX, SYLVIE/0000-0003-3207-9537;
   Treves, Susan/0000-0002-0007-9631
CR Balshaw DM, 2002, J MEMBRANE BIOL, V185, P1, DOI 10.1007/s00232-001-0111-4
   BETHLEM J, 1978, ARCH NEUROL-CHICAGO, V35, P555, DOI 10.1001/archneur.1978.00500330003002
   Cavagna D, 2000, BRIT J PHARMACOL, V131, P335, DOI 10.1038/sj.bjp.0703571
   Denborough M, 1998, LANCET, V352, P1131, DOI 10.1016/S0140-6736(98)03078-5
   DENBOROUGH MA, 1960, LANCET, V2, P45
   Du GG, 2002, P NATL ACAD SCI USA, V99, P16725, DOI 10.1073/pnas.012688999
   Ducreux S, 2004, J BIOL CHEM, V279, P43838, DOI 10.1074/jbc.M403612200
   ENDO M, 1977, PHYSIOL REV, V57, P71
   Ferreiro A, 2002, ANN NEUROL, V51, P750, DOI 10.1002/ana.10231
   Ferreiro A, 2002, AM J HUM GENET, V71, P739, DOI 10.1086/342719
   Ferreiro A, 2000, ANN NEUROL, V48, P745, DOI 10.1002/1531-8249(200011)48:5<745::AID-ANA8>3.0.CO;2-F
   Ferreiro Ana, 2002, Neuromuscul Disord, V12, P60, DOI 10.1016/S0960-8966(01)00237-1
   FLEISCHER S, 1989, ANNU REV BIOPHYS BIO, V18, P333, DOI 10.1146/annurev.biophys.18.1.333
   FRANZINIARMSTRONG C, 1994, ANNU REV PHYSIOL, V56, P509, DOI 10.1146/annurev.ph.56.030194.002453
   FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699
   Girard T, 2001, J BIOL CHEM, V276, P48077, DOI 10.1074/jbc.M107134200
   GREENFIELD JG, 1958, BRAIN, V81, P461, DOI 10.1093/brain/81.4.461
   HERRMANNFRANK A, 1996, BIOCHIM BIOPHYS ACTA, V1289, P1
   Jungbluth H, 2002, NEUROLOGY, V59, P284, DOI 10.1212/WNL.59.2.284
   Jurkat-Rott K, 2000, MUSCLE NERVE, V23, P4, DOI 10.1002/(SICI)1097-4598(200001)23:1<4::AID-MUS3>3.0.CO;2-D
   Litman RS, 2005, JAMA-J AM MED ASSOC, V293, P2918, DOI 10.1001/jama.293.23.2918
   Loke J, 1998, AM J MED, V104, P470, DOI 10.1016/S0002-9343(98)00108-9
   Lyfenko AD, 2004, BIOCHEM BIOPH RES CO, V322, P1256, DOI 10.1016/j.bbrc.2004.08.031
   MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759
   MacLennan DH, 2000, EUR J BIOCHEM, V267, P5291, DOI 10.1046/j.1432-1327.2000.01566.x
   Mathews KD, 2004, ARCH NEUROL-CHICAGO, V61, P27, DOI 10.1001/archneur.61.1.27
   McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D
   MEISSNER G, 1994, ANNU REV PHYSIOL, V56, P485, DOI 10.1146/annurev.ph.56.030194.002413
   Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581
   NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094
   Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660
   Sambuughin N, 2005, ANESTHESIOLOGY, V102, P515, DOI 10.1097/00000542-200503000-00007
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   Shepherd S, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.014274
   SHUAIB A, 1987, J COMP PATHOL, V97, P597
   TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0
   Tegazzin V, 1996, ANESTHESIOLOGY, V84, P1380, DOI 10.1097/00000542-199606000-00014
   Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879
   Treves S, 2005, NEUROMUSCULAR DISORD, V15, P577, DOI 10.1016/j.nmd.2005.06.008
   Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w
   Treves S, 2002, CELL CALCIUM, V31, P1, DOI 10.1054/ceca.2001.0252
   VALLAT JM, 1982, ACTA NEUROPATHOL, V58, P229, DOI 10.1007/BF00690806
   Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200
   Zorzato F, 2003, HUM MOL GENET, V12, P379, DOI 10.1093/hmg/ddg032
   ZORZATO F, 1990, J BIOL CHEM, V265, P2244
   ZORZATO F, 1993, MOL PHARMACOL, V44, P1192
   Zucchi R, 1997, PHARMACOL REV, V49, P1
NR 47
TC 43
Z9 44
U1 0
U2 0
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD APR 15
PY 2006
VL 395
BP 259
EP 266
DI 10.1042/BJ20051282
PN 2
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 033IL
UT WOS:000236840400004
PM 16372898
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Hermida, L
   Schaad, O
   Demougin, P
   Descombes, P
   Primig, M
AF Hermida, L
   Schaad, O
   Demougin, P
   Descombes, P
   Primig, M
TI MIMAS: an innovative tool for network-based high density oligonucleotide
   microarray data management and annotation
SO BMC BIOINFORMATICS
LA English
DT Database Review
ID GENE-EXPRESSION DATABASE; BIOLOGY; INFORMATION; STANDARDS; ONTOLOGY;
   IMPLEMENTATION; HYBRIDIZATION; TRANSCRIPTION; ARRAYEXPRESS; EXCHANGE
AB Background: The high-density oligonucleotide microarray (GeneChip) is an important tool for molecular biological research aiming at large-scale detection of small nucleotide polymorphisms in DNA and genome-wide analysis of mRNA concentrations. Local array data management solutions are instrumental for efficient processing of the results and for subsequent uploading of data and annotations to a global certified data repository at the EBI (ArrayExpress) or the NCBI (GeneOmnibus).
   Description: To facilitate and accelerate annotation of high-throughput expression profiling experiments, the Microarray Information Management and Annotation System (MIMAS) was developed. The system is fully compliant with the Minimal Information About a Microarray Experiment (MIAME) convention. MIMAS provides life scientists with a highly flexible and focused GeneChip data storage and annotation platform essential for subsequent analysis and interpretation of experimental results with clustering and mining tools. The system software can be downloaded for academic use upon request.
   Conclusion: MIMAS implements a novel concept for nation-wide GeneChip data management whereby a network of facilities is centered on one data node directly connected to the European certified public microarray data repository located at the EBI. The solution proposed may serve as a prototype approach to array data management between research institutes organized in a consortium.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Univ Geneva, Med Ctr, NCCR Frontier Genet, CH-1211 Geneva, Switzerland.
RP Primig, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM leandro.hermida@unibas.ch; olivier.schaad@biochem.unige.ch;
   philippe.demougin@unibas.ch;
   patrick.descombes@frontiers-in-genetics.org; michael.primig@unibas.ch
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Hermida,
   Leandro/0000-0003-3887-518X
CR Aderem A, 2005, CELL, V121, P511, DOI 10.1016/j.cell.2005.04.020
   Ball C, 2004, MICROBIOL-SGM, V150, P3522, DOI 10.1099/mic.0.27637-0
   Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580
   Ball CA, 2002, SCIENCE, V298, P539
   Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a
   Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21
   Barrett T, 2005, NUCLEIC ACIDS RES, V33, pD562
   Bertone P, 2005, CHROMOSOME RES, V13, P259, DOI 10.1007/s10577-005-2165-0
   Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365
   Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091
   Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625
   Eilbeck K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-r44
   Futcher B, 2000, CURR OPIN CELL BIOL, V12, P710, DOI 10.1016/S0955-0674(00)00156-3
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Grunenfelder B, 2002, NAT REV GENET, V3, P653, DOI 10.1038/nrg886
   Hanlon SE, 2004, CURR OPIN GENET DEV, V14, P697, DOI 10.1016/j.gde.2004.09.008
   Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034
   Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756
   Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32
   Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757
   Larsen L A, 2001, Pharmacogenomics, V2, P387, DOI 10.1517/14622416.2.4.387
   Lee CH, 2004, PHARMACOGENOMICS, V5, P611, DOI 10.1517/14622416.5.6.611
   Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701
   Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675
   Manduchi E, 2004, BIOINFORMATICS, V20, P452, DOI 10.1093/bioinformatics/btg428
   Mangalam H, 2001, IBM SYST J, V40, P552, DOI 10.1147/sj.402.0552
   Maurer M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-101
   Menten B, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-124
   Navarange M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-268
   Parkinson H, 2005, NUCLEIC ACIDS RES, V33, pD553
   Pinkel D, 2005, ANNU REV GENOM HUM G, V6, P331, DOI 10.1146/annurev.genom.6.080604.162140
   Psarros M, 2005, NUCLEIC ACIDS RES, V33, pW638, DOI 10.1093/nar/gki490
   Saal LH, 2002, GENOME BIOL, V3
   Sarkans U, 2005, BIOINFORMATICS, V21, P1495, DOI 10.1093/bioinformatics/bti157
   Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447
   Soldatova LN, 2005, NAT BIOTECHNOL, V23, P1095, DOI 10.1038/nbt0905-1095
   Spellman PT, 2002, GENOME BIOL, V3
   Stoeckert CJ, 2002, NAT GENET, V32, P469, DOI 10.1038/ng1028
   Stoughton RB, 2005, ANNU REV BIOCHEM, V74, P53, DOI 10.1146/annurev.biochem.74.082803.133212
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Whetzel PL, 2006, BIOINFORMATICS, V22, P866, DOI 10.1093/bioinformatics/btl005
   Wrobel G, 2005, BIOINFORMATICS, V21, P3575, DOI 10.1093/bioinformatics/bti574
   Wrobel G, 2005, REPRODUCTION, V129, P1, DOI 10.1530/rep.1.00408
   Young RA, 2000, CELL, V102, P9, DOI 10.1016/S0092-8674(00)00005-2
NR 46
TC 9
Z9 10
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD APR 5
PY 2006
VL 7
AR 190
DI 10.1186/1471-2105-7-190
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 040ZR
UT WOS:000237422900001
PM 16597336
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Braun, T
   Backmann, N
   Vogtli, M
   Bietsch, A
   Engel, A
   Lang, HP
   Gerber, C
   Hegner, M
AF Braun, T
   Backmann, N
   Vogtli, M
   Bietsch, A
   Engel, A
   Lang, HP
   Gerber, C
   Hegner, M
TI Conformational change of bacteriorhodopsin quantitatively monitored by
   microcantilever sensors
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID NANOMECHANICAL CANTILEVER ARRAY; ATOMIC-FORCE MICROSCOPY; INDUCED
   DEFLECTIONS; TARGET VALIDATION; ESCHERICHIA-COLI; PURPLE MEMBRANE;
   HYDROXYLAMINE; RESOLUTION; DNA; SPECTROSCOPY
AB Bacteriorhodopsin proteoliposomes were used as a model system to explore the applicability of micromechanical cantilever arrays to detect conformational changes in membrane protein patches. The three main results of our study concern: 1), reliable functionalization of micromechanical cantilever arrays with proteoliposomes using ink jet spotting; 2), successful detection of the prosthetic retinal removal (bleaching) from the bacteriorhodopsin protein by measuring the induced nanomechanical surface stress change; and 3), the quantitative response thereof, which depends linearly on the amount of removed retinal. Our results show this technique to be a potential tool to measure membrane protein-based receptor-ligand interactions and conformational changes.
C1 NCCR Nanoscale Sci, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Maurice E Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   IBM Zurich Res GmbH, CH-8803 Ruschlikon, Switzerland.
RP Hegner, M (corresponding author), NCCR Nanoscale Sci, Inst Phys, Klingelbergstr 82, CH-4056 Basel, Switzerland.
EM martin.hegner@unibas.ch
RI Gerber, Christoph E/G-4851-2011; Lang, Hans Peter/G-3884-2011
OI Lang, Hans Peter/0000-0002-0012-2564; Hegner,
   Martin/0000-0003-1514-3437; Gerber, Christoph/0000-0001-7035-3838
CR Alberts B., 2002, MOL BIOL CELL
   Arntz Y, 2003, NANOTECHNOLOGY, V14, P86, DOI 10.1088/0957-4484/14/1/319
   Backmann N, 2005, P NATL ACAD SCI USA, V102, P14587, DOI 10.1073/pnas.0504917102
   Battiston FM, 2001, SENSOR ACTUAT B-CHEM, V77, P122, DOI 10.1016/S0925-4005(01)00683-9
   Bietsch A, 2004, NANOTECHNOLOGY, V15, P873, DOI 10.1088/0957-4484/15/8/002
   Bietsch A, 2004, LANGMUIR, V20, P5119, DOI 10.1021/la049621m
   Bizet K, 1998, BIOSENS BIOELECTRON, V13, P259, DOI 10.1016/S0956-5663(97)00139-5
   Braun T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.031907
   Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316
   Gfeller KY, 2005, APPL ENVIRON MICROB, V71, P2626, DOI 10.1128/AEM.71.5.2626-2631.2005
   GIMZEWSKI JK, 1994, CHEM PHYS LETT, V217, P589, DOI 10.1016/0009-2614(93)E1419-H
   Gupta A, 2004, APPL PHYS LETT, V84, P1976, DOI 10.1063/1.1667011
   HEGNER M, 1998, PROCEDURES SCANNING, P169
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9
   Khaled ARA, 2003, SENSOR ACTUAT B-CHEM, V94, P103, DOI 10.1016/S0925-4005(03)00231-4
   Lang HP, 2005, MATER TODAY, V8, P30, DOI 10.1016/S1369-7021(05)00792-3
   Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027
   McKendry R, 2002, P NATL ACAD SCI USA, V99, P9783, DOI 10.1073/pnas.152330199
   Moller C, 2000, J MOL BIOL, V301, P869, DOI 10.1006/jmbi.2000.3995
   Muller DJ, 1996, BIOPHYS J, V70, P1796
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441
   Nelson BP, 2001, ANAL CHEM, V73, P1, DOI 10.1021/ac0010431
   Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7
   OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pepe IM, 2001, PROG RETIN EYE RES, V20, P733, DOI 10.1016/S1350-9462(01)00013-1
   Pfeiffer M, 1999, J MOL BIOL, V287, P163, DOI 10.1006/jmbi.1998.2593
   Porschke D, 2003, J MOL BIOL, V331, P667, DOI 10.1016/S0022-2836(03)00766-6
   Radzwill N, 2001, BIOPHYS J, V80, P2856, DOI 10.1016/S0006-3495(01)76252-2
   Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687
   Sader JE, 2001, J APPL PHYS, V89, P2911, DOI 10.1063/1.1342018
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   SUBRAMANIAM S, 1991, P NATL ACAD SCI USA, V88, P2583, DOI 10.1073/pnas.88.6.2583
   Tamayo J, 2001, ULTRAMICROSCOPY, V86, P167, DOI 10.1016/S0304-3991(00)00082-6
   THUNDAT T, 1994, APPL PHYS LETT, V64, P2894, DOI 10.1063/1.111407
   Tollin G, 2003, TRENDS PHARMACOL SCI, V24, P655, DOI 10.1016/j.tips.2003.10.010
   Tripathi UM, 1998, INORG CHEM, V37, P174, DOI 10.1021/ic9714448
   Williams M, 2003, CURR OPIN PHARMACOL, V3, P571, DOI 10.1016/j.coph.2003.06.001
   Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6
   Zhang YF, 2004, BIOSENS BIOELECTRON, V19, P1473, DOI 10.1016/j.bios.2003.12.011
NR 42
TC 56
Z9 57
U1 0
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR
PY 2006
VL 90
IS 8
BP 2970
EP 2977
DI 10.1529/biophysj.105.072934
PG 8
WC Biophysics
SC Biophysics
GA 024WK
UT WOS:000236226900031
PM 16443650
OA Green Published
DA 2021-01-25
ER

PT J
AU Cornelis, GR
   Agrain, C
   Sorg, I
AF Cornelis, GR
   Agrain, C
   Sorg, I
TI Length control of extended protein structures in bacteria and
   bacteriophages
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID FLAGELLAR HOOK-LENGTH; SECRETION SUBSTRATE-SPECIFICITY;
   SALMONELLA-TYPHIMURIUM; YERSINIA-ENTEROCOLITICA; NEEDLE LENGTH; YOP
   SECRETION; TAIL LENGTH; FLIK; YSCP; SYSTEM
AB The length of the tail of bacteriophages is controlled by a protein which acts as a molecular ruler. The needle of the injectisome, which is assembled by the polymerization of subunits that are exported through the nascent injectisome, is functionally related to the tail of bacteriophages. Interestingly, its length is controlled by a protein, which is itself exported and acts as a molecular ruler that is coupled to a substrate specificity switch. The bacterial flagellum is evolutionarily related to the injectisome. The length of the hook is also controlled by a secreted protein. This protein acts as a substrate specificity switch and, possibly, also as a ruler.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR ABULADZE NK, 1994, VIROLOGY, V199, P301, DOI 10.1006/viro.1994.1128
   Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Creighton T., 1992, PROTEINS STRUCTURES
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   FRANCIS NR, 1994, J MOL BIOL, V235, P1261, DOI 10.1006/jmbi.1994.1079
   Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hirano T, 2005, MOL MICROBIOL, V56, P346, DOI 10.1111/j.1365-2958.2005.04615.x
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0
   Katsura I, 1990, Adv Biophys, V26, P1, DOI 10.1016/0065-227X(90)90004-D
   KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Lavander M, 2003, ADV EXP MED BIOL, V529, P109
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muramoto K, 1998, J MOL BIOL, V277, P871, DOI 10.1006/jmbi.1998.1659
   PATTERSO.J, 1973, ARCH MIKROBIOL, V90, P107, DOI 10.1007/BF00414513
   Payne PL, 1999, J BACTERIOL, V181, P2852, DOI 10.1128/JB.181.9.2852-2862.1999
   Pedersen M, 2000, VIROLOGY, V276, P315, DOI 10.1006/viro.2000.0497
   Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2
   Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
NR 34
TC 33
Z9 34
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD APR
PY 2006
VL 9
IS 2
BP 201
EP 206
DI 10.1016/j.mib.2006.01.002
PG 6
WC Microbiology
SC Microbiology
GA 037ZC
UT WOS:000237185900013
PM 16458574
DA 2021-01-25
ER

PT J
AU Burri, L
   Vascotto, K
   Gentle, IE
   Chan, NC
   Beilharz, T
   Stapleton, DI
   Ramage, L
   Lithgow, T
AF Burri, L
   Vascotto, K
   Gentle, IE
   Chan, NC
   Beilharz, T
   Stapleton, DI
   Ramage, L
   Lithgow, T
TI Integral membrane proteins in the mitochondrial outer membrane of
   Saccharomyces cerevisiae
SO FEBS JOURNAL
LA English
DT Article
DE detergent phase; mitochondria; outer membrane; transmembrane segments
ID INDUCED PHASE-SEPARATION; TRITON X-114; BENZODIAZEPINE-RECEPTOR;
   INTRACELLULAR MEMBRANES; IMPORT MOTOR; OMP85 FAMILY; YEAST; DOMAINS;
   TRANSLOCASE; BIOGENESIS
AB Mitochondria evolved from a bacterial endosymbiont ancestor in which the integral outer membrane proteins would have been beta-barrel structured within the plane of the membrane. Initial proteomics on the outer membrane from yeast mitochondria suggest that while most of the protein components are integral in the membrane, most of these mitochondrial proteins behave as if they have alpha-helical transmembrane domains, rather than beta-barrels. These proteins are usually predicted to have a single alpha-helical transmembrane segment at either the N- or C-terminus, however, more complex topologies are also seen. We purified the novel outer membrane protein Om14 and show it is encoded in the gene YBR230e. Protein sequencing revealed in intron is spliced from the transcript, and both transcription from the YBR230c gene and steady-state level of the Om14 protein is dramatically less in cells grown on glucose than in cells grown oil nonfermentable carbon sources. Hydropathy predictions together with data from limited protease digestion show three alpha-helical transmembrane segments in Om14. The alpha-helical outer membrane proteins provide functions derived after the endosymbiotic event, and require the translocase in the outer mitochondrial membrane complex for insertion into the outer membrane.
C1 Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
   Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Lithgow, T (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia.
EM t.lithgow@unimelb.edu.au
RI Lithgow, Trevor J/H-5925-2017; Beilharz, Traude/I-1438-2014; Gentle,
   Ian/X-2888-2019; Beilharz, Traude/O-5457-2019
OI Lithgow, Trevor J/0000-0002-0102-7884; Beilharz,
   Traude/0000-0002-8942-9502; Gentle, Ian/0000-0002-6707-7809; Beilharz,
   Traude/0000-0002-8942-9502
CR ATENCIO DP, 1992, MOL CELL BIOL, V12, P283, DOI 10.1128/MCB.12.1.283
   Barrass JD, 2003, TRENDS GENET, V19, P295, DOI 10.1016/S0168-9525(03)00091-X
   Beilharz T, 1998, J BIOL CHEM, V273, P35268, DOI 10.1074/jbc.273.52.35268
   Beilharz T, 2003, J BIOL CHEM, V278, P8219, DOI 10.1074/jbc.M212725200
   Bomer U, 1998, EMBO J, V17, P4226, DOI 10.1093/emboj/17.15.4226
   BORDIER C, 1981, J BIOL CHEM, V256, P1604
   Bos MP, 2004, CURR OPIN MICROBIOL, V7, P610, DOI 10.1016/j.mib.2004.10.011
   Brandner K, 2005, MOL BIOL CELL, V16, P5202, DOI 10.1091/mbc.E05-03-0256
   BROWN D, 1992, J AM SOC NEPHROL, V3, P895
   CAPLAN AJ, 1992, CELL, V71, P1143, DOI 10.1016/S0092-8674(05)80063-7
   Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102
   Cserzo M, 1997, PROTEIN ENG, V10, P673, DOI 10.1093/protein/10.6.673
   CUNNINGHAM TM, 1988, J BACTERIOL, V170, P5789, DOI 10.1128/jb.170.12.5789-5796.1988
   D'Silva PD, 2003, P NATL ACAD SCI USA, V100, P13839, DOI 10.1073/pnas.1936150100
   Davis CA, 2000, NUCLEIC ACIDS RES, V28, P1700, DOI 10.1093/nar/28.8.1700
   Esser K, 2004, MOL GENET GENOMICS, V271, P616, DOI 10.1007/s00438-004-1011-y
   Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092
   Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x
   Gonzalez-Baro MR, 2001, J BIOL CHEM, V276, P43182, DOI 10.1074/jbc.M107885200
   Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476
   HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8
   Hermann GJ, 1998, J CELL BIOL, V143, P359, DOI 10.1083/jcb.143.2.359
   Hobbs AEA, 2001, J CELL BIOL, V152, P401, DOI 10.1083/jcb.152.2.401
   HOOPER NM, 1991, BIOCHEM J, V280, P745, DOI 10.1042/bj2800745
   Huh WK, 1998, MOL MICROBIOL, V30, P895, DOI 10.1046/j.1365-2958.1998.01133.x
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Joseph-Liauzun E, 1998, J BIOL CHEM, V273, P2146, DOI 10.1074/jbc.273.4.2146
   Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200
   Lacapere JJ, 2003, STEROIDS, V68, P569, DOI 10.1016/S0039-128X(03)00101-6
   Lee JS, 2001, BBA-GEN SUBJECTS, V1527, P31, DOI 10.1016/S0304-4165(01)00134-9
   LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973
   MIHARA K, 1985, EMBO J, V4, P769, DOI 10.1002/j.1460-2075.1985.tb03695.x
   Mihara K, 2000, BIOESSAYS, V22, P364, DOI 10.1002/(SICI)1521-1878(200004)22:4<364::AID-BIES6>3.0.CO;2-N
   Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485
   Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200
   Osanai K, 2005, BIOL CHEM, V386, P143, DOI 10.1515/BC.2005.018
   Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Pfanner N, 2004, NAT STRUCT MOL BIOL, V11, P1044, DOI 10.1038/nsmb852
   PRYDE JG, 1986, BIOCHEM J, V233, P525, DOI 10.1042/bj2330525
   Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937
   Rigoulet M, 2004, MOL CELL BIOCHEM, V256, P73, DOI 10.1023/B:MCBI.0000009888.79484.fd
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Tamm LK, 2001, J BIOL CHEM, V276, P32399, DOI 10.1074/jbc.R100021200
   Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005
   Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004
   Waizenegger T, 2003, J BIOL CHEM, V278, P42064, DOI 10.1074/jbc.M305736200
   Wattenberg B, 2001, TRAFFIC, V2, P66, DOI 10.1034/j.1600-0854.2001.20108.x
   Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144
   Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X
   YAFFE MP, 1989, J BIOL CHEM, V264, P21091
NR 52
TC 37
Z9 43
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD APR
PY 2006
VL 273
IS 7
BP 1507
EP 1515
DI 10.1111/j.1742-4658.2006.05171.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 040CU
UT WOS:000237357400014
PM 16689936
DA 2021-01-25
ER

PT J
AU Pauwels, K
   Lustig, A
   Wyns, L
   Tommassen, J
   Savvides, SN
   Van Gelder, P
AF Pauwels, K
   Lustig, A
   Wyns, L
   Tommassen, J
   Savvides, SN
   Van Gelder, P
TI Structure of a membrane-based steric chaperone in complex with its
   lipase substrate
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID PSEUDOMONAS-GLUMAE; PROTEIN
AB Secretion via the type II secretion pathway in Gram-negative bacteria often relies crucially on steric chaperones in the periplasm. Here, we report the crystal structure of the soluble form of a lipase-specific foldase ( Lif) from Burkholderia glumae in complex with its cognate lipase. The structure reveals how Lif uses a novel alpha-helical scaffold to embrace lipase, thereby creating an unusually extensive folding platform.
C1 Flanders Interuniv Inst Biotechnol, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium.
   Vrije Univ Brussel, B-1050 Brussels, Belgium.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Utrecht, Dept Mol Microbiol, NL-3584 CH Utrecht, Netherlands.
   Univ Utrecht, Inst Biomembranes, NL-3584 CH Utrecht, Netherlands.
   Univ Ghent, Lab Protein Biochem & Prot Engn, B-9000 Ghent, Belgium.
RP Savvides, SN (corresponding author), Flanders Interuniv Inst Biotechnol, Dept Mol & Cellular Interact, Pleinlaan 2, B-1050 Brussels, Belgium.
EM savvas.savvides@ugent.be; pvgelder@vub.ac.be
RI Savvides, Savvas/E-1938-2011; Tommassen, Jan/I-1690-2016
OI Savvides, Savvas/0000-0003-3420-5947; Tommassen,
   Jan/0000-0001-7633-4945; Pauwels, Kris/0000-0002-7341-0890
CR BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0
   El Khattabi M, 1999, MOL GEN GENET, V261, P770
   El Khattabi M, 2000, J BIOL CHEM, V275, P26885
   Ellis RJ, 1998, TRENDS BIOCHEM SCI, V23, P43, DOI 10.1016/S0968-0004(98)01175-X
   Filloux A, 2004, BBA-MOL CELL RES, V1694, P163, DOI 10.1016/j.bbamcr.2004.05.003
   FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x
   NOBLE MEM, 1993, FEBS LETT, V331, P123, DOI 10.1016/0014-5793(93)80310-Q
   Pauwels K, 2005, ACTA CRYSTALLOGR F, V61, P791, DOI 10.1107/S1744309105023055
   Rosenau F, 2004, CHEMBIOCHEM, V5, P153, DOI 10.1002/cbic.200300761
   Shibata H, 1998, BIOSCI BIOTECH BIOCH, V62, P354, DOI 10.1271/bbb.62.354
   Shinde UP, 1997, NATURE, V389, P520
   Wodak SJ, 2003, ADV PROTEIN CHEM, V61, P9
NR 12
TC 37
Z9 40
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD APR
PY 2006
VL 13
IS 4
BP 374
EP 375
DI 10.1038/nsmb1065
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 029RF
UT WOS:000236581400021
PM 16518399
DA 2021-01-25
ER

PT J
AU van Nimwegen, E
   Paul, N
   Sheridan, R
   Zavolan, M
AF van Nimwegen, Erik
   Paul, Nicodeme
   Sheridan, Robert
   Zavolan, Mihaela
TI SPA: A probabilistic algorithm for spliced alignment
SO PLOS GENETICS
LA English
DT Article
ID MESSENGER-RNA; GENOME BROWSER; SEQUENCE; TRANSCRIPTS; DATABASE; INTRONS;
   PROGRAM; SITES; CDNAS; UCSC
AB Recent large-scale cDNA sequencing efforts show that elaborate patterns of splice variation are responsible for much of the proteome diversity in higher eukaryotes. To obtain an accurate account of the repertoire of splice variants, and to gain insight into the mechanisms of alternative splicing, it is essential that cDNAs are very accurately mapped to their respective genomes. Currently available algorithms for cDNA-to-genome alignment do not reach the necessary level of accuracy because they use ad hoc scoring models that cannot correctly trade off the likelihoods of various sequencing errors against the probabilities of different gene structures. Here we develop a Bayesian probabilistic approach to cDNA-to-genome alignment. Gene structures are assigned prior probabilities based on the lengths of their introns and exons, and based on the sequences at their splice boundaries. A likelihood model for sequencing errors takes into account the rates at which misincorporation, as well as insertions and deletions of different lengths, occurs during sequencing. The parameters of both the prior and likelihood model can be automatically estimated from a set of cDNAs, thus enabling our method to adapt itself to different organisms and experimental procedures. We implemented our method in a fast cDNA-to-genome alignment program, SPA, and applied it to the FANTOM3 dataset of over 100,000 full- length mouse cDNAs and a dataset of over 20,000 full- length human cDNAs. Comparison with the results of four other mapping programs shows that SPA produces alignments of significantly higher quality. In particular, the quality of the SPA alignments near splice boundaries and SPA's mapping of the 59 and 39 ends of the cDNAs are highly improved, allowing for more accurate identification of transcript starts and ends, and accurate identification of subtle splice variations. Finally, our splice boundary analysis on the human dataset suggests the existence of a novel non-canonical splice site that we also find in the mouse dataset. The SPA software package is available at http:// www.biozentrum.unibas.ch/personal/nimwegen/cgi-bin/spa.cgi.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Rockefeller Univ, New York, NY 10021 USA.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; van Nimwegen,
   Erik/0000-0001-6338-1312
CR Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967
   HALL SL, 1994, J MOL BIOL, V239, P357, DOI 10.1006/jmbi.1994.1377
   JACKSON IJ, 1991, NUCLEIC ACIDS RES, V19, P3795
   Jaynes E. T., 2003, PROBABILITY THEORY L
   Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202. Article published online before March 2002, 10.1101/gr.229202]
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298
   *NAT CTR BIOT INF, 2005, CONC CDS DAT BETH MA
   Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Romani A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng017
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301
   Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310
   Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702
   Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303
NR 21
TC 15
Z9 16
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD APR
PY 2006
VL 2
IS 4
BP 587
EP 605
AR e24
DI 10.1371/journal.pgen.0020024
PG 19
WC Genetics & Heredity
SC Genetics & Heredity
GA 070BE
UT WOS:000239494500022
PM 16683023
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Chern, TM
   van Nimwegen, E
   Kai, C
   Kawai, J
   Carninci, P
   Hayashizaki, Y
   Zavolan, M
AF Chern, Tzu-Ming
   van Nimwegen, Erik
   Kai, Chikatoshi
   Kawai, Jun
   Carninci, Piero
   Hayashizaki, Yoshihide
   Zavolan, Mihaela
TI A simple physical model predicts small exon length variations
SO PLOS GENETICS
LA English
DT Article
ID PRE-MESSENGER-RNA; NAGNAG ACCEPTORS; MOUSE GENOME; HUMAN GENES;
   TRANSCRIPTS; COLLECTION; INITIATION; SEQUENCE; SITES; DECAY
AB One of the most common splice variations are small exon length variations caused by the use of alternative donor or acceptor splice sites that are in very close proximity on the pre- mRNA. Among these, three-nucleotide variations at so-called NAGNAG tandem acceptor sites have recently attracted considerable attention, and it has been suggested that these variations are regulated and serve to fine-tune protein forms by the addition or removal of a single amino acid. In this paper we first show that in-frame exon length variations are generally overrepresented and that this overrepresentation can be quantitatively explained by the effect of nonsense-mediated decay. Our analysis allows us to estimate that about 50% of frame-shifted coding transcripts are targeted by nonsense-mediated decay. Second, we show that a simple physical model that assumes that the splicing machinery stochastically binds to nearby splice sites in proportion to the affinities of the sites correctly predicts the relative abundances of different small length variations at both boundaries. Finally, using the same simple physical model, we show that for NAGNAG sites, the difference in affinities of the neighboring sites for the splicing machinery accurately predicts whether splicing will occur only at the first site, splicing will occur only at the second site, or three- nucleotide splice variants are likely to occur. Our analysis thus suggests that small exon length variations are the result of stochastic binding of the spliceosome at neighboring splice sites. Small exon length variations occur when there are nearby alternative splice sites that have similar affinity for the splicing machinery.
C1 Univ Basel, Biozentrum, Div Bioinformat, Basel, Switzerland.
   RIKEN, Genome Explorat Res Grp, Genome Network Project Core Grp, Genome Sci Ctr,Yokohama Inst, Yokohama, Kanagawa, Japan.
   RIKEN, Genome Sci Lab, Discovery Res Inst, Wako Inst, Wako, Saitama 35101, Japan.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Div Bioinformat, Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Carninci, Piero/K-1568-2014; Hayashizaki, Yoshihide/N-6590-2015; Kawai,
   Jun/A-6451-2016; Zavolan, Mihaela/S-3888-2016
OI Carninci, Piero/0000-0001-7202-7243; Zavolan,
   Mihaela/0000-0002-8832-2041; van Nimwegen, Erik/0000-0001-6338-1312
CR Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501
   Brett D, 2002, NAT GENET, V30, P29, DOI 10.1038/ng803
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Croft L, 2000, NAT GENET, V24, P340
   Gerhard DS, 2004, GENOME RES, V14, P2121
   Hiller M, 2006, AM J HUM GENET, V78, P291, DOI 10.1086/500151
   Hiller M, 2004, NAT GENET, V36, P1255, DOI 10.1038/ng1469
   IIDA Y, 1985, J BIOCHEM-TOKYO, V97, P1173, DOI 10.1093/oxfordjournals.jbchem.a135162
   Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100
   Kan ZY, 2002, GENOME RES, V12, P1837, DOI 10.1101/gr.764102
   Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Le Hir H, 2001, EMBO J, V20, P4987, DOI 10.1093/emboj/20.17.4987
   Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310
   MARTIN A, 2006, NUCLEIC ACIDS RES, V34, P23
   Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645
   Mironov AA, 1999, GENOME RES, V9, P1288, DOI 10.1101/gr.9.12.1288
   Modrek B, 2001, NUCLEIC ACIDS RES, V29, P2850, DOI 10.1093/nar/29.13.2850
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2
   SMTIH C, 1993, MOL CELL BIOL, V13, P4939
   Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051
   Sugnet C W, 2004, Pac Symp Biocomput, P66
   Suzuki Y, 2001, EMBO REP, V2, P388, DOI 10.1093/embo-reports/kve085
   Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9
   van Nimwegen E, 2006, PLOS GENET, V2, P587, DOI 10.1371/journal.pgen.0020024
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702
   Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303
NR 30
TC 55
Z9 55
U1 1
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7390
EI 1553-7404
J9 PLOS GENET
JI PLoS Genet.
PD APR
PY 2006
VL 2
IS 4
BP 606
EP 613
AR e45
DI 10.1371/journal.pgen.0020045
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 070BE
UT WOS:000239494500023
PM 16683028
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Nair, V
   Zavolan, M
AF Nair, V
   Zavolan, M
TI Virus-encoded microRNAs: novel regulators of gene expression
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID SARCOMA-ASSOCIATED HERPESVIRUS; EPSTEIN-BARR-VIRUS; MESSENGER-RNAS;
   VIRAL-INFECTION; IDENTIFICATION; TARGETS; DICER; TRBP; DIFFERENTIATION;
   MURINE
AB MicroRNAs (miRNAs) are a class of small RNAs that have recently been recognized as major regulators of gene expression. They influence diverse cellular processes ranging from cellular differentiation, proliferation, apoptosis and metabolism to cancer. Bioinformatic approaches and direct cloning methods have identified > 3500 miRNAs, including orthologues from various species. Experiments to identify the targets and potential functions of miRNAs in various species are continuing but the recent discovery of virus-encoded miRNAs indicates that viruses also use this fundamental mode of gene regulation. Virus-encoded miRNAs seem to evolve rapidly and regulate both the viral life cycle and the interaction between viruses and their hosts.
C1 Inst Anim Hlth, Div Microbiol, Viral Oncogenesis Grp, Compton RG20 7NN, Berks, England.
   Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
RP Nair, V (corresponding author), Inst Anim Hlth, Div Microbiol, Viral Oncogenesis Grp, Compton RG20 7NN, Berks, England.
EM venu.gopal@bbsrc.ac.uk
RI Zavolan, Mihaela/S-3888-2016; Nair, Venugopal/D-4447-2016
OI Nair, Venugopal/0000-0002-8255-516X; Zavolan,
   Mihaela/0000-0002-8832-2041
CR Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bartel B, 2003, PLANT PHYSIOL, V132, P709, DOI 10.1104/pp.103.023630
   Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bennasser Y, 2005, IMMUNITY, V22, P607, DOI 10.1016/j.immuni.2005.03.010
   Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102
   Cantalupo P, 2005, J VIROL, V79, P13094, DOI 10.1128/JVI.79.20.13094-13104.2005
   Castillo JP, 2004, INT REV IMMUNOL, V23, P113, DOI 10.1080/08830180490265565
   Caudy Amy A, 2004, Methods Mol Biol, V265, P59
   Chang S, 2004, NATURE, V430, P785, DOI 10.1038/nature02752
   Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Clambey ET, 2002, J VIROL, V76, P6532, DOI 10.1128/JVI.76.13.6532-6544.2002
   Dunn W, 2005, CELL MICROBIOL, V7, P1684, DOI 10.1111/j.1462-5822.2005.00598.x
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200
   FURNARI FB, 1993, P NATL ACAD SCI USA, V90, P378, DOI 10.1073/pnas.90.2.378
   Gatignol A, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-65
   Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020
   Grey F, 2005, J VIROL, V79, P12095, DOI 10.1128/JVI.79.18.12095-12099.2005
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kliche S, 2001, MOL CELL, V7, P833, DOI 10.1016/S1097-2765(01)00227-1
   Kluiver J, 2005, J PATHOL, V207, P243, DOI 10.1002/path.1825
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784
   LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403
   Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274
   McCormick C, 2005, SCIENCE, V307, P739, DOI 10.1126/science.1105779
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Mendell JT, 2005, CELL CYCLE, V4, P1179, DOI 10.4161/cc.4.9.2032
   Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   Omoto S, 2005, J GEN VIROL, V86, P751, DOI 10.1099/vir.0.80449-0
   Omoto Shinya, 2004, Retrovirology, V1, P44, DOI 10.1186/1742-4690-1-44
   Ong CL, 2005, J VIROL, V79, P12763, DOI 10.1128/JVI.79.20.12763-12772.2005
   Pearce M, 2005, J VIROL, V79, P14457, DOI 10.1128/JVI.79.22.14457-14464.2005
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   RAMKISSOON SH, 2005, LEUK RES
   Reinscheid RK, 2000, PEPTIDES, V21, P901, DOI 10.1016/S0196-9781(00)00226-6
   Rossi JJ, 2005, EMBO REP, V6, P927, DOI 10.1038/sj.embor.7400531
   Saenz-Robles MT, 2001, ONCOGENE, V20, P7899, DOI 10.1038/sj.onc.1204936
   Samols MA, 2005, J VIROL, V79, P9301, DOI 10.1128/JVI.79.14.9301-9305.2005
   Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13
   Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576
   Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012
   Yang WJ, 2005, J BIOL CHEM, V280, P9330, DOI 10.1074/jbc.M413394200
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452
   Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100
   Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817
NR 66
TC 96
Z9 111
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD APR
PY 2006
VL 14
IS 4
BP 169
EP 175
DI 10.1016/j.tim.2006.02.007
PG 7
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 038WB
UT WOS:000237259100006
PM 16531046
DA 2021-01-25
ER

PT J
AU Schatzle, M
   Kiefhaber, T
AF Schatzle, M
   Kiefhaber, T
TI Shape of the free energy barriers for protein folding probed by multiple
   perturbation analysis
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; Hammond behavior; rate-equilibrium free energy
   relationships; transition state movement
ID N-TERMINAL DOMAIN; TRANSITION-STATE; BETA-SHEET; TEMPERATURE-DEPENDENCE;
   HAMMOND BEHAVIOR; GLOBAL ANALYSIS; TENDAMISTAT; DENATURANT; KINETICS;
   STABILITY
AB The characterization of the free energy barriers has been a major goal in studies on the mechanism of protein folding. Testing the effect of mutations or denaturants on protein folding reactions revealed that transition state movement is rare, suggesting that folding barriers are robust and narrow maxima on the free energy landscape. Here we demonstrate that the application of multiple perturbations allows the observation of small transition state movements that escape detection in single perturbation experiments. We used tendamistat as a model protein to test the broadness of the free energy barriers. Tendamistat folds over two consecutive transition states and through a high-energy intermediate. Measuring the combined effect of temperature and denaturant on the position of the transition state in the wild-type protein and in several mutants revealed that the early transition state shows significant transition state movement. Its accessible surface area state becomes more native-like with destabilization of the native state by temperature. To the same extent, the entropy of the early transition state becomes more native-like with increasing denaturant concentration, in accordance with Hammond behavior. The position of the late transition state, in contrast, is much less sensitive to the applied perturbations. These results suggest that the barriers in protein folding become increasingly narrow as the folding polypeptide chain approaches the native state. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   CHEN WH, 1989, COMPUT MECH, V4, P1
   CHENG Y, 1989, SIAM J DISCRETE MATH, V2, P28
   FARCASIU D, 1975, J CHEM EDUC, V52, P76, DOI 10.1021/ed052p76
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Fierz B, 2005, PROTEIN FOLDING HANDBOOK, P809, DOI 10.1002/9783527619498.ch22
   Grosman C, 2000, NATURE, V403, P773, DOI 10.1038/35001586
   HAASLAUTERBACH S, 1993, APPL MICROBIOL BIOT, V38, P719, DOI 10.1007/BF00167134
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   Horovitz A, 2002, P NATL ACAD SCI USA, V99, P14095, DOI 10.1073/pnas.222303299
   Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873
   JENCKS DA, 1977, J AM CHEM SOC, V99, P7948, DOI 10.1021/ja00466a030
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM
   JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001
   Jonsson T, 1996, BIOCHEMISTRY-US, V35, P4795, DOI 10.1021/bi953056s
   Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391
   Kiefhaber T, 2005, PROTEIN FOLDING HANDBOOK, P411, DOI 10.1002/9783527619498.ch12b
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Kuhlman B, 1998, PROTEIN SCI, V7, P2405, DOI 10.1002/pro.5560071118
   Kuhlman B, 1998, J MOL BIOL, V284, P1661, DOI 10.1006/jmbi.1998.2246
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17
   Perl D, 2002, BIOPHYS CHEM, V96, P173, DOI 10.1016/S0301-4622(02)00024-8
   POHL FM, 1976, FEBS LETT, V65, P293, DOI 10.1016/0014-5793(76)80132-9
   Press W.H., 1992, NUMERICAL RECIPES AR
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   Schindler T, 1996, BIOCHEMISTRY-US, V35, P16833, DOI 10.1021/bi962090j
   Schonbrunner N, 1997, BIOCHEMISTRY-US, V36, P9057, DOI 10.1021/bi970594r
   Schonbrunner N, 1997, J MOL BIOL, V268, P526, DOI 10.1006/jmbi.1997.0960
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   THORNTON ER, 1967, J AM CHEM SOC, V89, P2915, DOI 10.1021/ja00988a020
   VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001
   Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476
NR 43
TC 9
Z9 9
U1 1
U2 7
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 24
PY 2006
VL 357
IS 2
BP 655
EP 664
DI 10.1016/j.jmb.2005.12.081
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 023IL
UT WOS:000236120200026
PM 16442561
DA 2021-01-25
ER

PT J
AU Gatlik-Landwojtowicz, E
   Aanismaa, P
   Seelig, A
AF Gatlik-Landwojtowicz, E
   Aanismaa, P
   Seelig, A
TI Quantification and characterization of P-glycoprotein-substrate
   interactions
SO BIOCHEMISTRY
LA English
DT Article
ID DEUTERIUM MAGNETIC-RESONANCE; ESCHERICHIA-COLI MEMBRANES;
   MULTIDRUG-RESISTANCE; IONIZATION-CONSTANTS; PLASMA-MEMBRANE; ATP
   HYDROLYSIS; DRUG TRANSPORT; DISTRIBUTION COEFFICIENTS;
   PARTITION-COEFFICIENTS; CYTOPLASMIC LEAFLET
AB It is generally accepted that P-glycoprotein binds its substrates in the lipid phase of the membrane. Quantification and characterization of the lipid-transporter binding step are, however, still a matter of debate. We therefore selected 15 structurally diverse drugs and measured the binding constants from water to the activating (inhibitory) binding region of P-glycoprotein, K-tw(1) (K-tw(2)), as well as the lipid-water partition coefficients, K-lw. The former were obtained by measuring the concentrations of half-maximum activation (inhibition), K-1 (K-2), in living NIH-MDR-G 185 mouse embryo fibroblasts using a Cytosensor microphysiometer, and the latter were derived from surface activity measurements. This allowed determination of the membrane concentration of drugs at half-maximum P-glycoprotein activation (C-b(1) = (0.02 to 67) mmol/L lipid), which is much higher than the corresponding aqueous concentration (K-1 = (0.02 to 376) mu M). Moreover we determined the free energy of drug binding from water to the activating binding region of the transporter (Delta G degrees(tw(1)) = (-30 to -54) kJ/mol), the free energy of drug partitioning into the lipid membrane (Delta G degrees(lw) = (-23 to -34) kJ/mol), and, as the difference of the two, the free energy of drug binding from the lipid membrane to the activating binding region of the transporter (Delta G degrees(tl(1)) = (-7 to -27) kJ/mol). For the compounds tested AG degrees(tl(1)) was less negative than Delta G degrees(tl(1)) but varied more strongly. The free energies of substrate binding to the transporter within the lipid phase, Delta G degrees(tl(1)), are consistent with a modular binding concept, where the energetically most efficient binding module comprises two hydrogen bond acceptor groups.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Baldwin RL, 2005, PROTEIN FOLDING HANDBOOK, P127
   BenTal N, 1997, J PHYS CHEM B, V101, P450, DOI 10.1021/jp961825r
   BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   Chen Y, 2001, CANCER RES, V61, P7763
   Cianchetta G, 2005, J MED CHEM, V48, P2927, DOI 10.1021/jm0491851
   CLARKE FH, 1984, J PHARM SCI, V73, P226, DOI 10.1002/jps.2600730221
   CLARKE FH, 1987, J PHARM SCI, V76, P611, DOI 10.1002/jps.2600760806
   Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594
   Ecker G, 1999, MOL PHARMACOL, V56, P791
   Figler RA, 2000, ARCH BIOCHEM BIOPHYS, V376, P34, DOI 10.1006/abbi.2000.1712
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Franke U, 1999, J PHARM SCI, V88, P89, DOI 10.1021/js980206m
   Frezard F, 1998, BBA-LIPID LIPID MET, V1389, P13, DOI 10.1016/S0005-2760(97)00070-2
   FRISKHOL.M, 1972, EUR J PHARMACOL, V18, P139, DOI 10.1016/0014-2999(72)90235-X
   GALLY HU, 1979, BIOCHEMISTRY-US, V18, P5605, DOI 10.1021/bi00592a013
   Garrigos M, 1997, EUR J BIOCHEM, V244, P664, DOI 10.1111/j.1432-1033.1997.00664.x
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   HASEGAWA J, 1984, J PHARM SCI, V73, P442, DOI 10.1002/jps.2600730405
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Hwang KK, 2003, J PHARM PHARM SCI, V6, P315
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912
   Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1327.2001.02041.x
   Martin C, 2000, MOL PHARMACOL, V58, P624
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   NICHOL CP, 1980, BIOCHEMISTRY-US, V19, P451, DOI 10.1021/bi00544a008
   OHKI S, 1981, BIOCHIM BIOPHYS ACTA, V645, P170, DOI 10.1016/0005-2736(81)90187-5
   Omote H, 2004, BIOCHEMISTRY-US, V43, P3917, DOI 10.1021/bi035365l
   Pajeva IK, 2002, J MED CHEM, V45, P5671, DOI 10.1021/jm020941h
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   RITCHIE JM, 1961, J PHARMACOL EXP THER, V133, P241
   Romani AMP, 2000, FRONT BIOSCI, V5, pD720, DOI 10.2741/Romani
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Sauna ZE, 2004, BIOCHEMISTRY-US, V43, P2262, DOI 10.1021/bi035965k
   Scala S, 1997, MOL PHARMACOL, V51, P1024
   Schmid D, 1999, BIOCHEM PHARMACOL, V58, P1447, DOI 10.1016/S0006-2952(99)00229-4
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 1996, BIOCHEMISTRY-US, V35, P4365, DOI 10.1021/bi952434q
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   SEELIG A, 2003, DRUG BIOAVAILABILITY, P461
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEILER P, 1974, EUR J MED CHEM, V9, P473
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x
   Shapiro AB, 1999, EUR J BIOCHEM, V259, P841, DOI 10.1046/j.1432-1327.1999.00098.x
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   Spooner PJR, 1998, BIOPHYS J, V75, P2794, DOI 10.1016/S0006-3495(98)77722-7
   Stouch TR, 2002, ADV DRUG DELIVER REV, V54, P315, DOI 10.1016/S0169-409X(02)00006-6
   TENTHOREY PA, 1981, J MED CHEM, V24, P798, DOI 10.1021/jm00139a007
   THURMOND RL, 1991, BIOPHYS J, V59, P108, DOI 10.1016/S0006-3495(91)82203-2
   Tobey SL, 2003, J AM CHEM SOC, V125, P10963, DOI 10.1021/ja030265o
   TOLLENAERE JP, 1977, EUR J MED CHEM, V12, P199
   Yu EW, 2003, SCIENCE, V300, P976, DOI 10.1126/science.1083137
NR 63
TC 87
Z9 88
U1 1
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAR 7
PY 2006
VL 45
IS 9
BP 3020
EP 3032
DI 10.1021/bi051380+
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 018VI
UT WOS:000235792500028
PM 16503657
DA 2021-01-25
ER

PT J
AU Goncalves, E
   Kitas, E
   Seelig, J
AF Goncalves, E
   Kitas, E
   Seelig, J
TI Structural and thermodynamic aspects of the interaction between heparan
   sulfate and analogues of melittin
SO BIOCHEMISTRY
LA English
DT Article
ID HIV-1 TAT PROTEIN; GENE DELIVERY; ANTIMICROBIAL PEPTIDES; TITRATION
   CALORIMETRY; MEMBRANE-BINDING; HELIX FORMATION; DNA; ASSOCIATION; MODEL;
   PERMEABILIZATION
AB Melittin is an amphipathic cationic peptide derived from honeybee venom with well-known cytolytic and antimicrobial properties. When coupled to cationic polymers or lipid molecules, it forms conjugates with high transfection efficiency and low toxicity with promising applications in gene therapy. A first step in the internalization of melittin and its conjugates is their binding to the cell surface, a reaction likely to involve heparan sulfate proteoglycans (HSPG). In the present work, we characterize the binding equilibrium of heparan sulfate (HS) with two melittin analogues, [Cys(1)]melittin (mel-SH) and retro-inverso [Cys(1)]melittin (ri-mel-SH). The terminal cysteine found in these peptides replaces the N-terminal glycine present in native melittin and allows covalent binding to other molecules. Isothermal titration calorimetry (ITC) reveals a high affinity of each melittin analogue to HS. Association constants of 4.7 x 10(4) and 3.5 x 10(5) M-1 are found at physiological ionic strength and 15 degrees C for ri-mel-SH and mel-SH, respectively. The reaction enthalpy measured under these conditions is Delta H degrees(pep) = 4.2 kcal/mol for ri-mel-SH and Delta H degrees(pep) = 1.1 kcal/mol for mel-SH. The peptide-to-HS stoichiometry is similar to 20 for ri-mel-SH and similar to 14 for mel-SH under the same conditions. Temperature dependence studies using ri-mel-SH (mel-SH) show that Delta H degrees(pep) decreases in magnitude upon increase in temperature, which results in a molar heat capacity of Delta H degrees(pep) = -322 cal mol(-1) K-1 (-45 cal mol(-1) K-1). Such a negative heat capacity change is not expected for a purely electrostatic interaction and indicates that hydrophobic and other interactions are also involved in the binding equilibrium. Salt dependence studies of the binding constants confirm that nonelectrostatic forces are an important component of the HS-melittin interaction. Binding to HS induces conformational changes in both peptides, with ri-mel-SH showing a 6-fold increase of the alpha-helix content when incubated with HS under saturation conditions.
C1 Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche Ltd, Pharma Div, Preclin Res, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Joachim.seelig@unibas.ch
CR Abdallah B, 1996, HUM GENE THER, V7, P1947, DOI 10.1089/hum.1996.7.16-1947
   Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817
   Asthana N, 2004, J BIOL CHEM, V279, P55042, DOI 10.1074/jbc.M408881200
   Atherton E., 1989, SOLID PHASE PEPTIDE
   BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007
   Bettinger T, 2001, NUCLEIC ACIDS RES, V29, P3882, DOI 10.1093/nar/29.18.3882
   BLONDELLE SE, 1991, BIOCHEMISTRY-US, V30, P4671, DOI 10.1021/bi00233a006
   BOECKLE S, 2005, J GENE
   CANTOR, 1980, BEHAV BIOL MACROMOLE, P849
   CHOREV M, 1995, TRENDS BIOTECHNOL, V13, P438, DOI 10.1016/S0167-7799(00)88999-4
   Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1
   DEHASETH PL, 1977, BIOCHEMISTRY-US, V16, P4783, DOI 10.1021/bi00641a004
   DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X
   DIAZACHIRICA P, 1994, EUR J BIOCHEM, V224, P257, DOI 10.1111/j.1432-1033.1994.tb20019.x
   DRAKE AF, 1979, BIOCHIM BIOPHYS ACTA, V555, P371, DOI 10.1016/0005-2736(79)90178-0
   Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4
   FALLER B, 1992, BIOCHEMISTRY-US, V31, P8285, DOI 10.1021/bi00150a023
   Fletcher MD, 1998, CHEM REV, V98, P763, DOI 10.1021/cr970468t
   Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147
   Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x
   Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i
   Goula D, 1998, GENE THER, V5, P1291, DOI 10.1038/sj.gt.3300717
   GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q
   HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314
   HAGIHARA Y, 1992, BIOCHEMISTRY-US, V31, P11908, DOI 10.1021/bi00162a033
   Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x
   Kourie JI, 2000, AM J PHYSIOL-CELL PH, V278, pC1063
   KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014
   Ladokhin AS, 1999, J MOL BIOL, V285, P1363, DOI 10.1006/jmbi.1998.2346
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lasic D. D., 1997, LIPOSOMES GENE DELIV
   Legendre JY, 1997, BIOCONJUGATE CHEM, V8, P57, DOI 10.1021/bc960076d
   Li YL, 2003, BIOCHEMISTRY-US, V42, P7245, DOI 10.1021/bi0341760
   Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979
   LOHMAN TM, 1980, BIOCHEMISTRY-US, V19, P3522, DOI 10.1021/bi00556a017
   MANNING GS, 1978, Q REV BIOPHYS, V11, P179, DOI 10.1017/S0033583500002031
   MASCOTTI DP, 1995, BIOCHEMISTRY-US, V34, P2908, DOI 10.1021/bi00009a022
   Matulis D, 2000, J MOL BIOL, V296, P1053, DOI 10.1006/jmbi.1999.3470
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   Mounkes LC, 1998, J BIOL CHEM, V273, P26164, DOI 10.1074/jbc.273.40.26164
   Ogris M, 2001, J BIOL CHEM, V276, P47550, DOI 10.1074/jbc.M108331200
   OLSON ST, 1991, J BIOL CHEM, V266, P6342
   Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l
   QUAY SC, 1983, BIOCHEMISTRY-US, V22, P695, DOI 10.1021/bi00272a026
   RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X
   RECORD MT, 1976, J MOL BIOL, V107, P145, DOI 10.1016/S0022-2836(76)80023-X
   Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355
   Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   van Holde K. E., 1998, PRINCIPLES PHYS BIOC, P587
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   VOGEL H, 1981, FEBS LETT, V134, P37, DOI 10.1016/0014-5793(81)80545-5
   Wieprecht T, 2002, CURR TOP MEMBR, V52, P31
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v
   Wiethoff CM, 2001, J BIOL CHEM, V276, P32806, DOI 10.1074/jbc.M007940200
   WILCOX W, 1992, PROTEIN SCI, V1, P641, DOI 10.1002/pro.5560010510
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   YANAGISHITA M, 1992, J BIOL CHEM, V267, P9451
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
NR 62
TC 27
Z9 27
U1 0
U2 13
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD MAR 7
PY 2006
VL 45
IS 9
BP 3086
EP 3094
DI 10.1021/bi052221t
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 018VI
UT WOS:000235792500035
PM 16503664
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
AF Fahrenkrog, Birthe
TI The nuclear pore complex, nuclear transport, and apoptosis
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Review
DE apoptosis; nuclear pore complex; nuclear transport
ID NUCLEOCYTOPLASMIC TRANSPORT; BINDING DOMAIN; PROTEIN IMPORT;
   CYTOCHROME-C; MECHANISMS; INHIBITION; EXPORT; TRANSLOCATION;
   LOCALIZATION; CASPASES
AB The nuclear pore complex (NPC) is the sole gateway between the nucleus and the cytoplasm of interphase eukaryotic cells. and it mediates all trafficking between these 2 cellular compartments. As such. the NPC and nuclear transport play central roles in translocating death signals from the cell membrane to the nucleus where they initiate biochemical and morphological changes occurring during apoptosis. Recent findings suggest that the correlation between the NPC. nuclear transport. and apoptosis goes beyond the simple fact that NPCs mediate nuclear transport of key players involved in the cell death program. In this context. the accessibility of Key regulators of apoptosis appears to be highly modulated by nuclear transport (e.g.. impaired nuclear import might be ail apoptotic trigger). In this review, recent findings concerning the unexpected tight link between NPCs. nuclear transport. and apoptosis will be presented and critically discussed.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR Altieri DC, 2004, J CELL BIOCHEM, V92, P656, DOI 10.1002/jcb.20140
   Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001
   BLINK EJ, 2005, J CELL BIOCH
   Boer J, 1998, MOL CELL BIOL, V18, P1236, DOI 10.1128/MCB.18.3.1236
   Buendia B, 2001, CELL MOL LIFE SCI, V58, P1781, DOI 10.1007/PL00000818
   Buendia B, 1999, J CELL SCI, V112, P1743
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Daugas E, 2000, FASEB J, V14, P729
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Dynlacht JR, 2000, RADIAT RES, V154, P515, DOI 10.1667/0033-7587(2000)154[0515:DPODFA]2.0.CO;2
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Faleiro L, 2000, J CELL BIOL, V151, P951, DOI 10.1083/jcb.151.5.951
   Ferrando-May E, 2001, CELL DEATH DIFFER, V8, P495, DOI 10.1038/sj.cdd.4400837
   Fischer U, 2003, CELL DEATH DIFFER, V10, P76, DOI 10.1038/sj.cdd.4401160
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Gotzmann J, 2000, J CELL SCI, V113, P3769
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794
   HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9
   Kamada S, 2005, J BIOL CHEM, V280, P857, DOI 10.1074/jbc.C400538200
   Kihlmark M, 2004, EXP CELL RES, V293, P346, DOI 10.1016/j.yexcr.2003.10.019
   Kihlmark M, 2001, J CELL SCI, V114, P3643
   King FW, 2004, MOL CELL BIOL, V24, P7091, DOI 10.1128/MCB.24.16.7091-7101.2004
   Kodiha M, 2004, CELL DEATH DIFFER, V11, P862, DOI 10.1038/sj.cdd.4401432
   Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136
   Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153
   Lawen A, 2003, BIOESSAYS, V25, P888, DOI 10.1002/bies.10329
   Liston P, 2001, NAT CELL BIOL, V3, P128, DOI 10.1038/35055027
   Morgan M, 2002, J CELL BIOL, V157, P975, DOI 10.1083/jcb.200204039
   NISHI K, 1994, J BIOL CHEM, V269, P6320
   Nur-E-Kamal A, 2004, J BIOL CHEM, V279, P24911, DOI 10.1074/jbc.C400051200
   Paroni G, 2002, J BIOL CHEM, V277, P15147, DOI 10.1074/jbc.M112338200
   Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x
   Plenchette S, 2004, BLOOD, V104, P2035, DOI 10.1182/blood-2004-01-0065
   Pujol G, 2002, BIOCHEM BIOPH RES CO, V294, P354, DOI 10.1016/S0006-291X(02)00492-8
   Quensel C, 2004, MOL CELL BIOL, V24, P10246, DOI 10.1128/MCB.24.23.10246-10255.2004
   Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496
   Rodriguez JA, 2002, EXP CELL RES, V275, P44, DOI 10.1006/excr.2002.5492
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830
   Samuel T, 2005, CANCER RES, V65, P210
   Schickling O, 2001, CELL DEATH DIFFER, V8, P1157, DOI 10.1038/sj.cdd.4400928
   Screaton RA, 2003, P NATL ACAD SCI USA, V100, P5211, DOI 10.1073/pnas.0431215100
   Shi WY, 2004, DEV BIOL, V270, P106, DOI 10.1016/j.ydbio.2004.02.011
   Shiozaki EN, 2004, TRENDS BIOCHEM SCI, V29, P486, DOI 10.1016/j.tibs.2004.07.003
   Shtivelman E, 1997, ONCOGENE, V14, P2167, DOI 10.1038/sj.onc.1201059
   Stochaj U, 2000, FASEB J, V14, P2130, DOI 10.1096/fj.99-0751fje
   Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135
   Trapani JA, 1998, INT REV CYTOL, V182, P111, DOI 10.1016/S0074-7696(08)62169-5
   Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040
   Whitman S, 2000, MOL CELL BIOL, V20, P583, DOI 10.1128/MCB.20.2.583-593.2000
   Yasuhara N, 1997, GENES CELLS, V2, P55, DOI 10.1046/j.1365-2443.1997.1010302.x
NR 54
TC 22
Z9 24
U1 1
U2 5
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4212
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD MAR-APR
PY 2006
VL 84
IS 3-4
BP 279
EP 286
DI 10.1139/Y05-100
PG 8
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA 065OA
UT WOS:000239168000002
PM 16902575
DA 2021-01-25
ER

PT J
AU Stoffler, D
   Schwarz-Herion, K
   Aebi, U
   Fahrenkrog, B
AF Stoffler, Daniel
   Schwarz-Herion, Kyrill
   Aebi, Ueli
   Fahrenkrog, Birthe
TI Getting across the nuclear pore complex: new insights into
   nucleocytoplasmic transport
SO CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
LA English
DT Article
DE nucleocytoplasmic transport; nuclear pore complex; electron microscopy;
   scanning force microscopy.
ID ATOMIC-FORCE MICROSCOPY; CRYOELECTRON TOMOGRAPHY; MOLECULAR
   ARCHITECTURE; ELECTRON-MICROSCOPY; NUCLEOPORIN NUP153; IMPORT; ENVELOPE;
   LOCALIZATION; SUBCOMPLEXES; DYNAMICS
AB Small ions and Molecules call traverse the nuclear pore complex (NPC) simply by diffusion. whereas larger proteins and RNAs require specific signals and factors that facilitate their passage through the NPC. Our understanding of the factors that participate and regulate nucleocytoplasmic transport has increased tremendously over the past years, whereas the actual translocation step through the NPC has remained largely unclear. Here. we present and discuss recent findings oil the interaction between the NPC and transport receptors and provide new evidence that the NPC acts as a constrained diffusion pore for molecules and particles without retention signal and as an affinity gate for signal-bearing cargos.
C1 Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
RP Stoffler, D (corresponding author), Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
EM Daniel.Stoffler@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413
CR ADAM SA, 1992, METHOD ENZYMOL, V219, P97
   AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1989, J CELL BIOL, V109, P955, DOI 10.1083/jcb.109.3.955
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bustamante JO, 2000, PFLUG ARCH EUR J PHY, V439, P433, DOI 10.1007/s004240050960
   Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Danker T, 2000, PFLUG ARCH EUR J PHY, V439, P671, DOI 10.1007/s004240050992
   Dilworth DJ, 2001, J CELL BIOL, V153, P1465, DOI 10.1083/jcb.153.7.1465
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Kiseleva E, 1997, EUR J CELL BIOL, V74, P407
   Lutzmann M, 2005, J BIOL CHEM, V280, P18442, DOI 10.1074/jbc.M412787200
   Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 1997, RNA, V3, P498
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   SANNER MF, 2002, P 10 INT PHYTH C 4 7
   Schafer C, 2002, P NATL ACAD SCI USA, V99, P7154, DOI 10.1073/pnas.092140799
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
NR 42
TC 18
Z9 18
U1 0
U2 5
PU NATL RESEARCH COUNCIL CANADA
PI OTTAWA
PA RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA
SN 0008-4212
J9 CAN J PHYSIOL PHARM
JI Can. J. Physiol. Pharmacol.
PD MAR-APR
PY 2006
VL 84
IS 3-4
BP 499
EP 507
DI 10.1139/Y06-001
PG 9
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA 065OA
UT WOS:000239168000022
PM 16902595
DA 2021-01-25
ER

PT J
AU Schroeder, UJ
   Buchmeier, S
   Tropel, D
   Burkhard, P
   Aebi, U
   Jockusch, BM
   Schoenenberger, CA
AF Schroeder, Ulrich J.
   Buchmeier, Sabine
   Tropel, David
   Burkhard, Peter
   Aebi, Ueli
   Jockusch, Brigitte M.
   Schoenenberger, Cora-Ann
TI Tailoring monoclonal antibodies to different forms of actin
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 29th Annual Meeting of the German Society for Cell Biology
CY MAR 29-APR 01, 2006
CL Braunschweig, GERMANY
C1 Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4003 Basel, Switzerland.
   Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-3300 Braunschweig, Germany.
EM Cora-Ann.Schoenberger@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
EI 1618-1298
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2006
VL 85
SU 56
BP 45
EP 45
PG 1
WC Cell Biology
SC Cell Biology
GA 037DS
UT WOS:000237127500088
DA 2021-01-25
ER

PT J
AU Barde, A
AF Barde, A
TI Embryonic stem cells and neurotrophin signalling
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 29th Annual Meeting of the German Society for Cell Biology
CY MAR 29-APR 01, 2006
CL Braunschweig, GERMANY
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
EM yves.barde@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2006
VL 85
SU 56
BP 49
EP 49
PG 1
WC Cell Biology
SC Cell Biology
GA 037DS
UT WOS:000237127500098
DA 2021-01-25
ER

PT J
AU Schmid, MC
   Dehio, M
   Scheidegger, F
   Biedermann, B
   Dehio, C
AF Schmid, Michael C.
   Dehio, Michaela
   Scheidegger, Florine
   Biedermann, Barbara
   Dehio, Christoph
TI A translocated protein of the tumor-inducing pathogen Bartonella
   protects endothelial cells from apoptosis
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 29th Annual Meeting of the German Society for Cell Biology
CY MAR 29-APR 01, 2006
CL Braunschweig, GERMANY
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4003 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
NR 2
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
EI 1618-1298
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2006
VL 85
SU 56
BP 116
EP 116
PG 1
WC Cell Biology
SC Cell Biology
GA 037DS
UT WOS:000237127500259
DA 2021-01-25
ER

PT J
AU Imer, R
   Akiyama, T
   De Rooji, NF
   Stolz, M
   Aebi, U
   Friederich, NF
   Koenig, U
   Wirz, D
   Daniels, AU
   Staufer, U
AF Imer, R
   Akiyama, T
   De Rooji, NF
   Stolz, M
   Aebi, U
   Friederich, NF
   Koenig, U
   Wirz, D
   Daniels, AU
   Staufer, U
TI Development of atomic force microscope for arthroscopic knee cartilage
   inspection
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Article; Proceedings Paper
CT 13th International Conference on Scanning Tunneling Microscopy,
   Spectroscopy and Related Technique held in Conjunction with the 13th
   International Colloquium on Scanning Probe Microscopy
CY JUL 03-08, 2005
CL Sapporo, JAPAN
SP Japan Soc Appl Phys, Japan Soc Appl Phys, Thin Film & Surface Phys Div, JSPS Nanoprobe Technol 167 Comm, Nanotechnol Res Inst, Natl Inst Mat Sci, RIKEN, Sapporo Int Commun Plaza Fdn, Fdn Adv Technol Inst
DE scanning force microscope; articular cartilage; arthroscopy;
   biomechanics; degradation; diagnostics; indentation; minimally invasive
   instrument; stiffness
ID ELASTIC-MODULUS; INDENTATION
AB A recent Study, based on ex vivo unconfined compression testing of normal, diseased, and enzymatically altered cartilage, revealed that a scanning force microscope (SFM), used as a nano-intender, is sensitive enough to enable measurement of alterations in the biomechanical properties of cartilage. Based oil these ex vivo measurements, we have designed a quantitative diagnosis tool, the scanning force arthroscope (SFA), able to perform in vivo measurements during a standard arthroscopic procedure. For stabilizing and positioning the instrument relative to the surface Under investigation, a pneumatic system has been developed. A segmented piezoelectric tube was used to perform the indentation displacement, and a pyramidal nanometer-scale silicon tip mounted on a cantilever with an integrated deflection sensor measured the biomechanical properties of cartilage. Mechanical means were designed to protect the fragile cantilever during the insertion of the instrument into the knee joint. The stability of the pneumatic stage was checked with it prototype SFA. In a series of tests, load-displacement curves were recorded in a knee phantom and, more recently, in a pig's leg.
C1 Univ Neuchatel, Inst Microtechnol, CH-2002 Neuchatel, Switzerland.
   Univ Basel, Biozentrum, Maurice E Mueller Inst, CH-4056 Basel, Switzerland.
   Kantonsspital Bruderholz, Clin Orthopaed Surg & Traumatol, CH-4101 Bruderholz, Switzerland.
   Univ Basel, Orthopaed Biomech Lab, CH-4056 Basel, Switzerland.
RP Imer, R (corresponding author), Univ Neuchatel, Inst Microtechnol, Jaquet Droz 1, CH-2002 Neuchatel, Switzerland.
EM raphael.imer@unine.ch
RI Staufer, Urs/J-6866-2016
OI Staufer, Urs/0000-0002-3519-6467
CR Duda GN, 2004, AM J SPORT MED, V32, P693, DOI 10.1177/0363546503261725
   EINHORN TA, 2000, ORTHOPAEDIC BASIC SC, P443
   Laasanen MS, 2003, J BIOMECH, V36, P1259, DOI 10.1016/S0021-9290(03)00163-5
   NEYRET P, 1993, J BONE JOINT SURG BR, V75, P36
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   Rho JY, 1997, BIOMATERIALS, V18, P1325, DOI 10.1016/S0142-9612(97)00073-2
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
NR 8
TC 14
Z9 14
U1 0
U2 4
PU INST PURE APPLIED PHYSICS
PI TOKYO
PA 5F YUSHIMA BLDG, 2-31-22 YUSHIMA, BUNKYO-KU, TOKYO, 113-0034, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PD MAR
PY 2006
VL 45
IS 3B
BP 2319
EP 2323
DI 10.1143/JJAP.45.2319
PG 5
WC Physics, Applied
SC Physics
GA 030HB
UT WOS:000236624100104
DA 2021-01-25
ER

PT J
AU Annies, M
   Bittcher, G
   Ramseger, R
   Loschinger, R
   Woll, S
   Porten, E
   Abraham, C
   Ruegg, MA
   Kroger, S
AF Annies, M
   Bittcher, G
   Ramseger, R
   Loschinger, R
   Woll, S
   Porten, E
   Abraham, C
   Ruegg, MA
   Kroger, S
TI Clustering transmembrane-agrin induces filopodia-like processes on axons
   and dendrites
SO MOLECULAR AND CELLULAR NEUROSCIENCE
LA English
DT Article
DE agrin; synapse formation; heparan sulfate proteoglycan; axonal growth;
   dendritic spine; cytoskeleton
ID HEPARAN-SULFATE PROTEOGLYCAN; HIPPOCAMPAL-NEURONS; BASAL LAMINA;
   SYNAPTIC DIFFERENTIATION; ACETYLCHOLINE-RECEPTORS; SUBSTRATE PROPERTIES;
   NEURITE OUTGROWTH; RECOMBINANT AGRIN; DEFICIENT MICE; GROWTH CONES
AB The transmembrane form of agrin (TM-agrin) is primarily expressed in the CNS, particularly on neurites. To analyze its function, we clustered TM-agrin on neurons using anti-agrin antibodies. On axons from the chick CNS and PNS as well as on axons and dendrites from mouse hippocampal neurons anti-agrin antibodies induced the dose-and time-dependent formation of numerous filopodia-like processes. The processes appeared within minutes after antibody addition and contained a complex cytoskeleton. Formation of processes required calcium, could be inhibited by cytochalasine D, but was not influenced by staurosporine, heparin or pervanadate. Time-lapse video microscopy revealed that the processes were dynamic and extended laterally along the entire length of the neuron. The lateral processes had growth cones at their tips that initially adhered to the substrate, but subsequently collapsed and were retracted. These data provide the first evidence for a specific role of TM-agrin in shaping the cytoskeleton of neurites in the developing nervous system. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Mainz, Dept Physiol Chem, D-55099 Mainz, Germany.
   Univ Basel, Biozentrum, CH-5046 Basel, Switzerland.
   Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.
RP Kroger, S (corresponding author), Univ Mainz, Dept Physiol Chem, Duesbergweg 6, D-55099 Mainz, Germany.
EM skroeger@uni-mainz.de
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Kroger, Stephan/0000-0002-4626-1690
CR Annies M, 2002, MOL CELL NEUROSCI, V20, P525, DOI 10.1006/mcne.2002.1125
   BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bose CM, 2000, J NEUROSCI, V20, P9086
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Chang S, 2001, NAT NEUROSCI, V4, P787, DOI 10.1038/90489
   Cohen NA, 1997, NEUROSCIENCE, V76, P581, DOI 10.1016/S0306-4522(96)00345-4
   Dailey ME, 1996, J NEUROSCI, V16, P2983
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978
   Escher G, 1996, J CELL SCI, V109, P2959
   Eusebio A, 2003, NEUROMUSCULAR DISORD, V13, P408, DOI 10.1016/S0960-8966(03)00036-1
   Ferreira A, 1999, J CELL SCI, V112, P4729
   Fiala JC, 1998, J NEUROSCI, V18, P8900
   Granes F, 1999, EXP CELL RES, V248, P439, DOI 10.1006/excr.1999.4437
   HALFTER W, 1987, J NEUROSCI, V7, P3712
   Halfter W, 1997, J COMP NEUROL, V383, P1
   Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3
   HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2
   Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061
   Hopf C, 1998, J BIOL CHEM, V273, P6467, DOI 10.1074/jbc.273.11.6467
   Hopf C, 1997, EUR J NEUROSCI, V9, P1170, DOI 10.1111/j.1460-9568.1997.tb01471.x
   Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Kim MJ, 2003, J NEUROBIOL, V55, P261, DOI 10.1002/neu.10213
   Kroger S, 2002, NEWS PHYSIOL SCI, V17, P207, DOI 10.1152/01390.2002
   Kroger S, 1996, J NEUROBIOL, V29, P165
   Kroger S, 1997, MOL CELL NEUROSCI, V10, P149, DOI 10.1006/mcne.1997.0651
   KROGER S, 1990, J NEUROSCI RES, V27, P169, DOI 10.1002/jnr.490270207
   KROGER S, 1990, J NEUROSCI, V10, P3118
   Li Z, 1999, J NEUROBIOL, V39, P547, DOI 10.1002/(SICI)1097-4695(19990615)39:4<547::AID-NEU8>3.0.CO;2-C
   Loschinger J, 1997, J NEUROBIOL, V33, P825, DOI 10.1002/(SICI)1097-4695(19971120)33:6<825::AID-NEU9>3.0.CO;2-B
   Mack TGA, 2000, MOL CELL NEUROSCI, V15, P51, DOI 10.1006/mcne.1999.0802
   Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923
   Mantych KB, 2001, J NEUROSCI, V21, P6802
   Neuhuber B, 2003, MOL CELL NEUROSCI, V24, P1180, DOI 10.1016/j.mcn.2003.08.008
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   Park PW, 2000, J BIOL CHEM, V275, P29923, DOI 10.1074/jbc.R000008200
   Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.0.CO;2-X
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2
   Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112
   STONE DM, 1995, J NEUROSCI, V15, P6767
   TAKAHASHI M, 1991, BRAIN RES, V551, P279, DOI 10.1016/0006-8993(91)90942-O
   TSEN G, 1995, J BIOL CHEM, V270, P3392, DOI 10.1074/jbc.270.7.3392
   TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V
   Uhm CS, 2001, J NEUROSCI, V21, P9678, DOI 10.1523/JNEUROSCI.21-24-09678.2001
   WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121
   WALLACE BG, 1994, J CELL BIOL, V125, P661, DOI 10.1083/jcb.125.3.661
   Weiss A, 1998, CELL, V94, P277, DOI 10.1016/S0092-8674(00)81469-5
   Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4
NR 52
TC 37
Z9 37
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1044-7431
EI 1095-9327
J9 MOL CELL NEUROSCI
JI Mol. Cell. Neurosci.
PD MAR
PY 2006
VL 31
IS 3
BP 515
EP 524
DI 10.1016/j.mcn.2005.11.005
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 026XF
UT WOS:000236375700013
PM 16364653
DA 2021-01-25
ER

PT J
AU Meier, KD
   Deloche, O
   Kajiwara, K
   Funato, K
   Riezman, H
AF Meier, KD
   Deloche, O
   Kajiwara, K
   Funato, K
   Riezman, H
TI Sphingoid base is required for translation initiation during heat stress
   in Saccharomyces cerevisiae
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID LONG-CHAIN BASES; PROTEIN-KINASE; CERAMIDE SYNTHESIS; ANCHORED PROTEINS;
   NUCLEAR EXPORT; SHOCK PROTEINS; CELL-GROWTH; BIOSYNTHESIS;
   SPHINGOLIPIDS; GENE
AB Sphingolipids are required for many cellular functions including response to heat shock. We analyzed the yeast lcb1-100 mutant, which is conditionally impaired in the first step of sphingolipid biosynthesis and shows a strong decrease in heat shock protein synthesis and viability. Transcription and nuclear export of heat shock protein mRNAs is not affected. However, lcb1-100 cells exhibited a strong decrease in protein synthesis caused by a defect in translation initiation under heat stress conditions. The essential lipid is sphingoid base, not ceramide or sphingoid base phosphates. Deletion of the eIF4E-binding protein Eap1p in lcb-100 cells restored translation of heat shock proteins and increased viability. The translation defect during heat stress in lcb1-100 was due at least partially to a reduced function of the sphingoid base-activated PKH1/2 protein kinases. In addition, depletion of the translation initiation factor eIF4G was observed in lcb1-100 cells and ubiquitin overexpression allowed partial recovery of translation after heat stress. Taken together, we have shown a requirement for sphingoid bases during the recovery from heat shock and suggest that this reflects a direct lipid-dependent signal to the cap-dependent translation initiation apparatus.
C1 Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.
   Univ Basel, Dept Biochem, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Geneva, CMU, Dept Microbiol & Mol Med, CH-1211 Geneva 4, Switzerland.
   Hiroshima Univ, Grad Sch Biosphere Sci, Fac Appl Biol Sci, Higashihiroshima 7398528, Japan.
RP Riezman, H (corresponding author), Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.
EM howard.riezman@biochem.unige.ch
OI Riezman, Howard/0000-0003-4680-9422; Kajiwara,
   Kentaro/0000-0001-7574-4010
CR Amorim ML, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-2
   Baetz K, 2004, P NATL ACAD SCI USA, V101, P4525, DOI 10.1073/pnas.0307122101
   Barz WP, 1999, MOL BIOL CELL, V10, P1043, DOI 10.1091/mbc.10.4.1043
   Berset C, 1998, P NATL ACAD SCI USA, V95, P4264, DOI 10.1073/pnas.95.8.4264
   BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   Chial HJ, 2000, CURR BIOL, V10, P1519, DOI 10.1016/S0960-9822(00)00829-0
   Chung N, 2000, J BIOL CHEM, V275, P17229, DOI 10.1074/jbc.C000229200
   Cole CN, 2002, METHOD ENZYMOL, V351, P568
   Cosentino GP, 2000, MOL CELL BIOL, V20, P4604, DOI 10.1128/MCB.20.13.4604-4613.2000
   Cowart LA, 2003, J BIOL CHEM, V278, P30328, DOI 10.1074/jbc.M300656200
   Delley PA, 1999, J CELL BIOL, V147, P163, DOI 10.1083/jcb.147.1.163
   Deloche O, 2004, MOL CELL, V13, P357, DOI 10.1016/S1097-2765(04)00008-5
   Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6
   Dickson RC, 2002, BBA-MOL CELL BIOL L, V1583, P13, DOI 10.1016/S1388-1981(02)00210-X
   Dickson RC, 1997, J BIOL CHEM, V272, P30196, DOI 10.1074/jbc.272.48.30196
   Emery B, 2004, MOL MICROBIOL, V52, P141, DOI 10.1111/j.1365-2958.2003.03973.x
   Ferguson-Yankey SR, 2002, YEAST, V19, P573, DOI 10.1002/yea.861
   FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203
   Friant S, 2000, EMBO J, V19, P2834, DOI 10.1093/emboj/19.12.2834
   Friant S, 2003, EMBO J, V22, P3783, DOI 10.1093/emboj/cdg375
   Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783
   Funato K, 2002, BIOCHEMISTRY-US, V41, P15105, DOI 10.1021/bi026616d
   Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241
   Gelperin D, 2002, GENETICS, V161, P1453
   Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913
   Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586
   Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655
   Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200
   Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185
   Horton LE, 2001, J BIOL CHEM, V276, P14426, DOI 10.1074/jbc.M100266200
   HORVATH A, 1994, EMBO J, V13, P3687, DOI 10.1002/j.1460-2075.1994.tb06678.x
   Hurt E, 2000, J BIOL CHEM, V275, P8361, DOI 10.1074/jbc.275.12.8361
   Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586
   Jenkins GM, 2003, CELL MOL LIFE SCI, V60, P701, DOI 10.1007/s00018-003-2239-0
   Jenkins GM, 2002, J BIOL CHEM, V277, P42572, DOI 10.1074/jbc.M207346200
   Jenkins GM, 2001, J BIOL CHEM, V276, P8574, DOI 10.1074/jbc.M007425200
   Jensen TH, 2001, MOL CELL, V7, P887, DOI 10.1016/S1097-2765(01)00232-5
   Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419
   Kim S, 2000, GENETICS, V156, P1519
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150
   Mao CG, 1999, BIOCHEM J, V342, P667, DOI 10.1042/0264-6021:3420667
   MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x
   MERRILL AH, 1988, BIOCHEMISTRY-US, V27, P340, DOI 10.1021/bi00401a051
   MILLER MJ, 1979, P NATL ACAD SCI USA, V76, P5222, DOI 10.1073/pnas.76.10.5222
   MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827
   Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799
   PATTON JL, 1992, J BACTERIOL, V174, P7180, DOI 10.1128/jb.174.22.7180-7184.1992
   Preiss T, 2003, NAT STRUCT BIOL, V10, P1039, DOI 10.1038/nsb1015
   Riezman H, 2004, CELL CYCLE, V3, P61
   Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777
   Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417
   Shin C, 2004, NATURE, V427, P553, DOI 10.1038/nature02288
   Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7
   Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103
   STONE DE, 1990, MOL CELL BIOL, V10, P1622, DOI 10.1128/MCB.10.4.1622
   Stutz F, 1998, GENE DEV, V12, P3303, DOI 10.1101/gad.12.21.3303
   Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000
   UESONO Y, 2002, J BIOL CHEM, V16, P16
   Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562
   Watanabe R, 2002, J BIOL CHEM, V277, P49538, DOI 10.1074/jbc.M206209200
   Wu C, 1995, ANNU REV CELL DEV BI, V11, P441, DOI 10.1146/annurev.cb.11.110195.002301
   Zanolari B, 2000, EMBO J, V19, P2824, DOI 10.1093/emboj/19.12.2824
NR 66
TC 57
Z9 57
U1 2
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2006
VL 17
IS 3
BP 1164
EP 1175
DI 10.1091/mbc.E05-11-1039
PG 12
WC Cell Biology
SC Cell Biology
GA 018UK
UT WOS:000235790100011
PM 16381812
OA Green Published
DA 2021-01-25
ER

PT J
AU Wahl, PR
   Serra, AL
   Le Hir, M
   Molle, KD
   Hall, MN
   Wuthrich, RP
AF Wahl, PR
   Serra, AL
   Le Hir, M
   Molle, KD
   Hall, MN
   Wuthrich, RP
TI Inhibition of mTOR with sirolimus slows disease progression in Han :
   SPRD rats with autosomal dominant polycystic kidney disease (ADPKD)
SO NEPHROLOGY DIALYSIS TRANSPLANTATION
LA English
DT Article
DE ADPKD; Han; SPRD rats; mTOR; rapamycin; sirolimus; S6K
ID MAMMALIAN TARGET; GROWTH; GENE; PKD2
AB Background. Autosomal dominant polycystic kidney disease (ADPKD) is characterized by dysregulated tubular epithelial cell growth, resulting in the formation of multiple renal cysts and progressive renal failure. To date, there is no effective treatment for ADPKD. The mammalian target of rapamycin (mTOR) is an atypical protein kinase and a central controller of cell growth and proliferation. We examined the effect of the mTOR inhibitor sirolimus (rapamycin) on renal functional loss and cyst progression in the Han:SPRD rat model of ADPKD.
   Methods. Five-week-old male heterozygous cystic (Cy/+) and wild-type normal (+/+) rats were administered sirolimus (2 mg/kg/day) orally through the drinking water for 3 months. The renal function was monitored throughout the treatment phase, and rats were sacrificed thereafter. Kidneys were analysed histomorphometrically, and for the expression and phosphorylation of S6K, a well-characterized target of mTOR in the regulation of cell growth.
   Results. The steady increase in BUN and creatinine in Cy/+ rats was reduced by 39 and 34%, respectively with sirolimus after 3 months treatment. Kidney weight and 2-kidney/total body weight (2K/TBW) ratios were reduced by 34 and 26% in sirolimus-treated Cy/+ rats. Cyst volume density was also reduced by 18%. Of importance, Cy/+ rats displayed enhanced levels of total and phosphorylated S6K. Sirolimus effectively reduced total and phosphorylated levels of S6K.
   Conclusion. We conclude that oral sirolimus markedly delays the loss of renal function and retards cyst development in Han:SPRD rats with ADPKD. Our data also suggest that activation of the S6K signalling pathway plays an important role in the pathogenesis of PKD. Sirolimus could be a useful drug to retard progressive renal failure in patients with ADPKD.
C1 Univ Zurich Hosp, Div Renal, CH-8091 Zurich, Switzerland.
   Univ Zurich Irchel, Inst Physiol, CH-8057 Zurich, Switzerland.
   Univ Zurich Irchel, Inst Anat, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, Div Biochem, Basel, Switzerland.
RP Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Renal, Ramistr 100, CH-8091 Zurich, Switzerland.
EM rudolf.wuethrich@usz.ch
OI Hall, Michael N/0000-0002-2998-0757
CR Delmas P, 2004, CELL, V118, P145, DOI 10.1016/j.cell.2004.07.007
   GLUCKSMANNKUIS MA, 1995, CELL, V81, P289
   Gretz N, 1996, NEPHROL DIAL TRANSPL, V11, P46
   Guba M, 2002, NAT MED, V8, P128, DOI 10.1038/nm0202-128
   Harris PC, 2002, CURR OPIN NEPHROL HY, V11, P309, DOI 10.1097/00041552-200205000-00007
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Khaleghpour K, 1999, MOL CELL BIOL, V19, P4302
   Lieberthal W, 2001, AM J PHYSIOL-RENAL, V281, pF693
   MATHIEU O, 1981, J MICROSC-OXFORD, V121, P75, DOI 10.1111/j.1365-2818.1981.tb01200.x
   Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339
   Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071
   PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x
   Saitoh M, 2002, J BIOL CHEM, V277, P20104, DOI 10.1074/jbc.M201745200
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831
   Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660
   Torres VE, 2004, KIDNEY INT, V66, P1766, DOI 10.1111/j.1523-1755.2004.00952.x
   Torres VE, 2004, NEPHRON EXP NEPHROL, V98, pE1, DOI 10.1159/000079926
   Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090
   WARD CJ, 1994, CELL, V77, P881
   Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161
NR 24
TC 198
Z9 209
U1 0
U2 8
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0931-0509
EI 1460-2385
J9 NEPHROL DIAL TRANSPL
JI Nephrol. Dial. Transplant.
PD MAR
PY 2006
VL 21
IS 3
BP 598
EP 604
DI 10.1093/ndt/gfi181
PG 7
WC Transplantation; Urology & Nephrology
SC Transplantation; Urology & Nephrology
GA 016FO
UT WOS:000235606300010
PM 16221708
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Affolter, M
AF Affolter, M
TI Q & A
SO CURRENT BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4053 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4053 Basel, Switzerland.
OI Affolter, Markus/0000-0002-5171-0016
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD FEB 21
PY 2006
VL 16
IS 4
BP R111
EP R112
DI 10.1016/j.cub.2006.02.010
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 018UD
UT WOS:000235789400004
PM 16532557
OA Bronze
DA 2021-01-25
ER

PT J
AU Sood, P
   Krek, A
   Zavolan, M
   Macino, G
   Rajewsky, N
AF Sood, P
   Krek, A
   Zavolan, M
   Macino, G
   Rajewsky, N
TI Cell-type-specific signatures of microRNAs on target mRNA expression
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE gene expression; microarray; posttranscriptional control
ID IDENTIFICATION; GENES; DEGRADATION; BIOGENESIS; MIRNAS; MOTIFS
AB Although it is known that the human genome contains hundreds of microRNA (miRNA) genes and that each miRNA can regulate a large number of mRNA targets, the overall effect of miRNAs on mRNA tissue profiles has not been systematically elucidated. Here, we show that predicted human mRNA targets of several highly tissue-specific miRNAs are typically expressed in the same tissue as the miRNA but at significantly lower levels than in tissues where the miRNA is not present. Conversely, highly expressed genes are often enriched in mRNAs that do not have the recognition motifs for the miRNAs expressed in these tissues. Together, our data support the hypothesis that miRNA expression broadly contributes to tissue specificity of mRNA expression in many human tissues. Based on these insights, we apply a computational tool to directly correlate 3' UTR motifs with changes in mRNA levels upon miRNA overexpression or knockdown. We show that this tool can identify functionally important 3' UTR motifs without cross-species comparison.
C1 NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA.
   NYU, Dept Phys, New York, NY 10003 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, I-00161 Rome, Italy.
RP Rajewsky, N (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, 100 Washington Sq E, New York, NY 10003 USA.
EM nikolaus.rajewsky@nyu.edu
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Rajewsky,
   Nikolaus/0000-0002-4785-4332
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905
   Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590
   Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792
   Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190
   Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038
   John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363
   Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219
NR 25
TC 443
Z9 475
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 21
PY 2006
VL 103
IS 8
BP 2746
EP 2751
DI 10.1073/pnas.0511045103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 015MG
UT WOS:000235554900049
PM 16477010
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kopp, C
   Ressel, V
   Wigger, E
   Tobler, I
AF Kopp, C
   Ressel, V
   Wigger, E
   Tobler, I
TI Influence of estrus cycle and ageing on activity patterns in two inbred
   mouse strains
SO BEHAVIOURAL BRAIN RESEARCH
LA English
DT Article
DE aging; circadian; cycle; estrus; female; mice; running-wheel activity
ID AGE-RELATED-CHANGES; CIRCADIAN ACTIVITY RHYTHMS; FREE-RUNNING PERIOD;
   SUPRACHIASMATIC NUCLEUS; ESTROUS-CYCLE; LOCOMOTOR-ACTIVITY;
   BODY-TEMPERATURE; SLEEP; MICE; FEMALE
AB Despite the widespread use of inbred mice in research. little is known about aging of the circadian system in female mice, although interactions between female gonadal hormones and circadian rhythms have been established. We investigated the influence of the estrus cycle on circadian aspects of running-wheel activity and changes in the course of aging in female C57BL/6 and C3H/He mice recorded continuously between the ages of 3 and 19 months. In the young, cycling mice the second part of the proestrus night was often, but not consistently, characterized by increased motor activity compared to the remaining estrus cycle nights. After estrus cycling had ceased ill the course of ageing. the estrus-dependent day-to-day variability in activity was reduced. The amplitude of the daily rest-activity rhythm decreased progressively after the age of 8 months in C3H/He and 10 months in C57BL/6 mice. The capacity for resynchronisation of activity onset to the LD-cycle was compared in young and old mice after an 8-h phase advance of the LD-cycle. Resynchronisation was significantly slower in old C3H/He mice and unaffected by age in C57BL/6 mice. The circadian period in constant darkness did not change with age in either strain. However, the period was shorter in 17-month old C57BL/6 mice compared to an additional group, which was recorded at the same age, after at least 1-month adaptation to the recording conditions. The results show that the reproductive state as well as ageing influence motor activity patterns of female mice in a strain- and cohort-dependent manner. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland.
RP Tobler, I (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Basel, Switzerland.
EM tobler@pharma.unizh.ch
RI Ressel, Volker/E-7657-2012
OI Ressel, Volker/0000-0002-2378-830X
CR Aujard F, 2001, NEUROSCIENCE, V106, P255, DOI 10.1016/S0306-4522(01)00285-8
   BARKLEY MS, 1981, P SOC EXP BIOL MED, V167, P70, DOI 10.3181/00379727-167-41127
   Benloucif S, 1997, BRAIN RES, V747, P34, DOI 10.1016/S0006-8993(96)01182-1
   COLVIN GERALD B., 1968, BRAIN RES, V7, P173, DOI 10.1016/0006-8993(68)90095-4
   DAVIS FC, 1981, J COMP PHYSIOL, V143, P527, DOI 10.1007/BF00609919
   DAVIS FC, 1998, AM J PHYSIOL, V44, P960
   Deboer T, 2000, J COMP PHYSIOL A, V186, P969, DOI 10.1007/s003590000150
   DELEON DD, 1990, J REPROD FERTIL, V89, P117, DOI 10.1530/jrf.0.0890117
   Duffy JF, 1999, NEUROSCI LETT, V271, P77, DOI 10.1016/S0304-3940(99)00519-4
   Dzaja A, 2005, J PSYCHIATR RES, V39, P55, DOI 10.1016/j.jpsychires.2004.05.008
   EDGAR DM, 1991, J BIOL RHYTHM, V6, P185, DOI 10.1177/074873049100600301
   Franken P, 1999, SLEEP, V22, P155
   INGRAM DK, 1982, NEUROBIOL AGING, V3, P287, DOI 10.1016/0197-4580(82)90017-3
   Jones MEE, 2000, P NATL ACAD SCI USA, V97, P12735, DOI 10.1073/pnas.97.23.12735
   KENT S, 1991, PHYSIOL BEHAV, V49, P1079, DOI 10.1016/0031-9384(91)90334-K
   KLEINLOGEL H, 1983, NEUROPSYCHOBIOLOGY, V10, P228, DOI 10.1159/000118016
   Koehl M, 2003, SLEEP, V26, P267, DOI 10.1093/sleep/26.3.267
   Kopp C, 1998, PHYSIOL BEHAV, V63, P577, DOI 10.1016/S0031-9384(97)00491-5
   Kopp C, 2000, PHYSIOL BEHAV, V70, P171, DOI 10.1016/S0031-9384(00)00251-1
   Kruijver FPM, 2002, NEUROENDOCRINOLOGY, V75, P296, DOI 10.1159/000057339
   LI H, 1995, AM J PHYSIOL-REG I, V269, pR208
   Li H, 1996, AM J PHYSIOL-REG I, V271, pR1753
   Maguire JL, 2005, NAT NEUROSCI, V8, P797, DOI 10.1038/nn1469
   Mayeda AR, 1997, CHRONOBIOL INT, V14, P19, DOI 10.3109/07420529709040538
   Mendelson WB, 1999, SLEEP, V22, P145, DOI 10.1093/sleep/22.2.145
   MICHAEL SD, 1976, P SOC EXP BIOL MED, V153, P254, DOI 10.3181/00379727-153-39522
   Mistlberger R. E., 2000, AM J PHYSIOL, V279, P813
   Moore-Ede M.C., 1982, CLOCKS TIME US
   Nakamura TJ, 2001, NEUROSCI RES, V41, P251, DOI 10.1016/S0168-0102(01)00285-1
   NELSON JF, 1982, BIOL REPROD, V27, P327, DOI 10.1095/biolreprod27.2.327
   Parkinson J, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-31
   Peterfi Z, 2004, NEUROSCIENCE, V124, P695, DOI 10.1016/j.neuroscience.2003.10.047
   PITTENDRIGH CS, 1974, SCIENCE, V186, P548, DOI 10.1126/science.186.4163.548
   PITTENDRIGH CS, 1976, J COMP PHYSIOL A, V106, P553
   POSSIDENTE B, 1995, PHYSIOL BEHAV, V57, P575, DOI 10.1016/0031-9384(94)00298-J
   PROVENCIO I, 1994, VISION RES, V34, P1799, DOI 10.1016/0042-6989(94)90304-2
   Schwierin B, 1998, BRAIN RES, V811, P96, DOI 10.1016/S0006-8993(98)00991-3
   THOMAS EMV, 1989, AM J PHYSIOL, V257, pR1241
   Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0
   VALATX JL, 1974, BRAIN RES, V69, P315, DOI 10.1016/0006-8993(74)90009-2
   VALENTINUZZI VS, 1997, AM J PHYSIOL, V42, P1957
   VANGOOL WA, 1987, BRAIN RES, V413, P384, DOI 10.1016/0006-8993(87)91034-1
   VANGOOL WA, 1983, BRAIN RES, V279, P394, DOI 10.1016/0006-8993(83)90217-2
   Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228
   Weinert D, 1999, PHYSIOL BEHAV, V66, P605, DOI 10.1016/S0031-9384(98)00342-4
   Weinert D, 2000, CHRONOBIOL INT, V17, P261, DOI 10.1081/CBI-100101048
   Weinert D, 1996, J EXP ANIM SCI, V37, P121
   Weisgerber D, 1997, PHYSIOL BEHAV, V62, P759, DOI 10.1016/S0031-9384(97)00192-3
   Wise PM, 1999, AM J PHYSIOL-ENDOC M, V277, pE965
   WITTING W, 1994, CHRONOBIOL INT, V11, P103, DOI 10.3109/07420529409055896
   YAMADA N, 1990, BRAIN RES BULL, V25, P115, DOI 10.1016/0361-9230(90)90261-W
NR 51
TC 35
Z9 36
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-4328
EI 1872-7549
J9 BEHAV BRAIN RES
JI Behav. Brain Res.
PD FEB 15
PY 2006
VL 167
IS 1
BP 165
EP 174
DI 10.1016/j.bbr.2005.09.001
PG 10
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA 008QL
UT WOS:000235055700021
PM 16214232
DA 2021-01-25
ER

PT J
AU Kramer, I
   Sigrist, M
   de Nooij, JC
   Taniuchi, I
   Jessel, TM
   Arber, S
AF Kramer, I
   Sigrist, M
   de Nooij, JC
   Taniuchi, I
   Jessel, TM
   Arber, S
TI A role for Runx transcription factor signaling in dorsal root ganglion
   sensory neuron diversification
SO NEURON
LA English
DT Article
ID NEUROTROPHIC FACTOR; GENE-EXPRESSION; NERVE GROWTH; ABSENCE; TRKC;
   IDENTIFICATION; INNERVATION; ACTIVATION; AFFERENTS; PHENOTYPE
AB Subpopulations of sensory neurons in the dorsal root ganglion (DRG) can be characterized on the basis of sensory modalities that convey distinct peripheral stimuli, but the molecular mechanisms that underlie sensory neuronal diversification remain unclear. Here, we have used genetic manipulations in the mouse embryo to examine how Runx transcription factor signaling controls the acquisition of distinct DRG neuronal subtype identities. Runx3 acts to diversify an Ngn1-independent neuronal cohort by promoting the differentiation of proprioceptive sensory neurons through erosion of TrkB expression in prospective TrkC(+) sensory neurons. In contrast, Runx1 controls neuronal diversification within Ngn1-dependent TrkA(+) neurons by repression of neuropeptide CGRP expression and controlling the fine pattern of laminar termination in the dorsal spinal cord. Together, our findings suggest that Runx transcription factor signaling plays a key role in sensory neuron diversification.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.
   NYU, Mol Pathogenesis Program, New York, NY 10016 USA.
   NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
RI Taniuchi, Ichiro/N-6399-2015
OI Taniuchi, Ichiro/0000-0002-9853-9068; Arber, Silvia/0000-0002-6261-250X
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Bai CB, 2002, DEVELOPMENT, V129, P4753
   Bangsow C, 2001, GENE, V279, P221, DOI 10.1016/S0378-1119(01)00760-0
   Baudet C, 2000, DEVELOPMENT, V127, P4335
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028
   Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036
   Farinas I, 1998, NEURON, V21, P325, DOI 10.1016/S0896-6273(00)80542-5
   Friedel RH, 1997, P NATL ACAD SCI USA, V94, P12670, DOI 10.1073/pnas.94.23.12670
   Funfschilling U, 2004, J COMP NEUROL, V480, P392, DOI 10.1002/cne.20359
   Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033
   Hellard D, 2004, DEV BIOL, V275, P34, DOI 10.1016/j.ydbio.2004.07.021
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012
   Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629
   Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925
   KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0
   Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370
   Levanon D, 2004, ONCOGENE, V23, P4211, DOI 10.1038/sj.onc.1207670
   Liebl DJ, 1997, J NEUROSCI, V17, P9113
   Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717
   Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0
   Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6
   Moqrich A, 2004, NAT NEUROSCI, V7, P812, DOI 10.1038/nn1283
   Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7
   Rini D, 2001, GENE, V273, P13, DOI 10.1016/S0378-1119(01)00579-0
   SCOTT SA, 1992, SENSORY NEURONS DIVE
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   Wang YK, 1996, NATURE, V379, P823, DOI 10.1038/379823a0
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Zirlinger M, 2002, P NATL ACAD SCI USA, V99, P8084, DOI 10.1073/pnas.122231199
NR 35
TC 164
Z9 168
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD FEB 2
PY 2006
VL 49
IS 3
BP 379
EP 393
DI 10.1016/j.neuron.2006.01.008
PG 15
WC Neurosciences
SC Neurosciences & Neurology
GA 011IF
UT WOS:000235260900010
PM 16446142
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Aebi, U
   Stoffler, D
AF Lim, RYH
   Aebi, U
   Stoffler, D
TI From the trap to the basket: getting to the bottom of the nuclear pore
   complex
SO CHROMOSOMA
LA English
DT Review
ID ATOMIC-FORCE MICROSCOPY; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOPORIN
   NUP153; STRUCTURAL BASIS; IMPORTIN-BETA; FG-REPEAT; PROTEIN IMPORT;
   CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPE
AB Nuclear pore complexes (NPCs) are large supramolecular assemblies that perforate the double-membraned nuclear envelope and serve as the sole gateways of molecular exchange between the cytoplasm and the nucleus in interphase cells. Combining novel specimen preparation regimes with innovative use of high-resolution scanning electron microscopy, Hans Ris produced in the late eighties stereo images of the NPC with unparalleled clarity and structural detail, thereby setting new standards in the field. Since that time, efforts undertaken to resolve the molecular structure and architecture, and the numerous interactions that occur between NPC proteins (nucleoporins), soluble transport receptors, and the small GTPase Ran, have led to a deeper understanding of the functional role of NPCs in nucleocytoplasmic transport. In spite of these breakthroughs, getting to the bottom of the actual cargo translocation mechanism through the NPC remains elusive and controversial. Here, we review recent insights into NPC function by correlating structural findings with biochemical data. By introducing new experimental and computational results, we reexamine how NPCs can discriminate between receptor-mediated and passive cargo to promote vectorial translocation in a highly regulated manner. Moreover, we comment on the importance and potential benefits of identifying and experimenting with individual key components implicated in the translocation mechanism. We conclude by dwelling on questions that we feel are pertinent to a more rational understanding of the physical aspects governing NPC mechanics. Last but not least, we substantiate these uncertainties by boldly suggesting a new direction in NPC research as a means to verify such novel concepts, for example, a de novo designed 'minimalist' NPC.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Aebi, U (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM Ueli.Aebi@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087
CR AEBI U, 1990, EMSA B, V20, P69
   AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X
   Allen NPC, 2001, J BIOL CHEM, V276, P29268, DOI 10.1074/jbc.M102629200
   Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5
   BRAUNSTEIN D, 1994, BIOPHYS J, V66, P1717, DOI 10.1016/S0006-3495(94)80964-6
   Bustamante JO, 2000, PFLUG ARCH EUR J PHY, V439, P433, DOI 10.1007/s004240050960
   Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Fahrenkrog Birthe, 2002, Results Probl Cell Differ, V35, P25
   Folprecht G, 1996, PFLUG ARCH EUR J PHY, V432, P831, DOI 10.1007/s004240050205
   Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Gilchrist D, 2002, J BIOL CHEM, V277, P18161, DOI 10.1074/jbc.M112306200
   Goldberg MW, 1997, J CELL SCI, V110, P409
   GOLDIE KN, 1994, J VAC SCI TECHNOL B, V12, P1482, DOI 10.1116/1.587321
   Grant RP, 2003, J MOL BIOL, V326, P849, DOI 10.1016/S0022-2836(02)01474-2
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Hoppener C, 2005, BIOPHYS J, V88, P3681, DOI 10.1529/biophysj.104.051458
   ISGRO TA, 2005, IN PRESS STRUCTURE
   Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535
   Jaggi RD, 2003, BIOPHYS J, V85, P4093, DOI 10.1016/S0006-3495(03)74821-8
   Jaggi RD, 2003, BIOPHYS J, V84, P665
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9
   Kiseleva E, 1998, J CELL SCI, V111, P223
   Kiskin NI, 2003, BIOPHYS J, V85, P2311, DOI 10.1016/S0006-3495(03)74655-4
   Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005
   Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9
   Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004
   Oberleithner H, 1996, PFLUG ARCH EUR J PHY, V432, P839, DOI 10.1007/s004240050206
   OBERLEITHNER H, 1994, P NATL ACAD SCI USA, V91, P9784, DOI 10.1073/pnas.91.21.9784
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   Pante N, 1996, CRIT REV BIOCHEM MOL, V31, P153, DOI 10.3109/10409239609106583
   PANTE N, 1993, J CELL BIOL, V122, P977, DOI 10.1083/jcb.122.5.977
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 1997, RNA, V3, P498
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   PerezTerzic C, 1996, SCIENCE, V273, P1875, DOI 10.1126/science.273.5283.1875
   Radtke T, 2001, P NATL ACAD SCI USA, V98, P2407, DOI 10.1073/pnas.051616598
   Rakowska A, 1998, J MEMBRANE BIOL, V163, P129, DOI 10.1007/s002329900377
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Ribbeck K, 2001, EMBO J, V20, P1320, DOI 10.1093/emboj/20.6.1320
   Richards SA, 1997, SCIENCE, V276, P1842, DOI 10.1126/science.276.5320.1842
   RIS H, 1989, Journal of Cell Biology, V109, p134A
   Ris H, 1997, SCANNING, V19, P368, DOI 10.1002/sca.4950190504
   RIS H, 1993, J STRUCT BIOL, V111, P148, DOI 10.1006/jsbi.1993.1045
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   ROUT MP, 1993, J CELL BIOL, V123, P771, DOI 10.1083/jcb.123.4.771
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Sanner M. F., 2005, NANOBIOTECHNOLOGY, V1, P7
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stoffler D, 1999, CURR OPIN CELL BIOL, V11, P391, DOI 10.1016/S0955-0674(99)80055-6
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156
   ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331
NR 79
TC 40
Z9 41
U1 1
U2 7
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0009-5915
EI 1432-0886
J9 CHROMOSOMA
JI Chromosoma
PD FEB
PY 2006
VL 115
IS 1
BP 15
EP 26
DI 10.1007/s00412-005-0037-1
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 006CZ
UT WOS:000234874100002
PM 16402261
OA Green Published
DA 2021-01-25
ER

PT J
AU Houben, ENG
   Nguyen, L
   Pieters, J
AF Houben, ENG
   Nguyen, L
   Pieters, J
TI Interaction of pathogenic mycobacteria with the host immune system
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID TOLL-LIKE RECEPTORS; PHAGOSOME MATURATION ARREST;
   BACILLUS-CALMETTE-GUERIN; PLASMA-MEMBRANE; PHOSPHATIDYLINOSITOL
   3-PHOSPHATE; INTRAMEMBRANE PROTEOLYSIS; TUBERCULOSIS PHAGOSOME;
   VIRULENCE FACTORS; ESAT-6 SECRETION; GENE-CLUSTER
AB Pathogenic mycobacteria, in particular Mycobacterium tuberculosis, the causative agent of tuberculosis, have the remarkable capacity to circumvent destruction within one of the most hostile cell types of a vertebrate host: the macrophage. The ability of pathogenic mycobacteria to survive inside macrophages has been known for more than 30 years; yet, only recently have advances in molecular genetics, biochemistry, immunology, as well as global analysis of gene expression, started to unravel the strategies utilized by these pathogens for intracellular persistence. In addition, the definition of key molecules that are important for intracellular survival opens the possibility to develop new drugs to combat mycobacterial diseases.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Houben, Edith N.G./B-2110-2015
OI Houben, Edith N.G./0000-0002-8805-2002; Pieters,
   Jean/0000-0002-5284-9757; Nguyen, Liem/0000-0002-1523-1472
CR Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008
   Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753
   Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002
   Bishal WR, 2000, LANCET, V356, P2113, DOI 10.1016/S0140-6736(00)03485-1
   Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158
   Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x
   Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732
   Brodin P, 2004, TRENDS MICROBIOL, V12, P500, DOI 10.1016/j.tim.2004.09.007
   Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3
   Butler D, 2000, NATURE, V406, P670, DOI 10.1038/35021291
   Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200
   Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905
   Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101
   Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102
   Fortune SM, 2004, J IMMUNOL, V172, P6272, DOI 10.4049/jimmunol.172.10.6272
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Gatfield J, 2000, PROTOPLASMA, V210, P99, DOI 10.1007/BF01276849
   Geisel RE, 2005, J IMMUNOL, V174, P5007, DOI 10.4049/jimmunol.174.8.5007
   Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003
   Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360
   Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   Hernandez-Pando R, 2000, LANCET, V356, P2133, DOI 10.1016/S0140-6736(00)03493-0
   Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646
   Kelley VA, 2004, CELL MICROBIOL, V6, P973, DOI 10.1111/j.1462-5822.2004.00415.x
   Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005
   Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246
   Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005
   MacGurn JA, 2005, MOL MICROBIOL, V57, P1653, DOI 10.1111/j.1365-2958.2005.04800.x
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Majlessi L, 2005, J IMMUNOL, V174, P3570, DOI 10.4049/jimmunol.174.6.3570
   Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713
   Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009
   NGUYEN L, IN PRESS J BACTERIOL
   Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036
   Pai RK, 2004, INFECT IMMUN, V72, P6603, DOI 10.1128/IAI.72.11.6603-6614.2004
   Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006
   Pieters J, 2003, SCIENCE, V302, P1900, DOI 10.1126/science.1092873
   Pieters J, 2002, TRENDS MICROBIOL, V10, P142, DOI 10.1016/S0966-842X(02)02305-3
   Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859
   Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668
   Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837
   Rengarajan J, 2005, P NATL ACAD SCI USA, V102, P8327, DOI 10.1073/pnas.0503272102
   Renshaw PS, 2005, EMBO J, V24, P2491, DOI 10.1038/sj.emboj.7600732
   Rhee KY, 2005, P NATL ACAD SCI USA, V102, P467, DOI 10.1073/pnas.0406133102
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Sassetti CM, 2001, P NATL ACAD SCI USA, V98, P12712, DOI 10.1073/pnas.231275498
   Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846
   Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039
   Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100
   Thompson CR, 2005, J IMMUNOL, V174, P3551, DOI 10.4049/jimmunol.174.6.3551
   VanderVen BC, 2005, SCIENCE, V309, P941, DOI 10.1126/science.1114347
   Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004
NR 75
TC 99
Z9 113
U1 2
U2 22
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD FEB
PY 2006
VL 9
IS 1
BP 76
EP 85
DI 10.1016/j.mib.2005.12.014
PG 10
WC Microbiology
SC Microbiology
GA 022MY
UT WOS:000236061100012
PM 16406837
DA 2021-01-25
ER

PT J
AU Vohradsky, J
   Thompson, CJ
AF Vohradsky, J
   Thompson, CJ
TI Systems level analysis of protein synthesis patterns associated with
   bacterial growth and metabolic transitions
SO PROTEOMICS
LA English
DT Article
DE fuzzy clustering; principal component analysis; protein profiling;
   Streptomyces
ID STREPTOMYCES-COELICOLOR; ANTIBIOTIC BIOSYNTHESIS; DEVELOPMENTAL CONTROL;
   STATISTICAL-ANALYSES; ESCHERICHIA-COLI; EXPRESSION; DIFFERENTIATION;
   ORGANIZATION; CAMP
AB Gene expression databases, acquired by proteomics and transcriptomics, describe physiological and developmental programs at the systems level. Here we analyze proteosynthetic profiles in a bacterium undergoing defined metabolic changes. Streptomyces coelicolor cultured in a defined liquid medium displays four distinct patterns of gene expression associated with growth on glutamate, diauxic transition, and growth on maltose and ammonia that terminates by starvation for nitrogen and entry into stationary phase. Principal component and fuzzy cluster analyses of the proteome database of 935 protein spot profiles revealed principal kinetic patterns. Online linkage of the proteome database (SWICZ) to a protein-function database (KEGG) revealed limited correlations between expression profiles and metabolic pathway activities. Proteins belonging to principal metabolic pathways defined characteristic kinetic profiles correlated with the physiological state of the culture. These analyses supported the concept that metabolic flux was regulated not by individual enzymes but rather by groups of enzymes whose synthesis responded to changes in nutritional conditions. Higher-level regulation is reflected by the distribution of all kinetic profiles into only nine groups. The observation that enzymes representing principal metabolic pathways displayed their own distinctive average kinetic profiles suggested that expression of a "high-flux backbone" may dominate regulation of metabolic flux.
C1 Acad Sci Czech Republ, Inst Microbiol, CR-14220 Prague, Czech Republic.
   Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
RP Vohradsky, J (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Videnska 1083, CR-14220 Prague, Czech Republic.
EM vohr@biomed.cas.cz
CR Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289
   APPEL R, 1988, ELECTROPHORESIS, V9, P136, DOI 10.1002/elps.1150090307
   Bezdek J. C., 1973, Journal of Cybernetics, V3, P58
   Cashel M., 1996, ESCHERICHIA COLI SAL, P1458
   CHATER KF, 1993, ANNU REV MICROBIOL, V47, P685, DOI 10.1146/annurev.mi.47.100193.003345
   CHATER KF, 1982, GENE, V19, P21, DOI 10.1016/0378-1119(82)90185-8
   CRABTREE B, 1987, TRENDS BIOCHEM SCI, V12, P4, DOI 10.1016/0968-0004(87)90004-1
   EFRON B, 1998, INTRO BOOTSTRAP, P149
   FELL DA, 1995, BIOCHEM J, V311, P35, DOI 10.1042/bj3110035
   GARRELS JI, 1990, ELECTROPHORESIS, V11, P1114, DOI 10.1002/elps.1150111204
   KACSER H, 1993, EUR J BIOCHEM, V216, P361, DOI 10.1111/j.1432-1033.1993.tb18153.x
   KOLB A, 1993, ANNU REV BIOCHEM, V62, P749, DOI 10.1146/annurev.bi.62.070193.003533
   Novotna J, 2003, MOL MICROBIOL, V48, P1289, DOI 10.1046/j.1365-2958.2003.03529.x
   Pope MK, 1996, MOL MICROBIOL, V19, P747, DOI 10.1046/j.1365-2958.1996.414933.x
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   TAYLOR J, 1992, ELECTROPHORESIS, V13, P162, DOI 10.1002/elps.1150130133
   Viollier PH, 2001, J BACTERIOL, V183, P3184, DOI 10.1128/JB.183.10.3184-3192.2001
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
   Vohradsky J, 2000, J BACTERIOL, V182, P4979, DOI 10.1128/JB.182.17.4979-4986.2000
NR 21
TC 10
Z9 11
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD FEB
PY 2006
VL 6
IS 3
BP 785
EP 793
DI 10.1002/pmic.200500206
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 013MY
UT WOS:000235414600006
PM 16400688
DA 2021-01-25
ER

PT J
AU Gladfelter, AS
   Hungerbuehler, AK
   Philippsen, P
AF Gladfelter, AS
   Hungerbuehler, AK
   Philippsen, P
TI Asynchronous nuclear division cycles in multinucleated cells
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID YEAST SACCHAROMYCES-CEREVISIAE; ASCOMYCETE ASHBYA-GOSSYPII;
   ASPERGILLUS-NIDULANS; BUDDING YEAST; PORE COMPLEX; KEN BOX; MITOSIS;
   PROTEOLYSIS; PROTEIN; APC
AB Synchronous mitosis is common in multinucleated cells. We analyzed a unique asynchronous nuclear division cycle in a multinucleated filamentous fungus, Ashbya gossypii. Nuclear pedigree analysis and observation of GFP-labeled spindle pole bodies demonstrated that neighboring nuclei in A. gossypii cells are in different cell cycle stages despite close physical proximity. Neighboring nuclei did not differ significantly in their patterns of cyclin protein localization such that both G1 and mitotic cyclins were present regardless of cell cycle stage, suggesting that the complete destruction of cyclins is not occurring in this system. Indeed, the expression of mitotic cyclin lacking NH2-terminal destruction box sequences did not block cell cycle progression. Cells lacking AgSic1p, a predicted cyclin-dependent kinase (CDK) inhibitor, however, showed aberrant multipolar spindles and fragmented nuclei that are indicative of. awed mitoses. We hypothesize that the continuous cytoplasm in these cells promoted the evolution of a nuclear division cycle in which CDK inhibitors primarily control CDK activity rather than oscillating mitotic cyclin proteins.
C1 Univ Basel, Dept Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Gladfelter, AS (corresponding author), Univ Basel, Dept Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
EM amy.gladfelter@unibas.ch
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Belmont AS, 1998, TRENDS CELL BIOL, V8, P121, DOI 10.1016/S0962-8924(97)01211-7
   Chen KC, 2000, MOL BIOL CELL, V11, P369, DOI 10.1091/mbc.11.1.369
   CLUTTERBUCK AJ, 1970, J GEN MICROBIOL, V60, P133, DOI 10.1099/00221287-60-1-133
   Cross FR, 2005, MOL BIOL CELL, V16, P2129, DOI 10.1091/mbc.E04-10-0897
   Cross FR, 2003, DEV CELL, V4, P741, DOI 10.1016/S1534-5807(03)00119-9
   Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265
   De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050
   Demeter J, 2000, MOL CELL, V6, P487, DOI 10.1016/S1097-2765(00)00047-2
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Edgington NP, 2001, J CELL SCI, V114, P4599
   GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0
   Hendrickson C, 2001, CURR BIOL, V11, P1781, DOI 10.1016/S0960-9822(01)00564-4
   Hinchcliffe EH, 1999, J CELL SCI, V112, P1139
   Hoepfner D, 2002, MOL BIOL CELL, V13, P1366, DOI 10.1091/mbc.01-07-0338
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   HOLLOWAY SL, 1993, CELL, V73, P1393, DOI 10.1016/0092-8674(93)90364-V
   Hood JK, 2001, J CELL SCI, V114, P589
   Iborra FJ, 2001, SCIENCE, V293, P1139, DOI 10.1126/science.1061216
   Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   KNECHTLE P, 2002, THESIS BIOZENTRUM U
   Maekawa H, 2003, EMBO J, V22, P438, DOI 10.1093/emboj/cdg063
   Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3
   Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160
   Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8
   NYGAARD OF, 1960, BIOCHIM BIOPHYS ACTA, V38, P298, DOI 10.1016/0006-3002(60)91245-2
   Pfleger CM, 2000, GENE DEV, V14, P655
   Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016
   Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954
   PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565
   RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0
   Rieder CL, 1997, P NATL ACAD SCI USA, V94, P5107, DOI 10.1073/pnas.94.10.5107
   SALAMA SR, 1994, MOL CELL BIOL, V14, P7953, DOI 10.1128/MCB.14.12.7953
   Sambrook J., 2001, MOL CLONING LAB MANU
   Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273
   Thornton BR, 2003, NAT CELL BIOL, V5, P1090, DOI 10.1038/ncb1066
   Thornton BR, 2004, CELL CYCLE, V3, P629
   Vodermaier HC, 2001, CURR BIOL, V11, pR834, DOI 10.1016/S0960-9822(01)00498-5
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Yamano H, 1996, EMBO J, V15, P5268, DOI 10.1002/j.1460-2075.1996.tb00912.x
NR 43
TC 83
Z9 84
U1 0
U2 3
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD JAN 30
PY 2006
VL 172
IS 3
BP 347
EP 362
DI 10.1083/jcb.200507003
PG 16
WC Cell Biology
SC Cell Biology
GA 010JI
UT WOS:000235184100006
PM 16449188
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Arnold, K
   Bordoli, L
   Kopp, J
   Schwede, T
AF Arnold, K
   Bordoli, L
   Kopp, J
   Schwede, T
TI The SWISS-MODEL workspace: a web-based environment for protein structure
   homology modelling
SO BIOINFORMATICS
LA English
DT Article
ID AUTOSOMAL RECESSIVE DEAFNESS; CYSTEINE-RICH REPEAT; HIDDEN
   MARKOV-MODELS; STRUCTURE PREDICTION; SECONDARY STRUCTURE; 3D STRUCTURES;
   HUMAN HEPSIN; DATABASE; MUTATIONS; RECEPTOR
AB Motivation: Homology models of proteins are of great interest for planning and analysing biological experiments when no experimental three-dimensional structures are available. Building homology models requires specialized programs and up-to-date sequence and structural databases. Integrating all required tools, programs and databases into a single web-based workspace facilitates access to homology modelling from a computer with web connection without the need of downloading and installing large program packages and databases.
   Results: SWISS-MODEL workspace is a web-based integrated service dedicated to protein structure homology modelling. It assists and guides the user in building protein homology models at different levels of complexity. A personal working environment is provided for each user where several modelling projects can be carried out in parallel. Protein sequence and structure databases necessary for modelling are accessible from the workspace and are updated in regular intervals. Tools for template selection, model building and structure quality evaluation can be invoked from within the workspace. Workflow and usage of the workspace are illustrated by modelling human Cyclin A1 and human Transmembrane Protease 3.
C1 Univ Basel, Biozentrum Basel, CH-4003 Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum Basel, CH-4003 Basel, Switzerland.
EM Torsten.Schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Kopp, Juergen/0000-0001-5633-7399
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Bates PA, 2001, PROTEINS, P39
   BIERI S, 1995, BIOCHEMISTRY-US, V34, P13059, DOI 10.1021/bi00040a017
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334
   Davies TG, 2002, NAT STRUCT BIOL, V9, P745, DOI 10.1038/nsb842
   Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805
   Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5
   Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Hughey R, 1996, COMPUT APPL BIOSCI, V12, P95
   Hutchinson EG, 1996, PROTEIN SCI, V5, P212
   Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5
   JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0
   Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250
   Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lee YJ, 2003, J MED GENET, V40, P629, DOI 10.1136/jmg.40.8.629
   Li WZ, 2002, PROTEIN ENG, V15, P643, DOI 10.1093/protein/15.8.643
   Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282
   Liu D, 1998, NAT GENET, V20, P377, DOI 10.1038/3855
   Lund O, 1997, PROTEIN ENG, V10, P1241, DOI 10.1093/protein/10.11.1241
   Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291
   Masmoudi S, 2001, HUM MUTAT, V18, P101, DOI 10.1002/humu.1159
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011
   Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106
   Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024
   PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Scott HS, 2001, NAT GENET, V27, P59
   SHINDYALOV IN, 2000, P 4 M CRIT ASS TECHN, P92
   Somoza JR, 2003, STRUCTURE, V11, P1123, DOI 10.1016/S0969-2126(03)00148-5
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   Tress M., 2005, PROTEINS
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Velankar S, 2005, NUCLEIC ACIDS RES, V33, pD262, DOI 10.1093/nar/gki058
   Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6
   Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068
   Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062
   Wolgemuth DJ, 2004, INT J ANDROL, V27, P192, DOI 10.1111/j.1365-2605.2004.00480.x
   Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847
NR 57
TC 5359
Z9 5790
U1 8
U2 361
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
J9 BIOINFORMATICS
JI Bioinformatics
PD JAN 15
PY 2006
VL 22
IS 2
BP 195
EP 201
DI 10.1093/bioinformatics/bti770
PG 7
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA 010ST
UT WOS:000235218900011
PM 16301204
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Zou, PJ
   Pinotsis, N
   Lange, S
   Song, YH
   Popov, A
   Mavridis, I
   Mayans, OM
   Gautel, M
   Wilmanns, M
AF Zou, PJ
   Pinotsis, N
   Lange, S
   Song, YH
   Popov, A
   Mavridis, I
   Mayans, OM
   Gautel, M
   Wilmanns, M
TI Palindromic assembly of the giant muscle protein titin in the sarcomeric
   Z-disk
SO NATURE
LA English
DT Article
ID CROSS-LINKING; T-CAP; TELETHONIN; DOMAINS; ULTRASTRUCTURE; ANTIBODIES;
   MUTATIONS; INTERACTS; SUGGESTS; COMPLEX
AB The Z-disk of striated and cardiac muscle sarcomeres is one of the most densely packed cellular structures in eukaryotic cells(1). It provides the architectural framework for assembling and anchoring the largest known muscle filament systems by an extensive network of protein - protein interactions, requiring an extraordinary level of mechanical stability. Here we show, using X-ray crystallography, how the amino terminus of the longest filament component, the giant muscle protein titin, is assembled into an antiparallel ( 2: 1) sandwich complex by the Z-disk ligand telethonin. The pseudosymmetric structure of telethonin mediates a unique palindromic arrangement of two titin filaments, a type of molecular assembly previously found only in protein DNA-complexes. We have confirmed its unique architecture in vivo by protein complementation assays, and in vitro by experiments using fluorescence resonance energy transfer. The model proposed may provide a molecular paradigm of how major sarcomeric filaments are crosslinked, anchored and aligned within complex cytoskeletal networks.
C1 DESY, EMBL Hamburg, D-22603 Hamburg, Germany.
   Demokritos Natl Ctr Sci Res, Inst Phys Chem, GR-15310 Athens, Greece.
   Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England.
   Kings Coll London, Div Cardiovasc, London SE1 1UL, England.
   ETH, Inst Cell Biol, CH-8093 Zurich, Switzerland.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Wilmanns, M (corresponding author), DESY, EMBL Hamburg, Notleststr 85, D-22603 Hamburg, Germany.
EM wilmanns@embl-hamburg.de
RI Pinotsis, Nikos/AAD-4013-2019; Gautel, Mathias/AAB-9860-2019; Popov,
   Alexander/A-8827-2008; Pinotsis, Nikolaos/G-3853-2011; Lange,
   Stephan/A-1422-2010
OI Pinotsis, Nikos/0000-0002-5096-257X; Lange, Stephan/0000-0001-9361-6602;
   Gautel, Mathias/0000-0003-4027-9803; Wilmanns,
   Matthias/0000-0002-4643-5435; Mayans, Olga/0000-0001-6876-8532; Popov,
   Alexander/0000-0002-3058-8912
FU Medical Research CouncilMedical Research Council UK (MRC) [G0200496]
   Funding Source: Medline
CR Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853
   Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297
   Clark KA, 2002, ANNU REV CELL DEV BI, V18, P637, DOI 10.1146/annurev.cellbio.18.012502.105840
   Djinovic-Carugo K, 1999, CELL, V98, P537, DOI 10.1016/S0092-8674(00)81981-9
   Fang DY, 2004, P NATL ACAD SCI USA, V101, P14782, DOI 10.1073/pnas.0404445101
   Faulkner G, 2001, IUBMB LIFE, V51, P275, DOI 10.1080/152165401317190761
   Frey N, 2002, J BIOL CHEM, V277, P13998, DOI 10.1074/jbc.M200712200
   FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563
   Furukawa T, 2001, J MOL BIOL, V313, P775, DOI 10.1006/jmbi.2001.5053
   Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013
   GUDDAT LW, 1995, FASEB J, V9, P101
   Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058
   Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6
   Kontrogianni-Konstantopoulos A, 2003, J BIOL CHEM, V278, P3985, DOI 10.1074/jbc.M209012200
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938
   Liversage AD, 2001, J MOL BIOL, V305, P401, DOI 10.1006/jmbi.2000.4279
   Luther PK, 2002, J MOL BIOL, V319, P1157, DOI 10.1016/S0022-2836(02)00372-8
   Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603
   Moreira ES, 2000, NAT GENET, V24, P163, DOI 10.1038/72822
   Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8
   Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9
   Ramsland PA, 2002, J MOL RECOGNIT, V15, P248, DOI 10.1002/jmr.585
   Remenyi A, 2004, NAT STRUCT MOL BIOL, V11, P812, DOI 10.1038/nsmb820
   Schroder R, 2001, J MUSCLE RES CELL M, V22, P259, DOI 10.1023/A:1012242011109
   Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145
   Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198
   Wang J, 2005, CELL MOTIL CYTOSKEL, V61, P34, DOI 10.1002/cm.20063
   Young P, 1998, EMBO J, V17, P1614, DOI 10.1093/emboj/17.6.1614
   Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200
NR 30
TC 120
Z9 123
U1 0
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JAN 12
PY 2006
VL 439
IS 7073
BP 229
EP 233
DI 10.1038/nature04343
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 001MT
UT WOS:000234538400046
PM 16407954
OA Green Published
DA 2021-01-25
ER

PT S
AU Burger, L
   van Nimwegen, E
AF Burger, Lukas
   van Nimwegen, Erik
BE Bucher, P
   Moret, BME
TI A Bayesian algorithm for reconstructing two-component signaling networks
SO ALGORITHMS IN BIOINFORMATICS, PROCEEDINGS
SE Lecture Notes in Computer Science
LA English
DT Article; Proceedings Paper
CT 6th International Workshop on Algorithms in Bioinformatics (WABI 2006)
CY SEP 11-13, 2006
CL Zurich, SWITZERLAND
SP Int Soc Computat Biol, European Assoc Theoret Comp Sci, Eidgenoss Tech Hochschule Zurich
ID CELL-CYCLE PROGRESSION
AB We present an algorithm, based on a Bayesian network model, for ab initio prediction of signaling interactions in bacterial two-component systems. The algorithm uses a large training set of known interacting kinase/receiver pairs to build a probabilistic model of dependency between the amino acid sequences of the two proteins and uses this model to predict which pairs interact. We show that the algorithm can accurately reconstruct cognate kinase/receiver pairs across all sequenced bacteria. We also present predictions of interacting orphan kinase/receiver pairs in the bacterium Caulobacter crescentus and show that these significantly overlap with experimentally observed interactions.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Burger, L (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM lukas.burger@unibas.ch; erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
CR Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142
   Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705
   Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8
   Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003
   Ramani AK, 2003, J MOL BIOL, V327, P273, DOI 10.1016/S0022-2836(03)00114-1
   Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864
   Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
NR 11
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
EI 1611-3349
BN 3-540-39583-0
J9 LECT NOTES COMPUT SC
PY 2006
VL 4175
BP 44
EP 55
PG 12
WC Biochemical Research Methods; Computer Science, Interdisciplinary
   Applications; Computer Science, Theory & Methods
SC Biochemistry & Molecular Biology; Computer Science
GA BFI95
UT WOS:000242125600005
DA 2021-01-25
ER

PT J
AU Bouvignies, G
   Meier, S
   Grzesiek, S
   Blackledge, M
AF Bouvignies, Guillaume
   Meier, Sebastian
   Grzesiek, Stephan
   Blackledge, Martin
TI Ultrahigh-resolution backbone structure of perdeuterated protein GB1
   using residual dipolar couplings from two alignment media
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE NMR spectroscopy; protein dynamics; protein structures; residual dipolar
   couplings
ID BINDING DOMAIN; NMR STRUCTURES; BIOMOLECULES; DYNAMICS; MACROMOLECULES
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Grenoble 1, CNRS, CEA, UMR 5075,Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch; martin.blackledge@ibs.fr
RI Bouvignies, Guillaume/C-1009-2008; Meier, Sebastian/A-4279-2015
OI Bouvignies, Guillaume/0000-0003-4398-0320; Meier,
   Sebastian/0000-0003-3761-3217; Grzesiek, Stephan/0000-0003-1998-4225
CR Beraud S, 2002, J AM CHEM SOC, V124, P13709, DOI 10.1021/ja0268783
   Bernado P, 2004, J AM CHEM SOC, V126, P4907, DOI 10.1021/ja036977w
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Bouvignies G, 2005, J MAGN RESON, V173, P328, DOI 10.1016/j.jmr.2005.01.001
   BRUSCHWEILER R, 1994, J AM CHEM SOC, V116, P8426
   Chou JJ, 2001, J AM CHEM SOC, V123, P3844, DOI 10.1021/ja015660y
   Clore GM, 1997, NAT STRUCT BIOL, V4, P849
   Delaglio F, 2000, J AM CHEM SOC, V122, P2142, DOI 10.1021/ja993603n
   DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   GALLAGHER T, 1994, BIOCHEMISTRY-US, V33, P4721, DOI 10.1021/bi00181a032
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HOLLAND PW, 1977, COMMUN STAT A-THEOR, V6, P813, DOI 10.1080/03610927708827533
   Hus JC, 2001, J AM CHEM SOC, V123, P1541, DOI 10.1021/ja005590f
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Neuhaus D., 2000, NUCL OVERHAUSER EFFE
   Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
NR 20
TC 24
Z9 24
U1 0
U2 8
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1433-7851
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2006
VL 45
IS 48
BP 8166
EP 8169
DI 10.1002/anie.200603627
PG 4
WC Chemistry, Multidisciplinary
SC Chemistry
GA 118GD
UT WOS:000242929500020
PM 17120284
DA 2021-01-25
ER

PT S
AU Jenal, U
   Malone, J
AF Jenal, Urs
   Malone, Jacob
TI Mechanisms of cyclic-di-GMP signaling in bacteria
SO ANNUAL REVIEW OF GENETICS
SE Annual Review of Genetics
LA English
DT Review; Book Chapter
DE cyclic-di-GMP (c-di-GMP); GGDEF; EAL; diguanylate cyclase;
   phosphodiesterase; biofilm
ID SMALL-COLONY VARIANTS; CHOLERAE BIOFILM FORMATION; EAL DOMAIN PROTEIN;
   PSEUDOMONAS-AERUGINOSA; ACETOBACTER-XYLINUM; VIBRIO-CHOLERAE; CELLULOSE
   SYNTHESIS; CAULOBACTER-CRESCENTUS; ESCHERICHIA-COLI; RESPONSE REGULATOR
AB Cyclic-di-GMP is a ubiquitous second messenger in bacteria. The recent discovery that c-di-GMP antagonistically controls motility and virulence of single, planktonic cells on one hand and cell adhesion and persistence of multicellular communities on the other has spurred interest in this regulatory compound. Cellular levels of c-di-GMP are controlled through the opposing activities of diguanylate cyclases and phosphodiesterases, which represent two large families of output domains found in bacterial one- and two-coniponent systems. This review concentrates on structural and functional aspects of diguanylate cyclases and phosphodiesterases, and on their role in transmitting environmental stimuli into a range of different cellular functions. In addition, we examine several well-established model systems for c-di-GMP signaling, including Pseudomonas, Vibrio, Caulobacter, and Salmonella.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Malone, Jacob/G-8319-2011
OI Malone, Jacob/0000-0003-1959-6820
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448
   ALONI Y, 1983, J BIOL CHEM, V258, P4419
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6
   ARICO B, 1989, P NATL ACAD SCI USA, V86, P6671, DOI 10.1073/pnas.86.17.6671
   Baker DA, 2004, MOL MICROBIOL, V52, P1229, DOI 10.1111/j.1365-2958.2004.04067.x
   BENZIMAN M, 1983, J APPL POLYM SCI, V37, P131
   Beyhan S, 2006, J BACTERIOL, V188, P3600, DOI 10.1128/JB.188.10.3600-3613.2006
   Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036
   Bodenmiller D, 2004, J BACTERIOL, V186, P1438, DOI 10.1128/JB.186.5.1438-1447.2004
   Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002
   Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003
   Boucher RC, 2004, EUR RESPIR J, V23, P146, DOI 10.1183/09031936.03.00057003
   Bradley J, 2005, CURR OPIN NEUROBIOL, V15, P343, DOI 10.1016/j.conb.2005.05.014
   Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004
   CHRISTEN B, 2006, IN PRESS J BIOL CHEM
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319
   Cui X, 2002, EUR J PHARMACOL, V451, P295, DOI 10.1016/S0014-2999(02)02294-X
   D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006
   DELMER DP, 1983, ADV CARBOHYD CHEM BI, V41, P105, DOI 10.1016/S0065-2318(08)60057-8
   Deziel E, 2001, J BACTERIOL, V183, P1195, DOI 10.1128/JB.183.4.1195-1204.2001
   Dow JM, 2003, P NATL ACAD SCI USA, V100, P10995, DOI 10.1073/pnas.1833360100
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Enos-Berlage JL, 2005, MOL MICROBIOL, V55, P1160, DOI 10.1111/j.1365-2958.2004.04453.x
   Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004
   Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006
   Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x
   Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x
   GLASER L, 1958, J BIOL CHEM, V232, P627
   Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020
   Goymer P, 2006, GENETICS, V173, P515, DOI 10.1534/genetics.106.055863
   Green J, 2001, ADV MICROB PHYSIOL, V44, P1, DOI 10.1016/S0065-2911(01)44010-0
   Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644
   Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0
   Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019
   Jackson KD, 2004, J BACTERIOL, V186, P4466, DOI 10.1128/JB.186.14.4466-4475.2004
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Johnson MR, 2005, MOL MICROBIOL, V55, P664, DOI 10.1111/j.1365-2958.2004.04419.x
   Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x
   Karatan E, 2005, J BACTERIOL, V187, P7434, DOI 10.1128/JB.187.21.7434-7443.2005
   KAUSHAL R, 1951, BIOCHEM J, V48, P618, DOI 10.1042/bj0480618
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Kim YR, 2003, INFECT IMMUN, V71, P5461, DOI 10.1128/IAI.71.10.5461-5471.2003
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005
   Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147
   Kovacikova G, 2005, MOL MICROBIOL, V57, P420, DOI 10.1111/j.1365-2958.2005.04700.x
   Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3
   Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005
   Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040
   Landry RM, 2006, MOL MICROBIOL, V59, P142, DOI 10.1111/j.1365-2958.2005.04941.x
   Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003
   Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05
   Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x
   MACLACHLAN G, 1979, METHODOLOGICAL SUR B, V9, P147
   MAYER R, 1991, P NATL ACAD SCI USA, V88, P5472, DOI 10.1073/pnas.88.12.5472
   McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694
   Mendez-Ortiz MM, 2006, J BIOL CHEM, V281, P8090, DOI 10.1074/jbc.M510701200
   Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   Perry RD, 2004, J BACTERIOL, V186, P1638, DOI 10.1128/JB.186.6.1638-1647.2004
   Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900
   RAINEY PB, 2006, UNPUB ADAPTIVE DIVER, V3
   Rajagopal S, 2004, PHOTOCHEM PHOTOBIOL, V80, P542, DOI 10.1562/0031-8655(2004)080<0542:PAICOA>2.0.CO;2
   Raphael BH, 2005, J BACTERIOL, V187, P3662, DOI 10.1128/JB.187.11.3662-3670.2005
   Rashid MH, 2003, FEMS MICROBIOL LETT, V227, P113, DOI 10.1016/S0378-1097(03)00657-8
   Roe Michael Wm., 2006, V319, P37
   Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x
   Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010
   ROSS P, 1986, CARBOHYD RES, V149, P101, DOI 10.1016/S0008-6215(00)90372-0
   ROSS P, 1985, FEBS LETT, V186, P191, DOI 10.1016/0014-5793(85)80706-7
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   ROSS P, 1990, J BIOL CHEM, V265, P18933
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864
   Spiers AJ, 2002, GENETICS, V161, P33
   Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Tischler AD, 2002, J BACTERIOL, V184, P4104, DOI 10.1128/JB.184.15.4104-4113.2002
   Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006
   Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898
   WEBER H, 2006, IN PRESS MOL MICROBI
   Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7
   Wilde A, 2002, MOL MICROBIOL, V44, P981, DOI 10.1046/j.1365-2958.2002.02923.x
   Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x
   Zogaj X, 2003, INFECT IMMUN, V71, P4151, DOI 10.1128/IAI.71.7.4151-4158.2003
NR 120
TC 450
Z9 476
U1 5
U2 122
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-4197
BN 978-0-8243-1240-4
J9 ANNU REV GENET
JI Annu. Rev. Genet.
PY 2006
VL 40
BP 385
EP 407
DI 10.1146/annurev.genet.40.110405.090423
PG 23
WC Genetics & Heredity
SC Genetics & Heredity
GA 119UB
UT WOS:000243038200015
PM 16895465
DA 2021-01-25
ER

PT J
AU Kaufmann, TC
   Engel, A
   Remigy, HW
AF Kaufmann, TC
   Engel, A
   Remigy, HW
TI A novel method for detergent concentration determination
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MEMBRANE-PROTEIN; SURFACTANT SOLUTIONS; NONIONIC DETERGENTS; SPREADING
   DYNAMICS; AQUEOUS FILMS; CRYSTALLIZATION; MICELLE; TRANSITION; LIPIDS;
   SIZE
AB A fast and precise method for detergent concentration determination is presented. Patent applications for the method described here have been submitted (EP05011904 and US60/702,261). Depending on the interest of the scientific community, the system will be commercialized. ( For further information contact Herve-W. Remigy at the e-mail address below.) A small droplet of the detergent solution is deposited on a piece of Parafilm M and side views are recorded by two orthogonally arranged TV cameras. The droplet contours are then approximated by ellipses to determine the contact angles. Comparison of the observed contact angle values to calibrated standard curves of known detergent concentrations gives the concentration of the detergent assessed. A range of commonly used detergents was studied to demonstrate the reproducibility and precision of this simple method. As a first application, the detergent binding capacity of the Escherichia coli galactose/proton symporter ( GalP) was assessed. Aggregation of GalP was observed when < 260 +/- 5 dodecyl-beta, D-maltoside molecules were bound to one GalP molecule. These measurements document the efficacy of the drop-shape based detergent concentration determination described.
C1 Univ Basel, ME Muller Inst Microscopy, Biozentrum, Basel, Switzerland.
RP Remigy, HW (corresponding author), Univ Basel, ME Muller Inst Microscopy, Biozentrum, Basel, Switzerland.
EM herve.remigy@unibas.ch
CR Ai X, 2000, BIOPHYS J, V79, P394, DOI 10.1016/S0006-3495(00)76301-6
   BHAIRI SM, 2001, GUID PROPERTIES USES
   Caffrey M, 2003, J STRUCT BIOL, V142, P108, DOI 10.1016/S1047-8477(03)00043-1
   daCosta CJB, 2003, ACTA CRYSTALLOGR D, V59, P77, DOI 10.1107/S0907444902019236
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0
   Dutschk V, 2003, J COLLOID INTERF SCI, V267, P456, DOI 10.1016/S0021-9797(03)00723-9
   Eriks LR, 2003, ANAL BIOCHEM, V323, P234, DOI 10.1016/j.ab.2003.09.002
   IKEDA S, 1979, J COLLOID INTERF SCI, V70, P448, DOI 10.1016/0021-9797(79)90052-3
   IKEDA S, 1978, J COLLOID INTERF SCI, V67, P336, DOI 10.1016/0021-9797(78)90018-8
   Janczuk B, 1999, J COLLOID INTERF SCI, V211, P96, DOI 10.1006/jcis.1998.5990
   Jang J, 2004, J MATER CHEM, V14, P2872, DOI 10.1039/b405607h
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   KONING RI, 2003, CRYOELECTRON CRYSTAL
   Kwok DY, 2000, COLLOID SURFACE A, V161, P31, DOI 10.1016/S0927-7757(99)00323-4
   Lau FW, 1997, BIOCHEMISTRY-US, V36, P5884, DOI 10.1021/bi963095j
   le Maire M, 2000, BBA-BIOMEMBRANES, V1508, P86, DOI 10.1016/S0304-4157(00)00010-1
   LEMAIRE M, 1983, EUR J BIOCHEM, V129, P525
   LI D, 1992, J COLLOID INTERF SCI, V148, P190, DOI 10.1016/0021-9797(92)90127-8
   Marone PA, 1999, J CRYST GROWTH, V207, P214, DOI 10.1016/S0022-0248(99)00372-3
   MOLLER JV, 1993, J BIOL CHEM, V268, P18659
   Myers D., 1991, SURFACES INTERFACES
   NEUMANN AW, 1974, J COLLOID INTERF SCI, V49, P291, DOI 10.1016/0021-9797(74)90365-8
   Noy D, 2003, ANAL BIOCHEM, V320, P185, DOI 10.1016/S0003-2697(03)00347-6
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467
   Ringler P, 2000, PRACT APPROACH SER, P229
   Ruso JM, 2000, COLLOID POLYM SCI, V278, P800, DOI 10.1007/s003960000343
   SCHICK MJ, 1962, J COLL SCI IMP U TOK, V17, P801, DOI 10.1016/0095-8522(62)90060-0
   Starov VM, 2000, J COLLOID INTERF SCI, V227, P185, DOI 10.1006/jcis.2000.6851
   Stoebe T, 1997, LANGMUIR, V13, P7276, DOI 10.1021/la9707033
   Stoebe T, 1997, LANGMUIR, V13, P7270, DOI 10.1021/la970702a
   von Bahr M, 2001, COLLOID SURFACE A, V193, P85, DOI 10.1016/S0927-7757(01)00756-7
   von Bahr M, 1999, LANGMUIR, V15, P7069, DOI 10.1021/la990276o
   Walter A, 2000, BBA-BIOMEMBRANES, V1508, P20, DOI 10.1016/S0304-4157(00)00005-8
   ZULAUF M, 1990, CRYSTALLIZATION MEMB, P209
   2004, SURFACE TENSION VALU
NR 37
TC 45
Z9 46
U1 2
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2006
VL 90
IS 1
BP 310
EP 317
DI 10.1529/biophysj.105.070193
PG 8
WC Biophysics
SC Biophysics
GA 992LJ
UT WOS:000233885100031
PM 16214861
OA Green Published
DA 2021-01-25
ER

PT J
AU Wullschleger, S
   Loewith, R
   Hall, MN
AF Wullschleger, Stephan
   Loewith, Robbie
   Hall, Michael N.
TI TOR signaling in growth and metabolism
SO CELL
LA English
DT Review
ID MAMMALIAN TARGET; TUMOR-SUPPRESSOR; TUBEROUS-SCLEROSIS; CELL-GROWTH;
   AMINO-ACIDS; RAPAMYCIN MTOR; S6 KINASE; ACTIN CYTOSKELETON;
   GENE-TRANSCRIPTION; BINDING PARTNER
AB The target of rapamycin (TOR) is a conserved Ser/Thr kinase that regulates cell growth and metabolism in response to environmental cues. Here, highlighting contributions from studies in model organisms, we review mammalian TOR complexes and the signaling branches they mediate. TOR is part of two distinct multiprotein complexes, TOR complex 1 (TORC1), which is sensitive to rapamycin, and TORC2, which is not. The physiological consequences of mammalian TORC1 dysregulation suggest that inhibitors of mammalian TOR may be useful in the treatment of cancer, cardiovascular disease, autoimmunity, and metabolic disorders.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Geneva, Dept Biol Mol, CH-1211 Geneva 4, Switzerland.
RP Wullschleger, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
CR Astrinidis A, 2002, ONCOGENE, V21, P8470, DOI 10.1038/sj.onc.1205962
   Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384
   Ballif BA, 2005, P NATL ACAD SCI USA, V102, P667, DOI 10.1073/pnas.0409143102
   Barlund M, 2000, J NATL CANCER I, V92, P1252, DOI 10.1093/jnci/92.15.1252
   Basso AD, 2005, J BIOL CHEM, V280, P31101, DOI 10.1074/jbc.M503763200
   Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028
   Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040
   Bjornsti MA, 2004, CANCER CELL, V5, P519, DOI 10.1016/j.ccr.2004.05.027
   Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804
   Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200
   Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0
   Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141
   Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200
   Choi KM, 2003, J BIOL CHEM, V278, P19667, DOI 10.1074/jbc.M301142200
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365
   Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X
   Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104
   Crespo JL, 2005, PLANT PHYSIOL, V139, P1736, DOI 10.1104/pp.105.070847
   Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Dancey JE, 2005, EXPERT OPIN INV DRUG, V14, P313, DOI 10.1517/13543784.14.3.313
   Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095
   Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504
   Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102
   Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542
   Gan BY, 2005, J CELL BIOL, V170, P379, DOI 10.1083/jcb.200411106
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Gershlick AH, 2005, HEART, V91, pIII24, DOI 10.1136/hrt.2005.060277
   Gstaiger M, 2003, SCIENCE, V302, P1208, DOI 10.1126/science.1088401
   Hahn-Windgassen A, 2005, J BIOL CHEM, V280, P32081, DOI 10.1074/jbc.M502876200
   Hannan KM, 2003, MOL CELL BIOL, V23, P8862, DOI 10.1128/MCB.23.23.8862-8877.2003
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200
   Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024
   Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Johannessen CM, 2005, P NATL ACAD SCI USA, V102, P8573, DOI 10.1073/pnas.0503224102
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748
   Kristof AS, 2003, J BIOL CHEM, V278, P33637, DOI 10.1074/jbc.M301053200
   Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x
   Lazar MA, 2005, SCIENCE, V307, P373, DOI 10.1126/science.1104342
   Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342
   Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith Robbie, 2004, VVolume 42, P139
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660
   Lynch M, 2004, J BIOL CHEM, V279, P3327, DOI 10.1074/jbc.M310872200
   Ma L, 2005, CELL, V121, P179, DOI 10.1016/j.cell.2005.02.031
   Ma L, 2005, GENE DEV, V19, P1779, DOI 10.1101/gad.1314405
   Manning BD, 2005, GENE DEV, V19, P1773, DOI 10.1101/gad.1314605
   Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161
   Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008
   Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047
   Martin PM, 2001, DEV BIOL, V240, P182, DOI 10.1006/dbio.2001.0461
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   McMahon LP, 2005, MOL ENDOCRINOL, V19, P175, DOI 10.1210/me.2004-0305
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102
   Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002
   Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101
   Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042
   Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005
   Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605
   Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141
   Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996
   Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4
   Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5
   Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Sigal A, 2000, CANCER RES, V60, P6788
   Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200
   Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005
   Teleman AA, 2005, DEV CELL, V9, P271, DOI 10.1016/j.devcel.2005.07.004
   Thomas G., 2004, TOR TARGET RAPAMYCIN
   Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x
   Tremblay F, 2005, CURR OPIN CLIN NUTR, V8, P457, DOI 10.1097/01.mco.0000172589.55434.03
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x
   Vignot S, 2005, ANN ONCOL, V16, P525, DOI 10.1093/annonc/mdi113
   Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839
   Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175
   Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Young DA, 2005, CURR OPIN PHARMACOL, V5, P418, DOI 10.1016/j.coph.2005.03.004
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   ZHANG Y, 2005, GENETICS        1011, DOI DOI 10.1534/GENETICS.105.051979
NR 117
TC 262
Z9 264
U1 1
U2 36
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PY 2006
VL 127
IS 3
SU S
BP 5
EP 19
DI 10.1016/j.cell.2006.01.016
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 105HV
UT WOS:000242021900002
OA Green Published
DA 2021-01-25
ER

PT J
AU Muller, SA
   Engel, A
AF Mueller, Shirley A.
   Engel, Andreas
TI Biological scanning transmission electron microscopy: Imaging and single
   molecule mass determination
SO CHIMIA
LA English
DT Article
DE mass determination; scanning transmission electron microscopy; STEM
ID URE2P PRION FILAMENTS; STRUCTURAL-ANALYSIS; SECRETIN PULD; FIBRILS;
   MODEL; ARCHITECTURE; PRECISION; COMPLEX; FORMS
AB Scanning transmission electron microscopes can both measure the mass of single protein complexes and take amazingly clear images thereof, offering a wide range of applications in structural biology The principle of mass measurement is presented and discussed and the scope of scanning transmission electron microscopy is illustrated by selected examples.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
CR Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185
   AUSTIN JW, 1989, J ULTRA MOL STRUCT R, V102, P255, DOI 10.1016/0889-1605(89)90020-7
   BASCHONG W, 1991, J STRUCT BIOL, V106, P93, DOI 10.1016/1047-8477(91)90078-B
   Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   Beniac DR, 2000, J STRUCT BIOL, V129, P80, DOI 10.1006/jsbi.1999.4200
   BINNIG G, 1982, HELV PHYS ACTA, V55, P726
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   COLLIEX C, 1994, BIOL CELL, V80, P175, DOI 10.1016/0248-4900(94)90040-X
   CREWE AV, 1970, J MOL BIOL, V48, P375, DOI 10.1016/0022-2836(70)90052-5
   CREWE AV, 1971, P 29 ANN EMSA M, P24
   Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619
   ENGEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4050, DOI 10.1073/pnas.79.13.4050
   ENGEL A, 1974, J APPL PHYS, V45, P2739, DOI 10.1063/1.1663659
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   Engel Andreas, 1993, Current Opinion in Biotechnology, V4, P403, DOI 10.1016/0958-1669(93)90005-H
   ENGELHARDT H, 1986, P NATL ACAD SCI USA, V83, P8972, DOI 10.1073/pnas.83.23.8972
   Gakh O, 2002, BIOCHEMISTRY-US, V41, P6798, DOI 10.1021/bi025566+
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Graham HK, 2000, J MOL BIOL, V295, P891, DOI 10.1006/jmbi.1999.3384
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Hahn E, 2000, J STRUCT BIOL, V132, P241, DOI 10.1006/jsbi.2000.4323
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   Hegner M, 2002, CHIMIA, V56, P506, DOI 10.2533/000942902777680090
   Holmes DF, 2005, J MOL BIOL, V345, P773, DOI 10.1016/j.jmb.2004.10.078
   Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Leapman RD, 2003, J MICROSC-OXFORD, V210, P5, DOI 10.1046/j.1365-2818.2003.01173.x
   LEAPMAN RD, 1992, J MICROSC-OXFORD, V165, P225, DOI 10.1111/j.1365-2818.1992.tb01482.x
   LEAPMAN RD, 1995, J MICROSC SOC AM, V1, P93
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078
   Muller SA, 1998, J STRUCT BIOL, V121, P219, DOI 10.1006/jsbi.1997.3953
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, J MOL BIOL, V305, P1035, DOI 10.1006/jmbi.2000.4363
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   Trachtenberg S, 2003, J BACTERIOL, V185, P1987, DOI 10.1128/JB.185.6.1987-1994.2003
   Trotter JA, 1998, J MOL BIOL, V284, P1417, DOI 10.1006/jmbi.1998.2230
   Tsiotis G, 1996, J MOL BIOL, V259, P241, DOI 10.1006/jmbi.1996.0316
   WALL J, 1974, P NATL ACAD SCI USA, V71, P1, DOI 10.1073/pnas.71.1.1
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   WALL JS, 1971, HIGH RESOLUTION SCAN
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   WALZTHONY D, 1984, EMBO J, V3, P2621, DOI 10.1002/j.1460-2075.1984.tb02183.x
   Wenzel RJ, 2005, ANAL CHEM, V77, P4329, DOI 10.1021/ac0482054
   Yuan JF, 2005, GENE DEV, V19, P840, DOI 10.1101/gad.1291405
NR 51
TC 22
Z9 22
U1 0
U2 17
PU SWISS CHEMICAL SOC
PI BERN
PA SCHWARZTORSTRASSE 9, CH-3007 BERN, SWITZERLAND
SN 0009-4293
J9 CHIMIA
JI Chimia
PY 2006
VL 60
IS 11
BP A749
EP A753
DI 10.2533/chimia.2006.749
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 112JB
UT WOS:000242520700005
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Neumann, M
   Affolter, M
AF Neumann, M
   Affolter, M
TI Remodelling epithelial tubes through cell rearrangements: from cells to
   molecules
SO EMBO REPORTS
LA English
DT Article
DE adherens junctions; Drosophila; E-cadherin; epithelia; intercalation;
   tubulogenesis
ID DROSOPHILA TRACHEAL SYSTEM; E-CADHERIN; BRANCHING MORPHOGENESIS;
   ADHERENS JUNCTIONS; IN-VIVO; PROTEIN; ENDOCYTOSIS; ADHESION; FGF;
   TUBULOGENESIS
AB Epithelial cell movements, such as those that occur during cell intercalation, largely contribute to the formation of epithelial structures during the morphogenesis of multicellular organisms. As the architecture of epithelial tissues relies on strong adhesion between cells at adherens junctions (AJs), the intercalation or rearrangements of epithelial cells might be controlled by modulating the adhesion dynamics of the AJs by internal or external forces. In this review, we describe recent progress in understanding cell rearrangements during epithelial tube remodelling and discuss several models that might account for the developmental control of the spatial dynamics of AJs.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Bauer R, 2005, CHEM BIOL, V12, P515, DOI 10.1016/j.chembiol.2005.02.013
   Beloussov LV, 2000, DEV GENES EVOL, V210, P92, DOI 10.1007/s004270050015
   Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590
   Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   D'Souza-Schorey C, 2005, TRENDS CELL BIOL, V15, P19, DOI 10.1016/j.tcb.2004.11.002
   Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903
   FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8
   Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758
   Fukata M, 2001, NAT REV MOL CELL BIO, V2, P887, DOI 10.1038/35103068
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004
   JACOBSON AG, 1986, J EMBRYOL EXP MORPH, V96, P19
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478
   Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007
   Llimargas M, 2000, DEVELOPMENT, V127, P4407
   Manning Gerards, 1993, P609
   Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246
   Palacios F, 2002, NAT CELL BIOL, V4, P929, DOI 10.1038/ncb881
   Paterson AD, 2003, J BIOL CHEM, V278, P21050, DOI 10.1074/jbc.M300082200
   Price LS, 2004, J BIOL CHEM, V279, P35127, DOI 10.1074/jbc.M404917200
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Takahashi M, 2005, DEVELOPMENT, V132, P2547, DOI 10.1242/dev.01850
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Wassarman PM, 2004, CYTOGENET GENOME RES, V105, P228, DOI 10.1159/000078193
   Williams-Masson EM, 1998, DEV BIOL, V204, P263, DOI 10.1006/dbio.1998.9048
   Wu VM, 2004, CURR OPIN CELL BIOL, V16, P493, DOI 10.1016/j.ceb.2004.07.008
   Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7
NR 39
TC 21
Z9 21
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD JAN
PY 2006
VL 7
IS 1
BP 36
EP 40
DI 10.1038/sj.embor.7400597
PG 5
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 023QV
UT WOS:000236142200011
PM 16391535
OA Green Published
DA 2021-01-25
ER

PT J
AU Brewster, AL
   Bender, RA
   Kuisle, M
   Pinault, D
   Shigemoto, R
   Anita, L
   Baram, TZ
AF Brewster, Amy L.
   Bender, Roland A.
   Kuisle, Mira
   Pinault, Didier
   Shigemoto, Ryuichi
   Anita, Luthi
   Baram, Tallie Z.
TI The normal and epileptic thalamus: Developmental expression of
   hyperpolarization-activated cyclic nucleotide-gated (HCN) channel
   isoforms and their role in epileptogenesis
SO EPILEPSIA
LA English
DT Meeting Abstract
CT 60th Annual Meeting of the American-Epilepsy-Society
CY DEC 01-05, 2006
CL San Diego, CA
SP Amer Epilepsy Soc
C1 Univ Calif Irvine, Irvine, CA USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi, Japan.
   Fac Med, Strasbourg, France.
RI Pinault, Didier/H-7816-2016; Shigemoto, Ryuichi/E-3628-2013
OI Pinault, Didier/0000-0003-3807-4817; Shigemoto,
   Ryuichi/0000-0001-8761-9444
NR 0
TC 0
Z9 0
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0013-9580
J9 EPILEPSIA
JI Epilepsia
PY 2006
VL 47
SU 4
BP 207
EP 207
PG 1
WC Clinical Neurology
SC Neurosciences & Neurology
GA 096OA
UT WOS:000241385501062
DA 2021-01-25
ER

PT S
AU Arber, W
AF Arber, Werner
BE ZurHausen, H
TI Molecular basis of the biological evolution
SO EVOLUTION UND MENSCHWERDUNG
SE NOVA ACTA LEOPOLDINA
LA German
DT Proceedings Paper
CT Conference on Evolution and Menschwerdung
CY OCT09, 2005
CL Halle, GERMANY
SP Deutsch Akad Naturforscher Leopoldina
AB According to the Neo-Darwinian theory Of evolution spontaneous mutagenesis is the driving force of biological evolution. while the direction of evolution depends on natural selection together with the available genetic variants. The methods of molecular genetics enable us to investigate the molecular mechanisms of genetic variation. Such studies can best be done with bacteria. Their haploid genome manifests rapidly the phenotypes of new mutations. Altered nucleotide sequences are rather rarely of advantage, more often they are of disadvantage or neutral. Several specific mechanisms contribute to the overall mutagenesis. These mechanisms can be classified into three natural strategies of genetic variation: (i) a local change of the nucleotide sequence, (ii) the rearrangement of DNA segments within the genome, and (iii) the acquisition of a DNA segment from another kind of organism by horizontal gene transfer. Selected examples for the three natural strategies of genetic variation can also illustrate the qualitative differences of the contribution,,, made by the strategies to the evolutionary process. On the basis of knowledge on the molecular mechanisms of genetic variation the theory of molecular evolution postulates that products of so-called evolution genes are involved in mutagenesis together with diverse non-genetic factors. The evolution genes provide to the organisms their evolutionary fitness. The knowledge on molecular evolution extends our knowledge on nature. With regard to its philosophical value we can search for ways to reach a general agreement between scientific knowledge, on the one hand, and traditional wisdom and religious beliefs on the other hand.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM werner.arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   Arber W, 2002, CURR TOP MICROBIOL, V264, P1
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   ARBER W, 1991, J MOL EVOL, V323, P4
   Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137
   SENGSTAG C, 1987, MOL GEN GENET, V206, P344, DOI 10.1007/BF00333593
   VAWTER B, 1973, ENCY AM, V12, P393
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
NR 10
TC 1
Z9 1
U1 0
U2 3
PU DEUTSCHE AKAD NATURFORSCHER LEOPOLD
PI HALLE
PA AUGUST-BEBEL STR 50A, O-4010 HALLE, GERMANY
SN 0369-5034
BN 978-3-8047-2370-2
J9 NOVA ACT LC
JI Nova Acta Leopold.
PY 2006
VL 93
IS 345
BP 69
EP 83
PG 15
WC Evolutionary Biology; Multidisciplinary Sciences
SC Evolutionary Biology; Science & Technology - Other Topics
GA BGO57
UT WOS:000249029800004
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI The evolutionary strategy of DNA acquisition as a possible reason for a
   universal genetic code
SO HISTORY AND PHILOSOPHY OF THE LIFE SCIENCES
LA English
DT Article; Proceedings Paper
CT Conference on History of Central Dogma of Moleculary Biology and Its
   Epistemological Status Today
CY FEB 22-23, 2007
CL Geneva, SWITZERLAND
DE biological evolution; horizontal gene transfer; genetic variation;
   evolution genes; natural selection; universal genetic code
ID MICROBIAL EVOLUTION; SYMMETRY; ELEMENTS
AB The evolutionary strategy to generate genetic variants by DNA acquisition involving horizontal gene transfer seems to be widely used by many, if not all, living organisms. A common language between donor and recipient organisms, as provided by the quasi universality of the genetic code, can favor the effectiveness of the DNA acquisition strategy. These considerations are here discussed in the context of our knowledge on the natural strategies of molecular evolution and on the commonly used genetic code.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1995, J MOL EVOL, V40, P7, DOI 10.1007/BF00166591
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   CRICK FHC, 1968, J MOL BIOL, V38, P367, DOI 10.1016/0022-2836(68)90392-6
   HEINEMANN JA, 2007, GENOMICS GENETICS, V1, P337
   Hornos JEM, 1999, INT J MOD PHYS B, V13, P2795, DOI 10.1142/S021797929900268X
   Hornos JEM, 2004, IUBMB LIFE, V56, P125, DOI 10.1080/15216540410001687838
   OSAWA S, 1992, MICROBIOL REV, V56, P229, DOI 10.1128/MMBR.56.1.229-264.1992
   Vetsigian K, 2006, P NATL ACAD SCI USA, V103, P10696, DOI 10.1073/pnas.0603780103
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
NR 12
TC 3
Z9 4
U1 0
U2 1
PU STAZIONE ZOOLOGICA ANTON DOHRN
PI NAPOLI
PA VILLA COMMUNALE, NAPOLI, 80121, ITALY
SN 0391-9714
J9 HIST PHIL LIFE SCI
JI Hist. Philos. Life Sci.
PY 2006
VL 28
IS 4
BP 525
EP 532
PG 8
WC History & Philosophy Of Science
SC History & Philosophy of Science
GA 259VK
UT WOS:000252968800004
PM 18351050
DA 2021-01-25
ER

PT J
AU Mueller, P
   Pieters, J
AF Mueller, Philipp
   Pieters, Jean
TI Modulation of macrophage antimicrobial mechanisms by pathogenic
   mycobacteria
SO IMMUNOBIOLOGY
LA English
DT Article; Proceedings Paper
CT 19th Meeting of the European-Macrophage-and-Dendritic-Cell-Society
CY OCT 06-08, 2005
CL Amsterdam, NETHERLANDS
SP European Macrophage & Dendrit Cell Soc
DE mycobacteria; host-pathogen interaction; phagocytosis; trafficking
ID PHAGOSOME MATURATION ARREST; PROTEIN-KINASE-G; INTRACELLULAR SURVIVAL;
   ACTIN CYTOSKELETON; PLASMA-MEMBRANE; TUBERCULOSIS; PHAGOCYTOSIS;
   BINDING; EEA1; RECEPTORS
AB Tuberculosis remained a mysterious disease until Koch was able to demonstrate in the late 1800s that it was caused by a bacterium spread by aerosols, Mycobacterium tuberculosis. Today, tuberculosis still is a major health problem causing similar to 2 million deaths annually with about one third of the world's population being latently infected with M. tuberculosis.
   The secret of success for M. tuberculosis lies in its ability to persist inside host cells, the macrophages. Whereas macrophages are designed to destroy any incoming microbe, pathogenic mycobacteria have evolved strategies to survive within macrophages by preventing phagosome-lysosome fusion, thereby creating a niche that allows them to persist within an otherwise hostile environment. In this contribution, we discuss recent advances in our understanding of the interplay between the host and this pathogen that lead to survival of mycobacteria within macrophages. (c) 2006 Elsevier GmbH. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Amer AO, 2002, CURR OPIN MICROBIOL, V5, P56, DOI 10.1016/S1369-5274(02)00286-2
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   Andrews NW, 2002, J CELL BIOL, V158, P389, DOI 10.1083/jcb.200205110
   Aslund F, 1999, J BACTERIOL, V181, P1375
   Bajno L, 2000, J CELL BIOL, V149, P697, DOI 10.1083/jcb.149.3.697
   Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x
   Becker T, 2005, P NATL ACAD SCI USA, V102, P4022, DOI 10.1073/pnas.0409219102
   Bentrup KHZ, 1999, J BACTERIOL, V181, P7161
   Braun V, 2004, EMBO J, V23, P4166, DOI 10.1038/sj.emboj.7600427
   Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467
   Callaghan L, 1999, EUR J BIOCHEM, V265, P361
   Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x
   Chinkers M, 2001, TRENDS ENDOCRIN MET, V12, P28, DOI 10.1016/S1043-2760(00)00335-0
   Christiansen OB, 1999, HUM REPROD UPDATE, V5, P249, DOI 10.1093/humupd/5.3.249
   Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200
   Colombo MI, 1997, J BIOL CHEM, V272, P7707, DOI 10.1074/jbc.272.12.7707
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Cox JS, 1999, NATURE, V402, P79
   Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997
   Dermine JF, 2001, J BIOL CHEM, V276, P18507, DOI 10.1074/jbc.M101113200
   DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677
   Ellson CD, 2002, J CELL SCI, V115, P1099
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263
   GRIFFIN FM, 1976, J EXP MED, V144, P788, DOI 10.1084/jem.144.3.788
   Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D
   Hackam DJ, 1996, J IMMUNOL, V156, P4377
   HARRIS EE, 2003, COMPLEXITY, V7, P23
   Holevinsky KO, 1998, BIOPHYS J, V75, P2577, DOI 10.1016/S0006-3495(98)77703-3
   Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3
   Kelley VA, 2003, MOL BIOL CELL, V14, P3366, DOI 10.1091/mbc.E02-12-0780
   KNUTH P, 1898, HDB BLUTENBIOLOGIE, V2, P1
   Lichter-Konecki U, 1999, DIFFERENTIATION, V65, P43, DOI 10.1046/j.1432-0436.1999.6510043.x
   Lippe R, 2001, MOL BIOL CELL, V12, P2219, DOI 10.1091/mbc.12.7.2219
   Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811
   Malik ZA, 2001, J IMMUNOL, V166, P3392, DOI 10.4049/jimmunol.166.5.3392
   McBride HM, 1999, CELL, V98, P377, DOI 10.1016/S0092-8674(00)81966-2
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Meresse S, 2001, CELL MICROBIOL, V3, P567, DOI 10.1046/j.1462-5822.2001.00141.x
   Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955
   MU FT, 1995, J BIOL CHEM, V270, P13503, DOI 10.1074/jbc.270.22.13503
   Nandan D, 2000, J LEUKOCYTE BIOL, V67, P464
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Niedergang F, 2003, J CELL BIOL, V161, P1143, DOI 10.1083/jcb.200210069
   Patki V, 1998, NATURE, V394, P433, DOI 10.1038/28771
   Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967
   Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006
   Pieters J, 2001, MICROBES INFECT, V3, P249, DOI 10.1016/S1286-4579(01)01376-4
   Pietra BA, 2000, PROG PEDIATR CARDIOL, V11, P115, DOI 10.1016/S1058-9813(00)00043-6
   ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   Sollner TH, 2002, DEV CELL, V2, P377, DOI 10.1016/S1534-5807(02)00161-2
   Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048
   Ting LM, 1999, J IMMUNOL, V163, P3898
   Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   VanHeyningen TK, 1997, J IMMUNOL, V158, P330
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Vieira OV, 2004, MOL CELL BIOL, V24, P4593, DOI 10.1128/MCB.24.10.4593-4604.2004
   Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Wishart MJ, 2001, CELL, V105, P817, DOI 10.1016/S0092-8674(01)00414-7
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
NR 77
TC 26
Z9 26
U1 0
U2 5
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PY 2006
VL 211
IS 6-8
BP 549
EP 556
DI 10.1016/j.imbio.2006.06.004
PG 8
WC Immunology
SC Immunology
GA 086OB
UT WOS:000240681800015
PM 16920493
DA 2021-01-25
ER

PT J
AU Ma, Y
   Gadermaier, G
   Bohle, B
   Bolhaar, S
   Knulst, A
   Markovic-Housley, Z
   Breiteneder, H
   Briza, P
   Hoffmann-Sommergruber, K
   Ferreira, F
AF Ma, Y
   Gadermaier, G
   Bohle, B
   Bolhaar, S
   Knulst, A
   Markovic-Housley, Z
   Breiteneder, H
   Briza, P
   Hoffmann-Sommergruber, K
   Ferreira, F
TI Mutational analysis of amino acid positions crucial for IgE-binding
   epitopes of the major apple (Malus domestica) allergen, Mal d 1
SO INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
LA English
DT Article
DE Mal d 1; Bet v 1; apple allergy; hypoallergenic; recombinant allergen;
   point mutation
ID BIRCH POLLEN ALLERGEN; BET V 1; CELERY APIUM-GRAVEOLENS; CROSS-REACTIVE
   IGE; FOOD ALLERGY; PRU AV-1; MOLECULAR CHARACTERIZATION; CLINICAL
   RELEVANCE; ESCHERICHIA-COLI; SKIN-TESTS
AB Background: Individual amino acid residues of the major birch pollen allergen, Bet v 1, have been identified to be crucial for IgE recognition. The objective of the present study was to evaluate whether this concept was applicable for the Bet v 1-homologous apple allergen, Mal d 1. Methods: A Mal d 1 five-point mutant was produced by PCR techniques, cloned into pMW 172 and expressed in Escherichia coli BL21(DE3) cells. To evaluate the allergenic properties of the engineered protein compared to Mal d 1 wild-type IgE immunoblotting, ELISA, peripheral blood monocytes proliferation assays, and skin prick tests were performed. Results: The Mal d 1 mutant showed reduced capacity to bind specific IgE as compared to wild-type Mal d 1 in in vitro assays in the majority of the sera tested. In ELISA, 10 out of 14 serum samples displayed an 88-30% decrease in IgE binding to Mal d 1 mutant compared to wild-type Mal d 1. Skin prick tests in apple-allergic patients (n = 2) confirmed the markedly decreased ability of the Mal d 1 mutant to induce allergic reactions in vivo. However, the relevant T cell epitopes were present in the mutated molecule according to peripheral blood mononuclear cell proliferation assays. Conclusions: Our findings suggest that it is possible to modulate the IgE-binding properties of allergens by single amino acid substitutions at crucial positions which might be useful for future immunotherapy of birch-pollen-associated food allergies which are not ameliorated by birch pollen immunotherapy. Copyright (C) 2006 S. Karger AG, Basel.
C1 Med Univ Vienna, Dept Pathophysiol, Vienna, Austria.
   Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria.
   Univ Med Ctr Utrecht, Dept Dermatol Allergol, Utrecht, Netherlands.
   Univ Basel, Biozentrum, Dept Biol Struct, Basel, Switzerland.
RP Hoffmann-Sommergruber, K (corresponding author), Med Univ Vienna AKH EBO 3Q, Dept Pathophysiol, Wahringer Gurtel 18-20, AT-1090 Vienna, Austria.
EM Karin.Hoffmann-Sommergruber@meduniwien.ac.at
RI Briza, Peter/D-7309-2012; Ferreira, Fatima/E-4889-2011; Ferreira,
   Fatima/AAB-4321-2019; Ma, Yan/G-2469-2016; Gadermaier,
   Gabriele/L-5997-2015
OI Briza, Peter/0000-0002-4941-6782; Ferreira, Fatima/0000-0003-0989-2335;
   Ferreira, Fatima/0000-0003-0989-2335; Gadermaier,
   Gabriele/0000-0002-4886-417X; Bohle, Barbara/0000-0002-5105-7985;
   Hoffmann-Sommergruber, Karin/0000-0002-8830-058X
CR Asero R, 2004, ALLERGY, V59, P1269, DOI 10.1111/j.1398-9995.2004.00561.x
   BJORKSTEN F, 1980, ALLERGY, V35, P671, DOI 10.1111/j.1398-9995.1980.tb02020.x
   Blaser K, 2004, CLIN EXP ALLERGY, V34, P328, DOI 10.1111/j.1365-2222.2004.01909.x
   Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321
   BOLHAAR STH, 2005, CLIN EXP ALLERGY
   Bolhaar STHP, 2004, CLIN EXP ALLERGY, V34, P761, DOI 10.1111/j.1365-2222.2004.1939.x
   BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x
   Crameri Reto, 2003, Biochem J, V376, pe1, DOI 10.1042/BJ20031363
   DREBORG S, 1993, ALLERGY, V48, P49, DOI 10.1111/j.1398-9995.1993.tb04756.x
   DREBORG S, 1983, ALLERGY, V38, P167, DOI 10.1111/j.1398-9995.1983.tb01602.x
   Ebner C, 1997, CLIN EXP ALLERGY, V27, P1007, DOI 10.1111/j.1365-2222.1997.tb01252.x
   EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X
   ERIKSSON NE, 1982, ALLERGY, V37, P437, DOI 10.1111/j.1398-9995.1982.tb02323.x
   Eyles SJ, 2000, J MOL BIOL, V301, P737, DOI 10.1006/jmbi.2000.4002
   Ferreira F, 1997, INT ARCH ALLERGY IMM, V113, P125, DOI 10.1159/000237524
   Ferreira F, 1998, FASEB J, V12, P231
   Friedl-Hajek R, 1999, MOL IMMUNOL, V36, P639, DOI 10.1016/S0161-5890(99)00078-4
   Fritsch R, 1997, CLIN REV ALLERG IMMU, V15, P397, DOI 10.1007/BF02737735
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hansen KS, 2004, MOL NUTR FOOD RES, V48, P441, DOI 10.1002/mnfr.200400037
   Helsper JPFG, 2002, J ALLERGY CLIN IMMUN, V110, P131, DOI 10.1067/mai.2002.125599
   Himly M, 2002, FASEB J, V16, P106, DOI 10.1096/fj.02-0472fje
   HIREL PH, 1989, P NATL ACAD SCI USA, V86, P8247, DOI 10.1073/pnas.86.21.8247
   Hoffmann-Sommergruber K, 1999, J ALLERGY CLIN IMMUN, V104, P478, DOI 10.1016/S0091-6749(99)70397-0
   Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P115, DOI 10.1159/000024367
   Hoffmann-Sommergruber K, 1999, CLIN EXP ALLERGY, V29, P840, DOI 10.1046/j.1365-2222.1999.00529.x
   HoffmannSommergruber K, 1997, PROTEIN EXPRES PURIF, V9, P33, DOI 10.1006/prep.1996.0671
   JAROLIM E, 1989, ALLERGY, V44, P385, DOI 10.1111/j.1398-9995.1989.tb04169.x
   Kumar S, 2000, PROTEIN ENG, V13, P179, DOI 10.1093/protein/13.3.179
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Miles S, 2005, NUTR FOOD SCI, V35, P220, DOI 10.1108/00346650510605612
   Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057
   Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200
   POULSEN LK, 1993, CLIN EXP ALLERGY, V23, P61, DOI 10.1111/j.1365-2222.1993.tb02485.x
   Puehringer HM, 2003, GENE, V321, P173, DOI 10.1016/S0378-1119(03)00822-9
   Savolainen J, 2004, CLIN EXP ALLERGY, V34, P413, DOI 10.1111/j.1365-2222.2004.01823.x
   Schindler T, 1996, EUR J BIOCHEM, V241, P516, DOI 10.1111/j.1432-1033.1996.00516.x
   Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tuft Louis, 1942, JOUR ALLERGY, V13, P574, DOI 10.1016/S0021-8707(42)90070-4
   VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320
   VANREE R, 1993, J CLIN IMMUNOASSAY, V16, P124
   Vieths S, 1996, MONOGR ALLERGY, V32, P63
   Vrtala S, 2001, FASEB J, V15, P2045, DOI 10.1096/fj.00-0767fje
   Wallner M, 2004, METHODS, V32, P219, DOI 10.1016/j.ymeth.2003.08.004
   Wensing M, 2002, J ALLERGY CLIN IMMUN, V110, P435, DOI 10.1067/mai.2002.126380
   Wiche R, 2005, BIOCHEM J, V385, P319, DOI 10.1042/BJ20040842
   Willerroider M, 2003, INT ARCH ALLERGY IMM, V131, P245, DOI 10.1159/000072136
   Wopfner N, 2002, BIOL CHEM, V383, P1779, DOI 10.1515/BC.2002.199
   WUTHRICH B, 1990, ALLERGY, V45, P566, DOI 10.1111/j.1398-9995.1990.tb00941.x
NR 50
TC 51
Z9 52
U1 1
U2 11
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-2438
EI 1423-0097
J9 INT ARCH ALLERGY IMM
JI Int. Arch. Allergy Immunol.
PY 2006
VL 139
IS 1
BP 53
EP 62
DI 10.1159/000089756
PG 10
WC Allergy; Immunology
SC Allergy; Immunology
GA 990WJ
UT WOS:000233773600008
PM 16293967
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Mundt, C
   Licence, S
   Maxwell, G
   Melchers, F
   Martensson, IL
AF Mundt, C
   Licence, S
   Maxwell, G
   Melchers, F
   Martensson, IL
TI Only VpreB1, but not VpreB2, is expressed at levels which allow normal
   development of B cells
SO INTERNATIONAL IMMUNOLOGY
LA English
DT Article
DE B cell development; pre-BCR; surrogate light chain; VpreB; lambda 5
ID SURROGATE LIGHT-CHAIN; MU-HEAVY-CHAIN; PRE-B; BONE-MARROW; LINEAGE
   DIFFERENTIATION; LAMBDA-5 PROTEIN; RECEPTOR; SURFACE; MICE; LOCUS
AB The surrogate light chain (SLC) consists of the polypeptides lambda 5 and, in the mouse, either VpreB1 or VpreB2. SLC associates with BILL-Cadherin and other glycoproteins to form the pro-B cell receptor (pro-BCR) at the pre-BI cell stage, and with the immunoglobulin mu heavy chain to form the pre-BCR at the pre-BII cell stage. The function of the pro-BCR, if any, is unknown, whereas the pre-BCR is crucial for proliferative expansion of pre-BII cells. To shed light on the functional properties of VpreB1 and VpreB2 in vivo, mice with either one or two VpreB1, or one or two VpreB2, alleles have been investigated. We show that B cell development in mice with two VpreB1 alleles is indistinguishable from that of normal mice. In contrast, mice with two VpreB2 alleles show an similar to 1.6-fold increase in pre-BI and a 35% decrease in pre-BII cell numbers, while mice with only one VpreB2 allele show a reduction in B cell development manifested in a 2-fold enrichment in pre-BI cells and a 75% reduction in pre-BII cells. However, such a gene dosage effect is not observed for VpreB1. Our results suggest that the difference between VpreB1- and VpreB2-deficient mice is due to lower VpreB2 protein expression, thus limiting the formation of pre-BCRs and thereby the number of large, cycling pre-BII cells.
C1 Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB2 4AT, England.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Max Planck Inst Infekt Biol, D-10117 Berlin, Germany.
RP Martensson, IL (corresponding author), Babraham Inst, Lab Lymphocyte Signaling & Dev, Babraham Res Campus, Cambridge CB2 4AT, England.
EM lill.martensson@bbsrc.ac.uk
OI Martensson, Inga-Lill/0000-0003-3415-0560
CR BAUER SR, 1988, EMBO J, V7, P111, DOI 10.1002/j.1460-2075.1988.tb02789.x
   Burrows PD, 2002, SEMIN IMMUNOL, V14, P343, DOI 10.1016/S1044-5323(02)00067-2
   Ceredig R, 1998, INT IMMUNOL, V10, P49, DOI 10.1093/intimm/10.1.49
   Dul JL, 1996, EUR J IMMUNOL, V26, P906, DOI 10.1002/eji.1830260428
   Galler GR, 2004, J EXP MED, V199, P1523, DOI 10.1084/jem.20031523
   Garner AP, 2002, ONCOGENE, V21, P8089, DOI 10.1038/sj.onc.1206000
   KARASUYAMA H, 1993, J EXP MED, V178, P469, DOI 10.1084/jem.178.2.469
   KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0
   KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969
   KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L
   KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x
   KUDO A, 1992, INT IMMUNOL, V4, P831, DOI 10.1093/intimm/4.8.831
   Martensson A, 1999, INT IMMUNOL, V11, P453, DOI 10.1093/intimm/11.3.453
   Martensson IL, 2000, IMMUNOLOGY, V101, P435, DOI 10.1046/j.1365-2567.2000.00151.x
   Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649
   Mundt C, 2001, J EXP MED, V193, P435, DOI 10.1084/jem.193.4.435
   Ohnishi K, 2005, EUR J IMMUNOL, V35, P957, DOI 10.1002/eji.200425853
   PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257
   Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23
   Sabbattini P, 1999, MOL CELL BIOL, V19, P671
   SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0
   SAKAGUCHI N, 1986, EMBO J, V5, P2139, DOI 10.1002/j.1460-2075.1986.tb04477.x
   Seidl T, 2001, EUR J IMMUNOL, V31, P1999, DOI 10.1002/1521-4141(200107)31:7<1999::AID-IMMU1999>3.3.CO;2-B
   Shimada Shinya, 2002, Gastric Cancer, V5, P168, DOI 10.1007/s101200200029
   Stephan RP, 2001, J IMMUNOL, V167, P3734, DOI 10.4049/jimmunol.167.7.3734
   TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973
   WINKLER T, 1999, MOL BIOL B CELL T CE
   WINKLER TH, 1995, EUR J IMMUNOL, V25, P446, DOI 10.1002/eji.1830250221
NR 30
TC 12
Z9 12
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0953-8178
EI 1460-2377
J9 INT IMMUNOL
JI Int. Immunol.
PD JAN
PY 2006
VL 18
IS 1
BP 163
EP 172
DI 10.1093/intimm/dxh359
PG 10
WC Immunology
SC Immunology
GA 000BS
UT WOS:000234436500016
PM 16361315
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Dames, SA
   Schonichen, A
   Grzesiek, S
   Geyer, M
AF Dames, Sonja A.
   Schoenichen, Andre
   Grzesiek, Stephan
   Geyer, Matthias
TI NMR assignment of the Cyclin T-binding domain of human Hexim1
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
C1 Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany.
RP Dames, SA (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sonja.dames@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225; Geyer,
   Matthias/0000-0002-7718-5002; Dames, Sonja/0000-0001-7495-6943
CR Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200
NR 1
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
J9 J BIOMOL NMR
JI J. Biomol. NMR
PY 2006
VL 36
SU 1
BP 39
EP 39
DI 10.1007/s10858-006-9010-4
PG 1
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 116XG
UT WOS:000242836500039
PM 16917728
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Meyer, RP
   Hagemeyer, CE
   Knoth, R
   Kaufmann, MR
   Volk, B
AF Meyer, RP
   Hagemeyer, CE
   Knoth, R
   Kaufmann, MR
   Volk, B
TI Anti-epileptic drug phenytoin enhances androgen metabolism and androgen
   receptor expression in murine hippocampus
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE androgen receptor; anti-epileptic drugs; cytochrome P450; hippocampus;
   endocrine system; phenytoin
ID MESSENGER-RIBONUCLEIC-ACID; RAT HIPPOCAMPUS; IN-VITRO; CYTOCHROME-P450
   ISOFORMS; TESTOSTERONE-METABOLISM; HORMONAL-REGULATION;
   STEROID-HORMONES; SEXUAL FUNCTION; BRAIN; EPILEPSY
AB Epilepsy is very often related to strong impairment of neuronal networks, particularly in the hippocampus. Previous studies of brain tissue have demonstrated that long-term administration of the anti-epileptic drug (AED) phenytoin leads to enhanced metabolism of testosterone mediated by cytochrome P450 (CYP) isoforms. Thus, we speculate that AEDs affect androgen signalling in the hippocampus. In the present study, we investigated how the AED phenytoin influences the levels of testosterone, 17 beta-oestradiol, and androgen receptor (AR) in the hippocampus of male C57Bl/6J mice. Phenytoin administration led to a 61.24% decreased hippocampal testosterone level as compared with controls, while serum levels were slightly enhanced. 17 beta-Oestradiol serum level was elevated 2.6-fold. Concomitantly, the testosterone metabolizing CYP isoforms CYP3A11 and CYP19 (aromatase) have been found to be induced 2.4- and 4.2-fold, respectively. CYP3A-mediated depletion of testosterone-forming 2 beta-, and 6 beta-hydroxytestosterone was significantly enhanced. Additionally, AR expression was increased 2-fold (mRNA) and 1.8-fold (protein), predominantly in the CA1 region. AR was shown to concentrate in nuclei of CA1 pyramidal neurons. We conclude that phenytoin affects testosterone metabolism via induction of CYP isoforms. The increased metabolism of testosterone leading to augmented androgen metabolite formation most likely led to enhanced expression of CYP19 and AR in hippocampus. Phenytoin obviously modulates the androgen signalling in the hippocampus.
C1 Univ Basel, Biozentrum, Dept Neurobiol Pharmacol, Basel, Switzerland.
   Univ Klin Freiburg, Inst Pathol, Abt Neuropathol, Neurozentrum, Freiburg, Germany.
RP Meyer, RP (corresponding author), Univ Freiburg, Inst Pathol, Abt Neuropathol, Neurozentrum, Breisacherstr 64, D-79106 Freiburg, Germany.
EM ralf.meyer@uniklinik-freiburg.de
RI Hagemeyer, Christoph/E-8958-2011
OI Hagemeyer, Christoph/0000-0002-7114-4023
CR Abdelgadir SE, 1997, BIOL REPROD, V57, P772, DOI 10.1095/biolreprod57.4.772
   ARLOTTO MP, 1991, METHOD ENZYMOL, V206, P454
   Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038
   Flockhart DA, 2000, CHILD ADOL PSYCH CL, V9, P43
   FLOOD JF, 1992, P NATL ACAD SCI USA, V89, P1567, DOI 10.1073/pnas.89.5.1567
   Forsgren L, 2005, EUR J NEUROL, V12, P245, DOI 10.1111/j.1468-1331.2004.00992.x
   Freiman TM, 2002, J NEUROSCI METH, V120, P95, DOI 10.1016/S0165-0270(02)00187-5
   Hagemeyer CE, 2003, NEUROSCIENCE, V117, P521, DOI 10.1016/S0306-4522(02)00955-7
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Herzog AG, 2004, EPILEPSIA, V45, P764, DOI 10.1111/j.0013-9580.2004.60703.x
   Herzog AG, 1998, NEUROLOGY, V50, P782, DOI 10.1212/WNL.50.3.782
   HERZOG AG, 1992, ARCH NEUROL-CHICAGO, V49, P133, DOI 10.1001/archneur.1992.00530260033014
   Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100
   Isojarvi JIT, 2005, CNS DRUGS, V19, P207, DOI 10.2165/00023210-200519030-00003
   JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325
   JAYYOSI Z, 1992, ARCH BIOCHEM BIOPHYS, V298, P265, DOI 10.1016/0003-9861(92)90122-D
   Joe I, 2001, STEROIDS, V66, P529, DOI 10.1016/S0039-128X(00)00220-8
   Kawata M, 1995, NEUROSCI RES, V24, P1, DOI 10.1016/0168-0102(96)81278-8
   KERR JE, 1995, ENDOCRINOLOGY, V136, P3213, DOI 10.1210/en.136.8.3213
   Kerr JE, 1996, J NEUROENDOCRINOL, V8, P439, DOI 10.1046/j.1365-2826.1996.04735.x
   KUS L, 1995, BRAIN RES, V683, P270, DOI 10.1016/0006-8993(95)00384-3
   KUTT H, 1982, ANTIEPILEPTIC DRUGS, P241
   Leranth C, 2003, J NEUROSCI, V23, P1588
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MASUDA Y, 1981, J PHARMACOL EXP THER, V217, P805
   McEwen BS, 1996, CELL MOL NEUROBIOL, V16, P103, DOI 10.1007/BF02088170
   McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1
   Meyer RP, 2002, MOL PHARMACOL, V62, P1061, DOI 10.1124/mol.62.5.1061
   Meyer RP, 2001, EXP NEUROL, V167, P376, DOI 10.1006/exnr.2000.7553
   Meyer RP, 2001, BIOCHEM BIOPH RES CO, V285, P32, DOI 10.1006/bbrc.2001.5111
   MEYER RP, 2004, ROLE GLIA NEUROTOXIC, P61
   Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001
   NIQUET J, 1993, BRAIN RES, V626, P106, DOI 10.1016/0006-8993(93)90569-9
   NTP (National Toxicology Program), 1993, NAT TOX PROGR TECH R, V404, P1
   Ramsden M, 2003, NEUROSCIENCE, V122, P573, DOI 10.1016/j.neuroscience.2003.08.048
   Reddy DS, 2004, EPILEPSY RES, V62, P99, DOI 10.1016/j.eplepsyres.2004.09.003
   Reddy DS, 2004, NEUROSCIENCE, V129, P195, DOI 10.1016/j.neuroscience.2004.08.002
   Rogawski MA, 2004, NAT REV NEUROSCI, V5, P553, DOI 10.1038/nrn1430
   Rogawski MA, 2004, NAT MED, V10, P685, DOI 10.1038/nm1074
   ROSELLI CE, 1989, NEUROENDOCRINOLOGY, V49, P449, DOI 10.1159/000125151
   Rosenbrock H, 1999, J NEUROENDOCRINOL, V11, P597
   Rune GM, 2002, NEUROSCIENCE, V113, P167, DOI 10.1016/S0306-4522(02)00152-5
   Russell JA, 2000, J CHROMATOGR B, V744, P157, DOI 10.1016/S0378-4347(00)00248-6
   Spearow JL, 1999, BIOL REPROD, V61, P857, DOI 10.1095/biolreprod61.4.857
   Strobel HW, 2001, CURR DRUG METAB, V2, P199, DOI 10.2174/1389200013338577
   SUZUKI Y, 1988, J CHROMATOGR-BIOMED, V426, P33, DOI 10.1016/S0378-4347(00)81924-6
   Tabori NE, 2005, NEUROSCIENCE, V130, P151, DOI 10.1016/j.neuroscience.2004.08.048
   Thenmozhiyal JC, 2004, J MED CHEM, V47, P1527, DOI 10.1021/jm030450c
   Thuerl C, 1997, BRAIN RES, V762, P47, DOI 10.1016/S0006-8993(97)00259-X
   Turner KJ, 2002, J ENDOCRINOL, V172, P21, DOI 10.1677/joe.0.1720021
   VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308
   Veiga S, 2004, EXP GERONTOL, V39, P1623, DOI 10.1016/j.exger.2004.05.008
   Volk B, 1995, TOXICOL LETT, V82-3, P655, DOI 10.1016/0378-4274(95)03511-7
   Woolley CS, 1997, J NEUROSCI, V17, P1848
   Xiao L, 2002, HORM BEHAV, V42, P327, DOI 10.1006/hbeh.2002.1822
   Yau JLW, 2003, NEUROSCIENCE, V121, P307, DOI 10.1016/S0306-4522(03)00438-X
   Yeh SY, 1998, P NATL ACAD SCI USA, V95, P5527, DOI 10.1073/pnas.95.10.5527
NR 57
TC 25
Z9 25
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD JAN
PY 2006
VL 96
IS 2
BP 460
EP 472
DI 10.1111/j.1471-4159.2005.03555.x
PG 13
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 994JX
UT WOS:000234029100016
PM 16336225
DA 2021-01-25
ER

PT J
AU Schmitz, HP
   Kaufmann, A
   Kohli, M
   Laissue, PP
   Philippsen, P
AF Schmitz, HP
   Kaufmann, A
   Kohli, M
   Laissue, PP
   Philippsen, P
TI From function to shape: A novel role of a formin in morphogenesis of the
   fungus Ashbya gossypii
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; CELL POLARITY; FISSION YEAST;
   NEUROSPORA-CRASSA; SMALL GTPASE; ACTIN CYTOSKELETON; HOMOLOGY-2 DOMAIN;
   ESCHERICHIA-COLI; BINDING PROTEIN; CAPPING PROTEIN
AB Morphogenesis of filamentous ascomycetes includes continuously elongating hyphae, frequently emerging lateral branches, and, under certain circumstances, symmetrically dividing hyphal tips. We identified the formin AgBnilp of the model fungus Ashbya gossypii as an essential factor in these processes. AgBni1p is an essential protein apparently lacking functional overlaps with the two additional A. gossypii formins that are nonessential. Agbni1 null mutants fail to develop hyphae and instead expand to potato-shaped giant cells, which lack actin cables and thus tip-directed transport of secretory vesicles. Consistent with the essential role in hyphal development, AgBni1p locates to tips, but not to septa. The presence of a diaphanous autoregulatory domain (DAD) indicates that the activation of AgBni1p depends on Rho-type GTPases. Deletion of this domain, which should render AgBni1p constitutively active, completely changes the branching pattern of young hyphae. New axes of polarity are no longer established subapically (lateral branching) but by symmetric divisions of hyphal tips (tip splitting). In wild-type hyphae, tip splitting is induced much later and only at much higher elongation speed. When GTP-locked Rho-type GTPases were tested, only the young hyphae with mutated AgCdc42p split at their tips, similar to the DAD deletion mutant. Two-hybrid experiments confirmed that AgBnilp interacts with GTP-bound AgCdc42p. These data suggest a pathway for transforming one axis into two new axes of polar growth, in which an increased activation of AgBni1p by a pulse of activated AgCdc42p stimulates additional actin cable formation and tip-directed vesicle transport, thus enlarging and ultimately splitting the polarity site.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Laissue, Pierre Philippe/0000-0002-0165-5354; Schmitz,
   Hans-Peter/0000-0001-5449-4593
CR Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bartel P.L., 1993, CELLULAR INTERACTION, P153
   Bauer Y, 2004, MOL BIOL CELL, V15, P4622, DOI 10.1091/mbc.E04-02-0104
   Bobola N, 1996, CELL, V84, P699, DOI 10.1016/S0092-8674(00)81048-X
   Bok JW, 2001, FUNGAL GENET BIOL, V32, P145, DOI 10.1006/fgbi.2000.1259
   BOLES E, 1995, CURR GENET, V28, P197, DOI 10.1007/BF00315788
   Caviston JP, 2002, P NATL ACAD SCI USA, V99, P12185, DOI 10.1073/pnas.182370299
   Chang F, 1997, J CELL BIOL, V137, P169, DOI 10.1083/jcb.137.1.169
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611
   Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118
   Evangelista Marie, 2002, Nature Cell Biology, V4, P260
   Feierbach B, 2001, CURR BIOL, V11, P1656, DOI 10.1016/S0960-9822(01)00525-5
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   GOW NAR, 1995, GROWING FUNGUS, P277
   Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Harris ES, 2004, J BIOL CHEM, V279, P20076, DOI 10.1074/jbc.M312718200
   Harris SD, 1997, EMBO J, V16, P3474, DOI 10.1093/emboj/16.12.3474
   Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005
   Higgs HN, 2005, MOL BIOL CELL, V16, P1, DOI 10.1091/mbc.E04-07-0565
   Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535
   Hoepfner D, 2001, J CELL BIOL, V155, P979, DOI 10.1083/jcb.200107028
   Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845
   Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745
   James P, 1996, GENETICS, V144, P1425
   JOHNSTON GC, 1991, J CELL BIOL, V113, P539, DOI 10.1083/jcb.113.3.539
   Kamei T, 1998, J BIOL CHEM, V273, P28341, DOI 10.1074/jbc.273.43.28341
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kobielak A, 2004, NAT CELL BIOL, V6, P21, DOI 10.1038/ncb1075
   Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x
   Kovar DR, 2003, J CELL BIOL, V161, P875, DOI 10.1083/jcb.200211078
   Li CR, 2005, J CELL SCI, V118, P2637, DOI 10.1242/jcs.02393
   Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2
   Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5
   Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621
   Nakano K, 2002, J CELL SCI, V115, P4629, DOI 10.1242/jcs.00150
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Nelson B, 2003, MOL BIOL CELL, V14, P3782, DOI 10.1091/mbc.E03-01-0018
   Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001
   PEARSON WR, 1990, METHOD ENZYMOL, V183, P63
   Petersen J, 1998, J CELL BIOL, V141, P1217, DOI 10.1083/jcb.141.5.1217
   Petersen J, 1998, J CELL SCI, V111, P867
   Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309
   Pruyne D, 2004, MOL BIOL CELL, V15, P4971, DOI 10.1091/mbc.E04-04-0296
   Reynaga-Pena CG, 1997, FUNGAL GENET BIOL, V22, P153, DOI 10.1006/fgbi.1997.1003
   Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47
   Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834
   Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schott DH, 2002, J CELL BIOL, V156, P35, DOI 10.1083/jcb.200110086
   Seiler S, 2003, MOL BIOL CELL, V14, P4352, DOI 10.1091/mbc.E02-07-0433
   Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356
   Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053
   Shimada A, 2004, MOL CELL, V13, P511, DOI 10.1016/S1097-2765(04)00059-0
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Sil A, 1996, CELL, V84, P711, DOI 10.1016/S0092-8674(00)81049-1
   SIMON VR, 1995, J CELL BIOL, V130, P345, DOI 10.1083/jcb.130.2.345
   Sone T, 1999, FUNGAL GENET BIOL, V28, P227, DOI 10.1006/fgbi.1999.1169
   STEINER S, 1994, MOL GEN GENET, V242, P263, DOI 10.1007/BF00280415
   STEINER S, 1995, GENETICS, V140, P973
   Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837
   Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341
   VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I
   Virag A, 2004, FUNGAL GENET BIOL, V41, P213, DOI 10.1016/j.fgb.2003.10.010
   Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3
   Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044
   Watanabe N, 1999, NAT CELL BIOL, V1, P136
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7
   Zahner JE, 1996, MOL CELL BIOL, V16, P1857
NR 77
TC 53
Z9 55
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD JAN
PY 2006
VL 17
IS 1
BP 130
EP 145
PG 16
WC Cell Biology
SC Cell Biology
GA 999ON
UT WOS:000234399300013
PM 16236798
DA 2021-01-25
ER

PT J
AU Hui, KM
   Orriss, GL
   Schirmer, T
   Magnadottir, B
   Schifferli, JA
   Inal, JM
AF Hui, KM
   Orriss, GL
   Schirmer, T
   Magnadottir, B
   Schifferli, JA
   Inal, JM
TI Expression of functional recombinant von Willebrand factor-A domain from
   human complement C2: Potential binding site for C4 and CRIT
SO MOLECULAR IMMUNOLOGY
LA English
DT Meeting Abstract
CT 10th Meeting on Complement in Human Disease
CY SEP 09-13, 2005
CL Heidelberg, GERMANY
C1 Univ Basel Hosp, Immunonephrol Dept Res, CH-4031 Basel, Switzerland.
   Univ Basel, Div Struct Biol, Biozentrum, Basel, Switzerland.
   Univ Iceland, Inst Expt Pathol, IS-112 Reykjavik, Iceland.
RI Inal, Jameel M/G-2995-2010; FRSB, Jameel Malhador Inal BSc MPhil PhD
   CBiol/AAU-9220-2020
OI Inal, Jameel M/0000-0002-7200-0363; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD JAN
PY 2006
VL 43
IS 1-2
MA 14
BP 126
EP 127
PG 2
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 966LO
UT WOS:000232021600027
DA 2021-01-25
ER

PT S
AU Arber, W
AF Arber, Werner
BE Paton, R
   McNamara, LA
TI The theory of molecular evolution and its medical implications
SO MULTIDISCIPLINARY APPROACHES TO THEORY IN MEDICINE
SE Studies in Multidisciplinarity
LA English
DT Article; Book Chapter
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1995, J MOL EVOL, V40, P7, DOI 10.1007/BF00166591
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   Arber W., 2003, CULTURAL VALUES SCI, V105, P45
   CAPORALE LH, 1999, ANN NEW YORK ACAD SC, V870
   Kohler G, 2002, CURR TOP MICROBIOL, V264, P149
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA SARA BURGERHARTSTRAAT 25, PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1571-0831
BN 978-0-08-045972-1; 978-0-44-451806-4
J9 STUD MULTIDISCIP
PY 2006
VL 3
BP 31
EP 45
PG 15
WC Medicine, General & Internal; Multidisciplinary Sciences
SC General & Internal Medicine; Science & Technology - Other Topics
GA BCP89
UT WOS:000310981300004
DA 2021-01-25
ER

PT J
AU Ino, A
   Kobayasi, M
   Nakajima, T
   Michaut, L
   Ghangrekar, I
   Takahashi, K
   Ueda, R
   Saigo, K
   Gehring, WJ
   Furukubo-Tokunaga, K
AF Ino, Ayako
   Kobayasi, Masatomo
   Nakajima, Taiki
   Michaut, Lydia
   Ghangrekar, Indrayani
   Takahashi, Kuniaki
   Ueda, Ryu
   Saigo, Kaoru
   Gehring, Walter J.
   Furukubo-Tokunaga, Katsuo
TI Differential microarray analysis of mushroom body transcripts using
   chemical ablation
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 Univ Tsukuba, Grad Sch Life Envir Sci, Tsukuba, Ibaraki 305, Japan.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Univ Tokyo, Natl Inst Genet, Genet Strains Res Ctr, Tokyo, Japan.
   Univ Tokyo, Grad Sch Sci, Dept Biophys Biochem, Tokyo, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2006
VL 55
SU 1
BP S184
EP S184
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 057QG
UT WOS:000238609702044
DA 2021-01-25
ER

PT J
AU Barde, YA
AF Barde, Y. -A.
TI Embryonic stem cells and neurotrophin signaling
SO NEUROSIGNALS
LA English
DT Meeting Abstract
CT Conference of the Croucher-Advanced-Study-Institute on Signaling in Cell
   Growth and Differentitation
CY JAN, 2006
CL Hong Kong, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Dept Biochem
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1424-862X
J9 NEUROSIGNALS
JI Neurosignals
PY 2006
VL 15
IS 1
MA 2
BP 40
EP 40
PG 1
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology;
   Neurosciences
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology;
   Neurosciences & Neurology
GA 073DX
UT WOS:000239724100006
DA 2021-01-25
ER

PT J
AU Kopp, J
   Schwede, T
AF Kopp, Juergen
   Schwede, Torsten
TI The SWISS-MODEL repository: new features and functionalities
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROTEIN-STRUCTURE PREDICTION; HOMOLOGY MODELS; PROGRESS; DATABASE;
   SERVER; GENOME
AB TheSWISS-MODEL Repository is a database of annotated 3D protein structure models generated by the SWISS-MODEL homology-modelling pipeline. As of September 2005, the repository contained 675000 models for 604000 different protein sequences of the UniProt database. Regular updates ensure that the content of the repository reflects the current state of sequence and structure databases, integrating new or modified target sequences, and making use of new template structures. Each Repository entry consists of one or more 3D models accompanied by detailed information about the target protein and the model building process: functional annotation, a detailed template selection log, target-template alignment, summary of the model building and model quality assessment. The SWISS-MODEL Repository is freely accessible at http://swissmodel.expasy.org/repository/.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM Torsten.Schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Kopp, Juergen/0000-0001-5633-7399
CR Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011
   Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Moult J, 2005, CURR OPIN STRUC BIOL, V15, P285, DOI 10.1016/j.sbi.2005.05.011
   Mulder NJ, 2005, NUCLEIC ACIDS RES, V33, pD201, DOI 10.1093/nar/gki106
   Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024
   PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658
   Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934
   Pieper U, 2004, NUCLEIC ACIDS RES, V32, pD217, DOI 10.1093/nar/gkh095
   Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597
   SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Todd AE, 2005, J MOL BIOL, V348, P1235, DOI 10.1016/j.jmb.2005.03.037
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Velankar S, 2005, NUCLEIC ACIDS RES, V33, pD262, DOI 10.1093/nar/gki058
   Xie L, 2005, PLOS COMPUT BIOL, V1, P222, DOI 10.1371/journal.pcbi.0010031
NR 27
TC 99
Z9 107
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN 1
PY 2006
VL 34
SI SI
BP D315
EP D318
DI 10.1093/nar/gkj056
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 067MR
UT WOS:000239307700068
PM 16381875
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Dube, P
   Herzog, F
   Gieffers, C
   Sander, B
   Riedel, D
   Muller, SA
   Engel, A
   Peters, JM
   Stark, H
AF Dube, P
   Herzog, F
   Gieffers, C
   Sander, B
   Riedel, D
   Muller, SA
   Engel, A
   Peters, JM
   Stark, H
TI Localization of the coactivator Cdh1 and the cullin subunit Apc2 in a
   cryo-electron microscopy model of vertebrate APC/C
SO MOLECULAR CELL
LA English
DT Article
ID ANAPHASE-PROMOTING COMPLEX; 3-DIMENSIONAL RECONSTRUCTION;
   ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; SINGLE PARTICLES; DESTRUCTION
   BOX; TILT SERIES; PROTEIN; UBIQUITINATION; IDENTIFICATION
AB The anaphase-promoting complex/cyclosome (APC/C) is a ubiquitin ligase with essential functions in mitosis, meiosis, and G1 phase of the cell cycle. APC/C recognizes substrates via coactivator proteins such as Cdh1, and bound substrates are ubiquitinated by E2 enzymes that interact with a hetero-dimer of the RING subunit Apc11 and the cullin Apc2. We have obtained three-dimensional (3D) models of human and Xenopus APC/C by angular reconstitution and random conical tilt (RCT) analyses of negatively stained cryo-electron microscopy (cryo-EM) preparations, have determined the masses of these particles by scanning transmission electron microscopy (STEM), and have mapped the locations of Cdh1 and Apc2. These proteins are located on the same side of the asymmetric APC/C, implying that this is where substrates are ubiquitinated. We have further identified a large flexible domain in APC/C that adopts a different orientation upon Cdh1 binding. Cdh1 may thus activate APC/C both by recruiting substrates and by inducing conformational changes.
C1 Res Inst Mol Pathol, A-1030 Vienna, Austria.
   Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
   Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
RP Peters, JM (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.
EM peters@imp.univie.ac.at; hstark1@gwdg.de
RI Herzog, Franz/G-4832-2012
OI Holger, Stark/0000-0002-6161-1118
CR Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399
   BOISSET N, 1993, J STRUCT BIOL, V111, P234, DOI 10.1006/jsbi.1993.1053
   Burton JL, 2005, MOL CELL, V18, P533, DOI 10.1016/j.molcel.2005.04.022
   Diaconu M, 2005, CELL, V121, P991, DOI 10.1016/j.cell.2005.04.015
   Gieffers C, 2001, MOL CELL, V7, P907, DOI 10.1016/S1097-2765(01)00234-9
   Gmachl M, 2000, P NATL ACAD SCI USA, V97, P8973, DOI 10.1073/pnas.97.16.8973
   Golas MM, 2003, SCIENCE, V300, P980, DOI 10.1126/science.1084155
   HARAUZ G, 1986, OPTIK, V73, P146
   Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102
   Herzog F, 2005, METHOD ENZYMOL, V398, P175, DOI 10.1016/S0076-6879(05)98016-6
   Kraft C, 2005, MOL CELL, V18, P543, DOI 10.1016/j.molcel.2005.04.023
   Kramer ER, 2000, MOL BIOL CELL, V11, P1555, DOI 10.1091/mbc.11.5.1555
   Leverson JD, 2000, MOL BIOL CELL, V11, P2315, DOI 10.1091/mbc.11.7.2315
   Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003
   Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198
   Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3
   Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547
   RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405
   RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x
   Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]
   Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001
   Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8
   Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004
   Tang ZY, 2001, MOL BIOL CELL, V12, P3839, DOI 10.1091/mbc.12.12.3839
   VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4
   VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P95, DOI 10.1016/0304-3991(87)90010-6
   vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004
   Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5
   Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784
   Yu HT, 1998, SCIENCE, V279, P1219, DOI 10.1126/science.279.5354.1219
   Zachariae W, 1998, SCIENCE, V279, P1216, DOI 10.1126/science.279.5354.1216
   Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a
   Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X
NR 35
TC 78
Z9 91
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD DEC 22
PY 2005
VL 20
IS 6
BP 867
EP 879
DI 10.1016/j.molcel.2005.11.008
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 998NS
UT WOS:000234326300006
PM 16364912
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Schneider, B
   Knochel, T
   Darimont, B
   Hennig, M
   Dietrich, S
   Babinger, K
   Kirschner, K
   Sterner, R
AF Schneider, B
   Knochel, T
   Darimont, B
   Hennig, M
   Dietrich, S
   Babinger, K
   Kirschner, K
   Sterner, R
TI Role of the N-terminal extension of the (beta alpha)(8)-barrel enzyme
   indole-3-glycerol phosphate synthase for its fold, stability, and
   catalytic activity
SO BIOCHEMISTRY
LA English
DT Article
ID PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; INDOLEGLYCEROL-PHOSPHATE;
   SULFOLOBUS-SOLFATARICUS; THERMOTOGA-MARITIMA; DIVERGENT EVOLUTION;
   CRYSTAL-STRUCTURE; MECHANISM; CONSERVATION
AB Indole-3-glycerol phosphate synthase (IGPS) catalyzes the fifth step in the biosynthesis of tryptophan. It belongs to the large and versatile family of (beta alpha)(8)-barrel enzymes but has an unusual N-terminal extension of about 40 residues. Limited proteolysis with trypsin of IGPS from both Sufolobus solfataricus (sIGPS) and Thermologa maritima (tIGPS) removes about 25 N-terminal residues and one of the two extra helices contained therein. To assess the role of the extension, the N-terminally truncated variants sIGPS Delta(1-26) and tlGPS Delta(1-25) were produced reconibinantly in Escherichia coli, purified, and characterized in comparison to the wild-type enzymes. Both sIGPS Delta(1-26) and tlGPS Delta(I -25) have unchanged oligomerization states and turnover numbers. In contrast, their Michaelis constants for the substrate 1-(O-carboxyphenylamino)-1-deoxyribulose 5-phosphate are increased, and their resistance toward unfolding induced by heat and guanidinium chloride is decreased. sIGPS Delta(1-26) was crystallized, and its X-ray structure was solved at 2.8 angstrom resolution. The comparison with the known structure of sIGPS reveals small differences that account for its reduced substrate affinity and protein stability. The structure of the core of sIGPS Delta(1-26) is, however, unchanged compared to sIGPS, explaining its retained catalytic activity and consistent with the idea that it evolved from the same ancestor as the phosphoribosyl anthranilate isomerase and the a.-subunit of tryptophan synthase. These (beta alpha)(8)-barrel enzymes catalyze the reactions preceding and following IGPS in tryptoplian biosynthesis but lack an N-terminal extension.
C1 Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany.
   Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   Univ Basel, Abt Strukturbiol & Abt Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Sterner, R (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.
EM Reinhard.Sterner@biologie.uni-regensburg.de
RI Sterner, Reinhard/ABI-6781-2020
OI Sterner, Reinhard/0000-0001-8177-8460
CR Andreotti G, 1997, BIOCHEM J, V323, P259, DOI 10.1042/bj3230259
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Beismann-Driemeyer S, 2001, J BIOL CHEM, V276, P20387, DOI 10.1074/jbc.M102012200
   BRUNGER AT, 1992, XPLOR VERSION 3 1 SY
   Copley RR, 2000, J MOL BIOL, V303, P627, DOI 10.1006/jmbi.2000.4152
   Darimont B, 1998, PROTEIN SCI, V7, P1221, DOI 10.1002/pro.5560070518
   EBERHARD M, 1995, BIOCHEMISTRY-US, V34, P5419, DOI 10.1021/bi00016a013
   Forsyth WR, 2002, J MOL BIOL, V320, P1119, DOI 10.1016/S0022-2836(02)00557-0
   Gerlt JA, 2005, ARCH BIOCHEM BIOPHYS, V433, P59, DOI 10.1016/j.abb.2004.07.034
   Gerlt JA, 2003, CURR OPIN CHEM BIOL, V7, P252, DOI 10.1016/S1367-5931(03)00019-X
   Henn-Sax M, 2001, BIOL CHEM, V382, P1315, DOI 10.1515/BC.2001.163
   Hennig M, 2002, J MOL BIOL, V319, P757, DOI 10.1016/S0022-2836(02)00378-9
   Hennig M, 1995, STRUCTURE, V3, P1295, DOI 10.1016/S0969-2126(01)00267-2
   HOMMEL U, 1995, BIOCHEMISTRY-US, V34, P5429, DOI 10.1021/bi00016a014
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Knochel T, 2002, J BIOL CHEM, V277, P8626, DOI 10.1074/jbc.M109517200
   Knochel TR, 1996, J MOL BIOL, V262, P502, DOI 10.1006/jmbi.1996.0531
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Leopoldseder S, 2004, J MOL BIOL, V337, P871, DOI 10.1016/j.jmb.2004.01.062
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   Merz A, 1999, J MOL BIOL, V288, P753, DOI 10.1006/jmbi.1999.2709
   Stehlin C, 1997, FEBS LETT, V403, P268, DOI 10.1016/S0014-5793(97)00066-5
   Sterner R, 2005, CHEM REV, V105, P4038, DOI 10.1021/cr030191z
   Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   WILMANNS M, 1991, BIOCHEMISTRY-US, V30, P9161, DOI 10.1021/bi00102a006
   Wise EL, 2004, ACCOUNTS CHEM RES, V37, P149, DOI 10.1021/ar030250v
NR 27
TC 18
Z9 18
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD DEC 20
PY 2005
VL 44
IS 50
BP 16405
EP 16412
DI 10.1021/bi051640n
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 994MQ
UT WOS:000234036300005
PM 16342933
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Voices of the night
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4153 Reinach, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Unterer Rebbergweg 33, CH-4153 Reinach, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD DEC 19
PY 2005
VL 579
IS 30
BP 6697
EP 6698
DI 10.1016/j.febslet.2005.11.025
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 995UP
UT WOS:000234130000001
DA 2021-01-25
ER

PT J
AU Smirnov, SP
   Barzaghi, P
   McKee, KK
   Ruegg, MA
   Yurchenco, PD
AF Smirnov, SP
   Barzaghi, P
   McKee, KK
   Ruegg, MA
   Yurchenco, PD
TI Conjugation of LG domains of agrins and perlecan to polymerizing
   laminin-2 promotes acetylcholine receptor clustering
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID BASEMENT-MEMBRANE; NEUROMUSCULAR-JUNCTION; ALPHA-DYSTROGLYCAN;
   POSTSYNAPTIC DIFFERENTIATION; TYROSINE PHOSPHORYLATION; ALPHA-7-BETA-1
   INTEGRIN; BINDING-SITES; SCHWANN-CELLS; MUSCLE; HEPARIN
AB Neuromuscular junction (NMJ) assembly is characterized by the clustering and neuronal alignment of acetylcholine receptors (AChRs). In this study we have addressed post-synaptic contributions to assembly that may arise from the NMJ basement membrane with cultured myotubes. We show that the cell surface-binding LG domains of non-neural (muscle) agrin and perlecan promote AChR clustering in the presence of laminin-2. This type of AChR clustering occurs with a several hour lag, requires muscle-specific kinase (MuSK), and is accompanied by tyrosine phosphorylation of MuSK and beta AChR. It also requires conjugation of the agrin or perlecan to laminin together with laminin polymerization. Furthermore, AChR clustering can be mimicked with antibody binding to non-neural agrin, supporting a mechanism of ligand aggregation. Neural agrin, in addition to its unique ability to cluster AChRs through its B/z sequence insert, also exhibits laminin-dependent AChR clustering, the latter enhancing and stabilizing its activity. Finally, we show that type IV collagen, which lacks clustering activity on its own, stabilizes laminin-dependent AChR clusters. These findings provide evidence for cooperative and partially redundant MuSK-dependent functions of basement membrane in AChR assembly that can enhance neural agrin activity yet operate in its absence. Such interactions may contribute to the assembly of aneural AChR clusters that precede neural agrin release as well as affect later NMJ development.
C1 Robert Wood Johnson Med Sch, Dept Pathol & Lab Med, Piscataway, NJ 08854 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Yurchenco, PD (corresponding author), 675 Hoes Lane, Piscataway, NJ 08854 USA.
EM yurchenc@umdnj.edu
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384; Yurchenco, Peter/0000-0003-0387-2317
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS038469, R01NS038469, R01NS038469, R01NS038469, R01NS038469,
   R01NS038469, R01NS038469, R01NS038469, R01NS038469, R01NS038469] Funding
   Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01 NS038469,
   R01-NS38469] Funding Source: Medline
CR Arikawa-Hirasawa E, 2002, NAT NEUROSCI, V5, P119, DOI 10.1038/nn801
   Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006
   Banks GB, 2003, J NEUROCYTOL, V32, P709, DOI 10.1023/B:NEUR.0000020619.24681.2b
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bix G, 2004, J CELL BIOL, V166, P97, DOI 10.1083/jcb.200401150
   Brown JC, 1997, EUR J BIOCHEM, V250, P39, DOI 10.1111/j.1432-1033.1997.t01-1-00039.x
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Burkin DJ, 1998, J CELL BIOL, V143, P1067, DOI 10.1083/jcb.143.4.1067
   Burkin DJ, 2000, J CELL SCI, V113, P2877
   Cheng YS, 1997, J BIOL CHEM, V272, P31525, DOI 10.1074/jbc.272.50.31525
   Colognato H, 1999, J CELL BIOL, V145, P619, DOI 10.1083/jcb.145.3.619
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Hoch W, 2003, TRENDS NEUROSCI, V26, P335, DOI 10.1016/S0166-2236(03)00131-0
   Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3
   Hopf C, 1998, J BIOL CHEM, V273, P6467, DOI 10.1074/jbc.273.11.6467
   Hopf M, 2001, J MOL BIOL, V311, P529, DOI 10.1006/jmbi.2001.4878
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435
   Jacobson C, 1998, J NEUROSCI, V18, P6340
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Kummer TT, 2004, J CELL BIOL, V164, P1077, DOI 10.1083/jcb.200401115
   Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073
   Li SH, 2005, J CELL BIOL, V169, P179, DOI 10.1083/jcb.200501098
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Marangi PA, 2002, J CELL BIOL, V157, P883, DOI 10.1083/jcb.200202110
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Sanes JR, 2003, J BIOL CHEM, V278, P12601, DOI 10.1074/jbc.R200027200
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Smirnov SP, 2002, J BIOL CHEM, V277, P18928, DOI 10.1074/jbc.M201880200
   Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151
   Sugiyama JE, 1997, J CELL BIOL, V139, P181, DOI 10.1083/jcb.139.1.181
   Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863
   Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432
   Tsiper MV, 2002, J CELL SCI, V115, P1005
   YURCHENCO PD, 1984, BIOCHEMISTRY-US, V23, P1839, DOI 10.1021/bi00303a040
   Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006
   YURCHENCO PD, 1987, J BIOL CHEM, V262, P17668
NR 47
TC 20
Z9 21
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 16
PY 2005
VL 280
IS 50
BP 41449
EP 41457
DI 10.1074/jbc.M508939200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 992EJ
UT WOS:000233866900042
PM 16219760
OA Bronze
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Bar, H
   Leterrier, JF
   Herrmann, H
   Aebi, U
AF Kreplak, L
   Bar, H
   Leterrier, JF
   Herrmann, H
   Aebi, U
TI Exploring the mechanical behavior of single intermediate filaments
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE AFM; stretching; desmin; neurofilament; keratin
ID ATOMIC-FORCE MICROSCOPY; HAGFISH SLIME THREADS; ALPHA-KERATIN FIBERS;
   LIVING CELLS; VIMENTIN; NETWORKS; INSIGHTS; IDENTIFICATION; MODEL
AB Intermediate filaments (IFs) are structural elements of eukaryotic cells with distinct mechanical properties. Tissue integrity is severely impaired, in particular in skin and muscle, when IFs are either absent or malfunctioning due to Mutations. Our knowledge on the mechanical properties of IFs is mainly based on tensile testing of macroscopic fibers and on the rheology of IF networks. At the single filament level, the only piece of data available is a measure of the persistence length of vimentin IFs.
   Here, we have employed an atomic force microscopy (AFM) based protocol to directly probe the mechanical properties of single cytoplasmic IFs when adsorbed to a solid Support in physiological buffer environment. Three IF types were studied in vitro: recombinant murine desmin, recombinant human keratin K5/K14 and neurofilaments isolated from rat brains, which are composed of the neurofilament triplet proteins NF-L, NF-M and NF-H. Depending on the experimental conditions, the AFM tip was used to laterally displace or to stretch single IFs on the support they had been adsorbed to. Upon applying force, IFs were stretched on average 2.6-fold. The maximum stretching that we encountered was 3.6-fold. A large reduction of the apparent filament diameter was observed concomitantly. The observed mechanical properties therefore Suggest that IFs may indeed function as mechanical shock absorbers in vivo. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Heidelberg, Med Klin, Dept Cardiol, D-69120 Heidelberg, Germany.
   Univ Poitiers, Inst Physiol & Biol Cellulaires, UMR 6187, CNRS, Poitiers, France.
   German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
RP Kreplak, L (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM laurent.kreplak@unibas.ch
OI kreplak, laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   FRASER RDB, 1969, POLYMER, V10, P810, DOI 10.1016/0032-3861(69)90110-4
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   Guthold M, 2004, BIOPHYS J, V87, P4226, DOI 10.1529/biophysj.104.042333
   HENDERSON D, 1982, J MOL BIOL, V155, P173, DOI 10.1016/0022-2836(82)90444-2
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   HISANAGA S, 1988, J MOL BIOL, V202, P297, DOI 10.1016/0022-2836(88)90459-7
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   KOCH EA, 1994, J CELL SCI, V107, P3133
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687
   Lewis MK, 2003, J STRUCT BIOL, V143, P56, DOI 10.1016/S1047-8477(03)00121-7
   Lin JK, 2004, J NEUROTRAUM, V21, P1671, DOI 10.1089/neu.2004.21.1671
   Lu JH, 2004, COLLOID SURFACE B, V39, P177, DOI 10.1016/j.colsurfb.2004.07.013
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Severin M, 2004, NANO LETT, V4, P577, DOI 10.1021/nl035147d
   Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071
   Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
NR 33
TC 145
Z9 145
U1 0
U2 21
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 2
PY 2005
VL 354
IS 3
BP 569
EP 577
DI 10.1016/j.jmb.2005.09.092
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 989LB
UT WOS:000233674100007
PM 16257415
DA 2021-01-25
ER

PT J
AU Cabernard, C
   Affolter, M
AF Cabernard, C
   Affolter, M
TI Distinct roles for two receptor tyrosine kinases in epithelial branching
   morphogenesis in Drosophila
SO DEVELOPMENTAL CELL
LA English
DT Article
ID MIDLINE GLIAL-CELLS; TRACHEAL SYSTEM; TUBE MORPHOGENESIS; MAP KINASE;
   PROTEIN; FGF; ACTIVATION; GROWTH; GENE; MIGRATION
AB Branching morphogenesis is a widespread mechanism used to increase the surface area of epithelial organs. Many signaling systems steer development of branched organs, but it is still unclear which cellular processes are regulated by the different pathways. We have used the development of the air sacs of the dorsal thorax of Drosophila to study cellular events and their regulation via cell-cell signaling. We find that two receptor tyrosine kinases play important but distinct roles in air sac outgrowth. Fgf signaling directs cell migration at the tip of the structure, while Egf signaling is instrumental for cell division and cell survival in the growing epithelial structure. Interestingly, we find that Fgf signaling requires Ras, the Mapk pathway, and Pointed to direct migration, suggesting that both cytoskeletal and nuclear events are downstream of receptor activation. Ras and the Mapk pathway are also needed for Egf-regulated cell division/survival, but Pointed is dispensable.
C1 Univ Basel, Biozentrum, Dept Biol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Dept Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Cabernard, Clemens/A-9033-2010
OI Cabernard, Clemens/0000-0003-3706-6401; Affolter,
   Markus/0000-0002-5171-0016
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   BRUNNER D, 1994, NATURE, V370, P386, DOI 10.1038/370386a0
   BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933
   FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Halfar K, 2001, DEVELOPMENT, V128, P1687
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   HOU XS, 1995, CELL, V81, P63, DOI 10.1016/0092-8674(95)90371-2
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   KARLHALOO A, 2005, NEPHROL EXP NEPHROL, V100, pE40
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   KLAMBT C, 1993, DEVELOPMENT, V117, P163
   Lee H.S., 1999, BIOTECHNOL BIOPROC E, V4, P151
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Luschnig S, 2000, MOL CELL, V5, P231, DOI 10.1016/S1097-2765(00)80419-0
   Manning Gerards, 1993, P609
   O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859
   Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246
   Ohshiro T, 2002, MECH DEVELOP, V114, P3, DOI 10.1016/S0925-4773(02)00042-4
   ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0
   Petit V, 2004, MOL CELL BIOL, V24, P3769, DOI 10.1128/MCB.24.9.3769-3781.2004
   Queenan AM, 1997, DEVELOPMENT, V124, P3871
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   SHIBATA K, 1990, EUR J BIOCHEM, V192, P87, DOI 10.1111/j.1432-1033.1990.tb19199.x
   Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1
   WHITTEN J, 1980, GENET BIOL DROSOPHIL, P499
   Wilson R, 2004, MOL CELL BIOL, V24, P2263, DOI 10.1128/MCB.24.6.2263-2276.2004
   Yu W, 2003, MOL BIOL CELL, V14, P748, DOI 10.1091/mbc.E02-06-0350
   Zegers MMP, 2003, TRENDS CELL BIOL, V13, P169, DOI 10.1016/S0962-8924(03)00036-9
NR 39
TC 77
Z9 77
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD DEC
PY 2005
VL 9
IS 6
BP 831
EP 842
DI 10.1016/j.devcel.2005.10.008
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 993MV
UT WOS:000233959100014
PM 16326394
DA 2021-01-25
ER

PT J
AU Marino, M
   Svergun, DI
   Kreplak, L
   Konarev, PV
   Maco, B
   Labeit, D
   Mayans, O
AF Marino, Marco
   Svergun, Dmitri I.
   Kreplak, Laurent
   Konarev, Peter V.
   Maco, Bohumil
   Labeit, Dietmar
   Mayans, Olga
TI Poly-Ig tandems from I-band titin share extended domain arrangements
   irrespective of the distinct features of their modular constituents
SO JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY
LA English
DT Article; Proceedings Paper
CT International Symposium on Muscle Elastic Proteins
CY NOV 19-21, 2004
CL Chiba Univ, Chiba, JAPAN
HO Chiba Univ
ID MUSCLE PROTEIN TITIN; IMMUNOGLOBULIN-LIKE MODULES; STEERED
   MOLECULAR-DYNAMICS; ELASTIC PEVK SEGMENT; FORCE MICROSCOPY; STRUCTURAL
   BASIS; GIANT; SCATTERING; MECHANICS; TITIN/CONNECTIN
AB The cellular function of the giant protein titin in striated muscle is a major focus of scientific attention. Particularly, its role in passive mechanics has been extensively investigated. In strong contrast, the structural details of this filament are very poorly understood. To date, only a handful of atomic models from single domain components have become available and data on poly-constructs are limited to scarce SAXS analyses. In this study, we examine the molecular parameters of poly-Ig tandems from I-band titin relevant to muscle elasticity. We revisit conservation patterns in domain and linker sequences of I-band modules and interpret these in the light of available atomic structures of Ig domains from muscle proteins. The emphasis is placed on features expected to affect inter-domain arrangements. We examine the overall conformation of a 6Ig fragment, I65-I70, from the skeletal I-band of soleus titin using SAXS and electron microscopy approaches. The possible effect of highly conserved glutamate groups at the linkers as well as the ionic strength of the medium on the overall molecular parameters of this sample is investigated. Our findings indicate that poly-Ig tandems from I-band titin tend to adopt extended arrangements with low or moderate intrinsic flexibility, independently of the specific features of linkers or component Ig domains across constitutively- and differentially-expressed tandems. Linkers do not appear to operate as free hinges so that lateral association of Ig domains must occur infrequently in samples in solution, even that inter-domain sequences of 4-5 residues length would well accommodate such geometry. It can be expected that this principle is generally applicable to all Ig-tandems from I-band titin.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   DESY, EMBL, D-22603 Hamburg, Germany.
   Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia.
   Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intensivmed, D-68167 Mannheim, Germany.
RP Mayans, O (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Olga.Mayans@unibas.ch
RI Mayans, Olga/A-3954-2008; Konarev, Petr V/W-1380-2017
OI Konarev, Petr/0000-0002-5606-1596; Svergun, Dmitri/0000-0003-0830-5696;
   Mayans, Olga/0000-0001-6876-8532; kreplak, laurent/0000-0001-9370-9809;
   Maco, Bohumil/0000-0001-8444-313X
CR Atkinson RA, 2001, NAT STRUCT BIOL, V8, P853, DOI 10.1038/nsb1001-853
   Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981
   Bullard B, 2002, J MUSCLE RES CELL M, V23, P435, DOI 10.1023/A:1023454305437
   Di Cola E, 2005, BIOPHYS J, V88, P4095, DOI 10.1529/biophysj.104.054908
   Feigin L.A., 1987, STRUCTURE ANAL SMALL
   Flory P.J., 1969, STAT MECH CHAIN MOL
   Fong S, 1996, J MOL BIOL, V264, P624, DOI 10.1006/jmbi.1996.0665
   Gao M, 2002, BIOPHYS J, V83, P3435, DOI 10.1016/S0006-3495(02)75343-5
   Gao M, 2001, BIOPHYS J, V81, P2268, DOI 10.1016/S0006-3495(01)75874-2
   Gautel M, 1996, ADV BIOPHYS, V33, P27
   Gautel M, 1996, FEBS LETT, V385, P11, DOI 10.1016/0014-5793(96)00338-9
   Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8
   HIGUCHI H, 1993, BIOPHYS J, V65, P1906, DOI 10.1016/S0006-3495(93)81261-X
   HOLDEN HM, 1992, J MOL BIOL, V227, P840, DOI 10.1016/0022-2836(92)90226-A
   Improta S, 1998, J MOL BIOL, V284, P761, DOI 10.1006/jmbi.1998.2028
   Improta S, 1996, STRUCTURE, V4, P323, DOI 10.1016/S0969-2126(96)00036-6
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kellermayer MSZ, 2003, BBA-BIOENERGETICS, V1604, P105, DOI 10.1016/S0005-2728(03)00029-X
   Kenny PA, 1999, GENE, V232, P11, DOI 10.1016/S0378-1119(99)00122-5
   Kobe B, 1996, EMBO J, V15, P6810, DOI 10.1002/j.1460-2075.1996.tb01072.x
   Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Li HB, 2000, NAT STRUCT BIOL, V7, P1117
   Li HB, 2003, J MOL BIOL, V334, P75, DOI 10.1016/j.jmb.2003.09.036
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938
   Linke WA, 1996, J MOL BIOL, V261, P62, DOI 10.1006/jmbi.1996.0441
   Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3
   Ma K, 2003, BIOCHEM J, V374, P687, DOI 10.1042/BJ20030702
   Ma K, 2001, BIOCHEMISTRY-US, V40, P3427, DOI 10.1021/bi0022792
   MARUYAMA K, 1977, J BIOCHEM, V82, P317
   Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603
   Mayans O, 2001, STRUCTURE, V9, P331, DOI 10.1016/S0969-2126(01)00591-3
   Miller MK, 2004, TRENDS CELL BIOL, V14, P119, DOI 10.1016/j.tcb.2004.01.003
   MUHLEGOLL C, 1998, STRUCTURE, V6, P1291
   PFUHL M, 1995, STRUCTURE, V3, P391, DOI 10.1016/S0969-2126(01)00170-8
   Politou AS, 1996, J MOL BIOL, V255, P604, DOI 10.1006/jmbi.1996.0050
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687
   Scott KA, 2002, J MOL BIOL, V315, P819, DOI 10.1006/jmbi.2001.5260
   SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663
   SVERGUN DI, 1993, J APPL CRYSTALLOGR, V26, P258, DOI 10.1107/S0021889892011828
   Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853
   Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   Tskhovrebova L, 2001, J MOL BIOL, V310, P755, DOI 10.1006/jmbi.2001.4700
   Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458
   Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993
   Zou PJ, 2003, J BIOL CHEM, V278, P2636, DOI 10.1074/jbc.M210217200
NR 48
TC 32
Z9 32
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0142-4319
EI 1573-2657
J9 J MUSCLE RES CELL M
JI J. Muscle Res. Cell Motil.
PD DEC
PY 2005
VL 26
IS 6-8
BP 355
EP 365
DI 10.1007/s10974-005-9017-6
PG 11
WC Cell Biology
SC Cell Biology
GA 059DI
UT WOS:000238713100011
PM 16341830
DA 2021-01-25
ER

PT J
AU Siddharthan, R
   Siggia, ED
   van Nimwegen, E
AF Siddharthan, Rahul
   Siggia, Eric D.
   van Nimwegen, Erik
TI PhyloGibbs: A Gibbs sampling motif finder that incorporates phylogeny
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID CIS-REGULATORY MODULES; FACTOR-BINDING SITES; SACCHAROMYCES-CEREVISIAE;
   TRANSCRIPTIONAL ACTIVATION; DEPENDENT TRANSCRIPTION; SEQUENCE ALIGNMENT;
   GENE-EXPRESSION; PROTEIN-BINDING; DNA; ELEMENTS
AB A central problem in the bioinformatics of gene regulation is to find the binding sites for regulatory proteins. One of the most promising approaches toward identifying these short and fuzzy sequence patterns is the comparative analysis of orthologous intergenic regions of related species. This analysis is complicated by various factors. First, one needs to take the phylogenetic relationship between the species into account in order to distinguish conservation that is due to the occurrence of functional sites from spurious conservation that is due to evolutionary proximity. Second, one has to deal with the complexities of multiple alignments of orthologous intergenic regions, and one has to consider the possibility that functional sites may occur outside of conserved segments. Here we present a new motif sampling algorithm, PhyloGibbs, that runs on arbitrary collections of multiple local sequence alignments of orthologous sequences. The algorithm searches over all ways in which an arbitrary number of binding sites for an arbitrary number of transcription factors ( TFs) can be assigned to the multiple sequence alignments. These binding site configurations are scored by a Bayesian probabilistic model that treats aligned sequences by a model for the evolution of binding sites and "background'' intergenic DNA. This model takes the phylogenetic relationship between the species in the alignment explicitly into account. The algorithm uses simulated annealing and Monte Carlo Markovchain sampling to rigorously assign posterior probabilities to all the binding sites that it reports. In tests on synthetic data and real data from five Saccharomyces species our algorithm performs significantly better than four other motif-finding algorithms, including algorithms that also take phylogeny into account. Our results also show that, in contrast to the other algorithms, PhyloGibbs can make realistic estimates of the reliability of its predictions. Our tests suggest that, running on the five-species multiple alignment of a single gene's upstream region, PhyloGibbs on average recovers over 50% of all binding sites in S. cerevisiae at a specificity of about 50%, and 33% of all binding sites at a specificity of about 85%. We also tested PhyloGibbs on collections of multiple alignments of intergenic regions that were recently annotated, based on ChIP-on-chip data, to contain binding sites for the same TF. We compared PhyloGibbs's results with the previous analysis of these data using six other motif-finding algorithms. For 16 of 21 TFs for which all other motif-finding methods failed to find a significant motif, PhyloGibbs did recover a motif that matches the literature consensus. In 11 cases where there was disagreement in the results we compiled lists of known target genes from the literature, and found that running PhyloGibbs on their regulatory regions yielded a binding motif matching the literature consensus in all but one of the cases. Interestingly, these literature gene lists had little overlap with the targets annotated based on the ChIP-on-chip data.
C1 Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA.
   Inst Math Sci, Madras 600113, Tamil Nadu, India.
   Univ Basel, Biozentrum, Div Bioinformat, CH-4003 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10021 USA.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
CR AXELROD JD, 1991, MOL CELL BIOL, V11, P564, DOI 10.1128/MCB.11.1.564
   BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8
   *BIOZ U BAS SWISS, 2005, SWISSREGULON
   Blaiseau PL, 1998, EMBO J, V17, P6327, DOI 10.1093/emboj/17.21.6327
   Blaiseau PL, 1997, MOL CELL BIOL, V17, P3640, DOI 10.1128/MCB.17.7.3640
   Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104
   Blanchette M, 2002, J COMPUT BIOL, V9, P211, DOI 10.1089/10665270252935421
   Blanchette M, 2002, GENOME RES, V12, P739, DOI 10.1101/gr.6902
   Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404
   Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603
   Chellappa R, 2001, J BIOL CHEM, V276, P43548, DOI 10.1074/jbc.M107845200
   Chin CS, 2005, GENOME RES, V15, P205, DOI 10.1101/gr.3243305
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997
   CUNNINGHAM TS, 1993, J BACTERIOL, V175, P5851, DOI 10.1128/JB.175.18.5851-5861.1993
   CUNNINGHAM TS, 1994, J BACTERIOL, V176, P4718, DOI 10.1128/JB.176.15.4718-4725.1994
   Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077
   Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603
   Dodou E, 1997, MOL CELL BIOL, V17, P1848, DOI 10.1128/MCB.17.4.1848
   Dormer UH, 2000, J BIOL CHEM, V275, P32611, DOI 10.1074/jbc.M004167200
   Durbin R., 1998, BIOL SEQUENCE ANAL
   Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57
   Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Herrero P, 1999, BIOCHEM J, V343, P319, DOI 10.1042/0264-6021:3430319
   Hongay C, 2002, EMBO J, V21, P4114, DOI 10.1093/emboj/cdf415
   Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519
   JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Labbe S, 1997, J BIOL CHEM, V272, P15951, DOI 10.1074/jbc.272.25.15951
   LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139
   LINDE JJT, 2002, YEAST, V19, P825
   Liu J. S., 2001, MONTE CARLO STRATEGI
   Liu JS, 1999, J AM STAT ASSOC, V94, P1, DOI 10.2307/2669673
   Liu X, 2001, Pac Symp Biocomput, P127
   Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717
   McCue LA, 2002, GENOME RES, V12, P1523, DOI 10.1101/gr.323602
   McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774
   Morgenstern B, 1996, P NATL ACAD SCI USA, V93, P12098, DOI 10.1073/pnas.93.22.12098
   Moses AM, 2003, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2004, P324
   *NAT HUM GEN RES I, 2005, SACCH GEN DAT
   Novoseler M, 2005, J BIOL CHEM, V280, P5169, DOI 10.1074/jbc.M406249200
   Pollard DA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-6
   Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302
   Rajewsky N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-30
   Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002
   Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x
   Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053
   Sasaki H, 2005, YEAST, V22, P305, DOI 10.1002/yea.1212
   Siddharthan R, 2005, LECT NOTES COMPUT SC, V3318, P30
   Siggia ED, 2005, CURR OPIN GENET DEV, V15, P214, DOI 10.1016/j.gde.2005.02.004
   Sinha S, 2005, MOL BIOL EVOL, V22, P874, DOI 10.1093/molbev/msi090
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   STORMO GD, 1989, P NATL ACAD SCI USA, V86, P1183, DOI 10.1073/pnas.86.4.1183
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Timothy B, 1994, P 2 INT C INT SYST M, V2, P28
   van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399
   Wang T, 2003, BIOINFORMATICS, V19, P2369, DOI 10.1093/bioinformatics/btg329
   YONA E, 1995, MOL GEN GENET, V246, P774, DOI 10.1007/BF00290726
   Young ET, 2003, J BIOL CHEM, V278, P26146, DOI 10.1074/jbc.M301981200
   Zavolan M, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P277, DOI 10.1109/CSB.2003.1227328
   Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607
NR 63
TC 193
Z9 200
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD DEC
PY 2005
VL 1
IS 7
BP 534
EP 556
AR e67
DI 10.1371/journal.pcbi.0010067
PG 23
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 069WS
UT WOS:000239480500003
PM 16477324
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Aebi, U
AF Lim, RYH
   Aebi, U
TI In silico access to the nuclear pore complex
SO STRUCTURE
LA English
DT Editorial Material
ID IMPORTIN-BETA; MOLECULAR-DYNAMICS; STRUCTURAL BASIS; NUCLEOPORINS;
   TRANSPORT; AFFINITY
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
OI Lim, Roderick/0000-0001-5015-6087
CR Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Humphrey W., 1986, J MOL GRAPHICS, V14, P33, DOI [10.1016/0263-7855(96)00018-5, DOI 10.1016/0263-7855(96)00018-5]
   Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201
   Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
NR 10
TC 1
Z9 1
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD DEC
PY 2005
VL 13
IS 12
BP 1741
EP 1743
DI 10.1016/j.str.2005.11.002
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 997ZF
UT WOS:000234286900004
PM 16338402
DA 2021-01-25
ER

PT J
AU Landgraf, P
   Rice, A
   Iovino, N
   Fulci, V
   Sheridan, R
   Fuchs, U
   Schmid, I
   Sander, C
   Chen, M
   Russo, JJ
   Ju, JY
   Tam, W
   Macino, G
   Zavolan, M
   Borkhardt, A
   Tuschl, T
AF Landgraf, P
   Rice, A
   Iovino, N
   Fulci, V
   Sheridan, R
   Fuchs, U
   Schmid, I
   Sander, C
   Chen, M
   Russo, JJ
   Ju, JY
   Tam, W
   Macino, G
   Zavolan, M
   Borkhardt, A
   Tuschl, T
TI miRNA profiling of pediatric ALL and non-hodgkin lymphomas.
SO BLOOD
LA English
DT Meeting Abstract
CT 47th Annual Meeting of the American-Society-of-Hematology
CY DEC 10-13, 2005
CL Atlanta, GA
SP Amer Soc Hematol
C1 Rockefeller Univ, RNA Mol Biol Lab, New York, NY 10021 USA.
   Univ Roma La Sapienza, Dept Cellular Biotechnol & Hematol, Rome, Italy.
   Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA.
   Univ Munich, Dr V Hauner Childrens Hosp, Dept Hematol & Oncol, Munich, Germany.
   Columbia Genome Ctr, New York, NY USA.
   Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
RI fulci, valerio/J-1963-2015; Sander, Chris/H-1452-2011; Zavolan,
   Mihaela/S-3888-2016
OI fulci, valerio/0000-0002-1173-585X; Sander, Chris/0000-0001-6059-6270; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD NOV 16
PY 2005
VL 106
IS 11
MA 2719
BP 763A
EP 764A
PN 1
PG 2
WC Hematology
SC Hematology
GA 986CF
UT WOS:000233426005039
DA 2021-01-25
ER

PT J
AU Chami, M
   Guilvout, I
   Gregorini, M
   Remigy, HW
   Muller, SA
   Valerio, M
   Engel, A
   Pugsley, AP
   Bayan, N
AF Chami, M
   Guilvout, I
   Gregorini, M
   Remigy, HW
   Muller, SA
   Valerio, M
   Engel, A
   Pugsley, AP
   Bayan, N
TI Structural insights into the secretin PulD and its trypsin-resistant
   core
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; PHAGE PIV MULTIMER; C-TERMINAL DOMAIN;
   ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; PILQ SECRETIN;
   FUNCTIONAL-CHARACTERIZATION; PULLULANASE SECRETION; ELECTRON-MICROSCOPY;
   CRYSTAL-STRUCTURE
AB Limited proteolysis, secondary structure and biochemical analyses, mass spectrometry, and mass measurements by scanning transmission electron microscopy were combined with cryo-electron microscopy to generate a three-dimensional model of the homomultimeric complex formed by the outer membrane secretin PulD, an essential channel-forming component of the type II secretion system from Klebsiella oxytoca. The complex is a dodecameric structure composed of two rings that sandwich a closed disc. The two rings form chambers on either side of a central plug that is part of the middle disc. The PulD polypeptide comprises two major, structurally quite distinct domains; an N domain, which forms the walls of one of the chambers, and a trypsin-resistant C domain, which contributes to the outer chamber, the central disc, and the plug. The C domain contains a lower proportion of potentially transmembrane beta-structure than classical outer membrane proteins, suggesting that only a small part of it is embedded within the outer membrane. Indeed, the C domain probably extends well beyond the confines of the outer membrane bilayer, forming a centrally plugged channel that penetrates both the peptidoglycan on the periplasmic side and the lipopolysaccharide and capsule layers on the cell surface. The inner chamber is proposed to constitute a docking site for the secreted exoprotein pullulanase, whereas the outer chamber could allow displacement of the plug to open the channel and permit the exoprotein to escape.
C1 Inst Pasteur, CNRS, URA 2175, Mol Genet Unit, F-75724 Paris, France.
   Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
   Univ Paris 11, Lab Modelisat & Ingn Prot, F-91405 Orsay, France.
RP Pugsley, AP (corresponding author), Inst Pasteur, CNRS, URA 2175, Mol Genet Unit, 25 Rue Dr Roux, F-75724 Paris, France.
EM max@pasteur.fr
RI Bayan, Nicolas/AAI-5034-2020
OI Bayan, Nicolas/0000-0001-7760-0811
CR BAICHWAL V, 1993, P NATL ACAD SCI USA, V90, P620, DOI 10.1073/pnas.90.2.620
   BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I
   Beis K, 2004, J BIOL CHEM, V279, P28227, DOI 10.1074/jbc.M402913200
   Bitter W, 1998, MOL MICROBIOL, V27, P209, DOI 10.1046/j.1365-2958.1998.00677.x
   Bleves S, 1999, J BACTERIOL, V181, P4012, DOI 10.1128/JB.181.13.4012-4019.1999
   Boulanger P, 1996, BIOCHEMISTRY-US, V35, P14216, DOI 10.1021/bi9608673
   Brok R, 1999, J MOL BIOL, V294, P1169, DOI 10.1006/jmbi.1999.3340
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Chen CJ, 2004, J BACTERIOL, V186, P730, DOI 10.1128/JB.186.3.730-739.2004
   Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003
   Collins RF, 2001, J BACTERIOL, V183, P3825, DOI 10.1128/JB.183.13.3825-3832.2001
   CROWTHER RA, 1971, J MOL BIOL, V60, P123, DOI 10.1016/0022-2836(71)90452-9
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   Daefler S, 1997, J MOL BIOL, V266, P978, DOI 10.1006/jmbi.1996.0866
   DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x
   Faller M, 2004, SCIENCE, V303, P1189, DOI 10.1126/science.1094114
   Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Gohlke U, 2005, P NATL ACAD SCI USA, V102, P10482, DOI 10.1073/pnas.0503558102
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Lario PI, 2005, EMBO J, V24, P1111, DOI 10.1038/sj.emboj.7600610
   Lee MS, 2005, J BIOL CHEM, V280, P4585, DOI 10.1074/jbc.M409362200
   Letellier L, 1997, J BIOL CHEM, V272, P11109
   Linderoth NA, 1997, SCIENCE, V278, P1635, DOI 10.1126/science.278.5343.1635
   Linderoth NA, 1996, J BACTERIOL, V178, P1962, DOI 10.1128/jb.178.7.1962-1970.1996
   Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Marabini R, 1996, J STRUCT BIOL, V116, P237, DOI 10.1006/jsbi.1996.0036
   Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516
   Marciano DK, 2001, P NATL ACAD SCI USA, V98, P9359, DOI 10.1073/pnas.161170398
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985
   MILLER JH, 1992, SHORT COURSE BACTERI, P437
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A
   Possot OM, 1997, MOL MICROBIOL, V24, P457, DOI 10.1046/j.1365-2958.1997.3451726.x
   Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000
   Possot OM, 1999, J BACTERIOL, V181, P4004, DOI 10.1128/JB.181.13.4004-4011.1999
   Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001
   PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993
   PUGSLEY AP, 1991, MOL MICROBIOL, V5, P343, DOI 10.1111/j.1365-2958.1991.tb02115.x
   Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x
   Sauvonnet N, 2000, EMBO J, V19, P2221, DOI 10.1093/emboj/19.10.2221
   Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   Vignon G, 2003, J BACTERIOL, V185, P3416, DOI 10.1128/JB.185.11.3416-3428.2003
   Voulhoux R, 2001, EMBO J, V20, P6735, DOI 10.1093/emboj/20.23.6735
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Zhao SQ, 2005, MOL MICROBIOL, V57, P1238, DOI 10.1111/j.1365-2958.2005.04752.x
NR 61
TC 114
Z9 117
U1 0
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 11
PY 2005
VL 280
IS 45
BP 37732
EP 37741
DI 10.1074/jbc.M504463200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 980UU
UT WOS:000233044500051
PM 16129681
OA Bronze
DA 2021-01-25
ER

PT J
AU Sewer, A
   Paul, N
   Landgraf, P
   Aravin, A
   Pfeffer, S
   Brownstein, MJ
   Tuschl, T
   van Nimwegen, E
   Zavolan, M
AF Sewer, A
   Paul, N
   Landgraf, P
   Aravin, A
   Pfeffer, S
   Brownstein, MJ
   Tuschl, T
   van Nimwegen, E
   Zavolan, M
TI Identification of clustered microRNAs using an ab initio prediction
   method
SO BMC BIOINFORMATICS
LA English
DT Article
ID RNA SECONDARY STRUCTURES; COMPUTATIONAL IDENTIFICATION; HOST GENES;
   PRECURSORS; BIOGENESIS; SEQUENCES
AB Background: MicroRNAs ( miRNAs) are endogenous 21 to 23-nucleotide RNA molecules that regulate protein-coding gene expression in plants and animals via the RNA interference pathway. Hundreds of them have been identified in the last five years and very recent works indicate that their total number is still larger. Therefore miRNAs gene discovery remains an important aspect of understanding this new and still widely unknown regulation mechanism. Bioinformatics approaches have proved to be very useful toward this goal by guiding the experimental investigations.
   Results: In this work we describe our computational method for miRNA prediction and the results of its application to the discovery of novel mammalian miRNAs. We focus on genomic regions around already known miRNAs, in order to exploit the property that miRNAs are occasionally found in clusters. Starting with the known human, mouse and rat miRNAs we analyze 20 kb of flanking genomic regions for the presence of putative precursor miRNAs (pre-miRNAs). Each genome is analyzed separately, allowing us to study the species-specific identity and genome organization of miRNA loci. We only use cross-species comparisons to make conservative estimates of the number of novel miRNAs. Our ab initio method predicts between fifty and hundred novel pre-miRNAs for each of the considered species. Around 30% of these already have experimental support in a large set of cloned mammalian small RNAs. The validation rate among predicted cases that are conserved in at least one other species is higher, about 60%, and many of them have not been detected by prediction methods that used cross-species comparisons. A large fraction of the experimentally confirmed predictions correspond to an imprinted locus residing on chromosome 14 in human, 12 in mouse and 6 in rat. Our computational tool can be accessed on the world-wide-web.
   Conclusion: Our results show that the assumption that many miRNAs occur in clusters is fruitful for the discovery of novel miRNAs. Additionally we show that although the overall miRNA content in the observed clusters is very similar across the three considered species, the internal organization of the clusters changes in evolution.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Rockefeller Univ, Lab RNA Mol Biol, New York, NY USA.
   J Craig Venter Inst, Rockville, MD USA.
   IBMP CNRS, Strasbourg, France.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM alain.sewer@unibas.ch; nicodeme.paul@unibas.ch;
   Pablo.Landgraf@rockefeller.edu; aravina@rockefeller.edu;
   sebastien.pfeffer@ibmp-ulp.u-strasbg.fr; mike@venterinstitute.org;
   ttuschl@rockefeller.edu; erik.vannimwegen@unibas.ch;
   mihaela.zavolan@unibas.ch
RI Pfeffer, Sebastien/H-3212-2019; Zavolan, Mihaela/S-3888-2016; Pfeffer,
   Sebastien/A-6512-2010
OI Pfeffer, Sebastien/0000-0002-8458-348X; Pfeffer,
   Sebastien/0000-0002-8458-348X; van Nimwegen, Erik/0000-0001-6338-1312;
   Zavolan, Mihaela/0000-0002-8832-2041
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P01-GM073047-01, P01 GM073047] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047] Funding Source: NIH RePORTER
CR Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905
   Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031
   Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374
   Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   Hofacker IL, 2004, BIOINFORMATICS, V20, P186, DOI 10.1093/bioinformatics/btg388
   Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961
   JOACHIMS T, 1993, ADV KERNEL METHODS S
   Krol J, 2004, J BIOL CHEM, V279, P42230, DOI 10.1074/jbc.M404931200
   Lai EC, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r42
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Legendre M, 2005, BIOINFORMATICS, V21, P841, DOI 10.1093/bioinformatics/bti073
   Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372
   Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403
   Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704
   Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304
   Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13
   Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065
   TSUCHL T, 2005, IN PRESS COMPREHENSI
   Wagner A, 1999, J EXP ZOOL, V285, P119
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 31
TC 175
Z9 286
U1 0
U2 13
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD NOV 7
PY 2005
VL 6
AR 267
DI 10.1186/1471-2105-6-267
PG 15
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 993PY
UT WOS:000233968600001
PM 16274478
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Fan, Y
   Soller, M
   Flister, S
   Hollmann, M
   Muller, M
   Bello, B
   Egger, B
   White, K
   Schafer, MA
   Reichert, H
AF Fan, Y
   Soller, M
   Flister, S
   Hollmann, M
   Muller, M
   Bello, B
   Egger, B
   White, K
   Schafer, MA
   Reichert, H
TI The egghead gene is required for compartmentalization in Drosophila
   optic lobe development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE egghead; compartment boundary; photoreceptor axon targeting; optic lobe;
   glycosyltransferase; Drosophila
ID PHOTORECEPTOR AXON GUIDANCE; LIPID RAFTS; RETINAL AXONS; TARGET
   SPECIFICITY; KINASE MISSHAPEN; LAYER-SELECTION; IMAGINAL DISCS; EGF
   RECEPTOR; LARVAL BRAIN; GLIAL-CELLS
AB The correct targeting of photoreceptor neurons (R-cells) in the developing Drosophila visual system requires multiple guidance systems in the eye-brain complex as well as the precise organization of the target area. Here, we report that the egghead (egh) gene, encoding a glycosyltransferase, is required for a compartment boundary between lamina glia and lobula cortex, which is necessary for appropriate R1-R6 innervation of the lamina. In the absence of egh, R1-R6 axons form a disorganized lamina plexus and some R1-R6 axons project abnormally to the medulla instead of the lamina. Mosaic analysis demonstrates that this is not due to a loss of egh function in the eye or in the neurons and glia of the lamina. Rather, as indicated by clonal analysis and cell-specific genetic rescue experiments, egh is required in cells of the lobula complex primordium which transiently abuts the lamina and medulla in the developing larval brain. In the absence of egh, perturbation of sheath-like glial processes Occurs at the boundary region delimiting lamina glia and lobula cortex, and inappropriate invasion of lobula cortex cells across this boundary region disrupts the pattern of lamina glia resulting in inappropriate R1-R6 innervation. This finding underscores the importance of the lamina/lobula compartment boundary in R1-R6 axon targeting. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
   Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.
   Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.
   Univ Kassel, FB18 Zool Entwicklungsbiol, D-34132 Kassel, Germany.
   Univ Cambridge, Wellcome Trust Canc Res Gurdon Inst, Cambridge CB2 1QN, England.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Yun.Fan@unibas.ch; Heinrich.Reichert@unibas.ch
RI Egger, Boris/B-7227-2012; Egger, Boris/N-3493-2019; Soller,
   Matthias/J-4844-2017
OI Egger, Boris/0000-0001-8551-9140; Egger, Boris/0000-0001-8551-9140;
   Soller, Matthias/0000-0003-3844-0258
CR Araujo SJ, 2003, NAT REV NEUROSCI, V4, P910, DOI 10.1038/nrn1243
   ASHBURNER M, 1989, DROSOPHILA LAB MANUA, P399
   BASLER K, 1988, CELL, V54, P299
   BOYAN G, 1995, DEVELOPMENT, V121, P75
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Cafferty P, 2004, DEVELOPMENT, V131, P5287, DOI 10.1242/dev.01406
   Casso D, 2000, MECH DEVELOP, V91, P449
   Cheng YC, 2004, DEV CELL, V6, P539, DOI 10.1016/S1534-5807(04)00097-8
   Chotard C, 2004, TRENDS NEUROSCI, V27, P655, DOI 10.1016/j.tins.2004.09.001
   Clandinin TR, 2002, NEURON, V35, P827, DOI 10.1016/S0896-6273(02)00876-0
   Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3
   CORDES SP, 1994, CELL, V79, P1025, DOI 10.1016/0092-8674(94)90033-7
   Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6
   Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111
   Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9
   Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3
   Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8
   GHOSH A, 1993, DEVELOPMENT, V117, P1031
   Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101
   GOODE S, 1992, DEVELOPMENT, V116, P177
   Goode S, 1996, DEVELOPMENT, V122, P3863
   Guirland C, 2004, NEURON, V42, P51, DOI 10.1016/S0896-6273(04)00157-6
   Hahnlein I, 1996, J COMP NEUROL, V367, P235, DOI 10.1002/(SICI)1096-9861(19960401)367:2&lt;235::AID-CNE6&gt;3.0.CO;2-6
   HALTER DA, 1995, DEVELOPMENT, V121, P317
   HEBERLEIN U, 1990, P NATL ACAD SCI USA, V87, P5916, DOI 10.1073/pnas.87.15.5916
   HOFBAUER A, 1990, ROUX ARCH DEV BIOL, V198, P264, DOI 10.1007/BF00377393
   Huang Z, 1998, DEVELOPMENT, V125, P3753
   Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189
   Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005
   JUDD BH, 1972, GENETICS, V71, P139
   Kaminker JS, 2002, NAT NEUROSCI, V5, P746, DOI 10.1038/nn889
   Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4
   Lee RC, 2003, NAT NEUROSCI, V6, P557, DOI 10.1038/nn1063
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109
   Manseau L, 1997, DEV DYNAM, V209, P310, DOI 10.1002/(SICI)1097-0177(199707)209:3<310::AID-AJA6>3.3.CO;2-O
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8
   McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540
   Meinertzhagen Ian A., 1993, P1363
   Metin C, 1996, J NEUROSCI, V16, P3219
   Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779
   MITROFANIS J, 1993, J COMP NEUROL, V338, P575, DOI 10.1002/cne.903380407
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024
   POECK B, 1993, DEVELOPMENT, V117, P1017
   Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0
   Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297
   Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786
   Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Rietveld A, 1999, J BIOL CHEM, V274, P12049, DOI 10.1074/jbc.274.17.12049
   ROBINOW S, 1988, SCIENCE, V242, P1570, DOI 10.1126/science.3144044
   Ruan WJ, 1999, NEURON, V24, P595, DOI 10.1016/S0896-6273(00)81115-0
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   Rubsam R, 1998, MECH DEVELOP, V72, P131, DOI 10.1016/S0925-4773(98)00023-9
   Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X
   SchneiderMaunoury S, 1997, DEVELOPMENT, V124, P1215
   Senti KA, 2000, DEVELOPMENT, V127, P2291
   Senti KA, 2003, CURR BIOL, V13, P828, DOI 10.1016/S0960-9822(03)00291-4
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Soller M, 2003, GENE DEV, V17, P2526, DOI 10.1101/gad.1106703
   Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006
   Stowers RS, 1999, GENETICS, V152, P1631
   Su YC, 2000, MOL CELL BIOL, V20, P4736, DOI 10.1128/MCB.20.13.4736-4744.2000
   Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Tayler TD, 2004, DEVELOPMENT, V131, P5935, DOI 10.1242/dev.01465
   Tayler TD, 2003, CURR OPIN NEUROBIOL, V13, P90, DOI 10.1016/S0959-4388(03)00004-7
   Ting CY, 2005, DEVELOPMENT, V132, P953, DOI 10.1242/dev.01661
   Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4
   Wandall HH, 2003, J BIOL CHEM, V278, P1411, DOI 10.1074/jbc.C200619200
   Wandall HH, 2005, J BIOL CHEM, V280, P4858, DOI 10.1074/jbc.C400571200
   Watts RWE, 2003, PHILOS T ROY SOC B, V358, P975, DOI 10.1098/rstb.2003.1280
   WILLIAMS BC, 1995, J CELL BIOL, V129, P709, DOI 10.1083/jcb.129.3.709
   Yang H, 2004, P NATL ACAD SCI USA, V101, P15213, DOI 10.1073/pnas.0308141101
   Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483
   Zecca M, 2002, DEVELOPMENT, V129, P1369
   Zeltser LM, 2001, NAT NEUROSCI, V4, P683, DOI 10.1038/89455
   ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2
NR 82
TC 16
Z9 16
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD NOV 1
PY 2005
VL 287
IS 1
BP 61
EP 73
DI 10.1016/j.ydbio.2005.08.031
PG 13
WC Developmental Biology
SC Developmental Biology
GA 988HN
UT WOS:000233584000006
PM 16182276
DA 2021-01-25
ER

PT J
AU Karamloo, F
   Schmid-Grendelmeier, P
   Kussebi, F
   Akdis, M
   Salagianni, M
   von Beust, BR
   Reimers, A
   Zumkehr, J
   Soldatova, L
   Housley-Markovic, Z
   Muller, U
   Kundig, T
   Kemeny, DM
   Spangfort, MD
   Blaser, K
   Akdis, CA
AF Karamloo, F
   Schmid-Grendelmeier, P
   Kussebi, F
   Akdis, M
   Salagianni, M
   von Beust, BR
   Reimers, A
   Zumkehr, J
   Soldatova, L
   Housley-Markovic, Z
   Muller, U
   Kundig, T
   Kemeny, DM
   Spangfort, MD
   Blaser, K
   Akdis, CA
TI Prevention of allergy by a recombinant multi-allergen vaccine with
   reduced IgE binding and preserved T cell epitopes
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE allergy; T cells; antibodies; antigens/peptides/epitopes; vaccination
ID BEE-VENOM PHOSPHOLIPASE-A2; BIRCH POLLEN; ASPERGILLUS-FUMIGATUS;
   CRYSTAL-STRUCTURE; HONEYBEE VENOM; IMMUNOTHERAPY; RESPONSES; ANTIGEN;
   MELITTIN; A(2)
AB Novel approaches for the prevention of allergy are required, because of the inevitably increasing prevalence of allergic diseases during the last 30 years. Here, a recombinant chimeric protein, which comprises the whole amino acid sequences of three bee venom major allergens has been engineered and used in prevention of bee venom sensitization in mice. Phospholipase A(2) (Api in 1), hyaluronidase (Api m 2) and melittin (Api in 3) fragments with overlapping amino acids were assembled in a different order in the Api in (1/2/3) chimeric protein, which preserved entire T cell epitopes, whereas B cell epitopes of all three allergens were abrogated. Accordingly, IgE cross-linking leading to mast cell and basophil mediator release was profoundly reduced in humans. Supporting these findings, the Api in (1/2/3) induced 100 to 1000 times less type-1 skin test reactivity in allergic patients. Treatment of mice with Api in (1/2/3) led to a significant reduction of specific IgE development towards native allergen, representing a protective vaccine effect in vivo. These results demonstrate a novel prototype of a preventive allergy vaccine, which preserves the entire T cell epitope repertoire, but bypasses induction of IgE against native allergen, and side effects related to mast cell/basophil IgE Fc epsilon;RI cross-linking in sensitized individuals.
C1 Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland.
   Dept Dermatol, Allergy Unit, Zurich, Switzerland.
   GKT Sch Med, Rayne Inst, Dept Immunol, London, England.
   Hosp Berne Ziegler, Div Med, Bern, Switzerland.
   US FDA, Ctr Drug Evaluat & Res, Bethesda, MD 20014 USA.
   Univ Basel, Biozentrum, Div Struct Biol, Basel, Switzerland.
   ALK Abello Inc, Horsholm, Denmark.
RP Karamloo, F (corresponding author), Swiss Inst Allergy & Asthma Res, Obere Str 22, CH-7270 Davos, Switzerland.
EM karamlooflory@compuserve.de; akdisac@siaf.unizh.ch
RI Akdis, Cezmi/AAV-4844-2020
CR Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250
   Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C
   Akdis CA, 2003, EUR J IMMUNOL, V33, P2717, DOI 10.1002/eji.200323329
   Akdis CA, 1996, J CLIN INVEST, V98, P1676, DOI 10.1172/JCI118963
   Akdis CA, 2001, TRENDS IMMUNOL, V22, P175, DOI 10.1016/S1471-4906(01)01862-2
   Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058
   BENTLEY AM, 1992, J ALLERGY CLIN IMMUN, V89, P877, DOI 10.1016/0091-6749(92)90444-7
   Cahen YD, 1997, SCHWEIZ MED WSCHR, V127, P5
   CARBALLIDO JM, 1993, J IMMUNOL, V150, P3582
   Coyle AJ, 1996, J EXP MED, V183, P1303, DOI 10.1084/jem.183.4.1303
   de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035
   DEMOLY P, 1991, J ALLERGY CLIN IMMUN, V88, P758, DOI 10.1016/0091-6749(91)90183-O
   DUDLER T, 1994, J IMMUNOL, V152, P5514
   Faith A, 1997, J IMMUNOL, V159, P53
   Hemmann S, 1997, AM J RESP CRIT CARE, V156, P1956, DOI 10.1164/ajrccm.156.6.9702087
   Herrick CA, 2000, J CLIN INVEST, V105, P765, DOI 10.1172/JCI8624
   Hopkin JM, 1997, CURR OPIN IMMUNOL, V9, P788, DOI 10.1016/S0952-7915(97)80179-3
   Jutel M, 2001, NATURE, V413, P420, DOI 10.1038/35096564
   Karamloo F, 2001, EUR J BIOCHEM, V268, P5310, DOI 10.1046/j.0014-2956.2001.02463.x
   Larche M, 2005, NAT MED, V11, pS69, DOI 10.1038/nm1226
   LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P
   Linhart B, 2002, FASEB J, V16, P1301, DOI 10.1096/fj.01-1012fje
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   MOSER M, 1992, J IMMUNOL, V149, P454
   Moverare R, 2002, ALLERGY, V57, P423, DOI 10.1034/j.1398-9995.2002.13248.x
   Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6
   MULLER UR, 1995, J ALLERGY CLIN IMMUN, V96, P395, DOI 10.1016/S0091-6749(95)70059-5
   Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101
   NISH WA, 1994, J ALLERGY CLIN IMMUN, V93, P484, DOI 10.1016/0091-6749(94)90358-1
   OWEN MD, 1995, TOXICON, V33, P1181, DOI 10.1016/0041-0101(95)00054-P
   PAULL BR, 1977, J ALLERGY CLIN IMMUN, V59, P334, DOI 10.1016/0091-6749(77)90056-2
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   Soldatova LN, 1998, J ALLERGY CLIN IMMUN, V101, P691, DOI 10.1016/S0091-6749(98)70179-4
   Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216
   VANDERHEIJDEN FL, 1993, J IMMUNOL, V150, P3643
   Vrtala S, 2000, J IMMUNOL, V165, P6653, DOI 10.4049/jimmunol.165.11.6653
   Waldmann TA, 2003, NAT MED, V9, P269, DOI 10.1038/nm0303-269
   WERKMEISTER JA, 1993, BIOCHIM BIOPHYS ACTA, V1157, P50, DOI 10.1016/0304-4165(93)90077-L
   Woodfolk JA, 2000, J IMMUNOL, V165, P4379, DOI 10.4049/jimmunol.165.8.4379
NR 39
TC 61
Z9 64
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD NOV
PY 2005
VL 35
IS 11
BP 3268
EP 3276
DI 10.1002/eji.200425522
PG 9
WC Immunology
SC Immunology
GA 987MQ
UT WOS:000233522400020
PM 16206231
DA 2021-01-25
ER

PT J
AU Mota, LJ
   Sorg, I
   Cornelis, GR
AF Mota, LJ
   Sorg, I
   Cornelis, GR
TI Type III secretion: The bacteria-eukaryotic cell express
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE bacterial pathogenesis; EPEC; Salmonella; Shigella; type III secretion;
   Yersinia
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; YERSINIA-ENTEROCOLITICA;
   SHIGELLA-FLEXNERI; PROTEIN SECRETION; SUPRAMOLECULAR STRUCTURE;
   SUBSTRATE-SPECIFICITY; TRANSLOCATORS YOPB; PLASMA-MEMBRANE; NEEDLE
   COMPLEX; MESSENGER-RNA
AB Type III secretion (T3S) is an export pathway used by Gram-negative pathogenic bacteria to inject bacterial proteins into the cytosol of eukaryotic host cells. This pathway is characterized by (i) a secretion nanomachine related to the bacterial flagellum, but usually topped by a stiff needle-like structure; (ii) the assembly in the eukaryotic cell membrane of a translocation pore formed by T3S substrates; (iii) a non-cleavable N-terminal secretion signal; (iv) T3S chaperones, assisting the secretion of some substrates; (v) a control mechanism ensuring protein delivery at the right place and time. Here, we review these different aspects focusing in open questions that promise exciting findings in the near future. (c) 2005 Published by Elsevier B.V. on behalf of the Federation of European Microbiological Societies.
C1 Univ Basel, Biozentrum, CH-4051 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4051 Basel, Switzerland.
EM j.mota@unibas.ch; guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397
CR Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Day JB, 1998, MOL MICROBIOL, V30, P777, DOI 10.1046/j.1365-2958.1998.01110.x
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Hartland EL, 2000, MOL MICROBIOL, V35, P1483, DOI 10.1046/j.1365-2958.2000.01814.x
   Hayward RD, 2005, MOL MICROBIOL, V56, P590, DOI 10.1111/j.1365-2958.2005.04568.x
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x
   Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x
   Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MENARD R, 1994, EMBO J, V13, P5293, DOI 10.1002/j.1460-2075.1994.tb06863.x
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nilles ML, 1997, J BACTERIOL, V179, P1307, DOI 10.1128/jb.179.4.1307-1316.1997
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
   Ramamurthi KS, 2005, J BACTERIOL, V187, P707, DOI 10.1128/JB.187.2.707-715.2005
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   SKRZYPEK E, 1993, J BACTERIOL, V175, P3520, DOI 10.1128/jb.175.11.3520-3528.1993
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stainier I, 1997, MOL MICROBIOL, V26, P833, DOI 10.1046/j.1365-2958.1997.6281995.x
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   van der Goot FG, 2004, J BIOL CHEM, V279, P47792, DOI 10.1074/jbc.M406824200
   Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
NR 59
TC 58
Z9 62
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD NOV 1
PY 2005
VL 252
IS 1
BP 1
EP 10
DI 10.1016/j.femsle.2005.08.036
PG 10
WC Microbiology
SC Microbiology
GA 979UZ
UT WOS:000232971800001
PM 16216444
OA Bronze
DA 2021-01-25
ER

PT J
AU Naguleswaran, A
   Alaeddine, F
   Guionaud, C
   Vonlaufen, N
   Sonda, S
   Jenoe, P
   Mevissen, M
   Hemphill, A
AF Naguleswaran, A
   Alaeddine, F
   Guionaud, C
   Vonlaufen, N
   Sonda, S
   Jenoe, P
   Mevissen, M
   Hemphill, A
TI Neospora caninum protein disulfide isomerase is involved in
   tachyzoite-host cell interaction
SO INTERNATIONAL JOURNAL FOR PARASITOLOGY
LA English
DT Article
DE Neospora; protein disulfide isomerase; host cell interaction; Toxoplasma
ID TOXOPLASMA-GONDII; 2-DIMENSIONAL ELECTROPHORESIS; MOLECULAR
   CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; SURFACE-ANTIGENS; IGA
   ANTIBODIES; INHIBITION; FAMILY; IDENTIFICATION; EXPRESSION
AB We have previously shown that treatment of Neospora caninum tachyzoites with the aspartyl protease inhibitor pepstatin A reduces host cell invasion [Naguleswaran, A., Muller, N., Hemphill, A., 2003. Neospora caninum and Toxoplasma gondii: a novel adhesion/invasion assay reveals distinct differences in tachyzoite-host cell interactions. Exp. Parasitol. 104, 149-158]. Pepstatin A-affinity-chromatography led to the isolation of a major band of similar to 52 kDa which was identified as a homologue of a previously described Toxoplasma gondii putative protein disulfide isomerase (TgPDI) through tandem mass spectrometry. A BLAST search against N. caninum expressed sequence tags (ESTs) on the ApiDots server using TgPDI cDNA as query sequence revealed a 2251 bp PDI-Iike consensus (NcPDI), which shows 94% identity to the T. gondii homologue. In N. caninum tachyzoites, NcPDI was found mainly in the soluble hydrophilic fraction. Immunofluorescence showed that expression of NcPDI was dramatically down-regulated in the bradyzoite stage, and immunogold-EM on tachyzoites localised the protein to the cytoplasm, mostly in close vicinity to the nuclear membrane, to the micronemes, and to the parasite cell surface. However, NcPDI was absent in rhoptries and dense granules. Preincubation of tachyzoites with the sulfhydryl blocker 5,5'-dithiobis(2-nitrobenzoic acid) (DTNB), p-chloromercuribenzoic acid (pCMBA), and with the PDI inhibitor bacitracin reduced adhesion of parasites to host cells. In addition, incubation of N. caninum tachyzoites with affinity-purified anti-NcPDI antibodies reduced host cell adhesion. PDIs catalyse the formation, reduction or isomerisation of disulfide bonds. Many major components of the adhesion and invasion machinery of apicomplexan parasites are cysteine-rich and dependent on correct folding via disulfide bond formation. Thus, our data points towards an important role for surface-associated NcPDI in Neospora-host cell interaction. (c) 2005 Australian Society for Parasitology Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ Bern, Inst Parasitol, CH-3012 Bern, Switzerland.
   Univ Bern, Inst Vet Pharmacol, CH-3012 Bern, Switzerland.
   Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland.
   Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
RP Hemphill, A (corresponding author), Univ Bern, Inst Parasitol, Langgass Str 122, CH-3012 Bern, Switzerland.
EM hemphill@ipa.unibe.ch
OI Mevissen, Meike/0000-0001-8766-9556
CR Barber JS, 1995, PARASITOLOGY, V111, P563, DOI 10.1017/S0031182000077039
   Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002
   Bjorkman C, 1998, PARASITE IMMUNOL, V20, P73, DOI 10.1046/j.1365-3024.1998.00127.x
   Blunt DS, 1996, GENE, V181, P221, DOI 10.1016/S0378-1119(96)00460-X
   Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992
   Cannas A, 2003, PARASITOLOGY, V126, P303, DOI 10.1017/S0031182002002895
   Cannas A, 2003, J PARASITOL, V89, P44, DOI 10.1645/0022-3395(2003)089[0044:RCIONC]2.0.CO;2
   CHOU Q, 1992, NUCLEIC ACIDS RES, V20, P1717, DOI 10.1093/nar/20.7.1717
   Cohen AM, 2002, INT J PARASITOL, V32, P39, DOI 10.1016/S0020-7519(01)00308-3
   Collet JF, 2002, MOL MICROBIOL, V44, P1, DOI 10.1046/j.1365-2958.2002.02851.x
   Conraths FJ, 2000, INT J PARASITOL, V30, P877, DOI 10.1016/S0020-7519(00)00072-2
   Davis CH, 2002, INFECT IMMUN, V70, P3413, DOI 10.1128/IAI.70.7.3413-3418.2002
   Delom F, 2001, J BIOL CHEM, V276, P21337, DOI 10.1074/jbc.M101086200
   Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7
   Ebel T, 2002, MOL BIOCHEM PARASIT, V121, P265, DOI 10.1016/S0166-6851(02)00036-1
   Ferrari DM, 1998, EUR J BIOCHEM, V255, P570, DOI 10.1046/j.1432-1327.1998.2550570.x
   Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001
   Florenta I, 2000, FEBS LETT, V484, P246, DOI 10.1016/S0014-5793(00)02170-0
   Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1
   Freedman RB, 2002, EMBO REP, V3, P136, DOI 10.1093/embo-reports/kvf035
   Geldhof P, 2003, INT J PARASITOL, V33, P129, DOI 10.1016/S0020-7519(02)00260-6
   GROSS U, 1995, CLIN DIAGN LAB IMMUN, V2, P542, DOI 10.1128/CDLI.2.5.542-548.1995
   Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996
   Hemphill A, 2004, MICROSC MICROANAL, V10, P602, DOI 10.1017/S1431927604040930
   Hemphill A, 1998, INT J PARASITOL, V28, P429, DOI 10.1016/S0020-7519(97)00193-8
   Hemphill A, 1999, ADV PARASIT, V43, P47, DOI 10.1016/S0065-308X(08)60241-9
   Howe DK, 1998, INFECT IMMUN, V66, P5322, DOI 10.1128/IAI.66.11.5322-5328.1998
   HSU MP, 1989, BIOCHEMISTRY-US, V28, P6440, DOI 10.1021/bi00441a042
   Innes EA, 2002, TRENDS PARASITOL, V18, P497, DOI 10.1016/S1471-4922(02)02372-3
   Keller N, 2004, INFECT IMMUN, V72, P4791, DOI 10.1128/IAI.72.8.4791-4800.2004
   Keller N, 2002, INFECT IMMUN, V70, P3187, DOI 10.1128/IAI.70.6.3187-3198.2002
   Lee EG, 2003, PROTEOMICS, V3, P2339, DOI 10.1002/pmic.200300617
   Lekutis C, 2001, INT J PARASITOL, V31, P1285, DOI 10.1016/S0020-7519(01)00261-2
   Lovett JL, 2000, MOL BIOCHEM PARASIT, V107, P33, DOI 10.1016/S0166-6851(99)00228-5
   MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112
   Matz M, 1999, NUCLEIC ACIDS RES, V27, P1558, DOI 10.1093/nar/27.6.1558
   Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3
   Meek B, 2002, INT IMMUNOL, V14, P1291, DOI 10.1093/intimm/dxf091
   Mou YL, 1998, J IMMUNOL, V161, P6323
   Naguleswaran A, 2003, EXP PARASITOL, V104, P149, DOI 10.1016/S0014-4894(03)00137-1
   Naguleswaran A, 2002, INT J PARASITOL, V32, P695, DOI 10.1016/S0020-7519(02)00014-0
   Naguleswaran A, 2001, INFECT IMMUN, V69, P6483, DOI 10.1128/IAI.69.10.6483-6494.2001
   Nishikawa Y, 2000, INT J PARASITOL, V30, P51, DOI 10.1016/S0020-7519(99)00162-9
   Nishikawa Y, 2002, J VET MED SCI, V64, P1, DOI 10.1292/jvms.64.1
   Nishikawa Y, 2001, VACCINE, V19, P1710, DOI 10.1016/S0264-410X(00)00407-2
   Padilla A, 2003, J BIOL CHEM, V278, P1872, DOI 10.1074/jbc.M210322200
   RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559
   Seeber F, 1997, PARASITOL RES, V83, P309, DOI 10.1007/s004360050254
   Sonda S, 1998, MOL BIOCHEM PARASIT, V97, P97, DOI 10.1016/S0166-6851(98)00133-9
   Sonda S, 2000, MOL BIOCHEM PARASIT, V108, P39, DOI 10.1016/S0166-6851(00)00200-0
   TERADA K, 1995, J BIOL CHEM, V270, P20410, DOI 10.1074/jbc.270.35.20410
   Turano C, 2002, J CELL PHYSIOL, V193, P154, DOI 10.1002/jcp.10172
   Vonlaufen N, 2004, INFECT IMMUN, V72, P576, DOI 10.1128/IAI.72.1.576-583.2004
   Voss TS, 2002, J BIOL CHEM, V277, P17493, DOI 10.1074/jbc.M200100200
   Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017
NR 55
TC 39
Z9 41
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0020-7519
EI 1879-0135
J9 INT J PARASITOL
JI Int. J. Parasit.
PD NOV
PY 2005
VL 35
IS 13
BP 1459
EP 1472
DI 10.1016/j.ijpara.2005.06.006
PG 14
WC Parasitology
SC Parasitology
GA 984TZ
UT WOS:000233328500015
PM 16129440
DA 2021-01-25
ER

PT J
AU Salie, R
   Steeves, JD
AF Salie, R
   Steeves, JD
TI IGF-1 and BDNF promote chick bulbospinal neurite outgrowth in vitro
SO INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE
LA English
DT Article
DE brainstem; chick; BDNF; IGF-1; axonal elongation
ID GROWTH-FACTOR-I; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD-INJURY;
   MYELIN-ASSOCIATED GLYCOPROTEIN; MESSENGER-RNA EXPRESSION; AXONAL
   REGENERATION; ADULT-RAT; NEUROTROPHIC FACTOR; GENE-EXPRESSION;
   BRAIN-STEM
AB Injured neurons in the CNS do not experience significant functional regeneration and so spinal cord insult often results in permanently compromised locomotor ability. The capability of a severed axon to re-grow is thought to depend on numerous factors, one of which is the decreased availability of neurotrophic factors. Application of trophic factors to axotomized neurons has been shown to enhance survival and neurite outgrowth. Although brainstem-spinal connections play a pivotal role in motor dysfunction after spinal cord injury, relatively little is known about the trophic sensitivity of these populations. This study explores the response of bulbospinal populations to various trophic factors. Several growth factors were initially examined for potential trophic effects on the projection neurons of the brainstem. Brain derived neurotrophic factor (BDNF) and insulin-like growth factor (IGF-1) significantly enhance mean process length in both the vestibulospinal neurons and spinal projection neurons from the raphe nuclei. Nerve growth factor (NGF), neurotrophin-4 (NT-4) and glial derived neurotrophic factor (GDNF) did not effect process outgrowth in vestibulospinal neurons. At the developmental stages used in this study, it was determined that receptors for BDNF and IGF-1 were present both on bulbospinal neurons and on surrounding cells with a non-neuronal morphology. (c) 2005 ISDN. Published by Elsevier Ltd. All rights reserved.
C1 Univ British Columbia, ICORD, Vancouver, BC V5Z 1M9, Canada.
RP Salie, R (corresponding author), Univ Basel, Dept Zellbiol, Biozentrum, Lab 2 81, CH-4056 Basel, Switzerland.
EM rishard.salie@unibas.ch
CR Asher RA, 2000, J NEUROSCI, V20, P2427
   BECK KD, 1995, NEURON, V14, P717, DOI 10.1016/0896-6273(95)90216-3
   BJORKLUND A, 1971, BRAIN RES, V31, P21, DOI 10.1016/0006-8993(71)90631-7
   BONDY C, 1993, J NEUROSCI, V13, P5092
   BONDY CA, 1991, J NEUROSCI, V11, P3442
   Borisoff JF, 2003, MOL CELL NEUROSCI, V22, P405, DOI 10.1016/S1044-7431(02)00032-5
   BUTLER EG, 1967, DEV BIOL, V15, P464, DOI 10.1016/0012-1606(67)90038-3
   Cajal R., 1928, DEGENERATION REGENER
   Camarero G, 2003, DEV BIOL, V262, P242, DOI 10.1016/S0012-1606(03)00387-7
   Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219
   Connor B, 1998, BRAIN RES REV, V27, P1, DOI 10.1016/S0165-0173(98)00004-6
   DAHLSTRO.A, 1965, ACTA PHYSIOL SCAND, VS 64, P7
   Davies AM, 2000, CURR BIOL, V10, pR198, DOI 10.1016/S0960-9822(00)00351-1
   DAVIS BM, 1990, EXP NEUROL, V108, P198, DOI 10.1016/0014-4886(90)90124-B
   DRAGO J, 1991, P NATL ACAD SCI USA, V88, P2199, DOI 10.1073/pnas.88.6.2199
   DUBE L, 1981, J COMP NEUROL, V196, P695, DOI 10.1002/cne.901960413
   Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X
   ENGELE J, 1991, J NEUROSCI, V11, P3070
   FEIGIN I, 1951, J NEUROPATH EXP NEUR, V10, P420, DOI 10.1097/00005072-195110000-00007
   FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F
   FISHMAN PS, 1993, J NEUROTRAUM, V10, P457, DOI 10.1089/neu.1993.10.457
   GEHRMANN J, 1994, EXP NEUROL, V128, P202, DOI 10.1006/exnr.1994.1128
   Gibbons A, 2005, INT J DEV NEUROSCI, V23, P389, DOI 10.1016/j.ijdevneu.2004.10.003
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   HANSSON HA, 1986, ACTA PHYSIOL SCAND, V126, P609, DOI 10.1111/j.1748-1716.1986.tb07862.x
   HASAN SJ, 1993, J NEUROSCI, V13, P492
   Holzenberger M, 2000, INT J DEV NEUROSCI, V18, P69, DOI 10.1016/S0736-5748(99)00076-3
   Houle JD, 1997, NEUROREPORT, V8, P751
   HUGHES RA, 1993, J NEUROSCI RES, V36, P663, DOI 10.1002/jnr.490360607
   IKEDA H, 1971, Japanese Journal of Pharmacology, V21, P763, DOI 10.1254/jjp.21.763
   KEIRSTEAD HS, 1992, P NATL ACAD SCI USA, V89, P11664, DOI 10.1073/pnas.89.24.11664
   Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268
   King VR, 1999, NEUROSCIENCE, V92, P935, DOI 10.1016/S0306-4522(99)00072-X
   KLEIN R, 1990, DEVELOPMENT, V109, P845
   Kobayashi NR, 1997, J NEUROSCI, V17, P9583
   Kurihara S, 2000, ENDOCR J, V47, P739, DOI 10.1507/endocrj.47.739
   Kwon Brian K, 2002, Mol Interv, V2, P244, DOI 10.1124/mi.2.4.244
   Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214
   Li SX, 2005, MOL CELL NEUROSCI, V29, P26, DOI 10.1016/j.mcn.2004.12.008
   Li SX, 2004, J NEUROSCI, V24, P10511, DOI 10.1523/JNEUROSCI.2828-04.2004
   Liu Y, 1999, J NEUROSCI, V19, P4370
   LOBIE PE, 1993, DEV BRAIN RES, V74, P225, DOI 10.1016/0165-3806(93)90008-X
   Lu P, 2005, EXP NEUROL, V191, P344, DOI 10.1016/j.expneurol.2004.09.018
   Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000
   Mamounas LA, 1995, J NEUROSCI, V15, P7929
   Menei P, 1998, EUR J NEUROSCI, V10, P607, DOI 10.1046/j.1460-9568.1998.00071.x
   Nachemson AK, 1990, GROWTH FACTORS, V3, P309, DOI 10.3109/08977199009003673
   Namiki J, 2000, J NEUROTRAUM, V17, P1219, DOI 10.1089/neu.2000.17.1219
   Pataky DM, 2000, EXP NEUROL, V163, P357, DOI 10.1006/exnr.2000.7365
   Piontek J, 1999, J NEUROCHEM, V73, P139, DOI 10.1046/j.1471-4159.1999.0730139.x
   Ramer LM, 2005, SPINAL CORD, V43, P134, DOI 10.1038/sj.sc.3101715
   Rind HB, 2002, MOL CELL NEUROSCI, V19, P58, DOI 10.1006/mcne.2001.1069
   Ruitenberg MJ, 2004, NEUROBIOL DIS, V15, P394, DOI 10.1016/j.nbd.2003.11.018
   Saunders NR, 1998, J NEUROSCI, V18, P339
   Simpson S. B., 1983, SPINAL CORD RECONSTR, P151
   Singleton JR, 1996, CANCER RES, V56, P4522
   Tang S, 1997, MOL CELL NEUROSCI, V9, P333, DOI 10.1006/mcne.1997.0633
   VALENZUELA JI, 1990, DEV BRAIN RES, V56, P13, DOI 10.1016/0165-3806(90)90158-U
   Wilson MT, 2000, J COMP NEUROL, V424, P532, DOI 10.1002/1096-9861(20000828)424:3<532::AID-CNE10>3.0.CO;2-Z
   WINDLE WF, 1956, PHYSIOL REV, V36, P427
   Yan Q, 1997, J COMP NEUROL, V378, P135
   Ye JH, 1997, EXP NEUROL, V143, P70, DOI 10.1006/exnr.1996.6353
   ZACKENFELS K, 1995, NEURON, V14, P731, DOI 10.1016/0896-6273(95)90217-1
NR 63
TC 27
Z9 30
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0736-5748
EI 1873-474X
J9 INT J DEV NEUROSCI
JI Int. J. Dev. Neurosci.
PD NOV
PY 2005
VL 23
IS 7
BP 587
EP 598
DI 10.1016/j.ijdevneu.2005.07.003
PG 12
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 986XL
UT WOS:000233482900004
PM 16143487
DA 2021-01-25
ER

PT J
AU de Paz, HD
   Sangari, FJ
   Bolland, S
   Garcia-Lobo, JM
   Dehio, C
   de la Cruz, F
   Llosa, M
AF de Paz, HD
   Sangari, FJ
   Bolland, S
   Garcia-Lobo, JM
   Dehio, C
   de la Cruz, F
   Llosa, M
TI Functional interactions between type IV secretion systems involved in
   DNA transfer and virulence
SO MICROBIOLOGY-SGM
LA English
DT Article
ID AGROBACTERIUM-TUMEFACIENS VIRB; BACTERIAL 2-HYBRID SYSTEM; INCW PLASMID
   R388; ESCHERICHIA-COLI; BRUCELLA-SUIS; COMPLEMENTATION ANALYSIS; PROTEIN
   SUBASSEMBLIES; BORDETELLA-PERTUSSIS; TRANSPORT PORE; PLANT-CELLS
AB This paper reports an analysis of the functional interactions between type IV secretion systems (T4SS) that are part of the conjugative machinery for horizontal DNA transfer (cT4SS), and T4SS involved in bacterial pathogenicity (pT4SS). The authors' previous work showed that a conjugative coupling protein (T4CP) interacts with the VirB10-type component of the T4SS in order to recruit the protein-DNA complex to the transporter for conjugative DNA transfer. This study now shows by two-hybrid analysis that conjugative T4CPs also interact with the VirB10 element of the pT4SS of Agrobacterium tumefaciens (At), Bartonella tribocorum (Bt) and Brucella suis (Bs). Moreover, the VirB10 component of a cT4SS (protein TrwE of plasmid R388) could be partially substituted by that of a pT4SS (protein TrwE of Bt) for conjugation. This result opens the way for the construction of hybrid T4SS that deliver DNA into animal cells. Interestingly, in the presence of part of the Bs T4SS the R388 T4SS protein levels were decreased and R388 conjugation was strongly inhibited. Complementation assays between the Trw systems of R388 and Bt showed that only individual components from the so-called 'core complex' could be exchanged, supporting the concept that this core is the common scaffold for the transport apparatus while the other 'peripheral components' are largely system-specific.
C1 Univ Cantabria, CIB CSIC, Dept Mol Biol, Santander 39011, Spain.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Llosa, M (corresponding author), Univ Cantabria, CIB CSIC, Dept Mol Biol, C-Herrera Oria S-N, Santander 39011, Spain.
EM llosam@unican.es
RI Dehio, Christoph/AAD-5572-2019; Sangari, Felix J/K-9104-2014; Dehio,
   Christoph/R-8277-2016; de la Cruz, Fernando/L-2812-2014; ,
   matxalen/ABG-5541-2020; Lobo, Juan M Garcia/K-2727-2014
OI Dehio, Christoph/0000-0001-7288-1052; Sangari, Felix
   J/0000-0002-3298-6076; Dehio, Christoph/0000-0001-7288-1052; de la Cruz,
   Fernando/0000-0003-4758-6857; , matxalen/0000-0002-4826-2240; Lobo, Juan
   M Garcia/0000-0002-9187-0671; de Paz Fernandez, Hector
   David/0000-0002-4190-5063
CR Alegria MC, 2005, J BACTERIOL, V187, P2315, DOI 10.1128/JB.187.7.2315-2325.2005
   Atmakuri K, 2004, MOL MICROBIOL, V54, P1199, DOI 10.1111/j.1365-2958.2004.04345.x
   Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x
   Baron C, 1997, J BACTERIOL, V179, P1211, DOI 10.1128/jb.179.4.1211-1218.1997
   BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I
   Beaupre CE, 1997, J BACTERIOL, V179, P78, DOI 10.1128/jb.179.1.78-89.1997
   BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994
   BOLLAND S, 1990, J BACTERIOL, V172, P5795, DOI 10.1128/jb.172.10.5795-5802.1990
   Boschiroli ML, 2002, P NATL ACAD SCI USA, V99, P1544, DOI 10.1073/pnas.032514299
   BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5
   BRUCE KD, 1991, J CLIN MICROBIOL, V29, P291, DOI 10.1128/JCM.29.2.291-296.1991
   Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432
   Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101
   Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   CHOW WY, 1988, P NATL ACAD SCI USA, V85, P6468, DOI 10.1073/pnas.85.17.6468
   Das A, 2000, J BACTERIOL, V182, P758, DOI 10.1128/JB.182.3.758-763.2000
   Das A, 1997, J BACTERIOL, V179, P3404, DOI 10.1128/jb.179.11.3404-3409.1997
   Farizo KM, 1996, J BIOL CHEM, V271, P31643, DOI 10.1074/jbc.271.49.31643
   Gomis-Ruth FX, 2001, NATURE, V409, P637, DOI 10.1038/35054586
   GRANDOSO G, 1994, EUR J BIOCHEM, V226, P403, DOI 10.1111/j.1432-1033.1994.tb20065.x
   GRANT SGN, 1990, P NATL ACAD SCI USA, V87, P4645, DOI 10.1073/pnas.87.12.4645
   HOPFELMEIER S, 2002, J BACTERIOL, V182, P4505
   Hoppner C, 2004, J BACTERIOL, V186, P1415, DOI 10.1128/JB.186.5.1415-1422.2004
   Jakubowski SJ, 2005, J BACTERIOL, V187, P3486, DOI 10.1128/JB.187.10.3486-3495.2005
   Jakubowski SJ, 2004, J MOL BIOL, V341, P961, DOI 10.1016/j.jmb.2004.06.052
   Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73
   Koraimann G, 2003, CELL MOL LIFE SCI, V60, P2371, DOI 10.1007/s00018-003-3056-1
   Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699
   Kumar RB, 2000, MOL MICROBIOL, V36, P608, DOI 10.1046/j.1365-2958.2000.01876.x
   KUSHNER SR, 1971, P NATL ACAD SCI USA, V68, P824, DOI 10.1073/pnas.68.4.824
   Lai EM, 1998, J BACTERIOL, V180, P2711, DOI 10.1128/JB.180.10.2711-2717.1998
   LLOSA M, 1994, J MOL BIOL, V235, P448, DOI 10.1006/jmbi.1994.1005
   Llosa M, 2005, RES MICROBIOL, V156, P1, DOI 10.1016/j.resmic.2004.07.008
   Llosa M, 2004, MOL MICROBIOL, V53, P1, DOI 10.1111/j.1365-2958.2004.04168.x
   Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100
   LLOSA M, 1991, PLASMID, V26, P222, DOI 10.1016/0147-619X(91)90045-X
   MARTINEZ E, 1988, MOL GEN GENET, V211, P320, DOI 10.1007/BF00330610
   Miller J.H., 1992, SHORT COURSE BACTERI
   Moncalian G, 1997, J MOL BIOL, V270, P188, DOI 10.1006/jmbi.1997.1082
   More MI, 1996, J BACTERIOL, V178, P4392, DOI 10.1128/jb.178.15.4392-4399.1996
   Nunez B, 2001, MOL MICROBIOL, V39, P1088, DOI 10.1046/j.1365-2958.2001.02308.x
   O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x
   Rivas S, 1997, J BIOL CHEM, V272, P25583, DOI 10.1074/jbc.272.41.25583
   Rouot B, 2003, INFECT IMMUN, V71, P1075, DOI 10.1128/IAI.71.3.1075-1082.2003
   SADLER JR, 1980, GENE, V8, P279, DOI 10.1016/0378-1119(80)90005-0
   Sambrook J, 1989, MOL CLONING LAB MANU
   SASTRE JI, 1996, THESIS U CANTABRIA
   Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004
   Spudich GM, 1996, P NATL ACAD SCI USA, V93, P7512, DOI 10.1073/pnas.93.15.7512
   STEWART GSAB, 1986, PLASMID, V15, P172, DOI 10.1016/0147-619X(86)90035-1
   Tato I, 2005, P NATL ACAD SCI USA, V102, P8156, DOI 10.1073/pnas.0503402102
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979
   Ward DV, 2002, P NATL ACAD SCI USA, V99, P11493, DOI 10.1073/pnas.172390299
NR 60
TC 41
Z9 44
U1 0
U2 3
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD NOV
PY 2005
VL 151
BP 3505
EP 3516
DI 10.1099/mic.0.28410-0
PN 11
PG 12
WC Microbiology
SC Microbiology
GA 985KL
UT WOS:000233376200008
PM 16272374
OA Bronze
DA 2021-01-25
ER

PT J
AU Pederson, T
   Aebi, U
AF Pederson, T
   Aebi, U
TI Nuclear actin extends, with no contraction in sight
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID MESSENGER-RNA; F-ACTIN; ANDROGEN RECEPTOR; ACANTHAMOEBA-CASTELLANII;
   CYTOPLASMIC ACTIN; CAJAL BODIES; MYOSIN-I; TRANSCRIPTION; INTRANUCLEAR;
   TRANSPORT
AB Within the past two years, actin has been implicated in eukaryotic gene transcription by all three classes of RNA polymerase. Moreover, within just the past year, actin has been identified as a constituent of filaments attached to the nuclear pore complexes and extending into the nucleus. This review summarizes these and other very recent advances in the nuclear actin field and emphasizes the key present issues. On the one hand, we are confronted with a body of evidence for a role of actin in gene transcription but with no known structural basis; on the other hand, there is now evidence for polymeric actin-not likely in the classical F-actin conformation-in the nuclear periphery with no known function. In addition, numerous proteins that interact with either G- or F-actin are increasingly being detected in the nucleus, suggesting that both monomeric and oligomeric or polymeric forms of actin are at play and raising the possibility that the equilibrium between them, perhaps differentially regulated at various intranuclear sites, may be a major determinant of nuclear function.
C1 Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.
   Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA.
   Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Pederson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA.
EM thoru.pederson@umassmed.edu; ueli.aebi@unibas.ch
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM060551, R01 GM-60551] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM060551, R01GM060551, R01GM060551, R01GM060551] Funding Source: NIH
   RePORTER
CR ADELMAN MR, 1969, BIOCHEMISTRY-US, V8, P4964, DOI 10.1021/bi00840a046
   ADELMAN MR, 1969, BIOCHEMISTRY-US, V8, P4976, DOI 10.1021/bi00840a047
   Aizawa H, 1999, GENES CELLS, V4, P311, DOI 10.1046/j.1365-2443.1999.00262.x
   Andrin C, 2004, J BIOL CHEM, V279, P25017, DOI 10.1074/jbc.M401805200
   Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370
   Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009
   Bubb MR, 2002, J BIOL CHEM, V277, P20999, DOI 10.1074/jbc.M201371200
   CLARK TG, 1977, CELL, V12, P883, DOI 10.1016/0092-8674(77)90152-0
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357
   Daneholt B, 1999, CURR BIOL, V9, pR412, DOI 10.1016/S0960-9822(99)80256-5
   De Corte V, 2004, J CELL SCI, V117, P5283, DOI 10.1242/jcs.01410
   EGLY JM, 1984, EMBO J, V3, P2363, DOI 10.1002/j.1460-2075.1984.tb02141.x
   Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028
   Forest T, 2005, NAT CELL BIOL, V7, P429, DOI 10.1038/ncb1243
   FUKUI Y, 1979, EXP CELL RES, V120, P451, DOI 10.1016/0014-4827(79)90412-9
   GARRELS JI, 1976, CELL, V9, P793, DOI 10.1016/0092-8674(76)90142-2
   Gedge LJE, 2005, EXP CELL RES, V303, P229, DOI 10.1016/j.yexcr.2004.06.034
   Gonsior SM, 1999, J CELL SCI, V112, P797
   GOUNON P, 1981, J CELL BIOL, V88, P410, DOI 10.1083/jcb.88.2.410
   HATANO S, 1966, BIOCHIM BIOPHYS ACTA, V127, P488, DOI 10.1016/0304-4165(66)90402-8
   Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895
   Hofmann WA, 2004, NAT CELL BIOL, V6, P1094, DOI 10.1038/ncb1182
   Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231
   Hu P, 2004, GENE DEV, V18, P3010, DOI 10.1101/gad.1250804
   Huff T, 2004, J CELL SCI, V117, P5333, DOI 10.1242/jcs.01404
   IIDA K, 1986, EXP CELL RES, V165, P207, DOI 10.1016/0014-4827(86)90545-8
   IIDA K, 1986, EXP CELL RES, V164, P492, DOI 10.1016/0014-4827(86)90047-9
   ISHIKAWA H, 1969, J CELL BIOL, V43, P312
   Kimura T, 2000, GENES CELLS, V5, P289, DOI 10.1046/j.1365-2443.2000.00326.x
   Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098
   Kong KY, 2004, J BIOL CHEM, V279, P30856, DOI 10.1074/jbc.M302845200
   Krauss SW, 2003, P NATL ACAD SCI USA, V100, P10752, DOI 10.1073/pnas.1934680100
   Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904
   LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268
   Lee E, 1998, CELL MOTIL CYTOSKEL, V39, P122, DOI 10.1002/(SICI)1097-0169(1998)39:2<122::AID-CM3>3.0.CO;2-8
   Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810
   Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009
   MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Misteli T, 2001, SCIENCE, V291, P843, DOI 10.1126/science.291.5505.843
   NISHIDA E, 1987, P NATL ACAD SCI USA, V84, P5262, DOI 10.1073/pnas.84.15.5262
   Nishimura K, 2003, CANCER RES, V63, P4888
   Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507
   Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618
   Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799
   Pederson T, 1998, J MOL BIOL, V277, P147, DOI 10.1006/jmbi.1997.1618
   Pederson T, 2002, J STRUCT BIOL, V140, P3, DOI 10.1016/S1047-8477(02)00528-2
   Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100
   Percipalle P, 2002, NUCLEIC ACIDS RES, V30, P1725, DOI 10.1093/nar/30.8.1725
   Percipalle P, 2001, J CELL BIOL, V153, P229, DOI 10.1083/jcb.153.1.229
   Pestic-Dragovich L, 2000, SCIENCE, V290, P337, DOI 10.1126/science.290.5490.337
   Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190
   Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5
   Politz JC, 2000, J STRUCT BIOL, V129, P252, DOI 10.1006/jsbi.2000.4227
   Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395
   POLLARD TD, 1973, J BIOL CHEM, V248, P4682
   Pollard TD, 2001, NATURE, V409, P842, DOI 10.1038/35057029
   POLLARD TD, 1970, J MOL BIOL, V50, P91, DOI 10.1016/0022-2836(70)90106-3
   Reutzel R, 2004, J STRUCT BIOL, V146, P291, DOI 10.1016/j.jsb.2003.12.006
   Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424
   SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X
   Schoenenberger CA, 2002, FEBS LETT, V529, P27, DOI 10.1016/S0014-5793(02)03267-2
   Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754
   Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4
   Sjolinder M, 2005, GENE DEV, V19, P1871, DOI 10.1101/gad.339405
   Skare P, 2003, EXP CELL RES, V286, P12, DOI 10.1016/S0014-4827(03)00102-2
   Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   STEVENS BJ, 1966, J CELL BIOL, V31, P55, DOI 10.1083/jcb.31.1.55
   Stuven T, 2003, EMBO J, V22, P5928, DOI 10.1093/emboj/cdg565
   Szent-Gyorgyi AG, 2004, J GEN PHYSIOL, V123, P631, DOI 10.1085/jgp.200409091
   Ting HJ, 2002, P NATL ACAD SCI USA, V99, P661, DOI 10.1073/pnas.022469899
   Trelles-Sticken E, 2005, J CELL BIOL, V170, P213, DOI 10.1083/jcb.200501042
   Wada A, 1998, EMBO J, V17, P1635, DOI 10.1093/emboj/17.6.1635
   WEIHING RR, 1971, BIOCHEMISTRY-US, V10, P590, DOI 10.1021/bi00780a008
   Zhang SS, 2002, J BIOL CHEM, V277, P843, DOI 10.1074/jbc.M109393200
   Zhen YY, 2002, J CELL SCI, V115, P3207
NR 77
TC 103
Z9 111
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD NOV
PY 2005
VL 16
IS 11
BP 5055
EP 5060
DI 10.1091/mbc.E05-07-0656
PG 6
WC Cell Biology
SC Cell Biology
GA 980NK
UT WOS:000233025000001
PM 16148048
OA Green Published
DA 2021-01-25
ER

PT J
AU Katsuyama, T
   Sugawara, T
   Tatsumi, M
   Oshima, Y
   Gehring, WJ
   Aigaki, T
   Kurata, S
AF Katsuyama, T
   Sugawara, T
   Tatsumi, M
   Oshima, Y
   Gehring, WJ
   Aigaki, T
   Kurata, S
TI Involvement of winged eye encoding a chromatin-associated bromo-adjacent
   homology domain protein in disc specification
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE determination; imaginal disc; organ identity; epigenetic regulation
ID DROSOPHILA EYE; POLYCOMB-GROUP; ABSENT GENE; IDENTITY; METHYLATION;
   EXPRESSION; ASH1; IDENTIFICATION; CONTAINS; SELECTOR
AB How organ identity is determined is a fundamental question in developmental biology. In Drosophila, field-specific selector genes, such as eyeless (ey) for eyes and vestigial (vg) for wings, participate in the determination of imaginal disc-specific identity. We performed gain-of-function screening and identified a gene named winged eye (wge), which encodes a bromo-adjacent homology domain protein that localizes at specific sites on chromosomes in a bromo-adjacent homology domain-dependent manner. Overexpression of wge-induced ectopic wings with antero-posterior and dorso-ventral axes in the eye field in a region-specific Hox gene(Antennapedia) independent manner. Overexpression of wge was sufficient for ectopic expression of vg in eye discs. A context-dependent requirement of wge was demonstrated for vg expression in wing discs and for expression of eyes absent (eya), a control gene for eye development downstream of ey, in eye discs. In contrast to vg, however, overexpression of wge inhibited EY-mediated expression of eya. Consistent with colocalization on polytene chromosomes of WGE and Posterior sex combs (PSC), a Polycomb group gene product, we demonstrated an antagonistic genetic interaction between wge and Psc. These findings suggest that wge functions in the determination of disc-specific identity, downstream of Hox genes.
C1 Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 1920397, Japan.
RP Gehring, WJ (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 9808578, Japan.
EM walter.gehring@unibas.ch; kurata@mail.pharm.tohoku.ac.jp
CR ADLER PN, 1989, DEV GENET, V10, P249, DOI 10.1002/dvg.1020100314
   Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Baena-Lopez LA, 2003, DEVELOPMENT, V130, P197, DOI 10.1242/dev.00187
   Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096
   Beisel C, 2002, NATURE, V419, P857, DOI 10.1038/nature01126
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Byrd KN, 2003, P NATL ACAD SCI USA, V100, P11535, DOI 10.1073/pnas.1933593100
   Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5
   CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48
   GEHRING W, 1972, RESULTS PROBLEMS CEL, V5, P36
   Gorfinkiel N, 1997, GENE DEV, V11, P2259, DOI 10.1101/gad.11.17.2259
   HADORN ERNST, 1965, BROOKHAVEN SYMP BIOL, V18, P148
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885
   Ito K, 1997, DEVELOPMENT, V124, P761
   Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(02)08063-7
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006
   Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   SANICOLA M, 1995, GENETICS, V139, P745
   SANTAMARIA P, 1995, MOL GEN GENET, V246, P282, DOI 10.1007/BF00288600
   Simmonds AJ, 1998, GENE DEV, V12, P3815, DOI 10.1101/gad.12.24.3815
   Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199
   Toba G, 1999, GENETICS, V151, P725
   Tripoulas N, 1996, GENETICS, V143, P913
   XU T, 1993, DEVELOPMENT, V117, P1223
   Yamamoto Y, 1997, DEVELOPMENT, V124, P3385
NR 34
TC 13
Z9 14
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 1
PY 2005
VL 102
IS 44
BP 15918
EP 15923
DI 10.1073/pnas.0507945102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 981LU
UT WOS:000233090900038
PM 16247005
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Markova, M
   Peneff, C
   Hewlins, MJE
   Schirmer, T
   John, RA
AF Markova, M
   Peneff, C
   Hewlins, MJE
   Schirmer, T
   John, RA
TI Determinants of substrate specificity in omega-aminotransferases
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CRYSTAL-STRUCTURE; ORNITHINE
AB Ornithine aminotransferase and 4-aminobutyrate aminotransferase are related pyridoxal phosphate-dependent enzymes having different substrate specificities. The atomic structures of these enzymes have shown (i) that active site differences are limited to the steric positions occupied by two tyrosine residues in ornithine aminotransferase and (ii) that, uniquely among related, structurally characterized aminotransferases, the conserved arginine that binds the alpha-carboxylate of alpha-amino acids interacts tightly with a glutamate residue. To determine the contribution of these residues to the specificities of the enzymes, we analyzed site-directed mutants of ornithine aminotransferase by rapid reaction kinetics, x-ray crystallography, and C-13 NMR spectroscopy. Mutation of one tyrosine (Tyr-85) to isoleucine, as found in aminobutyrate aminotransferase, decreased the rate of the reaction of the enzyme with ornithine 1000-fold and increased that with 4-aminobutyrate 16-fold, indicating that Tyr-85 is amajor determinant of specificity toward ornithine. Unexpectedly, the limiting rate of the second half of the reaction, conversion of ketoglutarate to glutamate, was greatly increased, although the kinetics of the reverse reaction were unaffected. A mutant in which the glutamate (Glu-235) that interacts with the conserved arginine was replaced by alanine retained its regiospecificity for the delta-amino group of ornithine, but the glutamate reaction was enhanced 650-fold, whereas only a 5-fold enhancement of the ketoglutarate reaction rate resulted. A model is proposed in which conversion of the enzyme to its pyridoxamine phosphate form disrupts the internal glutamate-arginine interaction, thus enabling ketoglutarate but not glutamate to be a good substrate.
C1 Cardiff Univ, Sch Biosci, Cardiff CF23 6QU, Wales.
   Cardiff Univ, Sch Chem, Cardiff CF23 6QU, Wales.
   Univ Basel, Biozentrum, Abt Strukturbiol, CH-4056 Basel, Switzerland.
RP John, RA (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave,POB 911, Cardiff CF10 3US, S Glam, Wales.
EM JohnRA@cf.ac.uk
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BANKS BEC, 1966, PYRIDOXAL CATALYSIS, P191
   DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712
   FORD GC, 1980, P NATL ACAD SCI-BIOL, V77, P2559, DOI 10.1073/pnas.77.5.2559
   JOHN RA, 1976, BIOCHEM J, V155, P645, DOI 10.1042/bj1550645
   JOHN RA, 1985, TRANSAMINASES, P413
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LIU W, 1994, BIOCHEMISTRY-US, V43, P10896
   Liu WS, 2005, BIOCHEMISTRY-US, V44, P2982, DOI 10.1021/bi048657a
   MEHTA PK, 1993, EUR J BIOCHEM, V214, P549, DOI 10.1111/j.1432-1033.1993.tb17953.x
   Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129
   PERAINO C, 1969, J BIOL CHEM, V255, P10284
   PHILIPPSEN A, 1998, DINO VISUALIZATION S
   Shen BW, 1998, J MOL BIOL, V277, P81, DOI 10.1006/jmbi.1997.1583
   SILVERMAN RB, 1981, BIOCHEMISTRY-US, V20, P1197, DOI 10.1021/bi00508a022
   Storici P, 1999, J MOL BIOL, V285, P297, DOI 10.1006/jmbi.1998.2289
   Storici P, 1999, BIOCHEMISTRY-US, V38, P8628, DOI 10.1021/bi990478j
   WILLIAMS JA, 1982, BIOCHEM J, V201, P221, DOI 10.1042/bj2010221
NR 20
TC 35
Z9 36
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 28
PY 2005
VL 280
IS 43
BP 36409
EP 36416
DI 10.1074/jbc.M506977200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 976IM
UT WOS:000232726900075
PM 16096275
DA 2021-01-25
ER

PT J
AU Mueller, CA
   Broz, P
   Muller, SA
   Ringler, P
   Erne-Brand, F
   Sorg, I
   Kuhn, M
   Engel, A
   Cornelis, GR
AF Mueller, CA
   Broz, P
   Muller, SA
   Ringler, P
   Erne-Brand, F
   Sorg, I
   Kuhn, M
   Engel, A
   Cornelis, GR
TI The V-antigen of Yersinia forms a distinct structure at the tip of
   injectisome needles
SO SCIENCE
LA English
DT Article
ID PROTEIN SECRETION; SHIGELLA-FLEXNERI; EUKARYOTIC CELLS; HOST MEMBRANES;
   VIRULENCE; SURFACE; PESTIS; SYSTEM; ENTEROCOLITICA; TRANSLOCATION
AB Many pathogenic bacteria use injectisomes to deliver effector proteins into host cells through type III secretion. Injectisomes consist of a basal body embedded in the bacterial membranes and a needle. In Yersinia, translocation of effectors requires the YopB and YopD proteins, which form a pore in the target cell membrane, and the LcrV protein, which assists the assembly of the pore. Here we report that LcrV forms a distinct structure at the tip of the needle, the tip complex. This unique localization of LcrV may explain its crucial role in the translocation process and its efficacy as the main protective antigen against plague.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Maurice E Muller Inst, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790
CR BURROWS TW, 1956, NATURE, V177, P426, DOI 10.1038/177426b0
   Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   LAWTON WD, 1963, J INFECT DIS, V113, P39, DOI 10.1093/infdis/113.1.39
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   MUELLER C, UNPUB
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Philipovskiy AV, 2005, INFECT IMMUN, V73, P1532, DOI 10.1128/IAI.73.3.1532-1542.2005
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
NR 17
TC 254
Z9 262
U1 0
U2 15
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD OCT 28
PY 2005
VL 310
IS 5748
BP 674
EP 676
DI 10.1126/science.1118476
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 980ET
UT WOS:000232997700041
PM 16254184
DA 2021-01-25
ER

PT J
AU Zagrebelsky, M
   Holz, A
   Dechant, G
   Barde, YA
   Bonhoeffer, T
   Korte, M
AF Zagrebelsky, M
   Holz, A
   Dechant, G
   Barde, YA
   Bonhoeffer, T
   Korte, M
TI The p75 neurotrophin receptor negatively modulates dendrite complexity
   and spine density in hippocampal neurons
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE dendritic morphology; neurotrophin receptors; spine density;
   hippocampus; pyramidal neurons; p75 neurotrophin receptor
ID LONG-TERM POTENTIATION; NERVE GROWTH-FACTOR; EXCITATORY SYNAPSES;
   SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; SMALL GTPASES;
   IN-VIVO; P75(NTR); SYSTEM
AB The correlation between functional and structural neuronal plasticity is by now well documented. However, the molecular mechanisms translating patterns of neuronal activity into specific changes in the structure of neurons remain unclear. Neurotrophins can be released in an activity-dependent manner, and they are capable of controlling both neuronal morphology and functional synaptic changes. They are thus attractive molecules to be studied in the context of synaptic plasticity. In the CNS, most of the work so far has focused on the role of BDNF and of its tyrosine kinase B receptor (TrkB), but relatively little is known about the function of the pan-neurotrophin receptor p75(NTR). In this study, we show in loss-of-function experiments that postnatal hippocampal pyramidal cells in two mutant lines of p75(NTR) have a higher spine density and greater dendritic complexity than wild-type (WT) mice. Conversely, in a gain-of-function approach, p75(NTR) overexpression in WT neurons significantly reduces dendritic complexity, as well as spine density in all dendritic compartments. These results show that p75(NTR) negatively modulates dendritic morphology in adult hippocampal pyramidal neurons and documents a new case of functional antagonism between Trk and p75(NTR) signaling.
C1 Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Martinsried, Germany.
   Max Planck Inst Neurobiol, Dept Neuroimmunol, D-82152 Martinsried, Germany.
   Univ Innsbruck, Inst Neurosci, A-6020 Innsbruck, Austria.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
RP Korte, M (corresponding author), Tech Univ Braunschweig, Inst Zool, Mendelssohnstr 4, D-38106 Braunschweig, Germany.
EM m.korte@tu-bs.de
RI Barde, Yves/F-6019-2011; Bonhoeffer, Tobias/B-9481-2009
OI Bonhoeffer, Tobias/0000-0001-7897-6634; Barde, Yves/0000-0002-7627-461X;
   Zagrebelsky, Marta/0000-0003-1083-7413; Holz,
   Andreas/0000-0002-8886-0915
CR Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0
   BUCK CR, 1988, DEV BRAIN RES, V44, P259, DOI 10.1016/0165-3806(88)90224-6
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159
   COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0
   Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131
   Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438
   Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978
   ERNFORS P, 1995, NEURON, V14, P1153, DOI 10.1016/0896-6273(95)90263-5
   Frade JM, 1996, NATURE, V383, P166
   Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000
   Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004
   Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261
   HARRIS KM, 1989, J NEUROSCI, V9, P2982
   HARRIS KM, 1992, J NEUROSCI, V12, P2685
   Hartmann M, 2004, J CELL SCI, V117, P5803, DOI 10.1242/jcs.01511
   Holz A, 1996, J NEUROSCI, V16, P467
   Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0
   Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945
   Lang C, 2004, P NATL ACAD SCI USA, V101, P16665, DOI 10.1073/pnas.0407581101
   LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L
   LEVIMONTALCINI R, 1960, P NATL ACAD SCI USA, V46, P384, DOI 10.1073/pnas.46.3.384
   Li Z, 2002, NEURON, V33, P741, DOI 10.1016/S0896-6273(02)00621-9
   LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X
   LU B, 1989, EXP NEUROL, V104, P191, DOI 10.1016/0014-4886(89)90029-0
   Majdan M, 1997, J NEUROSCI, V17, P6988
   Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000
   Majewska A, 2000, J NEUROSCI, V20, P1722
   Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870
   Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923
   Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617
   McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295
   McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5
   Megias M, 2001, NEUROSCIENCE, V102, P527, DOI 10.1016/S0306-4522(00)00496-6
   Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016
   Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000
   Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002
   Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7
   Paul CE, 2004, J NEUROSCI, V24, P1917, DOI 10.1523/JNEUROSCI.5397-03.2004
   PETERS A, 1969, Z ZELLFORSCH MIK ANA, V100, P487, DOI 10.1007/BF00344370
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102
   Salama-Cohen P, 2005, MOL BIOL CELL, V16, P339
   Shimada A, 1998, J NEUROSCI, V18, P8559
   SHOLL DA, 1953, J ANAT, V87, P387
   SNIDER WD, 1988, J NEUROSCI, V8, P2628
   STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M
   Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927
   Toni N, 1999, NATURE, V402, P421
   Troy CM, 2002, J BIOL CHEM, V277, P34295, DOI 10.1074/jbc.M205167200
   Tyler WJ, 2001, J NEUROSCI, V21, P4249, DOI 10.1523/JNEUROSCI.21-12-04249.2001
   von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730
   Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176
   Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510
   Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000
   Yacoubian TA, 2000, NAT NEUROSCI, V3, P342
   Yamashita T, 2002, J CELL BIOL, V157, P565, DOI 10.1083/jcb.200202010
   Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9
   Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300
   Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011
NR 61
TC 187
Z9 189
U1 0
U2 3
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD OCT 26
PY 2005
VL 25
IS 43
BP 9989
EP 9999
DI 10.1523/JNEUROSCI.2492-05.2005
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 977VU
UT WOS:000232832400019
PM 16251447
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Dingley, AJ
   Peterson, RD
   Grzesiek, S
   Feigon, J
AF Dingley, AJ
   Peterson, RD
   Grzesiek, S
   Feigon, J
TI Characterization of the cation and temperature dependence of DNA
   quadruplex hydrogen bond properties using high-resolution NMR
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SCALAR COUPLINGS; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS;
   AMMONIUM-IONS; BASE-PAIRS; G-QUARTETS; PROTEIN; (3H)J(NC'); POTASSIUM
AB Variations in the hydrogen bond network of the Oxy-1.5 DNA guanine quadruplex have been monitored by trans-H-bond scalar couplings, (h2)J(N2N7), for Na(+)-, K(+)-, and NH(4)(+)-bound forms over a temperature range from 5 to 55 degrees C. The variations in (h2)J(N2N7) Couplings exhibit an overall trend of Na(+) > K(+) > NH(4)(+) and correlate with the different cation positions and N2-H2... N7 H-bond lengths in the respective structures. A global weakening of the (h2)J(N2N7) couplings with increasing temperature for the three DNA quadruplex species is accompanied by a global increase of the acceptor (15)N(7) chemical shifts. Above 35 degrees C, spectral heterogeneity indicates thermal denaturation for the Na(+)-bound form, whereas spectral homogeneity persists up to 55 degrees C for the K(+)- and NH(4)(+)-coordinated forms. The average relative change of the (h2)J(N2N7) couplings amounts to similar to 0.8 x 10(-3)/K and is thus considerably smaller than respective values reported for nucleic acid duplexes. The significantly higher thermal stability of H-bond geometries in the DNA quadruplexes can be rationalized by their cation coordination of the G-quartets and the extensive H-bond network between the four strands. A detailed analysis of individual (h2)J(N2N7) couplings reveals that the 5' strand end, comprising base pairs G1 -G9* and G4*-G1, is the most thermolabile region of the DNA quadruplex in all three cation-bound forms.
C1 UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England.
   Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.
   Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
RP Dingley, AJ (corresponding author), UCL, Dept Biochem & Mol Biol, Gower St, London WC1E 6BT, England.
EM dingley@biochem.ucl.ac.uk; stephan.grzesiek@unibas.ch;
   feigon@mbi.ucla.edu
RI Dingley, Andrew/G-6427-2013
OI Dingley, Andrew/0000-0002-6838-5803; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Arthanari H, 2001, CHEM BIOL, V8, P221, DOI 10.1016/S1074-5521(01)00007-2
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5
   Brunger A.T., 1992, XPLOR
   Bytchenkoff D, 2002, MAGN RESON CHEM, V40, P377, DOI 10.1002/mrc.1018
   Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274
   Cordier F, 1999, J MAGN RESON, V140, P510, DOI 10.1006/jmre.1999.1899
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Davis JT, 2004, ANGEW CHEM INT EDIT, V43, P668, DOI 10.1002/anie.200300589
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Deng H, 1996, J MOL BIOL, V255, P476, DOI 10.1006/jmbi.1996.0039
   Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026
   Dingley AJ, 2000, J BIOMOL NMR, V16, P279, DOI 10.1023/A:1008307115641
   Dingley AJ, 2001, CONCEPT MAGNETIC RES, V13, P103
   Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   EMSLEY L, 1990, CHEM PHYS LETT, V165, P469, DOI 10.1016/0009-2614(90)87025-M
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Golubev NS, 1999, CHEM-EUR J, V5, P492, DOI 10.1002/(SICI)1521-3765(19990201)5:2<492::AID-CHEM492>3.0.CO;2-I
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P487
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GUSCHLBAUER W, 1990, J BIOMOL STRUCT DYN, V8, P491, DOI 10.1080/07391102.1990.10507825
   Haider S, 2002, J MOL BIOL, V320, P189, DOI 10.1016/S0022-2836(02)00428-X
   Horvath MP, 2001, J MOL BIOL, V310, P367, DOI 10.1006/jmbi.2001.4766
   Hud NV, 1999, J MOL BIOL, V285, P233, DOI 10.1006/jmbi.1998.2327
   Hud NV, 1996, BIOCHEMISTRY-US, V35, P15383, DOI 10.1021/bi9620565
   Ippel JH, 1996, MAGN RESON CHEM, V34, pS156, DOI 10.1002/(SICI)1097-458X(199612)34:13<S156::AID-OMR68>3.0.CO;2-U
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Kojima C, 2000, J BIOMOL NMR, V18, P269, DOI 10.1023/A:1026717101063
   Kwon O, 1998, J AM CHEM SOC, V120, P1588, DOI 10.1021/ja9724957
   Li H, 2000, J BIOMOL NMR, V18, P207, DOI 10.1023/A:1026537609584
   Lohr F, 2000, J AM CHEM SOC, V122, P9289, DOI 10.1021/ja001345k
   Lohr F, 2004, CHEMBIOCHEM, V5, P1523, DOI 10.1002/cbic.200400171
   LU M, 1992, BIOCHEMISTRY-US, V31, P2455, DOI 10.1021/bi00124a003
   Majumdar A, 1999, J BIOMOL NMR, V14, P67, DOI 10.1023/A:1008335502416
   Majumdar A, 1999, J BIOMOL NMR, V15, P207, DOI 10.1023/A:1008357304708
   Majumdar A, 2001, J BIOMOL NMR, V19, P103, DOI 10.1023/A:1008311624772
   Markley JL, 1998, J BIOMOL NMR, V12, P1, DOI 10.1023/A:1008290618449
   Masse JE, 1998, NUCLEIC ACIDS RES, V26, P2618, DOI 10.1093/nar/26.11.2618
   McEachern MJ, 2000, ANNU REV GENET, V34, P331, DOI 10.1146/annurev.genet.34.1.331
   Mishima M, 2000, J AM CHEM SOC, V122, P5883, DOI 10.1021/ja000005w
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Phillips K, 1997, J MOL BIOL, V273, P171, DOI 10.1006/jmbi.1997.1292
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   SCHULTZE P, 1994, STRUCTURE, V2, P221, DOI 10.1016/S0969-2126(00)00023-X
   Schultze P, 1999, NUCLEIC ACIDS RES, V27, P3018, DOI 10.1093/nar/27.15.3018
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   SMITH FW, 1993, BIOCHEMISTRY-US, V32, P8682, DOI 10.1021/bi00084a040
   SMITH FW, 1992, NATURE, V356, P164, DOI 10.1038/356164a0
   SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0
   VANMOURIK T, 2005, IN PRESS CHEM EUR J
NR 55
TC 42
Z9 42
U1 0
U2 22
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 19
PY 2005
VL 127
IS 41
BP 14466
EP 14472
DI 10.1021/ja0540369
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 974QD
UT WOS:000232605600071
PM 16218642
DA 2021-01-25
ER

PT J
AU Bar, H
   Mucke, N
   Kostareva, A
   Sjoberg, G
   Aebi, U
   Herrmann, H
AF Bar, H
   Mucke, N
   Kostareva, A
   Sjoberg, G
   Aebi, U
   Herrmann, H
TI Severe muscle disease-causing desmin mutations interfere with in vitro
   filament assembly at distinct stages
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE desmin-related myopathy; intermediate filaments
ID EPIDERMOLYSIS-BULLOSA SIMPLEX; ALPHA-B-CRYSTALLIN; KERATIN
   INTERMEDIATE-FILAMENTS; POINT MUTATIONS; ROD DOMAIN; MYOPATHY; VIMENTIN;
   PROTEINS; DYNAMICS; RESIDUES
AB Desmin is the major intermediate filament (IF) protein of muscle. Recently, mutations of the desmin gene have been reported to cause familial or sporadic forms of human skeletal, as well as cardiac, myopathy, termed desmin-related myopathy (DRM). The impact of any of these mutations on filament assembly and integration into the cytoskeletal network of myocytes is currently not understood, despite the fact that all cause the same histopathological defect, i.e., desmin aggregation. To gain more insight into the molecular basis of this process, we investigated how mutations within the alpha-helical rod domain of desmin affect both the assembly of the recombinant protein in vitro as well as the filament-forming capacity in cDNA-transfected cells. Whereas 6 of 14 mutants assemble into seemingly normal IFs in the test tube,the other mutants interfere with the assembly process at distinct stages, i.e., tetramer formation, unit-length filament (ULF) formation, filament elongation, and IF maturation. Correspondingly, the mutants with in vitro assembly defects yield dot-like aggregates in transfected cells, whereas the mutants that form IFs constitute a seemingly normal IF cytoskeleton in the cellular context. At present, it is entirely unclear why the latter mutant proteins also lead to aggregate formation in myocytes. Hence, these findings may be a starting point to dissect the contribution of the individual subdomains for desmin pathology and, eventually, the development of therapeutic interventions.
C1 German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   Univ Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany.
   Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden.
   Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Herrmann, H (corresponding author), German Canc Res Ctr, Dept Mol Genet, Technol Pk 3,Neuenheimer Feld 280, D-69120 Heidelberg, Germany.
RI Kostareva, Anna/AAO-5429-2020; Kostareva, Anna/H-2204-2016
OI Kostareva, Anna/0000-0002-9349-6257
CR Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bellin RM, 2001, J BIOL CHEM, V276, P32330, DOI 10.1074/jbc.M104005200
   BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288
   COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   Goebel Hansh, 2004, Neuromuscul Disord, V14, P767, DOI 10.1016/j.nmd.2004.08.003
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Gromiha MM, 2004, BIOPHYS CHEM, V111, P95, DOI 10.1016/j.bpc.2004.05.001
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Haubold K, 2003, CELL MOTIL CYTOSKEL, V54, P105, DOI 10.1002/cm.10090
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Herrmann H, 1998, Subcell Biochem, V31, P319
   HUIATT TW, 1980, J BIOL CHEM, V255, P6981
   Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425
   LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344
   LETAI A, 1993, P NATL ACAD SCI USA, V90, P3197, DOI 10.1073/pnas.90.8.3197
   LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181
   Ma LL, 2001, NAT CELL BIOL, V3, P503, DOI 10.1038/35074576
   MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Nilsson I, 1998, J MOL BIOL, V284, P1165, DOI 10.1006/jmbi.1998.2217
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893
   Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480
   Selcen D, 2004, BRAIN, V127, P439, DOI 10.1093/brain/awh052
   Smith TA, 2004, PROTEINS, V55, P1043, DOI 10.1002/prot.20089
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   Wawersik M, 1997, J BIOL CHEM, V272, P32557, DOI 10.1074/jbc.272.51.32557
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
NR 40
TC 89
Z9 92
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 18
PY 2005
VL 102
IS 42
BP 15099
EP 15104
DI 10.1073/pnas.0504568102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 977NZ
UT WOS:000232811800030
PM 16217025
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Senn, C
   Hangartner, C
   Moes, S
   Guerini, D
   Hofbauer, KG
AF Senn, C
   Hangartner, C
   Moes, S
   Guerini, D
   Hofbauer, KG
TI Central administration of small interfering RNAs in rats: A comparison
   with antisense oligonucleotides
SO EUROPEAN JOURNAL OF PHARMACOLOGY
LA English
DT Article
DE antisense oligonucleotide; food intake; melanocortin; small interfering
   RNA; (rat)
ID GENE-EXPRESSION; IN-VIVO; THERAPEUTICS; MELANOCORTIN; INHIBITION; BRAIN;
   SIRNA; MICE
AB To date there are only few reports of the use of small interfering RNA (siRNA) in whole animals and most of these are restricted to systemic application of siRNAs targeting the liver. In our present studies we have investigated whether siRNAs can be used against a central target after intracerebroventricular (i.c.v.) application and compared their effects with those of antisense oligonucleotides. For this purpose we designed different siRNA and antisense oligonucleotide molecules against the rat hypothalamic melanocortin MC4 receptor and selected the siRNA and antisense oligonucleotide with the highest efficacy in vitro. We observed that siRNA, encompassing the same gene sequence as antisense oligonucleotides, induced a stronger inhibition of melanocortin MC4 receptor expression than antisense oligonucleotides. When fluorescence-labeled siRNA were applied i.c.v. in rats no label was detected in brain tissue in spite of the use of cell detergents to improve the delivery. In contrast to these findings the i.c.v. administered fluorescence-labeled antisense oligonucleotides reached the brain structures expressing melanocortin MC4 receptor and were taken up by the cells in these areas. In summary it seems as if 'naked' antisense oligonucleotides have an advantage over 'naked' siRNA for experiments in vivo. The development of optimized vector systems seems to be a prerequisite before siRNA can be regarded as a suitable experimental tool for in vivo studies. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Novartis Pharma AG, Transplantat & Immunol, CH-4002 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
RI Lazarus, Michael/G-3130-2010
OI Lazarus, Michael/0000-0003-3863-4474
CR CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Fisher SL, 1999, J RECEPT SIGNAL TR R, V19, P203, DOI 10.3109/10799899909036646
   Husken D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng103
   Ichim TE, 2004, AM J TRANSPLANT, V4, P1227, DOI 10.1111/j.1600-6143.2004.00530.x
   Isacson R, 2003, ACTA PHYSIOL SCAND, V179, P173, DOI 10.1046/j.1365-201X.2003.01188.x
   LEONETTI JP, 1991, P NATL ACAD SCI USA, V88, P2702, DOI 10.1073/pnas.88.7.2702
   Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   McCaffrey AP, 2002, NATURE, V418, P38, DOI 10.1038/418038a
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   Paroo Z, 2004, TRENDS BIOTECHNOL, V22, P390, DOI 10.1016/j.tibtech.2004.06.004
   Scherr M, 2003, CURR MED CHEM, V10, P245, DOI 10.2174/0929867033368493
   SOMMER W, 1993, NEUROREPORT, V5, P277, DOI 10.1097/00001756-199312000-00024
   Thakker DR, 2004, P NATL ACAD SCI USA, V101, P17270, DOI 10.1073/pnas.0406214101
   Williams G, 2000, P NUTR SOC, V59, P385, DOI 10.1017/S0029665100000434
   Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739
NR 18
TC 34
Z9 37
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-2999
EI 1879-0712
J9 EUR J PHARMACOL
JI Eur. J. Pharmacol.
PD OCT 17
PY 2005
VL 522
IS 1-3
BP 30
EP 37
DI 10.1016/j.ejphar.2005.08.021
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 979SC
UT WOS:000232964100004
PM 16213482
DA 2021-01-25
ER

PT J
AU Saenz, HL
   Dehio, C
AF Saenz, HL
   Dehio, C
TI Signature-tagged mutagenesis: technical advances in a negative selection
   method for virulence gene identification
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID IN-VIVO; STAPHYLOCOCCUS-AUREUS; INTESTINAL COLONIZATION;
   PSEUDOMONAS-AERUGINOSA; GASTROINTESTINAL-TRACT; BACTERIAL VIRULENCE;
   FUNCTIONAL GENOMICS; BRUCELLA-MELITENSIS; VACCINE CANDIDATES;
   URINARY-TRACT
AB Signature-tagged mutagenesis (STM) is a powerful negative selection method, predominantly used to identify the genes of a pathogen that are required for the successful colonization of an animal host. Since its first description a decade ago, STM has been applied to screen a vast amount of transposon insertion mutants in 31 bacterial species. This has led to the identification of over 1700 bacterial genes that are involved in virulence. Despite the preservation of the basic design, the STM method has been developed further owing to recent advances including different designs of the signature-tags and profound changes in the mode of detection. These advances promoted substantially the application range and versatility of the STM method.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Saenz, Henri/0000-0001-7536-7817
CR Atkins T, 2002, J MED MICROBIOL, V51, P539, DOI 10.1099/0022-1317-51-7-539
   Bahrani-Mougeot FK, 2002, MOL MICROBIOL, V45, P1079, DOI 10.1046/j.1365-2958.2002.03078.x
   Benton BM, 2004, J BACTERIOL, V186, P8478, DOI 10.1128/JB.186.24.8478-8489.2004
   Burall LS, 2004, INFECT IMMUN, V72, P2922, DOI 10.1128/IAI.72.5.2922-2938.2004
   Chiang SL, 1999, ANNU REV MICROBIOL, V53, P129, DOI 10.1146/annurev.micro.53.1.129
   Collins DM, 2005, INFECT IMMUN, V73, P2379, DOI 10.1128/IAI.73.4.2379-2386.2005
   Coulter SN, 1998, MOL MICROBIOL, V30, P393, DOI 10.1046/j.1365-2958.1998.01075.x
   Darwin AJ, 1999, MOL MICROBIOL, V32, P51, DOI 10.1046/j.1365-2958.1999.01324.x
   DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990
   DOAK TG, 1994, P NATL ACAD SCI USA, V91, P942, DOI 10.1073/pnas.91.3.942
   Dziva F, 2004, MICROBIOL-SGM, V150, P3631, DOI 10.1099/mic.0.27448-0
   Flashner Y, 2004, INFECT IMMUN, V72, P908, DOI 10.1128/IAI.72.2.908-915.2004
   Geoffroy MC, 2003, GENOME RES, V13, P391, DOI 10.1101/gr.664303
   Harper M, 2003, INFECT IMMUN, V71, P5440, DOI 10.1128/IAI.71.9.5440-5446.2003
   Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x
   Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x
   HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105
   Herbert MA, 2002, MICROB PATHOGENESIS, V33, P211, DOI 10.1006/mpat.2002.0530
   Heungens K, 2002, MOL MICROBIOL, V45, P1337, DOI 10.1046/j.1365-2958.2002.03100.x
   Hidalgo-Grass C, 2002, MOL MICROBIOL, V46, P87, DOI 10.1046/j.1365-2958.2002.03127.x
   Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004
   Hunt TA, 2004, INFECT IMMUN, V72, P4010, DOI 10.1128/IAI.72.7.4010-4022.2004
   Karlyshev AV, 2001, INFECT IMMUN, V69, P7810, DOI 10.1128/IAI.69.12.7810-7819.2001
   Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531
   Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x
   Lehoux Dario E, 2004, Methods Mol Biol, V266, P289
   Lehoux DE, 2000, CURR OPIN BIOTECH, V11, P434, DOI 10.1016/S0958-1669(00)00124-5
   Lehoux DE, 1999, BIOTECHNIQUES, V26, P473, DOI 10.2144/99263st02
   Lehoux DE, 2002, FEMS MICROBIOL LETT, V210, P73, DOI 10.1111/j.1574-6968.2002.tb11162.x
   Lestrate P, 2000, MOL MICROBIOL, V38, P543, DOI 10.1046/j.1365-2958.2000.02150.x
   Lestrate P, 2003, INFECT IMMUN, V71, P7053, DOI 10.1128/IAI.71.12.7053-7060.2003
   Li GW, 2005, INFECT IMMUN, V73, P2818, DOI 10.1128/IAI.73.5.2818-2827.2005
   Lichtensteiger CA, 2003, MICROB PATHOGENESIS, V34, P149, DOI 10.1016/S0882-4010(02)00196-1
   Maroncle N, 2002, INFECT IMMUN, V70, P4729, DOI 10.1128/IAI.70.8.4729-4734.2002
   Mecsas J, 2002, CURR OPIN MICROBIOL, V5, P33, DOI 10.1016/S1369-5274(02)00282-5
   Mei JM, 1997, MOL MICROBIOL, V26, P399, DOI 10.1046/j.1365-2958.1997.5911966.x
   Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x
   Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x
   Mundy R, 2003, MOL MICROBIOL, V48, P795, DOI 10.1046/j.1365-2958.2003.03470.x
   Perry RD, 1999, TRENDS MICROBIOL, V7, P385, DOI 10.1016/S0966-842X(99)01582-6
   Perry RD, 1999, TRENDS MICROBIOL, V7, P388, DOI 10.1016/S0966-842X(99)01593-0
   Plasterk RHA, 1999, TRENDS GENET, V15, P326, DOI 10.1016/S0168-9525(99)01777-1
   Potvin E, 2003, ENVIRON MICROBIOL, V5, P1294, DOI 10.1046/j.1462-2920.2003.00542.x
   Ruley KM, 2004, FEMS MICROBIOL LETT, V232, P75, DOI 10.1016/S0378-1097(04)00017-5
   Shea JE, 2000, CURR OPIN MICROBIOL, V3, P451, DOI 10.1016/S1369-5274(00)00120-X
   Shea JE, 1996, P NATL ACAD SCI USA, V93, P2593, DOI 10.1073/pnas.93.6.2593
   Sheehan BJ, 2003, INFECT IMMUN, V71, P3960, DOI 10.1128/IAI.71.7.3960-3970.2003
   Struve C, 2003, MICROBIOL-SGM, V149, P167, DOI 10.1099/mic.0.25833-0
   Sun YH, 2000, NAT MED, V6, P1269
   van Diemen PA, 2005, INFECT IMMUN, V73, P1735, DOI 10.1128/IAI.73.3.1735-1743.2005
   WALSH C, 1992, SCIENCE, V255, P434, DOI 10.1126/science.1734520
NR 51
TC 55
Z9 63
U1 1
U2 12
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD OCT
PY 2005
VL 8
IS 5
BP 612
EP 619
DI 10.1016/j.mib.2005.08.013
PG 8
WC Microbiology
SC Microbiology
GA 976OW
UT WOS:000232744000018
PM 16126452
DA 2021-01-25
ER

PT J
AU Dunant, P
   Hofbauer, KG
AF Dunant, P
   Hofbauer, KG
TI Changes in blood pressure and body temperature during and after
   intermittent fasting in rats
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Meeting Abstract
CT 4th International Symposium on Obesity and Hypertension
CY OCT 27-29, 2005
CL Berlin, GERMANY
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
J9 INT J OBESITY
JI Int. J. Obes.
PD OCT
PY 2005
VL 29
SU 3
BP S16
EP S16
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 991HO
UT WOS:000233803400062
DA 2021-01-25
ER

PT J
AU Nguyen, L
   Walburger, A
   Houben, E
   Koul, A
   Muller, S
   Morbitzer, M
   Klebl, B
   Ferrari, G
   Pieters, J
AF Nguyen, L
   Walburger, A
   Houben, E
   Koul, A
   Muller, S
   Morbitzer, M
   Klebl, B
   Ferrari, G
   Pieters, J
TI Role of protein kinase G in growth and glutamine metabolism of
   Mycobacterium bovis BCG (vol 187, pg 5852, 2005)
SO JOURNAL OF BACTERIOLOGY
LA English
DT Correction
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Axxima Pharmaceut, Munich, Germany.
RP Nguyen, L (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
CR Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD OCT
PY 2005
VL 187
IS 20
BP 7165
EP 7165
DI 10.1128/JB.187.20.7165.2005
PG 1
WC Microbiology
SC Microbiology
GA 973FY
UT WOS:000232509500036
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Barrow, DJ
   Chandrasekaran, S
   Heerklotz, HH
   Henary, MM
   Michniak, BB
   Nguyen, PM
   Song, Y
   Smith, JC
   Strekowski, L
AF Barrow, DJ
   Chandrasekaran, S
   Heerklotz, HH
   Henary, MM
   Michniak, BB
   Nguyen, PM
   Song, Y
   Smith, JC
   Strekowski, L
TI Mechanistic studies on percutaneous penetration enhancement by
   N-(4-halobenzoyl)-S,S-dimethyliminosulfuranes
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE transdermal penetration enhancer; vesicle; bilayer; nuclear magnetic
   resonance; calorimetry; polarizability
ID HUMAN STRATUM-CORNEUM; DIFFERENTIAL SCANNING CALORIMETRY;
   X-RAY-DIFFRACTION; PHASE-TRANSITION; TITRATION CALORIMETRY; LIPID
   ORGANIZATION; SKIN BARRIER; DIPALMITOYLPHOSPHATIDYLCHOLINE;
   SPECTROSCOPY; VESICLES
AB Halogen- substituted iminosulfuranes are trans-dermal penetration enhancers ( TPEs) in permeation studies using hairless mouse or human cadaver skin. The interaction of N -( 4- R - benzoyl)- S, S - dimethyliminosulfuranes 1- 4, where R = H, Cl, Br, and I, with (L)- alpha - dimyristoyl- sn - glycero- 3- phosphocholine ( DMPC) has been studied using differential scanning calorimetry, isothermal titration calorimetry, nuclear Overhauser effect spectroscopy ( NOESY), and NMR spectroscopy, and by calculation of the iminosulfurane polarizabilities in order to elucidate the molecular basis of the TPE activity. The active compounds reduce the melting temperature of the gel- to- liquid- crystal phase transition and induce multiple components in the transition excess heat capacity profile. The partitioning of the bromo derivative 3, the most active compound, into DMPC is unique in that 3 may be trapped in the bilayer, affording an enhanced residence time and a reason for its high TPE activity. The entropy decrease associated with the transfer of 3 to the bilayer is much lower than that for the other compounds, indicating that 3 occupies or induces sites that afford it considerable local motional freedom. Correlations between the iminosulfurane TPE activities, the partition coefficients, and NOESY cross-peak volume were observed. Molecular polarizabilities are not consistent with a TPE mode of action involving interaction of these agents with protein side chains.
C1 Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.
   Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
   Univ Med & Dent New Jersey, Sch Med, Dept Physiol & Pharmacol, Newark, NJ USA.
RP Smith, JC (corresponding author), Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA.
EM chejcs@langate.gsu.edu
OI Heerklotz, Heiko/0000-0003-4615-7022
CR ANGST BJ, 1986, INT J PHARM, V33, P225
   BAMMEL BP, 1987, BIOCHIM BIOPHYS ACTA, V896, P136, DOI 10.1016/0005-2736(87)90174-X
   BILTONEN RL, 1978, CRC CR REV BIOCH MOL, V5, P85, DOI 10.3109/07388557809148191
   Bouwstra JA, 1996, INT J PHARM, V144, P81, DOI 10.1016/S0378-5173(96)04726-6
   BOUWSTRA JA, 1992, INT J PHARM, V79, P141, DOI 10.1016/0378-5173(92)90105-B
   BOUWSTRA JA, 1991, J CONTROL RELEASE, V15, P209, DOI 10.1016/0168-3659(91)90112-Q
   BROWN DE, 1995, J MAGN RESON SER A, V114, P268, DOI 10.1006/jmra.1995.1138
   FRISCH A, 1999, GAUSSIAN 98 USERS RE
   GARSON JC, 1991, J INVEST DERMATOL, V96, P43, DOI 10.1111/1523-1747.ep12514716
   Gazzara JA, 1997, J LIPID RES, V38, P2147
   GRAY G, VARIAN ASS NEWSLETTE, V7, P3033
   GUO J, 1999, CHEM ABSTR, V12, P6
   Hadgraft J, 1996, INT J PHARM, V141, P17, DOI 10.1016/0378-5173(96)04609-1
   Hadgraft J, 1999, INT J PHARMACEUT, V184, P1, DOI 10.1016/S0378-5173(99)00095-2
   Harrison JE, 1996, J CONTROL RELEASE, V41, P283, DOI 10.1016/0168-3659(96)01348-X
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Heerklotz HH, 1999, BIOPHYS J, V76, P2606, DOI 10.1016/S0006-3495(99)77413-8
   Hu B. L., 2003, CHEM ABSTR, V32, P20
   Huster D, 1999, J PHYS CHEM B, V103, P243, DOI 10.1021/jp983428h
   Kim N, 1999, INT J PHARMACEUT, V187, P219, DOI 10.1016/S0378-5173(99)00194-5
   MADISON KC, 1987, J INVEST DERMATOL, V88, P714, DOI 10.1111/1523-1747.ep12470386
   MICHNIAK BB, 1993, J PHARM SCI, V82, P214, DOI 10.1002/jps.2600820221
   ROLLAND A, 1991, INT J PHARM, V76, P217, DOI 10.1016/0378-5173(91)90274-R
   ROLLAND A, 1990, PREDICTION PERCUTANE, P110
   SALOMONSDEVRIES M, 1991, 18 INT S CONTR REL B
   SCHIRMER N, 1971, NUCL OVERHAUSER EFFE
   SCHURER NJ, 1992, ADV LIPID RES
   SEKURA DL, 1988, ADV BIOL SKIN, V12, P257
   SONG Y, 2004, THESIS U MED DENT NE
   Strekowski L, 1999, BIOORG MED CHEM LETT, V9, P1033, DOI 10.1016/S0960-894X(99)00131-6
   SUURKUUSK J, 1976, BIOCHEMISTRY-US, V15, P1393, DOI 10.1021/bi00652a007
   THOMPSON LK, 1986, BIOCHEMISTRY-US, V25, P6161, DOI 10.1021/bi00368a050
   TSUZUKI N, 1988, INT J PHARM, V46, P19
   van Duijnen PT, 1998, J PHYS CHEM A, V102, P2399, DOI 10.1021/jp980221f
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 35
TC 5
Z9 5
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD OCT
PY 2005
VL 46
IS 10
BP 2192
EP 2201
DI 10.1194/jlr.M500123-JLR200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 965UE
UT WOS:000231975000016
PM 16061953
OA Bronze
DA 2021-01-25
ER

PT J
AU Reichlin, T
   Wild, A
   Durrenberger, M
   Daniels, AU
   Aebi, U
   Hunziker, PR
   Stolz, M
AF Reichlin, T
   Wild, A
   Durrenberger, M
   Daniels, AU
   Aebi, U
   Hunziker, PR
   Stolz, M
TI Investigating native coronary artery endothelium in situ and in cell
   culture by scanning force microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE atherosclerosis; coronary disease; vulnerable plaques; soft biological
   tissues; endothelial cells; indentation-type SFM; AFM
ID ATOMIC-FORCE; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; LIVING CELLS;
   MORPHOLOGY; DYNAMICS; SURFACE; DAMAGE; RECEPTOR; PLAQUE
AB The purpose of our studies is to better understand the morphology and functioning of the arteries and their changes in pathogenesis. The most frequently used imaging techniques are intravascular ultrasound, magnetic resonance imaging, and optical coherence tomography. These methods do not image cell-level structural details and only provide biomechanical properties indirectly. We present a new protocol for imaging the endothelial surface and measuring elastic properties of vascular tissue by scanning force microscopy. Full-thickness sections of native pig coronary arteries were prepared. In addition, cultured human umbilical vein endothelial cells were studied as an in vitro model system and for comparison. We encountered a variety of difficulties mostly due to the softness of vascular tissue which required significant adaptations of standard equipment: (i) a new specimen holder designed to stably immobilize the coronary arteries; (ii) a phase-contrast microscope incorporated for assessing the status of the cultured endothelial cells and positioning the scanning force microscope (SFM) tip at a site of interest; and (iii) a continuous exchange of the culture medium at 37 degrees C to assure viability of the cells in the SFM over extended times. We were thus able to investigate both fresh arterial tissue and living endothelial cells in a near-physiological environment. We present initial SFM images of vascular tissue at a spatial resolution similar to scanning electron microscopy, but which also provide a closer view of the bona fide structure of native tissue. Novel morphological features such as distinct granular particles were observed. Moreover, we report initial measurements of vascular tissue surface stiffness, obtained by indentation-type SFM. (C) 2005 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   Univ Basel, Ctr Microscopy, CH-4003 Basel, Switzerland.
   Univ Basel, Felix Platter Hosp, Lab Orthoped Biomech, CH-4003 Basel, Switzerland.
   Univ Basel, Univ Basel Hosp, Med Intens Care Unit, CH-4003 Basel, Switzerland.
RP Aebi, U (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
EM Ueli.Aebi@unibas.ch
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Alexander RW, 2000, CIRCULATION, V102, P112
   Bian K, 2003, FRONT BIOSCI-LANDMRK, V8, pD264, DOI 10.2741/997
   Cottin Y, 2001, Cardiovasc Radiat Med, V2, P231, DOI 10.1016/S1522-1865(02)00129-4
   CWIKIEL M, 1995, SCANNING MICROSCOPY, V9, P561
   DAL SC, 2001, P EUR 2 INT C, V490, P1
   Domke J, 1999, EUR BIOPHYS J BIOPHY, V28, P179, DOI 10.1007/s002490050198
   Engel A, 1999, TRENDS CELL BIOL, V9, P77, DOI 10.1016/S0962-8924(98)01415-9
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Hay Jennifer L, 2000, ASM HDB, P232, DOI DOI 10.31399/asm.hb.v08.a0003273
   HENDERSON E, 1992, SCIENCE, V257, P1944, DOI 10.1126/science.1411511
   Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X
   Hidalgo MA, 1996, J THORAC CARDIOV SUR, V112, P1027, DOI 10.1016/S0022-5223(96)70104-6
   HOFER H, 1981, THORAC CARDIOV SURG, V29, P32, DOI 10.1055/s-2007-1023437
   HOH JH, 1994, J CELL SCI, V107, P1105
   Hunziker PR, 2002, CHIMIA, V56, P520, DOI 10.2533/000942902777680234
   Jurvelin JS, 1996, J STRUCT BIOL, V117, P45, DOI 10.1006/jsbi.1996.0068
   Kinhult S, 2003, ACTA ONCOL, V42, P304, DOI 10.1080/02841860310004409
   Kinhult S, 2003, SCAND CARDIOVASC J, V37, P30, DOI 10.1080/14017430310007009
   LAL R, 1994, AM J PHYSIOL, V266, pC1
   LAL R, 1995, AM J PHYSIOL-CELL PH, V269, pC275
   Lane P, 1999, SEMIN NEPHROL, V19, P215
   Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442
   Miyazaki H, 1999, MED BIOL ENG COMPUT, V37, P530, DOI 10.1007/BF02513342
   Nagao E, 1998, J MICROSC-OXFORD, V191, P8
   Oberleithner H, 2003, J MEMBRANE BIOL, V196, P163, DOI 10.1007/s00239-003-0635-6
   PARISE LV, 1985, J BIOL CHEM, V260, P698
   Park S, 2004, OSTEOARTHR CARTILAGE, V12, P65, DOI 10.1016/j.joca.2003.08.005
   Pasterkamp G, 2000, J AM COLL CARDIOL, V36, P13, DOI 10.1016/S0735-1097(00)00677-X
   PHARR GM, 1992, J MATER RES, V7, P613, DOI 10.1557/JMR.1992.0613
   Rotsch C, 1997, CELL BIOL INT, V21, P685, DOI 10.1006/cbir.1997.0213
   Rotsch C, 2001, ULTRAMICROSCOPY, V86, P97, DOI 10.1016/S0304-3991(00)00102-9
   Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8
   Schneider SW, 2000, PFLUG ARCH EUR J PHY, V439, P297, DOI 10.1007/s004240050943
   SCHOENENBERGER CA, 1994, BIOPHYS J, V67, P929, DOI 10.1016/S0006-3495(94)80556-9
   Schurmann G, 2001, APPL OPTICS, V40, P5040, DOI 10.1364/AO.40.005040
   SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286
   Sims FH, 2002, PATHOLOGY, V34, P433, DOI 10.1080/0031302021000009351
   SINCLAIR DA, 1982, ULTR S P IEEE NEW YO, V2, P1090
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   STOLZ M, 2003, DEV ARTHROSCOPIC ATO, P2
   Svedas E, 2003, AM J OBSTET GYNECOL, V188, P168, DOI 10.1067/mob.2003.110
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
   USHIYAMA S, 1993, J BIOL CHEM, V268, P15229
   Zhou H, 1999, APPL PHYS LETT, V75, P1824, DOI 10.1063/1.124840
NR 46
TC 35
Z9 40
U1 1
U2 15
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD OCT
PY 2005
VL 152
IS 1
BP 52
EP 63
DI 10.1016/j.jsb.2005.07.009
PG 12
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 974DU
UT WOS:000232572300005
PM 16169249
DA 2021-01-25
ER

PT J
AU Meyer, DM
   Crottet, P
   Maco, B
   Degtyar, E
   Cassel, D
   Spiess, M
AF Meyer, DM
   Crottet, P
   Maco, B
   Degtyar, E
   Cassel, D
   Spiess, M
TI Oligomerization and dissociation of AP-1 adaptors are regulated by cargo
   signals and by ArfGAP1-induced GTP hydrolysis
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID ADP-RIBOSYLATION FACTOR; CLATHRIN-COATED VESICLES; COPI VESICLES;
   ACTIVATING PROTEIN; SYNTHETIC LIPOSOMES; SORTING SIGNALS;
   PLASMA-MEMBRANE; IN-VITRO; NUCLEOTIDE EXCHANGE; RETROGRADE CARGO
AB The mechanism of AP-1/clathrin coat formation was analyzed using purified adaptor proteins and synthetic liposomes presenting tyrosine sorting signals. AP-1 adaptors recruited in the presence of Arf1 center dot GTP and sorting signals were found to oligomerize to high-molecular-weight complexes even in the absence of clathrin. The appendage domains of the AP-1 adaptins were not required for oligomerization. On GTP hydrolysis induced by the GTPase-activating protein ArfGAP1, the complexes were disassembled and AP-1 dissociated from the membrane. AP-1 stimulated ArfGAP1 activity, suggesting a role of AP-1 in the regulation of the Arf1 "GTPase timer." In the presence of cytosol, AP-1 could be recruited to liposomes without sorting signals, consistent with the existence of docking factors in the cytosol. Under these conditions, however, AP-1 remained monomeric, and recruitment in the presence of GTP was short-lived. Sorting signals allowed stable recruitment and oligomerization also in the presence of cytosol. These results suggest a mechanism whereby initial assembly of AP-1 with Arf1 center dot GTP and ArfGAP1 on the membrane stimulates Arf1 GTPase activity, whereas interaction with cargo induces oligomerization and reduces the rate of GTP hydrolysis, thus contributing to efficient cargo sorting.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM Martin.Spiess@unibas.ch
OI Maco, Bohumil/0000-0001-8444-313X; Spiess, Martin/0000-0001-7139-0550
CR AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x
   AHLE S, 1988, EMBO J, V7, P919, DOI 10.1002/j.1460-2075.1988.tb02897.x
   Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500
   Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305
   Aridor M, 2002, TRAFFIC, V3, P537, DOI 10.1034/j.1600-0854.2002.30804.x
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Brown G E, 1974, Methods Enzymol, V30, P368
   Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309
   CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999
   Drake MT, 2000, MOL BIOL CELL, V11, P3723, DOI 10.1091/mbc.11.11.3723
   Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8
   FRANCO M, 1995, J BIOL CHEM, V270, P1337, DOI 10.1074/jbc.270.3.1337
   Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X
   Haucke V, 2002, EUR J CELL BIOL, V81, P647, DOI 10.1078/0171-9335-00289
   Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268
   Heilker R, 1996, EMBO J, V15, P2893, DOI 10.1002/j.1460-2075.1996.tb00650.x
   Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552
   Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786
   Huber I, 2001, METHOD ENZYMOL, V329, P307
   Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200
   Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117
   Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935
   Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Liang JO, 1997, J BIOL CHEM, V272, P4141, DOI 10.1074/jbc.272.7.4141
   Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4
   Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6
   Nickel W, 1998, J CELL SCI, V111, P3081
   Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200
   Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140
   Pepperkok R, 2000, J CELL SCI, V113, P135
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012
   Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224
   Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0
   SCHRODER S, 1991, J BIOL CHEM, V266, P7910
   Shi GY, 1998, J CELL BIOL, V143, P947, DOI 10.1083/jcb.143.4.947
   Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   Szafer E, 2000, J BIOL CHEM, V275, P23615, DOI 10.1074/jbc.M003171200
   Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200
   TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365
   TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933
   Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0
   UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0
   Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x
   Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
   ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1
   Zhao XH, 2001, J CELL SCI, V114, P353
   Zhu YX, 1999, P NATL ACAD SCI USA, V96, P5013, DOI 10.1073/pnas.96.9.5013
   Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323
NR 58
TC 21
Z9 22
U1 0
U2 0
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD OCT
PY 2005
VL 16
IS 10
BP 4745
EP 4754
DI 10.1091/mbc.E05-06-0568
PG 10
WC Cell Biology
SC Cell Biology
GA 969TM
UT WOS:000232257700025
PM 16093346
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Troisfontaines, P
   Cornelis, GR
AF Troisfontaines, P
   Cornelis, GR
TI Type III secretion: More systems than you think
SO PHYSIOLOGY
LA English
DT Review
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; YERSINIA YOPE CYTOTOXIN;
   PSEUDOMONAS-AERUGINOSA; PROTEIN SECRETION; SHIGELLA-FLEXNERI;
   EPITHELIAL-CELLS; BURKHOLDERIA-PSEUDOMALLEI; GENOME SEQUENCE; EFFECTOR
   PROTEINS; VIRULENCE FACTOR
AB The type III secretion (T3S) pathway allows bacteria to inject effector proteins into the cytosol of target animal or plant cells. T3S systems evolved into seven families that were distributed among Gram-negative bacteria by horizontal gene transfer. There are probably a few hundred effectors interfering with control and signaling in eukaryotic cells and offering a wealth of new tools to cell biologists.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Troisfontaines, P (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Alfano JR, 1997, J BACTERIOL, V179, P5655, DOI 10.1128/jb.179.18.5655-5662.1997
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Attree O, 2001, MICROBIOL-SGM, V147, P3197, DOI 10.1099/00221287-147-12-3197
   Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597
   Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7
   Benabdillah R, 2004, MICROB PATHOGENESIS, V36, P247, DOI 10.1016/j.micpath.2003.12.006
   Betts HJ, 2004, TRENDS MICROBIOL, V12, P476, DOI 10.1016/j.tim.2004.09.010
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   BODEY GP, 1983, REV INFECT DIS, V5, P279
   Bourdet-Sicard R, 1999, TRENDS MICROBIOL, V7, P309, DOI 10.1016/S0966-842X(99)01548-6
   Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x
   Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003
   Buttner D, 2002, EMBO J, V21, P5313, DOI 10.1093/emboj/cdf536
   Buttner D, 2002, J BACTERIOL, V184, P2389, DOI 10.1128/JB.184.9.2389-2398.2002
   Campellone KG, 2003, CURR OPIN MICROBIOL, V6, P82, DOI 10.1016/S1369-5274(03)00005-5
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Celli J, 2000, CELL MICROBIOL, V2, P1, DOI 10.1046/j.1462-5822.2000.00033.x
   Chacon MR, 2004, J CLIN MICROBIOL, V42, P1285, DOI 10.1128/JCM.42.3.1285-1287.2004
   Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Coburn J, 1999, INFECT IMMUN, V67, P3151, DOI 10.1128/IAI.67.6.3151-3154.1999
   Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6
   Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846
   Collmer A, 2000, P NATL ACAD SCI USA, V97, P8770, DOI 10.1073/pnas.97.16.8770
   Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Dale C, 2005, MOL BIOL EVOL, V22, P758, DOI 10.1093/molbev/msi061
   Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299
   Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100
   De Geyter C, 2000, EUR J BIOCHEM, V267, P5769, DOI 10.1046/j.1432-1327.2000.01649.x
   Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200
   Demers B, 1998, EMBO J, V17, P2894, DOI 10.1093/emboj/17.10.2894
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100
   Dharakul Tararaj, 1999, Trends in Microbiology, V7, P138, DOI 10.1016/S0966-842X(99)01477-8
   Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747
   Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x
   Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x
   FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x
   Foultier B, 2003, INFECT IMMUN, V71, P242, DOI 10.1128/IAI.71.1.242-253.2003
   Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7
   Fu YX, 1999, NATURE, V401, P293
   Galan JE, 1999, CURR OPIN MICROBIOL, V2, P46, DOI 10.1016/S1369-5274(99)80008-3
   Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   Genin S, 2004, ANNU REV PHYTOPATHOL, V42, P107, DOI 10.1146/annurev.phyto.42.011204.104301
   Golubov A, 2003, FEMS IMMUNOL MED MIC, V38, P107, DOI 10.1016/S0928-8244(03)00182-2
   Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7
   Gruenheid S, 2004, MOL MICROBIOL, V51, P1233, DOI 10.1046/j.1365-2958.2003.03911.x
   Gunasena DK, 2003, ADV EXP MED BIOL, V529, P105
   Gupta RS, 2000, CRIT REV MICROBIOL, V26, P111, DOI 10.1080/10408410091154219
   HACKER J, 1999, PATHOGENICITY ISLAND, P1
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Haller JC, 2000, MOL MICROBIOL, V36, P1436, DOI 10.1046/j.1365-2958.2000.01964.x
   Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7
   Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11
   Hayward RD, 2002, TRENDS CELL BIOL, V12, P15, DOI 10.1016/S0962-8924(01)02183-3
   He SY, 2004, BBA-MOL CELL RES, V1694, P181, DOI 10.1016/j.bbamcr.2004.03.011
   Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188
   Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161
   Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396
   Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895
   Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330
   Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003
   Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x
   Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000
   Jepson MA, 2003, CELL MICROBIOL, V5, P773, DOI 10.1046/j.1462-5822.2003.00315.x
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Kim JF, 2001, TRENDS GENET, V17, P65, DOI 10.1016/S0168-9525(00)02175-2
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x
   Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x
   Makino K, 2003, LANCET, V361, P743, DOI 10.1016/S0140-6736(03)12659-1
   Makino SI, 2003, J CLIN MICROBIOL, V41, P2341, DOI 10.1128/JCM.41.6.2341-2347.2003
   Marches O, 2003, MOL MICROBIOL, V50, P1553, DOI 10.1046/j.1365-2958.2003.03821.x
   Marie C, 2001, CURR OPIN PLANT BIOL, V4, P336, DOI 10.1016/S1369-5266(00)00182-5
   McMorran B, 2003, INFECT IMMUN, V71, P6035, DOI 10.1128/IAI.71.10.6035-6044.2003
   Miao EA, 1999, MOL MICROBIOL, V34, P850, DOI 10.1046/j.1365-2958.1999.01651.x
   Minamino T, 2005, MOL MICROBIOL, V56, P303, DOI 10.1111/j.1365-2958.2005.04611.x
   Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Nguyen L, 2000, J MOL MICROB BIOTECH, V2, P125
   Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522
   Nogawa H, 2004, J BACTERIOL, V186, P3806, DOI 10.1128/JB.186.12.3806-3813.2004
   Ohnishi M, 2000, SYST APPL MICROBIOL, V23, P315, DOI 10.1016/S0723-2020(00)80059-4
   Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594
   Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001
   Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004
   Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083
   Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4
   Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003
   RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262
   Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374
   Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x
   Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x
   Ren CP, 2004, J BACTERIOL, V186, P3547, DOI 10.1128/JB.186.11.3547-3560.2004
   Rohmer L, 2004, GENETICS, V167, P1341, DOI 10.1534/genetics.103.019638
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Rossier O, 2000, MOL MICROBIOL, V38, P828, DOI 10.1046/j.1365-2958.2000.02173.x
   Ruckdeschel K, 2001, INFECT IMMUN, V69, P7652, DOI 10.1128/IAI.69.12.7652-7662.2001
   Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5
   Sansonetti PJ, 2001, FEMS MICROBIOL REV, V25, P3, DOI 10.1016/S0168-6445(00)00060-7
   Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x
   Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x
   Shao F, 2003, P NATL ACAD SCI USA, V100, P904, DOI 10.1073/pnas.252770599
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Smith AM, 2001, FEMS MICROBIOL REV, V25, P309, DOI 10.1111/j.1574-6976.2001.tb00580.x
   Sorg I, 2001, INFECT IMMUN, V69, P7535, DOI 10.1128/IAI.69.12.7535-7543.2001
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stephens RS, 1998, SCIENCE, V282, P754, DOI 10.1126/science.282.5389.754
   Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003
   Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x
   Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854
   Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200
   Ulrich RL, 2004, INFECT IMMUN, V72, P6589, DOI 10.1128/IAI.72.11.6589-6596.2004
   Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073/pnas.97.16.8799
   Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Walker KA, 2004, J BACTERIOL, V186, P4056, DOI 10.1128/JB.186.13.4056-4066.2004
   Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x
   Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899
   Yao T, 1999, J EXP MED, V190, P1343, DOI 10.1084/jem.190.9.1343
   Young BM, 2002, J BACTERIOL, V184, P1324, DOI 10.1128/JB.184.5.1324-1334.2002
   Yu HB, 2004, INFECT IMMUN, V72, P1248, DOI 10.1128/IAI.72.3.1248-1256.2004
   Yuk MH, 2000, MOL MICROBIOL, V35, P991, DOI 10.1046/j.1365-2958.2000.01785.x
   ZHANG ZY, 1992, J BIOL CHEM, V267, P23759
   Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092
   Zumbihl R, 1999, J BIOL CHEM, V274, P29289, DOI 10.1074/jbc.274.41.29289
NR 147
TC 170
Z9 178
U1 0
U2 21
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 1548-9213
EI 1548-9221
J9 PHYSIOLOGY
JI Physiology
PD OCT
PY 2005
VL 20
BP 326
EP 339
DI 10.1152/physiol.00011.2005
PG 14
WC Physiology
SC Physiology
GA 970HJ
UT WOS:000232295600006
PM 16174872
DA 2021-01-25
ER

PT J
AU Goldsbury, C
   Frey, P
   Olivieri, V
   Aebi, U
   Muller, SA
AF Goldsbury, C
   Frey, P
   Olivieri, V
   Aebi, U
   Muller, SA
TI Multiple assembly pathways underlie amyloid-beta fibril polymorphisms
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Alzheimer's disease; amyloid-beta protein; oligomer; fibril formation;
   protofibrils
ID ATOMIC-FORCE MICROSCOPY; ALZHEIMERS-DISEASE; IN-VITRO; PROTEIN
   FIBRILLOGENESIS; ELECTRON-MICROSCOPY; PEPTIDE; GROWTH; PROTOFIBRILLAR;
   MODEL; INHIBITORS
AB The amyloid beta-protein transiently forms low and high molecular mass oligomers and protofibrils in vitro, and after longer incubation times assembles into polymorphic mature fibrils. The precursor-to-product relationship of these species remains to be understood. Protofibrils are up to similar to 600 nm in length and have mass-per-lengths of 19(+/- 2) kDa/nm measured by scanning transmission electron microscopy. Two predominant mature fibril types, several microns in length and with mass-per-lengths of 18(+/- 3) and 27(+/- 3)kDa/nm, are identified after longer incubation times. The difference of similar to 9 kDa/nm between the two fibril types indicates a bona fide elementary protofilament subunit of this mass-per-length. Fibrils in the 18(+/- 3) kDa/nm group often exhibited distinct coiling with axial cross-over spacings of similar to 25 nm. Although strikingly different in morphology, the mass-per-length (MPL) of these coiled fibrils is equivalent to that measured for protofibrils. They could therefore arise from a conformational change in the protofibril concurrent with coiling and rapid elongation. Alternatively, we cannot rule out an assembly pathway not directly related to protofibrils. In contrast, the 27(+/- 3) kDa/nm fibrils correspond to a MPL of similar to 1.5 X the protofibril and thus can neither arise from a simple conformational transition nor from lateral association of 19 kDa/nm protofibril precursors. Twisted ribbons with axial periodicities ranging from similar to 80 nm to 130 nm were prominent in the 27(+/- 3) kDa/nm group as well as more tightly coiled fibrils. Individual fibril ribbons had elongation rates of 20(+/- 12) nm/min when imaged by time-lapse atomic force microscopy. Protofibrils exhibited growth rates similar to 15 X slower at 1.3(+/- 0.5) nm/min. The data support a model where concurrent multiple assembly pathways give rise to the various polymorphic fibril types. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
RP Muller, SA (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM shirley.mueller@unibas.ch
CR Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X
   ALLEN MJ, 1992, ULTRAMICROSCOPY, V42, P1095, DOI 10.1016/0304-3991(92)90408-C
   Antzutkin ON, 2002, BIOCHEMISTRY-US, V41, P15436, DOI 10.1021/bi0204185
   Ban T, 2004, J MOL BIOL, V344, P757, DOI 10.1016/j.jmb.2004.09.078
   Ban T, 2003, J BIOL CHEM, V278, P16462, DOI 10.1074/jbc.C300049200
   Bieschke J, 2005, BIOCHEMISTRY-US, V44, P4977, DOI 10.1021/bi0501030
   Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699
   Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200
   Blackley HKL, 2000, J MOL BIOL, V298, P833, DOI 10.1006/jmbi.2000.3711
   De Strooper B, 1999, NATURE, V402, P471, DOI 10.1038/44973
   ENGEL A, 1985, J ULTRA MOL STRUCT R, V90, P323, DOI 10.1016/S0022-5320(85)80010-1
   Esler WP, 1996, BIOCHEMISTRY-US, V35, P749, DOI 10.1021/bi951685w
   Findeis MA, 1999, METHOD ENZYMOL, V309, P476
   Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury CS, 2000, J STRUCT BIOL, V130, P217, DOI 10.1006/jsbi.2000.4259
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2
   Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200
   Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149
   Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3
   Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999
   Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100
   Howlett DR, 1999, BIOCHEM J, V340, P283, DOI 10.1042/0264-6021:3400283
   IVERSEN LL, 1995, BIOCHEM J, V311, P1
   Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029
   Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5
   Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688
   Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448
   LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312
   LeVine H, 1999, METHOD ENZYMOL, V309, P467
   Lomakin A, 1997, P NATL ACAD SCI USA, V94, P7942, DOI 10.1073/pnas.94.15.7942
   MARKIEWICZ P, 1988, THESIS U TORONTO
   MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Murphy RM, 2000, J STRUCT BIOL, V130, P109, DOI 10.1006/jsbi.2000.4253
   Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r
   Nybo M, 1999, SCAND J IMMUNOL, V49, P219
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631
   Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124
   Selkoe DJ, 2001, PHYSIOL REV, V81, P741
   Soto C, 1998, NAT MED, V4, P822, DOI 10.1038/nm0798-822
   Stine WB, 1996, J PROTEIN CHEM, V15, P193, DOI 10.1007/BF01887400
   Takahashi RH, 2002, HISTOL HISTOPATHOL, V17, P239, DOI 10.14670/HH-17.239
   TERRY RD, 1964, AM J PATHOL, V44, P269
   VanNoort SJT, 1997, ULTRAMICROSCOPY, V69, P117, DOI 10.1016/S0304-3991(97)00037-5
   Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364
   Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945
   Walsh DM, 2002, BIOCHEM SOC T, V30, P552, DOI 10.1042/BST0300552
   Walsh DM, 2004, PROTEIN PEPTIDE LETT, V11, P213, DOI 10.2174/0929866043407174
   Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004
   Ward RV, 2000, BIOCHEM J, V348, P137, DOI 10.1042/0264-6021:3480137
   WILDHABER I, 1985, ULTRAMICROSCOPY, V16, P411, DOI 10.1016/0304-3991(85)90108-1
   Winkler DT, 2001, J NEUROSCI, V21, P1619
   Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4
NR 60
TC 222
Z9 225
U1 0
U2 29
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 16
PY 2005
VL 352
IS 2
BP 282
EP 298
DI 10.1016/j.jmb.2005.07.029
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 965AI
UT WOS:000231921700004
PM 16095615
DA 2021-01-25
ER

PT J
AU Reichert, H
AF Reichert, H
TI A tripartite organization of the urbilaterian brain: Developmental
   genetic evidence from Drosophila
SO BRAIN RESEARCH BULLETIN
LA English
DT Article; Proceedings Paper
CT 4th European Conference on Comparative Neurobiology
CY APR 15-17, 2004
CL St John Coll, Oxford, ENGLAND
HO St John Coll
DE tripartite organization; urbilaterian brain; Drosophila; brain
   development; Hox genes; Pax genes; Otx genes
ID INSIGHTS; MIDBRAIN; ORIGIN; HINDBRAIN; INSECTS; OTX2
AB Developmental genetic studies suggest that the embryonic vertebrate brain has a tripartite ground plan consisting of a forebrain/midbrain, a hindbrain, and an intervening midbrain/hindbrain boundary region, which are characterized by the specific expression of the Otx, Hox and Pax-2/5/8 genes. Recent studies in Drosophila reveal similarities in the expression and function of these genes in patterning the embryonic brains of flies and vertebrates. Thus, in Drosophila, as is vertebrates, a Pax2/5/8 domain is located between an anterior otd/Otx2 region and a posterior Hox region of the embryonic brain. Moreover, in Drosophila, as in vertebrates, this Pax2/5/8 domain is located at the interface of the otd/Otx2 domain and a posterior unplugged/Gbx2 domain. Furthermore, in Drosophila, as in vertebrates, inactivation of otd/Otx2 or of unplugged/Gbx2 results in a comparable mispositioning or loss of orthologous gene expression domains in the embryonic brain. These developmental genetic similarities suggest that the tripartite ground plan, which characterizes the developing vertebrate brain, is also at the basis of the developing insect brain. This, in turn, implies that a tripartite organization of the embryonic brain may characterize all extant bilaterians, and thus may already have been established in the last common urbilaterian ancestor of all bilaterians. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
CR Arendt D, 1999, DEVELOPMENT, V126, P2309
   Bruce AEE, 1998, DEV BIOL, V201, P101, DOI 10.1006/dbio.1998.8968
   Brusca R.C., 1990, INVERTEBRATES
   CHAING C, 1995, DEVELOPMENT, V121, P3901
   Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.0.CO;2-8
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3
   Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869
   Martinez-Barbera JP, 2001, DEVELOPMENT, V128, P4789
   Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1
   NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   Reichert H, 2002, INT J DEV BIOL, V46, P81
   Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9
   SIEWING R, 1985, LEHRBUCH ZOOLOGIE
   Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X
   Sprecher SG, 2003, ARTHROPOD STRUCT DEV, V32, P141, DOI 10.1016/S1467-8039(03)00007-0
   Wada H, 1998, DEVELOPMENT, V125, P1113
   Wada H, 2001, CURR OPIN NEUROBIOL, V11, P16, DOI 10.1016/S0959-4388(00)00168-9
   Wassarman KM, 1997, DEVELOPMENT, V124, P2923
   Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516
NR 21
TC 30
Z9 30
U1 3
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0361-9230
EI 1873-2747
J9 BRAIN RES BULL
JI Brain Res. Bull.
PD SEP 15
PY 2005
VL 66
IS 4-6
BP 491
EP 494
DI 10.1016/j.brainresbull.2004.11.028
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 971CW
UT WOS:000232359800039
PM 16144638
DA 2021-01-25
ER

PT J
AU De Colibus, L
   Li, M
   Binda, C
   Lustig, A
   Edmondson, DE
   Mattevi, A
AF De Colibus, L
   Li, M
   Binda, C
   Lustig, A
   Edmondson, DE
   Mattevi, A
TI Three-dimensional structure of human monoamine oxidase A (MAO A):
   Relation to the structures of rat MAO A and human MAO B
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE flavin; neurotransmitter; membrane protein; antidepressant target
ID HIGH-LEVEL EXPRESSION; POSITIVE SELECTION; INHIBITION; SUBSTRATE;
   DENSITY; MOLSCRIPT
AB The three-dimensional structure of recombinant human monoamine oxidase A (hMAO A) as its clorgyline-inhibited adduct is described. Although the chain-fold of hMAO A is similar to that of rat MAO A and human MAO B (hMAO 13), hMAO A is unique in that it crystallizes as a monomer and exhibits the solution hydrodynamic behavior of a monomeric form rather than the dimeric form of hMAO B and rat MAO A. hMAO A's active site consists of a single hydrophobic cavity of approximate to 550 angstrom(3), which is smaller than that determined from the structure of deprenyl-inhibited hMAO B (approximate to 700 angstrom(3)) but larger than that of rat MAO A (approximate to 450 angstrom(3)). An important component of the active site structure of hMAO A is the loop conformation of residues 210-216, which differs from that of hMAO B and rat MAO A. The origin of this structural alteration is suggested to result from long-range interactions in the monomeric form of the enzyme. In addition to serving as a basis for the development of hMAO A specific inhibitors, these data support the proposal that hMAO A involves a change from the dimeric to the monomeric form through a Glu-151 -> Lys mutation that is specific of hMAO A [Andres, A. M., Soldevila, M., Navarro, A., Kidd, K. K., Oliva, B. & Bertranpetit, J. (2004) Hum. Genet. 115, 377-386]. These considerations put into question the use of MAO A from nonhuman sources in drug development for use in humans.
C1 Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy.
   Emory Univ, Dept Biochem, Atlanta, GA 30322 USA.
   Emory Univ, Dept Chem, Atlanta, GA 30322 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Edmondson, DE (corresponding author), Univ Pavia, Dept Genet & Microbiol, Via Abbiategrasso 207, I-27100 Pavia, Italy.
EM deedmon@emory.edu; mattevi@ipvgen.unipv.it
RI mattevi, andrea/K-5464-2012; Mattevi, Andrea/R-4469-2019
OI mattevi, andrea/0000-0002-9523-7128; Mattevi,
   Andrea/0000-0002-9523-7128; Binda, Claudia/0000-0003-2038-9845
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM029433,
   R01GM029433, R01GM029433, R01GM029433, R01GM029433, R01GM029433,
   R01GM029433, R01GM029433, R01GM029433, R01GM029433, R01GM029433,
   R01GM029433, R01GM029433, R01GM029433, R01GM029433, R01GM029433,
   R01GM029433, R01GM029433, R01GM029433, R01GM029433, R01GM029433,
   R01GM029433, R01GM029433, R01GM029433, R01GM029433, R01GM029433,
   R01GM029433, R01GM029433, R01GM029433] Funding Source: NIH RePORTER;
   NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM-29433, R01 GM029433] Funding Source:
   Medline
CR Andres AM, 2004, HUM GENET, V115, P377, DOI 10.1007/s00439-004-1179-6
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515
   Binda C, 2002, J BIOL CHEM, V277, P23973, DOI 10.1074/jbc.R200005200
   Binda C, 2002, NAT STRUCT BIOL, V9, P22, DOI 10.1038/nsb732
   Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c
   Binda C, 2003, P NATL ACAD SCI USA, V100, P9750, DOI 10.1073/pnas.1633804100
   BRUNNER HG, 1993, AM J HUM GENET, V52, P1032
   Caspi A, 2002, SCIENCE, V297, P851, DOI 10.1126/science.1072290
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   Edmondson DE, 2004, CURR MED CHEM, V11, P1983, DOI 10.2174/0929867043364784
   Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363
   Geha RM, 2000, J NEUROCHEM, V75, P1304, DOI 10.1046/j.1471-4159.2000.751304.x
   Gilad Y, 2002, P NATL ACAD SCI USA, V99, P862, DOI 10.1073/pnas.022614799
   Hubalek F, 2005, J BIOL CHEM, V280, P15761, DOI 10.1074/jbc.M500949200
   Hubalek F, 2003, J BIOL CHEM, V278, P28612, DOI 10.1074/jbc.M303712200
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X
   Li M, 2002, PROTEIN EXPRES PURIF, V24, P152, DOI 10.1006/prep.2001.1546
   Lustig A, 2000, BBA-BIOMEMBRANES, V1464, P199, DOI 10.1016/S0005-2736(99)00254-0
   Ma JC, 2004, J MOL BIOL, V338, P103, DOI 10.1016/j.jmb.2004.02.032
   Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nandigama RK, 2002, BIOCHEM PHARMACOL, V63, P865, DOI 10.1016/S0006-2952(02)00840-7
   Newton-Vinson P, 2000, PROTEIN EXPRES PURIF, V20, P334, DOI 10.1006/prep.2000.1309
   Tsugeno Y, 1997, J BIOL CHEM, V272, P14033, DOI 10.1074/jbc.272.22.14033
   TSUGENO Y, 1995, J BIOCHEM-TOKYO, V118, P974, DOI 10.1093/jb/118.5.974
   WEYLER W, 1985, J BIOL CHEM, V260, P3199
   WU HF, 1993, MOL PHARMACOL, V43, P888
NR 32
TC 324
Z9 331
U1 2
U2 34
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 6
PY 2005
VL 102
IS 36
BP 12684
EP 12689
DI 10.1073/pnas.0505975102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 962FP
UT WOS:000231716700010
PM 16129825
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Wullschleger, S
   Loewith, R
   Oppliger, W
   Hall, MN
AF Wullschleger, S
   Loewith, R
   Oppliger, W
   Hall, MN
TI Molecular organization of target of rapamycin complex 2
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; ACTIN CYTOSKELETON; TRYPTOPHAN
   PERMEASE; BINDING PARTNER; MAMMALIAN TOR; YEAST; PATHWAY; NUTRIENT;
   RAPTOR
AB The target of rapamycin ( TOR), a highly conserved serine/ threonine kinase, plays a central role in the control of eukaryotic cell growth. TOR exists in two functionally and structurally distinct complexes, TOR complex 1 ( TORC1) and TOR complex 2 ( TORC2). TORC1 controls cell growth via a rapamycin- sensitive signaling branch regulating translation, transcription, nutrient uptake, ribosome biogenesis, and autophagy. TORC2 controls the organization of the actin cytoskeleton through a rapamycin- insensitive signaling branch and in yeast consists of the six proteins AVO1, AVO2, AVO3, BIT61, LST8, and TOR2. Here we have focused on the characterization of TORC2. Our studies suggest that TORC2 is oligomeric, likely a TORC2- TORC2 dimer. AVO1 and AVO3 bind cooperatively to the N- terminal HEAT repeat region in TOR2 and are required for TORC2 integrity. AVO2 is a nonessential peripheral protein associated with AVO1 and AVO3. LST8 binds separately to the C- terminal kinase domain region in TOR2 and appears to modulate both the integrity and kinase activity of TORC2. TORC2 autophosphorylates sites in AVO1 and AVO3, but TORC2 kinase activity is not required for TORC2 integrity. We have demonstrated that mammalian TOR is also oligomeric. The architecture of TORC2 is discussed in the context of TORC2 assembly and regulation.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
RI Loewith, Robbie/S-6289-2016
OI Loewith, Robbie/0000-0002-2482-603X; Hall, Michael N/0000-0002-2998-0757
CR Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531
   Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384
   Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0
   Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harris Thurl E, 2003, Sci STKE, V2003, pre15
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Heinisch JJ, 1999, MOL MICROBIOL, V32, P671, DOI 10.1046/j.1365-2958.1999.01375.x
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Liu ZC, 2001, EMBO J, V20, P7209, DOI 10.1093/emboj/20.24.7209
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith Robbie, 2004, VVolume 42, P139
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Martin DE, 2005, CURR OPIN CELL BIOL, V17, P158, DOI 10.1016/j.ceb.2005.02.008
   Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3
   Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Roberg KJ, 1997, GENETICS, V147, P1569
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
NR 36
TC 171
Z9 181
U1 0
U2 11
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 2
PY 2005
VL 280
IS 35
BP 30697
EP 30704
DI 10.1074/jbc.M505553200
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958ZX
UT WOS:000231487800008
PM 16002396
OA Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Christen, M
   Christen, B
   Folcher, M
   Schauerte, A
   Jenal, U
AF Christen, M
   Christen, B
   Folcher, M
   Schauerte, A
   Jenal, U
TI Identification and characterization of a cyclic di-GMP-specific
   phosphodiesterase and its allosteric control by GTP
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BACILLUS-SUBTILIS; STRINGENT
   RESPONSE; BIOFILM FORMATION; DIGUANYLATE; PROTEIN; GGDEF; SPORULATION;
   REGULATOR
AB Cyclic diguanylic acid (c-di-GMP) is a global second messenger controlling motility and adhesion in bacterial cells. Synthesis and degradation of c-di-GMP is catalyzed by diguanylate cyclases (DGC) and c-di-GMP-specific phosphodiesterases (PDE), respectively. Whereas the DGC activity has recently been assigned to the widespread GGDEF domain, the enzymatic activity responsible for c-di-GMP cleavage has been associated with proteins containing an EAL domain. Here we show biochemically that CC3396, a GGDEF-EAL composite protein from Caulobacter crescentus is a soluble PDE. The PDE activity, which rapidly converts c-di-GMP into the linear dinucleotide pGpG, is confined to the C-terminal EAL domain of CC3396, depends on the presence of Mg2+ ions, and is strongly inhibited by Ca2+ ions. Remarkably, the associated GGDEF domain, which contains an altered active site motif (GEDEF), lacks detectable DGC activity. Instead, this domain is able to bind GTP and in response activates the PDE activity in the neighboring EAL domain. PDE activation is specific for GTP (K-D 4 mu M) and operates by lowering the K-m for c-di-GMP of the EAL domain to a physiologically significant level (420 nM). Mutational analysis suggested that the substrate-binding site (A-site) of the GGDEF domain is involved in the GTP-dependent regulatory function, arguing that a catalytically inactive GGDEF domain has retained the ability to bind GTP and in response can activate the neighboring EAL domain. Based on this we propose that the c-di-GMP-specific PDE activity is confined to the EAL domain, that GGDEF domains can either catalyze the formation of c-di-GMP or can serve as regulatory domains, and that c-di-GMP-specific phosphodiesterase activity is coupled to the cellular GTP level in bacteria.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Christen, Beat/AAC-2974-2021
OI Christen, Matthias/0000-0001-7724-4562; Christen,
   Beat/0000-0002-9528-3685
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Bergara F, 2003, J BACTERIOL, V185, P3118, DOI 10.1128/JB.185.10.3118-3126.2003
   BOCHNER BR, 1982, J BIOL CHEM, V257, P9759
   Bomchil N, 2003, J BACTERIOL, V185, P1384, DOI 10.1128/JB.185.4.1384-1390.2003
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   CHIAVEROTTI TA, 1981, J BACTERIOL, V145, P1463, DOI 10.1128/JB.145.3.1463-1465.1981
   Choy WK, 2004, J BACTERIOL, V186, P7221, DOI 10.1128/JB.186.21.7221-7228.2004
   Conti M, 2000, PROG NUCLEIC ACID RE, V63, P1
   Corbin JD, 1999, J BIOL CHEM, V274, P13729, DOI 10.1074/jbc.274.20.13729
   D'Argenio DA, 2004, MICROBIOL-SGM, V150, P2497, DOI 10.1099/mic.0.27099-0
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555
   FREESE E, 1979, J GEN MICROBIOL, V115, P193, DOI 10.1099/00221287-115-1-193
   Galperin Michael Y., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P303
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Galperin MY, 2004, ENVIRON MICROBIOL, V6, P543, DOI 10.1111/j.1462-2920.2004.00652.x
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x
   Guvener ZT, 2003, J BACTERIOL, V185, P5431, DOI 10.1128/JB.185.18.5431-5441.2003
   Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Johnson MR, 2005, MOL MICROBIOL, V55, P664, DOI 10.1111/j.1365-2958.2004.04419.x
   Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002
   Kirillina O, 2004, MOL MICROBIOL, V54, P75, DOI 10.1111/j.1365-2958.2004.04253.x
   LOPEZ JM, 1979, BIOCHIM BIOPHYS ACTA, V587, P238, DOI 10.1016/0304-4165(79)90357-X
   Lucas KA, 2000, PHARMACOL REV, V52, P375
   OCHI K, 1987, J BACTERIOL, V169, P3608, DOI 10.1128/jb.169.8.3608-3616.1987
   OCHI K, 1982, J BACTERIOL, V151, P1062, DOI 10.1128/JB.151.2.1062-1065.1982
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Ratnayake-Lecamwasam M, 2001, GENE DEV, V15, P1093, DOI 10.1101/gad.874201
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Spiers AJ, 2002, GENETICS, V161, P33
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Thomas C, 2004, MICROBIOL-SGM, V150, P1031, DOI 10.1099/mic.0.26915-0
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7
NR 41
TC 327
Z9 338
U1 1
U2 48
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD SEP 2
PY 2005
VL 280
IS 35
BP 30829
EP 30837
DI 10.1074/jbc.M504429200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 958ZX
UT WOS:000231487800023
PM 15994307
OA Bronze
DA 2021-01-25
ER

PT J
AU Schirmer, T
   Hoffimann-Sommergrube, K
   Susani, M
   Breiteneder, H
   Markovic-Housley, Z
AF Schirmer, T
   Hoffimann-Sommergrube, K
   Susani, M
   Breiteneder, H
   Markovic-Housley, Z
TI Crystal structure of the major celery allergen Api g 1: Molecular
   analysis of cross-reactivity
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE major celery allergen; Api g 1; crystal structure; IgE-binding;
   cross-reactive epitopes
ID BIRCH POLLEN ALLERGEN; BET V 1; IGE-BINDING; APIUM-GRAVEOLENS; EPITOPE
   ANALYSIS; POTENTIAL USE; X-RAY; PROTEIN; BET-V-1; SENSITIZATION
AB Many patients who have been sensitised to pollen, display allergic symptoms after ingestion of certain plant food such as fresh fruit, vegetables and nuts. The cause is the cross-reactivity between structurally very similar major plant allergens. In particular, allergy to celery is very frequently associated with birch and mugwort pollen sensitization, known as to the birch-mugwort-celery syndrome. The crystal structure of the major celery allergen Api g 1, a homologue of the major birch pollen allergen Bet v 1, has been determined to a resolution of 2.9 angstrom. The structure of Api g 1 is very similar to that of Bet v 1 with major differences occurring in the segment comprised of residues 23-45, preceding the well conserved glycine-rich P-loop, as well as in loops beta 3-beta 4 and beta 5-beta 6. In particular, Api g I lacks E45, which has been shown to be a crucial residue for antibody recognition in the crystal complex of Bet v I with the Fab fragment of a murine monoclonal IgG (BV16) antibody. The absence of E45 and the structural differences in the preceding segment suggest that this region of the Api g 1 surface is probably not responsible for the observed cross-reactivity with Bet v 1. A detailed analysis of the molecular surface in combination with sequence alignment revealed three conserved surface patches which may account for cross-reactivity with Bet v 1. Several residues of Bet v 1 which have been shown by mutagenesis studies to be involved in IgE recognition belong to these conserved surface regions. The structure of Api g I and the related epitope analysis provides a molecular basis for a better understanding of allergen cross-reactivity and may lead to the development of hypoallergens which would allow a safer immunotherapy. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria.
   Dept Pathophysiol Biomay, A-1030 Vienna, Austria.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
OI Hoffmann-Sommergruber, Karin/0000-0002-8830-058X
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Ballmer-Weber BK, 2000, J ALLERGY CLIN IMMUN, V106, P373, DOI 10.1067/mai.2000.107196
   Ballmer-Weber BK, 2002, ALLERGY, V57, P228, DOI 10.1034/j.1398-9995.2002.1o3319.x
   Bauer L, 1996, CLIN EXP ALLERGY, V26, P1161, DOI 10.1111/j.1365-2222.1996.tb00503.x
   Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6
   Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321
   BRADEN BC, 1995, FASEB J, V9, P9
   BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x
   BREITENEDER H, 1989, EMBO J, V8, P1935, DOI 10.1002/j.1460-2075.1989.tb03597.x
   EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X
   Ferreira F, 1998, FASEB J, V12, P231
   Ferreira F, 2000, J ALLERGY CLIN IMMUN, V105, pS137, DOI 10.1016/S0091-6749(00)90842-X
   Ferreira F, 1996, J EXP MED, V183, P599, DOI 10.1084/jem.183.2.599
   Fritsch R, 1997, CLIN REV ALLERG IMMU, V15, P397, DOI 10.1007/BF02737735
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hoffmann-Sommergruber K, 2000, INT ARCH ALLERGY IMM, V122, P115, DOI 10.1159/000024367
   Hoffmann-Sommergruber K, 1999, CLIN EXP ALLERGY, V29, P840, DOI 10.1046/j.1365-2222.1999.00529.x
   Holm J, 2004, J IMMUNOL, V173, P5258, DOI 10.4049/jimmunol.173.8.5258
   HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4
   Jankiewicz A, 1996, INT ARCH ALLERGY IMM, V111, P268, DOI 10.1159/000237377
   Jensen-Jarolim E, 1998, FASEB J, V12, P1635
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   LESLIE AGW, 1992, JOINT CCP4 ESF EACBM
   Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057
   Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200
   PAULI G, 1988, ANN ALLERGY, V60, P243
   Scheurer S, 1999, MOL IMMUNOL, V36, P155, DOI 10.1016/S0161-5890(99)00033-4
   Son S. H., 1999, J PLANT BIOTECHNOL, V1, P1
   Spangfort MD, 2003, J IMMUNOL, V171, P3084, DOI 10.4049/jimmunol.171.6.3084
   Valenta R, 1996, J ALLERGY CLIN IMMUN, V97, P893, DOI 10.1016/S0091-6749(96)80062-5
   Wuthrich B, 1997, ALLERGY, V52, P1187, DOI 10.1111/j.1398-9995.1997.tb02522.x
   WUTHRICH B, 1990, ALLERGY, V45, P566, DOI 10.1111/j.1398-9995.1990.tb00941.x
NR 37
TC 62
Z9 65
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 2
PY 2005
VL 351
IS 5
BP 1101
EP 1109
DI 10.1016/j.jmb.2005.06.054
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 959LN
UT WOS:000231519300014
PM 16051263
DA 2021-01-25
ER

PT J
AU Walz, D
   Caplan, SR
AF Walz, D
   Caplan, SR
TI A kinetic and Stochastic analysis of crossbridge-type stepping
   mechanisms in rotary molecular motors
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID BACTERIAL FLAGELLAR MOTOR; TORQUE-GENERATING UNITS; SINGLE
   ACTIN-FILAMENTS; ESCHERICHIA-COLI; SYNTHASE; SUBUNIT
AB The bacterial flagellar motor is generally supposed to be a stepping mechanism. The main evidence for this is based on a fluctuation analysis of experiments with tethered bacteria in which rotation frequency was varied by applying an external torque: the variance in time taken for a fixed number of revolutions was found to be essentially proportional to the inverse square of the frequency. This behavior was shown to characterize a Poissonian stepper. Here we present a rigorous kinetic and stochastic analysis of elastic crossbridge stepping in tethered bacteria. We demonstrate that Poissonian stepping is a virtually unachievable limit. To the extent that a system may approach Poissonian stepping it cannot be influenced by an externally applied torque; stepping mechanisms capable of being so influenced are necessarily non-Poissonian and exhibit an approximately inverse cubic dependence. This conclusion applies whatever the torsional characteristics of the tether may be, and contrary to claims, no perceptible relaxation of the tether following each step is found. Furthermore, the inverse square dependence is a necessary but not sufficient condition for Poissonian stepping, since a nonstepping mechanism, which closely reproduces most experimental data, also fulfills this condition. Hence the inference that crossbridge-type stepping occurs is not justified.
C1 Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
   Univ Basel, Biozentrum, Basel, Switzerland.
   McGill Univ, Dept Physiol, Montreal, PQ, Canada.
RP Caplan, SR (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.
EM caplan@weizmann.ac.il
CR Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737
   BERG HC, 1993, BIOPHYS J, V65, P2201, DOI 10.1016/S0006-3495(93)81278-5
   BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0
   Borsch M, 2002, FEBS LETT, V527, P147, DOI 10.1016/S0014-5793(02)03198-8
   Braun TF, 2001, BIOCHEMISTRY-US, V40, P13051, DOI 10.1021/bi011264g
   GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008
   Goldman R., 1976, CELL MOTILITY, P47
   Hill T., 1977, FREE ENERGY TRANSDUC
   KOJIMA H, 1994, P NATL ACAD SCI USA, V91, P12962, DOI 10.1073/pnas.91.26.12962
   Noji H, 2001, J BIOL CHEM, V276, P1665, DOI 10.1074/jbc.R000021200
   Panke O, 2000, FEBS LETT, V472, P34, DOI 10.1016/S0014-5793(00)01436-8
   Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233
   SAMUEL ADT, 1995, P NATL ACAD SCI USA, V92, P3502, DOI 10.1073/pnas.92.8.3502
   Samuel ADT, 1996, BIOPHYS J, V71, P918, DOI 10.1016/S0006-3495(96)79295-0
   Sato K, 2000, J BIOL CHEM, V275, P5718, DOI 10.1074/jbc.275.8.5718
   Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937
   Walz D, 2000, BIOPHYS J, V78, P626, DOI 10.1016/S0006-3495(00)76622-7
   Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7
NR 18
TC 3
Z9 3
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD SEP
PY 2005
VL 89
IS 3
BP 1650
EP 1656
DI 10.1529/biophysj.105.060095
PG 7
WC Biophysics
SC Biophysics
GA 959FL
UT WOS:000231502800022
PM 16006631
OA Green Published
DA 2021-01-25
ER

PT J
AU Collart, C
   Remacle, JE
   Barabino, S
   van Grunsven, LA
   Nelles, L
   Schellens, A
   Van de Putte, T
   Pype, S
   Huylebroeck, D
   Verschueren, K
AF Collart, C
   Remacle, JE
   Barabino, S
   van Grunsven, LA
   Nelles, L
   Schellens, A
   Van de Putte, T
   Pype, S
   Huylebroeck, D
   Verschueren, K
TI Smicl is a novel Smad interacting protein and cleavage and
   polyadenylation specificity factor associated protein
SO GENES TO CELLS
LA English
DT Article
ID GROWTH-FACTOR-BETA; SERINE/THREONINE KINASE RECEPTORS; ZINC-FINGER
   PROTEINS; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTIONAL ACTIVATION;
   BIOLOGICAL-ACTIVITY; BINDING; FAMILY; RNA; REPRESSOR
AB Ligand-bound receptors of the Transforming Growth Factor-beta (TGF-beta) family promote the formation of complexes between Smad proteins that subsequently accumulate in the nucleus and interact there with other transcriptional regulators, leading to modulation of target gene expression. We identified a novel nuclear protein, Smicl, which binds to Smad proteins. Smicl and Smads cooperate and enhance TGF-beta mediated activation of a Smad-responsive reporter gene. A domain with five CCCH-type zinc fingers in Smicl is structurally and functionally, at least in vitro, similar to a domain in CPSF-30, the 30 kDa subunit of Cleavage and Polyadenylation Specificity Factor (CPSF). Like CPSF-30, Smicl can associate with some other CPSF subunits characterized previously. Its effect on the induction of a reporter gene for TGF-beta requires the cleavage/polyadenylation signal downstream of the coding sequence of that gene. Thus, Smicl is a novel protein that displays CPSF-30-like activities, interacts in the nucleus with activated Smads, and potentiates in TGF-beta stimulated cells Smad-dependent transcriptional responses, possibly in conjunction with the activity of CPSF complexes.
C1 Univ Leuven VIB, Dept Dev Biol, B-3000 Louvain, Belgium.
   Univ Leuven, Lab Mol Biol Celgen, B-3000 Louvain, Belgium.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Verschueren, K (corresponding author), Univ Leuven VIB, Dept Dev Biol, B-3000 Louvain, Belgium.
EM kristin@med.kuleuven.ac.be
RI van Grunsven, Leo/E-5839-2010
OI van Grunsven, Leo/0000-0002-0990-7034; Huylebroeck,
   Danny/0000-0003-4862-1079
CR Bai CY, 1996, MOL CELL BIOL, V16, P6661
   Bai CY, 1998, NUCLEIC ACIDS RES, V26, P1597, DOI 10.1093/nar/26.7.1597
   Barabino SML, 2000, EMBO J, V19, P3778, DOI 10.1093/emboj/19.14.3778
   Barabino SML, 1997, GENE DEV, V11, P1703, DOI 10.1101/gad.11.13.1703
   Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X
   GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425
   Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7
   JENNY A, 1994, MOL CELL BIOL, V14, P8183, DOI 10.1128/MCB.14.12.8183
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145
   Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026
   Kretzschmar M, 1997, GENE DEV, V11, P984, DOI 10.1101/gad.11.8.984
   Liu SG, 1997, EXP NEPHROL, V5, P295
   Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745
   Massague J, 1996, CANCER SURV, V27, P41
   Meersseman G, 1997, MECH DEVELOP, V61, P127, DOI 10.1016/S0925-4773(96)00629-6
   Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0
   Murakami S, 1997, ENDOCRINOLOGY, V138, P1972, DOI 10.1210/en.138.5.1972
   Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353
   Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200
   Remacle JE, 1999, EMBO J, V18, P5073, DOI 10.1093/emboj/18.18.5073
   RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311
   SEKIDO R, 1994, MOL CELL BIOL, V14, P5692, DOI 10.1128/MCB.14.9.5692
   tenDijke P, 1996, CURR OPIN CELL BIOL, V8, P139
   Tylzanowski P, 2001, J BIOL CHEM, V276, P40001, DOI 10.1074/jbc.M104112200
   Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489
   Wuytens G, 1999, J BIOL CHEM, V274, P9821, DOI 10.1074/jbc.274.14.9821
   Zhang MC, 1999, MOL CELL BIOL, V19, P7314
NR 28
TC 12
Z9 18
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1356-9597
EI 1365-2443
J9 GENES CELLS
JI Genes Cells
PD SEP
PY 2005
VL 10
IS 9
BP 897
EP 906
DI 10.1111/j.1365-2443.2005.00887.x
PG 10
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 957TK
UT WOS:000231396000004
PM 16115198
OA Bronze
DA 2021-01-25
ER

PT J
AU Lindroos, HL
   Mira, A
   Repsilber, D
   Vinnere, O
   Naslund, K
   Dehio, M
   Dehio, C
   Andersson, SGE
AF Lindroos, HL
   Mira, A
   Repsilber, D
   Vinnere, O
   Naslund, K
   Dehio, M
   Dehio, C
   Andersson, SGE
TI Characterization of the genome composition of Bartonella koehlerae by
   microarray comparative genomic hybridization profiling
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID PATHOGENICITY ISLANDS; EVOLUTIONARY GENOMICS; DNA-MICROARRAY; GENES;
   VIRULENCE; SEQUENCE; HENSELAE; SYSTEM; SALMONELLA; QUINTANA
AB Bartonella henselae is present in a wide range of wild and domestic feline hosts and causes cat-scratch disease and bacillary angiomatosis in humans. We have estimated here the gene content of Bartonella koehlerae, a novel species isolated from cats that was recently identified as an agent of human endocarditis. The investigation was accomplished by comparative genomic hybridization (CGH) to a microarray constructed from the sequenced 1.93-Mb genome of B. henselae. Control hybridizations of labeled DNA from the human pathogen Bartonella quintana with a reduced genome of 1.58 Mb were performed to evaluate the accuracy of the array for genes with known levels of sequence divergence. Genome size estimates of B. koehlerae by pulsed-field gel electrophoresis matched that calculated by the CGH, indicating a genome of 1.7 to 1.8 Mb with few unique genes. As in B. quintana, sequences in the prophage and the genomic islands were reported absent in B. koehlerae. In addition, sequence variability was recorded in the chromosome II-like region, where B. koehlerae showed an intermediate retention pattern of both coding and noncoding sequences. Although most of the genes missing in B. koehlerae are also absent from B. quintana, its phylogenetic placement near B. henselae suggests independent deletion events, indicating that host specificity is not solely attributed to genes in the genomic islands. Rather, the results underscore the instability of the genomic islands even within bacterial populations adapted to the same host-vector system, as in the case of B. henselae and B. koehlerae.
C1 Uppsala Univ, Dept Mol Evolut, Evolut Biol Ctr, S-75236 Uppsala, Sweden.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4003 Basel, Switzerland.
RP Andersson, SGE (corresponding author), Uppsala Univ, Dept Mol Evolut, Evolut Biol Ctr, Norbyvagen 18C, S-75236 Uppsala, Sweden.
EM Siv.Andersson@ebc.uu.se
RI Mira, Alex/A-7244-2010; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amiri H, 2003, MOL BIOL EVOL, V20, P1575, DOI 10.1093/molbev/msg175
   Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208
   Andersson JO, 2001, MOL BIOL EVOL, V18, P829, DOI 10.1093/oxfordjournals.molbev.a003864
   Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094
   Avidor B, 2004, J CLIN MICROBIOL, V42, P3462, DOI 10.1128/JCM.42.8.3462-3468.2004
   Bloomfield GA, 1997, MICROBIOL-UK, V143, P553, DOI 10.1099/00221287-143-2-553
   Brunelle BW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r42
   Cornillot E, 1997, J BACTERIOL, V179, P7426, DOI 10.1128/jb.179.23.7426-7434.1997
   Cummings CA, 2004, J BACTERIOL, V186, P1484, DOI 10.1128/JB.186.5.1484-1492.2004
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003
   Dobrindt U, 2004, NAT REV MICROBIOL, V2, P414, DOI 10.1038/nrmicro884
   Dong YM, 2001, APPL ENVIRON MICROB, V67, P1911, DOI 10.1128/AEM.67.4.1911-1921.2001
   Droz S, 1999, J CLIN MICROBIOL, V37, P1117, DOI 10.1128/JCM.37.4.1117-1122.1999
   Dziejman M, 2002, P NATL ACAD SCI USA, V99, P1556, DOI 10.1073/pnas.042667999
   Evertsz EM, 2001, BIOTECHNIQUES, V31, P1182, DOI 10.2144/01315dd03
   Gundi VAKB, 2004, J CLIN MICROBIOL, V42, P3816, DOI 10.1128/JCM.42.8.3816-3818.2004
   Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2
   Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x
   Hakenbeck R, 2001, INFECT IMMUN, V69, P2477, DOI 10.1128/IAI.69.4.2477-2486.2001
   Hinchliffe SJ, 2003, GENOME RES, V13, P2018, DOI 10.1101/gr.1507303
   Houpikian P, 2001, FEMS MICROBIOL LETT, V200, P1, DOI 10.1111/j.1574-6968.2001.tb10684.x
   Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698
   Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002
   Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4
   Leung YF, 2003, TRENDS GENET, V19, P649, DOI 10.1016/j.tig.2003.09.015
   Marokhazi J, 2003, J BACTERIOL, V185, P4648, DOI 10.1128/JB.185.15.4648-4656.2003
   Maruyama S, 2001, VET MICROBIOL, V79, P337, DOI 10.1016/S0378-1135(00)00365-5
   Maurelli AT, 1998, P NATL ACAD SCI USA, V95, P3943, DOI 10.1073/pnas.95.7.3943
   NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4
   Ogata H, 2001, SCIENCE, V293, P2093, DOI 10.1126/science.1061471
   Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227
   Porwollik S, 2002, P NATL ACAD SCI USA, V99, P8956, DOI 10.1073/pnas.122153699
   Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032
   Raddatz G, 2001, BIOINFORMATICS, V17, P98, DOI 10.1093/bioinformatics/17.1.98
   Rajashekara G, 2004, J BACTERIOL, V186, P5040, DOI 10.1128/jb.186.15.5040-5051.2004
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Rolain JM, 2003, J CLIN MICROBIOL, V41, P4001, DOI 10.1128/JCM.41.8.4001-4002.2003
   Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278
   Rozen S., 1998, PRIMER3
   Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100
   Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396
   Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003
   Wei J, 2003, INFECT IMMUN, V71, P4223, DOI 10.1128/IAI.71.7.4223.2003
   Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100
   Wu LY, 2001, APPL ENVIRON MICROB, V67, P5780, DOI 10.1128/AEM.67.12.5780-5790.2001
   Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P3641, DOI 10.1128/JCM.40.10.3641-3647.2002
   Zhang CM, 2003, J BACTERIOL, V185, P5573, DOI 10.1128/JB.185.18.5573-5584.2003
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
NR 57
TC 24
Z9 28
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD SEP
PY 2005
VL 187
IS 17
BP 6155
EP 6165
DI 10.1128/JB.187.17.6155-6165.2005
PG 11
WC Microbiology
SC Microbiology
GA 957XF
UT WOS:000231406000032
PM 16109957
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, W. J.
TI Decyphering the eye developmental program and its evolutionary
   implications
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
C1 [Gehring, W. J.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD SEP
PY 2005
VL 122
SU 1
BP S9
EP S9
PG 1
WC Developmental Biology
SC Developmental Biology
GA V11IA
UT WOS:000207524100032
DA 2021-01-25
ER

PT J
AU Kurata, S
   Katsuyama, T
   Sugawara, T
   Tatsumi, M
   Oshima, Y
   Gehring, WJ
   Aigaki, T
AF Kurata, S.
   Katsuyama, T.
   Sugawara, T.
   Tatsumi, M.
   Oshima, Y.
   Gehring, W. J.
   Aigaki, T.
TI Context-dependent involvement of winged eye encoding a
   chromatin-associated bromo-adjacent homology domain protein in
   Drosophila disc specification
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
C1 [Kurata, S.; Katsuyama, T.; Sugawara, T.; Tatsumi, M.; Oshima, Y.] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi 980, Japan.
   [Gehring, W. J.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Aigaki, T.] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD SEP
PY 2005
VL 122
SU 1
BP S51
EP S51
PG 1
WC Developmental Biology
SC Developmental Biology
GA V11IA
UT WOS:000207524100187
DA 2021-01-25
ER

PT J
AU Michaut, L
   Gehring, WJ
AF Michaut, L.
   Gehring, W. J.
TI Evolutionary comparison of mouse and drosophila eye developmental
   cascades
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
C1 [Michaut, L.; Gehring, W. J.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD SEP
PY 2005
VL 122
SU 1
BP S149
EP S149
PG 1
WC Developmental Biology
SC Developmental Biology
GA V11IA
UT WOS:000207524100562
DA 2021-01-25
ER

PT J
AU Agrain, C
   Sorg, I
   Paroz, C
   Cornelis, GR
AF Agrain, C
   Sorg, I
   Paroz, C
   Cornelis, GR
TI Secretion of YscP from Yersinia enterocolitica is essential to control
   the length of the injectisome needle but not to change the type III
   secretion substrate specificity
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID MESSENGER-RNA SIGNAL; FLAGELLAR HOOK; SALMONELLA-TYPHIMURIUM; YOP
   SECRETION; MOLECULAR CHARACTERIZATION; BACTERIAL INJECTISOMES;
   SHIGELLA-FLEXNERI; ADENYLATE-CYCLASE; EUKARYOTIC CELLS; PROTEIN
AB The length of the needle of the Yersinia Ysc injectisome is determined by a protein called YscP. This protein, which acts both as a molecular ruler and as a substrate-specificity switch for type III secretion is itself secreted by the injectisome. In this report, we address the question why YscP is secreted. By a systematic deletion analysis and by fusing different parts of the molecule to the adenylate cyclase reporter, we identified two independent secretion signals. One of them is encompassed within the 35 N-terminal residues while the second one spans residues 97-137. These two signals are functionally different from Yop secretion signals. When both secretion signals were removed, Yops could still be secreted but the needle length control was lost. YscP possessing only one signal did not control needle length properly but the control was improved when more YscP was produced and secreted. YscP deprived of both signals could not control length, even when overproduced. We conclude from this that YscP needs to be secreted to exert its length control function but not its substrate-specificity switch function.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1016/S0378-1097(01)00301-9
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Anderson DM, 1999, MOL MICROBIOL, V31, P1139, DOI 10.1046/j.1365-2958.1999.01254.x
   Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   EMERSON SU, 1970, SCIENCE, V169, P190, DOI 10.1126/science.169.3941.190
   Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x
   Hirano T, 2003, J BACTERIOL, V185, P2485, DOI 10.1128/JB.185.8.2485-2492.2003
   Hirano T, 2005, MOL MICROBIOL, V56, P346, DOI 10.1111/j.1365-2958.2005.04615.x
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   IINO T, 1969, J GEN MICROBIOL, V56, P227, DOI 10.1099/00221287-56-2-227
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Kutsukake K, 1997, J BACTERIOL, V179, P1268, DOI 10.1128/jb.179.4.1268-1273.1997
   LADANT D, 1989, J BIOL CHEM, V264, P4015
   Lavander M, 2003, ADV EXP MED BIOL, V529, P109
   Lloyd SA, 2002, MOL MICROBIOL, V43, P51, DOI 10.1046/j.1365-2958.2002.02738.x
   Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Minamino T, 2005, MOL MICROBIOL, V56, P303, DOI 10.1111/j.1365-2958.2005.04611.x
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x
   Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014
   Ramamurthi KS, 2003, MOL MICROBIOL, V50, P1095, DOI 10.1046/j.1365-2958.2003.03777.x
   Russmann H, 2002, MOL MICROBIOL, V46, P769, DOI 10.1046/j.1365-2958.2002.03196.x
   Schesser K, 1996, J BACTERIOL, V178, P7227, DOI 10.1128/jb.178.24.7227-7233.1996
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   SUZUKI T, 1981, J BACTERIOL, V148, P973, DOI 10.1128/JB.148.3.973-979.1981
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
NR 50
TC 39
Z9 41
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD SEP
PY 2005
VL 57
IS 5
BP 1415
EP 1427
DI 10.1111/j.1365-2958.2005.04758.x
PG 13
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 952QW
UT WOS:000231021600017
PM 16102009
DA 2021-01-25
ER

PT J
AU Haberl, M
   Anwald, B
   Klein, K
   Weil, R
   Fuss, C
   Gepdiremen, A
   Zanger, UM
   Meyer, UA
   Wojnowski, L
AF Haberl, M
   Anwald, B
   Klein, K
   Weil, R
   Fuss, C
   Gepdiremen, A
   Zanger, UM
   Meyer, UA
   Wojnowski, L
TI Three haplotypes associated with CYP2A6 phenotypes in Caucasians
SO PHARMACOGENETICS AND GENOMICS
LA English
DT Article
DE cytochrome P450; CYP2A6; genetic polymorphism; haplotype;
   pharmacogenetics
ID SINGLE NUCLEOTIDE POLYMORPHISM; HUMAN LIVER; GENE DELETION;
   CYTOCHROME-P450 2A6; IN-VIVO;
   (+)-CIS-3,5-DIMETHYL-2-(3-PYRIDYL)THIAZOLIDIN-4-ONE HYDROCHLORIDE;
   COUMARIN 7-HYDROXYLATION; NICOTINE METABOLISM; ALLELE; IDENTIFICATION
AB The human cytochrome P450 2A6 (CYP2A6) enzyme metabolizes several xenobiotic compounds of clinical or toxicological importance. We aimed to identify genetic variants and major CYP2A6 haplotypes associated with CYP2A6 phenotypic variation. CYP2A6 mRNA level, protein level, activity and haplotypes were determined in Caucasian liver samples via real-time polymerase chain reaction, Western blot, coumarin 7-hydroxylation, DNA sequencing and genotyping, respectively. Phenotypes were then analyzed for associations with haplotypes. CYP2A6 transcript, protein and activity levels were correlated among each other. In 45 African-American, 156 Caucasian, 47 Chinese, 50 Japanese and 47 Korean DNA samples, we detected 95 different polymorphisms in the CYP2A6 gene, 49 of which had not been described previously. Caucasian variants formed 33 haplotypes which built four clades. Allele *9B and the CYP2A7/2A6 partial deletion allele CYP2A6*12B were both associated with decreased expression. The latter haplotype extends at least over 147 kb up into the CYP2B6 gene. A haplotype almost identical to allele *1A was associated with decreased expression and activity of CYP2A6 compared to all other haplotypes. In summary A CYP2A6* 1A-like allele, *9B and * 12B are major genetic determinants of CYP2A6 phenotype variation in Caucasians.
C1 EPIDAUROS Biotechnol AG, D-82347 Bernried, Germany.
   Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany.
   Ondokuz Mayis Univ, Dept Pharmacol, Samsun, Turkey.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
   Johannes Gutenberg Univ Mainz, Dept Pharmacol, D-6500 Mainz, Germany.
RP Haberl, M (corresponding author), EPIDAUROS Biotechnol AG, Neuland 1, D-82347 Bernried, Germany.
EM michael.haberl@epidauros.com
RI Zanger, Ulrich M./A-9364-2012
OI Zanger, Ulrich M./0000-0002-5276-2002
CR Agundez JAG, 2004, CURR DRUG METAB, V5, P211, DOI 10.2174/1389200043335621
   Ariyoshi N, 2004, PHARMACOGENETICS, V14, P701, DOI 10.1097/00008571-200410000-00008
   Ariyoshi N, 2002, PHARMACOGENETICS, V12, P501, DOI 10.1097/00008571-200208000-00012
   Ariyoshi N, 2001, BIOCHEM BIOPH RES CO, V281, P810, DOI 10.1006/bbrc.2001.4422
   Ariyoshi N, 2000, PHARMACOGENETICS, V10, P687, DOI 10.1097/00008571-200011000-00003
   Christian K, 2004, MOL PHARMACOL, V65, P1405, DOI 10.1124/mol.65.6.1405
   Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x
   Daigo S, 2002, PHARMACOGENETICS, V12, P299, DOI 10.1097/00008571-200206000-00005
   Draper AJ, 1997, ARCH BIOCHEM BIOPHYS, V341, P47, DOI 10.1006/abbi.1997.9964
   DUNNEN JT, 2001, HUM GENET, V109, P121
   FERNANDEZSALGUERO P, 1995, AM J HUM GENET, V57, P651
   Fukami T, 2004, CLIN PHARMACOL THER, V76, P519, DOI 10.1016/j.clpt.2004.08.014
   GUIDA M, 2001, Patent No. 194633
   Hadidi H, 1997, FOOD CHEM TOXICOL, V35, P903, DOI 10.1016/S0278-6915(97)00066-5
   Kitagawa K, 2001, J BIOL CHEM, V276, P17830, DOI 10.1074/jbc.M009432200
   Kiyotani Kazuma, 2002, Drug Metab Pharmacokinet, V17, P482, DOI 10.2133/dmpk.17.482
   Kiyotani Kazuma, 2003, Pharmacogenetics, V13, P689, DOI 10.1097/00008571-200311000-00005
   Koch I, 2002, DRUG METAB DISPOS, V30, P1108, DOI 10.1124/dmd.30.10.1108
   Koskela S, 1999, BIOCHEM PHARMACOL, V57, P1407, DOI 10.1016/S0006-2952(99)00015-5
   Kwon JT, 2001, PHARMACOGENETICS, V11, P317, DOI 10.1097/00008571-200106000-00006
   Lewis DFV, 2003, TOXICOL IN VITRO, V17, P179, DOI 10.1016/S0887-2333(02)00132-7
   LONDON SJ, 1999, J MEMBRANE BIOL, V167, P103
   Loriot MA, 2001, PHARMACOGENETICS, V11, P39, DOI 10.1097/00008571-200102000-00005
   MAURICE M, 1991, EUR J BIOCHEM, V200, P511, DOI 10.1111/j.1432-1033.1991.tb16212.x
   Meunier V, 2000, XENOBIOTICA, V30, P589, DOI 10.1080/004982500406426
   Miyamoto M, 1999, BIOCHEM BIOPH RES CO, V261, P658, DOI 10.1006/bbrc.1999.1089
   NAKAJIMA, 2001, CLIN PHARMACOL THER, V69, P73
   Nakajima M, 1996, J PHARMACOL EXP THER, V277, P1010
   Nakajima M, 2004, FEBS LETT, V569, P75, DOI 10.1016/j.febslet.2004.05.053
   Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212
   Nebert DW, 2002, HUM MUTAT, V20, P463, DOI 10.1002/humu.10143
   Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509
   Nunoya K, 1999, J PHARMACOL EXP THER, V289, P437
   Nunoya K, 1999, J BIOCHEM-TOKYO, V126, P402, DOI 10.1093/oxfordjournals.jbchem.a022464
   Nunoya K, 1998, PHARMACOGENETICS, V8, P239, DOI 10.1097/00008571-199806000-00006
   Nunoya KI, 1996, J PHARMACOL EXP THER, V277, P768
   Oscarson M, 1999, FEBS LETT, V460, P321, DOI 10.1016/S0014-5793(99)01364-2
   Oscarson M, 1999, FEBS LETT, V448, P105, DOI 10.1016/S0014-5793(99)00359-2
   Oscarson M, 2002, HUM MUTAT, V20, P275, DOI 10.1002/humu.10126
   Oscarson M, 2001, DRUG METAB DISPOS, V29, P91
   Pasanen M, 1997, TOXICOLOGY, V123, P177, DOI 10.1016/S0300-483X(97)00119-4
   PELKONEN O, 2000, DRUG METAB DISPOS, V28, P1321
   PIANEZZA ML, 1999, LANCET, V353, P898
   Pitarque M, 2004, HUM MUTAT, V23, P258, DOI 10.1002/humu.20002
   Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990
   Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493
   Rao YS, 2000, MOL PHARMACOL, V58, P747
   RAUNIO H, 1988, BIOCHEM PHARMACOL, V37, P3889, DOI 10.1016/0006-2952(88)90070-6
   Rautio A, 2003, PHARMACOGENOMICS J, V3, P5, DOI 10.1038/sj.tpj.6500154
   Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x
   Sabol SZ, 1999, BEHAV GENET, V29, P257, DOI 10.1023/A:1021642323602
   SCHNEIDER S, 2000, ARLEQUIN VER 2 000 S
   Schoedel KA, 2004, PHARMACOGENETICS, V14, P615, DOI 10.1097/00008571-200409000-00006
   Schulz TG, 2001, ADV EXP MED BIOL, V500, P213
   Sellers EM, 2000, ANN NY ACAD SCI, V909, P233
   Sellers EM, 2000, CLIN PHARMACOL THER, V68, P35, DOI 10.1067/mcp.2000.107651
   SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414
   Solus JF, 2004, PHARMACOGENOMICS, V5, P895, DOI 10.1517/14622416.5.7.895
   Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501
   TAN W, 2001, TISSUE ANTIGENS, V57, P169
   TEMPLETON AR, 1992, GENETICS, V132, P619
   Tiihonen J, 2000, MOL PSYCHIATR, V5, P347, DOI 10.1038/sj.mp.4000710
   Topcu Z, 2002, CARCINOGENESIS, V23, P595, DOI 10.1093/carcin/23.4.595
   Tsukino H, 2002, INT J CANCER, V100, P425, DOI 10.1002/ijc.10492
   von Richter O, 2004, PHARMACOGENETICS, V14, P369, DOI 10.1097/00008571-200406000-00006
   WAXMAN DJ, CYTOCHROME P450 PROT, P111
   Wolbold R, 2003, HEPATOLOGY, V38, P978, DOI 10.1053/jhep.2003.50393
   Xu P, 2002, EUR J CLIN PHARMACOL, V58, P333, DOI 10.1007/s00228-002-0480-3
   YAMANO S, 1990, BIOCHEMISTRY-US, V29, P1322, DOI 10.1021/bi00457a031
   YAMANO S, 1989, NUCLEIC ACIDS RES, V17, P4888, DOI 10.1093/nar/17.12.4888
   Yoshida R, 2003, CLIN PHARMACOL THER, V74, P69, DOI 10.1016/S0009-9236(03)00090-0
   YUN CH, 1991, MOL PHARMACOL, V40, P679
   Zabetian CP, 2000, AM J MED GENET, V96, P638, DOI 10.1002/1096-8628(20001009)96:5<638::AID-AJMG9>3.0.CO;2-R
   Zhang MQ, 1998, HUM MOL GENET, V7, P919, DOI 10.1093/hmg/7.5.919
   ZUKUNFT J, 2003, 13 C CYT P450 BIOCH, pS144
NR 75
TC 74
Z9 76
U1 0
U2 7
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1744-6872
EI 1744-6880
J9 PHARMACOGENET GENOM
JI Pharmacogenet. Genomics
PD SEP
PY 2005
VL 15
IS 9
BP 609
EP 624
DI 10.1097/01.fpc.0000171517.22258.f1
PG 16
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA 957SU
UT WOS:000231394400002
PM 16041240
DA 2021-01-25
ER

PT J
AU Stetefeld, J
   Ruegg, MA
AF Stetefeld, J
   Ruegg, MA
TI Structural and functional diversity generated by alternative mRNA
   splicing
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID GLUTATHIONE S-TRANSFERASES; TUMOR-SUPPRESSOR PROTEIN;
   ALPHA-DYSTROGLYCAN-BINDING; ZINC-FINGER PROTEIN; G-LIKE DOMAIN;
   CRYSTAL-STRUCTURES; RECEPTOR SPECIFICITY; ANOPHELES-DIRUS;
   MOLECULAR-BASIS; AGRIN ISOFORMS
AB Alternative mRNA splicing is becoming increasingly recognized as an important mechanism for the generation of structural and functional diversity in proteins. Recent estimations predict that similar to 50% of all eukaryotic proteins can be alternatively spliced. Several lines of evidence suggest that alternative mRNA splicing results in small changes in protein structure and is likely to fine-tune the function and specificity of the affected protein. However, knowledge of how alternative splicing regulates cellular processes on the molecular level is still limited. It is only recently that structures of alternatively spliced proteins have been solved. These studies have shown that alternative splicing affects the structure not only in the vicinity of the splice site but also at long distance.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch
RI Ruegg, Markus/X-7256-2019; Stetefeld, Joerg/H-7630-2017
OI Ruegg, Markus/0000-0002-4974-9384; Stetefeld, Joerg/0000-0003-1478-3248
CR Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   BICKMORE WA, 1992, SCIENCE, V257, P235, DOI 10.1126/science.1321494
   Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A
   Campanelli JT, 1996, DEVELOPMENT, V122, P1663
   Caricasole A, 1996, P NATL ACAD SCI USA, V93, P7562, DOI 10.1073/pnas.93.15.7562
   Chetkovich DM, 2002, J NEUROSCI, V22, P6415
   CONSTANTINE KL, 1993, PROTEINS, V15, P290, DOI 10.1002/prot.340150307
   COPPES MJ, 1993, FASEB J, V7, P886
   Croft L, 2000, NAT GENET, V24, P340
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1998, EMBO J, V17, P335, DOI 10.1093/emboj/17.2.335
   DIEKMAN AB, 1994, BIOL REPROD, V50, P1087, DOI 10.1095/biolreprod50.5.1087
   Duarte A, 1998, BRIT J CANCER, V77, P253, DOI 10.1038/bjc.1998.41
   Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1
   FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I
   Garcia J, 2004, NAT STRUCT MOL BIOL, V11, P45, DOI 10.1038/nsmb707
   Gerber SH, 2001, EMBO J, V20, P1605, DOI 10.1093/emboj/20.7.1605
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0
   Graveley BR, 2001, TRENDS GENET, V17, P100, DOI 10.1016/S0168-9525(00)02176-4
   Grishkovskaya I, 2000, EMBO J, V19, P504, DOI 10.1093/emboj/19.4.504
   HABER DA, 1991, P NATL ACAD SCI USA, V88, P9618, DOI 10.1073/pnas.88.21.9618
   Hanke J, 1999, TRENDS GENET, V15, P389, DOI 10.1016/S0168-9525(99)01830-2
   Hohenester E, 1999, MOL CELL, V4, P783, DOI 10.1016/S1097-2765(00)80388-3
   Hopf C, 1996, J BIOL CHEM, V271, P5231
   Hymowitz SG, 2003, STRUCTURE, V11, P1513, DOI 10.1016/j.str.2003.11.009
   Jirajaroenrat K, 2001, INSECT BIOCHEM MOLEC, V31, P867, DOI 10.1016/S0965-1748(01)00032-7
   Kan ZY, 2001, GENOME RES, V11, P889, DOI 10.1101/gr.155001
   Laity JH, 2000, BIOCHEMISTRY-US, V39, P5341, DOI 10.1021/bi9926678
   Laity JH, 2000, P NATL ACAD SCI USA, V97, P11932, DOI 10.1073/pnas.97.22.11932
   Laity JH, 2000, J MOL BIOL, V295, P719, DOI 10.1006/jmbi.1999.3406
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   LARSSON SH, 1995, CELL, V81, P391, DOI 10.1016/0092-8674(95)90392-5
   Lopez AJ, 1998, ANNU REV GENET, V32, P279, DOI 10.1146/annurev.genet.32.1.279
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200
   Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3
   Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201
   Neumann FR, 2001, MOL CELL NEUROSCI, V17, P208, DOI 10.1006/mcne.2000.0932
   NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471
   Oakley AJ, 2001, PROTEIN SCI, V10, P2176, DOI 10.1110/ps.21201
   PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256
   Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191
   Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X
   Pongjaroenkit S, 2001, INSECT BIOCHEM MOLEC, V31, P75, DOI 10.1016/S0965-1748(00)00107-7
   RAUSCHER FJ, 1990, SCIENCE, V250, P1259, DOI 10.1126/science.2244209
   Reddy JC, 1996, BBA-REV CANCER, V1287, P1, DOI 10.1016/0304-419X(95)00014-7
   Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879
   Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3
   Rudenko G, 2001, TRENDS BIOCHEM SCI, V26, P363, DOI 10.1016/S0968-0004(01)01832-1
   RUEGG MA, 1992, NEURON, V8, P691, DOI 10.1016/0896-6273(92)90090-Z
   Sasaki T, 2002, J BIOL CHEM, V277, P44164, DOI 10.1074/jbc.M207340200
   Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8
   Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h
   SHARP PA, 1994, CELL, V77, P805, DOI 10.1016/0092-8674(94)90130-9
   Smith CWJ, 2000, TRENDS BIOCHEM SCI, V25, P381, DOI 10.1016/S0968-0004(00)01604-2
   Stetefeld J, 2004, STRUCTURE, V12, P503, DOI 10.1016/j.str.2004.02.001
   Strehler EE, 2001, PHYSIOL REV, V81, P21
   Tisi D, 2000, EMBO J, V19, P1432, DOI 10.1093/emboj/19.7.1432
   Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921
   USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094
   Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040
   Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151
   Wang-Gillam A, 2000, J BIOL CHEM, V275, P1433, DOI 10.1074/jbc.275.2.1433
   Wu Q, 2000, P NATL ACAD SCI USA, V97, P3124, DOI 10.1073/pnas.060027397
   Xu Q, 2002, NUCLEIC ACIDS RES, V30, P3754, DOI 10.1093/nar/gkf492
NR 70
TC 87
Z9 94
U1 0
U2 3
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD SEP
PY 2005
VL 30
IS 9
BP 515
EP 521
DI 10.1016/j.tibs.2005.07.001
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 967IW
UT WOS:000232085900006
PM 16023350
DA 2021-01-25
ER

PT J
AU Noskov, S
   Berneche, S
   Roux, B
AF Noskov, Sergei
   Berneche, Simon
   Roux, Benoit
TI Ion selectivity in potassium channels: Interplay of structure and
   dynamics
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 230th National Meeting of the American-Chemical-Society
CY AUG 28-SEP 01, 2005
CL Washington, DC
SP Amer Chem Soc
C1 Cornell Univ, Dept Physiol & Biophys, Weill Med Coll, New York, NY 10021 USA.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4003 Basel, Switzerland.
EM syn2001@med.cornell.edu
RI Noskov, Sergei/B-3654-2010
NR 0
TC 0
Z9 0
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 28
PY 2005
VL 230
MA 398-PHYS
BP U2956
EP U2956
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 032TJ
UT WOS:000236797305855
DA 2021-01-25
ER

PT J
AU Fiedler, J
   Leucht, F
   Waltenberger, J
   Dehio, C
   Brenner, RE
AF Fiedler, J
   Leucht, F
   Waltenberger, J
   Dehio, C
   Brenner, RE
TI VEGF-A and PlGF-1 stimulate chemotactic migration of human mesenchymal
   progenitor cells
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE chemotaxis; vascular endothelial growth factor; cell migration; human
   mesenchymal progenitor cells; VEGF receptors; PIGF-1
ID ENDOTHELIAL GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-2;
   1,25-DIHYDROXYVITAMIN D-3; TYROSINE KINASE; STEM-CELLS; EXPRESSION;
   RECEPTOR; KDR; ANGIOGENESIS; OSTEOBLASTS
AB Vascular endothelial growth factor (VEGF) has been indicated to play a role during endochondral ossification by stimulation of blood vessel invasion into hypertrophic cartilage resulting in its replacement by trabecular bone. We could demonstrate a dose-dependent chemoattractive effect of VEGF-A and PIGF-1, but not VEGF-E or VEGF-C, on human mesenchymal progenitor cells. Quantitative realtime PCR revealed the expression of VEGFR-I (Flt-1), VEGFR-2 (KDR/Flk-1), and VEGFR-3 (Flt-4), which markedly declined during osteogenic differentiation. In addition, expression of neuropilin-1 and -2 was detected by RT-PCR. In an in vitro kinase assay, we could demonstrate activation of VEGFR-I and VEGFR-2 upon stimulation with specific ligands. These findings are consistent with the idea that the chemotactic effect of VEGF-A on MPC is mediated via VEGFR-1, and that VEGF-A and PIGF-1, have a functional role for recruitment of osteoprogenitor cells in the course of endochondral bone formation or remodeling. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Ulm, Dept Orthopaed, Div Biochem Joint & Connect Tissue Dis, Ulm, Germany.
   Univ Maastricht, Dept Invas Cardiol, Cardiovasc Res Inst, CARIM, Maastricht, Netherlands.
   Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
RP Brenner, RE (corresponding author), Univ Ulm, Dept Orthopaed, Div Biochem Joint & Connect Tissue Dis, Ulm, Germany.
EM joerg.fiedler@uni-ulm.de; frank.leucht@student.uni-ulm.de;
   j.waltenberger@cardio.azm.nl; christoph.dehio@unibas.ch;
   rolf.brenner@uni-ulm.de
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019;
   Waltenberger, Johannes/I-1813-2013
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Waltenberger,
   Johannes/0000-0002-2417-9880
CR Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884
   Barleon B, 1996, BLOOD, V87, P3336, DOI 10.1182/blood.V87.8.3336.bloodjournal8783336
   Brenner RE, 2001, PEDIATR PULM, V32, P1, DOI 10.1002/ppul.1081
   BRIGHTON CT, 1991, J BONE JOINT SURG AM, V73A, P832, DOI 10.2106/00004623-199173060-00006
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chen YJ, 2004, J ORTHOP RES, V22, P526, DOI 10.1016/j.orthres.2003.10.005
   Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629
   Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667
   DEVRIES C, 1992, SCIENCE, V255, P989, DOI 10.1126/science.1312256
   Ferguson C, 1999, MECH DEVELOP, V87, P57, DOI 10.1016/S0925-4773(99)00142-2
   Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610
   Ferrara N, 1996, Curr Opin Nephrol Hypertens, V5, P35, DOI 10.1097/00041552-199601000-00008
   Fickert S, 2004, ARTHRITIS RES THER, V6, pR422, DOI 10.1186/ar1210
   Fiedler J, 2004, J CELL BIOCHEM, V93, P990, DOI 10.1002/jcb.20219
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   Garcia-Ramirez M, 2000, J BONE MINER RES, V15, P534, DOI 10.1359/jbmr.2000.15.3.534
   Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467
   Goad DL, 1996, ENDOCRINOLOGY, V137, P2262, DOI 10.1210/en.137.6.2262
   GOSPODAROWICZ D, 1989, P NATL ACAD SCI USA, V86, P7311, DOI 10.1073/pnas.86.19.7311
   HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258
   Hirohata S, 2004, ARTHRITIS RHEUM-US, V50, P3888, DOI 10.1002/art.20729
   Horner A, 1999, J ANAT, V194, P519, DOI 10.1046/j.1469-7580.1999.19440519.x
   KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987
   Kroll J, 2000, Z KARDIOL, V89, P206, DOI 10.1007/s003920050472
   Larrivee B, 2000, INT J MOL MED, V5, P447
   Lind M, 1996, BONE, V18, P53, DOI 10.1016/8756-3282(95)00423-8
   Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Mayr-Wohlfart U, 2001, J BONE JOINT SURG BR, V83B, P144, DOI 10.1302/0301-620X.83B1.10219
   Meyer M, 1999, EMBO J, V18, P363, DOI 10.1093/emboj/18.2.363
   MIDY V, 1994, BIOCHEM BIOPH RES CO, V199, P380, DOI 10.1006/bbrc.1994.1240
   Pacicca DM, 2003, BONE, V33, P889, DOI 10.1016/j.bone.2003.06.002
   PARFITT AM, 1994, J CELL BIOCHEM, V55, P273, DOI 10.1002/jcb.240550303
   Rousseau S, 2000, J BIOL CHEM, V275, P10661, DOI 10.1074/jbc.275.14.10661
   Saadeh PB, 1999, AM J PHYSIOL-CELL PH, V277, pC628
   TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2
   Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647
   WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wang DS, 1996, J BONE MINER RES, V11, P472
   Wartiovaara U, 1998, THROMB HAEMOSTASIS, V80, P171
   YOUNG HE, 1995, DEV DYNAM, V202, P137, DOI 10.1002/aja.1002020205
   ZIGMOND SH, 1973, J EXP MED, V137, P387, DOI 10.1084/jem.137.2.387
NR 43
TC 148
Z9 153
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD AUG 26
PY 2005
VL 334
IS 2
BP 561
EP 568
DI 10.1016/j.bbrc.2005.06.116
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 950TI
UT WOS:000230880200037
PM 16005848
DA 2021-01-25
ER

PT J
AU Handschin, C
   Lin, JD
   Rhee, J
   Peyer, AK
   Chin, S
   Wu, PH
   Meyer, UA
   Spiegelman, BM
AF Handschin, C
   Lin, JD
   Rhee, J
   Peyer, AK
   Chin, S
   Wu, PH
   Meyer, UA
   Spiegelman, BM
TI Nutritional regulation of hepatic heme biosynthesis and porphyria
   through PGC-1 alpha
SO CELL
LA English
DT Article
ID SYNTHASE GENE-EXPRESSION; DELTA-AMINOLEVULINATE SYNTHASE; FORKHEAD
   TRANSCRIPTION FACTOR; ACUTE INTERMITTENT PORPHYRIA; ACTIVATED
   PROTEIN-KINASE; 5-AMINOLEVULINATE SYNTHASE; COACTIVATOR PGC-1; ACID
   SYNTHASE; MITOCHONDRIAL BIOGENESIS; RAT HEPATOCYTES
AB Inducible hepatic porphyrias are inherited genetic disorders of enzymes of heme biosynthesis. The main clinical manifestations are acute attacks of neuropsychiatric symptoms frequently precipitated by drugs, hormones, or fasting, associated with increased urinary excretion of delta-aminolevulinic acid (ALA). Acute attacks are treated by heme infusion and glucose administration, but the mechanisms underlying the precipitating effects of fasting and the beneficial effects of glucose are unknown. We show that the rate-limiting enzyme in hepatic heme biosynthesis, 5-amino-levulinate synthase (ALAS-1), is regulated by the peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha). Elevation of PGC-1 alpha in mice via adenoviral vectors increases the levels of heme precursors in vivo as observed in acute attacks. The induction of ALAS-1 by fasting is lost in liver-specific PGC-1 alpha knockout animals, as is the ability of porphyrogenic drugs to dysregulate heme biosynthesis. These data show that PGC-1 alpha links nutritional status to heme biosynthesis and acute hepatic porphyria.
C1 Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
   Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA.
EM bruce_spiegelman@dfci.harvard.edu
RI Rhee, James/V-9973-2019; Wu, Pei-Hsuan/AAL-1704-2020; Handschin,
   Christoph/E-6886-2015
OI Wu, Pei-Hsuan/0000-0002-6690-0744; Handschin,
   Christoph/0000-0003-0603-1097
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [K01DK065584, R01DK054477, R01DK060837,
   R01DK061562, R01DK054477, R56DK054477, R01DK054477, R01DK054477,
   R01DK054477, R01DK061562, R01DK054477, R01DK060837, R01DK061562,
   R01DK054477, R01DK054477, R01DK060837, R01DK061562, R01DK061562,
   R01DK061562, R01DK061562, K01DK065584, R01DK054477, R01DK061562,
   R01DK061562, R01DK061562, K01DK065584, R01DK054477, R01DK060837,
   R01DK054477, R01DK054477, R01DK054477, K01DK065584, R01DK054477,
   R01DK060837, R01DK054477, R01DK054477, R01DK054477, R01DK054477,
   R01DK060837, R01DK061562, R01DK061562, R01DK061562, K01DK065584,
   R01DK061562, R01DK061562, R01DK061562, R01DK061562, R01DK054477] Funding
   Source: NIH RePORTER; NIDDK NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [DK54477,
   R01DK060837, DK61562, 1K01DK065584] Funding Source: Medline
CR BONKOVSKY HL, 1992, BIOCHEM PHARMACOL, V43, P2359, DOI 10.1016/0006-2952(92)90314-9
   BRAIDOTTI G, 1993, J BIOL CHEM, V268, P1109
   Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4
   CANEPA ET, 1984, BIOCHIM BIOPHYS ACTA, V804, P8, DOI 10.1016/0167-4889(84)90092-2
   DAVIS JR, 1967, ARCH ENVIRON HEALTH, V15, P53, DOI 10.1080/00039896.1967.10664873
   DEMATTEIS F, 1973, ENZYME, V16, P266, DOI 10.1159/000459390
   DEMATTEIS F, 1973, BIOCHEM J, V134, P717, DOI 10.1042/bj1340717
   Elder GH, 1997, LANCET, V349, P1613, DOI 10.1016/S0140-6736(96)09070-8
   Elder GH, 1998, CLIN DERMATOL, V16, P225, DOI 10.1016/S0738-081X(97)00202-2
   Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200
   Fraser DJ, 2002, J BIOL CHEM, V277, P34717, DOI 10.1074/jbc.M204699200
   GIGER U, 1981, J BIOL CHEM, V256, P1182
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   IniguezLluhi JA, 1997, J BIOL CHEM, V272, P4149, DOI 10.1074/jbc.272.7.4149
   KAPPAS A, 1995, PORPHYRIAS
   Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lindberg RLP, 1996, NAT GENET, V12, P195, DOI 10.1038/ng0296-195
   Lindberg RLP, 1999, J CLIN INVEST, V103, P1127, DOI 10.1172/JCI5986
   LOFTUS LS, 1991, BRIT MED J, V303, P1589, DOI 10.1136/bmj.303.6817.1589
   MACALPINE I, 1968, BMJ-BRIT MED J, V1, P7, DOI 10.1136/bmj.1.5583.7
   MACALPINE I, 1966, BMJ-BRIT MED J, V5479, P65
   MAY BK, 1995, PROG NUCLEIC ACID RE, V51, P1, DOI 10.1016/S0079-6603(08)60875-2
   Mendez M, 1999, GEN PHARMACOL, V32, P259, DOI 10.1016/S0306-3623(98)00202-X
   Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI12876
   Pierach C A, 1999, Sudhoffs Arch, V83, P50
   Podvinec M, 2004, P NATL ACAD SCI USA, V101, P9127, DOI 10.1073/pnas.0401845101
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   ROBERT TL, 1994, NUTRITION, V10, P551
   Scassa ME, 2004, J BIOL CHEM, V279, P28082, DOI 10.1074/jbc.M401792200
   Scassa ME, 2001, EXP CELL RES, V271, P201, DOI 10.1006/excr.2001.5386
   Scassa ME, 1998, EXP CELL RES, V244, P460, DOI 10.1006/excr.1998.4206
   Thadani H, 2000, BMJ-BRIT MED J, V320, P1647, DOI 10.1136/bmj.320.7250.1647
   Thunell S, 2000, SCAND J CLIN LAB INV, V60, P509, DOI 10.1080/003655100448310
   Varone CL, 1999, ARCH BIOCHEM BIOPHYS, V372, P261, DOI 10.1006/abbi.1999.1470
   VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
NR 43
TC 223
Z9 230
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD AUG 26
PY 2005
VL 122
IS 4
BP 505
EP 515
DI 10.1016/j.cell.2005.06.040
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 959YI
UT WOS:000231555100007
PM 16122419
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Paulillo, SM
   Phillips, EM
   Koser, J
   Sauder, U
   Ullman, KS
   Powers, MA
   Fahrenkrog, B
AF Paulillo, SM
   Phillips, EM
   Koser, J
   Sauder, U
   Ullman, KS
   Powers, MA
   Fahrenkrog, B
TI Nucleoporin domain topology is linked to the transport status of the
   nuclear pore complex
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE nuclear pore complex; nuclear transport; FG-repeats; Nup214; Nup153
ID MESSENGER-RNA EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; STRUCTURAL BASIS;
   FG-REPEAT; IMPORTIN-BETA; CRYOELECTRON TOMOGRAPHY; ELECTRON-MICROSCOPY;
   BINDING DOMAIN; PROTEIN IMPORT; NUP153
AB Nuclear pore complexes (NPCs) facilitate macromolecular exchange between the nucleus and cytoplasm of eukaryotic cells. The vertebrate NPC is composed of similar to 30 different proteins (nucleoporins), of which around one third contain phenylalanine-glycine (FG)-repeat domains that are thought to mediate the main interaction between the NPC and soluble transport receptors. We have recently shown that the FG-repeat domain of Nup153 is flexible within the NPC, although this nucleoporin is anchored to the nuclear side of the NPC. By using domain-specific antibodies, we have now mapped the domain topology of Nup214 in Xenopus oocytes and in human somatic cells by immuno-EM. We have found that whereas Nup214 is anchored to the cytoplasmic side of the NPC via its N-terminal and central domain, its FG-repeat domain appears flexible, residing on both sides of the NPC. Moreover, the spatial distribution of the FG-repeat domains of both Nup153 and Nup214 shifts in a transport-dependent manner, suggesting that the location of FG-repeat domains within the NPC correlates with cargo/receptor interactions and that they concomitantly move with cargo through the central pore of the NPC. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct, CH-4056 Basel, Switzerland.
   Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.
   Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Ullman,
   Katharine/0000-0003-3693-2830
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM59975, GM61275, R01 GM061275-06, R01
   GM061275] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM059975, R01GM061275, R01GM059975,
   R01GM059975, R01GM061275, R01GM061275, R01GM059975, R01GM059975,
   R01GM059975, R01GM061275, R01GM059975, R01GM061275, R01GM061275,
   R01GM061275, R01GM061275, R01GM061275, R01GM061275, R01GM061275,
   R01GM059975, R01GM059975, R01GM061275, R01GM059975, R01GM061275,
   R01GM061275] Funding Source: NIH RePORTER
CR ADAM SA, 1992, METHOD ENZYMOL, V219, P97
   AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141
   Bayliss R, 2000, J STRUCT BIOL, V131, P240, DOI 10.1006/jsbi.2000.4297
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081
   Boer JM, 1997, EXP CELL RES, V232, P182, DOI 10.1006/excr.1997.3502
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2
   Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8
   Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 2004, TRENDS BIOCHEM SCI, V29, P175, DOI 10.1016/j.tibs.2004.02.006
   Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807
   Fribourg S, 2001, MOL CELL, V8, P645, DOI 10.1016/S1097-2765(01)00348-3
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1
   Grant RP, 2002, NAT STRUCT BIOL, V9, P247, DOI 10.1038/nsb773
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593
   KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519
   Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165
   Kuersten S, 2002, MOL CELL BIOL, V22, P5708, DOI 10.1128/MCB.22.16.5708-5720.2002
   Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153
   Matsuura Y, 2003, EMBO J, V22, P5358, DOI 10.1093/emboj/cdg538
   Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004
   Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982
   Pante N, 1996, SCIENCE, V273, P1729, DOI 10.1126/science.273.5282.1729
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 1997, RNA, V3, P498
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Rollenhagen C, 2003, MOL BIOL CELL, V14, P2104, DOI 10.1091/mbc.E02-06-0372
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X
   Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649
   Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x
   vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156
   Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200
NR 53
TC 58
Z9 58
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 26
PY 2005
VL 351
IS 4
BP 784
EP 798
DI 10.1016/j.jmb.2005.06.034
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 956ST
UT WOS:000231320800008
PM 16045929
DA 2021-01-25
ER

PT J
AU Chen, C
   Ouyang, W
   Grigura, V
   Zhou, Q
   Carnes, K
   Lim, H
   Zhao, GQ
   Arber, S
   Kurpios, N
   Murphy, TL
   Cheng, AM
   Hassell, JA
   Chandrashekar, V
   Hofmann, MC
   Hess, RA
   Murphy, KM
AF Chen, C
   Ouyang, W
   Grigura, V
   Zhou, Q
   Carnes, K
   Lim, H
   Zhao, GQ
   Arber, S
   Kurpios, N
   Murphy, TL
   Cheng, AM
   Hassell, JA
   Chandrashekar, V
   Hofmann, MC
   Hess, RA
   Murphy, KM
TI ERM is required for transcriptional control of the spermatogonial stem
   cell niche
SO NATURE
LA English
DT Article
ID SERTOLI-CELLS; RECEPTOR CXCR4; SELF-RENEWAL; MICE LACKING; GERM-CELLS;
   GENE; CHEMOKINE; PEA3; SPERMATOGENESIS; MAINTENANCE
AB Division of spermatogonial stem cells(1) produces daughter cells that either maintain their stem cell identity or undergo differentiation to form mature sperm. The Sertoli cell, the only somatic cell within seminiferous tubules, provides the stem cell niche through physical support and expression of surface proteins and soluble factors(2,3). Here we show that the Ets related molecule(4) (ERM) is expressed exclusively within Sertoli cells in the testis and is required for spermatogonial stem cell self-renewal. Mice with targeted disruption of ERM have a loss of maintenance of spermatogonial stem cell self-renewal without a block in normal spermatogenic differentiation and thus have progressive germ-cell depletion and a Sertoli-cell-only syndrome. Microarray analysis of primary Sertoli cells from ERM-deficient mice showed alterations in secreted factors known to regulate the haematopoietic stem cell niche. These results identify a new function for the Ets family transcription factors in spermatogenesis and provide an example of transcriptional control of a vertebrate stem cell niche.
C1 Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.
   Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.
   Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.
   Univ Illinois, Dept Vet Biosci, Urbana, IL 61802 USA.
   Univ Texas, SW Med Sch, Cecil H & Ida Green Ctr Reprod Biol Sci, Dallas, TX 75390 USA.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   McMaster Univ, Inst Mol Biol & Biotechnol, Hamilton, ON L8S 4K1, Canada.
   So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA.
   Univ Dayton, Dept Biol, Dayton, OH 45469 USA.
RP Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
EM murphy@pathbox.wustl.edu
RI Richburg, John H/B-8197-2009; Ouyang, Wenjun/ABA-8763-2020; Lim,
   Hyunjung J/D-5343-2011
OI Lim, Hyunjung J/0000-0003-2191-666X; Arber, Silvia/0000-0002-6261-250X;
   Hofmann, Marie-Claude/0000-0002-4899-8039; Hess,
   Rex/0000-0003-2649-3563; Ouyang, Wenjun/0000-0002-1811-5864; Chen,
   Chen/0000-0001-9159-4489
FU EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN
   DEVELOPMENTUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01HD044543,
   R01HD044543, R01HD044543, R01HD044543, K02HD054607, K02HD054607,
   K02HD054607, R01HD044543, K02HD054607, K02HD054607, K02HD054607,
   R01HD044543] Funding Source: NIH RePORTER; NICHD NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [K02 HD054607, R01 HD044543, R01 HD044543-02]
   Funding Source: Medline
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366
   Choong ML, 2004, CYTOKINE, V25, P239, DOI 10.1016/j.cyto.2003.11.002
   ChotteauLelievre A, 1997, ONCOGENE, V15, P937, DOI 10.1038/sj.onc.1201261
   Christensen JL, 2004, PLOS BIOL, V2, P368, DOI 10.1371/journal.pbio.0020075
   Colvin JS, 2001, CELL, V104, P875, DOI 10.1016/S0092-8674(01)00284-7
   Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367
   DEFRANCA LR, 1994, ANAT REC, V240, P225
   Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7
   Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203
   Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7
   KARL AF, 1990, METHOD ENZYMOL, V190, P71
   Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606
   Kubota H, 2003, P NATL ACAD SCI USA, V100, P6487, DOI 10.1073/pnas.0631767100
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489
   Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640
   MONTE D, 1994, ONCOGENE, V9, P1397
   Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0
   OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469
   Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888
   Raible F, 2001, MECH DEVELOP, V107, P105, DOI 10.1016/S0925-4773(01)00456-7
   Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963
   SETH A, 1992, CELL GROWTH DIFFER, V3, P327
   Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261
   Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613
NR 26
TC 225
Z9 246
U1 0
U2 28
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD AUG 18
PY 2005
VL 436
IS 7053
BP 1030
EP 1034
DI 10.1038/nature03894
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 955XQ
UT WOS:000231263900053
PM 16107850
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Bodenreider, C
   Kiefhaber, T
AF Bodenreider, C
   Kiefhaber, T
TI Interpretation of protein folding psi values
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; transition state; psi-analysis; rate-equilibrium; free
   energy relationshsips (REFERs); ligand-binding
ID TRANSITION-STATE; FREE-ENERGY; TEMPERATURE-DEPENDENCE; HAMMOND BEHAVIOR;
   TERMINAL DOMAIN; BETA-SHEET; KINETICS; 2-STATE; DENATURANT; STABILITY
AB The structural characterization of transition states is essential for understanding the mechanism of protein folding. Analyzing the effect of mutations on protein stability and folding kinetics in phi-value analysis is commonly used to gain information about the presence of side-chain interactions in transition states. Recently, specific binding of ligands to engineered binding sites was applied to monitor the formation of local structures in transition states (analysis). A surprising result from p analysis was the presence of parallel folding pathways in all reported studies and a major discrepancy between phi and psi values measured in the same protein. Here, we show that psi values cannot be analyzed in the same way as other rate-equilibrium free energy relationships due to the involvement of bimolecular reactions that may have different dissociation constants for the native, unfolded and transition state. As a consequence, values reflect the relative binding energy (K) of the transition state only for the extreme values of kappa = 0 or kappa = 1. In all other cases, non-linear rate-equilibrium free-energy relationships (Leffler plots) are observed. This apparently indicates the presence of parallel folding pathways even if folding occurs over a single homogeneous transition state. Consequently, the results from Leffler plots do not yield information about the structural properties of the transition state. This explains the lack of agreement between results from psi analysis and other methods used to characterize protein folding transition states. We further show that the same considerations apply for the analysis of the effect of pH on protein folding. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kieffhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
CR ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025
   Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   Bieri O, 1999, BIOCHEMISTRY-US, V38, P12460, DOI 10.1021/bi9909703
   FARCASIU D, 1975, J CHEM EDUC, V52, P76, DOI 10.1021/ed052p76
   Fersht AR, 2004, P NATL ACAD SCI USA, V101, P17327, DOI 10.1073/pnas.0407863101
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   Horng JC, 2005, J MOL BIOL, V345, P163, DOI 10.1016/j.jmb.2004.10.023
   Jager M, 2001, J MOL BIOL, V311, P373, DOI 10.1006/jmbi.2001.4873
   JENCKS DA, 1977, J AM CHEM SOC, V99, P7948, DOI 10.1021/ja00466a030
   JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001
   Kiefhaber T, 2005, PROTEIN FOLDING HANDBOOK, P411, DOI 10.1002/9783527619498.ch12b
   Krantz BA, 2001, NAT STRUCT BIOL, V8, P1042, DOI 10.1038/nsb723
   Krantz BA, 2004, J MOL BIOL, V337, P463, DOI 10.1016/j.jmb.2004.01.018
   Kuhlman B, 1998, J MOL BIOL, V284, P1661, DOI 10.1006/jmbi.1998.2246
   KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17
   POHL FM, 1976, FEBS LETT, V65, P293, DOI 10.1016/0014-5793(76)80132-9
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016
   SANCHO J, 1991, J MOL BIOL, V221, P1007, DOI 10.1016/0022-2836(91)80188-Z
   Sato S, 2002, J MOL BIOL, V318, P571, DOI 10.1016/S0022-2836(02)00015-3
   Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636
   Schindler T, 1996, BIOCHEMISTRY-US, V35, P16833, DOI 10.1021/bi962090j
   Schonbrunner N, 1997, BIOCHEMISTRY-US, V36, P9057, DOI 10.1021/bi970594r
   Sosnick TR, 2004, P NATL ACAD SCI USA, V101, P17377, DOI 10.1073/pnas.0407683101
   Tan YJ, 1996, J MOL BIOL, V264, P377, DOI 10.1006/jmbi.1996.0647
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   VIDUGIRIS GJA, 1995, BIOCHEMISTRY-US, V34, P4909, DOI 10.1021/bi00015a001
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947
NR 37
TC 17
Z9 17
U1 0
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD AUG 12
PY 2005
VL 351
IS 2
BP 393
EP 401
DI 10.1016/j.jmb.2005.05.062
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 952MV
UT WOS:000231009000014
PM 16005895
DA 2021-01-25
ER

PT J
AU Hui, KM
   Orriss, GL
   Schirmer, T
   Magnadottir, B
   Schifferli, JA
   Inal, JM
AF Hui, KM
   Orriss, GL
   Schirmer, T
   Magnadottir, B
   Schifferli, JA
   Inal, JM
TI Expression of functional recombinant von Willebrand factor-A domain from
   human complement C2: a potential binding site for C4 and CRIT
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE classical pathway; C4 beta chain; complement C2; complement C2 receptor
   inhibitor trispanning (CRIT); haemolytic assay; recombinant von
   Willebrand factor-A domain
ID FACTOR-B; CRYSTAL-STRUCTURE; SERINE PROTEASES; COMPONENT C2;
   AMINO-ACIDS; RECEPTOR; SYSTEM; CHAIN; CONVERTASES; PEPTIDE
AB CRIT (complement C2 receptor inhibitor trispanning) is a newly described transmembrane molecule that is capable of binding C2 via its first extracellular domain (ed1). CRIT competes with C4b for the binding of C2. Previous experiments have suggested that a major binding site for C2 is located on short, almost identical peptide sequences of CRIT-ed1 and the beta-chain of C4. The C2 domains involved in binding, however, remain unknown. We cloned the vWFA (von Willebrand factor-A) domain of C2, as it is a region likely to be involved in interactions with other proteins, and were able to functionally express the 25 kDa human complement C2 vWFA domain (amino acids 224-437). The recombinant vWFA protein fixed on MagneHis Ni-Particles bound C4 in normal human serum. The C4 alpha, beta and gamma chains were separated by SDS/PAGE and purified separately by electro-elution. The purified C4 chains were then used in a sandwich ELISA, which showed the vWFA to bind C4 only via the C4 beta chain. In a haemolyfic assay, the recombinant vWFA protein inhibited complement activation by the classical pathway in a dose-dependent manner by competing with native C2 for binding to C4b. vWFA bound the ed1 peptide of CRIT as well, and specifically to the 11-amino-acid peptide fragment of ed1 that is known to interact with whole C2. These findings show that the vWFA domain is centrally involved in the C2-CRIT and C2-C4b bindings. The cloned vWFA domain will allow us to dissect out the fine interactions between C2 and CRIT or C4b.
C1 Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Iceland, Inst Expt Pathol, IS-112 Reykjavik, Iceland.
RP Hui, KM (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.
EM kwok-min.hui@unibas.ch; jameel.inal@unibas.ch
RI Inal, Jameel M/G-2995-2010; FRSB, Jameel Malhador Inal BSc MPhil PhD
   CBiol/AAU-9220-2020
OI Inal, Jameel M/0000-0002-7200-0363; 
CR Arlaud GJ, 1998, ADV IMMUNOL, V69, P249, DOI 10.1016/S0065-2776(08)60609-4
   BENTLEY DR, 1986, BIOCHEM J, V239, P339, DOI 10.1042/bj2390339
   Bhattacharya AA, 2004, STRUCTURE, V12, P371, DOI 10.1016/j.str.2004.02.012
   Blom AM, 1999, J BIOL CHEM, V274, P19237, DOI 10.1074/jbc.274.27.19237
   COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9
   DODDS AW, 1997, HAEMOLYTIC ASSAY WHO, P19
   HORIUCHI T, 1991, J IMMUNOL, V147, P584
   Inal JM, 2005, J IMMUNOL, V174, P356, DOI 10.4049/jimmunol.174.1.356
   Inal JM, 2003, J IMMUNOL, V170, P4310, DOI 10.4049/jimmunol.170.8.4310
   Inal JM, 2002, J IMMUNOL, V168, P5213, DOI 10.4049/jimmunol.168.10.5213
   KERR MA, 1980, BIOCHEM J, V189, P173, DOI 10.1042/bj1890173
   Kuttner-Kondo LA, 2003, J BIOL CHEM, V278, P52386, DOI 10.1074/jbc.M304620200
   Laich A, 2001, BBA-PROTEIN STRUCT M, V1544, P96, DOI 10.1016/S0167-4838(00)00208-9
   Lange S, 2004, FISH SHELLFISH IMMUN, V16, P227, DOI 10.1016/S1050-4648(03)00081-0
   LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0
   NAGASAWA S, 1977, P NATL ACAD SCI USA, V74, P2998, DOI 10.1073/pnas.74.7.2998
   OGLESBY TJ, 1988, J IMMUNOL, V141, P926
   Pan Q, 2000, J IMMUNOL, V165, P2518, DOI 10.4049/jimmunol.165.5.2518
   PARKES C, 1983, BIOCHEM J, V213, P201, DOI 10.1042/bj2130201
   ROONEY IA, 1993, IMMUNOL RES, V12, P276, DOI 10.1007/BF02918258
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Sim RB, 2000, BIOCHEM SOC T, V28, P545, DOI 10.1042/bst0280545
   SMITH CA, 1984, J EXP MED, V159, P324, DOI 10.1084/jem.159.1.324
   Sohn JH, 2000, INVEST OPHTH VIS SCI, V41, P4195
   Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259
   Williams SC, 1999, BIOCHEM J, V342, P625, DOI 10.1042/0264-6021:3420625
NR 26
TC 10
Z9 10
U1 0
U2 1
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD AUG 1
PY 2005
VL 389
BP 863
EP 868
DI 10.1042/BJ20050183
PN 3
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 954WQ
UT WOS:000231186400029
PM 15823096
OA Green Published
DA 2021-01-25
ER

PT J
AU Tsamaloukas, A
   Szadkowska, H
   Slotte, JP
   Heerklotz, H
AF Tsamaloukas, A
   Szadkowska, H
   Slotte, JP
   Heerklotz, H
TI Interactions of cholesterol with lipid membranes and cyclodextrin
   characterized by calorimetry
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID TITRATION CALORIMETRY; CONDENSED COMPLEXES; MAXIMUM SOLUBILITY; CHEMICAL
   ACTIVITY; PHASE; RAFTS; THERMODYNAMICS; DOMAINS; MODEL;
   PHOSPHATIDYLCHOLINE
AB Interactions of cholesterol ( cho) with different lipids are commonly believed to play a key role in the formation of functional domains in membranes. We introduce a novel approach to characterize cho- lipid interactions by isothermal titration calorimetry. Cho is solubilized in the aqueous phase by reversible complexation with methyl- beta- cyclodextrin ( cyd). Uptake of cho into the membrane is measured upon a series of injections of lipid vesicles into a cyd/ cho solution. As an independent assay, cho release from membranes is measured upon titrating lipid/ cho mixed vesicles into a cyd solution. The most consistent fit to the data is obtained with a mole fraction ( rather than mole ratio) partition coefficient and considering a cho/ cyd stoichiometry of 1: 2. The results are discussed in terms of contributions from 1), the transfer of cho from cyd into a hypothetical, ideally mixed membrane and 2), from nonideal interactions with POPC. The latter are exothermic but opposed by a strong loss in entropy, in agreement with cho- induced acyl chain ordering and membrane condensation. They are accompanied by a positive heat capacity change which cannot be interpreted in terms of the hydrophobic effect, suggesting that additive- induced chain ordering itself increases the heat capacity. The new assays have a great potential for a better understanding of sterol- lipid interactions and yield suggestions how to optimize cho extraction from membranes.
C1 Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
   Abo Akad Univ, Dept Biochem & Pharm, SF-20500 Turku, Finland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
OI Heerklotz, Heiko/0000-0003-4615-7022
CR Anderson TG, 2004, BIOCHEMISTRY-US, V43, P2251, DOI 10.1021/bi0358869
   BLUME A, 1980, BIOCHEMISTRY-US, V19, P4908, DOI 10.1021/bi00562a032
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Cannon B, 2003, BIOPHYS J, V84, P3777, DOI 10.1016/S0006-3495(03)75106-6
   Cevc G., 1985, PHOSPHOLIPID BILAYER
   CHAPMAN D, 1974, J BIOL CHEM, V249, P2512
   Chellani Mohan, 1999, American Biotechnology Laboratory, V17, P18
   de Almeida RFM, 2003, BIOPHYS J, V85, P2406, DOI 10.1016/S0006-3495(03)74664-5
   Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439
   Heerklotz H, 2004, J PHYS-CONDENS MAT, V16, pR441, DOI 10.1088/0953-8984/16/15/R01
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Heerklotz HH, 1998, BIOCALORIMETRY, P89
   Heerklotz HH, 1998, J PHYS CHEM B, V102, P5363, DOI 10.1021/jp980884x
   Huang JY, 2002, BIOPHYS J, V83, P1014, DOI 10.1016/S0006-3495(02)75227-2
   Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8
   Huang JY, 1999, BBA-BIOMEMBRANES, V1417, P89, DOI 10.1016/S0005-2736(98)00260-0
   Huster D, 1998, BIOCHEMISTRY-US, V37, P17299, DOI 10.1021/bi980078g
   IPSEN JH, 1989, BIOPHYS J, V56, P661, DOI 10.1016/S0006-3495(89)82713-4
   Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9
   KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250
   LANGE Y, 1981, J BIOL CHEM, V256, P5321
   Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0
   London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1
   McMullen TPW, 1999, BBA-BIOMEMBRANES, V1416, P119, DOI 10.1016/S0005-2736(98)00214-4
   McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   Murphy KP, 1999, MED RES REV, V19, P333, DOI 10.1002/(SICI)1098-1128(199907)19:4<333::AID-MED6>3.0.CO;2-5
   Nernst W., 1891, Z PHYS CHEM, V8, P110
   Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X
   Nyholm TKM, 2003, BIOPHYS J, V84, P3138, DOI 10.1016/S0006-3495(03)70038-1
   Ohvo H, 1996, BIOCHEMISTRY-US, V35, P8018, DOI 10.1021/bi9528816
   Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0
   Radhakrishnan A, 2000, P NATL ACAD SCI USA, V97, P12422, DOI 10.1073/pnas.220418097
   Radhakrishnan A, 2000, BIOCHEMISTRY-US, V39, P8119, DOI 10.1021/bi0005097
   Radhakrishnan A, 1999, BIOPHYS J, V77, P1507, DOI 10.1016/S0006-3495(99)76998-5
   Rowe ES, 1998, BIOCHEMISTRY-US, V37, P2430, DOI 10.1021/bi9721602
   SCHURTENBERGER P, 1985, J PHYS CHEM-US, V89, P1042, DOI 10.1021/j100252a031
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   Silvius JR, 2003, BBA-BIOMEMBRANES, V1610, P174, DOI 10.1016/S0005-2736(03)00016-6
   Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Spink CH, 1996, BBA-BIOMEMBRANES, V1279, P190, DOI 10.1016/0005-2736(95)00267-7
   Steck TL, 2002, BIOPHYS J, V83, P2118, DOI 10.1016/S0006-3495(02)73972-6
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655
   Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8
   VIST MR, 1990, BIOCHEMISTRY-US, V29, P451, DOI 10.1021/bi00454a021
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   YEAGLE PL, 1986, J BIOL CHEM, V261, P8175
NR 52
TC 62
Z9 62
U1 0
U2 28
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD AUG
PY 2005
VL 89
IS 2
BP 1109
EP 1119
DI 10.1529/biophysj.105.061846
PG 11
WC Biophysics
SC Biophysics
GA 949XM
UT WOS:000230822200033
PM 15923231
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Renkl, AC
   Wussler, J
   Ahrens, T
   Thoma, K
   Kon, S
   Uede, T
   Martin, SF
   Simon, JC
   Weiss, JM
AF Renkl, AC
   Wussler, J
   Ahrens, T
   Thoma, K
   Kon, S
   Uede, T
   Martin, SF
   Simon, JC
   Weiss, JM
TI Osteopontin functionally activates dendritic cells and induces their
   differentiation toward a Th1-polarizing phenotype
SO BLOOD
LA English
DT Article
ID ANTIGEN-PRESENTING CELLS; NF-KAPPA-B; CD44 VARIANT ISOFORMS;
   T-HELPER-CELLS; IN-VITRO; COSTIMULATORY MOLECULES; CYTOKINE PRODUCTION;
   ADHESION MOLECULES; LANGERHANS CELLS; IL-12 PRODUCTION
AB Osteopontin (OPN) has been shown to have T helper 1 (Th1) cytokine functions in cell-mediated immunity. Deficiency of OPN is linked to a reduced Th1 immune response in autoimmunity, infectious disease, and delayed-type allergy. Dendritic cells (DCs) are central for the induction of T-cell-mediated immunity, when initially flexible DCs are instructed by priming signals and tissue-derived factors to adopt Th1, Th2, or regulatory T-cellinducing phenotypes. Although OPN influences the cytokine secretion of T cells and macrophages, its effects on DC polarization remain an important missing link in the understanding of OPN functions in Th1 immunity. Here we demonstrate that OPN promotes the emigration of human DCs from the epidermis and functionally activates myeloid-type DCs, augmenting their expression of HLA-DR, costimulatory, and adhesion molecules. OPN induces their Th1-promoting tumor necrosis factor alpha (TNF-alpha) and interieukin-12 (IL-12) secretion, and enhances their allostimulatory capacity. In mixed lymphocyte reactions (MLRs), OPN stimulates IL-1 2 secretion by DCs, inducing elevated interferon-gamma (IFN-gamma) production by T cells. Naive Th cells stimulated by OPN-activated DCs show a Th1-polarized cytokine production. Our findings identify OPN as an important tissue-derived factor that DCs encounter when traveling from peripheral sites of activation to secondary lymphatic organs, which induces DC maturation toward a Th1-promoting phenotype.
C1 Univ Ulm, Dept Dermatol & Allergol, D-89081 Ulm, Germany.
   Univ Freiburg, Dept Dermatol, D-7800 Freiburg, Germany.
   Univ Basel, Biozentrum Basel, Basel, Switzerland.
   Hokkaido Univ, Inst Med Genet, Sapporo, Hokkaido 060, Japan.
   Univ Leipzig, Dept Dermatol Venerol & Allergol, D-7010 Leipzig, Germany.
RP Renkl, AC (corresponding author), Univ Ulm, Dept Dermatol & Allergol, Maienweg 12, D-89081 Ulm, Germany.
EM andreas.renkl@medizin.uni-ulm.de
RI Weiss, Johannes Martin/P-6445-2016; uede, toshimitsu/A-4273-2012;
   Eckhardt, Erik/G-1567-2010; Kon, Shigeyuki/A-3809-2012
OI Weiss, Johannes/0000-0002-4071-8792
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [16209014] Funding Source: KAKEN
CR Ahn JH, 2002, BLOOD, V100, P1742, DOI 10.1182/blood.V100.5.1742.h81702001742_1742_1754
   Aicher A, 2003, CIRCULATION, V107, P604, DOI 10.1161/01.CIR.0000047279.42427.6D
   Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Braat H, 2004, J MOL MED, V82, P197, DOI 10.1007/s00109-003-0509-9
   Caron G, 2001, J IMMUNOL, V167, P3682, DOI 10.4049/jimmunol.167.7.3682
   Cella M, 1996, J EXP MED, V184, P747, DOI 10.1084/jem.184.2.747
   Cella M, 1999, J EXP MED, V189, P821, DOI 10.1084/jem.189.5.821
   Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960
   de Jong EC, 2002, J IMMUNOL, V168, P1704, DOI 10.4049/jimmunol.168.4.1704
   Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980
   Gagliardi MC, 2000, EUR J IMMUNOL, V30, P2394, DOI 10.1002/1521-4141(2000)30:8<2394::AID-IMMU2394>3.0.CO;2-Y
   Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920
   Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870
   Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375
   Jakob T, 2001, J ALLERGY CLIN IMMUN, V108, P688, DOI 10.1067/mai.2001.118797
   Jansson M, 2002, J IMMUNOL, V168, P2096, DOI 10.4049/jimmunol.168.5.2096
   Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9
   Kalinski P, 1997, J IMMUNOL, V159, P28
   Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246
   Kapsenberg ML, 1999, IMMUNOL LETT, V69, P5, DOI 10.1016/S0165-2478(99)00096-6
   Kawamura K, 2005, CLIN DIAGN LAB IMMUN, V12, P206, DOI 10.1128/CDLI.12.1.206-212.2005
   Kimber I, 2002, CONTACT DERMATITIS, V46, P1, DOI 10.1034/j.1600-0536.2002.460101.x
   la Sala A, 2001, J IMMUNOL, V166, P1611, DOI 10.4049/jimmunol.166.3.1611
   Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758
   LIAW L, 1995, J CLIN INVEST, V95, P713, DOI 10.1172/JCI117718
   Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200
   Luksch CR, 1999, P NATL ACAD SCI USA, V96, P3023, DOI 10.1073/pnas.96.6.3023
   MacDonald AS, 2001, J IMMUNOL, V167, P1982, DOI 10.4049/jimmunol.167.4.1982
   Moser M, 2001, IMMUNOBIOLOGY, V204, P551, DOI 10.1078/0171-2985-00092
   Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734
   MURPHY TL, 1995, MOL CELL BIOL, V15, P5258
   Nau GJ, 1999, INFECT IMMUN, V67, P4223, DOI 10.1128/IAI.67.8.4223-4230.1999
   Nau GJ, 1997, P NATL ACAD SCI USA, V94, P6414, DOI 10.1073/pnas.94.12.6414
   O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8
   O'Regan AW, 2000, J LEUKOCYTE BIOL, V68, P495
   O'Regan AW, 1999, J IMMUNOL, V162, P1024
   Oldenhove G, 2003, J EXP MED, V198, P259, DOI 10.1084/jem.20030654
   PICKER LJ, 1989, J CELL BIOL, V109, P927, DOI 10.1083/jcb.109.2.927
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   POPE M, 1995, J INVEST DERMATOL, V104, P11, DOI 10.1111/1523-1747.ep12613452
   Rittling SR, 1999, EXP NEPHROL, V7, P103
   Rogers PR, 2000, J IMMUNOL, V164, P2955, DOI 10.4049/jimmunol.164.6.2955
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Salomon B, 1998, J IMMUNOL, V161, P5138
   Scatena M, 1998, J CELL BIOL, V141, P1083, DOI 10.1083/jcb.141.4.1083
   Senger DR, 1996, BBA-MOL CELL RES, V1314, P13, DOI 10.1016/S0167-4889(96)00067-5
   Senger DR, 1996, AM J PATHOL, V149, P293
   Smits HH, 2002, J IMMUNOL, V168, P1710, DOI 10.4049/jimmunol.168.4.1710
   Snijders A, 1998, INT IMMUNOL, V10, P1593, DOI 10.1093/intimm/10.11.1593
   Sousa CRE, 1997, J EXP MED, V186, P1819, DOI 10.1084/jem.186.11.1819
   Sparwasser T, 1998, EUR J IMMUNOL, V28, P2045, DOI 10.1002/(SICI)1521-4141(199806)28:06<2045::AID-IMMU2045>3.0.CO;2-8
   Tanaka K, 2004, AM J PATHOL, V164, P567, DOI 10.1016/S0002-9440(10)63146-X
   Thurner B, 1999, J IMMUNOL METHODS, V223, P1, DOI 10.1016/S0022-1759(98)00208-7
   Trinchieri G, 1995, CIBA F SYMP, V195, P203
   Tsujimura H, 2004, J IMMUNOL, V172, P6820, DOI 10.4049/jimmunol.172.11.6820
   Verhasselt V, 1997, J IMMUNOL, V158, P2919
   Vieira PL, 2000, J IMMUNOL, V164, P4507, DOI 10.4049/jimmunol.164.9.4507
   Weiss JM, 1997, J CELL BIOL, V137, P1137, DOI 10.1083/jcb.137.5.1137
   WEISS JM, 1995, EUR J IMMUNOL, V25, P2858, DOI 10.1002/eji.1830251022
   Weiss JM, 2001, J EXP MED, V194, P1219, DOI 10.1084/jem.194.9.1219
   Weiss JM, 1998, CELL ADHES COMMUN, V6, P157, DOI 10.3109/15419069809004472
   Wilson HL, 2003, BLOOD, V102, P1661, DOI 10.1182/blood-2002-08-2426
   Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778
NR 65
TC 121
Z9 137
U1 0
U2 7
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD AUG 1
PY 2005
VL 106
IS 3
BP 946
EP 955
DI 10.1182/blood-2004-08-3228
PG 10
WC Hematology
SC Hematology
GA 951RT
UT WOS:000230949100038
PM 15855273
DA 2021-01-25
ER

PT J
AU Philippsen, P
   Kaufmann, A
   Schmitz, HP
AF Philippsen, P
   Kaufmann, A
   Schmitz, HP
TI Homologues of yeast polarity genes control the development of
   multinucleated hyphae in Ashbya gossypii
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID TRANSCRIPTION FACTOR PHO4; BUD SITE SELECTION; SACCHAROMYCES-CEREVISIAE;
   ACTIN CYTOSKELETON; CELL POLARITY; BUDDING YEAST; PROTEIN; GROWTH;
   PHOSPHORYLATION; MORPHOGENESIS
AB A few years ago, A. gossypii became recognized as an attractive model to study the growth of long and multinucleated fungal cells (hyphae) because of its small genome, haploid nuclei, and efficient gene targeting methods. It is generally assumed that a better understanding of filamentous fungal growth will greatly stimulate the development of novel fungicides. The use of Ashbya grossypii as a model is particularly promising because of the high level of gene order conservation (synteny) between the genomes of A. gossypii and the yeast Saccharomyces cerevisiae. Thus, a similar set of genes seems to control the surprisingly different growth modes of these two organisms, which predicts that orthologous growth control genes might not play identical cellular roles in both systems. Analyzing the phenotypes of A. gossypii mutants lacking factors with known functions in yeast morphogenesis and nuclear dynamics confirm this hypothesis. Comparative genomics of both organisms also reveals rare examples of differences in the gene sets for some cellular processes, which as shown for phosphate homeostasis can be associated with differences in control levels.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Osnabruck, D-49076 Osnabruck, Germany.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Schmitz, Hans-Peter/0000-0001-5449-4593
CR Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121
   Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022
   BATRA L R, 1973, U S Department of Agriculture Technical Bulletin, V1469, P1
   Bauer Y, 2004, MOL BIOL CELL, V15, P4622, DOI 10.1091/mbc.E04-02-0104
   BENDER A, 1998, MOL CELL BIOL, V86, P9976
   Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716
   Cid VJ, 1998, MICROBIOL-SGM, V144, P25, DOI 10.1099/00221287-144-1-25
   DAMMER KH, 1990, ARCH PHYTOPATHOL PFL, V26, P71, DOI 10.1080/03235409009438945
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118
   Evangelista Marie, 2002, Nature Cell Biology, V4, P260
   Gulli MP, 2000, MOL CELL, V6, P1155, DOI 10.1016/S1097-2765(00)00113-1
   Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005
   Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4
   Kaffman A, 1998, GENE DEV, V12, P2673, DOI 10.1101/gad.12.17.2673
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Komeili A, 1999, SCIENCE, V284, P977, DOI 10.1126/science.284.5416.977
   Li HJ, 2002, YEAST, V19, P1097, DOI 10.1002/yea.904
   Lipschutz JH, 2002, CURR BIOL, V12, pR212, DOI 10.1016/S0960-9822(02)00753-4
   Madania A, 1999, MOL BIOL CELL, V10, P3521, DOI 10.1091/mbc.10.10.3521
   Mulholland J, 1997, MOL BIOL CELL, V8, P1481
   Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309
   Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323
   Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9
   Pruyne D, 2000, J CELL SCI, V113, P571
   Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719
   Schmitz HP, 2003, YEAST, V20, pS65
   Sheu YJ, 2000, MOL CELL BIOL, V20, P5235, DOI 10.1128/MCB.20.14.5235-5247.2000
   SHEU YJ, 1990, J CELL BIOL, V18, P4053
   Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028
   Stahmann KP, 2000, APPL MICROBIOL BIOT, V53, P509, DOI 10.1007/s002530051649
   STAHMANN KP, 1994, APPL MICROBIOL BIOT, V42, P121, DOI 10.1007/s002530050226
   STEINER S, 1995, GENETICS, V140, P973
   THEVELEIN JM, 1984, J BACTERIOL, V158, P337, DOI 10.1128/JB.158.1.337-339.1984
   Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377
   Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005
   WANG TT, 1995, MOL BIOL CELL, V6, P1011
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727
   Wendland J, 2002, FUNGAL GENET BIOL, V37, P81, DOI 10.1016/S1087-1845(02)00034-8
   Wendland J, 2001, GENETICS, V157, P601
   Wendland J, 2000, J CELL SCI, V113, P1611
   Zahner JE, 1996, MOL CELL BIOL, V16, P1857
NR 48
TC 34
Z9 36
U1 0
U2 3
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD AUG
PY 2005
VL 8
IS 4
BP 370
EP 377
DI 10.1016/j.mib.2005.06.021
PG 8
WC Microbiology
SC Microbiology
GA 957OB
UT WOS:000231378100003
PM 16023404
DA 2021-01-25
ER

PT J
AU Merabet, S
   Ebner, A
   Affolter, M
AF Merabet, S
   Ebner, A
   Affolter, M
TI The Drosophila Extradenticle and Homothorax selector proteins control
   branchless/FGF expression in mesodermal bridge-cells
SO EMBO REPORTS
LA English
DT Article
DE cell migration; FGF; Hox proteins; Hunchback; organogenesis
ID BRANCHING MORPHOGENESIS; TRACHEAL SYSTEM; GENETIC-CONTROL; FINGER
   PROTEIN; MIGRATION; FGF; ENCODES; HOMOLOG; LOCALIZATION; OUTGROWTH
AB The stereotyped outgrowth of tubular branches of the Drosophila tracheal system is orchestrated by the local and highly dynamic expression profile of branchless (bnl), which encodes a secreted fibroblast growth factor (FGF)-like molecule. Despite the importance of the spatial and temporal bnl regulation, little is known about the upstream mechanisms that establish its complex expression pattern. Here, we show that the Extradenticle and Homothorax selector proteins control bnl transcription in a single cell per segment, the mesodermal bridge-cell. in addition, we observed that a key determinant of bridge-cell specification, the transcription factor Hunchback, is also required for bnl expression. Therefore, we propose that one of the functions of the bridge-cell is to synthesize and secrete the chemoattractant Bnl. These findings provide a hitherto unknown and interesting link between combinatorial inputs of transcription factors, cell-specific ligand expression and organ morphogenesis.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
CR Abu-Shaar M, 1999, GENE DEV, V13, P935, DOI 10.1101/gad.13.8.935
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   Dossenbach C, 2001, DEVELOPMENT, V128, P4563
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209
   RAUSKOLB C, 1993, CELL, V74, P1101, DOI 10.1016/0092-8674(93)90731-5
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0
   TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041
   Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Wolf C, 2002, EMBO REP, V3, P563, DOI 10.1093/embo-reports/kvf115
   Wolf C, 2000, GENE DEV, V14, P2140, DOI 10.1101/gad.180900
NR 25
TC 14
Z9 14
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-221X
EI 1469-3178
J9 EMBO REP
JI EMBO Rep.
PD AUG
PY 2005
VL 6
IS 8
BP 762
EP 768
DI 10.1038/sj.embor.7400462
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 955TC
UT WOS:000231249500016
PM 16007069
OA Green Published
DA 2021-01-25
ER

PT J
AU Nguyen, L
   Walburger, A
   Houben, E
   Koul, A
   Muller, S
   Morbitzer, M
   Klebl, B
   Ferrari, G
   Pieters, J
AF Nguyen, L
   Walburger, A
   Houben, E
   Koul, A
   Muller, S
   Morbitzer, M
   Klebl, B
   Ferrari, G
   Pieters, J
TI Role of protein kinase G in growth and glutamine metabolism of
   Mycobacterium bovis BCG
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID PATHOGENIC MYCOBACTERIA; GENOME SEQUENCE; AMINO-ACIDS; IN-VIVO;
   TUBERCULOSIS; SYNTHETASE; MACROPHAGES; SURVIVAL
AB The survival of pathogenic mycobacteria in macrophages requires the eukaryotic enzyme-like serine/threonine protein kinase G. This kinase with unknown specificity is secreted into the cytosol of infected macrophages and inhibits phagosome-lysosome fusion. The pknG gene is the terminal gene in a putative operon containing glnH, encoding a protein potentially involved in glutamine uptake. Here, we report that the deletion of pknG did not affect either glutamine uptake or intracellular glutamine concentrations. In vitro growth of Mycobacterium bovis BCG lacking pknG was identical to that of the wild type. We conclude that in M. bovis BCG, glutamine metabolism is not regulated by protein kinase G.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Axxima Pharmaceut, Munich, Germany.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Houben, Edith N.G./B-2110-2015
OI Houben, Edith N.G./0000-0002-8805-2002; Nguyen,
   Liem/0000-0002-1523-1472; Pieters, Jean/0000-0002-5284-9757
CR Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   BIDLINGMEYER BA, 1987, J ASSOC OFF ANA CHEM, V70, P241
   BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6
   Braibant M, 2000, FEMS MICROBIOL REV, V24, P449, DOI 10.1016/S0168-6445(00)00034-6
   CHANG JY, 1991, ANAL BIOCHEM, V197, P52, DOI 10.1016/0003-2697(91)90354-V
   Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Gatfield J, 2003, ADV IMMUNOL, V81, P45, DOI 10.1016/S0065-2776(03)81002-7
   HARTH G, 1994, P NATL ACAD SCI USA, V91, P9342, DOI 10.1073/pnas.91.20.9342
   Harth G, 2000, P NATL ACAD SCI USA, V97, P418, DOI 10.1073/pnas.97.1.418
   Harth G, 1999, J EXP MED, V189, P1425, DOI 10.1084/jem.189.9.1425
   NOHNO T, 1986, MOL GEN GENET, V205, P260, DOI 10.1007/BF00430437
   PARISH T, 1998, MYCOBACTERIA PROTOCO
   Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399
   Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
NR 19
TC 49
Z9 54
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD AUG
PY 2005
VL 187
IS 16
BP 5852
EP 5856
DI 10.1128/JB.187.16.5852-5856.2005
PG 5
WC Microbiology
SC Microbiology
GA 952SQ
UT WOS:000231026200041
PM 16077135
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Gnerre, C
   Schuster, GU
   Roth, A
   Handschin, C
   Johansson, L
   Looser, R
   Parini, P
   Podvinec, M
   Robertsson, K
   Gustafsson, JA
   Meyer, UA
AF Gnerre, C
   Schuster, GU
   Roth, A
   Handschin, C
   Johansson, L
   Looser, R
   Parini, P
   Podvinec, M
   Robertsson, K
   Gustafsson, JA
   Meyer, UA
TI LXR deficiency and cholesterol feeding affect the expression and
   phenobarbital-mediated induction of cytochromes P450 in mouse liver
SO JOURNAL OF LIPID RESEARCH
LA English
DT Article
DE liver X receptor; pregnane X receptor; constitutive androstane receptor;
   metabolism; cytochrome P450 3a11; cytochrome P450 2b10
ID CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; ORPHAN NUCLEAR
   RECEPTOR; BILE-ACID BIOSYNTHESIS; ANTIEPILEPTIC DRUGS;
   DIETARY-CHOLESTEROL; EPILEPTIC CHILDREN; LITHOCHOLIC ACID;
   GENE-EXPRESSION; SERUM-LIPIDS
AB Metabolic transformation by the superfamily of cytochromes P450 ( CYPs) plays an important role in the detoxification of xenobiotics such as drugs, environmental pollutants, and food additives. Endogenous substrates of CYPs include fatty acids, sterols, steroids, and bile acids. Induction of CYPs via transcriptional activation by substrates and other xenobiotics is an important adaptive mechanism that increases the organism's defense capability against toxicity. Numerous in vivo and in vitro data have highlighted the concept that the molecular mechanism of hepatic drug induction is linked to endogenous regulatory pathways. In particular, in vitro data suggest that oxysterols via the liver X receptor (LXR) inhibit phenobarbital (PB)-mediated induction of CYPs. To study the link between LXR, cholesterol homeostasis, and drug induction in vivo, we designed experiments in wild-type, LXR alpha-, LXR beta-, and LXR alpha/beta-deficient mice. Our data expose differential regulatory patterns for Cyp2b10 and Cyp3a11 dependent on the expression of LXR isoforms and on challenge of cholesterol homeostasis by excess dietary cholesterol. Our results suggest that, in the mouse, liver cholesterol status significantly alters the pattern of expression of Cyp3a11, whereas the absence of LXR leads to an increase in PB-mediated activation of Cyp2b10.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   Karolinska Inst, Novum, Dept Biosci, S-14157 Huddinge, Sweden.
   Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
   Huddinge Univ Hosp, Karolinska Inst, Novum, Ctr Metab & Endocrinol,Dept Med, S-14186 Huddinge, Sweden.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794
   Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Aynaci FM, 2001, J CHILD NEUROL, V16, P367
   Baader M, 2002, J BIOL CHEM, V277, P15647, DOI 10.1074/jbc.M109882200
   Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200
   BOSHART M, 1992, GENE, V110, P129, DOI 10.1016/0378-1119(92)90456-Y
   Brooks-Wilson A, 1999, NAT GENET, V22, P336
   Cherrington NJ, 2003, DRUG METAB DISPOS, V31, P1315, DOI 10.1124/dmd.31.11.1315
   Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   EIRIS JM, 1995, NEUROLOGY, V45, P1155, DOI 10.1212/WNL.45.6.1155
   Ferguson SS, 2002, MOL PHARMACOL, V62, P737, DOI 10.1124/mol.62.3.737
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   GONZALEZ FJ, 1993, PHARMACOGENETICS, V3, P51, DOI 10.1097/00008571-199302000-00006
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 2000, BIOCHEM J, V347, P321, DOI 10.1042/0264-6021:3470321
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Klucken J, 2000, P NATL ACAD SCI USA, V97, P817, DOI 10.1073/pnas.97.2.817
   Kosters A, 2003, J HEPATOL, V38, P710, DOI 10.1016/S0168-8278(03)00093-X
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Nebert DW, 2000, PHARMACOLOGY, V61, P124, DOI 10.1159/000028393
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   REMMER H, 1963, SCIENCE, V142, P1657, DOI 10.1126/science.142.3600.1657
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001
   SAUCIER SE, 1989, J BIOL CHEM, V264, P6863
   Schoonjans K, 1996, J LIPID RES, V37, P907
   Schuster GU, 2002, CIRCULATION, V106, P1147, DOI 10.1161/01.CIR.0000026802.79202.96
   Schwaninger M, 2000, J NEUROL, V247, P687, DOI 10.1007/s004150070111
   Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66
   Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   SUDJANASUGIAMAN E, 1994, BIOCHEM BIOPH RES CO, V2002, P896
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   THOMAS KD, 1984, ISRAEL J MED SCI, V20, P240
   Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Verrotti A, 1997, J PAEDIATR CHILD H, V33, P242, DOI 10.1111/j.1440-1754.1997.tb01588.x
   Wang HB, 2003, CURR DRUG METAB, V4, P515, DOI 10.2174/1389200033489262
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Yilmaz E, 2001, ACTA NEUROL BELG, V101, P217
   Zhang Z, 2001, J LIPID RES, V42, P649
NR 50
TC 27
Z9 28
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0022-2275
EI 1539-7262
J9 J LIPID RES
JI J. Lipid Res.
PD AUG
PY 2005
VL 46
IS 8
BP 1633
EP 1642
DI 10.1194/jlr.M400453-JLR200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 946UB
UT WOS:000230597400008
PM 15930522
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Aumailley, M
   Bruckner-Tuderman, L
   Carter, WG
   Deutzmann, R
   Edgar, D
   Ekblom, P
   Engel, J
   Engvall, E
   Hohenester, E
   Jones, JCR
   Kleinman, HK
   Marinkovich, MP
   Martin, GR
   Mayer, U
   Meneguzzi, G
   Miner, JH
   Miyazaki, K
   Patarroyo, M
   Paulsson, M
   Quaranta, V
   Sanes, JR
   Sasaki, T
   Sekiguchi, K
   Sorokin, LM
   Talts, JF
   Tryggvason, K
   Uitto, J
   Virtanen, I
   von der Mark, K
   Wewer, UM
   Yamada, Y
   Yurchenco, PD
AF Aumailley, M
   Bruckner-Tuderman, L
   Carter, WG
   Deutzmann, R
   Edgar, D
   Ekblom, P
   Engel, J
   Engvall, E
   Hohenester, E
   Jones, JCR
   Kleinman, HK
   Marinkovich, MP
   Martin, GR
   Mayer, U
   Meneguzzi, G
   Miner, JH
   Miyazaki, K
   Patarroyo, M
   Paulsson, M
   Quaranta, V
   Sanes, JR
   Sasaki, T
   Sekiguchi, K
   Sorokin, LM
   Talts, JF
   Tryggvason, K
   Uitto, J
   Virtanen, I
   von der Mark, K
   Wewer, UM
   Yamada, Y
   Yurchenco, PD
TI A simplified laminin nomenclature
SO MATRIX BIOLOGY
LA English
DT Review
DE basement membrane; laminin; laminin-type domains; nomenclature
AB A simplification of the laminin nomenclature is presented. Laminins are multidomain heterotrimers composed of alpha, beta and gamma chains. Previously, laminin trimers were numbered with Arabic numerals in the order discovered, that is laminins-1 to -5. We introduce a new identification system for a trimer using three Arabic numerals, based on the alpha, beta and gamma chain numbers. For example, the laminin with the chain composition alpha 5 beta 1 gamma 1 is termed laminin-511, and not laminin-10. The current practice is also to mix two overlapping domain and module nomenclatures. Instead of the older Roman numeral nomenclature and mixed nomenclature, all modules are now called domains. Some domains are renamed or renumbered. Laminin epidermal growth factor-like (LE) domains are renumbered starting at the N-termini, to be consistent with general protein nomenclature. Domain IVb of alpha chains is named laminin 4a (L4a), domain IVa of alpha chains is named L4b, domain IV of gamma chains is named L4, and domain IV of beta chains is named laminin four (LF). The two coiled-coil domains I and II are now considered one laminin coiled-coil domain (LCC). The interruption in the coiled-coil of 13 chains is named laminin beta-knob (L beta) domain. The chain origin of a domain is specified by the chain nomenclature, such as alpha IL4a. The abbreviation LM is suggested for laminin. Otherwise, the nomenclature remains unaltered. (C) 2005 Elsevier B.V./Intemational Society of Matrix Biology. All rights reserved.
C1 Lund Univ, Dept Expt Med Sci, Lund, Sweden.
   Univ Cologne, Fac Med, Ctr Biochem, Cologne, Germany.
   Univ Freiburg, Dept Dermatol, D-7800 Freiburg, Germany.
   Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA.
   Univ Regensburg, Dept Biochem Microbiol & Genet, D-8400 Regensburg, Germany.
   Univ Liverpool, Dept Anat, Liverpool L69 3BX, Merseyside, England.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Burnham Inst, La Jolla, CA 92037 USA.
   Univ London Imperial Coll Sci & Technol, Dept Biol Sci, London, England.
   Northwestern Univ, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
   Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA.
   Stanford Univ, Sch Med, VA Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA.
   Stanford Univ, Sch Med, Program Epithelial Biol, Palo Alto, CA 94304 USA.
   Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England.
   Univ Nice, Sch Med, INSERM, U634, Nice, France.
   Washington Univ, Sch Med, Div Renal, St Louis, MO 63110 USA.
   Yokohama City Univ, Kihara Inst Biol Res, Yokohama, Kanagawa 232, Japan.
   Karolinska Inst, Dept Odontol, Stockholm, Sweden.
   Vanderbilt Univ, Dept Canc Biol, Nashville, TN USA.
   Harvard Univ, Ctr Brain Sci, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.
   Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   Osaka Univ, Inst Prot Res, Osaka, Japan.
   Lund Univ, Dept Expt Pathol, Lund, Sweden.
   Royal Vet & Agr Univ, Dept Anim & Vet Basic Sci, Frederiksberg, Denmark.
   Karolinska Inst, Dept Biochem & Biophys, Stockholm, Sweden.
   Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA.
   Univ Helsinki, Dept Anat, FIN-00014 Helsinki, Finland.
   Univ Erlangen Nurnberg, Dept Expt Med 1, Erlangen, Germany.
   Univ Copenhagen, Inst Mol Pathol, Copenhagen, Denmark.
   Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08854 USA.
RP Ekblom, P (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.
EM Peter.Ekblom@med.lu.se
RI Quaranta, Vito/G-6512-2016; Jones, Jonathan C R/T-9467-2017;
   von+der+Mark, Klaus/AAJ-1443-2020
OI Quaranta, Vito/0000-0001-7491-8672; Jones, Jonathan C
   R/0000-0002-1496-4922; Meneguzzi, Guerrino/0000-0002-1609-6540;
   Yurchenco, Peter/0000-0003-0387-2317; Mayer, Ulrike/0000-0003-2328-0052
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37 DK036425] Funding Source:
   Medline; Wellcome TrustWellcome Trust [054334] Funding Source: Medline;
   NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [Z01DE000230, Z01DE000230, Z01DE000485, Z01DE000485, Z01DE000485,
   Z01DE000230, Z01DE000230, Z01DE000230, Z01DE000485, Z01DE000485,
   Z01DE000230, Z01DE000485, Z01DE000230, Z01DE000485, Z01DE000230,
   Z01DE000485, Z01DE000230, Z01DE000485, Z01DE000485, Z01DE000485,
   Z01DE000230, Z01DE000230, Z01DE000485, Z01DE000485, Z01DE000485,
   Z01DE000485, Z01DE000230, Z01DE000485, Z01DE000485, Z01DE000230,
   Z01DE000485, Z01DE000230, Z01DE000230, Z01DE000485, Z01DE000230,
   Z01DE000230, Z01DE000230, Z01DE000230, Z01DE000230] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [R37DK036425, R37DK036425,
   R37DK036425, R37DK036425, R37DK036425, R37DK036425, R37DK036425,
   R37DK036425, R37DK036425, R37DK036425] Funding Source: NIH RePORTER
CR BAIROCH A, 1994, NOMENCLATURE EXTRACE
   BECK K, 1990, FASEB J, V4, P148
   BURGESON RE, 1994, MATRIX BIOL, V14, P209, DOI 10.1016/0945-053X(94)90184-8
   EKBLOM P, 1996, LAMININS, P1
   Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3
   MAURER P, 1996, LAMININS, P27
   Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555
   Sasaki T, 1999, GUIDEBOOK EXTRACELLU, P434
   TIMPL R, 1979, J BIOL CHEM, V254, P9933
   Yurchenco PD, 2002, METHOD CELL BIOL, V69, P111, DOI 10.1016/S0091-679X(02)69010-7
NR 10
TC 570
Z9 585
U1 2
U2 49
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD AUG
PY 2005
VL 24
IS 5
BP 326
EP 332
DI 10.1016/j.matbio.2005.05.006
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 955DL
UT WOS:000231205300002
PM 15979864
DA 2021-01-25
ER

PT J
AU Ingham, RJ
   Colwill, K
   Howard, C
   Dettwiler, S
   Lim, CSH
   Yu, J
   Hersi, K
   Raaijmakers, J
   Gish, G
   Mbamalu, G
   Taylor, L
   Yeung, B
   Vassilovski, G
   Amin, M
   Chen, F
   Matskova, L
   Winberg, G
   Ernberg, I
   Linding, R
   O'Donnell, P
   Starostine, A
   Keller, W
   Metalnikov, P
   Stark, C
   Pawson, T
AF Ingham, RJ
   Colwill, K
   Howard, C
   Dettwiler, S
   Lim, CSH
   Yu, J
   Hersi, K
   Raaijmakers, J
   Gish, G
   Mbamalu, G
   Taylor, L
   Yeung, B
   Vassilovski, G
   Amin, M
   Chen, F
   Matskova, L
   Winberg, G
   Ernberg, I
   Linding, R
   O'Donnell, P
   Starostine, A
   Keller, W
   Metalnikov, P
   Stark, C
   Pawson, T
TI WW domains provide a platform for the assembly of multiprotein networks
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID UBIQUITIN-PROTEIN LIGASE; RNA-POLYMERASE-II; EPITHELIAL NA+ CHANNEL;
   YES-ASSOCIATED PROTEIN; PROLYL ISOMERASE PIN1; TRANSCRIPTION FACTOR;
   CA150 INTERACTS; NEDD4; BINDING; CLEAVAGE
AB WW domains are protein modules that mediate protein-protein interactions through recognition of proline-rich peptide motifs and phosphorylated serine/threonine-proline sites. To pursue the functional properties of WW domains, we employed mass spectrometry to identify 148 proteins that associate with 10 human WW domains. Many of these proteins represent novel WW domain-binding partners and are components of multiprotein complexes involved in molecular processes, such as transcription, RNA processing, and cytoskeletal regulation. We validated one complex in detail, showing that WW domains of the AIP4 E3 protein-ubiquitin ligase bind directly to a PPXY motif in the p68 subunit of pre-mRNA cleavage and polyadenylation factor Im in a manner that promotes p68 ubiquitylation. The tested WW domains fall into three broad groups on the basis of hierarchical clustering with respect to their associated proteins; each such cluster of bound proteins displayed a distinct set of WW domain-binding motifs. We also found that separate WW domains from the same protein or closely related proteins can have different specificities for protein ligands and also demonstrated that a single polypeptide can bind multiple classes of WW domains through separate proline-rich motifs. These data suggest that WW domains provide a versatile platform to link individual proteins into physiologically important networks.
C1 Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.
   Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada.
   Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Karolinska Inst, Ctr Microbiol & Tumor Biol, MTC, SE-171 Stockholm, Sweden.
RP Pawson, T (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.
EM pawson@mshri.on.ca
RI Winberg, Gosta/I-5686-2013; Gish, Gerald/C-7228-2017; Pawson,
   Tony/E-4578-2013; Matskova, Liudmila/J-3843-2017; Colwill,
   Karen/K-5101-2012; Matskova, Liudmila/AAF-4201-2020
OI Matskova, Liudmila/0000-0002-3174-1560; Colwill,
   Karen/0000-0002-8979-1659; Matskova, Liudmila/0000-0002-3174-1560;
   Winberg, Gosta/0000-0002-3371-4056; Linding, Rune/0000-0003-0420-4839
CR Beaudenon SL, 1999, MOL CELL BIOL, V19, P6972
   Bedford MT, 2000, J BIOL CHEM, V275, P10359, DOI 10.1074/jbc.275.14.10359
   Bedford MT, 1997, EMBO J, V16, P2376, DOI 10.1093/emboj/16.9.2376
   Bednarek AK, 2000, CANCER RES, V60, P2140
   Bompard G, 2004, J CELL BIOL, V166, P957, DOI 10.1083/jcb.200403127
   BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1
   Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22
   Buschdorf JP, 2004, J MOL MED, V82, P135, DOI 10.1007/s00109-003-0497-9
   Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9
   Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403
   Castellano F, 2001, EMBO J, V20, P5603, DOI 10.1093/emboj/20.20.5603
   Chang A, 2000, J BIOL CHEM, V275, P20562, DOI 10.1074/jbc.M002479200
   Chen HI, 1997, J BIOL CHEM, V272, P17070, DOI 10.1074/jbc.272.27.17070
   CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819
   Chung W, 1999, Mol Cell Biol Res Commun, V2, P162, DOI 10.1006/mcbr.1999.0168
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869
   Espanel X, 1999, J BIOL CHEM, V274, P17284, DOI 10.1074/jbc.274.24.17284
   Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463
   Fan H, 2003, BIOCHEM BIOPH RES CO, V301, P378, DOI 10.1016/S0006-291X(02)03015-2
   Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje
   Frank R, 2002, J IMMUNOL METHODS, V267, P13, DOI 10.1016/S0022-1759(02)00137-0
   Gautreau A, 2004, P NATL ACAD SCI USA, V101, P4379, DOI 10.1073/pnas.0400628101
   Goldstrohm AC, 2001, MOL CELL BIOL, V21, P7617, DOI 10.1128/MCB.21.22.7617-7628.2001
   Harvey KF, 1999, J BIOL CHEM, V274, P12525, DOI 10.1074/jbc.274.18.12525
   Holbert S, 2001, P NATL ACAD SCI USA, V98, P1811, DOI 10.1073/pnas.041566798
   HOUTHAEVE T, 1995, FEBS LETT, V376, P91, DOI 10.1016/0014-5793(95)01242-7
   Hu H, 2004, PROTEOMICS, V4, P643, DOI 10.1002/pmic.200300632
   Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923
   Ikeda M, 2000, VIROLOGY, V268, P178, DOI 10.1006/viro.1999.0166
   Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4
   Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436
   Ingham RJ, 2001, J BIOL CHEM, V276, P12257, DOI 10.1074/jbc.M010590200
   Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105
   Jolliffe CN, 2000, BIOCHEM J, V351, P557, DOI 10.1042/0264-6021:3510557
   Kaiser P, 2000, CELL, V102, P303, DOI 10.1016/S0092-8674(00)00036-2
   Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562
   Kato Y, 2004, J BIOL CHEM, V279, P31833, DOI 10.1074/jbc.M404719200
   Komuro A, 1999, J BIOL CHEM, V274, P36513, DOI 10.1074/jbc.274.51.36513
   Kovar H, 2003, ADV EXP MED BIOL, V532, P27
   Krebs Danielle L., 1999, Methods in Cell Science, V21, P57, DOI 10.1023/A:1009843325770
   Kuras L, 2002, MOL CELL, V10, P69, DOI 10.1016/S1097-2765(02)00561-0
   Lambrechts A, 2000, J BIOL CHEM, V275, P36143, DOI 10.1074/jbc.M006274200
   Lin KT, 2004, MOL CELL BIOL, V24, P9176, DOI 10.1128/MCB.24.20.9176-9185.2004
   Liou YC, 2003, NATURE, V424, P556, DOI 10.1038/nature01832
   Lott JS, 2002, BIOCHEM J, V361, P481, DOI 10.1042/0264-6021:3610481
   Lu PJ, 1999, NATURE, V399, P784
   Lu PJ, 1999, SCIENCE, V283, P1325, DOI 10.1126/science.283.5406.1325
   Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0
   Marchler-Bauer A, 2005, NUCLEIC ACIDS RES, V33, pD192, DOI 10.1093/nar/gki069
   Mizutani K, 2004, BIOCHEM BIOPH RES CO, V313, P468, DOI 10.1016/j.bbrc.2003.11.139
   Murillas R, 2002, J BIOL CHEM, V277, P2897, DOI 10.1074/jbc.M110047200
   Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203
   Passani LA, 2000, HUM MOL GENET, V9, P2175, DOI 10.1093/hmg/9.14.2175
   Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Perry WL, 1998, NAT GENET, V18, P143, DOI 10.1038/ng0298-143
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Ruegsegger U, 1998, MOL CELL, V1, P243, DOI 10.1016/S1097-2765(00)80025-8
   Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324
   Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200
   Smith MJ, 2004, MOL CELL BIOL, V24, P9274, DOI 10.1128/MCB.24.21.9274-9285.2004
   Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200
   Sokal R. R., 1958, U KANSAS SCI B, V38, P1409
   Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x
   Sudol M, 2001, FEBS LETT, V490, P190, DOI 10.1016/S0014-5793(01)02122-6
   Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8
   Sune C, 1997, MOL CELL BIOL, V17, P6029, DOI 10.1128/MCB.17.10.6029
   Tominaga T, 2002, J BIOL CHEM, V277, P47686, DOI 10.1074/jbc.M207539200
   Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0
   Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929
   Wallar BJ, 2003, TRENDS CELL BIOL, V13, P435, DOI 10.1016/S0962-8924(03)00153-3
   Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000
   Wulf GM, 2001, EMBO J, V20, P3459, DOI 10.1093/emboj/20.13.3459
   Yaffe MB, 1997, SCIENCE, V278, P1957, DOI 10.1126/science.278.5345.1957
NR 76
TC 149
Z9 154
U1 0
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD AUG
PY 2005
VL 25
IS 16
BP 7092
EP 7106
DI 10.1128/MCB.25.16.7092-7106.2005
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 952JW
UT WOS:000231000800021
PM 16055720
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kamada, Y
   Fujioka, Y
   Suzuki, NN
   Inagaki, F
   Wullschleger, S
   Loewith, R
   Hall, MN
   Ohsumi, Y
AF Kamada, Y
   Fujioka, Y
   Suzuki, NN
   Inagaki, F
   Wullschleger, S
   Loewith, R
   Hall, MN
   Ohsumi, Y
TI Tor2 directly phosphorylates the AGC kinase Ypk2 to regulate actin
   polarization
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; CELL-GROWTH; SIGNALING PATHWAY;
   SCHIZOSACCHAROMYCES-POMBE; TRANSLATION INITIATION; PROTEIN-KINASES;
   YEAST; STARVATION; HOMOLOG; CYTOSKELETON
AB The target of rapamycin (TOR) protein kinases, Tor1 and Tor2, form two distinct complexes (TOR complex I and 2) in the yeast Saccharomyces cerevisiae. TOR complex 2 (TORC2) contains Tor2 but not Tor1 and controls polarity of the actin cytoskeleton via the Rho1/Pkc1/MAPK cell integrity cascade. Substrates of TORC2 and how TORC2 regulates the cell integrity pathway are not well understood. Screening for multicopy suppressors of tor2, we obtained a plasmid expressing an N-terminally truncated Ypk2 protein kinase. This truncation appears to partially disrupt an autoinhibitory domain in Ypk2, and a point mutation in this region (Ypk2(D239A)) conferred upon full-length Ypk2 the ability to rescue growth of cells compromised in TORC2, but not TORCI, function. YPK2(D239A) also suppressed the lethality of tor2 Delta cells, suggesting that Ypks play an essential role in TORC2 signaling. Ypk2 is phosphorylated directly by Tor2 in vitro, and Ypk2 activity is largely reduced in tor2 Delta cells. In contrast, Ypk2(D239A) has increased and TOR2-independent activity in vivo. Thus, we propose that Ypk protein kinases are direct and essential targets of TORC2, coupling TORC2 to the cell integrity cascade.
C1 Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Aichi 4448585, Japan.
   Japan Sci & Technol Agcy, CREST, Kawaguchi 3320012, Japan.
   Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Sapporo, Hokkaido, Japan.
   Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Kamada, Y (corresponding author), Natl Inst Basic Biol, Dept Cell Biol, Maiodaiji Cho, Okazaki, Aichi 4448585, Japan.
EM yoshikam@nibb.ac.jp
RI Loewith, Robbie/S-6289-2016; Ohsumi, Yoshinori/C-6449-2009; Noda, Nobuo
   N./P-1397-2015
OI Loewith, Robbie/0000-0002-2482-603X; Ohsumi,
   Yoshinori/0000-0003-2384-2166; Noda, Nobuo N./0000-0002-6940-8069;
   Fujioka, Yuko/0000-0002-6905-0669; Hall, Michael N/0000-0002-2998-0757
CR Audhya A, 2004, EMBO J, V23, P3747, DOI 10.1038/sj.emboj.7600384
   Barbet NC, 1996, MOL BIOL CELL, V7, P25
   Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8
   CHEN P, 1993, MOL GEN GENET, V236, P443, DOI 10.1007/BF00277146
   Cherkasova VA, 2003, GENE DEV, V17, P859, DOI 10.1101/gad.1069003
   deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323
   deHart AKA, 2002, J CELL BIOL, V156, P241, DOI 10.1083/jcb.200107135
   Friant S, 2001, EMBO J, V20, P6783, DOI 10.1093/emboj/20.23.6783
   Gelperin D, 2002, GENETICS, V161, P1453
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harris Thurl E, 2003, Sci STKE, V2003, pre15
   Helliwell SB, 1998, GENETICS, V148, P99
   Hilti N, 1999, CURR GENET, V35, P585, DOI 10.1007/s002940050456
   Inagaki M, 1999, MOL CELL BIOL, V19, P8344
   Isotani S, 1999, J BIOL CHEM, V274, P34493, DOI 10.1074/jbc.274.48.34493
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   Kaiser C, 1994, METHODS YEAST GENETI
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   KAMADA Y, 1995, GENE DEV, V9, P1559, DOI 10.1101/gad.9.13.1559
   Kawai M, 2001, CURR GENET, V39, P166
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Krause SA, 2002, CURR BIOL, V12, P588, DOI 10.1016/S0960-9822(02)00760-1
   Kubota H, 2003, J BIOL CHEM, V278, P20457, DOI 10.1074/jbc.C300133200
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298
   Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704
   Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Roelants FM, 2002, MOL BIOL CELL, V13, P3005, DOI 10.1091/mbc.E02-04-0201
   Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5
   Schmelzle T, 2002, MOL CELL BIOL, V22, P1329, DOI 10.1128/MCB.22.5.1329-1339.2002
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Sun YD, 2000, MOL CELL BIOL, V20, P4411, DOI 10.1128/MCB.20.12.4411-4419.2000
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Wilkinson MG, 1999, EMBO J, V18, P4210, DOI 10.1093/emboj/18.15.4210
NR 38
TC 150
Z9 156
U1 1
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD AUG
PY 2005
VL 25
IS 16
BP 7239
EP 7248
DI 10.1128/MCB.25.16.7239-7248.2005
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 952JW
UT WOS:000231000800033
PM 16055732
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hahner, S
   Brand, S
   Jeno, P
   Jabs, W
   Vorweg, L
   Suckau, D
AF Hahner, S.
   Brand, S.
   Jenoe, P.
   Jabs, W.
   Vorweg, L.
   Suckau, D.
TI LC-MALDI for advanced characterization of complex protein samples
SO MOLECULAR & CELLULAR PROTEOMICS
LA English
DT Meeting Abstract
C1 [Hahner, S.; Brand, S.; Vorweg, L.; Suckau, D.] Bruker Daltonik GmbH, D-28359 Bremen, Germany.
   [Jenoe, P.] Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 1535-9476
J9 MOL CELL PROTEOMICS
JI Mol. Cell. Proteomics
PD AUG
PY 2005
VL 4
IS 8
SU 1
BP S217
EP S217
PG 1
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA V44IB
UT WOS:000202995300557
DA 2021-01-25
ER

PT J
AU Frederix, PLTM
   Gullo, MR
   Akiyama, T
   Tonin, A
   de Rooij, NF
   Staufer, U
   Engel, A
AF Frederix, PLTM
   Gullo, MR
   Akiyama, T
   Tonin, A
   de Rooij, NF
   Staufer, U
   Engel, A
TI Assessment of insulated conductive cantilevers for biology and
   electrochemistry
SO NANOTECHNOLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; ELECTRODE SURFACES; TIPS
AB This paper describes the characterization and application of electrically insulated conductive tips mounted on a cantilever for use in an atomic force microscope and operated in liquid. These multifunctional probes were microfabricated and designed for measurements on biological samples in buffer solution, but they can also be employed for electrochemical applications, in particular scanning electrochemical microscopy. The silicon nitride based cantilevers had a spring constant <= 0.1 N m(-1) and a conductive tip, which was insulated except at the apex. The conductive core of the tip consisted of a metal, e.g. platinum silicide, and exhibited a typical radius of 15 nm. The mechanical and electrical characterization of the probe is presented and discussed. First measurements on the hexagonally packed intermediate layer of Deinococcus radiodurans demonstrated the possibility to adjust the image contrast by applying a voltage between a support and the conductive tip and to measure variations of less than I pA in faradaic current with a lateral resolution of 7.8 nm.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Univ Neuchatel, Inst Microtechnol, CH-2007 Neuchatel, Switzerland.
   Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Gullo, Maurizio/B-4383-2012; Staufer, Urs/J-6866-2016
OI Staufer, Urs/0000-0002-3519-6467
CR Akiyama T, 2003, AIP CONF PROC, V696, P166
   Akiyama T, 2004, JPN J APPL PHYS 1, V43, P3865, DOI 10.1143/JJAP.43.3865
   ALBRECHT TR, 1990, J VAC SCI TECHNOL A, V8, P3386, DOI 10.1116/1.576520
   BARD AJ, 1989, ANAL CHEM, V61, P132, DOI 10.1021/ac00177a011
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNING G, 1982, PHYS REV LETT, V49, P57, DOI 10.1103/PhysRevLett.49.57
   BUTT HJ, 1992, BIOPHYS J, V63, P578, DOI 10.1016/S0006-3495(92)81601-6
   BUTT HJ, 1993, J MICROSC-OXFORD, V169, P75, DOI 10.1111/j.1365-2818.1993.tb03280.x
   Cussler E. L., 1997, DIFFUSION MASS TRANS
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   DURIG U, 1986, PHYS REV LETT, V57, P2403, DOI 10.1103/PhysRevLett.57.2403
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Fotiadis D, 1998, J MOL BIOL, V283, P83, DOI 10.1006/jmbi.1998.2097
   Frederix PLTM, 2003, CURR OPIN CHEM BIOL, V7, P641, DOI 10.1016/j.cbpa.2003.08.010
   Frederix PT, 2004, MRS BULL, V29, P449, DOI 10.1557/mrs2004.138
   HEBEN MJ, 1989, APPL PHYS LETT, V54, P1421, DOI 10.1063/1.100686
   HENZE G, 1986, ELEKTROCHEMISCHE ANA
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Kueng A, 2003, APPL PHYS LETT, V82, P1592, DOI 10.1063/1.1559652
   Lantz MA, 1998, REV SCI INSTRUM, V69, P1757, DOI 10.1063/1.1148838
   LIU HY, 1986, J AM CHEM SOC, V108, P3838, DOI 10.1021/ja00273a054
   Lugstein A, 2002, APPL PHYS LETT, V81, P349, DOI 10.1063/1.1492304
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   NAGAHARA LA, 1989, REV SCI INSTRUM, V60, P3128, DOI 10.1063/1.1140590
   OSHEA SJ, 1995, REV SCI INSTRUM, V66, P2508, DOI 10.1063/1.1145649
   Robinson R.A., 2002, ELECTROLYTE SOLUTION
   Sader JE, 1999, REV SCI INSTRUM, V70, P3967, DOI 10.1063/1.1150021
   Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002
   SALMERON M, 1991, J VAC SCI TECHNOL B, V9, P1347, DOI 10.1116/1.585194
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SONNENFELD R, 1986, SCIENCE, V232, P211, DOI 10.1126/science.232.4747.211
   SUGAWARA Y, 1991, J VAC SCI TECHNOL B, V9, P1092, DOI 10.1116/1.585267
   Zoski CG, 2004, ANAL CHEM, V76, P3646, DOI 10.1021/ac049938r
   Zoski CG, 2002, ELECTROANAL, V14, P1041, DOI 10.1002/1521-4109(200208)14:15/16<1041::AID-ELAN1041>3.0.CO;2-8
NR 36
TC 53
Z9 53
U1 0
U2 18
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD AUG
PY 2005
VL 16
IS 8
BP 997
EP 1005
DI 10.1088/0957-4484/16/8/001
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 957YX
UT WOS:000231410600001
DA 2021-01-25
ER

PT J
AU Bielle, F
   Griveau, A
   Narboux-Neme, N
   Vigneau, S
   Sigrist, M
   Arber, S
   Wassef, M
   Pierani, A
AF Bielle, F
   Griveau, A
   Narboux-Neme, N
   Vigneau, S
   Sigrist, M
   Arber, S
   Wassef, M
   Pierani, A
TI Multiple origins of Cajal-Retzius cells at the borders of the developing
   pallium
SO NATURE NEUROSCIENCE
LA English
DT Article
ID DEVELOPING CEREBRAL-CORTEX; MESSENGER-RNA EXPRESSION; SPINAL-CORD;
   GANGLIONIC EMINENCE; NEURONAL MIGRATION; MARGINAL ZONE; HIPPOCAMPAL
   CONNECTIONS; MAMMALIAN TELENCEPHALON; HOMEOBOX GENE; MOUSE
AB Cajal-Retzius cells are critical in cortical lamination, but very little is known about their origin and development. The homeodomain transcription factor Dbx1 is expressed in restricted progenitor domains of the developing pallium: the ventral pallium (VP) and the septum. Using genetic tracing and ablation experiments in mice, we show that two subpopulations of Reelin(+) Cajal-Retzius cells are generated from Dbx1-expressing progenitors. VP- and septum-derived Reelin(+) neurons differ in their onset of appearance, migration routes, destination and expression of molecular markers. Together with reported data supporting the generation of Reelin(+) cells in the cortical hem, our results show that Cajal-Retzius cells are generated at least at three focal sites at the borders of the developing pallium and are redistributed by tangential migration. Our data also strongly suggest that distinct Cajal-Retzius subtypes exist and that their presence in different territories of the developing cortex might contribute to region-specific properties.
C1 Ecole Normale Super, CNRS, UMR 8542, F-75005 Paris, France.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.
RP Pierani, A (corresponding author), Ecole Normale Super, CNRS, UMR 8542, 46 Rue Ulm, F-75005 Paris, France.
EM pierani@biologie.ens.fr
RI Pierani, Alessandra/O-6136-2017; Vigneau, Sebastien/B-2842-2008
OI Pierani, Alessandra/0000-0002-4872-4791; Arber,
   Silvia/0000-0002-6261-250X; Vigneau, Sebastien/0000-0002-9091-2067
CR Aboitiz F, 2002, BRAZ J MED BIOL RES, V35, P1455, DOI 10.1590/S0100-879X2002001200006
   Alcantara S, 1998, J NEUROSCI, V18, P7779
   Ang ESBC, 2003, J NEUROSCI, V23, P5805
   Borrell V, 1999, J NEUROSCI, V19, P1345
   Campbell K, 2003, CURR OPIN NEUROBIOL, V13, P50, DOI 10.1016/S0959-4388(03)00009-6
   Cohen-Tannoudji M, 1998, MOL CELL BIOL, V18, P1444, DOI 10.1128/MCB.18.3.1444
   Corbin JG, 2001, NAT NEUROSCI, V4, P1177, DOI 10.1038/nn749
   DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0
   DeCarlos JA, 1996, J NEUROSCI, V16, P6146
   DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0
   Gorski JA, 2002, J NEUROSCI, V22, P6309
   Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7
   Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001
   Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1
   Lavdas AA, 1999, J NEUROSCI, V19, P7881
   Lee KJ, 2000, NATURE, V403, P734
   LU S, 1992, P NATL ACAD SCI USA, V89, P8053, DOI 10.1073/pnas.89.17.8053
   LU SW, 1994, MECH DEVELOP, V47, P187, DOI 10.1016/0925-4773(94)90089-2
   Mallamaci A, 2000, NAT NEUROSCI, V3, P679, DOI 10.1038/76630
   Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marin O, 2001, NAT REV NEUROSCI, V2, P780, DOI 10.1038/35097509
   Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8
   Medina L, 2004, J COMP NEUROL, V474, P504, DOI 10.1002/cne.20141
   Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004
   Meyer G, 1999, EUR J NEUROSCI, V11, P3937, DOI 10.1046/j.1460-9568.1999.00818.x
   Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765
   Meyer G, 1998, J COMP NEUROL, V397, P493
   Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002
   OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1
   PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1
   Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4
   Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8
   Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x
   Schuurmans C, 2002, CURR OPIN NEUROBIOL, V12, P26, DOI 10.1016/S0959-4388(02)00286-6
   Shinozaki K, 2002, DEVELOPMENT, V129, P3479
   Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6
   Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602
   Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004
   Tamamaki N, 1997, J NEUROSCI, V17, P8313
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   WILKINSON DG, 1989, DEVELOPMENT, V106, P465
   Yun K, 2001, DEVELOPMENT, V128, P193
   Zecevic N, 2001, J NEUROSCI, V21, P5607
   Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6
NR 48
TC 284
Z9 290
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD AUG
PY 2005
VL 8
IS 8
BP 1002
EP 1012
DI 10.1038/nn1511
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 949BP
UT WOS:000230760200011
PM 16041369
DA 2021-01-25
ER

PT J
AU Dehio, C
AF Dehio, C
TI Bartonella-host-cell interactions and vascular tumour formation
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID HUMAN ENDOTHELIAL-CELLS; IV SECRETION SYSTEM; HELICOBACTER-PYLORI CAGA;
   OUTER-MEMBRANE PROTEINS; NF-KAPPA-B; BACILLARY ANGIOMATOSIS; PATHOGEN
   BARTONELLA; IN-VITRO; EPITHELIAL-CELLS; ADHESIN YADA
AB Bartonellae are arthropod-borne bacterial pathogens that typically cause persistent infection of erythrocytes and endothelial cells in their mammalian hosts. In human infection, these host-cell interactions result in a broad range of clinical manifestations. Most remarkably, bartonellae can trigger massive proliferation of endothelial cells, leading to vascular tumour formation. The recent availability of infection models and bacterial molecular genetic techniques has fostered research on the pathogenesis of the bartonellae and has advanced our understanding of the virulence mechanisms that underlie the host-cell tropism, the subversion of host-cell functions during bacterial persistence, as well as the formation of vascular tumours by these intriguing pathogens.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Christoph.Dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   BASS HN, 1979, CLIN GENET, V16, P163
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   BATTERMAN HJ, 1995, INFECT IMMUN, V63, P4553, DOI 10.1128/IAI.63.11.4553-4556.1995
   Battisti JM, 1999, APPL ENVIRON MICROB, V65, P3441
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Brouqui P, 1996, RES MICROBIOL, V147, P719, DOI 10.1016/S0923-2508(97)85119-4
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Coleman SA, 2001, INFECT IMMUN, V69, P4373, DOI 10.1128/IAI.69.7.4373-4381.2001
   Comanducci M, 2002, J EXP MED, V195, P1445, DOI 10.1084/jem.20020407
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Cornelis GR, 2002, NAT REV MOL CELL BIO, V3, P742, DOI 10.1038/nrm932
   Dang TA, 1999, MOL MICROBIOL, V32, P1239, DOI 10.1046/j.1365-2958.1999.01436.x
   de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   GARCIA FU, 1992, J INFECT DIS, V165, P1138, DOI 10.1093/infdis/165.6.1138
   Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   Joshi SG, 2003, INFECT IMMUN, V71, P4127, DOI 10.1128/IAI.71.7.4127-4136.2003
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   KOEHLER JE, 1993, CLIN INFECT DIS, V17, P612, DOI 10.1093/clinids/17.4.612
   KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Maeno N, 1999, MICROB PATHOGENESIS, V27, P419, DOI 10.1006/mpat.1999.0315
   Manders SM, 1996, CLIN DERMATOL, V14, P295, DOI 10.1016/0738-081X(96)00015-6
   MCCORD AM, IN PRESS INFECT IMMU
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   Minnick M F, 2000, Subcell Biochem, V33, P97
   MITCHELL SJ, 1995, INFECT IMMUN, V63, P1552, DOI 10.1128/IAI.63.4.1552-1562.1995
   Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003
   SANDER A, 1991, INFEKTIOLOGIE DIAGNO
   Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schroder G, 2005, PLASMID, V54, P1, DOI 10.1016/j.plasmid.2005.02.001
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004
   SLATER LN, 1992, ARCH INTERN MED, V152, P602, DOI 10.1001/archinte.152.3.602
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   TAPPERO JW, 1993, JAMA-J AM MED ASSOC, V269, P770, DOI 10.1001/jama.269.6.770
   Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D
   Verma A, 2000, INFECT IMMUN, V68, P5960, DOI 10.1128/IAI.68.10.5960-5969.2000
   Verma A, 2002, CELL MICROBIOL, V4, P557, DOI 10.1046/j.1462-5822.2002.00217.x
   Verma A, 2001, CELL MICROBIOL, V3, P169, DOI 10.1046/j.1462-5822.2001.00104.x
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
NR 70
TC 107
Z9 112
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD AUG
PY 2005
VL 3
IS 8
BP 621
EP 631
DI 10.1038/nrmicro1209
PG 11
WC Microbiology
SC Microbiology
GA 950TE
UT WOS:000230879700013
PM 16064054
DA 2021-01-25
ER

PT J
AU Marzban, G
   Puehringer, H
   Dey, R
   Brynda, S
   Ma, Y
   Martinelli, A
   Zaccarini, M
   van der Weg, E
   Housley, Z
   Kolarich, D
   Altmann, F
   Laimer, M
AF Marzban, G
   Puehringer, H
   Dey, R
   Brynda, S
   Ma, Y
   Martinelli, A
   Zaccarini, M
   van der Weg, E
   Housley, Z
   Kolarich, D
   Altmann, F
   Laimer, M
TI Localisation and distribution of the major allergens in apple fruits
SO PLANT SCIENCE
LA English
DT Article
DE Mal d 1 isoforms; Mal d 3; immuno-tissue-prints; ELISA; cultivar
   screening
ID LIPID TRANSFER PROTEIN; BIRCH POLLEN ALLERGEN; BET V 1; MALUS-DOMESTICA;
   GENES; FOOD; POSITIONS; MAL-D-1; CLONING; FAMILY
AB The importance of apple allergens, in particular Mal d 1, a Bet v 1 hornologue for the pollen-fruit syndrome in Northern Europe, and Mal d 3, responsible for true fruit allergy in Southern Europe, has been repeatedly emphasized. However, little is known about the distribution pattern of major allergens in fruits and whether differences exist among different cultivars. Transcript expression of Mal d 1 isoforms and Mal d 3 was examined by Real Time-PCR and Northern analysis, respectively. An immuno-tissue-print (ITP) assay was developed to localise major allergens in apple fruit tissue and a Mal d 1 specific, patient independent ELISA was established. ITP analyses show that Mal d 1 and Mal d 2 are distributed throughout the apple pulp and peel, while Mal d 3 is restricted to the peel. Data obtained by ELISA reveal a variation of Mal d 1 content ranging from 0.84 to 33.17 mu g/g fresh weight in 39 selected cultivars. Different apple cultivars show a markedly different expression of major allergens; this finding will influence the development of diagnostic tools as well as the dietary management of allergic individuals. (c) 2005 Elsevier Ireland Ltd. All rights reserved.
C1 BOKU, IAM, Plant Biotechnol Unit, Vienna, Austria.
   Consorzio Italiano Vivaisti, Ferrara, Italy.
   Plant Res Int, Wageningen, Netherlands.
   Univ Basel, Biozentrum, Dept Biol Struct, CH-4003 Basel, Switzerland.
   BOKU, Inst Chem, Vienna, Austria.
RP Laimer, M (corresponding author), Muthgasse 18,House B, A-1190 Vienna, Austria.
EM m.laimer@iam.boku.ac.at
RI Laimer, Margit/C-3524-2019; Marzban, PD Dr. Gorji/AAB-2161-2021;
   Kolarich, Daniel/AAJ-3550-2020; Kolarich, Daniel/B-6893-2012; Ma,
   Yan/G-2469-2016; Margit, Laimer/P-7096-2019; Van de Weg, Eric
   W/G-3225-2011
OI Marzban, PD Dr. Gorji/0000-0002-1315-811X; Kolarich,
   Daniel/0000-0002-8452-1350; Kolarich, Daniel/0000-0002-8452-1350;
   Margit, Laimer/0000-0002-6796-8126; Van de Weg, Eric
   W/0000-0002-9443-5974; Altmann, Friedrich/0000-0002-0112-7877
CR Asero R, 2003, J ALLERGY CLIN IMMUN, V112, P1009, DOI 10.1016/S0091-6749(03)02006-2
   Asero R, 1999, ALLERGY, V54, P87, DOI 10.1034/j.1398-9995.1999.00922.x
   Asero R, 2000, INT ARCH ALLERGY IMM, V122, P20, DOI 10.1159/000024355
   Beuning LL, 2004, PLANT MOL BIOL, V55, P369, DOI 10.1007/s11103-004-0904-9
   Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468
   Fernandez Rivas M, 2003, Allergol Immunopathol (Madr), V31, P141
   Fernandez-Rivas M, 1999, CLIN EXP ALLERGY, V29, P1239, DOI 10.1046/j.1365-2222.1999.00628.x
   Fourney R. M., 1988, FOCUS, V10, P5
   Gao ZS, 2005, THEOR APPL GENET, V110, P479, DOI 10.1007/s00122-004-1856-9
   GAO ZS, IN PRESS TAG
   HOFFMANNSOMEMRG, 2002, ALLERGY, V60, P436
   HoffmannSommergruber K, 1997, GENE, V197, P91, DOI 10.1016/S0378-1119(97)00246-1
   Hsieh LS, 1995, J ALLERGY CLIN IMMUN, V96, P960, DOI 10.1016/S0091-6749(95)70234-2
   Kader JC, 1997, TRENDS PLANT SCI, V2, P66, DOI 10.1016/S1360-1385(97)82565-4
   KNAPP E, 1995, J VIROL METHODS, V55, P157, DOI 10.1016/0166-0934(95)00033-Q
   Krebitz M, 2003, J MOL BIOL, V329, P721, DOI 10.1016/S0022-2836(03)00403-0
   Pastorello EA, 2000, J ALLERGY CLIN IMMUN, V105, P371, DOI 10.1016/S0091-6749(00)90090-3
   Puehringer HM, 2003, GENE, V321, P173, DOI 10.1016/S0378-1119(03)00822-9
   Puhringer H, 2000, PLANT SCI, V152, P35, DOI 10.1016/S0168-9452(99)00222-8
   Salcedo G, 1999, CLIN EXP ALLERGY, V29, P1158, DOI 10.1046/j.1365-2222.1999.00629.x
   Salcedo G, 2004, CLIN EXP ALLERGY, V34, P1336, DOI 10.1111/j.1365-2222.2004.02018.x
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sanchez-Monge R, 1999, J ALLERGY CLIN IMMUN, V103, P514, DOI 10.1016/S0091-6749(99)70479-3
   Schafer T, 2001, ALLERGY, V56, P1172, DOI 10.1034/j.1398-9995.2001.00196.x
   Son DY, 1999, EUR J NUTR, V38, P201, DOI 10.1007/s003940050063
   Steinmetz KA, 1996, J AM DIET ASSOC, V96, P1027, DOI 10.1016/S0002-8223(96)00273-8
   van't Veer P, 2000, PUBLIC HEALTH NUTR, V3, P103, DOI 10.1017/S1368980000000136
   VANEKKREBITZ M, 1995, BIOCHEM BIOPH RES CO, V214, P538, DOI 10.1006/bbrc.1995.2320
   vanRee R, 1997, ALLERGY, V52, P795
   VIETHS S, 1994, ALLERGY, V49, P262, DOI 10.1111/j.1398-9995.1994.tb02659.x
   VIETHS S, 1995, ALLERGY, V50, P421, DOI 10.1111/j.1398-9995.1995.tb01172.x
NR 31
TC 85
Z9 90
U1 0
U2 17
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-9452
J9 PLANT SCI
JI Plant Sci.
PD AUG
PY 2005
VL 169
IS 2
BP 387
EP 394
DI 10.1016/j.plantsci.2005.03.027
PG 8
WC Biochemistry & Molecular Biology; Plant Sciences
SC Biochemistry & Molecular Biology; Plant Sciences
GA 951NX
UT WOS:000230938500012
DA 2021-01-25
ER

PT J
AU Moscatelli, A
   Scali, M
   Prescianotto-Baschong, C
   Ferro, M
   Garin, J
   Vignani, R
   Ciampolini, F
   Cresti, M
AF Moscatelli, A
   Scali, M
   Prescianotto-Baschong, C
   Ferro, M
   Garin, J
   Vignani, R
   Ciampolini, F
   Cresti, M
TI A methionine synthase homolog is associated with secretory vesicles in
   tobacco pollen tubes
SO PLANTA
LA English
DT Article
DE methionine synthase; microtubules; Nicotiana tabacum; pollen tube;
   secretory vesicles
ID DYNEIN LIGHT-CHAIN; NICOTIANA-SYLVESTRIS; MOLECULAR MOTORS;
   HEAVY-CHAINS; GROWTH; IDENTIFICATION; MICROTUBULES; CHLAMYDOMONAS;
   PROTEINS; EXPRESSION
AB Seven isoforms of 85 kDa polypeptides (p85) were identified as methionine synthase (MetE) homologs by partial aminoacid sequencing in tobacco pollen tube extracts. Immunocytochemistry data showed a localization of the antigen on the surface of tip-focussed post-Golgi secretory vesicles (SVs), that appear to be partially associated with microtubules (Mts). The chemical dissection of pollen tube high speed supernatant (HSS) showed that two distinct pools of MetE are present in pollen tubes, one being the more acidic isoforms sedimenting at 15S and the remaining at 4S after zonal centrifugation through a sucrose density gradient. The identification of the MetE within the pollen tube and its possible participation as methyl donor in a wide range of metabolic reactions, makes it a good subject for studies on pollen tube growth regulation.
C1 Univ Siena, Dipartimento Sci Ambientali G Sarfatti, I-53100 Siena, Italy.
   Univ Milan, Dipartimento Biol, I-20133 Milan, Italy.
   Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   CEA, Dept Chim Prot, F-38054 Grenoble, France.
RP Cresti, M (corresponding author), Univ Siena, Dipartimento Sci Ambientali G Sarfatti, Via P A Mattioli 4, I-53100 Siena, Italy.
EM Cresti@unisi.it
RI vignani, rita/K-8184-2013; Scali, Monica/Q-7554-2016; FERRO,
   Myriam/O-6588-2014; vignani, rita/P-3829-2014; Moscatelli,
   alessandra/B-1138-2017
OI vignani, rita/0000-0002-7024-5965; Scali, Monica/0000-0002-8551-8823;
   FERRO, Myriam/0000-0002-4222-6847; vignani, rita/0000-0002-7024-5965;
   Moscatelli, alessandra/0000-0003-0912-5697
CR ASTROM H, 1995, SEX PLANT REPROD, V8, P61, DOI 10.1007/BF00230890
   BAXTERGABBARD KL, 1972, FEBS LETT, V20, P117, DOI 10.1016/0014-5793(72)80031-0
   Bini L, 1997, ELECTROPHORESIS, V18, P557, DOI 10.1002/elps.1150180337
   BREWBAKE JL, 1963, AM J BOT, V50, P859, DOI 10.2307/2439772
   Brown SS, 1999, ANNU REV CELL DEV BI, V15, P63, DOI 10.1146/annurev.cellbio.15.1.63
   Cai G, 1997, TRENDS PLANT SCI, V2, P86, DOI 10.1016/S1360-1385(96)10057-1
   Cai G, 2000, PLANT CELL, V12, P1719, DOI 10.1105/tpc.12.9.1719
   DELCASINO C, 1993, BIOL CELL, V79, P125, DOI 10.1016/0248-4900(93)90248-D
   Eckermann C, 2000, BIOL CHEM, V381, P695, DOI 10.1515/BC.2000.090
   EICHEL J, 1995, EUR J BIOCHEM, V230, P1053, DOI 10.1111/j.1432-1033.1995.tb20655.x
   Endo M, 2002, FEBS LETT, V514, P229, DOI 10.1016/S0014-5793(02)02371-2
   FATH KR, 1994, J CELL BIOL, V126, P661, DOI 10.1083/jcb.126.3.661
   Gingras D, 1996, J BIOL CHEM, V271, P12807, DOI 10.1074/jbc.271.22.12807
   Gross SP, 2002, J CELL BIOL, V156, P855, DOI 10.1083/jcb.200105055
   Hepler PK, 2001, ANNU REV CELL DEV BI, V17, P159, DOI 10.1146/annurev.cellbio.17.1.159
   Hepler PK, 1997, TRENDS PLANT SCI, V2, P79, DOI 10.1016/S1360-1385(97)88385-9
   JOOS U, 1995, PROTOPLASMA, V187, P182, DOI 10.1007/BF01280247
   JOOS U, 1994, PROTOPLASMA, V179, P5, DOI 10.1007/BF01360732
   Kastury K, 1997, J CLIN ENDOCR METAB, V82, P3047, DOI 10.1210/jc.82.9.3047
   King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4
   King SM, 2002, TRAFFIC, V3, P930, DOI 10.1034/j.1600-0854.2002.31208.x
   Kurvari V, 1995, PLANT MOL BIOL, V29, P1235, DOI 10.1007/BF00020465
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lawrence CJ, 2001, TRAFFIC, V2, P362, DOI 10.1034/j.1600-0854.2001.25020508.x
   LEDIZET M, 1995, MOL BIOL CELL, V6, P713
   LEDIZET M, 1995, MOL BIOL CELL, V6, P697
   LUCK D, 1977, P NATL ACAD SCI USA, V74, P3456, DOI 10.1073/pnas.74.8.3456
   Matthews RG, 1997, CURR OPIN CHEM BIOL, V1, P332, DOI 10.1016/S1367-5931(97)80070-1
   MILLER DD, 1995, J CELL SCI, V108, P2549
   MOSCATELLI A, 1995, J CELL SCI, V108, P1117
   Moutinho A, 1998, PLANT CELL, V10, P1499, DOI 10.1105/tpc.10.9.1499
   OLMSTED JB, 1981, J BIOL CHEM, V256, P1955
   Ranocha P, 2000, J BIOL CHEM, V275, P15962, DOI 10.1074/jbc.M001116200
   Ranocha P, 2001, PLANT J, V25, P575, DOI 10.1046/j.1365-313x.2001.00988.x
   Romagnoli S, 2003, PLANT CELL, V15, P251, DOI 10.1105/tpc.005645
   Sato Y, 2001, J CELL SCI, V114, P269
   Susalka SJ, 2000, BBA-MOL CELL RES, V1496, P76, DOI 10.1016/S0167-4889(00)00010-0
   TANG XJ, 1989, J CELL SCI, V92, P569
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Trewavas AJ, 1997, PLANT CELL, V9, P1181, DOI 10.1105/tpc.9.7.1181
   WITMAN GB, 1986, METHOD ENZYMOL, P280
   YOKOTA E, 1994, PROTOPLASMA, V177, P153, DOI 10.1007/BF01378989
   Zeh M, 2002, PLANT MOL BIOL, V48, P255, DOI 10.1023/A:1013333303554
NR 43
TC 8
Z9 8
U1 0
U2 8
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0032-0935
EI 1432-2048
J9 PLANTA
JI Planta
PD AUG
PY 2005
VL 221
IS 6
BP 776
EP 789
DI 10.1007/s00425-005-1487-7
PG 14
WC Plant Sciences
SC Plant Sciences
GA 956PV
UT WOS:000231313200005
PM 15940464
DA 2021-01-25
ER

PT J
AU Grzesiek, S
   Allan, M
   Cordier, F
   Haussinger, D
   Jensen, P
   Kahmann, J
   Meier, S
   Sass, HJ
AF Grzesiek, S.
   Allan, M.
   Cordier, F.
   Haeussinger, D.
   Jensen, P.
   Kahmann, J.
   Meier, S.
   Sass, H. J.
TI Nuclear magnetic resonance as a quantitative tool to study interactions
   in biomacromolecules
SO PURE AND APPLIED CHEMISTRY
LA English
DT Article
DE Biomacromolecules; biomolecular interactions; protein folding; thermal
   unfolding; hydrogen bonds; scalar coupling; anisotropic orientation;
   protein dynamics; TipA; foldon
AB High-resolution nuclear magnetic resonance (NMR) has emerged as one of the most versatile tools for the quantitative study of structure, kinetics, and thermodynamics of biomolecules and their interactions at atomic resolution. Traditionally, nuclear Overhauser enhancements (NOEs) and chemical shift perturbation methods are used to determine molecular geometries and to identify contact surfaces, but more recently, weak anisotropic orientation, anisotropic diffusion, and scalar couplings across hydrogen bonds provide additional information.
   Examples of such technologies are shown as applied to the quantitative characterization of function and thermodynamics of several biomacromolecules. In particular, (1) the structural and dynamical changes of the TipA multidrug resistance protein are followed upon antibiotic binding, (2) the trimer-monomer equilibrium and thermal unfolding of foldon, a small and very efficient trimerization domain of the 14 phagehead, is described in atomic detail, and (3) the changes of individual protein hydrogen bonds during thermal unfolding are quantitatively followed by scalar couplings across hydrogen bonds.
C1 [Grzesiek, S.; Allan, M.; Cordier, F.; Haeussinger, D.; Jensen, P.; Kahmann, J.; Meier, S.; Sass, H. J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Jensen, Pernille Rose/AAX-5696-2020; Haussinger, Daniel/C-6617-2016;
   Jensen, Pernille Rose/J-8648-2016
OI Jensen, Pernille Rose/0000-0003-4359-848X; Haussinger,
   Daniel/0000-0002-4798-0072; Jensen, Pernille Rose/0000-0003-4359-848X;
   Grzesiek, Stephan/0000-0003-1998-4225; Meier,
   Sebastian/0000-0003-3761-3217; Cordier, Florence/0000-0002-5963-7773
CR Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303
   BLAKE PR, 1992, J AM CHEM SOC, V114, P4931, DOI 10.1021/ja00038a084
   Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274
   Cordier F, 2004, BIOCHEMISTRY-US, V43, P11295, DOI 10.1021/bi049314f
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   FESIK SW, 1988, J MAGN RESON, V78, P588, DOI 10.1016/0022-2364(88)90144-8
   Fiaux J, 2002, NATURE, V418, P207, DOI 10.1038/nature00860
   Grkovic S, 2001, SEMIN CELL DEV BIOL, V12, P225, DOI 10.1006/scdb.2000.0248
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020
   HINZ HJ, 1994, BIOPHYS CHEM, V52, P275, DOI 10.1016/0301-4622(94)00098-5
   Jaravine VA, 2004, J BIOMOL NMR, V29, P309, DOI 10.1023/B:JNMR.0000032516.87434.35
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Kahmann JD, 2003, EMBO J, V22, P1824, DOI 10.1093/emboj/cdg181
   Klimov DK, 2000, P NATL ACAD SCI USA, V97, P2544, DOI 10.1073/pnas.97.6.2544
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Lide D. R., 1999, CRC HDB CHEM PHYS
   Louhivuori M, 2004, J BIOMOL NMR, V29, P517, DOI 10.1023/B:JNMR.0000034347.01925.ad
   MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Santiveri CM, 2002, J AM CHEM SOC, V124, P14903, DOI 10.1021/ja0278537
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Seemann H, 2001, J MOL BIOL, V307, P1091, DOI 10.1006/jmbi.2001.4517
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   Tugarinov V, 2002, J AM CHEM SOC, V124, P10025, DOI 10.1021/ja0205636
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   WILLIAMSON MP, 1985, J MOL BIOL, V182, P295, DOI 10.1016/0022-2836(85)90347-X
NR 44
TC 3
Z9 3
U1 2
U2 10
PU INT UNION PURE APPLIED CHEMISTRY
PI RES TRIANGLE PK
PA 104 TW ALEXANDER DR, PO BOX 13757, RES TRIANGLE PK, NC 27709-3757 USA
SN 0033-4545
J9 PURE APPL CHEM
JI Pure Appl. Chem.
PD AUG
PY 2005
VL 77
IS 8
BP 1409
EP 1424
DI 10.1351/pac200577081409
PG 16
WC Chemistry, Multidisciplinary
SC Chemistry
GA V16GG
UT WOS:000207857500009
OA Green Published
DA 2021-01-25
ER

PT J
AU Knechtle, P
   Goyard, S
   Brachat, S
   Ibrahim-Granet, O
   d'Enfert, C
AF Knechtle, P
   Goyard, S
   Brachat, S
   Ibrahim-Granet, O
   d'Enfert, C
TI Phosphatidylinositol-dependent phospholipases C Plc2 and Plc3 of Candida
   albicans are dispensable for morphogenesis and host-pathogen interaction
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE Candida albicans; candidiasis; virulence; PI-PLC; macrophage;
   yeast-to-hypha switch
ID SACCHAROMYCES-CEREVISIAE; LISTERIA-MONOCYTOGENES; CELLULAR FUNCTIONS;
   GENOME SEQUENCE; BUDDING YEAST; UNITED-STATES; PLB1 GENE; B GENE;
   CLONING; VIRULENCE
AB Phospholipases play an important role as virulence factors in human pathogens. Candida albicans, the major fungal pathogen of humans, encodes phospholipases of type A, B, C and D. Type B Plb2 and type D Pld1 phospholipases have been shown to contribute to virulence in this organism. We analyzed, in C. albicans, PLC2 and PLC3, two highly conserved genes coding for phosphatidylinositol-dependent phospholipases C with homology to the known virulence factor PlcA in the human pathogen Listeria monocytogenes. We show that expression of PLC2 and PLC3 is upregulated under different filament-inducing conditions and in the constitutive filamentous mutant tup1 Delta. In order to analyze PLC2 and PLC3 function in C albicans, we constructed strains that carry PLC2 or PLC3 under a constitutive promoter and strains that lack all four PLC2/3 alleles. These strains were not affected in their ability to produce filaments under non-inducing conditions, nor was filamentation modified under inducing conditions, suggesting that PLC2/3 are not critical determinants of the yeast-to-hypha switch. In a cell culture model for macrophage interaction, phagocytosis of C. albicans and subsequent killing were not influenced by PLC2/3. These results demonstrate that C. albicans PLC2 and PLC3 are dispensable for virulence; moreover, they underline the sharp contrast with the function of plcA in L. monocytogenes. (c) 2005 Elsevier SAS. All rights reserved.
C1 Inst Pasteur, INRA, USC 2019, Unite Postulante Biol & Pathogenicite Fongiques, F-75724 Paris, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Inst Pasteur, Unite Aspergillus, F-75724 Paris, France.
RP d'Enfert, C (corresponding author), Inst Pasteur, INRA, USC 2019, Unite Postulante Biol & Pathogenicite Fongiques, 25-28 Rue Du Docteur Roux, F-75724 Paris, France.
EM denfert@pasteur.fr
OI Knechtle, Philipp/0000-0003-0377-9446; Goyard,
   Sophie/0000-0002-8937-2796; Brachat, Sophie/0000-0002-3398-8225;
   d'Enfert, Christophe/0000-0002-6235-3886
CR Andaluz E, 2001, YEAST, V18, P711, DOI 10.1002/yea.716
   BATRA L R, 1973, U S Department of Agriculture Technical Bulletin, V1469, P1
   BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
   Bennett DE, 1998, MICROBIOL-SGM, V144, P55, DOI 10.1099/00221287-144-1-55
   Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948
   BIRSE CE, 1993, INFECT IMMUN, V61, P3648, DOI 10.1128/IAI.61.9.3648-3655.1993
   Braun BR, 1997, SCIENCE, V277, P105, DOI 10.1126/science.277.5322.105
   Braun BR, 2001, EMBO J, V20, P4753, DOI 10.1093/emboj/20.17.4753
   Burke D, 2000, METHODS YEAST GENETI
   Calderone R. A., 2002, CANDIDA CANDIDIASIS
   CARNILLI A, 1993, MOL MICROBIOL, V8, P143
   Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5
   d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dolan JW, 2004, MED MYCOL, V42, P439, DOI 10.1080/13693780410001657162
   Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579
   Enloe B, 2000, J BACTERIOL, V182, P5730, DOI 10.1128/JB.182.20.5730-5736.2000
   Ernst JF, 2000, MICROBIOL-UK, V146, P1763, DOI 10.1099/00221287-146-8-1763
   FONZI WA, 1993, GENETICS, V134, P717
   Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554
   Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000
   Goffeau A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546
   Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044
   Griffith OH, 1999, BBA-MOL CELL BIOL L, V1441, P237, DOI 10.1016/S1388-1981(99)00153-5
   Harbarth S, 1999, SCHWEIZ MED WSCHR, V129, P1521
   Hoover CI, 1998, FEMS MICROBIOL LETT, V167, P163, DOI 10.1111/j.1574-6968.1998.tb13223.x
   Hoyer LL, 2001, TRENDS MICROBIOL, V9, P176, DOI 10.1016/S0966-842X(01)01984-9
   Hube B, 2001, MICROBIOL-SGM, V147, P879, DOI 10.1099/00221287-147-4-879
   Hwang CS, 2003, MOL MICROBIOL, V47, P1029, DOI 10.1046/j.1365-2958.2003.03353.x
   Ibata-Ombetta S, 2003, ANN NY ACAD SCI, V1010, P573, DOI 10.1196/annals.1299.107
   Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101
   Jun Y, 2004, J BIOL CHEM, V279, P53186, DOI 10.1074/jbc.M411363200
   KIRK P, 2004, CABI BIOSCIENCE CBS
   LEE KL, 1975, SABOURAUDIA, V13, P148
   Leidich SD, 1998, J BIOL CHEM, V273, P26078, DOI 10.1074/jbc.273.40.26078
   Lin HY, 2000, MOL CELL BIOL, V20, P3597, DOI 10.1128/MCB.20.10.3597-3607.2000
   Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X
   Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139
   Mukherjee PK, 2001, MICROBIOL-SGM, V147, P2585, DOI 10.1099/00221287-147-9-2585
   Murad AMA, 2001, EMBO J, V20, P4742, DOI 10.1093/emboj/20.17.4742
   Murad AMA, 2001, MOL MICROBIOL, V42, P981, DOI 10.1046/j.1365-2958.2001.02713.x
   Naglik J, 2004, CELL MICROBIOL, V6, P915, DOI 10.1111/j.1462-5822.2004.00439.x
   Nozawa Y, 2002, J BIOCHEM, V131, P283, DOI 10.1093/oxfordjournals.jbchem.a003100
   Phaff H.J, 1987, YEASTS BIOL YEASTS, P123
   Pizarro-Cerda J, 2004, NAT CELL BIOL, V6, P1026, DOI 10.1038/ncb1104-1026
   Saville SP, 2003, EUKARYOT CELL, V2, P1053, DOI 10.1128/EC.2.5.1053-1060.2003
   Schmiel DH, 1999, MICROBES INFECT, V1, P1103, DOI 10.1016/S1286-4579(99)00205-1
   Sharkey LL, 1999, J BACTERIOL, V181, P5273, DOI 10.1128/JB.181.17.5273-5279.1999
   Smith D, 2001, J HIV Ther, V6, P25
   SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995
   Sugiyama Y, 1999, MED MYCOL, V37, P61, DOI 10.1080/02681219980000091
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tisi R, 2002, FEBS LETT, V520, P133, DOI 10.1016/S0014-5793(02)02806-5
   Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770
   Whiteway M, 2004, CURR OPIN MICROBIOL, V7, P350, DOI 10.1016/j.mib.2004.06.005
   Wilson RB, 2000, YEAST, V16, P65, DOI 10.1002/(SICI)1097-0061(20000115)16:1&lt;65::AID-YEA508&gt;3.0.CO;2-M
   Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
NR 58
TC 5
Z9 14
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD AUG
PY 2005
VL 156
IS 7
BP 822
EP 829
DI 10.1016/j.resmic.2005.04.007
PG 8
WC Microbiology
SC Microbiology
GA 967NN
UT WOS:000232098000007
PM 16040234
DA 2021-01-25
ER

PT J
AU Dehio, M
   Quebatte, M
   Foser, S
   Certa, U
AF Dehio, M
   Quebatte, M
   Foser, S
   Certa, U
TI The transcriptional response of human endothelial cells to infection
   with Bartonella henselae is dominated by genes controlling innate immune
   responses, cell cycle, and vascular remodelling
SO THROMBOSIS AND HAEMOSTASIS
LA English
DT Article
DE endothelial cells; Bartonella henselae; pathological angiogenesis;
   TNF-alpha; NF kappa B; interferon alpha; cell cycle control; forkhead
   box M I
ID NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; DNA MICROARRAYS; GROWTH-FACTOR;
   IN-VITRO; ACTIVATION; PROLIFERATION; ANGIOGENESIS; EXPRESSION; DEATH
AB The bacterial pathogen Bartonella henselae (Bh) is responsible for a broad range of clinical manifestations, including the formation of vascular tumours as the result of pathogen-triggered vaso-proliferation. In vitro, the interaction of Bh with human umbilical vein endothelial cells (Huvec) involves (i) cytoskeletal rearrangements in conjunction with bacterial internalization, (ii) nuclear factor kappa B (NF kappa B)-dependent proinflammatory activation, (iii) the inhibition of apoptosis, and (iv) the modulation of angiogenic properties such as proliferation, migration, and tubular differentiation. To study the transcriptional signature of these pathogen-triggered changes of Huvec, we performed transcriptional profiling with Affymetrix U 133 GeneChips. At 6 h or 30 h of infection, a total of 706 genes displayed a clear and statistically significant change of expression (> 2.5-fold, t-test p-value < 0.05). These included 314 up-regulated genes dominated by the innate immune response. The gene list comprises subsets of tumour necrosis factor alpha (TNF alpha, 99 genes) and interferon alpha (IFN alpha, 30 genes) inducible genes, which encode components of the NF-kappa B-dependent proinflammatory response and the type I IFN-dependent anti-infective response, respectively. The remaining set of 197 up-regulated genes mirrors other cellular changes induced by Bh, in particular proliferation and proangiogenic activation. The set of 362 down-regulated genes includes 41 TNF alpha- or IFN alpha-suppressible genes,and 52 genes involved in cell cycle control or progression. This comprehensive analysis of Bh-triggered changes of the Huvec transcriptome identified candidate genes putatively involved in controlling innate immune responses, cell cycle, and vascular remodelling, and may thus provide the basis for functional studies of the molecular mechanisms underlying these pathogen-induced cellular processes.
C1 Univ Basel, Div Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche & Co Ltd, Roche Ctr Med Genomics, CH-4002 Basel, Switzerland.
RP Dehio, M (corresponding author), Univ Basel, Div Mol Microbiol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM michaela_dehio@unibas.ch
OI Quebatte, Maxime/0000-0002-3733-1511
CR Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884
   Bogdan C, 2000, CURR OPIN IMMUNOL, V12, P419, DOI 10.1016/S0952-7915(00)00111-4
   Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008
   Bryant PA, 2004, LANCET INFECT DIS, V4, P100, DOI 10.1016/S1473-3099(04)00930-2
   Cerimele F, 2003, AM J PATHOL, V163, P1321, DOI 10.1016/S0002-9440(10)63491-8
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Costa RH, 2005, NAT CELL BIOL, V7, P108, DOI 10.1038/ncb0205-108
   Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635
   DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455
   Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   DEHIO C, 2005, IN PRESS NATURE REV
   Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Espert L, 2004, ONCOGENE, V23, P4636, DOI 10.1038/sj.onc.1207586
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Gomez D, 2003, J IMMUNOL, V170, P5373, DOI 10.4049/jimmunol.170.11.5373
   Karsan A, 1996, J BIOL CHEM, V271, P27201, DOI 10.1074/jbc.271.44.27201
   Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Kryczek I, 2005, CANCER RES, V65, P465
   Lu RQ, 2002, J BIOL CHEM, V277, P16592, DOI 10.1074/jbc.M111440200
   Navarro L, 1999, J BIOL CHEM, V274, P35535, DOI 10.1074/jbc.274.50.35535
   Park PJ, 2004, J BIOTECHNOL, V112, P225, DOI 10.1016/j.jbiotec.2004.05.006
   Pfeffer LM, 2004, J BIOL CHEM, V279, P31304, DOI 10.1074/jbc.M308975200
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2004, PROTEOMICS, V4, P3021, DOI 10.1002/pmic.200400933
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006
   Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Sevilla L, 1999, MOL CELL BIOL, V19, P2624
   Tait CR, 2004, J PATHOL, V204, P1, DOI 10.1002/path.1618
   Wagener C, 2000, EXP CELL RES, V261, P19, DOI 10.1006/excr.2000.5038
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
NR 40
TC 11
Z9 13
U1 0
U2 3
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0340-6245
J9 THROMB HAEMOSTASIS
JI Thromb. Haemost.
PD AUG
PY 2005
VL 94
IS 2
BP 347
EP 361
DI 10.1160/TH05-02-0106
PG 15
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 952RS
UT WOS:000231023800017
PM 16113825
DA 2021-01-25
ER

PT J
AU Lichtenberg, D
   Goni, FM
   Heerklotz, H
AF Lichtenberg, D
   Goni, FM
   Heerklotz, H
TI Detergent-resistant membranes should not be identified with membrane
   rafts
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Editorial Material
ID LIPID RAFTS; CELL-MEMBRANES; TRITON X-100; LECITHIN VESICLES; DOMAIN
   FORMATION; MODEL MEMBRANES; MIXED MEMBRANES; CHOLESTEROL;
   SOLUBILIZATION; BILAYERS
AB Three originally distinct concepts - lipid rafts, detergent-resistant membranes (DRMs) and liquid-ordered (lo) lipid phases - are often confused in current literature; many researchers have assumed that all three names refer to the same chemico-biological entity. In fact, theoretical and experimental findings provide strong evidence against identifying DRMs with rafts and lo domains. Because much of what we think we know about lipid rafts is based on their unjustified identification as DRMs, functional domains in biological membranes might differ markedly from the generally accepted picture.
C1 Univ Basque Country, EHU, CSIC, Unidad Biofis, E-48080 Bilbao, Spain.
   Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain.
   Tel Aviv Univ, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.
   Tel Aviv Univ, Sackler Fac Med, Lady Davis Chair Biochem, IL-69978 Tel Aviv, Israel.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Goni, FM (corresponding author), Univ Basque Country, EHU, CSIC, Unidad Biofis, E-48080 Bilbao, Spain.
EM gbpgourf@lg.ehu.es
RI Goni, Felix M/M-5425-2015
OI Goni, Felix M/0000-0001-6270-9216; Heerklotz, Heiko/0000-0003-4615-7022
CR ALONSO A, 1981, FEBS LETT, V123, P200, DOI 10.1016/0014-5793(81)80287-6
   ALONSO A, 2000, BIOCHIM BIOPHYS ACTA, V1508, P1
   Arni S, 1998, J BIOL CHEM, V273, P28478, DOI 10.1074/jbc.273.43.28478
   BOROCHOV H, 1976, P NATL ACAD SCI USA, V73, P4526, DOI 10.1073/pnas.73.12.4526
   BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J
   Collado MI, 2005, BIOCHEMISTRY-US, V44, P4911, DOI 10.1021/bi0474970
   Danielli JF, 1935, J CELL COMPAR PHYSL, V5, P495, DOI 10.1002/jcp.1030050409
   Dykstra M, 2003, ANNU REV IMMUNOL, V21, P457, DOI 10.1146/annurev.immunol.21.120601.141021
   Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439
   EDWARDS K, 1991, J COLLOID INTERF SCI, V147, P1, DOI 10.1016/0021-9797(91)90129-V
   FRYE LD, 1970, J CELL SCI, V7, P319
   Funari SS, 2001, P NATL ACAD SCI USA, V98, P8938, DOI 10.1073/pnas.161160998
   Giocondi MC, 2000, J STRUCT BIOL, V131, P38, DOI 10.1006/jsbi.2000.4266
   GONI FM, 1986, EUR J BIOCHEM, V160, P659, DOI 10.1111/j.1432-1033.1986.tb10088.x
   HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254
   Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8
   Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7
   Heerklotz H, 1997, J PHYS CHEM B, V101, P639, DOI 10.1021/jp962342q
   HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209
   HERTZ R, 1975, CHEM PHYS LIPIDS, V15, P216
   Holopainen JM, 2004, BIOPHYS J, V86, P1510, DOI 10.1016/S0006-3495(04)74219-8
   HOOPER NM, 1988, BIOCHEM J, V250, P865, DOI 10.1042/bj2500865
   IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162
   ISRAELACHVILI JN, 1980, Q REV BIOPHYS, V13, P121, DOI 10.1017/S0033583500001645
   Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200
   Korzeniowski M, 2003, BIOCHEMISTRY-US, V42, P5358, DOI 10.1021/bi027135x
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   LICHTENBERG D, 1979, BIOCHEMISTRY-US, V18, P2574, DOI 10.1021/bi00579a022
   Lichtenberg D, 2000, BBA-BIOMEMBRANES, V1508, P1, DOI 10.1016/S0304-4157(00)00004-6
   LISANTI MP, 1990, TRENDS BIOCHEM SCI, V15, P113, DOI 10.1016/0968-0004(90)90195-H
   London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1
   McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704
   McMullen TPW, 2004, CURR OPIN COLLOID IN, V8, P459, DOI 10.1016/j.cocis.2004.01.007
   Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1
   Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0
   PARSEGIAN VA, 1995, MOL MEMBR BIOL, V12, P5, DOI 10.3109/09687689509038488
   Patra SK, 1999, J LIPOSOME RES, V9, P247, DOI 10.3109/08982109909024788
   Patra SK, 1998, BBA-BIOMEMBRANES, V1373, P112, DOI 10.1016/S0005-2736(98)00095-9
   RACKER E, 1972, J BIOL CHEM, V247, P8198
   Rietveld A, 1998, BBA-REV BIOMEMBRANES, V1376, P467, DOI 10.1016/S0304-4157(98)00019-7
   Saez-Cirion A, 2000, LANGMUIR, V16, P1960, DOI 10.1021/la9908889
   Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501
   Schnitzer E, 2003, CHEM PHYS LIPIDS, V126, P55, DOI 10.1016/S0009-3084(03)00093-8
   Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100
   Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803
   Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720
   Sot J, 2002, LANGMUIR, V18, P2828, DOI 10.1021/la011381c
   VAN MEER G, 1982, EMBO J, V1, P847, DOI 10.1002/j.1460-2075.1982.tb01258.x
   Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803
   Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200
   YU J, 1973, Journal of Supramolecular Structure, V1, P233, DOI 10.1002/jss.400010308
NR 53
TC 364
Z9 370
U1 0
U2 26
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
EI 1362-4326
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD AUG
PY 2005
VL 30
IS 8
BP 430
EP 436
DI 10.1016/j.tibs.2005.06.004
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 957MU
UT WOS:000231374700003
PM 15996869
DA 2021-01-25
ER

PT J
AU Kukulski, W
   Schenk, AD
   Johanson, U
   Braun, T
   de Groot, BL
   Fotiadis, D
   Kjellbom, P
   Engel, A
AF Kukulski, W
   Schenk, AD
   Johanson, U
   Braun, T
   de Groot, BL
   Fotiadis, D
   Kjellbom, P
   Engel, A
TI The 5 angstrom structure of heterologously expressed plant aquaporin
   SoPIP2;1
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE aquaporin; electron diffraction; electron microscopy; three-dimensional
   structure; two-dimensional crystals
ID OSMOTIC WATER PERMEABILITY; PLASMA-MEMBRANE; INTRINSIC PROTEINS; PROTON
   BLOCKAGE; CHANNEL; SELECTIVITY; ARCHITECTURE; MOVEMENTS; SEQUENCES;
   TRANSPORT
AB SoPIP2;1 is one of the major integral proteins in spinach leaf plasma membranes. In the Xenopus oocyte expression system its water channel activity is regulated by phosphorylation at the C terminus and in the first cytosolic loop. To assess its structure, SoPIP2;1 was heterologously expressed in Pichia pastoris as a His-tagged protein and in the non-tagged form. Both forms were reconstituted into 2D crystals in the presence of lipids. Tubular crystals and double-layered crystalline sheets of non-tagged SoPIP2;1 were observed and analyzed by cryo-electron microscopy. Crystalline sheets were highly ordered and diffracted electrons to a resolution of 2.96 angstrom. High-resolution projection maps of tilted specimens provided a 3D structure at 5 angstrom resolution. Superposition of the SoPIP2;1 potential map with the atomic model of AQP1 demonstrates the generally well conserved overall structure of water channels. Differences concerning the extracellular loop A explain the particular crystal contacts between oppositely oriented membrane sheets of SoPIP2;1 2D crystals, and may have a function in rapid volume changes observed in stomatal guard cells or mesophyll protoplasts. This crystal packing arrangement provides access to the phosphorylated C terminus as well as the loop B phosphorylation site for studies of channel gating. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Lund Univ, Dept Plant Biochem, S-22100 Lund, Sweden.
   Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Microscopy, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Kukulski, Wanda/H-1766-2013; Johanson, Urban/D-4344-2015
OI Johanson, Urban/0000-0001-8862-128X; Schenk, Andreas/0000-0001-9214-2505
CR Blatt MR, 2000, ANNU REV CELL DEV BI, V16, P221, DOI 10.1146/annurev.cellbio.16.1.221
   Chakrabarti N, 2004, STRUCTURE, V12, P65, DOI 10.1016/j.str.2003.11.017
   Chakrabarti N, 2004, J MOL BIOL, V343, P493, DOI 10.1016/j.jmb.2004.08.036
   Chaumont F, 2000, PLANT PHYSIOL, V122, P1025, DOI 10.1104/pp.122.4.1025
   Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Daniels MJ, 1999, J MOL BIOL, V294, P1337, DOI 10.1006/jmbi.1999.3293
   de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   de Groot BL, 2003, J MOL BIOL, V333, P279, DOI 10.1016/j.jmb.2003.08.003
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Geelen D, 2002, PLANT CELL, V14, P387, DOI 10.1105/tpc.010328
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Johanson U, 2001, PLANT PHYSIOL, V126, P1358, DOI 10.1104/pp.126.4.1358
   Johansson I, 2000, BBA-BIOMEMBRANES, V1465, P324, DOI 10.1016/S0005-2736(00)00147-4
   Johansson I, 1998, PLANT CELL, V10, P451, DOI 10.1105/tpc.10.3.451
   Johansson I, 1996, PLANT CELL, V8, P1181, DOI 10.1105/tpc.8.7.1181
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   Kjellbom P, 1999, TRENDS PLANT SCI, V4, P308, DOI 10.1016/S1360-1385(99)01438-7
   Morillon R, 2001, PLANT PHYSIOL, V127, P720, DOI 10.1104/pp.010732
   Moshelion M, 2004, PLANT PHYSIOL, V135, P2301, DOI 10.1104/pp.104.043000
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Pratelli J, 2004, TRENDS PLANT SCI, V9, P187, DOI 10.1016/j.tplants.2004.02.007
   Ramahaleo T, 1999, PLANT PHYSIOL, V119, P885, DOI 10.1104/pp.119.3.885
   Robinson DC, 1996, PLANT PHYSIOL, V111, P645, DOI 10.1104/pp.111.2.645
   Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072
   SCHENK AD, 2005, IN PRESS J MOL BIOL
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
NR 35
TC 57
Z9 58
U1 2
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 22
PY 2005
VL 350
IS 4
BP 611
EP 616
DI 10.1016/j.jmb.2005.05.001
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 944RG
UT WOS:000230446000001
PM 15964017
DA 2021-01-25
ER

PT J
AU Otto, H
   Conz, C
   Maier, P
   Wolfle, T
   Suzuki, CK
   Jeno, P
   Rucknagel, P
   Stahl, J
   Rospert, S
AF Otto, H
   Conz, C
   Maier, P
   Wolfle, T
   Suzuki, CK
   Jeno, P
   Rucknagel, P
   Stahl, J
   Rospert, S
TI The chaperones MPP11 and Hsp70L1 form the mammalian ribosome-associated
   complex
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE myb domain; NatA; protein folding; translation
ID POLYACRYLAMIDE-GEL-ELECTROPHORESIS; LEUKEMIA-ASSOCIATED ANTIGENS; BLUE
   NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; DNA-BINDING-PROTEIN;
   SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; MYELOID-LEUKEMIA;
   NASCENT CHAIN; IN-VIVO
AB Soluble Hsp70 homologs cotranslationally interact with nascent polypeptides in all kingdoms of life. In addition, fungi possess a specialized Hsp70 system attached to ribosomes, which in Saccharomyces cerevisiae consists of the Hsp70 homologs Ssb1/2p, Ssz1p, and the Hsp40 homolog zuotin. Ssz1p and zuotin are assembled into a unique heterodimeric complex termed ribosome-associated complex. So far, no such specialized chaperones have been identified on ribosomes of higher eukaryotes. However, a family of proteins characterized by an N-terminal zuotin-homology domain fused to a C-terminal two-repeat Myb domain is present in animals and plants. Members of this family, like human MPP11 and mouse MIDA1, have been implicated in the regulation of cell growth. Specific targets of MPP11/MIDA1, however, have remained elusive. Here, we report that MPP11 is localized to the cytosol and associates with ribosomes. Purification of MPP11 revealed that it forms a stable complex with Hsp70L1, a distantly related homolog of Ssz1p. Complementation experiments indicate that mammalian ribosome-associated complex is functional in yeast. We conclude that despite a low degree of homology on the amino acid level cooperation of ribosome-associated chaperones with the translational apparatus is well conserved in eukaryotic cells.
C1 Univ Freiburg, Inst Biochem & Molekularbiol, D-79104 Freiburg, Germany.
   Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany.
   Univ Med & Dent New Jersey, Dept Biochem & Mol Biol, Newark, NJ 07103 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Max Planck Res Unit Enzymol Prot Folding, D-06120 Halle Saale, Germany.
   Max Delbruck Centrum Mol Med, D-13125 Berlin, Germany.
RP Rospert, S (corresponding author), Univ Freiburg, Inst Biochem & Molekularbiol, D-79104 Freiburg, Germany.
EM sabine.rospert@biochemie.uni-freiburg.de
OI Rospert, Sabine/0000-0002-3089-9614
CR Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006
   BLOBEL G, 1967, J MOL BIOL, V26, P279, DOI 10.1016/0022-2836(67)90297-5
   Braun EL, 2001, MOL BIOL EVOL, V18, P1401, DOI 10.1093/oxfordjournals.molbev.a003924
   Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5
   Clemens MJ, 1999, INT J BIOCHEM CELL B, V31, P1, DOI 10.1016/S1357-2725(98)00127-7
   Craig EA, 2003, CURR OPIN MICROBIOL, V6, P157, DOI 10.1016/S1369-5274(03)00030-4
   Dudek J, 2002, EMBO J, V21, P2958, DOI 10.1093/emboj/cdf315
   Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463
   Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198
   Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003
   Gautschi M, 2002, P NATL ACAD SCI USA, V99, P4209, DOI 10.1073/pnas.062048599
   Greiner J, 2003, INT J CANCER, V106, P224, DOI 10.1002/ijc.11200
   Greiner J, 2004, INT J CANCER, V108, P704, DOI 10.1002/ijc.11623
   HAID A, 1983, METHOD ENZYMOL, V96, P192
   Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408
   Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942
   HUGHES R, 1995, GENOMICS, V29, P546, DOI 10.1006/geno.1995.9969
   Hundley H, 2002, P NATL ACAD SCI USA, V99, P4203, DOI 10.1073/pnas.062048399
   Inoue T, 1999, BIOCHEM BIOPH RES CO, V266, P147, DOI 10.1006/bbrc.1999.1779
   Inoue T, 2000, GENES CELLS, V5, P699, DOI 10.1046/j.1365-2443.2000.00362.x
   Ito M, 2005, J PLANT RES, V118, P61, DOI 10.1007/s10265-005-0192-8
   Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410
   MatsumotoTaniura N, 1996, MOL BIOL CELL, V7, P1455
   NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I
   Okada H, 2001, CANCER RES, V61, P2625
   Perrot M, 1999, ELECTROPHORESIS, V20, P2280, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2280::AID-ELPS2280>3.3.CO;2-H
   Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981
   Polevoda B, 2003, BIOCHEM BIOPH RES CO, V308, P1, DOI 10.1016/S0006-291X(03)01316-0
   Rakwalska M, 2004, MOL CELL BIOL, V24, P9186, DOI 10.1128/MCB.24.20.9186-9197.2004
   Resto VA, 2000, CANCER RES, V60, P5529
   ROSPERT S, 2005, PROTEIN FOLDING HDB, V2, P429
   Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015
   SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sherman F., 1986, METHODS YEAST GENETI
   SHOJI W, 1995, J BIOL CHEM, V270, P24818, DOI 10.1074/jbc.270.42.24818
   Sugiura N, 2003, J BIOL CHEM, V278, P40113, DOI 10.1074/jbc.M301218200
   Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172
   Wan T, 2004, BLOOD, V103, P1747, DOI 10.1182/blood-2003-08-2828
   WANG K, 1982, METHOD ENZYMOL, V85, P514
   WILHELM ML, 1994, FEBS LETT, V349, P260, DOI 10.1016/0014-5793(94)00683-0
   Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809
   Yoshida M, 2004, BIOCHEM BIOPH RES CO, V324, P326, DOI 10.1016/j.bbrc.2004.09.059
   ZHANG SG, 1992, EMBO J, V11, P3787, DOI 10.1002/j.1460-2075.1992.tb05464.x
NR 45
TC 94
Z9 100
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 19
PY 2005
VL 102
IS 29
BP 10064
EP 10069
DI 10.1073/pnas.0504400102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 947SE
UT WOS:000230665800016
PM 16002468
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Rockel, B
   Peters, J
   Muller, SA
   Seyit, G
   Ringler, P
   Hegerl, R
   Glaeser, RM
   Baumeister, W
AF Rockel, B
   Peters, J
   Muller, SA
   Seyit, G
   Ringler, P
   Hegerl, R
   Glaeser, RM
   Baumeister, W
TI Molecular architecture and assembly mechanism of Drosophila tripeptidyl
   peptidase II
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE 3D reconstruction; cryoelectron microscopy; scanning transmission
   electron microscopy
ID TRANSMISSION ELECTRON-MICROSCOPY; TRICORN PROTEASE; PROTEOLYTIC SYSTEM;
   ANTIGENIC PEPTIDE; CRYSTAL-STRUCTURE; GIANT PROTEASE; DEGRADATION;
   COMPLEX; AMINOPEPTIDASE; ENZYME
AB In eukaryotes, tripeptidyl peptidase II (TPPII) is a crucial component of the proteolytic cascade acting downstream of the 26S proteasome in the ubiquitin-proteasome pathway. It is an amino peptidase belonging to the subtilase family removing tripeptides from the free N terminus of oligopeptides. The 150-kDa subunits of Drosophila TPPII assemble into a giant proteolytic complex of 6 MDa with a remarkable architecture consisting of two segmented and twisted strands that form a spindle-shaped structure. A refined 3D model has been obtained by cryoelectron microscopy, which reveals details of the molecular architecture and, in conjunction with biochemical data, provides insight into the assembly mechanism. The building blocks of this complex are apparently dimers, within which the 150-kDa monomers are oriented head to head. Stacking of these dimers leads to the formation of twisted single strands, two of which comprise the fully assembled spindle. This spindle also forms when TPPII is heterologously expressed in Escherichia coli, demonstrating that no scaffolding protein is required for complex formation and length determination. Reciprocal interactions of the N-terminal part of subunits from neighboring strands are probably involved in the formation of the native quaternary structure, lending the TPPII spindle a stability higher than that of single strands.
C1 Max Planck Inst Biochem, Dept Biol Mol & Struct, D-82152 Martinsried, Germany.
   Univ Basel, Maurice E Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.
RP Rockel, B (corresponding author), Max Planck Inst Biochem, Dept Biol Mol & Struct, D-82152 Martinsried, Germany.
EM rockel@biochem.mpg.de
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM062989, R01 GM062989] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM062989, R01GM062989, R01GM062989, R01GM062989] Funding Source: NIH
   RePORTER
CR Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Borissenko L, 2005, J MOL BIOL, V346, P1207, DOI 10.1016/j.jmb.2004.12.056
   Burri L, 2002, PROTEIN EXPRES PURIF, V26, P19, DOI 10.1016/S1046-5928(02)00507-7
   Franzetti B, 2002, EMBO J, V21, P2132, DOI 10.1093/emboj/21.9.2132
   Gavioli R, 2001, NAT CELL BIOL, V3, P283, DOI 10.1038/35060076
   Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978
   Glas R, 1998, NATURE, V392, P618
   GRAYCAR TP, 2004, HDB PROTEOLYTIC ENZY, V2, P1786
   HARRIS JR, 1990, MICRON MICROSC ACTA, V21, P77, DOI 10.1016/0739-6260(90)90008-4
   Hasselgren PO, 2002, BIOCHEM BIOPH RES CO, V290, P1, DOI 10.1006/bbrc.2001.5849
   Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006
   Hilbi H, 2000, INFECT IMMUN, V68, P5502, DOI 10.1128/IAI.68.10.5502-5508.2000
   Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119
   Hong X, 2003, J EXP MED, V197, P1731, DOI 10.1084/jem.20020801
   Levy F, 2002, J IMMUNOL, V169, P4161, DOI 10.4049/jimmunol.169.8.4161
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Margosiak SA, 1996, BIOCHEMISTRY-US, V35, P5300, DOI 10.1021/bi952842u
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Princiotta MF, 2001, P NATL ACAD SCI USA, V98, P513, DOI 10.1073/pnas.021132398
   Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3
   Renn SCP, 1998, J BIOL CHEM, V273, P19173, DOI 10.1074/jbc.273.30.19173
   Rockel B, 2002, EMBO J, V21, P5979, DOI 10.1093/emboj/cdf601
   Rose C, 1996, NATURE, V380, P403, DOI 10.1038/380403a0
   Russo S, 2004, J BIOL CHEM, V279, P51275, DOI 10.1074/jbc.M409455200
   Sachdev D, 2000, METHOD ENZYMOL, V326, P312
   Seifert U, 2003, NAT IMMUNOL, V4, P375, DOI 10.1038/ni905
   Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7
   Tamura T, 1996, SCIENCE, V274, P1385, DOI 10.1126/science.274.5291.1385
   Tirassa P, 2002, CNS NEUROL DISORD-DR, V1, P495, DOI 10.2174/1568007023338978
   TOMKINSON B, 1994, BIOCHEM J, V304, P517, DOI 10.1042/bj3040517
   Tomkinson B, 2000, ARCH BIOCHEM BIOPHYS, V376, P275, DOI 10.1006/abbi.2000.1713
   TOMKINSON B, 1991, BIOCHEMISTRY-US, V30, P168, DOI 10.1021/bi00215a025
   Tomkinson B, 1999, TRENDS BIOCHEM SCI, V24, P355, DOI 10.1016/S0968-0004(99)01435-8
   TOMKINSON B, 2004, HDB PROTEOLYTIC ENZY, V2, P1882
   Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015
   Walz J, 1997, MOL CELL, V1, P59, DOI 10.1016/S1097-2765(00)80007-6
   Wang EW, 2000, P NATL ACAD SCI USA, V97, P9990, DOI 10.1073/pnas.180328897
   Warburton MJ, 2002, NEUROSCI LETT, V331, P99, DOI 10.1016/S0304-3940(02)00841-8
   WILSON C, 1993, NEUROCHEM RES, V18, P743, DOI 10.1007/BF00966768
   Wray CJ, 2002, BIOCHEM BIOPH RES CO, V296, P41, DOI 10.1016/S0006-291X(02)00834-3
NR 41
TC 26
Z9 28
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 19
PY 2005
VL 102
IS 29
BP 10135
EP 10140
DI 10.1073/pnas.0504569102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 947SE
UT WOS:000230665800028
PM 16006508
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Tropis, M
   Meniche, X
   Wolf, A
   Gebhardt, H
   Strelkov, S
   Chami, M
   Schomburg, D
   Kramer, R
   Morbach, S
   Daffe, M
AF Tropis, M
   Meniche, X
   Wolf, A
   Gebhardt, H
   Strelkov, S
   Chami, M
   Schomburg, D
   Kramer, R
   Morbach, S
   Daffe, M
TI The crucial role of trehalose and structurally related oligosaccharides
   in the biosynthesis and transfer of mycolic acids in corynebacterineae
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CELL-FREE-EXTRACTS; BETA-KETO ESTER; MYCOBACTERIUM-TUBERCULOSIS;
   ELECTRON-MICROSCOPY; PALMITIC ACID; 3 PATHWAYS; WALL; GLUTAMICUM;
   SMEGMATIS; ENVELOPE
AB Trehalose (alpha-D-glucopyranosyl-alpha'-D-glucopyranoside) is essential for the growth of the human pathogen Mycobacterium tuberculosis but not for the viability of the phylogenetically related corynebacteria. To determine the role of trehalose in the physiology of these bacteria, the so-called Corynebacterineae, mutant strains of Corynebacterium glutamicum unable to synthesize trehalose due to the knock-out of the genes of the three pathways of trehalose biosynthesis, were biochemically analyzed. We demonstrated that the synthesis of trehalose under standard conditions is a prerequisite for the production of mycolates, major and structurally important constituents of the cell envelope of Corynebacterineae. Consistently, the trehalose-less cells also lack the cell wall fracture plane that typifies mycolate-containing bacteria. Importantly, however, the mutants were able to synthesize mycolates when grown on glucose, maltose, and maltotriose but not on other carbon sources known to be used for the production of internal glucose phosphate such as fructose, acetate, and pyruvate. The mycoloyl residues synthesized by the mutants grown on alpha-D-glucopyranosyl-containing oligosaccharides were transferred both onto the cell wall and free sugar acceptors. A combination of chemical analytical approaches showed that the newly synthesized glycolipids consisted of 1 mol of mycolate located on carbon 6 of the non reducing glucopyranosyl unit. Additionally, experiments with radioactively labeled trehalose showed that the transfer of mycoloyl residues onto sugars occurs outside the plasma membrane. Finally, and in contradiction to published data, we demonstrated that trehalose 6-phosphate has no impact on mycolate synthesis in vivo.
C1 CNRS, UMR 5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France.
   Univ Toulouse 3, F-31077 Toulouse, France.
   Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Daffe, M (corresponding author), CNRS, UMR 5089, Dept Mol Mech Mycobacterial Infect, Inst Pharmacol & Biol Struct, 205 Route Narbonne, F-31077 Toulouse, France.
EM mamadou.daffe@ipbs.fr
OI Schomburg, Dietmar/0000-0002-3354-822X
CR ABE S, 1967, J GEN APPL MICROBIOL, V13, P279, DOI 10.2323/jgam.13.279
   AGGERBECK LP, 1986, METHOD ENZYMOL, V128, P457
   Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192
   AURELLE H, 1980, TETRAHEDRON LETT, V21, P3277, DOI 10.1016/S0040-4039(00)78666-7
   BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6
   Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420
   BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   CHAMI M, 1995, BIOL CELL, V83, P219, DOI 10.1016/0248-4900(96)81311-6
   DAFFE M, 1989, J GEN MICROBIOL, V135, P2759
   DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x
   DAFFE M, 1983, ANN INST PASTEUR MIC, VB134, P241, DOI 10.1016/S0769-2609(83)80037-4
   DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   DAFFE M, 2005, HDB CORYNEBACTERIUM, P121
   DATTA AK, 1993, BIOCHIM BIOPHYS ACTA, V1169, P135, DOI 10.1016/0005-2760(93)90198-I
   De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199
   De Sousa-D'Auria C, 2003, FEMS MICROBIOL LETT, V224, P35, DOI 10.1016/S0378-1097(03)00396-3
   DITTMER JC, 1964, J LIPID RES, V5, P126
   Draper P, 1998, Front Biosci, V3, pD1253
   Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6
   Jackson M, 1999, MOL MICROBIOL, V31, P1573, DOI 10.1046/j.1365-2958.1999.01310.x
   Kacem R, 2004, MICROBIOL-SGM, V150, P73, DOI 10.1099/mic.0.26583-0
   LACAVE C, 1990, BIOCHIM BIOPHYS ACTA, V1042, P315, DOI 10.1016/0005-2760(90)90159-U
   Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181
   LIU J, 1995, P NATL ACAD SCI USA, V92, P11254, DOI 10.1073/pnas.92.24.11254
   LOPEZMARIN LM, 1991, BIOCHIM BIOPHYS ACTA, V1086, P22, DOI 10.1016/0005-2760(91)90150-G
   MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8
   Minnikin D.E., 1982, BIOL MYCOBACTERIA, P95
   Morbach S, 2002, CHEMBIOCHEM, V3, P385, DOI 10.1002/1439-7633(20020503)3:5<384::AID-CBIC384>3.0.CO;2-H
   Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200
   Padilla L, 2004, APPL ENVIRON MICROB, V70, P370, DOI 10.1128/AEM.70.1.370-376.2004
   Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200
   Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101
   PROME JC, 1974, CR ACAD SCI C CHIM, V278, P1065
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   Puech V, 2000, MOL MICROBIOL, V35, P1026, DOI 10.1046/j.1365-2958.2000.01738.x
   QUEMARD A, 1991, ANTIMICROB AGENTS CH, V35, P1035, DOI 10.1128/AAC.35.6.1035
   SATHYAMOORTHY N, 1987, J BIOL CHEM, V262, P13417
   SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7
   SCHWIND H, 1978, J CLIN CHEM CLIN BIO, V16, P145
   Shimakata T, 2000, ARCH BIOCHEM BIOPHYS, V380, P331, DOI 10.1006/abbi.2000.1924
   SHIMAKATA T, 1986, ARCH BIOCHEM BIOPHYS, V247, P302, DOI 10.1016/0003-9861(86)90588-6
   SWEELEY CC, 1963, J AM CHEM SOC, V85, P2497, DOI 10.1021/ja00899a032
   Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005
   Tzvetkov M, 2003, MICROBIOL-SGM, V149, P1659, DOI 10.1099/mic.0.26205-0
   WALKER RW, 1973, BIOCHIM BIOPHYS ACTA, V326, P52, DOI 10.1016/0005-2760(73)90027-1
   Wang J, 2004, BIOORGAN MED CHEM, V12, P6397, DOI 10.1016/j.bmc.2004.09.033
   WHEELER PR, 1993, BIOCHIM BIOPHYS ACTA, V1167, P182, DOI 10.1016/0005-2760(93)90160-B
   Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x
   Woodruff PJ, 2004, J BIOL CHEM, V279, P28835, DOI 10.1074/jbc.M313103200
NR 52
TC 57
Z9 59
U1 1
U2 15
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 15
PY 2005
VL 280
IS 28
BP 26573
EP 26585
DI 10.1074/jbc.M502104200
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 943WT
UT WOS:000230386800074
PM 15901732
OA Other Gold
DA 2021-01-25
ER

PT J
AU Goure, J
   Broz, P
   Attree, O
   Cornelis, GR
   Attree, I
AF Goure, J
   Broz, P
   Attree, O
   Cornelis, GR
   Attree, I
TI Protective anti-V antibodies inhibit Pseudomonas and Yersinia translocon
   assembly within host membranes
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
ID III SECRETION SYSTEM; TARGET-CELL CONTACT; YOP VIRULON;
   PASTEURELLA-PESTIS; PASSIVE-IMMUNITY; PLASMA-MEMBRANE; PORE FORMATION;
   HELA-CELLS; AERUGINOSA; ENTEROCOLITICA
AB Pathogenic Yersinia species and Pseudomonas aeruginosa share a similar type III secretion/translocation system. The translocation system consists of 3 secreted proteins, YopB/PopB, YopD/PopD, and LcrV/PcrV; the latter is known to be a protective antigen. In an in vitro assay, the translocation system causes the lysis of erythrocytes infected with wild-type (wt) P. aeruginosa. wt Y. enterocolitica is not hemolytic, but a multiknockout mutant deprived of all the effectors and of YopN (Delta HOPEMN) is hemolytic. In the presence of antibodies against PcrV and Y. pestis LcrV, the hemolytic activity of P. aeruginosa was inhibited. Similarly, the hemolytic activity of Delta HOPEMN was inhibited in the presence of anti-LcrV antibodies. The assembly of the translocon, composed of PopB/D and YopB/D proteins, was disturbed in immunoprotected erythrocyte membranes, mimicking the phenotypes of V knockout mutants. Thus, protective antibodies against the V antigens of Yersinia species and P. aeruginosa act at the level of the formation of the translocon pore in membranes of infected host cells by blocking the function of LcrV/PcrV. The hemolysis assay could be adapted for high-throughput screening of anti-infectious compounds that specifically target the type III translocon.
C1 CEA Grenoble, DRDC, BBSI, CNRS,UMR5092, F-38054 Grenoble, France.
   Ctr Rech, Serv Sante Armees, La Tronche, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Attree, I (corresponding author), CEA Grenoble, DRDC, BBSI, CNRS,UMR5092, 17 Rue Martyrs, F-38054 Grenoble, France.
EM jattreedelic@cea.fr
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790; Attree, Ina/0000-0002-2580-764X
CR BERGMAN T, 1991, J BACTERIOL, V173, P1607, DOI 10.1128/jb.173.5.1607-1616.1991
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452
   BURROWS TW, 1958, BRIT J EXP PATHOL, V39, P278
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Dacheux D, 1999, INFECT IMMUN, V67, P6164, DOI 10.1128/IAI.67.11.6164-6167.1999
   Davis HL, 1998, J IMMUNOL, V160, P870
   Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069
   Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   LAWTON WD, 1963, J IMMUNOL, V91, P179
   Lee VT, 2000, J BIOL CHEM, V275, P36869, DOI 10.1074/jbc.M002467200
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nowakowski A, 2002, P NATL ACAD SCI USA, V99, P11346, DOI 10.1073/pnas.172229899
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Roggenkamp A, 1997, INFECT IMMUN, V65, P446, DOI 10.1128/IAI.65.2.446-451.1997
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Sarker MR, 1998, J BACTERIOL, V180, P1207, DOI 10.1128/JB.180.5.1207-1214.1998
   Sawa T, 1999, NAT MED, V5, P392
   Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499
   Shime N, 2001, J IMMUNOL, V167, P5880, DOI 10.4049/jimmunol.167.10.5880
   SKRZYPEK E, 1995, J BACTERIOL, V177, P2530, DOI 10.1128/jb.177.9.2530-2542.1995
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Sundin C, 2002, MICROB PATHOGENESIS, V33, P265, DOI 10.1006/mpat.2002.0534
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265
   UNE T, 1984, J IMMUNOL, V133, P2226
   Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373
   Weeks S, 2002, MICROB PATHOGENESIS, V32, P227, DOI 10.1006/mpat.2002.0498
   Yahr TL, 1997, J BACTERIOL, V179, P7165, DOI 10.1128/jb.179.22.7165-7168.1997
NR 40
TC 95
Z9 98
U1 0
U2 3
PU UNIV CHICAGO PRESS
PI CHICAGO
PA 1427 E 60TH ST, CHICAGO, IL 60637-2954 USA
SN 0022-1899
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 15
PY 2005
VL 192
IS 2
BP 218
EP 225
DI 10.1086/430932
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 943WX
UT WOS:000230387300005
PM 15962216
OA Green Published
DA 2021-01-25
ER

PT J
AU Schenk, AD
   Werten, PJL
   Scheuring, S
   de Groot, BL
   Muller, SA
   Stahlberg, H
   Philippsen, A
   Engel, A
AF Schenk, AD
   Werten, PJL
   Scheuring, S
   de Groot, BL
   Muller, SA
   Stahlberg, H
   Philippsen, A
   Engel, A
TI The 4.5 angstrom structure of human AQP2
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE aquaporin; atomic force microscopy; electron crystallography;
   nephrogenic diabetes insipidus; 2D crystallization
ID AQUAPORIN-2 WATER CHANNEL; ELECTRON CRYSTALLOGRAPHY; EXPRESSION;
   PHYSIOLOGY; MEMBRANE; BALANCE; BACTERIORHODOPSIN; PATHOPHYSIOLOGY;
   CRYSTALLIZATION; CIRRHOSIS
AB Located in the principal cells of the collecting duct, aquaporin-2 (AQP2) is responsible for the regulated water reabsorbtion in the kidney and is indispensable for the maintenance of body water balance. Disregulation or malfunctioning of AQP2 can lead to severe diseases such as nephrogenic diabetes insipidus, congestive heart failure, liver cirrhosis and preeclampsia. Here we present the crystallization of recombinantly expressed human AQP2 into two-dimensional protein-lipid arrays and their structural characterization by atomic force microscopy and electron crystallography. These crystals are double-layered sheets that have a diameter of up to 30 mu m, diffract to 3 angstrom(-1) and are stacked by contacts between their cytosolic surfaces. The structure determined to 4.5 angstrom resolution in the plane of the membrane reveals the typical aquaporin fold but also a particular structure between the stacked layers that is likely to be related to the cytosolic N and C termini. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Inst Curie, CNRS, UMR 168, F-75231 Paris, France.
   CEA, LRC 34V, F-75231 Paris, France.
   Max Planck Inst Biophys Chem, Computat Biomol Dynam Grp, D-37077 Gottingen, Germany.
   Univ Calif Davis, Davis, CA 95616 USA.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Microscopy, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
RI Scheuring, Simon/L-9843-2018; Stahlberg, Henning/H-1868-2011
OI Scheuring, Simon/0000-0003-3534-069X; Stahlberg,
   Henning/0000-0002-1185-4592; Schenk, Andreas/0000-0001-9214-2505
CR Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818
   Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4
   ASAHINA Y, 1995, HEPATOLOGY, V21, P169, DOI 10.1016/0270-9139(95)90425-5
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BALDWIN J, 1984, ULTRAMICROSCOPY, V14, P319, DOI 10.1016/0304-3991(84)90217-1
   Brink J, 1998, J MICROSC-OXFORD, V191, P67
   de Groot BL, 2000, J MOL BIOL, V300, P987, DOI 10.1006/jmbi.2000.3913
   de Groot BL, 2001, FEBS LETT, V504, P206, DOI 10.1016/S0014-5793(01)02743-0
   Deen PMT, 1998, CURR OPIN CELL BIOL, V10, P435, DOI 10.1016/S0955-0674(98)80055-0
   Deen PMT, 1998, CURR OPIN NEPHROL HY, V7, P37
   DEEN PMT, 1994, SCIENCE, V264, P92, DOI 10.1126/science.8140421
   DOWNING KH, 1991, SCIENCE, V251, P53, DOI 10.1126/science.1846047
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800
   Fernandez-Llama P, 1999, J AM SOC NEPHROL, V10, P1950
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   FRANK J, 1981, ULTRAMICROSCOPY, V6, P343, DOI 10.1016/S0304-3991(81)80221-5
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Heymann JB, 2000, J MOL BIOL, V295, P1039, DOI 10.1006/jmbi.1999.3413
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Jonassen TEN, 1998, AM J PHYSIOL-RENAL, V275, pF216
   JUNG JS, 1994, J BIOL CHEM, V269, P14648
   King LS, 2000, MOL MED TODAY, V6, P60, DOI 10.1016/S1357-4310(99)01636-6
   Knepper MA, 1997, CURR OPIN NEPHROL HY, V6, P367
   Kunji ERS, 2001, J MOL BIOL, V308, P279, DOI 10.1006/jmbi.2001.4565
   MITRA AK, 1993, BIOPHYS J, V65, P1295, DOI 10.1016/S0006-3495(93)81169-X
   Mulders SM, 1998, J CLIN INVEST, V102, P57, DOI 10.1172/JCI2605
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 1997, BIOPHYS J, V73, P1633
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nielsen S, 1998, CURR OPIN NEPHROL HY, V7, P509, DOI 10.1097/00041552-199809000-00005
   Nielsen S, 1997, P NATL ACAD SCI USA, V94, P5450, DOI 10.1073/pnas.94.10.5450
   Nielsen S, 1999, J AM SOC NEPHROL, V10, P647
   PEARSON JF, 1992, BRIT J HOSP MED, V48, P47
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Ren G, 2001, P NATL ACAD SCI USA, V98, P1398, DOI 10.1073/pnas.041489198
   Ren G, 2000, J STRUCT BIOL, V130, P45, DOI 10.1006/jsbi.2000.4211
   Ringler P, 1999, J MOL BIOL, V291, P1181, DOI 10.1006/jmbi.1999.3031
   Savage DF, 2003, PLOS BIOL, V1, P334, DOI 10.1371/journal.pbio.0000072
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SAXTON WO, 1982, J MICROSC-OXFORD, V127, P127, DOI 10.1111/j.1365-2818.1982.tb00405.x
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Schrier RW, 1998, P ASSOC AM PHYSICIAN, V110, P407
   Schrier RW, 1998, MOL GENET METAB, V65, P255, DOI 10.1006/mgme.1998.2765
   Sui HX, 2001, NATURE, V414, P872, DOI 10.1038/414872a
   Tajkhorshid E, 2002, SCIENCE, V296, P525, DOI 10.1126/science.1067778
   van Os CH, 1998, NEPHROL DIAL TRANSPL, V13, P1645, DOI 10.1093/ndt/13.7.1645
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   Walz T, 1996, J MOL BIOL, V264, P907, DOI 10.1006/jmbi.1996.0686
   Werten PJL, 2001, FEBS LETT, V504, P200, DOI 10.1016/S0014-5793(01)02703-X
   Xu Linjing, 1998, Medicine and Science in Sports and Exercise, V30, P1230, DOI 10.1097/00005768-199808000-00008
NR 60
TC 53
Z9 55
U1 0
U2 9
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 8
PY 2005
VL 350
IS 2
BP 278
EP 289
DI 10.1016/j.jmb.2005.04.030
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 940ZE
UT WOS:000230183600008
PM 15922355
DA 2021-01-25
ER

PT J
AU Merabet, S
   Hombria, JCG
   Hu, N
   Pradel, J
   Graba, Y
AF Merabet, S
   Hombria, JCG
   Hu, N
   Pradel, J
   Graba, Y
TI Hox-controlled reorganisation of intrasegmental patterning cues
   underlies Drosophila posterior spiracle organogenesis
SO DEVELOPMENT
LA English
DT Article
DE Hox; signalling; organogenesis; Drosophila
ID HOMEOTIC GENE-FUNCTION; SEGMENTATION CLOCK; BITHORAX-COMPLEX; GERM
   LAYERS; EXPRESSION; PROTEIN; EMBRYO; MORPHOGENESIS; WINGLESS; TARGET
AB Hox proteins provide axial positional information and control segment morphology in development and evolution. Yet how they specify morphological traits that confer segment identity and how axial positional information interferes with intrasegmental patterning cues during organogenesis remain poorly understood. We have investigated the control of Drosophila posterior spiracle morphogenesis, a segment-specific structure that forms under Abdominal-B (AbdB) Hox control in the eighth abdominal segment (A8). We show that the Hedgehog (Hh), Wingless (Wg) and Epidermal Growth Factor Receptor (Egfr) pathways provide specific inputs for posterior spiracle morphogenesis and act in a genetic network made of multiple and rapidly evolving Hox/signalling interplays. A major function of AbdB during posterior spiracle organogenesis is to reset A8 intrasegmental patterning cues, first by reshaping wg and rhomboid expression patterns, then by reallocating the Hh signal and later by initiating de novo expression of the posterior compartment gene engrailed in anterior compartment cells. These changes in expression patterns confer axial specificity to otherwise reiteratively used segmental patterning cues, linking intrasegmental polarity and acquisition of segment identity.
C1 Univ Mediterranee, Lab Genet & Physiol Dev, IBDM, CNRS, F-13288 Marseille, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England.
   Univ Pablo de Olavide, Ctr Andaluz Biol Desarrollo, Seville 41013, Spain.
RP Graba, Y (corresponding author), Univ Mediterranee, Lab Genet & Physiol Dev, IBDM, CNRS, Parc Sci de Luminy,Case 907, F-13288 Marseille, France.
EM graba@ibdm.univ-mrs.fr
RI Hombria, James C-G/L-2036-2014; Graba, Yacine/AAC-9010-2019
OI Hombria, James C-G/0000-0003-4183-5250; 
FU Wellcome TrustWellcome Trust Funding Source: Medline
CR Alexandre C, 1999, DEVELOPMENT, V126, P5689
   Boube M, 2000, MECH DEVELOP, V91, P271, DOI 10.1016/S0925-4773(99)00315-9
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brodu V, 2002, DEVELOPMENT, V129, P2957
   Castelli-Gair J, 1998, DEVELOPMENT, V125, P1269
   CASTELLIGAIR J, 1994, DEVELOPMENT, V120, P1983
   Chen YT, 2004, DEVELOPMENT, V131, P2339, DOI 10.1242/dev.01115
   DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E
   Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8
   Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946
   Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094
   Gellon G, 1998, BIOESSAYS, V20, P116, DOI 10.1002/(SICI)1521-1878(199802)20:2<116::AID-BIES4>3.0.CO;2-R
   Gieseler K, 2001, DEV BIOL, V232, P339, DOI 10.1006/dbio.2001.0184
   Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505
   Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760
   Gustavson E, 1996, GENETICS, V142, P893
   Hepker J, 1997, DEVELOPMENT, V124, P549
   Hu N, 1999, DEV BIOL, V214, P197, DOI 10.1006/dbio.1999.9391
   IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K
   Isaac DD, 1996, GENE DEV, V10, P103, DOI 10.1101/gad.10.1.103
   JACK J, 1995, GENETICS, V139, P1689
   JONES B, 1993, GENE DEV, V7, P229, DOI 10.1101/gad.7.2.229
   Joulia L, 2005, DEV BIOL, V278, P496, DOI 10.1016/j.ydbio.2004.11.003
   Knosp WM, 2004, DEVELOPMENT, V131, P4581, DOI 10.1242/dev.01327
   KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9
   KUHN DT, 1992, DEVELOPMENT, V116, P11
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Lee JR, 2001, CELL, V107, P161, DOI 10.1016/S0092-8674(01)00526-8
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Llimargas M, 1997, DEVELOPMENT, V124, P3273
   MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0
   Marty T, 2001, DEVELOPMENT, V128, P2833
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   Merabet S, 2002, GENETICS, V162, P189
   PANGANIBAN GEF, 1990, DEVELOPMENT, V110, P1041
   Ponzielli R, 2002, DEVELOPMENT, V129, P4509
   REUTER R, 1990, DEVELOPMENT, V110, P1031
   SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0
   Sanson B, 1996, NATURE, V383, P627, DOI 10.1038/383627a0
   Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255
   TABATA T, 1992, GENE DEV, V6, P2635, DOI 10.1101/gad.6.12b.2635
   WARGA RM, 1990, DEVELOPMENT, V108, P569
   Wiellette EL, 1999, DEVELOPMENT, V126, P1985
   Zakany J, 2004, SCIENCE, V304, P1669, DOI 10.1126/science.1096049
   Zakany J, 2001, CELL, V106, P207, DOI 10.1016/S0092-8674(01)00436-6
NR 46
TC 20
Z9 20
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JUL
PY 2005
VL 132
IS 13
BP 3093
EP 3102
DI 10.1242/dev.01889
PG 10
WC Developmental Biology
SC Developmental Biology
GA 953BM
UT WOS:000231050700014
PM 15930099
OA Bronze
DA 2021-01-25
ER

PT J
AU Affolter, M
   Weijer, CJ
AF Affolter, M
   Weijer, CJ
TI Signaling to cytoskeletal dynamics during chemotaxis
SO DEVELOPMENTAL CELL
LA English
DT Review
ID GERM-CELL MIGRATION; DROSOPHILA TRACHEAL SYSTEM; II HEAVY-CHAIN;
   CONVERGENT EXTENSION MOVEMENTS; CHEMOATTRACTANT-ELICITED INCREASES;
   DICTYOSTELIUM-DISCOIDEUM CELLS; RECEPTOR TYROSINE KINASES;
   DOMAIN-CONTAINING PROTEIN; NA-H EXCHANGER; GROWTH-FACTOR
AB We review insights in signaling pathways controlling cell polarization and cytoskeletal organization during chemotactic movement in Dictyostelium amoebae and neutrophils. We compare and contrast these insights with our current understanding of pathways controlling chemotactic movements in more-complex multicellular developmental contexts.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Univ Dundee, Sch Life Sci, Wellcome Trust Bioctr, Dundee DD1 5EH, Scotland.
RP Weijer, CJ (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM c.j.weijer@dundee.ac.uk
RI weijer, cornelis/I-4538-2012
OI Weijer, Cornelis/0000-0003-2192-8150; Affolter,
   Markus/0000-0002-5171-0016
CR Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Ahmad SM, 2002, CELL, V109, P651, DOI 10.1016/S0092-8674(02)00744-4
   AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7
   Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100
   Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007
   ATALIOTIS P, 1995, DEVELOPMENT, V121, P3099
   Bailly M, 2000, MOL BIOL CELL, V11, P3873, DOI 10.1091/mbc.11.11.3873
   Bear JE, 1998, J CELL BIOL, V142, P1325, DOI 10.1083/jcb.142.5.1325
   BERLOT CH, 1985, CELL, V43, P307, DOI 10.1016/0092-8674(85)90036-4
   BERLOT CH, 1987, J BIOL CHEM, V262, P3918
   Blagg SL, 2004, BIOCHEM SOC T, V32, P1113, DOI 10.1042/BST0321113
   Blagg SL, 2004, NAT CELL BIOL, V6, P279, DOI 10.1038/ncb0404-279
   Blagg SL, 2003, CURR BIOL, V13, P1480, DOI 10.1016/S0960-9822(03)00580-3
   Bosgraaf L, 2005, J CELL SCI, V118, P1899, DOI 10.1242/jcs.02317
   Bosgraaf L, 2002, EMBO J, V21, P4560, DOI 10.1093/emboj/cdf438
   Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040
   Bretschneider T, 2004, CURR BIOL, V14, P1, DOI 10.1016/j.cub.2003.12.005
   Chapman SC, 2002, DEV BIOL, V245, P187, DOI 10.1006/dbio.2002.0641
   Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339
   Chien S, 2000, MOL BIOL CELL, V11, P1275, DOI 10.1091/mbc.11.4.1275
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Choi SC, 2002, DEV BIOL, V244, P342, DOI 10.1006/dbio.2002.0602
   Chung CY, 2000, P NATL ACAD SCI USA, V97, P5225, DOI 10.1073/pnas.97.10.5225
   Chung CY, 1999, J CELL BIOL, V147, P559, DOI 10.1083/jcb.147.3.559
   Chung CY, 2001, MOL CELL, V7, P937, DOI 10.1016/S1097-2765(01)00247-7
   Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X
   Ciruna BG, 1997, DEVELOPMENT, V124, P2829
   CLAVIEZ M, 1986, J CELL SCI, V86, P69
   de la Roche MA, 2001, BBA-GEN SUBJECTS, V1525, P245, DOI 10.1016/S0304-4165(01)00110-6
   DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222
   DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045
   Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050
   Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200
   Dikic I, 2003, CURR OPIN CELL BIOL, V15, P128, DOI 10.1016/S0955-0674(03)00004-8
   Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2
   Dormann D, 2004, J CELL SCI, V117, P6497, DOI 10.1242/jcs.01579
   Dormann D, 2002, CELL MOTIL CYTOSKEL, V52, P221, DOI 10.1002/cm.10048
   Dormann D, 2002, CURR BIOL, V12, P1178, DOI 10.1016/S0960-9822(02)00950-8
   Dormann D, 2001, J CELL SCI, V114, P2513
   Dormann D, 2001, DEVELOPMENT, V128, P4535
   Dossenbach C, 2001, DEVELOPMENT, V128, P4563
   Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5
   Duchek P, 2001, SCIENCE, V291, P131, DOI 10.1126/science.291.5501.131
   Dumontier M, 2000, J CELL SCI, V113, P2253
   Dumstrei K, 2004, J CELL SCI, V117, P4787, DOI 10.1242/jcs.01362
   DYNES JL, 1994, GENE DEV, V8, P948, DOI 10.1101/gad.8.8.948
   Eden S, 2002, NATURE, V418, P790, DOI 10.1038/nature00859
   Egelhoff TT, 2005, J BIOL CHEM, V280, P2879, DOI 10.1074/jbc.M410803200
   Englund C, 2002, DEVELOPMENT, V129, P4941
   Evangelista M, 2003, J CELL SCI, V116, P2603, DOI 10.1242/jcs.00611
   Faix J, 1996, FEBS LETT, V394, P251, DOI 10.1016/0014-5793(96)00963-5
   FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630
   Franch-Marro X, 2000, DEV BIOL, V227, P80, DOI 10.1006/dbio.2000.9890
   Fulga TA, 2002, NAT CELL BIOL, V4, P715, DOI 10.1038/ncb848
   Funamoto S, 2001, J CELL BIOL, V153, P795, DOI 10.1083/jcb.153.4.795
   Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9
   Garcia-Garcia MJ, 2003, CELL, V114, P727, DOI 10.1016/S0092-8674(03)00715-3
   Gardiner EM, 2002, CURR BIOL, V12, P2029, DOI 10.1016/S0960-9822(02)01334-9
   Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020
   Geisbrecht ER, 2002, NAT CELL BIOL, V4, P616, DOI 10.1038/ncb830
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561
   Gisselbrecht S, 1996, GENE DEV, V10, P3003, DOI 10.1101/gad.10.23.3003
   Gotoh N, 2005, MOL CELL BIOL, V25, P4105, DOI 10.1128/MCB.25.10.4105-4116.2005
   Gryzik T, 2004, CURR BIOL, V14, P659, DOI 10.1016/j.cub.2004.03.058
   Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203
   Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6
   HALL AL, 1989, DEV BIOL, V136, P517, DOI 10.1016/0012-1606(89)90277-7
   Han YH, 2002, J BIOL CHEM, V277, P49877, DOI 10.1074/jbc.M209107200
   Hannigan M, 2002, P NATL ACAD SCI USA, V99, P3603, DOI 10.1073/pnas.052010699
   Hannigan MO, 2004, CURR TOP MICROBIOL, V282, P165
   Heid PJ, 2005, J CELL SCI, V118, P2225, DOI 10.1242/jcs.02342
   Hill K, 2005, J BIOL CHEM, V280, P4166, DOI 10.1074/jbc.M411262200
   Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027
   Huang YE, 2003, MOL BIOL CELL, V14, P1913, DOI 10.1091/mbc.E02-10-0703
   Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200
   Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6
   Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7
   Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835
   Janetopoulos C, 2004, P NATL ACAD SCI USA, V101, P8951, DOI 10.1073/pnas.0402152101
   Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479
   Kae H, 2004, EMBO REP, V5, P602, DOI 10.1038/sj.embor.7400151
   Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7
   Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478
   Kempiak SJ, 2003, J CELL BIOL, V162, P781, DOI 10.1083/jcb.200303144
   Kim GH, 2005, DEV DYNAM, V232, P958, DOI 10.1002/dvdy.20262
   Kimmel AR, 2004, CURR OPIN GENET DEV, V14, P540, DOI 10.1016/j.gde.2004.08.001
   Kinoshita N, 2003, GENE DEV, V17, P1663, DOI 10.1101/gad.1101303
   Kitayama C, 2003, J CELL SCI, V116, P711, DOI 10.1242/jcs.00265
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338
   Laevsky G, 2003, J CELL SCI, V116, P3761, DOI 10.1242/jcs.00684
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Lawson A, 2001, ANAT RECORD, V262, P221
   Lee S, 2004, MOL BIOL CELL, V15, P5456, DOI 10.1091/mbc.E04-04-0323
   Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236
   Li Z, 2003, CELL, V114, P215, DOI 10.1016/S0092-8674(03)00559-2
   Liang WC, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-19
   Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104
   Lorenz M, 2004, CELL MOTIL CYTOSKEL, V57, P207, DOI 10.1002/cm.10171
   Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3
   McDonald JA, 2003, DEVELOPMENT, V130, P3469, DOI 10.1242/dev.00574
   Meinhardt H, 1999, J CELL SCI, V112, P2867
   Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635
   Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640
   Montell DJ, 2003, NAT REV MOL CELL BIO, V4, P13, DOI 10.1038/nrm1006
   Montero JA, 2003, CURR BIOL, V13, P1279, DOI 10.1016/S0960-9822(03)00505-0
   Muller-Taubenberger A, 2002, J MUSCLE RES CELL M, V23, P751, DOI 10.1023/A:1024475628061
   Murphy MB, 1999, EUR J BIOCHEM, V264, P582, DOI 10.1046/j.1432-1327.1999.00670.x
   Myers SA, 2005, MOL BIOL CELL, V16, P2191, DOI 10.1091/mbc.E04-09-0844
   Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141
   Nagel M, 1999, DEVELOPMENT, V126, P1975
   Niewiadomska P, 1999, J CELL BIOL, V144, P533, DOI 10.1083/jcb.144.3.533
   Nutt SL, 2001, GENE DEV, V15, P1152, DOI 10.1101/gad.191301
   Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292
   Parent CA, 2004, CURR OPIN CELL BIOL, V16, P4, DOI 10.1016/j.ceb.2003.11.008
   Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5
   Park KC, 2004, EMBO J, V23, P4177, DOI 10.1038/sj.emboj.7600368
   Patel H, 2005, J CELL BIOL, V169, P321, DOI 10.1083/jcb.200412145
   Patel H, 2000, EMBO J, V19, P2247, DOI 10.1093/emboj/19.10.2247
   PATTERSON B, 1995, GENETICS, V140, P505
   Perkins LA, 1996, DEV BIOL, V180, P63, DOI 10.1006/dbio.1996.0285
   Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117
   Petit V, 2004, MOL CELL BIOL, V24, P3769, DOI 10.1128/MCB.24.9.3769-3781.2004
   Pinheiro EM, 2004, DEVELOPMENT, V131, P5243, DOI 10.1242/dev.01412
   Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X
   Postma M, 2004, EMBO REP, V5, P35, DOI 10.1038/sj.embor.7400051
   Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003
   Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004
   Reichman-Fried M, 2004, DEV CELL, V6, P589, DOI 10.1016/S1534-5807(04)00074-7
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Rivero F, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-28
   Rivero F, 2002, J MUSCLE RES CELL M, V23, P737, DOI 10.1023/A:1024423611223
   Rivero F, 2001, NUCLEIC ACIDS RES, V29, P1068, DOI 10.1093/nar/29.5.1068
   Rivero F, 1996, J CELL SCI, V109, P2679
   Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1
   Rorth P, 2003, CELL, V112, P595, DOI 10.1016/S0092-8674(03)00156-9
   Rorth P, 2002, TRENDS CELL BIOL, V12, P325, DOI 10.1016/S0962-8924(02)02311-5
   Rubin C, 2005, CELL RES, V15, P66, DOI 10.1038/sj.cr.7290268
   Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sasaki AT, 2004, J CELL BIOL, V167, P505, DOI 10.1083/jcb.200406177
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Saxton TM, 1999, P NATL ACAD SCI USA, V96, P3790, DOI 10.1073/pnas.96.7.3790
   Saxton TM, 2000, NAT GENET, V24, P420, DOI 10.1038/74279
   Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8
   Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3
   SHELDEN E, 1995, J CELL SCI, V108, P1105
   Siu CH, 2004, SEMIN CELL DEV BIOL, V15, P633, DOI 10.1016/j.semcdb.2004.09.004
   Sivak JM, 2005, DEV CELL, V8, P689, DOI 10.1016/j.devcel.2005.02.011
   Soldati T, 2003, TRAFFIC, V4, P358, DOI 10.1034/j.1600-0854.2003.t01-1-00095.x
   Soll DR, 1999, COMPUT MED IMAG GRAP, V23, P3, DOI 10.1016/S0895-6111(98)00058-5
   Somogyi K, 2004, DEV CELL, V7, P85, DOI 10.1016/j.devcel.2004.05.020
   Stathopoulos A, 2004, GENE DEV, V18, P687, DOI 10.1101/gad.1166404
   Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009
   Stites J, 1998, CELL MOTIL CYTOSKEL, V39, P31, DOI 10.1002/(SICI)1097-0169(1998)39:1<31::AID-CM4>3.0.CO;2-J
   Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595
   Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Symes K, 1996, P NATL ACAD SCI USA, V93, P9641, DOI 10.1073/pnas.93.18.9641
   Tahinci E, 2003, DEV BIOL, V259, P318, DOI 10.1016/S0012-1606(03)00206-9
   Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072
   Tsujioka M, 2004, EMBO J, V23, P2216, DOI 10.1038/sj.emboj.7600238
   Tsujioka M, 1999, CURR BIOL, V9, P389, DOI 10.1016/S0960-9822(99)80169-9
   Ueda M, 2001, SCIENCE, V294, P864, DOI 10.1126/science.1063951
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Van Haastert PJM, 2004, NAT REV MOL CELL BIO, V5, P626, DOI 10.1038/nrm1435
   VANHAASTERT PJM, 1983, J CELL BIOL, V96, P1559, DOI 10.1083/jcb.96.6.1559
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1
   Wang J, 2000, DEV BIOL, V227, P734, DOI 10.1006/dbio.2000.9881
   Wang JX, 2002, INT J MOL SCI, V3, P4, DOI 10.3390/i3010004
   Weijer CJ, 2004, CURR OPIN GENET DEV, V14, P392, DOI 10.1016/j.gde.2004.06.006
   Weijer CJ, 2003, SCIENCE, V300, P96, DOI 10.1126/science.1082830
   Weiner OD, 2002, NAT CELL BIOL, V4, P509, DOI 10.1038/ncb811
   Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3
   Wilson R, 2005, DEVELOPMENT, V132, P491, DOI 10.1242/dev.01603
   Wilson R, 2004, MOL CELL BIOL, V24, P2263, DOI 10.1128/MCB.24.6.2263-2276.2004
   Wolf C, 2002, EMBO REP, V3, P563, DOI 10.1093/embo-reports/kvf115
   Wolf C, 2000, GENE DEV, V14, P2140, DOI 10.1101/gad.180900
   Wong E, 2002, DEVELOPMENT, V129, P3839
   Xiao Z, 1997, J CELL BIOL, V139, P365, DOI 10.1083/jcb.139.2.365
   Xu JS, 2005, P NATL ACAD SCI USA, V102, P6884, DOI 10.1073/pnas.0502106102
   Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5
   Xu XH, 2005, MOL BIOL CELL, V16, P676, DOI 10.1091/mbc.E04-07-0544
   Xu XXS, 2001, DEV BIOL, V232, P255, DOI 10.1006/dbio.2000.0132
   YAMAGUCHI TP, 1992, DEV BIOL, V152, P75, DOI 10.1016/0012-1606(92)90157-C
   YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032
   Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3
   Zigmond SH, 2004, CURR OPIN CELL BIOL, V16, P99, DOI 10.1016/j.ceb.2003.10.019
NR 194
TC 120
Z9 121
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JUL
PY 2005
VL 9
IS 1
BP 19
EP 34
DI 10.1016/j.devcel.2005.06.003
PG 16
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 947PR
UT WOS:000230659000003
PM 15992538
DA 2021-01-25
ER

PT J
AU Schenk, AD
   Philippsen, A
   Signorell, G
   Engel, A
   Werten, PJ
AF Schenk, AD
   Philippsen, A
   Signorell, G
   Engel, A
   Werten, PJ
TI The water channel aquaporin-2
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT IUBMB 50th Anniversary Symposium
CY JUL 02-07, 2005
CL Budapest, HUNGARY
SP Int Union Biochem Molecular Biol
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, Basel, Switzerland.
EM andreas.schenk@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2005
VL 272
SU 1
BP 20
EP 20
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 005MG
UT WOS:000234826100068
DA 2021-01-25
ER

PT J
AU Albrecht, I
   Gatfield, J
   Zanolari, B
   Steinmetz, MO
   Pieters, J
AF Albrecht, I
   Gatfield, J
   Zanolari, B
   Steinmetz, MO
   Pieters, J
TI Structural and functional analysis of coronin 1
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT IUBMB 50th Anniversary Symposium
CY JUL 02-07, 2005
CL Budapest, HUNGARY
SP Int Union Biochem Molecular Biol
C1 Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
   Paul Scherrer Inst, Villigen, Switzerland.
EM imke.albrecht@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2005
VL 272
SU 1
BP 320
EP 321
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 005MG
UT WOS:000234826101614
DA 2021-01-25
ER

PT J
AU Eifler, N
   Werten, PJ
   Duckely, M
   Luthi, A
   Engel, A
AF Eifler, N
   Werten, PJ
   Duckely, M
   Luthi, A
   Engel, A
TI Functional expression of mammalian receptors and membrane channels in
   different cells
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT IUBMB 50th Anniversary Symposium
CY JUL 02-07, 2005
CL Budapest, HUNGARY
SP Int Union Biochem Molecular Biol
C1 Univ Basel, Biozentrum, ME Muller Inst Microscopy, Basel, Switzerland.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
EM nora.eifler@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2005
VL 272
SU 1
BP 510
EP 510
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 005MG
UT WOS:000234826102558
DA 2021-01-25
ER

PT J
AU Jindrova, E
   Schmid-Nuoffer, S
   Hamburger, F
   Janscak, P
   Bickle, TA
AF Jindrova, E
   Schmid-Nuoffer, S
   Hamburger, F
   Janscak, P
   Bickle, TA
TI On the DNA cleavage mechanism of Type I restriction enzymes
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT IUBMB 50th Anniversary Symposium
CY JUL 02-07, 2005
CL Budapest, HUNGARY
SP Int Union Biochem Molecular Biol
C1 USB, Lab Dr Ettrich, Inst Phys Biol, Nove Hrady, Czech Republic.
   AS CR, Inst Landscape Ecol, Nove Hrady, Czech Republic.
   Univ Basel, Lab Dr Bickle, Dept Microbiol, Biozentrum, Basel, Switzerland.
   Univ Zurich, Dept Mol Canc Res, Zurich, Switzerland.
EM jindrova@greentech.cz
RI Janscak, Pavel/Q-3795-2018; Janscak, Pavel/G-6189-2014; Csefalvay,
   Eva/G-9768-2014
OI Janscak, Pavel/0000-0002-1748-7789; Csefalvay, Eva/0000-0002-9297-2784
NR 0
TC 1
Z9 1
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2005
VL 272
SU 1
BP 552
EP 552
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 005MG
UT WOS:000234826102697
DA 2021-01-25
ER

PT J
AU Escher, P
   Lacazette, E
   Courtet, M
   Blindenbacher, A
   Landmann, L
   Bezakova, G
   Lloyd, KC
   Mueller, U
   Brenner, HR
AF Escher, P
   Lacazette, E
   Courtet, M
   Blindenbacher, A
   Landmann, L
   Bezakova, G
   Lloyd, KC
   Mueller, U
   Brenner, HR
TI Synapses form in skeletal muscles lacking neuregulin receptors
SO SCIENCE
LA English
DT Article
ID ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION; TRANSCRIPTION FACTOR;
   GENE-EXPRESSION; IN-VIVO; DIFFERENTIATION; SUBUNIT; ERBB4; MICE; PROTEIN
AB The formation of the neuromuscular junction (NMJ) is directed by reciprocal interactions between motor neurons and muscle fibers. Neuregulin (NRG) and Agrin from motor nerve terminals are both implicated. Here, we demonstrate that NMJs can form in the absence of the NRG receptors ErbB2 and ErbB4 in mouse muscle. Postsynaptic differentiation is, however, induced by Agrin. We therefore conclude that NRG signaling to muscle is not required for NMJ formation. The effects of NRG signaling to muscle may be mediated indirectly through Schwann cells.
C1 Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland.
   Univ Basel, Inst Anat, Dept Clin Biol Sci, CH-4056 Basel, Switzerland.
   Univ Basel, Div Pharmacol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Calif Davis, Ctr Comparat Med, Sch Vet Med, Davis, CA 95616 USA.
   Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA.
   Scripps Res Inst, Inst Childhood & Neglected Dis, La Jolla, CA 92037 USA.
RP Escher, P (corresponding author), Univ Basel, Inst Physiol, CH-4056 Basel, Switzerland.
EM Hans-Rudolf.Brenner@unibas.ch
RI Lacazette, eric/M-7168-2014
OI lacazette, eric/0000-0003-1234-5260
CR BEZAKOVA G, UNPUB
   Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601
   CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9
   Cossins J, 2004, HUM MOL GENET, V13, P2947, DOI 10.1093/hmg/ddh320
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   ESCHER P, UNPUB
   FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H
   Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911
   JO SA, 1995, NATURE, V373, P158, DOI 10.1038/373158a0
   Leu M, 2003, DEVELOPMENT, V130, P2291, DOI 10.1242/dev.00447
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715
   Marques MJ, 2000, J NEUROSCI, V20, P3663
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Meier T, 1997, J NEUROSCI, V17, P6534
   Missias AC, 1996, DEV BIOL, V179, P223, DOI 10.1006/dbio.1996.0253
   MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012
   Ozaki M, 1997, NATURE, V390, P691
   Rimer M, 2004, MOL CELL NEUROSCI, V26, P271, DOI 10.1016/j.mcn.2004.02.002
   Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599
   Schaeffer L, 1998, EMBO J, V17, P3078, DOI 10.1093/emboj/17.11.3078
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   Tidcombe H, 2003, P NATL ACAD SCI USA, V100, P8281, DOI 10.1073/pnas.1436402100
   Tzahar E, 1996, MOL CELL BIOL, V16, P5276
   Witzemann V, 1996, P NATL ACAD SCI USA, V93, P13286, DOI 10.1073/pnas.93.23.13286
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
NR 28
TC 91
Z9 93
U1 0
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 24
PY 2005
VL 308
IS 5730
BP 1920
EP 1923
DI 10.1126/science.1108258
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 940BZ
UT WOS:000230120000043
PM 15976301
DA 2021-01-25
ER

PT J
AU Schoenauer, R
   Bertoncini, P
   Machaidze, G
   Aebi, U
   Perriard, JC
   Hegner, M
   Agarkova, I
AF Schoenauer, R
   Bertoncini, P
   Machaidze, G
   Aebi, U
   Perriard, JC
   Hegner, M
   Agarkova, I
TI Myomesin is a molecular spring with adaptable elasticity
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE striated muscle; M-band; myomesin; titin; atomic force microscopy
ID SARCOMERIC M-BAND; ACTIVATED SKELETAL-MUSCLE; ATOMIC-FORCE MICROSCOPY;
   THICK FILAMENT MOVEMENT; TITIN MOLECULES; PROTEIN TITIN; IMMUNOELECTRON
   MICROSCOPY; MYOSIN-BINDING; M-LINE; STRIATED-MUSCLE
AB The M-band is a transverse structure in the center of the sarcomere, which is thought to stabilize the thick filament lattice. It was shown recently that the constitutive vertebrate M-band component myomesin can form antiparallel dimers, which might cross-link the neighboring thick filaments. Myomesin consists mainly of immunoglobulin-like (Ig) and fibronectin type III (Fn) domains, while several muscle types express the EH-myomesin splice isoform, generated by the inclusion of the unique EH-segment of about 100 amino acid residues (aa) in the center of the molecule. Here we use atomic force microscopy (AFM), transmission electron microscopy (TEM) and circular dichroism (CD) spectroscopy for the biophysical characterization of myomesin. The AFM identifies the "mechanical fingerprints" of the modules constituting the myomesin molecule. Stretching of homomeric polyproteins, constructed of Ig and Fn domains of human myomesin, produces a typical saw-tooth pattern in the force-extension curve. The domains readily refold after relaxation. In contrast, stretching of a heterogeneous polyprotein, containing several repeats of the My6-EH fragment reveals a long initial plateau corresponding to the sum of EH-segment contour lengths, followed by several My6 unfolding peaks. According to this, the EH-segment is characterized as an entropic chain with a persistence length of about 0.3 nm. In TEM pictures, the EH-domain appears as a gap in the molecule, indicating a random coil conformation similar to the PEVK region of titin. CD spectroscopy measurements support this result, demonstrating a mostly non-folded conformation for the EH-segment. We suggest that similarly to titin, myomesin is a molecular spring, whose elasticity is modulated by alternative splicing. The Ig and Fn domains might function as reversible "shock absorbers" by sequential unfolding in the case of extremely high or long sustained stretching forces. These complex visco-elastic properties of myomesin might be crucial for the stability of the sarcomere. (c) 2005 Elsevier Ltd. All rights reserved.
C1 ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.
   Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Perriard, JC (corresponding author), ETH Honggerberg, Inst Cell Biol, CH-8093 Zurich, Switzerland.
EM jcp@cell.biol.ethz.ch
RI Bertoncini, Patricia/K-5398-2015
OI Bertoncini, Patricia/0000-0001-8508-2962; Hegner,
   Martin/0000-0003-1514-3437
CR Agarkova I, 2004, EUR J CELL BIOL, V83, P193, DOI 10.1078/0171-9335-00383
   Agarkova I, 2000, J BIOL CHEM, V275, P10256, DOI 10.1074/jbc.275.14.10256
   Agarkova I, 2003, J MUSCLE RES CELL M, V24, P191, DOI 10.1023/A:1026094924677
   Auerbach D, 1999, MOL BIOL CELL, V10, P1297, DOI 10.1091/mbc.10.5.1297
   Bantle S, 1996, J BIOL CHEM, V271, P19042, DOI 10.1074/jbc.271.32.19042
   BERGMAN RA, 1983, AM J ANAT, V166, P209, DOI 10.1002/aja.1001660206
   Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288
   Carrion-Vazquez M, 2000, PROG BIOPHYS MOL BIO, V74, P63, DOI 10.1016/S0079-6107(00)00017-1
   Ehler E, 1999, J CELL SCI, V112, P1529
   Freiburg A, 2000, CIRC RES, V86, P1114
   FURST DO, 1988, J CELL BIOL, V106, P1563, DOI 10.1083/jcb.106.5.1563
   Gotthardt M, 2003, J BIOL CHEM, V278, P6059, DOI 10.1074/jbc.M211723200
   Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8
   GROVE BK, 1987, DIFFERENTIATION, V34, P106, DOI 10.1111/j.1432-0436.1987.tb00056.x
   HARTLEY JL, 1981, GENE, V13, P347, DOI 10.1016/0378-1119(81)90014-7
   Hornemann T, 2003, J MOL BIOL, V332, P877, DOI 10.1016/S0022-2836(03)00921-5
   HOROWITS R, 1988, BIOPHYS J, V54, P165, DOI 10.1016/S0006-3495(88)82941-2
   HOROWITS R, 1987, J CELL BIOL, V105, P2217, DOI 10.1083/jcb.105.5.2217
   HOROWITS R, 1989, J CELL BIOL, V109, P2169, DOI 10.1083/jcb.109.5.2169
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kellermayer MSZ, 1998, J STRUCT BIOL, V122, P197, DOI 10.1006/jsbi.1998.3988
   Kenny PA, 1999, GENE, V232, P11, DOI 10.1016/S0378-1119(99)00122-5
   LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293
   Lahmers S, 2004, CIRC RES, V94, P505, DOI 10.1161/01.RES.0000115522.52554.86
   Lange S, 2005, J MOL BIOL, V345, P289, DOI 10.1016/j.jmb.2004.10.040
   Leake MC, 2004, BIOPHYS J, V87, P1112, DOI 10.1529/biophysj.103.033571
   Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938
   Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098
   Linke WA, 2002, J STRUCT BIOL, V137, P194, DOI 10.1006/jsbi.2002.4468
   LUTHER P, 1978, J MOL BIOL, V125, P313, DOI 10.1016/0022-2836(78)90405-9
   Ma K, 2003, BIOCHEM J, V374, P687, DOI 10.1042/BJ20030702
   NAVE R, 1989, J CELL BIOL, V109, P2177, DOI 10.1083/jcb.109.5.2177
   Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6
   Obermann WMJ, 1997, EMBO J, V16, P211, DOI 10.1093/emboj/16.2.211
   Obermann WMJ, 1996, J CELL BIOL, V134, P1441, DOI 10.1083/jcb.134.6.1441
   OBERMANN WMJ, 1995, EUR J BIOCHEM, V233, P110, DOI 10.1111/j.1432-1033.1995.110_1.x
   Opitz CA, 2004, CIRC RES, V94, P967, DOI 10.1161/01.RES.0000124301.48193.E1
   PAGE SG, 1963, J CELL BIOL, V19, P369, DOI 10.1083/jcb.19.2.369
   Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1
   PRICE MG, 1987, J CELL BIOL, V104, P1325, DOI 10.1083/jcb.104.5.1325
   PRICE MG, 1993, J BIOL CHEM, V268, P21800
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0
   SOTERIOU A, 1993, P ROY SOC B-BIOL SCI, V254, P83, DOI 10.1098/rspb.1993.0130
   Steiner F, 1999, GENOMICS, V56, P78, DOI 10.1006/geno.1998.5682
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   TRINICK J, 1984, J MOL BIOL, V180, P331, DOI 10.1016/S0022-2836(84)80007-8
   Trombitas K, 1999, BIOPHYS J, V77, P3189, DOI 10.1016/S0006-3495(99)77149-3
   Trombitas K, 1998, J CELL BIOL, V140, P853, DOI 10.1083/jcb.140.4.853
   Tskhovrebova L, 2004, J BIOL CHEM, V279, P46351, DOI 10.1074/jbc.R400023200
   Tskhovrebova L, 2003, NAT REV MOL CELL BIO, V4, P679, DOI 10.1038/nrm1198
   Tskhovrebova L, 1997, NATURE, V387, P308, DOI 10.1038/387308a0
   VINKEMEIER U, 1993, J CELL SCI, V106, P319
   Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458
   Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200
   Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993
   Zhang B, 2001, BIOPHYS J, V80, P597, DOI 10.1016/S0006-3495(01)76040-7
NR 59
TC 62
Z9 65
U1 0
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUN 3
PY 2005
VL 349
IS 2
BP 367
EP 379
DI 10.1016/j.jmb.2005.03.055
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 930BR
UT WOS:000229391300010
PM 15890201
DA 2021-01-25
ER

PT J
AU Nguyen, LD
   Kalachova, L
   Novotna, J
   Holub, M
   Kofronova, O
   Benada, O
   Thompson, CJ
   Weiser, J
AF Nguyen, LD
   Kalachova, L
   Novotna, J
   Holub, M
   Kofronova, O
   Benada, O
   Thompson, CJ
   Weiser, J
TI Cultivation system using glass beads immersed in liquid medium
   facilitates studies of Streptomyces differentiation
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID AERIAL MYCELIUM FORMATION; COMPLETE GENOME SEQUENCE; COELICOLOR A3(2);
   BIOSYNTHESIS
AB A two-phase cultivation system was developed which will enable studies of streptomycete differentiation by molecular biological and global techniques such as transcriptomics and proteomics. The system is based on a solid phase formed by glass beads corresponding to particles in soil, clay, or sand natural habitats of streptomycetes. The beads are immersed in a liquid medium that allows easy modification or replacement of nutrients and growth factors as well as radioactive labeling of proteins. Scanning electron microscopy was used to analyze morphological differentiation of streptomycetes on glass beads and two-dimensional protein electrophoresis to demonstrate the potential of the system for analyses of protein synthesis profiles during the developmental program. This system facilitates studies of differentiation including expression and post-translation modifications of streptomycetes proteins, secondary metabolite biosynthesis, and morphological development.
C1 Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague 4, Czech Republic.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Weiser, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague 4, Czech Republic.
EM weiser@biomed.cas.cz
RI Kofronova, Olga/H-7239-2014; Weiser, jaroslav/I-2078-2013; Weiser,
   Jaroslav/AAU-8548-2020; Benada, Oldrich/H-2437-2014; Novotna,
   Jana/H-6215-2014
OI Kofronova, Olga/0000-0002-5435-4088; Weiser,
   jaroslav/0000-0003-3541-4249; Benada, Oldrich/0000-0002-4592-6216;
   Nguyen, Liem/0000-0002-1523-1472
CR ALLAN EJ, 1983, J GEN MICROBIOL, V129, P2029
   Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Bystrykh LV, 1996, J BACTERIOL, V178, P2238, DOI 10.1128/jb.178.8.2238-2244.1996
   Chater KF, 2001, CURR OPIN MICROBIOL, V4, P667, DOI 10.1016/S1369-5274(01)00267-3
   CHATER KF, 1989, TRENDS GENET, V5, P372, DOI 10.1016/0168-9525(89)90172-8
   GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713
   Hodgson DA, 2000, ADV MICROB PHYSIOL, V42, P47, DOI 10.1016/S0065-2911(00)42003-5
   Ikeda H, 2003, NAT BIOTECHNOL, V21, P526, DOI 10.1038/nbt820
   Johnson B, 1998, SCIENTIST, V12, P23
   Kelemen GH, 1998, CURR OPIN MICROBIOL, V1, P656, DOI 10.1016/S1369-5274(98)80111-2
   Kofronova O, 2002, MICROSC RES TECHNIQ, V58, P111, DOI 10.1002/jemt.10126
   Kormanec J, 1997, MICROBIOL-UK, V143, P3555, DOI 10.1099/00221287-143-11-3555
   Miguelez EM, 1999, J CELL BIOL, V145, P515, DOI 10.1083/jcb.145.3.515
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   Vanek Z, 1997, ACTA BIOL HUNG, V48, P339
   WILDERMUTH H, 1970, J GEN MICROBIOL, V60, P43, DOI 10.1099/00221287-60-1-43
   WILLEY J, 1993, GENE DEV, V7, P895, DOI 10.1101/gad.7.5.895
NR 19
TC 14
Z9 14
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUN
PY 2005
VL 71
IS 6
BP 2848
EP 2852
DI 10.1128/AEM.71.6.2848-2852.2005
PG 5
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 935OF
UT WOS:000229790900006
PM 15932976
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Pauli, T
   Seimiya, M
   Blanco, J
   Gehring, WJ
AF Pauli, T
   Seimiya, M
   Blanco, J
   Gehring, WJ
TI Identification of functional sine oculis motifs in the autoregulatory
   element of its own gene, in the eyeless enhancer and in the signalling
   gene hedgehog
SO DEVELOPMENT
LA English
DT Article
DE sine oculis; so; hedgehog; hh; eyes absent; eya; eyeless; ey; Ocelli;
   Drosophila
ID DROSOPHILA EYE DEVELOPMENT; ABSENT MUTANTS REVEALS; TWIN-OF-EYELESS;
   MORPHOGENETIC FURROW; VISUAL-SYSTEM; POLARITY GENE; PAIRED DOMAIN;
   PROTEIN; EXPRESSION; DIFFERENTIATION
AB In Drosophila, the sine oculis (so) gene is important for the development of the entire visual system, including Bolwig's organ, compound eyes and ocelli. Together with twin of eyeless, eyeless, eyes absent and dachshund, so belongs to a network of genes that by complex interactions initiate eye development. Although much is known about the genetic interactions of the genes belonging to this retinal determination network, only a few such regulatory interactions have been analysed down to the level of DNA-protein interactions. Previous work in our laboratory identified an eye/ocellus specific enhancer of the sine oculis gene that is directly regulated by eyeless and twin of eyeless. We further characterized this regulatory element and identified a minimal enhancer fragment of so that sets up an autoregulatory feedback loop crucial for proper ocelli development. By systematic analysis of the DNA-binding specificity of so we identified the most important nucleotides for this interaction. Using the emerging consensus sequence for SO-DNA binding we performed a genome-wide search and have thereby been able to identify eyeless as well as the signalling gene hedgehog as putative targets of so. Our results strengthen the general assumption that feedback loops among the genes of the retinal determination network are crucial for proper development of eyes and ocelli.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Walter.Gehring@unibas.ch
CR BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brodbeck S, 2004, MECH DEVELOP, V121, P1211, DOI 10.1016/j.mod.2004.05.019
   Bui QT, 2000, GENETICS, V155, P709
   Bui QT, 2000, DEV BIOL, V221, P355, DOI 10.1006/dbio.2000.9688
   Chanut F, 1997, DEVELOPMENT, V124, P559
   Chao JL, 2004, DEVELOPMENT, V131, P3839, DOI 10.1242/dev.01258
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   Chen R, 1999, DEVELOPMENT, V126, P935
   CHEYETTE BNR, 1994, NEURON, V12, P977, DOI 10.1016/0896-6273(94)90308-5
   Curtiss J, 2000, DEVELOPMENT, V127, P1325
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281
   Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5
   EPSTEIN J, 1994, J BIOL CHEM, V269, P8355
   Greenwood S, 1999, DEVELOPMENT, V126, P5795
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Harris SE, 2000, NUCLEIC ACIDS RES, V28, P1871, DOI 10.1093/nar/28.9.1871
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   Hazbun TR, 1997, BIOCHEMISTRY-US, V36, P3680, DOI 10.1021/bi9625206
   Hazelett DJ, 1998, DEVELOPMENT, V125, P3741
   HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X
   HEBERLEIN U, 1995, NATURE, V373, P709, DOI 10.1038/373709a0
   HEITZLER P, 1993, GENETICS, V135, P105
   HIDAKA K, 1993, MOL CELL BIOL, V13, P6469, DOI 10.1128/MCB.13.10.6469
   Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004
   Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720
   Kango-Singh M, 2003, DEV BIOL, V256, P48, DOI 10.1016/S0012-1606(02)00123-9
   Kawakami K, 1998, Tanpakushitsu Kakusan Koso, V43, P2120
   Kawakami K, 1996, NUCLEIC ACIDS RES, V24, P303, DOI 10.1093/nar/24.2.303
   Kawakami K, 1996, FEBS LETT, V393, P259, DOI 10.1016/0014-5793(96)00899-X
   LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D
   Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083
   Lindsley D., 1992, GENOME DROSOPHILA ME
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199
   MOHLER J, 1988, GENETICS, V120, P1061
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Pignoni F, 1997, DEVELOPMENT, V124, P271
   Punzo C, 2002, DEVELOPMENT, V129, P625
   Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   RENFRANZ PJ, 1989, DEV BIOL, V136, P411, DOI 10.1016/0012-1606(89)90267-4
   Sambrook J., 2001, MOL CLONING LAB MANU
   SERIKAKU MA, 1994, GENETICS, V138, P1137
   Silver SJ, 2003, MOL CELL BIOL, V23, P5989, DOI 10.1128/MCB.23.17.5989-5999.2003
   Spitz F, 1998, P NATL ACAD SCI USA, V95, P14220, DOI 10.1073/pnas.95.24.14220
   STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219
   STARK WS, 1989, J NEUROGENET, V5, P127, DOI 10.3109/01677068909066203
   SUZUKIYAGAWA Y, 1992, MOL CELL BIOL, V12, P4046, DOI 10.1128/MCB.12.9.4046
   Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097
   Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8
   WOLFF T, 1993, DEV DROSOPHILA MELAN, V2
   Yan HJ, 2003, DEV BIOL, V263, P323, DOI 10.1016/j.ydbio.2003.08.003
   Zimmerman JE, 2000, GENETICS, V154, P237
NR 62
TC 65
Z9 65
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD JUN
PY 2005
VL 132
IS 12
BP 2771
EP 2782
DI 10.1242/dev.01841
PG 12
WC Developmental Biology
SC Developmental Biology
GA 944HS
UT WOS:000230418500009
PM 15901665
OA Bronze
DA 2021-01-25
ER

PT J
AU Hall, C
   Brachat, S
   Dietrich, FS
AF Hall, C
   Brachat, S
   Dietrich, FS
TI Contribution of horizontal gene transfer to the evolution of
   Saccharomyces cerevisiae
SO EUKARYOTIC CELL
LA English
DT Article
ID NEUROSPORA-CRASSA; PHYLOGENETIC-RELATIONSHIPS; GENOME SEQUENCE; YEAST;
   DNA; EUKARYOTES; INFERENCE; DATABASE; SULFUR; TREES
AB The genomes of the hemiascomycetes Saccharomyces cerevisiae and Ashbya gossypii have been completely sequenced, allowing a comparative analysis of these two genomes, which reveals that a small number of genes appear to have entered these genomes as a result of horizontal gene transfer from bacterial sources. One potential case of horizontal gene transfer in A. gossypii and 10 potential cases in S. cerevisiae were identified, of which two were investigated further. One gene, encoding the enzyme dihydroorotate dehydrogenase (DHOD), is potentially a case of horizontal gene transfer, as shown by sequencing of this gene from additional bacterial and fungal species to generate sufficient data to construct a well-supported phylogeny. The DHOD-encoding gene found in S. cerevisiae, URA1 (YKL216W), appears to have entered the Saccharomycetaceae after the divergence of the S. cerevisiae lineage from the Candida albicans lineage and possibly since the divergence from the A. gossypii lineage. This gene appears to have come from the Lactobacillales, and following its acquisition the endogenous eukaryotic DHOD gene was lost. It was also shown that the bacterially derived horizontally transferred DHOD is required for anaerobic synthesis of uracil in S. cerevisiae. The other gene discussed in detail is BDS1, an aryl- and alkyl-sulfatase gene of bacterial origin that we have shown allows utilization of sulfate from several organic sources. Among the eukaryotes, this gene is found in S. cerevisiae and Saccharomyces bayanus and appears to derive from the alpha-proteobacteria.
C1 Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dietrich, FS (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, 289 CARL Bldg,Box 3568, Durham, NC 27710 USA.
EM dietr003@mc.duke.edu
OI Brachat, Sophie/0000-0002-3398-8225
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329
   Benson DA, 1997, NUCLEIC ACIDS RES, V25, P1, DOI 10.1093/nar/25.1.1
   Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200
   Bolotin A, 2001, GENOME RES, V11, P731, DOI 10.1101/gr.GR-1697R
   Boucher Y, 2000, MOL MICROBIOL, V37, P703, DOI 10.1046/j.1365-2958.2000.02004.x
   Braun EL, 2000, GENOME RES, V10, P416, DOI 10.1101/gr.10.4.416
   Burke D, 2000, METHODS YEAST GENETI
   CHEREST H, 1992, GENETICS, V130, P51
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Diezmann S, 2004, J CLIN MICROBIOL, V42, P5624, DOI 10.1128/JCM.42.12.5624-5635.2004
   DREISEIKELMANN B, 1994, MICROBIOL REV, V58, P293, DOI 10.1128/MMBR.58.3.293-316.1994
   Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579
   FUKAMI K, 1989, J MOL EVOL, V28, P460, DOI 10.1007/BF02603081
   Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554
   Goffeau A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546
   Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7
   GONNET GH, 1992, SCIENCE, V256, P1443, DOI 10.1126/science.1604319
   GRAY MW, 1993, CURR OPIN GENET DEV, V3, P884, DOI 10.1016/0959-437X(93)90009-E
   HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0
   Horner DS, 2000, MOL BIOL EVOL, V17, P1695, DOI 10.1093/oxfordjournals.molbev.a026268
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Jensen KF, 1998, PATHS PYRIMIDINES, V6, P20
   Kahnert A, 2000, J BIOL CHEM, V275, P31661, DOI 10.1074/jbc.M005820200
   Katz LA, 2002, INT J SYST EVOL MICR, V52, P1893, DOI 10.1099/00207713-52-5-1893
   Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Klotz MG, 1997, MOL BIOL EVOL, V14, P951, DOI 10.1093/oxfordjournals.molbev.a025838
   Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709
   Kurtzman CP, 2003, FEMS YEAST RES, V3, P417, DOI 10.1016/S1567-1356(03)00012-6
   Lawrence JG, 2001, SYST BIOL, V50, P479, DOI 10.1080/10635150120286
   Moore JD, 1996, BIOESSAYS, V18, P207, DOI 10.1002/bies.950180308
   Morell V, 1996, SCIENCE, V273, P569, DOI 10.1126/science.273.5275.569
   Mower JP, 2004, NATURE, V432, P165, DOI 10.1038/432165b
   MULLIS K, 1986, COLD SPRING HARB SYM, V51, P263, DOI 10.1101/SQB.1986.051.01.032
   NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966
   Nara T, 2000, GENE, V257, P209, DOI 10.1016/S0378-1119(00)00411-X
   Nevoigt E, 2000, YEAST, V16, P1107, DOI 10.1002/1097-0061(20000915)16:12<1107::AID-YEA608>3.0.CO;2-3
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Ochman H, 2001, CURR OPIN GENET DEV, V11, P616, DOI 10.1016/S0959-437X(00)00243-4
   PAIETTA JV, 1989, MOL CELL BIOL, V9, P3630, DOI 10.1128/MCB.9.9.3630
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Pogorevc M, 2003, APPL ENVIRON MICROB, V69, P2810, DOI 10.1128/AEM.69.5.2810-2815.2003
   Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817
   REISS J, 1974, J HISTOCHEM CYTOCHEM, V22, P183, DOI 10.1177/22.3.183
   Rip JW, 1998, CLIN BIOCHEM, V31, P29, DOI 10.1016/S0009-9120(97)00142-2
   Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180
   ROY A, 1992, GENE, V118, P149, DOI 10.1016/0378-1119(92)90265-Q
   SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454
   Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201
   SIKORSKI RS, 1989, GENETICS, V122, P19
   SWOFFORD DL, 1999, PAUPASTERISK PHYLOGE
   Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876
   VISSER W, 1990, APPL ENVIRON MICROB, V56, P3785, DOI 10.1128/AEM.56.12.3785-3792.1990
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   Wood V, 2001, COMP FUNCT GENOM, V2, P143, DOI 10.1002/cfg.86
   Wuyts J, 2002, NUCLEIC ACIDS RES, V30, P183, DOI 10.1093/nar/30.1.183
   Zameitat E, 2004, FEBS LETT, V568, P129, DOI 10.1016/j.febslet.2004.05.017
   Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000
NR 62
TC 161
Z9 184
U1 0
U2 20
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD JUN
PY 2005
VL 4
IS 6
BP 1102
EP 1115
DI 10.1128/EC.4.6.1102-1115.2005
PG 14
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 937BX
UT WOS:000229900700012
PM 15947202
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Bentzinger, CF
   Barzaghi, P
   Lin, S
   Ruegg, MA
AF Bentzinger, CF
   Barzaghi, P
   Lin, S
   Ruegg, MA
TI Overexpression of mini-agrin in skeletal muscle increases muscle
   integrity and regenerative capacity in laminin-alpha 2-deficient mice
SO FASEB JOURNAL
LA English
DT Article
DE muscular dystrophy; laminin-alpha 2 deficiency; muscle regeneration
ID CONGENITAL MUSCULAR-DYSTROPHY; MUTANT MICE; DYSTROGLYCAN BINDING;
   LAMININ ALPHA-1; LAMA2 GENE; G-DOMAIN; CHAIN; MOUSE; EXPRESSION; FORM
AB Mutations in the gene encoding the alpha 2 subunit of laminins cause the severe "merosin- deficient congenital muscular dystrophy" ( MDC1A). We have recently shown that overexpression of a miniaturized form of the molecule agrin (mini-agrin) counteracts the disease in dy(W)/dy(W) mice, a model for MDC1A. However, these mice express some residual truncated laminin- 2, suggesting that the observed amelioration might be due to mini-agrin's presenting the residual laminin-alpha 2 2 to its receptors. Here we show that the mini-agrin counteracts the disease in dy(3K)/ dy(3K) mice, which are null for laminin-alpha 2. As in dy(W)/ dy(W) mice, mini-agrin improves both the function and structure of muscle. We show that muscle regeneration after injury is severely impaired in dy3K/ dy3K mice but is restored in the mini-agrin-expressing littermates. In summary, our results 1) show that the direct linkage of muscle basal lamina with the sarcolemma is the basis of mini-agrin-mediated amelioration and 2) provide unprecedented evidence that this linkage is important for proper regeneration of muscle fibers after injury. Our findings thus suggest that treatment with mini-agrin might be beneficial over the entire spectrum of the MDC1A disease, whose severity inversely correlates with expression levels and the size of the truncation in laminin- alpha 2.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019; Bentzinger, C. Florian/A-1151-2015
OI Ruegg, Markus/0000-0002-4974-9384; Bentzinger, C.
   Florian/0000-0003-0422-9622
CR AUFDERHEIDE E, 1987, J CELL BIOL, V105, P599, DOI 10.1083/jcb.105.1.599
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207
   Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8
   Colognato H, 1999, CURR BIOL, V9, P1327, DOI 10.1016/S0960-9822(00)80056-1
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   COVAULT J, 1986, J CELL BIOL, V102, P731, DOI 10.1083/jcb.102.3.731
   Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3
   HARRIS JB, 1990, ELECTRON MICROSC REV, V3, P183, DOI 10.1016/0892-0354(90)90001-9
   HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x
   Jones G, 1999, J NEUROSCI, V19, P3376
   Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuang W, 1999, LAB INVEST, V79, P1601
   Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258
   Li SH, 2003, DEV CELL, V4, P613, DOI 10.1016/S1534-5807(03)00128-X
   Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318
   MEIER H, 1970, LIFE SCI 2-BIOCH GEN, V9, P137, DOI 10.1016/0024-3205(70)90306-1
   MICHELSON AM, 1955, P NATL ACAD SCI USA, V41, P1079, DOI 10.1073/pnas.41.12.1079
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244
   RUEGG MA, 2005, IN PRESS MOL MECH MU
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140
   Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200
   TOME FMS, 1994, CR ACAD SCI III-VIE, V317, P351
   XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297
   Yu H, 2003, BIOCHEM J, V371, P289, DOI 10.1042/BJ20021500
NR 35
TC 72
Z9 72
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD JUN
PY 2005
VL 19
IS 8
BP 934
EP 942
DI 10.1096/fj.04-3376com
PG 9
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 941IF
UT WOS:000230207800040
PM 15923403
DA 2021-01-25
ER

PT J
AU Mucke, N
   Kirmse, R
   Wedig, T
   Leterrier, JF
   Kreplak, L
AF Mucke, N
   Kirmse, R
   Wedig, T
   Leterrier, JF
   Kreplak, L
TI Investigation of the morphology of intermediate filaments adsorbed to
   different solid supports
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE AFM; glutaraldehyde fixation; adsorption; surface interaction;
   supramolecular architecture; ULF
ID ATOMIC-FORCE MICROSCOPY; LIVING CELLS; IN-VITRO; VIMENTIN; DESMIN;
   ARCHITECTURE; PROTEINS; MICE; IDENTIFICATION; NEUROFILAMENTS
AB Morphologically, glutaraldehyde-fixed and -dried intermediate filaments (IFs) appear flexible, and with it width of 8 12 nm when observed by electron microscopy. Sometimes, the filaments are even unraveled on the carbon-coated grid and reveal a protofilamentous architecture. In this study, we have used atomic force microscopy to further investigate the morphology of IFs in a more physiological environment. First, we have imaged hydrated glutaraldehyde-fixed IFs adsorbed to a graphite support. in such conditions, human vimentin and desmin IFs appeared compact with a height or 5 8 nm and revealed either a beading repeat or a helical morphology. Second, we have analyzed the architecture of hydrated vimentin, desmin, and neurofilament IFs adsorbed to mica, graphite, and hydrophilic glass without the presence of fixative. On mica, vimentin IFs had it height of only 3 5 nm, whereas desmin IFs appeared as 8 10nm height filaments with a helical twist. Neurofilaments were 10 -12nm in height with a pronounced 30 50nm beading along their length. On graphite, the different IFs were either not adsorbing properly or their architecture was modified yielding, for example. broad. flattened filaments. Finally, hydrophilie glass Was the surface which seemed to best preserve the architecture of the three IFs, even if, in some cases, unraveled vimentin filaments were observed oil this support, These results are straightening the idea that mature IFs are dynamic polymers in vitro and that IFs can be distinguished front each others by their physicochemical properties. (c) 2005 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   German Canc Res Ctr, Div Biophys Macromol, D-69120 Heidelberg, Germany.
   German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   Univ Poitiers, CNRS, UMR 6558, Grp Biol Interact Cellulaires, Poitiers, France.
RP Kreplak, L (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Laurent.kreplak@unibas.ch
OI kreplak, laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Agbulut O, 2001, CELL MOTIL CYTOSKEL, V49, P51, DOI 10.1002/cm.1020
   Ando S, 2004, BBA-PROTEINS PROTEOM, V1702, P53, DOI 10.1016/j.bbapap.2004.07.008
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Brown HG, 1998, J MICROSC-OXFORD, V191, P229
   Carlsson L, 2001, ACTA PHYSIOL SCAND, V171, P341, DOI 10.1046/j.1365-201x.2001.00837.x
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   HENDERSON D, 1982, J MOL BIOL, V155, P173, DOI 10.1016/0022-2836(82)90444-2
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   IP W, 1985, J MOL BIOL, V183, P365, DOI 10.1016/0022-2836(85)90007-5
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7
   Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   LETERRIER JF, 1987, BIOCHEM J, V245, P93, DOI 10.1042/bj2450093
   Ma LL, 1999, J BIOL CHEM, V274, P19145, DOI 10.1074/jbc.274.27.19145
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Parry DAD, 2001, J BIOL CHEM, V276, P39253, DOI 10.1074/jbc.M104604200
   Russell D, 2004, J CELL SCI, V117, P5233, DOI 10.1242/jcs.01407
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Wagner OI, 2003, J NEUROSCI, V23, P9046
   WAGNER OI, 2004, MOL BIOL CELL
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
   Wieneke S, 2000, BIOCHEM BIOPH RES CO, V278, P419, DOI 10.1006/bbrc.2000.3810
   Windoffer R, 2004, MOL BIOL CELL, V15, P2436, DOI 10.1091/mbc.E03-09-0707
   Yoon KH, 2001, J CELL BIOL, V153, P503, DOI 10.1083/jcb.153.3.503
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
NR 38
TC 22
Z9 22
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD JUN
PY 2005
VL 150
IS 3
BP 268
EP 276
DI 10.1016/j.jsb.2005.02.012
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 929MW
UT WOS:000229351200004
PM 15890275
DA 2021-01-25
ER

PT J
AU Hochwagen, A
   Wrobel, G
   Cartron, M
   Demougin, P
   Niederhauser-Wiederkehr, C
   Boselli, MG
   Primig, M
   Amon, A
AF Hochwagen, A
   Wrobel, G
   Cartron, M
   Demougin, P
   Niederhauser-Wiederkehr, C
   Boselli, MG
   Primig, M
   Amon, A
TI Novel response to microtubule perturbation in meiosis
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL-CYCLE; TRANSCRIPTIONAL
   REGULATION; MEIOTIC RECOMBINATION; PACHYTENE CHECKPOINT; SPINDLE
   CHECKPOINT; CDC14 PHOSPHATASE; GENE-EXPRESSION; MALE-MOUSE
AB During the mitotic cell cycle, microtubule depolymerization leads to a cell cycle arrest in metaphase, due to activation of the spindle checkpoint. Here, we show that under microtubule-destabilizing conditions, such as low temperature or the presence of the spindle-depolymerizing drug benomyl, meiotic budding yeast cells arrest in G(1) or G(2), instead of metaphase. Cells arrest in G(1) if microtubule perturbation occurs as they enter the meiotic cell cycle and in G(2) if cells are already undergoing premeiotic S phase. Concomitantly, cells down-regulate genes required for cell cycle progression, meiotic differentiation, and spore formation in a highly coordinated manner. Decreased expression of these genes is likely to be responsible for halting both cell cycle progression and meiotic development. Our results point towards the existence of a novel surveillance mechanism of microtubule integrity that may be particularly important during specialized cell cycles when coordination of cell cycle progression with a developmental program is necessary.
C1 MIT, Howard Hughes Med Inst, Canc Res Ctr, Cambridge, MA 02139 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Amon, A (corresponding author), MIT, Howard Hughes Med Inst, Canc Res Ctr, E17-233,40 Ames St, Cambridge, MA 02139 USA.
EM angelika@mit.edu
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Amon, Angelika/0000-0001-9837-0314;
   Hochwagen, Andreas/0000-0002-6184-443X
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM062207,
   R01GM062207, R01GM062207, R01GM062207, R01GM062207, R01GM062207,
   R01GM062207, R01GM062207, R01GM062207, R01GM062207, R01GM062207,
   R01GM062207, R01GM062207, R01GM062207, R01GM062207, R01GM062207] Funding
   Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01 GM062207, GM62207]
   Funding Source: Medline
CR ALLEN JW, 1988, MUTAT RES, V201, P313, DOI 10.1016/0027-5107(88)90020-6
   AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3
   Bailis JM, 2000, CELL, V101, P211, DOI 10.1016/S0092-8674(00)80831-4
   BascomSlack CA, 1997, J CELL BIOL, V139, P459, DOI 10.1083/jcb.139.2.459
   Buonomo SBC, 2003, DEV CELL, V4, P727, DOI 10.1016/S1534-5807(03)00129-1
   CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M
   Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699
   Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4
   CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6
   Davis L, 2001, GENETICS, V157, P1179
   Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Gupta ML, 2001, CELL MOTIL CYTOSKEL, V49, P67, DOI 10.1002/cm.1021
   Guttmann-Raviv N, 2002, MOL CELL BIOL, V22, P2047, DOI 10.1128/MCB.22.7.2047-2056.2002
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750
   Honigberg SM, 2003, J CELL SCI, V116, P2137, DOI 10.1242/jcs.00460
   Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70
   Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96
   Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409
   KACZANOWSKI A, 1985, EXP CELL RES, V158, P244, DOI 10.1016/0014-4827(85)90447-1
   KANE SM, 1974, J BACTERIOL, V118, P8, DOI 10.1128/JB.118.1.8-14.1974
   Kassir Y, 2003, INT REV CYTOL, V224, P111, DOI 10.1016/S0074-7696(05)24004-4
   Kaufman L, 1987, STAT DATA ANAL BASED
   Klein F, 1999, CELL, V98, P91, DOI 10.1016/S0092-8674(00)80609-1
   KOHRER K, 1991, METHOD ENZYMOL, V194, P398
   Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846
   Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575
   Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1
   Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656
   LOIDL J, 1988, EXP CELL RES, V178, P93, DOI 10.1016/0014-4827(88)90381-3
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   MACHIN NA, 1995, MOL BIOL CELL, V6, P1241
   Marston AL, 2003, DEV CELL, V4, P711, DOI 10.1016/S1534-5807(03)00130-8
   Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220
   Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6
   Mikhailov A, 2002, CURR BIOL, V12, pR331, DOI 10.1016/S0960-9822(02)00833-3
   Miyake T, 2004, J BIOL CHEM, V279, P34865, DOI 10.1074/jbc.M405156200
   Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261
   Nairz K, 1997, GENE DEV, V11, P2272, DOI 10.1101/gad.11.17.2272
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Primig M, 2003, NAT GENET, V35, P291, DOI 10.1038/ng1203-291
   PRINZ S, 1995, NUCLEIC ACIDS RES, V23, P3449, DOI 10.1093/nar/23.17.3449
   Rabitsch KP, 2003, DEV CELL, V4, P535, DOI 10.1016/S1534-5807(03)00086-8
   Rieder CL, 2000, CURR BIOL, V10, P1067, DOI 10.1016/S0960-9822(00)00678-3
   Roeder GS, 2000, TRENDS GENET, V16, P395, DOI 10.1016/S0168-9525(00)02080-1
   Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600
   Saunders W, 1997, J CELL BIOL, V137, P417, DOI 10.1083/jcb.137.2.417
   Schlecht U, 2004, MOL BIOL CELL, V15, P1031, DOI 10.1091/mbc.E03-10-0762
   Schlecht U, 2003, REPRODUCTION, V125, P447, DOI 10.1530/reprod/125.4.447
   Shanks RMQ, 2004, CELL CYCLE, V3, P363
   Shanks RMQ, 2001, GENETICS, V159, P939
   SHEPARD J, 1974, CHROMOSOMA, V44, P423
   Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300
   Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057
   SORA S, 1988, MUTAT RES, V201, P9, DOI 10.1016/0027-5107(88)90106-6
   SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6
   Tepperberg JH, 1997, CHROMOSOMA, V106, P183, DOI 10.1007/s004120050238
   Tepperberg JH, 1999, MUTAT RES-FUND MOL M, V429, P93, DOI 10.1016/S0027-5107(99)00102-5
   THOMAS JH, 1985, GENETICS, V111, P715
   Tung KS, 2000, P NATL ACAD SCI USA, V97, P12187, DOI 10.1073/pnas.220464597
   Visintin R, 1999, NATURE, V398, P818
   Visintin R, 1998, MOL CELL, V2, P709, DOI 10.1016/S1097-2765(00)80286-5
   Wiederkehr C, 2004, BIOINFORMATICS, V20, P808, DOI 10.1093/bioinformatics/bth030
   Wiederkehr C, 2004, NUCLEIC ACIDS RES, V32, pD560, DOI 10.1093/nar/gkh055
   Williams RM, 2002, P NATL ACAD SCI USA, V99, P13431, DOI 10.1073/pnas.202495299
   Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106
   Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603
   Zickler D, 1998, ANNU REV GENET, V32, P619, DOI 10.1146/annurev.genet.32.1.619
   Ziegelbauer J, 2001, MOL CELL, V8, P339, DOI 10.1016/S1097-2765(01)00313-6
NR 73
TC 36
Z9 37
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD JUN
PY 2005
VL 25
IS 11
BP 4767
EP 4781
DI 10.1128/MCB.25.11.4767-4781.2005
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 928ME
UT WOS:000229275000038
PM 15899877
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Gatfield, J
   Albrecht, I
   Zanolari, B
   Steinmetz, MO
   Pieters, J
AF Gatfield, J
   Albrecht, I
   Zanolari, B
   Steinmetz, MO
   Pieters, J
TI Association of the leukocyte plasma membrane with the actin cytoskeleton
   through coiled coil-mediated trimeric coronin 1 molecules
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID BINDING-PROTEIN; LIPID RAFTS; WD-REPEAT; CRYSTAL-STRUCTURE; F-ACTIN;
   CELL; FAMILY; DYNAMICS; PHAGOCYTOSIS; CHOLESTEROL
AB Coronin 1 is a member of the coronin protein family specifically expressed in leukocytes and accumulates at sites of rearrangements of the F-actin cytoskeleton. Here, we describe that coronin 1 molecules are coiled coil-mediated homotrimeric complexes, which associate with the plasma membrane and with the cytoskeleton via two distinct domains. Association with the cytoskeleton was mediated by trimerization of a stretch of positively charged residues within a linker region between the N-terminal, WD repeat-containing domain and the C-terminal coiled coil. In contrast, neither the coiled coil nor the positively charged residues within the linker domain were required for plasma membrane binding, suggesting that the N-terminal, WD repeat-containing domain mediates membrane interaction. The capacity of coronin I to link the leukocyte cytoskeleton to the plasma membrane may serve to integrate outside-inside signaling with modulation of the cytoskeleton.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Pieters, Jan/S-8048-2019
OI Steinmetz, Michel/0000-0001-6157-3687; Pieters, Jean/0000-0002-5284-9757
CR Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6
   Asano S, 2001, GENES CELLS, V6, P225, DOI 10.1046/j.1365-2443.2001.00416.x
   Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549
   Cherukuri A, 2001, IMMUNITY, V14, P657, DOI 10.1016/S1074-7613(01)00156-X
   Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   EASON R, 1986, CENTRIFUGATION PRACT, P251
   Engering A, 2003, EUR J BIOCHEM, V270, P2412, DOI 10.1046/j.1432-1033.2003.03609.x
   Engering A, 1997, ELECTROPHORESIS, V18, P2523, DOI 10.1002/elps.1150181406
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Fischer KD, 1998, SEMIN IMMUNOL, V10, P317, DOI 10.1006/smim.1998.0124
   Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L
   Fuller CL, 2003, IMMUNOL REV, V191, P220, DOI 10.1034/j.1600-065X.2003.00004.x
   Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gautreau A, 2000, J CELL BIOL, V150, P193, DOI 10.1083/jcb.150.1.193
   Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83
   Gruenheid S, 2003, NATURE, V422, P775, DOI 10.1038/nature01603
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5
   Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0
   Lefkovits I, 1985, IMMUNOLOGICAL METHOD, V3, P163
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5
   Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022
   NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0
   Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020
   Oku T, 2003, BIOL PHARM BULL, V26, P409
   Okumura M, 1998, DNA CELL BIOL, V17, P779, DOI 10.1089/dna.1998.17.779
   PATTHY L, 1987, FEBS LETT, V214, P1, DOI 10.1016/0014-5793(87)80002-9
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Pietra BA, 2000, PROG PEDIATR CARDIOL, V11, P115, DOI 10.1016/S1058-9813(00)00043-6
   Rafael JA, 1996, J CELL BIOL, V134, P93, DOI 10.1083/jcb.134.1.93
   Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870
   Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066
   Schafer DA, 2002, CURR OPIN CELL BIOL, V14, P76, DOI 10.1016/S0955-0674(01)00297-6
   Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0
   Spoerl Z, 2002, J BIOL CHEM, V277, P48858, DOI 10.1074/jbc.M205136200
   Sprague ER, 2000, EMBO J, V19, P3016, DOI 10.1093/emboj/19.12.3016
   Springer TA, 1998, J MOL BIOL, V283, P837, DOI 10.1006/jmbi.1998.2115
   Steinmetz MO, 1997, J CELL BIOL, V138, P559, DOI 10.1083/jcb.138.3.559
   Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   van't Hof W, 1999, J CELL BIOL, V145, P377, DOI 10.1083/jcb.145.2.377
   VANDERVOORN L, 1992, FEBS LETT, V307, P131, DOI 10.1016/0014-5793(92)80751-2
   VANDERVOORN L, 1990, J MOL BIOL, V213, P17, DOI 10.1016/S0022-2836(05)80118-4
   Veithen A, 1996, J CELL SCI, V109, P2005
   VIHINEN M, 1994, PROTEINS, V19, P141, DOI 10.1002/prot.340190207
   Wohnsland F, 2000, J BIOL CHEM, V275, P20873, DOI 10.1074/jbc.M910298199
   WRIGLEY NG, 1968, J ULTRA MOL STRUCT R, V24, P454, DOI 10.1016/S0022-5320(68)80048-6
NR 63
TC 97
Z9 104
U1 0
U2 2
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD JUN
PY 2005
VL 16
IS 6
BP 2786
EP 2798
DI 10.1091/mbc.E05-01-0042
PG 13
WC Cell Biology
SC Cell Biology
GA 931EK
UT WOS:000229468400017
PM 15800061
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, W
TI Gene products with evolutionary functions
SO PROTEOMICS
LA English
DT Article; Proceedings Paper
CT 6th Siena Meeting on From Genome to Proteome
CY AUG 30-SEP 02, 2004
CL Siena, ITALY
DE duality of genome; evolution genes
ID MICROBIAL EVOLUTION; ELEMENTS; GENOMES
AB It is often tacitly assumed that all gene products serve the needs of life functions of the individual carrying the genome. However, a close look at the formation of genetic variations, which are the drivers of biological evolution, reveals a different view. While a majority of the products of genes, such as housekeeping genes and genes essential for each individual, when exposed to particular life conditions respond to the definition given above, other gene products clearly carry out evolutionary functions at the level of populations. Products of these evolution genes act as generators of genetic variations and/or as modulators of the frequency of genetic variation. This is most readily seen with bacterial populations. Many different mechanisms contribute to the occasional, overall formation of genetic variations. These mechanisms can be grouped into three mechanistically and qualitatively different strategies of generating genetic variations. in addition to the activities of evolution genes, specific properties of matter such as tautomery also contribute to the formation of genetic variations. The views that nature cares actively for biological evolution are documented by evidence taken mainly from microbial genetics. Essential elements of the theory of molecular evolution are discussed, as well as the relevance of this theory for higher organisms and its impact on our worldview.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM werner.arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   Arber W, 2002, CURR TOP MICROBIOL, V264, P1
   ARBER W, 1995, J MOL EVOL, V40, P7, DOI 10.1007/BF00166591
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   Arber W, 1999, ANN NY ACAD SCI, V870, P36, DOI 10.1111/j.1749-6632.1999.tb08863.x
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   Arber W., 2002, PONTIFICAL ACAD SCI, V103, P90
NR 8
TC 3
Z9 3
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1615-9853
J9 PROTEOMICS
JI Proteomics
PD JUN
PY 2005
VL 5
IS 9
DI 10.1002/pmic.200401124
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 937II
UT WOS:000229917400001
DA 2021-01-25
ER

PT J
AU Dames, SA
   Mulet, JM
   Rathgeb-Szabo, K
   Hall, MN
   Grzesiek, S
AF Dames, SA
   Mulet, JM
   Rathgeb-Szabo, K
   Hall, MN
   Grzesiek, S
TI The solution structure of the FATC domain of the protein kinase target
   of rapamycin suggests a role for redox-dependent structural and cellular
   stability
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MAGNETIC-RESONANCE RELAXATION; DISULFIDE BOND FORMATION; MODEL-FREE
   APPROACH; MAMMALIAN TARGET; SACCHAROMYCES-CEREVISIAE; IN-VITRO; TOR;
   GROWTH; NMR; COMPLEXES
AB The target of rapamycin ( TOR) is a highly conserved Ser/Thr kinase that plays a central role in the control of cellular growth. TOR has a characteristic multidomain structure. Only the kinase domain has catalytic function; the other domains are assumed to mediate interactions with TOR substrates and regulators. Except for the rapamycin-binding domain, there are no high-resolution structural data available for TOR. Here, we present a structural, biophysical, and mutagenesis study of the extremely conserved COOH-terminal FATC domain. The importance of this domain for TOR function has been highlighted in several publications. We show that the FATC domain, in its oxidized form, exhibits a novel structural motif consisting of an alpha-helix and a COOH-terminal disulfide-bonded loop between two completely conserved cysteine residues. Upon reduction, the flexibility of the loop region increases dramatically. The structural data, the redox potential of the disulfide bridge, and the biochemical data of a cysteine to serine mutant indicate that the intracellular redox potential can affect the cellular amount of the TOR protein via the FATC domain. Because the amount of TOR mRNA is not changed, the redox state of the FATC disulfide bond is probably influencing the degradation of TOR.
C1 Univ Basel, Dept Biol Struct, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Biochem, Biozentrum, CH-4056 Basel, Switzerland.
RP Dames, SA (corresponding author), Univ Basel, Dept Biol Struct, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sonja.dames@unibas.ch
RI Mulet, Jose Miguel/B-9063-2016
OI Mulet, Jose Miguel/0000-0002-9087-3838; Hall, Michael
   N/0000-0002-2998-0757; Grzesiek, Stephan/0000-0003-1998-4225; Dames,
   Sonja/0000-0001-7495-6943
CR Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200
   Bhattacharyya R, 2003, J MOL BIOL, V331, P925, DOI 10.1016/S0022-2836(03)00759-9
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   Cai JY, 2000, FREE RADICAL BIO MED, V29, P334, DOI 10.1016/S0891-5849(00)00312-9
   Cai JY, 1998, J BIOL CHEM, V273, P11401, DOI 10.1074/jbc.273.19.11401
   CREIGHTON TE, 1993, PROTEINS STRUCTURES, P157
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Grauschopf U, 2003, EMBO J, V22, P3503, DOI 10.1093/emboj/cdg356
   Grey MJ, 2003, J AM CHEM SOC, V125, P14324, DOI 10.1021/ja0367389
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harris Thurl E, 2003, Sci STKE, V2003, pre15
   Helliwell SB, 1998, GENETICS, V148, P99
   Huang CS, 2002, CANCER RES, V62, P5689
   Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002
   Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com
   Huth JR, 1997, PROTEIN SCI, V6, P2359
   HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jiang Y, 1999, EMBO J, V18, P2782, DOI 10.1093/emboj/18.10.2782
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kirlin WG, 1999, FREE RADICAL BIO MED, V27, P1208, DOI 10.1016/S0891-5849(99)00145-8
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513
   Linke K, 2003, ANTIOXID REDOX SIGN, V5, P425, DOI 10.1089/152308603768295168
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loo G, 2003, J NUTR BIOCHEM, V14, P64, DOI 10.1016/S0955-2863(02)00251-6
   Mulet JM, 2004, YEAST, V21, P569, DOI 10.1002/yea.1126
   Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798
   Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   Podsypanina K, 2001, P NATL ACAD SCI USA, V98, P10320, DOI 10.1073/pnas.171060098
   Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3
   Savitsky PA, 2002, J BIOL CHEM, V277, P20535, DOI 10.1074/jbc.M201589200
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x
   Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
   ZHENG XF, 1995, CELL, V82, P121, DOI 10.1016/0092-8674(95)90058-6
NR 55
TC 103
Z9 112
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 27
PY 2005
VL 280
IS 21
BP 20558
EP 20564
DI 10.1074/jbc.M501116200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 927ZX
UT WOS:000229242000050
PM 15772072
OA Green Accepted, Other Gold
DA 2021-01-25
ER

PT J
AU Kim, KT
   Choi, HH
   Steinmetz, MO
   Maco, B
   Kammerer, RA
   Ahn, SY
   Kim, HZ
   Lee, GM
   Koh, GY
AF Kim, KT
   Choi, HH
   Steinmetz, MO
   Maco, B
   Kammerer, RA
   Ahn, SY
   Kim, HZ
   Lee, GM
   Koh, GY
TI Oligomerization and multimerization are critical for angiopoietin-1 to
   bind and phosphorylate Tie2
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ENDOTHELIAL-CELLS; RECEPTOR; LIGAND; EXPRESSION; GROWTH; MICE; CAVEOLAE
AB Angiopoietin-1 (Ang1) is an essential molecule for blood vessel formation; however, little is known about the structure-function relationships of Ang1 with its receptor, Tie2 ( tyrosine kinase with immunoglobulin and epidermal growth factor homology domain-2'). In this study, we generated several Ang1 and angiopoietin-2 (Ang2) variants to define the role of the superclustering and oligomerization domains of the Ang1 protein. Then we analyzed the molecular structure of the variants with SDS-PAGE and rotary metal-shadowing transmission electron microscopy (RMSTEM) and determined the effects of these variants on the binding and activation of Tie2. Ang1 exists as heterogeneous multimers with basic trimeric, tetrameric, and pentameric oligomers, whereas Ang2 exists as trimeric, tetrameric, and pentameric oligomers. The variant Ang1C265S, consisting of trimers, tetramers, and pentamers without multimeric forms of Ang1, yielded less Tie2 activation than did Ang1, whereas monomeric Ang1 (Ang1/FD), dimeric Ang1 variants (Ang1D2, and Ang1D3), and dimeric and trimeric Ang1 variant (Ang1D1) dramatically lost their ability to bind and activate Tie2. An Ang1 protein in which two cysteines ( amino acids 41 and 54) were replaced with serines (Ang1C41S/C54S) formed mostly dimers and trimers that were not able to bind and activate Tie2. In addition, improper creation of a new cysteine in Ang2 (Ang2S263C) dramatically induced Ang2 aggregation without activating Tie2. In conclusion, proper oligomerization of Ang1 having at least four sub-units by the intermolecular disulfide linkage involving cysteines 41 and 54 is critical for Tie2 binding and activation. Thus, our data shed a light on the structure-function relationships of Ang1 with Tie2.
C1 Korea Adv Inst Sci & Technol, Ctr Biomed Res, Taejon 305701, South Korea.
   Korea Adv Inst Sci & Technol, Dept Sci Biol, Taejon 305701, South Korea.
   Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   Univ Basel, ME Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Manchester, Wellcome Trust Ctr Cell Matrix Res, Sch Biol Sci, Manchester M13 9PT, Lancs, England.
RP Koh, GY (corresponding author), Korea Adv Inst Sci & Technol, Ctr Biomed Res, 373-1,Guseong-Dong, Taejon 305701, South Korea.
EM gykoh@kaist.ac.kr
RI Lee, Gyun Min/C-2020-2011; Koh, Gou Young/C-1615-2011
OI Steinmetz, Michel/0000-0001-6157-3687; Kammerer,
   Richard/0000-0003-4570-5197; Maco, Bohumil/0000-0001-8444-313X
CR Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chae JK, 2000, ARTERIOSCL THROM VAS, V20, P2573, DOI 10.1161/01.ATV.20.12.2573
   Cho CH, 2004, P NATL ACAD SCI USA, V101, P5547, DOI 10.1073/pnas.0307574101
   Dallabrida SM, 2003, BIOCHEM BIOPH RES CO, V311, P563, DOI 10.1016/j.bbrc.2003.10.007
   Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7
   Davis S, 2003, NAT STRUCT BIOL, V10, P38, DOI 10.1038/nsb880
   Fiedler U, 2004, BLOOD, V103, P4150, DOI 10.1182/blood-2003-10-3685
   FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9
   Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200
   Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x
   Jones N, 2001, NAT REV MOL CELL BIO, V2, P257, DOI 10.1038/35067005
   Kim I, 2000, J BIOL CHEM, V275, P18550, DOI 10.1074/jbc.M910084199
   Kim I, 2000, CIRC RES, V86, P24, DOI 10.1161/01.RES.86.1.24
   Kim I, 2001, CARDIOVASC RES, V49, P872, DOI 10.1016/S0008-6363(00)00295-9
   Kim I, 2001, CIRC RES, V89, P477, DOI 10.1161/hh1801.097034
   Kwak HJ, 2000, CIRCULATION, V101, P2317, DOI 10.1161/01.CIR.101.19.2317
   Lee HJ, 2004, FASEB J, V18, P1200, DOI 10.1096/fj.03-1466com
   Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55
   Parton RG, 2003, NAT REV MOL CELL BIO, V4, P162, DOI 10.1038/nrm1017
   Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196
   SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355
   Suri C, 1996, CELL, V87, P1171, DOI 10.1016/S0092-8674(00)81813-9
   Suri C, 1998, SCIENCE, V282, P468, DOI 10.1126/science.282.5388.468
   Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8
   Teichert-Kuliszewska K, 2001, CARDIOVASC RES, V49, P659, DOI 10.1016/S0008-6363(00)00231-5
   Thurston G, 2000, NAT MED, V6, P460, DOI 10.1038/74725
   Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511
   Valenzuela DM, 1999, P NATL ACAD SCI USA, V96, P1904, DOI 10.1073/pnas.96.5.1904
   Ward NL, 2004, BIOCHEM BIOPH RES CO, V323, P937, DOI 10.1016/j.bbrc.2004.08.185
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694
   Yoon M, 2003, BIOCHEM BIOPH RES CO, V308, P101, DOI 10.1016/S0006-291X(03)01341-X
NR 32
TC 107
Z9 109
U1 0
U2 6
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 20
PY 2005
VL 280
IS 20
BP 20126
EP 20131
DI 10.1074/jbc.M500292200
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 926HH
UT WOS:000229113700084
PM 15769741
OA Other Gold, Green Published
DA 2021-01-25
ER

PT J
AU Fayon, F
   Massiot, D
   Levitt, MH
   Titman, JJ
   Gregory, DH
   Duma, L
   Emsley, L
   Brown, SP
AF Fayon, F
   Massiot, D
   Levitt, MH
   Titman, JJ
   Gregory, DH
   Duma, L
   Emsley, L
   Brown, SP
TI Through-space contributions to two-dimensional double-quantum J
   correlation NMR spectra of magic-angle-spinning solids
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Article
ID BOND CARBON-CARBON; MAS NMR; CROSS-POLARIZATION; DIRECT DIPOLAR; STATE;
   CONNECTIVITIES; ABUNDANCE; SUPERSTRUCTURE; ASSIGNMENT; SPECTROSCOPY
AB A routinely used assumption when interpreting two-dimensional NMR spectra obtained with a commonly used double-quantum (DQ) magic-angle-spining (MAS) pulse sequence referred to as the refocused incredible natural abundance double-quantum transfer experiment (INADEQUATE) [A. Lesage, M. Bardet, and L. Emsley, J. Am. Chem. Soc. 121, 10987 (1999)] has been that correlation peaks are only observed for pairs of nuclei with a through-bond connectivity. The validity of this assumption is addressed here by theory, experiment, and computer simulations. If the isotropic chemical shifts of the two nuclei are different and the MAS frequency is far from rotational resonance, the theoretical description demonstrates that DQ correlation peaks are indeed indicative of a J coupling. However, if the isotropic chemical shifts are the same, it is shown that DQ peaks can appear for pairs of nuclei even in the absence of a through-bond J coupling. These peaks appear in the specific case of a pair of nuclei with a nonzero through-space dipole-dipole coupling and chemical shift anisotropy tensors having different principal magnitudes or orientations, provided that the MAS frequency is comparable to or smaller than, the chemical shift anisotropies. Experimental P-31 Spectra recorded on a sample of TiP2O7 and computer simulations show that the magnitude of these anomalous peaks increases with increasing B-0 magnetic field and that they decrease with increasing MAS frequency. This behavior is explained theoretically. (c) 2005 American Institute of Physics.
C1 CNRS, Ctr Rech Mat Haute Temp, F-45071 Orleans, France.
   Univ Southampton, Dept Chem, Southampton SO17 1BJ, Hants, England.
   Univ Nottingham, Sch Chem, Nottingham NG7 2RD, England.
   Ecole Normale Super Lyon, ENS, CNRS, UMR 5182,Lab Chim, F-69364 Lyon, France.
   Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Fayon, F (corresponding author), CNRS, Ctr Rech Mat Haute Temp, F-45071 Orleans, France.
EM S.P.Brown@warwick.ac.uk
RI Emsley, Lyndon/C-6108-2008; Gregory, Duncan H/A-5489-2008; Titman,
   Jeremy/F-8262-2010; Massiot, Dominique/C-1287-2008; Fayon,
   Franck/C-1835-2008; Emsley, Lyndon/AAS-6384-2020; Brown,
   Steven/F-8765-2014; Levitt, Malcolm/B-3746-2010
OI Emsley, Lyndon/0000-0003-1360-2572; Gregory, Duncan
   H/0000-0002-4585-3280; Titman, Jeremy/0000-0001-9758-9146; Massiot,
   Dominique/0000-0003-1207-7040; Fayon, Franck/0000-0001-5086-5625;
   Emsley, Lyndon/0000-0003-1360-2572; Brown, Steven/0000-0003-2069-8496;
   Levitt, Malcolm/0000-0001-9878-1180
CR Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179
   Baldus M, 1996, J MAGN RESON SER A, V121, P65, DOI 10.1006/jmra.1996.0137
   BAX A, 1980, J AM CHEM SOC, V102, P4849, DOI 10.1021/ja00534a056
   Bechmann M, 2002, SOLID STATE NUCL MAG, V21, P71, DOI 10.1006/snmr.2001.0042
   BENN R, 1988, CHEM COMMUN, V2, P102
   Brown SP, 2002, J AM CHEM SOC, V124, P1152, DOI 10.1021/ja0172262
   Brus J, 2004, J PHYS CHEM A, V108, P3955, DOI 10.1021/jp0498163
   CHALLONER R, 1991, J CHEM PHYS, V94, P7038, DOI 10.1063/1.460237
   De Paepe G, 2004, CHEMPHYSCHEM, V5, P869, DOI 10.1002/cphc.200301062
   De Paepe G, 2003, J AM CHEM SOC, V125, P13938, DOI 10.1021/ja037213j
   Duma L, 2004, CHEMPHYSCHEM, V5, P815, DOI 10.1002/cphc.200301213
   Dusold S, 1997, J AM CHEM SOC, V119, P7121, DOI 10.1021/ja970890r
   Dusold S, 1998, J MAGN RESON, V135, P500, DOI 10.1006/jmre.1998.1603
   EARLY TA, 1987, J MAGN RESON, V75, P134, DOI 10.1016/0022-2364(87)90321-0
   EICHELE K, 1993, J MAGN RESON SER A, V101, P157, DOI 10.1006/jmra.1993.1025
   Fayon F, 2004, CR CHIM, V7, P351, DOI 10.1016/j.crci.2003.10.019
   Fayon F, 2003, CHEM MATER, V15, P2234, DOI 10.1021/cm031009d
   FAYON F, 2002, CHEM COMMUN, V2, P1702
   FYFE CA, 1990, J AM CHEM SOC, V112, P3264, DOI 10.1021/ja00165a002
   Grasso G, 2002, J PHYS CHEM B, V106, P8676, DOI 10.1021/jp026093j
   HAEBERLEN U, 1968, PHYS REV, V175, P453, DOI 10.1103/PhysRev.175.453
   Hedin N, 2004, J AM CHEM SOC, V126, P9425, DOI 10.1021/ja040030s
   Helluy X, 2000, J PHYS CHEM B, V104, P2836, DOI 10.1021/jp993626o
   HERZFELD J, 1980, J CHEM PHYS, V73, P6021, DOI 10.1063/1.440136
   Kono H, 2004, MACROMOLECULES, V37, P5310, DOI 10.1021/ma030465k
   Kono H, 2004, POLYMER, V45, P2843, DOI 10.1016/j.polymer.2004.01.075
   Kono H, 2003, MACROMOLECULES, V36, P5131, DOI 10.1021/ma021769u
   KUBO A, 1990, J CHEM PHYS, V92, P7156, DOI 10.1063/1.458255
   Lesage A, 1999, J AM CHEM SOC, V121, P10987, DOI 10.1021/ja992272b
   Lesage A, 1997, J AM CHEM SOC, V119, P7867, DOI 10.1021/ja971089k
   LEVITT MH, 1990, J CHEM PHYS, V92, P6347, DOI 10.1063/1.458314
   MARICQ MM, 1979, J CHEM PHYS, V70, P3300, DOI 10.1063/1.437915
   Mueller LJ, 2004, J MAGN RESON, V168, P327, DOI 10.1016/j.jmr.2004.03.017
   Mueller LJ, 2002, J AM CHEM SOC, V124, P9360, DOI 10.1021/ja0266619
   Norberg ST, 2001, ACTA CRYSTALLOGR C, V57, P510, DOI 10.1107/S0108270101003547
   Olsen RA, 2003, J AM CHEM SOC, V125, P11784, DOI 10.1021/ja036655s
   Sakellariou D, 2003, J AM CHEM SOC, V125, P4376, DOI 10.1021/ja0292389
   Sanz J, 1997, CHEM MATER, V9, P996, DOI 10.1021/cm970057t
   STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7
   TILLMANNS E, 1973, J SOLID STATE CHEM, V7, P69, DOI 10.1016/0022-4596(73)90124-2
NR 40
TC 68
Z9 69
U1 3
U2 36
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD MAY 15
PY 2005
VL 122
IS 19
AR 194313
DI 10.1063/1.1898219
PG 14
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 934XS
UT WOS:000229743500025
PM 16161579
DA 2021-01-25
ER

PT J
AU Gotz, M
   Barde, YA
AF Gotz, M
   Barde, YA
TI Radial glial cells: Defined and major intermediates between embryonic,
   stern cells and CNS neurons
SO NEURON
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC INHERITANCE; PROGENITOR CELLS; PAX6;
   LINEAGE; DIFFERENTIATION; TELENCEPHALON; SPECIFICATION; ARISE; FATE
C1 GSF, Natl Res Ctr Environm & Hlth, Inst Stem Celll Res, D-85764 Neuherberg, Germany.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Gotz, M (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Celll Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.
EM magdalena.goetz@gsf.de; yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X; Gotz, Magdalena/0000-0003-1551-9203
CR Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582
   Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0
   AUBERT J, 2002, NAT BIOTECHNOL, V12, P1208
   Backman M, 2005, DEV BIOL, V279, P155, DOI 10.1016/j.ydbio.2004.12.010
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005
   Fishell G, 2003, CURR OPIN NEUROBIOL, V13, P34, DOI 10.1016/S0959-4388(03)00013-8
   GOTZ M, 2005, IN PRESS NAT REV MOL
   HACK M, 2005, IN PRESS NAT NEUROSC
   Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012
   Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962
   Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   Haubst N, 2004, DEVELOPMENT, V131, P6131, DOI 10.1242/dev.01524
   Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828
   HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8
   Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101
   MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2
   MORI T, 2005, IN PRESS CURRENT TOP, V69
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420
   Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
NR 27
TC 208
Z9 211
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD MAY 5
PY 2005
VL 46
IS 3
BP 369
EP 372
DI 10.1016/j.neuron.2005.04.012
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 924WL
UT WOS:000229011400005
PM 15882633
DA 2021-01-25
ER

PT J
AU Nyfeler, B
   Michnick, SW
   Hauri, HP
AF Nyfeler, B
   Michnick, SW
   Hauri, HP
TI Capturing protein interactions in the secretory pathway of living cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ERGIC-53; lectin cargo receptor; protein fragment complementation assay;
   protein-protein interaction
ID MANNOSIDASE-LIKE PROTEIN; GREEN FLUORESCENT PROTEIN;
   ENDOPLASMIC-RETICULUM; COMPLEMENTATION ASSAYS; MEMBRANE-PROTEIN; LECTIN
   ERGIC-53; GOLGI; ER; TRANSPORT; VISUALIZATION
AB The secretory pathway is composed of membrane compartments specialized in protein folding, modification, transport, and sorting. Numerous transient protein-protein interactions guide the transport-competent proteins through the secretory pathway. Here we have adapted the yellow fluorescent protein (YFP)-based protein fragment complementation assay (PCA) to detect protein-protein interactions in the secretory pathway of living cells. Fragments of YFP were fused to the homooligomeric cargo-receptor lectin endoplasmic reticulum Golgi intermediate compartment (ERGIC)-53, to the ERGIC-53-interacting multicoagulation factor deficiency protein MCFD2, and to ERGIC-53's cargo glycoprotein cathepsin Z. YFP PCA analysis revealed the oligomerization of ERGIC-53 and its interaction with MCFD2, as well as its lectin-mediated interaction with cathepsin Z. Mutation of the lectin domain of ERGIC-53 selectively decreased YFP complementation with cathepsin Z. Using YFP PCA, we discovered a carbohydrate-mediated interaction between ERGIC-53 and cathrepsin C. We conclude that YFP PCA can detect weak and transient protein interactions in the secretory pathway and hence is a powerful approach to study luminal processes involved in protein secretion. The study extends the application of PCA to carbohydrate-mediated protein-protein interactions of low affinity.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Cabantous S, 2005, NAT BIOTECHNOL, V23, P102, DOI 10.1038/nbt1044
   Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3
   de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064
   Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882
   Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619
   GETHING MJ, 1992, NATURE, V355, P33, DOI 10.1038/355033a0
   Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w
   Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200
   Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084
   Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3
   Itin C, 1996, MOL BIOL CELL, V7, P483
   Jakob CA, 2001, EMBO REP, V2, P423
   Klumperman J, 1998, J CELL SCI, V111, P3411
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101
   Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601
   Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7
   Moussalli M, 1999, J BIOL CHEM, V274, P32539, DOI 10.1074/jbc.274.46.32539
   Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200
   Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7
   Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200
   Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299
   Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341
   Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113
   Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011
   Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004
   Remy I, 2001, P NATL ACAD SCI USA, V98, P7678, DOI 10.1073/pnas.131216098
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Spotts JM, 2002, P NATL ACAD SCI USA, V99, P15142, DOI 10.1073/pnas.232565699
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 35
TC 138
Z9 142
U1 0
U2 15
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 3
PY 2005
VL 102
IS 18
BP 6350
EP 6355
DI 10.1073/pnas.0501976102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 923OE
UT WOS:000228918400021
PM 15849265
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Sonda, S
   Sala, G
   Ghidoni, R
   Hemphill, A
   Pieters, J
AF Sonda, S
   Sala, G
   Ghidoni, R
   Hemphill, A
   Pieters, J
TI Inhibitory effect of aureobasidin A on Toxoplasma gondii
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID P-GLYCOPROTEIN; SPHINGOLIPID BIOSYNTHESIS; BETA-GALACTOSIDASE; SHIKIMATE
   PATHWAY; HUMAN MDR1; RESISTANCE; DIFFERENTIATION; LEISHMANIA;
   EXPRESSION; INDUCTION
AB The apicomplexan parasite Toxoplasma gondii is a leading opportunistic pathogen associated with AIDS and congenital birth defects. Due to the need for identifying new parasite-specific treatments, the possibility of targeting sphingolipid biosynthesis in the parasite was investigated. Aureobasidin A, an inhibitor of the enzyme synthesizing the sphingolipid inositol phosphorylceramide, which is present in fungi, plants, and some protozoa but absent in mammalian cells, was found to block in vitro T. gondii replication without affecting host cell metabolism. Aureobasidin A treatment did not induce tachyzoite to bradyzoite stage conversion in T. gondii but resulted in a loss of intracellular structures and vacuolization within the parasite. In addition, aureobasidin A inhibited sphingolipid synthesis in T. gondii. Sphingolipid biosynthetic pathways may therefore be considered targets for the development of anti-T. gondii agents.
C1 Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland.
   Univ Basel, Dept Biochem, Biozentrum, Basel, Switzerland.
   Univ Bern, Inst Parasitol, Bern, Switzerland.
   Univ Milan, Sch Med, San Paolo Univ Hosp, Biochem & Mol Biol Lab, Milan, Italy.
RP Sonda, S (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.
EM sabrina.sonda@vetparas.unizh.ch
OI GHIDONI, RICCARDO/0000-0002-6300-5867; Pieters, Jean/0000-0002-5284-9757
CR Aspinall TV, 2002, J INFECT DIS, V185, P1637, DOI 10.1086/340577
   Azzouz N, 2002, INT J PARASITOL, V32, P677, DOI 10.1016/S0020-7519(02)00009-7
   BLIGH EG, 1959, CANADIAN JOURNAL OF, V37, P911, DOI DOI 10.1139/Y59-099
   BOHNE W, 1994, INFECT IMMUN, V62, P1761, DOI 10.1128/IAI.62.5.1761-1767.1994
   Campbell SA, 2004, INT J PARASITOL, V34, P5, DOI 10.1016/j.ijpara.2003.10.006
   Carruthers VB, 2002, ACTA TROP, V81, P111, DOI 10.1016/S0001-706X(01)00201-7
   Cheng JJ, 2001, MOL CELL BIOL, V21, P6198, DOI 10.1128/MCB.21.18.6198-6209.2001
   DANNEMANN BR, 1991, AIDS, V5, P1363, DOI 10.1097/00002030-199111000-00013
   Denny PW, 2004, MOL MICROBIOL, V52, P313, DOI 10.1111/j.1365-2958.2003.03975.x
   Dubey JP, 1998, INT J PARASITOL, V28, P1019, DOI 10.1016/S0020-7519(98)00023-X
   Endo M, 1997, ANTIMICROB AGENTS CH, V41, P672, DOI 10.1128/AAC.41.3.672
   Fischl AS, 2000, METHOD ENZYMOL, V311, P123
   Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583
   Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855
   Hashida-Okado T, 1998, CURR GENET, V33, P38, DOI 10.1007/s002940050306
   HashidaOkado T, 1996, MOL GEN GENET, V251, P236
   Heidler SA, 2000, BBA-MOL BASIS DIS, V1500, P147, DOI 10.1016/S0925-4439(99)00097-6
   Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754
   Hemphill Andrew, 1997, P227
   Kino K, 1996, FEBS LETT, V399, P29, DOI 10.1016/S0014-5793(96)01265-3
   LESTER RL, 1993, ADV LIPID RES, V26, P253
   Mandala SM, 1998, J BIOL CHEM, V273, P14942, DOI 10.1074/jbc.273.24.14942
   Mathias S, 1998, BIOCHEM J, V335, P465, DOI 10.1042/bj3350465
   McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181
   MCCONVILLE MJ, 1989, J BIOL CHEM, V264, P757
   McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849
   McFadden DC, 2001, DRUG RESIST UPDATE, V4, P79, DOI 10.1054/drup.2001.0184
   Roberts F, 1998, NATURE, V393, P801, DOI 10.1038/31723
   Salto ML, 2003, EUKARYOT CELL, V2, P756, DOI 10.1128/EC.2.4.756-768.2003
   Sauvage V, 2004, MOL BIOCHEM PARASIT, V134, P89, DOI 10.1016/j.molbiopara.2003.08.015
   Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5
   Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859
   SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039
   TAKESAKO K, 1991, J ANTIBIOT, V44, P919, DOI 10.7164/antibiotics.44.919
   TAKESAKO K, 1993, J ANTIBIOT, V46, P1414, DOI 10.7164/antibiotics.46.1414
   Tiberghien F, 2000, J MED CHEM, V43, P2547, DOI 10.1021/jm990955w
   Wei S, 2002, INT J PARASITOL, V32, P969, DOI 10.1016/S0020-7519(02)00061-9
   WEISS LM, 1995, J EUKARYOT MICROBIOL, V42, P150, DOI 10.1111/j.1550-7408.1995.tb01556.x
   Weiss LM, 2000, FRONT BIOSCI-LANDMRK, V5, pD391, DOI 10.2741/Weiss
   WONG SY, 1993, AIDS, V7, P299, DOI 10.1097/00002030-199303000-00001
NR 40
TC 30
Z9 32
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAY
PY 2005
VL 49
IS 5
BP 1794
EP 1801
DI 10.1128/AAC.49.5.1794-1801.2005
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 924MJ
UT WOS:000228982600019
PM 15855498
OA Green Accepted, Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Miot, S
   Woodfield, T
   Daniels, AU
   Suetterlin, R
   Peterschmitt, I
   Heberer, M
   van Blitterswijk, CA
   Riesle, J
   Martin, I
AF Miot, S
   Woodfield, T
   Daniels, AU
   Suetterlin, R
   Peterschmitt, I
   Heberer, M
   van Blitterswijk, CA
   Riesle, J
   Martin, I
TI Effects of scaffold composition and architecture on human nasal
   chondrocyte redifferentiation and cartilaginous matrix deposition
SO BIOMATERIALS
LA English
DT Article
DE cartilage tissue engineering; nasal chondrocytes; extracellular matrix;
   wettability; porosity; scaffold
ID HUMAN ARTICULAR CHONDROCYTES; SMOOTH-MUSCLE ACTIN; BONE ARCHITECTURE;
   IN-VITRO; NONDESTRUCTIVE EVALUATION; CELL-SHAPE; TISSUE; SURFACES;
   PROLIFERATION; EXPRESSION
AB We investigated whether the post-expansion redifferentiation and cartilage tissue formation capacity of adult human nasal chondrocytes can be regulated by controlled modifications of scaffold composition and architecture. As a model system, we used poly(ethylene glycol)-terephthalate-poly(butylene)-terephthalate block copolymer scaffolds from two compositions (low or high PEG content, resulting in different wettability) and two architectures (generated by compression molding or three-dimensional (3D) fiber deposition) with similar porosity and mechanical properties, but different interconnecting pore architectures. Scaffolds were;ceded with expanded human chondrocytes and the resulting constructs assessed immunohistochemically, biochemically and at the mRNA expression level following up to 4 weeks of static culture.
   For a given 3D architecture, the more hydrophilic scaffold enhanced cell redifferentiation and cartilaginous tissue formation after 4 weeks culture, as assessed by higher mRNA expression of collagen type 11, increased deposition of glycosaminoglycan (GAG) and predominance of type 11 over type I collagen immunostain. The fiber-deposited scaffolds, with a more accessible pore volume and larger interconnecting pores, supported increased GAG deposition, but only if a more hydrophilic composition was used.
   By applying controlled and selective modifications of chemico-physical scaffold parameters, we demonstrate that both scaffold composition and architecture are instructive for expanded human chondrocytes in the generation of 3D cartilaginous tissues. The Observed effects of composition and architecture were likely to have been mediated, respectively, by differential serum protein adsorption and efficiency of nutrient/waste exchange. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
   IsoTis SA, NL-3720 AB Bilthoven, Netherlands.
   Univ Twente, Inst Biomed Technol, NL-7500 AE Enschede, Netherlands.
   Felix Platter Hosp, Orthopaed Biomech Lab, Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
   Univ Haute Alsace, UFR Pluridisciplinaire Enseignement Professionnal, Colmar, France.
RP Martin, I (corresponding author), Univ Basel Hosp, Dept Surg, Hebelstr 20, CH-4031 Basel, Switzerland.
EM imartin@uhbs.ch
RI Martin, Ivan/K-9286-2016; Woodfield, Tim B F/A-2705-2009
OI Woodfield, Tim B F/0000-0002-5428-7575; Martin,
   Ivan/0000-0001-6493-0432; van Blitterswijk, Clemens/0000-0003-2371-4615
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Binette F, 1998, J ORTHOP RES, V16, P207, DOI 10.1002/jor.1100160208
   BONAVENTURE J, 1994, EXP CELL RES, V212, P97, DOI 10.1006/excr.1994.1123
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Du C, 2002, BIOMATERIALS, V23, P4649, DOI 10.1016/S0142-9612(02)00214-4
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gopferich A, 1999, J BIOMED MATER RES, V46, P390
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   HAMBLETON J, 1994, J ORTHOPAED RES, V12, P542, DOI 10.1002/jor.1100120411
   HORBETT TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Kinner B, 2001, J ORTHOP RES, V19, P233, DOI 10.1016/S0736-0266(00)00081-4
   Krasteva N, 2002, BIOMATERIALS, V23, P2467, DOI 10.1016/S0142-9612(01)00381-7
   Lahiji A, 2000, J BIOMED MATER RES, V51, P586
   Laib A, 2000, MED BIOL ENG COMPUT, V38, P326, DOI 10.1007/BF02347054
   LEE JH, 1989, J BIOMED MATER RES, V23, P351, DOI 10.1002/jbm.820230306
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   LOESER RF, 1993, ARTHRITIS RHEUM, V36, P1103, DOI 10.1002/art.1780360811
   LOTY S, 1995, BIOL CELL, V83, P149, DOI 10.1016/0248-4900(96)81303-7
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   MAHMOOD TA, UNPUB DIFFERENTIAL P
   Malda J, 2003, BIOMATERIALS, V24, P5153, DOI 10.1016/S0142-9612(03)00428-9
   MALDA J, IN PRESS BIOMATERIAL
   Martem'yanov VI, 2001, J EVOL BIOCHEM PHYS+, V37, P141, DOI 10.1023/A:1017680829971
   Martin I, 2001, J CELL BIOCHEM, V83, P121, DOI 10.1002/jcb.1203
   Muller R, 1997, ST HEAL T, V40, P61
   Obradovic B, 2000, AICHE J, V46, P1860, DOI 10.1002/aic.690460914
   Odgaard A, 1997, BONE, V20, P315, DOI 10.1016/S8756-3282(97)00007-0
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   Premdas J, 2001, J ORTHOP RES, V19, P221, DOI 10.1016/S0736-0266(00)90011-1
   Rotter N, 2002, BIOMATERIALS, V23, P3087, DOI 10.1016/S0142-9612(02)00031-5
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   Treppo S, 2000, J ORTHOP RES, V18, P739, DOI 10.1002/jor.1100180510
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   ZANETTI NC, 1989, CELL SHAPE DETERMINA, P291
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 46
TC 125
Z9 131
U1 0
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD MAY
PY 2005
VL 26
IS 15
BP 2479
EP 2489
DI 10.1016/j.biomaterials.2004.06.048
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 893DB
UT WOS:000226698400030
PM 15585250
DA 2021-01-25
ER

PT J
AU Lichtneckert, R
   Reichert, H
AF Lichtneckert, R
   Reichert, H
TI Insights into the urbilaterian brain: conserved genetic patterning
   mechanisms in insect and vertebrate brain development
SO HEREDITY
LA English
DT Review
DE Drosophila; mouse; brain development; pattern formation;
   midbrain-hindbrain boundary; brain evolution
ID CENTRAL-NERVOUS-SYSTEM; DEVELOPING CEREBRAL-CORTEX; DROSOPHILA HEAD
   DEVELOPMENT; CORD DEVELOPMENT; EMPTY-SPIRACLES; HOX GENES; ANTERIOR
   NEUROECTODERM; ORTHODENTICLE GENE; HOMEOBOX GENES; NEURAL PLATE
AB Recent molecular genetic analyses of Drosophila melanogaster and mouse central nervous system (CNS) development revealed strikingly similar genetic patterning mechanisms in the formation of the insect and vertebrate brain. Thus, in both insects and vertebrates, the correct regionalization and neuronal identity of the anterior brain anlage is controlled by the cephalic gap genes otd/Otx and ems/Emx, whereas members of the Hox genes are involved in patterning of the posterior brain. A third intermediate domain on the anteroposterior axis of the vertebrate and insect brain is characterized by the expression of the Pax2/5/8 orthologues, suggesting that the tripartite ground plans of the protostome and deuterostome brains share a common evolutionary origin. Furthermore, cross-phylum rescue experiments demonstrate that insect and mammalian members of the otd/Otx and ems/Emx gene families can functionally replace each other in embryonic brain patterning. Homologous genes involved in dorsoventral regionalization of the CNS in vertebrates and insects show remarkably similar patterning and orientation with respect to the neurogenic region ( ventral in insects and dorsal in vertebrates). This supports the notion that a dorsoventral body axis inversion occurred after the separation of protostome and deuterostome lineages in evolution. Taken together, these findings demonstrate conserved genetic patterning mechanisms in insect and vertebrate brain development and suggest a monophyletic origin of the brain in protostome and deuterostome bilaterians.
C1 Univ Basel, Biozentrum Pharmazentrum, Inst Zool, CH-4056 Basel, Switzerland.
RP Lichtneckert, R (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Inst Zool, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Robert.Lichtneckert@stud.unibas.ch
CR ACAMPORA D, 1995, DEVELOPMENT, V121, P3279
   Acampora D, 1999, TRENDS NEUROSCI, V22, P116, DOI 10.1016/S0166-2236(98)01387-3
   Acampora D, 2003, GENE EXPR PATTERNS, V3, P497, DOI 10.1016/S1567-133X(03)00056-5
   Acampora D, 1998, DEVELOPMENT, V125, P1691
   Acampora D, 1999, DEVELOPMENT, V126, P1417
   Acampora D, 1998, DEVELOPMENT, V125, P5091
   Acampora D, 2001, PROG NEUROBIOL, V64, P69, DOI 10.1016/S0301-0082(00)00042-3
   Acampora D, 1997, DEVELOPMENT, V124, P3639
   Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218
   Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453
   ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0
   Arendt D, 1996, BIOESSAYS, V18, P255, DOI 10.1002/bies.950180314
   Arendt D, 1999, DEVELOPMENT, V126, P2309
   Bishop KM, 2002, J NEUROSCI, V22, P7627
   BODMER R, 1993, DEVELOPMENT, V118, P719
   Boyl PP, 2001, DEVELOPMENT, V128, P2989
   Brusca R.C., 1990, INVERTEBRATES
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943
   Chan YM, 1999, CURR OPIN NEUROBIOL, V9, P582, DOI 10.1016/S0959-4388(99)00017-3
   CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0
   Chu H, 1998, GENE DEV, V12, P3613, DOI 10.1101/gad.12.22.3613
   COHEN S, 1991, TRENDS GENET, V7, P267
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0
   Doe CQ, 1996, CURR OPIN NEUROBIOL, V6, P18, DOI 10.1016/S0959-4388(96)80004-3
   DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5
   Ferrier DEK, 2001, NAT REV GENET, V2, P33, DOI 10.1038/35047605
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0
   FRANTZ GD, 1994, J NEUROSCI, V14, P5725
   Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066
   GARSTANG WALTER, 1928, QUART JOUR MICROS SCI, V72, P51
   Gavalas A, 1998, DEVELOPMENT, V125, P1123
   Gerhart J, 2000, P NATL ACAD SCI USA, V97, P4445, DOI 10.1073/pnas.97.9.4445
   Goddard JM, 1996, DEVELOPMENT, V122, P3217
   Gould S. J., 2002, STRUCTURE EVOLUTIONA
   GROSSNIKLAUS U, 1994, DEVELOPMENT, V120, P3155
   Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x
   Haddon C, 1998, DEVELOPMENT, V125, P359
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   HATSCHEK B, 1891, LEHRBUCH ZOOLOGIE
   Hirth F, 1999, BIOESSAYS, V21, P677, DOI 10.1002/(SICI)1521-1878(199908)21:8<677::AID-BIES7>3.0.CO;2-8
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   Holland LZ, 1999, CURR OPIN NEUROBIOL, V9, P596, DOI 10.1016/S0959-4388(99)00003-3
   Holland ND, 2003, NAT REV NEUROSCI, V4, P617, DOI 10.1038/nrn1175
   Holley SA, 1997, BIOESSAYS, V19, P281, DOI 10.1002/bies.950190404
   HOLLEY SA, 1995, NATURE, V376, P249, DOI 10.1038/376249a0
   Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x
   Joyner AL, 2000, CURR OPIN CELL BIOL, V12, P736, DOI 10.1016/S0955-0674(00)00161-7
   JURGENS G, 1993, DEV DROSOPHILA MELAN, P687
   Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8
   Kaufman T C, 1990, Adv Genet, V27, P309
   Kozmik Z, 1999, DEVELOPMENT, V126, P1295
   Lacalli T, 2003, NATURE, V424, P263, DOI 10.1038/424263a
   Leuzinger S, 1998, DEVELOPMENT, V125, P1703
   Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869
   Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0
   Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109
   Maconochie M, 1996, ANNU REV GENET, V30, P529, DOI 10.1146/annurev.genet.30.1.529
   Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000
   Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804
   MARIN F, 1994, DEV BIOL, V163, P19, DOI 10.1006/dbio.1994.1120
   MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T
   McDonald JA, 1998, GENE DEV, V12, P3603, DOI 10.1101/gad.12.22.3603
   Millett S, 1999, NATURE, V401, P161
   Morsli H, 1999, DEVELOPMENT, V126, P2335
   Muzio L, 2002, NAT NEUROSCI, V5, P737, DOI 10.1038/nn892
   NOLL M, 1993, CURR OPIN GENET DEV, V3, P595, DOI 10.1016/0959-437X(93)90095-7
   O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4
   Pellegrini M, 1996, DEVELOPMENT, V122, P3893
   Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207
   Reichert H, 1999, CURR OPIN NEUROBIOL, V9, P589, DOI 10.1016/S0959-4388(99)00002-1
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Rhinn M, 1998, DEVELOPMENT, V125, P845
   Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9
   Rijli FM, 1998, INT J DEV BIOL, V42, P393
   Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445
   RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711
   Schilling TF, 2001, PHILOS T R SOC B, V356, P1599, DOI 10.1098/rstb.2001.0918
   SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x
   Simeone A, 1998, EMBO J, V17, P6790, DOI 10.1093/emboj/17.23.6790
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sprecher SG, 2003, ARTHROPOD STRUCT DEV, V32, P141, DOI 10.1016/S1467-8039(03)00007-0
   Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0
   Studer M, 1998, DEVELOPMENT, V125, P1025
   Tagawa K, 2001, EVOL DEV, V3, P443, DOI 10.1046/j.1525-142X.2001.01050.x
   Taguchi S, 2002, ZOOL SCI, V19, P57, DOI 10.2108/zsj.19.57
   Takacs CM, 2002, EVOL DEV, V4, P405, DOI 10.1046/j.1525-142X.2002.02029.x
   Takahashi T, 2004, DEVELOPMENT, V131, P3285, DOI 10.1242/dev.01201
   Tanaka M, 1999, DEVELOPMENT, V126, P1269
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Vervoort M, 2002, BIOESSAYS, V24, P775, DOI 10.1002/bies.10146
   Wada H, 1998, DEVELOPMENT, V125, P1113
   Wada H, 2001, CURR OPIN NEUROBIOL, V11, P16, DOI 10.1016/S0959-4388(00)00168-9
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wassarman KM, 1997, DEVELOPMENT, V124, P2923
   Weiss JB, 1998, GENE DEV, V12, P3591, DOI 10.1101/gad.12.22.3591
   Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516
   Yoshida M, 1997, DEVELOPMENT, V124, P101
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
NR 107
TC 89
Z9 91
U1 2
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0018-067X
J9 HEREDITY
JI Heredity
PD MAY
PY 2005
VL 94
IS 5
BP 465
EP 477
DI 10.1038/sj.hdy.6800664
PG 13
WC Ecology; Evolutionary Biology; Genetics & Heredity
SC Environmental Sciences & Ecology; Evolutionary Biology; Genetics &
   Heredity
GA 920LY
UT WOS:000228692200004
PM 15770230
OA Bronze
DA 2021-01-25
ER

PT J
AU Gehring, WJ
AF Gehring, WJ
TI New perspectives on eye development and the evolution of eyes and
   photoreceptors
SO JOURNAL OF HEREDITY
LA English
DT Article; Proceedings Paper
CT International Meeting on Genomes and Evolution 2004
CY JUN 17-20, 2004
CL Penn State Univ, State Coll, PA
SP Amer Genet Assoc, Int Soc Mol Biol & Evolut
HO Penn State Univ
ID TWIN-OF-EYELESS; HOMEOBOX-CONTAINING GENE; SINE-OCULIS; PAX GENES;
   DROSOPHILA; JELLYFISH; ENHANCER; REGENERATION; EXPRESSION; MUTATIONS
AB Recent experiments on the genetic control of eye development have opened up a completely new perspective on eye evolution. The demonstration that targeted expression of one and the same master control gene, that is, Pax6 can induce the formation of ectopic eyes in both insects and vertebrates, necessitates a reconsideration of the dogma of a polyphyletic origin of the various eye types in all the animal phyla. The involvement of Pax6 and six1 and six3 genes, which encode highly conserved transcription factors, in the genetic control of eye development in organisms ranging from planarians to humans argues strongly for a monophyletic origin of the eye. Because transcription factors can control the expression of any target gene provided it contains the appropriate gene regulatory elements, the conservation of the genetic control of eye development by Pax6 among all bilaterian animals is not due to functional constraints but a consequence of its evolutionary history. The prototypic eyes postulated by Darwin to consist of two cells only, a photoreceptor and a pigment cell, were accidentally controlled by Pax6 and the subsequent evolution of the various eye types occurred by building onto this original genetic program. A hypothesis of intercalary evolution is proposed that assumes that the eye morphogenetic pathway is progressively modified by intercalation of genes between the master control genes on the top of the hierarchy and the structural genes like rhodopsin at the bottom. The recruitment of novel genes into the eye morphogenetic pathway can be due to at least two different genetic mechanisms, gene duplication and enhancer fusion.
   In tracing back the evolution of eyes beyond bilaterians, we find highly developed eyes in some box-jellyfish as well as in some Hydrozoans. In Hydrozoans the same orthologous six genes (six1 and six3) are required for eye regeneration as in planarians, and in the box jellyfish Tripedalia a pax B gene, which may be a precursor of Pax6, was found to be expressed in the eyes. In contrast to the adults, which have highly evolved eyes, the Planula larva of Tripedalia has single- celled photoreceptors similar to some unicellular protists.
   For the origin of photoreceptor cells in metazoa, I propose two hypotheses, one based on cellular differentiation and a more speculative one based on symbiosis. The former assumes that photoreceptor cells originated from a colonial protist in which all the cells were photosensitive and subsequent cellular differentiation to give rise to photoreceptor cells. The symbiont hypothesis, which I call the Russian doll model, assumes that photosensitivity arose first in photosynthetic cyanobacteria that were subsequently taken up into red algae as primary chloroplasts. The red algae in turn were taken up by dinoflagellates as secondary chloroplasts and in some species evolved into the most sophisticated eye organelles, as found, for example, in some dinoflagellates like Erythropsis and Warnovia, which lack chloroplasts. Because dinoflagellates are commonly found as symbionts in cnidarians, the dinoflagellates may have transferred their photoreceptor genes to cnidarians. In cnidarians such as Tripedalia the step from photoreceptor organelles to multicellular eyes has occurred. These two hypotheses, the cellular differentiation and the symbiont hypothesis, are not mutually exclusive and are the subject of further investigations.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
CR Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   DARWIN C, 1882, ORIGIN SPECIES MEANS, P143
   Eggert T, 1998, P NATL ACAD SCI USA, V95, P2343, DOI 10.1073/pnas.95.5.2343
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100
   GRELL KG, 1973, PROTOZOOLOGY, P314
   GREUET C, 1965, CR HEBD ACAD SCI, V261, P1904
   Greuet C., 1969, THESIS U NICE
   Groger H, 2000, MECH DEVELOP, V94, P157, DOI 10.1016/S0925-4773(00)00286-0
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   Hesse R., 1897, Z WISS ZOOL, V62, P527
   HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0
   Hoge MA, 1915, AM NAT, V49, P47, DOI 10.1086/279455
   Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110
   HOROWITZ NH, 1945, P NATL ACAD SCI USA, V31, P153, DOI 10.1073/pnas.31.6.153
   JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134
   Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170
   Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475
   Mayr E., 2001, WHAT EVOLUTION IS
   Michaut L, 2003, P NATL ACAD SCI USA, V100, P4024, DOI 10.1073/pnas.0630561100
   Miller DJ, 2000, P NATL ACAD SCI USA, V97, P4475, DOI 10.1073/pnas.97.9.4475
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2
   Pineda D, 2000, P NATL ACAD SCI USA, V97, P4525, DOI 10.1073/pnas.97.9.4525
   Plaza S, 2003, J EXP ZOOL PART B, V299B, P26, DOI 10.1002/jez.b.00038
   Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278
   Punzo C, 2002, DEVELOPMENT, V129, P625
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   SALVINIPLAWEN L, 1961, EVOLUTIONARY BIOL, V10, P207
   Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018
   Sun HM, 1997, P NATL ACAD SCI USA, V94, P5156, DOI 10.1073/pnas.94.10.5156
   Sun HM, 2001, MOL BIOL EVOL, V18, P1905, DOI 10.1093/oxfordjournals.molbev.a003731
   TON CCT, 1991, CELL, V67, P1059, DOI 10.1016/0092-8674(91)90284-6
   WALTHER C, 1991, DEVELOPMENT, V113, P1435
NR 42
TC 143
Z9 151
U1 1
U2 101
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1503
J9 J HERED
JI J. Hered.
PD MAY
PY 2005
VL 96
IS 3
BP 171
EP 184
DI 10.1093/jhered/esi027
PG 14
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 908ER
UT WOS:000227770700002
PM 15653558
OA Bronze
DA 2021-01-25
ER

PT J
AU Hippenmeyer, S
   Vrieseling, E
   Sigrist, M
   Portmann, T
   Laengle, C
   Ladle, DR
   Arber, S
AF Hippenmeyer, S
   Vrieseling, E
   Sigrist, M
   Portmann, T
   Laengle, C
   Ladle, DR
   Arber, S
TI A developmental switch in the response of DRG neurons to ETS
   transcription factor signaling
SO PLOS BIOLOGY
LA English
DT Article
ID CELL FATE; GENE; NEUROTROPHINS; PROTEIN; PEA3; EXPRESSION; IDENTITY;
   SPECIFICATION; PARVALBUMIN; CONNECTIONS
AB Two ETS transcription factors of the Pea3 subfamily are induced in subpopulations of dorsal root ganglion (DRG) sensory and spinal motor neurons by target-derived factors. Their expression controls late aspects of neuronal differentiation such as target invasion and branching. Here, we show that the late onset of ETS gene expression is an essential requirement for normal sensory neuron differentiation. We provide genetic evidence in the mouse that precocious ETS expression in DRG sensory neurons perturbs axonal projections, the acquisition of terminal differentiation markers, and their dependence on neurotrophic support. Together, our findings indicate that DRG sensory neurons exhibit a temporal developmental switch that can be revealed by distinct responses to ETS transcription factor signaling at sequential steps of neuronal maturation.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4003 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4002 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, CH-4003 Basel, Switzerland.
EM silvia.arber@unibas.ch
RI Pecho-Vrieseling, Eline/AAP-7239-2020
OI Hippenmeyer, Simon/0000-0003-2279-1061; Arber,
   Silvia/0000-0002-6261-250X
CR Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6
   Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493
   Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0
   Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Bojovic BB, 2001, J BIOL CHEM, V276, P4509, DOI 10.1074/jbc.M005509200
   de Alava E, 2000, J CLIN ONCOL, V18, P204, DOI 10.1200/JCO.2000.18.1.204
   De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046
   deLaunoit Y, 1997, BIOCHEM MOL MED, V61, P127, DOI 10.1006/bmme.1997.2605
   Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9
   Greenall A, 2001, J BIOL CHEM, V276, P16207, DOI 10.1074/jbc.M011582200
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677
   Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629
   ICHIKAWA H, 1994, BRAIN RES, V655, P241, DOI 10.1016/0006-8993(94)91620-9
   Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2
   Knecht AK, 2002, NAT REV GENET, V3, P453, DOI 10.1038/nrg819
   Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3
   Kressler D, 2002, J BIOL CHEM, V277, P13918, DOI 10.1074/jbc.M201134200
   Lentz SI, 1999, J NEUROSCI, V19, P1038
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Markus A, 2002, CURR OPIN NEUROBIOL, V12, P523, DOI 10.1016/S0959-4388(02)00372-0
   Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3
   Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772
   MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x
   Mo Y, 1998, MOL CELL, V2, P201, DOI 10.1016/S1097-2765(00)80130-6
   OHNO T, 1993, CANCER RES, V53, P5859
   Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577
   Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5
   Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7
   Pearson BJ, 2003, NATURE, V425, P624, DOI 10.1038/nature01910
   Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1
   Pufall MA, 2002, ANNU REV CELL DEV BI, V18, P421, DOI 10.1146/annurev.cellbio.18.031502.133614
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Schwaller B, 1999, AM J PHYSIOL-CELL PH, V276, pC395
   Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   Urano F, 1996, BIOCHEM BIOPH RES CO, V219, P608, DOI 10.1006/bbrc.1996.0281
   Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068
   White FA, 1998, J NEUROSCI, V18, P1428
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   ZHANG JH, 1990, J COMP NEUROL, V302, P715, DOI 10.1002/cne.903020404
NR 49
TC 579
Z9 580
U1 0
U2 20
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD MAY
PY 2005
VL 3
IS 5
BP 878
EP 890
AR e159
DI 10.1371/journal.pbio.0030159
PG 13
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 926LT
UT WOS:000229125400016
PM 15836427
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Nguyen, L
   Pieters, J
AF Nguyen, L
   Pieters, J
TI The Trojan horse: survival tactics of pathogenic mycobacteria in
   macrophages
SO TRENDS IN CELL BIOLOGY
LA English
DT Review
ID ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTORS; ESCHERICHIA-COLI;
   INTRACELLULAR SURVIVAL; CONTAINING PHAGOSOMES; MEMBRANE TRAFFICKING;
   EARLY ENDOSOMES; CORONIN FAMILY; III SECRETION; NITRIC-OXIDE
AB Mycobacterium tuberculosis, the causative agent of tuberculosis, has infected billions of people worldwide. A key to the success of M. tuberculosis and related pathogenic mycobacteria lies in their ability to persist within the hostile environment of the host macrophage. After internalization by macrophages, most microbes are rapidly transported to lysosomes in which they are destroyed. By contrast, pathogenic mycobacteria prevent fusion of phagosomes with lysosomes, thereby surviving intracellularly. Recent progress in understanding the molecular biology of host-mycobacteria interactions is providing insights into these survival tactics.
C1 Univ Basel, Biozentrum, CH-04056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-04056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757; Nguyen, Liem/0000-0002-1523-1472
CR ADAMS DO, 1992, MACROPHAGE, P75
   Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Chan ED, 1999, CHEST, V116, p91S, DOI 10.1378/chest.116.suppl_1.91S
   Chen BC, 1999, IMMUNOLOGY, V97, P124, DOI 10.1046/j.1365-2567.1999.00747.x
   Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200
   Chua J, 2004, J BIOL CHEM, V279, P36982, DOI 10.1074/jbc.M405082200
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cywes C, 1997, INFECT IMMUN, V65, P4258, DOI 10.1128/IAI.65.10.4258-4266.1997
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718
   Flint JL, 2004, P NATL ACAD SCI USA, V101, P12598, DOI 10.1073/pnas.0404892101
   Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2000, PROTOPLASMA, V210, P99, DOI 10.1007/BF01276849
   Gentschev I, 2002, TRENDS MICROBIOL, V10, P39, DOI 10.1016/S0966-842X(01)02259-4
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6
   Griffiths G, 1991, Trends Cell Biol, V1, P5, DOI 10.1016/0962-8924(91)90047-D
   Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2
   Hing JDNY, 2004, BIOCHEM BIOPH RES CO, V319, P810, DOI 10.1016/j.bbrc.2004.05.054
   HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301
   Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837
   Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1
   Jouanguy E, 1997, J CLIN INVEST, V100, P2658, DOI 10.1172/JCI119810
   Knutson KL, 1998, J BIOL CHEM, V273, P645, DOI 10.1074/jbc.273.1.645
   Komada M, 1999, GENE DEV, V13, P1475, DOI 10.1101/gad.13.11.1475
   KOUKOLIKOVANICOLA Z, 1993, BIOCHIMIE, V75, P635, DOI 10.1016/0300-9084(93)90092-7
   Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Madden JC, 2001, CELL, V104, P143, DOI 10.1016/S0092-8674(01)00198-2
   Mao YX, 2000, CELL, V100, P447, DOI 10.1016/S0092-8674(00)80680-7
   Means TK, 1999, J IMMUNOL, V163, P3920
   Meresse S, 1999, NAT CELL BIOL, V1, pE183
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004
   Montaner LJ, 1999, J IMMUNOL, V162, P4606
   Murphy R F, 1991, Trends Cell Biol, V1, P77, DOI 10.1016/0962-8924(91)90022-2
   Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592
   Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Pieters J, 2003, SCIENCE, V302, P1900, DOI 10.1126/science.1092873
   POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0
   Pym AS, 2003, NAT MED, V9, P533, DOI 10.1038/nm859
   Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016
   Raiborg C, 2002, CELL STRUCT FUNCT, V27, P403, DOI 10.1247/csf.27.403
   Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791
   Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066
   Schaible UE, 1998, J IMMUNOL, V160, P1290
   Schorey JS, 2003, CELL MICROBIOL, V5, P133, DOI 10.1046/j.1462-5822.2003.00263.x
   Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x
   Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100
   STOUT RD, 1993, CURR OPIN IMMUNOL, V5, P398, DOI 10.1016/0952-7915(93)90059-2
   SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   TAKIZAWA N, 1985, APPL ENVIRON MICROB, V49, P294, DOI 10.1128/AEM.49.2.294-298.1985
   Thanabalu T, 1998, EMBO J, V17, P6487, DOI 10.1093/emboj/17.22.6487
   VANPITTIUS NCG, 1921, GENOME BIOL, V2
   Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6
   Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Via LE, 1998, J CELL SCI, V111, P897
   Vieira OV, 2004, MOL CELL BIOL, V24, P4593, DOI 10.1128/MCB.24.10.4593-4604.2004
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129
   Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004
   Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271
NR 85
TC 124
Z9 129
U1 1
U2 14
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0962-8924
EI 1879-3088
J9 TRENDS CELL BIOL
JI Trends Cell Biol.
PD MAY
PY 2005
VL 15
IS 5
BP 269
EP 276
DI 10.1016/j.tcb.2005.03.009
PG 8
WC Cell Biology
SC Cell Biology
GA 932JK
UT WOS:000229549800008
PM 15866031
DA 2021-01-25
ER

PT J
AU Kajava, AV
   Aebi, U
   Steven, AC
AF Kajava, AV
   Aebi, U
   Steven, AC
TI The parallel superpleated beta-structure as a model for amyloid fibrils
   of human amylin
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE atomic structure; diabetes mellitus; islet amyloid; fibrils
ID SOLID-STATE NMR; DIABETES-MELLITUS; IN-VITRO; CRYSTAL-STRUCTURE; HUMAN
   CALCITONIN; VIRULENCE FACTOR; FULL-LENGTH; POLYPEPTIDE; FIBRILLOGENESIS;
   IDENTIFICATION
AB Human amylin is a 37 amino acid residue peptide hormone whose fibrillogenesis has been correlated with type 2 diabetes. These fibrils are rope-like bundles of several 5 nm diameter protofilaments. Here, we propose, as a model for the protofilament, a variant of the parallel superpleated beta-structure previously derived for amyloid filaments of the yeast prion Ure2p. In the amylin model, individual polypeptides from residues 9 to 37 have a planar S-shaped fold with three beta-strands. These serpentines are stacked in register, with a 0.47 nm axial rise and a small rotational twist per step, generating an array of three parallel P-sheets in cross-beta conformation. The interior, the two "bays" sandwiched between adjacent sheets, are occupied by non-polar and by polar/uncharged residues that are predicted to form H-bonded ladders, similar to those found in P-helical proteins. The N-terminal peptide containing a disulfide bond occupies an extraneous peripheral position in the protofilament. The left-handed twist of the beta-sheets is shown to underlie left-handed coiling of amylin protofilaments in fibrils. The model is consistent with current biophysical, biochemical and genetic data and, in particular, affords a plausible explanation for why rodent amylin does not form fibrils. (c) 2005 Elsevier Ltd. All rights reserved.
C1 CNRS, FRE 2593, Ctr Rech Biochim Macromol, F-34293 Montpellier, France.
   Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   NIAMSD, Struct Biol Lab, NIH, Bethesda, MD 20892 USA.
RP Kajava, AV (corresponding author), CNRS, FRE 2593, Ctr Rech Biochim Macromol, 1919 Route Mende, F-34293 Montpellier, France.
EM andrey.kajava@crbm.cnrs.fr
RI Kajava, Andrey V/E-1107-2014
OI Kajava, Andrey V/0000-0002-2342-6886
CR Andreotti G, 2004, J BIOL CHEM, V279, P6364, DOI 10.1074/jbc.M310882200
   Anguiano M, 2002, BIOCHEMISTRY-US, V41, P11338, DOI 10.1021/bi020314u
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Balbach JJ, 2000, BIOCHEMISTRY-US, V39, P13748, DOI 10.1021/bi0011330
   BAUER HH, 1995, J STRUCT BIOL, V115, P1, DOI 10.1006/jsbi.1995.1024
   CHARGE SBP, 1995, BIOCHEMISTRY-US, V34, P14588, DOI 10.1021/bi00044a038
   DAYRINGER HE, 1986, J MOL GRAPHICS, V4, P82
   DEKONING EJP, 1993, DIABETOLOGIA, V36, P378, DOI 10.1007/BF00402271
   Emsley P, 1996, NATURE, V381, P90, DOI 10.1038/381090a0
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury C, 1999, J MOL BIOL, V285, P33, DOI 10.1006/jmbi.1998.2299
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   Green J, 2003, J MOL BIOL, V326, P1147, DOI 10.1016/S0022-2836(02)01377-3
   Green JD, 2004, J BIOL CHEM, V279, P12206, DOI 10.1074/jbc.M312452200
   GRIFFITHS JM, 1995, J AM CHEM SOC, V117, P3539, DOI 10.1021/ja00117a023
   Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3
   Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593
   Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200
   Johansson K, 2002, FEBS LETT, V514, P243, DOI 10.1016/S0014-5793(02)02372-4
   Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101
   Kayed R, 1999, J MOL BIOL, V287, P781, DOI 10.1006/jmbi.1999.2646
   King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P282
   Leckstrom A, 1997, BIOCHEM BIOPH RES CO, V239, P265, DOI 10.1006/bbrc.1997.7465
   Lee SH, 2001, J CERAM PROCESS RES, V2, P54
   Makin OS, 2004, J MOL BIOL, V335, P1279, DOI 10.1016/j.jmb.2003.11.048
   Naito A, 2004, MAGN RESON CHEM, V42, P247, DOI 10.1002/mrc.1323
   Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286
   Opie EL, 1901, J EXP MED, V5, P527, DOI 10.1084/jem.5.5.527
   Padrick SB, 2001, J MOL BIOL, V308, P783, DOI 10.1006/jmbi.2001.4608
   PAULING L, 1953, PROC R SOC SER B-BIO, V141, P21, DOI 10.1098/rspb.1953.0012
   STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158
   WESTERMARK P, 1978, DIABETOLOGIA, V15, P417, DOI 10.1007/BF01219652
   WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036
   Wimalawansa SJ, 1997, CRIT REV NEUROBIOL, V11, P167, DOI 10.1615/CritRevNeurobiol.v11.i2-3.40
   YANO BL, 1981, LAB INVEST, V45, P149
   YODER MD, 1993, SCIENCE, V260, P1503, DOI 10.1126/science.8502994
NR 37
TC 148
Z9 149
U1 0
U2 14
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD APR 29
PY 2005
VL 348
IS 2
BP 247
EP 252
DI 10.1016/j.jmb.2005.02.029
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 916UD
UT WOS:000228410800001
PM 15811365
DA 2021-01-25
ER

PT J
AU Zaric, B
   Chami, M
   Remigy, H
   Engel, A
   Ballmer-Hofer, K
   Winkler, FK
   Kambach, C
AF Zaric, B
   Chami, M
   Remigy, H
   Engel, A
   Ballmer-Hofer, K
   Winkler, FK
   Kambach, C
TI Reconstitution of two recombinant LSm protein complexes reveals aspects
   of their architecture, assembly, and function
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID SM-LIKE PROTEINS; SNRNP CORE; U7 SNRNPS; ELECTRON-MICROSCOPY;
   CRYSTAL-STRUCTURES; RNA DEGRADATION; YEAST; HFQ; ASSOCIATION; STABILITY
AB Sm and Sm-like (LSm) proteins form complexes engaging in various RNA-processing events. Composition and architecture of the complexes determine their intracellular distribution, RNA targets, and function. We have reconstituted the human LSm1-7 and LSm2-8 complexes from their constituent components in vitro. Based on the assembly pathway of the canonical Sm core domain, we used heterodimeric and heterotrimeric sub-complexes to assemble LSm1-7 and LSm2-8. Isolated sub-complexes form ring-like higher order structures. LSm1-7 is assembled and stable in the absence of RNA. LSm1-7 forms ring-like structures very similar to LSm2-8 at the EM level. Our in vitro reconstitution results illustrate likely features of the LSm complex assembly pathway. We prove the complexes to be functional both in an RNA bandshift and an in vivo cellular transport assay.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
RP Kambach, C (corresponding author), Paul Scherrer Inst, OFLC 110, CH-5232 Villigen, Switzerland.
EM christian.kambach@psi.ch
RI Zaric, Bozidarka/Y-9475-2019
OI Zaric, Bozidarka/0000-0003-4244-3283; Ballmer-Hofer,
   Kurt/0000-0002-3800-9129
CR Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789
   Albrecht M, 2004, FEBS LETT, V569, P18, DOI 10.1016/j.febslet.2004.03.126
   Anantharaman V, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-45
   Antson AA, 1996, CURR OPIN STRUC BIOL, V6, P142, DOI 10.1016/S0959-440X(96)80067-4
   BLUMENTHAL T, 1995, TRENDS GENET, V11, P132, DOI 10.1016/S0168-9525(00)89026-5
   BOELENS WC, 1995, RNA, V1, P273
   Bouveret E, 2000, EMBO J, V19, P1661, DOI 10.1093/emboj/19.7.1661
   Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X
   Cougot N, 2004, J CELL BIOL, V165, P31, DOI 10.1083/jcb.200309008
   Donahue WF, 2002, MOL CELL, V9, P7, DOI 10.1016/S1097-2765(02)00429-X
   Eystathioy T, 2003, RNA, V9, P1171, DOI 10.1261/rna.5810203
   Eystathioy T, 2002, ARTHRITIS RHEUM, V46, P726, DOI 10.1002/art.10220
   Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1
   Fromont-Racine M, 2000, YEAST, V17, P95, DOI 10.1002/1097-0061(20000630)17:2<95::AID-YEA16>3.0.CO;2-H
   Ingelfinger D, 2002, RNA, V8, P1489, DOI 10.1017/S1355838202021726
   Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5
   Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4
   KASTNER B, 1990, P NATL ACAD SCI USA, V87, P1710, DOI 10.1073/pnas.87.5.1710
   Kufel J, 2003, NUCLEIC ACIDS RES, V31, P6788, DOI 10.1093/nar/gkg904
   Kufel J, 2003, J BIOL CHEM, V278, P2147, DOI 10.1074/jbc.M208856200
   Kufel J, 2002, MOL CELL BIOL, V22, P5248, DOI 10.1128/MCB.22.14.5248-5256.2002
   Lange TS, 2000, MOL BIOL CELL, V11, P2419, DOI 10.1091/mbc.11.7.2419
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321
   Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1
   Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1
   Mura C, 2001, P NATL ACAD SCI USA, V98, P5532, DOI 10.1073/pnas.091102298
   NILSEN TW, 1995, MOL BIOCHEM PARASIT, V73, P1, DOI 10.1016/0166-6851(94)00107-X
   Pannone BK, 2000, CURR BIOL, V10, pR478, DOI 10.1016/S0960-9822(00)00552-2
   Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403
   Pillai RS, 2001, EMBO J, V20, P5470, DOI 10.1093/emboj/20.19.5470
   Plessel G, 1997, J MOL BIOL, V265, P87, DOI 10.1006/jmbi.1996.0713
   Raker VA, 1999, MOL CELL BIOL, V19, P6554
   Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x
   Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451
   Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322
   Seto AG, 1999, NATURE, V401, P177
   Stanek D, 2003, J CELL BIOL, V160, P505, DOI 10.1083/jcb.200210087
   Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102
   STEFANOVIC B, 1995, NUCLEIC ACIDS RES, V23, P3141, DOI 10.1093/nar/23.16.3141
   SUMPTER V, 1992, MOL BIOL REP, V16, P229, DOI 10.1007/BF00419662
   Tharun S, 2000, NATURE, V404, P515, DOI 10.1038/35006676
   Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200
   Tomasevic N, 2002, MOL CELL BIOL, V22, P4101, DOI 10.1128/MCB.22.12.4101-4112.2002
   Toro I, 2001, EMBO J, V20, P2293, DOI 10.1093/emboj/20.9.2293
   Urlaub H, 2001, EMBO J, V20, P187, DOI 10.1093/emboj/20.1.187
   Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x
   van Dijk E, 2002, EMBO J, V21, P6915, DOI 10.1093/emboj/cdf678
   VANKAN P, 1990, EMBO J, V9, P3397, DOI 10.1002/j.1460-2075.1990.tb07541.x
   Vivona JB, 2003, FEBS LETT, V546, P167, DOI 10.1016/S0014-5793(03)00622-7
   Walke S, 2001, J MOL BIOL, V308, P49, DOI 10.1006/jmbi.2001.4549
   Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8
   YONEDA Y, 1987, EXP CELL RES, V173, P586, DOI 10.1016/0014-4827(87)90297-7
   Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3
NR 54
TC 54
Z9 56
U1 0
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD APR 22
PY 2005
VL 280
IS 16
BP 16066
EP 16075
DI 10.1074/jbc.M414481200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 917GO
UT WOS:000228444800074
PM 15711010
OA Other Gold
DA 2021-01-25
ER

PT J
AU Ruegg, MA
AF Ruegg, MA
TI Organization of synaptic myonuclei by Syne proteins and their role
   during the formation of the nerve-muscle synapse
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Editorial Material
ID NEUROMUSCULAR-JUNCTION; POSTSYNAPTIC DIFFERENTIATION; NUCLEI;
   TRANSCRIPTION; BRAIN; AGRIN
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Briguet A, 2000, J NEUROSCI, V20, P5989, DOI 10.1523/JNEUROSCI.20-16-05989.2000
   Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5
   Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025
   Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101
   FATT P, 1950, NATURE, V166, P597, DOI 10.1038/166597a0
   Gough LL, 2003, MOL BIOL CELL, V14, P2410, DOI 10.1091/mbc.E02-07-0446
   Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Mislow JMK, 2002, J CELL SCI, V115, P61
   Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097
   NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0
   RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5
   Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557
   Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1
   Starr DA, 2003, J CELL SCI, V116, P211, DOI 10.1242/jcs.00248
   Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119
   Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131
NR 21
TC 11
Z9 13
U1 0
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 19
PY 2005
VL 102
IS 16
BP 5643
EP 5644
DI 10.1073/pnas.0501516102
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 918RL
UT WOS:000228565200003
PM 15827115
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Stettler, H
   Suri, G
   Spiess, M
AF Stettler, H
   Suri, G
   Spiess, M
TI Proprotein convertase PC3 is not a transmembrane protein
SO BIOCHEMISTRY
LA English
DT Article
ID REGULATED SECRETORY PATHWAY; PROHORMONE SORTING RECEPTOR;
   CARBOXYPEPTIDASE-E; ENDOPLASMIC-RETICULUM; SIGNAL SEQUENCE; RAFT
   ASSOCIATION; PRION PROTEIN; MEMBRANE; RESIDUES; KINASE
AB Proprotein convertase PC3 (also known as PC1) is an endopeptidase involved in proteolytic processing of peptide hormone precursors in granules of the regulated secretory pathway of endocrine cells. Lacking any extended hydrophobic segments, PC3 was considered to be a secretory protein only peripherally attached to the granule membrane. Recently, evidence has been presented that PC3 is a transmembrane protein with a 115-residue cytoplasmic domain and a membrane-spanning segment containing eight charged amino acids [Arnaoutova, I., et al. (2003) Biochemistry 42, 10445-10455]. Here, we analyzed the membrane topology of PO and of a PO construct containing a conventional transmembrane segment of 19 leucines. Alkaline extraction was performed to assess membrane integration. Exposure to the cytosol or to the ER lumen was tested by addition of C-terminal tags for phosphorylation or glycosylation, respectively. Protease sensitivity was assayed in permeabilized cells. The results show that the C-terminus of PC3 is translocated across the endoplasmic reticulum membrane. Furthermore, the proposed transmembrane segment of PC3 and a similar one of carboxypeptidase E did not stop polypeptide translocation when inserted into a stop-transfer tester construct. PC3 is thus not a transmembrane protein. These results have implications for the mechanism of granule sorting of PO as well as for the topology of PC2 and carboxypeptidase E, which have been reported to span the lipid membrane by homologous charged sequences.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
CR Arnaoutova I, 2003, MOL BIOL CELL, V14, P4448, DOI 10.1091/mbc.E02-11-0758
   Arnaoutova I, 2003, BIOCHEMISTRY-US, V42, P10445, DOI 10.1021/bi034277y
   Assadi M, 2004, BIOCHEMISTRY-US, V43, P7798, DOI 10.1021/bi036331g
   Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200
   Blazquez M, 2000, BIOCHEM J, V349, P843, DOI 10.1042/bj3490843
   Blazquez M, 2001, J MOL ENDOCRINOL, V27, P107, DOI 10.1677/jme.0.0270107
   BONIFACINO JS, 1991, EMBO J, V10, P2783, DOI 10.1002/j.1460-2075.1991.tb07827.x
   Boudreault A, 1998, PROTEIN EXPRES PURIF, V14, P353, DOI 10.1006/prep.1998.0964
   Cool DR, 1997, CELL, V88, P73, DOI 10.1016/S0092-8674(00)81860-7
   COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0
   Dhanvantari S, 2000, J BIOL CHEM, V275, P29887, DOI 10.1074/jbc.M005364200
   Dhanvantari S, 2002, BIOCHEMISTRY-US, V41, P52, DOI 10.1021/bi015698n
   ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5
   FRICKER LD, 1988, J CELL BIOCHEM, V38, P279, DOI 10.1002/jcb.240380407
   FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521
   FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   Goder V, 2000, EMBO J, V19, P6704, DOI 10.1093/emboj/19.24.6704
   Hegde RS, 2003, TRENDS NEUROSCI, V26, P337, DOI 10.1016/S0166-2236(03)00143-7
   Hegde RS, 1998, SCIENCE, V279, P827, DOI 10.1126/science.279.5352.827
   HJELMQUIST G, 1974, BIOCHEM BIOPH RES CO, V61, P559, DOI 10.1016/0006-291X(74)90993-0
   Irminger JC, 1997, J BIOL CHEM, V272, P27532, DOI 10.1074/jbc.272.44.27532
   KEMP BE, 1977, J BIOL CHEM, V252, P4888
   KUROIWA T, 1991, J BIOL CHEM, V266, P9251
   LANDOLTMARTICORENA C, 1993, J MOL BIOL, V229, P602, DOI 10.1006/jmbi.1993.1066
   REITHMEIER RAF, 1992, STRUCTURE BIOL MEMBR, P337
   SPIESS M, 1989, J BIOL CHEM, V264, P19117
   SPIESS M, 1986, CELL, V44, P177, DOI 10.1016/0092-8674(86)90496-4
   Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1
   Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
   WESSELS HP, 1988, CELL, V55, P61, DOI 10.1016/0092-8674(88)90009-8
   WESSELS HP, 1991, METHOD CELL BIOL, V34, P287
   Zhou A, 1999, J BIOL CHEM, V274, P20745, DOI 10.1074/jbc.274.30.20745
   ZHOU A, 1995, J BIOL CHEM, V270, P21509, DOI 10.1074/jbc.270.37.21509
NR 35
TC 6
Z9 6
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 12
PY 2005
VL 44
IS 14
BP 5339
EP 5345
DI 10.1021/bi047430c
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 914UC
UT WOS:000228252300007
PM 15807527
DA 2021-01-25
ER

PT J
AU Philippsen, A
   Schirmer, T
   Stein, MA
   Giffhorn, F
   Stetefeld, J
AF Philippsen, A
   Schirmer, T
   Stein, MA
   Giffhorn, F
   Stetefeld, J
TI Structure of zinc-independent sorbitol dehydrogenase from Rhodobacter
   sphaeroides at 2.4 angstrom resolution
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID PROTEIN MODELS; RECOGNITION
AB Recombinant sorbitol dehydrogenase (SDH) from Rhodobacter sphaeroides has been crystallized in the absence of the cofactor NAD(H) and its structure determined to 2.4 angstrom resolution using molecular replacement (refined R and R-free factors of 18.8 and 23.8%, respectively). As expected from the sequence and shown by the conserved fold, SDH can be assigned to the short-chain dehydrogenase/reductase protein family. The cofactor NAD and the substrate sorbitol have been modelled into the structure and the active-site architecture, which displays the highly conserved catalytic tetrad of Asn-Ser-Tyr-Lys residues, is discussed in relation to the enzyme mechanism. This is the first structure of a bacterial SDH belonging to the SDR family.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   Univ Saarland, Lehrstuhl Angew Mikrobiol, D-66123 Saarbrucken, Germany.
   Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Philippsen, A (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM ansgar.philippsen@unibas.ch
RI Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Beutler H. O., 1984, METHOD ENZYMAT AN, P484
   BEUTLER HO, 1984, METHOD ENZYMAT AN, V6, P356
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Laskowski RA, 1998, CURR OPIN STRUC BIOL, V8, P631, DOI 10.1016/S0959-440X(98)80156-5
   Lesk AM, 1995, CURR OPIN STRUC BIOL, V5, P775, DOI 10.1016/0959-440X(95)80010-7
   Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422
   Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3
   Otagiri M, 2001, J BIOCHEM, V129, P205, DOI 10.1093/oxfordjournals.jbchem.a002845
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   SCHAUDER S, 1995, MICROBIOL-UK, V141, P1857, DOI 10.1099/13500872-141-8-1857
   Silveira MM, 2002, APPL MICROBIOL BIOT, V59, P400, DOI 10.1007/s00253-002-1046-0
   Stein MA, 1997, J BACTERIOL, V179, P6335, DOI 10.1128/jb.179.20.6335-6340.1997
   Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d
NR 22
TC 27
Z9 28
U1 0
U2 3
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD APR
PY 2005
VL 61
BP 374
EP 379
DI 10.1107/S0907444904034390
PN 4
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 909NW
UT WOS:000227867600003
PM 15805591
DA 2021-01-25
ER

PT J
AU Ozbek, S
   Muller, JF
   Figgemeier, E
   Stetefeld, J
AF Ozbek, S
   Muller, JF
   Figgemeier, E
   Stetefeld, J
TI Favourable mediation of crystal contacts by cocoamidopropylbetaine
   (CAPB)
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID PROTEIN; TETRABRACHION
AB Crystals of excellent quality are a prerequisite for high-resolution X-ray data. However, in refinement protocols of crystallization conditions it is often difficult to obtain the right combination of, for example, protein concentration, drop size, temperature and additives. A novel approach for optimizing crystal contacts in a most favourable fashion by performing crystallization setups with the zwitterionic surfactant cocoamidoproylbetaine (CAPB) is introduced. In the presence of this surfactant, highly diffracting crystals were obtained. Here, data from a right-handed coiled coil (RHCC) in complex with CAPB at 1.4 angstrom resolution are presented. The addition of CAPB using otherwise identical crystallization conditions and the same X-ray source caused an improvement in resolution from 2.9 to 1.4 angstrom.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   Uppsala Univ, Dept Phys Chem, S-75123 Uppsala, Sweden.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joerg.stetefeld@unibas.ch
RI Ozbek, Suat/D-3701-2014; Stetefeld, Joerg/H-7630-2017
OI Stetefeld, Joerg/0000-0003-1478-3248; Ozbek, Suat/0000-0003-2569-3942
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   Harrison SC, 2004, NAT STRUCT MOL BIOL, V11, P12, DOI 10.1038/nsmb0104-12
   Herlofson BB, 1996, J CLIN PERIODONTOL, V23, P567, DOI 10.1111/j.1600-051X.1996.tb01826.x
   LESLIE AGW, 1994, MOSFLM USER GUIDE
   PETERS J, 1995, J MOL BIOL, V245, P385, DOI 10.1006/jmbi.1994.0032
   Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   TURK D, 1992, THESIS TU MUNCHEN MU
   VUILLARD L, 1994, FEBS LETT, V353, P294, DOI 10.1016/0014-5793(94)01060-9
NR 11
TC 13
Z9 13
U1 1
U2 2
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD APR
PY 2005
VL 61
BP 477
EP 480
DI 10.1107/S0907444905001204
PN 4
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 909NW
UT WOS:000227867600016
PM 15805603
DA 2021-01-25
ER

PT J
AU Martin, DE
   Hall, MN
AF Martin, DE
   Hall, MN
TI The expanding TOR signaling network
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Review
ID TUBEROUS SCLEROSIS COMPLEX; RNA-POLYMERASE-I; TUMOR-SUPPRESSOR PROTEINS;
   CELL-GROWTH; LIFE-SPAN; MAMMALIAN TARGET; SACCHAROMYCES-CEREVISIAE;
   GENE-EXPRESSION; C-ELEGANS; 3-KINASE/AKT PATHWAY
AB Cell growth (increase in cell mass or size) is tightly coupled to nutrient availability, growth factors and the energy status of the cell. The target of rapamycin (TOR) integrates all three inputs to control cell growth. The discovery of upstream regulators of TOR (AMPK, the TSC1-TSC2 complex and Rheb) has provided new insights into the mechanism by which TOR integrates its various inputs. A recent finding in flies reveals that TOR controls not only growth of the cell in which it resides (cell-autonomous growth) but also the growth of distant cells, thereby determining organ and organism size in addition to the size of isolated cells. In yeast and mammals, the identification of two structurally and functionally distinct multiprotein TOR complexes (TORC1 and TORC2) has provided a molecular basis for the complexity of TOR signaling. Furthermore, TOR has emerged as a regulator of growth-related processes such as development, aging and the response to hypoxia. Thus, TOR is part of an intra- and inter-cellular signaling network with a remarkably broad role in eukaryotic biology.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
OI Hall, Michael N/0000-0002-2998-0757
CR Arsham AM, 2003, J BIOL CHEM, V278, P29655, DOI 10.1074/jbc.M212770200
   Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028
   Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804
   Carter CS, 2002, TRENDS GENET, V18, P295, DOI 10.1016/S0168-9525(02)02696-3
   Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200
   Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X
   Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104
   Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200
   Dong JX, 2004, GENE DEV, V18, P2479, DOI 10.1101/gad.1240504
   Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Gao XS, 2002, NAT CELL BIOL, V4, P699, DOI 10.1038/ncb847
   Gao XS, 2001, GENE DEV, V15, P1383, DOI 10.1101/gad.901101
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Giannakou ME, 2004, TRENDS CELL BIOL, V14, P408, DOI 10.1016/j.tcb.2004.07.006
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Huang S, 2003, CURR OPIN PHARMACOL, V3, P371, DOI 10.1016/S1471-4892(03)00071-7
   Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Ito N, 1999, CELL, V96, P529, DOI 10.1016/S0092-8674(00)80657-1
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Jorgensen Paul, 2004, VVolume 42, P329
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x
   Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x
   Li Y, 2004, TRENDS BIOCHEM SCI, V29, P32, DOI 10.1016/j.tibs.2003.11.007
   Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Loewith Robbie, 2004, VVolume 42, P139
   Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161
   Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3
   Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003
   Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101
   Martin DE, 2004, CELL, V119, P969, DOI 10.1016/j.cell.2004.11.047
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   Pan DJ, 2004, TRENDS CELL BIOL, V14, P78, DOI 10.1016/j.tcb.2003.12.006
   Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473
   Potter CJ, 2002, NAT CELL BIOL, V4, P658, DOI 10.1038/ncb840
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Radimerski T, 2002, GENE DEV, V16, P2627, DOI 10.1101/gad.239102
   Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3
   Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704
   Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Saucedo LJ, 2003, NAT CELL BIOL, V5, P566, DOI 10.1038/ncb996
   Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995
   Tapon N, 2001, CELL, V105, P345, DOI 10.1016/S0092-8674(01)00332-4
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Tee AR, 2002, P NATL ACAD SCI USA, V99, P13571, DOI 10.1073/pnas.202476899
   Tee AR, 2003, J BIOL CHEM, V278, P37288, DOI 10.1074/jbc.M303257200
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Wade JT, 2004, NATURE, V432, P1054, DOI 10.1038/nature03175
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999
NR 77
TC 400
Z9 424
U1 0
U2 31
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD APR
PY 2005
VL 17
IS 2
BP 158
EP 166
DI 10.1016/j.ceb.2005.02.008
PG 9
WC Cell Biology
SC Cell Biology
GA 914GI
UT WOS:000228215400010
PM 15780592
DA 2021-01-25
ER

PT J
AU Ebner, A
   Cabernard, C
   Affolter, M
   Merabet, S
AF Ebner, A
   Cabernard, C
   Affolter, M
   Merabet, S
TI Recognition of distinct target sites by a unique
   Labial/Extradenticle/Homothorax complex
SO DEVELOPMENT
LA English
DT Article
DE transcription; enhancer; Hox proteins; binding selectivity; gene
   regulation
ID HOX RESPONSE ELEMENT; HOMEOTIC GENE; BINDING-SITES; DROSOPHILA;
   EXTRADENTICLE; SPECIFICITY; PROTEIN; DNA; EXPRESSION; ULTRABITHORAX
AB Hox genes encode evolutionarily conserved transcriptional regulators, which define regional identities along the anteroposterior axis of multicellular animals. In Drosophila, Hox proteins bind to target DNA sequences in association with the Extradenticle (Exd) and Homothorax (Hth) co-factors. The current model of Hox-binding selectivity proposes that the nucleotide sequence identity defines the Hox protein engaged in the trimeric complex, implying that distinct Hox/Exd/Hth complexes select different binding sites and that a given Hox/Exd/Hth complex recognizes a consensus DNA sequence. Here, we report that the regulation of a newly identified Lab target gene does not rely on the previously established consensus Lab/Exd/Hth-binding site, but on a strongly divergent sequence. Thus Lab, and most probably other Hox proteins, selects different DNA sequences in regulating downstream target genes. These observations have implications with regard to the current model of Hox-binding selectivity.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Kingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; merabet@ibdm.univ-mrs.fr
RI Cabernard, Clemens/A-9033-2010
OI Affolter, Markus/0000-0002-5171-0016; Cabernard,
   Clemens/0000-0003-3706-6401
CR CAPOVILLA M, 1994, CELL, V76, P461, DOI 10.1016/0092-8674(94)90111-2
   CELNIKER SE, 1989, GENE DEV, V3, P1424, DOI 10.1101/gad.3.9.1424
   Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x
   Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223
   Chan SK, 1997, DEVELOPMENT, V124, P2007
   CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8
   Chang CP, 1996, MOL CELL BIOL, V16, P1734
   CRIBBS DL, 1992, EMBO J, V11, P1437, DOI 10.1002/j.1460-2075.1992.tb05188.x
   DIEDERICH RJ, 1989, GENE DEV, V3, P399, DOI 10.1101/gad.3.3.399
   Galant R, 2002, DEVELOPMENT, V129, P3115
   Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717
   Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   Grienenberger A, 2003, DEVELOPMENT, V130, P5445, DOI 10.1242/dev.00760
   HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W
   Hirth F, 2001, DEVELOPMENT, V128, P4781
   IMMERGLUCK K, 1990, CELL, V62, P261, DOI 10.1016/0092-8674(90)90364-K
   LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x
   Li XL, 1999, DEVELOPMENT, V126, P5581
   LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071
   MANN RS, 1995, BIOESSAYS, V17, P855, DOI 10.1002/bies.950171007
   Marty T, 2001, DEVELOPMENT, V128, P2833
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6
   Pai CY, 1998, GENE DEV, V12, P435, DOI 10.1101/gad.12.3.435
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209
   Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5
   POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X
   RAUSKOLB C, 1993, CELL, V74, P1101, DOI 10.1016/0092-8674(93)90731-5
   Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6
   Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716
   Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   SCHNEUWLY S, 1987, EMBO J, V6, P201, DOI 10.1002/j.1460-2075.1987.tb04739.x
   Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544
   TREMML G, 1992, DEVELOPMENT, V116, P447
NR 38
TC 37
Z9 37
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR
PY 2005
VL 132
IS 7
BP 1591
EP 1600
DI 10.1242/dev.01721
PG 10
WC Developmental Biology
SC Developmental Biology
GA 919BI
UT WOS:000228592900010
PM 15753213
OA Bronze
DA 2021-01-25
ER

PT J
AU Blanco, J
   Girard, F
   Kamachi, Y
   Kondoh, H
   Gehring, WJ
AF Blanco, J
   Girard, F
   Kamachi, Y
   Kondoh, H
   Gehring, WJ
TI Functional analysis of the chicken delta 1-crystallin enhancer activity
   in Drosophila reveals remarkable evolutionary conservation between
   chicken and fly
SO DEVELOPMENT
LA English
DT Article
DE crystallin; enhancer conservation; Pax6; Pax2; Sox2; SoxN; Drosophila
ID LENS DEVELOPMENT; EYE DEVELOPMENT; EYELESS GENE; SOX GENE; HEAD
   DEVELOPMENT; CRYSTALLIN GENE; CNS DEVELOPMENT; DNA-BINDING; CELL FATES;
   FISH-HOOK
AB Functional conservation of enhancers among evolutionarily diverged organisms is a powerful way to identify basic regulatory circuits and key developmental regulators. This is especially applicable to Crystallin genes. Despite unexpected heterogeneity and diversity in their DNA sequences, many studies have revealed that most of the Crystallin genes are regulated by a relatively small set of developmentally important transcription factors. The chicken delta 1-crystallin is one of the best-characterized Crystallin genes. Its lens-specific regulation is governed by a 30 bp long DC5 fragment present in the third intron of the gene. DC5 contains PAX6 and SOX2 binding sites, and its activity depends on the cooperative binding of these two transcription factors. To test the idea that Pax6 and Sox2, together with the DC5 enhancer, could form a basic regulatory circuit functional in distantly related animals, we introduced the DC5 fragment into Drosophila and studied its activation pattern and regulation. The results show that the DC5 enhancer is not only active in the compound eye but, remarkably, is specifically active in those cells responsible for Crystallin secretion in Drosophila, i.e. the cone cells. However, regulation of the DC5 enhancer is carried out not by Pax6, but by Pax2 (D-Pax2; shaven - FlyBase) in combination with the Sox2 homologue SoxN. Both proteins (D-PAX2 and SOXN) bind cooperatively to the DC5 fragment and activate the enhancer synergistically. As PAX6 and PAX2 proteins derive from the same ancestor, we propose that during evolution Pax6 function in vertebrate lens development was retained by Pax2 in Drosophila.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   CNRS, UPR 1142, Inst Human Genet, F-34396 Montpellier, France.
   Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Walter.Gehring@unibas.ch
RI Kamachi, Yusuke/C-9029-2009
OI Girard, Franck/0000-0003-2587-4495; Kamachi, Yusuke/0000-0001-5018-1119
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [16570173] Funding Source: KAKEN
CR Acampora D, 2000, GENE, V246, P23, DOI 10.1016/S0378-1119(00)00070-6
   Benassayag C, 2003, DEVELOPMENT, V130, P575, DOI 10.1242/dev.00226
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Cremazy F, 2000, MECH DEVELOP, V93, P215, DOI 10.1016/S0925-4773(00)00268-9
   Cremazy F, 2001, MECH DEVELOP, V109, P371, DOI 10.1016/S0925-4773(01)00529-9
   Cvekl A, 1996, BIOESSAYS, V18, P621, DOI 10.1002/bies.950180805
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   CZERNY T, 1995, MOL CELL BIOL, V15, P2858
   Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9
   FRASCH M, 1995, DEVELOPMENT, V121, P957
   Fu WM, 1997, GENE DEV, V11, P2066, DOI 10.1101/gad.11.16.2066
   Fu WM, 1998, DEVELOPMENT, V125, P2943
   Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1
   Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111
   Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170
   KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206
   Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1
   KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x
   Kamachi Y, 2001, GENE DEV, V15, P1272, DOI 10.1101/gad.887101
   KOMORI N, 1992, J CELL SCI, V102, P191
   Kondoh H, 2004, INT J DEV BIOL, V48, P819, DOI 10.1387/ijdb.041868hk
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Mukherjee A, 2000, DEV BIOL, V217, P91, DOI 10.1006/dbio.1999.9506
   Nambu PA, 1996, DEVELOPMENT, V122, P3467
   Newsome TP, 2000, DEVELOPMENT, V127, P851
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   Overton PM, 2002, DEVELOPMENT, V129, P4219
   PIATIGORSKY J, 1993, DEV DYNAM, V196, P267, DOI 10.1002/aja.1001960408
   Piatigorsky J, 2004, INT J DEV BIOL, V48, P719, DOI 10.1387/ijdb.041851jp
   Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Russell SRH, 1996, DEVELOPMENT, V122, P3669
   Ruvinsky I, 2003, DEVELOPMENT, V130, P5133, DOI 10.1242/dev.00711
   Sanchez-Soriano N, 2000, DEV BIOL, V220, P307, DOI 10.1006/dbio.2000.9648
   STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219
   Streit A, 2002, DEV BIOL, V242, P96, DOI 10.1006/dbio.2001.0544
   Tomarev SI, 1996, EUR J BIOCHEM, V235, P449, DOI 10.1111/j.1432-1033.1996.00449.x
   Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4
   WISTOW G, 1987, SCIENCE, V236, P1554, DOI 10.1126/science.3589669
   WISTOW G, 1998, ANNU REV BIOCHEM, V57, P479
   Wolff Tanya, 1993, P1277
   Xu PX, 1999, DEVELOPMENT, V126, P383
   XU T, 1993, DEVELOPMENT, V117, P1223
NR 50
TC 27
Z9 28
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD APR
PY 2005
VL 132
IS 8
BP 1895
EP 1905
DI 10.1242/dev.01738
PG 11
WC Developmental Biology
SC Developmental Biology
GA 926DO
UT WOS:000229103300014
PM 15790965
OA Bronze
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, W
TI Dual nature of the genome: Genes for the individual life and genes for
   the evolutionary progress of the population
SO IUBMB LIFE
LA English
DT Article
DE biological evolution; DNA acquisition; DNA rearrangement; evolution
   gene; genetic variation; natural selection; properties of matter
AB Biological evolution is here postulated to be driven coordinately by the products of specific evolution genes and by non-genetic elements such as the intrinsic properties of matter and random encounter with environmental factors. Evolution genes are supposed to have their own evolutionary history in which second-order selection was exerted at the population level. The products of evolution genes can act as generators of genetic variations and/or as modulators of the frequency of genetic variation. Three major natural strategies, each with a number of specific mechanisms contribute to the overall spontaneous production of genetic variants. Each of these three strategies contributes its own specific quality to genetic variation. The difficulties of experimentally investigating these strategies and a wider discussion of some of the postulates within the scientific community are outlined. Finally, the general relevance of the postulated duality of the genome for our world view is briefly mentioned.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Werner.Arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   Caporale L.H., 2003, DARWIN GENOME MOL ST
   CAPORALE LH, 1999, ANN NY ACAD SCI, V870
   Foster PL, 1998, GENETICS, V148, P1453
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
NR 6
TC 2
Z9 3
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1521-6543
EI 1521-6551
J9 IUBMB LIFE
JI IUBMB Life
PD APR-MAY
PY 2005
VL 57
IS 4-5
BP 263
EP 266
DI 10.1080/15216540500092625
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 940CD
UT WOS:000230120400026
PM 16036608
OA Bronze
DA 2021-01-25
ER

PT J
AU Speirs, C
   van Nimwegen, E
   Bolton, D
   Zavolan, M
   Duvall, M
   Angleman, S
   Siegel, R
   Perelson, AS
   Lenardo, MJ
AF Speirs, C
   van Nimwegen, E
   Bolton, D
   Zavolan, M
   Duvall, M
   Angleman, S
   Siegel, R
   Perelson, AS
   Lenardo, MJ
TI Analysis of human immunodeficiency virus cytopathicity by using a new
   method for quantitating viral dynamics in cell culture
SO JOURNAL OF VIROLOGY
LA English
DT Article
ID HIV-1 VPR; T-CELLS; COMBINATION THERAPY; IN-VIVO; INFECTION; APOPTOSIS;
   TYPE-1; PROTEIN; PATHOGENESIS; LYMPHOCYTES
AB Human immunodeficiency virus (HIV) causes complex metabolic changes in infected CD4(+) T cells that lead to cell cycle arrest and cell death by necrosis. To study the viral functions responsible for deleterious effects on the host cell, we quantitated the course of HIV type I infection in tissue cultures by using How cytometry for a virally encoded marker protein, heat-stable antigen (HSA). We found that HSA appeared on the surface of the target cells in two phases: passive acquisition due to association and fusion of virions with target cells, followed by active protein expression from transcription of the integrated provirus. The latter event was necessary for decreased target cell viability. We developed a general mathematical model of viral dynamics in vitro in terms of three effective time-dependent rates: those of cell proliferation, infection, and death. Using this model we show that the predominant contribution to the depletion of viable target cells results from direct cell death rather than cell cycle blockade. This allows us to derive accurate bounds on the time-dependent death rates of infected cells. We infer that the death rate of HIV-infected cells is 80 times greater than that of uninfected cells and that the elimination of the vpr protein reduces the death rate by half. Our approach provides a general method for estimating time-dependent death rates that can be applied to study the dynamics of other viruses.
C1 NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.
   Univ Basel, Div Bioinformat, Biozentrum, Basel, Switzerland.
   Los Alamos Natl Lab, Los Alamos, NM USA.
RP Lenardo, MJ (corresponding author), NIAID, Immunol Lab, NIH, Bldg 10,Room 11N311,10 Ctr Dr,MSC 1892, Bethesda, MD 20892 USA.
EM Lenardo@nih.gov
RI Zavolan, Mihaela/S-3888-2016; Siegel, Richard/C-7592-2009; Perelson,
   Alan S/Z-1959-2019
OI Siegel, Richard/0000-0001-5953-9893; Perelson, Alan
   S/0000-0002-2455-0002; Angleman, Sara/0000-0002-9520-5716; van Nimwegen,
   Erik/0000-0001-6338-1312; Zavolan, Mihaela/0000-0002-8832-2041
FU NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Center for Research Resources (NCRR) [R01RR006555, R01RR006555,
   R01RR006555, R01RR006555, R01RR006555, R01RR006555, R01RR006555,
   R01RR006555, R01RR006555, R01RR006555, R01RR006555, R01RR006555,
   R01RR006555, R01RR006555, R01RR006555, R01RR006555, R01RR006555,
   R01RR006555, R01RR006555, R01RR006555, R01RR006555] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [Z01AI000718, R01AI028433, R37AI028433, R37AI028433,
   R01AI028433, Z01AI000718, R01AI028433, R01AI028433, R37AI028433,
   R37AI028433, Z01AI000718, R01AI028433, R37AI028433, R01AI028433,
   Z01AI000718, Z01AI000718, Z01AI000718, Z01AI000718, R01AI028433,
   R37AI028433, Z01AI000718, Z01AI000718, Z01AI000718, R01AI028433,
   Z01AI000718, R01AI028433, R01AI028433, R01AI028433, Z01AI000718,
   Z01AI000718, R01AI028433, R37AI028433, R01AI028433, R37AI028433,
   R01AI028433, R37AI028433, R01AI028433, R01AI028433, R37AI028433,
   R01AI028433, R37AI028433, Z01AI000718] Funding Source: NIH RePORTER;
   NCRR NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [RR06555, R01 RR006555] Funding Source: Medline; NIAID
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R37 AI028433, AI28433, R01 AI028433]
   Funding Source: Medline
CR Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997
   AMEISEN JC, 1991, IMMUNOL TODAY, V12, P102
   Bartz SR, 1997, METHODS, V12, P337, DOI 10.1006/meth.1997.0487
   Bolton DL, 2002, J VIROL, V76, P5094, DOI 10.1128/JVI.76.10.5094-5107.2002
   Brenner C, 2003, J CLIN INVEST, V111, P1455, DOI 10.1172/JCI200318609
   Cao J, 1996, J VIROL, V70, P1340, DOI 10.1128/JVI.70.3.1340-1354.1996
   COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947
   Fauci A. S., 1997, P587
   FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274
   FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X
   Gaynor EM, 2001, EXP CELL RES, V267, P243, DOI 10.1006/excr.2001.5247
   HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995
   HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0
   KIM SY, 1989, J VIROL, V63, P3708, DOI 10.1128/JVI.63.9.3708-3713.1989
   KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992
   Lenardo MJ, 2002, J VIROL, V76, P5082, DOI 10.1128/JVI.76.10.5082-5093.2002
   LEVY JA, 1993, MICROBIOL REV, V57, P183, DOI 10.1128/MMBR.57.1.183-289.1993
   Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233
   Manning WC, 1998, J VIROL METHODS, V73, P31, DOI 10.1016/S0166-0934(98)00034-2
   MATLIN KS, 1982, J MOL BIOL, V156, P609, DOI 10.1016/0022-2836(82)90269-8
   McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648
   Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150
   Mohri H, 2001, J EXP MED, V194, P1277, DOI 10.1084/jem.194.9.1277
   MOSIER DE, 1995, NATURE, V375, P193
   Muthumani K, 2003, BIOCHEM BIOPH RES CO, V304, P583, DOI 10.1016/S0006-291X(03)00631-4
   Muthumani K, 2002, J BIOL CHEM, V277, P37820, DOI 10.1074/jbc.M205313200
   Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208
   PANTALEO G, 1993, NEW ENGL J MED, V328, P327, DOI 10.1056/NEJM199302043280508
   PANTALEO G, 1993, NATURE, V362, P355, DOI 10.1038/362355a0
   Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582
   Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0
   Piot P, 2001, NATURE, V410, P968, DOI 10.1038/35073639
   ROCANCOURT D, 1990, J VIROL, V64, P2600
   Roumier T, 2002, CELL DEATH DIFFER, V9, P1212, DOI 10.1038/sj.cdd.4401089
   Saifuddin M, 1998, J ACQ IMMUN DEF SYND, V17, P196, DOI 10.1097/00042560-199803010-00002
   Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699
   Stewart SA, 1999, P NATL ACAD SCI USA, V96, P12039, DOI 10.1073/pnas.96.21.12039
   WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0
   Yasuda J, 2001, VIROLOGY, V285, P181, DOI 10.1006/viro.2001.0964
NR 39
TC 15
Z9 15
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2005
VL 79
IS 7
BP 4025
EP 4032
DI 10.1128/JVI.79.7.4025-4032.2005
PG 8
WC Virology
SC Virology
GA 907UO
UT WOS:000227743700013
PM 15767404
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Vedrenne, C
   Klopfenstein, DR
   Hauri, HP
AF Vedrenne, C
   Klopfenstein, DR
   Hauri, HP
TI Phosphorylation controls CLIMP-63-mediated anchoring of the endoplasmic
   reticulum to microtubules
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GOLGI INTERMEDIATE COMPARTMENT; CYCLE-DEPENDENT PHOSPHORYLATION; LIVING
   CELLS; ORGANELLE TRANSPORT; FUNCTIONAL-ANALYSIS; ALZHEIMERS-DISEASE;
   MEMBRANE-PROTEIN; TAU-PROTEIN; CIS-GOLGI; IN-VITRO
AB The microtubule-binding 63-kDa cytoskeleton-linking membrane protein (CLIMP-63) is an integral membrane protein that links the endoplasmic reticulum (ER) to microtubules. Here, we tested whether this interaction is regulated by phosphorylation. Metabolic labeling with P-32 showed that CLIMP-63 is a phosphoprotein with increased phosphorylation during mitosis. CLIMP-63 of mitotic cells is unable to bind to microtubules in vitro. Mitotic phosphorylation can be prevented by mutation of serines 3, 17, and 19 in the cytoplasmic domain of CLIMP-63. When these residues are mutated to glutamic acid, and hence mimic mitotic phosphorylation, CLIMP-63 does no longer bind to microtubules in vitro. Overexpression of the phospho-mimicking mitotic form of CLIMP-63 in interphase cells leads to a collapse of the ER around the nucleus, leaving the microtubular network intact. The results suggest that CLIMP-63-mediated stable anchoring of the ER to microtubules is required to maintain the spatial distribution of the ER during interphase and that this interaction is abolished by phosphorylation of CLIMP-63 during mitosis.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
CR Alexa A, 2002, BIOCHEMISTRY-US, V41, P12427, DOI 10.1021/bi025916s
   ALLAN V, 1995, J CELL BIOL, V128, P879, DOI 10.1083/jcb.128.5.879
   Amano M, 2003, J NEUROCHEM, V87, P780, DOI 10.1046/j.1471-4159.2003.02054.x
   Bobinnec Y, 2003, CELL MOTIL CYTOSKEL, V54, P217, DOI 10.1002/cm.10094
   BRUGG B, 1991, J CELL BIOL, V114, P735, DOI 10.1083/jcb.114.4.735
   Bulinski JC, 1997, J CELL SCI, V110, P3055
   Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7
   Cho JH, 2003, J BIOL CHEM, V278, P187, DOI 10.1074/jbc.M206236200
   Choi JH, 2002, EMBO REP, V3, P988, DOI 10.1093/embo-reports/kvf197
   COLE NB, 1995, CURR OPIN CELL BIOL, V7, P55, DOI 10.1016/0955-0674(95)80045-X
   CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
   DAILEY ME, 1989, J NEUROSCI, V9, P1897
   Dirac-Svejstrup AB, 2000, J CELL BIOL, V150, P475, DOI 10.1083/jcb.150.3.475
   Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883
   DREWES G, 1995, J BIOL CHEM, V270, P2679
   Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777
   Ebneth A, 1999, CELL MOTIL CYTOSKEL, V44, P209, DOI 10.1002/(SICI)1097-0169(199911)44:3<209::AID-CM6>3.3.CO;2-W
   Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193
   Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030
   FEIGUIN F, 1994, J CELL BIOL, V127, P1021, DOI 10.1083/jcb.127.4.1021
   Galjart N, 2003, CURR OPIN CELL BIOL, V15, P48, DOI 10.1016/S0955-0674(02)00007-8
   Goodson HV, 1997, CURR OPIN CELL BIOL, V9, P18, DOI 10.1016/S0955-0674(97)80147-0
   Hamdane M, 2003, J BIOL CHEM, V278, P34026, DOI 10.1074/jbc.M302872200
   Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519
   Hoogenraad CC, 2000, J CELL SCI, V113, P2285
   Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495
   Illenberger S, 1996, J BIOL CHEM, V271, P10834, DOI 10.1074/jbc.271.18.10834
   Infante C, 1999, J CELL BIOL, V145, P83, DOI 10.1083/jcb.145.1.83
   Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0
   Kamal A, 2002, CURR OPIN CELL BIOL, V14, P63, DOI 10.1016/S0955-0674(01)00295-2
   Kitazawa H, 2000, CELL STRUCT FUNCT, V25, P33, DOI 10.1247/csf.25.33
   Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0
   Klopfenstein DR, 2001, J CELL BIOL, V153, P1287, DOI 10.1083/jcb.153.6.1287
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lane JD, 1999, MOL BIOL CELL, V10, P1909, DOI 10.1091/mbc.10.6.1909
   LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8
   LEE C, 1989, J CELL BIOL, V109, P2045, DOI 10.1083/jcb.109.5.2045
   Leger J, 1997, J BIOL CHEM, V272, P8441, DOI 10.1074/jbc.272.13.8441
   LOPEZ LA, 1995, J BIOL CHEM, V270, P12511, DOI 10.1074/jbc.270.21.12511
   MASSON D, 1995, J CELL BIOL, V131, P1015, DOI 10.1083/jcb.131.4.1015
   Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w
   OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849
   Ozer RS, 2000, MOL BIOL CELL, V11, P3573, DOI 10.1091/mbc.11.10.3573
   Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461
   Ramelot TA, 2001, J MOL BIOL, V307, P871, DOI 10.1006/jmbi.2001.4535
   RICKARD JE, 1991, J BIOL CHEM, V266, P17597
   SatoHarada R, 1996, CELL STRUCT FUNCT, V21, P283, DOI 10.1247/csf.21.283
   SCHWEIZER A, 1994, J CELL BIOL, V126, P25, DOI 10.1083/jcb.126.1.25
   SCHWEIZER A, 1991, J CELL BIOL, V113, P45, DOI 10.1083/jcb.113.1.45
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1993, J CELL SCI, V104, P685
   Shiina N, 1999, MOL BIOL CELL, V10, P597, DOI 10.1091/mbc.10.3.597
   SHIINA N, 1992, EMBO J, V11, P3977, DOI 10.1002/j.1460-2075.1992.tb05491.x
   TERASAKI M, 1994, CELL MOTIL CYTOSKEL, V29, P291, DOI 10.1002/cm.970290402
   TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557
   Terasaki M, 2000, MOL BIOL CELL, V11, P897, DOI 10.1091/mbc.11.3.897
   Trinczek B, 1999, J CELL SCI, V112, P2355
   Upadhyaya A, 2004, BIOPHYS J, V86, P2923, DOI 10.1016/S0006-3495(04)74343-X
   Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029
   Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923
   WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543
   Waterman-Storer CM, 1998, CURR BIOL, V8, P798, DOI 10.1016/S0960-9822(98)70321-5
   WatermanStorer CM, 1997, J CELL BIOL, V139, P417, DOI 10.1083/jcb.139.2.417
   Wedlich-Soldner R, 2002, MOL BIOL CELL, V13, P965, DOI 10.1091/mbc.01-10-0475
   Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199
NR 67
TC 79
Z9 80
U1 0
U2 5
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD APR
PY 2005
VL 16
IS 4
BP 1928
EP 1937
DI 10.1091/mbc.E04-07-0554
PG 10
WC Cell Biology
SC Cell Biology
GA 913QA
UT WOS:000228166700031
PM 15703217
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Agrain, C
   Callebaut, I
   Journet, L
   Sorg, I
   Paroz, C
   Mota, LJ
   Cornelis, GR
AF Agrain, C
   Callebaut, I
   Journet, L
   Sorg, I
   Paroz, C
   Mota, LJ
   Cornelis, GR
TI Characterization of a Type III secretion substrate specificity switch
   (T3S4) domain in YscP from Yersinia enterocolitica
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID HYDROPHOBIC CLUSTER-ANALYSIS; HOOK-LENGTH CONTROL;
   SALMONELLA-TYPHIMURIUM; FLAGELLAR HOOK; NEEDLE COMPLEX; BACTERIAL
   FLAGELLA; SHIGELLA-FLEXNERI; ESCHERICHIA-COLI; EXPORT APPARATUS;
   EUKARYOTIC CELLS
AB The length of the needle ending the Yersinia Ysc injectisome is determined by YscP, a protein acting as a molecular ruler. In addition, YscP is required for Yop secretion. In the present paper, by a systematic deletion analysis, we localized accurately the region required for Yop secretion between residues 405 and 500. As this C-terminal region of YscP has also been shown to control needle length it probably represents the substrate specificity switch of the machinery. By a bioinformatics analysis, we show that this region has a globular structure, an original alpha/beta fold, a P-x-L-G signature and presumably no catalytic activity. In spite of very limited sequence similarities, this structure is conserved among the proteins that are presumed to control the needle length in many different injectisomes and also among members of the FliK family, which control the flagellar hook length. This region thus represents a new protein domain that we called T3S4 for Type III secretion substrate specificity switch. The T3S4 domain of YscP can be replaced by the T3S4 domain of AscP (Aeromonas salmonicida) or PscP (Pseudomonas aeruginosa) but not by the one from FliK, indicating that in spite of a common global structure, these domains need to fit their partner proteins in the secretion apparatus.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Paris 06, Dept Biol Struct, Lab Mineral Cristallog Paris, CNRS,UMR 7590, F-75252 Paris 05, France.
   Univ Paris 07, Dept Biol Struct, Lab Mineral Cristallog Paris, CNRSUMR 7590, F-75221 Paris 05, France.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM Laure.Journet@esbs.u-strasbg.fr; guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962
CR Aizawa S, 2001, FEMS MICROBIOL LETT, V202, P157, DOI 10.1016/S0378-1097(01)00301-9
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Anderson DM, 1999, CURR OPIN MICROBIOL, V2, P18, DOI 10.1016/S1369-5274(99)80003-4
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2003, P NATL ACAD SCI USA, V100, P3027, DOI 10.1073/pnas.0535335100
   Burr SE, 2003, DIS AQUAT ORGAN, V57, P167, DOI 10.3354/dao057167
   Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 2002, J CELL BIOL, V158, P401, DOI 10.1083/jcb.200205077
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Cuff JA, 1999, PROTEINS, V34, P508, DOI 10.1002/(SICI)1097-0134(19990301)34:4<508::AID-PROT10>3.0.CO;2-4
   Dale C, 2002, P NATL ACAD SCI USA, V99, P12397, DOI 10.1073/pnas.182213299
   Dale C, 2001, P NATL ACAD SCI USA, V98, P1883, DOI 10.1073/pnas.021450998
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   FIELDS KA, 1994, J BACTERIOL, V176, P569, DOI 10.1128/jb.176.3.569-579.1994
   Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7
   Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x
   Fraser GM, 2003, J BACTERIOL, V185, P5546, DOI 10.1128/JB.185.18.5546-5554.2003
   GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Hennetin J, 2003, PROTEINS, V51, P236, DOI 10.1002/prot.10355
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Kawagishi I, 1996, J BACTERIOL, V178, P2954, DOI 10.1128/jb.178.10.2954-2959.1996
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Kimbrough TG, 2000, P NATL ACAD SCI USA, V97, P11008, DOI 10.1073/pnas.200209497
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Lavander M, 2003, ADV EXP MED BIOL, V529, P109
   Magdalena J, 2002, J BACTERIOL, V184, P3433, DOI 10.1128/JB.184.13.3433-3441.2002
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   PATTERSO.J, 1973, ARCH MIKROBIOL, V90, P107, DOI 10.1007/BF00414513
   Plano GV, 2001, MOL MICROBIOL, V40, P284, DOI 10.1046/j.1365-2958.2001.02354.x
   Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459
   Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Sukhan A, 2003, J BACTERIOL, V185, P3480, DOI 10.1128/JB.185.11.3480-3483.2003
   SUZUKI T, 1981, J BACTERIOL, V148, P973, DOI 10.1128/JB.148.3.973-979.1981
   Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002
   Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x
   VANGIJSEGEM F, 1995, MOL MICROBIOL, V15, P1095, DOI 10.1111/j.1365-2958.1995.tb02284.x
   Viprey V, 1998, MOL MICROBIOL, V28, P1381, DOI 10.1046/j.1365-2958.1998.00920.x
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
   WOODCOCK S, 1992, PROTEIN ENG, V5, P629, DOI 10.1093/protein/5.7.629
NR 53
TC 79
Z9 82
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2005
VL 56
IS 1
BP 54
EP 67
DI 10.1111/j.1365-2958.2005.04534.x
PG 14
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 904LH
UT WOS:000227499000005
PM 15773978
DA 2021-01-25
ER

PT J
AU Berneche, S
   Roux, BI
AF Berneche, S
   Roux, BI
TI A gate in the selectivity filter of potassium channels
SO STRUCTURE
LA English
DT Article
ID C-TYPE INACTIVATION; SHAKER K+ CHANNELS; MOLECULAR-DYNAMICS; ION
   CONDUCTION; SLOW INACTIVATION; TETRAETHYLAMMONIUM BLOCKADE; KCSA; PORE;
   PERMEATION; MUTATIONS
AB The selectivity filter of potassium channels is the structural element directly responsible for the selective and rapid conduction of K+, whereas other parts of the protein are thought to function as a molecular gate that either permits or blocks the passage of ions. However, whether the selectivity filter itself also possesses the ability to play the role of a gate is an unresolved question. Using free energy molecular dynamics simulations, it is shown that the reorientation of two peptide linkages in the selectivity filter of the KcsA K+ channel can lead to a stable nonconducting conformational state. Two microscopic factors influence the transition toward such a conformational state: the occupancy of one specific cation binding site in the selectivity filter (S-2) and the strength of intersubunit interactions involving the GYG signature sequence. These results suggest that such conformational transitions occurring in the selectivity filter might be related to different K+ channel gating events, including C-type (slow) inactivation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10021 USA.
RP Berneche, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM simon.berneche@unibas.ch
RI Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094
CR Allen TW, 1999, BIOPHYS J, V77, P2502, DOI 10.1016/S0006-3495(99)77086-4
   Andalib P, 2004, BIOPHYS J, V87, P3148, DOI 10.1529/biophysj.104.046664
   Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114
   Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653
   BEGLOV D, 1994, J CHEM PHYS, V100, P9050, DOI 10.1063/1.466711
   Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7
   Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067
   Berneche S, 2003, P NATL ACAD SCI USA, V100, P8644, DOI 10.1073/pnas.1431750100
   Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Capener CE, 2003, BIOPHYS J, V84, P2345, DOI 10.1016/S0006-3495(03)75040-1
   Chapman ML, 2001, J PHYSIOL-LONDON, V530, P21, DOI 10.1111/j.1469-7793.2001.0021m.x
   CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092
   CROUZY S, 1994, BIOPHYS J, V67, P1370, DOI 10.1016/S0006-3495(94)80618-6
   Crouzy S, 2001, J GEN PHYSIOL, V118, P207, DOI 10.1085/jgp.118.2.207
   del Camino D, 2001, NEURON, V32, P649, DOI 10.1016/S0896-6273(01)00487-1
   Domene C, 2004, BIOPHYS J, V87, P256, DOI 10.1529/biophysj.104.039917
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Feig M, 2003, J PHYS CHEM B, V107, P2831, DOI 10.1021/jp027293y
   FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648
   Guidoni L, 2000, FEBS LETT, V477, P37, DOI 10.1016/S0014-5793(00)01712-9
   HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2
   Hille B, 1992, IONIC CHANNELS EXCIT
   Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4
   Klemic KG, 2001, BIOPHYS J, V81, P814, DOI 10.1016/S0006-3495(01)75743-8
   KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004
   Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2
   LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303
   Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3
   Loboda A, 2001, BIOPHYS J, V80, P2704, DOI 10.1016/S0006-3495(01)76239-X
   Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623
   LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61
   Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080
   Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933
   Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000
   Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943
   Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347
   Ogielska EM, 1995, BIOPHYS J, V69, P2449, DOI 10.1016/S0006-3495(95)80114-1
   Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579
   Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181
   PANYI G, 1995, BIOPHYS J, V69, P896, DOI 10.1016/S0006-3495(95)79963-5
   Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73
   PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3
   RIEK R, 1999, P NATL ACAD SCI USA, V96, P8
   Roux B, 2000, BIOCHEMISTRY-US, V39, P13295, DOI 10.1021/bi001567v
   Schlenkrich Michael, 1996, P31
   SCHONHERR R, 1996, J PHYSL, V39, P635
   Shrivastava IH, 2000, BIOPHYS J, V78, P557, DOI 10.1016/S0006-3495(00)76616-1
   Shrivastava IH, 2002, BIOPHYS J, V83, P633, DOI 10.1016/S0006-3495(02)75197-7
   Smith PL, 1996, NATURE, V379, P833, DOI 10.1038/379833a0
   Soler-Llavina GJ, 2003, NEURON, V38, P61, DOI 10.1016/S0896-6273(03)00157-0
   Spector PS, 1996, J GEN PHYSIOL, V107, P611, DOI 10.1085/jgp.107.5.611
   Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539
   Starkus JG, 2000, J GEN PHYSIOL, V115, P107, DOI 10.1085/jgp.115.2.107
   Thompson J, 2003, J GEN PHYSIOL, V122, P239, DOI 10.1085/jgp.200308848
   Torres J, 2002, BIOPHYS J, V82, P1068, DOI 10.1016/S0006-3495(02)75466-0
   Valiyaveetil FI, 2004, P NATL ACAD SCI USA, V101, P17045, DOI 10.1073/pnas.0407820101
   Valiyaveetil FI, 2002, J AM CHEM SOC, V124, P9113, DOI 10.1021/ja0266722
   Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779
   Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
NR 66
TC 156
Z9 158
U1 0
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD APR
PY 2005
VL 13
IS 4
BP 591
EP 600
DI 10.1016/j.str.2004.12.019
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 920JT
UT WOS:000228685900013
PM 15837197
DA 2021-01-25
ER

PT J
AU Yang, JL
   Despont, M
   Drechsler, U
   Hoogenboom, BW
   Frederix, PLTM
   Martin, S
   Engel, A
   Vettiger, P
   Hug, HJ
AF Yang, JL
   Despont, M
   Drechsler, U
   Hoogenboom, BW
   Frederix, PLTM
   Martin, S
   Engel, A
   Vettiger, P
   Hug, HJ
TI Miniaturized single-crystal silicon cantilevers for scanning force
   microscopy
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID QUALITY FACTORS
AB We report on a method to reproducibly batch fabricate single-crystal silicon cantilevers with dimensions an order of magnitude smaller than conventional cantilevers, i.e., with lengths between 10 and 35 mu m, a width of 4 mu m, and a thickness of 0.2 mu m. The cantilevers are attached to support chips specially tailored for use in a scanning force microscope. The resonance frequencies are 0.2-2 MHz, the spring constants about 0.05-1 N/m, and the quality factors 1.5-3.0 x 10(4). The resulting thermal force noise is 1-2 x 10(-16) N/root Hz at room temperature in vacuum. These cantilevers allow an enhancement of the measurement speed of more than one order of magnitude, and 2-5x better force sensitivity. After annealing in ultrahigh vacuum and measuring at liquid helium temperature, the thermal force noise of these cantilevers is expected to be further reduced down to 10(-18) N/root Hz. (C) 2005 American Institute of Physics.
C1 IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.
   Univ Basel, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
   Univ Neuchatel, Inst Microtechnol, CH-2007 Neuchatel, Switzerland.
   CSEM, CH-2007 Neuchatel, Switzerland.
   EMPA, Swiss Fed Labs Mat Testing & Res, CH-8600 Dubendorf, Switzerland.
RP Despont, M (corresponding author), IBM Res Corp, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.
EM dpt@zurich.ibm.com
RI Despont, Michel/U-4263-2018
OI Despont, Michel/0000-0003-3759-2161; Hoogenboom,
   Bart/0000-0002-8882-4324
CR ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347
   Despont M, 2000, SENSOR ACTUAT A-PHYS, V80, P100, DOI 10.1016/S0924-4247(99)00254-X
   Heer C.V., 1972, STAT MECH KINETIC TH
   Hoogenboom BW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866229
   HOOGENBOOM BW, 2003, Patent No. 03025187
   Hosaka S, 2000, J VAC SCI TECHNOL B, V18, P94, DOI 10.1116/1.591157
   Kawakatsu H, 2002, REV SCI INSTRUM, V73, P1188, DOI 10.1063/1.1448137
   SARID D, 1991, SCANNING FORCE MICRO
   Stowe TD, 1997, APPL PHYS LETT, V71, P288, DOI 10.1063/1.119522
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Yang JL, 2000, APPL PHYS LETT, V77, P3860, DOI 10.1063/1.1330225
   Yang JL, 2002, J MICROELECTROMECH S, V11, P775, DOI 10.1109/JMEMS.2002.805208
   Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786
NR 13
TC 26
Z9 26
U1 0
U2 11
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0003-6951
EI 1077-3118
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD MAR 28
PY 2005
VL 86
IS 13
AR 134101
DI 10.1063/1.1895482
PG 3
WC Physics, Applied
SC Physics
GA 916YL
UT WOS:000228422600084
OA Green Published
DA 2021-01-25
ER

PT J
AU Bokor, H
   Frere, SGA
   Eyre, MD
   Slezia, A
   Ulbert, I
   Luthi, A
   Acsady, L
AF Bokor, H
   Frere, SGA
   Eyre, MD
   Slezia, A
   Ulbert, I
   Luthi, A
   Acsady, L
TI Selective GABAergic control of higher-order thalamic relays
SO NEURON
LA English
DT Article
ID LATERAL GENICULATE-NUCLEUS; ANTERIOR PRETECTAL NUCLEUS;
   ELECTRON-MICROSCOPIC ANALYSIS; GLUTAMIC-ACID DECARBOXYLASE;
   GAMMA-AMINOBUTYRIC ACID; CENTRAL-NERVOUS-SYSTEM; RETICULAR NUCLEUS; ZONA
   INCERTA; SYNAPTIC INPUT; A-LAMINAE
AB GABAergic signaling is central to the function of the thalamus and has been traditionally attributed primarily to the nucleus reticularis thalami (nRT). Here we present a GABAergic pathway, distinct from the nRT, that exerts a powerful inhibitory effect selectively in higher-order thalamic relays of the rat. Axons originating in the anterior pretectal nucleus (APT) innervated the proximal dendrites of relay cells via large GABAergic terminals with multiple release sites. Stimulation of the APT in an in vitro slice preparation revealed a GABA(A) receptor-mediated, monosynaptic IPSC in relay cells. Activation of presumed single APT fibers induced rebound burst firing in relay cells. Different APT neurons recorded in vivo displayed fast bursting, tonic, or rhythmic firing. Our data suggest that selective extrareticular GABAergic control of relay cell activity will result in effective, state-dependent gating of thalamocortical information transfer in higher-order but not in first-order relays.
C1 Hungarian Acad Sci, Inst Expt Med, H-1450 Budapest, Hungary.
   Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Hungarian Acad Sci, Inst Psychol, H-1068 Budapest, Hungary.
RP Acsady, L (corresponding author), Hungarian Acad Sci, Inst Expt Med, POB 67, H-1450 Budapest, Hungary.
EM acsady@koki.hu
RI Acsady, Laszlo/C-7773-2014; Ulbert, Istvan/F-2213-2010
OI Acsady, Laszlo/0000-0002-0679-2980; Eyre, Mark/0000-0001-9102-2894;
   Luthi, Anita/0000-0002-4954-4143; Slezia, Andrea/0000-0002-4528-3169
FU Wellcome TrustWellcome Trust [067573] Funding Source: Medline
CR Ahissar E, 2001, NEURON, V32, P185, DOI 10.1016/S0896-6273(01)00466-4
   BAIMBRIDGE KG, 1982, BRAIN RES, V245, P223, DOI 10.1016/0006-8993(82)90804-6
   BAL T, 1995, J PHYSIOL-LONDON, V483, P641, DOI 10.1113/jphysiol.1995.sp020612
   Bartho P, 2002, EUR J NEUROSCI, V16, P999, DOI 10.1046/j.1460-9568.2002.02157.x
   BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9
   BENSON DL, 1992, NEUROSCIENCE, V46, P825, DOI 10.1016/0306-4522(92)90188-8
   BERMAN N, 1977, J COMP NEUROL, V174, P227, DOI 10.1002/cne.901740204
   CADUSSEAU J, 1991, NEUROSCI RES, V12, P83, DOI 10.1016/0168-0102(91)90102-5
   CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H
   CUCCHIARO JB, 1991, J COMP NEUROL, V310, P316, DOI 10.1002/cne.903100304
   CUCCHIARO JB, 1993, J COMP NEUROL, V334, P618, DOI 10.1002/cne.903340409
   DIAMOND ME, 1992, J COMP NEUROL, V319, P66, DOI 10.1002/cne.903190108
   ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834
   FOSTER GA, 1989, NEUROSCIENCE, V29, P685, DOI 10.1016/0306-4522(89)90141-3
   GRAHAM J, 1981, NEUROSCI LETT, V26, P209, DOI 10.1016/0304-3940(81)90134-8
   Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0
   Guillery RW, 2002, NEURON, V33, P163, DOI 10.1016/S0896-6273(01)00582-7
   HALLANGER AE, 1987, J COMP NEUROL, V262, P105, DOI 10.1002/cne.902620109
   HOOGLAND PV, 1991, EXP BRAIN RES, V87, P159, DOI 10.1007/BF00228517
   Huguenard JR, 1998, J SLEEP RES, V7, P24, DOI 10.1046/j.1365-2869.7.s1.5.x
   HUGUENARD JR, 1994, J NEUROSCI, V14, P5485
   Jones EG, 2001, TRENDS NEUROSCI, V24, P595, DOI 10.1016/S0166-2236(00)01922-6
   JOURDAIN A, 1989, BRAIN RES, V505, P55, DOI 10.1016/0006-8993(89)90115-7
   Kenigfest NB, 2000, J COMP NEUROL, V426, P31, DOI 10.1002/1096-9861(20001009)426:1<31::AID-CNE3>3.0.CO;2-S
   Kim U, 1998, J NEUROSCI, V18, P9500
   KINNEY HC, 1994, NEW ENGL J MED, V330, P1469, DOI 10.1056/NEJM199405263302101
   Kinomura S, 1996, SCIENCE, V271, P512, DOI 10.1126/science.271.5248.512
   Komura Y, 2001, NATURE, V412, P546, DOI 10.1038/35087595
   Kraushaar U, 2000, J NEUROSCI, V20, P5594
   LIU XB, 1995, J COMP NEUROL, V352, P187, DOI 10.1002/cne.903520203
   LLINAS R, 1997, COHERENT OSCILLATION, P501
   LUBKE J, 1993, J COMP NEUROL, V329, P458, DOI 10.1002/cne.903290404
   Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2
   May PJ, 1997, NEUROSCIENCE, V77, P1091, DOI 10.1016/S0306-4522(96)00535-0
   MONTERO VM, 1981, NEUROSCIENCE, V6, P2561, DOI 10.1016/0306-4522(81)90102-0
   Paxinos G., 1998, RAT BRAIN STEROTAXIC
   Pinault D, 1998, J COMP NEUROL, V391, P180, DOI 10.1002/(SICI)1096-9861(19980209)391:2<180::AID-CNE3>3.0.CO;2-Z
   Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008
   Pinault D, 1996, J NEUROSCI METH, V65, P113, DOI 10.1016/0165-0270(95)00144-1
   Reichova I, 2004, J NEUROPHYSIOL, V92, P2185, DOI 10.1152/jn.00322.2004
   ROBERTSON RT, 1983, EXP BRAIN RES, V51, P157
   Schiff ND, 2002, NEUROL RES, V24, P116, DOI 10.1179/016164102101199576
   Sherman SM, 2004, TRENDS NEUROSCI, V27, P670, DOI 10.1016/j.tins.2004.08.003
   Sherman SM, 2001, EXPLORING THALAMUS
   SOMOGYI P, 1985, J HISTOCHEM CYTOCHEM, V33, P240, DOI 10.1177/33.3.2579123
   Steriade M, 2004, NEURON, V41, P493, DOI 10.1016/S0896-6273(04)00076-5
   STERIADE M, 1985, J NEUROPHYSIOL, V54, P1473
   STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588
   STERIADE M, 1997, THALAMUS, V1
   Telgkamp P, 2004, NEURON, V41, P113, DOI 10.1016/S0896-6273(03)00802-X
   TERENZI MG, 1995, BRAIN RES, V701, P183, DOI 10.1016/0006-8993(95)01001-8
   Trageser JC, 2004, J NEUROSCI, V24, P8911, DOI 10.1523/JNEUROSCI.3218-04.2004
   Veinante P, 1999, J NEUROSCI, V19, P5085
   Vidnyanszky Z, 1996, EXP BRAIN RES, V109, P63
   Wang ST, 2002, NEUROSCI LETT, V323, P141, DOI 10.1016/S0304-3940(01)02533-2
   Ward R, 2002, NAT NEUROSCI, V5, P99, DOI 10.1038/nn794
   Xu-Friedman MA, 2004, PHYSIOL REV, V84, P69, DOI 10.1152/physrev.00016.2003
NR 57
TC 95
Z9 96
U1 0
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD MAR 24
PY 2005
VL 45
IS 6
BP 929
EP 940
DI 10.1016/j.neuron.2005.01.048
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 911UO
UT WOS:000228031300013
PM 15797553
DA 2021-01-25
ER

PT J
AU Krieger, F
   Moglich, A
   Kiefhaber, T
AF Krieger, F
   Moglich, A
   Kiefhaber, T
TI Effect of proline and glycine residues on dynamics and barriers of loop
   formation in polypeptide chains
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID INTRAMOLECULAR CONTACT FORMATION; CONFIGURATIONAL STATISTICS; INTRACHAIN
   DIFFUSION; DENATURED STATE; PSEUDO-PROLINES; ENERGY-TRANSFER; SPEED
   LIMIT; PROTEIN; ISOMERISM; TAXONOMY
AB Glycine and proline residues are frequently found in turn and loop structures of proteins and are believed to play an important role during chain compaction early in folding. We investigated their effect on the dynamics of intrachain loop formation in various unstructured polypeptide chains. Loop formation is significantly slower around trans prolyl peptide bonds and faster around glycine residues compared to any other amino acid. However, short loops are formed fastest around cis prolyl bonds with a time constant of 6 ns for end-to-end contact formation in a four-residue loop. Formation of short loops encounters activation energies in the range of 15 to 30 kJ/mol. The altered dynamics around glycine and trans prolyl bonds can be mainly ascribed to their effects on the activation energy. The fast dynamics around cis prolyl bonds, in contrast, originate in a higher Arrhenius pre-exponential factor, which compensates for an increased activation energy for loop formation compared to trans isomers. All-atom simulations of proline-containing peptides indicate that the conformational space for cis prolyl isomers is largely restricted compared to trans isomers. This leads to decreased average end-to-end distances and to a smaller loss in conformational entropy upon loop formation in cis isomers. The results further show that glycine and proline residues only influence formation of short loops containing between 2 and 10 residues, which is the typical loop size in native proteins. Formation of larger loops is not affected by the presence of a single glycine or proline residue.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiethaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
OI Moglich, Andreas/0000-0002-7382-2772
CR Bachmann A, 2002, BIOPHYS CHEM, V96, P141, DOI 10.1016/S0301-4622(02)00020-0
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100
   *CLEV OH, 1972, HDB CHEM PHYS
   Damaschun G, 1998, BIOCHEMISTRY-MOSCOW+, V63, P259
   Dumy P, 1997, J AM CHEM SOC, V119, P918, DOI 10.1021/ja962780a
   ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071
   Fierz B, 2005, PROTEIN FOLDING HANDBOOK, P809, DOI 10.1002/9783527619498.ch22
   Fitzkee NC, 2004, PROTEIN SCI, V13, P633, DOI 10.1110/ps.03503304
   Flory P.J., 1969, STAT MECH CHAIN MOL
   HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103
   Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615
   HOPFINGER AJ, 1973, CONFORMATIONAL PROPE
   Hudgins RR, 2002, J AM CHEM SOC, V124, P556, DOI 10.1021/ja010493n
   Jabs A, 1999, J MOL BIOL, V286, P291, DOI 10.1006/jmbi.1998.2459
   Keller M, 1998, J AM CHEM SOC, V120, P2714, DOI 10.1021/ja973966s
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Klessinger M., 1995, EXCITED STATES PHOTO
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2004, CHEM PHYS, V307, P209, DOI 10.1016/j.chemphys.2004.05.036
   Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Millet IS, 2002, ADV PROTEIN CHEM, V62, P241
   NAGARAJ R, 1980, INT J PEPT PROT RES, V16, P291
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Richardson J S, 1981, Adv Protein Chem, V34, P167, DOI 10.1016/S0065-3233(08)60520-3
   Satzger H, 2004, J PHYS CHEM A, V108, P10072, DOI 10.1021/jp047583+
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   SCHIMMEL PR, 1968, J MOL BIOL, V34, P105, DOI 10.1016/0022-2836(68)90237-4
   SCHIMMEL PR, 1967, P NATL ACAD SCI USA, V58, P52, DOI 10.1073/pnas.58.1.52
   SIBANDA BL, 1985, NATURE, V316, P170, DOI 10.1038/316170a0
   TANAKA S, 1975, MACROMOLECULES, V8, P623, DOI 10.1021/ma60047a009
   TANAKA S, 1972, POLYM J, V3, P500, DOI 10.1295/polymj.3.500
   WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9
NR 40
TC 121
Z9 121
U1 1
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 16
PY 2005
VL 127
IS 10
BP 3346
EP 3352
DI 10.1021/ja042798i
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 906GD
UT WOS:000227627800038
PM 15755151
DA 2021-01-25
ER

PT J
AU Soeberdt, M
   Bolliger, R
   Dunant, P
   Hennebohle, M
   Hofbauer, K
   Leuzinger, S
   Magyar, J
   Nicholson, J
   Scharer, F
   Schnuriger, F
   Stebler, M
   von Sprecher, A
   Weyermann, P
AF Soeberdt, M
   Bolliger, R
   Dunant, P
   Hennebohle, M
   Hofbauer, K
   Leuzinger, S
   Magyar, J
   Nicholson, J
   Scharer, F
   Schnuriger, F
   Stebler, M
   von Sprecher, A
   Weyermann, P
TI Discovery and optimization of novel 4,4-disubstituted piperidine
   derivatives as potent and selective melanocortin-4 receptor antagonists
   for the treatment of cancer cachexia.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 229th National Meeting of the American-Chemical-Society
CY MAR 13-17, 2005
CL San Diego, CA
SP Amer Chem Soc
C1 Santhera Pharmaceut Schweiz GmbH, Med Chem Dept, CH-4410 Liestal, Switzerland.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM michaelsoeberdt@santhera.com
RI Soeberdt, Michael/AAP-8617-2020
OI Soeberdt, Michael/0000-0003-2594-9901
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD MAR 13
PY 2005
VL 229
MA 027-MEDI
BP U109
EP U109
PN 2
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 008UQ
UT WOS:000235066600026
DA 2021-01-25
ER

PT J
AU Fahrenkrog, B
   Schwarz-Herion, K
   Paulillo, SM
   Koser, J
   Maco, B
   Aebi, U
AF Fahrenkrog, B
   Schwarz-Herion, K
   Paulillo, SM
   Koser, J
   Maco, B
   Aebi, U
TI The nuclear pore complex and nucleocytoplasmic transport: Who is doing
   what?
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutsche-Gesellschaft-fur-Zellbiologie
CY MAR 16-19, 2005
CL Heidelberg, GERMANY
SP Deutsch Gesell Zellbiol
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2005
VL 84
SU 55
BP 45
EP 46
PG 2
WC Cell Biology
SC Cell Biology
GA 918FM
UT WOS:000228527700083
DA 2021-01-25
ER

PT J
AU Paulillo, SM
   Phillips, EM
   Koser, J
   Ullman, KS
   Powers, MA
   Fahrenkrog, B
AF Paulillo, SM
   Phillips, EM
   Koser, J
   Ullman, KS
   Powers, MA
   Fahrenkrog, B
TI Nucleoporin domain topology is linked to the transport status of the
   nuclear pore complex
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutsche-Gesellschaft-fur-Zellbiologie
CY MAR 16-19, 2005
CL Heidelberg, GERMANY
SP Deutsch Gesell Zellbiol
C1 Univ Basel, Biozentrum, ME Muller Inst, Basel, Switzerland.
   Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA.
   Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA.
EM birthe.fahrenkrog@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
EI 1618-1298
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2005
VL 84
SU 55
BP 48
EP 48
PG 1
WC Cell Biology
SC Cell Biology
GA 918FM
UT WOS:000228527700089
DA 2021-01-25
ER

PT J
AU Schumacher, J
   Mucke, N
   Strelkov, SV
   Aebi, U
   Herrmann, H
AF Schumacher, J
   Mucke, N
   Strelkov, SV
   Aebi, U
   Herrmann, H
TI Towards unraveling the molecular assembly properties of human lamins
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutsche-Gesellschaft-fur-Zellbiologie
CY MAR 16-19, 2005
CL Heidelberg, GERMANY
SP Deutsch Gesell Zellbiol
C1 German Canc Res Ctr, Div Cell Biol, D-6900 Heidelberg, Germany.
   Univ Basel, Biozentrum, ME Muellner Inst, CH-4003 Basel, Switzerland.
EM J.Schumacher@dkfz.de
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
NR 0
TC 0
Z9 0
U1 0
U2 0
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2005
VL 84
SU 55
BP 98
EP 98
PG 1
WC Cell Biology
SC Cell Biology
GA 918FM
UT WOS:000228527700213
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Mucke, N
   Kirmse, R
   Wedig, T
   Leterrier, JF
   Herrmann, H
   Aebi, U
AF Kreplak, L
   Mucke, N
   Kirmse, R
   Wedig, T
   Leterrier, JF
   Herrmann, H
   Aebi, U
TI Morphology of intermediate filaments (IFs) adsorbed to solid supports
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the Deutsche-Gesellschaft-fur-Zellbiologie
CY MAR 16-19, 2005
CL Heidelberg, GERMANY
SP Deutsch Gesell Zellbiol
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   CNRS, F-75700 Paris, France.
   Univ Poitiers, Poitiers, France.
EM laurent.kreplak@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2005
VL 84
SU 55
BP 106
EP 107
PG 2
WC Cell Biology
SC Cell Biology
GA 918FM
UT WOS:000228527700236
DA 2021-01-25
ER

PT J
AU Ohnishi, K
   Melchers, F
   Shimizu, T
AF Ohnishi, K
   Melchers, F
   Shimizu, T
TI Lymphocyte-expressed BILL-cadherin/cadherin-17 contributes to the
   development of B cells at two stages
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE B cells; adhesion molecules; cell differentiation; knockout mouse;
   cadherin
ID CHEMOKINE RECEPTOR CXCR4; SPLENIC MARGINAL ZONE; IMMUNE-RESPONSES;
   T-LYMPHOCYTES; BONE-MARROW; ADHESION; PRECURSORS; INTEGRIN;
   IDENTIFICATION; RETENTION
AB The gene encoding BILL-cadherin/cadherin-17, a nonclassical cadherin expressed on B lymphocytes in a stage-and-site-specific manner, was inactivated by targeted disruption of its transmembrane/cytoplasmic portion-encoding parts. BILL-cadherin deficiency caused a threefold proB cell accumulation, as well as a reduction to half of the numbers of immature B cells in bone marrow. In spleen, CD21(hi)CD23(lo) marginal zone B cells were found reduced and the structure of the marginal zone was impaired. In addition, the size and number of germinal center as well as the number of PNA(+) cells were significantly reduced in BILL-cadherin-deficient mice. In the peritoneal cavity of mutant mice IgM(+)Mac-1(+)CD5(+) B1a cell, that express high BILL-cadherin in wild-type mice, was also reduced in number. The IgG1 and IgG3 antibody response to the T-independent antigen, TNP-Ficoll, was impaired in the mutant mice. These results indicate that BILL cadherin participates in B lymphocyte development at least at two stages, first at the transition of pro/preB-I cells to preB-II cells possibly in association with surrogate light chain in bone marrow, and later at the point of development, accumulation and reactiveness of immature B cells in spleen.
C1 Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan.
   Biozentrum, Dept Cell Biol, Basel, Switzerland.
   Univ Basel, Basel, Switzerland.
   Sapporo Med Univ, Sch Med, Dept Biochem, Sapporo, Hokkaido, Japan.
RP Ohnishi, K (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Toyama 1-23-1, Tokyo 1628640, Japan.
EM ohnishik@nih.go.jp
CR Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6
   Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8
   BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353
   Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276
   Cepek KL, 1996, P NATL ACAD SCI USA, V93, P6567, DOI 10.1073/pnas.93.13.6567
   CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0
   DANTZIG AH, 1994, SCIENCE, V264, P430, DOI 10.1126/science.8153632
   DApuzzo M, 1997, EUR J IMMUNOL, V27, P1788, DOI 10.1002/eji.1830270729
   Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386
   Gessner R, 2000, ANN NY ACAD SCI, V915, P136
   Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595
   Hoffmann R, 2003, CURR OPIN IMMUNOL, V15, P239, DOI 10.1016/S0952-7915(03)00047-5
   Horsfield J, 2002, MECH DEVELOP, V115, P15, DOI 10.1016/S0925-4773(02)00094-1
   Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569
   Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632
   Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1
   Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4
   MELCHERS F, 2003, MOL BIOL B CELLS, P101
   Ogawa M, 2000, INT IMMUNOL, V12, P313, DOI 10.1093/intimm/12.3.313
   Ohnishi K, 2000, J BIOL CHEM, V275, P31134, DOI 10.1074/jbc.M005901200
   Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959
   Osmond D G, 1990, Semin Immunol, V2, P173
   SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9
   TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419
NR 24
TC 16
Z9 17
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD MAR
PY 2005
VL 35
IS 3
BP 957
EP 963
DI 10.1002/eji.200425853
PG 7
WC Immunology
SC Immunology
GA 906II
UT WOS:000227633900030
PM 15688343
DA 2021-01-25
ER

PT J
AU Gullo, MR
   Akiyama, T
   Frederix, PLTM
   Tonin, A
   Staufer, U
   Engel, A
   de Rooij, NF
AF Gullo, MR
   Akiyama, T
   Frederix, PLTM
   Tonin, A
   Staufer, U
   Engel, A
   de Rooij, NF
TI Towards a planar sample support for in situ experiments in structural
   biology
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 30th International Conference on Micro and Nano Engineering
CY SEP 19-22, 2004
CL Rotterdam, NETHERLANDS
DE nano; nanotechnology; biology; nanobiology; structural biology;
   biological membrane; patch-clamp; conductive probe; scanning
   electrochemical microscopy
ID FORCE
AB We report about the development of a planar support for biological samples. The aim is to combine AFM and patch-clamp measurements, in order to perform simultaneous measurements of topography and electrical properties of biological membranes. Sub-micrometer apertures have been fabricated using standard MEMS techniques. The electrical quality of the support has been experimentally assessed. (c) 2005 Elsevier B.V. All rights reserved.
C1 Univ Neuchatel, Inst Microtechnol, CH-2007 Neuchatel, Switzerland.
   Univ Basel, ME Muller Inst, Biozentrum, Basel, Switzerland.
   Univ Basel, Inst Phys, Basel, Switzerland.
RP Gullo, MR (corresponding author), Univ Neuchatel, Inst Microtechnol, Jaquet Droz 1, CH-2007 Neuchatel, Switzerland.
EM rosario.gullo@unine.ch
RI Staufer, Urs/J-6866-2016; Gullo, Maurizio/B-4383-2012
OI Staufer, Urs/0000-0002-3519-6467; 
CR Akiyama T, 2004, JPN J APPL PHYS 1, V43, P3865, DOI 10.1143/JJAP.43.3865
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Fertig N, 2002, APPL PHYS LETT, V81, P4865, DOI 10.1063/1.1531228
   Fertig N, 2002, BIOPHYS J, V82, P3056, DOI 10.1016/S0006-3495(02)75646-4
   Fertig N, 2000, APPL PHYS LETT, V77, P1218, DOI 10.1063/1.1289490
   Langer MG, 1997, REV SCI INSTRUM, V68, P2583, DOI 10.1063/1.1148063
   Macpherson JV, 2002, ANAL CHEM, V74, P1841, DOI 10.1021/ac0157472
   Mosbacher J, 1996, J VAC SCI TECHNOL B, V14, P1449, DOI 10.1116/1.589117
   SAKMANN B, 1983, SINGLE CHANNEL RECOR
   Scheuring S, 2001, SINGLE MOL, V2, P59
   Thompson RE, 2001, BIOPHYS J, V81, P937, DOI 10.1016/S0006-3495(01)75752-9
   YPEY DL, 1999, PATCH CLAMP TECHNIQU
NR 12
TC 3
Z9 4
U1 0
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-9317
EI 1873-5568
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD MAR
PY 2005
VL 78-79
SI SI
BP 571
EP 574
DI 10.1016/j.mee.2004.12.072
PG 4
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 919AC
UT WOS:000228589700093
DA 2021-01-25
ER

PT J
AU Madhavan, R
   Zhao, XTT
   Ruegg, MA
   Peng, HB
AF Madhavan, R
   Zhao, XTT
   Ruegg, MA
   Peng, HB
TI Tyrosine phosphatase regulation of MuSK-dependent acetylcholine receptor
   clustering
SO MOLECULAR AND CELLULAR NEUROSCIENCE
LA English
DT Article
ID VERTEBRATE NEUROMUSCULAR-JUNCTION; SKELETAL-MUSCLE FIBERS; SH2 DOMAINS;
   IN-VIVO; POSTSYNAPTIC SPECIALIZATIONS; SIGNAL-TRANSDUCTION; C2 MYOTUBES;
   AGRIN; KINASE; PHOSPHORYLATION
AB During vertebrate neuromuscular junction (NMJ) development, nerve-secreted agrin induces acetylcholine receptor (AChR) clustering in muscle by activating the muscle-specific tyrosine kinase MuSK. Recently, it has been recognized that MuSK activation-dependent AChR clustering occurs in embryonic muscle even in the absence of agrin, but how this process is regulated is poorly understood. We report that inhibition of tyrosine phosphatases in cultured C2 mouse myotubes using pervanadate enhanced MuSK auto-activation and agrin-independent AChR clustering. Moreover, phosphatase inhibition also enlarged the AChR clusters induced by agrin in these cells. Conversely, in situ activation of MuSK in cultured Xenopus embryonic muscle cells, either focally by anti-MuSK antibody-coated beads or globally by agrin, stimulated downstream tyrosine phosphatases, which could be blocked by pervanadate treatment. Immunoscreening identified Shp2 as a major tyrosine phosphatase in C2 myotubes and downregulation of its expression by RNA interference alleviated tyrosine phosphatase suppression of MUSK activation. Significantly, depletion of Shp2 increased both agrin-independent and agrin-dependent AChR clustering in myotubes. Our results suggest that muscle tyrosine phosphatases tightly regulate MuSK activation and signaling and support a novel role of Shp2 in MuSK-dependent AChR clustering. (c) 2004 Elsevier Inc. All rights reserved.
C1 Hong Kong Univ Sci & Technol, Dept Biol, Kowloon, Hong Kong, Peoples R China.
   Univ Basel, Dept Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
RP Peng, HB (corresponding author), Hong Kong Univ Sci & Technol, Dept Biol, Clear Water Bay, Kowloon, Hong Kong, Peoples R China.
EM penghb@ust.hk
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS023583, R01NS023583, R01NS023583, R01NS023583, R01NS023583,
   R01NS036754, R01NS023583, R01NS036754, R01NS023583, R01NS023583,
   R01NS023583, R01NS023583, R01NS036754, R01NS023583, R01NS036754,
   R01NS023583, R01NS023583, R01NS023583, R01NS023583, R01NS023583,
   R01NS023583, R01NS023583] Funding Source: NIH RePORTER; NINDS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [NS36754, NS23583] Funding Source: Medline
CR AHMAD F, 1995, BBA-PROTEIN STRUCT M, V1248, P57, DOI 10.1016/0167-4838(95)00003-D
   AHMAD S, 1993, P NATL ACAD SCI USA, V90, P2197, DOI 10.1073/pnas.90.6.2197
   Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200
   BOWE MA, 1995, ANNU REV NEUROSCI, V18, P443
   Cole GJ, 1996, PERSPECT DEV NEUROBI, V3, P359
   Daggett DF, 1996, MOL CELL NEUROSCI, V7, P75, DOI 10.1006/mcne.1996.0006
   Dai ZS, 1998, J CELL BIOL, V141, P1613, DOI 10.1083/jcb.141.7.1613
   Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321
   Daniels MP, 1997, MOL NEUROBIOL, V14, P143, DOI 10.1007/BF02740654
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   FENG GS, 1994, TRENDS GENET, V10, P54, DOI 10.1016/0168-9525(94)90149-X
   FERTUCK HC, 1976, J CELL BIOL, V69, P144, DOI 10.1083/jcb.69.1.144
   Fu AKY, 1999, MOL CELL NEUROSCI, V14, P241, DOI 10.1006/mcne.1999.0784
   Fuhrer C, 1996, J BIOL CHEM, V271, P32474, DOI 10.1074/jbc.271.50.32474
   GANJU P, 1995, ONCOGENE, V11, P281
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0
   Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9
   Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6
   HALL ZW, 1993, NEURON S, V10, P99
   Herbst R, 2000, EMBO J, V19, P67, DOI 10.1093/emboj/19.1.67
   Hopf C, 1998, J BIOL CHEM, V273, P6467, DOI 10.1074/jbc.273.11.6467
   Jones G, 1999, J NEUROSCI, V19, P3376
   KIDOKORO Y, 1985, J PHYSIOLOGY PARIS, V80, P212
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Luo ZG, 2002, NEURON, V35, P489, DOI 10.1016/S0896-6273(02)00783-3
   Maile LA, 2002, J BIOL CHEM, V277, P8955, DOI 10.1074/jbc.M109258200
   McMahan Uel J., 1992, Current Opinion in Cell Biology, V4, P869, DOI 10.1016/0955-0674(92)90113-Q
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908
   Megeath LJ, 1998, J NEUROSCI, V18, P672
   Mei L, 1996, EXP CELL RES, V224, P379, DOI 10.1006/excr.1996.0148
   MEIER T, 1995, J CELL BIOL, V131, P441, DOI 10.1083/jcb.131.2.441
   Meier T, 1997, J NEUROSCI, V17, P6534
   Mohamed AS, 2001, J NEUROSCI, V21, P3806, DOI 10.1523/JNEUROSCI.21-11-03806.2001
   MOODYCORBETT F, 1982, J NEUROSCI, V2, P633
   Neel BG, 1997, CURR OPIN CELL BIOL, V9, P193, DOI 10.1016/S0955-0674(97)80063-4
   PENG HB, 1986, J NEUROSCI, V6, P581
   PENG HB, 1995, J NEUROSCI, V15, P3027
   PENG HB, 1991, XENOPUR LAEVIS PRACT, V36, P511
   PLUSKEY S, 1995, J BIOL CHEM, V270, P2897, DOI 10.1074/jbc.270.7.2897
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Saxton TM, 1997, EMBO J, V16, P2352, DOI 10.1093/emboj/16.9.2352
   Strochlic L, 2001, J CELL BIOL, V153, P1127, DOI 10.1083/jcb.153.5.1127
   TANG TL, 1995, CELL, V80, P473, DOI 10.1016/0092-8674(95)90498-0
   Tanowitz M, 1999, J NEUROSCI, V19, P9426
   WALLACE BG, 1995, J CELL BIOL, V128, P1121, DOI 10.1083/jcb.128.6.1121
   Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997
   Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205
   Xie MH, 1997, NAT BIOTECHNOL, V15, P768, DOI 10.1038/nbt0897-768
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
   Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131
   Zhou H, 1999, J CELL BIOL, V146, P1133, DOI 10.1083/jcb.146.5.1133
NR 55
TC 32
Z9 33
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1044-7431
EI 1095-9327
J9 MOL CELL NEUROSCI
JI Mol. Cell. Neurosci.
PD MAR
PY 2005
VL 28
IS 3
BP 403
EP 416
DI 10.1016/j.mcn.2004.10.005
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 906DK
UT WOS:000227620500001
PM 15737732
DA 2021-01-25
ER

PT J
AU Appenzeller-Herzog, C
   Nyfeler, B
   Burkhard, P
   Santamaria, I
   Lopez-Otin, C
   Hauri, HP
AF Appenzeller-Herzog, C
   Nyfeler, B
   Burkhard, P
   Santamaria, I
   Lopez-Otin, C
   Hauri, HP
TI Carbohydrate- and conformation-dependent cargo capture for ER-exit
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID ROUGH ENDOPLASMIC-RETICULUM; LECTIN ERGIC-53; CATHEPSIN-X; TRANSPORT;
   PROTEIN; GOLGI; GLYCOPROTEINS; COMPARTMENT; MATURATION; SECRETION
AB Some secretory proteins leave the endoplasmic reticulum (ER) by a receptor-mediated cargo capture mechanism, but the signals required for the cargo-receptor interaction are largely unknown. Here, we describe a novel targeting motif that is composed of a high-mannose type oligosaccharide intimately associated with a surface-exposed peptide beta-hairpin loop. The motif accounts for lectin ERGIC-53-assisted ER-export of the lyososomal enzyme procathepsin Z. The second oligosaccharide chain of procathepsin Z exhibits no binding activity for ERGIC-53, illustrating the selective lectin properties of ERGIC-53. Our data suggest that the conformation-based motif is only present in fully folded procathepsin Z and that its recognition by ERGIC-53 reflects a quality control mechanism that acts complementary to the primary folding machinery in the ER. A similar oligosaccharide/beta-hairpin loop structure is present in cathepsin C, another cargo of ERGIC-53, suggesting the general nature of this ER-exit signal. To our knowledge this is the first documentation of an ER-exit signal in soluble cargo in conjunction with its decoding by a transport receptor.
C1 Univ Basel, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Oviedo, Inst Oncol, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.
RP Hauri, HP (corresponding author), Univ Basel, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI Appenzeller-Herzog, Christian/A-2894-2014; Santamaria,
   Inigo/H-6727-2015; Lopez-Otin, Carlos/AAB-2106-2020
OI Appenzeller-Herzog, Christian/0000-0001-7430-294X; Santamaria,
   Inigo/0000-0001-8718-5359; Lopez-Otin, Carlos/0000-0001-6964-1904
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200
   Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   CAPLAN S, 1991, J BACTERIOL, V173, P627, DOI 10.1128/jb.173.2.627-635.1991
   Cunningham MA, 2003, J THROMB HAEMOST, V1, P2360, DOI 10.1046/j.1538-7836.2003.00415.x
   Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   Fatal N, 2004, J CELL SCI, V117, P1665, DOI 10.1242/jcs.01019
   Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klemencic I, 2000, EUR J BIOCHEM, V267, P5404, DOI 10.1046/j.1432-1327.2000.01592.x
   KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631
   LODISH HF, 1988, J BIOL CHEM, V263, P2107
   LODISH HF, 1984, J CELL BIOL, V98, P1720, DOI 10.1083/jcb.98.5.1720
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759
   Sakamoto E, 1999, IMMUNOPHARMACOLOGY, V45, P207, DOI 10.1016/S0162-3109(99)00079-X
   Santamaria I, 1998, J BIOL CHEM, V273, P16816, DOI 10.1074/jbc.273.27.16816
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sivaraman J, 2000, J MOL BIOL, V295, P939, DOI 10.1006/jmbi.1999.3410
   STANLEY P, 1975, CELL, V6, P121, DOI 10.1016/0092-8674(75)90002-1
   Therrien C, 2001, BIOCHEMISTRY-US, V40, P2702, DOI 10.1021/bi002460a
   Turk D, 2001, EMBO J, V20, P6570, DOI 10.1093/emboj/20.23.6570
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 29
TC 52
Z9 53
U1 0
U2 3
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2005
VL 16
IS 3
BP 1258
EP 1267
DI 10.1091/mbc.E04-08-0708
PG 10
WC Cell Biology
SC Cell Biology
GA 902SZ
UT WOS:000227378100021
PM 15635097
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Chauvinism in science
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4153 Reinach, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Unterer Rebbergweg 33, CH-4153 Reinach, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD FEB 28
PY 2005
VL 579
IS 6
BP 1321
EP 1323
DI 10.1016/j.febslet.2005.01.033
PG 3
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 902YX
UT WOS:000227393700001
PM 15733835
OA Bronze
DA 2021-01-25
ER

PT J
AU Mota, LJ
   Journet, L
   Sorg, I
   Agrain, C
   Cornelis, GR
AF Mota, LJ
   Journet, L
   Sorg, I
   Agrain, C
   Cornelis, GR
TI Bacterial injectisomes: Needle length does matter
SO SCIENCE
LA English
DT Article
ID PROTEIN
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397; Journet, Laure/0000-0002-5847-2962
CR COMELIS GR, 2002, NATURE REV MOL CELL, V3, P742
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   Hamburger ZA, 1999, SCIENCE, V286, P291, DOI 10.1126/science.286.5438.291
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
NR 6
TC 104
Z9 106
U1 0
U2 7
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD FEB 25
PY 2005
VL 307
IS 5713
BP 1278
EP 1278
DI 10.1126/science.1107679
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 901WP
UT WOS:000227313200049
PM 15731447
DA 2021-01-25
ER

PT J
AU Goncalves, E
   Kitas, E
   Seelig, J
AF Goncalves, E
   Kitas, E
   Seelig, J
TI Binding of oligoarginine to membrane lipids and heparan sulfate:
   Structural and thermodynamic characterization of a cell-penetrating
   peptide
SO BIOCHEMISTRY
LA English
DT Article
ID PROTEIN TRANSDUCTION DOMAINS; NUCLEAR-MAGNETIC-RESONANCE; HIV-1 TAT
   PROTEIN; ANTENNAPEDIA HOMEODOMAIN; 3RD HELIX; CATIONIC POLYPEPTIDES;
   EPITHELIAL-CELLS; AQUEOUS-SOLUTION; PLASMA-MEMBRANE; RICH PEPTIDES
AB Cell-penetrating peptides (CPPs) comprise a group of arginine-rich oligopeptides that are able to deliver exogenous cargo into cells. A first step in the internalization of CPPs is their binding to the cell surface, a reaction likely to involve membrane phospholipids and/or heparan sulfate proteoglycans (HSPGs). The present work characterizes the interaction of R-9, one of the most efficient CPPs, with either heparan sulfate (HS) or lipid vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylcholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylglycerol (POPG). Isothermal titration calorimetry shows that R9 binds to HS with high affinity. Assuming that HS has n independent and equivalent binding sites for R-9, we find an association constant of 3.1 x 10(6) M-1 at 28 degreesC. At this temperature, the reaction enthalpy is DeltaH(pep)degrees = -5.5 kcal/mol and similar to7 R-9 molecules bind per HS chain, which is equivalent to similar to0.95 cationic/anionic charge ratio. AH' decreases in magnitude upon an increase in temperature, and the reaction becomes entropy-driven at higher temperatures (greater than or equal to 37 degreesC). The positive heat-capacity change entailed by this reaction (DeltaC(p)degrees = +167 cal mol(-1) K-1) indicates the loss of polar residues on R-9-HS binding, suggesting that hydrophobic forces play no major role on binding. Calorimetric analysis of the interaction of R-9 with POPC/POPG (75:25) vesicles reveals an association constant of 8.2 x 10(4) M-1 at 28 T. Using a surface partition equilibrium model to correct for electrostatic effects, we find an intrinsic partition constant of similar to900 M-1, a value that is also confirmed by electrophoretic mobility measurements. This corresponds to an electrostatic contribution of similar to33% to the total free energy of binding. Deuterium nuclear magnetic resonance (NMR) shows no change in the headgroup, conformation of POPC and POPG, suggesting that binding takes place at some distance from the plane of the polar groups. P-31 NMR indicates that the lipid bilayer remains intact upon R9 binding. The fact that R9 binds with greater affinity to HS than to anionic lipid vesicles makes the former molecule a more likely target in binding this CPP to the cell surface.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   F Hoffmann La Roche Ltd, Pharma Div, Preclin Res, CH-4070 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR AKUTSU H, 1981, BIOCHEMISTRY-US, V20, P7366, DOI 10.1021/bi00529a007
   Astriab-Fisher A, 2002, PHARMACEUT RES, V19, P744, DOI 10.1023/A:1016136328329
   Atherton E., 1989, SOLID PHASE PEPTIDE
   Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x
   BESCHIASCHVILI G, 1991, BIOCHIM BIOPHYS ACTA, V1061, P78, DOI 10.1016/0005-2736(91)90270-I
   BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P10995, DOI 10.1021/bi00501a018
   BESCHIASCHVILI G, 1990, BIOCHEMISTRY-US, V29, P52, DOI 10.1021/bi00453a007
   BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340
   Connors K. A., 1987, BINDING CONSTANTS
   Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200
   DAVID G, 1993, FASEB J, V7, P1023
   Dehio C, 1998, EXP CELL RES, V242, P528, DOI 10.1006/excr.1998.4116
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s
   Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200
   Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200
   Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147
   Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x
   Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200
   Futaki S, 2002, BIOCHEMISTRY-US, V41, P7925, DOI 10.1021/bi0256173
   GELMAN RA, 1973, BIOPOLYMERS, V12, P1223, DOI 10.1002/bip.1973.360120603
   GELMAN RA, 1974, BIOPOLYMERS, V13, P139, DOI 10.1002/bip.1974.360130109
   GELMAN RA, 1973, BIOPOLYMERS, V12, P1959, DOI 10.1002/bip.1973.360120904
   GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q
   Hiemenz P. C., 1997, PRINCIPLES COLLOID S
   Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x
   HUNTER RJ, 1981, POTENTIAL COLLOID SC
   Jarver P, 2004, DRUG DISCOV TODAY, V9, P395, DOI 10.1016/S1359-6446(04)03042-9
   KIM JY, 1991, BIOPHYS J, V60, P135, DOI 10.1016/S0006-3495(91)82037-9
   KUCHINKA E, 1989, BIOCHEMISTRY-US, V28, P4216, DOI 10.1021/bi00436a014
   Lewis G.N., 1961, THERMODYNAMICS
   LOVE DC, 1993, J CELL BIOL, V123, P759, DOI 10.1083/jcb.123.3.759
   Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450
   Lundberg P, 2003, J MOL RECOGNIT, V16, P227, DOI 10.1002/jmr.630
   Mason J T, 1978, Ann N Y Acad Sci, V308, P29, DOI 10.1111/j.1749-6632.1978.tb22012.x
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   MURPHY KP, 1991, J MOL BIOL, V222, P699, DOI 10.1016/0022-2836(91)90506-2
   Nebel S, 1997, BIOCHEMISTRY-US, V36, P2853, DOI 10.1021/bi961839n
   Nori A, 2003, BIOCONJUGATE CHEM, V14, P44, DOI 10.1021/bc0255900
   RAND RP, 1989, BIOCHIM BIOPHYS ACTA, V988, P351, DOI 10.1016/0304-4157(89)90010-5
   RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536
   ROUX M, 1988, EUR BIOPHYS J BIOPHY, V16, P267
   Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313
   Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l
   SCHERER PG, 1987, EMBO J, V6, P2915, DOI 10.1002/j.1460-2075.1987.tb02595.x
   Schimmel P, 1980, BIOPHYSICAL CHEM 3, P849
   Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569
   SEELIG A, 1988, BIOCHIM BIOPHYS ACTA, V939, P267, DOI 10.1016/0005-2736(88)90070-3
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   SEELIG J, 1987, BIOCHEMISTRY-US, V26, P7535, DOI 10.1021/bi00398a001
   SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273
   Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x
   Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200
   TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525
   TERZI E, 1994, BIOCHEMISTRY-US, V33, P7434, DOI 10.1021/bi00189a051
   Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049
   Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5
   Torchilin VP, 2003, P NATL ACAD SCI USA, V100, P1972, DOI 10.1073/pnas.0435906100
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   van Holde K. E., 1998, PRINCIPLES PHYS BIOC, P587
   Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Wender PA, 2002, J AM CHEM SOC, V124, P13382, DOI 10.1021/ja0275109
   Wenk MR, 1998, BIOCHEMISTRY-US, V37, P3909, DOI 10.1021/bi972615n
   Wieprecht T, 2002, CURR TOP MEMBR, V52, P31
   WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3
   WOHLGEMUTH R, 1980, BIOCHEMISTRY-US, V19, P3315, DOI 10.1021/bi00555a033
   Xu YH, 1996, BIOCHEMISTRY-US, V35, P5616, DOI 10.1021/bi9602019
   Zhao M, 2004, MED RES REV, V24, P1, DOI 10.1002/med.10056
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
   ZIEGLER A, 2004, IN PRESS BIOCHEMISTR
NR 80
TC 159
Z9 161
U1 2
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 22
PY 2005
VL 44
IS 7
BP 2692
EP 2702
DI 10.1021/bi048046i
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 898KH
UT WOS:000227075200049
PM 15709783
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Frederix, PLTM
   Yang, JL
   Martin, S
   Pellmont, Y
   Steinacher, M
   Zach, S
   Langenbach, E
   Heimbeck, HJ
AF Hoogenboom, BW
   Frederix, PLTM
   Yang, JL
   Martin, S
   Pellmont, Y
   Steinacher, M
   Zach, S
   Langenbach, E
   Heimbeck, HJ
TI A Fabry-Perot interferometer for micrometer-sized cantilevers
SO APPLIED PHYSICS LETTERS
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; NANOELECTROMECHANICAL SYSTEMS
AB We have developed a Fabry-Perot interferometer detecting the deflection of micrometer-sized cantilevers and other micromechanical devices, at a working distance of 0.8 mm. At 1 MHz, a noise floor of fm/ rootHz is obtained. The detector is mounted on a piezo motor for three-axis alignment. The angular alignment is not critical. The interferometer can be operated in vacuum, air, and liquid. It is particularly suited for scanning force microscopy with small cantilevers, or with larger cantilevers simultaneously monitoring vertical and lateral forces. (C) 2005 American Institute of Physics.
C1 Univ Basel, Biozentrum, Inst Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, ME Muller Inst Biomech, CH-4056 Basel, Switzerland.
   IBM Corp, Div Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland.
   FISBA OPT AG, CH-9016 St Gallen, Switzerland.
   Swiss Fed Labs Mat Testing & Res, EMPA, CH-8600 Dubendorf, Switzerland.
RP Hoogenboom, BW (corresponding author), Univ Basel, Biozentrum, Inst Phys, CH-4056 Basel, Switzerland.
EM bart.hoogenboom@unibas.ch
OI Hoogenboom, Bart/0000-0002-8882-4324
CR Carr DW, 1997, J VAC SCI TECHNOL B, V15, P2760, DOI 10.1116/1.589722
   Craighead HG, 2000, SCIENCE, V290, P1532, DOI 10.1126/science.290.5496.1532
   FREDERIX PLT, 2002, Patent No. 0203253
   HOOGENBOOM BW, 2003, Patent No. 03025187
   Kawakatsu H, 2002, REV SCI INSTRUM, V73, P2317, DOI 10.1063/1.1480459
   Oral A, 2003, REV SCI INSTRUM, V74, P3656, DOI 10.1063/1.1593786
   RUGAR D, 1989, APPL PHYS LETT, V55, P2588, DOI 10.1063/1.101987
   SARID D, 1991, SCANNING FORCE MICRO
   Schaffer TE, 1996, J APPL PHYS, V80, P3622, DOI 10.1063/1.363308
   Vaughan J. M., 1989, FABRY PEROT INTERFER
   Waters RL, 2002, APPL PHYS LETT, V81, P3320, DOI 10.1063/1.1518557
   YANG J, IN PRESS APPL PHYS L
NR 12
TC 66
Z9 67
U1 3
U2 16
PU AMER INST PHYSICS
PI MELVILLE
PA CIRCULATION & FULFILLMENT DIV, 2 HUNTINGTON QUADRANGLE, STE 1 N O 1,
   MELVILLE, NY 11747-4501 USA
SN 0003-6951
J9 APPL PHYS LETT
JI Appl. Phys. Lett.
PD FEB 14
PY 2005
VL 86
IS 7
AR 074101
DI 10.1063/1.1866229
PG 3
WC Physics, Applied
SC Physics
GA 903PZ
UT WOS:000227439400104
OA Green Published
DA 2021-01-25
ER

PT J
AU Handschin, C
   Gnerre, C
   Fraser, DJ
   Martinez-Jimenez, C
   Jover, R
   Meyer, UA
AF Handschin, C
   Gnerre, C
   Fraser, DJ
   Martinez-Jimenez, C
   Jover, R
   Meyer, UA
TI Species-specific mechanisms for cholesterol 7 alpha-hydroxylase (CYP7A1)
   regulation by drugs and bile acids
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE phenobarbital; CXR; CYP7A1; HNF4 alpha; bile acids; xenosensors; nuclear
   receptors; drugs; xenobiotics; chicken
ID ORPHAN NUCLEAR RECEPTOR; PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE
   RECEPTOR; NEGATIVE FEEDBACK-REGULATION; HYDROXYLASE GENE CYP7A;
   DIETARY-CHOLESTEROL; TRANSCRIPTIONAL ACTIVATION; STEROL 27-HYDROXYLASE;
   HORMONAL-REGULATION; DOWN-REGULATION
AB The gene encoding cholesterol 7alpha-hydroxylase (CYP7A1) is tightly regulated in order to control intrahepatic cholesterol and bile acid levels. Ligands of the xenobiotic-sensing pregnane X receptor inhibit CYP7A1 expression. To retrace the evolution of the molecular mechanisms underlying CYP7A1 inhibition, we used a chicken hepatoma cell system that retains the ability to be induced by phenobarbital and other drugs. Whereas bile acids regulate CYP7A1 via small heterodimer partner and liver receptor homolog-1, mRNA expression of these nuclear receptors is unchanged by xenobiotics. Instead, drugs repress chicken hepatic nuclear factor 4alpha (HNF4alpha) transcript levels concomitant with a reduction in CYP7A1 expression. Importantly, no reduction of HNF4alpha levels is found in mouse liver in vivo and in human primary hepatocyte cultures, respectively. Thus, besides the importance of HNF4alpha in CYP7A1 regulation in all species, birds and mammals use different signaling pathways to adjust CYP7A1 levels after exposure to xenobiotics. (C) 2004 Elsevier Inc. All rights reserved.
C1 Univ Basel, Div Pharmacol Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   Hosp Univ La Fe, Unidad Hepatol Expt, Ctr Invest, E-46009 Valencia, Spain.
   Univ Valencia, Fac Med, Dept Bioquim & Biol Mol, E-46010 Valencia, Spain.
RP Meyer, UA (corresponding author), Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
RI Handschin, Christoph/E-6886-2015; Martinez, Celia/AAO-8191-2020;
   Martinez, Celia/K-8751-2012; Jover, Ramiro/O-9796-2017
OI Handschin, Christoph/0000-0003-0603-1097; Martinez,
   Celia/0000-0002-9534-6201; Martinez, Celia/0000-0002-9534-6201; Jover,
   Ramiro/0000-0002-4914-5804
CR Agellon LB, 2002, J BIOL CHEM, V277, P20131, DOI 10.1074/jbc.C200105200
   Bailly A, 2001, NUCLEIC ACIDS RES, V29, P3495, DOI 10.1093/nar/29.17.3495
   Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Cheema SK, 2000, J BIOL CHEM, V275, P12530, DOI 10.1074/jbc.275.17.12530
   Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200
   Chen WL, 2001, J LIPID RES, V42, P1402
   Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   Chiang JYL, 1998, FRONT BIOSCI, V3, P176
   Cooper AD, 1997, J BIOL CHEM, V272, P3444, DOI 10.1074/jbc.272.6.3444
   CRESTANI M, 1995, J LIPID RES, V36, P2419
   Crestani M, 1998, J LIPID RES, V39, P2192
   Davis RA, 2002, J LIPID RES, V43, P533
   De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200
   De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200
   DeFabiani E, 1996, BIOCHEM BIOPH RES CO, V226, P663, DOI 10.1006/bbrc.1996.1412
   del Castillo-Olivares A, 2000, NUCLEIC ACIDS RES, V28, P3587
   Drewes T, 1996, MOL CELL BIOL, V16, P925
   Fuchs M, 2003, AM J PHYSIOL-GASTR L, V284, pG551, DOI 10.1152/ajpgi.00468.2002
   Gbaguidi GF, 2002, BBA-MOL CELL BIOL L, V1583, P229, DOI 10.1016/S1388-1981(02)00217-2
   Goodwin B, 2002, AM J PHYSIOL-GASTR L, V282, pG926, DOI 10.1152/ajpgi.00044.2002
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246
   Gullberg H, 2000, MOL ENDOCRINOL, V14, P1739, DOI 10.1210/me.14.11.1739
   Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Hatzis P, 2001, MOL CELL BIOL, V21, P7320, DOI 10.1128/MCB.21.21.7320-7330.2001
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Holewa B, 1997, MOL CELL BIOL, V17, P687, DOI 10.1128/MCB.17.2.687
   Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503
   HORTON JD, 1995, J BIOL CHEM, V270, P5381, DOI 10.1074/jbc.270.10.5381
   Jover R, 2001, HEPATOLOGY, V33, P668, DOI 10.1053/jhep.2001.22176
   Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   Kocarek TA, 2002, MOL PHARMACOL, V62, P1177, DOI 10.1124/mol.62.5.1177
   Kudo T, 1997, GENE, V197, P261, DOI 10.1016/S0378-1119(97)00270-9
   LAVERY DJ, 1993, GENE DEV, V7, P1871, DOI 10.1101/gad.7.10.1871
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Marrapodi M, 2000, J LIPID RES, V41, P514
   Mitchell SMS, 2002, MOL GENET METAB, V76, P148, DOI 10.1016/S1096-7192(02)00027-6
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Nguyen LB, 1999, METABOLISM, V48, P1542, DOI 10.1016/S0026-0495(99)90243-3
   Niesor EJ, 2001, CURR PHARM DESIGN, V7, P231, DOI 10.2174/1381612013398185
   Nitta M, 1999, P NATL ACAD SCI USA, V96, P6660, DOI 10.1073/pnas.96.12.6660
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Pandak WM, 1997, J LIPID RES, V38, P2483
   Patel DD, 2000, BIOCHEM J, V351, P747, DOI 10.1042/0264-6021:3510747
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Pietrokovski S, 1998, TRENDS GENET, V14, P162, DOI 10.1016/S0168-9525(98)01421-8
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Post SM, 2001, ARTERIOSCL THROM VAS, V21, P1840, DOI 10.1161/hq1101.098228
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Repa JJ, 2000, SCIENCE, V289, P1524, DOI 10.1126/science.289.5484.1524
   Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628
   RUDEL L, 1994, J CLIN INVEST, V93, P2463, DOI 10.1172/JCI117255
   RUSSELL DW, 1992, BIOCHEMISTRY-US, V31, P4737, DOI 10.1021/bi00135a001
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Stroup D, 2000, J LIPID RES, V41, P1
   Stroup D, 1997, J BIOL CHEM, V272, P9833
   Wang DP, 1996, J LIPID RES, V37, P1831
   Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Yang YZ, 2002, BBA-MOL CELL BIOL L, V1583, P63, DOI 10.1016/S1388-1981(02)00186-5
NR 74
TC 5
Z9 5
U1 2
U2 8
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD FEB 1
PY 2005
VL 434
IS 1
BP 75
EP 85
DI 10.1016/j.abb.2004.10.010
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 889QO
UT WOS:000226457700011
PM 15629111
DA 2021-01-25
ER

PT J
AU Kussebi, F
   Karamloo, F
   Rhyner, C
   Schmid-Grendelmeier, P
   Salagianni, M
   Mannhart, C
   Akdis, M
   Soldatova, L
   Markovic-Housley, Z
   von Beust, BR
   Kundig, T
   Kemeny, DM
   Blaser, K
   Crameri, R
   Akdis, CA
AF Kussebi, F
   Karamloo, F
   Rhyner, C
   Schmid-Grendelmeier, P
   Salagianni, M
   Mannhart, C
   Akdis, M
   Soldatova, L
   Markovic-Housley, Z
   von Beust, BR
   Kundig, T
   Kemeny, DM
   Blaser, K
   Crameri, R
   Akdis, CA
TI A major allergen gene-fusion protein for potential usage in
   allergen-specific immunotherapy
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE specific immunnotherapy; allergy; bee venom; T cells; IgE
ID BIRCH POLLEN ALLERGEN; T-CELL; BEE VENOM; PHOSPHOLIPASE A(2); IGE;
   ANTIBODIES; INDUCTION; FRAGMENTS; BINDING; ANERGY
AB Background: Specific immunotherapy is a common treatment of allergic diseases and could potentially be applied to other immunologic disorders. Despite its use in clinical practice, more defined and safer allergy vaccine preparations are required. Differences between epitopes of IgE that recognize the 3-dimensional structure of allergens and T cells that recognize linear amino acid sequences provide a suitable tool for novel vaccine development for specific immunotherapy.
   Objective: The aim of the study was to delete B-cell epitopes and prevent IgE crosslinking, but to preserve T-cell epitopes by fusion of 2 major allergens of bee venom because of a change in the conformation.
   Methods: By genetic engineering, we produced a fusion protein composed of the 2 major bee venom allergens: phospholipase A(2) (Api m 1) and hyaluronidase (Api m 2).
   Results: The Api m [1/2] fusion protein induced T-cell proliferation and both T(H)1-type and T(H)2-type cytokine responses. In contrast, IgE reactivity was abolished, and profoundly reduced basophil degranulation and type 1 skin test reactivity was observed. Pretreatment of mice with Api m [1/2] fusion protein significantly suppressed the development of specific IgE as well as other antibody isotypes after immunization with the native allergen.
   Conclusion: The novel fusion protein of 2 major allergens bypasses IgE binding and mast cell/basophil IgE FcepsilonRI crosslinking and protects from IgE development.
C1 Swiss Inst Allergy & Asthma Res, CH-7270 Davos, Switzerland.
   Dept Dermatol, Allergy Unit, Zurich, Switzerland.
   Rayne Inst, Sch Med, Dept Immunol, London, England.
   US FDA, Ctr Biol Evaluat & Res, Div Allergen Prod & Parasitol, Lab Immunobiochem, Bethesda, MD 20014 USA.
   Univ Basel, Biozentrum, Div Struct Biol, Basel, Switzerland.
RP Kussebi, F (corresponding author), Charite, Childrens Hosp, Dept Pneumol & Immunol, Augustenburger Pl 1, D-13353 Berlin, Germany.
EM fatimah.kussebi@charite.de
RI Akdis, Cezmi/AAV-4844-2020
CR Achatz G, 1997, SCIENCE, V276, P409, DOI 10.1126/science.276.5311.409
   Akdis CA, 1998, J CLIN INVEST, V102, P98, DOI 10.1172/JCI2250
   Akdis CA, 1998, EUR J IMMUNOL, V28, P914, DOI 10.1002/(SICI)1521-4141(199803)28:03<914::AID-IMMU914>3.0.CO;2-C
   Akdis CA, 1999, FASEB J, V13, P603
   Akdis CA, 1996, J CLIN INVEST, V98, P1676, DOI 10.1172/JCI118963
   Akdis CA, 2001, TRENDS IMMUNOL, V22, P175, DOI 10.1016/S1471-4906(01)01862-2
   Akdis M, 2004, J EXP MED, V199, P1567, DOI 10.1084/jem.20032058
   Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4
   Brehler R, 2000, J ALLERGY CLIN IMMUN, V105, P1231, DOI 10.1067/mai.2000.105708
   CAHEN YDM, 1997, SCHWEIZ MED WOCHENSC, V7, P5
   CARBALLIDO JM, 1993, J IMMUNOL, V150, P3582
   Clark ED, 2001, CURR OPIN BIOTECH, V12, P202, DOI 10.1016/S0958-1669(00)00200-7
   Coyle AJ, 1996, J EXP MED, V183, P1303, DOI 10.1084/jem.183.4.1303
   Durham SR, 1998, J ALLERGY CLIN IMMUN, V102, P157, DOI 10.1016/S0091-6749(98)70079-X
   Faith A, 1997, J IMMUNOL, V159, P53
   LIVINGSTONE AM, 1987, ANNU REV IMMUNOL, V5, P477, DOI 10.1146/annurev.iy.05.040187.002401
   Marcotte GV, 1998, J ALLERGY CLIN IMMUN, V101, P506, DOI 10.1016/S0091-6749(98)70358-6
   MARSH DG, 1981, J ALLERGY CLIN IMMUN, V68, P449, DOI 10.1016/0091-6749(81)90199-8
   MOSER M, 1992, J IMMUNOL, V149, P454
   Muller U, 1998, J ALLERGY CLIN IMMUN, V101, P747, DOI 10.1016/S0091-6749(98)70402-6
   Muller UR, 2001, INT ARCH ALLERGY IMM, V124, P447, DOI 10.1159/000053779
   Neudecker P, 2003, BIOCHEM J, V376, P97, DOI 10.1042/BJ20031057
   OBRIEN RM, 1995, IMMUNOLOGY, V86, P176
   SCHNEIDER T, 1994, INT ARCH ALLERGY IMM, V104, P262, DOI 10.1159/000236675
   Thomas MJ, 2002, J IMMUNOL, V168, P216, DOI 10.4049/jimmunol.168.1.216
   Valenta R, 2002, NAT REV IMMUNOL, V2, P446, DOI 10.1038/nri824
   van Neerven RJJ, 1999, J IMMUNOL, V163, P2944
   Vrtala S, 2000, J IMMUNOL, V165, P6653, DOI 10.4049/jimmunol.165.11.6653
   Vrtala S, 1997, J CLIN INVEST, V99, P1673, DOI 10.1172/JCI119330
   Xu XB, 1998, BIOCHEMISTRY-US, V37, P7561, DOI 10.1021/bi980086x
NR 30
TC 76
Z9 84
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD FEB
PY 2005
VL 115
IS 2
BP 323
EP 329
DI 10.1016/j.jaci.2004.11.041
PG 7
WC Allergy; Immunology
SC Allergy; Immunology
GA 897YU
UT WOS:000227043600017
PM 15696088
DA 2021-01-25
ER

PT J
AU Jung, AC
   Denholm, B
   Skaer, H
   Affolter, M
AF Jung, AC
   Denholm, B
   Skaer, H
   Affolter, M
TI Renal tubule development in Drosophila: A closer look at the cellular
   level
SO JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
LA English
DT Article
ID MALPIGHIAN TUBULES; BRANCHING MORPHOGENESIS; EPITHELIAL TISSUES;
   MELANOGASTER; GENE; PROTEIN; KRUPPEL; RIBBON; TUBE; TRANSPORT
AB The function of excretion in insects is performed by the Malpighian tubules, a functional equivalent of the vertebrate kidney. Malpighian tubules are long, thin tubes connected to the hindgut. Upon the determination of the Malpighian tubule major cell type early in embryogenesis, the tubular architecture is achieved by extensive cell division and cell rearrangements. During the tube elongation process, cells exchange their neighbors, allowing the short and fat Malpighian tubule primordia to grow and become a thin tube. Cell rearrangement and intercalation underlie the morphogenesis of other epithelial tissues in Drosophila melanogaster, such as the embryonic epidermis. Recent work has provided insights in the cellular and molecular basis of cell intercalation. These advances are reviewed and discussed with regard to what is known about Malpighian tubule morphogenesis. Mature Malpighian tubules are composed of two cell types, each having a specific function in excretion: The principal cells and the stellate cells. Drosophila and mammalian kidney development show striking similarities, as the recruitment of the stellate cells to the Malpighian tubules, like the cells of the metartephric mesenchyme, requires that cells undergo a mesenchymal-to-epithelial transition. The molecular similarities between these two cases is reviewed here.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   Univ Cambridge, Dept Zool, Cambridge, England.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Jung, Alain/AAC-6598-2019; Jung, Alain/X-5384-2019
OI Jung, Alain/0000-0002-4049-4151; Affolter, Markus/0000-0002-5171-0016
CR Abrams EW, 2003, TRENDS CELL BIOL, V13, P247, DOI 10.1016/S0962-8924(03)00055-2
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Ainsworth C, 2000, PHILOS T ROY SOC B, V355, P931, DOI 10.1098/rstb.2000.0628
   BAKER NE, 1988, DEVELOPMENT, V103, P289
   Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590
   Blake KJ, 1999, DEV GENES EVOL, V209, P555, DOI 10.1007/s004270050288
   Cagan R, 2003, CURR OPIN NEPHROL HY, V12, P11, DOI 10.1097/00041552-200301000-00003
   Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677
   Denholm B, 2003, CURR BIOL, V13, P1052, DOI 10.1016/S0960-9822(03)00375-0
   DENHOLM B, 2004, COMPREHENSIVE MOL IN
   GLOOR H., 1950, ARCH JULIUS KLAUS STIFT, V25, P38
   HARBECKE R, 1989, GENE DEV, V3, P114, DOI 10.1101/gad.3.1.114
   HOCH M, 1994, DEVELOPMENT, V120, P3439
   Jack J, 1997, GENETICS, V147, P243
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X
   KISPERT A, 2003, WNT SIGNALING DEV, P120
   Linton SM, 1999, J EXP BIOL, V202, P1561
   LIU S, 1992, DEV BIOL, V150, P133, DOI 10.1016/0012-1606(92)90013-7
   O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039
   O'Donnell MJ, 2000, J INSECT PHYSIOL, V46, P107, DOI 10.1016/S0022-1910(99)00119-5
   ODonnell MJ, 1996, J EXP BIOL, V199, P1163
   REDEMANN N, 1988, NATURE, V332, P90, DOI 10.1038/332090a0
   Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962
   Shah MM, 2004, DEVELOPMENT, V131, P1449, DOI 10.1242/dev.01089
   Shim K, 2001, DEVELOPMENT, V128, P4923
   SKAER H, 1989, NATURE, V342, P566, DOI 10.1038/342566a0
   STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0
   YOUNG PE, 1993, GENE DEV, V7, P29, DOI 10.1101/gad.7.1.29
NR 29
TC 57
Z9 59
U1 1
U2 4
PU AMER SOC NEPHROLOGY
PI WASHINGTON
PA 1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA
SN 1046-6673
EI 1533-3450
J9 J AM SOC NEPHROL
JI J. Am. Soc. Nephrol.
PD FEB
PY 2005
VL 16
IS 2
BP 322
EP 328
DI 10.1681/ASN.2004090729
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 896UM
UT WOS:000226959400007
PM 15647336
OA Bronze
DA 2021-01-25
ER

PT J
AU Kanbe, M
   Shibata, S
   Umino, Y
   Jenal, U
   Aizawa, SI
AF Kanbe, M
   Shibata, S
   Umino, Y
   Jenal, U
   Aizawa, SI
TI Protease susceptibility of the Caulobacter crescentus flagellar
   hook-basal body: a possible mechanism of flagellar ejection during cell
   differentiation
SO MICROBIOLOGY-SGM
LA English
DT Article
ID SALMONELLA-TYPHIMURIUM; RESPONSE REGULATOR; BACILLUS-SUBTILIS;
   PURIFICATION; COMPLEX; RING
AB When motile swarmer cells of Caulobacter crescentus differentiate into sessile stalked cells, the flagellum is ejected. To elucidate the molecular mechanism of the flagellar ejection, flagellar hook-basal body (HBB) complexes from C. crescentus were purified and characterized. The purified HBBs were less stable against acidic pH or protease treatment than HBBs of Salmonella typhimurium, supporting the view that flagellar ejection from C. crescentus is initiated by destruction of the fragile basal structures. In addition, protease treatment of the purified flagella resulted in the specific digestion of the MS ring complex, revealing for the first time the intact structure of the whole rod.
C1 Japan Sci & Technol Agcy, JST, CREST, Takanezawa, Tochigi 3291206, Japan.
   Nagoya City Univ, Grad Sch Nat Sci, Nagoya, Aichi 4678501, Japan.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Aizawa, SI (corresponding author), Japan Sci & Technol Agcy, JST, CREST, 1064-18 Takahori, Takanezawa, Tochigi 3291206, Japan.
EM aizawa@softnano.org
CR AIZAWA S, 1985, J BACTERIOL, V161, P836, DOI 10.1128/JB.161.3.836-849.1985
   Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   DEPAMPHI.ML, 1971, J BACTERIOL, V105, P384, DOI 10.1128/JB.105.1.384-395.1971
   Ely B, 2000, J BACTERIOL, V182, P5001, DOI 10.1128/JB.182.17.5001-5004.2000
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100
   Kobayashi K, 2003, J BACTERIOL, V185, P5295, DOI 10.1128/JB.185.17.5295-5300.2003
   Kubori T, 1997, MOL MICROBIOL, V24, P399, DOI 10.1046/j.1365-2958.1997.3341714.x
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Schoenhals GJ, 1996, J BACTERIOL, V178, P4200, DOI 10.1128/jb.178.14.4200-4207.1996
   SHAPIRO L, 1973, J BACTERIOL, V113, P478, DOI 10.1128/JB.113.1.478-485.1973
   STALLMEYER MJB, 1989, J MOL BIOL, V205, P511, DOI 10.1016/0022-2836(89)90222-2
   Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210
   UENO T, 1992, J MOL BIOL, V227, P672, DOI 10.1016/0022-2836(92)90216-7
   UENO TK, 1994, J MOL BIOL, V235, P546
   Wu JG, 1997, MOL MICROBIOL, V24, P233, DOI 10.1046/j.1365-2958.1997.3281691.x
NR 17
TC 20
Z9 20
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 1350-0872
EI 1465-2080
J9 MICROBIOL-SGM
JI Microbiology-(UK)
PD FEB
PY 2005
VL 151
BP 433
EP 438
DI 10.1099/mic.0.27386-0
PN 2
PG 6
WC Microbiology
SC Microbiology
GA 897UN
UT WOS:000227031000009
PM 15699192
DA 2021-01-25
ER

PT J
AU Seelig, A
   Gatlik-Landwojtowicz, E
AF Seelig, A
   Gatlik-Landwojtowicz, E
TI Inhibitors of multidrug efflux transporters: Their membrane and protein
   interactions
SO MINI-REVIEWS IN MEDICINAL CHEMISTRY
LA English
DT Review
DE P-glycoprotein; first-; second-; and third-generation inhibitors;
   modulators; membrane partitioning; transporter binding; transport
   kinetics
ID BLOOD-BRAIN-BARRIER; HUMAN P-GLYCOPROTEIN; POTENT
   CYCLOPROPYLDIBENZOSUBERANE MODULATOR; HUMAN LIVER-MICROSOMES; IN-VIVO
   REVERSAL; ATPASE ACTIVITY; DRUG-RESISTANCE; MONOCLONAL-ANTIBODY; ABC
   TRANSPORTERS; PLASMA-MEMBRANE
AB Modulators and inhibitors of multidrug efflux transporters, like P-glycoprotein, are used to reduce or inhibit multidrug resistance, MDR, which leads to a failure of the chemotherapy of e.g. cancers, epilepsy, bacterial, parasitic, and fungal diseases. Binding and transport of first-, second-, and third-generation modulators and inhibitors of P-glycoprotein are discussed, taking into account the properties of the drug (H-bonding potential, dimensions, and pK(a) values) as well as the properties of the membrane.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Abderrabi M, 1996, ANTI-CANCER DRUG, V7, P430, DOI 10.1097/00001813-199606000-00009
   Aebi S, 1999, CANCER CHEMOTH PHARM, V44, P259, DOI 10.1007/s002800050976
   ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
   ALSHAWI MK, 1994, J BIOL CHEM, V269, P8986
   Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361
   Avendano C, 2002, CURR MED CHEM, V9, P159, DOI 10.2174/0929867023371175
   Batrakova EV, 2003, J PHARMACOL EXP THER, V304, P845, DOI 10.1124/jpet.102.043307
   Bauer B, 2003, PHARM RES-DORDR, V20, P1170, DOI 10.1023/A:1025040712857
   BLUME A, 1979, BIOCHIM BIOPHYS ACTA, V557, P32, DOI 10.1016/0005-2736(79)90087-7
   Bogman K, 2003, J PHARM SCI, V92, P1250, DOI 10.1002/jps.10395
   BOGUSLAVSKY V, 1994, BIOCHEMISTRY-US, V33, P3032, DOI 10.1021/bi00176a036
   BORST P, 1995, ANNU REV MICROBIOL, V49, P427, DOI 10.1146/annurev.mi.49.100195.002235
   Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055
   Busse D, 1995, N-S ARCH PHARMACOL, V353, P116
   Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5
   Cantor C.R., 1980, BIOPHYSICAL CHEM
   Chen Y, 2001, CANCER RES, V61, P7763
   CHIN KV, 1990, J BIOL CHEM, V265, P221
   Dale IL, 1998, BRIT J CANCER, V78, P885, DOI 10.1038/bjc.1998.597
   Dantzig AH, 2003, ADV DRUG DELIVER REV, V55, P133, DOI 10.1016/S0169-409X(02)00175-8
   Dantzig AH, 1996, CANCER RES, V56, P4171
   Deferme S, 2002, J PHARM PHARMACOL, V54, P1213, DOI 10.1211/002235702320402053
   DEMEL RA, 1975, BIOCHIM BIOPHYS ACTA, V406, P97, DOI 10.1016/0005-2736(75)90045-0
   Doppenschmitt S, 1999, J PHARMACOL EXP THER, V288, P348
   Erdlenbruch B, 2000, EXP BRAIN RES, V135, P417
   Essodaigui M, 1999, MOL BIOCHEM PARASIT, V100, P73, DOI 10.1016/S0166-6851(99)00036-5
   Eytan GD, 1996, J BIOL CHEM, V271, P3172, DOI 10.1074/jbc.271.6.3172
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FORD JM, 1993, CYTOTECHNOLOGY, V12, P171, DOI 10.1007/BF00744664
   FORD JM, 1990, CANCER RES, V50, P1748
   Fricker G, 2002, E SCHERING RES FDN W, V37, P139
   Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69
   Germann UA, 1997, ANTI-CANCER DRUG, V8, P125, DOI 10.1097/00001813-199702000-00004
   Germann UA, 1997, ANTI-CANCER DRUG, V8, P141, DOI 10.1097/00001813-199702000-00005
   Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706
   Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188
   GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125
   Guns ES, 2001, EUR J DRUG METAB PH, V26, P273, DOI 10.1007/BF03226382
   GUPTA S, 1995, DRUG AGING, V7, P19, DOI 10.2165/00002512-199507010-00003
   Hait W N, 1989, Cancer Commun, V1, P35
   HAMADA H, 1988, CANCER RES, V48, P4926
   Hebert MF, 1999, ANN PHARMACOTHER, V33, P680, DOI 10.1345/aph.18356
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Hochman JH, 2002, CURR DRUG METAB, V3, P257, DOI 10.2174/1389200023337559
   HOFMANN J, 1991, INT J CANCER, V47, P870, DOI 10.1002/ijc.2910470614
   HOFMANN J, 1995, BIOCHEM PHARMACOL, V49, P603, DOI 10.1016/0006-2952(94)00479-6
   Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993
   HUET S, 1993, EUR J CANCER, V29A, P1377, DOI 10.1016/0959-8049(93)90005-Z
   HYAFIL F, 1993, CANCER RES, V53, P4595
   JANSEN WJM, 1994, ANN ONCOL, V5, P733, DOI 10.1093/oxfordjournals.annonc.a058978
   Jeffrey G. A., 1997, INTRO HYDROGEN BONDI
   JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7
   Kabanov AV, 2003, ADV DRUG DELIVER REV, V55, P151, DOI 10.1016/S0169-409X(02)00176-X
   Kokubu N, 1997, BIOCHEM BIOPH RES CO, V230, P398, DOI 10.1006/bbrc.1996.5970
   Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7
   Krupka RM, 1999, J MEMBRANE BIOL, V172, P129, DOI 10.1007/s002329900591
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Lavie Y, 1999, LIPIDS, V34, pS57, DOI 10.1007/BF02562229
   Lehne G, 2000, INT J CLIN PHARM TH, V38, P187
   Lentz KA, 2000, PHARM RES-DORDR, V17, P1456, DOI 10.1023/A:1007692622216
   Leonard Gregory D, 2002, Curr Opin Investig Drugs, V3, P1652
   Litman T, 2001, CELL MOL LIFE SCI, V58, P931, DOI 10.1007/PL00000912
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P147, DOI 10.1016/S0925-4439(97)00025-2
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1327.2001.02041.x
   LUM BL, 1995, HEMATOL ONCOL CLIN N, V9, P319
   Martin C, 2000, MOL PHARMACOL, V58, P624
   MCCLEAN S, 1993, BIOCHIM BIOPHYS ACTA, V1177, P117, DOI 10.1016/0167-4889(93)90030-S
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   MCMURRY L, 1980, P NATL ACAD SCI-BIOL, V77, P3974, DOI 10.1073/pnas.77.7.3974
   MECHETNER EB, 1992, P NATL ACAD SCI USA, V89, P5824, DOI 10.1073/pnas.89.13.5824
   Meyer UA, 2002, TOXICOLOGY, V181, P463, DOI 10.1016/S0300-483X(02)00452-3
   MICKISCH GH, 1990, CANCER RES, V50, P3670
   Mistry P, 2001, CANCER RES, V61, P749
   MOTZER RJ, 1995, J CLIN ONCOL, V13, P1958, DOI 10.1200/JCO.1995.13.8.1958
   Newman MJ, 2000, CANCER RES, V60, P2964
   Orlowski S, 1996, BIOCHEM J, V317, P515, DOI 10.1042/bj3170515
   PEARSON JW, 1991, J NATL CANCER I, V83, P1386, DOI 10.1093/jnci/83.19.1386
   PIERRE A, 1992, INVEST NEW DRUG, V10, P137, DOI 10.1007/BF00877238
   Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000
   Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Roe M, 1999, BIOORG MED CHEM LETT, V9, P595, DOI 10.1016/S0960-894X(99)00030-X
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Rowinsky EK, 1998, J CLIN ONCOL, V16, P2964, DOI 10.1200/JCO.1998.16.9.2964
   SAEKI T, 1993, FEBS LETT, V324, P99, DOI 10.1016/0014-5793(93)81540-G
   Sarkadi B, 1997, SEMIN CANCER BIOL, V8, P171, DOI 10.1006/scbi.1997.0069
   SATO W, 1995, CANCER CHEMOTH PHARM, V35, P271, DOI 10.1007/s002800050232
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   Schuetz EG, 1996, MOL PHARMACOL, V49, P311
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1994, P NATL ACAD SCI USA, V91, P68, DOI 10.1073/pnas.91.1.68
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Seelig A., 2002, ENCY PHYS SCI TECHNO, P355
   SEELLIG A, 2003, BIOAVAILABILITY ESTI, P461
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P189, DOI 10.1046/j.1432-1327.1998.2540189.x
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   Shepard RL, 1998, BIOCHEM PHARMACOL, V56, P719, DOI 10.1016/S0006-2952(98)00212-3
   SLATE DL, 1995, ANTICANCER RES, V15, P811
   Starling JJ, 1997, ADV ENZYME REGUL, V37, P335, DOI 10.1016/S0065-2571(96)00021-0
   Stein WD, 1997, PHYSIOL REV, V77, P545
   Stouch TR, 2002, ADV DRUG DELIVER REV, V54, P315, DOI 10.1016/S0169-409X(02)00006-6
   Syed SK, 1996, BIOCHEM MOL BIOL INT, V39, P687
   Takanaga H, 1998, BIOL PHARM BULL, V21, P1062, DOI 10.1248/bpb.21.1062
   Theodoulou FL, 2000, BBA-BIOMEMBRANES, V1465, P79, DOI 10.1199/tab.0153
   TISHLER DM, 1995, EPILEPSIA, V36, P1, DOI 10.1111/j.1528-1157.1995.tb01657.x
   TOFFOLI G, 1995, BIOCHEM PHARMACOL, V50, P1245, DOI 10.1016/0006-2952(95)02003-U
   TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G
   UCHIUMI T, 1993, CELL GROWTH DIFFER, V4, P147
   UEDA K, 1992, J BIOL CHEM, V267, P24248
   URBATSCH IL, 2003, J BIOL CHEM, V2, P2
   Valoti M, 1998, J PHARM PHARMACOL, V50, P1005, DOI 10.1111/j.2042-7158.1998.tb06915.x
   Van Bambeke F, 2000, BIOCHEM PHARMACOL, V60, P457, DOI 10.1016/S0006-2952(00)00291-4
   van Zuylen L, 2000, CLIN CANCER RES, V6, P1365
   WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302
   Wang EJ, 2001, CHEM RES TOXICOL, V14, P1596, DOI 10.1021/tx010125x
   Wolfger H, 2001, RES MICROBIOL, V152, P375, DOI 10.1016/S0923-2508(01)01209-8
   Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V346, P161, DOI 10.1006/abbi.1997.0302
   YUSA K, 1989, CANCER RES, V49, P5002
   Zhong WG, 1998, P NATL ACAD SCI USA, V95, P12088, DOI 10.1073/pnas.95.21.12088
NR 123
TC 57
Z9 57
U1 0
U2 7
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1389-5575
EI 1875-5607
J9 MINI-REV MED CHEM
JI Mini-Rev. Med. Chem.
PD FEB
PY 2005
VL 5
IS 2
BP 135
EP 151
DI 10.2174/1389557053402693
PG 17
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 896PR
UT WOS:000226946500003
PM 15720284
DA 2021-01-25
ER

PT J
AU Zhou, XHJ
   Kao, MCJ
   Huang, HY
   Wong, A
   Nunez-Iglesias, J
   Primig, M
   Aparicio, OM
   Finch, CE
   Morgan, TE
   Wong, WH
AF Zhou, XHJ
   Kao, MCJ
   Huang, HY
   Wong, A
   Nunez-Iglesias, J
   Primig, M
   Aparicio, OM
   Finch, CE
   Morgan, TE
   Wong, WH
TI Functional annotation and network reconstruction through cross-platform
   integration of microarray data
SO NATURE BIOTECHNOLOGY
LA English
DT Article
ID TRANSCRIPTIONAL REGULATORY NETWORKS; GENE-EXPRESSION;
   SACCHAROMYCES-CEREVISIAE; DISCOVERY; CIRCUITRY; MODULES
AB The rapid accumulation of microarray data translates into a need for methods to effectively integrate data generated with different platforms. Here we introduce an approach, 2(nd)-order expression analysis, that addresses this challenge by first extracting expression patterns as meta-information from each data set (1(st)-order expression analysis) and then analyzing them across multiple data sets. Using yeast as a model system, we demonstrate two distinct advantages of our approach: we can identify genes of the same function yet without coexpression patterns and we can elucidate the cooperativities between transcription factors for regulatory network reconstruction by overcoming a key obstacle, namely the quantification of activities of transcription factors. Experiments reported in the literature and performed in our lab support a significant number of our predictions.
C1 Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.
   Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA.
   Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.
   Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   Harvard Univ, Dept Stat, Cambridge, MA 02138 USA.
RP Zhou, XHJ (corresponding author), Univ So Calif, Program Mol & Computat Biol, Los Angeles, CA 90089 USA.
EM xjzhou@usc.edu; whwong@stanford.edu
RI Primig, Michael/G-3175-2013
OI Primig, Michael/0000-0002-2061-0119; Aparicio,
   Oscar/0000-0002-5591-0277; Nunez-Iglesias, Juan/0000-0002-7239-5828;
   Wong, Angela/0000-0003-2530-5727
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P20CA096470, P20CA096470, P20CA096470] Funding Source:
   NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [R01HG002341,
   R01HG002341, R01HG002341, R01HG002341, R01HG002341, R01HG002341,
   R01HG002341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM067243, R01GM067243,
   R01GM067243, R01GM067243] Funding Source: NIH RePORTER; NCI NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P20CA96470] Funding Source: Medline; NHGRI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Human Genome Research Institute (NHGRI) [R01HG02341]
   Funding Source: Medline; NIGMS NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM067243] Funding
   Source: Medline
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890
   Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Futcher B, 2002, CURR OPIN CELL BIOL, V14, P676, DOI 10.1016/S0955-0674(02)00391-5
   Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602
   Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Martins LJ, 1998, J BIOL CHEM, V273, P23716, DOI 10.1074/jbc.273.37.23716
   MOUNTAIN HA, 1993, MOL MICROBIOL, V7, P215, DOI 10.1111/j.1365-2958.1993.tb01113.x
   Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001
   Peng WT, 2004, NUCLEIC ACIDS RES, V32, P1993, DOI 10.1093/nar/gkh518
   Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539
   Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101
   Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873
   Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165
   Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447
   Tanay A, 2004, P NATL ACAD SCI USA, V101, P2981, DOI 10.1073/pnas.0308661100
   Tavazoie S, 1999, NAT GENET, V22, P281
   Tseng GC, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P396, DOI 10.1109/CSB.2003.1227343
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   ZHOU K, 1987, NUCLEIC ACIDS RES, V15, P5261, DOI 10.1093/nar/15.13.5261
   Zhou XH, 2002, P NATL ACAD SCI USA, V99, P12783, DOI 10.1073/pnas.192159399
NR 30
TC 108
Z9 112
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
PD FEB
PY 2005
VL 23
IS 2
BP 238
EP 243
DI 10.1038/nbt1058
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 894NC
UT WOS:000226797600032
PM 15654329
DA 2021-01-25
ER

PT J
AU Haberl, M
   Klein, K
   Weil, R
   Gepdiremen, A
   Zanger, UM
   Wojnowski, L
AF Haberl, M
   Klein, K
   Weil, R
   Gepdiremen, A
   Zanger, UM
   Wojnowski, L
TI CYP2A6 phenotype variation in Caucasians
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 46th Spring Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie
CY MAR 15-17, 2005
CL Mainz, GERMANY
SP Deutsche Gesellsch Experimentelle Klinische Pharmakolog Toxikolog
C1 EPIDAUROS Biotechnol AG, D-82347 Bernried, Germany.
   Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.
   Univ Basel, Div Pharmacol Neurobiol, Biozentrum, Basel, Switzerland.
   Univ Mainz, Inst Pharmakol, D-55101 Mainz, Germany.
RI Zanger, Ulrich M./A-9364-2012
OI Zanger, Ulrich M./0000-0002-5276-2002
NR 0
TC 0
Z9 0
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD FEB
PY 2005
VL 371
SU 1
MA 571
BP R137
EP R137
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 925IM
UT WOS:000229046800571
DA 2021-01-25
ER

PT J
AU Bachler, C
   Schneider, P
   Bahler, P
   Lustig, A
   Erni, B
AF Bachler, C
   Schneider, P
   Bahler, P
   Lustig, A
   Erni, B
TI Escherichia coli dihydroxyacetone kinase controls gene expression by
   binding to transcription factor DhaR
SO EMBO JOURNAL
LA English
DT Article
DE AAA plus ATPase; enhancer binding proteins; protein-protein interaction;
   PTS; transcription
ID COVALENT SUBSTRATE-BINDING; GLOBAL REPRESSOR MLC; PHOSPHOTRANSFERASE
   SYSTEM; GLUCOSE-TRANSPORTER; MECHANISM; ACTIVATOR; ATP;
   PHOSPHOENOLPYRUVATE; GLYCEROL; PRODUCTS
AB Dihydroxyacetone (Dha) kinases are a sequence-conserved family of enzymes, which utilize either ATP ( in animals, plants, bacteria) or the bacterial phosphoenolpyruvate carbohydrate phosphotransferase system (PTS) as a source of high-energy phosphate. The PTS-dependent kinase of Escherichia coli consists of three subunits: DhaK contains the Dha binding site, DhaL contains ADP as cofactor for the double displacement of phosphate from DhaM to Dha, and DhaM provides a phospho-histidine relay between the PTS and DhaL::ADP. DhaR is a transcription activator belonging to the AAA+ family of enhancer binding proteins. It stimulates transcription of the dhaKLM operon from a sigma70 promoter and autorepresses dhaR transcription. Genetic and biochemical studies indicate that the enzyme subunits DhaL and DhaK act antagonistically as coactivator and corepressor of the transcription activator by mutually exclusive binding to the sensing domain of DhaR. In the presence of Dha, DhaL is dephosphorylated and DhaL::ADP displaces DhaK and stimulates DhaR activity. In the absence of Dha, DhaL::ADP is converted by the PTS to DhaL::ATP, which does not bind to DhaR.
C1 Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.
   Univ Basel, Biozentrum, Div Biophys, Basel, Switzerland.
RP Erni, B (corresponding author), Univ Bern, Dept Chem & Biochem, Freiestr 3, CH-3012 Bern, Switzerland.
EM erni@ibc.unibe.ch
CR Beutler R, 2001, MICROBIOL-SGM, V147, P249, DOI 10.1099/00221287-147-2-249
   Boos W, 1998, MICROBIOL MOL BIOL R, V62, P204, DOI 10.1128/MMBR.62.1.204-229.1998
   Boyd D, 2000, J BACTERIOL, V182, P842, DOI 10.1128/JB.182.3.842-847.2000
   Buck M, 2000, J BACTERIOL, V182, P4129, DOI 10.1128/JB.182.15.4129-4136.2000
   DANIEL R, 1995, J BACTERIOL, V177, P4392, DOI 10.1128/jb.177.15.4392-4401.1995
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   DEUTSCHER J, 2002, BACILLUS SUBTILIS IT, P129
   FORAGE RG, 1982, J BACTERIOL, V151, P591, DOI 10.1128/JB.151.2.591-599.1982
   Garcia-Alles LF, 2004, BIOCHEMISTRY-US, V43, P13037, DOI 10.1021/bi048575m
   Gorke B, 2003, J BIOL CHEM, V278, P46219, DOI 10.1074/jbc.M308002200
   Gutknecht R, 2001, EMBO J, V20, P2480, DOI 10.1093/emboj/20.10.2480
   Hesterkamp Thomas, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P309
   Huang Sheng-he, 2001, Functional and Integrative Genomics, V1, P312, DOI 10.1007/s101420100039
   JIN RZ, 1984, J GEN MICROBIOL, V130, P83
   Joly N, 2002, J BIOL CHEM, V277, P16606, DOI 10.1074/jbc.M200991200
   Lamanda A, 2004, PROTEOMICS, V4, P599, DOI 10.1002/pmic.200300587
   Lee SJ, 2000, EMBO J, V19, P5353, DOI 10.1093/emboj/19.20.5353
   LUBINI DGE, 1979, P NATL ACAD SCI USA, V76, P2527, DOI 10.1073/pnas.76.6.2527
   Lupas AN, 2002, CURR OPIN STRUC BIOL, V12, P746, DOI 10.1016/S0959-440X(02)00388-3
   Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203
   MAO QC, 1995, J BIOL CHEM, V270, P5258, DOI 10.1074/jbc.270.10.5258
   Maze A, 2004, J BACTERIOL, V186, P4543, DOI 10.1128/JB.186.14.4543-4555.2004
   Miller J.H., 1992, SHORT COURSE BACTERI
   Molin M, 2003, J BIOL CHEM, V278, P1415, DOI 10.1074/jbc.M203030200
   MORETT E, 1993, J BACTERIOL, V175, P6067, DOI 10.1128/JB.175.19.6067-6074.1993
   Nam TW, 2001, EMBO J, V20, P491, DOI 10.1093/emboj/20.3.491
   NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13
   Paulsen IT, 2000, MICROBIOL-UK, V146, P2343, DOI 10.1099/00221287-146-10-2343
   Petersen AB, 2004, MUTAT RES-GEN TOX EN, V560, P173, DOI 10.1016/j.mrgentox.2004.03.002
   Plumbridge J, 2002, CURR OPIN MICROBIOL, V5, P187, DOI 10.1016/S1369-5274(02)00296-5
   PONTING CP, 1997, CURR BIOL, V7, P674
   Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149
   Reitzer L, 2001, MICROBIOL MOL BIOL R, V65, P422, DOI 10.1128/MMBR.65.3.422-444.2001
   SAIER MH, 1996, ESCHERICHIA COLI SAL, P1325
   Sambrook J, 1989, MOL CLONING LAB MANU
   Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777
   Schlegel A, 2002, J BACTERIOL, V184, P3069, DOI 10.1128/JB.184.11.3069-3077.2002
   Schreiber V, 2000, MOL MICROBIOL, V35, P765, DOI 10.1046/j.1365-2958.2000.01747.x
   Schurmann M, 2001, J BIOL CHEM, V276, P11055, DOI 10.1074/jbc.M008061200
   Siebold C, 2003, P NATL ACAD SCI USA, V100, P8188, DOI 10.1073/pnas.0932787100
   Studholme DJ, 2003, J BACTERIOL, V185, P1757, DOI 10.1128/JB.185.6.1757-1767.2003
   Sun JB, 2003, BIOTECHNOL PROGR, V19, P263, DOI 10.1021/bp025739m
   Tanaka Y, 2000, EMBO J, V19, P5344, DOI 10.1093/emboj/19.20.5344
   Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999
   Tessier FJ, 2003, BIOCHEM J, V369, P705, DOI 10.1042/BJ20020668
   WAITES MJ, 1981, J GEN MICROBIOL, V124, P309
   Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4
   Xu H, 2004, MOL MICROBIOL, V54, P32, DOI 10.1111/j.1365-2958.2004.04246.x
   Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X
NR 49
TC 57
Z9 58
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD JAN 26
PY 2005
VL 24
IS 2
BP 283
EP 293
DI 10.1038/sj.emboj.7600517
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 897CQ
UT WOS:000226982000006
PM 15616579
OA Green Published
DA 2021-01-25
ER

PT J
AU Salie, R
   Niederkofler, V
   Arber, S
AF Salie, R
   Niederkofler, V
   Arber, S
TI Patterning molecules: Multitasking in the nervous system
SO NEURON
LA English
DT Review
ID DROSOPHILA DERAILED RECEPTOR; AXON GUIDANCE; COMMISSURAL AXONS; NEURAL
   CREST; SPECIFICATION; REPULSION
AB Classical patterning molecules that were previously implicated in controlling cell fate choices in the nervous system have recently been shown to play additional roles in axon guidance and synaptogenesis. Bone morphogenetic proteins (BMPs), Sonic hedgehog (Shh), Writs, and fibroblast growth factors (FGFs) all participate in multiple acts of controlling neuronal circuit assembly. Depending on the cellular context, they can provide instructive signals at the growth cone or synapse or alternatively can elicit responses in the nucleus initiating transcriptional changes. Differences in signal transduction pathways may contribute to the diversity of the functional repertoire of these versatile molecules.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
CR Altmann CR, 2001, INT REV CYTOL, V203, P447
   Anderson DJ, 1997, COLD SPRING HARB SYM, V62, P493
   Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2
   Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122
   Butler SJ, 2003, NEURON, V38, P389, DOI 10.1016/S0896-6273(03)00254-X
   Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5
   Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051
   Irving C, 2002, DEVELOPMENT, V129, P5389, DOI 10.1242/dev.00117
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611
   Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019
   Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610
   Packard M, 2003, NAT REV NEUROSCI, V4, P113, DOI 10.1038/nrn1036
   Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8
   Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940
   Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025
   Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522
   Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748
NR 20
TC 32
Z9 32
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD JAN 20
PY 2005
VL 45
IS 2
BP 189
EP 192
DI 10.1016/j.neuron.2005.01.002
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 889OE
UT WOS:000226451500005
PM 15664170
DA 2021-01-25
ER

PT J
AU Schulein, R
   Guye, P
   Rhomberg, TA
   Schmid, MC
   Schroder, G
   Vergunst, AC
   Carena, I
   Dehio, C
AF Schulein, R
   Guye, P
   Rhomberg, TA
   Schmid, MC
   Schroder, G
   Vergunst, AC
   Carena, I
   Dehio, C
TI A bipartite signal mediates the transfer of type IV secretion substrates
   of Bartonella henselae into human cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE conjugative relaxase; effector protein; endothelial cell; protein
   translocation; antiapoptosis
ID HELICOBACTER-PYLORI CAGA; ENDOTHELIAL-CELLS; AGROBACTERIUM-TUMEFACIENS;
   SYSTEM; TRANSLOCATION; CONJUGATION; TRANSPORT; PROTEINS; ANTIGEN; TRAG
AB Bacterial type IV secretion (T4S) systems mediate the transfer of macromolecular substrates into various target cells, e.g., the conjugative transfer of DNA into bacteria or the transfer of virulence proteins into eukaryotic host cells. The T4S apparatus VirB of the vascular tumor-inducing pathogen Bartonella henselae causes subversion of human endothelial cell (HEC) function. Here we report the identification of multiple protein substrates of VirB, which, upon translocation into HEC, mediate all known VirB-dependent cellular changes. These Bartonella-translocated effector proteins (Beps) A-G are encoded together with the VirB system and the T4S coupling protein VirD4 on a Bartonella-specific pathogenicity island. The Beps display a modular architecture, suggesting an evolution by extensive domain duplication and reshuffling. The C terminus of each Bep harbors at least one copy of the Bep-intracellular delivery domain and a short positively charged tail sequence. This biparte C terminus constitutes a transfer signal that is sufficient to mediate VirB/VirD4-dependent intracellular delivery of reporter protein fusions. The Bep-intracellular delivery domain is also present in conjugative relaxases of bacterial conjugation systems. We exemplarily show that the C terminus of such a conjugative relaxase mediates protein transfer through the Bartonella henselae VirB/VirD4 system into HEC. Conjugative relaxases may thus represent the evolutionary origin of the here defined T4S signal for protein transfer into human cells.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Leiden Univ, Clusius Lab, Inst Biol, NL-2333 AL Leiden, Netherlands.
RP Schulein, R (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Vergunst, Annette C./O-5139-2017; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016
OI Vergunst, Annette C./0000-0002-4359-1491; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052;
   Schmid, Michael/0000-0002-3445-0013
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Chen LS, 2002, J BACTERIOL, V184, P4838, DOI 10.1128/JB.184.17.4838-4845.2002
   Christie PJ, 2001, MOL MICROBIOL, V40, P294, DOI 10.1046/j.1365-2958.2001.02302.x
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Ding ZY, 2003, TRENDS MICROBIOL, V11, P527, DOI 10.1016/j.tim.2003.09.004
   Hacker J, 2003, SCIENCE, V301, P790, DOI 10.1126/science.1086802
   KAWAMUKAI M, 1988, J BACTERIOL, V170, P3864, DOI 10.1128/jb.170.9.3864-3869.1988
   Kempf VAJ, 2000, CELL MICROBIOL, V2, P431, DOI 10.1046/j.1462-5822.2000.00072.x
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   Llosa M, 2003, P NATL ACAD SCI USA, V100, P10465, DOI 10.1073/pnas.1830264100
   Luo ZQ, 2004, P NATL ACAD SCI USA, V101, P841, DOI 10.1073/pnas.0304916101
   Nagai H, 2002, SCIENCE, V295, P679, DOI 10.1126/science.1067025
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200
   Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320
   Stein M, 2000, P NATL ACAD SCI USA, V97, P1263, DOI 10.1073/pnas.97.3.1263
   Szpirer CY, 2000, MOL MICROBIOL, V37, P1283, DOI 10.1046/j.1365-2958.2000.02077.x
   Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979
   Vergunst AC, 2003, PLANT PHYSIOL, V133, P978, DOI 10.1104/pp.103.029223
NR 26
TC 163
Z9 181
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 18
PY 2005
VL 102
IS 3
BP 856
EP 861
DI 10.1073/pnas.0406796102
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 889IF
UT WOS:000226436000060
PM 15642951
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Handschin, C
   Meyer, UA
AF Handschin, C
   Meyer, UA
TI Regulatory network of lipid-sensing nuclear receptors: roles for CAR,
   PXR, LXR, and FXR
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article; Proceedings Paper
CT 15th International Symposium on Microsomes and Drug Oxidations
CY JUL 04-09, 2004
CL Mainz, GERMANY
DE nuclear receptors; drug-induction; lipids; bile acids; cholesterol; CAR;
   PXR; LXR; FXR; cytochrome P450
ID CONSTITUTIVE-ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR;
   PROLIFERATOR-ACTIVATED RECEPTOR; 7-ALPHA-HYDROXYLASE GENE CYP7A1;
   PRIMARY CULTURED RAT; BILE-ACID SYNTHESIS; COACTIVATOR 1-ALPHA
   PGC-1-ALPHA; NEGATIVE FEEDBACK-REGULATION; CHICKEN CYP2H1 GENE;
   VITAMIN-D-RECEPTOR
AB Cloning and characterization of the orphan nuclear receptors Constitutive androstane receptor (CAR, NR1I3) and pregnane X receptor (PXR, NR1I2) led to major breakthroughs in Studying drug-mediated transcriptional induction of drug-metabolizing cytochromes P450 (CYPs). More recently, additional roles for CAR and PXR have been discovered. As examples, these xenosensors are involved in the homeostasis of cholesterol, bile acids, bilirubin, and other endogenous hydrophobic molecules in the liver: CAR and PXR thus form an intricate regulatory network with other members of the nuclear receptor superfamily, foremost the cholesterol-sensing liver X receptor (LXR, NR1H2/3) and the bile-acid-activated farnesoid X receptor (FXR, NR1H4). In this review, functional interactions between these nuclear receptors as well as the consequences on physiology and pathophysiology of the liver are discussed. (C) 2004 Elsevier Inc. All rights reserved.
C1 Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, Boston, MA 02115 USA.
   Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
RP Handschin, C (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Cell Biol, 1 Jimmy Fund Way, Boston, MA 02115 USA.
EM christoph_handschin@dfci.harvard.edu
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
CR Agellon LB, 2002, J BIOL CHEM, V277, P20131, DOI 10.1074/jbc.C200105200
   ANDERSSON M, 1994, BBA-LIPID LIPID MET, V1214, P79, DOI 10.1016/0005-2760(94)90012-4
   Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Assem M, 2004, J BIOL CHEM, V279, P22250, DOI 10.1074/jbc.M314111200
   Auwerx J, 1999, CELL, V97, P161
   Aynaci FM, 2001, J CHILD NEUROL, V16, P367
   Bachmann K, 2004, PHARMACOL RES, V50, P237, DOI 10.1016/j.phrs.2004.03.005
   BACK P, 1987, PHARMACOL THERAPEUT, V33, P153, DOI 10.1016/0163-7258(87)90044-1
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   BLOUIN RA, 1993, ARCH BIOCHEM BIOPHYS, V303, P313, DOI 10.1006/abbi.1993.1289
   Blumberg B, 1998, GENE DEV, V12, P3195, DOI 10.1101/gad.12.20.3195
   Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149
   Bodin K, 2001, J BIOL CHEM, V276, P38685, DOI 10.1074/jbc.M105127200
   Bodin K, 2002, J BIOL CHEM, V277, P31534, DOI 10.1074/jbc.M201712200
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chen JY, 2002, J BIOL CHEM, V277, P42588, DOI 10.1074/jbc.M205117200
   Cherrington NJ, 2002, J PHARMACOL EXP THER, V300, P97, DOI 10.1124/jpet.300.1.97
   Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035
   Chiang JYL, 2004, J HEPATOL, V40, P539, DOI 10.1016/j.jhep.2003.11.006
   Chiang JYL, 2003, AM J PHYSIOL-GASTR L, V284, pG349, DOI 10.1152/ajpgi.00417.2002
   Chiang JYL, 2001, GENE, V262, P257, DOI 10.1016/S0378-1119(00)00518-7
   Columbano A, 2001, HEPATOLOGY, V34, P262, DOI 10.1053/jhep.2001.26172
   Crestani M, 1998, J LIPID RES, V39, P2192
   Davis RA, 2002, J LIPID RES, V43, P533
   De Fabiani E, 2001, J BIOL CHEM, V276, P30708, DOI 10.1074/jbc.M103270200
   DeBose-Boyd RA, 2001, P NATL ACAD SCI USA, V98, P1477, DOI 10.1073/pnas.98.4.1477
   DENISON MS, 1995, J BIOL CHEM, V270, P18175, DOI 10.1074/jbc.270.31.18175
   Dessens AB, 2001, TERATOLOGY, V64, P181, DOI 10.1002/tera.1063
   Dessens AB, 1999, ARCH SEX BEHAV, V28, P31, DOI 10.1023/A:1018789521375
   Dogra SC, 1999, MOL PHARMACOL, V55, P14
   Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200
   EIRIS JM, 1995, NEUROLOGY, V45, P1155, DOI 10.1212/WNL.45.6.1155
   Forman BM, 1997, P NATL ACAD SCI USA, V94, P10588, DOI 10.1073/pnas.94.20.10588
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   Furster C, 1999, BBA-MOL CELL BIOL L, V1437, P46, DOI 10.1016/S0005-2760(98)00175-1
   Goodwin B, 2004, TRENDS PHARMACOL SCI, V25, P437, DOI 10.1016/j.tips.2004.06.007
   Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246
   Grun F, 2002, J BIOL CHEM, V277, P43691, DOI 10.1074/jbc.M206553200
   Guengrich FP, 1999, ANNU REV PHARMACOL, V39, P1, DOI 10.1146/annurev.pharmtox.39.1.1
   Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200
   GUPTA C, 1980, SCIENCE, V208, P508, DOI 10.1126/science.7367874
   GUPTA C, 1982, SCIENCE, V216, P640, DOI 10.1126/science.7200262
   GUPTA C, 1980, PEDIATR PHARMACOL, V1, P55
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2003, DRUG NEWS PERSPECT, V16, P423, DOI 10.1358/dnp.2003.16.7.829354
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   HELLER FR, 1988, INT J CLIN PHARM TH, V26, P138
   HOLLANDERS B, 1986, COMP BIOCHEM PHYS B, V84, P83, DOI 10.1016/0305-0491(86)90275-0
   Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503
   Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100
   Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385
   Ide T, 2003, MOL ENDOCRINOL, V17, P1255, DOI 10.1210/me.2002-0191
   Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0
   Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27
   Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200
   Kakizaki S, 2003, BBA-GEN SUBJECTS, V1619, P239, DOI 10.1016/S0304-4165(02)00482-8
   Kassam A, 2000, J BIOL CHEM, V275, P4345, DOI 10.1074/jbc.275.6.4345
   Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200
   Kawamoto T, 2000, MOL ENDOCRINOL, V14, P1897, DOI 10.1210/me.14.11.1897
   Kerr TA, 2002, DEV CELL, V2, P713, DOI 10.1016/S1534-5807(02)00154-5
   Kiyosawa N, 2004, ARCH TOXICOL, V78, P435, DOI 10.1007/s00204-004-0565-0
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   KOCAREK TA, 1993, TOXICOL APPL PHARM, V120, P298, DOI 10.1006/taap.1993.1115
   Kocarek TA, 2002, MOL PHARMACOL, V62, P1177, DOI 10.1124/mol.62.5.1177
   KOCAREK TA, 1995, DRUG METAB DISPOS, V23, P415
   Kocarek TA, 2002, J PHARMACOL TOXICOL, V47, P177, DOI 10.1016/S1056-8719(03)00002-9
   Kocarek TA, 1998, BIOCHEM PHARMACOL, V55, P1435, DOI 10.1016/S0006-2952(97)00658-8
   Lazar MA, 2004, J CLIN INVEST, V113, P23, DOI 10.1172/JCI200420661
   Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Lindblom TH, 2001, CURR BIOL, V11, P864, DOI 10.1016/S0960-9822(01)00236-6
   Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2
   Maglich JM, 2004, J BIOL CHEM, V279, P19832, DOI 10.1074/jbc.M313601200
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Maglich JM, 2003, NUCLEIC ACIDS RES, V31, P4051, DOI 10.1093/nar/gkg444
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362
   MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   MCDONNELL DP, 1987, SCIENCE, V235, P1214, DOI 10.1126/science.3029866
   Miyata KS, 1996, J BIOL CHEM, V271, P9189, DOI 10.1074/jbc.271.16.9189
   Moore JT, 2003, BBA-GEN SUBJECTS, V1619, P235, DOI 10.1016/S0304-4165(02)00481-6
   Moore LB, 2000, P NATL ACAD SCI USA, V97, P7500, DOI 10.1073/pnas.130155097
   Moore LB, 2000, J BIOL CHEM, V275, P15122, DOI 10.1074/jbc.M001215200
   Moore LB, 2002, MOL ENDOCRINOL, V16, P977, DOI 10.1210/me.16.5.977
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   Nikolaos T, 2004, MED SCI MONITOR, V10, pMT50
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383
   Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365
   Pascussi JM, 2003, BBA-GEN SUBJECTS, V1619, P243, DOI 10.1016/S0304-4165(02)00483-X
   Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4
   Plewka A, 1996, EXP TOXICOL PATHOL, V48, P249, DOI 10.1016/S0940-2993(96)80009-1
   Popov Y, 2004, HEPATOLOGY, V40, p463A
   Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012
   Qatanani M, 2004, PHARMACOL BIOCHEM BE, V78, P285, DOI 10.1016/j.pbb.2004.04.001
   REMMER H, 1958, NATURWISSENSCHAFTEN, V45, P522, DOI 10.1007/BF00707842
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421
   Saini SPS, 2004, MOL PHARMACOL, V65, P292, DOI 10.1124/mol.65.2.292
   Schuetz EG, 2001, J BIOL CHEM, V276, P39411, DOI 10.1074/jbc.M106340200
   Schwaninger M, 2000, J NEUROL, V247, P687, DOI 10.1007/s004150070111
   Shenoy SD, 2004, MOL PHARMACOL, V65, P1302, DOI 10.1124/mol.65.5.1302
   Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   Song C, 2000, STEROIDS, V65, P423, DOI 10.1016/S0039-128X(00)00127-6
   Staudinger J, 2001, DRUG METAB DISPOS, V29, P1467
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Staudinger JL, 2003, DRUG METAB DISPOS, V31, P523, DOI 10.1124/dmd.31.5.523
   Stedman C, 2004, J BIOL CHEM, V279, P11336, DOI 10.1074/jbc.M310258200
   SUDJANASUGIAMAN E, 1994, J LIPID RES, V35, P319
   Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397
   TERZOLO M, 1995, HORM METAB RES, V27, P148, DOI 10.1055/s-2007-979927
   THOMAS KD, 1984, ISRAEL J MED SCI, V20, P240
   Tutor-Crespo MJ, 2004, J CLIN PHARMACOL, V44, P974, DOI 10.1177/0091270004266486
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Verrotti A, 1997, J PAEDIATR CHILD H, V33, P242, DOI 10.1111/j.1440-1754.1997.tb01588.x
   Verrotti A, 1998, PEDIATR NEUROL, V19, P364, DOI 10.1016/S0887-8994(98)00084-8
   Wang HB, 2003, CURR DRUG METAB, V4, P515, DOI 10.2174/1389200033489262
   Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2
   Wang L, 2002, DEV CELL, V2, P721, DOI 10.1016/S1534-5807(02)00187-9
   Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025
   Watanabe M, 1996, MED SCI RES, V24, P257
   Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762
   Watkins RE, 2003, BIOCHEMISTRY-US, V42, P1430, DOI 10.1021/bi0268753
   WAXMAN DJ, 1992, BIOCHEM J, V281, P577, DOI 10.1042/bj2810577
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   Wietholtz H, 1996, J HEPATOL, V24, P713, DOI 10.1016/S0168-8278(96)80268-6
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023
   Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116
   Xie W, 2003, P NATL ACAD SCI USA, V100, P4150, DOI 10.1073/pnas.0438010100
   Xie W, 2000, GENE DEV, V14, P3014, DOI 10.1101/gad.846800
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   YAFFE SJ, 1966, NEW ENGL J MED, V275, P1461, DOI 10.1056/NEJM196612292752602
   Yilmaz E, 2001, ACTA NEUROL BELG, V101, P217
   Yoshikawa T, 2003, MOL ENDOCRINOL, V17, P1240, DOI 10.1210/me.2002-0190
   You L, 2004, CHEM-BIOL INTERACT, V147, P233, DOI 10.1016/j.cbi.2004.01.006
   ZANNIKOS PN, 1993, DRUG METAB DISPOS, V21, P782
   ZANNIKOS PN, 1994, INT J OBESITY, V18, P369
   Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502
   Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104
   Zhang Z, 2001, J LIPID RES, V42, P649
NR 157
TC 131
Z9 142
U1 0
U2 21
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD JAN 15
PY 2005
VL 433
IS 2
BP 387
EP 396
DI 10.1016/j.abb.2004.08.030
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 888SF
UT WOS:000226393800007
PM 15581595
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Ben-Tekaya, H
   Miura, K
   Pepperkok, R
   Hauri, HP
AF Ben-Tekaya, H
   Miura, K
   Pepperkok, R
   Hauri, HP
TI Live imaging of bidirectional traffic from the ERGIC
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE ERGIC-53; live cell imaging; membrane traffic; secretory pathway;
   vesicular stomatitis virus G protein
ID TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; INTERMEDIATE COMPARTMENT;
   SECRETORY PATHWAY; MEMBRANE-PROTEIN; ER; COPII; EXIT; IDENTIFICATION;
   DYNAMICS
AB The endoplasmic reticulum-Golgi intermediate compartment (ERGIC) defined by the cycling lectin ERGIC-53 consists of tubulovesicular clusters, but it is unknown if these membranes are transport vehicles or stationary entities. Here, we show by live imaging that GFP-ERGIC-53 mainly localizes to long-lived stationary and some short-lived highly mobile elements. Unlike the anterograde marker VSV-G-GFP, GFP-ERGIC-53 does not vectorially move to the Golgi upon exit from the ERGIC, as assessed by a novel quantitative vector field method. Dual-color imaging of GFP-ERGIC-53 and a secretory protein (signal-sequence-tagged dsRed) reveals that the stationary elements are sites of repeated sorting of retrograde and anterograde cargo, and are interconnected by highly mobile elements. These results suggest that the ERGIC is stationary and not simply a collection of mobile carriers that mediate protein traffic from endoplasmic reticulum to. Golgi.
C1 Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   European Mol Biol Lab, Dept Cell Biol & Biophys, D-69117 Heidelberg, Germany.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
OI Pepperkok, Rainer/0000-0002-9762-3583
CR ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200
   Bannykh SI, 1996, J CELL BIOL, V135, P19, DOI 10.1083/jcb.135.1.19
   Bannykh SI, 1997, J CELL BIOL, V138, P1, DOI 10.1083/jcb.138.1.1
   Bevis BJ, 2002, NAT BIOTECHNOL, V20, P83, DOI 10.1038/nbt0102-83
   Beznoussenko GV, 2002, ANAT RECORD, V268, P226, DOI 10.1002/ar.10157
   Blum R, 2000, J CELL SCI, V113, P3151
   FARQUHAR MG, 1985, ANNU REV CELL BIOL, V1, P447, DOI 10.1146/annurev.cb.01.110185.002311
   Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4
   Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013
   Hauri HP, 2000, J CELL SCI, V113, P587
   Horstmann H, 2002, J CELL SCI, V115, P4263, DOI 10.1242/jcs.00115
   Kappeler F, 1997, J BIOL CHEM, V272, P31801, DOI 10.1074/jbc.272.50.31801
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577
   Lippincott-Schwartz J, 2000, ANNU REV CELL DEV BI, V16, P557, DOI 10.1146/annurev.cellbio.16.1.557
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   LOTTI LV, 1992, J CELL BIOL, V118, P43, DOI 10.1083/jcb.118.1.43
   Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101
   Martinez-Menarguez JA, 1999, CELL, V98, P81, DOI 10.1016/S0092-8674(00)80608-X
   Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x
   Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6
   NOMURA A, 1991, PATTERN RECOGN LETT, V12, P183, DOI 10.1016/0167-8655(91)90048-Q
   Nufer O, 2003, J CELL SCI, V116, P4429, DOI 10.1242/jcs.00759
   Nufer O, 2002, J CELL SCI, V115, P619
   PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303
   PELHAM HRB, 1989, ANNU REV CELL BIOL, V5, P1, DOI 10.1146/annurev.cb.05.110189.000245
   PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   ROTHMAN JE, 1990, FASEB J, V4, P1460
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526
   SCHINDLER R, 1993, EUR J CELL BIOL, V61, P1
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   Stephens DJ, 2000, J CELL SCI, V113, P2177
   Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736
   Stephens DJ, 2001, J CELL SCI, V114, P1053
   Storrie B, 2002, TRAFFIC, V3, P521, DOI 10.1034/j.1600-0854.2002.30802.x
   Tang BL, 1995, EUR J CELL BIOL, V68, P398
   Tang Q, 1997, BIOSPECTROSCOPY, V3, P17, DOI 10.1002/(SICI)1520-6343(1997)3:1<17::AID-BSPY2>3.3.CO;2-P
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
NR 45
TC 111
Z9 116
U1 0
U2 6
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 15
PY 2005
VL 118
IS 2
BP 357
EP 367
DI 10.1242/jcs.01615
PG 11
WC Cell Biology
SC Cell Biology
GA 898UT
UT WOS:000227102400010
PM 15632110
OA Bronze
DA 2021-01-25
ER

PT J
AU Most, P
   Boerries, M
   Eicher, C
   Schweda, C
   Volkers, M
   Wedel, T
   Sollner, S
   Katus, HA
   Remppis, A
   Aebi, U
   Koch, WJ
   Schoenenberger, CA
AF Most, P
   Boerries, M
   Eicher, C
   Schweda, C
   Volkers, M
   Wedel, T
   Sollner, S
   Katus, HA
   Remppis, A
   Aebi, U
   Koch, WJ
   Schoenenberger, CA
TI Distinct subcellular location of the Ca2+-binding protein S100A1
   differentially modulates Ca2+-cycling in ventricular rat cardiomyocytes
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE S100A1; sodium-calcium exchanger; SERCA2a; calcium-cycling
ID RAGE-INDEPENDENT MANNER; ALPHA-ALPHA PROTEIN; EN-RAGE; NEURITE
   OUTGROWTH; RABBIT; EXPRESSION; EXCHANGER; MYOCYTES; BINDING; FAMILY
AB Calcium is a key regulator of cardiac function and is modulated through the Ca2+-sensor protein S100A1. S100 proteins are considered to exert both intracellular and extracellular functions on their target cells. Here we report the impact of an increased intracellular S100A1 protein level on Ca2+-homeostasis in neonatal ventricular cardiomyocytes in vitro. Specifically, we compare the effects of exogenously added recombinant S100A1 to those resulting from the overexpression of a transduced S100A1 gene. Extracellularly added S100A1 enhanced the Ca2+-transient amplitude in neonatal ventricular cardiomyocytes; (NVCMs) through a marked decrease in intracellular diastolic Ca2+-concentrations ([Ca2+](i)). The decrease in [Ca2+](i) was independent of sarcoplasmic reticulum Ca2+-ATPase (SERCA2a) activity and was probably the result of an increased sarcolemmal Ca2+. extrusion through the sodium-calcium exchanger (NCX). At the same time the Ca2+-content of the sarcoplasmic reticulum (SR) decreased. These effects were dependent on the uptake of extracellularly added S100A1 protein and its subsequent routing to the endosomal compartment. Phospholipase C and protein kinase C, which are tightly associated with this subcellular compartment, were found to be activated by endocytosed S100A1 By contrast, adenoviral-mediated intracellular S100A1 overexpression enhanced the Ca2+-transient amplitude in NVCMs mainly through an increase in systolic [Ca2+](i). The increased Ca2+-load in the SR was based on an enhanced SERCA2a activity while NCX function was unaltered. Overexpressed S100A1 colocalized with SERCA2a and other Ca2+-regulatory proteins at the SR, whereas recombinant S100A1 protein that had been endocytosed did not colocalize with SR proteins. This study provides the first evidence that intracellular S100A1, depending on its subcellular location, modulates cardiac Ca2+-turnover via different Ca2+ regulatory proteins.
C1 Univ Basel, Biozentrum, Maurice E Mueller Inst, CH-4056 Basel, Switzerland.
   Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA.
   Univ Heidelberg, Dept Internal Med 3, Div Cardiol, D-69115 Heidelberg, Germany.
   Med Univ Lubeck, Inst Anat, D-23538 Lubeck, Germany.
   Med Univ Lubeck, Dept Plast Surg, D-23538 Lubeck, Germany.
RP Most, P (corresponding author), Univ Basel, Biozentrum, Maurice E Mueller Inst, CH-4056 Basel, Switzerland.
EM patrick.most@jefferson.edu; cora-ann.schoenenberger@unibas.ch
RI Volkers, Mirko/E-7947-2010; Wedel, Thilo/B-1247-2010
OI Volkers, Mirko/0000-0003-2344-1856; Wedel, Thilo/0000-0002-8146-2711
FU NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01HL056205, R01HL059533,
   R01HL059533, R01HL059533, R01HL059533, R01HL059533, R01HL056205,
   R01HL056205, R01HL056205, R01HL056205, R01HL059533, R01HL059533,
   R01HL056205, R01HL056205, R01HL059533, R01HL056205, R01HL056205,
   R01HL056205, R01HL056205, R01HL056205] Funding Source: NIH RePORTER;
   NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01-HL56205, R01-HL59533] Funding Source: Medline
CR BARGER SW, 1992, J BIOL CHEM, V267, P9689
   BASSANI JWM, 1994, J PHYSIOL-LONDON, V476, P279, DOI 10.1113/jphysiol.1994.sp020130
   Convery MK, 1998, PFLUG ARCH EUR J PHY, V436, P581, DOI 10.1007/s004240050675
   Despa S, 2002, J PHYSIOL-LONDON, V539, P133, DOI 10.1113/jphysiol.2001.012940
   Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296
   Foell D, 2003, RHEUMATOLOGY, V42, P1383, DOI 10.1093/rheumatology/keg385
   Foell D, 2003, THORAX, V58, P613, DOI 10.1136/thorax.58.7.613
   Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847
   Foell D, 2003, LANCET, V361, P1270, DOI 10.1016/S0140-6736(03)12986-8
   HAIMOTO H, 1988, EUR J BIOCHEM, V171, P409, DOI 10.1111/j.1432-1033.1988.tb13805.x
   Heizmann CW, 1998, BIOMETALS, V11, P383, DOI 10.1023/A:1009212521172
   Hobai IA, 1997, PFLUG ARCH EUR J PHY, V433, P455, DOI 10.1007/s004240050300
   Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6
   Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200
   Iwamoto T, 1996, J BIOL CHEM, V271, P13609, DOI 10.1074/jbc.271.23.13609
   KATO K, 1985, BIOCHIM BIOPHYS ACTA, V842, P146, DOI 10.1016/0304-4165(85)90196-5
   KHANANSHVILI D, 1995, J BIOL CHEM, V270, P16182, DOI 10.1074/jbc.270.27.16182
   Kiewitz R, 2000, BIOCHEM BIOPH RES CO, V274, P865, DOI 10.1006/bbrc.2000.3229
   Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2
   Kubista H, 1999, NEUROSCIENCE, V90, P493, DOI 10.1016/S0306-4522(98)00422-9
   Mikkelsen SE, 2001, J NEUROCHEM, V79, P767, DOI 10.1046/j.1471-4159.2001.00605.x
   Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454
   Most P, 2003, J BIOL CHEM, V278, P48404, DOI 10.1074/jbc.M308587200
   Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200
   Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200
   Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598
   Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200
   Rammes A, 1997, J BIOL CHEM, V272, P9496
   Remppis A, 2004, J GENE MED, V6, P387, DOI 10.1002/jgm.513
   Remppis A, 2002, BASIC RES CARDIOL S1, V97, P156
   Reuter H, 2002, CIRC RES, V91, P90, DOI 10.1161/01.RES.0000027529.37429.38
   SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554
   Sorci G, 2004, MOL CELL BIOL, V24, P4880, DOI 10.1128/MCB.24.11.4880-4894.2004
   Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462
   Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003
   Wang ZL, 2001, ACTA CRYSTALLOGR D, V57, P882, DOI 10.1107/S0907444901005273
   ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2
NR 37
TC 50
Z9 51
U1 0
U2 2
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 15
PY 2005
VL 118
IS 2
BP 421
EP 431
DI 10.1242/jcs.01614
PG 11
WC Cell Biology
SC Cell Biology
GA 898UT
UT WOS:000227102400015
PM 15654019
OA Bronze
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Nervi, P
   Durrenberger, M
   Seelig, J
AF Ziegler, A
   Nervi, P
   Durrenberger, M
   Seelig, J
TI The cationic cell-penetrating peptide Cpp(TAT) derived from the HIV-1
   protein TAT is rapidly transported into living fibroblasts: Optical,
   biophysical, and metabolic evidence
SO BIOCHEMISTRY
LA English
DT Article
ID HEPARAN-SULFATE PROTEOGLYCANS; HUMAN-IMMUNODEFICIENCY-VIRUS;
   ARGININE-RICH PEPTIDES; TRANSDUCTION DOMAINS; BINDING MECHANISM;
   MAMMALIAN-CELLS; PLASMA-MEMBRANE; DELIVERY; SURFACE; INTERNALIZATION
AB Cell-penetratin peptides (CPPs) are cationic peptides which, when linked to genes, proteins, or nanoparticles, facilitate the transport of these entities across the cell membrane. Despite their potential use for gene transfer and drug delivery, the mode of action of CPPs is still mysterious. It has even been argued that the observed transport across the cell membrane is an artifact caused by chemical fixation of the cells, a common preparation method for microscopic observation. Here we have synthesized a fluorescent derivative of the HIV-1 TAT protein transduction domain [Fg-CPPTAT(PTD)] and have observed its uptake into nonfixated living fibroblasts with time-lapse confocal microscopy, eliminating the need for fixation. We observe that Fg-CPPTAT(PTD) enters the cytoplasm and nucleus of nonfixated fibroblasts within seconds, arguing against the suggested artifact of cell fixation. Using differential interference contrast microscopy, dense aggregates are detected on the cell surface. Several observations suggest that these 4 aggregates consist of Fg-CPPTAT(PTD) bound to membrane-associated heparan sulfate (HS). The aggregates arow in parallel with Fg-CPPTAT(PTD) uptake and are detected only on fibroblasts showing, Fg-CPPTAT(PTD) uptake. These observations resemble earlier reports of "capping" of cell surface molecules combined with a polarized endocytotic flow. Enzymatic removal of extracellular HS reduced the rate of both Fg-CPPTAT(PTD) uptake and aggregate formation, demonstrating that HS is involved in the uptake mechanism. The functionality of the fibroblasts during the CPP uptake was investigated with a cytosensor microphysiometer measuring the extracellular acidification rate (ECAR). Short exposures (2.5 min) to the CPP reduced the ECAR which was, however, reversible upon reperfusion with buffer only. In contrast, no recovery to baseline values was observed after repeated exposures to the CPP, suggesting that the CPP is toxic in long-term applications.
C1 Univ Basel, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, Ctr Microscopy, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
CR Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8
   Bretscher MS, 1996, CELL, V87, P601, DOI 10.1016/S0092-8674(00)81380-X
   CAREY DJ, 1994, EXP CELL RES, V214, P12, DOI 10.1006/excr.1994.1228
   Dehio C, 1998, EXP CELL RES, V242, P528, DOI 10.1006/excr.1998.4116
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2
   EFTNIK MR, 1981, ANAL BIOCHEM, V114, P199
   FAWELL S, 1994, P NATL ACAD SCI USA, V91, P664, DOI 10.1073/pnas.91.2.664
   FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210
   FEDARKO NS, 1986, J CELL BIOL, V102, P587, DOI 10.1083/jcb.102.2.587
   Fischer R, 2004, J BIOL CHEM, V279, P12625, DOI 10.1074/jbc.M311461200
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607
   Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q
   Hallbrink M, 2001, BBA-BIOMEMBRANES, V1515, P101, DOI 10.1016/S0005-2736(01)00398-4
   Ho A, 2001, CANCER RES, V61, P474
   ISHIHARA M, 1986, J BIOL CHEM, V261, P3575
   KRAEMER PM, 1972, J CELL BIOL, V55, P713, DOI 10.1083/jcb.55.3.713
   Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4
   LINHARDT RJ, 1990, BIOCHEMISTRY-US, V29, P2611, DOI 10.1021/bi00462a026
   Lundberg M, 2001, NAT BIOTECHNOL, V19, P713, DOI 10.1038/90741
   MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x
   Martinho RG, 1996, MOL BIOL CELL, V7, P1771
   Maxfield F R, 1987, Adv Exp Med Biol, V225, P189
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   MORAD N, 1984, BIOCHIM BIOPHYS ACTA, V801, P117, DOI 10.1016/0304-4165(84)90219-8
   Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042
   Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996
   Nomarski G, 1955, J PHYS RADIUM, V16, P9
   Potocky TB, 2003, J BIOL CHEM, V278, P50188, DOI 10.1074/jbc.M308719200
   Prochiantz A, 2000, CURR OPIN CELL BIOL, V12, P400, DOI 10.1016/S0955-0674(00)00108-3
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   ROEDERER M, 1987, J CELL PHYSIOL, V131, P200, DOI 10.1002/jcp.1041310209
   Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313
   RYSER HJP, 1965, SCIENCE, V150, P501, DOI 10.1126/science.150.3695.501
   RYSER HJP, 1968, SCIENCE, V159, P390, DOI 10.1126/science.159.3813.390
   Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200
   Schulz JG, 1998, EUR J NEUROSCI, V10, P2085, DOI 10.1046/j.1460-9568.1998.00220.x
   Schwarze SR, 2000, TRENDS CELL BIOL, V10, P290, DOI 10.1016/S0962-8924(00)01771-2
   SHEN WC, 1978, P NATL ACAD SCI USA, V75, P1872, DOI 10.1073/pnas.75.4.1872
   Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x
   Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200
   Tumova S, 1999, BIOCHEM J, V337, P471, DOI 10.1042/0264-6021:3370471
   TURNBULL JE, 1991, BIOCHEM J, V273, P553, DOI 10.1042/bj2730553
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   VANDYKE RW, 1995, AM J PHYSIOL-CELL PH, V269, pC943
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Williams KJ, 1997, CURR OPIN LIPIDOL, V8, P253
   Zaro JL, 2003, BIOCHEM BIOPH RES CO, V307, P241, DOI 10.1016/S0006-291X(03)01167-7
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
NR 57
TC 190
Z9 197
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JAN 11
PY 2005
VL 44
IS 1
BP 138
EP 148
DI 10.1021/bi0491604
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 886GJ
UT WOS:000226214600016
PM 15628854
DA 2021-01-25
ER

PT J
AU Moglich, A
   Krieger, F
   Kiefhaber, T
AF Moglich, A
   Krieger, F
   Kiefhaber, T
TI Molecular basis for the effect of urea and guanidinium chloride on the
   dynamics of unfolded polypeptide chains
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; polypeptide chain dynamics; solvent denaturation;
   denaturant binding; Schellman model
ID AMINO-ACIDS; PROTEIN INTERACTIONS; ALPHA-CHYMOTRYPSIN; HAMMOND BEHAVIOR;
   PEPTIDE HELICES; DENATURATION; SOLUBILITY; BINDING; MODEL; BARRIERS
AB Chemical denaturants are frequently used to unfold proteins and to characterize mechanisms and transition states of protein folding reactions. The molecular basis of the effect of urea and guanidinium chloride (GdmCl) on polypeptide chains is still not well understood. Models for denaturant-protein interaction include both direct binding and indirect changes in solvent properties. Here we report studies on the effect of urea and GdmCl on the rate constants (k(c)) of end-to-end diffusion in unstructured poly(glycine-serine) chains of different length. Urea and GdmCl both lead to a linear decrease of ln k(c) with denaturant concentration, as observed for the rate constants for protein folding. This suggests that the effect of denaturants on chain dynamics significantly contributes to the denaturant-dependence of folding rate constants for small proteins. We show that this linear dependency is the result of two additive nonlinear effects, namely increased solvent viscosity and denaturant binding. The contribution from denaturant binding can be quantitatively described by Schellman's weak binding model with binding constants (K) of 0.62(+/-0.01) M-1 for GdmCl and 0.26(+/-0.01) M-1 for urea. In our model peptides the number of binding sites and the effect of a bound denaturant molecule on chain dynamics is identical for urea and GdmCl. The results further identify the polypeptide backbone as the major denaturant binding site and give an upper limit of a few nanoseconds for residence times of denaturant molecules on the polypeptide chain. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM t.kiefhaber@unibas.ch
RI Kiefhaber, Thomas/A-3028-2010
OI Moglich, Andreas/0000-0002-7382-2772
CR ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323
   AUNE KC, 1969, BIOCHEMISTRY-US, V8, P4586, DOI 10.1021/bi00839a053
   Bennion BJ, 2003, P NATL ACAD SCI USA, V100, P5142, DOI 10.1073/pnas.0930122100
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   Denisov VP, 1999, NAT STRUCT BIOL, V6, P253, DOI 10.1038/6692
   FRENSDORFF HK, 1953, J AM CHEM SOC, V75, P5167, DOI 10.1021/ja01117a005
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/revmodphys.62.251
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   LIEPINSH E, 1994, J AM CHEM SOC, V116, P9670, DOI 10.1021/ja00100a036
   Makhatadze GI, 1999, J PHYS CHEM B, V103, P4781, DOI 10.1021/jp990413q
   MAKHATADZE GI, 1992, J MOL BIOL, V226, P491, DOI 10.1016/0022-2836(92)90963-K
   Modig K, 2003, PROTEIN SCI, V12, P2768, DOI 10.1110/ps.03262603
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   NOZAKI Y, 1970, J BIOL CHEM, V245, P1648
   NOZAKI Y, 1971, J BIOL CHEM, V246, P2211
   NOZAKI Y, 1963, J BIOL CHEM, V238, P4074
   Pace C N, 1986, Methods Enzymol, V131, P266
   Perl D, 2002, BIOPHYS CHEM, V96, P173, DOI 10.1016/S0301-4622(02)00024-8
   PFEIL W, 1991, STUD BIOPHYS, V140, P5
   RAMSDEN W, 1902, J PHYSL, V28, P23
   ROBINSON DR, 1965, J AM CHEM SOC, V87, P2462, DOI 10.1021/ja01089a028
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SCHELLMAN JA, 1978, BIOPOLYMERS, V17, P1305, DOI 10.1002/bip.1978.360170515
   SCHELLMAN JA, 1987, BIOPOLYMERS, V26, P549, DOI 10.1002/bip.360260408
   Schellman JA, 2002, BIOPHYS CHEM, V96, P91, DOI 10.1016/S0301-4622(02)00009-1
   SCHELLMAN JA, 1959, J PHYS CHEM-US, V62, P1485
   SCHELLMAN JA, 1975, BIOPOLYMERS, V14, P999, DOI 10.1002/bip.1975.360140509
   SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230
   SCHOLTZ JM, 1995, P NATL ACAD SCI USA, V92, P185, DOI 10.1073/pnas.92.1.185
   SIMPSON RB, 1953, J AM CHEM SOC, V75, P5139, DOI 10.1021/ja01117a001
   Smith JS, 1996, BIOCHEMISTRY-US, V35, P7292, DOI 10.1021/bi960341i
   SPIRO K, 1900, Z PHYSL CHEM, V30, P182
   TANFORD C, 1964, J AM CHEM SOC, V86, P2050, DOI 10.1021/ja01064a028
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Timasheff SN, 2002, BIOPHYS CHEM, V101, P99, DOI 10.1016/S0301-4622(02)00188-6
   Tobi D, 2003, BIOPOLYMERS, V68, P359, DOI 10.1002/bip.10290
   VANTHOFF JH, 1884, EDUTES DYNAMIQUE
   WETLAUFER DB, 1964, J AM CHEM SOC, V86, P508
NR 46
TC 105
Z9 106
U1 0
U2 35
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 7
PY 2005
VL 345
IS 1
BP 153
EP 162
DI 10.1016/j.jmb.2004.10.036
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 877UX
UT WOS:000225600500013
PM 15567418
DA 2021-01-25
ER

PT J
AU Chan, C
   Paul, R
   Samoray, D
   Amiot, N
   Giese, B
   Jenal, U
   Schirmer, T
AF Chan, Carmen
   Paul, Ralf
   Samoray, Dietrich
   Amiot, Nicolas
   Giese, Bernd
   Jenal, Urs
   Schirmer, Tilman
TI Structural Basis for the Activity and Allosteric Control of Diguanylate
   Cyclase
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE response regulator; cyclic dinucleotide; allosteric control
C1 [Chan, Carmen; Samoray, Dietrich; Schirmer, Tilman] Univ Basel, Biozentrum, Struct Biol, Basel, Switzerland.
   [Paul, Ralf; Jenal, Urs] Univ Basel, Biozentrum, Microbiol, Basel, Switzerland.
   [Amiot, Nicolas; Giese, Bernd] Univ Basel, Dept Chem, Basel, Switzerland.
EM carmen.chan@unibas.ch
CR Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
NR 2
TC 0
Z9 0
U1 1
U2 1
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA P.04.12.18
BP C235
EP C235
DI 10.1107/S0108767305089993
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085801231
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Li, XD
   Zheng, L
   Kostrewa, D
   Berneche, S
   Winkler, FK
AF Li, Xiao-Dan
   Zheng, Lei
   Kostrewa, Dirk
   Berneche, Simon
   Winkler, Fritz K.
TI Does the Crystal Structure of Ammonium Transporter Tell us its Function?
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE ammonia transport; conformational change; X-ray structure
C1 [Li, Xiao-Dan; Zheng, Lei; Kostrewa, Dirk; Winkler, Fritz K.] Paul Scherrer Inst, Biomol Res, CH-5232 Villigen, Switzerland.
   [Berneche, Simon] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM xiao.li@psi.ch
CR Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
NR 1
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA MS08.24.1
BP C16
EP C16
DI 10.1107/S0108767305099307
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085800071
OA Bronze
DA 2021-01-25
ER

PT J
AU Miki, K
   Stuart, D
   Strelkov, SV
   Kapinos, L
   Ivaninskii, S
   Kreplak, L
   Herrmann, H
   Aebi, U
AF Miki, Kunio
   Stuart, David
   Strelkov, Sergei V.
   Kapinos, Larisa
   Ivaninskii, Sergei
   Kreplak, Laurent
   Herrmann, Harald
   Aebi, Ueli
TI Intermediate Filaments: from the Elementary Dimer Structure to the
   Complete Filament Architecture
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE intermediate filaments; macromolecular assemblies; human disease
C1 [Strelkov, Sergei V.; Kapinos, Larisa; Ivaninskii, Sergei; Kreplak, Laurent; Aebi, Ueli] Univ Basel, Biozentrum, Mueller Inst Struct Biol, Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Div Cell Biol, Heidelberg, Germany.
EM sergei-v.strelkov@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA MS57.28.1
BP C75
EP C75
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085800315
DA 2021-01-25
ER

PT J
AU Philippsen, A
   Schenk, A
   Signorell, G
   Kukulski, W
   Engel, A
AF Philippsen, Ansgar
   Schenk, Andreas
   Signorell, Giani
   Kukulski, Wanda
   Engel, Andreas
TI Methods Development and Software Engineering for 2D Electron
   Crystallography
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE membrane proteins; electron crystallography; methods development
C1 [Philippsen, Ansgar] Univ Basel, Biozentrum, Maurice Muller Inst Struct Biol, Basel, Switzerland.
EM ansgar.philippsen@unibas.ch
CR HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
NR 3
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA MS69.28.2
BP C88
EP C89
DI 10.1107/S0108767305096248
PG 2
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085800376
OA Bronze
DA 2021-01-25
ER

PT J
AU Sokolova, AV
   Kreplak, L
   Herrmann, H
   Aebi, U
   Svergun, DI
   Strelkov, SV
AF Sokolova, Anna V.
   Kreplak, L.
   Herrmann, H.
   Aebi, U.
   Svergun, D. I.
   Strelkov, S. V.
TI Probing Intermediate Filament Structure and Assembly with Small-angle
   X-ray Scattering
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE intermediate filaments; filament assembly; small angle X-ray scattering
C1 [Sokolova, Anna V.; Svergun, D. I.] Inst Crystallog, Moscow, Russia.
   [Sokolova, Anna V.; Strelkov, S. V.] Inst Bioorgan Chem, Moscow, Russia.
   [Kreplak, L.; Aebi, U.; Strelkov, S. V.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Herrmann, H.] German Canc Res Ctr, Heidelberg, Germany.
   [Svergun, D. I.] DESY, EMBL, Hamburg, Germany.
EM sokolova@crys.ras.ru
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2005
VL 61
SU S
MA P.12.07.2
BP C411
EP C411
DI 10.1107/S0108767305082619
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3UX
UT WOS:000478085802204
OA Bronze
DA 2021-01-25
ER

PT J
AU Mota, LJ
   Cornelis, GR
AF Mota, LJ
   Cornelis, GR
TI The bacterial injection kit: Type III secretion systems
SO ANNALS OF MEDICINE
LA English
DT Review
DE Bacteria; inflammation; injectisome; invasion; pathogenesis;
   phagocytosis; Salmonella; Shigella; type III secretion; Yersinia
ID PROTEIN-TYROSINE-PHOSPHATASE; GTPASE-ACTIVATING PROTEIN; IMPORTANT
   VIRULENCE MECHANISM; NUCLEOTIDE EXCHANGE FACTOR; YERSINIA EFFECTOR YOPJ;
   AERUGINOSA EXOENZYME S; KAPPA-B PATHWAY; PSEUDOMONAS-AERUGINOSA;
   HOST-CELL; EPITHELIAL-CELLS
AB Type III secretion (T3S) systems are widespread among Gram-negative bacteria pathogenic for animals and plants, including Yersinia spp., Salmonella spp., Shigella spp., enteropathogenic Escherichia coli, enterohaemorrhagic E. coli, or Pseudomonas spp. T3S systems allow bacteria to inject virulence proteins, called T3S effectors, into the cytosol of their eukaryotic host cells. These virulence factors will paralyze or reprogram the eukaryotic cell to the benefit of the pathogen. T3S effectors display a large repertoire of biochemical activities and modulate the function of crucial host regulatory molecules such as small guanosine triphosphate (GTP)-binding proteins, mitogen-activated protein kinases (MAPKs), nuclear factor (NF)-kappa B, or phosphoinositides. The activity of T3S effectors allows bacteria, for example, to invade nonphagocytic cells or to inhibit phagocytosis, to downregulate or promote pro-inflammatory responses, to induce apoptosis, to prevent autophagy, or to modulate intracellular trafficking. In this review, we present the most recent advances in the understanding of the mode of action of T3S effectors. We highlight the biochemical activities of these eukaryotic-like bacterial proteins that are shared among pathogens carrying T3S systems and the sequence, structural and functional resemblances between T3S effectors and eukaryotic proteins.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Mota, Luis J/B-9497-2008
OI Mota, Luis J/0000-0002-5592-8397
CR Aepfelbacher M, 2003, J BIOL CHEM, V278, P33217, DOI 10.1074/jbc.M303349200
   Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731
   Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200
   Andor A, 2001, CELL MICROBIOL, V3, P301, DOI 10.1046/j.1462-5822.2001.00114.x
   Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7
   Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x
   Black DS, 1997, EMBO J, V16, P2730, DOI 10.1093/emboj/16.10.2730
   BLISKA JB, 1991, P NATL ACAD SCI USA, V88, P1187, DOI 10.1073/pnas.88.4.1187
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boland A, 1998, INFECT IMMUN, V66, P1878, DOI 10.1128/IAI.66.5.1878-1884.1998
   Bourdet-Sicard R, 1999, EMBO J, V18, P5853, DOI 10.1093/emboj/18.21.5853
   Brugirard-Ricaud K, 2005, CELL MICROBIOL, V7, P363, DOI 10.1111/j.1462-5822.2004.00466.x
   Buchwald G, 2002, EMBO J, V21, P3286, DOI 10.1093/emboj/cdf329
   Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003
   Campellone KG, 2004, DEV CELL, V7, P217, DOI 10.1016/j.devcel.2004.07.004
   Carter RS, 2003, J BIOL CHEM, V278, P48903, DOI 10.1074/jbc.M310686200
   Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Dai SP, 2004, CELL MICROBIOL, V6, P459, DOI 10.1111/j.1462-5822.2004.00375.x
   Dean P, 2005, CURR OPIN MICROBIOL, V8, P28, DOI 10.1016/j.mib.2004.12.010
   Deleuil F, 2003, CELL MICROBIOL, V5, P53, DOI 10.1046/j.1462-5822.2003.00236.x
   Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200
   Denecker G, 2001, J BIOL CHEM, V276, P19706, DOI 10.1074/jbc.M101573200
   Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100
   DeVinney R, 1999, INFECT IMMUN, V67, P2389, DOI 10.1128/IAI.67.5.2389-2398.1999
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Evdokimov AG, 2002, PROTEIN SCI, V11, P401, DOI 10.1110/ps.34102
   Evdokimov AG, 2001, J MOL BIOL, V312, P807, DOI 10.1006/jmbi.2001.4973
   Fraylick JE, 2001, INFECT IMMUN, V69, P5318, DOI 10.1128/IAI.69.9.5318-5328.2001
   FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x
   Fu YX, 1999, NATURE, V401, P293
   GALYOV EE, 1993, NATURE, V361, P730, DOI 10.1038/361730a0
   Garrity-Ryan L, 2000, INFECT IMMUN, V68, P7100, DOI 10.1128/IAI.68.12.7100-7113.2000
   Glendinning KJ, 2004, FEMS MICROBIOL LETT, V235, P229, DOI 10.1016/j.femsle.2004.04.039
   Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369
   Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856
   Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509
   Hamid N, 1999, MICROB PATHOGENESIS, V27, P231, DOI 10.1006/mpat.1999.0301
   Haraga A, 2003, INFECT IMMUN, V71, P4052, DOI 10.1128/IAI.71.7.4052-4058.2003
   Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7
   Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926
   Hernandez LD, 2004, SCIENCE, V304, P1805, DOI 10.1126/science.1098188
   Hernandez LD, 2003, J CELL BIOL, V163, P1123, DOI 10.1083/jcb.200309161
   Hersh D, 1999, P NATL ACAD SCI USA, V96, P2396, DOI 10.1073/pnas.96.5.2396
   Hilbi H, 1998, J BIOL CHEM, V273, P32895, DOI 10.1074/jbc.273.49.32895
   Hines J, 2001, MICROB PATHOGENESIS, V30, P193, DOI 10.1006/mpat.2000.0424
   Hotson A, 2004, CURR OPIN PLANT BIOL, V7, P384, DOI 10.1016/j.pbi.2004.05.003
   Hotson A, 2003, MOL MICROBIOL, V50, P377, DOI 10.1046/j.1365-2958.2003.03730.x
   Iriarte M, 1998, MOL MICROBIOL, V29, P915, DOI 10.1046/j.1365-2958.1998.00992.x
   Jesenberger V, 2000, J EXP MED, V192, P1035, DOI 10.1084/jem.192.7.1035
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Kazmierczak BI, 2002, INFECT IMMUN, V70, P2198, DOI 10.1128/IAI.70.4.2198-2205.2002
   Kenny B, 1999, MOL MICROBIOL, V31, P1229, DOI 10.1046/j.1365-2958.1999.01265.x
   Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7
   Kerschen EJ, 2004, INFECT IMMUN, V72, P4589, DOI 10.1128/IAI.72.8.4589-4602.2004
   Krall R, 2002, INFECT IMMUN, V70, P360, DOI 10.1128/IAI.70.1.360-367.2002
   Kubori T, 2003, CELL, V115, P333, DOI 10.1016/S0092-8674(03)00849-3
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   KUJAT CSL, 2004, INFECT IMMUN, V72, P5115
   Lilic M, 2003, SCIENCE, V301, P1918, DOI 10.1126/science.1088433
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   McDonald C, 2003, J BIOL CHEM, V278, P18514, DOI 10.1074/jbc.M301226200
   McGhie EJ, 2004, MOL CELL, V13, P497, DOI 10.1016/S1097-2765(04)00053-X
   McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131
   Miao EA, 2003, MOL MICROBIOL, V48, P401, DOI 10.1046/j.1365-2958.2003.t01-1-03456.x
   Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638
   Monack DM, 2000, J EXP MED, V192, P249, DOI 10.1084/jem.192.2.249
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   Murli S, 2001, CELL MICROBIOL, V3, P795, DOI 10.1046/j.1462-5822.2001.00158.x
   Niebuhr K, 2002, EMBO J, V21, P5069, DOI 10.1093/emboj/cdf522
   Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057
   Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036
   Olson JC, 1999, INFECT IMMUN, V67, P2847, DOI 10.1128/IAI.67.6.2847-2854.1999
   Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594
   Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920
   Orth K, 2002, CURR OPIN MICROBIOL, V5, P38, DOI 10.1016/S1369-5274(02)00283-7
   Park KS, 2004, INFECT IMMUN, V72, P6659, DOI 10.1128/IAI.72.11.6659-6665.2004
   Persson C, 1999, MOL MICROBIOL, V33, P828, DOI 10.1046/j.1365-2958.1999.01529.x
   Persson C, 1997, EMBO J, V16, P2307, DOI 10.1093/emboj/16.9.2307
   Pujol C, 2003, INFECT IMMUN, V71, P5892, DOI 10.1128/IAI.71.10.5892-5899.2003
   Ruckdeschel K, 2001, J IMMUNOL, V166, P1823, DOI 10.4049/jimmunol.166.3.1823
   Salcedo SP, 2003, EMBO J, V22, P5003, DOI 10.1093/emboj/cdg517
   Sansonetti PJ, 2000, IMMUNITY, V12, P581, DOI 10.1016/S1074-7613(00)80209-5
   Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290
   Sauvonnet N, 2002, MOL MICROBIOL, V45, P805, DOI 10.1046/j.1365-2958.2002.03053.x
   Scherer CA, 2000, MOL MICROBIOL, V37, P1133, DOI 10.1046/j.1365-2958.2000.02066.x
   Schesser K, 1998, MOL MICROBIOL, V28, P1067, DOI 10.1046/j.1365-2958.1998.00851.x
   Schotte P, 2004, J BIOL CHEM, V279, P25134, DOI 10.1074/jbc.M401245200
   Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3
   Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671
   Skrzypek E, 1998, MOL MICROBIOL, V30, P1051, DOI 10.1046/j.1365-2958.1998.01135.x
   Stebbins CE, 2000, MOL CELL, V6, P1449, DOI 10.1016/S1097-2765(00)00141-6
   Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x
   Stevens MP, 2003, J BACTERIOL, V185, P4992, DOI 10.1128/JB.185.16.4992-4996.2003
   Stevens MP, 2002, MOL MICROBIOL, V46, P649, DOI 10.1046/j.1365-2958.2002.03190.x
   STUCKEY JA, 1994, NATURE, V370, P571, DOI 10.1038/370571a0
   Sun JJ, 2004, NAT STRUCT MOL BIOL, V11, P868, DOI 10.1038/nsmb818
   Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200
   Suzuki T, 2001, INFECT IMMUN, V69, P5959, DOI 10.1128/IAI.69.10.5959-5966.2001
   Takai Y, 2001, PHYSIOL REV, V81, P153
   Terebiznik MR, 2002, NAT CELL BIOL, V4, P766, DOI 10.1038/ncb854
   Trosky JE, 2004, J BIOL CHEM, V279, P51953, DOI 10.1074/jbc.M407001200
   UCHIYA KI, 1995, MOL MICROBIOL, V17, P241, DOI 10.1111/j.1365-2958.1995.mmi_17020241.x
   Ulrich RL, 2004, INFECT IMMUN, V72, P6589, DOI 10.1128/IAI.72.11.6589-6596.2004
   Van Nhieu GT, 1999, EMBO J, V18, P3249, DOI 10.1093/emboj/18.12.3249
   Viboud GI, 2003, MOL MICROBIOL, V47, P1305, DOI 10.1046/j.1365-2958.2003.03350.x
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x
   WEST NP, SCIENCE, P1313
   Wurtele M, 2001, FEBS LETT, V491, P26, DOI 10.1016/S0014-5793(01)02105-6
   Wurtele M, 2001, NAT STRUCT BIOL, V8, P23
   Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899
   Zhou D, 1999, SCIENCE, V283, P2092, DOI 10.1126/science.283.5410.2092
   Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x
   Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176
   Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100
NR 119
TC 121
Z9 131
U1 0
U2 19
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0785-3890
EI 1365-2060
J9 ANN MED
JI Ann. Med.
PY 2005
VL 37
IS 4
BP 234
EP 249
DI 10.1080/07853890510037329
PG 16
WC Medicine, General & Internal
SC General & Internal Medicine
GA 943PX
UT WOS:000230367300001
PM 16019722
DA 2021-01-25
ER

PT J
AU Vergnolle, MAS
   Sawney, H
   Junne, T
   Dolfini, L
   Tokatlidis, K
AF Vergnolle, MAS
   Sawney, H
   Junne, T
   Dolfini, L
   Tokatlidis, K
TI A cryptic matrix targeting signal of the yeast ADP/ATP carrier normally
   inserted by the TIM22 complex is recognized by the TIM23 machinery
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE ADP/ATP carrier; dihydrofolate reductase (DHFR) fusion; mitochondria
   biogenesis; protein translocation; translocase of the inner membrane
ID ADP-ATP CARRIER; MITOCHONDRIAL INNER MEMBRANE; PROTEIN IMPORT;
   SACCHAROMYCES-CEREVISIAE; INTERMEMBRANE SPACE; PRESEQUENCE TRANSLOCASE;
   OUTER-MEMBRANE; TOM COMPLEX; PREPROTEINS; SEQUENCES
AB The yeast ADP/ATP carrier (AAC) is a mitochondrial protein that is targeted to the inner membrane via the TIM10 and TIM22 translocase complexes. AAC is devoid of a typical mitochondrial targeting signal and its targeting and insertion are thought to be guided by internal amino acid sequences. Here we show that AAC contains a cryptic matrix targeting signal that can target up to two thirds of the N-terminal part of the protein to the matrix. This event is coordinated by the TIM23 translocase and displays all the features of the matrix-targeting pathway. However, in the context of the whole protein, this signal is 'masked' and rendered non-functional as the polypeptide is targeted to the inner membrane via the TIM10 and TIM22 translocases. Our data suggest that after crossing the outer membrane the whole polypeptide chain of AAC is necessary to commit the precursor to the TIM22-mediated inner membrane insertion pathway.
C1 Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   FORTH, IMBB, GR-71110 Iraklion, Greece.
   Univ Crete, Dept Chem, GR-71409 Iraklion, Greece.
RP Tokatlidis, K (corresponding author), Univ Manchester, Sch Biol Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.
EM tokatlid@imbb.forth.gr
OI Tokatlidis, Kostas/0000-0001-6295-8183
FU Medical Research CouncilMedical Research Council UK (MRC) [G0000153]
   Funding Source: Medline
CR ADRIAN GS, 1986, MOL CELL BIOL, V6, P626, DOI 10.1128/MCB.6.2.626
   BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117
   Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730
   Curran SP, 2002, EMBO J, V21, P942, DOI 10.1093/emboj/21.5.942
   DAUM G, 1982, J BIOL CHEM, V257, P3028
   Dyall SD, 2003, J BIOL CHEM, V278, P26757, DOI 10.1074/jbc.M302700200
   ElMoualij B, 1997, YEAST, V13, P573, DOI 10.1002/(SICI)1097-0061(199705)13:6<573::AID-YEA107>3.0.CO;2-I
   Endres M, 1999, EMBO J, V18, P3214, DOI 10.1093/emboj/18.12.3214
   Geissler A, 2002, CELL, V111, P507, DOI 10.1016/S0092-8674(02)01073-5
   Glick BS, 1995, METHOD ENZYMOL, V260, P213, DOI 10.1016/0076-6879(95)60139-2
   GLICK BS, 1991, METHOD CELL BIOL, V34, P389
   Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200
   HURT EC, 1987, NATURE, V325, P499, DOI 10.1038/325499a0
   ISAYA G, 1991, J CELL BIOL, V113, P65, DOI 10.1083/jcb.113.1.65
   Koehler CM, 1998, EMBO J, V17, P6477, DOI 10.1093/emboj/17.22.6477
   Koehler CM, 1998, SCIENCE, V279, P369, DOI 10.1126/science.279.5349.369
   Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886
   Kubrich M, 1998, J BIOL CHEM, V273, P16374, DOI 10.1074/jbc.273.26.16374
   Kurz M, 1999, MOL BIOL CELL, V10, P2461, DOI 10.1091/mbc.10.7.2461
   Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574
   Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485
   Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090
   Moro F, 2002, J BIOL CHEM, V277, P6874, DOI 10.1074/jbc.M107935200
   PFANNER N, 1987, CELL, V49, P815, DOI 10.1016/0092-8674(87)90619-2
   PFANNER N, 1987, J BIOL CHEM, V262, P7528
   Ryan MT, 1999, J BIOL CHEM, V274, P20619, DOI 10.1074/jbc.274.29.20619
   Sirrenberg C, 1998, NATURE, V391, P912, DOI 10.1038/36136
   Sirrenberg C, 1996, NATURE, V384, P582, DOI 10.1038/384582a0
   SMAGULA CS, 1988, J CELL BIOCHEM, V36, P323, DOI 10.1002/jcb.240360402
   Stan T, 2000, EMBO J, V19, P4895, DOI 10.1093/emboj/19.18.4895
   Truscott KN, 2003, CURR BIOL, V13, pR326, DOI 10.1016/S0960-9822(03)00239-2
   Truscott KN, 2003, J CELL BIOL, V163, P707, DOI 10.1083/jcb.200308004
   Vasiljev A, 2004, MOL BIOL CELL, V15, P1445, DOI 10.1091/mbc.E03-05-0272
   Vial S, 2002, J BIOL CHEM, V277, P36100, DOI 10.1074/jbc.M202310200
   Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753
   Wiedemann N, 2001, EMBO J, V20, P951, DOI 10.1093/emboj/20.5.951
   Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X
   Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3
   ZIMMERMANN R, 1980, EUR J BIOCHEM, V109, P217, DOI 10.1111/j.1432-1033.1980.tb04787.x
NR 39
TC 11
Z9 11
U1 0
U2 0
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD JAN
PY 2005
VL 385
BP 173
EP 180
DI 10.1042/BJ20040650
PN 1
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 888AL
UT WOS:000226346500019
PM 15320873
OA Green Published
DA 2021-01-25
ER

PT J
AU Rockel, B
   Peters, J
   Glaeser, RM
   Mueller, S
   Baumeister, W
AF Rockel, B
   Peters, J
   Glaeser, RM
   Mueller, S
   Baumeister, W
TI A model describing the architecture and assembly of TPP II from
   Drosophila melanogaster
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 MPI Biochem, Martinsried, Germany.
   Univ Calif Berkeley, Berkeley, CA 94720 USA.
   Univ Basel, Biozentrum, Maurice E Mueller Inst, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 28A
EP 28A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378500128
DA 2021-01-25
ER

PT J
AU Tsamaloukas, A
   Heerklotz, H
AF Tsamaloukas, A
   Heerklotz, H
TI Interactions of cholesterol with glycero- and sphingolipids
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 70A
EP 70A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378500344
DA 2021-01-25
ER

PT J
AU Goncalves, E
   Kitas, E
   Seelig, J
AF Goncalves, E
   Kitas, E
   Seelig, J
TI Binding of oligoarginine to membrane lipids and heparan sulfate:
   Structural and thermodynamic characterization of a cell-penetrating
   peptide
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
   Pharma Div, Basel, Switzerland.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 234A
EP 235A
PN 2
PG 2
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378501143
DA 2021-01-25
ER

PT J
AU Anderson, TG
   Seelig, J
AF Anderson, TG
   Seelig, J
TI Measurements of mixing enthalpy for phospholipids in bilayer membranes
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 237A
EP 237A
PN 2
PG 1
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378501158
DA 2021-01-25
ER

PT J
AU Smith, JC
   Barrow, DJ
   Chandrasekaran, S
   Heerklotz, H
   Henary, MM
   Michniak, BB
   Nguyen, PM
   Strekowski, L
   Song, Y
AF Smith, JC
   Barrow, DJ
   Chandrasekaran, S
   Heerklotz, H
   Henary, MM
   Michniak, BB
   Nguyen, PM
   Strekowski, L
   Song, Y
TI Interaction of imminosulfurane transdermal penetration enhancers with
   DMPC membrane preparations
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
CT 49th Annual Meeting of the Biopysical-Society
CY FEB 12-16, 2005
CL Long Beach, CA
SP Biopys Soc
C1 Georgia State Univ, Atlanta, GA 30303 USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
   Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ 07103 USA.
RI , /AAP-1001-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOCIETY
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2005
VL 88
IS 1
SU S
BP 415A
EP 416A
PN 2
PG 2
WC Biophysics
SC Biophysics
GA 888MM
UT WOS:000226378502031
DA 2021-01-25
ER

PT S
AU Melchers, F
AF Melchers, F
BE Caligaris, F
   DallaFavera, R
TI B cell development and its deregulation to transformed states at the
   pre-B cell receptor-expressing pre-bill cell stage
SO CHRONIC LYMPHOCYTIC LEUKEMIA
SE Current Topics in Microbiology and Immunology
LA English
DT Review
ID CYTIDINE DEAMINASE AID; IN-VIVO; SOMATIC HYPERMUTATION; ALLELIC
   EXCLUSION; TUMOR-SUPPRESSOR; PROTEIN SLP-65; ACTIVATION; SELECTION;
   GENE; RECONSTITUTION
AB This chapter will review the scenario of normal B cell development-from the decision of a lymphoid progenitor to enter the B-lineage, over the stages of the generation of the repertoires of antigen-receptor (immunoglobulin)-expressing cells, to the response of mature B cells to develop memory and plasma cells-highlighting some of the cellular stages and the molecular mechanisms that can generate and select transformed states of cells. The scenarios for pre-B lymphoma (lymphocytic leukaemia) development are discussed in more detail.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Melchers, F (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM fritz.melchers@unibas.ch
CR ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0
   Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308
   Bachl J, 2001, J IMMUNOL, V166, P5051, DOI 10.4049/jimmunol.166.8.5051
   Bradl H, 2003, J IMMUNOL, V171, P2338, DOI 10.4049/jimmunol.171.5.2338
   Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807
   Ceredig R, 1999, EUR J IMMUNOL, V29, P2797, DOI 10.1002/(SICI)1521-4141(199909)29:09<2797::AID-IMMU2797>3.0.CO;2-8
   DeKoter RP, 2002, IMMUNITY, V16, P297, DOI 10.1016/S1074-7613(02)00269-8
   Flemming A, 2003, NAT IMMUNOL, V4, P38, DOI 10.1038/ni862
   Harless SM, 2001, CURR BIOL, V11, P1986, DOI 10.1016/S0960-9822(01)00598-X
   Hayashi K, 2003, IMMUNITY, V18, P825, DOI 10.1016/S1074-7613(03)00142-0
   Jumaa H, 2003, NATURE, V423, P452, DOI 10.1038/nature01608
   Kersseboom R, 2003, J EXP MED, V198, P91, DOI 10.1084/jem.20030615
   Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640
   Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803
   Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571
   MELCHERS F, 2004, MOL BIOL B CELLS, P101
   Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7
   Muschen M, 2000, J EXP MED, V192, P1833, DOI 10.1084/jem.192.12.1833
   Nutt SL, 1998, EMBO J, V17, P2319, DOI 10.1093/emboj/17.8.2319
   Ohnishi K, 2003, NAT IMMUNOL, V4, P849, DOI 10.1038/ni959
   Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588
   Pasqualucci L, 1998, P NATL ACAD SCI USA, V95, P11816, DOI 10.1073/pnas.95.20.11816
   Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   Rolink A, 1995, Semin Immunol, V7, P155, DOI 10.1016/1044-5323(95)90043-8
   Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164
   Rolink AG, 2002, IMMUNOL REV, V187, P87, DOI 10.1034/j.1600-065X.2002.18708.x
   Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5
   Rolink AG, 2001, CURR OPIN IMMUNOL, V13, P202, DOI 10.1016/S0952-7915(00)00205-3
   Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472
   Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760
   Schebesta M, 2002, IMMUNITY, V17, P473, DOI 10.1016/S1074-7613(02)00418-1
   Shen HM, 1998, SCIENCE, V280, P1750, DOI 10.1126/science.280.5370.1750
   Shimizu T, 2002, J IMMUNOL, V168, P6286, DOI 10.4049/jimmunol.168.12.6286
   URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5
   WINKLER TH, 1995, BLOOD, V85, P2045, DOI 10.1182/blood.V85.8.2045.bloodjournal8582045
   Yamagami T, 1999, IMMUNITY, V11, P317, DOI 10.1016/S1074-7613(00)80107-7
NR 39
TC 4
Z9 4
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
EI 2196-9965
BN 3-540-25279-7
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2005
VL 294
BP 1
EP 17
DI 10.1007/3-540-29933-5_1
PG 17
WC Oncology; Cell Biology; Immunology; Microbiology
SC Oncology; Cell Biology; Immunology; Microbiology
GA BDP68
UT WOS:000234799400001
PM 16323425
DA 2021-01-25
ER

PT S
AU Engel, J
   Bachinger, HP
AF Engel, J
   Bachinger, HP
BE Brinckmann, J
   Notbohm, H
   Muller, PK
TI Structure, stability and folding of the collagen triple helix
SO COLLAGEN: PRIMER IN STRUCTURE, PROCESSING AND ASSEMBLY
SE Topics in Current Chemistry
LA English
DT Review; Book Chapter
DE collagen; folding; thermodynamics; kinetics; nucleation; alignment;
   oligomerization
ID COIL OLIGOMERIZATION DOMAINS; DEFINED MOLECULAR-WEIGHTS;
   CRYSTAL-STRUCTURE; PEPTIDE-BONDS; III COLLAGEN; CLEAVAGE SITE; MODEL
   PEPTIDE; CONFORMATIONAL PROPERTIES; MODULAR ORGANIZATION; TRANS
   ISOMERIZATION
AB The collagen triple helix is a widespread structural element, which not only occurs in collagens but also in many other proteins. The triple helix consists of three identical or different polypeptide chains with the absolute requirement of a -Gly-Xaa-Yaa- repeat, in which the amino acid residues in X- and Y-position are frequently proline or hydroxyproline. The freezing of phi-angles in polypeptide backbone by proline rings and other steric restrictions are essential for stabilization. The OH-group of 4(R)-hydroxyproline, normally located in the Y-position, has an additional stabilizing effect. On the other hand, peptide bonds preceding proline and hydroxyproline are up to 20% in cis-configuration in unfolded chains and the need for a relatively slow cis-trans isomerization provides kinetic difficulties in triple helix formation. Because of their repeating structure, collagen chains easily misalign during folding. Therefore, oligomerization domains flank triple helical domains in natural collagens. The mechanism by which these domains influence stability and kinetics was elucidated with model peptides using different types of trimerization domains. Finally, the review briefly describes mutations in collagen triple helices, which cause severe inherited diseases by disturbances of folding.
C1 Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   Oregon Hlth & Sci Univ, Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
RP Engel, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
EM juergen.engel@unibas.ch
CR BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2
   BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   Bachinger HP, 2001, MATRIX BIOL, V20, P267, DOI 10.1016/S0945-053X(01)00138-X
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200
   Barth D, 2003, CHEM-EUR J, V9, P3692, DOI 10.1002/chem.200304917
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   BATEMAN JF, 1996, EXTRACELLULAR MATRIX, V2, P27
   BAUM J., 2000, FRONTIERS MOL BIOL M
   Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5
   Bella J, 1996, CONNECT TISSUE RES, V35, P401, DOI 10.3109/03008209609029218
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   BRUCKNER P, 1984, EUR J BIOCHEM, V140, P391, DOI 10.1111/j.1432-1033.1984.tb08114.x
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   BURJANADZE TV, 1979, BIOPOLYMERS, V18, P931, DOI 10.1002/bip.1979.360180413
   CDOLZ R, 1986, BIOPOLYMERS, V25, P1069
   CHAN VC, 1997, J BIOL CHEM, V272, P3144
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   DARAGAN VA, 1993, BIOPOLYMERS, V33, P5
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   DESANTIS P, 1965, NATURE, V206, P456, DOI 10.1038/206456a0
   DICKERSON RE, 1969, STRUCTURE ACTION PRO, pCH2
   Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v
   DOLZ R, 1988, EUR J BIOCHEM, V178, P357, DOI 10.1111/j.1432-1033.1988.tb14458.x
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel J, 1998, MATRIX BIOL, V17, P679, DOI 10.1016/S0945-053X(98)90119-6
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Engel J., 1987, ADV MEAT RES, V4, P145
   FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.0.CO;2-Z
   FIELDS CG, 1993, BIOPOLYMERS, V33, P16
   Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9
   FRASER RDB, 1983, J MOL BIOL, V167, P497, DOI 10.1016/S0022-2836(83)80347-7
   GO N, 1973, BIOPOLYMERS, V12, P1927, DOI 10.1002/bip.1973.360120818
   Golbik R, 2000, J MOL BIOL, V297, P501, DOI 10.1006/jmbi.2000.3575
   Gough CA, 1999, J BIOMOL STRUCT DYN, V17, P481, DOI 10.1080/07391102.1999.10508379
   GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2025, DOI 10.1002/bip.1976.360151012
   HEIDEMANN E, 1977, POLYMER, V18, P420, DOI 10.1016/0032-3861(77)90155-0
   HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Hongo C, 2001, POLYM J, V33, P812
   INOUYE K, 1976, BIOCHIM BIOPHYS ACTA, V420, P133, DOI 10.1016/0005-2795(76)90352-4
   INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7
   Kishore U, 1999, IMMUNOPHARMACOLOGY, V42, P15, DOI 10.1016/S0162-3109(99)00011-9
   Kishore U, 1997, MATRIX BIOL, V15, P583, DOI 10.1016/S0945-053X(97)90035-4
   Koide T, 2002, J AM CHEM SOC, V124, P9388, DOI 10.1021/ja026182+
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849
   KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125
   Kuhn K, 1969, Essays Biochem, V5, P59
   KUHN K, 1995, MATRIX BIOL, V14, P439, DOI 10.1016/0945-053X(95)90001-2
   KUIVANIEMI H, 1991, FASEB J, V5, P2052
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   Kwak J, 1999, BIOORGAN MED CHEM, V7, P153, DOI 10.1016/S0968-0896(98)00230-2
   Latvanlehto A, 2003, J BIOL CHEM, V278, P37590, DOI 10.1074/jbc.M305974200
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   Melacini G, 1996, J AM CHEM SOC, V118, P10359, DOI 10.1021/ja9612615
   Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919
   Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200
   Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229
   Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   Ottl J, 1999, J PEPT SCI, V5, P103, DOI 10.1002/(SICI)1099-1387(199902)5:2<103::AID-PSC188>3.0.CO;2-N
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2003, J AM CHEM SOC, V125, P11500, DOI 10.1021/ja036673+
   PIEZ KA, 1981, BIOSCIENCE REP, V1, P801, DOI 10.1007/BF01114803
   PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4
   RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199
   RAINES RT, 1999, PEPTIDES NEW MILLENI
   RAMACHANDRAN GN, 1967, TREATISE COLLAGEN, P103
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Renner C, 2001, ANGEW CHEM INT EDIT, V40, P923, DOI 10.1002/1521-3773(20010302)40:5<923::AID-ANIE923>3.0.CO;2-#
   Ricard-Blum S, 2000, UNCONVENTIONAL COLLA
   RICH A, 1961, J MOL BIOL, V3, P483, DOI 10.1016/S0022-2836(61)80016-8
   ROTHE M, 1970, ANGEW CHEM INT EDIT, V9, P535
   Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SAKAKIBARA S, 1968, B CHEM SOC JPN, V41, P1273, DOI 10.1246/bcsj.41.1273
   SARKAR SK, 1984, P NATL ACAD SCI-BIOL, V81, P4800, DOI 10.1073/pnas.81.15.4800
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   Schulz G. E., 1979, SPRINGER ADV TEXTS C
   SCHWARZ G, 1972, ANGEW CHEM INT EDIT, V11, P568, DOI 10.1002/anie.197205681
   Shah NK, 1997, BIOCHEMISTRY-US, V36, P5878, DOI 10.1021/bi963146c
   Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422
   SUTOH K, 1974, BIOPOLYMERS, V13, P2477, DOI 10.1002/bip.1974.360131207
   Tanaka Y, 1998, J PEPT RES, V51, P413
   TORCHIA DA, 1975, BIOCHEMISTRY-US, V14, P887, DOI 10.1021/bi00676a004
   TSCHOPP J, 1982, MOL IMMUNOL, V19, P651, DOI 10.1016/0161-5890(82)90365-0
   UITTO J, 1976, J INVEST DERMATOL, V66, P59, DOI 10.1111/1523-1747.ep12481404
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Vitagliano L, 2001, PROTEIN SCI, V10, P2627, DOI 10.1110/ps.ps.26601a
   Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V
   VOGEL BE, 1988, J BIOL CHEM, V263, P19249
   WEBER RW, 1978, HELV CHIM ACTA, V61, P701, DOI 10.1002/hlca.19780610218
   Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x
   WRIGHT JK, 1980, BIOCHEM J, V187, P775, DOI 10.1042/bj1870775
   Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
NR 122
TC 154
Z9 163
U1 0
U2 68
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0340-1022
BN 3-540-23272-9
J9 TOP CURR CHEM
JI Top. Curr. Chem.
PY 2005
VL 247
BP 7
EP 33
DI 10.1007/b103818
PG 27
WC Chemistry, Multidisciplinary
SC Chemistry
GA BCR88
UT WOS:000230977100002
DA 2021-01-25
ER

PT S
AU Boeva, V
   Clement, J
   Regnier, M
   Vandenbogaert, M
AF Boeva, V
   Clement, J
   Regnier, M
   Vandenbogaert, M
BE Apostolico, A
   Crochemore, M
   Park, K
TI Assessing the significance of sets of words
SO COMBINATORIAL PATTERN MATCHING, PROCEEDINGS
SE Lecture Notes in Computer Science
LA English
DT Article; Proceedings Paper
CT 16th Annual Symposium on Combinatorial Pattern Matching
CY JUN 19-22, 2005
CL Jeju Isl, SOUTH KOREA
ID SEQUENCES
AB Various criteria have been defined to evaluate the significance of sets of words, the computation of them often being difficult. We provide explicit expressions for the waiting time in such a context. In order to assess the significance of a cluster of potential binding sites, we extend them to the co-occurrence problem. We point out that these criteria values depend on a few fundamental parameters. We provide efficient algorithms to compute them, that rely on a combinatorial interpretation of the formulae. We show that our results axe very tight in the so-called twilight zone and improve on previous rough approximations. One assumes that the text is generated according to a Markov stationary process. These results axe developed for an extended model of consensus.
C1 Moscow MV Lomonosov State Univ, Moscow, Russia.
   Univ Marne La Vallee, IGM, Marne La Vallee, France.
   Inst Natl Rech Informat & Automat, F-78153 Le Chesnay, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Boeva, V (corresponding author), Moscow MV Lomonosov State Univ, Vorobevy Gory, Moscow, Russia.
EM valeyo@mail333.com; Julien.Clement@univ-mlv.fr;
   Mireille.Regnier@inria.fr; mathias.vandenbogaert@unibas.ch
CR AHO AV, 1975, COMMUN ACM, V18, P333, DOI 10.1145/360825.360855
   Beaudoing E, 2000, GENOME RES, V10, P1001, DOI 10.1101/gr.10.7.1001
   BENDER EA, 1993, EUR J COMBIN, V14, P265, DOI 10.1006/eujc.1993.1030
   BLANCHETTE M, 2001, BIOINFORMATICS, V817, P30
   Bubhler J, 2001, P 5 ANN INT C COMP B, P69
   Chiang DY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r43
   CHRYSAPHINOU C, 1990, THEOR PROBAB APPL, V79, P167
   Crochemore M., 2002, JEWELS STRINGOLOGY
   FLAJOLET P, 1996, ANAL ALGORITHMS
   GUIBAS LJ, 1981, J COMB THEORY A, V30, P183, DOI 10.1016/0097-3165(81)90005-4
   Klaerr-Blanchard M, 2000, COMPUT CHEM, V24, P57, DOI 10.1016/S0097-8485(99)00047-9
   Knuth D.E., 1978, INDAGATIONES MATH, V40, P238
   Nicodeme P, 2002, THEOR COMPUT SCI, V287, P593, DOI 10.1016/S0304-3975(01)00264-X
   Panina EM, 2000, MOL BIOL+, V34, P215, DOI 10.1007/BF02759642
   PEVZNER PA, 1989, J BIOMOL STRUCT DYN, V6, P1013, DOI 10.1080/07391102.1989.10506528
   Regnier M, 2004, BIOINFORMATICS OF GENOME REGULATION AND STRUCTURE, P61
   Regnier M, 1998, COMPRESSION AND COMPLEXITY OF SEQUENCES 1997 - PROCEEDINGS, P253, DOI 10.1109/SEQUEN.1997.666920
   Regnier M, 1998, ALGORITHMICA, V22, P631, DOI 10.1007/PL00009244
   Regnier M, 2000, DISCRETE APPL MATH, V104, P259, DOI 10.1016/S0166-218X(00)00195-5
   Robin S, 1999, J APPL PROBAB, V36, P179, DOI 10.1017/S0021900200016958
   Robin S, 2002, J COMPUT BIOL, V9, P761, DOI 10.1089/10665270260518254
   Robin S, 2001, J COMPUT BIOL, V8, P349, DOI 10.1089/106652701752236179
   Szpankowski W., 2001, AVERAGE CASE ANAL AL
   Tanushev MS, 1997, J COMPUT BIOL, V4, P35, DOI 10.1089/cmb.1997.4.35
   van Helden J, 1998, J MOL BIOL, V281, P827, DOI 10.1006/jmbi.1998.1947
   VANDENBOGAERT M, 2003, IN SILICO BIOL, V3, P12
NR 26
TC 7
Z9 8
U1 0
U2 0
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0302-9743
EI 1611-3349
BN 3-540-26201-6
J9 LECT NOTES COMPUT SC
PY 2005
VL 3537
BP 358
EP 370
PG 13
WC Computer Science, Artificial Intelligence; Computer Science, Theory &
   Methods
SC Computer Science
GA BCO99
UT WOS:000230459400031
DA 2021-01-25
ER

PT J
AU Meyer, UA
   Roth, A
   Blattler, S
   Rencurel, F
AF Meyer, UA
   Roth, A
   Blattler, S
   Rencurel, F
TI Xenosensors and regulation of drug metabolism
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 9th European ISSX Meeting
CY JUN 12-17, 2005
CL Nice, FRANCE
C1 Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2532
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2005
VL 37
SU 1
MA 8
BP 4
EP 4
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 973PP
UT WOS:000232535400009
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Europe's innovation barriers
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 1
Z9 1
U1 0
U2 3
PU URBAN & FISCHER VERLAG
PI JENA
PA BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD JAN
PY 2005
VL 84
IS 1
BP 1
EP 3
DI 10.1016/j.ejcb.2004.10.001
PG 3
WC Cell Biology
SC Cell Biology
GA 899RX
UT WOS:000227163600001
PM 15724811
DA 2021-01-25
ER

PT S
AU Stoffler, D
   Aebi, U
AF Stoffler, D
   Aebi, U
BE Evangelista, V
   Barsanti, L
   Passarelli, V
   Gualtieri, P
TI Imaging, measuring and manipulating biological matter from the
   millimeter to nanometer scale
SO FROM CELLS TO PROTEINS: IMAGING NATURE ACROSS DIMENSIONS
SE NATO SECURITY THROUGH SCIENCE SERIES B: PHYSICS AND BIOPHYSICS
LA English
DT Proceedings Paper
CT Conference of the NATO-Advanced-Study-Institute on From Cells to
   Proteins - Imaging Nature across Dimensions
CY SEP 12-23, 2004
CL Pisa, ITALY
SP NATO Sci Affairs Div
DE electron microscopy; scanning force microscopy; scientific
   visualization; image processing; interactive computer graphics
ID ATOMIC-FORCE MICROSCOPY; TRANSMISSION ELECTRON-MICROSCOPY; ACTIN
   FILAMENT; F-ACTIN; MYOSIN; PORE; JUNCTIONS; MOTILITY; COMPLEX; MUSCLE
AB Visualizing the structure and dynamics of proteins, molecular assemblies and cellular components is usually key to our understanding of biological function. Here, we discuss the major approaches in imaging, measuring, and manipulating biological matter ranging from the millimeter to the nanometer scale. Relevant biomedical applications at different length scales are chosen to discuss the various aspects of data acquisition with multiple modalities including confocal laser scanning microscopy, electron microscopy and scanning force microscopy.
C1 Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
RP Stoffler, D (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
CR BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOYDE A, 1994, SCANNING, V16, P33
   BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   COSTELLO MJ, 1989, INVEST OPHTH VIS SCI, V30, P975
   DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599
   Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   Engel Andreas, 1993, Current Opinion in Biotechnology, V4, P403, DOI 10.1016/0958-1669(93)90005-H
   FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0
   FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   Huxley HE, 1996, ANNU REV PHYSIOL, V58, P1, DOI 10.1146/annurev.ph.58.030196.000245
   INOUE S, 1986, VIDEO MICROSCOPY
   KRO SJ, 1991, METHOD ENZYMOL, V196, P399
   Kull FJ, 1996, NATURE, V380, P550, DOI 10.1038/380550a0
   LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628
   LICHTMAN JW, 1994, SCI AM, V271, P40, DOI 10.1038/scientificamerican0894-40
   LUTZ M, 2001, PROGRAMMING PHTHON
   MOY VT, 1994, SCIENCE, V266, P257, DOI 10.1126/science.7939660
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   PAWLEY JP, 1990, HDB BIOL CONFOCAL MI
   RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858
   RAYMENT I, 1994, TRENDS BIOCHEM SCI, V19, P129, DOI 10.1016/0968-0004(94)90206-2
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   SANNER MF, 2005, IN PRESS ENCY GENOMI
   SANNER MF, 2002, P 10 INT PYTH C, P103
   SANNER MFA, 2005, IN PRESS COMPONENT B
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Stoffler D, 2002, PROTEINS, V48, P63, DOI 10.1002/prot.10130
   STOFFLER D, 2003, P 36 ANN HAW INT C S
   Stolz M, 2000, J STRUCT BIOL, V131, P171, DOI 10.1006/jsbi.2000.4301
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   STOLZ M, 2003, BIOWORLD, V3, P2
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WARRICK HM, 1987, ANNU REV CELL BIOL, V3, P379, DOI 10.1146/annurev.cb.03.110187.002115
   Wilson T, 1984, THEORY PRACTICE SCAN
   2004, SCIPY PYTHON SCI COM
NR 42
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS
SN 1874-6500
BN 1-4020-3614-0
J9 NATO SEC SCI B PHYS
PY 2005
VL 3
BP 85
EP 110
DI 10.1007/1-4020-3616-7_6
PG 26
WC Biochemical Research Methods; Microscopy; Imaging Science & Photographic
   Technology
SC Biochemistry & Molecular Biology; Microscopy; Imaging Science &
   Photographic Technology
GA BDR25
UT WOS:000235038500006
DA 2021-01-25
ER

PT S
AU Pagano, A
   Spiess, M
AF Pagano, A
   Spiess, M
BE Balch, WE
   Der, CJ
   Hall, A
TI Reconstitution of Rab4-dependent vesicle formation in vitro
SO GTPASES REGULATING MEMBRANE TARGETING AND FUSION
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID EARLY ENDOSOMES; ENDOCYTIC PATHWAY; RAB4; MEMBRANE; RABAPTIN-5;
   IDENTIFICATION; TRANSPORT
AB We have developed an in vitro assay to reconstitute the formation of endosomal recycling vesicles. To achieve specificity for endosomes as the donor organelle, cells are surface-biotinylated and allowed to endocytose for 10 min, after which the remaining surface-biotin is stripped off. The cells are then permeabilized and the cytosol washed away. Upon addition of exogenous cytosol and energy, sealed vesicles containing biotinylated recycling receptors are produced. Modification of the cytosol, for example, by immunodepletion or addition of purified proteins, allows the identification of proteins involved in vesicle formation. The results show that recycling is mediated by AP-1/clathrin-coated vesicles, requires Rab4, and is negatively regulated by rabaptin-5/rabex-5.
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Pagano, A (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
OI Spiess, Martin/0000-0001-7139-0550
CR CAMPBELL C, 1984, BIOCHEMISTRY-US, V23, P4420, DOI 10.1021/bi00314a028
   De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744
   de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703
   Deneka M, 2003, EMBO J, V22, P2645, DOI 10.1093/emboj/cdg257
   Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279
   Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3
   LEITINGER B, 1995, P NATL ACAD SCI USA, V92, P10109, DOI 10.1073/pnas.92.22.10109
   Lim SN, 2001, MOL BIOL CELL, V12, P981, DOI 10.1091/mbc.12.4.981
   Lippe R, 2001, METHOD ENZYMOL, V329, P132
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   Mohrmann K, 2002, J BIOL CHEM, V277, P10474, DOI 10.1074/jbc.M111237200
   Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355
   Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123
   SPIESS M, 1990, BIOCHEMISTRY-US, V29, P1009, DOI 10.1021/bi00495a001
   TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cellbio.9.1.129
   van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200
   VANDERSLUIJS P, 1992, CELL, V70, P729, DOI 10.1016/0092-8674(92)90307-X
   Vitale G, 1998, EMBO J, V17, P1941, DOI 10.1093/emboj/17.7.1941
NR 18
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 0-12-182808-5
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2005
VL 403
BP 81
EP 92
DI 10.1016/S0076-6879(05)03008-9
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BDQ05
UT WOS:000234855400008
PM 16473579
DA 2021-01-25
ER

PT S
AU Choudhury, A
   Marks, DL
   Pagano, RE
AF Choudhury, A
   Marks, DL
   Pagano, RE
BE Balch, WE
   Der, CJ
   Hall, A
TI Use of Rab GTPases to study lipid trafficking in normal and sphingolipid
   storage disease fibroblasts
SO GTPASES REGULATING MEMBRANE TARGETING AND FUSION
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID HUMAN SKIN FIBROBLASTS; PICK-C CELLS; GOLGI-APPARATUS; SPECTRAL
   PROPERTIES; PROTEIN-TRANSPORT; CERAMIDE ANALOG; ANIMAL-CELLS; LIVING
   CELLS; CHOLESTEROL; ENDOCYTOSIS
AB We describe methods for studying lipid transport in normal and sphingolipid storage disease fibroblasts. These techniques include endocytic assays with fluorescent sphingolipid analogs, expression of dominant negative (DN) Rab GTPases, and methods of manipulating cholesterol levels in intact cells and isolated cell membranes. These methods should be useful in future studies of lipid trafficking in normal and disease cell types.
C1 Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Choudhury, A (corresponding author), Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit, Rochester, MN 55905 USA.
CR BALCH WE, 1985, ARCH BIOCHEM BIOPHYS, V240, P413, DOI 10.1016/0003-9861(85)90046-3
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Chen CS, 1997, BIOPHYS J, V72, P37, DOI 10.1016/S0006-3495(97)78645-4
   Choudhury A, 2004, MOL BIOL CELL, V15, P4500, DOI 10.1091/mbc.E04-05-0432
   Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420
   Choudhury AK, 2002, MOL BIOL CELL, V13, p93A
   del Real G, 2004, J EXP MED, V200, P541, DOI 10.1084/jem.20040061
   HANADA K, 1995, J CELL BIOL, V128, P793, DOI 10.1083/jcb.128.5.793
   Hirosaki K, 2002, J INVEST DERMATOL, V119, P475, DOI 10.1046/j.1523-1747.2002.01832.x
   KLEIN U, 1995, BIOCHEMISTRY-US, V34, P13784, DOI 10.1021/bi00042a009
   Lebrand C, 2002, EMBO J, V21, P1289, DOI 10.1093/emboj/21.6.1289
   Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285
   Lim SN, 2001, MOL BIOL CELL, V12, P981, DOI 10.1091/mbc.12.4.981
   MARTIN OC, 1993, P NATL ACAD SCI USA, V90, P2661, DOI 10.1073/pnas.90.7.2661
   MARTIN OC, 1994, J CELL BIOL, V125, P769, DOI 10.1083/jcb.125.4.769
   Narita K, 2005, FASEB J, V19, P1558, DOI 10.1096/fj.04-2714fje
   Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627
   Olkkonen VM, 1997, INT REV CYTOL, V176, P1, DOI 10.1016/S0074-7696(08)61608-3
   PAGANO RE, 1985, SCIENCE, V229, P1051, DOI 10.1126/science.4035344
   PAGANO RE, 1991, J CELL BIOL, V113, P1267, DOI 10.1083/jcb.113.6.1267
   PATTERSON MC, 2001, METABOLIC MOL BASES, P3611
   Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X
   Puri V, 1999, NAT CELL BIOL, V1, P386
   Puri V, 2001, J CELL BIOL, V154, P535, DOI 10.1083/jcb.200102084
   Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200
   SCRIVER CR, 2001, METABOLIC MOL BASES, V3, P3371
   Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4
   Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8
   SHAPIRO AD, 1993, J BIOL CHEM, V268, P6925
   Sharma DK, 2003, J BIOL CHEM, V278, P7564, DOI 10.1074/jbc.M210457200
   Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189
   Singh RD, 2003, MOL BIOL CELL, V14, P3254, DOI 10.1091/mbc.E02-12-0809
   Stein MP, 2003, ADV DRUG DELIVER REV, V55, P1421, DOI 10.1016/j.addr.2003.07.009
   STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x
   Stenmark H, 2001, GENOME BIOL, V2
   Sturley SL, 2004, BBA-MOL CELL BIOL L, V1685, P83, DOI 10.1016/j.bbalip.2004.08.014
   Troost J, 2004, MOL PHARMACOL, V66, P1332, DOI 10.1124/mol.104.002329
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
NR 38
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 0-12-182808-5
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2005
VL 403
BP 166
EP 182
DI 10.1016/S0076-6879(05)03014-4
PG 17
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BDQ05
UT WOS:000234855400014
PM 16473585
DA 2021-01-25
ER

PT J
AU Scotet, E
   Martinez, LO
   Grant, E
   Barbaras, R
   Jeno, P
   Guiraud, M
   Monsarrat, B
   Saulquin, X
   Maillet, S
   Esteve, JP
   Lopez, F
   Perret, B
   Collet, X
   Bonneville, M
   Champagne, E
AF Scotet, E
   Martinez, LO
   Grant, E
   Barbaras, R
   Jeno, P
   Guiraud, M
   Monsarrat, B
   Saulquin, X
   Maillet, S
   Esteve, JP
   Lopez, F
   Perret, B
   Collet, X
   Bonneville, M
   Champagne, E
TI Tumor recognition following V gamma 9V delta 2 T cell receptor
   interactions with a surface F1-ATPase-related structure and
   apolipoprotein A-I
SO IMMUNITY
LA English
DT Article
ID NONPEPTIDIC MYCOBACTERIAL LIGANDS; KILLER INHIBITORY RECEPTORS; ATP
   SYNTHASE; ANTIGEN RECOGNITION; INNATE IMMUNITY; LYMPHOMA; PURIFICATION;
   REQUIREMENTS; CYTOTOXICITY; LYMPHOCYTES
AB Vgamma9Vdelta2 T lymphocytes, a major gammadelta T lymphocyte subset in humans, display cytolytic activity against various tumor cells upon recognition of yet uncharacterized structures. Here, we show that an entity related to the mitochondrial F1-ATPase is expressed on tumor cell surface and promotes tumor recognition by Vgamma9Vdelta2 T cells. When immobilized, purified F1-ATPase induces selective activation of this lymphocyte subset. The Vgamma9Vdelta2 T cell receptors (TCR) and the F1-ATPase also bind a delipidated form of apolipoprotein A-I (apo A-I), as demonstrated by surface plasmon resonance. Moreover, the presence of apo A-I in the culture medium is required for optimal activation of Vgamma9Vdelta2 T cells by tumors expressing F1-ATPase. This study thus describes an unanticipated tumor recognition mechanism by Vgamma9Vdelta2 lymphocytes and a possible link between gammadelta T cell immunity and lipid metabolism.
C1 CHU Purpan, CPTP, U563, IFR30,INSERM, F-31024 Toulouse 3, France.
   Inst Biol, INSERM, U601, F-44035 Nantes 01, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France.
   INSERM, IFR 31, F-31403 Toulouse, France.
RP Bonneville, M (corresponding author), CHU Purpan, CPTP, U563, IFR30,INSERM, F-31024 Toulouse 3, France.
EM bonnevil@nantes.inserm.fr; eric.champagne@toulouse.inserm.fr
RI Martinez, Laurent/ABD-6880-2020; Martinez, Laurent O/B-8343-2015;
   SAULQUIN, Xavier/L-2886-2015; SCOTET, Emmanuel/L-2576-2015; SCOTET,
   Emmanuel/AAC-9971-2019; Collet, Xavier/M-6938-2017
OI Martinez, Laurent/0000-0002-0985-3152; Martinez, Laurent
   O/0000-0002-0985-3152; SCOTET, Emmanuel/0000-0001-8010-9556; SCOTET,
   Emmanuel/0000-0001-8010-9556; Bertrand, PERRET/0000-0001-7568-445X;
   Champagne, Eric/0000-0002-8852-0734; Saulquin,
   Xavier/0000-0002-5209-7030
CR Allison TJ, 2001, NATURE, V411, P820, DOI 10.1038/35081115
   Bae TJ, 2004, PROTEOMICS, V4, P3536, DOI 10.1002/pmic.200400952
   BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0
   Brossay L, 1998, J IMMUNOL, V161, P5124
   BUKOWSKI JF, 1994, J IMMUNOL, V153, P5133
   BUKOWSKI JF, 1995, J IMMUNOL, V154, P998
   Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3
   Chambenoit O, 2001, J BIOL CHEM, V276, P9955, DOI 10.1074/jbc.M010265200
   Collet X, 1997, J LIPID RES, V38, P634
   CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660
   Crowley MP, 2000, SCIENCE, V287, P314, DOI 10.1126/science.287.5451.314
   DAS B, 1994, J EXP MED, V180, P273, DOI 10.1084/jem.180.1.273
   Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523
   DAVODEAU F, 1993, SCIENCE, V260, P1800, DOI 10.1126/science.8390096
   DELIBERO G, 1991, J EXP MED, V173, P1311, DOI 10.1084/jem.173.6.1311
   Fahrer AM, 2001, P NATL ACAD SCI USA, V98, P10261, DOI 10.1073/pnas.171320798
   Fisch P, 1997, EUR J IMMUNOL, V27, P3368, DOI 10.1002/eji.1830271236
   FISCH P, 1990, SCIENCE, V250, P1269, DOI 10.1126/science.1978758
   Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282
   Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916
   Gober HJ, 2003, J EXP MED, V197, P163, DOI 10.1084/jem.20021500
   Groh V, 1998, SCIENCE, V279, P1737, DOI 10.1126/science.279.5357.1737
   Halary F, 1997, EUR J IMMUNOL, V27, P2812, DOI 10.1002/eji.1830271111
   HARLOW E, 1988, ANTIBODIES LABORATOR, P312
   LANG F, 1995, J IMMUNOL, V154, P5986
   LUTTER R, 1993, BIOCHEM J, V295, P799, DOI 10.1042/bj2950799
   MAHLEY RW, 1989, ARTERIOSCLER, V9, P114
   MALKOVSKA V, 1994, CLIN EXP IMMUNOL, V96, P158
   Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250
   MEZDOUR H, 1987, J CHROMATOGR-BIOMED, V414, P35, DOI 10.1016/0378-4347(87)80022-1
   Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283
   MORITA CT, 1995, IMMUNITY, V3, P495, DOI 10.1016/1074-7613(95)90178-7
   Moser TL, 1999, P NATL ACAD SCI USA, V96, P2811, DOI 10.1073/pnas.96.6.2811
   Murao K, 1997, J BIOL CHEM, V272, P17551, DOI 10.1074/jbc.272.28.17551
   Ramsburg E, 2003, J EXP MED, V198, P1403, DOI 10.1084/jem.20030050
   Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937
   Stanic AK, 2003, J IMMUNOL, V171, P4539, DOI 10.4049/jimmunol.171.9.4539
   TANAKA Y, 1994, P NATL ACAD SCI USA, V91, P8175, DOI 10.1073/pnas.91.17.8175
   Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236
NR 39
TC 231
Z9 244
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1074-7613
EI 1097-4180
J9 IMMUNITY
JI Immunity
PD JAN
PY 2005
VL 22
IS 1
BP 71
EP 80
DI 10.1016/j.immuni.2004.11.012
PG 10
WC Immunology
SC Immunology
GA 892XI
UT WOS:000226682900008
PM 15664160
DA 2021-01-25
ER

PT J
AU Armitage, JP
   Holland, IB
   Jenal, U
   Kenny, B
AF Armitage, JP
   Holland, IB
   Jenal, U
   Kenny, B
TI "Neural networks" in bacteria: Making connections
SO JOURNAL OF BACTERIOLOGY
LA English
DT Review
ID BACILLUS-SUBTILIS; MECHANOSENSITIVE CHANNELS; CELL-DIVISION; SYSTEM;
   LOCALIZATION; EXPRESSION; REGULATOR; PROTEIN; MOTIFS; OUTPUT
C1 Univ Oxford, Dept Biochem, Oxford, England.
   Univ Bristol, Sch Med Sci, Dept Pathol & Microbiol, Bristol BS8 1TD, Avon, England.
   Univ Paris 11, Inst Microbiol & Genet, Orsay, France.
   Univ Basel, Biozentrum, Basel, Switzerland.
RP Armitage, JP (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford, England.
EM judith.armitage@bioch.ox.ac.uk
OI , Brendan/0000-0001-7455-360X
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072
   Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6
   Bennett HPJ, 2005, J BACTERIOL, V187, P77, DOI 10.1128/JB.187.1.77-84.2005
   Chen S, 2002, BIOSYSTEMS, V65, P157, DOI 10.1016/S0303-2647(02)00013-8
   Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x
   Danino VE, 2003, MOL MICROBIOL, V50, P511, DOI 10.1046/j.1365-2958.2003.03699.x
   Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006
   Francke C, 2003, BIOPHYS J, V85, P612, DOI 10.1016/S0006-3495(03)74505-6
   Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003
   HEINRICH R, 1991, EUR J BIOCHEM, V201, P1, DOI 10.1111/j.1432-1033.1991.tb16251.x
   Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003
   Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001
   Hong HJ, 2004, MOL MICROBIOL, V52, P1107, DOI 10.1111/j.1365-2958.2004.04032.x
   HORAK R, IN PRESS MOL MICROBI
   Ilves H, 2001, J BACTERIOL, V183, P5445, DOI 10.1128/JB.183.18.5445-5448.2001
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a
   Joyce SA, 2003, MOL MICROBIOL, V47, P1445, DOI 10.1046/j.1365-2958.2003.03389.x
   Julkowska D, 2004, MICROBIOL-SGM, V150, P1839, DOI 10.1099/mic.0.27061-0
   Klipp E, 2002, EUR J BIOCHEM, V269, P5406, DOI 10.1046/j.1432-1033.2002.03223.x
   Kremling A, 2001, METAB ENG, V3, P362, DOI 10.1006/mben.2001.0199
   Laurie AD, 2003, J BIOL CHEM, V278, P1494, DOI 10.1074/jbc.M209268200
   Lengeler JW, 2000, BIOL CHEM, V381, P911, DOI 10.1515/BC.2000.112
   Lequette Y, 2005, J BACTERIOL, V187, P37, DOI 10.1128/JB.187.1.37-44.2005
   Li JH, 2003, MICROBIOL-SGM, V149, P3257, DOI 10.1099/mic.0.26462-0
   Lipkow K, 2005, J BACTERIOL, V187, P45, DOI 10.1128/JB.187.1.45-53.2005
   Madec E, 2003, J MOL BIOL, V330, P459, DOI 10.1016/S0022-2836(03)00579-5
   Magnusson LU, 2003, J BIOL CHEM, V278, P968, DOI 10.1074/jbc.M209881200
   Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100
   Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419
   Mascher T, 2003, J BACTERIOL, V185, P60, DOI 10.1128/JB.185.1.60-70.2003
   Miller S, 2003, J BIOL CHEM, V278, P32246, DOI 10.1074/jbc.M303188200
   Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824
   MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6
   Oh JI, 2004, BIOCHEMISTRY-US, V43, P7915, DOI 10.1021/bi0496440
   Oh JI, 2000, EMBO J, V19, P4237, DOI 10.1093/emboj/19.16.4237
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881
   Shimizu TS, 2003, J MOL BIOL, V329, P291, DOI 10.1016/S0022-2836(03)00437-6
   Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406
   Stokes NR, 2003, P NATL ACAD SCI USA, V100, P15959, DOI 10.1073/pnas.2536607100
   Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015
   Studemann A, 2003, EMBO J, V22, P4111, DOI 10.1093/emboj/cdg411
   Vogel J, 2003, NUCLEIC ACIDS RES, V31, P6435, DOI 10.1093/nar/gkg867
   Wadhams GH, 2003, MOL MICROBIOL, V50, P763, DOI 10.1046/j.1365-2958.2003.03716.x
   WAGNER EGH, 2003, NONCODING RNAS, P243
   Wassarman KM, 2001, GENE DEV, V15, P1637, DOI 10.1101/gad.901001
   Wisniewski-Dye F, 2002, ANTON LEEUW INT J G, V81, P397, DOI 10.1023/A:1020501104051
   Wolanin PM, 2004, CURR BIOL, V14, pR486, DOI 10.1016/j.cub.2004.06.018
   Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002
   Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348
NR 52
TC 11
Z9 13
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JAN
PY 2005
VL 187
IS 1
BP 26
EP 36
DI 10.1128/JB.187.1.26-36.2005
PG 11
WC Microbiology
SC Microbiology
GA 888QX
UT WOS:000226390400003
PM 15601685
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Mascarenhas, JB
   Ruegg, MA
   Sasaki, T
   Eble, JA
   Engel, M
   Stetefeld, J
AF Mascarenhas, JB
   Ruegg, MA
   Sasaki, T
   Eble, JA
   Engel, M
   Stetefeld, J
TI Structure and laminin-binding specificity of the NtA domain expressed in
   eukaryotic cells
SO MATRIX BIOLOGY
LA English
DT Article
DE agrin; N-terminal agrin; agrin-laminin interaction
ID BASAL LAMINA; AGRIN; PROTEIN; KALININ; SITE
AB Agrin is a key organizer for postsynaptic differentiation at the neuromuscular junction (NMJ). This activity requires the binding of agrin to the synaptic basal lamina via its N-terminal (NtA) domain. It has been suggested that this binding is mediated by conserved amino acids in the gamma1 chain of laminin. Here, we report the crystal structure of chicken NtA expressed in eukaryotic HEK293 cells. In contrast to the previously published structure [Stetefeld, J., Jenny, M., Schulthess, T., Landwehr, R., Schumacher, B., Frank, S., Ruegg, M.A., Engel, J., Kammerer, R.A., 2001. The laminin-binding domain of agrin is structurally related to N-TIMP-1. Nat. Struct. Biol., 8, 705-709.], which was derived from the NtA domain expressed in E. coli, the new data show that the N-terminal tail region (amino acid residues Asn1-Arg5) is highly structured. Moreover, the disulfide bridge between Cys2 and Cys74 was also present. In addition, we show that the binding of NtA requires the gamma1 chain of laminin and is not greatly affected by the composition of beta chains. These results confirm a model of the NtA-laminin complex where conserved amino acids in the gamma1 chain are prerequisite for the binding to agrin and they further emphasize that the source of protein can be critical in structure determination. (C) 2004 Elsevier B.V/International Society of Matrix Biology. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   MPI Biochem, Martinsried, Germany.
   Muenster Univ Hosp, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany.
RP Stetefeld, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Joerg.Stetefeld@unibas.ch
RI Stetefeld, Joerg/H-7630-2017; Ruegg, Markus/X-7256-2019
OI Stetefeld, Joerg/0000-0003-1478-3248; Ruegg, Markus/0000-0002-4974-9384;
   Mascarenhas, Joseph B/0000-0002-4735-3140
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BECK K, 1990, FASEB J, V4, P148
   Bork P, 1996, Q REV BIOPHYS, V29, P119, DOI 10.1017/S0033583500005783
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   DENZER AJ, 1995, J CELL BIOL, V131, P1547, DOI 10.1083/jcb.131.6.1547
   Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+
   Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Hohenester E, 2002, MATRIX BIOL, V21, P115, DOI 10.1016/S0945-053X(01)00191-3
   Kammerer RA, 1999, EMBO J, V18, P6762, DOI 10.1093/emboj/18.23.6762
   Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3
   Leslie AGW, 1994, MOSFLM USERS GUIDE
   Libby RT, 2000, J NEUROSCI, V20, P6517, DOI 10.1523/JNEUROSCI.20-17-06517.2000
   MARINKOVICH MP, 1992, J BIOL CHEM, V267, P17900
   Mascarenhas JB, 2003, EMBO J, V22, P529, DOI 10.1093/emboj/cdg041
   ROUSSELLE P, 1991, J CELL BIOL, V114, P567, DOI 10.1083/jcb.114.3.567
   Ruegg MA, 1998, TRENDS NEUROSCI, V21, P22, DOI 10.1016/S0166-2236(97)01154-5
   Stetefeld J, 2001, NAT STRUCT BIOL, V8, P705, DOI 10.1038/90422
   TIMPL R, 1994, MATRIX BIOL, V14, P275, DOI 10.1016/0945-053X(94)90192-9
   TIMPL R, 1987, METHOD ENZYMOL, V145, P363
   TURK D, 1992, THESIS TU MUNCHEN MU
   YURCHENCO PD, 1994, CURR OPIN CELL BIOL, V6, P674, DOI 10.1016/0955-0674(94)90093-0
NR 24
TC 11
Z9 12
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0945-053X
EI 1569-1802
J9 MATRIX BIOL
JI Matrix Biol.
PD JAN
PY 2005
VL 23
IS 8
BP 507
EP 513
DI 10.1016/j.matbio.2004.11.003
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 899KK
UT WOS:000227143100003
PM 15694127
DA 2021-01-25
ER

PT J
AU Journet, L
   Hughes, KT
   Cornelis, GR
AF Journet, L
   Hughes, KT
   Cornelis, GR
TI Type III secretion: a secretory pathway serving both motility and
   virulence (Review)
SO MOLECULAR MEMBRANE BIOLOGY
LA English
DT Review
DE flagellum; nanomachines; microbial pathogenesis; effectors
ID FLAGELLAR HOOK-LENGTH; ENTEROPATHOGENIC ESCHERICHIA-COLI; YERSINIA YOP
   VIRULON; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; PROTEIN-SECRETION;
   DOMAIN ORGANIZATION; EXPORT APPARATUS; EUKARYOTIC CELLS; MESSENGER-RNA
AB Type III secretion' (T3S) refers to a secretion pathway that is common to the flagellae of eubacteria and the injectisomes of some Gram-negative bacteria. Flagellae are rotary nanomachines allowing motility but they contain a built-in secretion apparatus that exports their own distal components to the distal end of the growing structure where they polymerize. In some cases they have been shown to export non-flagellar proteins. Injectisomes are transkingdom communication apparatuses allowing bacteria docked at the surface of a eukaryotic cell membrane to inject effector proteins across the two bacterial membranes and the eukaryotic cell membrane. Both nanomachines share a similar basal body embedded in the two bacterial membranes, topped either by a hook and a filament or by a stiff short needle. Both appear to be assembled in the same fashion. They recognize their substrate by a loose N-terminal peptide signal and the help of individual chaperones of a new type.
C1 Univ Basel, Biozentrum, CH-4051 Basel, Switzerland.
   Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4051 Basel, Switzerland.
EM guy.cornelis@unibas.ch
OI Journet, Laure/0000-0002-5847-2962
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM56141] Funding Source: Medline; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM056141, R01GM056141,
   R01GM056141, R01GM056141, R01GM056141, R01GM056141, R01GM056141,
   R01GM056141, R01GM056141, R01GM056141, R01GM056141, R01GM056141,
   R01GM056141, R01GM056141, R01GM056141, R01GM056141, R01GM056141,
   R01GM056141, R01GM056141, R01GM056141, R01GM056141, R01GM056141,
   R01GM056141] Funding Source: NIH RePORTER
CR AGRAIN C, 2005, IN PRESS MOL MICROBI
   Anderson DM, 1997, SCIENCE, V278, P1140, DOI 10.1126/science.278.5340.1140
   Anderson DM, 1999, P NATL ACAD SCI USA, V96, P12839, DOI 10.1073/pnas.96.22.12839
   Auvray F, 2001, J MOL BIOL, V308, P221, DOI 10.1006/jmbi.2001.4597
   Bennett JCQ, 2000, TRENDS MICROBIOL, V8, P202, DOI 10.1016/S0966-842X(00)01751-0
   Bennett JCQ, 2001, MOL MICROBIOL, V39, P781, DOI 10.1046/j.1365-2958.2001.02268.x
   Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Bogdanove AJ, 1996, MOL MICROBIOL, V20, P681, DOI 10.1046/j.1365-2958.1996.5731077.x
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Boyd AP, 2000, J BACTERIOL, V182, P4811, DOI 10.1128/JB.182.17.4811-4821.2000
   Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004
   Cheng LW, 1997, MOL MICROBIOL, V24, P757, DOI 10.1046/j.1365-2958.1997.3831750.x
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735
   Cornelis GR, 1997, MOL MICROBIOL, V23, P861, DOI 10.1046/j.1365-2958.1997.2731623.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Daughdrill GW, 1997, NAT STRUCT BIOL, V4, P285, DOI 10.1038/nsb0497-285
   Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003
   Fadouloglou VE, 2004, P NATL ACAD SCI USA, V101, P70, DOI 10.1073/pnas.0304579101
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Feldman MF, 2002, MOL MICROBIOL, V46, P1183, DOI 10.1046/j.1365-2958.2002.03241.x
   Foultier B, 2002, J MOL EVOL, V55, P37, DOI 10.1007/s00239-001-0089-7
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Fraser GM, 1999, MOL MICROBIOL, V32, P569, DOI 10.1046/j.1365-2958.1999.01372.x
   Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322
   GENIN S, 1994, MOL GEN GENET, V243, P112, DOI 10.1007/BF00283883
   Ghelardi E, 2002, J BACTERIOL, V184, P6424, DOI 10.1128/JB.184.23.6424-6433.2002
   Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   HUGHES KT, 1993, SCIENCE, V262, P1277, DOI 10.1126/science.8235660
   Hume PJ, 2003, MOL MICROBIOL, V49, P425, DOI 10.1046/j.1365-2958.2003.03559.x
   Jin QL, 2001, SCIENCE, V294, P2556, DOI 10.1126/science.1066397
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Konkel ME, 2004, J BACTERIOL, V186, P3296, DOI 10.1128/JB.186.11.3296-3303.2004
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Krall R, 2004, J BIOL CHEM, V279, P2747, DOI 10.1074/jbc.M301963200
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   KUTSUKAKE K, 1994, J BACTERIOL, V176, P7625, DOI 10.1128/JB.176.24.7625-7629.1994
   Lee SH, 2004, MOL MICROBIOL, V51, P483, DOI 10.1046/j.1365-2958.2003.03840.x
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Lloyd SA, 2001, MOL MICROBIOL, V39, P520, DOI 10.1046/j.1365-2958.2001.02271.x
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   McGhie EJ, 2002, MOL MICROBIOL, V44, P1309, DOI 10.1046/j.1365-2958.2002.02958.x
   MENARD R, 1994, CELL, V79, P515, DOI 10.1016/0092-8674(94)90260-7
   MICHIELS T, 1990, INFECT IMMUN, V58, P2840, DOI 10.1128/IAI.58.9.2840-2849.1990
   Miller VL, 2002, CURR OPIN MICROBIOL, V5, P211, DOI 10.1016/S1369-5274(02)00303-X
   MIMORI Y, 1995, J MOL BIOL, V249, P69, DOI 10.1006/jmbi.1995.0281
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   MORGAN DG, 1993, J MOL BIOL, V229, P79, DOI 10.1006/jmbi.1993.1009
   Namba K, 2001, GENES CELLS, V6, P1, DOI 10.1046/j.1365-2443.2001.00384.x
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Nguyen L, 2000, J MOL MICROB BIOTECH, V2, P125
   Page AL, 2002, MOL MICROBIOL, V43, P1533, DOI 10.1046/j.1365-2958.2002.02835.x
   Page AL, 2002, MOL MICROBIOL, V46, P1, DOI 10.1046/j.1365-2958.2002.03138.x
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Saijo-Hamano Y, 2004, J MOL BIOL, V339, P423, DOI 10.1016/j.jmb.2004.03.070
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Song YC, 2004, MOL MICROBIOL, V53, P541, DOI 10.1111/j.1365-2958.2004.04175.x
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073
   Tamano K, 2000, EMBO J, V19, P3876, DOI 10.1093/emboj/19.15.3876
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101
   VONDERVISZT F, 1992, J MOL BIOL, V226, P575, DOI 10.1016/0022-2836(92)90616-R
   VONDERVISZT F, 1989, J MOL BIOL, V209, P127, DOI 10.1016/0022-2836(89)90176-9
   WATTIAU P, 1993, MOL MICROBIOL, V8, P123, DOI 10.1111/j.1365-2958.1993.tb01209.x
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x
   YAHR TL, 1996, MOL MICROBIOL, V22, P91
   Yonekura K, 2000, SCIENCE, V290, P2148, DOI 10.1126/science.290.5499.2148
   Young GM, 1999, P NATL ACAD SCI USA, V96, P6456, DOI 10.1073/pnas.96.11.6456
NR 83
TC 52
Z9 56
U1 0
U2 11
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0968-7688
EI 1464-5203
J9 MOL MEMBR BIOL
JI Mol. Membr. Biol.
PD JAN-APR
PY 2005
VL 22
IS 1-2
BP 41
EP 50
DI 10.1080/09687860500041858
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 921ZS
UT WOS:000228805500005
PM 16092523
DA 2021-01-25
ER

PT J
AU Rodal, AA
   Sokolova, O
   Robins, DB
   Daugherty, KM
   Hippenmeyer, S
   Riezman, H
   Grigorieff, N
   Goode, BL
AF Rodal, AA
   Sokolova, O
   Robins, DB
   Daugherty, KM
   Hippenmeyer, S
   Riezman, H
   Grigorieff, N
   Goode, BL
TI Conformational changes in the Arp2/3 complex leading to actin nucleation
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID ALDRICH-SYNDROME PROTEIN; BINDING-ACTIVITY; 3-DIMENSIONAL
   RECONSTRUCTION; ELECTRON-MICROSCOPY; ATP HYDROLYSIS; N-WASP; ACTIVATION;
   FILAMENT; SUBUNIT; CDC42
AB The two actin-related subunits of the Arp2/3 complex, Arp2 and Arp3, are proposed to form a pseudo actin dimer that nucleates actin polymerization. However, in the crystal structure of the inactive complex, they are too far apart to form such a nucleus. Here, we show using EM that yeast and bovine Arp2/3 complexes exist in a distribution among open, intermediate and closed conformations. The crystal structure docks well into the open conformation. The activator WASp binds at the cleft between Arp2 and Arp3, and all WASp-bound complexes are closed. The inhibitor coronin binds near the p35 subunit, and all coronin-bound complexes are open. Activating and loss-of-function mutations in the p35 subunit skew conformational distribution in opposite directions, closed and open, respectively. We conclude that WASp stabilizes p35-dependent closure of the complex, holding Arp2 and Arp3 closer together to nucleate an actin filament.
C1 Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.
   Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Howard Hughes Med Inst, Waltham, MA 02454 USA.
   Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biochem, Waltham, MA 02454 USA.
   Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.
RP Goode, BL (corresponding author), Brandeis Univ, Rosenstiel Basic Med Sci Res Ctr, Dept Biol, Waltham, MA 02454 USA.
EM goode@brandeis.edu
RI Sokolova, Olga/AAM-8289-2020; Sokolova, Olga/G-7794-2016
OI Sokolova, Olga/0000-0003-4678-232X; Riezman, Howard/0000-0003-4680-9422;
   Hippenmeyer, Simon/0000-0003-2279-1061
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [T32GM007596,
   T32GM007596, T32GM007596, R01GM063691, T32GM007596, R01GM063691,
   T32GM007596, T32GM007596, T32GM007596, T32GM007596, T32GM007596,
   T32GM007596, R01GM063691, T32GM007596, T32GM007596, T32GM007596,
   T32GM007596, T32GM007596, R01GM063691, R01GM063691, R01GM063691,
   R01GM063691, T32GM007596, T32GM007596, T32GM007596, T32GM007596,
   T32GM007596, R01GM063691, T32GM007596, R01GM063691, R01GM063691,
   T32GM007596, T32GM007596, R01GM063691, T32GM007596, R01GM063691,
   R01GM063691, R01GM063691, T32GM007596, R01GM063691, R01GM063691,
   T32GM007596, T32GM007596, T32GM007596, T32GM007596, R01GM063691,
   T32GM007596, R01GM063691, T32GM007596, T32GM007596] Funding Source: NIH
   RePORTER; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01 GM063691, T32 GM007596] Funding
   Source: Medline
CR Bailly M, 2001, CURR BIOL, V11, P620, DOI 10.1016/S0960-9822(01)00152-X
   Dayel MJ, 2004, PLOS BIOL, V2, P476, DOI 10.1371/journal.pbio.0020091
   Dayel MJ, 2001, P NATL ACAD SCI USA, V98, P14871, DOI 10.1073/pnas.261419298
   Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319
   FRANK J, 1992, ULTRAMICROSCOPY, V46, P241, DOI 10.1016/0304-3991(92)90018-F
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   HARAUZ G, 1986, OPTIK, V73, P146
   Higgs HN, 2000, J CELL BIOL, V150, P1311, DOI 10.1083/jcb.150.6.1311
   Huang CC, 1996, PAC S BIOCOMPUT, DOI DOI 10.1142/9789814531399
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   Le Clainche C, 2003, P NATL ACAD SCI USA, V100, P6337, DOI 10.1073/pnas.1130513100
   Le Clainche C, 2001, J BIOL CHEM, V276, P46689, DOI 10.1074/jbc.C100476200
   Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739
   Mullins RD, 1997, J CELL BIOL, V136, P331, DOI 10.1083/jcb.136.2.331
   Pantaloni D, 2000, NAT CELL BIOL, V2, P385
   Robinson RC, 2001, SCIENCE, V294, P1679, DOI 10.1126/science.1066333
   Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X
   Suetsugu S, 2001, J CELL SCI, V114, P4533
   vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004
   Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025
   Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7
   Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133
   Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8
   Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080
   Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0
NR 28
TC 128
Z9 134
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA
SN 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JAN
PY 2005
VL 12
IS 1
BP 26
EP 31
DI 10.1038/nsmb870
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 886GU
UT WOS:000226215700008
PM 15592479
DA 2021-01-25
ER

PT J
AU Jindrova, E
   Schmid-Nuoffer, S
   Hamburger, F
   Janscak, P
   Bickle, TA
AF Jindrova, E
   Schmid-Nuoffer, S
   Hamburger, F
   Janscak, P
   Bickle, TA
TI On the DNA cleavage mechanism of Type I restriction enzymes
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID ESCHERICHIA-COLI-B; TRANSLOCATION; ENDONUCLEASE; ECOR124I; SUBUNIT;
   RECOGNITION; SELECTION; SYSTEMS; SITES
AB Although the DNA cleavage mechanism of Type I restriction-modification enzymes has been extensively studied, the mode of cleavage remains elusive. In this work, DNA ends produced by EcoKI, EcoAI and EcoR124I, members of the Type IA, IB and IC families, respectively, have been characterized by cloning and sequencing restriction products from the reactions with a plasmid DNA substrate containing a single recognition site for each enzyme. Here, we show that all three enzymes cut this substrate randomly with no preference for a particular base composition surrounding the cleavage site, producing both 5'- and 3'-overhangs of varying lengths. EcoAI preferentially generated 3'-overhangs of 2-3 nt, whereas EcoKI and EcoR124I displayed some preference for the formation of 5'-overhangs of a length of similar to 6-7 and 3-5 nt, respectively. A mutant EcoAI endonuclease assembled from wild-type and nuclease-deficient restriction subunits generated a high proportion of nicked circular DNA, whereas the wild-type enzyme catalyzed efficient cleavage of both DNA strands. We conclude that Type I restriction enzymes require two restriction subunits to introduce DNA double-strand breaks, each providing one catalytic center for phosphodiester bond hydrolysis. Possible models for DNA cleavage are discussed.
C1 Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
   Univ Zurich, Inst Mol Canc Res, CH-8008 Zurich, Switzerland.
RP Bickle, TA (corresponding author), Univ Basel, Biozentrum, Div Mol Microbiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM thomas-a.bickle@unibas.ch
CR Bitinaite J, 1998, P NATL ACAD SCI USA, V95, P10570, DOI 10.1073/pnas.95.18.10570
   Bourniquel AA, 2002, BIOCHIMIE, V84, P1047, DOI 10.1016/S0300-9084(02)00020-2
   Davies GP, 1999, J MOL BIOL, V290, P565, DOI 10.1006/jmbi.1999.2908
   Dreier J, 1996, J MOL BIOL, V264, P722, DOI 10.1006/jmbi.1996.0672
   ENDLICH B, 1985, J BIOL CHEM, V260, P5729
   ESKIN B, 1972, J BIOL CHEM, V247, P6192
   Janscak P, 1998, NUCLEIC ACIDS RES, V26, P4439, DOI 10.1093/nar/26.19.4439
   Janscak P, 1998, J MOL BIOL, V284, P937, DOI 10.1006/jmbi.1998.2250
   Janscak P, 1999, NUCLEIC ACIDS RES, V27, P2638, DOI 10.1093/nar/27.13.2638
   Janscak P, 1999, EMBO J, V18, P2638, DOI 10.1093/emboj/18.9.2638
   Janscak P, 2000, J MOL BIOL, V295, P1089, DOI 10.1006/jmbi.1999.3414
   Janscak P, 1996, J MOL BIOL, V257, P977, DOI 10.1006/jmbi.1996.0217
   Keatch SA, 2004, NUCLEIC ACIDS RES, V32, P5841, DOI 10.1093/nar/gkh918
   KIMBALL M, 1976, BIOCHEM BIOPH RES CO, V68, P585, DOI 10.1016/0006-291X(76)91185-2
   Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000
   Pingoud A, 1997, EUR J BIOCHEM, V246, P1, DOI 10.1111/j.1432-1033.1997.t01-6-00001.x
   Redaschi N, 1996, ESCHERICHIA COLI SAL, P773
   Sasnauskas G, 2003, P NATL ACAD SCI USA, V100, P6410, DOI 10.1073/pnas.1131003100
   Seidel R, 2004, NAT STRUCT MOL BIOL, V11, P838, DOI 10.1038/nsmb816
   STUDIER FW, 1988, P NATL ACAD SCI USA, V85, P4677, DOI 10.1073/pnas.85.13.4677
   Szczelkun MD, 1997, J MOL BIOL, V271, P112, DOI 10.1006/jmbi.1997.1172
   TAYLOR I, 1992, NUCLEIC ACIDS RES, V20, P179, DOI 10.1093/nar/20.2.179
   Titheradge AJB, 2001, NUCLEIC ACIDS RES, V29, P4195, DOI 10.1093/nar/29.20.4195
   WEISEROVA M, 1993, NUCLEIC ACIDS RES, V21, P373, DOI 10.1093/nar/21.3.373
NR 24
TC 14
Z9 14
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PY 2005
VL 33
IS 6
BP 1760
EP 1766
DI 10.1093/nar/gki322
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 916PR
UT WOS:000228398400016
PM 15788748
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT B
AU Buchner, J
   Kiefhaber, T
AF Buchner, Johannes
   Kiefhaber, Thomas
BE Buchner, J
   Kiefhaber, T
TI Protein Folding Handbook Preface
SO PROTEIN FOLDING HANDBOOK
LA English
DT Editorial Material; Book Chapter
C1 [Buchner, Johannes] Tech Univ Munich, Inst Organ Chem & Biochem, D-85747 Garching, Germany.
   [Kiefhaber, Thomas] Biozentrum Univ Basel, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Buchner, J (corresponding author), Tech Univ Munich, Inst Organ Chem & Biochem, Lichtenbergstr 4, D-85747 Garching, Germany.
EM johannes.buchner@ch.tum.de; t.kiefhaber@unibas.ch
CR JAENICKE R., 1980, PROTEIN FOLDING
NR 1
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-52761-949-8
PY 2005
BP LVIII
EP LIX
D2 10.1002/9783527619498
PG 2
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAD19
UT WOS:000303836100001
DA 2021-01-25
ER

PT B
AU Bachmann, A
   Kiefhaber, T
AF Bachmann, Annett
   Kiefhaber, Thomas
BE Buchner, J
   Kiefhaber, T
TI Kinetic Mechanisms in Protein Folding
SO PROTEIN FOLDING HANDBOOK
LA English
DT Article; Book Chapter
ID EGG-WHITE LYSOZYME; LACTALBUMIN MOLTEN GLOBULE; ALPHA-LACTALBUMIN;
   CYTOCHROME-C; HYDROGEN-EXCHANGE; RIBONUCLEASE-A; HEN LYSOZYME; SPEED
   LIMIT; PROLYL ISOMERIZATION; HAMMOND BEHAVIOR
C1 [Bachmann, Annett; Kiefhaber, Thomas] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Bachmann, A (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
CR AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021
   Bachmann A, 2002, BIOPHYS CHEM, V96, P141, DOI 10.1016/S0301-4622(02)00020-0
   Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   Bieri O, 2001, J MOL BIOL, V310, P919, DOI 10.1006/jmbi.2001.4804
   Bieri O, 1999, BIOL CHEM, V380, P923, DOI 10.1515/BC.1999.114
   Bieri O, 1999, BIOCHEMISTRY-US, V38, P12460, DOI 10.1021/bi9909703
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   Bieri O., 1999, ANN PHYS CHEM, V38, P12460
   BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0
   BLAKE CCF, 1967, PROC R SOC SER B-BIO, V167, P365, DOI 10.1098/rspb.1967.0034
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   CHAFFOTTE AF, 1992, BIOCHEMISTRY-US, V31, P9694, DOI 10.1021/bi00155a024
   Colon W, 1997, BIOCHEMISTRY-US, V36, P12535, DOI 10.1021/bi971697c
   Evans MG, 1935, T FARADAY SOC, V31, P0875, DOI 10.1039/tf9353100875
   Eyring H, 1935, J CHEM PHYS, V3, P107, DOI 10.1063/1.1749604
   GAREL JR, 1973, P NATL ACAD SCI USA, V70, P3347, DOI 10.1073/pnas.70.12.3347
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   HAGEN SJ, 1995, SCIENCE, V269, P959, DOI 10.1126/science.7638618
   Hill T., 1977, FREE ENERGY TRANSDUC
   Hill T.L., 1974, Progress Biophys Molec Biol, V28, P267, DOI 10.1016/0079-6107(74)90020-0
   IKAI A, 1973, J MOL BIOL, V73, P165, DOI 10.1016/0022-2836(73)90321-5
   IKAI A, 1973, J MOL BIOL, V73, P145, DOI 10.1016/0022-2836(73)90320-3
   ITZHAKI LS, 1994, BIOCHEMISTRY-US, V33, P5212, DOI 10.1021/bi00183a026
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM
   JENCKS WP, 1980, ACCOUNTS CHEM RES, V13, P161, DOI 10.1021/ar50150a001
   Khorasanizadeh S, 1996, NAT STRUCT BIOL, V3, P193, DOI 10.1038/nsb0296-193
   Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P6475, DOI 10.1021/bi00479a020
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3061, DOI 10.1021/bi00464a024
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P9029, DOI 10.1073/pnas.92.20.9029
   Kiefhaber T, 1995, Methods Mol Biol, V40, P313
   KIEFHABER T, 1992, J MOL BIOL, V224, P231, DOI 10.1016/0022-2836(92)90586-9
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   KIEFHABER T, 1990, BIOCHEMISTRY-US, V29, P3053, DOI 10.1021/bi00464a023
   KIEFHABER T, 1992, PROTEINS, V12, P171, DOI 10.1002/prot.340120210
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013
   Kulkarni SK, 1999, PROTEIN SCI, V8, P35
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   KUWAJIMA K, 1985, BIOCHEMISTRY-US, V24, P874, DOI 10.1021/bi00325a010
   LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   Luo YZ, 1997, NAT STRUCT BIOL, V4, P925, DOI 10.1038/nsb1197-925
   Luo YZ, 1999, P NATL ACAD SCI USA, V96, P11283, DOI 10.1073/pnas.96.20.11283
   Matagne A, 1998, J MOL BIOL, V277, P997, DOI 10.1006/jmbi.1998.1657
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MIRANKER A, 1993, SCIENCE, V262, P896, DOI 10.1126/science.8235611
   Moore JW, 1981, KINETICS MECH
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   ODEFEY C, 1995, J MOL BIOL, V245, P69, DOI 10.1006/jmbi.1994.0007
   Pappenberger G, 2001, NAT STRUCT BIOL, V8, P452, DOI 10.1038/87624
   RADFORD SE, 1992, PROTEINS, V14, P237, DOI 10.1002/prot.340140210
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Reimer U., 1998, PROTEIN FOLDING FRON, V279, P449
   Rothwarf DM, 1996, BIOCHEMISTRY-US, V35, P13797, DOI 10.1021/bi9608119
   Sabelko J, 1999, P NATL ACAD SCI USA, V96, P6031, DOI 10.1073/pnas.96.11.6031
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SAVEN JG, 1994, J CHEM PHYS, V101, P11037, DOI 10.1063/1.467855
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   SCHMID FX, 1983, BIOCHEMISTRY-US, V22, P4690, DOI 10.1021/bi00289a013
   Segel DJ, 1999, J MOL BIOL, V288, P489, DOI 10.1006/jmbi.1999.2703
   SHLESINGER MF, 1993, NATURE, V363, P31, DOI 10.1038/363031a0
   Silow M, 1997, P NATL ACAD SCI USA, V94, P6084, DOI 10.1073/pnas.94.12.6084
   Skorobogatiy M, 1998, J CHEM PHYS, V109, P2528, DOI 10.1063/1.476825
   Szabo Z. G., 1969, COMPREHENSIVE CHEM K, V2, P1
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   TANFORD C, 1973, J MOL BIOL, V73, P185, DOI 10.1016/0022-2836(73)90322-7
   Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476
   WEISSMAN JS, 1991, SCIENCE, V253, P1386, DOI 10.1126/science.1716783
   Wildegger G, 1997, J MOL BIOL, V270, P294, DOI 10.1006/jmbi.1997.1030
   Wu LC, 1998, J MOL BIOL, V280, P175, DOI 10.1006/jmbi.1998.1825
   WU LC, 1995, NAT STRUCT BIOL, V2, P281, DOI 10.1038/nsb0495-281
   Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609
   Yeh SR, 1997, NAT STRUCT BIOL, V4, P51, DOI 10.1038/nsb0197-51
   Yeh SR, 1998, NAT STRUCT BIOL, V5, P222, DOI 10.1038/nsb0398-222
NR 83
TC 16
Z9 16
U1 0
U2 5
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-52761-949-8; 978-3-527-30784-5
PY 2005
BP 379
EP 410
D2 10.1002/9783527619498
PG 32
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAD19
UT WOS:000303836100013
DA 2021-01-25
ER

PT B
AU Kiefhaber, T
   Sanchez, IE
   Bachmann, A
AF Kiefhaber, Thomas
   Sanchez, Ignacio E.
   Bachmann, Annett
BE Buchner, J
   Kiefhaber, T
TI Characterization of Protein Folding Barriers with Rate Equilibrium Free
   Energy Relationships
SO PROTEIN FOLDING HANDBOOK
LA English
DT Article; Book Chapter
ID NUCLEATION-CONDENSATION MECHANISM; PHYSICAL ORGANIC-CHEMISTRY;
   N-TERMINAL DOMAIN; TRANSITION-STATE; DENATURED STATE; RESIDUAL
   STRUCTURE; SH3 DOMAIN; HAMMOND BEHAVIOR; CHYMOTRYPSIN INHIBITOR-2;
   GUANIDINE-HYDROCHLORIDE
C1 [Kiefhaber, Thomas; Sanchez, Ignacio E.; Bachmann, Annett] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   Bieri O, 1999, BIOCHEMISTRY-US, V38, P12460, DOI 10.1021/bi9909703
   Bronsted JN, 1924, Z PHYS CHEM-STOCH VE, V108, P185
   CHEN BL, 1989, BIOCHEMISTRY-US, V28, P691, DOI 10.1021/bi00428a042
   Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750
   Dalby PA, 1998, BIOCHEMISTRY-US, V37, P4674, DOI 10.1021/bi972798d
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   FARCASIU D, 1975, J CHEM EDUC, V52, P76, DOI 10.1021/ed052p76
   FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426
   FERSHT AR, 1995, P NATL ACAD SCI USA, V92, P10869, DOI 10.1073/pnas.92.24.10869
   FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W
   Fowler SB, 2001, STRUCTURE, V9, P355, DOI 10.1016/S0969-2126(01)00596-2
   Friel CT, 2003, J MOL BIOL, V326, P293, DOI 10.1016/S0022-2836(02)01249-4
   Fulton KF, 1999, J MOL BIOL, V291, P445, DOI 10.1006/jmbi.1999.2942
   Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701
   GOLDENBERG DP, 1989, NATURE, V338, P127, DOI 10.1038/338127a0
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   Guerois R, 2000, J MOL BIOL, V304, P967, DOI 10.1006/jmbi.2000.4234
   GUO ZY, 1995, BIOPOLYMERS, V36, P83, DOI 10.1002/bip.360360108
   HAMMOND GS, 1955, J AM CHEM SOC, V77, P334, DOI 10.1021/ja01607a027
   IKAI A, 1973, J MOL BIOL, V73, P165, DOI 10.1016/0022-2836(73)90321-5
   ITZHAKI LS, 1995, J MOL BIOL, V254, P260, DOI 10.1006/jmbi.1995.0616
   Jencks W. P., 1969, CATALYSIS CHEM ENZYM
   JENCKS WP, 1985, CHEM REV, V85, P511, DOI 10.1021/cr00070a001
   Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398
   Kiefhaber T, 1997, BIOCHEMISTRY-US, V36, P5108, DOI 10.1021/bi9702391
   Kim DE, 2000, J MOL BIOL, V298, P971, DOI 10.1006/jmbi.2000.3701
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Kragelund BB, 1999, NAT STRUCT BIOL, V6, P594
   Krantz BA, 2000, NAT STRUCT BIOL, V7, P62
   Krantz BA, 2001, NAT STRUCT BIOL, V8, P1042, DOI 10.1038/nsb723
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Kuhlman B, 1998, J MOL BIOL, V284, P1661, DOI 10.1006/jmbi.1998.2246
   KUWAJIMA K, 1989, PROTEINS, V6, P87, DOI 10.1002/prot.340060202
   Leffler J.E., 1963, RATES EQUILIBRIA ORG
   LEFFLER JE, 1953, SCIENCE, V117, P340, DOI 10.1126/science.117.3039.340
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Luisi DL, 2000, J MOL BIOL, V299, P1091, DOI 10.1006/jmbi.2000.3752
   Main ERG, 1999, J MOL BIOL, V291, P429, DOI 10.1006/jmbi.1999.2941
   Makarov DE, 2003, PROTEIN SCI, V12, P17, DOI 10.1110/ps.0220003
   Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599
   Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010
   Martinez JC, 1998, NAT STRUCT BIOL, V5, P721, DOI 10.1038/1418
   MATOUSCHEK A, 1995, BIOCHEMISTRY-US, V34, P13656, DOI 10.1021/bi00041a047
   MATOUSCHEK A, 1993, P NATL ACAD SCI USA, V90, P7814, DOI 10.1073/pnas.90.16.7814
   MATOUSCHEK A, 1994, PROTEIN ENG, V7, P1089, DOI 10.1093/protein/7.9.1089
   MATTHEWS CR, 1987, METHOD ENZYMOL, V154, P498
   MATTHEWS JM, 1995, BIOCHEMISTRY-US, V34, P6805, DOI 10.1021/bi00020a027
   Mok YK, 2001, J MOL BIOL, V307, P913, DOI 10.1006/jmbi.2001.4521
   MULLER P, 1994, PURE APPL CHEM, V66, P1077, DOI 10.1351/pac199466051077
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   Nauli S, 2001, NAT STRUCT BIOL, V8, P602, DOI 10.1038/89638
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Northey JGB, 2002, J MOL BIOL, V320, P389, DOI 10.1016/S0022-2836(02)00445-X
   Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612
   Pappenberger G, 2000, P NATL ACAD SCI USA, V97, P17, DOI 10.1073/pnas.97.1.17
   Perl D, 2001, BIOCHEMISTRY-US, V40, P15501, DOI 10.1021/bi011378s
   Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591
   POHL FM, 1976, FEBS LETT, V65, P293, DOI 10.1016/0014-5793(76)80132-9
   PRIVALOV PL, 1992, J MOL BIOL, V224, P715, DOI 10.1016/0022-2836(92)90555-X
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016
   SANCHO J, 1991, J MOL BIOL, V221, P1007, DOI 10.1016/0022-2836(91)80188-Z
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   Sari N, 2000, BIOCHEMISTRY-US, V39, P965, DOI 10.1021/bi9920230
   Sato S, 2004, P NATL ACAD SCI USA, V101, P6952, DOI 10.1073/pnas.0401396101
   Sato S, 2002, J MOL BIOL, V318, P571, DOI 10.1016/S0022-2836(02)00015-3
   Scalley ML, 1997, P NATL ACAD SCI USA, V94, P10636, DOI 10.1073/pnas.94.20.10636
   Schonbrunner N, 1997, BIOCHEMISTRY-US, V36, P9057, DOI 10.1021/bi970594r
   Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x
   Smith CK, 1996, PROTEIN SCI, V5, P2009, DOI 10.1002/pro.5560051007
   Taddei N, 2000, J MOL BIOL, V300, P633, DOI 10.1006/jmbi.2000.3870
   Tan YJ, 1996, J MOL BIOL, V264, P377, DOI 10.1006/jmbi.1996.0647
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Teilum K, 2000, J MOL BIOL, V301, P1307, DOI 10.1006/jmbi.2000.4003
   THORNTON ER, 1967, J AM CHEM SOC, V89, P2915, DOI 10.1021/ja00988a020
   Vendruscolo M, 2001, NATURE, V409, P641, DOI 10.1038/35054591
   Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158
   Wallenhorst WF, 1997, BIOCHEMISTRY-US, V36, P5795, DOI 10.1021/bi9700476
   Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170
   WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447
   Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523
   Wright CF, 2003, NAT STRUCT BIOL, V10, P658, DOI 10.1038/nsb947
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
   ZHOU HX, 1991, J CHEM PHYS, V94, P6147, DOI 10.1063/1.460427
   Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148
NR 89
TC 6
Z9 6
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-52761-949-8; 978-3-527-30784-5
PY 2005
BP 411
EP 444
DI 10.1002/9783527619498.ch12b
D2 10.1002/9783527619498
PG 34
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAD19
UT WOS:000303836100014
DA 2021-01-25
ER

PT B
AU Fierz, B
   Kiefhaber, T
AF Fierz, Beat
   Kiefhaber, Thomas
BE Buchner, J
   Kiefhaber, T
TI Dynamics of Unfolded Polypeptide Chains
SO PROTEIN FOLDING HANDBOOK
LA English
DT Article; Book Chapter
ID HELIX-COIL TRANSITION; INTRAMOLECULAR CONTACT FORMATION; DENATURED
   STATE; RESIDUAL STRUCTURE; ENERGY-TRANSFER; VISCOSITY DEPENDENCE; LOCAL
   DYNAMICS; CONFORMATIONAL DYNAMICS; HAMMOND BEHAVIOR; FOLDING PATHWAY
C1 [Fierz, Beat; Kiefhaber, Thomas] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Fierz, B (corresponding author), Univ Basel, Div Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Fierz, Beat/H-3143-2012
OI Fierz, Beat/0000-0002-2991-3044
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BEECE D, 1980, BIOCHEMISTRY-US, V19, P5147, DOI 10.1021/bi00564a001
   BEECHEM JM, 1989, BIOPHYS J, V55, P1225, DOI 10.1016/S0006-3495(89)82918-2
   BENT DV, 1975, J AM CHEM SOC, V97, P2612, DOI 10.1021/ja00843a004
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   Bieri O, 1999, BIOL CHEM, V380, P923, DOI 10.1515/BC.1999.114
   BIERI O., 2000, MECH PROTEIN FOLDING, P34
   BRANT DA, 1965, J AM CHEM SOC, V87, P2791, DOI 10.1021/ja01091a003
   BRANT DA, 1967, J MOL BIOL, V23, P47, DOI 10.1016/S0022-2836(67)80066-4
   Bredenbeck J, 2003, P NATL ACAD SCI USA, V100, P6452, DOI 10.1073/pnas.1036583100
   Burton RE, 1996, J MOL BIOL, V263, P311, DOI 10.1006/jmbi.1996.0577
   CAMACHO CJ, 1995, P NATL ACAD SCI USA, V92, P1277, DOI 10.1073/pnas.92.5.1277
   Chang IJ, 2003, P NATL ACAD SCI USA, V100, P3838, DOI 10.1073/pnas.0637283100
   Choy WY, 2001, J MOL BIOL, V308, P1011, DOI 10.1006/jmbi.2001.4750
   CLOSS GL, 1989, J AM CHEM SOC, V111, P3751, DOI 10.1021/ja00192a044
   de Gennes P. G., 1979, SCALING CONCEPTS POL
   DEGENNES PG, 1985, J PHYS LETT-PARIS, V46, pL639
   Doi M., 1986, THEORY POLYM DYNAMIC
   DOI M., 1996, INTRO POLYM SCI
   DOSTER W, 1983, BIOPHYS CHEM, V17, P97, DOI 10.1016/0301-4622(83)80002-7
   Dyson HJ, 2002, ADV PROTEIN CHEM, V62, P311
   EDWARDS SF, 1965, P PHYS SOC LOND, V85, P613, DOI 10.1088/0370-1328/85/4/301
   Einstein A, 1906, ANN PHYS-BERLIN, V19, P289, DOI 10.1002/andp.19063240204
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   Ferguson N, 2001, P NATL ACAD SCI USA, V98, P13002, DOI 10.1073/pnas.221467198
   FIXMAN M, 1987, FARADAY DISCUSS, V83, P199, DOI 10.1039/dc9878300199
   Flory P. J., 1953, PRINCIPLES POLYM CHE
   Flory P.J., 1969, STAT MECH CHAIN MOL
   Garcia P, 2001, PROTEIN SCI, V10, P1100, DOI 10.1110/ps.52701
   Gardiner C. W., 1985, HDB STOCHASTIC METHO
   GAVISH B, 1980, PHYS REV LETT, V44, P1160, DOI 10.1103/PhysRevLett.44.1160
   GONNELLI M, 1995, BIOCHEMISTRY-US, V34, P13847, DOI 10.1021/bi00042a017
   GRUENEWALD B, 1979, BIOPHYS CHEM, V9, P137, DOI 10.1016/0301-4622(79)87008-8
   HAAS E, 1978, BIOPOLYMERS, V17, P11, DOI 10.1002/bip.1978.360170103
   HAAS E, 1975, P NATL ACAD SCI USA, V72, P1807, DOI 10.1073/pnas.72.5.1807
   Hagen SJ, 1996, P NATL ACAD SCI USA, V93, P11615, DOI 10.1073/pnas.93.21.11615
   HANGGI P, 1990, REV MOD PHYS, V62, P251, DOI 10.1103/revmodphys.62.251
   Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684
   HUANG GS, 1995, P NATL ACAD SCI USA, V92, P6878, DOI 10.1073/pnas.92.15.6878
   Hudgins RR, 2002, J AM CHEM SOC, V124, P556, DOI 10.1021/ja010493n
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   Jacob M, 1997, P NATL ACAD SCI USA, V94, P5622, DOI 10.1073/pnas.94.11.5622
   JACOBSON H, 1950, J CHEM PHYS, V18, P1600, DOI 10.1063/1.1747547
   Kazmirski SL, 2001, P NATL ACAD SCI USA, V98, P4349, DOI 10.1073/pnas.071054398
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kleinert T, 1998, BIOCHEMISTRY-US, V37, P717, DOI 10.1021/bi971508q
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kortemme T, 2000, J MOL BIOL, V297, P1217, DOI 10.1006/jmbi.2000.3618
   Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   KRIEGER F., 2004, CHEM PHYS IN PRESS
   Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013
   Kuhn W, 1936, KOLLOID Z, V76, P258, DOI 10.1007/BF01451143
   KUHN W., 1934, KOLLOID Z, V52, P269
   KUMAR VD, 1990, BIOCHEMISTRY-US, V29, P1404, DOI 10.1021/bi00458a010
   KUWAJIMA K, 1989, J MOL BIOL, V206, P547, DOI 10.1016/0022-2836(89)90500-7
   LAPIDUS L. J., 2001, PHYS REV LETT
   Lapidus LJ, 2002, J PHYS CHEM B, V106, P11628, DOI 10.1021/jp020829v
   Lapidus LJ, 2000, P NATL ACAD SCI USA, V97, P7220, DOI 10.1073/pnas.97.13.7220
   Lee S, 1997, MACROMOLECULES, V30, P2633, DOI 10.1021/ma961351u
   LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   LOGAN TM, 1994, J MOL BIOL, V236, P637, DOI 10.1006/jmbi.1994.1173
   Makarov DE, 2003, PROTEIN SCI, V12, P17, DOI 10.1110/ps.0220003
   Makarov DE, 2002, P NATL ACAD SCI USA, V99, P3535, DOI 10.1073/pnas.052713599
   MAR A, 1985, J AM CHEM SOC, V107, P5376, DOI 10.1021/ja00305a009
   Mayor U, 2003, NATURE, V421, P863, DOI 10.1038/nature01428
   MILLER WG, 1967, J MOL BIOL, V23, P67, DOI 10.1016/S0022-2836(67)80067-6
   MOGLICH A., 2004, MOL BASIS EFF UNPUB
   Moore JW, 1981, KINETICS MECH
   Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626
   Neidigh JW, 2002, NAT STRUCT BIOL, V9, P425, DOI 10.1038/nsb798
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Neuweiler H, 2003, J AM CHEM SOC, V125, P5324, DOI 10.1021/ja034040p
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pappu RV, 2000, P NATL ACAD SCI USA, V97, P12565, DOI 10.1073/pnas.97.23.12565
   PERICO A, 1990, MACROMOLECULES, V23, P797, DOI 10.1021/ma00205a017
   PERKINS TT, 1994, SCIENCE, V264, P822, DOI 10.1126/science.8171336
   Perl D, 1998, NAT STRUCT BIOL, V5, P229, DOI 10.1038/nsb0398-229
   Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591
   Qiu LL, 2002, J AM CHEM SOC, V124, P12952, DOI 10.1021/ja0279141
   Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   Robinson CR, 1996, BIOCHEMISTRY-US, V35, P13878, DOI 10.1021/bi961375t
   ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180
   Rubinstein M., 2003, POLYM PHYS
   SAKANISH.A, 1968, J CHEM PHYS, V48, P3850, DOI 10.1063/1.1669708
   Sanchez IE, 2003, BIOPHYS CHEM, V100, P397, DOI 10.1016/S0301-4622(02)00294-6
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Sanchez IE, 2003, J MOL BIOL, V334, P1077, DOI 10.1016/j.jmb.2003.10.016
   Sari N, 2000, BIOCHEMISTRY-US, V39, P965, DOI 10.1021/bi9920230
   SATZGER H., 2004, ULTRAFAST Q IN PRESS
   SCHIMMEL PR, 1967, P NATL ACAD SCI USA, V58, P52, DOI 10.1073/pnas.58.1.52
   SCHLITTER J, 1988, CHEM PHYS, V120, P187, DOI 10.1016/0301-0104(88)87165-9
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   SCHWARZ G, 1968, BIOPOLYMERS, V6, P1263, DOI 10.1002/bip.1968.360060904
   SCHWARZ G, 1965, J MOL BIOL, V11, P64, DOI 10.1016/S0022-2836(65)80171-1
   Smith CK, 1996, PROTEIN SCI, V5, P2009, DOI 10.1002/pro.5560051007
   Sporlein S, 2002, P NATL ACAD SCI USA, V99, P7998, DOI 10.1073/pnas.122238799
   Stern O, 1919, PHYS Z, V20, P183
   STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719
   SZABO A, 1980, J CHEM PHYS, V72, P4350, DOI 10.1063/1.439715
   Szabo Z. G., 1969, COMPREHENSIVE CHEM K, V2, P1
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Teilum K, 2000, J MOL BIOL, V301, P1307, DOI 10.1006/jmbi.2000.4003
   THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209
   Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764
   Timasheff SN, 2002, BIOCHEMISTRY-US, V41, P13473, DOI 10.1021/bi020316e
   Tylianakis EI, 1997, J POLYM SCI POL PHYS, V35, P317, DOI 10.1002/(SICI)1099-0488(19970130)35:2<317::AID-POLB9>3.0.CO;2-O
   VAN'T HOFF J. H., 1884, ETUDES DYNAMIQUE
   VOLKERT WA, 1977, PHOTOCHEM PHOTOBIOL, V26, P3, DOI 10.1111/j.1751-1097.1977.tb07441.x
   von Smoluchowski M, 1916, PHYS Z, V17, P557
   von Smoluchowski M, 1906, ANN PHYS-BERLIN, V21, P756
   Wagner PJ, 1999, J AM CHEM SOC, V121, P9626, DOI 10.1021/ja990224l
   Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p
   WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9
   Wong KB, 2000, J MOL BIOL, V296, P1257, DOI 10.1006/jmbi.2000.3523
   Yamakawa H., 1971, MODERN THEORY POLYM
   YEDGAR S, 1995, BIOPHYS J, V68, P665, DOI 10.1016/S0006-3495(95)80227-4
   Yeh IC, 2002, J AM CHEM SOC, V124, P6563, DOI 10.1021/ja025789n
   Yi Q, 2000, J MOL BIOL, V299, P1341, DOI 10.1006/jmbi.2000.3816
   Zhu W, 1997, MACROMOLECULES, V30, P1205, DOI 10.1021/ma961426u
   ZHU W, 1994, J POLYM SCI POL PHYS, V32, P2251, DOI 10.1002/polb.1994.090321312
   ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
   Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148
NR 128
TC 12
Z9 12
U1 0
U2 1
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-52761-949-8; 978-3-527-30784-5
PY 2005
BP 809
EP 855
DI 10.1002/9783527619498.ch22
D2 10.1002/9783527619498
PG 47
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAD19
UT WOS:000303836100024
DA 2021-01-25
ER

PT B
AU Bachinger, HP
   Engel, J
AF Baechinger, Hans Peter
   Engel, Juergen
BE Buchner, J
   Kiefhaber, T
TI The Thermodynamics and Kinetics of Collagen Folding
SO PROTEIN FOLDING HANDBOOK
LA English
DT Article; Book Chapter
ID HELIX-COIL TRANSITION; DEFINED MOLECULAR-WEIGHTS; CYANOGEN-BROMIDE
   PEPTIDES; AMINO ACID ANALOGUES; X-Y TRIPLETS; GLY-PRO-HYP;
   CRYSTAL-STRUCTURE; THERMAL-STABILITY; HOST-GUEST; OSTEOGENESIS
   IMPERFECTA
C1 [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA.
   [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Bachinger, HP (corresponding author), Oregon Hlth & Sci Univ, Shriners Hosp Children, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
CR Ackerman MS, 1999, J BIOL CHEM, V274, P7668, DOI 10.1074/jbc.274.12.7668
   Babu IR, 2001, J AM CHEM SOC, V123, P2079, DOI 10.1021/ja002165d
   BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204
   BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2
   BACHINGER HP, 1987, J BIOL CHEM, V262, P17144
   BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x
   Bachinger HP, 2001, MATRIX BIOL, V20, P267, DOI 10.1016/S0945-053X(01)00138-X
   BACHINGER HP, 1978, EUR J BIOCHEM, V90, P605, DOI 10.1111/j.1432-1033.1978.tb12641.x
   BAKERMAN S, 1966, NATURE, V212, P849, DOI 10.1038/212849a0
   Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200
   Bann JG, 2000, FEBS LETT, V473, P237, DOI 10.1016/S0014-5793(00)01493-9
   Bann JG, 2003, BIOCHEMISTRY-US, V42, P4042, DOI 10.1021/bi027050w
   Barth D, 2003, CHEM-EUR J, V9, P3692, DOI 10.1002/chem.200304917
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   BARTSCH H.-J., 1982, TASCHENBUCH MATHEMAT, P66
   BATEMAN J. F., 1996, EXTRACELLULAR MATRIX, P27
   BATEMAN JF, 1996, EXTRACELLULAR MATRIX, V2, P22
   BAUM J., 2000, FRONTIERS MOL BIOL M
   Baum Jean, 1999, Current Opinion in Structural Biology, V9, P122, DOI 10.1016/S0959-440X(99)80016-5
   Bella J, 1996, CONNECT TISSUE RES, V35, P401, DOI 10.3109/03008209609029218
   BELLA J, 1995, STRUCTURE, V3, P893, DOI 10.1016/S0969-2126(01)00224-6
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7
   Bos KJ, 1999, MATRIX BIOL, V18, P149, DOI 10.1016/S0945-053X(99)00015-3
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   BRANDT A, 1984, BIOCHEM J, V219, P625, DOI 10.1042/bj2190625
   BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026
   Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v
   BRUCKNER P, 1981, ANAL BIOCHEM, V110, P360, DOI 10.1016/0003-2697(81)90204-9
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   Buevich AV, 2000, BIOCHEMISTRY-US, V39, P4299, DOI 10.1021/bi992584r
   BURGESON RE, 1976, P NATL ACAD SCI USA, V73, P2579, DOI 10.1073/pnas.73.8.2579
   BURJANADZE TV, 1979, BIOPOLYMERS, V18, P931, DOI 10.1002/bip.1979.360180413
   Burjanadze TV, 1997, CONNECT TISSUE RES, V36, P347, DOI 10.3109/03008209709160233
   Chan VC, 1997, J BIOL CHEM, V272, P31441, DOI 10.1074/jbc.272.50.31441
   CHENG HN, 1977, BIOPOLYMERS, V16, P1465, DOI 10.1002/bip.1977.360160707
   COMPTON LA, 1992, EUR J BIOCHEM, V206, P927, DOI 10.1111/j.1432-1033.1992.tb17002.x
   Consonni R, 2000, BIOPOLYMERS, V53, P99, DOI 10.1002/(SICI)1097-0282(200001)53:1<99::AID-BIP9>3.0.CO;2-D
   DAVIS JM, 1993, J BIOL CHEM, V268, P25965
   DAVIS JM, 1989, J BIOL CHEM, V264, P8956
   Doi M, 2003, J AM CHEM SOC, V125, P9922, DOI 10.1021/ja035997v
   DOLZ R, 1986, BIOPOLYMERS, V25, P1069, DOI 10.1002/bip.360250607
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Engel J, 1997, SCIENCE, V277, P1785, DOI 10.1126/science.277.5333.1785
   Engel J, 1998, MATRIX BIOL, V17, P679, DOI 10.1016/S0945-053X(98)90119-6
   ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137
   Engel J, 2000, MATRIX BIOL, V19, P283, DOI 10.1016/S0945-053X(00)00075-5
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Engel J., 1987, ADV MEAT RES, V4, P145
   FAN P, 1993, BIOCHEMISTRY-US, V32, P13299, DOI 10.1021/bi00211a043
   Feng YB, 1996, BIOPOLYMERS, V39, P859, DOI 10.1002/(SICI)1097-0282(199612)39:6<859::AID-BIP10>3.0.CO;2-Z
   FIELDS CG, 1993, BIOPOLYMERS, V33, P1695, DOI 10.1002/bip.360331107
   Fiori S, 2002, J MOL BIOL, V319, P1235, DOI 10.1016/S0022-2836(02)00365-0
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Franzke CW, 2003, MATRIX BIOL, V22, P299, DOI 10.1016/S0945-053X(03)00051-9
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084
   GERMANN HP, 1988, BIOPOLYMERS, V27, P157, DOI 10.1002/bip.360270112
   GO N, 1973, BIOPOLYMERS, V12, P1927, DOI 10.1002/bip.1973.360120818
   Gough CA, 1999, J BIOMOL STRUCT DYN, V17, P481, DOI 10.1080/07391102.1999.10508379
   GRATHWOHL C, 1976, BIOPOLYMERS, V15, P2025, DOI 10.1002/bip.1976.360151012
   GREICHE Y, 1979, BIOPOLYMERS, V18, P2359, DOI 10.1002/bip.1979.360180923
   GROSS J, 1971, DEV BIOL, V26, P36, DOI 10.1016/0012-1606(71)90105-9
   HARRINGT.WF, 1970, BIOCHEMISTRY-US, V9, P3714, DOI 10.1021/bi00821a010
   HEIDEMANN E, 1977, POLYMER, V18, P420, DOI 10.1016/0032-3861(77)90155-0
   HEIDEMANN E., 1982, ADV POLYM SCI, V43, P144
   Hendershot LM, 2000, CURR BIOL, V10, pR912, DOI 10.1016/S0960-9822(00)00850-2
   Henkel W, 1999, BIOCHEMISTRY-US, V38, P13610, DOI 10.1021/bi9905157
   Hodges JA, 2003, J AM CHEM SOC, V125, P9262, DOI 10.1021/ja035881z
   Holmgren SK, 1998, NATURE, V392, P666, DOI 10.1038/33573
   Holmgren SK, 1999, CHEM BIOL, V6, P63, DOI 10.1016/S1074-5521(99)80003-9
   INOUYE K, 1976, BIOCHIM BIOPHYS ACTA, V420, P133, DOI 10.1016/0005-2795(76)90352-4
   INOUYE K, 1982, ARCH BIOCHEM BIOPHYS, V219, P198, DOI 10.1016/0003-9861(82)90149-7
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   Jenkins CL, 2002, NAT PROD REP, V19, P49, DOI 10.1039/a903001h
   KAO WWY, 1977, J BIOL CHEM, V252, P8391
   Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   Kivirikko KI, 1998, MATRIX BIOL, V16, P357, DOI 10.1016/S0945-053X(98)90009-9
   Kivirikko KI, 1998, MATRIX BIOL, V16, P355, DOI 10.1016/S0945-053X(98)90008-7
   Koide T, 2002, J AM CHEM SOC, V124, P9388, DOI 10.1021/ja026182+
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849
   KRESINA TF, 1979, BIOCHEMISTRY-US, V18, P3089, DOI 10.1021/bi00581a028
   KUHN K, 1964, ARCH BIOCHEM BIOPHYS, V105, P387, DOI 10.1016/0003-9861(64)90023-2
   KUIVANIEMI H, 1991, FASEB J, V5, P2052
   Kwak J, 2002, J AM CHEM SOC, V124, P14085, DOI 10.1021/ja0209621
   Kwak J, 1999, BIOORGAN MED CHEM, V7, P153, DOI 10.1016/S0968-0896(98)00230-2
   Lamande SR, 1999, SEMIN CELL DEV BIOL, V10, P455, DOI 10.1006/scdb.1999.0317
   LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0
   Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099
   LI MH, 1993, BIOCHEMISTRY-US, V32, P7377, DOI 10.1021/bi00080a007
   Liu XY, 1996, BIOCHEMISTRY-US, V35, P4306, DOI 10.1021/bi952270d
   Mann K, 1996, J MOL BIOL, V261, P255, DOI 10.1006/jmbi.1996.0457
   Mayne R, 1987, STRUCTURE FUNCTION C
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   Melacini G, 1996, J AM CHEM SOC, V118, P10359, DOI 10.1021/ja9612615
   Melacini G, 2000, J MOL BIOL, V300, P1041, DOI 10.1006/jmbi.2000.3919
   MILES CA, 1995, J MOL BIOL, V245, P437, DOI 10.1006/jmbi.1994.0035
   MILES CA, 1994, EQUINE VET J, V26, P291, DOI 10.1111/j.2042-3306.1994.tb04389.x
   MILLER EJ, 1973, J BIOL CHEM, V248, P1666
   Mironov AA, 1997, J CELL BIOL, V138, P481, DOI 10.1083/jcb.138.3.481
   Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200
   Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200
   MORRIS NP, 1990, J BIOL CHEM, V265, P10081
   MORRIS NP, 1975, J BIOL CHEM, V250, P5719
   Nagai N, 2000, J CELL BIOL, V150, P1499, DOI 10.1083/jcb.150.6.1499
   Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229
   Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   Olsen B. R., 1991, CELL BIOL EXTRACELLU, P177
   Ottl J, 1999, J PEPT SCI, V5, P103, DOI 10.1002/(SICI)1099-1387(199902)5:2<103::AID-PSC188>3.0.CO;2-N
   PANASIK N, 1994, INT J PEPT PROT RES, V44, P262
   Persikov AV, 2000, BIOCHEMISTRY-US, V39, P14960, DOI 10.1021/bi001560d
   Persikov AV, 2003, J AM CHEM SOC, V125, P11500, DOI 10.1021/ja036673+
   Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899
   Persikov AV, 2002, J MOL BIOL, V316, P385, DOI 10.1006/jmbi.2001.5342
   PIEZ K. A., 1964, BIOCHEMISTRY-US, V155, P908
   PIEZ KA, 1970, BIOCHEMISTRY-US, V9, P4134, DOI 10.1021/bi00823a016
   PORSCHKE D, 1971, J MOL BIOL, V62, P361, DOI 10.1016/0022-2836(71)90433-5
   PRIVALOV PL, 1979, J MOL BIOL, V127, P203, DOI 10.1016/0022-2836(79)90240-7
   PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4
   RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199
   RAINES R. T., 1999, PEPTIDES NEW MILLENN
   RAMACHANDRAN GN, 1955, NATURE, V176, P593, DOI 10.1038/176593a0
   Ramshaw JAM, 1998, J STRUCT BIOL, V122, P86, DOI 10.1006/jsbi.1998.3977
   Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770
   RHODES RK, 1978, BIOCHEMISTRY-US, V17, P3442, DOI 10.1021/bi00610a003
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   ROTHE M, 1970, ANGEW CHEM INT EDIT, V9, P535
   Sacca B, 2002, J MOL BIOL, V324, P309, DOI 10.1016/S0022-2836(02)01065-3
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   SAKAKIBARA S, 1968, B CHEM SOC JPN, V41, P1273, DOI 10.1246/bcsj.41.1273
   SARKAR SK, 1984, P NATL ACAD SCI-BIOL, V81, P4800, DOI 10.1073/pnas.81.15.4800
   SAYGIN O, 1978, BIOPOLYMERS, V17, P511, DOI 10.1002/bip.1978.360170215
   Scherer G, 1998, J AM CHEM SOC, V120, P5568, DOI 10.1021/ja980181t
   Shah NK, 1997, BIOCHEMISTRY-US, V36, P5878, DOI 10.1021/bi963146c
   Shah NK, 1996, BIOCHEMISTRY-US, V35, P10262, DOI 10.1021/bi960046y
   Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051
   STEINMANN B, 1991, J BIOL CHEM, V266, P1299
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   SUTOH K, 1974, BIOPOLYMERS, V13, P2477, DOI 10.1002/bip.1974.360131207
   TAKEUCHI T, 1969, BIOCHIM BIOPHYS ACTA, V175, P142, DOI 10.1016/0005-2795(69)90153-6
   TAKEUCHI T, 1969, BIOCHIM BIOPHYS ACTA, V175, P156, DOI 10.1016/0005-2795(69)90154-8
   Tanaka Y, 1998, J PEPT RES, V51, P413
   Tasab M, 2000, EMBO J, V19, P2204, DOI 10.1093/emboj/19.10.2204
   THAKUR S, 1986, BIOPOLYMERS, V25, P1081, DOI 10.1002/bip.360250608
   UITTO J, 1976, J INVEST DERMATOL, V66, P59, DOI 10.1111/1523-1747.ep12481404
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
   Vitagliano L, 2001, PROTEIN SCI, V10, P2627, DOI 10.1110/ps.ps.26601a
   Vitagliano L, 2001, BIOPOLYMERS, V58, P459, DOI 10.1002/1097-0282(20010415)58:5<459::AID-BIP1021>3.0.CO;2-V
   VUUST J, 1972, J BIOL CHEM, V247, P856
   WEBER RW, 1978, HELV CHIM ACTA, V61, P701, DOI 10.1002/hlca.19780610218
   Xu YJ, 2003, BIOCHEMISTRY-US, V42, P8696, DOI 10.1021/bi034006n
   Xu YJ, 2002, BIOCHEMISTRY-US, V41, P8143, DOI 10.1021/bi015952b
   Yang W, 1997, J BIOL CHEM, V272, P28837, DOI 10.1074/jbc.272.46.28837
   Yang W, 1997, BIOCHEMISTRY-US, V36, P6930, DOI 10.1021/bi970051h
   Yu YC, 1998, J AM CHEM SOC, V120, P9979, DOI 10.1021/ja981654z
   Yu YC, 1999, BIOCHEMISTRY-US, V38, P1659, DOI 10.1021/bi982315l
   Yu YC, 1996, J AM CHEM SOC, V118, P12515, DOI 10.1021/ja9627656
   Yuan L, 1973, Biophys Chem, V1, P117, DOI 10.1016/0301-4622(73)80008-0
   Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109
NR 166
TC 12
Z9 13
U1 0
U2 6
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PAPPELALLEE 3, W-69469 WEINHEIM, GERMANY
BN 978-3-52761-949-8
PY 2005
BP 1059
EP 1110
D2 10.1002/9783527619498
PG 52
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BAD19
UT WOS:000303836100032
DA 2021-01-25
ER

PT J
AU Bilecen, D
   Schulte, AC
   Heidecker, HG
   Aschwanden, M
   Huegli, R
   Jaeger, KA
   Ostheim-Dzerowycz, W
   Bongartz, G
AF Bilecen, D
   Schulte, AC
   Heidecker, HG
   Aschwanden, M
   Huegli, R
   Jaeger, KA
   Ostheim-Dzerowycz, W
   Bongartz, G
TI Lower extremity: Low-dose contrast agent intraarterial MR angiography in
   patients - Initial results
SO RADIOLOGY
LA English
DT Article
ID REAL-TIME; INJECTION PARAMETERS; ABDOMINAL-AORTA; FEASIBILITY; ARTERIES;
   CATHETERS; TRACKING; VESSELS
C1 Univ Basel, Dept Diagnost Radiol, CH-4031 Basel, Switzerland.
   Univ Basel, Dept Angiol, CH-4031 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   Hochrheinklin, Bad Saeckingen, Germany.
RP Bilecen, D (corresponding author), Univ Basel, Dept Diagnost Radiol, Petersgraben 4, CH-4031 Basel, Switzerland.
EM dbilecen@uhbs.ch
CR Bos C, 2000, MAGN RESON MED, V44, P575, DOI 10.1002/1522-2594(200010)44:4<575::AID-MRM11>3.3.CO;2-J
   Earls JP, 1998, AM J ROENTGENOL, V171, P599, DOI 10.2214/ajr.171.3.9725281
   Frayne R, 2000, J VASC INTERV RADIOL, V11, P1277, DOI 10.1016/S1051-0443(07)61301-3
   Goyen M, 2004, J MAGN RESON IMAGING, V19, P261, DOI 10.1002/jmri.20005
   Green JD, 2003, MAGNET RESON MED, V50, P1317, DOI 10.1002/mrm.10642
   Ho KYJAM, 1998, RADIOLOGY, V206, P683, DOI 10.1148/radiology.206.3.9494486
   Ho KYJAM, 1999, EUR RADIOL, V9, P1285, DOI 10.1007/s003300050835
   Hwang KP, 2002, J MAGN RESON IMAGING, V15, P55, DOI 10.1002/jmri.10027
   JAGER KA, 1985, DUPLEX SCANNING EVAL, P619
   Korosec FR, 1996, MAGNET RESON MED, V36, P345, DOI 10.1002/mrm.1910360304
   Meaney JFM, 1999, RADIOLOGY, V211, P59, DOI 10.1148/radiology.211.1.r99ap1859
   Omary RA, 1999, J VASC INTERV RADIOL, V10, P1315, DOI 10.1016/S1051-0443(99)70237-X
   Omary RA, 2000, J VASC INTERV RADIOL, V11, P373, DOI 10.1016/S1051-0443(07)61433-X
   Omary RA, 2002, ACAD RADIOL, V9, P172, DOI 10.1016/S1076-6332(03)80167-8
   Omary RA, 2000, J VASC INTERV RADIOL, V11, P1079, DOI 10.1016/S1051-0443(07)61343-8
   Prince MR, 2002, RADIOLOGY, V224, P55, DOI 10.1148/radiol.2241011338
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   Schoenberg SO, 2001, INVEST RADIOL, V36, P283, DOI 10.1097/00004424-200105000-00006
   Serfaty JM, 2000, J MAGN RESON IMAGING, V12, P590, DOI 10.1002/1522-2586(200010)12:4<590::AID-JMRI11>3.0.CO;2-3
   Serfaty JM, 2000, RADIOLOGY, V217, P290, DOI 10.1148/radiology.217.1.r00se42290
   Strother CM, 2000, RADIOLOGY, V215, P516, DOI 10.1148/radiology.215.2.r00ma34516
   Svensson J, 1999, J MAGN RESON IMAGING, V10, P919, DOI 10.1002/(SICI)1522-2586(199912)10:6<919::AID-JMRI3>3.0.CO;2-W
   Wang Y, 2001, INVEST RADIOL, V36, P170, DOI 10.1097/00004424-200103000-00006
NR 23
TC 9
Z9 11
U1 0
U2 0
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD JAN
PY 2005
VL 234
IS 1
BP 250
EP 255
DI 10.1148/radiol.2341040508
PG 6
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 881JW
UT WOS:000225864800035
PM 15564395
DA 2021-01-25
ER

PT S
AU Mavris, M
   Saenz, H
   Monteil, M
   Boulouis, HJ
   DeHio, C
   Vayssier-Taussat, M
AF Mavris, Maria
   Saenz, Henri
   Monteil, Martine
   Boulouis, Henri-Jean
   DeHio, Christoph
   Vayssier-Taussat, Muriel
BE Hechemy, KE
   Oteo, JA
   Raoult, DA
   Silverman, DJ
   Blanco, JR
TI Characterization of genes involved in long-term bacteremia in mice by
   Bartonella birtlesii
SO RICKETTSIOSES: FROM GENOME TO PROTEOME, PATHOBIOLOGY, AND RICKETTSIAE AS
   AN INTERNATIONAL THREAT
SE Annals of the New York Academy of Sciences
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Rickettsiae and Rickettsial Diseases
CY JUN 18-21, 2005
CL Logrono, SPAIN
SP Gobierno Rioja, Fund Rioja Salud, European Soc Clin Microbiol & Infect Dis, Amer Soc Rickettsiol
DE signature-tagged; mutagenesis; erythrocytes infection; virulence factors
ID INFECTION
C1 Ecole Natl Vet Alfort, UMR 956 BIPAR, Maisons Alfort, France.
   Univ Basel, Biozentrum, Div Mol Microbiol, CH-4003 Basel, Switzerland.
RP Vayssier-Taussat, M (corresponding author), Ecole Natl Vet Alfort, UMR 956 BIPAR, 7 Ave Gen de Gaulle, Maisons Alfort, France.
EM mvayssier@vet-alfort.fr
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Saenz, Henri/0000-0001-7536-7817
CR Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
NR 4
TC 11
Z9 11
U1 1
U2 4
PU NEW YORK ACAD SCIENCES
PI NEW YORK
PA 2 EAST 63RD ST, NEW YORK, NY 10021 USA
SN 0077-8923
BN 1-57331-600-8
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2005
VL 1063
BP 312
EP 314
DI 10.1196/annals.1355.050
PG 3
WC Immunology; Infectious Diseases; Microbiology; Multidisciplinary
   Sciences
SC Immunology; Infectious Diseases; Microbiology; Science & Technology -
   Other Topics
GA BEE03
UT WOS:000236907200049
PM 16481533
DA 2021-01-25
ER

PT J
AU Martin, DE
   Soulard, A
   Hall, MN
AF Martin, DE
   Soulard, A
   Hall, MN
TI TOR regulates ribosomal protein gene expression via PKA and the forkhead
   transcription factor FHL1
SO CELL
LA English
DT Article
ID RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; SIGNALING PATHWAY; HEAD
   PROTEIN; FHA DOMAIN; YEAST; RAPAMYCIN; RECRUITMENT; PHOSPHORYLATION;
   LOCALIZATION
AB The regulation of ribosome biogenesis in response to environmental conditions is a key aspect of cell growth control. Ribosomal protein (RP) genes are regulated by the nutrient-sensitive, conserved target of rapamycin (TOR) signaling pathway. TOR controls the subcellular localization of protein kinase A (PKA) and the PKA-regulated kinase YAK1. However, the target transcription factor(s) of the TOR-PKA pathway are unknown. We show that regulation of RP gene transcription via TOR and PKA in yeast involves the Forkhead-like transcription factor FHL1 and the two cofactors IFH1 (a coactivator) and CRF1 (a corepressor). TOR, via PKA, negatively regulates YAK1 and maintains CRF1 in the cytoplasm. Upon TOR inactivation, activated YAK1 phosphorylates and activates CRF1. Phosphorylated CRF1 accumulates in the nucleus and competes with IFH1 for binding to FHL1 at RP gene promoters, and thereby inhibits transcription of RP genes. Thus, we describe a signaling mechanism linking an environmental sensor to ribosome biogenesis.
C1 Univ Basel, Biozentrum, Div Biochem, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Div Biochem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Hall, Michael N/0000-0002-2998-0757; Soulard,
   Alexandre/0000-0003-3556-1994
CR Ausubel F.M., 1998, CURRENT PROTOCOLS MO
   Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287
   CHEREL I, 1995, YEAST, V11, P261, DOI 10.1002/yea.320110308
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Darieva Z, 2003, CURR BIOL, V13, P1740, DOI 10.1016/j.cub.2003.08.053
   Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X
   Fath S, 2001, P NATL ACAD SCI USA, V98, P14334, DOI 10.1073/pnas.231181398
   GARRETT S, 1989, GENE DEV, V3, P1336, DOI 10.1101/gad.3.9.1336
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Griffioen G, 2001, MOL CELL BIOL, V21, P511, DOI 10.1128/MCB.21.2.511-523.2001
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Harris Thurl E, 2003, Sci STKE, V2003, pre15
   Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0
   HERMANNLEDENMAT S, 1994, MOL CELL BIOL, V14, P2905, DOI 10.1128/MCB.14.5.2905
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Humphrey EL, 2004, CHEM BIOL, V11, P295, DOI 10.1016/j.chembiol.2004.03.001
   Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   James P, 1996, GENETICS, V144, P1425
   Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804
   Jorgensen Paul, 2004, VVolume 42, P329
   Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Koranda M, 2000, NATURE, V406, P94
   Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   Nomura M, 2001, COLD SPRING HARB SYM, V66, P555, DOI 10.1101/sqb.2001.66.555
   Peyroche G, 2000, EMBO J, V19, P5473, DOI 10.1093/emboj/19.20.5473
   Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987
   Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3
   Reynolds D, 2003, GENE DEV, V17, P1789, DOI 10.1101/gad.1074103
   Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Schmelzle T, 2000, CELL, V103, P253, DOI 10.1016/S0092-8674(00)00117-3
   SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091
   Shamji AF, 2000, CURR BIOL, V10, P1574, DOI 10.1016/S0960-9822(00)00866-6
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P12
   Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
   Zappacosta F, 2002, ANAL CHEM, V74, P3221, DOI 10.1021/ac025538x
   Zaragoza D, 1998, MOL CELL BIOL, V18, P4463, DOI 10.1128/MCB.18.8.4463
NR 49
TC 333
Z9 345
U1 0
U2 23
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD DEC 29
PY 2004
VL 119
IS 7
BP 969
EP 979
DI 10.1016/j.cell.2004.11.047
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 884TQ
UT WOS:000226109700009
PM 15620355
DA 2021-01-25
ER

PT J
AU Ribeiro, C
   Neumann, M
   Affolter, M
AF Ribeiro, C
   Neumann, M
   Affolter, M
TI Genetic control of cell intercalation during tracheal morphogenesis in
   Drosophila
SO CURRENT BIOLOGY
LA English
DT Article
ID FGF RECEPTOR HOMOLOG; BRANCHING MORPHOGENESIS; FUSION PROTEIN;
   EPITHELIAL MORPHOGENESIS; FLUORESCENT PROTEIN; TUBE MORPHOGENESIS;
   ADHERENS JUNCTIONS; MIGRATION; SYSTEM; SPALT
AB Background: Branching morphogenesis transforms an epithelial sheet into a tubular network with distinct features regarding the length and diameter of individual tubes. Branching is controlled by several signaling pathways, but the molecular consequences of these pathways in the responding cells are poorly understood.
   Results: We have undertaken a detailed characterization of cell rearrangements during tracheal branching morphogenesis in Drosophila embryos with a GFP fusion protein labeling the adherens junctions (AJs) and high-resolution live imaging. To analyze the branching process at the cellular level, we further developed an imaging approach that allows us to follow single cells during the branching process. We find that controlled cell intercalation, which requires extensive AJ remodeling, is key to the formation of tracheal branches of different cellular complexities. In particular, most branches consist of tubes with individual cells wrapped around the lumen. These branches form through cell intercalation, which requires the transformation of most of the initial intercellular AJs into autocellular AJs. We propose a step-wise model explaining how this AJ remodeling occurs and use this model to better understand defects in various mutants. We find that Dpp and Wnt signaling control cell intercalation by regulating the expression of Spalt, a zinc finger transcription factor; Spalt inhibits intercalation, leading to the formation of large, multicellular tubes.
   Conclusion: Tracheal morphogenesis is regulated by an interplay of different signaling systems that control cell migration and cell intercalation, respectively. Only the combined action of these signaling systems allows efficient branch elongation and the formation of morphologically distinct branches.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Ribeiro, Carlos/0000-0002-9542-7335; Affolter,
   Markus/0000-0002-5171-0016
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434
   BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Franch-Marro X, 2002, DEV BIOL, V250, P374, DOI 10.1006/dbio.2002.0799
   FRISTROM D, 1988, TISSUE CELL, V20, P645, DOI 10.1016/0040-8166(88)90015-8
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Haerry TE, 1998, DEVELOPMENT, V125, P3977
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   JACOBSON AG, 1986, J EMBRYOL EXP MORPH, V96, P19
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Lee S, 2002, DEVELOPMENT, V129, P1509
   Llimargas M, 2000, DEVELOPMENT, V127, P4407
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Manning Gerards, 1993, P609
   Oda H, 1999, DEV GENES EVOL, V209, P218, DOI 10.1007/s004270050246
   Ohashi T, 2002, J CELL SCI, V115, P1221
   Ohshiro T, 1997, DEVELOPMENT, V124, P3975
   PATEL NH, 1994, METHOD CELL BIOL, V44, P445, DOI 10.1016/S0091-679X(08)60927-9
   Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Williams-Masson EM, 1998, DEV BIOL, V204, P263, DOI 10.1006/dbio.1998.9048
   Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7
NR 45
TC 111
Z9 114
U1 0
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD DEC 29
PY 2004
VL 14
IS 24
BP 2197
EP 2207
DI 10.1016/j.cub.2004.11.056
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 884FE
UT WOS:000226069400020
PM 15620646
DA 2021-01-25
ER

PT J
AU Jastrzebska, B
   Maeda, T
   Zhu, L
   Fotiadis, D
   Filipek, S
   Engel, A
   Stenkamp, RE
   Palczewski, K
AF Jastrzebska, B
   Maeda, T
   Zhu, L
   Fotiadis, D
   Filipek, S
   Engel, A
   Stenkamp, RE
   Palczewski, K
TI Functional characterization of rhodopsin monomers and dimers in
   detergents
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROTEIN-COUPLED RECEPTOR; ROD OUTER SEGMENT; PHOTORECEPTOR DISK
   MEMBRANES; BLUE NATIVE ELECTROPHORESIS; CYTOCHROME-C-OXIDASE; BOVINE
   RHODOPSIN; METARHODOPSIN-II; 3-DIMENSIONAL STRUCTURE; TRANSDUCIN
   ACTIVATION; TRANSMEMBRANE HELICES
AB Rhodopsin (Rho) is a G protein-coupled receptor that initiates phototransduction in rod photoreceptors. High expression levels of Rho in the disc membranes of rod outer segments and the propensity of Rho to form higher oligomeric structures are evident from atomic force microscopy, transmission electron microscopy, and chemical cross-linking experiments. To explore the structural and functional properties of Rho in n-dodecyl-beta-maltoside, frequently used to purify heterologously expressed Rho and its mutants, we used gel filtration techniques, blue native gel electrophoresis, and functional assays. Here, we show that in micelles containing n-dodecyl-beta-maltoside at concentrations greater than 3 mM, Rho is present as a single monomer per detergent micelle. In contrast, in 12 mM 3-[(3-cholamidopropyl)dimethyl-ammonio]-1-propanesulfonate (CHAPS), micelles contain mostly dimeric Rho. The cognate G protein transducin (Gt) appears to have a preference for binding to the Rho dimer, and the complexes fall apart in the presence of guanosine 5'-3-O-(thio)triphosphate. Cross-linked Rho dimers release the chromophore at a slower rate than monomers and are much more resistant to heat denaturation. Both Rho* monomers and dimers are capable of activating Gt, and both of them are phosphorylated by Rho kinase. Rho expressed in HEK293 cells is also readily cross-linked by a bifunctional reagent. These studies provide an explanation of how detergent influences the oligomer-dimer-monomer equilibrium of Rho and describe the functional characterization of Rho monomers and dimers in detergent.
C1 Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.
   Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem, Seattle, WA 98195 USA.
   Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.
   Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   Univ Washington, Biomol Struct Ctr, Seattle, WA 98195 USA.
   Univ Basel, Biozentrum, ME Muller Inst Microscopy, CH-4056 Basel, Switzerland.
   Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland.
RP Palczewski, K (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.
EM palczews@u.washington.edu
RI Filipek, Slawomir/A-2985-2008
OI Filipek, Slawomir/0000-0003-3147-3858
FU NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   R29EY008061, R01EY008061, P30EY001730, R01EY008061, P30EY001730,
   R29EY008061, R01EY008061, P30EY001730, P30EY001730, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, R01EY008061,
   R01EY008061, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, R01EY008061, R01EY008061,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, R01EY008061, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   R01EY008061, P30EY001730, R29EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, R01EY008061, P30EY001730, R29EY008061,
   R29EY008061, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, R29EY008061,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, R01EY008061, P30EY001730, P30EY001730,
   P30EY001730, R01EY008061, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730, P30EY001730, P30EY001730, P30EY001730,
   P30EY001730, P30EY001730] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01GM063020, R01GM063020,
   R01GM063020, R01GM063020] Funding Source: NIH RePORTER; NEI NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01
   EY008061, P30 EY001730, EY08061, EY01730] Funding Source: Medline; NIGMS
   NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM63020, R01 GM063020] Funding Source: Medline
CR Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314
   APPLEBURY ML, 1974, BIOCHEMISTRY-US, V13, P3448, DOI 10.1021/bi00714a005
   Aveldano MI, 1995, ARCH BIOCHEM BIOPHYS, V324, P331, DOI 10.1006/abbi.1995.0046
   Ballesteros JA, 2001, MOL PHARMACOL, V60, P1
   BUCZYLKO J, 1991, P NATL ACAD SCI USA, V88, P2568, DOI 10.1073/pnas.88.6.2568
   Butler PJG, 2004, J MOL BIOL, V340, P797, DOI 10.1016/j.jmb.2004.05.014
   Carrillo JJ, 2004, MOL PHARMACOL, V66, P1123, DOI 10.1124/mol.104.001586
   CONE RA, 1972, NATURE-NEW BIOL, V236, P39
   CONNELL GJ, 1990, BIOCHEMISTRY-US, V29, P4691, DOI 10.1021/bi00471a025
   Dupuy C, 1997, LANGMUIR, V13, P3965, DOI 10.1021/la9604285
   FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020
   FAHMY K, 1993, BIOCHEMISTRY-US, V32, P9165, DOI 10.1021/bi00086a023
   FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073
   Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768
   Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c
   Filipek S, 2003, ANNU REV BIOPH BIOM, V32, P375, DOI 10.1146/annurev.biophys.32.110601.142520
   Filipek S, 2003, ANNU REV PHYSIOL, V65, P851, DOI 10.1146/annurev.physiol.65.092101.142611
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   FUNG BKK, 1981, P NATL ACAD SCI-BIOL, V78, P152, DOI 10.1073/pnas.78.1.152
   Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90
   Hamm HE, 2001, P NATL ACAD SCI USA, V98, P4819, DOI 10.1073/pnas.011099798
   Heck M, 2003, J BIOL CHEM, V278, P3162, DOI 10.1074/jbc.M209675200
   Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   HJELMELAND LM, 1983, ANAL BIOCHEM, V130, P485, DOI 10.1016/0003-2697(83)90621-8
   Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243
   Krebs A, 2003, J BIOL CHEM, V278, P50217, DOI 10.1074/jbc.M307995200
   KUSUMI A, 1982, BIOCHEMISTRY-US, V21, P5978, DOI 10.1021/bi00266a039
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Liang Y, 2004, J BIOL CHEM, V279, P48189, DOI 10.1074/jbc.M408362200
   LIEBMAN PA, 1987, ANNU REV PHYSIOL, V49, P765, DOI 10.1146/annurev.ph.49.030187.004001
   LIEBMAN PA, 1974, SCIENCE, V185, P457, DOI 10.1126/science.185.4149.457
   Medina R, 2004, J BIOL CHEM, V279, P39565, DOI 10.1074/jbc.M402446200
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50
   MOLLER JV, 1993, J BIOL CHEM, V268, P18659
   Musatov A, 2000, BIOCHEMISTRY-US, V39, P12996, DOI 10.1021/bi000884z
   NATHANS J, 1983, CELL, V34, P807, DOI 10.1016/0092-8674(83)90537-8
   Noorwez SM, 2003, J BIOL CHEM, V278, P14442, DOI 10.1074/jbc.M300087200
   Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209
   Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044
   Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6
   OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010
   PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P48
   PHILLIPS WJ, 1988, J BIOL CHEM, V263, P15498
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   POO MM, 1974, NATURE, V247, P438, DOI 10.1038/247438a0
   PREININGER AM, 2004, SCI STKE
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374
   SAIBIL H, 1976, NATURE, V262, P266, DOI 10.1038/262266a0
   Sakmar TP, 2002, ANNU REV BIOPH BIOM, V31, P443, DOI 10.1146/annurev.biophys.31.082901.134348
   Sakmar TP, 2002, CURR OPIN CELL BIOL, V14, P189, DOI 10.1016/S0955-0674(02)00306-X
   Salahpour A, 2004, J BIOL CHEM, V279, P33390, DOI 10.1074/jbc.M403363200
   Schadel SA, 2003, J BIOL CHEM, V278, P24896, DOI 10.1074/jbc.M302115200
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033
   Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0
   SUAREZ MD, 1984, J BIOL CHEM, V259, P3791
   Teller DC, 2001, BIOCHEMISTRY-US, V40, P7761, DOI 10.1021/bi0155091
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   Vogel R, 2004, J MOL BIOL, V338, P597, DOI 10.1016/j.jmb.2004.03.006
NR 66
TC 114
Z9 117
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 24
PY 2004
VL 279
IS 52
BP 54663
EP 54675
DI 10.1074/jbc.M408691200
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 880MJ
UT WOS:000225793600093
PM 15489507
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Heerklotz, H
   Tsamaloukas, A
   Kita-Tokarczyk, K
   Strunz, P
   Gutberlet, T
AF Heerklotz, H
   Tsamaloukas, A
   Kita-Tokarczyk, K
   Strunz, P
   Gutberlet, T
TI Structural, volumetric, and thermodynamic characterization of a micellar
   sphere-to-rod transition
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID PRESSURE PERTURBATION CALORIMETRY; SODIUM DODECYL-SULFATE;
   PHASE-TRANSITION; AQUEOUS-SOLUTION; 2ND CMC; ALKYLDIMETHYLPHOSPHINE
   OXIDES; NONIONIC SURFACTANT; BINDING ENERGETICS; SCATTERING; WATER
AB The thermotropic sphere-to-rod transition of nonionic surfactants was characterized in terms of a large set of parameters: the transition temperature and width, the partial volume, coefficient of thermal volume expansion, enthalpy, isobaric heat capacity, and structural parameters, such as radius of gyration and hydrodynamic radius. Data were recorded as a function of concentration of surfactants in H2O and in D2O. To this end, pressure perturbation calorimetry (PPC), small angle neutron scattering (SANS), dynamic light scattering (DLS), differential scanning calorimetry (DSC), and isothermal titration calorimetry (ITC) were applied in a study of aqueous solutions containing myristyl, tridecyl, and lauryl maltoside and heptaethyleneglycoltetradecyl ether (C14EO7). Small changes in the thermodynamic and volumetric parameters (e.g., the partial volume change is similar to+2parts per thousand) are discussed in detail as the result of three effects governing the transition. (i) Reduction of the water accessible hydrophobic surface area (ASA(ap)) drives the transition. (ii) Shrinking in headgroup size by thermal dehydration triggers the transition. (iii) Hypothesized gradual ordering of the chains may control the effect of chain length on the transition.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
RP Heerklotz, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heiko.heerklotz@unibas.ch
RI Kita-Tokarczyk, Katarzyna/A-5614-2009; Kita-Tokarczyk,
   Katarzyna/V-4285-2019; Gutberlet, Thomas/D-5613-2014; Strunz,
   Pavel/D-1610-2011
OI Kita-Tokarczyk, Katarzyna/0000-0003-0741-134X; Gutberlet,
   Thomas/0000-0002-6194-2259; Strunz, Pavel/0000-0002-0829-4926;
   Heerklotz, Heiko/0000-0003-4615-7022
CR Al-Anber ZA, 2003, J CHEM PHYS, V118, P3816, DOI 10.1063/1.1539048
   ANTHONY FH, 1981, ANAL BIOCHEM, V116, P161, DOI 10.1016/0003-2697(81)90339-0
   Baker BM, 1998, METHOD ENZYMOL, V295, P294
   Bernheim-Groswasser A, 2000, LANGMUIR, V16, P4131, DOI 10.1021/la991231q
   BLANDAMER MJ, 1992, J CHEM SOC FARADAY T, V88, P979, DOI 10.1039/ft9928800979
   BLANDAMER MJ, 1991, J CHEM SOC FARADAY T, V87, P1169, DOI 10.1039/ft9918701169
   Bossev DP, 2001, LANGMUIR, V17, P7728, DOI 10.1021/la011300c
   Boyd BJ, 2000, LANGMUIR, V16, P7359, DOI 10.1021/la991573w
   Brandts JF, 2004, THERMOCHIM ACTA, V414, P95, DOI 10.1016/j.tca.2003.11.013
   Briganti G, 1998, J NON-CRYST SOLIDS, V235, P704, DOI 10.1016/S0022-3093(98)00622-X
   Chalikian TV, 2001, J PHYS CHEM B, V105, P12566, DOI 10.1021/jp0115244
   Cirkel PA, 1998, LANGMUIR, V14, P7095, DOI 10.1021/la971326x
   DOULIEZ JP, 1995, BIOPHYS J, V68, P1727, DOI 10.1016/S0006-3495(95)80350-4
   Ebel H, 2001, J PHYS CHEM B, V105, P7353, DOI 10.1021/jp010515s
   Glatter O, 2000, LANGMUIR, V16, P8692, DOI 10.1021/la000315s
   Gonzalez-Perez A, 2001, COLLOID SURFACE A, V193, P129, DOI 10.1016/S0927-7757(01)00754-3
   Grell E, 2002, J THERM ANAL CALORIM, V68, P469, DOI 10.1023/A:1016083501500
   Gu GX, 1996, J COLLOID INTERF SCI, V178, P614, DOI 10.1006/jcis.1996.0158
   Gutberlet T, 2000, PHYSICA B, V276, P381, DOI 10.1016/S0921-4526(99)01499-4
   He LZ, 2002, J PHYS CHEM B, V106, P7596, DOI 10.1021/jp020034o
   He LZ, 2000, J MOL LIQ, V89, P239, DOI 10.1016/S0167-7322(00)90017-5
   Heerklotz H, 2004, J PHYS-CONDENS MAT, V16, pR441, DOI 10.1088/0953-8984/16/15/R01
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7
   Heerklotz H, 2002, BIOPHYS J, V82, P1445, DOI 10.1016/S0006-3495(02)75498-2
   Heerklotz HH, 1998, J PHYS CHEM B, V102, P5363, DOI 10.1021/jp980884x
   HERMANS J, 1959, BIOCHIM BIOPHYS ACTA, V36, P534, DOI 10.1016/0006-3002(59)90197-0
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   KANESHINA S, 1990, J COLLOID INTERF SCI, V140, P474, DOI 10.1016/0021-9797(90)90368-X
   Kresheck GC, 2003, CHEM PHYS LIPIDS, V123, P45, DOI 10.1016/S0009-3084(02)00165-2
   Kresheck GC, 1998, J AM CHEM SOC, V120, P10964, DOI 10.1021/ja982156t
   Kresheck GC, 1998, J PHYS CHEM B, V102, P6596, DOI 10.1021/jp9820469
   KUBOTA Y, 1973, B CHEM SOC JPN, V46, P100, DOI 10.1246/bcsj.46.100
   Kujawa P, 2001, MACROMOLECULES, V34, P4130, DOI 10.1021/ma002082h
   LANDWEHR A, 1994, BER BUNSEN PHYS CHEM, V98, P214, DOI 10.1002/bbpc.19940980214
   Leharne SA, 1998, BIOCALORIMETRY, P157
   Likhodi O, 1999, J AM CHEM SOC, V121, P1156, DOI 10.1021/ja983127l
   Likhodi O, 2000, J AM CHEM SOC, V122, P7860, DOI 10.1021/ja001188p
   Lin LN, 2002, ANAL BIOCHEM, V302, P144, DOI 10.1006/abio.2001.5524
   LINDMAN B, 1991, J PHYS CHEM-US, V95, P6053, DOI 10.1021/j100168a063
   LIPKA G, 1984, J PHYS CHEM-US, V88, P5401, DOI 10.1021/j150666a058
   May S, 2001, J PHYS CHEM B, V105, P630, DOI 10.1021/jp003021o
   MAZER NA, 1982, J PHYS CHEM-US, V86, P4584, DOI 10.1021/j100220a026
   MIURA M, 1972, B CHEM SOC JPN, V45, P428, DOI 10.1246/bcsj.45.428
   Murphy KP, 1999, MED RES REV, V19, P333, DOI 10.1002/(SICI)1098-1128(199907)19:4<333::AID-MED6>3.0.CO;2-5
   PRASAD SK, 1990, BIOPHYS J, V57, pA557
   Raghavan SR, 2002, LANGMUIR, V18, P3797, DOI 10.1021/la0115583
   Randzio SL, 2003, THERMOCHIM ACTA, V398, P75, DOI 10.1016/S0040-6031(02)00366-0
   Ravindra R, 2004, CHEMPHYSCHEM, V5, P566, DOI 10.1002/cphc.200301080
   REISSHUSSON F, 1964, J PHYS CHEM-US, V68, P3504, DOI 10.1021/j100794a011
   Sasisanker P, 2004, PHYS CHEM CHEM PHYS, V6, P1899, DOI 10.1039/b314070a
   SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024
   SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948
   Stradner A, 2000, LANGMUIR, V16, P5354, DOI 10.1021/la991679r
   Tanford C., 1980, HYDROPHOBIC EFFECT F
   vonBerlepsch H, 1996, LANGMUIR, V12, P3613, DOI 10.1021/la960036y
   WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5
   Wang SL, 2004, CHEM PHYS LIPIDS, V129, P21, DOI 10.1016/j.chemphyslip.2003.09.017
   WIENER MC, 1988, BIOCHIM BIOPHYS ACTA, V938, P135, DOI 10.1016/0005-2736(88)90153-8
NR 59
TC 59
Z9 60
U1 1
U2 34
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
EI 1520-5126
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 22
PY 2004
VL 126
IS 50
BP 16544
EP 16552
DI 10.1021/ja045525w
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA 880RZ
UT WOS:000225808200059
PM 15600359
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, G
TI Five easy steps to get rid of your lab
SO FEBS LETTERS
LA English
DT Editorial Material
C1 Univ Basel, Biozentrum, Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0014-5793
J9 FEBS LETT
JI FEBS Lett.
PD DEC 17
PY 2004
VL 578
IS 3
BP 205
EP 206
DI 10.1016/j.febslet.2004.11.033
PG 2
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 882LH
UT WOS:000225939900001
OA Bronze
DA 2021-01-25
ER

PT J
AU Grzesiek, S
   Cordier, F
   Jaravine, V
   Barfield, M
AF Grzesiek, S
   Cordier, F
   Jaravine, V
   Barfield, M
TI Insights into biomolecular hydrogen bonds from hydrogen bond scalar
   couplings
SO PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY
LA English
DT Review
DE hydrogen bond; scalar coupling; chemical shift; secondary structure;
   tertiary structure; protein; nucleic acid; NMR; density functional
   theory
ID NUCLEAR-MAGNETIC-RESONANCE; DENSITY-FUNCTIONAL THEORY; SPIN-SPIN
   COUPLINGS; CRICK BASE-PAIRS; CENTER-DOT-O=C; N-H-N; CONSISTENT
   PERTURBATION-THEORY; RESIDUAL DIPOLAR COUPLINGS; MOLECULAR ORBITAL
   THEORY; DIMERIC DNA QUADRUPLEX
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Arizona, Dept Chem, Tucson, AZ 85721 USA.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch; barfield@u.arizona.edu
OI Cordier, Florence/0000-0002-5963-7773; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Addlagatta A, 2001, ACTA CRYSTALLOGR D, V57, P649, DOI 10.1107/S0907444901003468
   Al-Hashimi HM, 2002, J MOL BIOL, V318, P637, DOI 10.1016/S0022-2836(02)00160-2
   Al-Hashimi HM, 2002, J BIOMOL NMR, V22, P1, DOI 10.1023/A:1013801714041
   Al-Hashimi HM, 2001, J AM CHEM SOC, V123, P633, DOI 10.1021/ja003379y
   Al-Hashimi HM, 2001, J AM CHEM SOC, V123, P3179, DOI 10.1021/ja004133w
   ALBERTSEN P, 1980, CHEM PHYS LETT, V76, P354, DOI 10.1016/0009-2614(80)87040-0
   Alexandrescu AT, 2001, PROTEIN SCI, V10, P1856, DOI 10.1110/ps.14301
   Alkon A, 2003, DEV PSYCHOBIOL, V42, P64, DOI 10.1002/dev.10082
   Arnesano F, 2002, BIOCHEMISTRY-US, V41, P13587, DOI 10.1021/bi026362w
   Arnold WD, 2000, J AM CHEM SOC, V122, P12835, DOI 10.1021/ja0025705
   Assadi-Porter FM, 2003, J BIOL CHEM, V278, P31331, DOI 10.1074/jbc.M302663200
   Atkins P. W., 1997, MOL QUANTUM MECH
   Bacskay GB, 1996, J AM CHEM SOC, V118, P3753, DOI 10.1021/ja953611d
   Bader R. F. W., 1994, ATOMS MOL QUANTUM TH
   Bagno A, 2000, CHEM-EUR J, V6, P2925
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Banci L, 2002, BIOCHEMISTRY-US, V41, P2913, DOI 10.1021/bi011617b
   Barbiellini B, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.235101
   BARFIELD M, 1968, J CHEM PHYS, V48, P4458, DOI 10.1063/1.1668013
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   BARFIELD M, 1969, J AM CHEM SOC, V91, P1, DOI 10.1021/ja01029a001
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   Barfield M, 2001, MAGN RESON CHEM, V39, pS115, DOI 10.1002/mrc.930
   BARFIELD M, 1989, J AM CHEM SOC, V111, P4285, DOI 10.1021/ja00194a020
   BARFIELD M, 1996, ENC NUCL MAGNETIC RE, V4, P2520
   BARFIELD M, 1965, ADV MAGN RESON, V1, P149
   Bartlett RJ, 2002, ACS SYM SER, V827, P150
   BAX A, 1994, METHOD ENZYMOL, V239, P79
   Becker E.D., 1996, ENCY NUCL MAGNETIC R, V4, P2409
   Bellanda M., 2004, ANGEW CHEM, V116, P3214
   Benedict H, 1998, J AM CHEM SOC, V120, P2939, DOI 10.1021/ja9719790
   Benedict H, 2000, J AM CHEM SOC, V122, P1979, DOI 10.1021/ja9907461
   BLAKE PR, 1992, J BIOMOL NMR, V2, P527, DOI 10.1007/BF02192814
   BLAKE PR, 1992, J AM CHEM SOC, V114, P4931, DOI 10.1021/ja00038a084
   Blanchard SC, 2001, P NATL ACAD SCI USA, V98, P3720, DOI 10.1073/pnas.051608498
   Bonvin AMJJ, 2001, J BIOMOL NMR, V21, P221, DOI 10.1023/A:1012935005256
   BORMAN S, 1999, CHEM ENG NEWS, P36
   Bougault CM, 2003, BIOCHEMISTRY-US, V42, P4357, DOI 10.1021/bi027264d
   Brown SP, 2002, J AM CHEM SOC, V124, P1152, DOI 10.1021/ja0172262
   Brown SP, 2002, CHEM COMMUN, P1852, DOI 10.1039/b205324a
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   Bryce DL, 2001, J BIOMOL NMR, V19, P371, DOI 10.1023/A:1011273125189
   Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462
   Bytchenkoff D, 2003, J MAGN RESON, V165, P1, DOI 10.1016/S1090-7807(03)00271-4
   Bytchenkoff D, 2002, MAGN RESON CHEM, V40, P377, DOI 10.1002/mrc.1018
   CARMICHAEL I, 1993, J PHYS CHEM-US, V97, P1789, DOI 10.1021/j100111a013
   Chiarparin E, 2001, CHEMPHYSCHEM, V2, P41, DOI 10.1002/1439-7641(20010119)2:1<41::AID-CPHC41>3.0.CO;2-H
   Cilley CD, 2003, RNA, V9, P663, DOI 10.1261/rna.2189203
   CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219
   Collin D, 2000, NUCLEIC ACIDS RES, V28, P3386, DOI 10.1093/nar/28.17.3386
   Contreras RH, 2000, ANNU REP NMR SPECTRO, V41, P55, DOI 10.1016/S0066-4103(00)41009-4
   Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274
   Cordier F, 2004, BIOCHEMISTRY-US, V43, P11295, DOI 10.1021/bi049314f
   Cordier F, 2003, J AM CHEM SOC, V125, P15750, DOI 10.1021/ja038616m
   Cordier F, 1999, J MAGN RESON, V140, P510, DOI 10.1006/jmre.1999.1899
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   COULSON CA, 1947, PROC R SOC LON SER-A, V191, P39, DOI 10.1098/rspa.1947.0102
   COULSON CA, 1948, PROC R SOC LON SER-A, V193, P447, DOI 10.1098/rspa.1948.0056
   COX JPL, 1993, J MOL BIOL, V234, P483, DOI 10.1006/jmbi.1993.1600
   Crabtree RH, 1996, ACCOUNTS CHEM RES, V29, P348, DOI 10.1021/ar950150s
   Czernek J, 2001, J AM CHEM SOC, V123, P11079, DOI 10.1021/ja011618r
   Dayie KT, 2002, J MOL BIOL, V317, P263, DOI 10.1006/jmbi.2001.5424
   DeJong ES, 2003, BIOCHEMISTRY-US, V42, P8035, DOI 10.1021/bi034252z
   Del Bene JE, 2000, J AM CHEM SOC, V122, P3560, DOI 10.1021/ja994312h
   Del Bene JE, 2000, J AM CHEM SOC, V122, P4794, DOI 10.1021/ja994458g
   Del Bene JE, 2000, J PHYS CHEM A, V104, P7165, DOI 10.1021/jp001681n
   Del Bene JE, 2004, MAGN RESON CHEM, V42, P421, DOI 10.1002/mrc.1386
   Del Bene JE, 2003, J PHYS CHEM A, V107, P3121, DOI 10.1021/jp022555h
   Del Bene JE, 2002, J AM CHEM SOC, V124, P6393, DOI 10.1021/ja011755o
   Del Bene JE, 2001, MAGN RESON CHEM, V39, pS109, DOI 10.1002/mrc.913
   Del Bene JE, 2001, J PHYS CHEM A, V105, P930, DOI 10.1021/jp003470o
   Del Bene JE, 2000, J AM CHEM SOC, V122, P10480, DOI 10.1021/ja002735+
   DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492
   DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   Dickson RM, 1996, J PHYS CHEM-US, V100, P5286, DOI 10.1021/jp951930l
   Dingley AJ, 2000, J BIOMOL NMR, V16, P279, DOI 10.1023/A:1008307115641
   Dingley AJ, 2001, CONCEPT MAGNETIC RES, V13, P103
   Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   DITCHFIELD R, 1974, MOL PHYS, V27, P789, DOI 10.1080/00268977400100711
   Dittmer J, 2003, J BIOMOL NMR, V26, P259, DOI 10.1023/A:1023829129379
   Eletsky A, 2002, J BIOMOL NMR, V24, P31, DOI 10.1023/A:1020697627485
   Englaender S.W., 1996, ENCY NUCL MAGNETIC R, V4, P2415
   Fierman M, 2000, ORG LETT, V2, P2077, DOI 10.1021/ol0060679
   Fourmy D, 2002, J MOL BIOL, V324, P137, DOI 10.1016/S0022-2836(02)01030-6
   FREY PA, 1994, SCIENCE, V264, P1927, DOI 10.1126/science.7661899
   FRONZONI G, 1986, CHEM PHYS, V103, P29, DOI 10.1016/0301-0104(86)85099-6
   FUKUI H, 1991, J CHEM PHYS, V94, P533, DOI 10.1063/1.460371
   FUKUI H, 2003, NUCL MAGNETIC RESONA
   GALASSO V, 1985, J CHEM PHYS, V82, P899, DOI 10.1063/1.448518
   GEERTSEN J, 1987, INT J QUANTUM CHEM, P475
   GEERTSEN J, 1987, J CHEM PHYS, V87, P2138, DOI 10.1063/1.453722
   Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115
   Ghanty TK, 2000, J AM CHEM SOC, V122, P1210, DOI 10.1021/ja9937019
   Giedroc DP, 2003, J AM CHEM SOC, V125, P4676, DOI 10.1021/ja029286t
   Giribet CG, 2003, INT J MOL SCI, V4, P203, DOI 10.3390/i4040203
   Golubev NS, 1999, CHEM-EUR J, V5, P492, DOI 10.1002/(SICI)1521-3765(19990201)5:2<492::AID-CHEM492>3.0.CO;2-I
   Gosser Y, 2001, NAT STRUCT BIOL, V8, P146, DOI 10.1038/84138
   GRAYCE CJ, 1995, CHEM PHYS LETT, V234, P319, DOI 10.1016/0009-2614(95)00073-D
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P627
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GRZESIEK S, 2003, BIOL MAGN RESON, V20, P255
   Hansen MJ, 2002, MOL PHYS, V100, P2807, DOI 10.1080/00268970210142602
   HANSEN PE, 1988, PROG NUCL MAG RES SP, V20, P207, DOI 10.1016/0079-6565(88)80002-5
   Heinz T, 2002, HELV CHIM ACTA, V85, P3984, DOI 10.1002/1522-2675(200211)85:11<3984::AID-HLCA3984>3.0.CO;2-4
   Helgaker T, 1999, CHEM REV, V99, P293, DOI 10.1021/cr960017t
   Helgaker T, 2000, J CHEM PHYS, V113, P9402, DOI 10.1063/1.1321296
   Hellemans A, 1999, SCIENCE, V283, P614, DOI 10.1126/science.283.5402.614
   Hennig M, 2000, NUCLEIC ACIDS RES, V28, P1585, DOI 10.1093/nar/28.7.1585
   Hennig M, 1999, J AM CHEM SOC, V121, P5123, DOI 10.1021/ja990340o
   HINZ HJ, 1994, BIOPHYS CHEM, V52, P275, DOI 10.1016/0301-4622(94)00098-5
   Hoffmann B, 2003, P NATL ACAD SCI USA, V100, P7003, DOI 10.1073/pnas.0832440100
   Hush NS, 1997, J AM CHEM SOC, V119, P1717, DOI 10.1021/ja963150b
   Isaacs ED, 1999, PHYS REV LETT, V82, P600, DOI 10.1103/PhysRevLett.82.600
   Jameson CJ, 1996, ENCY NUCL MAGNETIC R, V4, P2638
   JAMESON CJ, 2003, NUCL MAGNETIC RESONA
   Jaravine VA, 2004, J BIOMOL NMR, V29, P309, DOI 10.1023/B:JNMR.0000032516.87434.35
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Jee JG, 2002, J BIOL CHEM, V277, P1388, DOI 10.1074/jbc.M109726200
   Jeffrey G.A., 1991, HYDROGEN BONDING BIO
   Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171
   Jiang LC, 1999, STRUCTURE, V7, P817, DOI 10.1016/S0969-2126(99)80105-1
   Jordan MJT, 2001, CHEM PHYS LETT, V346, P288, DOI 10.1016/S0009-2614(01)00978-2
   Juranic N, 2003, PROTEIN SCI, V12, P2633, DOI 10.1110/ps.03127103
   JURANIC N, 1995, J AM CHEM SOC, V117, P405, DOI 10.1021/ja00106a046
   Juranic N, 2002, J AM CHEM SOC, V124, P14221, DOI 10.1021/ja0273288
   Juranic N, 2001, J AM CHEM SOC, V123, P4099, DOI 10.1021/ja015647d
   KAINOSHO M, 1969, TETRAHEDRON, V25, P4071, DOI 10.1016/S0040-4020(01)82939-2
   Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562
   Kawahara S, 2003, HELV CHIM ACTA, V86, P3265, DOI 10.1002/hlca.200390267
   Kettani A, 2000, J MOL BIOL, V297, P627, DOI 10.1006/jmbi.2000.3524
   Kettani A, 2000, J MOL BIOL, V301, P129, DOI 10.1006/jmbi.2000.3932
   Kettani A, 1999, STRUCTURE, V7, P803, DOI 10.1016/S0969-2126(99)80104-X
   Khandelwal P, 2002, BIOCHEMISTRY-US, V41, P11425, DOI 10.1021/bi026333l
   Kim CH, 2000, P NATL ACAD SCI USA, V97, P9396, DOI 10.1073/pnas.170283697
   KIM PS, 1984, NATURE, V307, P329, DOI 10.1038/307329a0
   Kojima C, 2000, J BIOMOL NMR, V18, P269, DOI 10.1023/A:1026717101063
   KOWALEWSKI J, 1981, J CHEM PHYS, V74, P2412, DOI 10.1063/1.441362
   Krantz BA, 2002, NAT STRUCT BIOL, V9, P458, DOI 10.1038/nsb794
   Kreevoy MM, 1999, CAN J CHEM, V77, P733, DOI 10.1139/cjc-77-5-6-733
   KUNTZ ID, 1991, J AM CHEM SOC, V113, P1406, DOI 10.1021/ja00004a050
   Lebars I, 2003, EMBO J, V22, P183, DOI 10.1093/emboj/cdg022
   Lebars I, 2001, EMBO J, V20, P7250, DOI 10.1093/emboj/20.24.7250
   LEGON AC, 1988, CHEM PHYS LETT, V147, P484, DOI 10.1016/0009-2614(88)85013-9
   LGUERO J, 2002, J CHEM RES S, P34
   Li H, 2000, J BIOMOL NMR, V18, P207, DOI 10.1023/A:1026537609584
   Lide D. R., 1999, CRC HDB CHEM PHYS
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   Lipsitz RS, 2002, J AM CHEM SOC, V124, P10621, DOI 10.1021/ja020676p
   Liu A, 2000, J BIOMOL NMR, V17, P55, DOI 10.1023/A:1008340116418
   Liu AZ, 2000, J BIOMOL NMR, V17, P305, DOI 10.1023/A:1008390813387
   Liu AZ, 2000, J AM CHEM SOC, V122, P11226, DOI 10.1021/ja003080f
   Liu AZ, 2000, J AM CHEM SOC, V122, P3206, DOI 10.1021/ja994255s
   Liu AZ, 2000, J BIOMOL NMR, V17, P79, DOI 10.1023/A:1008373501591
   Lohr F, 2000, J AM CHEM SOC, V122, P9289, DOI 10.1021/ja001345k
   Lukavsky PJ, 2000, NAT STRUCT BIOL, V7, P1105
   Lukavsky PJ, 2003, NAT STRUCT BIOL, V10, P1033, DOI 10.1038/nsb1004
   Luy B, 2000, J AM CHEM SOC, V122, P8095, DOI 10.1021/ja0000910
   Luy B, 2002, J BIOMOL NMR, V24, P133, DOI 10.1023/A:1020919131801
   Majumdar A, 2001, J BIOMOL NMR, V21, P289, DOI 10.1023/A:1013340227140
   Majumdar A, 2002, ACCOUNTS CHEM RES, V35, P1, DOI 10.1021/ar010097+
   Majumdar A, 2001, MAGN RESON CHEM, V39, pS166, DOI 10.1002/mrc.947
   Majumdar A, 1999, J BIOMOL NMR, V14, P67, DOI 10.1023/A:1008335502416
   Majumdar A, 1999, J BIOMOL NMR, V15, P207, DOI 10.1023/A:1008357304708
   Majumdar A, 2001, J BIOMOL NMR, V19, P103, DOI 10.1023/A:1008311624772
   MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852
   MALKIN VG, 1994, CHEM PHYS LETT, V221, P91, DOI 10.1016/0009-2614(94)87023-3
   Malkina OL, 2003, ANGEW CHEM INT EDIT, V42, P4335, DOI 10.1002/anie.200351713
   Malkina OL, 1996, J CHEM PHYS, V105, P8793, DOI 10.1063/1.472658
   Markley JL, 1996, BIOCHEMISTRY-US, V35, P11092, DOI 10.1021/bi961366k
   Markwick PRL, 2003, J AM CHEM SOC, V125, P644, DOI 10.1021/ja028875w
   Martin TW, 1999, NAT STRUCT BIOL, V6, P403, DOI 10.1038/8195
   Matsugami A, 2003, STRUCTURE, V11, P533, DOI 10.1016/S0969-2126(03)00069-8
   MCCONNELL HM, 1956, J CHEM PHYS, V24, P460, DOI 10.1063/1.1742498
   Meissner A, 2000, J MAGN RESON, V143, P387, DOI 10.1006/jmre.1999.1998
   Meissner A, 2000, J MAGN RESON, V143, P431, DOI 10.1006/jmre.2000.2048
   Mildvan AS, 1999, METHOD ENZYMOL, V308, P219
   Mishima M, 2000, J AM CHEM SOC, V122, P5883, DOI 10.1021/ja000005w
   Munoz A, 2002, J BIOL INORG CHEM, V7, P713, DOI 10.1007/s00775-002-0345-3
   NELSON JW, 1989, BIOCHEMISTRY-US, V28, P5256, DOI 10.1021/bi00438a050
   Nixon PL, 2002, J MOL BIOL, V322, P621, DOI 10.1016/S0022-2836(02)00779-9
   Nutt DR, 2004, P NATL ACAD SCI USA, V101, P5998, DOI 10.1073/pnas.0306712101
   ODDERSHEDE J, 1975, J CHEM PHYS, V63, P2996, DOI 10.1063/1.431725
   Ohki S, 2001, J MOL BIOL, V305, P109, DOI 10.1006/jmbi.2000.4244
   Onak T, 1999, J AM CHEM SOC, V121, P2850, DOI 10.1021/ja9841097
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205
   PAULING L, 1949, J CHIM PHYS PCB, V46, P435
   Pauling L., 1960, NATURE CHEM BOND
   Pecul M, 2000, J PHYS CHEM A, V104, P8105, DOI 10.1021/jp001251x
   Pecul M, 2000, J CHEM PHYS, V112, P7930, DOI 10.1063/1.481394
   Pecul M, 2003, CHEM PHYS LETT, V372, P476, DOI 10.1016/S0009-2614(03)00475-5
   Pervushin K, 2000, J BIOMOL NMR, V16, P39, DOI 10.1023/A:1008367405025
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   POPLE JA, 1968, J CHEM PHYS, V49, P2960, DOI 10.1063/1.1670536
   POPLE JA, 1964, MOL PHYS, V8, P1, DOI 10.1080/00268976400100011
   POPLE JA, 1964, MOL PHYS, V7, P269, DOI 10.1080/00268976300101031
   QIAN H, 1992, J PHYS CHEM-US, V96, P3987, DOI 10.1021/j100189a015
   RAMSEY NF, 1953, PHYS REV, V91, P303, DOI 10.1103/PhysRev.91.303
   RAMSEY NF, 1950, PHYS REV, V78, P699, DOI 10.1103/PhysRev.78.699
   REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005
   Riek R, 2001, J MAGN RESON, V149, P149, DOI 10.1006/jmre.2001.2291
   Romero AH, 2001, J CHEM PHYS, V115, P115, DOI 10.1063/1.1372183
   Romero AH, 2000, PHYS STATUS SOLIDI B, V220, P703, DOI 10.1002/1521-3951(200007)220:1<703::AID-PSSB703>3.0.CO;2-0
   Rudisser S, 2000, J MOL BIOL, V295, P1211, DOI 10.1006/jmbi.1999.3421
   Sakamoto T, 2002, J BIOCHEM, V132, P177, DOI 10.1093/oxfordjournals.jbchem.a003207
   Sashital DG, 2003, BIOCHEMISTRY-US, V42, P1470, DOI 10.1021/bi027137h
   Scheurer C, 1999, J AM CHEM SOC, V121, P8661, DOI 10.1021/ja9917417
   SCHWALBE H, 1996, ENCY NUCL MAGNETIC R, V3, P1473
   Schweimer K, 2000, PROTEIN SCI, V9, P1474, DOI 10.1110/ps.9.8.1474
   Seemann H, 2001, J MOL BIOL, V307, P1091, DOI 10.1006/jmbi.2001.4517
   SEKINO H, 1986, J CHEM PHYS, V85, P3945, DOI 10.1063/1.450916
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697
   Smirnov SN, 1996, J AM CHEM SOC, V118, P4094, DOI 10.1021/ja953445+
   SOKOLOV ND, 1994, CHEM PHYS, V181, P305, DOI 10.1016/0301-0104(93)E0436-Y
   Soncini A, 2003, J CHEM PHYS, V118, P7165, DOI 10.1063/1.1561871
   Song JK, 2003, BIOCHEMISTRY-US, V42, P5186, DOI 10.1021/bi034041u
   Sprangers R, 2003, J MOL BIOL, V327, P507, DOI 10.1016/S0022-2836(03)00148-7
   Staple DW, 2003, NUCLEIC ACIDS RES, V31, P4326, DOI 10.1093/nar/gkg654
   STEIN BP, 1999, PHYS TODAY, V52, P9
   Steiner T, 2002, ANGEW CHEM INT EDIT, V41, P48, DOI 10.1002/1521-3773(20020104)41:1<48::AID-ANIE48>3.0.CO;2-U
   Suhnel J, 2001, BIOPOLYMERS, V61, P32, DOI 10.1002/1097-0282(2001)61:1<32::AID-BIP10063>3.0.CO;2-B
   Sychrovsky V, 2002, J PHYS CHEM B, V106, P10242, DOI 10.1021/jp020673z
   Tessari M, 1997, J AM CHEM SOC, V119, P8985, DOI 10.1021/ja970573k
   Tjandra N, 1997, J AM CHEM SOC, V119, P8076, DOI 10.1021/ja970876e
   Toh JSS, 2001, J PHYS CHEM A, V105, P10906, DOI 10.1021/jp0129176
   Tuttle T, 2004, J PHYS CHEM B, V108, P1115, DOI 10.1021/jp0363951
   VAHTRAS O, 1992, J CHEM PHYS, V96, P6120, DOI 10.1063/1.462654
   VAHTRAS O, 1993, CHEM PHYS LETT, V209, P201, DOI 10.1016/0009-2614(93)80093-5
   Vallurupalli P, 2003, J MOL BIOL, V325, P843, DOI 10.1016/S0022-2836(02)01270-6
   WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056
   WAGNER G, 1983, Q REV BIOPHYS, V16, P1, DOI 10.1017/S0033583500004911
   Wahl MC, 1997, TRENDS BIOCHEM SCI, V22, P97, DOI 10.1016/S0968-0004(97)01004-9
   Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Weiss P., 1999, SCI NEWS WASHINGTON, V155, P52
   Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2
   Wilkens SJ, 2001, J AM CHEM SOC, V123, P12026, DOI 10.1021/ja016284k
   Wilkens SJ, 2002, J AM CHEM SOC, V124, P1190, DOI 10.1021/ja017169c
   WILKINSON KD, 1986, ARCH BIOCHEM BIOPHYS, V250, P390, DOI 10.1016/0003-9861(86)90741-1
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Wohnert J, 1999, NUCLEIC ACIDS RES, V27, P3104, DOI 10.1093/nar/27.15.3104
   Wu A, 2003, PHYS CHEM CHEM PHYS, V5, P4541, DOI 10.1039/b304891h
   Wu AA, 2003, J PHYS CHEM A, V107, P7043, DOI 10.1021/jp030541l
   Wu ZR, 2001, J BIOMOL NMR, V19, P361, DOI 10.1023/A:1011250219293
   Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276
   Yan XZ, 2000, J MAGN RESON, V147, P357, DOI 10.1006/jmre.2000.2221
   Zanier K, 2002, RNA, V8, P29, DOI 10.1017/S1355838202014061
   Zerella R, 1999, PROTEIN SCI, V8, P1320, DOI 10.1110/ps.8.6.1320
   Zhang N, 2001, J MOL BIOL, V311, P1063, DOI 10.1006/jmbi.2001.4916
   Zhang N, 2001, J MOL BIOL, V312, P1073, DOI 10.1006/jmbi.2001.5002
   ZHOU NE, 1992, J AM CHEM SOC, V114, P4320, DOI 10.1021/ja00037a042
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 256
TC 133
Z9 134
U1 6
U2 61
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0079-6565
EI 1873-3301
J9 PROG NUCL MAG RES SP
JI Prog. Nucl. Magn. Reson. Spectrosc.
PD DEC 17
PY 2004
VL 45
IS 3-4
BP 275
EP 300
DI 10.1016/j.pnmrs.2004.08.001
PG 26
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical; Spectroscopy
SC Chemistry; Physics; Spectroscopy
GA 878YD
UT WOS:000225682500003
DA 2021-01-25
ER

PT J
AU Kuhnel, K
   Jarchau, T
   Wolf, E
   Schlichting, I
   Walter, U
   Wittinghofer, A
   Strelkov, SV
AF Kuhnel, K
   Jarchau, T
   Wolf, E
   Schlichting, I
   Walter, U
   Wittinghofer, A
   Strelkov, SV
TI The VASP tetramerization domain is a right-handed coiled coil based on a
   15-residue repeat
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID ACTIN-BASED MOTILITY; ELECTRON-DENSITY MAPS; PI-PI-INTERACTIONS;
   ENA/VASP PROTEINS; LISTERIA-MONOCYTOGENES; BINDING; PROGRAM;
   POLYMERIZATION; CYTOSKELETON; REGULATORS
AB The vasodilator-stimulated phosphoprotein (VASP) is a key regulator of actin dynamics. We have determined the 1.3-Angstrom resolution crystal structure of the 45-residue-long tetramerization domain (TD) from human VASP. This domain forms a right-handed a-helical coiled-coil structure with a similar degree of supercoiling as found in the widespread left-handed coiled coils with heptad repeats. The basis for the right-handed geometry of VASP TD is a 15-residue repeat in its amino acid sequence, which reveals a characteristic pattern of hydrophobic residues. Hydrophobic interactions and a network of salt bridges render VASP TD highly thermostable with a melting point of 120degreesC.
C1 Max Planck Inst Mol Physiol, Abt Strukturelle Biol, D-44227 Dortmund, Germany.
   Inst Klin Biochem & Pathobiochem, D-97080 Wurzburg, Germany.
   Max Planck Inst Med Res, Abt Biomol Mechanismen, D-69120 Heidelberg, Germany.
   Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Walter, U (corresponding author), Max Planck Inst Mol Physiol, Abt Strukturelle Biol, Otto Hahn Str 11, D-44227 Dortmund, Germany.
EM u.walter@medizin.uni-wuerzburg.de;
   alfred.wittinghofer@mpi-dortmund.mpg.de
RI Wolf, Eva/G-7340-2014
OI Kuehnel, Karin/0000-0002-2663-703X
CR Bachmann C, 1999, J BIOL CHEM, V274, P23549, DOI 10.1074/jbc.274.33.23549
   Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6
   Brown JH, 1996, PROTEINS, V26, P134
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   CHOTHIA C, 1981, J MOL BIOL, V145, P215, DOI 10.1016/0022-2836(81)90341-7
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363
   Grosse R, 2003, EMBO J, V22, P3050, DOI 10.1093/emboj/cdg287
   Gruber M, 2003, TRENDS BIOCHEM SCI, V28, P679, DOI 10.1016/j.tibs.2003.10.008
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Harbury PB, 1998, SCIENCE, V282, P1462, DOI 10.1126/science.282.5393.1462
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7
   HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016
   Huttelmaier S, 1999, FEBS LETT, V451, P68, DOI 10.1016/S0014-5793(99)00546-3
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399
   Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356
   Lassalle MW, 1998, J MOL BIOL, V279, P987, DOI 10.1006/jmbi.1998.1776
   Laurent V, 1999, J CELL BIOL, V144, P1245, DOI 10.1083/jcb.144.6.1245
   LUPAS A, 1995, J MOL BIOL, V248, P180, DOI 10.1006/jmbi.1995.0210
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Mittl PRE, 2000, P NATL ACAD SCI USA, V97, P2562, DOI 10.1073/pnas.97.6.2562
   Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X
   MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159
   Niebuhr K, 1997, EMBO J, V16, P5433, DOI 10.1093/emboj/16.17.5433
   Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205
   Peters J, 1996, J MOL BIOL, V257, P1031, DOI 10.1006/jmbi.1996.0221
   REINHARD M, 1995, EMBO J, V14, P1583, DOI 10.1002/j.1460-2075.1995.tb07146.x
   Reinhard M, 2001, TRENDS BIOCHEM SCI, V26, P243, DOI 10.1016/S0968-0004(00)01785-0
   Samarin S, 2003, J CELL BIOL, V163, P131, DOI 10.1083/jcb.200303191
   Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324
   Skoble J, 2001, J CELL BIOL, V155, P89, DOI 10.1083/jcb.200106061
   Stetefeld J, 2000, NAT STRUCT BIOL, V7, P772, DOI 10.1038/79006
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Svitkina TM, 2003, J CELL BIOL, V160, P409, DOI 10.1083/jcb.200210174
   Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036
   Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072
   VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012
   Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7
   Walders-Harbeck B, 2002, FEBS LETT, V529, P275, DOI 10.1016/S0014-5793(02)03356-2
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   Zhuang SH, 2004, J BIOL CHEM, V279, P10397, DOI 10.1074/jbc.M313048200
   Zimmermann J, 2002, BIOCHEMISTRY-US, V41, P11143, DOI 10.1021/bi020379x
NR 49
TC 81
Z9 83
U1 1
U2 10
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 7
PY 2004
VL 101
IS 49
BP 17027
EP 17032
DI 10.1073/pnas.0403069101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 879SV
UT WOS:000225740100011
PM 15569942
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Chan, C
   Paul, R
   Samoray, D
   Amiot, NC
   Giese, B
   Jenal, U
   Schirmer, T
AF Chan, C
   Paul, R
   Samoray, D
   Amiot, NC
   Giese, B
   Jenal, U
   Schirmer, T
TI Structural basis of activity and allosteric control of diguanylate
   cyclase
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE allosteric regulation; signal transduction; x-ray crystallography
ID 2-COMPONENT SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; ADENYLYL-CYCLASE;
   CAULOBACTER-CRESCENTUS; CRYSTAL-STRUCTURE; DOMAIN; ACID; GGDEF;
   PHOSPHORYLATION; TRANSITION
AB Recent discoveries suggest that a novel second messenger, bis(3'-->5')-cyclic di-GMP (c-diGMP), is extensively used by bacteria to control multicellular behavior. Condensation of two GTP to the dinucleotide is catalyzed by the widely distributed diguanylate cyclase (DGC or GGDEF) domain that occurs in various combinations with sensory and/or regulatory modules. The crystal structure of the unorthodox response regulator PleD from Caulobacter crescentus, which consists of two CheY-like receiver domains and a DGC domain, has been solved in complex with the product c-diGMP. PleD forms a dinner with the CheY-like domains (the stem) mediating weak monomer-monomer interactions. The fold of the DGC domain is similar to adenylate cyclase, but the nucleotide-binding mode is substantially different. The guanine base is H-bonded to Asn-335 and Asp-344, whereas the ribosyl and alpha-phosphate moieties extend over the beta2-beta3-hairpin that carries the GGEEF signature motif. In the crystal, c-diGMP molecules are crosslinking active sites of adjacent dimers. It is inferred that, in solution, the two DGC domains of a dimer align in a two-fold symmetric way to catalyze c-diGMP synthesis. Two mutually intercalated c-diGMP molecules are found tightly bound at the stem-DGC interface. This allosteric site explains the observed noncompetitive product inhibition. We propose that product inhibition is due to domain immobilization and sets an upper limit for the concentration of this second messenger in the cell.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Div Mol Microbiol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Birck C, 1999, STRUCTURE, V7, P1505, DOI 10.1016/S0969-2126(00)88341-0
   BIRNBAUMER L, 1979, ANAL BIOCHEM, V93, P124, DOI 10.1016/S0003-2697(79)80054-8
   Collaborative Computational Project Number 4, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112
   Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5
   Djordjevic S, 1998, J STRUCT BIOL, V124, P189, DOI 10.1006/jsbi.1998.4034
   Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381
   Doublie S, 1998, NATURE, V391, P251
   EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Galperin MY, 2004, ENVIRON MICROBIOL, V6, P552, DOI 10.1111/j.1462-2920.2004.00633.x
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Lee SY, 2001, J BIOL CHEM, V276, P16425, DOI 10.1074/jbc.M101002200
   LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F
   Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860
   Maris AE, 2002, NAT STRUCT BIOL, V9, P771, DOI 10.1038/nsb845
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Pei JM, 2001, PROTEINS, V42, P210, DOI 10.1002/1097-0134(20010201)42:2<210::AID-PROT80>3.0.CO;2-8
   Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915
   Robinson VL, 2003, J BACTERIOL, V185, P4186, DOI 10.1128/JB.185.14.4186-4194.2003
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756
   Tesmer JJG, 1998, CURR OPIN STRUC BIOL, V8, P713, DOI 10.1016/S0959-440X(98)80090-0
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Uzzau S, 2000, CELL MICROBIOL, V2, P83, DOI 10.1046/j.1462-5822.2000.00041.x
NR 31
TC 299
Z9 312
U1 4
U2 46
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 7
PY 2004
VL 101
IS 49
BP 17084
EP 17089
DI 10.1073/pnas.0406134101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 879SV
UT WOS:000225740100021
PM 15569936
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Zheng, L
   Kostrewa, D
   Berneche, S
   Winkler, FK
   Li, XD
AF Zheng, L
   Kostrewa, D
   Berneche, S
   Winkler, FK
   Li, XD
TI The mechanism of ammonia transport based on the crystal structure of
   AmtB of Escherichia coli
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE conformational change; x-ray structure
ID SACCHAROMYCES-CEREVISIAE; RH SUPERFAMILY; UPTAKE SYSTEMS; GREEN-ALGA;
   PROTEIN; GLYCOPROTEIN; NH3; EXPRESSION; MEMBRANE; FAMILY
AB Ammonium is one of the most important nitrogen sources for bacteria, fungi, and plants, but it is toxic to animals. The ammonium transport proteins (methylamine permeases/ammonium transporters/rhesus) are present in all domains of life; however, functional studies with members of this family have yielded controversial results with respect to the chemical identity (NH4+ or NH3) of the transported species. We have solved the structure of wild-type AmtB from Escherichia coli in two crystal forms at 1.8-and 2.1-Angstrom resolution, respectively. Substrate transport occurs through a narrow mainly hydrophobic pore located at the center of each monomer of the trimeric AmtB. At the periplasmic entry, a binding site for NH4+ is observed. Two phenylalanine side chains (F107 and F215) block access into the pore from the periplasmic side. Further into the pore, the side chains of two highly conserved histicline residues (H168 and H318) bridged by a H-bond lie adjacent, with their edges pointing into the cavity. These histicline residues may facilitate the deprotonation of an ammonium ion entering the pore. Adiabatic free energy calculations support the hypothesis that an electrostatic barrier between H168 and H318 hinders the permeation of cations but not that of the uncharged NH3. The structural data and energetic considerations strongly indicate that the methylamine permeases/ammonium transporters/rhesus proteins are ammonia gas channels. Interestingly, at the cytoplasmic exit of the pore, two different conformational states are observed that might be related to the inactivation mechanism by its regulatory partner.
C1 Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Li, XD (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM xiao.li@psi.ch
RI Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094; li, xiaodan/0000-0001-8647-7317
CR Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754
   Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200
   Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761
   CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881
   Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857
   Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a
   Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937
   GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456
   HACKETTE SL, 1970, J BIOL CHEM, V245, P4241
   Heitman J, 2000, NAT GENET, V26, P258, DOI 10.1038/81532
   Huang CH, 2001, BLOOD CELL MOL DIS, V27, P90, DOI 10.1006/bcmd.2000.0355
   Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619
   JAYAKUMAR A, 1989, J BACTERIOL, V171, P996, DOI 10.1128/jb.171.2.996-1001.1989
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KAHSCH W, 1993, J APPL CRYSTALLOGR, V26, P795
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   KLCINER D, 1985, FEMS MICROBIOL REV, V32, P87
   KLEINER D, 1985, FEBS LETT, V187, P237, DOI 10.1016/0014-5793(85)81249-7
   Kleiner D., 1993, ALKALI CATION TRANSP, P379
   LAMZIN VS, 2001, CRYSTALLOGRAPHY BIOL, P720
   Liu Z, 2000, J BIOL CHEM, V275, P25641, DOI 10.1074/jbc.M003353200
   Liu Z, 2001, J BIOL CHEM, V276, P1424, DOI 10.1074/jbc.M007528200
   Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142
   Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200
   LUDEWIG U, 2001, GENOME BIOL, P2
   MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x
   Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8
   Marini AM, 2000, NAT GENET, V26, P341
   Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282
   Meier-Wagner J, 2001, MICROBIOL-UK, V147, P135, DOI 10.1099/00221287-147-1-135
   Monahan BJ, 2002, EUKARYOT CELL, V1, P85, DOI 10.1128/EC.1.1.85-94.2002
   Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597
   NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x
   Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820
   Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678
   Soupene E, 2004, P NATL ACAD SCI USA, V101, P7787, DOI 10.1073/pnas.0401809101
   Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P7769, DOI 10.1073/pnas.112225599
   Soupene E, 2002, J BACTERIOL, V184, P3396, DOI 10.1128/JB.184.12.3396-3400.2002
   Soupene E, 2002, P NATL ACAD SCI USA, V99, P3926, DOI 10.1073/pnas.062043799
   Soupene E, 2001, MOL CELL BIOL, V21, P5733, DOI 10.1128/MCB.21.17.5733-5741.2001
   Stroud RM, 2003, FEBS LETT, V555, P79, DOI 10.1016/S0014-5793(03)01195-5
   Thomas GH, 2000, MOL MICROBIOL, V37, P331, DOI 10.1046/j.1365-2958.2000.01994.x
   von Wiren N, 2000, CURR OPIN PLANT BIOL, V3, P254, DOI 10.1016/S1369-5266(00)00073-X
   VONLUDEWIG U, 2002, J BIOL CHEM, V277, P13548
   Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200
NR 53
TC 260
Z9 268
U1 0
U2 26
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 7
PY 2004
VL 101
IS 49
BP 17090
EP 17095
DI 10.1073/pnas.0406475101
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 879SV
UT WOS:000225740100022
PM 15563598
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Meier, S
   Guthe, S
   Kiefhaber, T
   Grzesiek, S
AF Meier, S
   Guthe, S
   Kiefhaber, T
   Grzesiek, S
TI Foldon, the natural trimerization domain of T4 fibritin, dissociates
   into a monomeric A-state form containing a stable beta-hairpin: Atomic
   details of trimer dissociation and local beta-hairpin stability from
   residual dipolar couplings
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE NMR spectroscopy; protein folding; thermodynamics; structure; order
   parameter
ID MAGNETIC-RESONANCE RELAXATION; H-1-NMR CHEMICAL-SHIFTS; SEGMENTED
   COILED-COIL; AMINO-ACID-SEQUENCE; MODEL-FREE APPROACH; BACTERIOPHAGE-T4
   FIBRITIN; STAPHYLOCOCCAL NUCLEASE; THERMODYNAMIC ANALYSIS;
   POLYACRYLAMIDE GELS; FOLDING KINETICS
AB The C-terminal domain of T4 fibritin (foldon) is obligatory for the formation of the fibritin trimer structure and can be used as an artificial trimerization domain. Its native structure consists of a trimeric-hairpin propeller. At low pH, the foldon trimer disintegrates into a monomeric (A-state) form that has similar properties as that of an early intermediate of the trimer folding pathway. The formation of this A-state monomer from the trimer, its structure, thermodynamic stability equilibrium association and folding dynamics have been characterized to atomic detail by modern high-resolution NMR techniques. The foldon A-state monomer forms a beta-hairpin with intact and stable H-bonds that is similar to the monomer in the foldon trimer, but lacks a defined structure in its N and C-terminal parts. Its thermodynamic stability in pure water is comparable to designed hairpins stabilized in alcohol/ water mixtures.
   Details of the thermal unfolding of the foldon A-state have been characterized by chemical shifts and residual dipolar couplings (RDCs) detected in inert, mechanically stretched polyacrylamide gels. At the onset of the thermat transition, uniform relative changes in RDC values indicate a uniform decrease of local N-H-N and C-alpha-H-alpha order parameters for the hairpin strand residues. In contrast, near-turn residues show particular thermal stability in RDC values and hence in local order parameters. This coincides with increased transition temperatures of the beta-turn residues observed by chemical shifts. At high temperatures, the RDCs converge to non-zero average values consistent with predictions from random chain polymer models. Residue-specific deviations above the unfolding transition reveal the persistence of residual order around proline residues, large hydrophobic residues and at the beta-turn. (C) 2004 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   Univ Basel, Div Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015; Kiefhaber, Thomas/A-3028-2010
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Ackerman MS, 2002, BIOCHEMISTRY-US, V41, P13791, DOI 10.1021/bi020511t
   Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   ANDERSON DE, 1990, BIOCHEMISTRY-US, V29, P2403, DOI 10.1021/bi00461a025
   Atkins P., 1998, PHYS CHEM, V6th
   BLANCO FJ, 1994, NAT STRUCT BIOL, V1, P584, DOI 10.1038/nsb0994-584
   Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0
   Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   CONLEY MP, 1975, P NATL ACAD SCI USA, V72, P3701, DOI 10.1073/pnas.72.9.3701
   COOMBS DH, 1977, J MOL BIOL, V116, P375, DOI 10.1016/0022-2836(77)90076-6
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DILL KA, 1993, P NATL ACAD SCI USA, V90, P1942, DOI 10.1073/pnas.90.5.1942
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Espinosa JF, 2001, J MOL BIOL, V306, P397, DOI 10.1006/jmbi.2000.4349
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   FRIEDRICHS MS, 1995, J AM CHEM SOC, V117, P10855, DOI 10.1021/ja00149a008
   GARRETT DS, 1995, J CELL BIOCH, V71
   Gellman SH, 1998, CURR OPIN CHEM BIOL, V2, P717, DOI 10.1016/S1367-5931(98)80109-9
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020
   Klimov DK, 2000, P NATL ACAD SCI USA, V97, P2544, DOI 10.1073/pnas.97.6.2544
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   Lacroix E, 1999, CURR OPIN STRUC BIOL, V9, P487, DOI 10.1016/S0959-440X(99)80069-4
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   LIPARI G, 1982, J AM CHEM SOC, V104, P4559, DOI 10.1021/ja00381a010
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Louhivuori M, 2004, J BIOMOL NMR, V29, P517, DOI 10.1023/B:JNMR.0000034347.01925.ad
   Maynard AJ, 1998, J AM CHEM SOC, V120, P1996, DOI 10.1021/ja9726769
   McCallister EL, 2000, NAT STRUCT BIOL, V7, P669, DOI 10.1038/77971
   Millet O, 2000, J AM CHEM SOC, V122, P2867, DOI 10.1021/ja993511y
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Munoz V, 1998, P NATL ACAD SCI USA, V95, P5872, DOI 10.1073/pnas.95.11.5872
   Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626
   Nesmelova I, 2001, BIOCHEMISTRY-US, V40, P2844, DOI 10.1021/bi001293b
   NICHOLSON LK, 1995, NAT STRUCT BIOL, V2, P274, DOI 10.1038/nsb0495-274
   Ohnishi S, 2003, PROTEINS, V50, P546, DOI 10.1002/prot.10327
   Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962
   RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040
   RamirezAlvarado M, 1997, J MOL BIOL, V273, P898, DOI 10.1006/jmbi.1997.1347
   RamirezAlvarado M, 1996, NAT STRUCT BIOL, V3, P604, DOI 10.1038/nsb0796-604
   Santiveri CM, 2002, J AM CHEM SOC, V124, P14903, DOI 10.1021/ja0278537
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Searle MS, 1999, J AM CHEM SOC, V121, P11615, DOI 10.1021/ja992029c
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074
   Strelkov SV, 1998, ACTA CRYSTALLOGR D, V54, P805, DOI 10.1107/S0907444997018878
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   TERZAGHI BE, 1979, J MOL BIOL, V127, P1, DOI 10.1016/0022-2836(79)90454-6
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   WAGNER G, 1983, J AM CHEM SOC, V105, P5948, DOI 10.1021/ja00356a056
   Walkenhorst WF, 2002, PROTEIN SCI, V11, P82, DOI 10.1110/ps.ps.28202
   Wang L, 1996, J MOL BIOL, V262, P283, DOI 10.1006/jmbi.1996.0513
   WENNERSTROM H, 1972, MOL PHYS, V24, P69, DOI 10.1080/00268977200101261
   WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471
   Xu XP, 2002, BIOPOLYMERS, V65, P408, DOI 10.1002/bip.10276
   Xu Y, 2003, J AM CHEM SOC, V125, P15388, DOI 10.1021/ja037053b
   Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002
   ZIMM BH, 1959, P NATL ACAD SCI USA, V45, P1601, DOI 10.1073/pnas.45.11.1601
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 73
TC 76
Z9 78
U1 1
U2 19
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 3
PY 2004
VL 344
IS 4
BP 1051
EP 1069
DI 10.1016/j.jmb.2004.09.079
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 874LC
UT WOS:000225350900014
PM 15544812
DA 2021-01-25
ER

PT J
AU Garcia, P
   Marino, M
   Mayans, O
AF Garcia, P
   Marino, M
   Mayans, O
TI Crystallization and preliminary X-ray analysis of the coiled-coil domain
   of dystrophia myotonica kinase
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID BINDING; RHOA; REGIONS; ALPHA
AB The coiled-coil domain of dystrophia myotonica protein kinase ( DMPK) has been cloned, overexpressed, purified and crystallized. Two crystal forms have been obtained that belong to space groups P3 and P2(1)2(1)2(1) and diffract to 2.4 and 1.6 Angstrom resolution, respectively. Experimental phases were obtained by MAD from an SeMet derivative. The location of selenium sites used molecular-replacement phases obtained from search models lacking sequence similarity with the coiled-coil under study. Both crystal forms contain three polypeptide chains in the asymmetric unit.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Mayans, O (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM olga.mayans@unibas.ch
RI Mayans, Olga/A-3954-2008
OI Mayans, Olga/0000-0001-6876-8532
CR BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chen XQ, 2002, J BIOL CHEM, V277, P12680, DOI 10.1074/jbc.M109839200
   Di Cunto F, 1998, J BIOL CHEM, V273, P29706, DOI 10.1074/jbc.273.45.29706
   Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200
   KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903
   LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472
   Larkin K, 2001, BRAIN RES BULL, V56, P389, DOI 10.1016/S0361-9230(01)00656-6
   LESLIE AGW, 1992, JNT CCP4 ESF EAMCB N, V26
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mayans O, 1997, STRUCTURE, V5, P677, DOI 10.1016/S0969-2126(97)00222-0
   Navaza J, 2001, ACTA CRYSTALLOGR D, V57, P1367, DOI 10.1107/S0907444901012422
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Shimizu T, 2003, J BIOL CHEM, V278, P46046, DOI 10.1074/jbc.M306458200
   Tan I, 2001, MOL CELL BIOL, V21, P2767, DOI 10.1128/MCB.21.8.2767-2778.2001
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Zhang RX, 2003, FEBS LETT, V546, P281, DOI 10.1016/S0014-5793(03)00601-X
NR 16
TC 2
Z9 3
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD DEC
PY 2004
VL 60
SI 2
BP 2336
EP 2339
DI 10.1107/S0907444904026873
PN 12
PG 4
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 874OX
UT WOS:000225360800008
PM 15583383
DA 2021-01-25
ER

PT J
AU Golding, JP
   Partridge, TA
   Beauchamp, JR
   King, T
   Brown, NA
   Gassmann, M
   Zammit, PS
AF Golding, JP
   Partridge, TA
   Beauchamp, JR
   King, T
   Brown, NA
   Gassmann, M
   Zammit, PS
TI Mouse myotomes pairs exhibit left-right asymmetric expression of MLC3F
   and alpha-skeletal actin
SO DEVELOPMENTAL DYNAMICS
LA English
DT Article
DE myotome; embryogenesis; left-right asymmetry; differentiation; iv
   mutation; Pitx2; alpha-SA; MLC3F
ID MYOGENIC REGULATORY FACTORS; MUSCLE PROGENITOR CELLS; GENE-EXPRESSION;
   MYF5; WNT; TRANSCRIPTS; ACTIVATION; MECHANISMS; MESODERM; EMBRYOS
AB Most muscle originates from the myotomal compartment of the somites, paired structures flanking the neural tube. Whereas vertebrate embryos show molecular and morphological asymmetry about the left-right body axis, somitic myogenesis is thought to occur symmetrically. Here, we provide the first evidence that myotome pairs are transiently left-right asymmetric, with higher expression of a-skeletal actin and myosin light chain 3F (MLC3F) on the left side between embryonic day 9.5-10.25. In iv mutants with situs inversus, the asymmetric expression of a-skeletal actin and MLC3F was inverted, showing that this process is regulated by global left-right axis cues, initiated before gastrulation. However, although left-sided identity is later maintained by Pitx2 genes, we found that Pitx2c null embryos have normal left-biased expression of a-skeletal actin and MLC3F. Myotome asymmetry, therefore, is downstream of the iv mutation but upstream of, or unrelated to, the Pitx2c pathway. (C) 2004 Wiley-Liss, Inc.
C1 MRC, Ctr Clin Sci, Muscle Cell Biol Grp, London W12 0NN, England.
   St George Hosp, Sch Med, Dept Anat & Dev Biol, London, England.
   Univ Basel, Dept Physiol, Biozentrum, Pharmazentrum, Basel, Switzerland.
RP Golding, JP (corresponding author), MRC, Ctr Clin Sci, Muscle Cell Biol Grp, Du Cane Rd, London W12 0NN, England.
EM jon.golding@csc.mrc.ac.uk
RI Golding, Jon/L-2700-2017
OI Golding, Jon/0000-0002-7910-7382; zammit, peter/0000-0001-9562-3072;
   Gassmann, Martin/0000-0001-6201-3032; Beauchamp,
   Jonathan/0000-0003-2067-3088
FU Medical Research CouncilMedical Research Council UK (MRC) [G113/31]
   Funding Source: Medline
CR ALLISON SC, 1993, J ORTHOP SPORT PHYS, V18, P661, DOI 10.2519/jospt.1993.18.6.661
   Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221
   Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7
   Borycki AG, 1999, DEVELOPMENT, V126, P1665
   BROWN N A, 1990, Teratology, V41, P541
   BROWN NA, 1991, CIBA F SYMP, V162, P182
   Burdine RD, 2000, GENE DEV, V14, P763
   Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825
   Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4
   CHHIBBER SR, 1972, ACTA ANAT, V81, P462
   CHHIBBER SR, 1970, J ANAT, V106, P553
   Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867
   DAWSON S, 1986, J HAND SURG-BRIT EUR, V11B, P378, DOI 10.1016/0266-7681(86)90161-0
   ERNST H, 1991, MOL CELL BIOL, V11, P3735, DOI 10.1128/MCB.11.7.3735
   FANTEL AG, 1991, TERATOLOGY, V44, P355, DOI 10.1002/tera.1420440311
   GeorgeWeinstein M, 1996, DEV BIOL, V173, P279, DOI 10.1006/dbio.1996.0023
   Grove EA, 1998, DEVELOPMENT, V125, P2315
   Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702
   Hirsinger E, 1997, DEVELOPMENT, V124, P4605
   Kelly RG, 1998, J MOL CELL CARDIOL, V30, P1067, DOI 10.1006/jmcc.1998.0705
   Kitamura K, 1999, DEVELOPMENT, V126, P5749
   Linker C, 2003, DEVELOPMENT, V130, P4797, DOI 10.1242/dev.00688
   Liu CY, 2002, DEVELOPMENT, V129, P5081
   LYONS GE, 1990, J CELL BIOL, V111, P1465, DOI 10.1083/jcb.111.4.1465
   Miller SA, 1998, ANAT REC, V250, P103
   Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5
   ONTELL M, 1993, DEVELOPMENT, V117, P1435
   OTT MO, 1991, DEVELOPMENT, V111, P1097
   Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887
   Pourquie O, 1996, CELL, V84, P461, DOI 10.1016/S0092-8674(00)81291-X
   Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758
   SASSOON D, 1989, NATURE, V341, P303, DOI 10.1038/341303a0
   SASSOON DA, 1988, DEVELOPMENT, V104, P155
   Tajbakhsh S, 2000, CURR TOP DEV BIOL, V48, P225
   Tajbakhsh S, 1996, NATURE, V384, P266, DOI 10.1038/384266a0
   Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155
   Tremblay P, 1998, DEV BIOL, V203, P49, DOI 10.1006/dbio.1998.9041
   WENTWORTH BM, 1991, P NATL ACAD SCI USA, V88, P1242, DOI 10.1073/pnas.88.4.1242
   Yan YT, 1999, GENE DEV, V13, P2527, DOI 10.1101/gad.13.19.2527
   Zammit PS, 2000, DEV DYNAM, V217, P75, DOI 10.1002/(SICI)1097-0177(200001)217:1<75::AID-DVDY7>3.0.CO;2-L
NR 40
TC 10
Z9 11
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
PD DEC
PY 2004
VL 231
IS 4
BP 795
EP 800
DI 10.1002/dvdy.20176
PG 6
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA 874DM
UT WOS:000225331100015
PM 15499557
OA Bronze
DA 2021-01-25
ER

PT J
AU Cabernard, C
   Neumann, M
   Affolter, M
AF Cabernard, C
   Neumann, M
   Affolter, M
TI Cellular and molecular mechanisms involved in branching morphogenesis of
   the Drosophila tracheal system
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Article
DE tubulogenesis; cell migration; fibroblast growth factor signaling; air
   sacs; zona pellucida domain; containing proteins; adherens junction
   remodeling
ID EPITHELIAL TUBE-SIZE; SERUM RESPONSE FACTOR; FGF RECEPTOR HOMOLOG;
   BINDING-PROTEIN; GENETIC-CONTROL; GROWTH; MIGRATION; LUNG;
   TUBULOGENESIS; BREATHLESS
AB Recent comparative studies have shown that, in many instances, the genetic network underlying the development of distinct organ systems is similar in invertebrate and vertebrate organisms. Genetically well-characterized, simple invertebrate model systems, such as Caenorhabditis elegans and Drosophila melanogaster, can thus provide useful insight for understanding more complex organ systems in vertebrates. Here, we summarize recent progress in the genetic analysis of tracheal development in Drosophila and compare the results to studies aimed at a better understanding of lung development in mouse and man. Clearly, both striking similarities and important differences are apparent, but it might still be too early to conclude whether the former or the latter prevail.
C1 Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Cabernard, Clemens/A-9033-2010
OI Cabernard, Clemens/0000-0003-3706-6401; Affolter,
   Markus/0000-0002-5171-0016
CR Abrams EW, 2003, TRENDS CELL BIOL, V13, P247, DOI 10.1016/S0962-8924(03)00055-2
   Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   AFFOLTER M, 1994, DEVELOPMENT, V120, P743
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Baylies MK, 2001, CURR OPIN GENET DEV, V11, P431, DOI 10.1016/S0959-437X(00)00214-8
   Behr M, 2003, DEV CELL, V5, P611, DOI 10.1016/S1534-5807(03)00275-2
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774
   Cheng H, 1996, ANAT REC, V244, P327
   Chihara T, 2000, DEVELOPMENT, V127, P4433
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303
   Chuang PT, 2003, TRENDS CELL BIOL, V13, P86, DOI 10.1016/S0962-8924(02)00031-4
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Dossenbach C, 2001, DEVELOPMENT, V128, P4563
   Gehring WJ, 2002, INT J DEV BIOL, V46, P65
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   GOLIC KG, 1991, SCIENCE, V252, P958, DOI 10.1126/science.2035025
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Hartmann B, 1998, MOL CELL NEUROSCI, V12, P194, DOI 10.1006/mcne.1998.0716
   Hemphala J, 2003, DEVELOPMENT, V130, P249, DOI 10.1242/dev.00218
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   HOOPS TC, 1991, J BIOL CHEM, V266, P4257
   Imam F, 1999, GENETICS, V152, P307
   Jarecki J, 1995, J NEUROSCI, V15, P8177
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kokot F, 2000, NEPHRON, V85, P97, DOI 10.1159/000045640
   Lavista-Llanos S, 2002, MOL CELL BIOL, V22, P6842, DOI 10.1128/MCB.22.19.6842-6853.2002
   Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534
   LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674
   Liu L, 2003, P NATL ACAD SCI USA, V100, P2128, DOI 10.1073/pnas.252785099
   Llimargas M, 2000, DEVELOPMENT, V127, P4407
   Llimargas M, 2004, DEVELOPMENT, V131, P181, DOI 10.1242/dev.00917
   Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1
   Manning G., 1993, DEV DROSOPHILA MELAN, V1, P609
   MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345
   Michelson AM, 1998, DEVELOPMENT, V125, P4379
   Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156
   Montagne J, 1996, DEVELOPMENT, V122, P2589
   Paul SM, 2003, DEVELOPMENT, V130, P4963, DOI 10.1242/dev.00691
   Petit V, 2004, MOL CELL BIOL, V24, P3769, DOI 10.1128/MCB.24.9.3769-3781.2004
   REICHMANFRIED M, 1994, GENE DEV, V8, P428, DOI 10.1101/gad.8.4.428
   Ribeiro C, 2003, DEV BIOL, V260, P1, DOI 10.1016/S0012-1606(03)00211-2
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Warburton D, 2003, RESP RES, V4, DOI 10.1186/1465-9921-4-5
   Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1
   Wassarman PM, 2001, NAT CELL BIOL, V3, pE59, DOI 10.1038/35055178
   Weatherbee SD, 1999, CELL, V97, P283, DOI 10.1016/S0092-8674(00)80737-0
   Weaver M, 2000, DEVELOPMENT, V127, P2695
   Wilson R, 2004, MOL CELL BIOL, V24, P2263, DOI 10.1128/MCB.24.6.2263-2276.2004
   Wu VM, 2004, J CELL BIOL, V164, P313, DOI 10.1083/jcb.200309134
   XU T, 1993, DEVELOPMENT, V117, P1223
NR 61
TC 22
Z9 22
U1 0
U2 4
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
EI 1522-1601
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD DEC
PY 2004
VL 97
IS 6
BP 2347
EP 2353
DI 10.1152/japplphysiol.00435.2004
PG 7
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA 868FM
UT WOS:000224899500040
PM 15531575
DA 2021-01-25
ER

PT J
AU Jensen, P
   Sass, HJ
   Grzesiek, S
AF Jensen, P
   Sass, HJ
   Grzesiek, S
TI Improved detection of long-range residual dipolar couplings in weakly
   aligned samples by Lee-Goldburg decoupling of homonuclear dipolar
   truncation
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE NMR; protein; structure; weak alignment
ID NMR-SPECTROSCOPY; PROTEIN-STRUCTURE; PULSE SEQUENCES; PHASE; FIELD;
   EXCITATION; ALIGNMENT; SOLIDS
AB Homonuclear H-1 residual dipolar couplings (RDCs) truncate the evolution of transverse H-1 magnetization of weakly aligned molecules in high-resolution NMR experiments. This leads to losses in sensitivity or resolution in experiments that require extended H-1 evolution times. Lee-Goldburg decoupling schemes have been shown to remove the effects of homonuclear dipolar couplings, while preserving chemical shift evolution in a number of solid-state NMR applications. Here, it is shown that the Lee-Goldburg sequence can be effectively incorporated into INEPT- or HMQC-type transfer schemes in liquid state weak alignment experiments in order to increase the efficiency of the magnetization transfer. The method is applied to the sensitive detection of (HN)-H-1-C-13 long-range RDCs in a three-dimensional HCN experiment. As compared to a conventional HCN experiment, an average sensitivity increase by a factor of 2.4 is obtained for a sample of weakly aligned protein G. This makes it possible to detect 170 long-range (HN-13C)-H-1 RDCs for distances up to 4.9 Angstrom.
C1 Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
RI Jensen, Pernille Rose/AAX-5696-2020; Jensen, Pernille Rose/J-8648-2016
OI Jensen, Pernille Rose/0000-0003-4359-848X; Jensen, Pernille
   Rose/0000-0003-4359-848X; Grzesiek, Stephan/0000-0003-1998-4225
CR Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303
   BIELECKI A, 1989, CHEM PHYS LETT, V155, P341, DOI 10.1016/0009-2614(89)87166-0
   Boisbouvier J, 2003, P NATL ACAD SCI USA, V100, P11333, DOI 10.1073/pnas.1534664100
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   EMSLEY L, 1990, CHEM PHYS LETT, V165, P469, DOI 10.1016/0009-2614(90)87025-M
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   LEE M, 1965, PHYS REV, V140, P1261, DOI 10.1103/PhysRev.140.A1261
   LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022
   Marjanska M, 2002, J MAGN RESON, V158, P52, DOI 10.1016/S1090-7807(02)00059-9
   MEHRING M, 1972, PHYS REV B, V5, P3459, DOI 10.1103/PhysRevB.5.3459
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   TORCHIA DA, 1988, J AM CHEM SOC, V110, P2320, DOI 10.1021/ja00215a063
   Vega AJ, 2004, J MAGN RESON, V170, P22, DOI 10.1016/j.jmr.2004.05.017
   Vinogradov E, 1999, CHEM PHYS LETT, V314, P443, DOI 10.1016/S0009-2614(99)01174-4
   Wu ZR, 2002, J AM CHEM SOC, V124, P9672, DOI 10.1021/ja026845n
NR 21
TC 9
Z9 9
U1 0
U2 13
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD DEC
PY 2004
VL 30
IS 4
BP 443
EP 450
DI 10.1007/s10858-004-5318-0
PG 8
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 885TJ
UT WOS:000226179500006
PM 15630564
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Most, P
   Pleger, ST
   Volkers, M
   Heidt, B
   Boerries, M
   Weichenhan, D
   Loffler, E
   Janssen, PML
   Eckhart, AD
   Martini, J
   Williams, ML
   Katus, HA
   Remppis, A
   Koch, WJ
AF Most, P
   Pleger, ST
   Volkers, M
   Heidt, B
   Boerries, M
   Weichenhan, D
   Loffler, E
   Janssen, PML
   Eckhart, AD
   Martini, J
   Williams, ML
   Katus, HA
   Remppis, A
   Koch, WJ
TI Cardiac adenoviral S100A1 gene delivery rescues failing myocardium
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Article
ID CA2+-BINDING PROTEIN S100A1; CA2+ RELEASE; VENTRICULAR-FUNCTION;
   RYANODINE RECEPTOR; HEART; MUSCLE; EXPRESSION; CALCIUM; BINDING
AB Cardiac-restricted overexpression of the Ca2+-binding protein S100A1 has been shown to lead to increased myocardial contractile performance in vitro and in vivo. Since decreased cardiac expression of S100A1 is a characteristic of heart failure, we tested the hypothesis that S100A1 gene transfer could restore contractile function of failing myocardium. Adenoviral S100A1 gene delivery normalized S100A1 protein expression in a postinfarction rat heart failure model and reversed contractile dysfunction of failing myocardium in vivo and in vitro. S100A1 gene transfer to failing cardiomyocytes restored diminished intracellular Ca2+ transients and sarcoplasmic reticulum (SR) Ca2+ load mechanistically due to increased SR Ca2+ uptake and reduced SR Ca2+ leak. Moreover, S100A1 gene transfer decreased elevated intracellular Na+ concentrations to levels detected in nonfailing cardiomyocytes, reversed reactivated fetal gene expression, and restored energy supply in failing cardiomyocytes. Intracoronary adenovirus-mediated S100A1 gene delivery in vivo to the postinfarcted failing rat heart normalized myocardial contractile function and Ca2+ handling, which provided support in a physiological context for results found in myocytes. Thus, the present study demonstrates that restoration of S100A1 protein levels in failing myocardium by gene transfer may be a novel therapeutic strategy for the treatment of heart failure.
C1 Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA.
   Heidelberg Univ, Dept Internal Med 3, Div Cardiol, Heidelberg, Germany.
   Univ Basel, Biozentrum, Maurice E Mueller Inst, Basel, Switzerland.
   Ohio State Univ, Coll Med & Publ Hlth, Dept Physiol & Cell Biol, Columbus, OH 43210 USA.
RP Most, P (corresponding author), Thomas Jefferson Univ, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA.
EM patrick.most@jefferson.edu; walter.koch@jefferson.edu
RI Janssen, Paul ML/E-3307-2011; Volkers, Mirko/E-7947-2010
OI Volkers, Mirko/0000-0003-2344-1856; Janssen, Paul/0000-0002-9682-3014
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [R01 HL56205, R01 HL059533, R01 HL59533, R01 HL056205]
   Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL056205, R01HL059533, R01HL056205, R01HL059533, R01HL056205,
   R01HL056205, R01HL056205, R01HL056205, R01HL056205, R01HL056205,
   R01HL059533, R01HL056205, R01HL059533, R01HL059533, R01HL059533,
   R01HL056205, R01HL056205, R01HL059533, R01HL059533, R01HL056205] Funding
   Source: NIH RePORTER
CR *AM HEART ASS, 2003, HEARE DIS STROK STAT
   ARRIODUPONT M, 1988, BIOCHIM BIOPHYS ACTA, V934, P264, DOI 10.1016/0005-2728(88)90190-9
   Balaban RS, 2002, J MOL CELL CARDIOL, V34, P1259, DOI 10.1006/jmcc.2002.2082
   Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a
   del Monte F, 1999, CIRCULATION, V100, P2308, DOI 10.1161/01.CIR.100.23.2308
   Despa S, 2002, J PHYSIOL-LONDON, V539, P133, DOI 10.1113/jphysiol.2001.012940
   Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296
   Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002
   HAIMOTO H, 1988, EUR J BIOCHEM, V171, P409, DOI 10.1111/j.1432-1033.1988.tb13805.x
   Hajjar RJ, 1998, P NATL ACAD SCI USA, V95, P5251, DOI 10.1073/pnas.95.9.5251
   Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2
   Marks AR, 2003, J CLIN INVEST, V111, P597, DOI 10.1172/JCI200318067
   Miyamoto MI, 2000, P NATL ACAD SCI USA, V97, P793, DOI 10.1073/pnas.97.2.793
   Most P, 2003, J BIOL CHEM, V278, P48404, DOI 10.1074/jbc.M308587200
   Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200
   Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200
   Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598
   Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200
   Pieske B, 2003, CARDIOVASC RES, V57, P874, DOI 10.1016/S0008-6363(02)00841-6
   Remppis A, 2004, J GENE MED, V6, P387, DOI 10.1002/jgm.513
   Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3
   REMPPIS A, 2002, BASIC RES CARDIOL, V97
   Strock C, 1998, J BIOL CHEM, V273, P15104, DOI 10.1074/jbc.273.24.15104
   Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w
   Tsoporis JN, 2003, MOL CELL BIOCHEM, V242, P27, DOI 10.1023/A:1021148503861
   Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200
   Yano M, 2000, CIRCULATION, V102, P2131, DOI 10.1161/01.CIR.102.17.2131
NR 29
TC 155
Z9 160
U1 0
U2 6
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD DEC
PY 2004
VL 114
IS 11
BP 1550
EP 1563
DI 10.1172/JCI200421454
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 876DK
UT WOS:000225475900007
PM 15578088
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Thuret, S
   Alavian, KN
   Gassmann, M
   Lloyd, CK
   Smits, SM
   Smidt, MP
   Klein, R
   Dyck, RH
   Simon, HH
AF Thuret, S
   Alavian, KN
   Gassmann, M
   Lloyd, CK
   Smits, SM
   Smidt, MP
   Klein, R
   Dyck, RH
   Simon, HH
TI The neuregulin receptor, ErbB4, is not required for normal development
   and adult maintenance of the substantia nigra pars compacta
SO JOURNAL OF NEUROCHEMISTRY
LA English
DT Article
DE caudate putamen; conditional knock-out; locomotor; midbrain;
   neurodegenerative disease; receptor tyrosine kinase
ID MESENCEPHALIC DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; NERVOUS-SYSTEM;
   MICE LACKING; ENGRAILED GENES; BRAIN-STEM; EXPRESSION; MIGRATION;
   FAILURE; LIGAND
AB Degeneration of dopaminergic neurons in the substantia nigra is associated with one of the most prominent human neurological disorders, Parkinson's disease. It is therefore of high interest to identify molecules with trophic effects on this neuronal population. We show here that the neuregulin receptor ErbB4 is differentially expressed in mesencephalic dopaminergic neurons, found in the substantia nigra and in a subregion of the ventral tegmentum but not in the retrorubral field. Early developmental onset and continued expression of ErbB4 into the adult and the presence of two high affinity ligands, neuregulin-1 and betacellulin, in the basal ganglia, suggested that these molecules might participate in the differentiation and/or maintenance of the nigrostriatal system. In order to address this hypothesis, we used a IoxP flanked ErbB4 allele in combination with a nestin-Cre transgene and generated brain-specific ErbB4 null mice. These mutant animals survived into adulthood. The distribution of dopaminergic cell bodies in the midbrain, the expression of numerous genes specific to mesencephalic dopaminergic neurons, and the axonal projection to the basal ganglia all appeared normal. Finally, an assessment of their motor function revealed no behavioral deficits. The apparent lack of any mutant phenotype suggests the presence of a strong compensatory mechanism.
C1 Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neuroanat, Heidelberg, Germany.
   Univ Basel, Biozentrum, Pharmazentrum, Dept Physiol, Basel, Switzerland.
   Univ Calif Davis, Dept Anat Physiol & Cell Biol, Davis, CA 95616 USA.
   Univ Utrecht, Rudolf Magnus Inst Neurosci, Med Ctr, Dept Pharmacol & Anat, Utrecht, Netherlands.
   Max Planck Inst Neurobiol, Martinsried, Germany.
   Univ Calgary, Dept Psychol, Calgary, AB T2N 1N4, Canada.
RP Simon, HH (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Neurosci, Dept Neuroanat, Bergheimer Str 58, Heidelberg, Germany.
EM horst.simon@urz.uni-heidelberg.de
RI Alavian, Kambiz N/D-7720-2012; Alavian, Kambiz/O-2831-2017; Klein,
   Ruediger/C-6147-2008; Thuret, Sandrine/Y-5784-2019
OI Alavian, Kambiz/0000-0002-0653-3057; Klein,
   Ruediger/0000-0002-3109-0163; Thuret, Sandrine/0000-0003-1260-8083;
   Smidt, Marten/0000-0002-8815-747X; Gassmann, Martin/0000-0001-6201-3032;
   Dyck, Richard/0000-0002-3254-8332
CR Alberi L, 2004, DEVELOPMENT, V131, P3229, DOI 10.1242/dev.01128
   ALTMAN J, 1981, J COMP NEUROL, V198, P677, DOI 10.1002/cne.901980409
   Anton ES, 1997, DEVELOPMENT, V124, P3501
   Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550
   Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825
   Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5
   Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4
   Carraway KL, 1997, NATURE, V387, P512, DOI 10.1038/387512a0
   Demyanenko GP, 2001, DEV BRAIN RES, V126, P21, DOI 10.1016/S0165-3806(00)00129-2
   Dixon M, 1999, MOL CELL NEUROSCI, V13, P237, DOI 10.1006/mcne.1999.0749
   Dunbar AJ, 2000, INT J BIOCHEM CELL B, V32, P805, DOI 10.1016/S1357-2725(00)00028-5
   Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268
   FALLON JH, 1994, RAT NERVOUS SYSTEM, P215
   Fernagut PO, 2002, J NEUROSCI METH, V113, P123, DOI 10.1016/S0165-0270(01)00485-X
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Golding JP, 2000, NAT CELL BIOL, V2, P103, DOI 10.1038/35000058
   GOULDING M, 1994, DEVELOPMENT, V120, P957
   HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0
   Hirsch EC, 1997, J NEURAL TRANSM-SUPP, P79
   Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9
   JIMENEZCASTELLANOS J, 1989, EXP BRAIN RES, V74, P227
   JIMENEZCASTELLANOS J, 1989, NEUROSCIENCE, V32, P297, DOI 10.1016/0306-4522(89)90080-8
   JOYNER AL, 1991, SCIENCE, V251, P1239, DOI 10.1126/science.1672471
   Junttila TT, 2000, TRENDS CARDIOVAS MED, V10, P304, DOI 10.1016/S1050-1738(01)00065-2
   Kelly MA, 1998, J NEUROSCI, V18, P3470
   Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833
   Long WW, 2003, DEVELOPMENT, V130, P5257, DOI 10.1242/dev.00715
   Mahanthappa NK, 1996, J NEUROSCI, V16, P4673
   Meyer D, 1997, DEVELOPMENT, V124, P3575
   Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5
   Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3
   Ohyama K, 1998, DEV BRAIN RES, V107, P219, DOI 10.1016/S0165-3806(97)00220-4
   Olanow CW, 1999, ANNU REV NEUROSCI, V22, P123, DOI 10.1146/annurev.neuro.22.1.123
   Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3
   Saueressig H, 1999, DEVELOPMENT, V126, P4201
   Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398
   Sedelis M, 2001, BEHAV BRAIN RES, V125, P109, DOI 10.1016/S0166-4328(01)00309-6
   Simon HH, 2001, J NEUROSCI, V21, P3126, DOI 10.1523/JNEUROSCI.21-09-03126.2001
   Smidt MP, 2000, NAT NEUROSCI, V3, P337
   Smidt MP, 2004, DEVELOPMENT, V131, P1145, DOI 10.1242/dev.01022
   Smidt MP, 1997, P NATL ACAD SCI USA, V94, P13305, DOI 10.1073/pnas.94.24.13305
   Steiner H, 1999, EXP NEUROL, V159, P494, DOI 10.1006/exnr.1999.7163
   Thuret S, 2004, MOL CELL NEUROSCI, V25, P394, DOI 10.1016/j.mcn.2003.11.004
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Wallen A, 2001, MOL CELL NEUROSCI, V18, P649, DOI 10.1006/mcne.2001.1057
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3
   Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5
   Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248
   Zhang DX, 1997, P NATL ACAD SCI USA, V94, P9562, DOI 10.1073/pnas.94.18.9562
NR 50
TC 36
Z9 37
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3042
EI 1471-4159
J9 J NEUROCHEM
JI J. Neurochem.
PD DEC
PY 2004
VL 91
IS 6
BP 1302
EP 1311
DI 10.1111/j.1471-4159.2004.02809.x
PG 10
WC Biochemistry & Molecular Biology; Neurosciences
SC Biochemistry & Molecular Biology; Neurosciences & Neurology
GA 884VX
UT WOS:000226115900006
PM 15584907
OA Bronze
DA 2021-01-25
ER

PT J
AU Anton, ES
   Ghashghaei, HT
   Weber, JL
   McCann, C
   Fischer, TM
   Cheung, ID
   Gassmann, M
   Messing, A
   Klein, R
   Schwab, MH
   Lloyd, KCK
   Lai, C
AF Anton, ES
   Ghashghaei, HT
   Weber, JL
   McCann, C
   Fischer, TM
   Cheung, ID
   Gassmann, M
   Messing, A
   Klein, R
   Schwab, MH
   Lloyd, KCK
   Lai, C
TI Receptor tyrosine kinase ErbB4 modulates neuroblast migration and
   placement in the adult forebrain
SO NATURE NEUROSCIENCE
LA English
DT Article
ID RADIAL GLIA; NEURONAL PRECURSORS; CHAIN-MIGRATION; CELL-MIGRATION; MICE
   LACKING; STEM-CELLS; NEUREGULIN; PROLIFERATION; EXPRESSION; BRAIN
AB Neural progenitor proliferation, differentiation and migration are continually active in the rostral migratory stream of the adult brain. Here, we show that the receptor tyrosine kinase ErbB4 is expressed prominently by the neuroblasts present in the subventricular zone and the rostral migratory stream. The neuregulins (NRG1-NRG3), which have been identified as ErbB4 ligands, are detected either in the stream or in adjacent regions. Mice deficient in ErbB4 expressed under the control of either the nestin or the hGFAP promoter have altered neuroblast chain organization and migration and deficits in the placement and differentiation of olfactory interneurons. These findings suggest that ErbB4 activation helps to regulate the organization of neural chains that form the rostral migratory stream and influences the differentiation of olfactory interneuronal precursors.
C1 Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.
   Univ N Carolina, Sch Med, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA.
   Scripps Res Inst, Dept Neuropharmacol, La Jolla, CA 92037 USA.
   Univ Basel, Biozentrum Pharmazentrum, Dept Physiol, CH-4056 Basel, Switzerland.
   Univ Wisconsin, Waisman Ctr Mental Retardat & Human Dev, Madison, WI 53705 USA.
   Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.
   Max Planck Inst Expt Med, D-37075 Gottingen, Germany.
   Univ Calif Davis, Sch Vet Med, Ctr Comparat Med, Davis, CA 95616 USA.
RP Anton, ES (corresponding author), Univ N Carolina, Sch Med, UNC Neurosci Ctr, Chapel Hill, NC 27599 USA.
EM anton@med.unc.edu
RI Klein, Ruediger/C-6147-2008
OI Klein, Ruediger/0000-0002-3109-0163; Gassmann,
   Martin/0000-0001-6201-3032
FU NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [F32MH071013, F32MH071013] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND
   STROKEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [P30NS045892, R01NS039411, R01NS039411,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, R01NS039411, P30NS045892, P30NS045892, P30NS045892,
   R01NS039411, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, R01NS039411, P30NS045892, P30NS045892,
   P30NS045892, R01NS039411, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, R01NS039411, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, R01NS039411, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, R01NS039411, P30NS045892,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, R01NS039411,
   P30NS045892, P30NS045892, P30NS045892, P30NS045892, P30NS045892] Funding
   Source: NIH RePORTER; NIMH NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [F32 MH071013, F32 MH071013-01A1, F32
   MH071013-02] Funding Source: Medline; NINDS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [P30NS045892, NS39411] Funding Source: Medline
CR Alvarez-Buylla A, 2002, BRAIN RES BULL, V57, P751, DOI 10.1016/S0361-9230(01)00770-5
   Anderson MF, 2002, DEV BRAIN RES, V134, P115
   Anton ES, 1997, DEVELOPMENT, V124, P3501
   Buonanno A, 2001, CURR OPIN NEUROBIOL, V11, P287, DOI 10.1016/S0959-4388(00)00210-5
   Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8
   Carpenter G, 2003, EXP CELL RES, V284, P66, DOI 10.1016/S0014-4827(02)00100-3
   Chazal G, 2000, J NEUROSCI, V20, P1446
   Chiu K, 1996, DEV BRAIN RES, V95, P28, DOI 10.1016/0165-3806(96)00055-7
   Colognato H, 2002, NAT CELL BIOL, V4, P833, DOI 10.1038/ncb865
   CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9
   Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9
   Doetsch F, 1997, J NEUROSCI, V17, P5046
   Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7
   Gage FH, 2002, J NEUROSCI, V22, P612, DOI 10.1523/JNEUROSCI.22-03-00612.2002
   Garratt AN, 2000, BIOESSAYS, V22, P987, DOI 10.1002/1521-1878(200011)22:11<987::AID-BIES5>3.3.CO;2-X
   GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0
   Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010
   Gongidi V, 2004, NEURON, V41, P57, DOI 10.1016/S0896-6273(03)00818-3
   Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9
   GREGG CT, 2001, S SOC EXP BIOL, V53, P1
   Hack I, 2002, NAT NEUROSCI, V5, P939, DOI 10.1038/nn923
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   Jacques TS, 1998, DEVELOPMENT, V125, P3167
   Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476
   Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998
   LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174
   LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Mason HA, 2001, J NEUROSCI, V21, P7654
   Michailov GV, 2004, SCIENCE, V304, P700, DOI 10.1126/science.1095862
   MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9
   Murase S, 2002, J NEUROSCI, V22, P3568
   Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V
   Rio C, 1997, NEURON, V19, P39, DOI 10.1016/S0896-6273(00)80346-3
   Saghatelyan A, 2004, NAT NEUROSCI, V7, P347, DOI 10.1038/nn1211
   Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100
   Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001
   Sibilia M, 1998, EMBO J, V17, P719, DOI 10.1093/emboj/17.3.719
   SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169
   Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734
   Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703
   Tropepe V, 1997, J NEUROSCI, V17, P7850
   WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102
   Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7
   Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073
   Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252
   YEE KT, 2001, ABSTR SOC NEUR
   Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6
   Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008
NR 49
TC 182
Z9 190
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD DEC
PY 2004
VL 7
IS 12
BP 1319
EP 1328
DI 10.1038/nn1345
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 874MG
UT WOS:000225353900012
PM 15543145
DA 2021-01-25
ER

PT J
AU Gatlik-Landwojtowicz, E
   Aanismaa, P
   Seelig, A
AF Gatlik-Landwojtowicz, E
   Aanismaa, P
   Seelig, A
TI The rate of P-glycoprotein activation depends on the metabolic state of
   the cell
SO BIOCHEMISTRY
LA English
DT Article
ID MULTIDRUG-RESISTANCE; INTRACELLULAR PH; ATPASE ACTIVITY;
   ADENOSINE-TRIPHOSPHATASE; GLUCOSE-TRANSPORT; EXTRACELLULAR PH;
   TRANSITION-STATE; CATALYTIC CYCLE; MAMMALIAN-CELLS; CYCLOSPORINE-A
AB P-glycoprotein ATPase activity has been studied almost exclusively by measuring inorganic phosphate release from inside-out cellular vesicles. We have recently proposed a new method based on measurements of the extracellular acidification rate (ECAR) of living cells with a Cytosensor microphysiometer. This method allows for systematic investigation of the various factors influencing P-glycoprotein activation in living cells. Basal metabolic rates or ECARs of different MDR1-transfected cell lines were compared with those of the Mdr1a(-/-)1b(-/-) knockout, MRP1-transfected, and corresponding wild-type cell lines. Basal ECARs of all cells were on the order of 10(7) protons/cell/s, whereby those of genetically modified cells were on average (over all cell lines) slightly lower than those of wild-type cells. The expression level of P-glycoprotein in MDR1-transfected cells had no influence on basal ECARs. Verapamil-induced ECARs were specific for MDR1-transfected cells and increased with the expression level of P-glycoprotein. Moreover, ECARs were dependent on the metabolic state of the cell and were (2.8 +/- 1.2) x 10(6) and (8.0 +/- 1.5) x 10(6) protons/cell/s in glucose-deficient and glucose-fed NIH-MDR-G185 cells, respectively, after verapamil (10 muM) stimulation. The ECARs were practically identical to the rates of lactate extrusion and thus reflect the rates of ATP synthesis via glycolysis. Taking into account the number of P-glycoprotein molecules per cell, the rate of ATP hydrolysis in inside-out vesicles of the same cells was determined as (9.2 +/- 1.5) x 10(6) phosphates/cell/s, in good agreement with the rate of ATP synthesized in glucose-fed cells. The energy required for P-glycoprotein activation relative to the basal metabolic energy was twice as large in glucose-deficient as in glucose-fed cells, suggesting cellular protection by P-glycoprotein even under conditions of starvation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Allen JD, 2000, CANCER RES, V60, P5761
   ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
   ALTENBERG GA, 1993, P NATL ACAD SCI USA, V90, P9735, DOI 10.1073/pnas.90.20.9735
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361
   Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504
   BOSCOBOINIK D, 1990, BRIT J CANCER, V61, P568, DOI 10.1038/bjc.1990.127
   BROXTERMAN HJ, 1989, FEBS LETT, V247, P405, DOI 10.1016/0014-5793(89)81380-8
   CARDARELLI CO, 1995, CANCER RES, V55, P1086
   Chen Y, 2000, J CELL BIOL, V148, P863, DOI 10.1083/jcb.148.5.863
   *CIBA GEIGY, 1979, WISS TAB GEIG, P331
   Decorti G, 2001, BIOCHEM PHARMACOL, V61, P61, DOI 10.1016/S0006-2952(00)00535-9
   Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219
   Evers R, 1996, J CLIN INVEST, V97, P1211, DOI 10.1172/JCI118535
   Eytan GD, 1996, J BIOL CHEM, V271, P12897, DOI 10.1074/jbc.271.22.12897
   Garrigues A, 2002, ANAL BIOCHEM, V305, P106, DOI 10.1006/abio.2002.5650
   Goda K, 1996, J PHOTOCH PHOTOBIO B, V34, P177, DOI 10.1016/1011-1344(95)07282-9
   HAMILTON G, 1993, ANTICANCER RES, V13, P2059
   Hewitt CO, 1999, PROTEIN ENG, V12, P491, DOI 10.1093/protein/12.6.491
   Hoffman MM, 1996, J GEN PHYSIOL, V108, P295, DOI 10.1085/jgp.108.4.295
   Jackson VN, 1996, J BIOL CHEM, V271, P861, DOI 10.1074/jbc.271.2.861
   KEIZER HG, 1989, J NATL CANCER I, V81, P706, DOI 10.1093/jnci/81.9.706
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   KRUPKA RM, 1985, J MEMBRANE BIOL, V83, P71, DOI 10.1007/BF01868739
   Krupka RM, 1999, J MEMBRANE BIOL, V172, P129, DOI 10.1007/s002329900591
   Landwojtowicz E, 2002, BIOCHEMISTRY-US, V41, P8050, DOI 10.1021/bi025720s
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Litman T, 1998, CELL PHYSIOL BIOCHEM, V8, P138, DOI 10.1159/000016277
   Marbeuf-Gueye C, 2000, BIOCHEM PHARMACOL, V60, P1485, DOI 10.1016/S0006-2952(00)00453-6
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   MILLER DL, 1993, BIOPHYS J, V64, P813, DOI 10.1016/S0006-3495(93)81442-5
   OWICKI JC, 1992, BIOSENS BIOELECTRON, V7, P255, DOI 10.1016/0956-5663(92)87004-9
   PARCE JW, 1989, SCIENCE, V246, P243, DOI 10.1126/science.2799384
   PELSTER B, 1997, AM J PHYSIOL-REG I, V273, pR1719
   Porcelli AM, 2002, BBA-MOL CELL RES, V1542, P125, DOI 10.1016/S0167-4889(01)00173-2
   Raggers RJ, 2000, TRAFFIC, V1, P226, DOI 10.1034/j.1600-0854.2000.010305.x
   Ramachandra M, 1998, BIOCHEMISTRY-US, V37, P5010, DOI 10.1021/bi973045u
   Ramachandra M, 1996, MOL BIOL CELL, V7, P1485
   RESTREPO D, 1991, AM J PHYSIOL, V260, pC535
   ROEPE PD, 1992, BIOCHEMISTRY-US, V31, P12555, DOI 10.1021/bi00165a003
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Romsicki Y, 2001, BIOCHEMISTRY-US, V40, P6937, DOI 10.1021/bi0024456
   SARKADI B, 1992, J BIOL CHEM, V267, P4854
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214
   Schmid D, 1999, BIOCHEM PHARMACOL, V58, P1447, DOI 10.1016/S0006-2952(99)00229-4
   SEELIG A, 2004, IN PRESS MINIREV MED
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P189, DOI 10.1046/j.1432-1327.1998.2540189.x
   SHAPIRO AB, 1994, J BIOL CHEM, V269, P3745
   Sharom FJ, 1999, BIOCHEM PHARMACOL, V58, P571, DOI 10.1016/S0006-2952(99)00139-2
   SIMON S, 1994, P NATL ACAD SCI USA, V91, P1128, DOI 10.1073/pnas.91.3.1128
   Stein WD, 1997, PHYSIOL REV, V77, P545
   THIEBAUT F, 1990, J HISTOCHEM CYTOCHEM, V38, P685, DOI 10.1177/38.5.1692055
   TSE CM, 1990, J EXP BIOL, V148, P367
   URBATSCH IL, 1994, BIOCHEMISTRY-US, V33, P7069, DOI 10.1021/bi00189a008
   URBATSCH IL, 2003, J BIOL CHEM, V2, P2
   Venter H, 2003, NATURE, V426, P866, DOI 10.1038/nature02173
   Wiley C, 2002, ANAL BIOCHEM, V304, P139, DOI 10.1006/abio.2002.5613
   Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920
NR 60
TC 21
Z9 22
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD NOV 23
PY 2004
VL 43
IS 46
BP 14840
EP 14851
DI 10.1021/bi048761s
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 871YO
UT WOS:000225172800035
PM 15544355
DA 2021-01-25
ER

EF